{"bottom_cover_set": ["SCN1A", "KCNN3", "SYNE1", "APC", "SCN3A", "MMP9", "GRIK2", "COL12A1", "TP53", "PLXNA4", "FN1", "CACNA1H", "UQCRC2", "PTPRK", "PBRM1", "LAMA3", "TTN", "ACACB", "TNN", "DNAH5", "RBP4", "TGFBR2", "P2RY4", "LAMC3", "ABCC8", "DPYD", "LAMA2", "SPATA5", "FMO2", "DCN", "COL27A1", "FBN2", "DOCK4", "FZD10", "TBXA2R", "KRAS", "MTOR", "NCAM1", "NEFH", "FLT4", "EGLN3", "SPTB", "ATP2A1", "CUBN", "TUBB1", "ATM", "POLA2", "SOX9", "SOX3", "IRF5", "PIK3CA", "OR52D1", "GDNF", "MYH9", "NRBP1", "EXT1", "TBX3", "DST", "F10", "OR5T2", "RXFP3", "SERPIND1", "SP100", "COL5A3", "TNXB", "NEDD4L", "GALNT6", "NEFM", "TNS1", "TBP", "TNRC6A", "RYR1", "ATP6V0E2", "DGKB", "PI4K2B", "ITPR1", "F8", "OR5M8", "B3GALT2", "HAVCR2", "NFATC4", "CTNNA1", "TLN1", "ATP1A3", "FBXW7", "CACNA1I", "TIAM1", "PKD1L1", "HGF", "RALYL", "BAX", "OCA2", "MUC5B", "GALNTL5", "DLGAP2", "FHOD1", "ADCY2", "KCNA1", "IQCA1", "NID1", "COL6A6", "OR5H15", "OR10J5", "OR6P1", "BAIAP2", "WDFY4", "MME", "PAPPA", "CACNA2D3", "DLG2", "MED12L", "MMP16", "CD109", "IQSEC1", "NRXN2", "IVL", "CANT1", "IRS1", "OR2W3", "SCN5A", "EP300", "UNC13C", "PPFIA2", "OR5D18", "PLCB3", "PCLO", "FFAR1", "OR5H1", "MAF", "CCDC129", "RGS20", "PDGFRA", "UNC80", "MYC", "PPP2R2B", "USP42", "CHST2", "PON3", "GCNT2", "CNTN4", "EPHB1", "FASN", "PLCB1", "GNA12", "TFAP2B", "NGFR", "COL11A1", "COL22A1", "KIF1A", "NRG3", "SLIT1", "OR5AS1", "NRXN1", "GRIA4", "CACNA1B", "TF", "IL12RB1", "OR5B21", "A2M", "KCNQ2", "MYH6", "OR2B11", "DLGAP1", "PTPN13", "PRKCB", "SLC18A3", "SPTBN2", "ACTN2", "ACTN4", "CDH23", "FAT1", "NCOA2", "OR4D9", "OR4D5", "VWF", "HS6ST3", "GRIA2", "DOCK1", "EPHA8", "COL9A3", "HK3", "XBP1", "RELN", "CASQ2", "COL6A1", "COL6A5", "MUC16", "OR52K2", "INPP4A", "CNOT1", "DOCK11", "SULT2A1", "IL21R", "PRKD3", "MAP3K11", "FHL5", "FLNB", "RGSL1", "ASAP2", "SRRM1", "KCNK1", "ACOX1", "FLNC", "STAB1", "TRIM29", "MAPK10", "AMFR", "AOC2", "CTNND1", "NPAS3", "TMX3", "NOS1", "COL5A2", "GRIK4", "PYGB", "BRAF", "NLRP4", "GNAO1", "POFUT2", "MAP4K4", "NRG1", "SEC16A", "ADAMTS13", "GRM7", "DGKD", "DNAH3", "ANK2", "ANK3", "LYPLA2", "ABCA3", "SCN8A", "FBN3", "CYP7A1", "PLXNA2", "IFT122", "ETV1", "NRXN3", "DYNC2H1", "NEB", "PDE4DIP", "EPS8", "ADAMTSL4", "SARDH", "SEMA5B", "ASPG", "CTNNB1", "ORAI2", "AP3D1", "EPHX1", "CACNA1A", "CACNA1F", "EPHA2", "CYP4F3", "CCNB3", "AKT1", "OCRL", "GPR156", "TG", "ELMO1", "OR4K17", "KALRN", "ENPEP", "COL28A1", "ROBO1", "TRAF3", "COLEC12", "AKAP13", "TNRC6B", "USP28", "ADAMTS4", "ARHGEF6", "CDH1", "MYO3A", "GRM4", "RNF213", "ALDH4A1", "PDE6C", "SLC1A6", "ABCC3", "RYR3", "RYR2", "GOLGA2", "RAD23A", "COL4A6", "EIF2AK4", "AKAP9", "TAS2R4", "CLTC", "PPP2R5D", "LTBP1", "DGKZ", "PIK3CD", "KCNG2", "ATP12A", "AMPH", "TEK", "IL6", "PGR", "SLC9A1", "AR", "MYOF", "GLI3", "C2CD3", "PLB1", "NLK", "WIPF3", "CP", "PPP1CB", "VWCE", "TAS1R1", "TNPO1", "MOV10L1", "CNGA1", "FBXO21", "BMPR2", "TSPAN7", "PPP2R2C", "IBTK", "SHROOM4", "RGMA", "DPP7", "KCNQ1", "CAPN6", "AVPR1B", "MCHR2", "NR5A2", "SERPINB13", "GREB1L", "DISP1", "MUC17", "BPI", "MANEAL", "CNTN5", "DAGLB", "HEPH", "DMXL1", "NTNG1", "SHANK1", "IGSF11", "VCAM1", "RB1", "TCTN3", "GRIK1", "ZFYVE28", "CR1", "CD1B", "ADAMTS8", "CCR7", "MYL1", "KCNQ5", "LCT", "POU4F2", "NOTCH3", "RBP1", "MYLK", "SP5", "SMAD4", "CATSPERD", "SLC12A2", "AKR1D1", "ITGA1", "ITGA2", "CHST3", "DLGAP3", "SNAP91", "OBSCN", "UNC5C", "EPB41L5", "HAGH", "OR2K2", "AHRR", "ADCY10", "PLA2G2E", "SERPINB1", "USP9X", "RGS2", "NCOA1", "PDE1B", "DOCK7", "PLCL1", "ITGB2", "ABCB1", "HERC1", "LRP2", "CHRNA4", "CHRNA1", "TEX15", "SLCO1A2", "EGR1", "COL6A3", "NFATC1", "DCAF5", "ERCC6", "NPHS1", "CAMK2G", "JAK1", "TLL1", "EPRS", "CXCR3", "FLNA", "CTNNA2", "SMAD1", "PKD2", "LLGL1", "SPTBN5", "APOB", "TRIP6", "EVC2", "IL13RA1", "OR2T10", "KRT14", "ARFGEF1", "KIF4B", "AGRN", "FZD6", "LRRFIP1", "HLA-B", "HLA-A", "SLITRK1", "CEP170", "TICAM1", "DSEL", "KCNH1", "KCNH3", "ACAN", "KCNK10", "TRAPPC6A", "SUCLA2", "OR1L3", "RNF220", "AMPD3", "CD38", "NPR2", "GRM5", "GRM6", "TPO", "SNAI1", "PPP4R4", "SETD2", "COL2A1", "EXOC1", "MALT1", "GREB1", "DCLRE1C", "KCNU1", "LUZP1", "PBX1", "MYO1A", "MPO", "CDK14", "PTK2", "SCNN1G", "COL15A1", "PELP1", "MAD1L1", "KLKB1", "AOX1", "ADAMTS20", "OR4C15", "TUB", "RDH12", "NALCN", "CACNB1", "OR13C5", "NOTUM", "FCGRT", "FGFR4", "FGFR3", "PDE3A", "PLXNB3", "OR4S1", "ASPN", "SSTR4", "MED12", "MUSK", "TRIO", "CACNA1E", "PAX5", "PDE7A", "NCOR2", "NCOR1", "NME1", "OR10A5", "OR2T27", "KCNB1", "CNTNAP2", "OR2B6", "OR4K13", "NDST1", "GFRA1", "NBEA", "PPARGC1A", "CHRNG", "ADAMTS3", "CARD11", "SLC6A3", "ALB", "CRTC1", "TSHR", "COL7A1", "HRH2", "COL4A3", "COL4A2", "LHCGR", "IFT140", "NTRK2", "AKAP7", "ATP6V1B1", "TBK1", "ERBB4", "CAPN12", "LRP12", "NPHP4", "KCNG4", "OR8D1", "ACVR2A", "HCN4", "UBE4B", "RB1CC1", "ESR1", "SCN7A", "CREB3L2", "RASAL3", "MRVI1", "FURIN", "ATP2B3", "ATP2B4", "ORC2", "RGS22", "ST3GAL3", "C3", "PPP2CB", "CHSY3", "THSD7A", "CSF1", "CNTN2", "CNTN6", "IQGAP1", "PCCB", "GPSM1", "GATA3", "LAMA1", "LAMA4", "LAMA5", "F2", "KCND2", "SERPING1", "THBS2", "RNF165", "PELI1", "CREBBP", "OR51E1", "ACTA1", "HLA-DRA", "MYH2", "CADM1", "PIP5K1C", "ARID1A", "USP5", "CPS1", "GALNTL6", "MATN3", "KRT2", "CES5A", "NAGA", "MUC4", "COLEC11", "CES3", "DLK1", "ADD3", "CYP7B1", "CYP27B1", "FUT1", "SRCAP", "ASIC2", "ADCY7", "NRCAM", "CHST15", "SALL4", "HTR2C", "COL5A1", "EFEMP2", "DSCAM", "TRPV6", "FGFR2", "COL4A1", "CATSPER1", "SEMA3A", "KLF5", "ASAH1", "KCNH5", "SCAF8", "DNMT3B", "ANKHD1", "TRPM7", "PDK2", "DOCK9", "EPHA3", "OBSL1", "GRIN3B", "RHOT2", "KCNJ16", "GRP", "TGFB1", "SLC16A8", "MTDH", "CD7", "DTX1", "IGF1R", "PHF2", "HAP1", "ESRRA", "OR51S1", "COL1A2", "LRRK2", "HOXD4", "TCF7L2", "SCN2A", "TFEC", "OPN4", "COL3A1", "SELP", "GLRA1", "CHIT1", "OR2C1", "NRP2", "UCKL1", "PLCG2", "ZNF217", "PAX6", "RANBP3", "TSC2", "NLGN4Y", "MAP1B", "PARP3", "MYH15", "SELL", "B3GAT2", "ZNF429", "MAMLD1", "POLR3E", "CD82", "SERPINB10", "GP6", "GLI2", "PRKACG", "OR6C74", "TYK2", "TNFRSF10A", "PYGL", "TAS2R16", "HSP90B1", "TFRC", "ARHGAP35", "GSTM4", "ADAMTS9", "EPN3", "PLEC", "PDE6A", "COL4A4", "OR2A5", "OAS1", "LDHAL6B", "MTMR6", "GMPR", "TRPA1", "AHCYL2", "MYO5A", "ARSF", "RNF17", "ITGAX", "CFI", "UNC5D", "OR8J3", "RASA2", "RGS3", "HIST1H1A", "UBA6", "GOLGB1", "MSR1", "GRIN3A", "OR2L3", "DMD", "PAX3", "OTUD7A", "MAPK12", "CHRM2", "NPAS4", "NOS3", "CACNA2D1", "ANKRD1", "KCNH7", "UBR5", "TGM2", "LPA", "AMPD1", "MYO18B", "OR51A7", "GAD2", "GYS2", "CDK13", "GNAS", "CPSF3", "RLN2", "GUCY2F", "TRPV5", "ARHGEF10", "ASB15", "DICER1", "OR4K5", "OR2AG1", "UNC13B", "CD163", "CYP2E1", "HTT", "HDC", "MAPRE3", "BCAR3", "AGTR1", "CAPN11", "OAS2", "PTPRG", "PTPRM", "IFIT1", "ITK", "FNTA", "IL31RA", "FYN", "PRKCI", "RANBP2", "GUCY1A2", "PTK2B", "PCCA", "UGT2B4", "LIFR", "SLC25A3", "KIF5A", "CDK1", "FMO5", "COL24A1", "SPTAN1", "PLG", "SLC12A7", "ABCC2", "PDE7B", "IGFALS", "EIF3A", "ADAMTS18", "DEF6", "LRFN4", "ST3GAL4", "DPP4", "KCNJ1", "KCNC4", "ADCY8", "ALDH5A1", "JAK3", "SUPT16H", "MYCT1", "CYP1A2", "TEC", "GABRA5", "CDK5R1", "OPRM1", "ST6GALNAC2", "FSHR", "ATP2B2", "B4GALT6", "CCT6A", "ADAMTSL3", "OR1A1", "TNFRSF13B", "FBN1", "MLXIPL", "TAS2R46", "APOBR", "IRS2", "WNK1", "MED15", "TUBA3C", "TYRO3", "KCNAB2", "PRDM9", "CYP51A1", "FUBP1", "ZFPM1", "COL18A1", "TRIM26", "SYT5", "OR14J1", "OR56A1", "DHTKD1", "HERPUD1", "DIRAS1", "OR6F1", "KCNH8", "ITGAL", "EPB41L1", "EPB41L3", "LAMB2", "ADCY5", "ADCY6", "ADCY9", "RAPGEF3", "NCOA3", "NCOA7", "F13B", "SCRIB", "CTSC", "NR5A1", "NFATC3", "DRD5", "ENTPD2", "UGT2B11", "RARB", "EXOC3L2", "OR2M4", "UBQLN2", "PLCG1", "PREX2", "RGS12", "GRIN1", "ARHGAP22", "PKD1", "APBA1", "APBA2", "PTPRZ1", "TGFB3", "KEL", "STAB2", "HIP1", "NDOR1", "WDFY3", "KCNJ11", "HIF3A", "B2M", "DCC", "C9orf3", "DBT", "AMPD2", "OR51A2", "SDC1", "PCDH7", "DHX30", "CHRNB2", "BEGAIN", "PTGS1", "BMP1", "CYP26A1", "ACAT1", "CPSF6", "SLCO1B1", "TJP2", "NR2C2", "WLS", "GRIA1", "MED13", "CACNA1C", "CACNA1D", "CACNA1S", "KCNJ4", "KCNB2", "PPFIA3", "GAA", "PDIA3", "ITGA10", "MIA3", "FGD2", "CD9", "COL4A5", "SLCO1B3", "GBE1", "PPP2R5A", "MBD6", "PANX2", "PIK3CG", "ESR2", "C6", "RBMS1", "SH3BP2", "MAGI1", "NGEF", "KCNQ3", "PLEKHA7", "GPR32", "NFASC", "VCAN", "LOXL2", "CYP8B1", "CHST5", "GPC5", "OR2M2", "LEO1", "ELANE", "PDGFRB", "IFNG", "GABBR1", "PDLIM5", "PASK", "REG3A", "SH3PXD2A", "CALCR", "TBL1XR1", "ALDH1A3", "HSD3B1", "ITGA8", "ITGAM", "IGF2R", "PRKAR2A", "PAXIP1", "BCL9", "MARK3", "GPC3", "PDHA2", "PIP4K2A", "NCOA6", "DOCK3", "DOCK6", "EPHA6", "USP34", "CCKBR", "MAML1", "LRP1", "PDHX", "COL6A2", "CYP26B1", "HCK", "HTR1B", "GABARAPL1", "TLL2", "RIMS1", "OR10R2", "SLC8A2", "KCNS3", "EFCAB6", "TUBAL3", "NOG", "SMAD2", "IGFBP4", "ARHGAP21", "CAV2", "PLA2G4E", "HCAR3", "F2R", "ALDH6A1", "MMP8", "KIF26A", "ATP6V0D1", "SDHA", "DLG1", "HMGB1", "GRIK3", "HUNK", "BPTF", "PRCP", "WDR26", "ADAMTS14", "ECHS1", "FLT1", "ANK1", "ABCA1", "ATP2A2", "TAS2R13", "C1S", "LONRF1", "WRN", "SHF", "PLK1", "TUBA1B", "CCT4", "ATP1B2", "LILRB5", "CACNA1G", "OR4K2", "ADO", "FBXL4", "SOX7", "COL20A1", "PLCZ1", "SHC1", "PTEN", "LRFN2", "PTGDR2", "ZBTB17", "RHOBTB2", "KCNG1", "EEF2K", "COG4", "SEMA3E", "SEMA3D", "OSGEP", "ITPR3", "FKBP9", "CNGA4", "KDR", "AP1G2", "TRPC3", "MYH7", "SELE", "MATN1", "GIF", "PARP14", "UGT3A1", "LMX1B", "ATAD5", "PPL", "ARSJ", "CHST6", "CASP9", "PTCH1", "PTPN12", "ADSL", "ACTN1", "SIPA1L1", "RTN1", "NOTCH2", "MRPS9", "NLGN4X", "CTSF", "JARID2", "VAV2", "FGA", "CEL", "SCARF1", "DIAPH1", "DVL3", "ADAM9", "KRT1", "OR6C75", "KRT16", "FZD2", "LPAR3", "FADS2", "OR1J1", "SMOX", "SLC8A1", "CACNA2D2", "TAS1R3", "MAPK8IP3", "DGAT1", "PPP1R3D", "VPS37B", "GRIP1", "SETD1B", "GALNT3", "LOXL1", "LOXL4", "APOA5", "CABIN1", "ABCC1", "OSMR", "IL2RG", "GATA4", "KIF2B", "PKN1", "CRIM1", "SSTR2", "SCNN1B", "LILRB2", "CPT1B", "OPRD1", "ALOX15B", "TRPC6", "LAMC2", "PRODH2", "GAK", "MOV10", "CD19", "INPPL1", "LRP4", "LRP5", "ADAMTS7", "VTN", "MED25", "ST14", "INF2", "ANGPT1", "TXLNA", "GSPT1", "KIT", "MTMR1", "RAB8A", "PAK2", "STAT5A", "DOK1", "DOK4", "CYP2B6", "PANK4", "KIF13A", "EFNB3", "MYO5C", "PDE4B", "SLC7A11", "ISYNA1", "HSD17B2", "CARNS1", "TBXAS1", "CYP2S1", "CNGA3", "UGT2B7", "FMO4", "PSAP", "ADAM22", "BCORL1", "ACOX2", "GALNT8", "NCLN", "KCND1", "ADCY1", "USP12", "PROS1", "F2RL3", "PDGFA", "COL25A1", "RPS6KA2", "ADAMTSL1", "TRAM1", "GABBR2", "E2F2", "FARP2", "RHOBTB1", "CMA1", "SLC1A7", "RIMKLB", "OR8B8", "HPR", "OR11G2", "MMP11", "CSNK2A1", "ENTPD4", "LNPEP", "SLC17A7", "AP5B1", "SMPD1", "PLA2G6", "OR2T33", "PLA2G2C", "RASA3", "SCNN1A", "OR52K1", "KIF3C", "POLR3A", "ALDH3B2", "HSPG2", "PRKD2", "KIF6", "CEP350", "HDAC5", "PHKB", "THADA", "AP2A1", "OR5T3", "INSR", "POR", "OR5L2", "PRKG2", "NTSR2", "KANK1", "SLC27A5", "ADAMTS2", "PLOD2", "CEP78", "MMP2", "LCP2", "PIK3R4", "TAS1R2", "NCAM2", "KCNH4", "KCNH6", "FOXO1", "FOXO4", "CASK", "TXK", "KLHL21", "ICAM5", "KAT2A", "ADAMTS15", "ALDH1A2", "ST8SIA2", "RXFP2", "RXRA", "PLXNA1", "OR4P4", "BDNF", "PTGS2", "CHD7", "HLA-DRB1", "MUC20", "HIPK2", "SHB", "BRCA1", "SPP1", "TJP1", "ECHDC1", "GPLD1", "WNK2", "ATP1B4", "PLD2", "GABRA1", "DOCK2", "APEX1", "TNC", "KCNJ3", "KCNJ8", "EP400", "NRAS", "EHD4", "GLUD2", "XDH", "PPARA", "LRRTM4", "CTRC", "JAG2", "GRM1", "SPOCK3", "RAP1GDS1", "LILRA6", "IL4I1", "CRYZ", "CES1", "RLBP1", "POMC", "PTPRF", "FGFRL1", "GUSB", "CYP2F1", "OR7C1", "OR6C4", "LRP10", "AGT", "SCN10A", "SMARCA2", "ARHGAP5", "SNIP1", "CFTR", "MYO6", "MYT1", "OR10K1", "BCKDHA", "WIPF2", "BEST1", "CDC42BPA", "MAGI2", "OR5M9", "SLC25A4", "KIF5C", "SLC2A8", "BGN", "PDE4D", "DAGLA", "GALNT14", "ST8SIA1", "ARID5B", "RPE65", "MUC6", "CNNM1", "GATA1", "GBGT1", "CHST13", "MAML3", "HSD17B6", "RARS", "CPE", "ROR1", "ADAMTS16", "MYO1F", "GRIN2C", "ATP1B3", "PLCH2", "ERBB2", "ACSBG1", "RAD9A", "NRK", "ROBO2", "OR8K5", "MCCC2", "HNF4A", "AP5M1", "ITGA7", "STXBP3", "CYP2D6", "DGAT2", "AKAP1", "DMTF1", "DOK2", "OR10H2", "OR6N2", "OR5I1", "CX3CR1", "CHL1", "MCCC1", "INHBA", "OR2A14", "PTDSS1", "TCEA3", "ATP1A4", "INSL3", "UBXN11", "TAAR5", "SMAD9", "PLA2G4D", "NPW", "TRIB2", "SPHK1", "GFI1", "OR5F1", "AMY1A", "TGIF1", "KCNA5", "TRAPPC5", "ITGAV", "NUP107", "ALPL", "ZFYVE19", "KIDINS220", "PCSK1", "ADCY4", "BPNT1", "BCL6", "SERPINB3", "ANAPC7", "WNT9A", "SKIL", "FLRT1", "SCN1B", "PNMT", "DOCK8", "COL9A1", "IFNB1", "C8B", "LIN7A", "RASGRP2", "ITSN2", "CTBP2", "WDHD1", "SLC32A1", "CAMK2D", "MAP3K10", "PHACTR2", "NET1", "RGS10", "AP2A2", "TFAP2C", "EDNRB", "PKLR", "KCNC3", "KPNA3", "IL1RAP", "FZD7", "PTGDS", "USP20", "GSK3B", "NOS2", "ALDH2", "EPN2", "CACNA2D4", "COL21A1", "PTPN5", "FOXO3", "TTC38", "GGH", "EPS15", "XK", "AFP", "HOXB1", "PRKX", "SOD3", "ATP1A1", "ACOT12", "GRIN2A", "PTK7", "DLL1", "PTGER4", "TRPV1", "NDUFA9", "SLC39A3", "RET", "WASF3", "ASPH", "GABRA6", "CDC42", "MEF2A", "KCNJ2", "MATK", "CTGF", "DUSP16", "SPRY1", "ALOX12", "AKAP11", "ALK", "A1BG", "SRY", "E2F7", "MTNR1B", "LTBP3", "CNDP2", "SIN3A", "RAMP3", "CCR5", "ITPR2", "CNTN1", "ATP4A", "UXS1", "RECQL5", "GTF2IRD1", "CWC27", "OR2T6", "USP8", "FCN3", "SLC25A22", "SUMF1", "FLVCR1", "SYT1", "CSNK1A1L", "TAAR1", "IL18", "DOCK10", "CSF2RB", "APBA3", "GSTP1", "SDC4", "USP15", "PPP2R3A", "GUCY2D", "HOMER3", "NSMAF", "ABCC9", "PIGQ", "TLE1", "SH3BP5", "CYP3A7", "MMP15", "SOAT1", "ITGA3", "CAMKK2", "ALPP", "UGT1A4", "OR5W2", "KREMEN2", "CBR3", "SCIN", "GYS1", "NMNAT2", "WNT8B", "FGFR1", "TERT", "SOX2", "ITGAD", "ACSS1", "LAMB1", "ARID4B", "ABLIM3", "NOTCH4", "ALDH3A1", "CYP4A11", "ITGB4", "RNF123", "ADSSL1", "RASA1", "OR4A15", "HTR1E", "EPS15L1", "SLC6A11", "CALHM1", "PRKD1", "KCNS1", "PHC2", "CYP2C19", "KCNJ12", "TSC1", "DPEP2", "KLC4", "NECAP2", "CPB2", "JMJD7-PLA2G4B", "SNX1", "MED16", "LRRTM1", "ENAH", "ENPP3", "SERPINH1", "MYBL1", "ATP6V1B2", "CDX2", "GNAI3", "AWAT2", "EPHB4", "SERPINB8", "STAT4", "LOXL3", "LOX", "CPA1", "PLA2G3", "GPC1", "PAH", "LYN", "HLA-DOA", "IL3RA", "HTR1A", "OSM", "GATAD2A", "SV2B", "APOA4", "BRD7", "DNAJB11", "CLPB", "SULT2B1", "LSS", "XIAP", "AK7", "PTPN3", "POLR1A", "RGS14", "STK36", "STAT3", "TPM1", "CA9", "MED14", "HSD3B7", "IDH1", "NTRK3", "DNAJC6", "GGT5", "OLA1", "CYP11A1", "PIK3AP1", "SLC2A1", "SCN4A", "ALDH9A1", "BMPR1B", "PLIN4", "TIE1", "ATXN3", "C9", "SLC18A1", "SCNN1D", "GRIK5", "PAPPA2", "SYT12", "ELN", "KCNV1", "CNTNAP1", "A4GNT", "MFAP3", "CYSLTR2", "PTGES2", "NOXRED1", "RIPK1", "MAGEH1", "KCNMA1", "SCAI", "CCT6B", "MYBPC2", "HRH4", "SDC3", "TRPC7", "ITGA4", "ITGA6", "PTCH2", "PPP3CA", "OR7A5", "USP10", "ISLR", "HPSE2", "STAMBP", "NPTN", "CYP2A6", "RHOT1", "PF4", "SPTBN4", "OR9Q1", "TAF3", "OR13A1", "PICK1", "ADAMTS5", "ASIP", "OR5AC2", "LRIG1", "GNB3", "KAT6A", "OR6B2", "ADAMTS17", "ALDH1A1", "CCR10", "ST8SIA4", "SH3GL1", "CYP4A22", "MAP2K2", "ETV5", "TRPC5", "LGI1", "ATF6", "COL8A1", "CPT1A", "PPFIA1", "OR4C3", "IDH2", "MERTK", "RENBP", "NCL", "WNT1", "GNAI2", "NPNT", "PRKCA", "SLC9A3", "TBX5", "FAS", "PASD1", "NR0B1", "TACR2", "OR10H3", "SLC6A13", "SLPI", "ST6GAL2", "DPPA4", "PCDH15", "OSTM1", "OR5K1", "SHC4", "SYT9", "FBXL7", "ADAMTS10", "COL14A1", "TTC27", "CAMKK1", "USP33", "IGF1", "SCN11A", "NMT1", "APP", "PRKG1", "FZD3", "OR52I2", "TSSK1B", "RHOA", "ESD", "OR14I1", "FGF8", "ARHGEF25", "AGFG1", "TRIM45", "MX1", "MOGAT2", "CCT8", "TRPC1", "CYP2A13", "TUBA3E", "AP2M1", "AIFM1", "INSRR", "SLC11A2", "KL", "CYP11B1", "SLC40A1", "FUT2", "NTNG2", "GPC6", "OR4D10", "SRC", "SPI1", "OR52N4", "LIN28A", "AVPR2", "MC4R", "SRMS", "NDUFA13", "LPAR6", "OR6B3", "OR4C13", "PAK1", "PTPN11", "DYNC1I1", "LAMB4", "ITGB1", "POLR3B", "SPTBN1", "OR8H2", "MMP3", "GPC2", "FCGR3A", "GAD1", "ATP1A2", "SPHK2", "TBC1D1", "HIPK1", "MAGED2", "SLC2A14", "OR10A7", "TCF4", "CAPNS2", "ARPC1A", "LMAN1", "EGFR", "CHRND", "GRB2", "FARP1", "PPP1CA", "OR1C1", "ACSL6", "UGT2A3", "GPR50", "ADAM23", "CLIP4", "RTN3", "DPYSL4", "NOTCH1", "EPHA5", "CREB3", "ELK1", "TFB1M", "DNMT3A", "NHLRC2", "ADAM12", "ADAM17", "IBSP", "CTSB", "IL20RA", "JAK2", "OR10J1", "SH2B1", "OR7E24", "OR9Q2", "PLOD1", "GHR", "KCNJ15", "OR51Q1", "PTPN7", "GRK6", "WNT5A", "TAS2R43", "NR1H3", "OR1L4", "HEXB", "OR6Y1", "IRAK2", "PPFIA4", "OR5K3", "OR13F1", "OR11H4", "NTRK1", "OR4N2", "OR6C1", "OR51B5", "OR1N2", "OR1N1", "S1PR2", "PRKCQ", "COG5", "GLI1", "IL7R", "GATA2", "SERPINA1", "THBS1", "OR6N1", "OR2T4", "BCAN", "GBP6", "COX5A", "INPP5F", "MAL", "SUOX", "SFTPD", "AOC3", "FCN2", "FCN1", "PMEPA1", "AK5", "NR1H2", "HSD17B3", "UGT2B15", "ABCG5", "DISP2", "MMP17", "AKR1C4", "UGT1A7", "LRRTM3", "IDO2", "FMO1", "KCNQ4", "B3GNTL1", "CNDP1", "GCDH", "PTPRD", "SETMAR", "HYAL4", "PSMB1", "OR2T35", "ABLIM2", "ALDH1B1", "RUNX3", "TAAR6", "NADSYN1", "NOX1", "PRSS3", "YEATS2", "PIP4K2C", "AP1S3", "CETP", "OPN1LW", "PPP6R1", "IL2RB", "OR6A2", "ARSG", "CCT2", "KDM6A", "GSTM3", "OR6C68", "FOXA1", "CCRL2", "PEMT", "OR1I1", "INHBC", "ENPP1", "OR2Y1", "GMPS", "ORC3", "CLSPN", "SOAT2", "OR10C1", "OR4A5", "ACYP2", "FMO3", "GLP1R", "OR10H5", "HLA-DQB1", "ADAM28", "SEC16B", "MIA2", "TREML2", "GCNT4", "CHIA", "SLC26A7", "WNT5B", "DTNA", "ALOX5", "MPP1", "NEU3", "KLK13", "WDR5", "ATP6V0A4", "B4GALT5", "HLA-E", "TFDP1", "XCR1", "PGM2L1", "CLCF1", "VCL", "TRPV2", "NAPA", "PAX8", "MITF", "ARNT", "SLC2A4", "HSD17B1", "SULT1E1", "ABCC4", "SYN1", "PDYN", "ADAMTS1", "PRKAG1", "PAK4", "KCND3", "DTX3", "LONP1", "ST6GAL1", "SH2B3", "LCMT2", "DVL2", "SLC17A6", "NRIP1", "KCNC2", "NTSR1", "HLA-G", "GH2", "PRKAR1A", "OR10G2", "RASGRF2", "RSPO3", "CYP2U1", "PRKAB1", "AP1M2", "ADK", "GHSR", "ACAA1", "PPP1R3F", "PPP1R16B", "B3GAT1", "AVP", "WNT11", "MCM3", "PTHLH", "PREB", "ARR3", "OR2M3", "OR51V1", "B4GALT2", "BAG4", "PIK3R2", "TCF3", "SGK1", "SSTR5", "MED17", "AKR1C3", "CX3CL1", "RHOQ", "STMN2", "PEX5L", "x", "OR52M1", "SDC2", "DBNL", "WASF1", "ADCYAP1", "SCO2", "PRKCG", "ADCY3", "RAB5A", "MAP3K12", "KRT19", "IHH", "AZU1", "SSH1", "SMURF1", "GBA", "SLC3A2", "TRPV4", "STRA6", "OR13D1", "REN", "ROCK1", "MYLK3", "RPAP3", "UGT1A5", "DGKI", "C2", "LTB", "CYP46A1", "ST3GAL5", "DOLK", "LGALS9C", "PDCD1LG2", "INPP5D", "MAP3K7", "TRIM62", "FBP1", "SDSL", "OR4D11", "KCNMB2", "ATP6V1D", "DGKH", "SMARCC1", "GSTA4", "MADD", "SLA2", "KRT8", "PIK3R5", "ZAP70", "ACVR1B", "JAG1", "LRPPRC", "CES2", "GGT6", "ZIC3", "IL1R2", "TBC1D7", "GCG", "GPX5", "CRMP1", "OR6C70", "GNG4", "VAMP3", "PCOLCE", "OR2L5", "RCAN1", "AKR7A3", "IKBKB", "OR5AN1", "IMPAD1", "OR4A16", "PLA2G4A", "OR8H1", "FZD4", "EGLN1", "ANPEP", "CD22", "MAP2K6", "NMU", "ADH5", "HIF1A", "GNAT3", "CEPT1", "FABP6", "HADHB", "GGCT", "ZRANB2", "PAK3", "OPN3", "RASGRP1", "GPCPD1", "CFHR3", "KCNK2", "RAB3C", "C5", "STK40", "GJD2", "OR10AG1", "GPR132", "SOS1", "NPY2R", "SMAD3", "ANXA1", "UBL7", "RHEB", "TRIM39", "MAP3K15", "NXF3", "TUBGCP2", "SLA", "IL6ST", "RPS6KA4", "ADH1B", "OR2J3", "OR8I2", "RGS4", "ARF5", "GPX7", "IDS", "PON2", "MC3R", "FGF12", "SPRED1", "CDC37", "RGS6", "NFKB2", "PSMD2", "STK11", "THBS4", "KLRD1", "GGT7", "RNF25", "GPR84", "KLHDC3", "FGF17", "CAP1", "PARD6G", "OR1L8", "EIF4G1", "CD79A", "MAPK4", "SLC1A2", "MGP", "OR2AK2", "UFL1", "PRKACB", "CTPS2", "RAF1", "ITPKA", "RXRG", "ATP6V0C", "NR1H4", "ABI2", "PRSS1", "EDNRA", "AKT3", "GPC4", "ITGA5", "RPS6KB1", "ADAM2", "AKR1B10", "MMP10", "OR8K1", "CCNB1", "HP", "GUCA1A", "MTMR14", "CCKAR", "SEPHS1", "ACSL3", "GNRH1", "SERPINA3", "PDE8A", "CLEC7A", "TESK2", "CREB3L3", "OR4K1", "UBA52", "RAC3", "PEG10", "S1PR1", "DEFB113", "TECR", "G6PD", "CYP2C8", "PCOLCE2", "MKLN1", "TRAPPC6B", "OR4F15", "OR2Z1", "OR10G9", "HNRNPH1", "GPT2", "APOOL", "ITGB5", "KLF4", "OR51T1", "OR52B2", "TRIM33", "TCP1", "OR51B4", "GOT2", "TOM1L2", "CYP3A5", "CLCN7", "EZR", "RALB", "OR1D5", "CD151", "ELOVL2", "DNTT", "CDK8", "HMGB2", "PDXK", "GDA", "CDC73", "CALN1", "XRCC3", "HSPA1L", "ATP4B", "ETS1", "GABRR2", "SLC16A3", "KLB", "DPYS", "TAS2R3", "MASP2", "UTP3", "UQCR10", "APLNR", "POLR3GL", "DOK6", "CLEC5A", "OR51F2", "PNLIP", "IL22", "OR8B3", "OR1M1", "PTPRA", "KCNIP4", "OR10A3", "HEY1", "TFDP2", "CBS", "AK3", "VPS37D", "OR1A2", "PDE1C", "OPHN1", "GCSH", "STIM2", "SLC7A7", "MAPT", "HBP1", "CAPZB", "MED1", "CAPNS1", "SUCLG1", "NPBWR2", "VIP", "TAAR8", "ARNTL", "SORT1", "F11", "MAX", "SDF4", "ARSI", "CYP26C1", "CAPN10", "ASB7", "CACNB3", "DECR1", "RELT", "CGN", "IFNA2", "NSF", "COASY", "BBOX1", "RPS6KA3", "PIK3CB", "NFATC2", "RASGRP3", "FBXL5", "LIPE", "TXNRD1", "PLS3", "PSMD3", "AGER", "FBXO4", "OR5C1", "GZMH", "MAPKBP1", "PTGES3", "WNT3A", "PTGIS", "CACNG7", "PFKFB4", "FANCG", "GNB2", "COLEC10", "OR6T1", "TAS2R30", "OR4D6", "SAR1A", "OR10V1", "GCLC", "NCAN", "CST7", "SPATA2", "OR1S2", "MED27", "MAPKAP1", "CXCL14", "PAPSS1", "SUMF2", "SOX4", "ASNS", "HADH", "CSNK1G1", "RNF207", "CCT7", "HSD17B8", "HCN2", "CLIC2", "LIN28B", "MSN", "LAP3", "IKZF3", "ADH1A", "PIK3R3", "DTWD2", "CTSZ", "OR1E2", "MMRN1", "CYP2C18", "DPEP1", "LIF", "FGF3", "AMBP", "GATA6", "KLRG1", "NR4A1", "RAC2", "APCS", "POLR2G", "TNNC2", "STX4", "PTP4A1", "ELOVL3", "OR52L1", "RDH5", "P4HA2", "VBP1", "ABAT", "DBH", "PCYOX1L", "ADRB2", "CPSF4", "GSN", "OR2W1", "PPARG", "OR11L1", "CBL", "HSPA4", "FAAH", "FTL", "IRF4", "CDC37L1", "PSMA1", "KLK6", "NPPA", "FGF14", "STAT2", "CYB5R1", "MMP1", "BLNK", "NME4", "LRFN1", "COX11", "RGS8", "PTGES", "RDH14", "KIF22"], "top_cover_set": [["TCGA.A6.2671.01", "Extracellular matrix organization"], ["TCGA.A6.2671.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.2671.01", "Integration of energy metabolism"], ["TCGA.A6.2671.01", "Regulation of insulin secretion"], ["TCGA.A6.2671.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.A6.2671.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.2671.01", "Glucuronidation"], ["TCGA.A6.2671.01", "Collagen formation"], ["TCGA.A6.2671.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.2671.01", "G alpha (z) signalling events"], ["TCGA.A6.2671.01", "Signal amplification"], ["TCGA.A6.2671.01", "G alpha (s) signalling events"], ["TCGA.A6.2671.01", "Neuronal System"], ["TCGA.A6.2671.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.2671.01", "Glucagon-type ligand receptors"], ["TCGA.A6.2671.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.2671.01", "GABA receptor activation"], ["TCGA.A6.2675.01", "Extracellular matrix organization"], ["TCGA.A6.2675.01", "Collagen formation"], ["TCGA.A6.2675.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.2675.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.2675.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.2675.01", "Collagen chain trimerization"], ["TCGA.A6.2675.01", "Ethanol oxidation"], ["TCGA.A6.2675.01", "Degradation of the extracellular matrix"], ["TCGA.A6.2675.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.A6.2675.01", "RA biosynthesis pathway"], ["TCGA.A6.2675.01", "Scavenging by Class A Receptors"], ["TCGA.A6.4105.01", "Extracellular matrix organization"], ["TCGA.A6.4105.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.4105.01", "Neuronal System"], ["TCGA.A6.4105.01", "Drug ADME"], ["TCGA.A6.4105.01", "Transmission across Chemical Synapses"], ["TCGA.A6.4105.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.4105.01", "Degradation of the extracellular matrix"], ["TCGA.A6.4105.01", "Biological oxidations"], ["TCGA.A6.4105.01", "Collagen formation"], ["TCGA.A6.4105.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.4105.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.4105.01", "FGFR4 ligand binding and activation"], ["TCGA.A6.4105.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.4105.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.4105.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.4105.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.4105.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.A6.4105.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.4105.01", "Metabolism"], ["TCGA.A6.4105.01", "Glucuronidation"], ["TCGA.A6.4105.01", "PI-3K cascade:FGFR4"], ["TCGA.A6.4105.01", "Transcription of E2F targets under negative control by DREAM complex"], ["TCGA.A6.4105.01", "FGFR2 ligand binding and activation"], ["TCGA.A6.4105.01", "APAP ADME"], ["TCGA.A6.4105.01", "FGFR2c ligand binding and activation"], ["TCGA.A6.4105.01", "Cardiac conduction"], ["TCGA.A6.4105.01", "SHC-mediated cascade:FGFR4"], ["TCGA.A6.4105.01", "GABA receptor activation"], ["TCGA.A6.4105.01", "GPCR ligand binding"], ["TCGA.A6.4105.01", "NCAM1 interactions"], ["TCGA.A6.4105.01", "FRS-mediated FGFR4 signaling"], ["TCGA.A6.5656.01", "Signaling by GPCR"], ["TCGA.A6.5656.01", "GPCR downstream signalling"], ["TCGA.A6.5656.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.A6.5656.01", "GPCR ligand binding"], ["TCGA.A6.5656.01", "G alpha (i) signalling events"], ["TCGA.A6.5656.01", "Signaling Pathways"], ["TCGA.A6.5656.01", "Generation of second messenger molecules"], ["TCGA.A6.5656.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.5656.01", "Peptide ligand-binding receptors"], ["TCGA.A6.5656.01", "Potassium Channels"], ["TCGA.A6.5656.01", "G alpha (s) signalling events"], ["TCGA.A6.5656.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.A6.5656.01", "Biological oxidations"], ["TCGA.A6.5656.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.A6.5656.01", "Blood group systems biosynthesis"], ["TCGA.A6.5656.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.A6.5656.01", "Leishmania parasite growth and survival"], ["TCGA.A6.5656.01", "PD-1 signaling"], ["TCGA.A6.5656.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.A6.5656.01", "Chemokine receptors bind chemokines"], ["TCGA.A6.5656.01", "Immune System"], ["TCGA.A6.5656.01", "Neuronal System"], ["TCGA.A6.5656.01", "Leishmania infection"], ["TCGA.A6.5656.01", "Parasitic Infection Pathways"], ["TCGA.A6.5656.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.A6.5656.01", "Lewis blood group biosynthesis"], ["TCGA.A6.5656.01", "Extracellular matrix organization"], ["TCGA.A6.5656.01", "G alpha (q) signalling events"], ["TCGA.A6.5656.01", "RA biosynthesis pathway"], ["TCGA.A6.5656.01", "Signal amplification"], ["TCGA.A6.5656.01", "Costimulation by the CD28 family"], ["TCGA.A6.5656.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.5656.01", "Molecules associated with elastic fibres"], ["TCGA.A6.5656.01", "Glucuronidation"], ["TCGA.A6.5656.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5656.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.5656.01", "Regulation of Complement cascade"], ["TCGA.A6.5656.01", "Complement cascade"], ["TCGA.A6.5656.01", "Inwardly rectifying K+ channels"], ["TCGA.A6.5656.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.A6.5656.01", "Insulin processing"], ["TCGA.A6.5656.01", "Interleukin-10 signaling"], ["TCGA.A6.5656.01", "G-protein beta:gamma signalling"], ["TCGA.A6.5656.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.A6.5656.01", "Peptide hormone metabolism"], ["TCGA.A6.5656.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.A6.5656.01", "Regulation of insulin secretion"], ["TCGA.A6.5656.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.5656.01", "CD22 mediated BCR regulation"], ["TCGA.A6.5656.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.A6.5656.01", "Cardiac conduction"], ["TCGA.A6.5656.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5656.01", "Regulation of FZD by ubiquitination"], ["TCGA.A6.5656.01", "Diseases of Immune System"], ["TCGA.A6.5656.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.A6.5656.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.A6.5656.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.A6.5656.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5656.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5656.01", "Activation of G protein gated Potassium channels"], ["TCGA.A6.5656.01", "G protein gated Potassium channels"], ["TCGA.A6.5656.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.5656.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.A6.5656.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.A6.5656.01", "Cell surface interactions at the vascular wall"], ["TCGA.A6.5656.01", "Transmission across Chemical Synapses"], ["TCGA.A6.5656.01", "Defective B3GALTL causes PpS"], ["TCGA.A6.5656.01", "DAP12 signaling"], ["TCGA.A6.5656.01", "Sialic acid metabolism"], ["TCGA.A6.5656.01", "G-protein activation"], ["TCGA.A6.5656.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.A6.5656.01", "TNFs bind their physiological receptors"], ["TCGA.A6.5656.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.5656.01", "Ethanol oxidation"], ["TCGA.A6.5656.01", "G beta:gamma signalling through CDC42"], ["TCGA.A6.5656.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.5656.01", "Platelet activation, signaling and aggregation"], ["TCGA.A6.5656.01", "Glycosaminoglycan metabolism"], ["TCGA.A6.5656.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.A6.5656.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.A6.5656.01", "Presynaptic function of Kainate receptors"], ["TCGA.A6.5656.01", "O-linked glycosylation"], ["TCGA.A6.5656.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5656.01", "Defensins"], ["TCGA.A6.5656.01", "Heme degradation"], ["TCGA.A6.5656.01", "Formation of axial mesoderm"], ["TCGA.A6.5656.01", "DAP12 interactions"], ["TCGA.A6.5657.01", "Drug ADME"], ["TCGA.A6.5657.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5657.01", "Biological oxidations"], ["TCGA.A6.5657.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5657.01", "Collagen formation"], ["TCGA.A6.5657.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.5657.01", "Collagen chain trimerization"], ["TCGA.A6.5657.01", "Extracellular matrix organization"], ["TCGA.A6.5657.01", "Ethanol oxidation"], ["TCGA.A6.5657.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.5657.01", "Glucuronidation"], ["TCGA.A6.5657.01", "APAP ADME"], ["TCGA.A6.5657.01", "Metabolism"], ["TCGA.A6.5657.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.5657.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.5657.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5657.01", "Defective GALNT12 causes CRCS1"], ["TCGA.A6.5659.01", "Neuronal System"], ["TCGA.A6.5659.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.A6.5659.01", "Potassium Channels"], ["TCGA.A6.5659.01", "G alpha (i) signalling events"], ["TCGA.A6.5659.01", "Drug ADME"], ["TCGA.A6.5659.01", "GPCR downstream signalling"], ["TCGA.A6.5659.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5659.01", "APAP ADME"], ["TCGA.A6.5659.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.5659.01", "Regulation of insulin secretion"], ["TCGA.A6.5659.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5659.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.5659.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.A6.5659.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.A6.5659.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.A6.5659.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5659.01", "Neurexins and neuroligins"], ["TCGA.A6.5659.01", "Signaling by GPCR"], ["TCGA.A6.5659.01", "G-protein beta:gamma signalling"], ["TCGA.A6.5659.01", "Sensory processing of sound"], ["TCGA.A6.5659.01", "Cardiac conduction"], ["TCGA.A6.5659.01", "Transmission across Chemical Synapses"], ["TCGA.A6.5659.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.A6.5659.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.5659.01", "Ethanol oxidation"], ["TCGA.A6.5659.01", "Integration of energy metabolism"], ["TCGA.A6.5659.01", "Presynaptic function of Kainate receptors"], ["TCGA.A6.5659.01", "Signaling Pathways"], ["TCGA.A6.5659.01", "Diseases of Immune System"], ["TCGA.A6.5659.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.A6.5659.01", "Extracellular matrix organization"], ["TCGA.A6.5659.01", "G alpha (s) signalling events"], ["TCGA.A6.5659.01", "Inwardly rectifying K+ channels"], ["TCGA.A6.5659.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5659.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.A6.5659.01", "Activation of G protein gated Potassium channels"], ["TCGA.A6.5659.01", "G protein gated Potassium channels"], ["TCGA.A6.5659.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.A6.5659.01", "Heme degradation"], ["TCGA.A6.5659.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.A6.5659.01", "Blood group systems biosynthesis"], ["TCGA.A6.5659.01", "Platelet homeostasis"], ["TCGA.A6.5659.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.A6.5659.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5659.01", "RA biosynthesis pathway"], ["TCGA.A6.5659.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.5659.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.5660.01", "Neuronal System"], ["TCGA.A6.5660.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.A6.5660.01", "GPCR downstream signalling"], ["TCGA.A6.5660.01", "Potassium Channels"], ["TCGA.A6.5660.01", "Signaling by GPCR"], ["TCGA.A6.5660.01", "G alpha (s) signalling events"], ["TCGA.A6.5660.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.5660.01", "Transmission across Chemical Synapses"], ["TCGA.A6.5660.01", "G alpha (i) signalling events"], ["TCGA.A6.5660.01", "Biological oxidations"], ["TCGA.A6.5660.01", "GPCR ligand binding"], ["TCGA.A6.5660.01", "Signaling Pathways"], ["TCGA.A6.5660.01", "Voltage gated Potassium channels"], ["TCGA.A6.5660.01", "Extracellular matrix organization"], ["TCGA.A6.5660.01", "Cardiac conduction"], ["TCGA.A6.5660.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.A6.5660.01", "Leishmania parasite growth and survival"], ["TCGA.A6.5660.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.5660.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.5660.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.5660.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.5660.01", "NCAM1 interactions"], ["TCGA.A6.5660.01", "Drug ADME"], ["TCGA.A6.5660.01", "Peptide hormone metabolism"], ["TCGA.A6.5660.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.5660.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5660.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5660.01", "Regulation of insulin secretion"], ["TCGA.A6.5660.01", "Regulation of FZD by ubiquitination"], ["TCGA.A6.5660.01", "Platelet homeostasis"], ["TCGA.A6.5660.01", "Peptide ligand-binding receptors"], ["TCGA.A6.5660.01", "NCAM signaling for neurite out-growth"], ["TCGA.A6.5660.01", "Collagen chain trimerization"], ["TCGA.A6.5660.01", "Protein-protein interactions at synapses"], ["TCGA.A6.5660.01", "Synaptic adhesion-like molecules"], ["TCGA.A6.5660.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.5661.01", "Neuronal System"], ["TCGA.A6.5661.01", "GPCR ligand binding"], ["TCGA.A6.5661.01", "Extracellular matrix organization"], ["TCGA.A6.5661.01", "Transmission across Chemical Synapses"], ["TCGA.A6.5661.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.5661.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.5661.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.5661.01", "Signaling by GPCR"], ["TCGA.A6.5661.01", "L1CAM interactions"], ["TCGA.A6.5661.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.5661.01", "Protein-protein interactions at synapses"], ["TCGA.A6.5661.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5661.01", "Degradation of the extracellular matrix"], ["TCGA.A6.5661.01", "Biological oxidations"], ["TCGA.A6.5661.01", "Chemokine receptors bind chemokines"], ["TCGA.A6.5661.01", "GPCR downstream signalling"], ["TCGA.A6.5661.01", "Cardiac conduction"], ["TCGA.A6.5661.01", "G alpha (s) signalling events"], ["TCGA.A6.5661.01", "Peptide ligand-binding receptors"], ["TCGA.A6.5661.01", "Complement cascade"], ["TCGA.A6.5661.01", "Potassium Channels"], ["TCGA.A6.5661.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.A6.5661.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5661.01", "Muscle contraction"], ["TCGA.A6.5661.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.5661.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.5661.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.5661.01", "Synaptic adhesion-like molecules"], ["TCGA.A6.5661.01", "Metabolism of water-soluble vitamins and cofactors"], ["TCGA.A6.5661.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.5661.01", "Neurexins and neuroligins"], ["TCGA.A6.5661.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.A6.5661.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.A6.5661.01", "Glycosaminoglycan metabolism"], ["TCGA.A6.5661.01", "NCAM1 interactions"], ["TCGA.A6.5661.01", "Arachidonic acid metabolism"], ["TCGA.A6.5661.01", "G alpha (i) signalling events"], ["TCGA.A6.5661.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5661.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5661.01", "Diseases of metabolism"], ["TCGA.A6.5661.01", "Diseases of glycosylation"], ["TCGA.A6.5661.01", "Regulation of Complement cascade"], ["TCGA.A6.5661.01", "Interleukin-10 signaling"], ["TCGA.A6.5661.01", "Axon guidance"], ["TCGA.A6.5661.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5661.01", "Defective B3GALTL causes PpS"], ["TCGA.A6.5661.01", "GABA receptor activation"], ["TCGA.A6.5661.01", "Nervous system development"], ["TCGA.A6.5661.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.A6.5661.01", "Molecules associated with elastic fibres"], ["TCGA.A6.5661.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.A6.5661.01", "Collagen chain trimerization"], ["TCGA.A6.5661.01", "NCAM signaling for neurite out-growth"], ["TCGA.A6.5661.01", "Activation of NMDA receptors and postsynaptic events"], ["TCGA.A6.5662.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.A6.5662.01", "Biological oxidations"], ["TCGA.A6.5662.01", "Signaling by GPCR"], ["TCGA.A6.5662.01", "GPCR downstream signalling"], ["TCGA.A6.5662.01", "Neuronal System"], ["TCGA.A6.5662.01", "Generation of second messenger molecules"], ["TCGA.A6.5662.01", "Signaling Pathways"], ["TCGA.A6.5662.01", "Glucuronidation"], ["TCGA.A6.5662.01", "G alpha (i) signalling events"], ["TCGA.A6.5662.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5662.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.A6.5662.01", "GPCR ligand binding"], ["TCGA.A6.5662.01", "Transmission across Chemical Synapses"], ["TCGA.A6.5662.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.5662.01", "Regulation of insulin secretion"], ["TCGA.A6.5662.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.A6.5662.01", "Immune System"], ["TCGA.A6.5662.01", "Phase I - Functionalization of compounds"], ["TCGA.A6.5662.01", "G alpha (s) signalling events"], ["TCGA.A6.5662.01", "TNFs bind their physiological receptors"], ["TCGA.A6.5662.01", "Drug ADME"], ["TCGA.A6.5662.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.5662.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.A6.5662.01", "Peptide ligand-binding receptors"], ["TCGA.A6.5662.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.A6.5662.01", "NCAM1 interactions"], ["TCGA.A6.5662.01", "Integration of energy metabolism"], ["TCGA.A6.5662.01", "Chemokine receptors bind chemokines"], ["TCGA.A6.5662.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.A6.5662.01", "Leishmania parasite growth and survival"], ["TCGA.A6.5662.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.A6.5662.01", "Aspirin ADME"], ["TCGA.A6.5662.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.5662.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.A6.5662.01", "Ethanol oxidation"], ["TCGA.A6.5662.01", "G alpha (z) signalling events"], ["TCGA.A6.5662.01", "Leishmania infection"], ["TCGA.A6.5662.01", "Parasitic Infection Pathways"], ["TCGA.A6.5662.01", "G-protein beta:gamma signalling"], ["TCGA.A6.5662.01", "G-protein mediated events"], ["TCGA.A6.5662.01", "PD-1 signaling"], ["TCGA.A6.5662.01", "PLC beta mediated events"], ["TCGA.A6.5662.01", "Signal amplification"], ["TCGA.A6.5662.01", "NCAM signaling for neurite out-growth"], ["TCGA.A6.5662.01", "Complement cascade"], ["TCGA.A6.5662.01", "Regulation of Complement cascade"], ["TCGA.A6.5662.01", "Potassium Channels"], ["TCGA.A6.5662.01", "Opioid Signalling"], ["TCGA.A6.5662.01", "Activation of the phototransduction cascade"], ["TCGA.A6.5662.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.5662.01", "Inflammasomes"], ["TCGA.A6.5662.01", "GABA receptor activation"], ["TCGA.A6.5662.01", "O-linked glycosylation"], ["TCGA.A6.5662.01", "DAG and IP3 signaling"], ["TCGA.A6.5662.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.A6.5662.01", "GABA B receptor activation"], ["TCGA.A6.5662.01", "Activation of GABAB receptors"], ["TCGA.A6.5662.01", "Calmodulin induced events"], ["TCGA.A6.5662.01", "CaM pathway"], ["TCGA.A6.5662.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.A6.5662.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.A6.5662.01", "Extracellular matrix organization"], ["TCGA.A6.5662.01", "Signaling by Retinoic Acid"], ["TCGA.A6.5662.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5662.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.5662.01", "Transport of small molecules"], ["TCGA.A6.5662.01", "Ca-dependent events"], ["TCGA.A6.5662.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.A6.5662.01", "G alpha (q) signalling events"], ["TCGA.A6.5662.01", "Presynaptic function of Kainate receptors"], ["TCGA.A6.5662.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.A6.5662.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.5662.01", "Costimulation by the CD28 family"], ["TCGA.A6.5662.01", "Trafficking of AMPA receptors"], ["TCGA.A6.5662.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.A6.5662.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.5662.01", "Stimuli-sensing channels"], ["TCGA.A6.5662.01", "Defensins"], ["TCGA.A6.5662.01", "Heme degradation"], ["TCGA.A6.5662.01", "Scavenging of heme from plasma"], ["TCGA.A6.5662.01", "Free fatty acids regulate insulin secretion"], ["TCGA.A6.5662.01", "TP53 Regulates Transcription of Caspase Activators and Caspases"], ["TCGA.A6.5662.01", "Formation of axial mesoderm"], ["TCGA.A6.5662.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5662.01", "Estrogen-dependent nuclear events downstream of ESR-membrane signaling"], ["TCGA.A6.5662.01", "Interleukin-10 signaling"], ["TCGA.A6.5662.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.A6.5662.01", "Activation of G protein gated Potassium channels"], ["TCGA.A6.5662.01", "G protein gated Potassium channels"], ["TCGA.A6.5662.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.A6.5662.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.A6.5662.01", "Inwardly rectifying K+ channels"], ["TCGA.A6.5662.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.A6.5662.01", "Collagen chain trimerization"], ["TCGA.A6.5662.01", "Peptide hormone metabolism"], ["TCGA.A6.5662.01", "Platelet activation, signaling and aggregation"], ["TCGA.A6.5662.01", "Defective GALNT3 causes HFTC"], ["TCGA.A6.5662.01", "Defective GALNT12 causes CRCS1"], ["TCGA.A6.5662.01", "Interleukin-35 Signalling"], ["TCGA.A6.5662.01", "RA biosynthesis pathway"], ["TCGA.A6.5662.01", "Synaptic adhesion-like molecules"], ["TCGA.A6.5662.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5662.01", "Binding and entry of HIV virion"], ["TCGA.A6.5662.01", "GPER1 signaling"], ["TCGA.A6.5662.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.A6.5662.01", "Extra-nuclear estrogen signaling"], ["TCGA.A6.5662.01", "G-protein activation"], ["TCGA.A6.5662.01", "Thromboxane signalling through TP receptor"], ["TCGA.A6.5662.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.5662.01", "Metabolism"], ["TCGA.A6.5664.01", "Extracellular matrix organization"], ["TCGA.A6.5664.01", "Glucuronidation"], ["TCGA.A6.5664.01", "Collagen formation"], ["TCGA.A6.5664.01", "Collagen chain trimerization"], ["TCGA.A6.5664.01", "FGFR4 ligand binding and activation"], ["TCGA.A6.5664.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.5664.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.A6.5664.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.5664.01", "Biological oxidations"], ["TCGA.A6.5664.01", "IRS-related events triggered by IGF1R"], ["TCGA.A6.5664.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.A6.5664.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.A6.5664.01", "IGF1R signaling cascade"], ["TCGA.A6.5664.01", "PI-3K cascade:FGFR4"], ["TCGA.A6.5664.01", "Formation of axial mesoderm"], ["TCGA.A6.5664.01", "SHC-mediated cascade:FGFR4"], ["TCGA.A6.5664.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5664.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5664.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.A6.5664.01", "FRS-mediated FGFR4 signaling"], ["TCGA.A6.5664.01", "IRS-mediated signalling"], ["TCGA.A6.5664.01", "FGFR2c ligand binding and activation"], ["TCGA.A6.5664.01", "Peptide hormone biosynthesis"], ["TCGA.A6.5664.01", "Post-translational protein phosphorylation"], ["TCGA.A6.5664.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.A6.5664.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.A6.5664.01", "Drug ADME"], ["TCGA.A6.5664.01", "Downstream signaling of activated FGFR4"], ["TCGA.A6.5664.01", "Insulin receptor signalling cascade"], ["TCGA.A6.5664.01", "Primitive streak formation"], ["TCGA.A6.5665.01", "Neuronal System"], ["TCGA.A6.5665.01", "Transmission across Chemical Synapses"], ["TCGA.A6.5665.01", "Signaling by GPCR"], ["TCGA.A6.5665.01", "GPCR ligand binding"], ["TCGA.A6.5665.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.5665.01", "Biological oxidations"], ["TCGA.A6.5665.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.5665.01", "Extracellular matrix organization"], ["TCGA.A6.5665.01", "GPCR downstream signalling"], ["TCGA.A6.5665.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.5665.01", "Potassium Channels"], ["TCGA.A6.5665.01", "Cardiac conduction"], ["TCGA.A6.5665.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.5665.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.A6.5665.01", "L1CAM interactions"], ["TCGA.A6.5665.01", "Protein-protein interactions at synapses"], ["TCGA.A6.5665.01", "G alpha (s) signalling events"], ["TCGA.A6.5665.01", "Signaling Pathways"], ["TCGA.A6.5665.01", "G alpha (i) signalling events"], ["TCGA.A6.5665.01", "Muscle contraction"], ["TCGA.A6.5665.01", "Phase I - Functionalization of compounds"], ["TCGA.A6.5665.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5665.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.5665.01", "Neurexins and neuroligins"], ["TCGA.A6.5665.01", "Drug ADME"], ["TCGA.A6.5665.01", "Neurotransmitter release cycle"], ["TCGA.A6.5665.01", "Platelet homeostasis"], ["TCGA.A6.5665.01", "RA biosynthesis pathway"], ["TCGA.A6.5665.01", "Synaptic adhesion-like molecules"], ["TCGA.A6.5665.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.5665.01", "Peptide ligand-binding receptors"], ["TCGA.A6.5665.01", "Ethanol oxidation"], ["TCGA.A6.5665.01", "Metabolism of fat-soluble vitamins"], ["TCGA.A6.5665.01", "Retinoid metabolism and transport"], ["TCGA.A6.5665.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.A6.5665.01", "Glucuronidation"], ["TCGA.A6.5665.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.A6.5665.01", "Chemokine receptors bind chemokines"], ["TCGA.A6.5665.01", "Voltage gated Potassium channels"], ["TCGA.A6.5665.01", "Sensory processing of sound"], ["TCGA.A6.5665.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5665.01", "G-protein beta:gamma signalling"], ["TCGA.A6.5665.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.A6.5665.01", "Long-term potentiation"], ["TCGA.A6.5665.01", "Blood group systems biosynthesis"], ["TCGA.A6.5665.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.A6.5665.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.A6.5665.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.A6.5665.01", "Stimuli-sensing channels"], ["TCGA.A6.5665.01", "Regulation of insulin secretion"], ["TCGA.A6.5665.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.A6.5665.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5665.01", "Trafficking of AMPA receptors"], ["TCGA.A6.5665.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.A6.5665.01", "GABA receptor activation"], ["TCGA.A6.5665.01", "Activation of SMO"], ["TCGA.A6.5665.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5665.01", "Collagen formation"], ["TCGA.A6.5665.01", "LGI-ADAM interactions"], ["TCGA.A6.5665.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.5665.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.A6.5665.01", "Other interleukin signaling"], ["TCGA.A6.5665.01", "Collagen chain trimerization"], ["TCGA.A6.5665.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.5665.01", "Arachidonic acid metabolism"], ["TCGA.A6.5665.01", "Integration of energy metabolism"], ["TCGA.A6.5665.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.A6.5665.01", "ECM proteoglycans"], ["TCGA.A6.5665.01", "Other semaphorin interactions"], ["TCGA.A6.5665.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.A6.5665.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.A6.5665.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5665.01", "Metabolism of vitamins and cofactors"], ["TCGA.A6.5665.01", "G beta:gamma signalling through CDC42"], ["TCGA.A6.5665.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.A6.5665.01", "Aquaporin-mediated transport"], ["TCGA.A6.5665.01", "Activation of NMDA receptors and postsynaptic events"], ["TCGA.A6.5666.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.A6.5666.01", "Neuronal System"], ["TCGA.A6.5666.01", "Signaling by GPCR"], ["TCGA.A6.5666.01", "Signaling Pathways"], ["TCGA.A6.5666.01", "GPCR downstream signalling"], ["TCGA.A6.5666.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.A6.5666.01", "Transmission across Chemical Synapses"], ["TCGA.A6.5666.01", "G alpha (i) signalling events"], ["TCGA.A6.5666.01", "GPCR ligand binding"], ["TCGA.A6.5666.01", "Immune System"], ["TCGA.A6.5666.01", "Complement cascade"], ["TCGA.A6.5666.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.5666.01", "G alpha (s) signalling events"], ["TCGA.A6.5666.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.A6.5666.01", "Chemokine receptors bind chemokines"], ["TCGA.A6.5666.01", "Regulation of Complement cascade"], ["TCGA.A6.5666.01", "Potassium Channels"], ["TCGA.A6.5666.01", "Integration of energy metabolism"], ["TCGA.A6.5666.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.A6.5666.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.A6.5666.01", "Regulation of insulin secretion"], ["TCGA.A6.5666.01", "Extracellular matrix organization"], ["TCGA.A6.5666.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.5666.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.A6.5666.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.5666.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.A6.5666.01", "Peptide ligand-binding receptors"], ["TCGA.A6.5666.01", "Initial triggering of complement"], ["TCGA.A6.5666.01", "Generation of second messenger molecules"], ["TCGA.A6.5666.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.A6.5666.01", "Cardiac conduction"], ["TCGA.A6.5666.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5666.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.A6.5666.01", "NCAM1 interactions"], ["TCGA.A6.5666.01", "GABA receptor activation"], ["TCGA.A6.5666.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.5666.01", "TNFs bind their physiological receptors"], ["TCGA.A6.5666.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.5666.01", "Biological oxidations"], ["TCGA.A6.5666.01", "NCAM signaling for neurite out-growth"], ["TCGA.A6.5666.01", "Blood group systems biosynthesis"], ["TCGA.A6.5666.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.5666.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.A6.5666.01", "PD-1 signaling"], ["TCGA.A6.5666.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.5666.01", "Regulation of FZD by ubiquitination"], ["TCGA.A6.5666.01", "GABA B receptor activation"], ["TCGA.A6.5666.01", "Activation of GABAB receptors"], ["TCGA.A6.5666.01", "Muscle contraction"], ["TCGA.A6.5666.01", "Protein-protein interactions at synapses"], ["TCGA.A6.5666.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.A6.5666.01", "Leishmania parasite growth and survival"], ["TCGA.A6.5666.01", "G-protein beta:gamma signalling"], ["TCGA.A6.5666.01", "Signaling by Interleukins"], ["TCGA.A6.5666.01", "Molecules associated with elastic fibres"], ["TCGA.A6.5666.01", "Lewis blood group biosynthesis"], ["TCGA.A6.5666.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.A6.5666.01", "Voltage gated Potassium channels"], ["TCGA.A6.5666.01", "Drug ADME"], ["TCGA.A6.5666.01", "Interleukin-10 signaling"], ["TCGA.A6.5666.01", "Cytokine Signaling in Immune system"], ["TCGA.A6.5666.01", "Ion channel transport"], ["TCGA.A6.5666.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.5666.01", "Signal amplification"], ["TCGA.A6.5666.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5666.01", "Neurexins and neuroligins"], ["TCGA.A6.5666.01", "G alpha (z) signalling events"], ["TCGA.A6.5666.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.A6.5666.01", "Aquaporin-mediated transport"], ["TCGA.A6.5666.01", "Platelet homeostasis"], ["TCGA.A6.5666.01", "Presynaptic function of Kainate receptors"], ["TCGA.A6.5666.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.5666.01", "Creation of C4 and C2 activators"], ["TCGA.A6.5666.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.A6.5666.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.5666.01", "Peptide hormone metabolism"], ["TCGA.A6.5666.01", "Elastic fibre formation"], ["TCGA.A6.5666.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5666.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5666.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.A6.5666.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.A6.5666.01", "Transport of small molecules"], ["TCGA.A6.5666.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.A6.5666.01", "Developmental Biology"], ["TCGA.A6.5666.01", "Leishmania infection"], ["TCGA.A6.5666.01", "Parasitic Infection Pathways"], ["TCGA.A6.5666.01", "Glucuronidation"], ["TCGA.A6.5666.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.A6.5666.01", "CD22 mediated BCR regulation"], ["TCGA.A6.5666.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.A6.5666.01", "Other interleukin signaling"], ["TCGA.A6.5666.01", "Integrin cell surface interactions"], ["TCGA.A6.5666.01", "Heme degradation"], ["TCGA.A6.5666.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.A6.5666.01", "L1CAM interactions"], ["TCGA.A6.5666.01", "IRS-related events triggered by IGF1R"], ["TCGA.A6.5666.01", "IRS-mediated signalling"], ["TCGA.A6.5666.01", "G alpha (q) signalling events"], ["TCGA.A6.5666.01", "PI3K events in ERBB2 signaling"], ["TCGA.A6.5666.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.A6.5666.01", "IGF1R signaling cascade"], ["TCGA.A6.5666.01", "G beta:gamma signalling through PLC beta"], ["TCGA.A6.5666.01", "PI-3K cascade:FGFR1"], ["TCGA.A6.5666.01", "G beta:gamma signalling through CDC42"], ["TCGA.A6.5666.01", "ERK1/ERK2 pathway"], ["TCGA.A6.5666.01", "GPER1 signaling"], ["TCGA.A6.5666.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.A6.5666.01", "Ca2+ pathway"], ["TCGA.A6.5666.01", "Sialic acid metabolism"], ["TCGA.A6.5666.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.5666.01", "MAPK family signaling cascades"], ["TCGA.A6.5666.01", "Keratan sulfate biosynthesis"], ["TCGA.A6.5666.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.A6.5666.01", "Phospholipase C-mediated cascade: FGFR1"], ["TCGA.A6.5666.01", "Long-term potentiation"], ["TCGA.A6.5667.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.A6.5667.01", "Signaling by GPCR"], ["TCGA.A6.5667.01", "GPCR downstream signalling"], ["TCGA.A6.5667.01", "G alpha (s) signalling events"], ["TCGA.A6.5667.01", "G alpha (i) signalling events"], ["TCGA.A6.5667.01", "Biological oxidations"], ["TCGA.A6.5667.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.5667.01", "GPCR ligand binding"], ["TCGA.A6.5667.01", "Blood group systems biosynthesis"], ["TCGA.A6.5667.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.5667.01", "Signal amplification"], ["TCGA.A6.5667.01", "Glucagon-type ligand receptors"], ["TCGA.A6.5667.01", "Inwardly rectifying K+ channels"], ["TCGA.A6.5667.01", "Activation of G protein gated Potassium channels"], ["TCGA.A6.5667.01", "G protein gated Potassium channels"], ["TCGA.A6.5667.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.A6.5667.01", "Lewis blood group biosynthesis"], ["TCGA.A6.5667.01", "Signaling Pathways"], ["TCGA.A6.5667.01", "Ethanol oxidation"], ["TCGA.A6.5667.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.5667.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.A6.5667.01", "G-protein beta:gamma signalling"], ["TCGA.A6.5667.01", "GABA receptor activation"], ["TCGA.A6.5667.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.5667.01", "RA biosynthesis pathway"], ["TCGA.A6.5667.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.5667.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.A6.5667.01", "Leishmania parasite growth and survival"], ["TCGA.A6.5667.01", "Glucuronidation"], ["TCGA.A6.5667.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.5667.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.5667.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.A6.5667.01", "GABA B receptor activation"], ["TCGA.A6.5667.01", "Activation of GABAB receptors"], ["TCGA.A6.5667.01", "Extracellular matrix organization"], ["TCGA.A6.5667.01", "Platelet homeostasis"], ["TCGA.A6.5667.01", "G0 and Early G1"], ["TCGA.A6.5667.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.A6.6137.01", "Extracellular matrix organization"], ["TCGA.A6.6137.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6137.01", "Neuronal System"], ["TCGA.A6.6137.01", "Degradation of the extracellular matrix"], ["TCGA.A6.6137.01", "GPCR ligand binding"], ["TCGA.A6.6137.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.A6.6137.01", "G alpha (i) signalling events"], ["TCGA.A6.6137.01", "Signaling by GPCR"], ["TCGA.A6.6137.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6137.01", "GPCR downstream signalling"], ["TCGA.A6.6137.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.A6.6137.01", "Glucagon-type ligand receptors"], ["TCGA.A6.6137.01", "Regulation of FZD by ubiquitination"], ["TCGA.A6.6137.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.6137.01", "Molecules associated with elastic fibres"], ["TCGA.A6.6137.01", "Peptide ligand-binding receptors"], ["TCGA.A6.6137.01", "Transcriptional Regulation by MECP2"], ["TCGA.A6.6137.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6137.01", "Interleukin-6 family signaling"], ["TCGA.A6.6137.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.6137.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.6137.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6137.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6137.01", "Protein-protein interactions at synapses"], ["TCGA.A6.6137.01", "Glutathione conjugation"], ["TCGA.A6.6138.01", "Biological oxidations"], ["TCGA.A6.6138.01", "Neuronal System"], ["TCGA.A6.6138.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6138.01", "Extracellular matrix organization"], ["TCGA.A6.6138.01", "Degradation of the extracellular matrix"], ["TCGA.A6.6138.01", "Drug ADME"], ["TCGA.A6.6138.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6138.01", "Neurexins and neuroligins"], ["TCGA.A6.6138.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6138.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6138.01", "Potassium Channels"], ["TCGA.A6.6138.01", "Phase I - Functionalization of compounds"], ["TCGA.A6.6138.01", "Protein-protein interactions at synapses"], ["TCGA.A6.6138.01", "Regulation of insulin secretion"], ["TCGA.A6.6138.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.A6.6138.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6138.01", "Ethanol oxidation"], ["TCGA.A6.6138.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6138.01", "Cardiac conduction"], ["TCGA.A6.6138.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6138.01", "Metabolism"], ["TCGA.A6.6138.01", "Formation of axial mesoderm"], ["TCGA.A6.6138.01", "RA biosynthesis pathway"], ["TCGA.A6.6138.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.A6.6138.01", "Integration of energy metabolism"], ["TCGA.A6.6138.01", "G alpha (i) signalling events"], ["TCGA.A6.6138.01", "Glucuronidation"], ["TCGA.A6.6138.01", "APAP ADME"], ["TCGA.A6.6138.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6138.01", "Carnitine metabolism"], ["TCGA.A6.6138.01", "Signaling by Retinoic Acid"], ["TCGA.A6.6138.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.A6.6138.01", "GPCR ligand binding"], ["TCGA.A6.6140.01", "Signaling by GPCR"], ["TCGA.A6.6140.01", "Neuronal System"], ["TCGA.A6.6140.01", "GPCR downstream signalling"], ["TCGA.A6.6140.01", "GPCR ligand binding"], ["TCGA.A6.6140.01", "G alpha (i) signalling events"], ["TCGA.A6.6140.01", "Signaling Pathways"], ["TCGA.A6.6140.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6140.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.6140.01", "Cardiac conduction"], ["TCGA.A6.6140.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6140.01", "Biological oxidations"], ["TCGA.A6.6140.01", "G alpha (s) signalling events"], ["TCGA.A6.6140.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.6140.01", "Molecules associated with elastic fibres"], ["TCGA.A6.6140.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.A6.6140.01", "Leishmania parasite growth and survival"], ["TCGA.A6.6140.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6140.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.6140.01", "Regulation of insulin secretion"], ["TCGA.A6.6140.01", "Potassium Channels"], ["TCGA.A6.6140.01", "Heme degradation"], ["TCGA.A6.6140.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6140.01", "Regulation of Complement cascade"], ["TCGA.A6.6140.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.A6.6140.01", "Extracellular matrix organization"], ["TCGA.A6.6140.01", "Interleukin-10 signaling"], ["TCGA.A6.6140.01", "Neurexins and neuroligins"], ["TCGA.A6.6140.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.A6.6140.01", "Chemokine receptors bind chemokines"], ["TCGA.A6.6140.01", "Phospholipase C-mediated cascade; FGFR2"], ["TCGA.A6.6140.01", "Platelet homeostasis"], ["TCGA.A6.6140.01", "Complement cascade"], ["TCGA.A6.6140.01", "Ion homeostasis"], ["TCGA.A6.6140.01", "G alpha (q) signalling events"], ["TCGA.A6.6140.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.A6.6140.01", "Arachidonic acid metabolism"], ["TCGA.A6.6140.01", "Initial triggering of complement"], ["TCGA.A6.6140.01", "FGFR2 ligand binding and activation"], ["TCGA.A6.6140.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6140.01", "Ion channel transport"], ["TCGA.A6.6140.01", "Signal amplification"], ["TCGA.A6.6140.01", "Protein-protein interactions at synapses"], ["TCGA.A6.6140.01", "Ca2+ pathway"], ["TCGA.A6.6140.01", "L1CAM interactions"], ["TCGA.A6.6140.01", "Peptide ligand-binding receptors"], ["TCGA.A6.6140.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6140.01", "Presynaptic function of Kainate receptors"], ["TCGA.A6.6140.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.6140.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6140.01", "G-protein mediated events"], ["TCGA.A6.6140.01", "Elastic fibre formation"], ["TCGA.A6.6140.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.6140.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6140.01", "Muscle contraction"], ["TCGA.A6.6140.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.6140.01", "Opioid Signalling"], ["TCGA.A6.6140.01", "Activated point mutants of FGFR2"], ["TCGA.A6.6140.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.A6.6140.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.A6.6140.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.6140.01", "Ion transport by P-type ATPases"], ["TCGA.A6.6140.01", "Porphyrin metabolism"], ["TCGA.A6.6140.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.6140.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.6140.01", "Ca-dependent events"], ["TCGA.A6.6140.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.A6.6140.01", "Glucuronidation"], ["TCGA.A6.6140.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.A6.6140.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.A6.6140.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.A6.6140.01", "Creation of C4 and C2 activators"], ["TCGA.A6.6140.01", "GABA receptor activation"], ["TCGA.A6.6140.01", "Leishmania infection"], ["TCGA.A6.6140.01", "Parasitic Infection Pathways"], ["TCGA.A6.6141.01", "Neuronal System"], ["TCGA.A6.6141.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6141.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6141.01", "Drug ADME"], ["TCGA.A6.6142.01", "Extracellular matrix organization"], ["TCGA.A6.6142.01", "Collagen formation"], ["TCGA.A6.6142.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6142.01", "Signaling by GPCR"], ["TCGA.A6.6142.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.A6.6142.01", "Collagen chain trimerization"], ["TCGA.A6.6142.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.6142.01", "Cardiac conduction"], ["TCGA.A6.6142.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6142.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6142.01", "Regulation of insulin secretion"], ["TCGA.A6.6142.01", "GPCR downstream signalling"], ["TCGA.A6.6142.01", "G alpha (i) signalling events"], ["TCGA.A6.6142.01", "Neuronal System"], ["TCGA.A6.6142.01", "GPCR ligand binding"], ["TCGA.A6.6142.01", "Signaling Pathways"], ["TCGA.A6.6142.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6142.01", "ECM proteoglycans"], ["TCGA.A6.6142.01", "Visual phototransduction"], ["TCGA.A6.6142.01", "Integration of energy metabolism"], ["TCGA.A6.6142.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.A6.6142.01", "Interleukin-10 signaling"], ["TCGA.A6.6142.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6142.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.A6.6142.01", "Glucuronidation"], ["TCGA.A6.6142.01", "Peptide ligand-binding receptors"], ["TCGA.A6.6142.01", "Metabolism of fat-soluble vitamins"], ["TCGA.A6.6142.01", "Retinoid metabolism and transport"], ["TCGA.A6.6142.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.A6.6142.01", "Interleukin-6 family signaling"], ["TCGA.A6.6142.01", "Degradation of the extracellular matrix"], ["TCGA.A6.6142.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.A6.6142.01", "Leishmania parasite growth and survival"], ["TCGA.A6.6142.01", "Drug ADME"], ["TCGA.A6.6142.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.6142.01", "Signal amplification"], ["TCGA.A6.6142.01", "Phase 2 - plateau phase"], ["TCGA.A6.6142.01", "WNT ligand biogenesis and trafficking"], ["TCGA.A6.6142.01", "Potassium Channels"], ["TCGA.A6.6142.01", "Muscle contraction"], ["TCGA.A6.6142.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.6142.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6142.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.6142.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6142.01", "Primitive streak formation"], ["TCGA.A6.6142.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6142.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.6142.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6142.01", "Heme degradation"], ["TCGA.A6.6142.01", "Formation of axial mesoderm"], ["TCGA.A6.6142.01", "L1CAM interactions"], ["TCGA.A6.6142.01", "Collagen degradation"], ["TCGA.A6.6142.01", "Glycosaminoglycan metabolism"], ["TCGA.A6.6142.01", "NCAM1 interactions"], ["TCGA.A6.6142.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.6142.01", "G alpha (z) signalling events"], ["TCGA.A6.6142.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.A6.6142.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.A6.6142.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.6142.01", "Glucagon-type ligand receptors"], ["TCGA.A6.6142.01", "FGFR2 ligand binding and activation"], ["TCGA.A6.6142.01", "APAP ADME"], ["TCGA.A6.6142.01", "NCAM signaling for neurite out-growth"], ["TCGA.A6.6142.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.A6.6648.01", "Neuronal System"], ["TCGA.A6.6648.01", "Cardiac conduction"], ["TCGA.A6.6648.01", "Protein-protein interactions at synapses"], ["TCGA.A6.6648.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.A6.6648.01", "G0 and Early G1"], ["TCGA.A6.6648.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6648.01", "Complement cascade"], ["TCGA.A6.6648.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], ["TCGA.A6.6648.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], ["TCGA.A6.6648.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], ["TCGA.A6.6648.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], ["TCGA.A6.6648.01", "Impaired BRCA2 binding to PALB2"], ["TCGA.A6.6648.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.A6.6648.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.6648.01", "Muscle contraction"], ["TCGA.A6.6648.01", "Resolution of D-Loop Structures"], ["TCGA.A6.6648.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.6648.01", "Neurexins and neuroligins"], ["TCGA.A6.6648.01", "GABA receptor activation"], ["TCGA.A6.6648.01", "Regulation of Complement cascade"], ["TCGA.A6.6648.01", "Transcription of E2F targets under negative control by DREAM complex"], ["TCGA.A6.6648.01", "Initial triggering of complement"], ["TCGA.A6.6648.01", "Inwardly rectifying K+ channels"], ["TCGA.A6.6648.01", "Presynaptic phase of homologous DNA pairing and strand exchange"], ["TCGA.A6.6648.01", "Potassium Channels"], ["TCGA.A6.6648.01", "GABA B receptor activation"], ["TCGA.A6.6648.01", "Activation of GABAB receptors"], ["TCGA.A6.6648.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6648.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6648.01", "Regulation of FZD by ubiquitination"], ["TCGA.A6.6648.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], ["TCGA.A6.6648.01", "Molecules associated with elastic fibres"], ["TCGA.A6.6648.01", "Homologous DNA Pairing and Strand Exchange"], ["TCGA.A6.6648.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6648.01", "Cell Cycle Checkpoints"], ["TCGA.A6.6648.01", "Diseases of DNA repair"], ["TCGA.A6.6648.01", "Diseases of DNA Double-Strand Break Repair"], ["TCGA.A6.6648.01", "Defective homologous recombination repair (HRR) due to BRCA2 loss of function"], ["TCGA.A6.6648.01", "LGI-ADAM interactions"], ["TCGA.A6.6648.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.A6.6648.01", "Cell Cycle"], ["TCGA.A6.6648.01", "Activation of G protein gated Potassium channels"], ["TCGA.A6.6648.01", "G protein gated Potassium channels"], ["TCGA.A6.6648.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.A6.6648.01", "Arachidonic acid metabolism"], ["TCGA.A6.6648.01", "TP53 Regulates Transcription of Cell Cycle Genes"], ["TCGA.A6.6648.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.A6.6648.01", "L1CAM interactions"], ["TCGA.A6.6648.01", "Cell Cycle, Mitotic"], ["TCGA.A6.6649.01", "Extracellular matrix organization"], ["TCGA.A6.6649.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6649.01", "Collagen formation"], ["TCGA.A6.6649.01", "Peptide hormone biosynthesis"], ["TCGA.A6.6649.01", "Interleukin-6 family signaling"], ["TCGA.A6.6649.01", "Degradation of the extracellular matrix"], ["TCGA.A6.6650.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.A6.6650.01", "Signaling by GPCR"], ["TCGA.A6.6650.01", "GPCR downstream signalling"], ["TCGA.A6.6650.01", "Neuronal System"], ["TCGA.A6.6650.01", "Regulation of Complement cascade"], ["TCGA.A6.6650.01", "Complement cascade"], ["TCGA.A6.6650.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.A6.6650.01", "PD-1 signaling"], ["TCGA.A6.6650.01", "Signaling Pathways"], ["TCGA.A6.6650.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.A6.6650.01", "G alpha (i) signalling events"], ["TCGA.A6.6650.01", "GPCR ligand binding"], ["TCGA.A6.6650.01", "G alpha (s) signalling events"], ["TCGA.A6.6650.01", "Classical antibody-mediated complement activation"], ["TCGA.A6.6650.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6650.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6650.01", "Glucagon-type ligand receptors"], ["TCGA.A6.6650.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.6650.01", "Initial triggering of complement"], ["TCGA.A6.6650.01", "Biological oxidations"], ["TCGA.A6.6650.01", "Generation of second messenger molecules"], ["TCGA.A6.6650.01", "Regulation of insulin secretion"], ["TCGA.A6.6650.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.A6.6650.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.A6.6650.01", "Diseases of Immune System"], ["TCGA.A6.6650.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.A6.6650.01", "Potassium Channels"], ["TCGA.A6.6650.01", "Molecules associated with elastic fibres"], ["TCGA.A6.6650.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.6650.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6650.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.A6.6650.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.A6.6650.01", "Leishmania parasite growth and survival"], ["TCGA.A6.6650.01", "Immune System"], ["TCGA.A6.6650.01", "Peptide hormone metabolism"], ["TCGA.A6.6650.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6650.01", "Costimulation by the CD28 family"], ["TCGA.A6.6650.01", "Cardiac conduction"], ["TCGA.A6.6650.01", "Integration of energy metabolism"], ["TCGA.A6.6650.01", "Neurexins and neuroligins"], ["TCGA.A6.6650.01", "Adaptive Immune System"], ["TCGA.A6.6650.01", "Signal amplification"], ["TCGA.A6.6650.01", "MHC class II antigen presentation"], ["TCGA.A6.6650.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.6650.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.A6.6650.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.6650.01", "G beta:gamma signalling through BTK"], ["TCGA.A6.6650.01", "G alpha (z) signalling events"], ["TCGA.A6.6650.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.A6.6650.01", "Transport of small molecules"], ["TCGA.A6.6650.01", "Glucuronidation"], ["TCGA.A6.6650.01", "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"], ["TCGA.A6.6650.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.6650.01", "G-protein beta:gamma signalling"], ["TCGA.A6.6650.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.A6.6650.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.A6.6650.01", "Protein-protein interactions at synapses"], ["TCGA.A6.6650.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.A6.6650.01", "Keratan sulfate biosynthesis"], ["TCGA.A6.6650.01", "Insulin processing"], ["TCGA.A6.6650.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.A6.6650.01", "Leishmania infection"], ["TCGA.A6.6650.01", "Parasitic Infection Pathways"], ["TCGA.A6.6650.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6650.01", "Ethanol oxidation"], ["TCGA.A6.6650.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.6650.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.A6.6650.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.6650.01", "Regulation of TLR by endogenous ligand"], ["TCGA.A6.6650.01", "TP53 Regulates Transcription of Cell Cycle Genes"], ["TCGA.A6.6650.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.A6.6650.01", "Heme degradation"], ["TCGA.A6.6650.01", "Platelet homeostasis"], ["TCGA.A6.6650.01", "Extracellular matrix organization"], ["TCGA.A6.6650.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.A6.6650.01", "Polo-like kinase mediated events"], ["TCGA.A6.6650.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.A6.6650.01", "Opioid Signalling"], ["TCGA.A6.6651.01", "Extracellular matrix organization"], ["TCGA.A6.6651.01", "Collagen formation"], ["TCGA.A6.6651.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.6651.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6651.01", "Collagen chain trimerization"], ["TCGA.A6.6651.01", "Degradation of the extracellular matrix"], ["TCGA.A6.6651.01", "Biological oxidations"], ["TCGA.A6.6651.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.A6.6651.01", "Metabolism"], ["TCGA.A6.6651.01", "Drug ADME"], ["TCGA.A6.6651.01", "Collagen degradation"], ["TCGA.A6.6651.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6651.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6651.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6651.01", "RA biosynthesis pathway"], ["TCGA.A6.6651.01", "Post-translational protein phosphorylation"], ["TCGA.A6.6651.01", "APAP ADME"], ["TCGA.A6.6651.01", "Integrin cell surface interactions"], ["TCGA.A6.6651.01", "Glucuronidation"], ["TCGA.A6.6651.01", "Scavenging by Class A Receptors"], ["TCGA.A6.6651.01", "Nucleotide catabolism"], ["TCGA.A6.6652.01", "Signaling by GPCR"], ["TCGA.A6.6652.01", "GPCR downstream signalling"], ["TCGA.A6.6652.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.A6.6652.01", "Neuronal System"], ["TCGA.A6.6652.01", "G alpha (i) signalling events"], ["TCGA.A6.6652.01", "GPCR ligand binding"], ["TCGA.A6.6652.01", "Generation of second messenger molecules"], ["TCGA.A6.6652.01", "Signaling Pathways"], ["TCGA.A6.6652.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.A6.6652.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6652.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.6652.01", "PD-1 signaling"], ["TCGA.A6.6652.01", "Biological oxidations"], ["TCGA.A6.6652.01", "Glucuronidation"], ["TCGA.A6.6652.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.A6.6652.01", "Regulation of insulin secretion"], ["TCGA.A6.6652.01", "Complement cascade"], ["TCGA.A6.6652.01", "Peptide ligand-binding receptors"], ["TCGA.A6.6652.01", "Regulation of Complement cascade"], ["TCGA.A6.6652.01", "Leishmania infection"], ["TCGA.A6.6652.01", "Parasitic Infection Pathways"], ["TCGA.A6.6652.01", "Cardiac conduction"], ["TCGA.A6.6652.01", "Chemokine receptors bind chemokines"], ["TCGA.A6.6652.01", "Potassium Channels"], ["TCGA.A6.6652.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.A6.6652.01", "Leishmania parasite growth and survival"], ["TCGA.A6.6652.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6652.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.6652.01", "G alpha (s) signalling events"], ["TCGA.A6.6652.01", "Voltage gated Potassium channels"], ["TCGA.A6.6652.01", "Drug ADME"], ["TCGA.A6.6652.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6652.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6652.01", "G-protein mediated events"], ["TCGA.A6.6652.01", "Integration of energy metabolism"], ["TCGA.A6.6652.01", "Extracellular matrix organization"], ["TCGA.A6.6652.01", "Peptide hormone metabolism"], ["TCGA.A6.6652.01", "Ca-dependent events"], ["TCGA.A6.6652.01", "Immune System"], ["TCGA.A6.6652.01", "Opioid Signalling"], ["TCGA.A6.6652.01", "Molecules associated with elastic fibres"], ["TCGA.A6.6652.01", "PLC beta mediated events"], ["TCGA.A6.6652.01", "Calmodulin induced events"], ["TCGA.A6.6652.01", "CaM pathway"], ["TCGA.A6.6652.01", "Visual phototransduction"], ["TCGA.A6.6652.01", "Signal amplification"], ["TCGA.A6.6652.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6652.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.A6.6652.01", "Metabolism of fat-soluble vitamins"], ["TCGA.A6.6652.01", "Retinoid metabolism and transport"], ["TCGA.A6.6652.01", "Metabolism of vitamins and cofactors"], ["TCGA.A6.6652.01", "Aspirin ADME"], ["TCGA.A6.6652.01", "Muscle contraction"], ["TCGA.A6.6652.01", "Arachidonic acid metabolism"], ["TCGA.A6.6652.01", "Neurexins and neuroligins"], ["TCGA.A6.6652.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.6652.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.A6.6652.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.A6.6652.01", "DAG and IP3 signaling"], ["TCGA.A6.6652.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.A6.6652.01", "CD22 mediated BCR regulation"], ["TCGA.A6.6652.01", "G alpha (q) signalling events"], ["TCGA.A6.6652.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.A6.6652.01", "Cell surface interactions at the vascular wall"], ["TCGA.A6.6652.01", "Transport of small molecules"], ["TCGA.A6.6652.01", "Stimuli-sensing channels"], ["TCGA.A6.6652.01", "GABA receptor activation"], ["TCGA.A6.6652.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.A6.6652.01", "Long-term potentiation"], ["TCGA.A6.6652.01", "G-protein beta:gamma signalling"], ["TCGA.A6.6652.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.A6.6652.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.A6.6652.01", "Ion channel transport"], ["TCGA.A6.6652.01", "Activation of the phototransduction cascade"], ["TCGA.A6.6652.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.A6.6652.01", "Regulation of FZD by ubiquitination"], ["TCGA.A6.6652.01", "Platelet homeostasis"], ["TCGA.A6.6653.01", "Neuronal System"], ["TCGA.A6.6653.01", "Signaling by GPCR"], ["TCGA.A6.6653.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6653.01", "GPCR downstream signalling"], ["TCGA.A6.6653.01", "G alpha (i) signalling events"], ["TCGA.A6.6653.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.6653.01", "GPCR ligand binding"], ["TCGA.A6.6653.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6653.01", "Neurexins and neuroligins"], ["TCGA.A6.6653.01", "GABA receptor activation"], ["TCGA.A6.6653.01", "Protein-protein interactions at synapses"], ["TCGA.A6.6653.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6653.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.6653.01", "Peptide ligand-binding receptors"], ["TCGA.A6.6653.01", "Cardiac conduction"], ["TCGA.A6.6653.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6653.01", "G alpha (s) signalling events"], ["TCGA.A6.6653.01", "Extracellular matrix organization"], ["TCGA.A6.6653.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.A6.6653.01", "Biological oxidations"], ["TCGA.A6.6653.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.A6.6653.01", "Signaling Pathways"], ["TCGA.A6.6653.01", "CD22 mediated BCR regulation"], ["TCGA.A6.6653.01", "Peptide hormone metabolism"], ["TCGA.A6.6653.01", "RA biosynthesis pathway"], ["TCGA.A6.6653.01", "Aspartate and asparagine metabolism"], ["TCGA.A6.6653.01", "Glucuronidation"], ["TCGA.A6.6653.01", "G-protein mediated events"], ["TCGA.A6.6653.01", "DAG and IP3 signaling"], ["TCGA.A6.6653.01", "GABA B receptor activation"], ["TCGA.A6.6653.01", "Activation of GABAB receptors"], ["TCGA.A6.6653.01", "Calmodulin induced events"], ["TCGA.A6.6653.01", "CaM pathway"], ["TCGA.A6.6653.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.A6.6653.01", "Degradation of the extracellular matrix"], ["TCGA.A6.6653.01", "L1CAM interactions"], ["TCGA.A6.6653.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.6653.01", "Phase 4 - resting membrane potential"], ["TCGA.A6.6653.01", "Integration of energy metabolism"], ["TCGA.A6.6653.01", "Regulation of insulin secretion"], ["TCGA.A6.6653.01", "Ca-dependent events"], ["TCGA.A6.6653.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.A6.6653.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6653.01", "Collagen formation"], ["TCGA.A6.6654.01", "Extracellular matrix organization"], ["TCGA.A6.6654.01", "Collagen formation"], ["TCGA.A6.6654.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6654.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.6654.01", "Collagen chain trimerization"], ["TCGA.A6.6654.01", "Degradation of the extracellular matrix"], ["TCGA.A6.6654.01", "Biological oxidations"], ["TCGA.A6.6654.01", "Drug ADME"], ["TCGA.A6.6654.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6654.01", "Glucuronidation"], ["TCGA.A6.6654.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.A6.6654.01", "APAP ADME"], ["TCGA.A6.6654.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6654.01", "Ethanol oxidation"], ["TCGA.A6.6654.01", "Collagen degradation"], ["TCGA.A6.6654.01", "RA biosynthesis pathway"], ["TCGA.A6.6654.01", "Metabolism"], ["TCGA.A6.6654.01", "ECM proteoglycans"], ["TCGA.A6.6654.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6654.01", "Integrin cell surface interactions"], ["TCGA.A6.6654.01", "Stimuli-sensing channels"], ["TCGA.A6.6654.01", "Chondroitin sulfate biosynthesis"], ["TCGA.A6.6654.01", "Defective B3GALTL causes PpS"], ["TCGA.A6.6654.01", "Degradation of cysteine and homocysteine"], ["TCGA.A6.6654.01", "Signaling by PDGF"], ["TCGA.A6.6654.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.A6.6654.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.A6.6654.01", "Signaling by Retinoic Acid"], ["TCGA.A6.6654.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.6654.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.A6.6654.01", "TNFs bind their physiological receptors"], ["TCGA.A6.6654.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.A6.6654.01", "Phase I - Functionalization of compounds"], ["TCGA.A6.6654.01", "Aspirin ADME"], ["TCGA.A6.6654.01", "Sulfur amino acid metabolism"], ["TCGA.A6.6654.01", "Interleukin-6 family signaling"], ["TCGA.A6.6654.01", "Glycosaminoglycan metabolism"], ["TCGA.A6.6654.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.6654.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.A6.6654.01", "Arachidonic acid metabolism"], ["TCGA.A6.6654.01", "WNT ligand biogenesis and trafficking"], ["TCGA.A6.6780.01", "Neuronal System"], ["TCGA.A6.6780.01", "Extracellular matrix organization"], ["TCGA.A6.6780.01", "Signaling Pathways"], ["TCGA.A6.6780.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6780.01", "Interaction between L1 and Ankyrins"], ["TCGA.A6.6780.01", "GPCR ligand binding"], ["TCGA.A6.6780.01", "Signaling by GPCR"], ["TCGA.A6.6780.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.6780.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.6780.01", "GPCR downstream signalling"], ["TCGA.A6.6780.01", "G alpha (i) signalling events"], ["TCGA.A6.6780.01", "L1CAM interactions"], ["TCGA.A6.6780.01", "Phase 0 - rapid depolarisation"], ["TCGA.A6.6780.01", "GABA receptor activation"], ["TCGA.A6.6780.01", "Glucagon-type ligand receptors"], ["TCGA.A6.6780.01", "Cardiac conduction"], ["TCGA.A6.6780.01", "G alpha (s) signalling events"], ["TCGA.A6.6780.01", "WNT ligand biogenesis and trafficking"], ["TCGA.A6.6780.01", "RA biosynthesis pathway"], ["TCGA.A6.6780.01", "Muscle contraction"], ["TCGA.A6.6780.01", "G alpha (q) signalling events"], ["TCGA.A6.6780.01", "Molecules associated with elastic fibres"], ["TCGA.A6.6780.01", "Protein-protein interactions at synapses"], ["TCGA.A6.6780.01", "Developmental Biology"], ["TCGA.A6.6780.01", "ECM proteoglycans"], ["TCGA.A6.6780.01", "Other semaphorin interactions"], ["TCGA.A6.6780.01", "G alpha (z) signalling events"], ["TCGA.A6.6780.01", "Elastic fibre formation"], ["TCGA.A6.6780.01", "Neurexins and neuroligins"], ["TCGA.A6.6780.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.A6.6780.01", "Regulation of FZD by ubiquitination"], ["TCGA.A6.6780.01", "Degradation of the extracellular matrix"], ["TCGA.A6.6780.01", "Glucagon signaling in metabolic regulation"], ["TCGA.A6.6780.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.6780.01", "Collagen chain trimerization"], ["TCGA.A6.6780.01", "Collagen formation"], ["TCGA.A6.6780.01", "Glucuronidation"], ["TCGA.A6.6780.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.A6.6780.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.A6.6780.01", "Aquaporin-mediated transport"], ["TCGA.A6.6780.01", "Signaling by BMP"], ["TCGA.A6.6780.01", "DAG and IP3 signaling"], ["TCGA.A6.6780.01", "GABA B receptor activation"], ["TCGA.A6.6780.01", "Activation of GABAB receptors"], ["TCGA.A6.6780.01", "O-linked glycosylation"], ["TCGA.A6.6780.01", "Formation of the anterior neural plate"], ["TCGA.A6.6780.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.6780.01", "Peptide hormone metabolism"], ["TCGA.A6.6780.01", "Biological oxidations"], ["TCGA.A6.6780.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.A6.6780.01", "Transcriptional regulation of testis differentiation"], ["TCGA.A6.6780.01", "NCAM1 interactions"], ["TCGA.A6.6780.01", "Signaling by Retinoic Acid"], ["TCGA.A6.6780.01", "Peptide ligand-binding receptors"], ["TCGA.A6.6780.01", "IRS-related events triggered by IGF1R"], ["TCGA.A6.6780.01", "Axon guidance"], ["TCGA.A6.6780.01", "Potassium Channels"], ["TCGA.A6.6780.01", "Neurotransmitter release cycle"], ["TCGA.A6.6780.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6780.01", "Long-term potentiation"], ["TCGA.A6.6780.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6780.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.A6.6780.01", "IGF1R signaling cascade"], ["TCGA.A6.6780.01", "Glycosaminoglycan metabolism"], ["TCGA.A6.6780.01", "Platelet homeostasis"], ["TCGA.A6.6780.01", "Nervous system development"], ["TCGA.A6.6780.01", "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"], ["TCGA.A6.6780.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.A6.6780.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6780.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.A6.6780.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.A6.6780.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.6780.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.A6.6780.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.A6.6780.01", "G-protein mediated events"], ["TCGA.A6.6781.01", "Extracellular matrix organization"], ["TCGA.A6.6781.01", "Collagen formation"], ["TCGA.A6.6781.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6781.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.A6.6781.01", "Collagen chain trimerization"], ["TCGA.A6.6781.01", "Activation of Matrix Metalloproteinases"], ["TCGA.A6.6781.01", "Degradation of the extracellular matrix"], ["TCGA.A6.6781.01", "Collagen degradation"], ["TCGA.A6.6781.01", "Drug ADME"], ["TCGA.A6.6781.01", "GPCR ligand binding"], ["TCGA.A6.6781.01", "Integrin cell surface interactions"], ["TCGA.A6.6781.01", "Signaling by GPCR"], ["TCGA.A6.6781.01", "ECM proteoglycans"], ["TCGA.A6.6781.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6781.01", "Biological oxidations"], ["TCGA.A6.6781.01", "G alpha (i) signalling events"], ["TCGA.A6.6781.01", "Glucuronidation"], ["TCGA.A6.6781.01", "Glycosaminoglycan metabolism"], ["TCGA.A6.6781.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.A6.6781.01", "Class B/2 (Secretin family receptors)"], ["TCGA.A6.6781.01", "GPCR downstream signalling"], ["TCGA.A6.6781.01", "Fatty acid metabolism"], ["TCGA.A6.6781.01", "Keratan sulfate biosynthesis"], ["TCGA.A6.6781.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.A6.6781.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.A6.6781.01", "O-linked glycosylation"], ["TCGA.A6.6781.01", "Peptide ligand-binding receptors"], ["TCGA.A6.6781.01", "Defective B3GALTL causes PpS"], ["TCGA.A6.6781.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.A6.6781.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.A6.6781.01", "Keratan sulfate/keratin metabolism"], ["TCGA.A6.6781.01", "Other semaphorin interactions"], ["TCGA.A6.6781.01", "Glucagon-type ligand receptors"], ["TCGA.A6.6781.01", "Scavenging by Class A Receptors"], ["TCGA.A6.6781.01", "APAP ADME"], ["TCGA.A6.6781.01", "Elastic fibre formation"], ["TCGA.A6.6781.01", "Diseases of glycosylation"], ["TCGA.A6.6782.01", "Extracellular matrix organization"], ["TCGA.A6.6782.01", "Neuronal System"], ["TCGA.A6.6782.01", "Transmission across Chemical Synapses"], ["TCGA.A6.6782.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.A6.6782.01", "Biological oxidations"], ["TCGA.A6.6782.01", "Surfactant metabolism"], ["TCGA.A6.6782.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.A6.6782.01", "Phase II - Conjugation of compounds"], ["TCGA.A6.6782.01", "ECM proteoglycans"], ["TCGA.A6.6782.01", "Collagen chain trimerization"], ["TCGA.A6.6782.01", "Collagen formation"], ["TCGA.A6.6782.01", "Cytosolic sulfonation of small molecules"], ["TCGA.A6.6782.01", "Glucuronidation"], ["TCGA.A6.6782.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.A6.6782.01", "Integrin cell surface interactions"], ["TCGA.A6.6782.01", "Formation of axial mesoderm"], ["TCGA.A6.6782.01", "Nucleotide catabolism"], ["TCGA.A6.6782.01", "Metabolism"], ["TCGA.A6.6782.01", "Visual phototransduction"], ["TCGA.A6.6782.01", "Defective GALNT3 causes HFTC"], ["TCGA.A6.6782.01", "Defective GALNT12 causes CRCS1"], ["TCGA.A6.6782.01", "Physiological factors"], ["TCGA.A6.6782.01", "SLC-mediated transmembrane transport"], ["TCGA.A6.6782.01", "Drug ADME"], ["TCGA.A6.6782.01", "Regulation of FZD by ubiquitination"], ["TCGA.A6.6782.01", "NCAM signaling for neurite out-growth"], ["TCGA.AA.3489.01", "Extracellular matrix organization"], ["TCGA.AA.3489.01", "Drug ADME"], ["TCGA.AA.3489.01", "Biological oxidations"], ["TCGA.AA.3489.01", "Collagen formation"], ["TCGA.AA.3489.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3489.01", "Glucuronidation"], ["TCGA.AA.3489.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3489.01", "Metabolism"], ["TCGA.AA.3489.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AA.3489.01", "Collagen chain trimerization"], ["TCGA.AA.3489.01", "ECM proteoglycans"], ["TCGA.AA.3489.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AA.3489.01", "Degradation of the extracellular matrix"], ["TCGA.AA.3489.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3489.01", "APAP ADME"], ["TCGA.AA.3489.01", "Collagen degradation"], ["TCGA.AA.3489.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3489.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AA.3489.01", "Aspirin ADME"], ["TCGA.AA.3489.01", "O-linked glycosylation"], ["TCGA.AA.3489.01", "Defective B3GALTL causes PpS"], ["TCGA.AA.3489.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3489.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AA.3489.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], ["TCGA.AA.3489.01", "Glycosaminoglycan metabolism"], ["TCGA.AA.3489.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AA.3489.01", "Activation of G protein gated Potassium channels"], ["TCGA.AA.3489.01", "G protein gated Potassium channels"], ["TCGA.AA.3489.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AA.3492.01", "Neuronal System"], ["TCGA.AA.3492.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3492.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3492.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3492.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3492.01", "Potassium Channels"], ["TCGA.AA.3492.01", "GPCR downstream signalling"], ["TCGA.AA.3492.01", "Cardiac conduction"], ["TCGA.AA.3492.01", "G alpha (i) signalling events"], ["TCGA.AA.3492.01", "Signaling by GPCR"], ["TCGA.AA.3492.01", "L1CAM interactions"], ["TCGA.AA.3492.01", "G alpha (s) signalling events"], ["TCGA.AA.3492.01", "Regulation of insulin secretion"], ["TCGA.AA.3492.01", "GPCR ligand binding"], ["TCGA.AA.3492.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AA.3492.01", "NCAM1 interactions"], ["TCGA.AA.3492.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3492.01", "Muscle contraction"], ["TCGA.AA.3492.01", "Protein-protein interactions at synapses"], ["TCGA.AA.3492.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3492.01", "Drug ADME"], ["TCGA.AA.3492.01", "Glucuronidation"], ["TCGA.AA.3492.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AA.3492.01", "Integration of energy metabolism"], ["TCGA.AA.3492.01", "Platelet homeostasis"], ["TCGA.AA.3492.01", "Biological oxidations"], ["TCGA.AA.3492.01", "GABA receptor activation"], ["TCGA.AA.3492.01", "Chemokine receptors bind chemokines"], ["TCGA.AA.3492.01", "Signal amplification"], ["TCGA.AA.3492.01", "Trafficking of AMPA receptors"], ["TCGA.AA.3492.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.AA.3492.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3492.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AA.3492.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AA.3492.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3492.01", "Activation of G protein gated Potassium channels"], ["TCGA.AA.3492.01", "G protein gated Potassium channels"], ["TCGA.AA.3492.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AA.3492.01", "Synaptic adhesion-like molecules"], ["TCGA.AA.3492.01", "Collagen chain trimerization"], ["TCGA.AA.3492.01", "Signaling Pathways"], ["TCGA.AA.3492.01", "Extracellular matrix organization"], ["TCGA.AA.3492.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AA.3492.01", "Termination of O-glycan biosynthesis"], ["TCGA.AA.3492.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AA.3492.01", "Leishmania parasite growth and survival"], ["TCGA.AA.3492.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AA.3492.01", "O-linked glycosylation"], ["TCGA.AA.3492.01", "GABA B receptor activation"], ["TCGA.AA.3492.01", "Activation of GABAB receptors"], ["TCGA.AA.3492.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AA.3492.01", "Peptide hormone metabolism"], ["TCGA.AA.3492.01", "Insulin processing"], ["TCGA.AA.3492.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AA.3492.01", "Peptide ligand-binding receptors"], ["TCGA.AA.3492.01", "NCAM signaling for neurite out-growth"], ["TCGA.AA.3492.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3492.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AA.3492.01", "Sensory processing of sound"], ["TCGA.AA.3492.01", "Voltage gated Potassium channels"], ["TCGA.AA.3492.01", "Presynaptic function of Kainate receptors"], ["TCGA.AA.3492.01", "Nuclear Receptor transcription pathway"], ["TCGA.AA.3492.01", "O-linked glycosylation of mucins"], ["TCGA.AA.3492.01", "Aspirin ADME"], ["TCGA.AA.3492.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3492.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.AA.3492.01", "Blood group systems biosynthesis"], ["TCGA.AA.3492.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AA.3492.01", "Inwardly rectifying K+ channels"], ["TCGA.AA.3492.01", "Neurexins and neuroligins"], ["TCGA.AA.3502.01", "Neuronal System"], ["TCGA.AA.3502.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3502.01", "Signaling by GPCR"], ["TCGA.AA.3502.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3502.01", "Extracellular matrix organization"], ["TCGA.AA.3502.01", "GPCR downstream signalling"], ["TCGA.AA.3502.01", "Potassium Channels"], ["TCGA.AA.3502.01", "G alpha (s) signalling events"], ["TCGA.AA.3502.01", "Defective B3GALTL causes PpS"], ["TCGA.AA.3502.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AA.3502.01", "G alpha (z) signalling events"], ["TCGA.AA.3502.01", "GABA B receptor activation"], ["TCGA.AA.3502.01", "Activation of GABAB receptors"], ["TCGA.AA.3502.01", "Signal amplification"], ["TCGA.AA.3502.01", "G alpha (i) signalling events"], ["TCGA.AA.3502.01", "Cardiac conduction"], ["TCGA.AA.3502.01", "Muscle contraction"], ["TCGA.AA.3502.01", "Drug ADME"], ["TCGA.AA.3502.01", "Biological oxidations"], ["TCGA.AA.3502.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AA.3502.01", "Aquaporin-mediated transport"], ["TCGA.AA.3502.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.AA.3502.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.AA.3502.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3502.01", "GABA receptor activation"], ["TCGA.AA.3502.01", "Integration of energy metabolism"], ["TCGA.AA.3502.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AA.3502.01", "Molecules associated with elastic fibres"], ["TCGA.AA.3502.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AA.3502.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3502.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3502.01", "GPCR ligand binding"], ["TCGA.AA.3502.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AA.3502.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AA.3502.01", "O-linked glycosylation"], ["TCGA.AA.3502.01", "Inwardly rectifying K+ channels"], ["TCGA.AA.3502.01", "Elastic fibre formation"], ["TCGA.AA.3502.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AA.3502.01", "Thromboxane signalling through TP receptor"], ["TCGA.AA.3502.01", "Regulation of insulin secretion"], ["TCGA.AA.3502.01", "Signaling Pathways"], ["TCGA.AA.3502.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AA.3502.01", "GPER1 signaling"], ["TCGA.AA.3502.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AA.3502.01", "Opioid Signalling"], ["TCGA.AA.3502.01", "Presynaptic function of Kainate receptors"], ["TCGA.AA.3502.01", "Diseases of glycosylation"], ["TCGA.AA.3502.01", "Voltage gated Potassium channels"], ["TCGA.AA.3502.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3502.01", "Bile acid and bile salt metabolism"], ["TCGA.AA.3502.01", "Diseases of metabolism"], ["TCGA.AA.3502.01", "G alpha (12/13) signalling events"], ["TCGA.AA.3502.01", "Activation of G protein gated Potassium channels"], ["TCGA.AA.3502.01", "G protein gated Potassium channels"], ["TCGA.AA.3502.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3502.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AA.3502.01", "RA biosynthesis pathway"], ["TCGA.AA.3502.01", "G beta:gamma signalling through BTK"], ["TCGA.AA.3502.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.AA.3502.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AA.3502.01", "Platelet homeostasis"], ["TCGA.AA.3502.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3502.01", "G-protein activation"], ["TCGA.AA.3502.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AA.3502.01", "Phase I - Functionalization of compounds"], ["TCGA.AA.3502.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3502.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.AA.3502.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AA.3502.01", "Scavenging by Class A Receptors"], ["TCGA.AA.3502.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AA.3502.01", "G beta:gamma signalling through CDC42"], ["TCGA.AA.3502.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AA.3502.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3502.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3502.01", "Ethanol oxidation"], ["TCGA.AA.3502.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AA.3502.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.AA.3502.01", "Regulation of beta-cell development"], ["TCGA.AA.3502.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.AA.3502.01", "Long-term potentiation"], ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AA.3502.01", "Regulation of gene expression in beta cells"], ["TCGA.AA.3502.01", "Collagen formation"], ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts"], ["TCGA.AA.3502.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AA.3502.01", "Protein-protein interactions at synapses"], ["TCGA.AA.3502.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AA.3502.01", "Leishmania parasite growth and survival"], ["TCGA.AA.3502.01", "Fatty acid metabolism"], ["TCGA.AA.3502.01", "G-protein mediated events"], ["TCGA.AA.3502.01", "L1CAM interactions"], ["TCGA.AA.3502.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AA.3502.01", "G alpha (q) signalling events"], ["TCGA.AA.3502.01", "FGFR1 ligand binding and activation"], ["TCGA.AA.3502.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AA.3502.01", "G-protein beta:gamma signalling"], ["TCGA.AA.3511.01", "Neuronal System"], ["TCGA.AA.3511.01", "Signaling by GPCR"], ["TCGA.AA.3511.01", "GPCR downstream signalling"], ["TCGA.AA.3511.01", "GPCR ligand binding"], ["TCGA.AA.3511.01", "Extracellular matrix organization"], ["TCGA.AA.3511.01", "G alpha (i) signalling events"], ["TCGA.AA.3511.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AA.3511.01", "Peptide ligand-binding receptors"], ["TCGA.AA.3511.01", "Potassium Channels"], ["TCGA.AA.3511.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3511.01", "Chemokine receptors bind chemokines"], ["TCGA.AA.3511.01", "Ethanol oxidation"], ["TCGA.AA.3511.01", "Biological oxidations"], ["TCGA.AA.3511.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3511.01", "Glucuronidation"], ["TCGA.AA.3511.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3511.01", "Collagen formation"], ["TCGA.AA.3511.01", "Signaling Pathways"], ["TCGA.AA.3511.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3511.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AA.3511.01", "TNFs bind their physiological receptors"], ["TCGA.AA.3511.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.AA.3511.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.AA.3511.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3511.01", "Collagen chain trimerization"], ["TCGA.AA.3511.01", "Voltage gated Potassium channels"], ["TCGA.AA.3511.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3511.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.AA.3511.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AA.3511.01", "Formation of axial mesoderm"], ["TCGA.AA.3511.01", "Protein-protein interactions at synapses"], ["TCGA.AA.3511.01", "ECM proteoglycans"], ["TCGA.AA.3511.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3511.01", "Integrin cell surface interactions"], ["TCGA.AA.3511.01", "Regulation of insulin secretion"], ["TCGA.AA.3511.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3655.01", "Neuronal System"], ["TCGA.AA.3655.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3655.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3655.01", "Biological oxidations"], ["TCGA.AA.3655.01", "G alpha (i) signalling events"], ["TCGA.AA.3655.01", "Extracellular matrix organization"], ["TCGA.AA.3655.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3655.01", "GPCR ligand binding"], ["TCGA.AA.3655.01", "RA biosynthesis pathway"], ["TCGA.AA.3655.01", "L1CAM interactions"], ["TCGA.AA.3655.01", "Protein-protein interactions at synapses"], ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AA.3655.01", "Signaling by GPCR"], ["TCGA.AA.3655.01", "Ethanol oxidation"], ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AA.3655.01", "GABA receptor activation"], ["TCGA.AA.3655.01", "GPCR downstream signalling"], ["TCGA.AA.3655.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3655.01", "Potassium Channels"], ["TCGA.AA.3655.01", "Synaptic adhesion-like molecules"], ["TCGA.AA.3655.01", "Signaling Pathways"], ["TCGA.AA.3655.01", "Glucuronidation"], ["TCGA.AA.3655.01", "Peptide ligand-binding receptors"], ["TCGA.AA.3655.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3655.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AA.3655.01", "Phase I - Functionalization of compounds"], ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts"], ["TCGA.AA.3655.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AA.3655.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AA.3655.01", "Regulation of gene expression by Hypoxia-inducible Factor"], ["TCGA.AA.3655.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3655.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3655.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AA.3655.01", "Signaling by Retinoic Acid"], ["TCGA.AA.3655.01", "Signaling by BMP"], ["TCGA.AA.3655.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3655.01", "Neurexins and neuroligins"], ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AA.3655.01", "Drug ADME"], ["TCGA.AA.3655.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3655.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AA.3655.01", "Bile acid and bile salt metabolism"], ["TCGA.AA.3655.01", "Aspirin ADME"], ["TCGA.AA.3655.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AA.3655.01", "Chemokine receptors bind chemokines"], ["TCGA.AA.3655.01", "Peptide hormone metabolism"], ["TCGA.AA.3655.01", "LGI-ADAM interactions"], ["TCGA.AA.3655.01", "Muscle contraction"], ["TCGA.AA.3655.01", "Visual phototransduction"], ["TCGA.AA.3655.01", "Degradation of the extracellular matrix"], ["TCGA.AA.3655.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AA.3655.01", "Cardiac conduction"], ["TCGA.AA.3655.01", "Metabolism of fat-soluble vitamins"], ["TCGA.AA.3655.01", "Retinoid metabolism and transport"], ["TCGA.AA.3655.01", "Collagen chain trimerization"], ["TCGA.AA.3660.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3660.01", "Neuronal System"], ["TCGA.AA.3660.01", "Cardiac conduction"], ["TCGA.AA.3660.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3660.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3660.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3660.01", "FGFR4 ligand binding and activation"], ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AA.3660.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3660.01", "Signaling Pathways"], ["TCGA.AA.3660.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.AA.3660.01", "G alpha (s) signalling events"], ["TCGA.AA.3660.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3660.01", "Biological oxidations"], ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AA.3660.01", "Extracellular matrix organization"], ["TCGA.AA.3660.01", "IRS-related events triggered by IGF1R"], ["TCGA.AA.3660.01", "Bile acid and bile salt metabolism"], ["TCGA.AA.3660.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.AA.3660.01", "IGF1R signaling cascade"], ["TCGA.AA.3660.01", "Drug ADME"], ["TCGA.AA.3660.01", "Glucuronidation"], ["TCGA.AA.3660.01", "PI-3K cascade:FGFR4"], ["TCGA.AA.3660.01", "Integration of energy metabolism"], ["TCGA.AA.3660.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts"], ["TCGA.AA.3660.01", "FGFR2 ligand binding and activation"], ["TCGA.AA.3660.01", "G alpha (z) signalling events"], ["TCGA.AA.3660.01", "Peptide hormone metabolism"], ["TCGA.AA.3660.01", "FGFR2c ligand binding and activation"], ["TCGA.AA.3660.01", "IRS-mediated signalling"], ["TCGA.AA.3660.01", "NCAM1 interactions"], ["TCGA.AA.3660.01", "Regulation of insulin secretion"], ["TCGA.AA.3660.01", "NCAM signaling for neurite out-growth"], ["TCGA.AA.3660.01", "Presynaptic function of Kainate receptors"], ["TCGA.AA.3660.01", "SHC-mediated cascade:FGFR4"], ["TCGA.AA.3660.01", "L1CAM interactions"], ["TCGA.AA.3660.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3660.01", "Regulation of FZD by ubiquitination"], ["TCGA.AA.3660.01", "FRS-mediated FGFR4 signaling"], ["TCGA.AA.3660.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3660.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AA.3660.01", "Collagen chain trimerization"], ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AA.3660.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AA.3660.01", "Muscle contraction"], ["TCGA.AA.3660.01", "GPER1 signaling"], ["TCGA.AA.3660.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AA.3660.01", "Ca2+ pathway"], ["TCGA.AA.3660.01", "Insulin receptor signalling cascade"], ["TCGA.AA.3660.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AA.3660.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3660.01", "Phospholipase C-mediated cascade: FGFR1"], ["TCGA.AA.3660.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AA.3660.01", "Ethanol oxidation"], ["TCGA.AA.3660.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AA.3660.01", "FGFR1 ligand binding and activation"], ["TCGA.AA.3660.01", "Activated point mutants of FGFR2"], ["TCGA.AA.3660.01", "G beta:gamma signalling through BTK"], ["TCGA.AA.3660.01", "Downstream signaling of activated FGFR4"], ["TCGA.AA.3660.01", "Collagen formation"], ["TCGA.AA.3660.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AA.3660.01", "Phospholipase C-mediated cascade; FGFR2"], ["TCGA.AA.3660.01", "Signaling by activated point mutants of FGFR1"], ["TCGA.AA.3660.01", "Formation of axial mesoderm"], ["TCGA.AA.3660.01", "Signaling by Retinoic Acid"], ["TCGA.AA.3660.01", "Signaling by GPCR"], ["TCGA.AA.3660.01", "Stimuli-sensing channels"], ["TCGA.AA.3660.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AA.3660.01", "PI-3K cascade:FGFR1"], ["TCGA.AA.3660.01", "G beta:gamma signalling through CDC42"], ["TCGA.AA.3660.01", "GPCR downstream signalling"], ["TCGA.AA.3660.01", "Recycling of bile acids and salts"], ["TCGA.AA.3660.01", "Signaling by activated point mutants of FGFR3"], ["TCGA.AA.3660.01", "FGFR3 mutant receptor activation"], ["TCGA.AA.3660.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3660.01", "Physiological factors"], ["TCGA.AA.3660.01", "Developmental Biology"], ["TCGA.AA.3660.01", "Signaling by WNT"], ["TCGA.AA.3660.01", "G alpha (i) signalling events"], ["TCGA.AA.3660.01", "Negative regulation of FGFR4 signaling"], ["TCGA.AA.3660.01", "FGFR3 ligand binding and activation"], ["TCGA.AA.3660.01", "FGFR3c ligand binding and activation"], ["TCGA.AA.3660.01", "FGFR1c ligand binding and activation"], ["TCGA.AA.3660.01", "Phospholipase C-mediated cascade; FGFR3"], ["TCGA.AA.3660.01", "LGI-ADAM interactions"], ["TCGA.AA.3660.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AA.3660.01", "Aquaporin-mediated transport"], ["TCGA.AA.3660.01", "SHC-mediated cascade:FGFR1"], ["TCGA.AA.3660.01", "PI-3K cascade:FGFR2"], ["TCGA.AA.3660.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AA.3660.01", "GABA B receptor activation"], ["TCGA.AA.3660.01", "Activation of GABAB receptors"], ["TCGA.AA.3660.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3660.01", "Signal amplification"], ["TCGA.AA.3662.01", "Biological oxidations"], ["TCGA.AA.3662.01", "Neuronal System"], ["TCGA.AA.3662.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3662.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3662.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3662.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3662.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3662.01", "Phase I - Functionalization of compounds"], ["TCGA.AA.3662.01", "Metabolism"], ["TCGA.AA.3662.01", "Regulation of insulin secretion"], ["TCGA.AA.3662.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3662.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AA.3662.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3662.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3662.01", "Ethanol oxidation"], ["TCGA.AA.3662.01", "Visual phototransduction"], ["TCGA.AA.3662.01", "G alpha (z) signalling events"], ["TCGA.AA.3662.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3662.01", "GABA receptor activation"], ["TCGA.AA.3662.01", "Formation of axial mesoderm"], ["TCGA.AA.3662.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AA.3662.01", "RA biosynthesis pathway"], ["TCGA.AA.3662.01", "Signal amplification"], ["TCGA.AA.3662.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AA.3662.01", "Integration of energy metabolism"], ["TCGA.AA.3662.01", "Glucuronidation"], ["TCGA.AA.3662.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AA.3662.01", "Aquaporin-mediated transport"], ["TCGA.AA.3662.01", "IRS-related events triggered by IGF1R"], ["TCGA.AA.3662.01", "GPER1 signaling"], ["TCGA.AA.3662.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AA.3662.01", "GABA B receptor activation"], ["TCGA.AA.3662.01", "Activation of GABAB receptors"], ["TCGA.AA.3662.01", "Inwardly rectifying K+ channels"], ["TCGA.AA.3662.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.AA.3662.01", "IGF1R signaling cascade"], ["TCGA.AA.3662.01", "Extra-nuclear estrogen signaling"], ["TCGA.AA.3662.01", "L1CAM interactions"], ["TCGA.AA.3662.01", "FGFR4 ligand binding and activation"], ["TCGA.AA.3662.01", "Protein-protein interactions at synapses"], ["TCGA.AA.3662.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3662.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.AA.3662.01", "IRS-mediated signalling"], ["TCGA.AA.3662.01", "TNFs bind their physiological receptors"], ["TCGA.AA.3662.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.AA.3662.01", "Peptide hormone metabolism"], ["TCGA.AA.3662.01", "Opioid Signalling"], ["TCGA.AA.3662.01", "G alpha (s) signalling events"], ["TCGA.AA.3662.01", "Extracellular matrix organization"], ["TCGA.AA.3662.01", "G-protein activation"], ["TCGA.AA.3662.01", "Thromboxane signalling through TP receptor"], ["TCGA.AA.3663.01", "Neuronal System"], ["TCGA.AA.3663.01", "Signaling by GPCR"], ["TCGA.AA.3663.01", "G alpha (i) signalling events"], ["TCGA.AA.3663.01", "GPCR ligand binding"], ["TCGA.AA.3663.01", "GPCR downstream signalling"], ["TCGA.AA.3663.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3663.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3663.01", "Cardiac conduction"], ["TCGA.AA.3663.01", "Protein-protein interactions at synapses"], ["TCGA.AA.3663.01", "Neurexins and neuroligins"], ["TCGA.AA.3663.01", "Biological oxidations"], ["TCGA.AA.3663.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3663.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AA.3663.01", "Potassium Channels"], ["TCGA.AA.3663.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AA.3663.01", "Chemokine receptors bind chemokines"], ["TCGA.AA.3663.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3663.01", "Muscle contraction"], ["TCGA.AA.3663.01", "Signaling Pathways"], ["TCGA.AA.3663.01", "Peptide ligand-binding receptors"], ["TCGA.AA.3663.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3663.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AA.3663.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AA.3663.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3663.01", "Extracellular matrix organization"], ["TCGA.AA.3663.01", "L1CAM interactions"], ["TCGA.AA.3663.01", "Regulation of Complement cascade"], ["TCGA.AA.3663.01", "Complement cascade"], ["TCGA.AA.3663.01", "Ion homeostasis"], ["TCGA.AA.3663.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3663.01", "Drug ADME"], ["TCGA.AA.3663.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3663.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.AA.3663.01", "GABA receptor activation"], ["TCGA.AA.3697.01", "Neuronal System"], ["TCGA.AA.3697.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3697.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3697.01", "Biological oxidations"], ["TCGA.AA.3697.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3697.01", "Cardiac conduction"], ["TCGA.AA.3697.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AA.3697.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3697.01", "Platelet homeostasis"], ["TCGA.AA.3697.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3697.01", "G alpha (s) signalling events"], ["TCGA.AA.3697.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3697.01", "Regulation of insulin secretion"], ["TCGA.AA.3697.01", "GABA receptor activation"], ["TCGA.AA.3697.01", "Signal amplification"], ["TCGA.AA.3697.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AA.3697.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3697.01", "Integration of energy metabolism"], ["TCGA.AA.3697.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3697.01", "Phase 4 - resting membrane potential"], ["TCGA.AA.3697.01", "Ethanol oxidation"], ["TCGA.AA.3697.01", "Muscle contraction"], ["TCGA.AA.3697.01", "Molecules associated with elastic fibres"], ["TCGA.AA.3697.01", "Presynaptic nicotinic acetylcholine receptors"], ["TCGA.AA.3697.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AA.3697.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AA.3697.01", "Potassium Channels"], ["TCGA.AA.3697.01", "G alpha (i) signalling events"], ["TCGA.AA.3697.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.AA.3697.01", "Protein-protein interactions at synapses"], ["TCGA.AA.3697.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3697.01", "Glucuronidation"], ["TCGA.AA.3697.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AA.3697.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3697.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AA.3697.01", "GPER1 signaling"], ["TCGA.AA.3697.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AA.3697.01", "GABA B receptor activation"], ["TCGA.AA.3697.01", "Activation of GABAB receptors"], ["TCGA.AA.3697.01", "Inwardly rectifying K+ channels"], ["TCGA.AA.3697.01", "APAP ADME"], ["TCGA.AA.3697.01", "Acetylcholine binding and downstream events"], ["TCGA.AA.3697.01", "Postsynaptic nicotinic acetylcholine receptors"], ["TCGA.AA.3697.01", "Visual phototransduction"], ["TCGA.AA.3697.01", "L1CAM interactions"], ["TCGA.AA.3697.01", "Activation of G protein gated Potassium channels"], ["TCGA.AA.3697.01", "G protein gated Potassium channels"], ["TCGA.AA.3697.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AA.3697.01", "Drug ADME"], ["TCGA.AA.3697.01", "Extracellular matrix organization"], ["TCGA.AA.3697.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AA.3697.01", "SUMOylation of DNA methylation proteins"], ["TCGA.AA.3697.01", "Transport of small molecules"], ["TCGA.AA.3697.01", "Neurexins and neuroligins"], ["TCGA.AA.3697.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AA.3697.01", "Activation of the phototransduction cascade"], ["TCGA.AA.3697.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.AA.3697.01", "RET signaling"], ["TCGA.AA.3697.01", "GPCR downstream signalling"], ["TCGA.AA.3697.01", "Glycosaminoglycan metabolism"], ["TCGA.AA.3697.01", "Metabolism"], ["TCGA.AA.3697.01", "GPCR ligand binding"], ["TCGA.AA.3697.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AA.3697.01", "Aquaporin-mediated transport"], ["TCGA.AA.3697.01", "Extra-nuclear estrogen signaling"], ["TCGA.AA.3712.01", "Neuronal System"], ["TCGA.AA.3712.01", "Transmission across Chemical Synapses"], ["TCGA.AA.3712.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AA.3712.01", "Interaction between L1 and Ankyrins"], ["TCGA.AA.3712.01", "Biological oxidations"], ["TCGA.AA.3712.01", "Signaling by GPCR"], ["TCGA.AA.3712.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AA.3712.01", "GPCR downstream signalling"], ["TCGA.AA.3712.01", "Extracellular matrix organization"], ["TCGA.AA.3712.01", "G alpha (s) signalling events"], ["TCGA.AA.3712.01", "Cardiac conduction"], ["TCGA.AA.3712.01", "Signaling Pathways"], ["TCGA.AA.3712.01", "Collagen formation"], ["TCGA.AA.3712.01", "Phase II - Conjugation of compounds"], ["TCGA.AA.3712.01", "G alpha (i) signalling events"], ["TCGA.AA.3712.01", "Glucuronidation"], ["TCGA.AA.3712.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AA.3712.01", "GABA receptor activation"], ["TCGA.AA.3712.01", "Drug ADME"], ["TCGA.AA.3712.01", "GPCR ligand binding"], ["TCGA.AA.3712.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AA.3712.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AA.3712.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AA.3712.01", "L1CAM interactions"], ["TCGA.AA.3712.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AA.3712.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.AA.3712.01", "Phase 0 - rapid depolarisation"], ["TCGA.AA.3712.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AA.3712.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AA.3712.01", "Platelet homeostasis"], ["TCGA.AA.3712.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AA.3712.01", "Protein-protein interactions at synapses"], ["TCGA.AA.3712.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AA.3712.01", "Glucagon-type ligand receptors"], ["TCGA.AA.3712.01", "Regulation of insulin secretion"], ["TCGA.AA.3712.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AA.3712.01", "Regulation of FZD by ubiquitination"], ["TCGA.AA.3712.01", "G0 and Early G1"], ["TCGA.AA.3712.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AA.3712.01", "Heme degradation"], ["TCGA.AA.3712.01", "Formation of axial mesoderm"], ["TCGA.AA.3712.01", "GPER1 signaling"], ["TCGA.AA.3712.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AA.3712.01", "GABA B receptor activation"], ["TCGA.AA.3712.01", "Activation of GABAB receptors"], ["TCGA.AA.3712.01", "Visual phototransduction"], ["TCGA.AA.3712.01", "Calmodulin induced events"], ["TCGA.AA.3712.01", "CaM pathway"], ["TCGA.AA.3712.01", "Integration of energy metabolism"], ["TCGA.AA.3712.01", "Degradation of the extracellular matrix"], ["TCGA.AA.3712.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.AA.3712.01", "G beta:gamma signalling through BTK"], ["TCGA.AA.3712.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AA.3712.01", "Leishmania parasite growth and survival"], ["TCGA.AA.3712.01", "Metabolism of fat-soluble vitamins"], ["TCGA.AA.3712.01", "Retinoid metabolism and transport"], ["TCGA.AA.3712.01", "TP53 Regulates Transcription of Cell Cycle Genes"], ["TCGA.AA.3712.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AA.3712.01", "Caspase-mediated cleavage of cytoskeletal proteins"], ["TCGA.AA.3712.01", "Muscle contraction"], ["TCGA.AA.3712.01", "Ca2+ pathway"], ["TCGA.AA.3712.01", "Potassium Channels"], ["TCGA.AA.3712.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AA.3712.01", "G alpha (z) signalling events"], ["TCGA.AA.3712.01", "Ca-dependent events"], ["TCGA.AA.3712.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AA.3712.01", "G-protein mediated events"], ["TCGA.AA.3712.01", "Neurexins and neuroligins"], ["TCGA.AA.3713.01", "Neuronal System"], ["TCGA.AA.3713.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AA.3713.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.AA.3713.01", "Potassium Channels"], ["TCGA.AA.3713.01", "Resolution of D-Loop Structures"], ["TCGA.AA.3713.01", "Glycosaminoglycan metabolism"], ["TCGA.AA.3713.01", "Extracellular matrix organization"], ["TCGA.AA.3713.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AA.3713.01", "RA biosynthesis pathway"], ["TCGA.AA.3713.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], ["TCGA.AA.3713.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], ["TCGA.AA.3713.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], ["TCGA.AA.3713.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], ["TCGA.AA.3713.01", "Impaired BRCA2 binding to PALB2"], ["TCGA.AA.3713.01", "Ethanol oxidation"], ["TCGA.AA.3713.01", "Protein-protein interactions at synapses"], ["TCGA.AD.5900.01", "Drug ADME"], ["TCGA.AD.5900.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.5900.01", "Glucuronidation"], ["TCGA.AD.5900.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.5900.01", "Biological oxidations"], ["TCGA.AD.5900.01", "Transmission across Chemical Synapses"], ["TCGA.AD.5900.01", "GPCR ligand binding"], ["TCGA.AD.5900.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.5900.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AD.5900.01", "Neuronal System"], ["TCGA.AD.5900.01", "Signaling by GPCR"], ["TCGA.AD.5900.01", "G alpha (i) signalling events"], ["TCGA.AD.5900.01", "Ethanol oxidation"], ["TCGA.AD.5900.01", "O-linked glycosylation"], ["TCGA.AD.5900.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.5900.01", "Degradation of the extracellular matrix"], ["TCGA.AD.5900.01", "Metabolism of vitamins and cofactors"], ["TCGA.AD.5900.01", "Extracellular matrix organization"], ["TCGA.AD.5900.01", "Aspirin ADME"], ["TCGA.AD.5900.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AD.5900.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AD.5900.01", "Stimuli-sensing channels"], ["TCGA.AD.5900.01", "GPCR downstream signalling"], ["TCGA.AD.5900.01", "Metabolism of water-soluble vitamins and cofactors"], ["TCGA.AD.5900.01", "O-linked glycosylation of mucins"], ["TCGA.AD.5900.01", "G alpha (s) signalling events"], ["TCGA.AD.5900.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.5900.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.5900.01", "Neurotransmitter release cycle"], ["TCGA.AD.5900.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AD.5900.01", "Glycogen synthesis"], ["TCGA.AD.5900.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AD.6548.01", "Biological oxidations"], ["TCGA.AD.6548.01", "Extracellular matrix organization"], ["TCGA.AD.6548.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6548.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6548.01", "Trafficking of AMPA receptors"], ["TCGA.AD.6548.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.AD.6548.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AD.6548.01", "Signaling by GPCR"], ["TCGA.AD.6548.01", "G alpha (s) signalling events"], ["TCGA.AD.6548.01", "Neuronal System"], ["TCGA.AD.6548.01", "L1CAM interactions"], ["TCGA.AD.6548.01", "GPCR ligand binding"], ["TCGA.AD.6548.01", "Signaling by Retinoic Acid"], ["TCGA.AD.6548.01", "Ethanol oxidation"], ["TCGA.AD.6548.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AD.6548.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6548.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AD.6548.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AD.6548.01", "GPCR downstream signalling"], ["TCGA.AD.6548.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6548.01", "Signaling Pathways"], ["TCGA.AD.6548.01", "Collagen formation"], ["TCGA.AD.6548.01", "Transmission across Chemical Synapses"], ["TCGA.AD.6888.01", "Signaling by GPCR"], ["TCGA.AD.6888.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AD.6888.01", "GPCR downstream signalling"], ["TCGA.AD.6888.01", "Signaling Pathways"], ["TCGA.AD.6888.01", "G alpha (i) signalling events"], ["TCGA.AD.6888.01", "GPCR ligand binding"], ["TCGA.AD.6888.01", "Extracellular matrix organization"], ["TCGA.AD.6888.01", "Neuronal System"], ["TCGA.AD.6888.01", "Chemokine receptors bind chemokines"], ["TCGA.AD.6888.01", "Cardiac conduction"], ["TCGA.AD.6888.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.AD.6888.01", "Generation of second messenger molecules"], ["TCGA.AD.6888.01", "Muscle contraction"], ["TCGA.AD.6888.01", "G alpha (s) signalling events"], ["TCGA.AD.6888.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AD.6888.01", "Potassium Channels"], ["TCGA.AD.6888.01", "Peptide ligand-binding receptors"], ["TCGA.AD.6888.01", "Immune System"], ["TCGA.AD.6888.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AD.6888.01", "Platelet homeostasis"], ["TCGA.AD.6888.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AD.6888.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.AD.6888.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AD.6888.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AD.6888.01", "Leishmania parasite growth and survival"], ["TCGA.AD.6888.01", "Integration of energy metabolism"], ["TCGA.AD.6888.01", "PD-1 signaling"], ["TCGA.AD.6888.01", "Elastic fibre formation"], ["TCGA.AD.6888.01", "Complement cascade"], ["TCGA.AD.6888.01", "Regulation of Complement cascade"], ["TCGA.AD.6888.01", "Integrin cell surface interactions"], ["TCGA.AD.6888.01", "Glycosaminoglycan metabolism"], ["TCGA.AD.6888.01", "Regulation of insulin secretion"], ["TCGA.AD.6888.01", "Cell surface interactions at the vascular wall"], ["TCGA.AD.6888.01", "Transmission across Chemical Synapses"], ["TCGA.AD.6888.01", "G alpha (q) signalling events"], ["TCGA.AD.6888.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6888.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.AD.6888.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6888.01", "Classical antibody-mediated complement activation"], ["TCGA.AD.6888.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AD.6888.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.AD.6888.01", "G-protein beta:gamma signalling"], ["TCGA.AD.6888.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6888.01", "Molecules associated with elastic fibres"], ["TCGA.AD.6888.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AD.6888.01", "Defective B3GALTL causes PpS"], ["TCGA.AD.6888.01", "Leishmania infection"], ["TCGA.AD.6888.01", "Parasitic Infection Pathways"], ["TCGA.AD.6888.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AD.6888.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AD.6888.01", "Opioid Signalling"], ["TCGA.AD.6888.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AD.6888.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6888.01", "Signal amplification"], ["TCGA.AD.6888.01", "Voltage gated Potassium channels"], ["TCGA.AD.6888.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.AD.6888.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AD.6888.01", "G beta:gamma signalling through BTK"], ["TCGA.AD.6888.01", "G alpha (z) signalling events"], ["TCGA.AD.6888.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AD.6888.01", "Aquaporin-mediated transport"], ["TCGA.AD.6888.01", "NCAM1 interactions"], ["TCGA.AD.6888.01", "GABA receptor activation"], ["TCGA.AD.6888.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.AD.6888.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AD.6888.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AD.6888.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AD.6888.01", "Binding and entry of HIV virion"], ["TCGA.AD.6888.01", "Ca2+ pathway"], ["TCGA.AD.6888.01", "Diseases of glycosylation"], ["TCGA.AD.6888.01", "Signaling by Interleukins"], ["TCGA.AD.6888.01", "G beta:gamma signalling through CDC42"], ["TCGA.AD.6888.01", "Degradation of the extracellular matrix"], ["TCGA.AD.6888.01", "Peptide hormone metabolism"], ["TCGA.AD.6888.01", "G-protein activation"], ["TCGA.AD.6888.01", "Thromboxane signalling through TP receptor"], ["TCGA.AD.6888.01", "Creation of C4 and C2 activators"], ["TCGA.AD.6888.01", "Presynaptic function of Kainate receptors"], ["TCGA.AD.6888.01", "IRS-related events triggered by IGF1R"], ["TCGA.AD.6888.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6888.01", "Calcitonin-like ligand receptors"], ["TCGA.AD.6888.01", "Keratan sulfate biosynthesis"], ["TCGA.AD.6888.01", "Interleukin-6 family signaling"], ["TCGA.AD.6888.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6888.01", "HS-GAG biosynthesis"], ["TCGA.AD.6888.01", "DAP12 signaling"], ["TCGA.AD.6888.01", "Developmental Biology"], ["TCGA.AD.6888.01", "Collagen formation"], ["TCGA.AD.6888.01", "GPER1 signaling"], ["TCGA.AD.6888.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AD.6888.01", "GABA B receptor activation"], ["TCGA.AD.6888.01", "Activation of GABAB receptors"], ["TCGA.AD.6888.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.AD.6888.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.AD.6888.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.AD.6888.01", "IGF1R signaling cascade"], ["TCGA.AD.6888.01", "Costimulation by the CD28 family"], ["TCGA.AD.6888.01", "DAP12 interactions"], ["TCGA.AD.6888.01", "NCAM signaling for neurite out-growth"], ["TCGA.AD.6888.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AD.6888.01", "Diseases of metabolism"], ["TCGA.AD.6888.01", "TNFs bind their physiological receptors"], ["TCGA.AD.6888.01", "FGFR4 ligand binding and activation"], ["TCGA.AD.6888.01", "CD22 mediated BCR regulation"], ["TCGA.AD.6888.01", "Signaling by Receptor Tyrosine Kinases"], ["TCGA.AD.6888.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.AD.6888.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AD.6888.01", "Other interleukin signaling"], ["TCGA.AD.6888.01", "Diseases of Immune System"], ["TCGA.AD.6888.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.AD.6888.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.AD.6888.01", "Transport of small molecules"], ["TCGA.AD.6888.01", "Interleukin-10 signaling"], ["TCGA.AD.6888.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AD.6888.01", "Stimuli-sensing channels"], ["TCGA.AD.6888.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AD.6888.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.AD.6888.01", "Innate Immune System"], ["TCGA.AD.6888.01", "Carbohydrate metabolism"], ["TCGA.AD.6888.01", "O-linked glycosylation"], ["TCGA.AD.6888.01", "Protein-protein interactions at synapses"], ["TCGA.AD.6888.01", "Ion homeostasis"], ["TCGA.AD.6888.01", "ERK1/ERK2 pathway"], ["TCGA.AD.6888.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AD.6888.01", "Initial triggering of complement"], ["TCGA.AD.6888.01", "FGFR2 ligand binding and activation"], ["TCGA.AD.6888.01", "Insulin processing"], ["TCGA.AD.6888.01", "Scavenging by Class A Receptors"], ["TCGA.AD.6888.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AD.6888.01", "IRS-mediated signalling"], ["TCGA.AD.6888.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.AD.6888.01", "Metabolism of fat-soluble vitamins"], ["TCGA.AD.6888.01", "Retinoid metabolism and transport"], ["TCGA.AD.6888.01", "L1CAM interactions"], ["TCGA.AD.6888.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AD.6888.01", "FCGR activation"], ["TCGA.AD.6888.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AD.6888.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.AD.6888.01", "MAPK family signaling cascades"], ["TCGA.AD.6888.01", "Netrin-1 signaling"], ["TCGA.AD.6888.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.AD.6888.01", "Phospholipase C-mediated cascade: FGFR1"], ["TCGA.AD.6888.01", "Blood group systems biosynthesis"], ["TCGA.AD.6888.01", "Ca-dependent events"], ["TCGA.AD.6888.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.AD.6888.01", "Activation of the phototransduction cascade"], ["TCGA.AD.6888.01", "Specification of primordial germ cells"], ["TCGA.AD.6889.01", "Signaling by GPCR"], ["TCGA.AD.6889.01", "GPCR ligand binding"], ["TCGA.AD.6889.01", "Neuronal System"], ["TCGA.AD.6889.01", "GPCR downstream signalling"], ["TCGA.AD.6889.01", "Cardiac conduction"], ["TCGA.AD.6889.01", "Complement cascade"], ["TCGA.AD.6889.01", "Transmission across Chemical Synapses"], ["TCGA.AD.6889.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AD.6889.01", "Signaling Pathways"], ["TCGA.AD.6889.01", "Extracellular matrix organization"], ["TCGA.AD.6889.01", "Peptide ligand-binding receptors"], ["TCGA.AD.6889.01", "G alpha (i) signalling events"], ["TCGA.AD.6889.01", "Regulation of Complement cascade"], ["TCGA.AD.6889.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AD.6889.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AD.6889.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AD.6889.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6889.01", "Chemokine receptors bind chemokines"], ["TCGA.AD.6889.01", "Initial triggering of complement"], ["TCGA.AD.6889.01", "Muscle contraction"], ["TCGA.AD.6889.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6889.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6889.01", "G alpha (s) signalling events"], ["TCGA.AD.6889.01", "Classical antibody-mediated complement activation"], ["TCGA.AD.6889.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AD.6889.01", "Potassium Channels"], ["TCGA.AD.6889.01", "Ion homeostasis"], ["TCGA.AD.6889.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AD.6889.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6889.01", "Creation of C4 and C2 activators"], ["TCGA.AD.6889.01", "Integration of energy metabolism"], ["TCGA.AD.6889.01", "Regulation of insulin secretion"], ["TCGA.AD.6889.01", "Sensory processing of sound"], ["TCGA.AD.6889.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.AD.6889.01", "Biological oxidations"], ["TCGA.AD.6889.01", "Antimicrobial peptides"], ["TCGA.AD.6889.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AD.6889.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AD.6889.01", "G alpha (q) signalling events"], ["TCGA.AD.6889.01", "Leishmania infection"], ["TCGA.AD.6889.01", "Parasitic Infection Pathways"], ["TCGA.AD.6889.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AD.6889.01", "Drug ADME"], ["TCGA.AD.6889.01", "G-protein mediated events"], ["TCGA.AD.6889.01", "GABA receptor activation"], ["TCGA.AD.6889.01", "PLC beta mediated events"], ["TCGA.AD.6889.01", "Sialic acid metabolism"], ["TCGA.AD.6889.01", "Voltage gated Potassium channels"], ["TCGA.AD.6889.01", "CD22 mediated BCR regulation"], ["TCGA.AD.6889.01", "Degradation of the extracellular matrix"], ["TCGA.AD.6889.01", "L1CAM interactions"], ["TCGA.AD.6889.01", "Transport of small molecules"], ["TCGA.AD.6889.01", "G-protein beta:gamma signalling"], ["TCGA.AD.6889.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AD.6889.01", "Leishmania parasite growth and survival"], ["TCGA.AD.6889.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AD.6889.01", "Calmodulin induced events"], ["TCGA.AD.6889.01", "CaM pathway"], ["TCGA.AD.6889.01", "SUMOylation of intracellular receptors"], ["TCGA.AD.6889.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AD.6889.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AD.6889.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.AD.6889.01", "Ion channel transport"], ["TCGA.AD.6889.01", "DAG and IP3 signaling"], ["TCGA.AD.6889.01", "Activation of the phototransduction cascade"], ["TCGA.AD.6889.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.AD.6889.01", "Stimuli-sensing channels"], ["TCGA.AD.6889.01", "RA biosynthesis pathway"], ["TCGA.AD.6889.01", "Synaptic adhesion-like molecules"], ["TCGA.AD.6889.01", "LGI-ADAM interactions"], ["TCGA.AD.6889.01", "Molecules associated with elastic fibres"], ["TCGA.AD.6889.01", "Ca-dependent events"], ["TCGA.AD.6889.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6889.01", "Arachidonic acid metabolism"], ["TCGA.AD.6889.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AD.6889.01", "Metabolism of vitamins and cofactors"], ["TCGA.AD.6890.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6890.01", "Cardiac conduction"], ["TCGA.AD.6890.01", "Neuronal System"], ["TCGA.AD.6890.01", "GPCR downstream signalling"], ["TCGA.AD.6890.01", "Signaling by GPCR"], ["TCGA.AD.6890.01", "Extracellular matrix organization"], ["TCGA.AD.6890.01", "Blood group systems biosynthesis"], ["TCGA.AD.6890.01", "Potassium Channels"], ["TCGA.AD.6890.01", "Signaling Pathways"], ["TCGA.AD.6890.01", "G alpha (s) signalling events"], ["TCGA.AD.6890.01", "Inwardly rectifying K+ channels"], ["TCGA.AD.6890.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AD.6890.01", "G alpha (q) signalling events"], ["TCGA.AD.6890.01", "Transmission across Chemical Synapses"], ["TCGA.AD.6890.01", "Muscle contraction"], ["TCGA.AD.6890.01", "L1CAM interactions"], ["TCGA.AD.6890.01", "Phase 4 - resting membrane potential"], ["TCGA.AD.6890.01", "Lewis blood group biosynthesis"], ["TCGA.AD.6890.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AD.6890.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6890.01", "G alpha (i) signalling events"], ["TCGA.AD.6890.01", "Peptide hormone metabolism"], ["TCGA.AD.6890.01", "Regulation of insulin secretion"], ["TCGA.AD.6890.01", "G beta:gamma signalling through BTK"], ["TCGA.AD.6890.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AD.6890.01", "Platelet homeostasis"], ["TCGA.AD.6890.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AD.6890.01", "G-protein beta:gamma signalling"], ["TCGA.AD.6890.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6890.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AD.6890.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AD.6890.01", "Leishmania parasite growth and survival"], ["TCGA.AD.6890.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AD.6890.01", "G beta:gamma signalling through CDC42"], ["TCGA.AD.6890.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6890.01", "Signal amplification"], ["TCGA.AD.6890.01", "GABA receptor activation"], ["TCGA.AD.6890.01", "Presynaptic function of Kainate receptors"], ["TCGA.AD.6890.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AD.6890.01", "Acyl chain remodelling of PE"], ["TCGA.AD.6890.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6890.01", "Activation of G protein gated Potassium channels"], ["TCGA.AD.6890.01", "G protein gated Potassium channels"], ["TCGA.AD.6890.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AD.6890.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AD.6890.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AD.6890.01", "Integration of energy metabolism"], ["TCGA.AD.6890.01", "GABA B receptor activation"], ["TCGA.AD.6890.01", "Activation of GABAB receptors"], ["TCGA.AD.6890.01", "Degradation of the extracellular matrix"], ["TCGA.AD.6890.01", "Ion homeostasis"], ["TCGA.AD.6890.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AD.6890.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AD.6890.01", "SUMOylation of intracellular receptors"], ["TCGA.AD.6890.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AD.6890.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.AD.6890.01", "Interleukin-6 family signaling"], ["TCGA.AD.6890.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AD.6890.01", "Neurexins and neuroligins"], ["TCGA.AD.6890.01", "Insulin processing"], ["TCGA.AD.6890.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AD.6890.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.AD.6890.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.AD.6890.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6890.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AD.6890.01", "Aquaporin-mediated transport"], ["TCGA.AD.6890.01", "GPCR ligand binding"], ["TCGA.AD.6890.01", "Drug ADME"], ["TCGA.AD.6890.01", "Diseases of Immune System"], ["TCGA.AD.6890.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.AD.6890.01", "Chemokine receptors bind chemokines"], ["TCGA.AD.6890.01", "Protein-protein interactions at synapses"], ["TCGA.AD.6890.01", "GPER1 signaling"], ["TCGA.AD.6890.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AD.6890.01", "Sensory processing of sound"], ["TCGA.AD.6890.01", "Biological oxidations"], ["TCGA.AD.6890.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.AD.6890.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6895.01", "Neuronal System"], ["TCGA.AD.6895.01", "Drug ADME"], ["TCGA.AD.6895.01", "Biological oxidations"], ["TCGA.AD.6895.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6895.01", "Transmission across Chemical Synapses"], ["TCGA.AD.6895.01", "G alpha (i) signalling events"], ["TCGA.AD.6895.01", "GPCR downstream signalling"], ["TCGA.AD.6895.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AD.6895.01", "Signaling by GPCR"], ["TCGA.AD.6895.01", "Extracellular matrix organization"], ["TCGA.AD.6895.01", "RA biosynthesis pathway"], ["TCGA.AD.6895.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6895.01", "GPCR ligand binding"], ["TCGA.AD.6895.01", "Glucuronidation"], ["TCGA.AD.6895.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6895.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6895.01", "APAP ADME"], ["TCGA.AD.6895.01", "Signaling by Retinoic Acid"], ["TCGA.AD.6895.01", "Voltage gated Potassium channels"], ["TCGA.AD.6895.01", "Collagen formation"], ["TCGA.AD.6895.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AD.6895.01", "Stimuli-sensing channels"], ["TCGA.AD.6895.01", "Ion channel transport"], ["TCGA.AD.6895.01", "Transport of small molecules"], ["TCGA.AD.6895.01", "L1CAM interactions"], ["TCGA.AD.6895.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AD.6895.01", "Collagen chain trimerization"], ["TCGA.AD.6895.01", "Peptide ligand-binding receptors"], ["TCGA.AD.6895.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AD.6895.01", "NCAM1 interactions"], ["TCGA.AD.6895.01", "Metabolism of fat-soluble vitamins"], ["TCGA.AD.6895.01", "Retinoid metabolism and transport"], ["TCGA.AD.6895.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AD.6895.01", "Visual phototransduction"], ["TCGA.AD.6895.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AD.6895.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AD.6895.01", "Metabolism"], ["TCGA.AD.6895.01", "Ethanol oxidation"], ["TCGA.AD.6895.01", "Aspirin ADME"], ["TCGA.AD.6895.01", "Trafficking of AMPA receptors"], ["TCGA.AD.6895.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.AD.6895.01", "Potassium Channels"], ["TCGA.AD.6895.01", "Regulation of insulin secretion"], ["TCGA.AD.6895.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6895.01", "Heme degradation"], ["TCGA.AD.6895.01", "NCAM signaling for neurite out-growth"], ["TCGA.AD.6895.01", "Glutathione conjugation"], ["TCGA.AD.6895.01", "ECM proteoglycans"], ["TCGA.AD.6895.01", "O-linked glycosylation"], ["TCGA.AD.6895.01", "Integration of energy metabolism"], ["TCGA.AD.6895.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AD.6895.01", "Nuclear Receptor transcription pathway"], ["TCGA.AD.6895.01", "Protein-protein interactions at synapses"], ["TCGA.AD.6895.01", "TP53 Regulates Transcription of Death Receptors and Ligands"], ["TCGA.AD.6895.01", "G alpha (s) signalling events"], ["TCGA.AD.6895.01", "SUMOylation of intracellular receptors"], ["TCGA.AD.6899.01", "Extracellular matrix organization"], ["TCGA.AD.6899.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6899.01", "Collagen formation"], ["TCGA.AD.6899.01", "Biological oxidations"], ["TCGA.AD.6899.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AD.6899.01", "Degradation of the extracellular matrix"], ["TCGA.AD.6899.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6899.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6899.01", "Ethanol oxidation"], ["TCGA.AD.6899.01", "Drug ADME"], ["TCGA.AD.6899.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AD.6901.01", "Extracellular matrix organization"], ["TCGA.AD.6901.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AD.6901.01", "Collagen chain trimerization"], ["TCGA.AD.6901.01", "Collagen formation"], ["TCGA.AD.6901.01", "Drug ADME"], ["TCGA.AD.6901.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6901.01", "NCAM1 interactions"], ["TCGA.AD.6901.01", "Glucuronidation"], ["TCGA.AD.6901.01", "Neuronal System"], ["TCGA.AD.6901.01", "Biological oxidations"], ["TCGA.AD.6901.01", "APAP ADME"], ["TCGA.AD.6901.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AD.6901.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6901.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6901.01", "NCAM signaling for neurite out-growth"], ["TCGA.AD.6901.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AD.6901.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AD.6901.01", "Transmission across Chemical Synapses"], ["TCGA.AD.6901.01", "Peptide hormone biosynthesis"], ["TCGA.AD.6901.01", "Regulation of insulin secretion"], ["TCGA.AD.6901.01", "ECM proteoglycans"], ["TCGA.AD.6901.01", "Metabolism"], ["TCGA.AD.6901.01", "Presynaptic function of Kainate receptors"], ["TCGA.AD.6901.01", "G alpha (q) signalling events"], ["TCGA.AD.6901.01", "Potassium Channels"], ["TCGA.AD.6901.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AD.6901.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AD.6901.01", "G-protein activation"], ["TCGA.AD.6901.01", "Thromboxane signalling through TP receptor"], ["TCGA.AD.6901.01", "Signal amplification"], ["TCGA.AD.6901.01", "G beta:gamma signalling through BTK"], ["TCGA.AD.6901.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6901.01", "Degradation of the extracellular matrix"], ["TCGA.AD.6901.01", "Visual phototransduction"], ["TCGA.AD.6901.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AD.6901.01", "Degradation of cysteine and homocysteine"], ["TCGA.AD.6901.01", "Inwardly rectifying K+ channels"], ["TCGA.AD.6901.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AD.6901.01", "G beta:gamma signalling through CDC42"], ["TCGA.AD.6901.01", "GPCR ligand binding"], ["TCGA.AD.6901.01", "Integration of energy metabolism"], ["TCGA.AD.6901.01", "GABA receptor activation"], ["TCGA.AD.6901.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6901.01", "Integrin cell surface interactions"], ["TCGA.AD.6901.01", "G alpha (z) signalling events"], ["TCGA.AD.6901.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AD.6901.01", "Peptide hormone metabolism"], ["TCGA.AD.6901.01", "Phase 2 - plateau phase"], ["TCGA.AD.6901.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AD.6901.01", "Signaling by GPCR"], ["TCGA.AD.6901.01", "G-protein beta:gamma signalling"], ["TCGA.AD.6901.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6901.01", "Cardiac conduction"], ["TCGA.AD.6901.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AD.6901.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AD.6901.01", "Activation of the phototransduction cascade"], ["TCGA.AD.6901.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.AD.6901.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AD.6901.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.AD.6901.01", "Glycosaminoglycan metabolism"], ["TCGA.AD.6901.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AD.6901.01", "Trafficking of AMPA receptors"], ["TCGA.AD.6901.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.AD.6963.01", "Neuronal System"], ["TCGA.AD.6963.01", "Transmission across Chemical Synapses"], ["TCGA.AD.6963.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AD.6963.01", "Biological oxidations"], ["TCGA.AD.6963.01", "G alpha (i) signalling events"], ["TCGA.AD.6963.01", "Drug ADME"], ["TCGA.AD.6963.01", "GPCR downstream signalling"], ["TCGA.AD.6963.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6963.01", "Signaling by GPCR"], ["TCGA.AD.6963.01", "Cardiac conduction"], ["TCGA.AD.6963.01", "GABA receptor activation"], ["TCGA.AD.6963.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6963.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AD.6963.01", "Chemokine receptors bind chemokines"], ["TCGA.AD.6963.01", "Platelet homeostasis"], ["TCGA.AD.6963.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6963.01", "Extracellular matrix organization"], ["TCGA.AD.6963.01", "Peptide ligand-binding receptors"], ["TCGA.AD.6963.01", "Neurexins and neuroligins"], ["TCGA.AD.6963.01", "GPCR ligand binding"], ["TCGA.AD.6963.01", "Muscle contraction"], ["TCGA.AD.6963.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AD.6963.01", "Protein-protein interactions at synapses"], ["TCGA.AD.6963.01", "G alpha (s) signalling events"], ["TCGA.AD.6963.01", "Phase I - Functionalization of compounds"], ["TCGA.AD.6963.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6963.01", "L1CAM interactions"], ["TCGA.AD.6963.01", "Potassium Channels"], ["TCGA.AD.6963.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AD.6963.01", "GABA B receptor activation"], ["TCGA.AD.6963.01", "Activation of GABAB receptors"], ["TCGA.AD.6963.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.AD.6963.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6963.01", "Signaling Pathways"], ["TCGA.AD.6963.01", "Ca-dependent events"], ["TCGA.AD.6963.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6963.01", "Aspirin ADME"], ["TCGA.AD.6963.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6963.01", "Glucuronidation"], ["TCGA.AD.6963.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AD.6963.01", "Aquaporin-mediated transport"], ["TCGA.AD.6963.01", "Transport of small molecules"], ["TCGA.AD.6963.01", "G-protein mediated events"], ["TCGA.AD.6963.01", "Calmodulin induced events"], ["TCGA.AD.6963.01", "CaM pathway"], ["TCGA.AD.6963.01", "GPER1 signaling"], ["TCGA.AD.6963.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AD.6963.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.AD.6963.01", "Degradation of the extracellular matrix"], ["TCGA.AD.6963.01", "Phase 4 - resting membrane potential"], ["TCGA.AD.6963.01", "Ethanol oxidation"], ["TCGA.AD.6963.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AD.6963.01", "Regulation of insulin secretion"], ["TCGA.AD.6963.01", "Signal amplification"], ["TCGA.AD.6963.01", "G alpha (z) signalling events"], ["TCGA.AD.6963.01", "Heme degradation"], ["TCGA.AD.6964.01", "Extracellular matrix organization"], ["TCGA.AD.6964.01", "Drug ADME"], ["TCGA.AD.6964.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6964.01", "Biological oxidations"], ["TCGA.AD.6964.01", "Collagen formation"], ["TCGA.AD.6964.01", "Metabolism"], ["TCGA.AD.6964.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AD.6964.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AD.6964.01", "Collagen chain trimerization"], ["TCGA.AD.6964.01", "Glucuronidation"], ["TCGA.AD.6964.01", "Other semaphorin interactions"], ["TCGA.AD.6964.01", "ECM proteoglycans"], ["TCGA.AD.6964.01", "APAP ADME"], ["TCGA.AD.6964.01", "PI3K events in ERBB2 signaling"], ["TCGA.AD.6964.01", "Glycosaminoglycan metabolism"], ["TCGA.AD.6964.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AD.6964.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AD.6964.01", "Scavenging by Class A Receptors"], ["TCGA.AD.6964.01", "Transmission across Chemical Synapses"], ["TCGA.AD.6964.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AD.6964.01", "Neuronal System"], ["TCGA.AD.6964.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.AD.6964.01", "Regulation of insulin secretion"], ["TCGA.AD.6964.01", "Glutathione conjugation"], ["TCGA.AD.6964.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.AD.6964.01", "Visual phototransduction"], ["TCGA.AD.6964.01", "GAB1 signalosome"], ["TCGA.AD.6964.01", "Collagen degradation"], ["TCGA.AD.6964.01", "ERBB2 Regulates Cell Motility"], ["TCGA.AD.6964.01", "O-linked glycosylation of mucins"], ["TCGA.AD.6964.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.AD.6964.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AD.6964.01", "Signaling by ERBB2 KD Mutants"], ["TCGA.AD.6964.01", "Glucagon-type ligand receptors"], ["TCGA.AD.6964.01", "Aspirin ADME"], ["TCGA.AD.6964.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AD.6964.01", "GRB2 events in ERBB2 signaling"], ["TCGA.AD.6964.01", "Signaling by ERBB2 in Cancer"], ["TCGA.AD.6964.01", "O-linked glycosylation"], ["TCGA.AD.6964.01", "Synaptic adhesion-like molecules"], ["TCGA.AD.6964.01", "GABA synthesis, release, reuptake and degradation"], ["TCGA.AD.6964.01", "Degradation of the extracellular matrix"], ["TCGA.AD.6964.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.AD.6964.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AD.6964.01", "GRB2 events in EGFR signaling"], ["TCGA.AD.6964.01", "Scavenging of heme from plasma"], ["TCGA.AD.6964.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AD.6964.01", "Integration of energy metabolism"], ["TCGA.AD.6964.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6964.01", "GPCR ligand binding"], ["TCGA.AD.6964.01", "Recycling of bile acids and salts"], ["TCGA.AD.6964.01", "SHC1 events in EGFR signaling"], ["TCGA.AD.6964.01", "Defective GALNT3 causes HFTC"], ["TCGA.AD.6964.01", "Defective GALNT12 causes CRCS1"], ["TCGA.AD.6964.01", "Sensory perception of taste"], ["TCGA.AD.6964.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.AD.6964.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.AD.6965.01", "Neuronal System"], ["TCGA.AD.6965.01", "Cardiac conduction"], ["TCGA.AD.6965.01", "Signaling by GPCR"], ["TCGA.AD.6965.01", "Biological oxidations"], ["TCGA.AD.6965.01", "Phase 0 - rapid depolarisation"], ["TCGA.AD.6965.01", "GPCR downstream signalling"], ["TCGA.AD.6965.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AD.6965.01", "Extracellular matrix organization"], ["TCGA.AD.6965.01", "Interaction between L1 and Ankyrins"], ["TCGA.AD.6965.01", "PD-1 signaling"], ["TCGA.AD.6965.01", "Complement cascade"], ["TCGA.AD.6965.01", "GPCR ligand binding"], ["TCGA.AD.6965.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.AD.6965.01", "Regulation of Complement cascade"], ["TCGA.AD.6965.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AD.6965.01", "Phase II - Conjugation of compounds"], ["TCGA.AD.6965.01", "G alpha (s) signalling events"], ["TCGA.AD.6965.01", "Classical antibody-mediated complement activation"], ["TCGA.AD.6965.01", "Neurexins and neuroligins"], ["TCGA.AD.6965.01", "Potassium Channels"], ["TCGA.AD.6965.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.AD.6965.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.AD.6965.01", "Signaling Pathways"], ["TCGA.AD.6965.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AD.6965.01", "Phase 4 - resting membrane potential"], ["TCGA.AD.6965.01", "Transmission across Chemical Synapses"], ["TCGA.AD.6965.01", "Degradation of the extracellular matrix"], ["TCGA.AD.6965.01", "L1CAM interactions"], ["TCGA.AD.6965.01", "Peptide hormone metabolism"], ["TCGA.AD.6965.01", "Regulation of insulin secretion"], ["TCGA.AD.6965.01", "Defensins"], ["TCGA.AD.6965.01", "Blood group systems biosynthesis"], ["TCGA.AD.6965.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AD.6965.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AD.6965.01", "G alpha (i) signalling events"], ["TCGA.AD.6965.01", "Other interleukin signaling"], ["TCGA.AD.6965.01", "Collagen chain trimerization"], ["TCGA.AD.6965.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AD.6965.01", "Chemokine receptors bind chemokines"], ["TCGA.AD.6965.01", "Collagen formation"], ["TCGA.AD.6965.01", "Muscle contraction"], ["TCGA.AM.5820.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.AM.5820.01", "Generation of second messenger molecules"], ["TCGA.AM.5820.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.AM.5820.01", "PD-1 signaling"], ["TCGA.AM.5820.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AM.5820.01", "GPCR downstream signalling"], ["TCGA.AM.5820.01", "Signaling by GPCR"], ["TCGA.AM.5820.01", "Costimulation by the CD28 family"], ["TCGA.AM.5820.01", "Chemokine receptors bind chemokines"], ["TCGA.AM.5820.01", "GPCR ligand binding"], ["TCGA.AM.5820.01", "G alpha (i) signalling events"], ["TCGA.AM.5820.01", "Neuronal System"], ["TCGA.AM.5820.01", "Immune System"], ["TCGA.AM.5820.01", "TCR signaling"], ["TCGA.AM.5820.01", "Signaling Pathways"], ["TCGA.AM.5820.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AM.5820.01", "Extracellular matrix organization"], ["TCGA.AM.5820.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AM.5820.01", "Transmission across Chemical Synapses"], ["TCGA.AM.5820.01", "Peptide ligand-binding receptors"], ["TCGA.AM.5820.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AM.5820.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AM.5820.01", "TNFs bind their physiological receptors"], ["TCGA.AM.5820.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.AM.5820.01", "Adaptive Immune System"], ["TCGA.AM.5820.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AM.5820.01", "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"], ["TCGA.AM.5820.01", "Blood group systems biosynthesis"], ["TCGA.AM.5820.01", "Activation of G protein gated Potassium channels"], ["TCGA.AM.5820.01", "G protein gated Potassium channels"], ["TCGA.AM.5820.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AM.5820.01", "Inwardly rectifying K+ channels"], ["TCGA.AM.5820.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.AM.5820.01", "GABA receptor activation"], ["TCGA.AM.5820.01", "FOXO-mediated transcription"], ["TCGA.AM.5820.01", "Cytokine Signaling in Immune system"], ["TCGA.AM.5820.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.AM.5820.01", "Downstream TCR signaling"], ["TCGA.AM.5820.01", "Protein-protein interactions at synapses"], ["TCGA.AM.5820.01", "Potassium Channels"], ["TCGA.AM.5820.01", "Lewis blood group biosynthesis"], ["TCGA.AM.5820.01", "Neurexins and neuroligins"], ["TCGA.AM.5820.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AM.5820.01", "Formation of axial mesoderm"], ["TCGA.AM.5820.01", "FOXO-mediated transcription of cell death genes"], ["TCGA.AM.5820.01", "Signaling by Activin"], ["TCGA.AM.5820.01", "Synaptic adhesion-like molecules"], ["TCGA.AM.5820.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AM.5821.01", "Biological oxidations"], ["TCGA.AM.5821.01", "Neuronal System"], ["TCGA.AM.5821.01", "Drug ADME"], ["TCGA.AM.5821.01", "Transmission across Chemical Synapses"], ["TCGA.AM.5821.01", "Phase I - Functionalization of compounds"], ["TCGA.AM.5821.01", "Extracellular matrix organization"], ["TCGA.AM.5821.01", "Glucuronidation"], ["TCGA.AM.5821.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AM.5821.01", "Integration of energy metabolism"], ["TCGA.AM.5821.01", "Regulation of insulin secretion"], ["TCGA.AM.5821.01", "Phase II - Conjugation of compounds"], ["TCGA.AM.5821.01", "G-protein mediated events"], ["TCGA.AM.5821.01", "Signaling by GPCR"], ["TCGA.AM.5821.01", "PLC beta mediated events"], ["TCGA.AM.5821.01", "Interaction between L1 and Ankyrins"], ["TCGA.AM.5821.01", "Ethanol oxidation"], ["TCGA.AM.5821.01", "G alpha (i) signalling events"], ["TCGA.AM.5821.01", "Arachidonic acid metabolism"], ["TCGA.AM.5821.01", "Cardiac conduction"], ["TCGA.AM.5821.01", "Protein-protein interactions at synapses"], ["TCGA.AM.5821.01", "GPCR downstream signalling"], ["TCGA.AM.5821.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AM.5821.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AM.5821.01", "Bile acid and bile salt metabolism"], ["TCGA.AM.5821.01", "Aspirin ADME"], ["TCGA.AM.5821.01", "Opioid Signalling"], ["TCGA.AM.5821.01", "Cytochrome P450 - arranged by substrate type"], ["TCGA.AM.5821.01", "Fatty acid metabolism"], ["TCGA.AM.5821.01", "Phase 0 - rapid depolarisation"], ["TCGA.AM.5821.01", "Collagen formation"], ["TCGA.AM.5821.01", "Tryptophan catabolism"], ["TCGA.AM.5821.01", "GABA receptor activation"], ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts"], ["TCGA.AM.5821.01", "Metabolism"], ["TCGA.AM.5821.01", "Muscle contraction"], ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AM.5821.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AM.5821.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AM.5821.01", "Signal amplification"], ["TCGA.AM.5821.01", "Potassium Channels"], ["TCGA.AM.5821.01", "Amino acid transport across the plasma membrane"], ["TCGA.AM.5821.01", "Free fatty acids regulate insulin secretion"], ["TCGA.AM.5821.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AM.5821.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AM.5821.01", "G alpha (s) signalling events"], ["TCGA.AM.5821.01", "Neurexins and neuroligins"], ["TCGA.AM.5821.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AM.5821.01", "DAG and IP3 signaling"], ["TCGA.AM.5821.01", "GABA B receptor activation"], ["TCGA.AM.5821.01", "Activation of GABAB receptors"], ["TCGA.AM.5821.01", "Ca-dependent events"], ["TCGA.AM.5821.01", "Defective GALNT12 causes CRCS1"], ["TCGA.AM.5821.01", "Nuclear Receptor transcription pathway"], ["TCGA.AM.5821.01", "Trafficking of AMPA receptors"], ["TCGA.AM.5821.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.AM.5821.01", "SUMOylation of intracellular receptors"], ["TCGA.AM.5821.01", "APAP ADME"], ["TCGA.AM.5821.01", "O-linked glycosylation"], ["TCGA.AM.5821.01", "Neurotransmitter release cycle"], ["TCGA.AM.5821.01", "Calmodulin induced events"], ["TCGA.AM.5821.01", "CaM pathway"], ["TCGA.AM.5821.01", "L1CAM interactions"], ["TCGA.AM.5821.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AM.5821.01", "Aflatoxin activation and detoxification"], ["TCGA.AM.5821.01", "Regulation of RUNX1 Expression and Activity"], ["TCGA.AM.5821.01", "Kinesins"], ["TCGA.AM.5821.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AM.5821.01", "GPCR ligand binding"], ["TCGA.AM.5821.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AM.5821.01", "SLC-mediated transmembrane transport"], ["TCGA.AM.5821.01", "PKA activation in glucagon signalling"], ["TCGA.AM.5821.01", "Synaptic adhesion-like molecules"], ["TCGA.AM.5821.01", "Biosynthesis of DHA-derived SPMs"], ["TCGA.AM.5821.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.AM.5821.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.AM.5821.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AM.5821.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.AM.5821.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AM.5821.01", "Phase 2 - plateau phase"], ["TCGA.AU.3779.01", "GPCR ligand binding"], ["TCGA.AU.3779.01", "Biological oxidations"], ["TCGA.AU.3779.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AU.3779.01", "Extracellular matrix organization"], ["TCGA.AU.3779.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AU.3779.01", "Peptide ligand-binding receptors"], ["TCGA.AU.3779.01", "Neuronal System"], ["TCGA.AU.3779.01", "G alpha (s) signalling events"], ["TCGA.AU.3779.01", "GPCR downstream signalling"], ["TCGA.AU.3779.01", "Signaling by GPCR"], ["TCGA.AU.3779.01", "Phase II - Conjugation of compounds"], ["TCGA.AU.3779.01", "Cardiac conduction"], ["TCGA.AU.3779.01", "G alpha (i) signalling events"], ["TCGA.AU.3779.01", "GABA receptor activation"], ["TCGA.AU.3779.01", "Degradation of the extracellular matrix"], ["TCGA.AU.3779.01", "Glucuronidation"], ["TCGA.AU.3779.01", "Drug ADME"], ["TCGA.AU.3779.01", "Potassium Channels"], ["TCGA.AU.3779.01", "Glucagon-type ligand receptors"], ["TCGA.AU.3779.01", "Chemokine receptors bind chemokines"], ["TCGA.AU.3779.01", "Sensory processing of sound"], ["TCGA.AU.3779.01", "Integration of energy metabolism"], ["TCGA.AU.3779.01", "Regulation of insulin secretion"], ["TCGA.AU.3779.01", "O-linked glycosylation of mucins"], ["TCGA.AU.3779.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AU.3779.01", "Platelet homeostasis"], ["TCGA.AU.3779.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AU.3779.01", "Ethanol oxidation"], ["TCGA.AU.3779.01", "Metabolism"], ["TCGA.AU.3779.01", "Signaling Pathways"], ["TCGA.AU.3779.01", "Transmission across Chemical Synapses"], ["TCGA.AU.3779.01", "Signaling by BMP"], ["TCGA.AU.3779.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.AU.3779.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AU.3779.01", "Signal amplification"], ["TCGA.AU.3779.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.AU.3779.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AU.3779.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AU.3779.01", "Aspirin ADME"], ["TCGA.AU.3779.01", "GABA B receptor activation"], ["TCGA.AU.3779.01", "Activation of GABAB receptors"], ["TCGA.AU.3779.01", "Phase I - Functionalization of compounds"], ["TCGA.AU.3779.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AU.3779.01", "Interaction between L1 and Ankyrins"], ["TCGA.AU.3779.01", "Presynaptic function of Kainate receptors"], ["TCGA.AU.3779.01", "Metabolism of amine-derived hormones"], ["TCGA.AU.3779.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AU.3779.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AU.3779.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.AU.3779.01", "Peptide hormone metabolism"], ["TCGA.AU.3779.01", "Phase 0 - rapid depolarisation"], ["TCGA.AU.3779.01", "Collagen formation"], ["TCGA.AU.3779.01", "G-protein activation"], ["TCGA.AU.3779.01", "Thromboxane signalling through TP receptor"], ["TCGA.AU.3779.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.AU.3779.01", "Muscle contraction"], ["TCGA.AU.3779.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AU.3779.01", "Phase 4 - resting membrane potential"], ["TCGA.AU.3779.01", "GPER1 signaling"], ["TCGA.AU.3779.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AU.3779.01", "Keratan sulfate biosynthesis"], ["TCGA.AU.3779.01", "Interleukin-6 family signaling"], ["TCGA.AU.3779.01", "RA biosynthesis pathway"], ["TCGA.AU.3779.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AU.3779.01", "G beta:gamma signalling through BTK"], ["TCGA.AU.3779.01", "Inwardly rectifying K+ channels"], ["TCGA.AU.3779.01", "G alpha (q) signalling events"], ["TCGA.AU.3779.01", "Heme degradation"], ["TCGA.AU.3779.01", "Formation of axial mesoderm"], ["TCGA.AU.6004.01", "Extracellular matrix organization"], ["TCGA.AU.6004.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AU.6004.01", "Neuronal System"], ["TCGA.AU.6004.01", "Degradation of the extracellular matrix"], ["TCGA.AU.6004.01", "Interaction between L1 and Ankyrins"], ["TCGA.AU.6004.01", "Drug ADME"], ["TCGA.AU.6004.01", "Glucuronidation"], ["TCGA.AU.6004.01", "Collagen formation"], ["TCGA.AU.6004.01", "Transmission across Chemical Synapses"], ["TCGA.AU.6004.01", "Phase II - Conjugation of compounds"], ["TCGA.AU.6004.01", "Potassium Channels"], ["TCGA.AU.6004.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AU.6004.01", "Collagen chain trimerization"], ["TCGA.AU.6004.01", "Biological oxidations"], ["TCGA.AU.6004.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AU.6004.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AU.6004.01", "Aspirin ADME"], ["TCGA.AU.6004.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AU.6004.01", "Integration of energy metabolism"], ["TCGA.AU.6004.01", "L1CAM interactions"], ["TCGA.AU.6004.01", "Phase 4 - resting membrane potential"], ["TCGA.AU.6004.01", "Cardiac conduction"], ["TCGA.AU.6004.01", "NCAM1 interactions"], ["TCGA.AU.6004.01", "Phase 0 - rapid depolarisation"], ["TCGA.AU.6004.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AU.6004.01", "NCAM signaling for neurite out-growth"], ["TCGA.AU.6004.01", "Peptide hormone metabolism"], ["TCGA.AU.6004.01", "Regulation of insulin secretion"], ["TCGA.AU.6004.01", "GPCR ligand binding"], ["TCGA.AU.6004.01", "O-linked glycosylation"], ["TCGA.AU.6004.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AU.6004.01", "Inwardly rectifying K+ channels"], ["TCGA.AU.6004.01", "SLC-mediated transmembrane transport"], ["TCGA.AU.6004.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AU.6004.01", "Integrin cell surface interactions"], ["TCGA.AU.6004.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AU.6004.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.AU.6004.01", "Stimuli-sensing channels"], ["TCGA.AU.6004.01", "ECM proteoglycans"], ["TCGA.AU.6004.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.AU.6004.01", "Diseases of glycosylation"], ["TCGA.AU.6004.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AU.6004.01", "Glucagon-type ligand receptors"], ["TCGA.AU.6004.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AU.6004.01", "Ethanol oxidation"], ["TCGA.AU.6004.01", "Interleukin-6 family signaling"], ["TCGA.AY.5543.01", "Neuronal System"], ["TCGA.AY.5543.01", "Extracellular matrix organization"], ["TCGA.AY.5543.01", "Biological oxidations"], ["TCGA.AY.5543.01", "Cardiac conduction"], ["TCGA.AY.5543.01", "Molecules associated with elastic fibres"], ["TCGA.AY.5543.01", "Signaling by GPCR"], ["TCGA.AY.5543.01", "Muscle contraction"], ["TCGA.AY.5543.01", "Phase I - Functionalization of compounds"], ["TCGA.AY.5543.01", "Elastic fibre formation"], ["TCGA.AY.5543.01", "Phase 0 - rapid depolarisation"], ["TCGA.AY.5543.01", "GPCR ligand binding"], ["TCGA.AY.5543.01", "GPCR downstream signalling"], ["TCGA.AY.5543.01", "Degradation of the extracellular matrix"], ["TCGA.AY.5543.01", "Protein-protein interactions at synapses"], ["TCGA.AY.5543.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AY.5543.01", "Interaction between L1 and Ankyrins"], ["TCGA.AY.5543.01", "Transmission across Chemical Synapses"], ["TCGA.AY.5543.01", "ECM proteoglycans"], ["TCGA.AY.5543.01", "G alpha (i) signalling events"], ["TCGA.AY.5543.01", "Signaling Pathways"], ["TCGA.AY.5543.01", "L1CAM interactions"], ["TCGA.AY.5543.01", "Other semaphorin interactions"], ["TCGA.AY.5543.01", "Insulin processing"], ["TCGA.AY.5543.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AY.5543.01", "Neurexins and neuroligins"], ["TCGA.AY.5543.01", "Chemokine receptors bind chemokines"], ["TCGA.AY.5543.01", "IRS-related events triggered by IGF1R"], ["TCGA.AY.5543.01", "Ion homeostasis"], ["TCGA.AY.5543.01", "Endogenous sterols"], ["TCGA.AY.5543.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AY.5543.01", "Peptide hormone metabolism"], ["TCGA.AY.5543.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.AY.5543.01", "IGF1R signaling cascade"], ["TCGA.AY.5543.01", "Glutathione conjugation"], ["TCGA.AY.5543.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AY.5543.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AY.5543.01", "Peptide ligand-binding receptors"], ["TCGA.AY.6196.01", "Extracellular matrix organization"], ["TCGA.AY.6196.01", "Collagen formation"], ["TCGA.AY.6196.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AY.6196.01", "Biological oxidations"], ["TCGA.AY.6196.01", "Collagen chain trimerization"], ["TCGA.AY.6196.01", "Drug ADME"], ["TCGA.AY.6196.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.AY.6196.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AY.6196.01", "Diseases of glycosylation"], ["TCGA.AY.6196.01", "Diseases of metabolism"], ["TCGA.AY.6196.01", "APAP ADME"], ["TCGA.AY.6196.01", "Metabolism"], ["TCGA.AY.6196.01", "Triglyceride metabolism"], ["TCGA.AY.6196.01", "O-linked glycosylation"], ["TCGA.AY.6196.01", "Defective B3GALTL causes PpS"], ["TCGA.AY.6196.01", "Degradation of the extracellular matrix"], ["TCGA.AY.6196.01", "Phase II - Conjugation of compounds"], ["TCGA.AY.6196.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AY.6196.01", "Triglyceride biosynthesis"], ["TCGA.AY.6196.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AY.6196.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AY.6196.01", "SLC-mediated transmembrane transport"], ["TCGA.AY.6196.01", "ECM proteoglycans"], ["TCGA.AY.6196.01", "Stimuli-sensing channels"], ["TCGA.AY.6196.01", "Phase I - Functionalization of compounds"], ["TCGA.AY.6196.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AY.6196.01", "Peptide ligand-binding receptors"], ["TCGA.AY.6196.01", "Integrin cell surface interactions"], ["TCGA.AY.6196.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AY.6196.01", "Surfactant metabolism"], ["TCGA.AY.6196.01", "Defective GALNT12 causes CRCS1"], ["TCGA.AY.6196.01", "Glucuronidation"], ["TCGA.AY.6196.01", "Other semaphorin interactions"], ["TCGA.AY.6196.01", "Aspirin ADME"], ["TCGA.AY.6196.01", "Scavenging by Class A Receptors"], ["TCGA.AY.6196.01", "Signaling by GPCR"], ["TCGA.AY.6196.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AY.6196.01", "Interaction between L1 and Ankyrins"], ["TCGA.AY.6196.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AY.6196.01", "GPCR ligand binding"], ["TCGA.AY.6196.01", "Regulation of gene expression in beta cells"], ["TCGA.AY.6196.01", "Collagen degradation"], ["TCGA.AY.6197.01", "GPCR ligand binding"], ["TCGA.AY.6197.01", "Signaling by GPCR"], ["TCGA.AY.6197.01", "Neuronal System"], ["TCGA.AY.6197.01", "Cardiac conduction"], ["TCGA.AY.6197.01", "Chemokine receptors bind chemokines"], ["TCGA.AY.6197.01", "GPCR downstream signalling"], ["TCGA.AY.6197.01", "Interaction between L1 and Ankyrins"], ["TCGA.AY.6197.01", "Transmission across Chemical Synapses"], ["TCGA.AY.6197.01", "Muscle contraction"], ["TCGA.AY.6197.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AY.6197.01", "Peptide ligand-binding receptors"], ["TCGA.AY.6197.01", "G alpha (i) signalling events"], ["TCGA.AY.6197.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AY.6197.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AY.6197.01", "L1CAM interactions"], ["TCGA.AY.6197.01", "Extracellular matrix organization"], ["TCGA.AY.6197.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.AY.6197.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.AY.6197.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AY.6197.01", "Glucagon-type ligand receptors"], ["TCGA.AY.6197.01", "G alpha (s) signalling events"], ["TCGA.AY.6197.01", "Potassium Channels"], ["TCGA.AY.6197.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AY.6197.01", "Interleukin-10 signaling"], ["TCGA.AY.6197.01", "Platelet homeostasis"], ["TCGA.AY.6197.01", "Phase 0 - rapid depolarisation"], ["TCGA.AY.6197.01", "Signaling Pathways"], ["TCGA.AY.6197.01", "Regulation of TLR by endogenous ligand"], ["TCGA.AY.6197.01", "Response to elevated platelet cytosolic Ca2+"], ["TCGA.AY.6197.01", "Blood group systems biosynthesis"], ["TCGA.AY.6197.01", "Diseases of Immune System"], ["TCGA.AY.6197.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.AY.6197.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AY.6197.01", "Activation of G protein gated Potassium channels"], ["TCGA.AY.6197.01", "G protein gated Potassium channels"], ["TCGA.AY.6197.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AY.6197.01", "G beta:gamma signalling through BTK"], ["TCGA.AY.6197.01", "Sialic acid metabolism"], ["TCGA.AY.6197.01", "Neurexins and neuroligins"], ["TCGA.AY.6197.01", "GABA receptor activation"], ["TCGA.AY.6197.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AY.6197.01", "GABA B receptor activation"], ["TCGA.AY.6197.01", "Activation of GABAB receptors"], ["TCGA.AY.6197.01", "Glycosaminoglycan metabolism"], ["TCGA.AY.6197.01", "Complement cascade"], ["TCGA.AY.6197.01", "Phase 4 - resting membrane potential"], ["TCGA.AY.6197.01", "G alpha (z) signalling events"], ["TCGA.AY.6197.01", "Presynaptic function of Kainate receptors"], ["TCGA.AY.6197.01", "Stimuli-sensing channels"], ["TCGA.AY.6197.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AY.6197.01", "Lewis blood group biosynthesis"], ["TCGA.AY.6197.01", "Regulation of Complement cascade"], ["TCGA.AY.6197.01", "Protein-protein interactions at synapses"], ["TCGA.AY.6197.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AY.6197.01", "Leishmania parasite growth and survival"], ["TCGA.AY.6197.01", "Ion channel transport"], ["TCGA.AY.6197.01", "G alpha (q) signalling events"], ["TCGA.AY.6197.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AY.6197.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AY.6197.01", "Inwardly rectifying K+ channels"], ["TCGA.AY.6197.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AY.6197.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AY.6197.01", "Aquaporin-mediated transport"], ["TCGA.AY.6197.01", "Regulation of insulin secretion"], ["TCGA.AY.6197.01", "Biological oxidations"], ["TCGA.AY.6197.01", "Molecules associated with elastic fibres"], ["TCGA.AY.6197.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AY.6197.01", "GPER1 signaling"], ["TCGA.AY.6197.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AY.6197.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.AY.6197.01", "ECM proteoglycans"], ["TCGA.AY.6197.01", "Ion homeostasis"], ["TCGA.AY.6197.01", "G-protein beta:gamma signalling"], ["TCGA.AY.6197.01", "Visual phototransduction"], ["TCGA.AY.6197.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.AY.6197.01", "Diseases associated with glycosaminoglycan metabolism"], ["TCGA.AY.6197.01", "Metabolism of fat-soluble vitamins"], ["TCGA.AY.6197.01", "Retinoid metabolism and transport"], ["TCGA.AY.6197.01", "Phase II - Conjugation of compounds"], ["TCGA.AY.6197.01", "Glucuronidation"], ["TCGA.AY.6197.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AY.6197.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AY.6197.01", "Termination of O-glycan biosynthesis"], ["TCGA.AY.6197.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AY.6197.01", "Integration of energy metabolism"], ["TCGA.AY.6197.01", "Keratan sulfate biosynthesis"], ["TCGA.AY.6197.01", "Interleukin-6 family signaling"], ["TCGA.AY.6386.01", "Neuronal System"], ["TCGA.AY.6386.01", "Transmission across Chemical Synapses"], ["TCGA.AY.6386.01", "Interaction between L1 and Ankyrins"], ["TCGA.AY.6386.01", "Cardiac conduction"], ["TCGA.AY.6386.01", "Extracellular matrix organization"], ["TCGA.AY.6386.01", "Potassium Channels"], ["TCGA.AY.6386.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AY.6386.01", "L1CAM interactions"], ["TCGA.AY.6386.01", "Muscle contraction"], ["TCGA.AY.6386.01", "Phase 0 - rapid depolarisation"], ["TCGA.AY.6386.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AY.6386.01", "GPCR ligand binding"], ["TCGA.AY.6386.01", "Glucagon-type ligand receptors"], ["TCGA.AY.6386.01", "Signaling by GPCR"], ["TCGA.AY.6386.01", "G alpha (s) signalling events"], ["TCGA.AY.6386.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AY.6386.01", "Integration of energy metabolism"], ["TCGA.AY.6386.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AY.6386.01", "GABA receptor activation"], ["TCGA.AY.6386.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AY.6386.01", "Collagen formation"], ["TCGA.AY.6386.01", "GPCR downstream signalling"], ["TCGA.AY.6386.01", "NCAM1 interactions"], ["TCGA.AY.6386.01", "Voltage gated Potassium channels"], ["TCGA.AY.6386.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AY.6386.01", "Degradation of the extracellular matrix"], ["TCGA.AY.6386.01", "Biological oxidations"], ["TCGA.AY.6386.01", "Regulation of Complement cascade"], ["TCGA.AY.6386.01", "Peptide hormone metabolism"], ["TCGA.AY.6386.01", "Phase 4 - resting membrane potential"], ["TCGA.AY.6386.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AY.6386.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AY.6386.01", "Inwardly rectifying K+ channels"], ["TCGA.AY.6386.01", "Activation of G protein gated Potassium channels"], ["TCGA.AY.6386.01", "G protein gated Potassium channels"], ["TCGA.AY.6386.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AY.6386.01", "Platelet homeostasis"], ["TCGA.AY.6386.01", "Developmental Biology"], ["TCGA.AY.6386.01", "NCAM signaling for neurite out-growth"], ["TCGA.AY.6386.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AY.6386.01", "GABA B receptor activation"], ["TCGA.AY.6386.01", "Activation of GABAB receptors"], ["TCGA.AY.6386.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.AY.6386.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AY.6386.01", "Molecules associated with elastic fibres"], ["TCGA.AY.6386.01", "Collagen chain trimerization"], ["TCGA.AY.6386.01", "Phase I - Functionalization of compounds"], ["TCGA.AY.6386.01", "Complement cascade"], ["TCGA.AY.6386.01", "Glycosaminoglycan metabolism"], ["TCGA.AY.6386.01", "FGFR1 ligand binding and activation"], ["TCGA.AY.6386.01", "G beta:gamma signalling through BTK"], ["TCGA.AY.6386.01", "Arachidonic acid metabolism"], ["TCGA.AY.6386.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AY.6386.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AY.6386.01", "Transport of small molecules"], ["TCGA.AY.6386.01", "G alpha (i) signalling events"], ["TCGA.AY.6386.01", "Regulation of insulin secretion"], ["TCGA.AY.6386.01", "Peptide ligand-binding receptors"], ["TCGA.AY.6386.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AY.6386.01", "Signal amplification"], ["TCGA.AY.6386.01", "Neurexins and neuroligins"], ["TCGA.AY.6386.01", "LGI-ADAM interactions"], ["TCGA.AY.6386.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AY.6386.01", "G beta:gamma signalling through CDC42"], ["TCGA.AZ.4323.01", "Neuronal System"], ["TCGA.AZ.4323.01", "Peptide hormone biosynthesis"], ["TCGA.AZ.4323.01", "Cardiac conduction"], ["TCGA.AZ.4323.01", "Ion channel transport"], ["TCGA.AZ.4323.01", "GPCR ligand binding"], ["TCGA.AZ.4323.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.4323.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.4323.01", "Muscle contraction"], ["TCGA.AZ.4323.01", "Potassium Channels"], ["TCGA.AZ.4323.01", "Biological oxidations"], ["TCGA.AZ.4323.01", "Visual phototransduction"], ["TCGA.AZ.4323.01", "Drug ADME"], ["TCGA.AZ.4323.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.4323.01", "Keratinization"], ["TCGA.AZ.4323.01", "Peptide hormone metabolism"], ["TCGA.AZ.4323.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.4323.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AZ.4323.01", "Stimuli-sensing channels"], ["TCGA.AZ.4323.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.4323.01", "APAP ADME"], ["TCGA.AZ.4323.01", "O-linked glycosylation"], ["TCGA.AZ.4323.01", "G alpha (s) signalling events"], ["TCGA.AZ.4323.01", "Metabolism of fat-soluble vitamins"], ["TCGA.AZ.4323.01", "Retinoid metabolism and transport"], ["TCGA.AZ.4323.01", "Voltage gated Potassium channels"], ["TCGA.AZ.4323.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.4323.01", "Glucuronidation"], ["TCGA.AZ.4323.01", "Extracellular matrix organization"], ["TCGA.AZ.4323.01", "Metabolism"], ["TCGA.AZ.4323.01", "Signaling by GPCR"], ["TCGA.AZ.4323.01", "Receptor-type tyrosine-protein phosphatases"], ["TCGA.AZ.4323.01", "Phase 4 - resting membrane potential"], ["TCGA.AZ.4323.01", "Ethanol oxidation"], ["TCGA.AZ.4323.01", "Long-term potentiation"], ["TCGA.AZ.4323.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.AZ.4323.01", "Protein-protein interactions at synapses"], ["TCGA.AZ.4323.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AZ.4323.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.AZ.4323.01", "Defective B3GALTL causes PpS"], ["TCGA.AZ.4323.01", "Vitamin D (calciferol) metabolism"], ["TCGA.AZ.4323.01", "Presynaptic nicotinic acetylcholine receptors"], ["TCGA.AZ.4323.01", "Peptide ligand-binding receptors"], ["TCGA.AZ.4615.01", "Neuronal System"], ["TCGA.AZ.4615.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.4615.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.4615.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AZ.4615.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.4615.01", "L1CAM interactions"], ["TCGA.AZ.4615.01", "GPCR ligand binding"], ["TCGA.AZ.4615.01", "Signaling by GPCR"], ["TCGA.AZ.4615.01", "GABA receptor activation"], ["TCGA.AZ.4615.01", "Extracellular matrix organization"], ["TCGA.AZ.4615.01", "Potassium Channels"], ["TCGA.AZ.4615.01", "G alpha (s) signalling events"], ["TCGA.AZ.4615.01", "G alpha (i) signalling events"], ["TCGA.AZ.4615.01", "GPCR downstream signalling"], ["TCGA.AZ.4615.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.4615.01", "Protein-protein interactions at synapses"], ["TCGA.AZ.4615.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AZ.4615.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.4615.01", "NCAM1 interactions"], ["TCGA.AZ.4615.01", "Drug ADME"], ["TCGA.AZ.4615.01", "O-linked glycosylation"], ["TCGA.AZ.4615.01", "Collagen chain trimerization"], ["TCGA.AZ.4615.01", "Cardiac conduction"], ["TCGA.AZ.4615.01", "Neurexins and neuroligins"], ["TCGA.AZ.4615.01", "GABA B receptor activation"], ["TCGA.AZ.4615.01", "Activation of GABAB receptors"], ["TCGA.AZ.4615.01", "Peptide hormone metabolism"], ["TCGA.AZ.4615.01", "Biological oxidations"], ["TCGA.AZ.4615.01", "NCAM signaling for neurite out-growth"], ["TCGA.AZ.4615.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.AZ.4615.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.4615.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.4615.01", "Digestion and absorption"], ["TCGA.AZ.4615.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.4615.01", "RA biosynthesis pathway"], ["TCGA.AZ.4615.01", "Glutathione conjugation"], ["TCGA.AZ.4615.01", "Digestion"], ["TCGA.AZ.4615.01", "Integration of energy metabolism"], ["TCGA.AZ.4615.01", "Regulation of insulin secretion"], ["TCGA.AZ.4615.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AZ.4615.01", "Signaling by Retinoic Acid"], ["TCGA.AZ.4615.01", "APAP ADME"], ["TCGA.AZ.4615.01", "Neurotransmitter release cycle"], ["TCGA.AZ.4615.01", "Voltage gated Potassium channels"], ["TCGA.AZ.4615.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.4615.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.4615.01", "O-linked glycosylation of mucins"], ["TCGA.AZ.4615.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.4615.01", "Peptide ligand-binding receptors"], ["TCGA.AZ.4615.01", "Visual phototransduction"], ["TCGA.AZ.4615.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AZ.4615.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.4615.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AZ.4615.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AZ.4615.01", "Inwardly rectifying K+ channels"], ["TCGA.AZ.4615.01", "Defective B3GALTL causes PpS"], ["TCGA.AZ.4615.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.4615.01", "G protein gated Potassium channels"], ["TCGA.AZ.4615.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.4615.01", "Signaling Pathways"], ["TCGA.AZ.4615.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AZ.4615.01", "Antimicrobial peptides"], ["TCGA.AZ.4615.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.4615.01", "Chemokine receptors bind chemokines"], ["TCGA.AZ.4615.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.AZ.4615.01", "Synaptic adhesion-like molecules"], ["TCGA.AZ.4615.01", "Collagen formation"], ["TCGA.AZ.4616.01", "Signaling by GPCR"], ["TCGA.AZ.4616.01", "GPCR downstream signalling"], ["TCGA.AZ.4616.01", "G alpha (i) signalling events"], ["TCGA.AZ.4616.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.4616.01", "Neuronal System"], ["TCGA.AZ.4616.01", "Signaling Pathways"], ["TCGA.AZ.4616.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.4616.01", "Cardiac conduction"], ["TCGA.AZ.4616.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AZ.4616.01", "Drug ADME"], ["TCGA.AZ.4616.01", "GPCR ligand binding"], ["TCGA.AZ.4616.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AZ.4616.01", "Chemokine receptors bind chemokines"], ["TCGA.AZ.4616.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.4616.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AZ.4616.01", "Extracellular matrix organization"], ["TCGA.AZ.4616.01", "G alpha (s) signalling events"], ["TCGA.AZ.4616.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AZ.4616.01", "Leishmania parasite growth and survival"], ["TCGA.AZ.4616.01", "Peptide ligand-binding receptors"], ["TCGA.AZ.4616.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.4616.01", "Calmodulin induced events"], ["TCGA.AZ.4616.01", "CaM pathway"], ["TCGA.AZ.4616.01", "Degradation of the extracellular matrix"], ["TCGA.AZ.4616.01", "DAG and IP3 signaling"], ["TCGA.AZ.4616.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AZ.4616.01", "PKA activation in glucagon signalling"], ["TCGA.AZ.4616.01", "G-protein mediated events"], ["TCGA.AZ.4616.01", "Platelet homeostasis"], ["TCGA.AZ.4616.01", "PLC beta mediated events"], ["TCGA.AZ.4616.01", "Ca-dependent events"], ["TCGA.AZ.4616.01", "Integration of energy metabolism"], ["TCGA.AZ.4616.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.4616.01", "Azathioprine ADME"], ["TCGA.AZ.4616.01", "G alpha (z) signalling events"], ["TCGA.AZ.4616.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AZ.4616.01", "L1CAM interactions"], ["TCGA.AZ.4616.01", "Regulation of insulin secretion"], ["TCGA.AZ.4616.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AZ.4616.01", "Aquaporin-mediated transport"], ["TCGA.AZ.4616.01", "GPER1 signaling"], ["TCGA.AZ.4616.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AZ.4616.01", "GABA B receptor activation"], ["TCGA.AZ.4616.01", "Activation of GABAB receptors"], ["TCGA.AZ.4616.01", "GABA receptor activation"], ["TCGA.AZ.4616.01", "Opioid Signalling"], ["TCGA.AZ.4616.01", "Blood group systems biosynthesis"], ["TCGA.AZ.4616.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.4616.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AZ.4616.01", "Muscle contraction"], ["TCGA.AZ.4616.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.AZ.4616.01", "Phase 2 - plateau phase"], ["TCGA.AZ.4616.01", "Leishmania infection"], ["TCGA.AZ.4616.01", "Parasitic Infection Pathways"], ["TCGA.AZ.4616.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AZ.4616.01", "Regulation of gene expression by Hypoxia-inducible Factor"], ["TCGA.AZ.4616.01", "Peptide hormone metabolism"], ["TCGA.AZ.4616.01", "Biological oxidations"], ["TCGA.AZ.4616.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AZ.4616.01", "Lewis blood group biosynthesis"], ["TCGA.AZ.4616.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AZ.4616.01", "Diseases of Immune System"], ["TCGA.AZ.4616.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.AZ.4616.01", "Defensins"], ["TCGA.AZ.4616.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AZ.4616.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.4616.01", "Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3"], ["TCGA.AZ.4616.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.AZ.4681.01", "Binding and entry of HIV virion"], ["TCGA.AZ.4681.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AZ.4681.01", "Unwinding of DNA"], ["TCGA.AZ.4681.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AZ.4681.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AZ.4681.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AZ.4681.01", "Leishmania parasite growth and survival"], ["TCGA.AZ.4681.01", "G-protein beta:gamma signalling"], ["TCGA.AZ.4681.01", "DNA strand elongation"], ["TCGA.AZ.4681.01", "Cellular response to starvation"], ["TCGA.AZ.4681.01", "Azathioprine ADME"], ["TCGA.AZ.4681.01", "Viral mRNA Translation"], ["TCGA.AZ.4681.01", "Eukaryotic Translation Elongation"], ["TCGA.AZ.4681.01", "Eukaryotic Translation Termination"], ["TCGA.AZ.4681.01", "Peptide chain elongation"], ["TCGA.AZ.4681.01", "Formation of a pool of free 40S subunits"], ["TCGA.AZ.4681.01", "G beta:gamma signalling through CDC42"], ["TCGA.AZ.4681.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AZ.4681.01", "rRNA processing"], ["TCGA.AZ.4681.01", "Selenocysteine synthesis"], ["TCGA.AZ.4681.01", "Regulation of insulin secretion"], ["TCGA.AZ.4681.01", "G alpha (z) signalling events"], ["TCGA.AZ.4681.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AZ.4681.01", "rRNA processing in the nucleus and cytosol"], ["TCGA.AZ.4681.01", "Immune System"], ["TCGA.AZ.4681.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AZ.4681.01", "Post-chaperonin tubulin folding pathway"], ["TCGA.AZ.4681.01", "Major pathway of rRNA processing in the nucleolus and cytosol"], ["TCGA.AZ.4681.01", "Influenza Viral RNA Transcription and Replication"], ["TCGA.AZ.4681.01", "Integration of energy metabolism"], ["TCGA.AZ.4681.01", "Leishmania infection"], ["TCGA.AZ.4681.01", "Parasitic Infection Pathways"], ["TCGA.AZ.4681.01", "Signal amplification"], ["TCGA.AZ.4681.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.4681.01", "Selenoamino acid metabolism"], ["TCGA.AZ.4681.01", "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"], ["TCGA.AZ.4681.01", "Response of EIF2AK4 (GCN2) to amino acid deficiency"], ["TCGA.AZ.4681.01", "L13a-mediated translational silencing of Ceruloplasmin expression"], ["TCGA.AZ.4681.01", "GTP hydrolysis and joining of the 60S ribosomal subunit"], ["TCGA.AZ.4681.01", "GPER1 signaling"], ["TCGA.AZ.4681.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AZ.4681.01", "G alpha (i) signalling events"], ["TCGA.AZ.4681.01", "Influenza Infection"], ["TCGA.AZ.4681.01", "Ribavirin ADME"], ["TCGA.AZ.4681.01", "Eukaryotic Translation Initiation"], ["TCGA.AZ.4681.01", "Cap-dependent Translation Initiation"], ["TCGA.AZ.4681.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.AZ.4681.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.AZ.4681.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AZ.4681.01", "Aquaporin-mediated transport"], ["TCGA.AZ.4681.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.AZ.4681.01", "Protein folding"], ["TCGA.AZ.4681.01", "Cell surface interactions at the vascular wall"], ["TCGA.AZ.4681.01", "Telomere Maintenance"], ["TCGA.AZ.4681.01", "Nonsense-Mediated Decay (NMD)"], ["TCGA.AZ.4681.01", "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"], ["TCGA.AZ.4681.01", "Nervous system development"], ["TCGA.AZ.4681.01", "Diseases of Immune System"], ["TCGA.AZ.4681.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.AZ.4681.01", "Chromosome Maintenance"], ["TCGA.AZ.4681.01", "Platelet homeostasis"], ["TCGA.AZ.4681.01", "Extra-nuclear estrogen signaling"], ["TCGA.AZ.4681.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.AZ.4681.01", "Chemokine receptors bind chemokines"], ["TCGA.AZ.4681.01", "SARS-CoV-2 modulates host translation machinery"], ["TCGA.AZ.4681.01", "CD28 dependent PI3K/Akt signaling"], ["TCGA.AZ.4681.01", "Signaling Pathways"], ["TCGA.AZ.4681.01", "SRP-dependent cotranslational protein targeting to membrane"], ["TCGA.AZ.4681.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.AZ.4681.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.AZ.4681.01", "Translesion synthesis by POLK"], ["TCGA.AZ.4681.01", "Translesion synthesis by POLI"], ["TCGA.AZ.4681.01", "EGR2 and SOX10-mediated initiation of Schwann cell myelination"], ["TCGA.AZ.4681.01", "Opioid Signalling"], ["TCGA.AZ.4681.01", "B Cell Activation"], ["TCGA.AZ.4681.01", "APOBEC3G mediated resistance to HIV-1 infection"], ["TCGA.AZ.4681.01", "CD22 mediated BCR regulation"], ["TCGA.AZ.4681.01", "Early Phase of HIV Life Cycle"], ["TCGA.AZ.4681.01", "Activation of the pre-replicative complex"], ["TCGA.AZ.4681.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.AZ.4681.01", "Heme degradation"], ["TCGA.AZ.4681.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AZ.4681.01", "Regulation of Complement cascade"], ["TCGA.AZ.4681.01", "Chaperonin-mediated protein folding"], ["TCGA.AZ.4682.01", "Neuronal System"], ["TCGA.AZ.4682.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.4682.01", "G alpha (i) signalling events"], ["TCGA.AZ.4682.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AZ.4682.01", "GPCR downstream signalling"], ["TCGA.AZ.4682.01", "GABA receptor activation"], ["TCGA.AZ.4682.01", "Signaling Pathways"], ["TCGA.AZ.4682.01", "Signaling by GPCR"], ["TCGA.AZ.4682.01", "GABA B receptor activation"], ["TCGA.AZ.4682.01", "Activation of GABAB receptors"], ["TCGA.AZ.4682.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AZ.4682.01", "Leishmania parasite growth and survival"], ["TCGA.AZ.4682.01", "G-protein beta:gamma signalling"], ["TCGA.AZ.4682.01", "Leishmania infection"], ["TCGA.AZ.4682.01", "Parasitic Infection Pathways"], ["TCGA.AZ.4682.01", "Potassium Channels"], ["TCGA.AZ.4682.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.4682.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AZ.4682.01", "G alpha (s) signalling events"], ["TCGA.AZ.4682.01", "Biological oxidations"], ["TCGA.AZ.4682.01", "Integration of energy metabolism"], ["TCGA.AZ.4682.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.4682.01", "Chemokine receptors bind chemokines"], ["TCGA.AZ.4682.01", "Presynaptic function of Kainate receptors"], ["TCGA.AZ.4682.01", "Signal amplification"], ["TCGA.AZ.4682.01", "Complement cascade"], ["TCGA.AZ.4682.01", "Regulation of insulin secretion"], ["TCGA.AZ.4682.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AZ.4682.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AZ.4682.01", "Regulation of Complement cascade"], ["TCGA.AZ.4682.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.4682.01", "Platelet homeostasis"], ["TCGA.AZ.4682.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AZ.4682.01", "CD22 mediated BCR regulation"], ["TCGA.AZ.4682.01", "Ca2+ pathway"], ["TCGA.AZ.4682.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.4682.01", "G protein gated Potassium channels"], ["TCGA.AZ.4682.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.4682.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.4682.01", "Inwardly rectifying K+ channels"], ["TCGA.AZ.4682.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.AZ.4682.01", "G beta:gamma signalling through BTK"], ["TCGA.AZ.4682.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AZ.4682.01", "Other interleukin signaling"], ["TCGA.AZ.4682.01", "Peptide ligand-binding receptors"], ["TCGA.AZ.4682.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.AZ.4682.01", "Aquaporin-mediated transport"], ["TCGA.AZ.4682.01", "Cardiac conduction"], ["TCGA.AZ.4682.01", "LGI-ADAM interactions"], ["TCGA.AZ.4682.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AZ.4682.01", "Activation of the phototransduction cascade"], ["TCGA.AZ.4682.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AZ.4682.01", "GPER1 signaling"], ["TCGA.AZ.4682.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.AZ.4682.01", "GPCR ligand binding"], ["TCGA.AZ.4682.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.AZ.4682.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.AZ.4682.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AZ.4682.01", "G beta:gamma signalling through CDC42"], ["TCGA.AZ.4682.01", "Opioid Signalling"], ["TCGA.AZ.4682.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.4682.01", "Phase 4 - resting membrane potential"], ["TCGA.AZ.4682.01", "G alpha (z) signalling events"], ["TCGA.AZ.4682.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.4682.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.AZ.4682.01", "Diseases of Immune System"], ["TCGA.AZ.4682.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.AZ.4682.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AZ.4682.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AZ.4682.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.AZ.4682.01", "G-protein mediated events"], ["TCGA.AZ.4682.01", "Neurexins and neuroligins"], ["TCGA.AZ.4682.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.AZ.4682.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.AZ.4682.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.AZ.4682.01", "GABA synthesis, release, reuptake and degradation"], ["TCGA.AZ.4682.01", "Generation of second messenger molecules"], ["TCGA.AZ.4682.01", "Arachidonic acid metabolism"], ["TCGA.AZ.4682.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.AZ.4682.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AZ.5403.01", "GPCR downstream signalling"], ["TCGA.AZ.5403.01", "Signaling Pathways"], ["TCGA.AZ.5403.01", "Signaling by GPCR"], ["TCGA.AZ.5403.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AZ.5403.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.5403.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AZ.5403.01", "Extracellular matrix organization"], ["TCGA.AZ.5403.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.5403.01", "TNFs bind their physiological receptors"], ["TCGA.AZ.5403.01", "G alpha (i) signalling events"], ["TCGA.AZ.5403.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AZ.5403.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.5403.01", "GABA receptor activation"], ["TCGA.AZ.5403.01", "Neuronal System"], ["TCGA.AZ.5403.01", "GPCR ligand binding"], ["TCGA.AZ.5403.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AZ.5403.01", "Leishmania parasite growth and survival"], ["TCGA.AZ.5403.01", "GABA B receptor activation"], ["TCGA.AZ.5403.01", "Activation of GABAB receptors"], ["TCGA.AZ.5403.01", "Peptide ligand-binding receptors"], ["TCGA.AZ.5403.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.5403.01", "G alpha (q) signalling events"], ["TCGA.AZ.5403.01", "Collagen formation"], ["TCGA.AZ.5403.01", "NCAM1 interactions"], ["TCGA.AZ.5403.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AZ.5403.01", "G alpha (s) signalling events"], ["TCGA.AZ.5403.01", "Signal amplification"], ["TCGA.AZ.5403.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AZ.5403.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.5403.01", "Chemokine receptors bind chemokines"], ["TCGA.AZ.5403.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.AZ.5403.01", "Complement cascade"], ["TCGA.AZ.5403.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.5403.01", "Initial triggering of complement"], ["TCGA.AZ.5403.01", "Trafficking of AMPA receptors"], ["TCGA.AZ.5403.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.AZ.5403.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.5403.01", "G protein gated Potassium channels"], ["TCGA.AZ.5403.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.5403.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AZ.5403.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.5403.01", "Cardiac conduction"], ["TCGA.AZ.5403.01", "Signaling by Retinoic Acid"], ["TCGA.AZ.5403.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.AZ.5403.01", "Biological oxidations"], ["TCGA.AZ.5403.01", "Immune System"], ["TCGA.AZ.5403.01", "Ca-dependent events"], ["TCGA.AZ.5403.01", "G-protein beta:gamma signalling"], ["TCGA.AZ.5403.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AZ.5403.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.AZ.5403.01", "NCAM signaling for neurite out-growth"], ["TCGA.AZ.5403.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AZ.5403.01", "Collagen chain trimerization"], ["TCGA.AZ.5403.01", "Interleukin-10 signaling"], ["TCGA.AZ.5403.01", "PLC beta mediated events"], ["TCGA.AZ.5403.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.5403.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.AZ.5403.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.5403.01", "Ethanol oxidation"], ["TCGA.AZ.5407.01", "Neuronal System"], ["TCGA.AZ.5407.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.5407.01", "Biological oxidations"], ["TCGA.AZ.5407.01", "Drug ADME"], ["TCGA.AZ.5407.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AZ.5407.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.5407.01", "GPCR ligand binding"], ["TCGA.AZ.5407.01", "Long-term potentiation"], ["TCGA.AZ.5407.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.5407.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.5407.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.5407.01", "Protein-protein interactions at synapses"], ["TCGA.AZ.5407.01", "Extracellular matrix organization"], ["TCGA.AZ.5407.01", "Neurexins and neuroligins"], ["TCGA.AZ.5407.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.5407.01", "Cardiac conduction"], ["TCGA.AZ.5407.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.AZ.5407.01", "L1CAM interactions"], ["TCGA.AZ.5407.01", "G alpha (s) signalling events"], ["TCGA.AZ.5407.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AZ.5407.01", "Signaling by GPCR"], ["TCGA.AZ.5407.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.5407.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.5407.01", "Peptide ligand-binding receptors"], ["TCGA.AZ.5407.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.AZ.5407.01", "GPCR downstream signalling"], ["TCGA.AZ.5407.01", "Complement cascade"], ["TCGA.AZ.5407.01", "Degradation of the extracellular matrix"], ["TCGA.AZ.5407.01", "Molecules associated with elastic fibres"], ["TCGA.AZ.6598.01", "Neuronal System"], ["TCGA.AZ.6598.01", "G alpha (i) signalling events"], ["TCGA.AZ.6598.01", "Signaling by GPCR"], ["TCGA.AZ.6598.01", "GPCR downstream signalling"], ["TCGA.AZ.6598.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.6598.01", "GPCR ligand binding"], ["TCGA.AZ.6598.01", "Cardiac conduction"], ["TCGA.AZ.6598.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AZ.6598.01", "Extracellular matrix organization"], ["TCGA.AZ.6598.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.6598.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.6598.01", "NCAM1 interactions"], ["TCGA.AZ.6598.01", "Protein-protein interactions at synapses"], ["TCGA.AZ.6598.01", "Signaling Pathways"], ["TCGA.AZ.6598.01", "Peptide ligand-binding receptors"], ["TCGA.AZ.6598.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AZ.6598.01", "Muscle contraction"], ["TCGA.AZ.6598.01", "Regulation of insulin secretion"], ["TCGA.AZ.6598.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.AZ.6598.01", "Neurexins and neuroligins"], ["TCGA.AZ.6598.01", "Integration of energy metabolism"], ["TCGA.AZ.6598.01", "Drug ADME"], ["TCGA.AZ.6598.01", "Biological oxidations"], ["TCGA.AZ.6598.01", "Response to elevated platelet cytosolic Ca2+"], ["TCGA.AZ.6598.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AZ.6598.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AZ.6598.01", "Collagen chain trimerization"], ["TCGA.AZ.6598.01", "Ion homeostasis"], ["TCGA.AZ.6598.01", "NCAM signaling for neurite out-growth"], ["TCGA.AZ.6598.01", "Bile acid and bile salt metabolism"], ["TCGA.AZ.6598.01", "Long-term potentiation"], ["TCGA.AZ.6598.01", "GABA receptor activation"], ["TCGA.AZ.6598.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.AZ.6598.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6598.01", "Calmodulin induced events"], ["TCGA.AZ.6598.01", "CaM pathway"], ["TCGA.AZ.6598.01", "Transport of small molecules"], ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts"], ["TCGA.AZ.6598.01", "L1CAM interactions"], ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AZ.6598.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6598.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AZ.6598.01", "DAG and IP3 signaling"], ["TCGA.AZ.6598.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.AZ.6598.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.6598.01", "Potassium Channels"], ["TCGA.AZ.6598.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AZ.6598.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.6598.01", "Ca-dependent events"], ["TCGA.AZ.6598.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AZ.6598.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6598.01", "Peptide hormone metabolism"], ["TCGA.AZ.6598.01", "APAP ADME"], ["TCGA.AZ.6598.01", "G-protein mediated events"], ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.AZ.6598.01", "PI3K events in ERBB2 signaling"], ["TCGA.AZ.6598.01", "ERBB2 Regulates Cell Motility"], ["TCGA.AZ.6598.01", "G alpha (s) signalling events"], ["TCGA.AZ.6598.01", "PLC beta mediated events"], ["TCGA.AZ.6598.01", "Chemokine receptors bind chemokines"], ["TCGA.AZ.6598.01", "CD22 mediated BCR regulation"], ["TCGA.AZ.6598.01", "Arachidonic acid metabolism"], ["TCGA.AZ.6598.01", "G alpha (z) signalling events"], ["TCGA.AZ.6598.01", "Degradation of the extracellular matrix"], ["TCGA.AZ.6598.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.6598.01", "Collagen formation"], ["TCGA.AZ.6598.01", "GRB2 events in ERBB2 signaling"], ["TCGA.AZ.6598.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.AZ.6598.01", "G alpha (q) signalling events"], ["TCGA.AZ.6598.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.AZ.6598.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.AZ.6598.01", "Opioid Signalling"], ["TCGA.AZ.6598.01", "GPER1 signaling"], ["TCGA.AZ.6598.01", "GABA B receptor activation"], ["TCGA.AZ.6598.01", "Activation of GABAB receptors"], ["TCGA.AZ.6598.01", "Trafficking of AMPA receptors"], ["TCGA.AZ.6598.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.AZ.6598.01", "RA biosynthesis pathway"], ["TCGA.AZ.6598.01", "Synaptic adhesion-like molecules"], ["TCGA.AZ.6598.01", "Nuclear signaling by ERBB4"], ["TCGA.AZ.6598.01", "LGI-ADAM interactions"], ["TCGA.AZ.6598.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.AZ.6598.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.AZ.6598.01", "Activation of NMDA receptors and postsynaptic events"], ["TCGA.AZ.6598.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.AZ.6598.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.AZ.6598.01", "Aspirin ADME"], ["TCGA.AZ.6598.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.6598.01", "Glucuronidation"], ["TCGA.AZ.6598.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.AZ.6598.01", "Signaling by ERBB4"], ["TCGA.AZ.6598.01", "RET signaling"], ["TCGA.AZ.6598.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6598.01", "SHC1 events in ERBB4 signaling"], ["TCGA.AZ.6598.01", "GAB1 signalosome"], ["TCGA.AZ.6598.01", "Glycogen synthesis"], ["TCGA.AZ.6598.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AZ.6598.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.6599.01", "Extracellular matrix organization"], ["TCGA.AZ.6599.01", "Signaling by GPCR"], ["TCGA.AZ.6599.01", "GPCR downstream signalling"], ["TCGA.AZ.6599.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.AZ.6599.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.AZ.6599.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AZ.6599.01", "Signaling Pathways"], ["TCGA.AZ.6599.01", "G alpha (i) signalling events"], ["TCGA.AZ.6599.01", "Immune System"], ["TCGA.AZ.6599.01", "Neuronal System"], ["TCGA.AZ.6599.01", "Cell surface interactions at the vascular wall"], ["TCGA.AZ.6599.01", "Complement cascade"], ["TCGA.AZ.6599.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6599.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.AZ.6599.01", "Integrin cell surface interactions"], ["TCGA.AZ.6599.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6599.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.AZ.6599.01", "Leishmania parasite growth and survival"], ["TCGA.AZ.6599.01", "Collagen formation"], ["TCGA.AZ.6599.01", "Leishmania infection"], ["TCGA.AZ.6599.01", "Parasitic Infection Pathways"], ["TCGA.AZ.6599.01", "Generation of second messenger molecules"], ["TCGA.AZ.6599.01", "Regulation of Complement cascade"], ["TCGA.AZ.6599.01", "Muscle contraction"], ["TCGA.AZ.6599.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.6599.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.6599.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.AZ.6599.01", "G-protein beta:gamma signalling"], ["TCGA.AZ.6599.01", "Elastic fibre formation"], ["TCGA.AZ.6599.01", "Molecules associated with elastic fibres"], ["TCGA.AZ.6599.01", "Collagen chain trimerization"], ["TCGA.AZ.6599.01", "Cardiac conduction"], ["TCGA.AZ.6599.01", "Scavenging by Class A Receptors"], ["TCGA.AZ.6599.01", "Classical antibody-mediated complement activation"], ["TCGA.AZ.6599.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.AZ.6599.01", "PD-1 signaling"], ["TCGA.AZ.6599.01", "GPCR ligand binding"], ["TCGA.AZ.6599.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.AZ.6599.01", "G alpha (s) signalling events"], ["TCGA.AZ.6599.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.AZ.6599.01", "GABA receptor activation"], ["TCGA.AZ.6599.01", "Degradation of the extracellular matrix"], ["TCGA.AZ.6599.01", "Post-translational protein phosphorylation"], ["TCGA.AZ.6599.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.AZ.6599.01", "Initial triggering of complement"], ["TCGA.AZ.6599.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.6599.01", "NCAM1 interactions"], ["TCGA.AZ.6599.01", "Creation of C4 and C2 activators"], ["TCGA.AZ.6599.01", "Protein-protein interactions at synapses"], ["TCGA.AZ.6599.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.6599.01", "Stimuli-sensing channels"], ["TCGA.AZ.6599.01", "Neurexins and neuroligins"], ["TCGA.AZ.6599.01", "FGFR1 ligand binding and activation"], ["TCGA.AZ.6599.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.AZ.6599.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.AZ.6599.01", "Activation of SMO"], ["TCGA.AZ.6599.01", "G beta:gamma signalling through BTK"], ["TCGA.AZ.6599.01", "G alpha (q) signalling events"], ["TCGA.AZ.6599.01", "G alpha (z) signalling events"], ["TCGA.AZ.6599.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.AZ.6599.01", "GPVI-mediated activation cascade"], ["TCGA.AZ.6599.01", "FCERI mediated Ca+2 mobilization"], ["TCGA.AZ.6599.01", "Metabolism of fat-soluble vitamins"], ["TCGA.AZ.6599.01", "Retinoid metabolism and transport"], ["TCGA.AZ.6599.01", "GABA B receptor activation"], ["TCGA.AZ.6599.01", "Activation of GABAB receptors"], ["TCGA.AZ.6599.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.AZ.6599.01", "Defensins"], ["TCGA.AZ.6599.01", "Scavenging of heme from plasma"], ["TCGA.AZ.6599.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AZ.6599.01", "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"], ["TCGA.AZ.6599.01", "L1CAM interactions"], ["TCGA.AZ.6599.01", "G-protein activation"], ["TCGA.AZ.6599.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AZ.6599.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.6599.01", "Glycosaminoglycan metabolism"], ["TCGA.AZ.6599.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AZ.6599.01", "G beta:gamma signalling through CDC42"], ["TCGA.AZ.6599.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AZ.6599.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.AZ.6599.01", "Transport of small molecules"], ["TCGA.AZ.6599.01", "Opioid Signalling"], ["TCGA.AZ.6599.01", "Platelet activation, signaling and aggregation"], ["TCGA.AZ.6599.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AZ.6599.01", "Costimulation by the CD28 family"], ["TCGA.AZ.6599.01", "SLC-mediated transmembrane transport"], ["TCGA.AZ.6599.01", "Drug ADME"], ["TCGA.AZ.6599.01", "FCGR activation"], ["TCGA.AZ.6599.01", "Presynaptic function of Kainate receptors"], ["TCGA.AZ.6599.01", "Phospholipase C-mediated cascade: FGFR1"], ["TCGA.AZ.6599.01", "Regulation of insulin secretion"], ["TCGA.AZ.6599.01", "Interleukin-10 signaling"], ["TCGA.AZ.6599.01", "NCAM signaling for neurite out-growth"], ["TCGA.AZ.6599.01", "Activation of the phototransduction cascade"], ["TCGA.AZ.6599.01", "Role of phospholipids in phagocytosis"], ["TCGA.AZ.6599.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AZ.6599.01", "Peptide ligand-binding receptors"], ["TCGA.AZ.6599.01", "Platelet homeostasis"], ["TCGA.AZ.6599.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AZ.6599.01", "Innate Immune System"], ["TCGA.AZ.6599.01", "Ca2+ pathway"], ["TCGA.AZ.6599.01", "FGFR1c ligand binding and activation"], ["TCGA.AZ.6599.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.AZ.6599.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.AZ.6599.01", "Diseases of Immune System"], ["TCGA.AZ.6599.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.AZ.6599.01", "Signal amplification"], ["TCGA.AZ.6599.01", "Potassium Channels"], ["TCGA.AZ.6599.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.AZ.6599.01", "Signaling by Receptor Tyrosine Kinases"], ["TCGA.AZ.6599.01", "Other interleukin signaling"], ["TCGA.AZ.6599.01", "Cytokine Signaling in Immune system"], ["TCGA.AZ.6599.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.6599.01", "G protein gated Potassium channels"], ["TCGA.AZ.6599.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.6599.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.6599.01", "DAP12 interactions"], ["TCGA.AZ.6599.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AZ.6599.01", "Glucuronidation"], ["TCGA.AZ.6599.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.AZ.6599.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AZ.6599.01", "Signaling by Interleukins"], ["TCGA.AZ.6599.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6599.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.6600.01", "Extracellular matrix organization"], ["TCGA.AZ.6600.01", "Glucuronidation"], ["TCGA.AZ.6600.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6600.01", "Collagen formation"], ["TCGA.AZ.6600.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6600.01", "Collagen chain trimerization"], ["TCGA.AZ.6600.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6600.01", "Aspirin ADME"], ["TCGA.AZ.6600.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6600.01", "G alpha (s) signalling events"], ["TCGA.AZ.6600.01", "Biological oxidations"], ["TCGA.AZ.6600.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.6600.01", "Antimicrobial peptides"], ["TCGA.AZ.6600.01", "Drug ADME"], ["TCGA.AZ.6600.01", "Degradation of the extracellular matrix"], ["TCGA.AZ.6600.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], ["TCGA.AZ.6600.01", "Transcriptional regulation of testis differentiation"], ["TCGA.AZ.6600.01", "Metabolism"], ["TCGA.AZ.6600.01", "G alpha (i) signalling events"], ["TCGA.AZ.6600.01", "Signaling by GPCR"], ["TCGA.AZ.6600.01", "GPCR downstream signalling"], ["TCGA.AZ.6600.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.6600.01", "Signal amplification"], ["TCGA.AZ.6600.01", "Physiological factors"], ["TCGA.AZ.6600.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AZ.6600.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AZ.6600.01", "Glucagon signaling in metabolic regulation"], ["TCGA.AZ.6600.01", "YAP1- and WWTR1 (TAZ)-stimulated gene expression"], ["TCGA.AZ.6600.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AZ.6600.01", "GPCR ligand binding"], ["TCGA.AZ.6600.01", "Glycogen synthesis"], ["TCGA.AZ.6600.01", "Integrin cell surface interactions"], ["TCGA.AZ.6600.01", "Metal ion SLC transporters"], ["TCGA.AZ.6600.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.AZ.6601.01", "Extracellular matrix organization"], ["TCGA.AZ.6601.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.6601.01", "Neuronal System"], ["TCGA.AZ.6601.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6601.01", "Drug ADME"], ["TCGA.AZ.6601.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.AZ.6601.01", "Glucuronidation"], ["TCGA.AZ.6601.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6601.01", "Degradation of the extracellular matrix"], ["TCGA.AZ.6601.01", "Collagen chain trimerization"], ["TCGA.AZ.6601.01", "ECM proteoglycans"], ["TCGA.AZ.6601.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.6601.01", "Stimuli-sensing channels"], ["TCGA.AZ.6601.01", "Biological oxidations"], ["TCGA.AZ.6601.01", "Signaling by GPCR"], ["TCGA.AZ.6601.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.AZ.6601.01", "L1CAM interactions"], ["TCGA.AZ.6601.01", "Protein-protein interactions at synapses"], ["TCGA.AZ.6601.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6601.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.AZ.6601.01", "Blood group systems biosynthesis"], ["TCGA.AZ.6601.01", "NCAM1 interactions"], ["TCGA.AZ.6601.01", "GPCR ligand binding"], ["TCGA.AZ.6601.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.AZ.6601.01", "GABA receptor activation"], ["TCGA.AZ.6601.01", "Synaptic adhesion-like molecules"], ["TCGA.AZ.6601.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.AZ.6601.01", "Defective GALNT3 causes HFTC"], ["TCGA.AZ.6601.01", "Defective GALNT12 causes CRCS1"], ["TCGA.AZ.6601.01", "Termination of O-glycan biosynthesis"], ["TCGA.AZ.6601.01", "Ion channel transport"], ["TCGA.AZ.6601.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AZ.6601.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.6601.01", "GPCR downstream signalling"], ["TCGA.AZ.6601.01", "APAP ADME"], ["TCGA.AZ.6601.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.AZ.6601.01", "Collagen formation"], ["TCGA.AZ.6601.01", "Interaction between L1 and Ankyrins"], ["TCGA.AZ.6601.01", "Developmental Biology"], ["TCGA.AZ.6601.01", "Phase 2 - plateau phase"], ["TCGA.AZ.6603.01", "Biological oxidations"], ["TCGA.AZ.6603.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6603.01", "Glucuronidation"], ["TCGA.AZ.6603.01", "Drug ADME"], ["TCGA.AZ.6603.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.AZ.6603.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6603.01", "Ethanol oxidation"], ["TCGA.AZ.6603.01", "GPCR ligand binding"], ["TCGA.AZ.6603.01", "APAP ADME"], ["TCGA.AZ.6603.01", "Extracellular matrix organization"], ["TCGA.AZ.6603.01", "Signal amplification"], ["TCGA.AZ.6603.01", "Neuronal System"], ["TCGA.AZ.6603.01", "NCAM signaling for neurite out-growth"], ["TCGA.AZ.6603.01", "Signaling by GPCR"], ["TCGA.AZ.6603.01", "G alpha (s) signalling events"], ["TCGA.AZ.6603.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.AZ.6603.01", "NCAM1 interactions"], ["TCGA.AZ.6603.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.6603.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.AZ.6603.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.AZ.6603.01", "GPCR downstream signalling"], ["TCGA.AZ.6603.01", "Signaling Pathways"], ["TCGA.AZ.6603.01", "Platelet homeostasis"], ["TCGA.AZ.6603.01", "Long-term potentiation"], ["TCGA.AZ.6603.01", "Neurexins and neuroligins"], ["TCGA.AZ.6603.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.AZ.6603.01", "Regulation of FZD by ubiquitination"], ["TCGA.AZ.6603.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.AZ.6603.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6605.01", "Extracellular matrix organization"], ["TCGA.AZ.6605.01", "Collagen formation"], ["TCGA.AZ.6605.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6605.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.6605.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6605.01", "Degradation of the extracellular matrix"], ["TCGA.AZ.6605.01", "Collagen degradation"], ["TCGA.AZ.6605.01", "Collagen chain trimerization"], ["TCGA.AZ.6605.01", "Defective B3GALTL causes PpS"], ["TCGA.AZ.6605.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AZ.6605.01", "ECM proteoglycans"], ["TCGA.AZ.6605.01", "Diseases of glycosylation"], ["TCGA.AZ.6605.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6605.01", "Scavenging by Class A Receptors"], ["TCGA.AZ.6605.01", "Drug ADME"], ["TCGA.AZ.6605.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.AZ.6605.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AZ.6605.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.AZ.6605.01", "Glycosaminoglycan metabolism"], ["TCGA.AZ.6607.01", "Extracellular matrix organization"], ["TCGA.AZ.6607.01", "Collagen formation"], ["TCGA.AZ.6607.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.AZ.6607.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.AZ.6607.01", "Collagen chain trimerization"], ["TCGA.AZ.6607.01", "ECM proteoglycans"], ["TCGA.AZ.6607.01", "Integrin cell surface interactions"], ["TCGA.AZ.6607.01", "Drug ADME"], ["TCGA.AZ.6607.01", "Degradation of the extracellular matrix"], ["TCGA.AZ.6607.01", "Biological oxidations"], ["TCGA.AZ.6607.01", "Ethanol oxidation"], ["TCGA.AZ.6607.01", "Metabolism"], ["TCGA.AZ.6607.01", "Activation of Matrix Metalloproteinases"], ["TCGA.AZ.6607.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.AZ.6607.01", "Cytosolic sulfonation of small molecules"], ["TCGA.AZ.6607.01", "Molecules associated with elastic fibres"], ["TCGA.AZ.6607.01", "Laminin interactions"], ["TCGA.AZ.6607.01", "Elastic fibre formation"], ["TCGA.AZ.6607.01", "Signaling by PDGF"], ["TCGA.AZ.6607.01", "Phase I - Functionalization of compounds"], ["TCGA.AZ.6607.01", "NCAM1 interactions"], ["TCGA.AZ.6607.01", "Collagen degradation"], ["TCGA.AZ.6607.01", "Non-integrin membrane-ECM interactions"], ["TCGA.AZ.6607.01", "WNT ligand biogenesis and trafficking"], ["TCGA.AZ.6607.01", "TGF-beta receptor signaling activates SMADs"], ["TCGA.AZ.6607.01", "Phase II - Conjugation of compounds"], ["TCGA.AZ.6607.01", "Inwardly rectifying K+ channels"], ["TCGA.AZ.6607.01", "Defective B3GALTL causes PpS"], ["TCGA.AZ.6607.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.AZ.6607.01", "Glycosaminoglycan metabolism"], ["TCGA.AZ.6607.01", "Chondroitin sulfate biosynthesis"], ["TCGA.AZ.6607.01", "MET activates PTK2 signaling"], ["TCGA.AZ.6607.01", "NCAM signaling for neurite out-growth"], ["TCGA.AZ.6607.01", "GPCR ligand binding"], ["TCGA.AZ.6607.01", "Syndecan interactions"], ["TCGA.AZ.6607.01", "APAP ADME"], ["TCGA.AZ.6607.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.AZ.6607.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], ["TCGA.AZ.6607.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.AZ.6607.01", "Bile acid and bile salt metabolism"], ["TCGA.AZ.6607.01", "Keratinization"], ["TCGA.AZ.6607.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.AZ.6607.01", "Signaling Pathways"], ["TCGA.AZ.6607.01", "Neuronal System"], ["TCGA.AZ.6607.01", "Potassium Channels"], ["TCGA.AZ.6607.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.6607.01", "G protein gated Potassium channels"], ["TCGA.AZ.6607.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.6607.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.6607.01", "Class B/2 (Secretin family receptors)"], ["TCGA.AZ.6607.01", "Signaling by TGFB family members"], ["TCGA.AZ.6607.01", "Fatty acid metabolism"], ["TCGA.AZ.6607.01", "IRS-related events triggered by IGF1R"], ["TCGA.AZ.6607.01", "Sensory processing of sound"], ["TCGA.AZ.6607.01", "Formation of the cornified envelope"], ["TCGA.AZ.6607.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.AZ.6607.01", "Phase 0 - rapid depolarisation"], ["TCGA.AZ.6607.01", "Degradation of cysteine and homocysteine"], ["TCGA.AZ.6607.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.AZ.6607.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.AZ.6607.01", "IGF1R signaling cascade"], ["TCGA.AZ.6607.01", "Signaling by Retinoic Acid"], ["TCGA.AZ.6607.01", "Metabolism of fat-soluble vitamins"], ["TCGA.AZ.6607.01", "Retinoid metabolism and transport"], ["TCGA.AZ.6607.01", "Arachidonic acid metabolism"], ["TCGA.AZ.6607.01", "Signaling by GPCR"], ["TCGA.AZ.6607.01", "Other semaphorin interactions"], ["TCGA.AZ.6607.01", "Transmission across Chemical Synapses"], ["TCGA.AZ.6607.01", "Metabolism of vitamins and cofactors"], ["TCGA.CA.5796.01", "Neuronal System"], ["TCGA.CA.5796.01", "Transmission across Chemical Synapses"], ["TCGA.CA.5796.01", "Phase 0 - rapid depolarisation"], ["TCGA.CA.5796.01", "Extracellular matrix organization"], ["TCGA.CA.5796.01", "GPCR ligand binding"], ["TCGA.CA.5796.01", "Cardiac conduction"], ["TCGA.CA.5796.01", "Signaling by GPCR"], ["TCGA.CA.5796.01", "Elastic fibre formation"], ["TCGA.CA.5796.01", "Molecules associated with elastic fibres"], ["TCGA.CA.5796.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CA.5796.01", "GPCR downstream signalling"], ["TCGA.CA.5796.01", "Glucagon-type ligand receptors"], ["TCGA.CA.5796.01", "Interaction between L1 and Ankyrins"], ["TCGA.CA.5796.01", "G alpha (s) signalling events"], ["TCGA.CA.5796.01", "Muscle contraction"], ["TCGA.CA.5796.01", "Complement cascade"], ["TCGA.CA.5796.01", "Protein-protein interactions at synapses"], ["TCGA.CA.5796.01", "LGI-ADAM interactions"], ["TCGA.CA.5796.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CA.5796.01", "Biological oxidations"], ["TCGA.CA.5796.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CA.5796.01", "GABA receptor activation"], ["TCGA.CA.5796.01", "Integration of energy metabolism"], ["TCGA.CA.5796.01", "Chemokine receptors bind chemokines"], ["TCGA.CA.5796.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CA.5796.01", "Sensory processing of sound"], ["TCGA.CA.5796.01", "Regulation of insulin secretion"], ["TCGA.CA.5796.01", "G alpha (i) signalling events"], ["TCGA.CA.5796.01", "Peptide ligand-binding receptors"], ["TCGA.CA.5796.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CA.5796.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.CA.5796.01", "Neurexins and neuroligins"], ["TCGA.CA.5796.01", "O-linked glycosylation"], ["TCGA.CA.5796.01", "Sensory perception of taste"], ["TCGA.CA.5796.01", "Regulation of Complement cascade"], ["TCGA.CA.5796.01", "Degradation of the extracellular matrix"], ["TCGA.CA.5796.01", "L1CAM interactions"], ["TCGA.CA.5796.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CA.5796.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CA.5796.01", "Scavenging by Class A Receptors"], ["TCGA.CA.5796.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CA.5796.01", "Carnitine metabolism"], ["TCGA.CA.5796.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.CA.5796.01", "Defective B3GALTL causes PpS"], ["TCGA.CA.5796.01", "Diseases of glycosylation"], ["TCGA.CA.5796.01", "Trafficking of AMPA receptors"], ["TCGA.CA.5796.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.CA.5796.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CA.5796.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.CA.5796.01", "Presynaptic function of Kainate receptors"], ["TCGA.CA.5796.01", "Long-term potentiation"], ["TCGA.CA.5796.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CA.5796.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.CA.5796.01", "Ca2+ pathway"], ["TCGA.CA.5796.01", "Glycosaminoglycan metabolism"], ["TCGA.CA.5796.01", "Aspartate and asparagine metabolism"], ["TCGA.CA.5796.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.CA.5797.01", "Neuronal System"], ["TCGA.CA.5797.01", "Transmission across Chemical Synapses"], ["TCGA.CA.5797.01", "GPCR downstream signalling"], ["TCGA.CA.5797.01", "Signaling by GPCR"], ["TCGA.CA.5797.01", "Regulation of insulin secretion"], ["TCGA.CA.5797.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CA.5797.01", "G alpha (i) signalling events"], ["TCGA.CA.5797.01", "Cardiac conduction"], ["TCGA.CA.5797.01", "Integration of energy metabolism"], ["TCGA.CA.5797.01", "Phase 0 - rapid depolarisation"], ["TCGA.CA.5797.01", "GABA receptor activation"], ["TCGA.CA.5797.01", "GPCR ligand binding"], ["TCGA.CA.5797.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CA.5797.01", "O-linked glycosylation"], ["TCGA.CA.5797.01", "Interaction between L1 and Ankyrins"], ["TCGA.CA.5797.01", "Potassium Channels"], ["TCGA.CA.5797.01", "O-linked glycosylation of mucins"], ["TCGA.CA.5797.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CA.5797.01", "G alpha (s) signalling events"], ["TCGA.CA.5797.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CA.5797.01", "Signaling by ERBB4"], ["TCGA.CA.5797.01", "Signaling Pathways"], ["TCGA.CA.5797.01", "Peptide ligand-binding receptors"], ["TCGA.CA.5797.01", "Sensory processing of sound"], ["TCGA.CA.5797.01", "Signal amplification"], ["TCGA.CA.5797.01", "APAP ADME"], ["TCGA.CA.5797.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.CA.5797.01", "G alpha (q) signalling events"], ["TCGA.CA.5797.01", "Glucagon-type ligand receptors"], ["TCGA.CA.5797.01", "Muscle contraction"], ["TCGA.CA.5797.01", "Inwardly rectifying K+ channels"], ["TCGA.CA.5797.01", "Phase 4 - resting membrane potential"], ["TCGA.CA.5797.01", "L1CAM interactions"], ["TCGA.CA.5797.01", "Activation of G protein gated Potassium channels"], ["TCGA.CA.5797.01", "G protein gated Potassium channels"], ["TCGA.CA.5797.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CA.5797.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CA.5797.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CA.5797.01", "GABA B receptor activation"], ["TCGA.CA.5797.01", "Activation of GABAB receptors"], ["TCGA.CA.5797.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.CA.5797.01", "NCAM1 interactions"], ["TCGA.CA.5797.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CA.5797.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.CA.5797.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CA.5797.01", "Extra-nuclear estrogen signaling"], ["TCGA.CA.5797.01", "Platelet homeostasis"], ["TCGA.CA.5797.01", "Sensory perception of taste"], ["TCGA.CA.5797.01", "Nuclear signaling by ERBB4"], ["TCGA.CA.5797.01", "Glucuronidation"], ["TCGA.CA.5797.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CA.5797.01", "NCAM signaling for neurite out-growth"], ["TCGA.CA.5797.01", "Drug ADME"], ["TCGA.CA.5797.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CA.5797.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.CA.5797.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CA.5797.01", "Leishmania parasite growth and survival"], ["TCGA.CA.5797.01", "Chemokine receptors bind chemokines"], ["TCGA.CA.5797.01", "Transport of small molecules"], ["TCGA.CA.5797.01", "Presynaptic function of Kainate receptors"], ["TCGA.CA.5797.01", "Phase 2 - plateau phase"], ["TCGA.CA.5797.01", "Opioid Signalling"], ["TCGA.CA.5797.01", "Activation of the phototransduction cascade"], ["TCGA.CA.5797.01", "Signaling by Nuclear Receptors"], ["TCGA.CA.6716.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CA.6716.01", "Generation of second messenger molecules"], ["TCGA.CA.6716.01", "Immune System"], ["TCGA.CA.6716.01", "Signaling by GPCR"], ["TCGA.CA.6716.01", "GPCR downstream signalling"], ["TCGA.CA.6716.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.CA.6716.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CA.6716.01", "G alpha (i) signalling events"], ["TCGA.CA.6716.01", "PD-1 signaling"], ["TCGA.CA.6716.01", "Chemokine receptors bind chemokines"], ["TCGA.CA.6716.01", "GPCR ligand binding"], ["TCGA.CA.6716.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CA.6716.01", "Peptide ligand-binding receptors"], ["TCGA.CA.6716.01", "Signaling Pathways"], ["TCGA.CA.6716.01", "Leishmania infection"], ["TCGA.CA.6716.01", "Parasitic Infection Pathways"], ["TCGA.CA.6716.01", "Adaptive Immune System"], ["TCGA.CA.6716.01", "Complement cascade"], ["TCGA.CA.6716.01", "G alpha (q) signalling events"], ["TCGA.CA.6716.01", "RA biosynthesis pathway"], ["TCGA.CA.6716.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CA.6716.01", "Leishmania parasite growth and survival"], ["TCGA.CA.6716.01", "Peptide hormone metabolism"], ["TCGA.CA.6716.01", "Costimulation by the CD28 family"], ["TCGA.CA.6716.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CA.6716.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CA.6716.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CA.6716.01", "Cytokine Signaling in Immune system"], ["TCGA.CA.6716.01", "Neuronal System"], ["TCGA.CA.6716.01", "Initial triggering of complement"], ["TCGA.CA.6716.01", "Interleukin-10 signaling"], ["TCGA.CA.6716.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CA.6716.01", "TCR signaling"], ["TCGA.CA.6716.01", "Biological oxidations"], ["TCGA.CA.6716.01", "Signaling by Retinoic Acid"], ["TCGA.CA.6716.01", "Interferon gamma signaling"], ["TCGA.CA.6716.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.CA.6716.01", "Aspirin ADME"], ["TCGA.CA.6716.01", "Glucuronidation"], ["TCGA.CA.6716.01", "Regulation of Complement cascade"], ["TCGA.CA.6716.01", "Regulation of insulin secretion"], ["TCGA.CA.6716.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.CA.6716.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.CA.6716.01", "TNFs bind their physiological receptors"], ["TCGA.CA.6716.01", "Extracellular matrix organization"], ["TCGA.CA.6716.01", "G alpha (s) signalling events"], ["TCGA.CA.6716.01", "Innate Immune System"], ["TCGA.CA.6716.01", "Blood group systems biosynthesis"], ["TCGA.CA.6716.01", "Signal amplification"], ["TCGA.CA.6716.01", "Classical antibody-mediated complement activation"], ["TCGA.CA.6716.01", "CD22 mediated BCR regulation"], ["TCGA.CA.6716.01", "Regulation of FZD by ubiquitination"], ["TCGA.CA.6716.01", "Arachidonic acid metabolism"], ["TCGA.CA.6716.01", "G alpha (z) signalling events"], ["TCGA.CA.6716.01", "Interaction between L1 and Ankyrins"], ["TCGA.CA.6716.01", "Potassium Channels"], ["TCGA.CA.6716.01", "Creation of C4 and C2 activators"], ["TCGA.CA.6716.01", "Activation of the phototransduction cascade"], ["TCGA.CA.6716.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CA.6716.01", "Cell surface interactions at the vascular wall"], ["TCGA.CA.6716.01", "Scavenging by Class A Receptors"], ["TCGA.CA.6716.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.CA.6716.01", "Acyl chain remodelling of PE"], ["TCGA.CA.6716.01", "Phase 4 - resting membrane potential"], ["TCGA.CA.6716.01", "Ethanol oxidation"], ["TCGA.CA.6716.01", "The role of Nef in HIV-1 replication and disease pathogenesis"], ["TCGA.CA.6716.01", "Integration of energy metabolism"], ["TCGA.CA.6716.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CA.6716.01", "Lewis blood group biosynthesis"], ["TCGA.CA.6716.01", "Transmission across Chemical Synapses"], ["TCGA.CA.6716.01", "DAP12 interactions"], ["TCGA.CA.6716.01", "Platelet activation, signaling and aggregation"], ["TCGA.CA.6716.01", "Signaling by Interleukins"], ["TCGA.CA.6716.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CA.6716.01", "Defensins"], ["TCGA.CA.6716.01", "Heme degradation"], ["TCGA.CA.6716.01", "Visual phototransduction"], ["TCGA.CA.6716.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CA.6716.01", "Phase II - Conjugation of compounds"], ["TCGA.CA.6716.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CA.6716.01", "SLC-mediated transmembrane transport"], ["TCGA.CA.6716.01", "Drug ADME"], ["TCGA.CA.6716.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CA.6716.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CA.6716.01", "Degradation of the extracellular matrix"], ["TCGA.CA.6716.01", "Binding and entry of HIV virion"], ["TCGA.CA.6716.01", "DAP12 signaling"], ["TCGA.CA.6716.01", "Sialic acid metabolism"], ["TCGA.CA.6716.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.CA.6716.01", "FCGR activation"], ["TCGA.CA.6716.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CA.6716.01", "G beta:gamma signalling through BTK"], ["TCGA.CA.6717.01", "TCOF1"], ["TCGA.CA.6717.01", "NSRP1"], ["TCGA.CA.6717.01", "OPA1"], ["TCGA.CA.6717.01", "ITGA8"], ["TCGA.CA.6717.01", "ITGA1"], ["TCGA.CA.6717.01", "ITGA2"], ["TCGA.CA.6717.01", "ITGA6"], ["TCGA.CA.6717.01", "ITGA7"], ["TCGA.CA.6717.01", "BCL2A1"], ["TCGA.CA.6717.01", "ITGAV"], ["TCGA.CA.6717.01", "ITGAL"], ["TCGA.CA.6717.01", "ITGAD"], ["TCGA.CA.6717.01", "ITGAE"], ["TCGA.CA.6717.01", "IGF2R"], ["TCGA.CA.6717.01", "CPEB4"], ["TCGA.CA.6717.01", "CPEB3"], ["TCGA.CA.6717.01", "CPEB2"], ["TCGA.CA.6717.01", "STAT5B"], ["TCGA.CA.6717.01", "CFI"], ["TCGA.CA.6717.01", "CFP"], ["TCGA.CA.6717.01", "ZNF479"], ["TCGA.CA.6717.01", "NLGN3"], ["TCGA.CA.6717.01", "NUP107"], ["TCGA.CA.6717.01", "ZNF471"], ["TCGA.CA.6717.01", "NR1D2"], ["TCGA.CA.6717.01", "DLGAP3"], ["TCGA.CA.6717.01", "PTPN13"], ["TCGA.CA.6717.01", "PTPN12"], ["TCGA.CA.6717.01", "CDK7"], ["TCGA.CA.6717.01", "OR52N2"], ["TCGA.CA.6717.01", "HOXA10"], ["TCGA.CA.6717.01", "GALNTL5"], ["TCGA.CA.6717.01", "GALNTL6"], ["TCGA.CA.6717.01", "GCNT4"], ["TCGA.CA.6717.01", "PDK2"], ["TCGA.CA.6717.01", "PDK4"], ["TCGA.CA.6717.01", "LNPEP"], ["TCGA.CA.6717.01", "SEC61A1"], ["TCGA.CA.6717.01", "PRKCB"], ["TCGA.CA.6717.01", "RAB3GAP2"], ["TCGA.CA.6717.01", "LTN1"], ["TCGA.CA.6717.01", "COL14A1"], ["TCGA.CA.6717.01", "SNAP91"], ["TCGA.CA.6717.01", "TMEFF1"], ["TCGA.CA.6717.01", "ZNF300"], ["TCGA.CA.6717.01", "PPP3CC"], ["TCGA.CA.6717.01", "ADRA2A"], ["TCGA.CA.6717.01", "SYT1"], ["TCGA.CA.6717.01", "NBN"], ["TCGA.CA.6717.01", "FUBP1"], ["TCGA.CA.6717.01", "BRIP1"], ["TCGA.CA.6717.01", "PDE11A"], ["TCGA.CA.6717.01", "TTC28"], ["TCGA.CA.6717.01", "OBSCN"], ["TCGA.CA.6717.01", "SORBS3"], ["TCGA.CA.6717.01", "BCLAF1"], ["TCGA.CA.6717.01", "CCP110"], ["TCGA.CA.6717.01", "EPB41L1"], ["TCGA.CA.6717.01", "EPB41L3"], ["TCGA.CA.6717.01", "EPB41L2"], ["TCGA.CA.6717.01", "EPB41L5"], ["TCGA.CA.6717.01", "ACSS3"], ["TCGA.CA.6717.01", "ACSS2"], ["TCGA.CA.6717.01", "KIDINS220"], ["TCGA.CA.6717.01", "UTY"], ["TCGA.CA.6717.01", "PACRG"], ["TCGA.CA.6717.01", "SAFB"], ["TCGA.CA.6717.01", "NGLY1"], ["TCGA.CA.6717.01", "LMX1B"], ["TCGA.CA.6717.01", "ADAM15"], ["TCGA.CA.6717.01", "ADAM17"], ["TCGA.CA.6717.01", "G3BP1"], ["TCGA.CA.6717.01", "SHANK1"], ["TCGA.CA.6717.01", "PCSK1"], ["TCGA.CA.6717.01", "PCSK5"], ["TCGA.CA.6717.01", "DPYSL4"], ["TCGA.CA.6717.01", "OR2T33"], ["TCGA.CA.6717.01", "LAMB1"], ["TCGA.CA.6717.01", "LAMB2"], ["TCGA.CA.6717.01", "CYSLTR2"], ["TCGA.CA.6717.01", "LAMB4"], ["TCGA.CA.6717.01", "RSRC1"], ["TCGA.CA.6717.01", "ARHGAP40"], ["TCGA.CA.6717.01", "NLGN1"], ["TCGA.CA.6717.01", "GPRC6A"], ["TCGA.CA.6717.01", "ABI1"], ["TCGA.CA.6717.01", "AOC3"], ["TCGA.CA.6717.01", "CLINT1"], ["TCGA.CA.6717.01", "ADCY4"], ["TCGA.CA.6717.01", "ADCY1"], ["TCGA.CA.6717.01", "ADCY8"], ["TCGA.CA.6717.01", "DDI1"], ["TCGA.CA.6717.01", "XRCC5"], ["TCGA.CA.6717.01", "MEIS1"], ["TCGA.CA.6717.01", "CTLA4"], ["TCGA.CA.6717.01", "KCNA4"], ["TCGA.CA.6717.01", "KCNA2"], ["TCGA.CA.6717.01", "KCNA3"], ["TCGA.CA.6717.01", "ACACB"], ["TCGA.CA.6717.01", "ZDHHC9"], ["TCGA.CA.6717.01", "OR8J3"], ["TCGA.CA.6717.01", "OR8J1"], ["TCGA.CA.6717.01", "BPNT1"], ["TCGA.CA.6717.01", "SERPINB3"], ["TCGA.CA.6717.01", "SERPINB4"], ["TCGA.CA.6717.01", "ELP2"], ["TCGA.CA.6717.01", "ZNF682"], ["TCGA.CA.6717.01", "HFE"], ["TCGA.CA.6717.01", "CSNK1A1L"], ["TCGA.CA.6717.01", "RIN3"], ["TCGA.CA.6717.01", "RIN2"], ["TCGA.CA.6717.01", "RIPK1"], ["TCGA.CA.6717.01", "PDCL"], ["TCGA.CA.6717.01", "ZNF416"], ["TCGA.CA.6717.01", "ACTN1"], ["TCGA.CA.6717.01", "ABLIM3"], ["TCGA.CA.6717.01", "TTC30A"], ["TCGA.CA.6717.01", "TTC30B"], ["TCGA.CA.6717.01", "TMPRSS6"], ["TCGA.CA.6717.01", "SIPA1L1"], ["TCGA.CA.6717.01", "QKI"], ["TCGA.CA.6717.01", "SLC17A8"], ["TCGA.CA.6717.01", "EAF2"], ["TCGA.CA.6717.01", "SYNCRIP"], ["TCGA.CA.6717.01", "TYR"], ["TCGA.CA.6717.01", "ZNF202"], ["TCGA.CA.6717.01", "SLU7"], ["TCGA.CA.6717.01", "SLK"], ["TCGA.CA.6717.01", "NOTCH2"], ["TCGA.CA.6717.01", "ZNF655"], ["TCGA.CA.6717.01", "TCTEX1D2"], ["TCGA.CA.6717.01", "RAPGEF5"], ["TCGA.CA.6717.01", "RAPGEF6"], ["TCGA.CA.6717.01", "RAPGEF2"], ["TCGA.CA.6717.01", "GLDC"], ["TCGA.CA.6717.01", "MARK4"], ["TCGA.CA.6717.01", "MARK1"], ["TCGA.CA.6717.01", "MARK3"], ["TCGA.CA.6717.01", "WDR19"], ["TCGA.CA.6717.01", "APEH"], ["TCGA.CA.6717.01", "DEFB136"], ["TCGA.CA.6717.01", "RIMKLB"], ["TCGA.CA.6717.01", "POMT1"], ["TCGA.CA.6717.01", "POMT2"], ["TCGA.CA.6717.01", "EDC3"], ["TCGA.CA.6717.01", "ANAPC1"], ["TCGA.CA.6717.01", "ANAPC4"], ["TCGA.CA.6717.01", "PSMD13"], ["TCGA.CA.6717.01", "EXOSC10"], ["TCGA.CA.6717.01", "MYLK4"], ["TCGA.CA.6717.01", "FYCO1"], ["TCGA.CA.6717.01", "MND1"], ["TCGA.CA.6717.01", "RAB27A"], ["TCGA.CA.6717.01", "ZNF770"], ["TCGA.CA.6717.01", "TRIM6"], ["TCGA.CA.6717.01", "DPH2"], ["TCGA.CA.6717.01", "PAH"], ["TCGA.CA.6717.01", "DCN"], ["TCGA.CA.6717.01", "FLRT3"], ["TCGA.CA.6717.01", "HSPA4L"], ["TCGA.CA.6717.01", "SEL1L2"], ["TCGA.CA.6717.01", "RGS5"], ["TCGA.CA.6717.01", "CD28"], ["TCGA.CA.6717.01", "FAT1"], ["TCGA.CA.6717.01", "COL27A1"], ["TCGA.CA.6717.01", "HIST1H1D"], ["TCGA.CA.6717.01", "HIST1H1E"], ["TCGA.CA.6717.01", "CAB39"], ["TCGA.CA.6717.01", "BCL2L14"], ["TCGA.CA.6717.01", "BLOC1S1"], ["TCGA.CA.6717.01", "NPC1"], ["TCGA.CA.6717.01", "NCOA2"], ["TCGA.CA.6717.01", "NCOA3"], ["TCGA.CA.6717.01", "NCOA1"], ["TCGA.CA.6717.01", "NCOA6"], ["TCGA.CA.6717.01", "SREK1"], ["TCGA.CA.6717.01", "ZNF490"], ["TCGA.CA.6717.01", "NLGN4Y"], ["TCGA.CA.6717.01", "FBN2"], ["TCGA.CA.6717.01", "FBN1"], ["TCGA.CA.6717.01", "PDE1C"], ["TCGA.CA.6717.01", "TRAIP"], ["TCGA.CA.6717.01", "NID2"], ["TCGA.CA.6717.01", "NID1"], ["TCGA.CA.6717.01", "FCER1A"], ["TCGA.CA.6717.01", "OR4D1"], ["TCGA.CA.6717.01", "FANCM"], ["TCGA.CA.6717.01", "FANCL"], ["TCGA.CA.6717.01", "FANCI"], ["TCGA.CA.6717.01", "F13B"], ["TCGA.CA.6717.01", "IGLL1"], ["TCGA.CA.6717.01", "HSPD1"], ["TCGA.CA.6717.01", "WWP1"], ["TCGA.CA.6717.01", "CTSC"], ["TCGA.CA.6717.01", "CTSG"], ["TCGA.CA.6717.01", "CTSS"], ["TCGA.CA.6717.01", "EMD"], ["TCGA.CA.6717.01", "AFF4"], ["TCGA.CA.6717.01", "AFF1"], ["TCGA.CA.6717.01", "PDPR"], ["TCGA.CA.6717.01", "PDP2"], ["TCGA.CA.6717.01", "UBA5"], ["TCGA.CA.6717.01", "NRCAM"], ["TCGA.CA.6717.01", "LYZ"], ["TCGA.CA.6717.01", "IP6K3"], ["TCGA.CA.6717.01", "NFKBIE"], ["TCGA.CA.6717.01", "NR5A2"], ["TCGA.CA.6717.01", "VAV3"], ["TCGA.CA.6717.01", "FOXN2"], ["TCGA.CA.6717.01", "PYGO1"], ["TCGA.CA.6717.01", "FERMT2"], ["TCGA.CA.6717.01", "FERMT3"], ["TCGA.CA.6717.01", "USP16"], ["TCGA.CA.6717.01", "USP19"], ["TCGA.CA.6717.01", "KLC3"], ["TCGA.CA.6717.01", "ZNF519"], ["TCGA.CA.6717.01", "ZNF510"], ["TCGA.CA.6717.01", "ZNF20"], ["TCGA.CA.6717.01", "SI"], ["TCGA.CA.6717.01", "NRP2"], ["TCGA.CA.6717.01", "SPHKAP"], ["TCGA.CA.6717.01", "PROS1"], ["TCGA.CA.6717.01", "TNKS2"], ["TCGA.CA.6717.01", "PON1"], ["TCGA.CA.6717.01", "ROCK2"], ["TCGA.CA.6717.01", "DOCK8"], ["TCGA.CA.6717.01", "GRIA2"], ["TCGA.CA.6717.01", "DOCK1"], ["TCGA.CA.6717.01", "DOCK5"], ["TCGA.CA.6717.01", "ZNF750"], ["TCGA.CA.6717.01", "ZNF665"], ["TCGA.CA.6717.01", "ATF6B"], ["TCGA.CA.6717.01", "PIR"], ["TCGA.CA.6717.01", "PHAX"], ["TCGA.CA.6717.01", "EPHA7"], ["TCGA.CA.6717.01", "EPHA5"], ["TCGA.CA.6717.01", "COL9A2"], ["TCGA.CA.6717.01", "ARL6"], ["TCGA.CA.6717.01", "TSR1"], ["TCGA.CA.6717.01", "CYP4A11"], ["TCGA.CA.6717.01", "SLC17A6"], ["TCGA.CA.6717.01", "ARL13B"], ["TCGA.CA.6717.01", "GFM1"], ["TCGA.CA.6717.01", "DCTN1"], ["TCGA.CA.6717.01", "KCMF1"], ["TCGA.CA.6717.01", "KNTC1"], ["TCGA.CA.6717.01", "PLCL1"], ["TCGA.CA.6717.01", "IGSF3"], ["TCGA.CA.6717.01", "ITGB2"], ["TCGA.CA.6717.01", "ITGB7"], ["TCGA.CA.6717.01", "ITGB6"], ["TCGA.CA.6717.01", "SLC37A1"], ["TCGA.CA.6717.01", "USP34"], ["TCGA.CA.6717.01", "FGG"], ["TCGA.CA.6717.01", "FGA"], ["TCGA.CA.6717.01", "OSBP"], ["TCGA.CA.6717.01", "TMED7"], ["TCGA.CA.6717.01", "ZNF304"], ["TCGA.CA.6717.01", "TAAR1"], ["TCGA.CA.6717.01", "SCN9A"], ["TCGA.CA.6717.01", "ABCB1"], ["TCGA.CA.6717.01", "ABCB4"], ["TCGA.CA.6717.01", "GOLGB1"], ["TCGA.CA.6717.01", "SNRNP200"], ["TCGA.CA.6717.01", "GADD45G"], ["TCGA.CA.6717.01", "SCN1A"], ["TCGA.CA.6717.01", "ZNF273"], ["TCGA.CA.6717.01", "KCNV2"], ["TCGA.CA.6717.01", "ITGA11"], ["TCGA.CA.6717.01", "MAML3"], ["TCGA.CA.6717.01", "HERC3"], ["TCGA.CA.6717.01", "HERC4"], ["TCGA.CA.6717.01", "HERC6"], ["TCGA.CA.6717.01", "PEX5L"], ["TCGA.CA.6717.01", "CD58"], ["TCGA.CA.6717.01", "LRP2"], ["TCGA.CA.6717.01", "LRP1"], ["TCGA.CA.6717.01", "LRP6"], ["TCGA.CA.6717.01", "MAP2"], ["TCGA.CA.6717.01", "C8A"], ["TCGA.CA.6717.01", "MAP7"], ["TCGA.CA.6717.01", "PTPN22"], ["TCGA.CA.6717.01", "SPATA5L1"], ["TCGA.CA.6717.01", "MTPN"], ["TCGA.CA.6717.01", "MAPT"], ["TCGA.CA.6717.01", "MSR1"], ["TCGA.CA.6717.01", "CHRNA6"], ["TCGA.CA.6717.01", "CHRNA1"], ["TCGA.CA.6717.01", "CHRNA2"], ["TCGA.CA.6717.01", "FSHR"], ["TCGA.CA.6717.01", "AP5Z1"], ["TCGA.CA.6717.01", "SPATA5"], ["TCGA.CA.6717.01", "KDM2A"], ["TCGA.CA.6717.01", "SIRPA"], ["TCGA.CA.6717.01", "TRAPPC8"], ["TCGA.CA.6717.01", "SIM1"], ["TCGA.CA.6717.01", "NADSYN1"], ["TCGA.CA.6717.01", "RELT"], ["TCGA.CA.6717.01", "RELN"], ["TCGA.CA.6717.01", "PTH2R"], ["TCGA.CA.6717.01", "KLK2"], ["TCGA.CA.6717.01", "KLK3"], ["TCGA.CA.6717.01", "COPS3"], ["TCGA.CA.6717.01", "ZNF596"], ["TCGA.CA.6717.01", "ZNF599"], ["TCGA.CA.6717.01", "SSB"], ["TCGA.CA.6717.01", "ZNF334"], ["TCGA.CA.6717.01", "ZNF333"], ["TCGA.CA.6717.01", "TEX15"], ["TCGA.CA.6717.01", "SNRNP40"], ["TCGA.CA.6717.01", "CYP24A1"], ["TCGA.CA.6717.01", "ZNF33B"], ["TCGA.CA.6717.01", "SNRNP48"], ["TCGA.CA.6717.01", "CASQ2"], ["TCGA.CA.6717.01", "NPY2R"], ["TCGA.CA.6717.01", "ZFP90"], ["TCGA.CA.6717.01", "PROK1"], ["TCGA.CA.6717.01", "FBXO45"], ["TCGA.CA.6717.01", "KIF16B"], ["TCGA.CA.6717.01", "COL6A3"], ["TCGA.CA.6717.01", "COL6A2"], ["TCGA.CA.6717.01", "COL6A5"], ["TCGA.CA.6717.01", "LRRK2"], ["TCGA.CA.6717.01", "TGFB1I1"], ["TCGA.CA.6717.01", "MRPL15"], ["TCGA.CA.6717.01", "MRPL17"], ["TCGA.CA.6717.01", "RNF123"], ["TCGA.CA.6717.01", "PHLPP1"], ["TCGA.CA.6717.01", "SCN11A"], ["TCGA.CA.6717.01", "DIS3"], ["TCGA.CA.6717.01", "CHKA"], ["TCGA.CA.6717.01", "BMS1"], ["TCGA.CA.6717.01", "DST"], ["TCGA.CA.6717.01", "DSP"], ["TCGA.CA.6717.01", "DSE"], ["TCGA.CA.6717.01", "GRIN3A"], ["TCGA.CA.6717.01", "HECW2"], ["TCGA.CA.6717.01", "NFATC3"], ["TCGA.CA.6717.01", "ALKBH8"], ["TCGA.CA.6717.01", "CDK20"], ["TCGA.CA.6717.01", "OCIAD1"], ["TCGA.CA.6717.01", "HELQ"], ["TCGA.CA.6717.01", "MAP1B"], ["TCGA.CA.6717.01", "UPF1"], ["TCGA.CA.6717.01", "IL1B"], ["TCGA.CA.6717.01", "COMP"], ["TCGA.CA.6717.01", "ZNF154"], ["TCGA.CA.6717.01", "KIFAP3"], ["TCGA.CA.6717.01", "ZNF143"], ["TCGA.CA.6717.01", "KCNN3"], ["TCGA.CA.6717.01", "PKIA"], ["TCGA.CA.6717.01", "NIT2"], ["TCGA.CA.6717.01", "MAPK6"], ["TCGA.CA.6717.01", "CUZD1"], ["TCGA.CA.6717.01", "MUC16"], ["TCGA.CA.6717.01", "RASGRP2"], ["TCGA.CA.6717.01", "RASGRP3"], ["TCGA.CA.6717.01", "HCK"], ["TCGA.CA.6717.01", "C7orf26"], ["TCGA.CA.6717.01", "ZNF426"], ["TCGA.CA.6717.01", "ZNF423"], ["TCGA.CA.6717.01", "NEDD4"], ["TCGA.CA.6717.01", "LMOD1"], ["TCGA.CA.6717.01", "OR5W2"], ["TCGA.CA.6717.01", "AGXT2"], ["TCGA.CA.6717.01", "SYNJ2"], ["TCGA.CA.6717.01", "RAB5C"], ["TCGA.CA.6717.01", "WNT7A"], ["TCGA.CA.6717.01", "ADSSL1"], ["TCGA.CA.6717.01", "HCLS1"], ["TCGA.CA.6717.01", "FCHO2"], ["TCGA.CA.6717.01", "PHF7"], ["TCGA.CA.6717.01", "PHF1"], ["TCGA.CA.6717.01", "RPS24"], ["TCGA.CA.6717.01", "OR1E1"], ["TCGA.CA.6717.01", "ATRX"], ["TCGA.CA.6717.01", "ZC3H6"], ["TCGA.CA.6717.01", "DRD5"], ["TCGA.CA.6717.01", "SNAPC1"], ["TCGA.CA.6717.01", "KIF3A"], ["TCGA.CA.6717.01", "DCAF5"], ["TCGA.CA.6717.01", "DIAPH2"], ["TCGA.CA.6717.01", "SNX32"], ["TCGA.CA.6717.01", "GABRR2"], ["TCGA.CA.6717.01", "TRIM55"], ["TCGA.CA.6717.01", "ZNF212"], ["TCGA.CA.6717.01", "PRMT3"], ["TCGA.CA.6717.01", "HSD17B2"], ["TCGA.CA.6717.01", "HSD17B4"], ["TCGA.CA.6717.01", "PARD3"], ["TCGA.CA.6717.01", "CEP192"], ["TCGA.CA.6717.01", "CNOT1"], ["TCGA.CA.6717.01", "RFC1"], ["TCGA.CA.6717.01", "SHOC2"], ["TCGA.CA.6717.01", "ERCC2"], ["TCGA.CA.6717.01", "ERCC3"], ["TCGA.CA.6717.01", "ERCC4"], ["TCGA.CA.6717.01", "ERCC6"], ["TCGA.CA.6717.01", "MRPS16"], ["TCGA.CA.6717.01", "PFKP"], ["TCGA.CA.6717.01", "SSR2"], ["TCGA.CA.6717.01", "ZFPM2"], ["TCGA.CA.6717.01", "UBE2O"], ["TCGA.CA.6717.01", "RASA1"], ["TCGA.CA.6717.01", "DOCK10"], ["TCGA.CA.6717.01", "DOCK11"], ["TCGA.CA.6717.01", "CDH11"], ["TCGA.CA.6717.01", "CDH10"], ["TCGA.CA.6717.01", "CDH12"], ["TCGA.CA.6717.01", "CDH18"], ["TCGA.CA.6717.01", "OR4A16"], ["TCGA.CA.6717.01", "OR4A15"], ["TCGA.CA.6717.01", "NIPBL"], ["TCGA.CA.6717.01", "ITSN1"], ["TCGA.CA.6717.01", "ITSN2"], ["TCGA.CA.6717.01", "MEFV"], ["TCGA.CA.6717.01", "ABL2"], ["TCGA.CA.6717.01", "IL9R"], ["TCGA.CA.6717.01", "AARS"], ["TCGA.CA.6717.01", "SRA1"], ["TCGA.CA.6717.01", "OR9I1"], ["TCGA.CA.6717.01", "GTF3C6"], ["TCGA.CA.6717.01", "GARS"], ["TCGA.CA.6717.01", "ATAD5"], ["TCGA.CA.6717.01", "MTIF2"], ["TCGA.CA.6717.01", "CALB1"], ["TCGA.CA.6717.01", "AGGF1"], ["TCGA.CA.6717.01", "WDHD1"], ["TCGA.CA.6717.01", "AHCTF1"], ["TCGA.CA.6717.01", "NPFFR2"], ["TCGA.CA.6717.01", "SALL4"], ["TCGA.CA.6717.01", "RPS6KB1"], ["TCGA.CA.6717.01", "ISY1"], ["TCGA.CA.6717.01", "F2RL2"], ["TCGA.CA.6717.01", "XAB2"], ["TCGA.CA.6717.01", "TRIM50"], ["TCGA.CA.6717.01", "HPX"], ["TCGA.CA.6717.01", "CALHM1"], ["TCGA.CA.6717.01", "HPR"], ["TCGA.CA.6717.01", "RPL3"], ["TCGA.CA.6717.01", "INHA"], ["TCGA.CA.6717.01", "UGT8"], ["TCGA.CA.6717.01", "ZNF624"], ["TCGA.CA.6717.01", "CAMK2G"], ["TCGA.CA.6717.01", "JAK2"], ["TCGA.CA.6717.01", "JAK1"], ["TCGA.CA.6717.01", "PRKDC"], ["TCGA.CA.6717.01", "TLL1"], ["TCGA.CA.6717.01", "PBK"], ["TCGA.CA.6717.01", "KIF21A"], ["TCGA.CA.6717.01", "RIMS1"], ["TCGA.CA.6717.01", "TMEM67"], ["TCGA.CA.6717.01", "TAGLN3"], ["TCGA.CA.6717.01", "PRKD1"], ["TCGA.CA.6717.01", "MCTS1"], ["TCGA.CA.6717.01", "REST"], ["TCGA.CA.6717.01", "POU1F1"], ["TCGA.CA.6717.01", "ZNF543"], ["TCGA.CA.6717.01", "ZNF549"], ["TCGA.CA.6717.01", "TAS2R50"], ["TCGA.CA.6717.01", "RARB"], ["TCGA.CA.6717.01", "SLC25A5"], ["TCGA.CA.6717.01", "SYF2"], ["TCGA.CA.6717.01", "MCM8"], ["TCGA.CA.6717.01", "ZNF625"], ["TCGA.CA.6717.01", "UGT2B15"], ["TCGA.CA.6717.01", "VPS52"], ["TCGA.CA.6717.01", "EPRS"], ["TCGA.CA.6717.01", "SUPT16H"], ["TCGA.CA.6717.01", "NRK"], ["TCGA.CA.6717.01", "EME1"], ["TCGA.CA.6717.01", "MOGS"], ["TCGA.CA.6717.01", "SALL1"], ["TCGA.CA.6717.01", "ZNF782"], ["TCGA.CA.6717.01", "UBE3C"], ["TCGA.CA.6717.01", "UBE3D"], ["TCGA.CA.6717.01", "GLOD4"], ["TCGA.CA.6717.01", "STX3"], ["TCGA.CA.6717.01", "CNKSR2"], ["TCGA.CA.6717.01", "AUTS2"], ["TCGA.CA.6717.01", "ATP7A"], ["TCGA.CA.6717.01", "PDE2A"], ["TCGA.CA.6717.01", "SCFD2"], ["TCGA.CA.6717.01", "TTI1"], ["TCGA.CA.6717.01", "TADA2B"], ["TCGA.CA.6717.01", "KIF9"], ["TCGA.CA.6717.01", "KIF6"], ["TCGA.CA.6717.01", "AP3M1"], ["TCGA.CA.6717.01", "AP3M2"], ["TCGA.CA.6717.01", "ESYT2"], ["TCGA.CA.6717.01", "OR9A4"], ["TCGA.CA.6717.01", "RB1"], ["TCGA.CA.6717.01", "FAM160A2"], ["TCGA.CA.6717.01", "NAALADL2"], ["TCGA.CA.6717.01", "AQP5"], ["TCGA.CA.6717.01", "ACTC1"], ["TCGA.CA.6717.01", "DNA2"], ["TCGA.CA.6717.01", "OR2M4"], ["TCGA.CA.6717.01", "OR2M7"], ["TCGA.CA.6717.01", "TP53BP1"], ["TCGA.CA.6717.01", "OR2M3"], ["TCGA.CA.6717.01", "GRK7"], ["TCGA.CA.6717.01", "KLHL5"], ["TCGA.CA.6717.01", "KLHL8"], ["TCGA.CA.6717.01", "TCTN2"], ["TCGA.CA.6717.01", "TCTN1"], ["TCGA.CA.6717.01", "SYNE1"], ["TCGA.CA.6717.01", "SYNE2"], ["TCGA.CA.6717.01", "OTC"], ["TCGA.CA.6717.01", "UBQLN1"], ["TCGA.CA.6717.01", "TNR"], ["TCGA.CA.6717.01", "SV2C"], ["TCGA.CA.6717.01", "GPR15"], ["TCGA.CA.6717.01", "ARNTL"], ["TCGA.CA.6717.01", "KCNMA1"], ["TCGA.CA.6717.01", "ARNT2"], ["TCGA.CA.6717.01", "LETM1"], ["TCGA.CA.6717.01", "RAD51AP1"], ["TCGA.CA.6717.01", "PLCG2"], ["TCGA.CA.6717.01", "DKK4"], ["TCGA.CA.6717.01", "CEP350"], ["TCGA.CA.6717.01", "HDAC2"], ["TCGA.CA.6717.01", "HDAC8"], ["TCGA.CA.6717.01", "CST3"], ["TCGA.CA.6717.01", "CST6"], ["TCGA.CA.6717.01", "STARD8"], ["TCGA.CA.6717.01", "ZNF547"], ["TCGA.CA.6717.01", "CEBPZ"], ["TCGA.CA.6717.01", "CTNNA2"], ["TCGA.CA.6717.01", "CERS6"], ["TCGA.CA.6717.01", "CERS5"], ["TCGA.CA.6717.01", "RGSL1"], ["TCGA.CA.6717.01", "MAN1A1"], ["TCGA.CA.6717.01", "LCT"], ["TCGA.CA.6717.01", "POLE2"], ["TCGA.CA.6717.01", "NLRC4"], ["TCGA.CA.6717.01", "COL18A1"], ["TCGA.CA.6717.01", "OPRK1"], ["TCGA.CA.6717.01", "DNAH17"], ["TCGA.CA.6717.01", "DNAH10"], ["TCGA.CA.6717.01", "GLI2"], ["TCGA.CA.6717.01", "EDN3"], ["TCGA.CA.6717.01", "PREX2"], ["TCGA.CA.6717.01", "OXGR1"], ["TCGA.CA.6717.01", "MADD"], ["TCGA.CA.6717.01", "OR10J5"], ["TCGA.CA.6717.01", "ZNF701"], ["TCGA.CA.6717.01", "ZNF700"], ["TCGA.CA.6717.01", "ZNF704"], ["TCGA.CA.6717.01", "RNF111"], ["TCGA.CA.6717.01", "DHX8"], ["TCGA.CA.6717.01", "DHX9"], ["TCGA.CA.6717.01", "NUP98"], ["TCGA.CA.6717.01", "NSL1"], ["TCGA.CA.6717.01", "SMAD1"], ["TCGA.CA.6717.01", "TCEA1"], ["TCGA.CA.6717.01", "LEO1"], ["TCGA.CA.6717.01", "MR1"], ["TCGA.CA.6717.01", "APC"], ["TCGA.CA.6717.01", "CLIC4"], ["TCGA.CA.6717.01", "CDC5L"], ["TCGA.CA.6717.01", "AP2A1"], ["TCGA.CA.6717.01", "BRD7"], ["TCGA.CA.6717.01", "DMD"], ["TCGA.CA.6717.01", "EREG"], ["TCGA.CA.6717.01", "ASAP2"], ["TCGA.CA.6717.01", "SRRM2"], ["TCGA.CA.6717.01", "ARHGAP20"], ["TCGA.CA.6717.01", "ARHGAP25"], ["TCGA.CA.6717.01", "ARHGAP29"], ["TCGA.CA.6717.01", "OR2H2"], ["TCGA.CA.6717.01", "RSAD2"], ["TCGA.CA.6717.01", "DYNC1LI1"], ["TCGA.CA.6717.01", "ABCG2"], ["TCGA.CA.6717.01", "ABCG8"], ["TCGA.CA.6717.01", "AKR1B15"], ["TCGA.CA.6717.01", "ZNF136"], ["TCGA.CA.6717.01", "DAZL"], ["TCGA.CA.6717.01", "CCL28"], ["TCGA.CA.6717.01", "CCL26"], ["TCGA.CA.6717.01", "LDLR"], ["TCGA.CA.6717.01", "OR52L1"], ["TCGA.CA.6717.01", "AASDH"], ["TCGA.CA.6717.01", "LRRC40"], ["TCGA.CA.6717.01", "LRRC49"], ["TCGA.CA.6717.01", "ATP6V0A4"], ["TCGA.CA.6717.01", "NACA2"], ["TCGA.CA.6717.01", "KRT3"], ["TCGA.CA.6717.01", "KRT1"], ["TCGA.CA.6717.01", "DACT1"], ["TCGA.CA.6717.01", "ZNF382"], ["TCGA.CA.6717.01", "RIPK4"], ["TCGA.CA.6717.01", "RECK"], ["TCGA.CA.6717.01", "SPTBN5"], ["TCGA.CA.6717.01", "SPTBN1"], ["TCGA.CA.6717.01", "PYCARD"], ["TCGA.CA.6717.01", "APOB"], ["TCGA.CA.6717.01", "NUFIP1"], ["TCGA.CA.6717.01", "FBXO32"], ["TCGA.CA.6717.01", "ALAS2"], ["TCGA.CA.6717.01", "TIGIT"], ["TCGA.CA.6717.01", "REV3L"], ["TCGA.CA.6717.01", "RNF19A"], ["TCGA.CA.6717.01", "NEK7"], ["TCGA.CA.6717.01", "CIB3"], ["TCGA.CA.6717.01", "OR6X1"], ["TCGA.CA.6717.01", "STAB1"], ["TCGA.CA.6717.01", "STAB2"], ["TCGA.CA.6717.01", "IMPACT"], ["TCGA.CA.6717.01", "EVC2"], ["TCGA.CA.6717.01", "OR6C74"], ["TCGA.CA.6717.01", "CHN1"], ["TCGA.CA.6717.01", "APPL1"], ["TCGA.CA.6717.01", "APPL2"], ["TCGA.CA.6717.01", "OR2T10"], ["TCGA.CA.6717.01", "OR6S1"], ["TCGA.CA.6717.01", "POR"], ["TCGA.CA.6717.01", "ROBO3"], ["TCGA.CA.6717.01", "ROBO2"], ["TCGA.CA.6717.01", "HTR2A"], ["TCGA.CA.6717.01", "HTR2C"], ["TCGA.CA.6717.01", "HTR2B"], ["TCGA.CA.6717.01", "TBPL1"], ["TCGA.CA.6717.01", "ATP5S"], ["TCGA.CA.6717.01", "ME1"], ["TCGA.CA.6717.01", "CYP7B1"], ["TCGA.CA.6717.01", "CPD"], ["TCGA.CA.6717.01", "HHIP"], ["TCGA.CA.6717.01", "KRT10"], ["TCGA.CA.6717.01", "ARIH1"], ["TCGA.CA.6717.01", "PLA2G4A"], ["TCGA.CA.6717.01", "PLA2G4E"], ["TCGA.CA.6717.01", "OR8H1"], ["TCGA.CA.6717.01", "COL11A1"], ["TCGA.CA.6717.01", "SIPA1L2"], ["TCGA.CA.6717.01", "SERPIND1"], ["TCGA.CA.6717.01", "PRPF4B"], ["TCGA.CA.6717.01", "RORB"], ["TCGA.CA.6717.01", "ZNF470"], ["TCGA.CA.6717.01", "KPNA4"], ["TCGA.CA.6717.01", "B4GALT1"], ["TCGA.CA.6717.01", "B4GALT7"], ["TCGA.CA.6717.01", "OR5L2"], ["TCGA.CA.6717.01", "BOLL"], ["TCGA.CA.6717.01", "ZKSCAN5"], ["TCGA.CA.6717.01", "TMEM181"], ["TCGA.CA.6717.01", "HCAR3"], ["TCGA.CA.6717.01", "TAF7"], ["TCGA.CA.6717.01", "TAF5"], ["TCGA.CA.6717.01", "TAF3"], ["TCGA.CA.6717.01", "TAF2"], ["TCGA.CA.6717.01", "TAF1"], ["TCGA.CA.6717.01", "FNIP1"], ["TCGA.CA.6717.01", "FNIP2"], ["TCGA.CA.6717.01", "ARFGEF1"], ["TCGA.CA.6717.01", "ARFGEF2"], ["TCGA.CA.6717.01", "SEC22A"], ["TCGA.CA.6717.01", "PDCD11"], ["TCGA.CA.6717.01", "ZNF677"], ["TCGA.CA.6717.01", "ZNF676"], ["TCGA.CA.6717.01", "ACLY"], ["TCGA.CA.6717.01", "IFIH1"], ["TCGA.CA.6717.01", "KIF4B"], ["TCGA.CA.6717.01", "MCF2"], ["TCGA.CA.6717.01", "PCF11"], ["TCGA.CA.6717.01", "PRKG1"], ["TCGA.CA.6717.01", "PRKG2"], ["TCGA.CA.6717.01", "CREM"], ["TCGA.CA.6717.01", "ACSM1"], ["TCGA.CA.6717.01", "ACSM4"], ["TCGA.CA.6717.01", "EIF4ENIF1"], ["TCGA.CA.6717.01", "TRIM26"], ["TCGA.CA.6717.01", "GNPAT"], ["TCGA.CA.6717.01", "NTSR2"], ["TCGA.CA.6717.01", "OR4D10"], ["TCGA.CA.6717.01", "BAG4"], ["TCGA.CA.6717.01", "KMO"], ["TCGA.CA.6717.01", "TMPO"], ["TCGA.CA.6717.01", "NAP1L1"], ["TCGA.CA.6717.01", "XIAP"], ["TCGA.CA.6717.01", "KANK1"], ["TCGA.CA.6717.01", "UBR2"], ["TCGA.CA.6717.01", "MYLIP"], ["TCGA.CA.6717.01", "GTF3A"], ["TCGA.CA.6717.01", "MAPK10"], ["TCGA.CA.6717.01", "FZD3"], ["TCGA.CA.6717.01", "ASH1L"], ["TCGA.CA.6717.01", "LPXN"], ["TCGA.CA.6717.01", "ESCO2"], ["TCGA.CA.6717.01", "ESCO1"], ["TCGA.CA.6717.01", "TARBP2"], ["TCGA.CA.6717.01", "PSPC1"], ["TCGA.CA.6717.01", "RAPGEF4"], ["TCGA.CA.6717.01", "ATR"], ["TCGA.CA.6717.01", "CDC25A"], ["TCGA.CA.6717.01", "WDFY4"], ["TCGA.CA.6717.01", "WDFY3"], ["TCGA.CA.6717.01", "AK7"], ["TCGA.CA.6717.01", "MME"], ["TCGA.CA.6717.01", "MDC1"], ["TCGA.CA.6717.01", "EXOSC5"], ["TCGA.CA.6717.01", "SKP1"], ["TCGA.CA.6717.01", "IFI16"], ["TCGA.CA.6717.01", "SPECC1"], ["TCGA.CA.6717.01", "USP22"], ["TCGA.CA.6717.01", "CARD9"], ["TCGA.CA.6717.01", "ADAMTS5"], ["TCGA.CA.6717.01", "ZNF311"], ["TCGA.CA.6717.01", "ARHGEF3"], ["TCGA.CA.6717.01", "BMP2K"], ["TCGA.CA.6717.01", "COCH"], ["TCGA.CA.6717.01", "MAEL"], ["TCGA.CA.6717.01", "GRM3"], ["TCGA.CA.6717.01", "SP100"], ["TCGA.CA.6717.01", "PARG"], ["TCGA.CA.6717.01", "AOC2"], ["TCGA.CA.6717.01", "DDX4"], ["TCGA.CA.6717.01", "SCN3A"], ["TCGA.CA.6717.01", "ZNF211"], ["TCGA.CA.6717.01", "SLC7A5"], ["TCGA.CA.6717.01", "IPO8"], ["TCGA.CA.6717.01", "IPO5"], ["TCGA.CA.6717.01", "NRBP1"], ["TCGA.CA.6717.01", "PLOD2"], ["TCGA.CA.6717.01", "RAD21"], ["TCGA.CA.6717.01", "PAPPA"], ["TCGA.CA.6717.01", "PIK3C2A"], ["TCGA.CA.6717.01", "PIK3C2G"], ["TCGA.CA.6717.01", "CEP72"], ["TCGA.CA.6717.01", "CEP78"], ["TCGA.CA.6717.01", "MST1"], ["TCGA.CA.6717.01", "SMG6"], ["TCGA.CA.6717.01", "PPEF1"], ["TCGA.CA.6717.01", "GPR45"], ["TCGA.CA.6717.01", "FUT5"], ["TCGA.CA.6717.01", "FUT8"], ["TCGA.CA.6717.01", "OR1J4"], ["TCGA.CA.6717.01", "CSPP1"], ["TCGA.CA.6717.01", "NOP58"], ["TCGA.CA.6717.01", "ETS1"], ["TCGA.CA.6717.01", "CHRM2"], ["TCGA.CA.6717.01", "GLRX"], ["TCGA.CA.6717.01", "MMP2"], ["TCGA.CA.6717.01", "MMP1"], ["TCGA.CA.6717.01", "USP38"], ["TCGA.CA.6717.01", "REV1"], ["TCGA.CA.6717.01", "ZNF532"], ["TCGA.CA.6717.01", "NPAS4"], ["TCGA.CA.6717.01", "NPAS2"], ["TCGA.CA.6717.01", "AP4E1"], ["TCGA.CA.6717.01", "FSTL1"], ["TCGA.CA.6717.01", "NUF2"], ["TCGA.CA.6717.01", "MED31"], ["TCGA.CA.6717.01", "FGF14"], ["TCGA.CA.6717.01", "OXNAD1"], ["TCGA.CA.6717.01", "CYP2C19"], ["TCGA.CA.6717.01", "KCNJ16"], ["TCGA.CA.6717.01", "KCNJ15"], ["TCGA.CA.6717.01", "PUM1"], ["TCGA.CA.6717.01", "NOS1"], ["TCGA.CA.6717.01", "NOS2"], ["TCGA.CA.6717.01", "NOS3"], ["TCGA.CA.6717.01", "LCP2"], ["TCGA.CA.6717.01", "LCP1"], ["TCGA.CA.6717.01", "TESK2"], ["TCGA.CA.6717.01", "NUP85"], ["TCGA.CA.6717.01", "MED23"], ["TCGA.CA.6717.01", "COL5A1"], ["TCGA.CA.6717.01", "LAMP2"], ["TCGA.CA.6717.01", "NAT10"], ["TCGA.CA.6717.01", "NCAPG"], ["TCGA.CA.6717.01", "PARP4"], ["TCGA.CA.6717.01", "BCAS3"], ["TCGA.CA.6717.01", "CD80"], ["TCGA.CA.6717.01", "CD86"], ["TCGA.CA.6717.01", "AFG3L2"], ["TCGA.CA.6717.01", "PTBP2"], ["TCGA.CA.6717.01", "CACNA2D2"], ["TCGA.CA.6717.01", "CACNA2D1"], ["TCGA.CA.6717.01", "MTA1"], ["TCGA.CA.6717.01", "NCAM2"], ["TCGA.CA.6717.01", "CGN"], ["TCGA.CA.6717.01", "ARL6IP5"], ["TCGA.CA.6717.01", "SEC31A"], ["TCGA.CA.6717.01", "PDGFD"], ["TCGA.CA.6717.01", "B2M"], ["TCGA.CA.6717.01", "ABCD2"], ["TCGA.CA.6717.01", "DSEL"], ["TCGA.CA.6717.01", "COL21A1"], ["TCGA.CA.6717.01", "KCNH7"], ["TCGA.CA.6717.01", "KCNH1"], ["TCGA.CA.6717.01", "KCNH3"], ["TCGA.CA.6717.01", "KCNH8"], ["TCGA.CA.6717.01", "HLA-DMB"], ["TCGA.CA.6717.01", "SYTL4"], ["TCGA.CA.6717.01", "MTRR"], ["TCGA.CA.6717.01", "IL10RB"], ["TCGA.CA.6717.01", "BMP10"], ["TCGA.CA.6717.01", "ZNF454"], ["TCGA.CA.6717.01", "PTPN1"], ["TCGA.CA.6717.01", "GRK6"], ["TCGA.CA.6717.01", "GPNMB"], ["TCGA.CA.6717.01", "PSMA4"], ["TCGA.CA.6717.01", "MSH4"], ["TCGA.CA.6717.01", "FOXO1"], ["TCGA.CA.6717.01", "FOXO4"], ["TCGA.CA.6717.01", "UBR5"], ["TCGA.CA.6717.01", "UBR4"], ["TCGA.CA.6717.01", "INVS"], ["TCGA.CA.6717.01", "CDC25C"], ["TCGA.CA.6717.01", "ACAN"], ["TCGA.CA.6717.01", "SAE1"], ["TCGA.CA.6717.01", "SDHD"], ["TCGA.CA.6717.01", "TNXB"], ["TCGA.CA.6717.01", "DLG1"], ["TCGA.CA.6717.01", "DLG2"], ["TCGA.CA.6717.01", "GABRG1"], ["TCGA.CA.6717.01", "TOMM6"], ["TCGA.CA.6717.01", "GEMIN5"], ["TCGA.CA.6717.01", "KIF18A"], ["TCGA.CA.6717.01", "EIF3A"], ["TCGA.CA.6717.01", "EIF3E"], ["TCGA.CA.6717.01", "MKKS"], ["TCGA.CA.6717.01", "BARD1"], ["TCGA.CA.6717.01", "SMG1"], ["TCGA.CA.6717.01", "OR10G4"], ["TCGA.CA.6717.01", "OR10G3"], ["TCGA.CA.6717.01", "OR10G9"], ["TCGA.CA.6717.01", "DBF4B"], ["TCGA.CA.6717.01", "GRIK1"], ["TCGA.CA.6717.01", "GRIK2"], ["TCGA.CA.6717.01", "GRIK4"], ["TCGA.CA.6717.01", "GRIK5"], ["TCGA.CA.6717.01", "ZNF732"], ["TCGA.CA.6717.01", "PPP1R3A"], ["TCGA.CA.6717.01", "INPP5F"], ["TCGA.CA.6717.01", "CNST"], ["TCGA.CA.6717.01", "CHIA"], ["TCGA.CA.6717.01", "CASR"], ["TCGA.CA.6717.01", "ADAM23"], ["TCGA.CA.6717.01", "TTF1"], ["TCGA.CA.6717.01", "ANXA1"], ["TCGA.CA.6717.01", "ANXA3"], ["TCGA.CA.6717.01", "ANXA6"], ["TCGA.CA.6717.01", "POU5F1"], ["TCGA.CA.6717.01", "SASS6"], ["TCGA.CA.6717.01", "PUS7"], ["TCGA.CA.6717.01", "COL12A1"], ["TCGA.CA.6717.01", "PFAS"], ["TCGA.CA.6717.01", "PMS1"], ["TCGA.CA.6717.01", "GRIP1"], ["TCGA.CA.6717.01", "MED12L"], ["TCGA.CA.6717.01", "FAF1"], ["TCGA.CA.6717.01", "FAF2"], ["TCGA.CA.6717.01", "PGM1"], ["TCGA.CA.6717.01", "CDC27"], ["TCGA.CA.6717.01", "CDC23"], ["TCGA.CA.6717.01", "STRADB"], ["TCGA.CA.6717.01", "VPS35"], ["TCGA.CA.6717.01", "TAS2R41"], ["TCGA.CA.6717.01", "BRAP"], ["TCGA.CA.6717.01", "NEDD4L"], ["TCGA.CA.6717.01", "BRAF"], ["TCGA.CA.6717.01", "TRAF3IP1"], ["TCGA.CA.6717.01", "MMP16"], ["TCGA.CA.6717.01", "MMP11"], ["TCGA.CA.6717.01", "MMP13"], ["TCGA.CA.6717.01", "SCLT1"], ["TCGA.CA.6717.01", "ALG10"], ["TCGA.CA.6717.01", "DDX58"], ["TCGA.CA.6717.01", "DNAH2"], ["TCGA.CA.6717.01", "DNAH1"], ["TCGA.CA.6717.01", "DNAH6"], ["TCGA.CA.6717.01", "DNAH7"], ["TCGA.CA.6717.01", "DNAH5"], ["TCGA.CA.6717.01", "DNAH8"], ["TCGA.CA.6717.01", "OR8K1"], ["TCGA.CA.6717.01", "CALD1"], ["TCGA.CA.6717.01", "CSTF3"], ["TCGA.CA.6717.01", "CSTF2"], ["TCGA.CA.6717.01", "BPTF"], ["TCGA.CA.6717.01", "JMJD1C"], ["TCGA.CA.6717.01", "PPP6R3"], ["TCGA.CA.6717.01", "EFCAB7"], ["TCGA.CA.6717.01", "SIAE"], ["TCGA.CA.6717.01", "NPEPPS"], ["TCGA.CA.6717.01", "GNPNAT1"], ["TCGA.CA.6717.01", "OR4M1"], ["TCGA.CA.6717.01", "SCTR"], ["TCGA.CA.6717.01", "WNT5A"], ["TCGA.CA.6717.01", "HNRNPH1"], ["TCGA.CA.6717.01", "HNRNPUL2"], ["TCGA.CA.6717.01", "PAIP1"], ["TCGA.CA.6717.01", "DCAF12"], ["TCGA.CA.6717.01", "PAPSS1"], ["TCGA.CA.6717.01", "TXK"], ["TCGA.CA.6717.01", "SIGLEC11"], ["TCGA.CA.6717.01", "PLXND1"], ["TCGA.CA.6717.01", "UROS"], ["TCGA.CA.6717.01", "NXF3"], ["TCGA.CA.6717.01", "ANPEP"], ["TCGA.CA.6717.01", "DCC"], ["TCGA.CA.6717.01", "POLE"], ["TCGA.CA.6717.01", "POLN"], ["TCGA.CA.6717.01", "IL17F"], ["TCGA.CA.6717.01", "IL17A"], ["TCGA.CA.6717.01", "PSMD1"], ["TCGA.CA.6717.01", "CHRDL1"], ["TCGA.CA.6717.01", "SGMS2"], ["TCGA.CA.6717.01", "EPS15"], ["TCGA.CA.6717.01", "ZNF649"], ["TCGA.CA.6717.01", "ZNF644"], ["TCGA.CA.6717.01", "STON2"], ["TCGA.CA.6717.01", "PRCC"], ["TCGA.CA.6717.01", "PRCP"], ["TCGA.CA.6717.01", "ZNF397"], ["TCGA.CA.6717.01", "IFT52"], ["TCGA.CA.6717.01", "LPA"], ["TCGA.CA.6717.01", "JAM3"], ["TCGA.CA.6717.01", "GALNT5"], ["TCGA.CA.6717.01", "GALNT7"], ["TCGA.CA.6717.01", "GALNT2"], ["TCGA.CA.6717.01", "GALNT3"], ["TCGA.CA.6717.01", "KIF14"], ["TCGA.CA.6717.01", "KIF15"], ["TCGA.CA.6717.01", "KIF11"], ["TCGA.CA.6717.01", "NLRP4"], ["TCGA.CA.6717.01", "NLRP1"], ["TCGA.CA.6717.01", "NLRP2"], ["TCGA.CA.6717.01", "NLRP8"], ["TCGA.CA.6717.01", "CD101"], ["TCGA.CA.6717.01", "KIF1B"], ["TCGA.CA.6717.01", "CD109"], ["TCGA.CA.6717.01", "ZFP30"], ["TCGA.CA.6717.01", "LOXL3"], ["TCGA.CA.6717.01", "DEFB126"], ["TCGA.CA.6717.01", "COPB1"], ["TCGA.CA.6717.01", "POFUT2"], ["TCGA.CA.6717.01", "ZNF616"], ["TCGA.CA.6717.01", "BOD1L1"], ["TCGA.CA.6717.01", "MAP4K3"], ["TCGA.CA.6717.01", "TRIM71"], ["TCGA.CA.6717.01", "NRG1"], ["TCGA.CA.6717.01", "NRG3"], ["TCGA.CA.6717.01", "KHK"], ["TCGA.CA.6717.01", "OR1L1"], ["TCGA.CA.6717.01", "TRAK1"], ["TCGA.CA.6717.01", "ZFC3H1"], ["TCGA.CA.6717.01", "STAG1"], ["TCGA.CA.6717.01", "RNF220"], ["TCGA.CA.6717.01", "PLS1"], ["TCGA.CA.6717.01", "CLASP1"], ["TCGA.CA.6717.01", "RAD54L2"], ["TCGA.CA.6717.01", "HACL1"], ["TCGA.CA.6717.01", "IQSEC1"], ["TCGA.CA.6717.01", "SESN1"], ["TCGA.CA.6717.01", "ZFYVE16"], ["TCGA.CA.6717.01", "SLIT1"], ["TCGA.CA.6717.01", "ZNF680"], ["TCGA.CA.6717.01", "PDE8A"], ["TCGA.CA.6717.01", "DBT"], ["TCGA.CA.6717.01", "MED1"], ["TCGA.CA.6717.01", "TCF7"], ["TCGA.CA.6717.01", "PPP5C"], ["TCGA.CA.6717.01", "MDN1"], ["TCGA.CA.6717.01", "AMPD1"], ["TCGA.CA.6717.01", "MYO18B"], ["TCGA.CA.6717.01", "AXIN1"], ["TCGA.CA.6717.01", "MMRN1"], ["TCGA.CA.6717.01", "PLA2R1"], ["TCGA.CA.6717.01", "TSSK1B"], ["TCGA.CA.6717.01", "CD34"], ["TCGA.CA.6717.01", "CD36"], ["TCGA.CA.6717.01", "TOPORS"], ["TCGA.CA.6717.01", "OR9K2"], ["TCGA.CA.6717.01", "ADAMTS12"], ["TCGA.CA.6717.01", "ADAMTS16"], ["TCGA.CA.6717.01", "ADAMTS18"], ["TCGA.CA.6717.01", "KERA"], ["TCGA.CA.6717.01", "OR51A7"], ["TCGA.CA.6717.01", "OR52A1"], ["TCGA.CA.6717.01", "RASGRF2"], ["TCGA.CA.6717.01", "ZNF480"], ["TCGA.CA.6717.01", "ZNF483"], ["TCGA.CA.6717.01", "ZNF485"], ["TCGA.CA.6717.01", "ESD"], ["TCGA.CA.6717.01", "DSPP"], ["TCGA.CA.6717.01", "NR1H4"], ["TCGA.CA.6717.01", "GRM7"], ["TCGA.CA.6717.01", "NR2F1"], ["TCGA.CA.6717.01", "NOXRED1"], ["TCGA.CA.6717.01", "EIF2S2"], ["TCGA.CA.6717.01", "TRAT1"], ["TCGA.CA.6717.01", "TPR"], ["TCGA.CA.6717.01", "SNAI2"], ["TCGA.CA.6717.01", "HRG"], ["TCGA.CA.6717.01", "ECHS1"], ["TCGA.CA.6717.01", "PVALB"], ["TCGA.CA.6717.01", "SCIN"], ["TCGA.CA.6717.01", "PPP4R4"], ["TCGA.CA.6717.01", "PPP4R1"], ["TCGA.CA.6717.01", "MAP3K2"], ["TCGA.CA.6717.01", "MAP3K1"], ["TCGA.CA.6717.01", "ZWILCH"], ["TCGA.CA.6717.01", "SETD2"], ["TCGA.CA.6717.01", "DZIP3"], ["TCGA.CA.6717.01", "TACC2"], ["TCGA.CA.6717.01", "ST8SIA4"], ["TCGA.CA.6717.01", "OR2A25"], ["TCGA.CA.6717.01", "CTDNEP1"], ["TCGA.CA.6717.01", "MASTL"], ["TCGA.CA.6717.01", "MAST4"], ["TCGA.CA.6717.01", "CD180"], ["TCGA.CA.6717.01", "IL23R"], ["TCGA.CA.6717.01", "TLN1"], ["TCGA.CA.6717.01", "STRN"], ["TCGA.CA.6717.01", "SYN3"], ["TCGA.CA.6717.01", "ZNF556"], ["TCGA.CA.6717.01", "RNASEL"], ["TCGA.CA.6717.01", "USP26"], ["TCGA.CA.6717.01", "ZNF558"], ["TCGA.CA.6717.01", "ZNF568"], ["TCGA.CA.6717.01", "ZNF564"], ["TCGA.CA.6717.01", "OR5AS1"], ["TCGA.CA.6717.01", "SDAD1"], ["TCGA.CA.6717.01", "FGF8"], ["TCGA.CA.6717.01", "SDC2"], ["TCGA.CA.6717.01", "NMRK1"], ["TCGA.CA.6717.01", "XYLB"], ["TCGA.CA.6717.01", "PCDH7"], ["TCGA.CA.6717.01", "DGKG"], ["TCGA.CA.6717.01", "DDX55"], ["TCGA.CA.6717.01", "BTAF1"], ["TCGA.CA.6717.01", "KIAA0319"], ["TCGA.CA.6717.01", "LHX6"], ["TCGA.CA.6717.01", "COL2A1"], ["TCGA.CA.6717.01", "DNAH3"], ["TCGA.CA.6717.01", "FOLH1"], ["TCGA.CA.6717.01", "EXOC3"], ["TCGA.CA.6717.01", "EXOC1"], ["TCGA.CA.6717.01", "HAP1"], ["TCGA.CA.6717.01", "ANK1"], ["TCGA.CA.6717.01", "ANK2"], ["TCGA.CA.6717.01", "ANK3"], ["TCGA.CA.6717.01", "CENPO"], ["TCGA.CA.6717.01", "CENPJ"], ["TCGA.CA.6717.01", "CENPH"], ["TCGA.CA.6717.01", "CENPF"], ["TCGA.CA.6717.01", "CENPE"], ["TCGA.CA.6717.01", "SSH2"], ["TCGA.CA.6717.01", "CENPW"], ["TCGA.CA.6717.01", "DHX30"], ["TCGA.CA.6717.01", "DHX34"], ["TCGA.CA.6717.01", "GREB1"], ["TCGA.CA.6717.01", "MYO9A"], ["TCGA.CA.6717.01", "ARSJ"], ["TCGA.CA.6717.01", "EZH2"], ["TCGA.CA.6717.01", "STIP1"], ["TCGA.CA.6717.01", "ABCC1"], ["TCGA.CA.6717.01", "STAP1"], ["TCGA.CA.6717.01", "MRRF"], ["TCGA.CA.6717.01", "PGGT1B"], ["TCGA.CA.6717.01", "RXFP2"], ["TCGA.CA.6717.01", "RBM34"], ["TCGA.CA.6717.01", "TIE1"], ["TCGA.CA.6717.01", "SH3GL3"], ["TCGA.CA.6717.01", "SH3GL2"], ["TCGA.CA.6717.01", "UGGT2"], ["TCGA.CA.6717.01", "DCLRE1C"], ["TCGA.CA.6717.01", "CYP4A22"], ["TCGA.CA.6717.01", "ZNF804B"], ["TCGA.CA.6717.01", "LYPLA1"], ["TCGA.CA.6717.01", "MC2R"], ["TCGA.CA.6717.01", "RBPMS2"], ["TCGA.CA.6717.01", "MTHFD2L"], ["TCGA.CA.6717.01", "GOPC"], ["TCGA.CA.6717.01", "ARHGEF26"], ["TCGA.CA.6717.01", "DSCAM"], ["TCGA.CA.6717.01", "OSMR"], ["TCGA.CA.6717.01", "BIVM"], ["TCGA.CA.6717.01", "SPTSSB"], ["TCGA.CA.6717.01", "ANKRA2"], ["TCGA.CA.6717.01", "HFM1"], ["TCGA.CA.6717.01", "RXRG"], ["TCGA.CA.6717.01", "ABCA7"], ["TCGA.CA.6717.01", "NBEAL1"], ["TCGA.CA.6717.01", "NBEAL2"], ["TCGA.CA.6717.01", "ACSM2A"], ["TCGA.CA.6717.01", "KCNU1"], ["TCGA.CA.6717.01", "TRA2A"], ["TCGA.CA.6717.01", "VLDLR"], ["TCGA.CA.6717.01", "ETFA"], ["TCGA.CA.6717.01", "TRAF3IP3"], ["TCGA.CA.6717.01", "NDC80"], ["TCGA.CA.6717.01", "INTS6"], ["TCGA.CA.6717.01", "INTS8"], ["TCGA.CA.6717.01", "MPP1"], ["TCGA.CA.6717.01", "SFTPC"], ["TCGA.CA.6717.01", "MPP4"], ["TCGA.CA.6717.01", "MYLK"], ["TCGA.CA.6717.01", "YME1L1"], ["TCGA.CA.6717.01", "GORASP1"], ["TCGA.CA.6717.01", "FNDC3A"], ["TCGA.CA.6717.01", "CCDC138"], ["TCGA.CA.6717.01", "STK36"], ["TCGA.CA.6717.01", "CHRNB3"], ["TCGA.CA.6717.01", "PLXNA4"], ["TCGA.CA.6717.01", "SCAI"], ["TCGA.CA.6717.01", "BDNF"], ["TCGA.CA.6717.01", "KDM5A"], ["TCGA.CA.6717.01", "KDM5B"], ["TCGA.CA.6717.01", "GYS2"], ["TCGA.CA.6717.01", "ETV1"], ["TCGA.CA.6717.01", "CACYBP"], ["TCGA.CA.6717.01", "BRPF3"], ["TCGA.CA.6717.01", "BRPF1"], ["TCGA.CA.6717.01", "OVCH1"], ["TCGA.CA.6717.01", "FBXL13"], ["TCGA.CA.6717.01", "FBXL17"], ["TCGA.CA.6717.01", "FBXL18"], ["TCGA.CA.6717.01", "GRP"], ["TCGA.CA.6717.01", "THSD4"], ["TCGA.CA.6717.01", "AFTPH"], ["TCGA.CA.6717.01", "ZC3H15"], ["TCGA.CA.6717.01", "ATP1A4"], ["TCGA.CA.6717.01", "ATP1A2"], ["TCGA.CA.6717.01", "ATP1A1"], ["TCGA.CA.6717.01", "IFT88"], ["TCGA.CA.6717.01", "HMG20A"], ["TCGA.CA.6717.01", "NRXN2"], ["TCGA.CA.6717.01", "NRXN1"], ["TCGA.CA.6717.01", "PPP6R2"], ["TCGA.CA.6717.01", "LARP4B"], ["TCGA.CA.6717.01", "VCL"], ["TCGA.CA.6717.01", "DNAJA4"], ["TCGA.CA.6717.01", "UTRN"], ["TCGA.CA.6717.01", "UBR1"], ["TCGA.CA.6717.01", "MYO1H"], ["TCGA.CA.6717.01", "MYO1E"], ["TCGA.CA.6717.01", "MYO1D"], ["TCGA.CA.6717.01", "MYO1B"], ["TCGA.CA.6717.01", "NEMF"], ["TCGA.CA.6717.01", "NMS"], ["TCGA.CA.6717.01", "MYO16"], ["TCGA.CA.6717.01", "TRNT1"], ["TCGA.CA.6717.01", "PTGS2"], ["TCGA.CA.6717.01", "ZFAND5"], ["TCGA.CA.6717.01", "EVI5"], ["TCGA.CA.6717.01", "TERF1"], ["TCGA.CA.6717.01", "CHD1"], ["TCGA.CA.6717.01", "CHD4"], ["TCGA.CA.6717.01", "CHD7"], ["TCGA.CA.6717.01", "CHD9"], ["TCGA.CA.6717.01", "CHD8"], ["TCGA.CA.6717.01", "CAP1"], ["TCGA.CA.6717.01", "CAP2"], ["TCGA.CA.6717.01", "TTC5"], ["TCGA.CA.6717.01", "TTC4"], ["TCGA.CA.6717.01", "PIKFYVE"], ["TCGA.CA.6717.01", "TTC8"], ["TCGA.CA.6717.01", "PRDM16"], ["TCGA.CA.6717.01", "MPO"], ["TCGA.CA.6717.01", "TRPC5"], ["TCGA.CA.6717.01", "ADH5"], ["TCGA.CA.6717.01", "RMI1"], ["TCGA.CA.6717.01", "GRIN2A"], ["TCGA.CA.6717.01", "IL6ST"], ["TCGA.CA.6717.01", "TAS2R16"], ["TCGA.CA.6717.01", "TAS2R10"], ["TCGA.CA.6717.01", "TAS2R13"], ["TCGA.CA.6717.01", "CYP26A1"], ["TCGA.CA.6717.01", "RRP12"], ["TCGA.CA.6717.01", "ACAT1"], ["TCGA.CA.6717.01", "OR8S1"], ["TCGA.CA.6717.01", "IL2RG"], ["TCGA.CA.6717.01", "ZFYVE28"], ["TCGA.CA.6717.01", "ERC1"], ["TCGA.CA.6717.01", "ERC2"], ["TCGA.CA.6717.01", "SLC37A2"], ["TCGA.CA.6717.01", "B3GNT4"], ["TCGA.CA.6717.01", "B3GNT2"], ["TCGA.CA.6717.01", "FN1"], ["TCGA.CA.6717.01", "TBC1D4"], ["TCGA.CA.6717.01", "PTK2"], ["TCGA.CA.6717.01", "PRKAA2"], ["TCGA.CA.6717.01", "PRKAA1"], ["TCGA.CA.6717.01", "ATG16L1"], ["TCGA.CA.6717.01", "DDX23"], ["TCGA.CA.6717.01", "DDX20"], ["TCGA.CA.6717.01", "ZNF157"], ["TCGA.CA.6717.01", "DDX24"], ["TCGA.CA.6717.01", "NT5M"], ["TCGA.CA.6717.01", "NT5E"], ["TCGA.CA.6717.01", "ZNF430"], ["TCGA.CA.6717.01", "PTCD3"], ["TCGA.CA.6717.01", "NAA15"], ["TCGA.CA.6717.01", "OR52J3"], ["TCGA.CA.6717.01", "RNF6"], ["TCGA.CA.6717.01", "TMCO3"], ["TCGA.CA.6717.01", "ACTR3"], ["TCGA.CA.6717.01", "GNRHR"], ["TCGA.CA.6717.01", "KHDRBS2"], ["TCGA.CA.6717.01", "WNT8B"], ["TCGA.CA.6717.01", "HIPK1"], ["TCGA.CA.6717.01", "LEMD3"], ["TCGA.CA.6717.01", "NAPA"], ["TCGA.CA.6717.01", "LARP7"], ["TCGA.CA.6717.01", "LGR5"], ["TCGA.CA.6717.01", "BIRC6"], ["TCGA.CA.6717.01", "S100A7"], ["TCGA.CA.6717.01", "AIP"], ["TCGA.CA.6717.01", "ZNF528"], ["TCGA.CA.6717.01", "KDM3B"], ["TCGA.CA.6717.01", "URB1"], ["TCGA.CA.6717.01", "SEC24D"], ["TCGA.CA.6717.01", "SEC24A"], ["TCGA.CA.6717.01", "SHF"], ["TCGA.CA.6717.01", "DYNC2H1"], ["TCGA.CA.6717.01", "OR1D2"], ["TCGA.CA.6717.01", "STX7"], ["TCGA.CA.6717.01", "KIF2B"], ["TCGA.CA.6717.01", "BRCA1"], ["TCGA.CA.6717.01", "BRCA2"], ["TCGA.CA.6717.01", "SMURF1"], ["TCGA.CA.6717.01", "SYCE1"], ["TCGA.CA.6717.01", "UVRAG"], ["TCGA.CA.6717.01", "COPG1"], ["TCGA.CA.6717.01", "POLQ"], ["TCGA.CA.6717.01", "PCGF5"], ["TCGA.CA.6717.01", "CX3CR1"], ["TCGA.CA.6717.01", "SMC1A"], ["TCGA.CA.6717.01", "SMC1B"], ["TCGA.CA.6717.01", "TRIM45"], ["TCGA.CA.6717.01", "NEB"], ["TCGA.CA.6717.01", "PFDN4"], ["TCGA.CA.6717.01", "MTHFR"], ["TCGA.CA.6717.01", "PDE4DIP"], ["TCGA.CA.6717.01", "LATS2"], ["TCGA.CA.6717.01", "TAF1B"], ["TCGA.CA.6717.01", "F9"], ["TCGA.CA.6717.01", "CHL1"], ["TCGA.CA.6717.01", "ERLIN1"], ["TCGA.CA.6717.01", "CPSF3"], ["TCGA.CA.6717.01", "TTLL5"], ["TCGA.CA.6717.01", "DBF4"], ["TCGA.CA.6717.01", "GCC1"], ["TCGA.CA.6717.01", "TBC1D8B"], ["TCGA.CA.6717.01", "OR6A2"], ["TCGA.CA.6717.01", "ZNF398"], ["TCGA.CA.6717.01", "RLN2"], ["TCGA.CA.6717.01", "CRNKL1"], ["TCGA.CA.6717.01", "CPB2"], ["TCGA.CA.6717.01", "ZNF583"], ["TCGA.CA.6717.01", "GPD1L"], ["TCGA.CA.6717.01", "AOX1"], ["TCGA.CA.6717.01", "TIMM9"], ["TCGA.CA.6717.01", "PKN2"], ["TCGA.CA.6717.01", "KCNE2"], ["TCGA.CA.6717.01", "PRAM1"], ["TCGA.CA.6717.01", "CSNK1D"], ["TCGA.CA.6717.01", "ADAMTS20"], ["TCGA.CA.6717.01", "USP15"], ["TCGA.CA.6717.01", "CIT"], ["TCGA.CA.6717.01", "CUBN"], ["TCGA.CA.6717.01", "OR52B6"], ["TCGA.CA.6717.01", "DIMT1"], ["TCGA.CA.6717.01", "PARP14"], ["TCGA.CA.6717.01", "TUBA1B"], ["TCGA.CA.6717.01", "EVC"], ["TCGA.CA.6717.01", "WSB1"], ["TCGA.CA.6717.01", "FTCD"], ["TCGA.CA.6717.01", "MINPP1"], ["TCGA.CA.6717.01", "GANAB"], ["TCGA.CA.6717.01", "RAB2A"], ["TCGA.CA.6717.01", "ETNK2"], ["TCGA.CA.6717.01", "RAB23"], ["TCGA.CA.6717.01", "PPP2R3A"], ["TCGA.CA.6717.01", "ARRDC1"], ["TCGA.CA.6717.01", "OR4C13"], ["TCGA.CA.6717.01", "TNS1"], ["TCGA.CA.6717.01", "HIF1A"], ["TCGA.CA.6717.01", "FBXW7"], ["TCGA.CA.6717.01", "TGFBR1"], ["TCGA.CA.6717.01", "TJP2"], ["TCGA.CA.6717.01", "CCT6A"], ["TCGA.CA.6717.01", "PER2"], ["TCGA.CA.6717.01", "ZNF610"], ["TCGA.CA.6717.01", "ZNF615"], ["TCGA.CA.6717.01", "SLC3A1"], ["TCGA.CA.6717.01", "MS4A13"], ["TCGA.CA.6717.01", "OR1L8"], ["TCGA.CA.6717.01", "MSRB3"], ["TCGA.CA.6717.01", "CAMK1G"], ["TCGA.CA.6717.01", "HHAT"], ["TCGA.CA.6717.01", "WDR5B"], ["TCGA.CA.6717.01", "NALCN"], ["TCGA.CA.6717.01", "TDRD9"], ["TCGA.CA.6717.01", "TDRD3"], ["TCGA.CA.6717.01", "TDRD7"], ["TCGA.CA.6717.01", "TLK2"], ["TCGA.CA.6717.01", "CACNB4"], ["TCGA.CA.6717.01", "B3GALNT1"], ["TCGA.CA.6717.01", "KIF20B"], ["TCGA.CA.6717.01", "GNAT3"], ["TCGA.CA.6717.01", "ZNF551"], ["TCGA.CA.6717.01", "ZNF559"], ["TCGA.CA.6717.01", "CACNG3"], ["TCGA.CA.6717.01", "CACNG4"], ["TCGA.CA.6717.01", "ATF4"], ["TCGA.CA.6717.01", "PTGER3"], ["TCGA.CA.6717.01", "OR13C4"], ["TCGA.CA.6717.01", "SENP5"], ["TCGA.CA.6717.01", "EPS8"], ["TCGA.CA.6717.01", "ADAMTSL3"], ["TCGA.CA.6717.01", "SEPSECS"], ["TCGA.CA.6717.01", "CEPT1"], ["TCGA.CA.6717.01", "ZNF790"], ["TCGA.CA.6717.01", "ZNF791"], ["TCGA.CA.6717.01", "ZNF792"], ["TCGA.CA.6717.01", "PPP1R7"], ["TCGA.CA.6717.01", "FGFR2"], ["TCGA.CA.6717.01", "FGFR1"], ["TCGA.CA.6717.01", "DCTD"], ["TCGA.CA.6717.01", "UBE2T"], ["TCGA.CA.6717.01", "PDE3B"], ["TCGA.CA.6717.01", "ASMT"], ["TCGA.CA.6717.01", "BIRC7"], ["TCGA.CA.6717.01", "EIF1"], ["TCGA.CA.6717.01", "BIRC2"], ["TCGA.CA.6717.01", "ANKRD17"], ["TCGA.CA.6717.01", "STRA6"], ["TCGA.CA.6717.01", "NT5C2"], ["TCGA.CA.6717.01", "SIGLEC10"], ["TCGA.CA.6717.01", "HIBADH"], ["TCGA.CA.6717.01", "TNFAIP3"], ["TCGA.CA.6717.01", "OR13D1"], ["TCGA.CA.6717.01", "ARHGEF10"], ["TCGA.CA.6717.01", "ARHGEF17"], ["TCGA.CA.6717.01", "REN"], ["TCGA.CA.6717.01", "SCAF8"], ["TCGA.CA.6717.01", "GPD2"], ["TCGA.CA.6717.01", "CAD"], ["TCGA.CA.6717.01", "FBLN5"], ["TCGA.CA.6717.01", "CYLD"], ["TCGA.CA.6717.01", "ZNF184"], ["TCGA.CA.6717.01", "ZNF180"], ["TCGA.CA.6717.01", "ZNF189"], ["TCGA.CA.6717.01", "SEMA5A"], ["TCGA.CA.6717.01", "SCN5A"], ["TCGA.CA.6717.01", "TGFB2"], ["TCGA.CA.6717.01", "TNIP3"], ["TCGA.CA.6717.01", "HSPH1"], ["TCGA.CA.6717.01", "MYOM1"], ["TCGA.CA.6717.01", "FBXO5"], ["TCGA.CA.6717.01", "FBXO7"], ["TCGA.CA.6717.01", "SNTB2"], ["TCGA.CA.6717.01", "CORO1C"], ["TCGA.CA.6717.01", "HECTD2"], ["TCGA.CA.6717.01", "ADAD1"], ["TCGA.CA.6717.01", "GPR22"], ["TCGA.CA.6717.01", "EPSTI1"], ["TCGA.CA.6717.01", "PLXNB2"], ["TCGA.CA.6717.01", "PLXNB1"], ["TCGA.CA.6717.01", "PAPPA2"], ["TCGA.CA.6717.01", "ROCK1"], ["TCGA.CA.6717.01", "NAGK"], ["TCGA.CA.6717.01", "THBS4"], ["TCGA.CA.6717.01", "TNFSF11"], ["TCGA.CA.6717.01", "CCT2"], ["TCGA.CA.6717.01", "ASPH"], ["TCGA.CA.6717.01", "SSTR4"], ["TCGA.CA.6717.01", "CTNNB1"], ["TCGA.CA.6717.01", "WNK2"], ["TCGA.CA.6717.01", "WNK3"], ["TCGA.CA.6717.01", "TNIP1"], ["TCGA.CA.6717.01", "LBR"], ["TCGA.CA.6717.01", "ATP1B3"], ["TCGA.CA.6717.01", "SNX2"], ["TCGA.CA.6717.01", "SNX5"], ["TCGA.CA.6717.01", "FABP4"], ["TCGA.CA.6717.01", "GABRA4"], ["TCGA.CA.6717.01", "GABRA1"], ["TCGA.CA.6717.01", "FABP9"], ["TCGA.CA.6717.01", "DOCK2"], ["TCGA.CA.6717.01", "GRIA1"], ["TCGA.CA.6717.01", "NPY5R"], ["TCGA.CA.6717.01", "NEU1"], ["TCGA.CA.6717.01", "OPRL1"], ["TCGA.CA.6717.01", "MED13"], ["TCGA.CA.6717.01", "MUSK"], ["TCGA.CA.6717.01", "RSPO3"], ["TCGA.CA.6717.01", "EIF5B"], ["TCGA.CA.6717.01", "STK39"], ["TCGA.CA.6717.01", "RAF1"], ["TCGA.CA.6717.01", "ZNF716"], ["TCGA.CA.6717.01", "ZNF713"], ["TCGA.CA.6717.01", "ASB11"], ["TCGA.CA.6717.01", "ASB16"], ["TCGA.CA.6717.01", "RPP38"], ["TCGA.CA.6717.01", "TROVE2"], ["TCGA.CA.6717.01", "FDPS"], ["TCGA.CA.6717.01", "TNC"], ["TCGA.CA.6717.01", "DICER1"], ["TCGA.CA.6717.01", "AQR"], ["TCGA.CA.6717.01", "DNM1L"], ["TCGA.CA.6717.01", "DPYS"], ["TCGA.CA.6717.01", "YLPM1"], ["TCGA.CA.6717.01", "ATM"], ["TCGA.CA.6717.01", "PLCH1"], ["TCGA.CA.6717.01", "MEF2A"], ["TCGA.CA.6717.01", "TRIO"], ["TCGA.CA.6717.01", "RABL2A"], ["TCGA.CA.6717.01", "SLC16A1"], ["TCGA.CA.6717.01", "ARHGAP35"], ["TCGA.CA.6717.01", "PIBF1"], ["TCGA.CA.6717.01", "CACNA1H"], ["TCGA.CA.6717.01", "CACNA1I"], ["TCGA.CA.6717.01", "CACNA1A"], ["TCGA.CA.6717.01", "CACNA1B"], ["TCGA.CA.6717.01", "CACNA1C"], ["TCGA.CA.6717.01", "CACNA1D"], ["TCGA.CA.6717.01", "CACNA1E"], ["TCGA.CA.6717.01", "CACNA1F"], ["TCGA.CA.6717.01", "XPOT"], ["TCGA.CA.6717.01", "NSMCE1"], ["TCGA.CA.6717.01", "PRKAB2"], ["TCGA.CA.6717.01", "PAX6"], ["TCGA.CA.6717.01", "MBD3L1"], ["TCGA.CA.6717.01", "DSG2"], ["TCGA.CA.6717.01", "DSG3"], ["TCGA.CA.6717.01", "DSG1"], ["TCGA.CA.6717.01", "DET1"], ["TCGA.CA.6717.01", "KCNJ8"], ["TCGA.CA.6717.01", "MTTP"], ["TCGA.CA.6717.01", "FOXR1"], ["TCGA.CA.6717.01", "NCOR1"], ["TCGA.CA.6717.01", "TEC"], ["TCGA.CA.6717.01", "HADHB"], ["TCGA.CA.6717.01", "ALS2"], ["TCGA.CA.6717.01", "AP1M1"], ["TCGA.CA.6717.01", "TKTL2"], ["TCGA.CA.6717.01", "OR4K2"], ["TCGA.CA.6717.01", "LMO7"], ["TCGA.CA.6717.01", "PSMC1"], ["TCGA.CA.6717.01", "PSMC2"], ["TCGA.CA.6717.01", "MARCH6"], ["TCGA.CA.6717.01", "SLIT2"], ["TCGA.CA.6717.01", "OR4S2"], ["TCGA.CA.6717.01", "LUC7L2"], ["TCGA.CA.6717.01", "CYP4F3"], ["TCGA.CA.6717.01", "TIAM1"], ["TCGA.CA.6717.01", "KATNAL2"], ["TCGA.CA.6717.01", "GSTM4"], ["TCGA.CA.6717.01", "MED13L"], ["TCGA.CA.6717.01", "MCM6"], ["TCGA.CA.6717.01", "MCM4"], ["TCGA.CA.6717.01", "DUSP11"], ["TCGA.CA.6717.01", "EPC1"], ["TCGA.CA.6717.01", "TMF1"], ["TCGA.CA.6717.01", "NRAP"], ["TCGA.CA.6717.01", "CABLES1"], ["TCGA.CA.6717.01", "ZNF607"], ["TCGA.CA.6717.01", "MRPL53"], ["TCGA.CA.6717.01", "IQCE"], ["TCGA.CA.6717.01", "TCF4"], ["TCGA.CA.6717.01", "DSTYK"], ["TCGA.CA.6717.01", "NF2"], ["TCGA.CA.6717.01", "NF1"], ["TCGA.CA.6717.01", "IL5RA"], ["TCGA.CA.6717.01", "ATXN2"], ["TCGA.CA.6717.01", "RUNX1T1"], ["TCGA.CA.6717.01", "TAOK3"], ["TCGA.CA.6717.01", "OR6C65"], ["TCGA.CA.6717.01", "SULT1E1"], ["TCGA.CA.6717.01", "MYBPC1"], ["TCGA.CA.6717.01", "SPRY3"], ["TCGA.CA.6717.01", "TRPC1"], ["TCGA.CA.6717.01", "TRPC6"], ["TCGA.CA.6717.01", "RBMX"], ["TCGA.CA.6717.01", "NDUFS1"], ["TCGA.CA.6717.01", "NOD1"], ["TCGA.CA.6717.01", "CCNB3"], ["TCGA.CA.6717.01", "CCNB1"], ["TCGA.CA.6717.01", "LAMC3"], ["TCGA.CA.6717.01", "CWF19L2"], ["TCGA.CA.6717.01", "ERN2"], ["TCGA.CA.6717.01", "MDH1"], ["TCGA.CA.6717.01", "CASP6"], ["TCGA.CA.6717.01", "CASP4"], ["TCGA.CA.6717.01", "CASP8"], ["TCGA.CA.6717.01", "AKT3"], ["TCGA.CA.6717.01", "HYAL4"], ["TCGA.CA.6717.01", "NCF2"], ["TCGA.CA.6717.01", "UNC13C"], ["TCGA.CA.6717.01", "UNC13A"], ["TCGA.CA.6717.01", "KCNB2"], ["TCGA.CA.6717.01", "GABRA2"], ["TCGA.CA.6717.01", "OR8I2"], ["TCGA.CA.6717.01", "BLZF1"], ["TCGA.CA.6717.01", "G3BP2"], ["TCGA.CA.6717.01", "RPTN"], ["TCGA.CA.6717.01", "IRAK2"], ["TCGA.CA.6717.01", "IRAK3"], ["TCGA.CA.6717.01", "CEP290"], ["TCGA.CA.6717.01", "ACVR1B"], ["TCGA.CA.6717.01", "GABBR1"], ["TCGA.CA.6717.01", "SERPINE1"], ["TCGA.CA.6717.01", "CAPNS2"], ["TCGA.CA.6717.01", "CDC123"], ["TCGA.CA.6717.01", "OCRL"], ["TCGA.CA.6717.01", "WDR60"], ["TCGA.CA.6717.01", "GPR156"], ["TCGA.CA.6717.01", "TG"], ["TCGA.CA.6717.01", "PPFIA2"], ["TCGA.CA.6717.01", "RTN4"], ["TCGA.CA.6717.01", "HGF"], ["TCGA.CA.6717.01", "ELMO1"], ["TCGA.CA.6717.01", "OR5K4"], ["TCGA.CA.6717.01", "OR5K3"], ["TCGA.CA.6717.01", "ATXN7L1"], ["TCGA.CA.6717.01", "BTLA"], ["TCGA.CA.6717.01", "RAB18"], ["TCGA.CA.6717.01", "LYST"], ["TCGA.CA.6717.01", "LSM3"], ["TCGA.CA.6717.01", "USP48"], ["TCGA.CA.6717.01", "USP46"], ["TCGA.CA.6717.01", "RPAP3"], ["TCGA.CA.6717.01", "SEC23A"], ["TCGA.CA.6717.01", "OR4K15"], ["TCGA.CA.6717.01", "OR4K17"], ["TCGA.CA.6717.01", "SCAF11"], ["TCGA.CA.6717.01", "SON"], ["TCGA.CA.6717.01", "PON3"], ["TCGA.CA.6717.01", "PON2"], ["TCGA.CA.6717.01", "UGP2"], ["TCGA.CA.6717.01", "NDST3"], ["TCGA.CA.6717.01", "NDST4"], ["TCGA.CA.6717.01", "OR1A2"], ["TCGA.CA.6717.01", "NBEA"], ["TCGA.CA.6717.01", "DCAF4L1"], ["TCGA.CA.6717.01", "DIS3L"], ["TCGA.CA.6717.01", "SYDE2"], ["TCGA.CA.6717.01", "SYDE1"], ["TCGA.CA.6717.01", "GLUD2"], ["TCGA.CA.6717.01", "PDIA2"], ["TCGA.CA.6717.01", "TTC21B"], ["TCGA.CA.6717.01", "MUC6"], ["TCGA.CA.6717.01", "ADRB2"], ["TCGA.CA.6717.01", "HOMER2"], ["TCGA.CA.6717.01", "TRIM10"], ["TCGA.CA.6717.01", "CCRL2"], ["TCGA.CA.6717.01", "BTK"], ["TCGA.CA.6717.01", "PRELP"], ["TCGA.CA.6717.01", "NUP155"], ["TCGA.CA.6717.01", "ATXN2L"], ["TCGA.CA.6717.01", "WTAP"], ["TCGA.CA.6717.01", "PPARGC1A"], ["TCGA.CA.6717.01", "XDH"], ["TCGA.CA.6717.01", "RBPJ"], ["TCGA.CA.6717.01", "PPBP"], ["TCGA.CA.6717.01", "DDIT4L"], ["TCGA.CA.6717.01", "PRICKLE2"], ["TCGA.CA.6717.01", "PCYOX1"], ["TCGA.CA.6717.01", "KALRN"], ["TCGA.CA.6717.01", "CD1B"], ["TCGA.CA.6717.01", "CELF6"], ["TCGA.CA.6717.01", "SPAM1"], ["TCGA.CA.6717.01", "ENPEP"], ["TCGA.CA.6717.01", "HEATR1"], ["TCGA.CA.6717.01", "IKBKB"], ["TCGA.CA.6717.01", "GNL3"], ["TCGA.CA.6717.01", "GNL2"], ["TCGA.CA.6717.01", "COL28A1"], ["TCGA.CA.6717.01", "SMARCAL1"], ["TCGA.CA.6717.01", "RSPO4"], ["TCGA.CA.6717.01", "VCP"], ["TCGA.CA.6717.01", "MTDH"], ["TCGA.CA.6717.01", "EXO1"], ["TCGA.CA.6717.01", "LRRTM4"], ["TCGA.CA.6717.01", "LRRTM3"], ["TCGA.CA.6717.01", "EPAS1"], ["TCGA.CA.6717.01", "TTBK2"], ["TCGA.CA.6717.01", "KNG1"], ["TCGA.CA.6717.01", "ITGA10"], ["TCGA.CA.6717.01", "SEMA6D"], ["TCGA.CA.6717.01", "SCN2B"], ["TCGA.CA.6717.01", "SCN2A"], ["TCGA.CA.6717.01", "ZNF208"], ["TCGA.CA.6717.01", "DECR1"], ["TCGA.CA.6717.01", "OR5C1"], ["TCGA.CA.6717.01", "HERC2"], ["TCGA.CA.6717.01", "TDRD12"], ["TCGA.CA.6717.01", "QARS"], ["TCGA.CA.6717.01", "OGDHL"], ["TCGA.CA.6717.01", "CEP68"], ["TCGA.CA.6717.01", "ZFYVE9"], ["TCGA.CA.6717.01", "ZFYVE1"], ["TCGA.CA.6717.01", "RXFP1"], ["TCGA.CA.6717.01", "CCDC88A"], ["TCGA.CA.6717.01", "ROBO1"], ["TCGA.CA.6717.01", "FBXL5"], ["TCGA.CA.6717.01", "FBXL4"], ["TCGA.CA.6717.01", "CTR9"], ["TCGA.CA.6717.01", "SLC26A2"], ["TCGA.CA.6717.01", "MIA2"], ["TCGA.CA.6717.01", "PEMT"], ["TCGA.CA.6717.01", "LRP4"], ["TCGA.CA.6717.01", "OR1I1"], ["TCGA.CA.6717.01", "AKAP14"], ["TCGA.CA.6717.01", "AKAP13"], ["TCGA.CA.6717.01", "AKAP11"], ["TCGA.CA.6717.01", "WDR88"], ["TCGA.CA.6717.01", "JAG1"], ["TCGA.CA.6717.01", "PTPN21"], ["TCGA.CA.6717.01", "TNRC6C"], ["TCGA.CA.6717.01", "TNRC6A"], ["TCGA.CA.6717.01", "ARHGEF6"], ["TCGA.CA.6717.01", "ARHGEF4"], ["TCGA.CA.6717.01", "ADAMTS9"], ["TCGA.CA.6717.01", "CDH9"], ["TCGA.CA.6717.01", "CDH8"], ["TCGA.CA.6717.01", "CDH1"], ["TCGA.CA.6717.01", "CDH2"], ["TCGA.CA.6717.01", "CDH7"], ["TCGA.CA.6717.01", "DOPEY2"], ["TCGA.CA.6717.01", "DOPEY1"], ["TCGA.CA.6717.01", "MYO3A"], ["TCGA.CA.6717.01", "ZNF436"], ["TCGA.CA.6717.01", "ZNF431"], ["TCGA.CA.6717.01", "MERTK"], ["TCGA.CA.6717.01", "CUL4A"], ["TCGA.CA.6717.01", "IMMT"], ["TCGA.CA.6717.01", "LRPPRC"], ["TCGA.CA.6717.01", "FMNL1"], ["TCGA.CA.6717.01", "GRM8"], ["TCGA.CA.6717.01", "MAPRE1"], ["TCGA.CA.6717.01", "MAPRE3"], ["TCGA.CA.6717.01", "MAPRE2"], ["TCGA.CA.6717.01", "GRM1"], ["TCGA.CA.6717.01", "SEPT6"], ["TCGA.CA.6717.01", "NVL"], ["TCGA.CA.6717.01", "ST13"], ["TCGA.CA.6717.01", "ZNF546"], ["TCGA.CA.6717.01", "SPOCK3"], ["TCGA.CA.6717.01", "YTHDC2"], ["TCGA.CA.6717.01", "NR3C2"], ["TCGA.CA.6717.01", "SEC23IP"], ["TCGA.CA.6717.01", "ATP6V1A"], ["TCGA.CA.6717.01", "DTL"], ["TCGA.CA.6717.01", "RAP1GDS1"], ["TCGA.CA.6717.01", "PDE6B"], ["TCGA.CA.6717.01", "MVK"], ["TCGA.CA.6717.01", "ALK"], ["TCGA.CA.6717.01", "ALB"], ["TCGA.CA.6717.01", "ZNF19"], ["TCGA.CA.6717.01", "ZNF14"], ["TCGA.CA.6717.01", "ZNF17"], ["TCGA.CA.6717.01", "ZNF10"], ["TCGA.CA.6717.01", "RRN3"], ["TCGA.CA.6717.01", "TGFBR3"], ["TCGA.CA.6717.01", "BCAR3"], ["TCGA.CA.6717.01", "SOX6"], ["TCGA.CA.6717.01", "SOX7"], ["TCGA.CA.6717.01", "KLRC2"], ["TCGA.CA.6717.01", "INHBA"], ["TCGA.CA.6717.01", "STAU2"], ["TCGA.CA.6717.01", "SDHAF2"], ["TCGA.CA.6717.01", "AGTR2"], ["TCGA.CA.6717.01", "BAZ1B"], ["TCGA.CA.6717.01", "ABCC8"], ["TCGA.CA.6717.01", "RYR3"], ["TCGA.CA.6717.01", "RYR2"], ["TCGA.CA.6717.01", "GOLGA4"], ["TCGA.CA.6717.01", "ENPP6"], ["TCGA.CA.6717.01", "ENPP2"], ["TCGA.CA.6717.01", "ENPP3"], ["TCGA.CA.6717.01", "ENPP1"], ["TCGA.CA.6717.01", "ZNF287"], ["TCGA.CA.6717.01", "RFXAP"], ["TCGA.CA.6717.01", "IFNA8"], ["TCGA.CA.6717.01", "TIMM22"], ["TCGA.CA.6717.01", "CRYAB"], ["TCGA.CA.6717.01", "ELF1"], ["TCGA.CA.6717.01", "CFL2"], ["TCGA.CA.6717.01", "RNF17"], ["TCGA.CA.6717.01", "COL7A1"], ["TCGA.CA.6717.01", "RIT2"], ["TCGA.CA.6717.01", "HRH2"], ["TCGA.CA.6717.01", "COL4A6"], ["TCGA.CA.6717.01", "COL4A4"], ["TCGA.CA.6717.01", "COL4A1"], ["TCGA.CA.6717.01", "PLCZ1"], ["TCGA.CA.6717.01", "GGCX"], ["TCGA.CA.6717.01", "LHCGR"], ["TCGA.CA.6717.01", "KDM3A"], ["TCGA.CA.6717.01", "CFHR3"], ["TCGA.CA.6717.01", "SUGP2"], ["TCGA.CA.6717.01", "MYBL1"], ["TCGA.CA.6717.01", "TUFM"], ["TCGA.CA.6717.01", "A1BG"], ["TCGA.CA.6717.01", "OR4L1"], ["TCGA.CA.6717.01", "ZNF587"], ["TCGA.CA.6717.01", "ZNF326"], ["TCGA.CA.6717.01", "SRY"], ["TCGA.CA.6717.01", "EIF2AK3"], ["TCGA.CA.6717.01", "EIF2AK4"], ["TCGA.CA.6717.01", "PIGF"], ["TCGA.CA.6717.01", "PIGK"], ["TCGA.CA.6717.01", "PIGP"], ["TCGA.CA.6717.01", "PIGV"], ["TCGA.CA.6717.01", "NTRK2"], ["TCGA.CA.6717.01", "ATG2B"], ["TCGA.CA.6717.01", "GPR4"], ["TCGA.CA.6717.01", "C1orf35"], ["TCGA.CA.6717.01", "TPRKB"], ["TCGA.CA.6717.01", "MLH3"], ["TCGA.CA.6717.01", "ZNF418"], ["TCGA.CA.6717.01", "AKAP4"], ["TCGA.CA.6717.01", "AKAP6"], ["TCGA.CA.6717.01", "EIF2D"], ["TCGA.CA.6717.01", "AKAP9"], ["TCGA.CA.6717.01", "EIF2A"], ["TCGA.CA.6717.01", "CETN3"], ["TCGA.CA.6717.01", "PCLO"], ["TCGA.CA.6717.01", "DNAJC8"], ["TCGA.CA.6717.01", "DNAJC7"], ["TCGA.CA.6717.01", "GOSR1"], ["TCGA.CA.6717.01", "TAS2R5"], ["TCGA.CA.6717.01", "TAS2R3"], ["TCGA.CA.6717.01", "CDK5RAP2"], ["TCGA.CA.6717.01", "NEO1"], ["TCGA.CA.6717.01", "ZC3H13"], ["TCGA.CA.6717.01", "DPYD"], ["TCGA.CA.6717.01", "MEP1A"], ["TCGA.CA.6717.01", "ME2"], ["TCGA.CA.6717.01", "ANGPT2"], ["TCGA.CA.6717.01", "ANGPT4"], ["TCGA.CA.6717.01", "GUCA1C"], ["TCGA.CA.6717.01", "DOT1L"], ["TCGA.CA.6717.01", "SYCP2"], ["TCGA.CA.6717.01", "SYCP1"], ["TCGA.CA.6717.01", "ARHGDIB"], ["TCGA.CA.6717.01", "TANC2"], ["TCGA.CA.6717.01", "KBTBD13"], ["TCGA.CA.6717.01", "ZNF99"], ["TCGA.CA.6717.01", "RAET1E"], ["TCGA.CA.6717.01", "ERBB4"], ["TCGA.CA.6717.01", "SPRED1"], ["TCGA.CA.6717.01", "AHNAK"], ["TCGA.CA.6717.01", "BCAP29"], ["TCGA.CA.6717.01", "TAS2R30"], ["TCGA.CA.6717.01", "TAS2R31"], ["TCGA.CA.6717.01", "NDUFS6"], ["TCGA.CA.6717.01", "ZRANB1"], ["TCGA.CA.6717.01", "ZRANB2"], ["TCGA.CA.6717.01", "MICAL2"], ["TCGA.CA.6717.01", "CLTC"], ["TCGA.CA.6717.01", "ZNF597"], ["TCGA.CA.6717.01", "AAK1"], ["TCGA.CA.6717.01", "SNRPN"], ["TCGA.CA.6717.01", "ZDHHC17"], ["TCGA.CA.6717.01", "NCAN"], ["TCGA.CA.6717.01", "DDX42"], ["TCGA.CA.6717.01", "DDX46"], ["TCGA.CA.6717.01", "LSM14A"], ["TCGA.CA.6717.01", "STX19"], ["TCGA.CA.6717.01", "OR2A5"], ["TCGA.CA.6717.01", "OR9G4"], ["TCGA.CA.6717.01", "E2F5"], ["TCGA.CA.6717.01", "OR10AD1"], ["TCGA.CA.6717.01", "GPR161"], ["TCGA.CA.6717.01", "MTHFD1"], ["TCGA.CA.6717.01", "SLX4"], ["TCGA.CA.6717.01", "AZI2"], ["TCGA.CA.6717.01", "ZNF433"], ["TCGA.CA.6717.01", "ZNF439"], ["TCGA.CA.6717.01", "SECISBP2"], ["TCGA.CA.6717.01", "OR5H2"], ["TCGA.CA.6717.01", "TXLNG"], ["TCGA.CA.6717.01", "GTF3C3"], ["TCGA.CA.6717.01", "IL12RB2"], ["TCGA.CA.6717.01", "ATP6AP2"], ["TCGA.CA.6717.01", "ACOT4"], ["TCGA.CA.6717.01", "ACOT2"], ["TCGA.CA.6717.01", "RBBP8"], ["TCGA.CA.6717.01", "RBBP7"], ["TCGA.CA.6717.01", "RBBP5"], ["TCGA.CA.6717.01", "ZFP28"], ["TCGA.CA.6717.01", "TCP1"], ["TCGA.CA.6717.01", "NARF"], ["TCGA.CA.6717.01", "LRBA"], ["TCGA.CA.6717.01", "PPP2R5D"], ["TCGA.CA.6717.01", "PPP2R5E"], ["TCGA.CA.6717.01", "NAMPT"], ["TCGA.CA.6717.01", "SYNJ1"], ["TCGA.CA.6717.01", "LRFN2"], ["TCGA.CA.6717.01", "PAG1"], ["TCGA.CA.6717.01", "ZNF667"], ["TCGA.CA.6717.01", "MTNR1B"], ["TCGA.CA.6717.01", "ZEB1"], ["TCGA.CA.6717.01", "OR1F1"], ["TCGA.CA.6717.01", "RRAGB"], ["TCGA.CA.6717.01", "PTPRB"], ["TCGA.CA.6717.01", "PTPRO"], ["TCGA.CA.6717.01", "PTPRM"], ["TCGA.CA.6717.01", "PTPRJ"], ["TCGA.CA.6717.01", "DMP1"], ["TCGA.CA.6717.01", "IFIT2"], ["TCGA.CA.6717.01", "WDR35"], ["TCGA.CA.6717.01", "WDR36"], ["TCGA.CA.6717.01", "WDR31"], ["TCGA.CA.6717.01", "TLE4"], ["TCGA.CA.6717.01", "CDC7"], ["TCGA.CA.6717.01", "MBD5"], ["TCGA.CA.6717.01", "SLC25A12"], ["TCGA.CA.6717.01", "CCDC14"], ["TCGA.CA.6717.01", "IRF5"], ["TCGA.CA.6717.01", "ITK"], ["TCGA.CA.6717.01", "RICTOR"], ["TCGA.CA.6717.01", "ARAP1"], ["TCGA.CA.6717.01", "RDX"], ["TCGA.CA.6717.01", "PPP1R42"], ["TCGA.CA.6717.01", "KIT"], ["TCGA.CA.6717.01", "WASL"], ["TCGA.CA.6717.01", "DGKH"], ["TCGA.CA.6717.01", "TNFSF13B"], ["TCGA.CA.6717.01", "PDE9A"], ["TCGA.CA.6717.01", "LRP12"], ["TCGA.CA.6717.01", "BBS9"], ["TCGA.CA.6717.01", "BBS5"], ["TCGA.CA.6717.01", "AGL"], ["TCGA.CA.6717.01", "RAB11A"], ["TCGA.CA.6717.01", "PIK3CA"], ["TCGA.CA.6717.01", "PIK3CB"], ["TCGA.CA.6717.01", "PIK3CG"], ["TCGA.CA.6717.01", "MAK"], ["TCGA.CA.6717.01", "UTP20"], ["TCGA.CA.6717.01", "CTH"], ["TCGA.CA.6717.01", "RAB11FIP1"], ["TCGA.CA.6717.01", "CLIP3"], ["TCGA.CA.6717.01", "CD47"], ["TCGA.CA.6717.01", "FPGT"], ["TCGA.CA.6717.01", "ZNF43"], ["TCGA.CA.6717.01", "IL31RA"], ["TCGA.CA.6717.01", "OR8D4"], ["TCGA.CA.6717.01", "WEE2"], ["TCGA.CA.6717.01", "SCN10A"], ["TCGA.CA.6717.01", "PDS5B"], ["TCGA.CA.6717.01", "ACVR2A"], ["TCGA.CA.6717.01", "CLGN"], ["TCGA.CA.6717.01", "SMARCA1"], ["TCGA.CA.6717.01", "SMARCA5"], ["TCGA.CA.6717.01", "OR51B4"], ["TCGA.CA.6717.01", "CUL1"], ["TCGA.CA.6717.01", "CUL2"], ["TCGA.CA.6717.01", "ARHGAP5"], ["TCGA.CA.6717.01", "ARHGAP6"], ["TCGA.CA.6717.01", "MRPL2"], ["TCGA.CA.6717.01", "IDO2"], ["TCGA.CA.6717.01", "ARAP2"], ["TCGA.CA.6717.01", "DOLK"], ["TCGA.CA.6717.01", "ANKHD1"], ["TCGA.CA.6717.01", "SIN3A"], ["TCGA.CA.6717.01", "LRIT1"], ["TCGA.CA.6717.01", "CCT8L2"], ["TCGA.CA.6717.01", "MEX3C"], ["TCGA.CA.6717.01", "LACTB2"], ["TCGA.CA.6717.01", "BTRC"], ["TCGA.CA.6717.01", "MTMR2"], ["TCGA.CA.6717.01", "MTMR1"], ["TCGA.CA.6717.01", "FARP2"], ["TCGA.CA.6717.01", "FARP1"], ["TCGA.CA.6717.01", "STXBP1"], ["TCGA.CA.6717.01", "EXOC2"], ["TCGA.CA.6717.01", "FRS3"], ["TCGA.CA.6717.01", "EXOC6"], ["TCGA.CA.6717.01", "MGAT4B"], ["TCGA.CA.6717.01", "PRKCG"], ["TCGA.CA.6717.01", "MUL1"], ["TCGA.CA.6717.01", "ZNF571"], ["TCGA.CA.6717.01", "ZNF577"], ["TCGA.CA.6717.01", "SETDB2"], ["TCGA.CA.6717.01", "PHKA1"], ["TCGA.CA.6717.01", "PHKA2"], ["TCGA.CA.6717.01", "ILK"], ["TCGA.CA.6717.01", "MORF4L1"], ["TCGA.CA.6717.01", "IL6"], ["TCGA.CA.6717.01", "IL4"], ["TCGA.CA.6717.01", "IL2"], ["TCGA.CA.6717.01", "DTX1"], ["TCGA.CA.6717.01", "RB1CC1"], ["TCGA.CA.6717.01", "PI4K2B"], ["TCGA.CA.6717.01", "CENPP"], ["TCGA.CA.6717.01", "TLR3"], ["TCGA.CA.6717.01", "TLR1"], ["TCGA.CA.6717.01", "TLR6"], ["TCGA.CA.6717.01", "TLR7"], ["TCGA.CA.6717.01", "NUP205"], ["TCGA.CA.6717.01", "TFEC"], ["TCGA.CA.6717.01", "SMCHD1"], ["TCGA.CA.6717.01", "DGUOK"], ["TCGA.CA.6717.01", "SSBP2"], ["TCGA.CA.6717.01", "ZCCHC12"], ["TCGA.CA.6717.01", "FBXW12"], ["TCGA.CA.6717.01", "FBXW11"], ["TCGA.CA.6717.01", "CYP11A1"], ["TCGA.CA.6717.01", "MYH10"], ["TCGA.CA.6717.01", "MYH13"], ["TCGA.CA.6717.01", "OR6K3"], ["TCGA.CA.6717.01", "LEF1"], ["TCGA.CA.6717.01", "NAA35"], ["TCGA.CA.6717.01", "ATAD2B"], ["TCGA.CA.6717.01", "PGD"], ["TCGA.CA.6717.01", "PGR"], ["TCGA.CA.6717.01", "DMXL2"], ["TCGA.CA.6717.01", "DMXL1"], ["TCGA.CA.6717.01", "ADAR"], ["TCGA.CA.6717.01", "RNF113B"], ["TCGA.CA.6717.01", "RNF113A"], ["TCGA.CA.6717.01", "RANBP6"], ["TCGA.CA.6717.01", "UBQLNL"], ["TCGA.CA.6717.01", "UIMC1"], ["TCGA.CA.6717.01", "SLC9A4"], ["TCGA.CA.6717.01", "MSMO1"], ["TCGA.CA.6717.01", "A2M"], ["TCGA.CA.6717.01", "FAS"], ["TCGA.CA.6717.01", "CSPG4"], ["TCGA.CA.6717.01", "GUCY1A2"], ["TCGA.CA.6717.01", "SCN7A"], ["TCGA.CA.6717.01", "TRMT1"], ["TCGA.CA.6717.01", "SEMA3A"], ["TCGA.CA.6717.01", "SEMA3C"], ["TCGA.CA.6717.01", "SEMA3D"], ["TCGA.CA.6717.01", "SEMA3G"], ["TCGA.CA.6717.01", "GLP2R"], ["TCGA.CA.6717.01", "ZNF253"], ["TCGA.CA.6717.01", "ZNF257"], ["TCGA.CA.6717.01", "AR"], ["TCGA.CA.6717.01", "NDUFAB1"], ["TCGA.CA.6717.01", "NDUFB8"], ["TCGA.CA.6717.01", "TRPC4AP"], ["TCGA.CA.6717.01", "MARS"], ["TCGA.CA.6717.01", "TAF8"], ["TCGA.CA.6717.01", "MYOF"], ["TCGA.CA.6717.01", "CNOT7"], ["TCGA.CA.6717.01", "GNPDA1"], ["TCGA.CA.6717.01", "SLC12A2"], ["TCGA.CA.6717.01", "CCDC129"], ["TCGA.CA.6717.01", "PIWIL2"], ["TCGA.CA.6717.01", "PIWIL1"], ["TCGA.CA.6717.01", "GABARAPL2"], ["TCGA.CA.6717.01", "KDM4D"], ["TCGA.CA.6717.01", "PSME4"], ["TCGA.CA.6717.01", "TOPBP1"], ["TCGA.CA.6717.01", "NARS2"], ["TCGA.CA.6717.01", "GMPS"], ["TCGA.CA.6717.01", "EPHB3"], ["TCGA.CA.6717.01", "NOP10"], ["TCGA.CA.6717.01", "CCR5"], ["TCGA.CA.6717.01", "ZNF860"], ["TCGA.CA.6717.01", "ZFP2"], ["TCGA.CA.6717.01", "XRN1"], ["TCGA.CA.6717.01", "PABPC3"], ["TCGA.CA.6717.01", "CTNNBL1"], ["TCGA.CA.6717.01", "DLC1"], ["TCGA.CA.6717.01", "GLI3"], ["TCGA.CA.6717.01", "ORC2"], ["TCGA.CA.6717.01", "RARS2"], ["TCGA.CA.6717.01", "BAK1"], ["TCGA.CA.6717.01", "CNTFR"], ["TCGA.CA.6717.01", "TACR3"], ["TCGA.CA.6717.01", "TACR1"], ["TCGA.CA.6717.01", "RGS22"], ["TCGA.CA.6717.01", "VPS53"], ["TCGA.CA.6717.01", "OR10K2"], ["TCGA.CA.6717.01", "PIK3C3"], ["TCGA.CA.6717.01", "ZMPSTE24"], ["TCGA.CA.6717.01", "MRPL37"], ["TCGA.CA.6717.01", "MRPL38"], ["TCGA.CA.6717.01", "THOC2"], ["TCGA.CA.6717.01", "ZNF671"], ["TCGA.CA.6717.01", "RNF103"], ["TCGA.CA.6717.01", "ZNF679"], ["TCGA.CA.6717.01", "ZNF678"], ["TCGA.CA.6717.01", "PHLDB2"], ["TCGA.CA.6717.01", "MTMR14"], ["TCGA.CA.6717.01", "MTMR12"], ["TCGA.CA.6717.01", "ST3GAL3"], ["TCGA.CA.6717.01", "CEP135"], ["TCGA.CA.6717.01", "WIPF1"], ["TCGA.CA.6717.01", "MON1B"], ["TCGA.CA.6717.01", "PPM1A"], ["TCGA.CA.6717.01", "PPM1L"], ["TCGA.CA.6717.01", "CHEK2"], ["TCGA.CA.6717.01", "GINS3"], ["TCGA.CA.6717.01", "C9"], ["TCGA.CA.6717.01", "C3"], ["TCGA.CA.6717.01", "C2"], ["TCGA.CA.6717.01", "C7"], ["TCGA.CA.6717.01", "C6"], ["TCGA.CA.6717.01", "CP"], ["TCGA.CA.6717.01", "RMND5A"], ["TCGA.CA.6717.01", "AP3B1"], ["TCGA.CA.6717.01", "PPP1CB"], ["TCGA.CA.6717.01", "MPPED1"], ["TCGA.CA.6717.01", "ZYX"], ["TCGA.CA.6717.01", "IL1R2"], ["TCGA.CA.6717.01", "ARPC3"], ["TCGA.CA.6717.01", "ITPR2"], ["TCGA.CA.6717.01", "ITPR1"], ["TCGA.CA.6717.01", "IL1RN"], ["TCGA.CA.6717.01", "LAP3"], ["TCGA.CA.6717.01", "HIVEP1"], ["TCGA.CA.6717.01", "HIVEP2"], ["TCGA.CA.6717.01", "CHSY1"], ["TCGA.CA.6717.01", "ARHGAP15"], ["TCGA.CA.6717.01", "ARHGAP12"], ["TCGA.CA.6717.01", "SETX"], ["TCGA.CA.6717.01", "ZNF540"], ["TCGA.CA.6717.01", "DDX17"], ["TCGA.CA.6717.01", "DDX18"], ["TCGA.CA.6717.01", "ARFIP1"], ["TCGA.CA.6717.01", "TRIP11"], ["TCGA.CA.6717.01", "OR2D2"], ["TCGA.CA.6717.01", "EHHADH"], ["TCGA.CA.6717.01", "NTPCR"], ["TCGA.CA.6717.01", "TAS1R1"], ["TCGA.CA.6717.01", "GTF2E1"], ["TCGA.CA.6717.01", "TCTE3"], ["TCGA.CA.6717.01", "CLSPN"], ["TCGA.CA.6717.01", "MSH2"], ["TCGA.CA.6717.01", "MSH3"], ["TCGA.CA.6717.01", "MSH6"], ["TCGA.CA.6717.01", "OR10AG1"], ["TCGA.CA.6717.01", "HAL"], ["TCGA.CA.6717.01", "MCMDC2"], ["TCGA.CA.6717.01", "THSD7A"], ["TCGA.CA.6717.01", "RBMS3"], ["TCGA.CA.6717.01", "CNTRL"], ["TCGA.CA.6717.01", "BRMS1"], ["TCGA.CA.6717.01", "FOXK2"], ["TCGA.CA.6717.01", "TNPO3"], ["TCGA.CA.6717.01", "SLC18B1"], ["TCGA.CA.6717.01", "HCFC2"], ["TCGA.CA.6717.01", "FKBP6"], ["TCGA.CA.6717.01", "ACE2"], ["TCGA.CA.6717.01", "NCAPD3"], ["TCGA.CA.6717.01", "SOAT1"], ["TCGA.CA.6717.01", "SRGAP1"], ["TCGA.CA.6717.01", "SRGAP3"], ["TCGA.CA.6717.01", "SMC3"], ["TCGA.CA.6717.01", "SMC2"], ["TCGA.CA.6717.01", "SMC5"], ["TCGA.CA.6717.01", "PYROXD1"], ["TCGA.CA.6717.01", "SMC6"], ["TCGA.CA.6717.01", "LTF"], ["TCGA.CA.6717.01", "LTV1"], ["TCGA.CA.6717.01", "PDGFRA"], ["TCGA.CA.6717.01", "CNTN1"], ["TCGA.CA.6717.01", "CNTN6"], ["TCGA.CA.6717.01", "CNGA4"], ["TCGA.CA.6717.01", "COASY"], ["TCGA.CA.6717.01", "UNC80"], ["TCGA.CA.6717.01", "IQGAP2"], ["TCGA.CA.6717.01", "PCMTD1"], ["TCGA.CA.6717.01", "BMPR2"], ["TCGA.CA.6717.01", "CLVS1"], ["TCGA.CA.6717.01", "KDR"], ["TCGA.CA.6717.01", "ZNF354B"], ["TCGA.CA.6717.01", "GPSM2"], ["TCGA.CA.6717.01", "GPSM1"], ["TCGA.CA.6717.01", "VPS33B"], ["TCGA.CA.6717.01", "PRDM9"], ["TCGA.CA.6717.01", "OLAH"], ["TCGA.CA.6717.01", "KL"], ["TCGA.CA.6717.01", "OR7D2"], ["TCGA.CA.6717.01", "OR7D4"], ["TCGA.CA.6717.01", "SART3"], ["TCGA.CA.6717.01", "NDUFV3"], ["TCGA.CA.6717.01", "LAMA1"], ["TCGA.CA.6717.01", "LAMA2"], ["TCGA.CA.6717.01", "LAMA3"], ["TCGA.CA.6717.01", "LAMA4"], ["TCGA.CA.6717.01", "F5"], ["TCGA.CA.6717.01", "F7"], ["TCGA.CA.6717.01", "F8"], ["TCGA.CA.6717.01", "ATP4A"], ["TCGA.CA.6717.01", "CNOT10"], ["TCGA.CA.6717.01", "KCND2"], ["TCGA.CA.6717.01", "MAGI2"], ["TCGA.CA.6717.01", "MAGI1"], ["TCGA.CA.6717.01", "UGT2B7"], ["TCGA.CA.6717.01", "UGT2B4"], ["TCGA.CA.6717.01", "SELL"], ["TCGA.CA.6717.01", "BST1"], ["TCGA.CA.6717.01", "TNIK"], ["TCGA.CA.6717.01", "OR52E6"], ["TCGA.CA.6717.01", "EXOC6B"], ["TCGA.CA.6717.01", "CYP39A1"], ["TCGA.CA.6717.01", "ZNF442"], ["TCGA.CA.6717.01", "ZNF443"], ["TCGA.CA.6717.01", "AP1G1"], ["TCGA.CA.6717.01", "OR5M3"], ["TCGA.CA.6717.01", "OR5M1"], ["TCGA.CA.6717.01", "DOK6"], ["TCGA.CA.6717.01", "ARMC1"], ["TCGA.CA.6717.01", "HSPA5"], ["TCGA.CA.6717.01", "HSPA4"], ["TCGA.CA.6717.01", "HSPA8"], ["TCGA.CA.6717.01", "LIFR"], ["TCGA.CA.6717.01", "PPP2R2C"], ["TCGA.CA.6717.01", "TTR"], ["TCGA.CA.6717.01", "TTN"], ["TCGA.CA.6717.01", "MIOS"], ["TCGA.CA.6717.01", "PELI3"], ["TCGA.CA.6717.01", "SRPK2"], ["TCGA.CA.6717.01", "BDKRB1"], ["TCGA.CA.6717.01", "PES1"], ["TCGA.CA.6717.01", "ZNF600"], ["TCGA.CA.6717.01", "ZNF606"], ["TCGA.CA.6717.01", "GCK"], ["TCGA.CA.6717.01", "PRPF40B"], ["TCGA.CA.6717.01", "PAPOLG"], ["TCGA.CA.6717.01", "PAPOLA"], ["TCGA.CA.6717.01", "SLC25A3"], ["TCGA.CA.6717.01", "KIF5C"], ["TCGA.CA.6717.01", "CDK1"], ["TCGA.CA.6717.01", "USP45"], ["TCGA.CA.6717.01", "USP47"], ["TCGA.CA.6717.01", "VDAC1"], ["TCGA.CA.6717.01", "ADRB3"], ["TCGA.CA.6717.01", "MCM3AP"], ["TCGA.CA.6717.01", "RPL22"], ["TCGA.CA.6717.01", "TRIM37"], ["TCGA.CA.6717.01", "TPP2"], ["TCGA.CA.6717.01", "ULBP3"], ["TCGA.CA.6717.01", "ULBP1"], ["TCGA.CA.6717.01", "IFIT1B"], ["TCGA.CA.6717.01", "P2RY13"], ["TCGA.CA.6717.01", "LEPR"], ["TCGA.CA.6717.01", "CYP2C8"], ["TCGA.CA.6717.01", "OR10P1"], ["TCGA.CA.6717.01", "DHFR"], ["TCGA.CA.6717.01", "SNTG2"], ["TCGA.CA.6717.01", "SLC1A3"], ["TCGA.CA.6717.01", "SF3B1"], ["TCGA.CA.6717.01", "ADD1"], ["TCGA.CA.6717.01", "SLC11A1"], ["TCGA.CA.6717.01", "CWC22"], ["TCGA.CA.6717.01", "FMO2"], ["TCGA.CA.6717.01", "FMO3"], ["TCGA.CA.6717.01", "SH2D2A"], ["TCGA.CA.6717.01", "DPP4"], ["TCGA.CA.6717.01", "OR6N1"], ["TCGA.CA.6717.01", "NOC3L"], ["TCGA.CA.6717.01", "OR2T6"], ["TCGA.CA.6717.01", "CEP164"], ["TCGA.CA.6717.01", "STAT4"], ["TCGA.CA.6717.01", "ELOVL2"], ["TCGA.CA.6717.01", "ELOVL1"], ["TCGA.CA.6717.01", "DUSP4"], ["TCGA.CA.6717.01", "RBL1"], ["TCGA.CA.6717.01", "HEY1"], ["TCGA.CA.6717.01", "TRPA1"], ["TCGA.CA.6717.01", "SCN4A"], ["TCGA.CA.6717.01", "SCN4B"], ["TCGA.CA.6717.01", "ACTA2"], ["TCGA.CA.6717.01", "ACTA1"], ["TCGA.CA.6717.01", "ZNF221"], ["TCGA.CA.6717.01", "ZNF224"], ["TCGA.CA.6717.01", "ZNF226"], ["TCGA.CA.6717.01", "OTUD5"], ["TCGA.CA.6717.01", "SPCS3"], ["TCGA.CA.6717.01", "MGAT4A"], ["TCGA.CA.6717.01", "BZW1"], ["TCGA.CA.6717.01", "CYP3A7"], ["TCGA.CA.6717.01", "CYP3A4"], ["TCGA.CA.6717.01", "LDB1"], ["TCGA.CA.6717.01", "TRPC3"], ["TCGA.CA.6717.01", "TRPC7"], ["TCGA.CA.6717.01", "SEC62"], ["TCGA.CA.6717.01", "MGAM"], ["TCGA.CA.6717.01", "MYH2"], ["TCGA.CA.6717.01", "MYH1"], ["TCGA.CA.6717.01", "MYH7"], ["TCGA.CA.6717.01", "MYH4"], ["TCGA.CA.6717.01", "MYH8"], ["TCGA.CA.6717.01", "CADM3"], ["TCGA.CA.6717.01", "PNLIPRP3"], ["TCGA.CA.6717.01", "TMOD1"], ["TCGA.CA.6717.01", "GPR37"], ["TCGA.CA.6717.01", "GK2"], ["TCGA.CA.6717.01", "GK5"], ["TCGA.CA.6717.01", "AHCYL2"], ["TCGA.CA.6717.01", "SEPT10"], ["TCGA.CA.6717.01", "CLDN18"], ["TCGA.CA.6717.01", "PHIP"], ["TCGA.CA.6717.01", "ZNF521"], ["TCGA.CA.6717.01", "ZNF529"], ["TCGA.CA.6717.01", "IFNA14"], ["TCGA.CA.6717.01", "MAN2C1"], ["TCGA.CA.6717.01", "LAT"], ["TCGA.CA.6717.01", "PANK1"], ["TCGA.CA.6717.01", "NFASC"], ["TCGA.CA.6717.01", "OPRM1"], ["TCGA.CA.6717.01", "NTS"], ["TCGA.CA.6717.01", "ST6GALNAC3"], ["TCGA.CA.6717.01", "KIF13A"], ["TCGA.CA.6717.01", "KIF13B"], ["TCGA.CA.6717.01", "AVPR1A"], ["TCGA.CA.6717.01", "HPS4"], ["TCGA.CA.6717.01", "NCKIPSD"], ["TCGA.CA.6717.01", "MCHR2"], ["TCGA.CA.6717.01", "HPSE"], ["TCGA.CA.6717.01", "ARID1A"], ["TCGA.CA.6717.01", "SPTAN1"], ["TCGA.CA.6717.01", "SND1"], ["TCGA.CA.6717.01", "USP8"], ["TCGA.CA.6717.01", "USP1"], ["TCGA.CA.6717.01", "USP6"], ["TCGA.CA.6717.01", "USP7"], ["TCGA.CA.6717.01", "ZNF721"], ["TCGA.CA.6717.01", "ETFDH"], ["TCGA.CA.6717.01", "MYO5B"], ["TCGA.CA.6717.01", "MYO5A"], ["TCGA.CA.6717.01", "GBP3"], ["TCGA.CA.6717.01", "GBP6"], ["TCGA.CA.6717.01", "GBP4"], ["TCGA.CA.6717.01", "UBLCP1"], ["TCGA.CA.6717.01", "DARS2"], ["TCGA.CA.6717.01", "APH1B"], ["TCGA.CA.6717.01", "STAT1"], ["TCGA.CA.6717.01", "HTATSF1"], ["TCGA.CA.6717.01", "PDE4D"], ["TCGA.CA.6717.01", "CAND2"], ["TCGA.CA.6717.01", "TMOD2"], ["TCGA.CA.6717.01", "ZNF71"], ["TCGA.CA.6717.01", "SFTPA2"], ["TCGA.CA.6717.01", "CD2AP"], ["TCGA.CA.6717.01", "CPS1"], ["TCGA.CA.6717.01", "ACAP2"], ["TCGA.CA.6717.01", "NOM1"], ["TCGA.CA.6717.01", "SELE"], ["TCGA.CA.6717.01", "VCAN"], ["TCGA.CA.6718.01", "Drug ADME"], ["TCGA.CA.6718.01", "Biological oxidations"], ["TCGA.CA.6718.01", "Neuronal System"], ["TCGA.CA.6718.01", "Metabolism"], ["TCGA.CA.6718.01", "Transmission across Chemical Synapses"], ["TCGA.CA.6718.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CA.6718.01", "Ethanol oxidation"], ["TCGA.CA.6718.01", "Extracellular matrix organization"], ["TCGA.CA.6718.01", "Phase II - Conjugation of compounds"], ["TCGA.CA.6718.01", "SLC-mediated transmembrane transport"], ["TCGA.CA.6718.01", "Degradation of the extracellular matrix"], ["TCGA.CA.6718.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CA.6718.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CA.6718.01", "Signaling by GPCR"], ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], ["TCGA.CA.6718.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], ["TCGA.CA.6718.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], ["TCGA.CA.6718.01", "Impaired BRCA2 binding to PALB2"], ["TCGA.CA.6718.01", "Bile acid and bile salt metabolism"], ["TCGA.CA.6718.01", "Phase I - Functionalization of compounds"], ["TCGA.CA.6718.01", "Glucuronidation"], ["TCGA.CA.6718.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CA.6718.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.CA.6718.01", "G alpha (i) signalling events"], ["TCGA.CA.6718.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CA.6718.01", "GPCR downstream signalling"], ["TCGA.CA.6718.01", "APAP ADME"], ["TCGA.CA.6718.01", "Resolution of D-Loop Structures"], ["TCGA.CA.6718.01", "Metabolism of lipids"], ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.CA.6718.01", "Heme degradation"], ["TCGA.CA.6718.01", "Metabolism of fat-soluble vitamins"], ["TCGA.CA.6718.01", "Retinoid metabolism and transport"], ["TCGA.CA.6718.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts"], ["TCGA.CA.6718.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], ["TCGA.CA.6718.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CA.6718.01", "Interaction between L1 and Ankyrins"], ["TCGA.CA.6718.01", "Metabolism of vitamins and cofactors"], ["TCGA.CA.6718.01", "Synaptic adhesion-like molecules"], ["TCGA.CA.6718.01", "Collagen chain trimerization"], ["TCGA.CA.6718.01", "Transport of small molecules"], ["TCGA.CA.6718.01", "GPCR ligand binding"], ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.CA.6718.01", "Protein-protein interactions at synapses"], ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.CA.6718.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.CA.6718.01", "WNT ligand biogenesis and trafficking"], ["TCGA.CA.6718.01", "Neurotransmitter release cycle"], ["TCGA.CA.6718.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CA.6718.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CA.6718.01", "Nuclear Receptor transcription pathway"], ["TCGA.CA.6718.01", "Diseases of DNA repair"], ["TCGA.CA.6718.01", "Diseases of DNA Double-Strand Break Repair"], ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to BRCA2 loss of function"], ["TCGA.CA.6718.01", "Aspirin ADME"], ["TCGA.CA.6718.01", "Visual phototransduction"], ["TCGA.CA.6718.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CA.6718.01", "Unwinding of DNA"], ["TCGA.CA.6718.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.CA.6718.01", "Metal ion SLC transporters"], ["TCGA.CA.6718.01", "Blood group systems biosynthesis"], ["TCGA.CA.6718.01", "Presynaptic phase of homologous DNA pairing and strand exchange"], ["TCGA.CA.6718.01", "Fatty acid metabolism"], ["TCGA.CA.6718.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CA.6718.01", "GABA receptor activation"], ["TCGA.CA.6719.01", "Biological oxidations"], ["TCGA.CA.6719.01", "Phase II - Conjugation of compounds"], ["TCGA.CA.6719.01", "Collagen chain trimerization"], ["TCGA.CA.6719.01", "Extracellular matrix organization"], ["TCGA.CA.6719.01", "Glucuronidation"], ["TCGA.CA.6719.01", "Metabolism"], ["TCGA.CA.6719.01", "Drug ADME"], ["TCGA.CA.6719.01", "APAP ADME"], ["TCGA.CA.6719.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CA.6719.01", "Collagen formation"], ["TCGA.CA.6719.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CA.6719.01", "Ethanol oxidation"], ["TCGA.CA.6719.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CA.6719.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CA.6719.01", "Degradation of the extracellular matrix"], ["TCGA.CK.4947.01", "RA biosynthesis pathway"], ["TCGA.CK.4947.01", "Neuronal System"], ["TCGA.CK.4947.01", "Signaling by Retinoic Acid"], ["TCGA.CK.4947.01", "Biological oxidations"], ["TCGA.CK.4947.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CK.4947.01", "Cardiac conduction"], ["TCGA.CK.4947.01", "Transmission across Chemical Synapses"], ["TCGA.CK.4947.01", "Complement cascade"], ["TCGA.CK.4947.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.4947.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CK.4947.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.4947.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CK.4947.01", "GABA receptor activation"], ["TCGA.CK.4947.01", "Visual phototransduction"], ["TCGA.CK.4947.01", "Phase 4 - resting membrane potential"], ["TCGA.CK.4947.01", "Ethanol oxidation"], ["TCGA.CK.4947.01", "Stimuli-sensing channels"], ["TCGA.CK.4947.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.4948.01", "Extracellular matrix organization"], ["TCGA.CK.4948.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.4948.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CK.4948.01", "Collagen formation"], ["TCGA.CK.4948.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.4948.01", "G alpha (i) signalling events"], ["TCGA.CK.4948.01", "Degradation of the extracellular matrix"], ["TCGA.CK.4948.01", "GPCR downstream signalling"], ["TCGA.CK.4948.01", "Neuronal System"], ["TCGA.CK.4948.01", "Signaling by GPCR"], ["TCGA.CK.4948.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.4948.01", "Collagen chain trimerization"], ["TCGA.CK.4948.01", "Drug ADME"], ["TCGA.CK.4948.01", "GPCR ligand binding"], ["TCGA.CK.4948.01", "Glucuronidation"], ["TCGA.CK.4948.01", "Termination of O-glycan biosynthesis"], ["TCGA.CK.4948.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.4948.01", "O-linked glycosylation of mucins"], ["TCGA.CK.4948.01", "O-linked glycosylation"], ["TCGA.CK.4948.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CK.4948.01", "Biological oxidations"], ["TCGA.CK.4948.01", "Transmission across Chemical Synapses"], ["TCGA.CK.4948.01", "Glucagon-type ligand receptors"], ["TCGA.CK.4948.01", "Defective GALNT3 causes HFTC"], ["TCGA.CK.4948.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CK.4948.01", "Cardiac conduction"], ["TCGA.CK.4948.01", "Chemokine receptors bind chemokines"], ["TCGA.CK.4948.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CK.4948.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.CK.4948.01", "G alpha (s) signalling events"], ["TCGA.CK.4948.01", "Signal amplification"], ["TCGA.CK.4948.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CK.4948.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CK.4948.01", "Peptide ligand-binding receptors"], ["TCGA.CK.4948.01", "Formation of axial mesoderm"], ["TCGA.CK.4948.01", "Peptide hormone metabolism"], ["TCGA.CK.4948.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CK.4948.01", "Metal ion SLC transporters"], ["TCGA.CK.4948.01", "Regulation of insulin secretion"], ["TCGA.CK.4948.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CK.4948.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CK.4948.01", "Muscle contraction"], ["TCGA.CK.4948.01", "Platelet homeostasis"], ["TCGA.CK.4948.01", "Neurexins and neuroligins"], ["TCGA.CK.4948.01", "Azathioprine ADME"], ["TCGA.CK.4948.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CK.4948.01", "L1CAM interactions"], ["TCGA.CK.4948.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CK.4948.01", "Keratinization"], ["TCGA.CK.4948.01", "Protein-protein interactions at synapses"], ["TCGA.CK.4950.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.4950.01", "Neuronal System"], ["TCGA.CK.4950.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.CK.4950.01", "Post-translational protein phosphorylation"], ["TCGA.CK.4950.01", "Transmission across Chemical Synapses"], ["TCGA.CK.4950.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CK.4950.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.4950.01", "Response to elevated platelet cytosolic Ca2+"], ["TCGA.CK.4950.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.CK.4950.01", "Extracellular matrix organization"], ["TCGA.CK.4950.01", "L1CAM interactions"], ["TCGA.CK.4950.01", "GABA receptor activation"], ["TCGA.CK.4950.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CK.4950.01", "Regulation of TLR by endogenous ligand"], ["TCGA.CK.4950.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CK.4950.01", "Signaling by BMP"], ["TCGA.CK.4950.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.4950.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.CK.4950.01", "RA biosynthesis pathway"], ["TCGA.CK.4950.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.CK.4950.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.CK.4950.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.CK.4950.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CK.4950.01", "Cardiac conduction"], ["TCGA.CK.4952.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CK.4952.01", "Neuronal System"], ["TCGA.CK.4952.01", "Protein-protein interactions at synapses"], ["TCGA.CK.4952.01", "Biological oxidations"], ["TCGA.CK.4952.01", "Transmission across Chemical Synapses"], ["TCGA.CK.4952.01", "Unwinding of DNA"], ["TCGA.CK.4952.01", "Signaling by GPCR"], ["TCGA.CK.4952.01", "GPCR downstream signalling"], ["TCGA.CK.4952.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CK.4952.01", "Neurexins and neuroligins"], ["TCGA.CK.4952.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CK.4952.01", "Drug ADME"], ["TCGA.CK.4952.01", "G alpha (i) signalling events"], ["TCGA.CK.4952.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CK.4952.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.CK.4952.01", "Activation of the pre-replicative complex"], ["TCGA.CK.4952.01", "Complement cascade"], ["TCGA.CK.4952.01", "Generation of second messenger molecules"], ["TCGA.CK.4952.01", "DNA strand elongation"], ["TCGA.CK.4952.01", "CD22 mediated BCR regulation"], ["TCGA.CK.4952.01", "Activation of ATR in response to replication stress"], ["TCGA.CK.4952.01", "Regulation of Complement cascade"], ["TCGA.CK.4952.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CK.4952.01", "GPCR ligand binding"], ["TCGA.CK.4952.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.4952.01", "Chemokine receptors bind chemokines"], ["TCGA.CK.4952.01", "Cardiac conduction"], ["TCGA.CK.4952.01", "Synaptic adhesion-like molecules"], ["TCGA.CK.4952.01", "Signaling Pathways"], ["TCGA.CK.4952.01", "DAP12 interactions"], ["TCGA.CK.4952.01", "Phase I - Functionalization of compounds"], ["TCGA.CK.4952.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.CK.4952.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CK.4952.01", "DAP12 signaling"], ["TCGA.CK.4952.01", "Resolution of D-Loop Structures"], ["TCGA.CK.4952.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], ["TCGA.CK.4952.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], ["TCGA.CK.4952.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], ["TCGA.CK.4952.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], ["TCGA.CK.4952.01", "Impaired BRCA2 binding to PALB2"], ["TCGA.CK.4952.01", "Intrinsic Pathway of Fibrin Clot Formation"], ["TCGA.CK.4952.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], ["TCGA.CK.4952.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.CK.4952.01", "Extracellular matrix organization"], ["TCGA.CK.4952.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.4952.01", "Arachidonic acid metabolism"], ["TCGA.CK.4952.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CK.4952.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.CK.4952.01", "SUMOylation of intracellular receptors"], ["TCGA.CK.4952.01", "Glucuronidation"], ["TCGA.CK.4952.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CK.4952.01", "Molecules associated with elastic fibres"], ["TCGA.CK.4952.01", "Carnitine metabolism"], ["TCGA.CK.4952.01", "Peptide ligand-binding receptors"], ["TCGA.CK.4952.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.CK.4952.01", "Homologous DNA Pairing and Strand Exchange"], ["TCGA.CK.4952.01", "Metabolism of fat-soluble vitamins"], ["TCGA.CK.4952.01", "Retinoid metabolism and transport"], ["TCGA.CK.5912.01", "Neuronal System"], ["TCGA.CK.5912.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CK.5912.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CK.5912.01", "Transmission across Chemical Synapses"], ["TCGA.CK.5912.01", "Potassium Channels"], ["TCGA.CK.5912.01", "Signaling by GPCR"], ["TCGA.CK.5912.01", "GPCR downstream signalling"], ["TCGA.CK.5912.01", "G alpha (i) signalling events"], ["TCGA.CK.5912.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.5912.01", "Cardiac conduction"], ["TCGA.CK.5912.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.CK.5912.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CK.5912.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CK.5912.01", "Regulation of Complement cascade"], ["TCGA.CK.5912.01", "Complement cascade"], ["TCGA.CK.5912.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CK.5912.01", "Leishmania parasite growth and survival"], ["TCGA.CK.5912.01", "Platelet homeostasis"], ["TCGA.CK.5912.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5912.01", "Arachidonic acid metabolism"], ["TCGA.CK.5912.01", "Biological oxidations"], ["TCGA.CK.5912.01", "Peptide hormone metabolism"], ["TCGA.CK.5912.01", "GPCR ligand binding"], ["TCGA.CK.5912.01", "GABA receptor activation"], ["TCGA.CK.5912.01", "Carnitine metabolism"], ["TCGA.CK.5912.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CK.5912.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.5912.01", "Classical antibody-mediated complement activation"], ["TCGA.CK.5912.01", "Signaling Pathways"], ["TCGA.CK.5912.01", "Voltage gated Potassium channels"], ["TCGA.CK.5912.01", "Leishmania infection"], ["TCGA.CK.5912.01", "Parasitic Infection Pathways"], ["TCGA.CK.5912.01", "Regulation of insulin secretion"], ["TCGA.CK.5912.01", "Activation of G protein gated Potassium channels"], ["TCGA.CK.5912.01", "G protein gated Potassium channels"], ["TCGA.CK.5912.01", "Platelet calcium homeostasis"], ["TCGA.CK.5912.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CK.5912.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.CK.5912.01", "Inwardly rectifying K+ channels"], ["TCGA.CK.5912.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CK.5912.01", "Opioid Signalling"], ["TCGA.CK.5912.01", "G-protein mediated events"], ["TCGA.CK.5912.01", "Neurexins and neuroligins"], ["TCGA.CK.5912.01", "Protein-protein interactions at synapses"], ["TCGA.CK.5912.01", "G-protein beta:gamma signalling"], ["TCGA.CK.5912.01", "Muscle contraction"], ["TCGA.CK.5912.01", "GABA B receptor activation"], ["TCGA.CK.5912.01", "Activation of GABAB receptors"], ["TCGA.CK.5912.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CK.5912.01", "Phase 2 - plateau phase"], ["TCGA.CK.5912.01", "Keratan sulfate biosynthesis"], ["TCGA.CK.5912.01", "Initial triggering of complement"], ["TCGA.CK.5912.01", "Nucleotide catabolism"], ["TCGA.CK.5912.01", "PLC beta mediated events"], ["TCGA.CK.5912.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CK.5912.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CK.5912.01", "Phase 4 - resting membrane potential"], ["TCGA.CK.5912.01", "Fatty acid metabolism"], ["TCGA.CK.5912.01", "Signal amplification"], ["TCGA.CK.5912.01", "G alpha (q) signalling events"], ["TCGA.CK.5912.01", "Glucagon-type ligand receptors"], ["TCGA.CK.5912.01", "Ca2+ pathway"], ["TCGA.CK.5912.01", "Heme degradation"], ["TCGA.CK.5912.01", "Scavenging of heme from plasma"], ["TCGA.CK.5912.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.CK.5912.01", "Phase I - Functionalization of compounds"], ["TCGA.CK.5912.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CK.5913.01", "Neuronal System"], ["TCGA.CK.5913.01", "Transmission across Chemical Synapses"], ["TCGA.CK.5913.01", "GPCR ligand binding"], ["TCGA.CK.5913.01", "Protein-protein interactions at synapses"], ["TCGA.CK.5913.01", "Neurexins and neuroligins"], ["TCGA.CK.5913.01", "G alpha (i) signalling events"], ["TCGA.CK.5913.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5913.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CK.5913.01", "Biological oxidations"], ["TCGA.CK.5913.01", "Cardiac conduction"], ["TCGA.CK.5913.01", "Signaling by GPCR"], ["TCGA.CK.5913.01", "GPCR downstream signalling"], ["TCGA.CK.5913.01", "Extracellular matrix organization"], ["TCGA.CK.5913.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.5913.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CK.5913.01", "Peptide ligand-binding receptors"], ["TCGA.CK.5913.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.5913.01", "Drug ADME"], ["TCGA.CK.5913.01", "L1CAM interactions"], ["TCGA.CK.5913.01", "Collagen chain trimerization"], ["TCGA.CK.5913.01", "Ethanol oxidation"], ["TCGA.CK.5913.01", "GABA receptor activation"], ["TCGA.CK.5913.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CK.5913.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.5913.01", "Potassium Channels"], ["TCGA.CK.5913.01", "Muscle contraction"], ["TCGA.CK.5913.01", "Glucagon-type ligand receptors"], ["TCGA.CK.5913.01", "Collagen formation"], ["TCGA.CK.5913.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CK.5913.01", "Defective B3GALTL causes PpS"], ["TCGA.CK.5913.01", "Synaptic adhesion-like molecules"], ["TCGA.CK.5913.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CK.5913.01", "Glucuronidation"], ["TCGA.CK.5913.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CK.5913.01", "TNFs bind their physiological receptors"], ["TCGA.CK.5913.01", "Chemokine receptors bind chemokines"], ["TCGA.CK.5913.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.CK.5913.01", "O-linked glycosylation"], ["TCGA.CK.5913.01", "Degradation of the extracellular matrix"], ["TCGA.CK.5913.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CK.5913.01", "Activation of G protein gated Potassium channels"], ["TCGA.CK.5913.01", "G protein gated Potassium channels"], ["TCGA.CK.5913.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CK.5913.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CK.5913.01", "Antimicrobial peptides"], ["TCGA.CK.5913.01", "Glutathione conjugation"], ["TCGA.CK.5913.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CK.5913.01", "GABA B receptor activation"], ["TCGA.CK.5913.01", "Activation of GABAB receptors"], ["TCGA.CK.5914.01", "Neuronal System"], ["TCGA.CK.5914.01", "GPCR downstream signalling"], ["TCGA.CK.5914.01", "Signaling by GPCR"], ["TCGA.CK.5914.01", "Transmission across Chemical Synapses"], ["TCGA.CK.5914.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CK.5914.01", "G alpha (i) signalling events"], ["TCGA.CK.5914.01", "Signaling Pathways"], ["TCGA.CK.5914.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5914.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.5914.01", "Potassium Channels"], ["TCGA.CK.5914.01", "GPCR ligand binding"], ["TCGA.CK.5914.01", "Cardiac conduction"], ["TCGA.CK.5914.01", "G alpha (s) signalling events"], ["TCGA.CK.5914.01", "L1CAM interactions"], ["TCGA.CK.5914.01", "Ca-dependent events"], ["TCGA.CK.5914.01", "G-protein mediated events"], ["TCGA.CK.5914.01", "GABA receptor activation"], ["TCGA.CK.5914.01", "G alpha (z) signalling events"], ["TCGA.CK.5914.01", "Regulation of insulin secretion"], ["TCGA.CK.5914.01", "Calmodulin induced events"], ["TCGA.CK.5914.01", "CaM pathway"], ["TCGA.CK.5914.01", "G alpha (q) signalling events"], ["TCGA.CK.5914.01", "DAG and IP3 signaling"], ["TCGA.CK.5914.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CK.5914.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CK.5914.01", "Glucagon-type ligand receptors"], ["TCGA.CK.5914.01", "Opioid Signalling"], ["TCGA.CK.5914.01", "Integration of energy metabolism"], ["TCGA.CK.5914.01", "PLC beta mediated events"], ["TCGA.CK.5914.01", "Arachidonic acid metabolism"], ["TCGA.CK.5914.01", "Biological oxidations"], ["TCGA.CK.5914.01", "Blood group systems biosynthesis"], ["TCGA.CK.5914.01", "Platelet homeostasis"], ["TCGA.CK.5914.01", "Protein-protein interactions at synapses"], ["TCGA.CK.5914.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CK.5914.01", "Leishmania parasite growth and survival"], ["TCGA.CK.5914.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.CK.5914.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CK.5914.01", "GABA B receptor activation"], ["TCGA.CK.5914.01", "Activation of GABAB receptors"], ["TCGA.CK.5914.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.5914.01", "Signal amplification"], ["TCGA.CK.5914.01", "Extracellular matrix organization"], ["TCGA.CK.5914.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CK.5914.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CK.5914.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CK.5914.01", "Neurexins and neuroligins"], ["TCGA.CK.5914.01", "Transport of small molecules"], ["TCGA.CK.5914.01", "Chemokine receptors bind chemokines"], ["TCGA.CK.5914.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CK.5914.01", "Lewis blood group biosynthesis"], ["TCGA.CK.5914.01", "Peptide ligand-binding receptors"], ["TCGA.CK.5914.01", "CD22 mediated BCR regulation"], ["TCGA.CK.5914.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.CK.5914.01", "Aquaporin-mediated transport"], ["TCGA.CK.5914.01", "Platelet activation, signaling and aggregation"], ["TCGA.CK.5914.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CK.5914.01", "Activation of NMDA receptors and postsynaptic events"], ["TCGA.CK.5914.01", "GPER1 signaling"], ["TCGA.CK.5914.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.CK.5914.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CK.5914.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.CK.5914.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.5914.01", "G beta:gamma signalling through BTK"], ["TCGA.CK.5914.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CK.5914.01", "Molecules associated with elastic fibres"], ["TCGA.CK.5914.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CK.5914.01", "Complement cascade"], ["TCGA.CK.5914.01", "Sensory perception of taste"], ["TCGA.CK.5914.01", "Regulation of Complement cascade"], ["TCGA.CK.5914.01", "Drug ADME"], ["TCGA.CK.5914.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CK.5914.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CK.5914.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CK.5914.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.CK.5914.01", "Muscle contraction"], ["TCGA.CK.5914.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.CK.5914.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.CK.5914.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CK.5914.01", "Phase 4 - resting membrane potential"], ["TCGA.CK.5914.01", "G-protein beta:gamma signalling"], ["TCGA.CK.5914.01", "Nucleotide catabolism"], ["TCGA.CK.5914.01", "Post NMDA receptor activation events"], ["TCGA.CK.5914.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CK.5914.01", "SUMOylation of intracellular receptors"], ["TCGA.CK.5915.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CK.5915.01", "Signaling by GPCR"], ["TCGA.CK.5915.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CK.5915.01", "Generation of second messenger molecules"], ["TCGA.CK.5915.01", "GPCR downstream signalling"], ["TCGA.CK.5915.01", "Neuronal System"], ["TCGA.CK.5915.01", "Immune System"], ["TCGA.CK.5915.01", "PD-1 signaling"], ["TCGA.CK.5915.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.CK.5915.01", "Potassium Channels"], ["TCGA.CK.5915.01", "GPCR ligand binding"], ["TCGA.CK.5915.01", "Complement cascade"], ["TCGA.CK.5915.01", "G alpha (i) signalling events"], ["TCGA.CK.5915.01", "Signaling Pathways"], ["TCGA.CK.5915.01", "Regulation of Complement cascade"], ["TCGA.CK.5915.01", "Transmission across Chemical Synapses"], ["TCGA.CK.5915.01", "Cardiac conduction"], ["TCGA.CK.5915.01", "Muscle contraction"], ["TCGA.CK.5915.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CK.5915.01", "G alpha (s) signalling events"], ["TCGA.CK.5915.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CK.5915.01", "Chemokine receptors bind chemokines"], ["TCGA.CK.5915.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CK.5915.01", "Leishmania parasite growth and survival"], ["TCGA.CK.5915.01", "GABA B receptor activation"], ["TCGA.CK.5915.01", "Activation of GABAB receptors"], ["TCGA.CK.5915.01", "Platelet homeostasis"], ["TCGA.CK.5915.01", "GABA receptor activation"], ["TCGA.CK.5915.01", "G alpha (q) signalling events"], ["TCGA.CK.5915.01", "Adaptive Immune System"], ["TCGA.CK.5915.01", "Leishmania infection"], ["TCGA.CK.5915.01", "Parasitic Infection Pathways"], ["TCGA.CK.5915.01", "Arachidonic acid metabolism"], ["TCGA.CK.5915.01", "Glucagon-type ligand receptors"], ["TCGA.CK.5915.01", "Initial triggering of complement"], ["TCGA.CK.5915.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.5915.01", "TNFs bind their physiological receptors"], ["TCGA.CK.5915.01", "DAP12 interactions"], ["TCGA.CK.5915.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CK.5915.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CK.5915.01", "Innate Immune System"], ["TCGA.CK.5915.01", "Regulation of insulin secretion"], ["TCGA.CK.5915.01", "Activation of G protein gated Potassium channels"], ["TCGA.CK.5915.01", "G protein gated Potassium channels"], ["TCGA.CK.5915.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CK.5915.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5915.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CK.5915.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CK.5915.01", "Peptide ligand-binding receptors"], ["TCGA.CK.5915.01", "Costimulation by the CD28 family"], ["TCGA.CK.5915.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CK.5915.01", "Other semaphorin interactions"], ["TCGA.CK.5915.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CK.5915.01", "Cell surface interactions at the vascular wall"], ["TCGA.CK.5915.01", "G-protein beta:gamma signalling"], ["TCGA.CK.5915.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CK.5915.01", "Inwardly rectifying K+ channels"], ["TCGA.CK.5915.01", "Integration of energy metabolism"], ["TCGA.CK.5915.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.CK.5915.01", "Blood group systems biosynthesis"], ["TCGA.CK.5915.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CK.5915.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CK.5915.01", "Peptide hormone metabolism"], ["TCGA.CK.5915.01", "G beta:gamma signalling through BTK"], ["TCGA.CK.5915.01", "G alpha (z) signalling events"], ["TCGA.CK.5915.01", "DAP12 signaling"], ["TCGA.CK.5915.01", "NCAM1 interactions"], ["TCGA.CK.5915.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CK.5915.01", "Opioid Signalling"], ["TCGA.CK.5915.01", "Ion homeostasis"], ["TCGA.CK.5915.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.CK.5915.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CK.5915.01", "Ca2+ pathway"], ["TCGA.CK.5915.01", "Molecules associated with elastic fibres"], ["TCGA.CK.5915.01", "Lewis blood group biosynthesis"], ["TCGA.CK.5915.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CK.5915.01", "Biological oxidations"], ["TCGA.CK.5915.01", "Scavenging by Class A Receptors"], ["TCGA.CK.5915.01", "G beta:gamma signalling through CDC42"], ["TCGA.CK.5915.01", "Drug ADME"], ["TCGA.CK.5915.01", "Interferon gamma signaling"], ["TCGA.CK.5915.01", "G-protein activation"], ["TCGA.CK.5915.01", "Signal amplification"], ["TCGA.CK.5915.01", "Cytokine Signaling in Immune system"], ["TCGA.CK.5915.01", "Aspirin ADME"], ["TCGA.CK.5915.01", "Sialic acid metabolism"], ["TCGA.CK.5915.01", "Keratan sulfate biosynthesis"], ["TCGA.CK.5915.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CK.5915.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CK.5915.01", "Phase 4 - resting membrane potential"], ["TCGA.CK.5915.01", "NCAM signaling for neurite out-growth"], ["TCGA.CK.5915.01", "Biosynthesis of DHA-derived SPMs"], ["TCGA.CK.5915.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CK.5915.01", "Voltage gated Potassium channels"], ["TCGA.CK.5915.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CK.5915.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CK.5915.01", "CD22 mediated BCR regulation"], ["TCGA.CK.5915.01", "Extracellular matrix organization"], ["TCGA.CK.5915.01", "L1CAM interactions"], ["TCGA.CK.5915.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.CK.5915.01", "Aquaporin-mediated transport"], ["TCGA.CK.5915.01", "Thromboxane signalling through TP receptor"], ["TCGA.CK.5915.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CK.5915.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.CK.5915.01", "GPER1 signaling"], ["TCGA.CK.5915.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.CK.5915.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CK.5915.01", "Netrin-1 signaling"], ["TCGA.CK.5915.01", "FCGR activation"], ["TCGA.CK.5915.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.CK.5915.01", "Ca-dependent events"], ["TCGA.CK.5915.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.CK.5915.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CK.5915.01", "Presynaptic function of Kainate receptors"], ["TCGA.CK.5915.01", "Elastic fibre formation"], ["TCGA.CK.5916.01", "Neuronal System"], ["TCGA.CK.5916.01", "Drug ADME"], ["TCGA.CK.5916.01", "Biological oxidations"], ["TCGA.CK.5916.01", "Ethanol oxidation"], ["TCGA.CK.5916.01", "Transmission across Chemical Synapses"], ["TCGA.CK.5916.01", "Stimuli-sensing channels"], ["TCGA.CK.5916.01", "Phase 0 - rapid depolarisation"], ["TCGA.CK.5916.01", "Phase II - Conjugation of compounds"], ["TCGA.CK.5916.01", "Cardiac conduction"], ["TCGA.CK.5916.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CK.5916.01", "Extracellular matrix organization"], ["TCGA.CK.5916.01", "O-linked glycosylation of mucins"], ["TCGA.CK.5916.01", "G alpha (i) signalling events"], ["TCGA.CK.5916.01", "APAP ADME"], ["TCGA.CK.5916.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CK.5916.01", "Ion channel transport"], ["TCGA.CK.5916.01", "Interaction between L1 and Ankyrins"], ["TCGA.CK.5916.01", "Signaling by GPCR"], ["TCGA.CK.5916.01", "Potassium Channels"], ["TCGA.CK.5916.01", "RA biosynthesis pathway"], ["TCGA.CK.5916.01", "Glucuronidation"], ["TCGA.CK.5916.01", "Termination of O-glycan biosynthesis"], ["TCGA.CK.5916.01", "GPCR ligand binding"], ["TCGA.CK.5916.01", "O-linked glycosylation"], ["TCGA.CK.5916.01", "Protein-protein interactions at synapses"], ["TCGA.CK.5916.01", "Transport of small molecules"], ["TCGA.CK.5916.01", "Metabolism"], ["TCGA.CK.5916.01", "Peptide hormone metabolism"], ["TCGA.CK.5916.01", "Neurexins and neuroligins"], ["TCGA.CK.5916.01", "GABA receptor activation"], ["TCGA.CK.5916.01", "Free fatty acids regulate insulin secretion"], ["TCGA.CK.5916.01", "Glutathione conjugation"], ["TCGA.CK.5916.01", "GPCR downstream signalling"], ["TCGA.CK.5916.01", "ECM proteoglycans"], ["TCGA.CK.5916.01", "Degradation of the extracellular matrix"], ["TCGA.CK.5916.01", "Muscle contraction"], ["TCGA.CK.5916.01", "Signaling by Retinoic Acid"], ["TCGA.CK.5916.01", "Defective GALNT3 causes HFTC"], ["TCGA.CK.5916.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CK.5916.01", "Digestion and absorption"], ["TCGA.CK.5916.01", "Regulation of insulin secretion"], ["TCGA.CK.5916.01", "Keratan sulfate biosynthesis"], ["TCGA.CM.4743.01", "GPCR ligand binding"], ["TCGA.CM.4743.01", "Signaling by GPCR"], ["TCGA.CM.4743.01", "GPCR downstream signalling"], ["TCGA.CM.4743.01", "Neuronal System"], ["TCGA.CM.4743.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.4743.01", "Peptide ligand-binding receptors"], ["TCGA.CM.4743.01", "Drug ADME"], ["TCGA.CM.4743.01", "G alpha (i) signalling events"], ["TCGA.CM.4743.01", "Signaling Pathways"], ["TCGA.CM.4743.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.4743.01", "Extracellular matrix organization"], ["TCGA.CM.4743.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.4743.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CM.4743.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.4743.01", "Regulation of Complement cascade"], ["TCGA.CM.4743.01", "Cardiac conduction"], ["TCGA.CM.4743.01", "Biological oxidations"], ["TCGA.CM.4743.01", "Complement cascade"], ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.CM.4743.01", "Transmission across Chemical Synapses"], ["TCGA.CM.4743.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.4743.01", "NCAM1 interactions"], ["TCGA.CM.4743.01", "Muscle contraction"], ["TCGA.CM.4743.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts"], ["TCGA.CM.4743.01", "G alpha (s) signalling events"], ["TCGA.CM.4743.01", "Collagen chain trimerization"], ["TCGA.CM.4743.01", "Metabolism of fat-soluble vitamins"], ["TCGA.CM.4743.01", "Retinoid metabolism and transport"], ["TCGA.CM.4743.01", "Protein-protein interactions at synapses"], ["TCGA.CM.4743.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.4743.01", "Bile acid and bile salt metabolism"], ["TCGA.CM.4743.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.CM.4743.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CM.4743.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CM.4743.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.4743.01", "CD22 mediated BCR regulation"], ["TCGA.CM.4743.01", "Neurexins and neuroligins"], ["TCGA.CM.4743.01", "Regulation of signaling by NODAL"], ["TCGA.CM.4743.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.4743.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.CM.4743.01", "Developmental Biology"], ["TCGA.CM.4743.01", "L1CAM interactions"], ["TCGA.CM.4743.01", "Glycosaminoglycan metabolism"], ["TCGA.CM.4743.01", "Recycling of bile acids and salts"], ["TCGA.CM.4744.01", "Neuronal System"], ["TCGA.CM.4744.01", "Cardiac conduction"], ["TCGA.CM.4744.01", "Transmission across Chemical Synapses"], ["TCGA.CM.4744.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.4744.01", "Signaling by GPCR"], ["TCGA.CM.4744.01", "Muscle contraction"], ["TCGA.CM.4744.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.4744.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.4744.01", "GPCR downstream signalling"], ["TCGA.CM.4744.01", "G alpha (i) signalling events"], ["TCGA.CM.4744.01", "Developmental Biology"], ["TCGA.CM.4744.01", "L1CAM interactions"], ["TCGA.CM.4744.01", "Drug ADME"], ["TCGA.CM.4744.01", "Nervous system development"], ["TCGA.CM.4744.01", "Biological oxidations"], ["TCGA.CM.4744.01", "Extracellular matrix organization"], ["TCGA.CM.4744.01", "Potassium Channels"], ["TCGA.CM.4744.01", "Axon guidance"], ["TCGA.CM.4744.01", "DAG and IP3 signaling"], ["TCGA.CM.4744.01", "Signaling Pathways"], ["TCGA.CM.4744.01", "Protein-protein interactions at synapses"], ["TCGA.CM.4744.01", "Integration of energy metabolism"], ["TCGA.CM.4744.01", "G-protein mediated events"], ["TCGA.CM.4744.01", "Neurexins and neuroligins"], ["TCGA.CM.4744.01", "GABA receptor activation"], ["TCGA.CM.4744.01", "Complement cascade"], ["TCGA.CM.4744.01", "GABA B receptor activation"], ["TCGA.CM.4744.01", "Activation of GABAB receptors"], ["TCGA.CM.4744.01", "GPCR ligand binding"], ["TCGA.CM.4744.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CM.4744.01", "Ribavirin ADME"], ["TCGA.CM.4744.01", "Calmodulin induced events"], ["TCGA.CM.4744.01", "CaM pathway"], ["TCGA.CM.4744.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.CM.4744.01", "PLC beta mediated events"], ["TCGA.CM.4744.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.4744.01", "Ion homeostasis"], ["TCGA.CM.4744.01", "Regulation of insulin secretion"], ["TCGA.CM.4744.01", "Glucuronidation"], ["TCGA.CM.4744.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.4744.01", "Azathioprine ADME"], ["TCGA.CM.4744.01", "Ca-dependent events"], ["TCGA.CM.4744.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.4744.01", "Elastic fibre formation"], ["TCGA.CM.4744.01", "Molecules associated with elastic fibres"], ["TCGA.CM.4744.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.4744.01", "Leishmania parasite growth and survival"], ["TCGA.CM.4744.01", "G alpha (s) signalling events"], ["TCGA.CM.4744.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.4744.01", "Ion channel transport"], ["TCGA.CM.4744.01", "Regulation of Complement cascade"], ["TCGA.CM.4744.01", "Voltage gated Potassium channels"], ["TCGA.CM.4744.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.4744.01", "Viral mRNA Translation"], ["TCGA.CM.4744.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.4744.01", "Eukaryotic Translation Elongation"], ["TCGA.CM.4744.01", "G alpha (z) signalling events"], ["TCGA.CM.4744.01", "Peptide chain elongation"], ["TCGA.CM.4744.01", "Endogenous sterols"], ["TCGA.CM.4744.01", "LGI-ADAM interactions"], ["TCGA.CM.4744.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.4744.01", "Sialic acid metabolism"], ["TCGA.CM.4744.01", "Metabolism of vitamins and cofactors"], ["TCGA.CM.4744.01", "Selenoamino acid metabolism"], ["TCGA.CM.4744.01", "Platelet homeostasis"], ["TCGA.CM.4744.01", "PKA activation in glucagon signalling"], ["TCGA.CM.4744.01", "Selenocysteine synthesis"], ["TCGA.CM.4744.01", "Defective B3GALTL causes PpS"], ["TCGA.CM.4744.01", "Intrinsic Pathway of Fibrin Clot Formation"], ["TCGA.CM.4744.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.CM.4744.01", "Eukaryotic Translation Termination"], ["TCGA.CM.4744.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CM.4744.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.CM.4744.01", "Neurotransmitter release cycle"], ["TCGA.CM.4747.01", "Signaling by GPCR"], ["TCGA.CM.4747.01", "Neuronal System"], ["TCGA.CM.4747.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.4747.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.4747.01", "GPCR downstream signalling"], ["TCGA.CM.4747.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.4747.01", "Biological oxidations"], ["TCGA.CM.4747.01", "Signaling Pathways"], ["TCGA.CM.4747.01", "Glucuronidation"], ["TCGA.CM.4747.01", "GPCR ligand binding"], ["TCGA.CM.4747.01", "Leishmania infection"], ["TCGA.CM.4747.01", "Parasitic Infection Pathways"], ["TCGA.CM.4747.01", "G alpha (i) signalling events"], ["TCGA.CM.4747.01", "Transmission across Chemical Synapses"], ["TCGA.CM.4747.01", "Cardiac conduction"], ["TCGA.CM.4747.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.CM.4747.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.CM.4747.01", "G-protein beta:gamma signalling"], ["TCGA.CM.4747.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.4747.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CM.4747.01", "Interleukin-10 signaling"], ["TCGA.CM.4747.01", "Diseases of Immune System"], ["TCGA.CM.4747.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.CM.4747.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.4747.01", "Ethanol oxidation"], ["TCGA.CM.4747.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.4747.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CM.4747.01", "Regulation of TLR by endogenous ligand"], ["TCGA.CM.4747.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.4747.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.4747.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.4747.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.CM.4747.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.4747.01", "Leishmania parasite growth and survival"], ["TCGA.CM.4747.01", "Potassium Channels"], ["TCGA.CM.4747.01", "Heme degradation"], ["TCGA.CM.4747.01", "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"], ["TCGA.CM.4747.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CM.4747.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.CM.4747.01", "Arachidonic acid metabolism"], ["TCGA.CM.4747.01", "Peptide hormone metabolism"], ["TCGA.CM.4747.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.4747.01", "Extracellular matrix organization"], ["TCGA.CM.4747.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.4747.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.4747.01", "G alpha (s) signalling events"], ["TCGA.CM.4747.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.4747.01", "Physiological factors"], ["TCGA.CM.4747.01", "GABA receptor activation"], ["TCGA.CM.4747.01", "Signaling by Erythropoietin"], ["TCGA.CM.4747.01", "Peptide ligand-binding receptors"], ["TCGA.CM.4747.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.4747.01", "Drug ADME"], ["TCGA.CM.4747.01", "G beta:gamma signalling through CDC42"], ["TCGA.CM.4747.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.4747.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CM.4747.01", "GABA B receptor activation"], ["TCGA.CM.4747.01", "Activation of GABAB receptors"], ["TCGA.CM.4747.01", "IRS-related events triggered by IGF1R"], ["TCGA.CM.4747.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.4747.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.4747.01", "G protein gated Potassium channels"], ["TCGA.CM.4747.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.4747.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.4747.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.CM.4747.01", "IGF1R signaling cascade"], ["TCGA.CM.4747.01", "Regulation of insulin secretion"], ["TCGA.CM.4748.01", "Neuronal System"], ["TCGA.CM.4748.01", "Peptide hormone biosynthesis"], ["TCGA.CM.4748.01", "Potassium Channels"], ["TCGA.CM.4748.01", "Biological oxidations"], ["TCGA.CM.4748.01", "Cardiac conduction"], ["TCGA.CM.4748.01", "Transmission across Chemical Synapses"], ["TCGA.CM.4748.01", "Keratinization"], ["TCGA.CM.4748.01", "Muscle contraction"], ["TCGA.CM.4748.01", "Phase I - Functionalization of compounds"], ["TCGA.CM.4748.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.4748.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.4750.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.4750.01", "Cardiac conduction"], ["TCGA.CM.4750.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.4750.01", "Regulation of insulin secretion"], ["TCGA.CM.4750.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.CM.4750.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.CM.4750.01", "Transmission across Chemical Synapses"], ["TCGA.CM.4750.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.CM.4750.01", "GABA receptor activation"], ["TCGA.CM.4750.01", "G alpha (s) signalling events"], ["TCGA.CM.4750.01", "Neuronal System"], ["TCGA.CM.4750.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.4750.01", "Platelet homeostasis"], ["TCGA.CM.4750.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.4750.01", "Opioid Signalling"], ["TCGA.CM.4750.01", "GPCR downstream signalling"], ["TCGA.CM.4750.01", "Diseases of Immune System"], ["TCGA.CM.4750.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.CM.4750.01", "Signaling by GPCR"], ["TCGA.CM.4750.01", "GABA B receptor activation"], ["TCGA.CM.4750.01", "Activation of GABAB receptors"], ["TCGA.CM.4750.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.4750.01", "Potassium Channels"], ["TCGA.CM.4750.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.4750.01", "Dermatan sulfate biosynthesis"], ["TCGA.CM.4750.01", "Insulin processing"], ["TCGA.CM.4750.01", "Nucleotide catabolism"], ["TCGA.CM.4750.01", "Peptide hormone metabolism"], ["TCGA.CM.4750.01", "G-protein mediated events"], ["TCGA.CM.4750.01", "Regulation of TLR by endogenous ligand"], ["TCGA.CM.4750.01", "G alpha (i) signalling events"], ["TCGA.CM.4750.01", "Integration of energy metabolism"], ["TCGA.CM.4750.01", "Ribavirin ADME"], ["TCGA.CM.4752.01", "G alpha (s) signalling events"], ["TCGA.CM.4752.01", "Transmission across Chemical Synapses"], ["TCGA.CM.4752.01", "Neuronal System"], ["TCGA.CM.4752.01", "Biological oxidations"], ["TCGA.CM.4752.01", "GABA receptor activation"], ["TCGA.CM.4752.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.4752.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.4752.01", "Signal amplification"], ["TCGA.CM.4752.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CM.4752.01", "GPER1 signaling"], ["TCGA.CM.4752.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.CM.4752.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.4752.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.4752.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.4752.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.4752.01", "Integration of energy metabolism"], ["TCGA.CM.4752.01", "Ethanol oxidation"], ["TCGA.CM.4752.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CM.4752.01", "Regulation of insulin secretion"], ["TCGA.CM.4752.01", "Signaling by GPCR"], ["TCGA.CM.4752.01", "GPCR downstream signalling"], ["TCGA.CM.4752.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.4752.01", "Platelet homeostasis"], ["TCGA.CM.4752.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.CM.4752.01", "Aquaporin-mediated transport"], ["TCGA.CM.4752.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.4752.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.4752.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.4752.01", "G beta:gamma signalling through CDC42"], ["TCGA.CM.4752.01", "Extracellular matrix organization"], ["TCGA.CM.4752.01", "Nervous system development"], ["TCGA.CM.4752.01", "Axon guidance"], ["TCGA.CM.4752.01", "G-protein beta:gamma signalling"], ["TCGA.CM.4752.01", "L1CAM interactions"], ["TCGA.CM.4752.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.4752.01", "Phase I - Functionalization of compounds"], ["TCGA.CM.4752.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.4752.01", "GPCR ligand binding"], ["TCGA.CM.4752.01", "G-protein activation"], ["TCGA.CM.4752.01", "Thromboxane signalling through TP receptor"], ["TCGA.CM.4752.01", "GABA B receptor activation"], ["TCGA.CM.4752.01", "Activation of GABAB receptors"], ["TCGA.CM.4752.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.4752.01", "Glucagon-type ligand receptors"], ["TCGA.CM.4752.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.4752.01", "Leishmania parasite growth and survival"], ["TCGA.CM.4752.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.4752.01", "Opioid Signalling"], ["TCGA.CM.4752.01", "Neurotransmitter release cycle"], ["TCGA.CM.4752.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.CM.4752.01", "Peptide hormone metabolism"], ["TCGA.CM.4752.01", "Developmental Biology"], ["TCGA.CM.4752.01", "G alpha (z) signalling events"], ["TCGA.CM.4752.01", "Heme degradation"], ["TCGA.CM.4752.01", "Signaling Pathways"], ["TCGA.CM.4752.01", "Collagen formation"], ["TCGA.CM.4752.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.4752.01", "G protein gated Potassium channels"], ["TCGA.CM.4752.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.4752.01", "G alpha (i) signalling events"], ["TCGA.CM.4752.01", "Potassium Channels"], ["TCGA.CM.5341.01", "Induction of Cell-Cell Fusion"], ["TCGA.CM.5341.01", "Eukaryotic Translation Elongation"], ["TCGA.CM.5341.01", "Peptide chain elongation"], ["TCGA.CM.5341.01", "Viral mRNA Translation"], ["TCGA.CM.5341.01", "Eukaryotic Translation Termination"], ["TCGA.CM.5341.01", "Selenoamino acid metabolism"], ["TCGA.CM.5341.01", "Selenocysteine synthesis"], ["TCGA.CM.5341.01", "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"], ["TCGA.CM.5341.01", "Response of EIF2AK4 (GCN2) to amino acid deficiency"], ["TCGA.CM.5341.01", "Formation of a pool of free 40S subunits"], ["TCGA.CM.5341.01", "L13a-mediated translational silencing of Ceruloplasmin expression"], ["TCGA.CM.5341.01", "GTP hydrolysis and joining of the 60S ribosomal subunit"], ["TCGA.CM.5341.01", "SRP-dependent cotranslational protein targeting to membrane"], ["TCGA.CM.5341.01", "Nonsense-Mediated Decay (NMD)"], ["TCGA.CM.5341.01", "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"], ["TCGA.CM.5341.01", "Eukaryotic Translation Initiation"], ["TCGA.CM.5341.01", "Cap-dependent Translation Initiation"], ["TCGA.CM.5341.01", "Cellular response to starvation"], ["TCGA.CM.5341.01", "Influenza Viral RNA Transcription and Replication"], ["TCGA.CM.5341.01", "Regulation of expression of SLITs and ROBOs"], ["TCGA.CM.5341.01", "Influenza Infection"], ["TCGA.CM.5341.01", "Signaling by ROBO receptors"], ["TCGA.CM.5341.01", "Major pathway of rRNA processing in the nucleolus and cytosol"], ["TCGA.CM.5341.01", "rRNA processing in the nucleus and cytosol"], ["TCGA.CM.5341.01", "rRNA processing"], ["TCGA.CM.5341.01", "Translation"], ["TCGA.CM.5341.01", "Axon guidance"], ["TCGA.CM.5341.01", "Developmental Biology"], ["TCGA.CM.5341.01", "Nervous system development"], ["TCGA.CM.5341.01", "Amino acid and derivative metabolism"], ["TCGA.CM.5341.01", "SARS-CoV-1 modulates host translation machinery"], ["TCGA.CM.5341.01", "SARS-CoV-2 modulates host translation machinery"], ["TCGA.CM.5341.01", "Formation of the ternary complex, and subsequently, the 43S complex"], ["TCGA.CM.5341.01", "Ribosomal scanning and start codon recognition"], ["TCGA.CM.5341.01", "Translation initiation complex formation"], ["TCGA.CM.5341.01", "Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S"], ["TCGA.CM.5341.01", "Cellular responses to stress"], ["TCGA.CM.5341.01", "Cellular responses to stimuli"], ["TCGA.CM.5341.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5341.01", "Metabolism"], ["TCGA.CM.5341.01", "SARS-CoV-1-host interactions"], ["TCGA.CM.5341.01", "SARS-CoV-1 Infection"], ["TCGA.CM.5341.01", "Biological oxidations"], ["TCGA.CM.5341.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5341.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.CM.5341.01", "Regulation of gene expression by Hypoxia-inducible Factor"], ["TCGA.CM.5341.01", "Viral Infection Pathways"], ["TCGA.CM.5341.01", "Cardiac conduction"], ["TCGA.CM.5341.01", "Signaling by Retinoic Acid"], ["TCGA.CM.5341.01", "Degradation of the extracellular matrix"], ["TCGA.CM.5341.01", "Infectious disease"], ["TCGA.CM.5341.01", "Extracellular matrix organization"], ["TCGA.CM.5341.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.5341.01", "Metabolism of RNA"], ["TCGA.CM.5341.01", "Phase I - Functionalization of compounds"], ["TCGA.CM.5341.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5341.01", "TNFs bind their physiological receptors"], ["TCGA.CM.5341.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CM.5341.01", "Recycling of bile acids and salts"], ["TCGA.CM.5341.01", "G alpha (z) signalling events"], ["TCGA.CM.5341.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.5341.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.CM.5341.01", "L1CAM interactions"], ["TCGA.CM.5344.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.5344.01", "Extracellular matrix organization"], ["TCGA.CM.5344.01", "Signaling by GPCR"], ["TCGA.CM.5344.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5344.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CM.5344.01", "GPCR downstream signalling"], ["TCGA.CM.5344.01", "Collagen formation"], ["TCGA.CM.5344.01", "Collagen chain trimerization"], ["TCGA.CM.5344.01", "Generation of second messenger molecules"], ["TCGA.CM.5344.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.CM.5344.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.5344.01", "Biological oxidations"], ["TCGA.CM.5344.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5344.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5344.01", "Signaling Pathways"], ["TCGA.CM.5344.01", "G alpha (i) signalling events"], ["TCGA.CM.5344.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.5344.01", "PD-1 signaling"], ["TCGA.CM.5344.01", "GPCR ligand binding"], ["TCGA.CM.5344.01", "Synaptic adhesion-like molecules"], ["TCGA.CM.5344.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5344.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.5344.01", "Leishmania parasite growth and survival"], ["TCGA.CM.5344.01", "Glucuronidation"], ["TCGA.CM.5344.01", "WNT ligand biogenesis and trafficking"], ["TCGA.CM.5344.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.5344.01", "G alpha (s) signalling events"], ["TCGA.CM.5344.01", "Ethanol oxidation"], ["TCGA.CM.5344.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.5344.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.5344.01", "Leishmania infection"], ["TCGA.CM.5344.01", "Parasitic Infection Pathways"], ["TCGA.CM.5344.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.5344.01", "G alpha (q) signalling events"], ["TCGA.CM.5344.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5344.01", "TNFs bind their physiological receptors"], ["TCGA.CM.5344.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.5344.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.CM.5344.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.5344.01", "Immune System"], ["TCGA.CM.5344.01", "Peptide ligand-binding receptors"], ["TCGA.CM.5344.01", "Nuclear signaling by ERBB4"], ["TCGA.CM.5344.01", "Signal amplification"], ["TCGA.CM.5344.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CM.5344.01", "Degradation of the extracellular matrix"], ["TCGA.CM.5344.01", "L1CAM interactions"], ["TCGA.CM.5344.01", "Costimulation by the CD28 family"], ["TCGA.CM.5344.01", "Neuronal System"], ["TCGA.CM.5344.01", "Nucleotide catabolism"], ["TCGA.CM.5344.01", "Cardiac conduction"], ["TCGA.CM.5344.01", "Peptide hormone metabolism"], ["TCGA.CM.5344.01", "Long-term potentiation"], ["TCGA.CM.5344.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.CM.5348.01", "Extracellular matrix organization"], ["TCGA.CM.5348.01", "Collagen formation"], ["TCGA.CM.5348.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5348.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5348.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.5348.01", "Glucuronidation"], ["TCGA.CM.5348.01", "Biological oxidations"], ["TCGA.CM.5348.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5348.01", "GPCR ligand binding"], ["TCGA.CM.5348.01", "Collagen chain trimerization"], ["TCGA.CM.5348.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5348.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.5348.01", "Drug ADME"], ["TCGA.CM.5348.01", "Peptide ligand-binding receptors"], ["TCGA.CM.5348.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CM.5348.01", "Neuronal System"], ["TCGA.CM.5348.01", "Degradation of the extracellular matrix"], ["TCGA.CM.5348.01", "APAP ADME"], ["TCGA.CM.5348.01", "LGI-ADAM interactions"], ["TCGA.CM.5348.01", "Potassium Channels"], ["TCGA.CM.5348.01", "Signaling by GPCR"], ["TCGA.CM.5348.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.CM.5348.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.CM.5348.01", "Integrin cell surface interactions"], ["TCGA.CM.5348.01", "Apoptotic cleavage of cell adhesion  proteins"], ["TCGA.CM.5349.01", "Extracellular matrix organization"], ["TCGA.CM.5349.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5349.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.5349.01", "Degradation of the extracellular matrix"], ["TCGA.CM.5349.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.5349.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.5349.01", "Collagen formation"], ["TCGA.CM.5349.01", "Signaling by GPCR"], ["TCGA.CM.5349.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5349.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5349.01", "Collagen degradation"], ["TCGA.CM.5349.01", "Peptide ligand-binding receptors"], ["TCGA.CM.5349.01", "GPCR ligand binding"], ["TCGA.CM.5349.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.5349.01", "GPCR downstream signalling"], ["TCGA.CM.5349.01", "Glucuronidation"], ["TCGA.CM.5349.01", "Drug ADME"], ["TCGA.CM.5349.01", "Glycosaminoglycan metabolism"], ["TCGA.CM.5349.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.CM.5349.01", "Metabolism of fat-soluble vitamins"], ["TCGA.CM.5349.01", "Retinoid metabolism and transport"], ["TCGA.CM.5349.01", "Biological oxidations"], ["TCGA.CM.5349.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.5349.01", "Visual phototransduction"], ["TCGA.CM.5349.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5349.01", "Regulation of TLR by endogenous ligand"], ["TCGA.CM.5349.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.5860.01", "Extracellular matrix organization"], ["TCGA.CM.5860.01", "Neuronal System"], ["TCGA.CM.5860.01", "Collagen formation"], ["TCGA.CM.5860.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5860.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.5860.01", "Collagen chain trimerization"], ["TCGA.CM.5860.01", "Biological oxidations"], ["TCGA.CM.5860.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5860.01", "Drug ADME"], ["TCGA.CM.5860.01", "GPCR downstream signalling"], ["TCGA.CM.5860.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5860.01", "Transmission across Chemical Synapses"], ["TCGA.CM.5860.01", "Degradation of the extracellular matrix"], ["TCGA.CM.5860.01", "Potassium Channels"], ["TCGA.CM.5860.01", "Signaling by GPCR"], ["TCGA.CM.5860.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5860.01", "NCAM1 interactions"], ["TCGA.CM.5860.01", "APAP ADME"], ["TCGA.CM.5860.01", "Cardiac conduction"], ["TCGA.CM.5860.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.5860.01", "Integrin cell surface interactions"], ["TCGA.CM.5860.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.5860.01", "ECM proteoglycans"], ["TCGA.CM.5860.01", "Synaptic adhesion-like molecules"], ["TCGA.CM.5860.01", "Protein-protein interactions at synapses"], ["TCGA.CM.5860.01", "Voltage gated Potassium channels"], ["TCGA.CM.5860.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CM.5860.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.5860.01", "Neurexins and neuroligins"], ["TCGA.CM.5860.01", "GPCR ligand binding"], ["TCGA.CM.5860.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.CM.5860.01", "G alpha (i) signalling events"], ["TCGA.CM.5860.01", "Phase I - Functionalization of compounds"], ["TCGA.CM.5860.01", "Defective B3GALTL causes PpS"], ["TCGA.CM.5860.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5860.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5860.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CM.5860.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.CM.5860.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.CM.5860.01", "Peptide hormone metabolism"], ["TCGA.CM.5860.01", "G alpha (s) signalling events"], ["TCGA.CM.5860.01", "Collagen degradation"], ["TCGA.CM.5860.01", "Heme degradation"], ["TCGA.CM.5860.01", "Response to elevated platelet cytosolic Ca2+"], ["TCGA.CM.5860.01", "Formation of axial mesoderm"], ["TCGA.CM.5860.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.5860.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.CM.5860.01", "NCAM signaling for neurite out-growth"], ["TCGA.CM.5860.01", "Glucagon-type ligand receptors"], ["TCGA.CM.5860.01", "Platelet activation, signaling and aggregation"], ["TCGA.CM.5860.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CM.5860.01", "Peptide hormone biosynthesis"], ["TCGA.CM.5860.01", "Diseases of glycosylation"], ["TCGA.CM.5860.01", "Peptide ligand-binding receptors"], ["TCGA.CM.5860.01", "Complement cascade"], ["TCGA.CM.5860.01", "Sensory processing of sound"], ["TCGA.CM.5860.01", "Trafficking of AMPA receptors"], ["TCGA.CM.5860.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.CM.5860.01", "Regulation of insulin secretion"], ["TCGA.CM.5860.01", "Integration of energy metabolism"], ["TCGA.CM.5860.01", "Long-term potentiation"], ["TCGA.CM.5860.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.5860.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.5860.01", "Ca2+ pathway"], ["TCGA.CM.5860.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.CM.5860.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.CM.5860.01", "Signaling Pathways"], ["TCGA.CM.5860.01", "TNFs bind their physiological receptors"], ["TCGA.CM.5861.01", "Signaling by GPCR"], ["TCGA.CM.5861.01", "GPCR downstream signalling"], ["TCGA.CM.5861.01", "Extracellular matrix organization"], ["TCGA.CM.5861.01", "Neuronal System"], ["TCGA.CM.5861.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.5861.01", "G alpha (i) signalling events"], ["TCGA.CM.5861.01", "GPCR ligand binding"], ["TCGA.CM.5861.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.5861.01", "Signaling Pathways"], ["TCGA.CM.5861.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.5861.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5861.01", "Peptide ligand-binding receptors"], ["TCGA.CM.5861.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5861.01", "Transmission across Chemical Synapses"], ["TCGA.CM.5861.01", "L1CAM interactions"], ["TCGA.CM.5861.01", "RA biosynthesis pathway"], ["TCGA.CM.5861.01", "Leishmania infection"], ["TCGA.CM.5861.01", "Parasitic Infection Pathways"], ["TCGA.CM.5861.01", "Generation of second messenger molecules"], ["TCGA.CM.5861.01", "Drug ADME"], ["TCGA.CM.5861.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.5861.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CM.5861.01", "Biological oxidations"], ["TCGA.CM.5861.01", "Integrin cell surface interactions"], ["TCGA.CM.5861.01", "SUMOylation of intracellular receptors"], ["TCGA.CM.5861.01", "Glucuronidation"], ["TCGA.CM.5861.01", "G alpha (q) signalling events"], ["TCGA.CM.5861.01", "G alpha (s) signalling events"], ["TCGA.CM.5861.01", "NCAM1 interactions"], ["TCGA.CM.5861.01", "Protein-protein interactions at synapses"], ["TCGA.CM.5861.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.5861.01", "Leishmania parasite growth and survival"], ["TCGA.CM.5861.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CM.5861.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.5861.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.5861.01", "Digestion"], ["TCGA.CM.5861.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CM.5861.01", "Cardiac conduction"], ["TCGA.CM.5861.01", "Complement cascade"], ["TCGA.CM.5861.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.CM.5861.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.CM.5861.01", "Degradation of the extracellular matrix"], ["TCGA.CM.5861.01", "Nuclear Receptor transcription pathway"], ["TCGA.CM.5861.01", "Ethanol oxidation"], ["TCGA.CM.5861.01", "Signaling by Retinoic Acid"], ["TCGA.CM.5861.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.CM.5861.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CM.5861.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.5861.01", "Aspirin ADME"], ["TCGA.CM.5861.01", "Neurexins and neuroligins"], ["TCGA.CM.5861.01", "Regulation of insulin secretion"], ["TCGA.CM.5861.01", "Initial triggering of complement"], ["TCGA.CM.5861.01", "Sensory processing of sound"], ["TCGA.CM.5861.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.5861.01", "CD22 mediated BCR regulation"], ["TCGA.CM.5861.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.5861.01", "Immune System"], ["TCGA.CM.5861.01", "Long-term potentiation"], ["TCGA.CM.5861.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.CM.5861.01", "Digestion and absorption"], ["TCGA.CM.5861.01", "Phase I - Functionalization of compounds"], ["TCGA.CM.5861.01", "FCERI mediated Ca+2 mobilization"], ["TCGA.CM.5861.01", "Integration of energy metabolism"], ["TCGA.CM.5861.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.CM.5861.01", "Stimuli-sensing channels"], ["TCGA.CM.5861.01", "Trafficking of AMPA receptors"], ["TCGA.CM.5861.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.CM.5861.01", "Diseases of Immune System"], ["TCGA.CM.5861.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.CM.5861.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5861.01", "Activation of the phototransduction cascade"], ["TCGA.CM.5861.01", "Synaptic adhesion-like molecules"], ["TCGA.CM.5861.01", "Creation of C4 and C2 activators"], ["TCGA.CM.5861.01", "Nicotinate metabolism"], ["TCGA.CM.5861.01", "Cell surface interactions at the vascular wall"], ["TCGA.CM.5861.01", "Innate Immune System"], ["TCGA.CM.5861.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.5861.01", "Collagen chain trimerization"], ["TCGA.CM.5861.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.5861.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.5861.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CM.5861.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CM.5861.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5861.01", "ECM proteoglycans"], ["TCGA.CM.5861.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.CM.5861.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.5861.01", "MET activates PTK2 signaling"], ["TCGA.CM.5861.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.CM.5861.01", "Regulation of Complement cascade"], ["TCGA.CM.5861.01", "NCAM signaling for neurite out-growth"], ["TCGA.CM.5861.01", "G alpha (z) signalling events"], ["TCGA.CM.5861.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5861.01", "Non-integrin membrane-ECM interactions"], ["TCGA.CM.5861.01", "Interleukin-10 signaling"], ["TCGA.CM.5862.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.CM.5862.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CM.5862.01", "Generation of second messenger molecules"], ["TCGA.CM.5862.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.5862.01", "PD-1 signaling"], ["TCGA.CM.5862.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.5862.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5862.01", "GPCR downstream signalling"], ["TCGA.CM.5862.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5862.01", "Complement cascade"], ["TCGA.CM.5862.01", "Signaling by GPCR"], ["TCGA.CM.5862.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.5862.01", "Regulation of Complement cascade"], ["TCGA.CM.5862.01", "APAP ADME"], ["TCGA.CM.5862.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5862.01", "Biological oxidations"], ["TCGA.CM.5862.01", "Immune System"], ["TCGA.CM.5862.01", "RA biosynthesis pathway"], ["TCGA.CM.5862.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5862.01", "Neuronal System"], ["TCGA.CM.5862.01", "Costimulation by the CD28 family"], ["TCGA.CM.5862.01", "G alpha (i) signalling events"], ["TCGA.CM.5862.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.5862.01", "Drug ADME"], ["TCGA.CM.5862.01", "Extracellular matrix organization"], ["TCGA.CM.5862.01", "Peptide ligand-binding receptors"], ["TCGA.CM.5862.01", "Synaptic adhesion-like molecules"], ["TCGA.CM.5862.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.5862.01", "Cardiac conduction"], ["TCGA.CM.5862.01", "O-linked glycosylation of mucins"], ["TCGA.CM.5862.01", "Termination of O-glycan biosynthesis"], ["TCGA.CM.5862.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5862.01", "Degradation of the extracellular matrix"], ["TCGA.CM.5862.01", "Signaling Pathways"], ["TCGA.CM.5862.01", "Potassium Channels"], ["TCGA.CM.5862.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CM.5862.01", "Initial triggering of complement"], ["TCGA.CM.5862.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.5862.01", "CD22 mediated BCR regulation"], ["TCGA.CM.5862.01", "GPCR ligand binding"], ["TCGA.CM.5862.01", "O-linked glycosylation"], ["TCGA.CM.5863.01", "Extracellular matrix organization"], ["TCGA.CM.5863.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5863.01", "Collagen formation"], ["TCGA.CM.5863.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.5863.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5863.01", "GPCR ligand binding"], ["TCGA.CM.5863.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5863.01", "Degradation of the extracellular matrix"], ["TCGA.CM.5863.01", "Signaling by GPCR"], ["TCGA.CM.5863.01", "LGI-ADAM interactions"], ["TCGA.CM.5863.01", "Peptide ligand-binding receptors"], ["TCGA.CM.5863.01", "Collagen chain trimerization"], ["TCGA.CM.5863.01", "Basigin interactions"], ["TCGA.CM.5863.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.5863.01", "GPCR downstream signalling"], ["TCGA.CM.5863.01", "Drug ADME"], ["TCGA.CM.5863.01", "Response to elevated platelet cytosolic Ca2+"], ["TCGA.CM.5863.01", "Aspirin ADME"], ["TCGA.CM.5863.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5863.01", "Biological oxidations"], ["TCGA.CM.5863.01", "Peptide hormone biosynthesis"], ["TCGA.CM.5863.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.5864.01", "Neuronal System"], ["TCGA.CM.5864.01", "Transmission across Chemical Synapses"], ["TCGA.CM.5864.01", "Signaling by GPCR"], ["TCGA.CM.5864.01", "GPCR downstream signalling"], ["TCGA.CM.5864.01", "Signaling Pathways"], ["TCGA.CM.5864.01", "Potassium Channels"], ["TCGA.CM.5864.01", "Cardiac conduction"], ["TCGA.CM.5864.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.5864.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5864.01", "G alpha (s) signalling events"], ["TCGA.CM.5864.01", "G-protein beta:gamma signalling"], ["TCGA.CM.5864.01", "Ca2+ pathway"], ["TCGA.CM.5864.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.5864.01", "Glucagon-type ligand receptors"], ["TCGA.CM.5864.01", "Sensory processing of sound"], ["TCGA.CM.5864.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.5864.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.5864.01", "Peptide hormone metabolism"], ["TCGA.CM.5864.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.CM.5864.01", "Extracellular matrix organization"], ["TCGA.CM.5864.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5864.01", "Heme degradation"], ["TCGA.CM.5864.01", "GABA receptor activation"], ["TCGA.CM.5864.01", "GABA B receptor activation"], ["TCGA.CM.5864.01", "Activation of GABAB receptors"], ["TCGA.CM.5864.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.5864.01", "NCAM1 interactions"], ["TCGA.CM.5864.01", "GPCR ligand binding"], ["TCGA.CM.5864.01", "Regulation of insulin secretion"], ["TCGA.CM.5864.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.5864.01", "Biological oxidations"], ["TCGA.CM.5864.01", "Integration of energy metabolism"], ["TCGA.CM.5864.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.5864.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.5864.01", "G protein gated Potassium channels"], ["TCGA.CM.5864.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.5864.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.5864.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.5864.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CM.5864.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.5864.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.5864.01", "G alpha (q) signalling events"], ["TCGA.CM.5864.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.5864.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.5864.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.5864.01", "G beta:gamma signalling through CDC42"], ["TCGA.CM.5864.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.5864.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.5864.01", "Muscle contraction"], ["TCGA.CM.5864.01", "Lewis blood group biosynthesis"], ["TCGA.CM.5864.01", "Platelet homeostasis"], ["TCGA.CM.5864.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5868.01", "Signaling by GPCR"], ["TCGA.CM.5868.01", "GPCR downstream signalling"], ["TCGA.CM.5868.01", "G alpha (i) signalling events"], ["TCGA.CM.5868.01", "Signaling Pathways"], ["TCGA.CM.5868.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.5868.01", "Neuronal System"], ["TCGA.CM.5868.01", "GPCR ligand binding"], ["TCGA.CM.5868.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.5868.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.5868.01", "Peptide ligand-binding receptors"], ["TCGA.CM.5868.01", "Transmission across Chemical Synapses"], ["TCGA.CM.5868.01", "Extracellular matrix organization"], ["TCGA.CM.5868.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.5868.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CM.5868.01", "G alpha (q) signalling events"], ["TCGA.CM.5868.01", "Generation of second messenger molecules"], ["TCGA.CM.5868.01", "Signal amplification"], ["TCGA.CM.5868.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.5868.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.CM.5868.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.5868.01", "GABA receptor activation"], ["TCGA.CM.5868.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.5868.01", "G alpha (s) signalling events"], ["TCGA.CM.5868.01", "PD-1 signaling"], ["TCGA.CM.5868.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.5868.01", "Visual phototransduction"], ["TCGA.CM.5868.01", "Cardiac conduction"], ["TCGA.CM.5868.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.5868.01", "Leishmania parasite growth and survival"], ["TCGA.CM.5868.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.5868.01", "L1CAM interactions"], ["TCGA.CM.5868.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.5868.01", "Potassium Channels"], ["TCGA.CM.5868.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CM.5868.01", "Collagen chain trimerization"], ["TCGA.CM.5868.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.5868.01", "GABA B receptor activation"], ["TCGA.CM.5868.01", "Activation of GABAB receptors"], ["TCGA.CM.5868.01", "Platelet homeostasis"], ["TCGA.CM.5868.01", "G-protein beta:gamma signalling"], ["TCGA.CM.5868.01", "NCAM1 interactions"], ["TCGA.CM.5868.01", "Activation of the phototransduction cascade"], ["TCGA.CM.5868.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.5868.01", "Peptide hormone metabolism"], ["TCGA.CM.5868.01", "Glucagon-type ligand receptors"], ["TCGA.CM.5868.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.5868.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.5868.01", "Trafficking of AMPA receptors"], ["TCGA.CM.5868.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.CM.5868.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CM.5868.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.5868.01", "Opioid Signalling"], ["TCGA.CM.5868.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.5868.01", "G protein gated Potassium channels"], ["TCGA.CM.5868.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.5868.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.5868.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.5868.01", "Blood group systems biosynthesis"], ["TCGA.CM.5868.01", "Scavenging of heme from plasma"], ["TCGA.CM.5868.01", "ECM proteoglycans"], ["TCGA.CM.5868.01", "TNFs bind their physiological receptors"], ["TCGA.CM.5868.01", "Cell surface interactions at the vascular wall"], ["TCGA.CM.5868.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.5868.01", "RA biosynthesis pathway"], ["TCGA.CM.5868.01", "G-protein activation"], ["TCGA.CM.5868.01", "Thromboxane signalling through TP receptor"], ["TCGA.CM.5868.01", "G alpha (z) signalling events"], ["TCGA.CM.5868.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.5868.01", "Regulation of insulin secretion"], ["TCGA.CM.5868.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.5868.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.5868.01", "Platelet activation, signaling and aggregation"], ["TCGA.CM.5868.01", "Binding and entry of HIV virion"], ["TCGA.CM.5868.01", "Sensory perception of taste"], ["TCGA.CM.5868.01", "Neurexins and neuroligins"], ["TCGA.CM.5868.01", "Collagen formation"], ["TCGA.CM.5868.01", "LGI-ADAM interactions"], ["TCGA.CM.5868.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.5868.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.5868.01", "G beta:gamma signalling through CDC42"], ["TCGA.CM.5868.01", "Integrin cell surface interactions"], ["TCGA.CM.5868.01", "NCAM signaling for neurite out-growth"], ["TCGA.CM.5868.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.5868.01", "Diseases of Immune System"], ["TCGA.CM.5868.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.CM.5868.01", "Costimulation by the CD28 family"], ["TCGA.CM.5868.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.5868.01", "Drug ADME"], ["TCGA.CM.5868.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.CM.5868.01", "Long-term potentiation"], ["TCGA.CM.5868.01", "Protein-protein interactions at synapses"], ["TCGA.CM.5868.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CM.5868.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.CM.5868.01", "Inactivation, recovery and regulation of the phototransduction cascade"], ["TCGA.CM.5868.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.6161.01", "Neuronal System"], ["TCGA.CM.6161.01", "Lewis blood group biosynthesis"], ["TCGA.CM.6161.01", "Blood group systems biosynthesis"], ["TCGA.CM.6161.01", "Metabolism"], ["TCGA.CM.6161.01", "Glucuronidation"], ["TCGA.CM.6161.01", "Biological oxidations"], ["TCGA.CM.6161.01", "Drug ADME"], ["TCGA.CM.6161.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6161.01", "G alpha (s) signalling events"], ["TCGA.CM.6161.01", "GPCR ligand binding"], ["TCGA.CM.6161.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6161.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6161.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6161.01", "Sialic acid metabolism"], ["TCGA.CM.6161.01", "Formation of axial mesoderm"], ["TCGA.CM.6161.01", "RA biosynthesis pathway"], ["TCGA.CM.6161.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CM.6161.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6161.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CM.6161.01", "Termination of O-glycan biosynthesis"], ["TCGA.CM.6161.01", "Potassium Channels"], ["TCGA.CM.6161.01", "Signaling by GPCR"], ["TCGA.CM.6161.01", "Cardiac conduction"], ["TCGA.CM.6161.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6161.01", "Aspirin ADME"], ["TCGA.CM.6162.01", "Extracellular matrix organization"], ["TCGA.CM.6162.01", "Collagen formation"], ["TCGA.CM.6162.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6162.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.6162.01", "Collagen chain trimerization"], ["TCGA.CM.6162.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6162.01", "Degradation of the extracellular matrix"], ["TCGA.CM.6162.01", "GPCR ligand binding"], ["TCGA.CM.6162.01", "Drug ADME"], ["TCGA.CM.6162.01", "Collagen degradation"], ["TCGA.CM.6162.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6162.01", "Integrin cell surface interactions"], ["TCGA.CM.6162.01", "Scavenging by Class A Receptors"], ["TCGA.CM.6162.01", "Signaling by GPCR"], ["TCGA.CM.6162.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6162.01", "Antimicrobial peptides"], ["TCGA.CM.6162.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CM.6162.01", "Metabolism"], ["TCGA.CM.6162.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6162.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.6162.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6162.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.CM.6162.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.6162.01", "ECM proteoglycans"], ["TCGA.CM.6162.01", "Glucuronidation"], ["TCGA.CM.6162.01", "Chondroitin sulfate biosynthesis"], ["TCGA.CM.6162.01", "Defensins"], ["TCGA.CM.6162.01", "G alpha (i) signalling events"], ["TCGA.CM.6162.01", "Biological oxidations"], ["TCGA.CM.6162.01", "SLC-mediated transmembrane transport"], ["TCGA.CM.6162.01", "GPCR downstream signalling"], ["TCGA.CM.6162.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6162.01", "Elastic fibre formation"], ["TCGA.CM.6163.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6163.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6163.01", "Ethanol oxidation"], ["TCGA.CM.6163.01", "Neuronal System"], ["TCGA.CM.6163.01", "GPCR ligand binding"], ["TCGA.CM.6163.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6163.01", "Extracellular matrix organization"], ["TCGA.CM.6163.01", "Signaling by GPCR"], ["TCGA.CM.6163.01", "Potassium Channels"], ["TCGA.CM.6163.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.6163.01", "Signaling Pathways"], ["TCGA.CM.6163.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.CM.6163.01", "GPCR downstream signalling"], ["TCGA.CM.6163.01", "Collagen chain trimerization"], ["TCGA.CM.6163.01", "Cardiac conduction"], ["TCGA.CM.6163.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.6163.01", "Collagen formation"], ["TCGA.CM.6164.01", "Biological oxidations"], ["TCGA.CM.6164.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6164.01", "Signaling by GPCR"], ["TCGA.CM.6164.01", "GPCR downstream signalling"], ["TCGA.CM.6164.01", "Neuronal System"], ["TCGA.CM.6164.01", "G alpha (i) signalling events"], ["TCGA.CM.6164.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.6164.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6164.01", "Extracellular matrix organization"], ["TCGA.CM.6164.01", "Glucuronidation"], ["TCGA.CM.6164.01", "Drug ADME"], ["TCGA.CM.6164.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6164.01", "Long-term potentiation"], ["TCGA.CM.6164.01", "Metabolism"], ["TCGA.CM.6164.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.CM.6164.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.CM.6164.01", "GABA receptor activation"], ["TCGA.CM.6164.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6164.01", "Signal amplification"], ["TCGA.CM.6164.01", "Trafficking of AMPA receptors"], ["TCGA.CM.6164.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.CM.6164.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.6164.01", "Ethanol oxidation"], ["TCGA.CM.6164.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6164.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6164.01", "Regulation of insulin secretion"], ["TCGA.CM.6164.01", "Glutathione conjugation"], ["TCGA.CM.6164.01", "GPCR ligand binding"], ["TCGA.CM.6164.01", "Signaling Pathways"], ["TCGA.CM.6164.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6164.01", "Heme degradation"], ["TCGA.CM.6164.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.6164.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6164.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6164.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.6164.01", "Aspirin ADME"], ["TCGA.CM.6164.01", "Peptide hormone metabolism"], ["TCGA.CM.6164.01", "Transport of small molecules"], ["TCGA.CM.6164.01", "Integration of energy metabolism"], ["TCGA.CM.6164.01", "Complement cascade"], ["TCGA.CM.6164.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6164.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CM.6164.01", "GABA B receptor activation"], ["TCGA.CM.6164.01", "Activation of GABAB receptors"], ["TCGA.CM.6164.01", "Opioid Signalling"], ["TCGA.CM.6164.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.CM.6164.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.6164.01", "Glycosaminoglycan metabolism"], ["TCGA.CM.6164.01", "Collagen formation"], ["TCGA.CM.6164.01", "Platelet homeostasis"], ["TCGA.CM.6164.01", "Ca2+ pathway"], ["TCGA.CM.6164.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6164.01", "Degradation of the extracellular matrix"], ["TCGA.CM.6164.01", "G alpha (s) signalling events"], ["TCGA.CM.6164.01", "Phase I - Functionalization of compounds"], ["TCGA.CM.6164.01", "Cardiac conduction"], ["TCGA.CM.6164.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6164.01", "Potassium Channels"], ["TCGA.CM.6164.01", "G-protein mediated events"], ["TCGA.CM.6164.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.CM.6164.01", "G-protein beta:gamma signalling"], ["TCGA.CM.6164.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.6164.01", "Leishmania parasite growth and survival"], ["TCGA.CM.6164.01", "Ca-dependent events"], ["TCGA.CM.6164.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CM.6164.01", "Collagen chain trimerization"], ["TCGA.CM.6164.01", "Regulation of Complement cascade"], ["TCGA.CM.6164.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.6164.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.6164.01", "Blood group systems biosynthesis"], ["TCGA.CM.6164.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.6164.01", "Regulation of beta-cell development"], ["TCGA.CM.6165.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6165.01", "Extracellular matrix organization"], ["TCGA.CM.6165.01", "TNFs bind their physiological receptors"], ["TCGA.CM.6165.01", "Signaling by Retinoic Acid"], ["TCGA.CM.6165.01", "Collagen formation"], ["TCGA.CM.6165.01", "RA biosynthesis pathway"], ["TCGA.CM.6165.01", "Ethanol oxidation"], ["TCGA.CM.6165.01", "Stimuli-sensing channels"], ["TCGA.CM.6165.01", "TP53 Regulates Transcription of Death Receptors and Ligands"], ["TCGA.CM.6165.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6165.01", "Ion channel transport"], ["TCGA.CM.6165.01", "Neuronal System"], ["TCGA.CM.6165.01", "GPCR downstream signalling"], ["TCGA.CM.6165.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.6165.01", "GPCR ligand binding"], ["TCGA.CM.6166.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.6166.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CM.6166.01", "GPCR downstream signalling"], ["TCGA.CM.6166.01", "Signaling by GPCR"], ["TCGA.CM.6166.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.CM.6166.01", "G alpha (i) signalling events"], ["TCGA.CM.6166.01", "Generation of second messenger molecules"], ["TCGA.CM.6166.01", "PD-1 signaling"], ["TCGA.CM.6166.01", "Immune System"], ["TCGA.CM.6166.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.6166.01", "Leishmania parasite growth and survival"], ["TCGA.CM.6166.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.6166.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.6166.01", "Adaptive Immune System"], ["TCGA.CM.6166.01", "Neuronal System"], ["TCGA.CM.6166.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6166.01", "GPCR ligand binding"], ["TCGA.CM.6166.01", "Regulation of Complement cascade"], ["TCGA.CM.6166.01", "Arachidonic acid metabolism"], ["TCGA.CM.6166.01", "Extracellular matrix organization"], ["TCGA.CM.6166.01", "Complement cascade"], ["TCGA.CM.6166.01", "Regulation of insulin secretion"], ["TCGA.CM.6166.01", "Signal amplification"], ["TCGA.CM.6166.01", "G alpha (q) signalling events"], ["TCGA.CM.6166.01", "Signaling Pathways"], ["TCGA.CM.6166.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6166.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.6166.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.6166.01", "Integrin cell surface interactions"], ["TCGA.CM.6166.01", "G-protein mediated events"], ["TCGA.CM.6166.01", "Opioid Signalling"], ["TCGA.CM.6166.01", "PLC beta mediated events"], ["TCGA.CM.6166.01", "Peptide hormone metabolism"], ["TCGA.CM.6166.01", "Costimulation by the CD28 family"], ["TCGA.CM.6166.01", "Drug ADME"], ["TCGA.CM.6166.01", "G alpha (s) signalling events"], ["TCGA.CM.6166.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6166.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.CM.6166.01", "Platelet homeostasis"], ["TCGA.CM.6166.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.CM.6166.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.6166.01", "Leishmania infection"], ["TCGA.CM.6166.01", "Parasitic Infection Pathways"], ["TCGA.CM.6166.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.6166.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.6166.01", "G-protein activation"], ["TCGA.CM.6166.01", "Thromboxane signalling through TP receptor"], ["TCGA.CM.6166.01", "GABA receptor activation"], ["TCGA.CM.6166.01", "Heme degradation"], ["TCGA.CM.6166.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.6166.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.CM.6166.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.CM.6166.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.6166.01", "CD22 mediated BCR regulation"], ["TCGA.CM.6166.01", "Degradation of the extracellular matrix"], ["TCGA.CM.6166.01", "G-protein beta:gamma signalling"], ["TCGA.CM.6166.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6166.01", "TNFs bind their physiological receptors"], ["TCGA.CM.6166.01", "Platelet activation, signaling and aggregation"], ["TCGA.CM.6166.01", "Recycling of bile acids and salts"], ["TCGA.CM.6166.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6166.01", "Defective GALNT12 causes CRCS1"], ["TCGA.CM.6166.01", "Cardiac conduction"], ["TCGA.CM.6166.01", "Integration of energy metabolism"], ["TCGA.CM.6166.01", "GABA B receptor activation"], ["TCGA.CM.6166.01", "Activation of GABAB receptors"], ["TCGA.CM.6166.01", "Biological oxidations"], ["TCGA.CM.6166.01", "Diseases of Immune System"], ["TCGA.CM.6166.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.CM.6166.01", "RA biosynthesis pathway"], ["TCGA.CM.6166.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.CM.6166.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.CM.6166.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6166.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.CM.6166.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CM.6166.01", "Other interleukin signaling"], ["TCGA.CM.6166.01", "Collagen chain trimerization"], ["TCGA.CM.6166.01", "Ca-dependent events"], ["TCGA.CM.6166.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CM.6166.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CM.6166.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6166.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6166.01", "G protein gated Potassium channels"], ["TCGA.CM.6166.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6166.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.CM.6166.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.CM.6166.01", "Interferon gamma signaling"], ["TCGA.CM.6166.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.CM.6166.01", "Acyl chain remodelling of PE"], ["TCGA.CM.6166.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6166.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6168.01", "Extracellular matrix organization"], ["TCGA.CM.6168.01", "Collagen formation"], ["TCGA.CM.6168.01", "Degradation of the extracellular matrix"], ["TCGA.CM.6168.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6168.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6168.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.6168.01", "Collagen chain trimerization"], ["TCGA.CM.6168.01", "Ethanol oxidation"], ["TCGA.CM.6169.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6169.01", "Drug ADME"], ["TCGA.CM.6169.01", "Metabolism"], ["TCGA.CM.6169.01", "APAP ADME"], ["TCGA.CM.6169.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6169.01", "Biological oxidations"], ["TCGA.CM.6169.01", "Extracellular matrix organization"], ["TCGA.CM.6169.01", "GPCR ligand binding"], ["TCGA.CM.6169.01", "SLC-mediated transmembrane transport"], ["TCGA.CM.6169.01", "Glycosaminoglycan metabolism"], ["TCGA.CM.6169.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.CM.6169.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6169.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6169.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6169.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6169.01", "RA biosynthesis pathway"], ["TCGA.CM.6169.01", "Ethanol oxidation"], ["TCGA.CM.6169.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6169.01", "G protein gated Potassium channels"], ["TCGA.CM.6169.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6169.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.6169.01", "Repression of WNT target genes"], ["TCGA.CM.6169.01", "Formation of axial mesoderm"], ["TCGA.CM.6170.01", "Neuronal System"], ["TCGA.CM.6170.01", "Biological oxidations"], ["TCGA.CM.6170.01", "Glucuronidation"], ["TCGA.CM.6170.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6170.01", "Potassium Channels"], ["TCGA.CM.6170.01", "Drug ADME"], ["TCGA.CM.6170.01", "Cardiac conduction"], ["TCGA.CM.6170.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.6170.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6170.01", "Extracellular matrix organization"], ["TCGA.CM.6170.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6170.01", "Metabolism"], ["TCGA.CM.6170.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.CM.6170.01", "Regulation of insulin secretion"], ["TCGA.CM.6170.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6170.01", "PI3K events in ERBB2 signaling"], ["TCGA.CM.6170.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.CM.6170.01", "ERBB2 Regulates Cell Motility"], ["TCGA.CM.6170.01", "GABA receptor activation"], ["TCGA.CM.6170.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6170.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6170.01", "Ethanol oxidation"], ["TCGA.CM.6170.01", "GRB2 events in ERBB2 signaling"], ["TCGA.CM.6170.01", "Blood group systems biosynthesis"], ["TCGA.CM.6170.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.6170.01", "G alpha (s) signalling events"], ["TCGA.CM.6170.01", "Heme degradation"], ["TCGA.CM.6170.01", "Signal amplification"], ["TCGA.CM.6170.01", "RA biosynthesis pathway"], ["TCGA.CM.6170.01", "Platelet homeostasis"], ["TCGA.CM.6170.01", "Aspirin ADME"], ["TCGA.CM.6170.01", "Signaling by GPCR"], ["TCGA.CM.6170.01", "Extra-nuclear estrogen signaling"], ["TCGA.CM.6170.01", "GPCR downstream signalling"], ["TCGA.CM.6170.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.6170.01", "GPCR ligand binding"], ["TCGA.CM.6170.01", "Integration of energy metabolism"], ["TCGA.CM.6170.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6170.01", "G protein gated Potassium channels"], ["TCGA.CM.6170.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.6170.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6170.01", "Downregulation of ERBB2 signaling"], ["TCGA.CM.6170.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6170.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CM.6170.01", "Signaling by ERBB4"], ["TCGA.CM.6170.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6170.01", "Signaling by Retinoic Acid"], ["TCGA.CM.6170.01", "Transport of small molecules"], ["TCGA.CM.6170.01", "SHC1 events in ERBB4 signaling"], ["TCGA.CM.6170.01", "Metabolism of amine-derived hormones"], ["TCGA.CM.6170.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6170.01", "Signaling by ERBB2 TMD/JMD mutants"], ["TCGA.CM.6170.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.6170.01", "SHC1 events in ERBB2 signaling"], ["TCGA.CM.6170.01", "Lewis blood group biosynthesis"], ["TCGA.CM.6170.01", "Nuclear signaling by ERBB4"], ["TCGA.CM.6170.01", "G alpha (q) signalling events"], ["TCGA.CM.6170.01", "Signaling by ERBB2 KD Mutants"], ["TCGA.CM.6170.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CM.6170.01", "GABA B receptor activation"], ["TCGA.CM.6170.01", "Activation of GABAB receptors"], ["TCGA.CM.6170.01", "Signaling by Nuclear Receptors"], ["TCGA.CM.6170.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.6170.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6170.01", "Signaling by ERBB2 in Cancer"], ["TCGA.CM.6170.01", "Muscle contraction"], ["TCGA.CM.6170.01", "G alpha (i) signalling events"], ["TCGA.CM.6170.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6170.01", "Arachidonic acid metabolism"], ["TCGA.CM.6170.01", "GRB2 events in EGFR signaling"], ["TCGA.CM.6170.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.6170.01", "L1CAM interactions"], ["TCGA.CM.6170.01", "Collagen formation"], ["TCGA.CM.6170.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.6170.01", "G beta:gamma signalling through CDC42"], ["TCGA.CM.6170.01", "APAP ADME"], ["TCGA.CM.6170.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.6170.01", "Phase I - Functionalization of compounds"], ["TCGA.CM.6170.01", "SHC1 events in EGFR signaling"], ["TCGA.CM.6170.01", "Physiological factors"], ["TCGA.CM.6170.01", "Stimuli-sensing channels"], ["TCGA.CM.6170.01", "Signaling Pathways"], ["TCGA.CM.6171.01", "GPCR ligand binding"], ["TCGA.CM.6171.01", "Signaling by GPCR"], ["TCGA.CM.6171.01", "Neuronal System"], ["TCGA.CM.6171.01", "Biological oxidations"], ["TCGA.CM.6171.01", "GPCR downstream signalling"], ["TCGA.CM.6171.01", "G alpha (i) signalling events"], ["TCGA.CM.6171.01", "Blood group systems biosynthesis"], ["TCGA.CM.6171.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.CM.6171.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6171.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6171.01", "Cardiac conduction"], ["TCGA.CM.6171.01", "Drug ADME"], ["TCGA.CM.6171.01", "Lewis blood group biosynthesis"], ["TCGA.CM.6171.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6171.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6171.01", "Potassium Channels"], ["TCGA.CM.6171.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6171.01", "Muscle contraction"], ["TCGA.CM.6171.01", "Voltage gated Potassium channels"], ["TCGA.CM.6171.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6171.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.6171.01", "Post-translational protein phosphorylation"], ["TCGA.CM.6171.01", "Transport of small molecules"], ["TCGA.CM.6171.01", "Signaling Pathways"], ["TCGA.CM.6171.01", "Molecules associated with elastic fibres"], ["TCGA.CM.6171.01", "Ion homeostasis"], ["TCGA.CM.6171.01", "Elastic fibre formation"], ["TCGA.CM.6171.01", "APAP ADME"], ["TCGA.CM.6171.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6171.01", "Extracellular matrix organization"], ["TCGA.CM.6171.01", "Protein-protein interactions at synapses"], ["TCGA.CM.6171.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6171.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.CM.6171.01", "SLC-mediated transmembrane transport"], ["TCGA.CM.6171.01", "Neurotransmitter release cycle"], ["TCGA.CM.6171.01", "Arachidonic acid metabolism"], ["TCGA.CM.6171.01", "Sensory processing of sound"], ["TCGA.CM.6171.01", "Aspirin ADME"], ["TCGA.CM.6171.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6171.01", "Defective B3GALTL causes PpS"], ["TCGA.CM.6171.01", "LGI-ADAM interactions"], ["TCGA.CM.6171.01", "Ion channel transport"], ["TCGA.CM.6171.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.CM.6171.01", "G alpha (s) signalling events"], ["TCGA.CM.6171.01", "Stimuli-sensing channels"], ["TCGA.CM.6171.01", "Glucuronidation"], ["TCGA.CM.6171.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.CM.6171.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CM.6171.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.CM.6171.01", "Phase I - Functionalization of compounds"], ["TCGA.CM.6171.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.6171.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.6171.01", "O-linked glycosylation"], ["TCGA.CM.6171.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.6171.01", "L1CAM interactions"], ["TCGA.CM.6171.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.CM.6171.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.CM.6171.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6171.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.CM.6172.01", "GPCR ligand binding"], ["TCGA.CM.6172.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6172.01", "Signaling by GPCR"], ["TCGA.CM.6172.01", "GPCR downstream signalling"], ["TCGA.CM.6172.01", "Signaling Pathways"], ["TCGA.CM.6172.01", "G alpha (s) signalling events"], ["TCGA.CM.6172.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6172.01", "Platelet homeostasis"], ["TCGA.CM.6172.01", "G alpha (i) signalling events"], ["TCGA.CM.6172.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6172.01", "Peptide hormone metabolism"], ["TCGA.CM.6172.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.CM.6172.01", "GABA receptor activation"], ["TCGA.CM.6172.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6172.01", "G-protein activation"], ["TCGA.CM.6172.01", "G alpha (z) signalling events"], ["TCGA.CM.6172.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6172.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.6172.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6172.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.6172.01", "Complement cascade"], ["TCGA.CM.6172.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.6172.01", "Potassium Channels"], ["TCGA.CM.6172.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.6172.01", "G beta:gamma signalling through CDC42"], ["TCGA.CM.6172.01", "Signaling by Nuclear Receptors"], ["TCGA.CM.6172.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6172.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.6172.01", "Signal amplification"], ["TCGA.CM.6172.01", "Neuronal System"], ["TCGA.CM.6172.01", "Extra-nuclear estrogen signaling"], ["TCGA.CM.6172.01", "Extracellular matrix organization"], ["TCGA.CM.6172.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.6172.01", "Peptide hormone biosynthesis"], ["TCGA.CM.6172.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CM.6172.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6172.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.6172.01", "Thromboxane signalling through TP receptor"], ["TCGA.CM.6674.01", "Neuronal System"], ["TCGA.CM.6674.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6674.01", "Signaling by GPCR"], ["TCGA.CM.6674.01", "Extracellular matrix organization"], ["TCGA.CM.6674.01", "GPCR downstream signalling"], ["TCGA.CM.6674.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.6674.01", "G alpha (i) signalling events"], ["TCGA.CM.6674.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6674.01", "GPCR ligand binding"], ["TCGA.CM.6674.01", "Collagen formation"], ["TCGA.CM.6674.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6674.01", "Potassium Channels"], ["TCGA.CM.6674.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6674.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6674.01", "NCAM1 interactions"], ["TCGA.CM.6674.01", "Glucuronidation"], ["TCGA.CM.6674.01", "GABA receptor activation"], ["TCGA.CM.6674.01", "Activation of the phototransduction cascade"], ["TCGA.CM.6674.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.CM.6674.01", "Transport of small molecules"], ["TCGA.CM.6674.01", "Biological oxidations"], ["TCGA.CM.6674.01", "Drug ADME"], ["TCGA.CM.6674.01", "G alpha (q) signalling events"], ["TCGA.CM.6674.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.6674.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6674.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6674.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CM.6674.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.CM.6674.01", "Peptide hormone metabolism"], ["TCGA.CM.6674.01", "Collagen chain trimerization"], ["TCGA.CM.6674.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.6674.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6674.01", "Degradation of the extracellular matrix"], ["TCGA.CM.6674.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.CM.6674.01", "SLC-mediated transmembrane transport"], ["TCGA.CM.6674.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6674.01", "NCAM signaling for neurite out-growth"], ["TCGA.CM.6674.01", "Protein-protein interactions at synapses"], ["TCGA.CM.6674.01", "G alpha (s) signalling events"], ["TCGA.CM.6674.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.6674.01", "Aspirin ADME"], ["TCGA.CM.6674.01", "Trafficking of AMPA receptors"], ["TCGA.CM.6674.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.CM.6674.01", "L1CAM interactions"], ["TCGA.CM.6675.01", "Neuronal System"], ["TCGA.CM.6675.01", "Signaling by GPCR"], ["TCGA.CM.6675.01", "GPCR downstream signalling"], ["TCGA.CM.6675.01", "Potassium Channels"], ["TCGA.CM.6675.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6675.01", "Cardiac conduction"], ["TCGA.CM.6675.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.6675.01", "GPCR ligand binding"], ["TCGA.CM.6675.01", "G alpha (i) signalling events"], ["TCGA.CM.6675.01", "Voltage gated Potassium channels"], ["TCGA.CM.6675.01", "G alpha (q) signalling events"], ["TCGA.CM.6675.01", "Muscle contraction"], ["TCGA.CM.6675.01", "Signaling Pathways"], ["TCGA.CM.6675.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6675.01", "Extracellular matrix organization"], ["TCGA.CM.6675.01", "Regulation of insulin secretion"], ["TCGA.CM.6675.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6675.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6675.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.6675.01", "Stimuli-sensing channels"], ["TCGA.CM.6675.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.6675.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6675.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.6675.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.6675.01", "Ion channel transport"], ["TCGA.CM.6675.01", "Platelet homeostasis"], ["TCGA.CM.6675.01", "Protein-protein interactions at synapses"], ["TCGA.CM.6675.01", "G-protein beta:gamma signalling"], ["TCGA.CM.6675.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.CM.6675.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6675.01", "G alpha (s) signalling events"], ["TCGA.CM.6675.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6675.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CM.6675.01", "NCAM1 interactions"], ["TCGA.CM.6675.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CM.6675.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6675.01", "G protein gated Potassium channels"], ["TCGA.CM.6675.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6675.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6675.01", "GABA receptor activation"], ["TCGA.CM.6675.01", "G beta:gamma signalling through CDC42"], ["TCGA.CM.6675.01", "G alpha (12/13) signalling events"], ["TCGA.CM.6675.01", "CD22 mediated BCR regulation"], ["TCGA.CM.6675.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6675.01", "Complement cascade"], ["TCGA.CM.6675.01", "Ion homeostasis"], ["TCGA.CM.6675.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6675.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.CM.6675.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.CM.6675.01", "Activation of ATR in response to replication stress"], ["TCGA.CM.6675.01", "Transport of small molecules"], ["TCGA.CM.6675.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CM.6675.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6675.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.CM.6675.01", "Integration of energy metabolism"], ["TCGA.CM.6675.01", "Activation of the phototransduction cascade"], ["TCGA.CM.6675.01", "Synaptic adhesion-like molecules"], ["TCGA.CM.6675.01", "Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects"], ["TCGA.CM.6675.01", "Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"], ["TCGA.CM.6675.01", "Nicotinate metabolism"], ["TCGA.CM.6675.01", "LGI-ADAM interactions"], ["TCGA.CM.6675.01", "Activation of NMDA receptors and postsynaptic events"], ["TCGA.CM.6676.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.6676.01", "Biological oxidations"], ["TCGA.CM.6676.01", "Signaling by GPCR"], ["TCGA.CM.6676.01", "GPCR downstream signalling"], ["TCGA.CM.6676.01", "Signaling Pathways"], ["TCGA.CM.6676.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6676.01", "Visual phototransduction"], ["TCGA.CM.6676.01", "GPCR ligand binding"], ["TCGA.CM.6676.01", "Immune System"], ["TCGA.CM.6676.01", "Diseases of Immune System"], ["TCGA.CM.6676.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.CM.6676.01", "Neuronal System"], ["TCGA.CM.6676.01", "Activation of the phototransduction cascade"], ["TCGA.CM.6676.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.CM.6676.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.CM.6676.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.6676.01", "Ca2+ pathway"], ["TCGA.CM.6676.01", "Glucuronidation"], ["TCGA.CM.6676.01", "Complement cascade"], ["TCGA.CM.6676.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6676.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6676.01", "Drug ADME"], ["TCGA.CM.6676.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6676.01", "RA biosynthesis pathway"], ["TCGA.CM.6676.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6676.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.6676.01", "G alpha (i) signalling events"], ["TCGA.CM.6676.01", "Metabolism of fat-soluble vitamins"], ["TCGA.CM.6676.01", "Retinoid metabolism and transport"], ["TCGA.CM.6676.01", "Initial triggering of complement"], ["TCGA.CM.6676.01", "Regulation of Complement cascade"], ["TCGA.CM.6676.01", "G alpha (s) signalling events"], ["TCGA.CM.6676.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6676.01", "Peptide hormone metabolism"], ["TCGA.CM.6676.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.6676.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6676.01", "Trafficking of AMPA receptors"], ["TCGA.CM.6676.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.CM.6676.01", "Ligand-dependent caspase activation"], ["TCGA.CM.6676.01", "Regulation of TLR by endogenous ligand"], ["TCGA.CM.6676.01", "Cardiac conduction"], ["TCGA.CM.6676.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6676.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6676.01", "G protein gated Potassium channels"], ["TCGA.CM.6676.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6676.01", "Extracellular matrix organization"], ["TCGA.CM.6676.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6676.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.6676.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.CM.6676.01", "Adaptive Immune System"], ["TCGA.CM.6676.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.CM.6676.01", "Innate Immune System"], ["TCGA.CM.6676.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.6676.01", "Leishmania parasite growth and survival"], ["TCGA.CM.6676.01", "G-protein beta:gamma signalling"], ["TCGA.CM.6676.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CM.6676.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.6676.01", "Potassium Channels"], ["TCGA.CM.6676.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.6676.01", "DAP12 interactions"], ["TCGA.CM.6676.01", "Regulation of insulin secretion"], ["TCGA.CM.6676.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.6676.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.6676.01", "Regulation of beta-cell development"], ["TCGA.CM.6676.01", "Signal amplification"], ["TCGA.CM.6676.01", "GABA receptor activation"], ["TCGA.CM.6676.01", "Creation of C4 and C2 activators"], ["TCGA.CM.6676.01", "Caspase activation via extrinsic apoptotic signalling pathway"], ["TCGA.CM.6676.01", "FGFR2 ligand binding and activation"], ["TCGA.CM.6676.01", "Insulin processing"], ["TCGA.CM.6676.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.6676.01", "G beta:gamma signalling through CDC42"], ["TCGA.CM.6676.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.6676.01", "Aspirin ADME"], ["TCGA.CM.6676.01", "Integrin cell surface interactions"], ["TCGA.CM.6677.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6677.01", "Biological oxidations"], ["TCGA.CM.6677.01", "Peptide hormone metabolism"], ["TCGA.CM.6677.01", "GABA receptor activation"], ["TCGA.CM.6677.01", "Neuronal System"], ["TCGA.CM.6677.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6677.01", "Glucagon-type ligand receptors"], ["TCGA.CM.6677.01", "Cardiac conduction"], ["TCGA.CM.6677.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.6677.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6677.01", "Blood group systems biosynthesis"], ["TCGA.CM.6677.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.6677.01", "G alpha (s) signalling events"], ["TCGA.CM.6677.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6677.01", "Drug ADME"], ["TCGA.CM.6677.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6677.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.6677.01", "Potassium Channels"], ["TCGA.CM.6677.01", "Metabolism"], ["TCGA.CM.6677.01", "Glucuronidation"], ["TCGA.CM.6677.01", "Signal amplification"], ["TCGA.CM.6677.01", "Transcription of E2F targets under negative control by DREAM complex"], ["TCGA.CM.6677.01", "Platelet homeostasis"], ["TCGA.CM.6677.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.6677.01", "L1CAM interactions"], ["TCGA.CM.6677.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6677.01", "Ethanol oxidation"], ["TCGA.CM.6677.01", "Transcriptional regulation of testis differentiation"], ["TCGA.CM.6677.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.CM.6677.01", "GABA B receptor activation"], ["TCGA.CM.6677.01", "Activation of GABAB receptors"], ["TCGA.CM.6677.01", "Lewis blood group biosynthesis"], ["TCGA.CM.6677.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6677.01", "G protein gated Potassium channels"], ["TCGA.CM.6677.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6677.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6677.01", "Regulation of insulin secretion"], ["TCGA.CM.6677.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.CM.6677.01", "G beta:gamma signalling through BTK"], ["TCGA.CM.6677.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.CM.6677.01", "Insulin processing"], ["TCGA.CM.6677.01", "G beta:gamma signalling through PLC beta"], ["TCGA.CM.6677.01", "Nucleotide catabolism"], ["TCGA.CM.6677.01", "G beta:gamma signalling through CDC42"], ["TCGA.CM.6677.01", "Sensory processing of sound"], ["TCGA.CM.6677.01", "Class B/2 (Secretin family receptors)"], ["TCGA.CM.6677.01", "Integration of energy metabolism"], ["TCGA.CM.6677.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6677.01", "G0 and Early G1"], ["TCGA.CM.6677.01", "Extra-nuclear estrogen signaling"], ["TCGA.CM.6677.01", "TP53 Regulates Transcription of Cell Cycle Genes"], ["TCGA.CM.6677.01", "Signaling by Retinoic Acid"], ["TCGA.CM.6678.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.CM.6678.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.CM.6678.01", "Generation of second messenger molecules"], ["TCGA.CM.6678.01", "PD-1 signaling"], ["TCGA.CM.6678.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.CM.6678.01", "Immune System"], ["TCGA.CM.6678.01", "GPCR downstream signalling"], ["TCGA.CM.6678.01", "Adaptive Immune System"], ["TCGA.CM.6678.01", "Extracellular matrix organization"], ["TCGA.CM.6678.01", "Signaling by GPCR"], ["TCGA.CM.6678.01", "Costimulation by the CD28 family"], ["TCGA.CM.6678.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6678.01", "G alpha (i) signalling events"], ["TCGA.CM.6678.01", "Complement cascade"], ["TCGA.CM.6678.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.6678.01", "Signaling Pathways"], ["TCGA.CM.6678.01", "Regulation of Complement cascade"], ["TCGA.CM.6678.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6678.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6678.01", "Classical antibody-mediated complement activation"], ["TCGA.CM.6678.01", "CD22 mediated BCR regulation"], ["TCGA.CM.6678.01", "Chemokine receptors bind chemokines"], ["TCGA.CM.6678.01", "TNFs bind their physiological receptors"], ["TCGA.CM.6678.01", "Innate Immune System"], ["TCGA.CM.6678.01", "Glucuronidation"], ["TCGA.CM.6678.01", "Leishmania infection"], ["TCGA.CM.6678.01", "Parasitic Infection Pathways"], ["TCGA.CM.6678.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6678.01", "Degradation of the extracellular matrix"], ["TCGA.CM.6678.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.CM.6678.01", "G alpha (s) signalling events"], ["TCGA.CM.6678.01", "TCR signaling"], ["TCGA.CM.6678.01", "Diseases of Immune System"], ["TCGA.CM.6678.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.CM.6678.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.CM.6678.01", "Regulation of FZD by ubiquitination"], ["TCGA.CM.6678.01", "GPCR ligand binding"], ["TCGA.CM.6678.01", "G alpha (q) signalling events"], ["TCGA.CM.6678.01", "Transport of small molecules"], ["TCGA.CM.6678.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.CM.6678.01", "Leishmania parasite growth and survival"], ["TCGA.CM.6678.01", "Phase 0 - rapid depolarisation"], ["TCGA.CM.6678.01", "Stimuli-sensing channels"], ["TCGA.CM.6678.01", "Potassium Channels"], ["TCGA.CM.6678.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.CM.6678.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.CM.6678.01", "SUMOylation of intracellular receptors"], ["TCGA.CM.6678.01", "Cardiac conduction"], ["TCGA.CM.6678.01", "Other semaphorin interactions"], ["TCGA.CM.6678.01", "Collagen formation"], ["TCGA.CM.6679.01", "Extracellular matrix organization"], ["TCGA.CM.6679.01", "Collagen formation"], ["TCGA.CM.6679.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.CM.6679.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.6679.01", "Collagen chain trimerization"], ["TCGA.CM.6679.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6679.01", "Neuronal System"], ["TCGA.CM.6679.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.CM.6679.01", "Biological oxidations"], ["TCGA.CM.6679.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6679.01", "Glucuronidation"], ["TCGA.CM.6679.01", "Potassium Channels"], ["TCGA.CM.6679.01", "Transmission across Chemical Synapses"], ["TCGA.CM.6679.01", "O-linked glycosylation"], ["TCGA.CM.6679.01", "Signaling by GPCR"], ["TCGA.CM.6679.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.CM.6679.01", "Drug ADME"], ["TCGA.CM.6679.01", "Signal amplification"], ["TCGA.CM.6679.01", "GPCR ligand binding"], ["TCGA.CM.6679.01", "Defective B3GALTL causes PpS"], ["TCGA.CM.6679.01", "GPCR downstream signalling"], ["TCGA.CM.6679.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.CM.6679.01", "G alpha (q) signalling events"], ["TCGA.CM.6679.01", "Degradation of the extracellular matrix"], ["TCGA.CM.6679.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.CM.6679.01", "Signaling Pathways"], ["TCGA.CM.6679.01", "GABA receptor activation"], ["TCGA.CM.6679.01", "Inwardly rectifying K+ channels"], ["TCGA.CM.6679.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.CM.6679.01", "NCAM signaling for neurite out-growth"], ["TCGA.CM.6679.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6679.01", "Phase 4 - resting membrane potential"], ["TCGA.CM.6679.01", "Ethanol oxidation"], ["TCGA.CM.6679.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.CM.6679.01", "NCAM1 interactions"], ["TCGA.CM.6679.01", "Activation of G protein gated Potassium channels"], ["TCGA.CM.6679.01", "G protein gated Potassium channels"], ["TCGA.CM.6679.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.CM.6679.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6679.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.CM.6679.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.CM.6679.01", "Heme degradation"], ["TCGA.CM.6679.01", "Scavenging by Class A Receptors"], ["TCGA.CM.6679.01", "APAP ADME"], ["TCGA.CM.6679.01", "ECM proteoglycans"], ["TCGA.CM.6679.01", "G alpha (s) signalling events"], ["TCGA.CM.6679.01", "Peptide ligand-binding receptors"], ["TCGA.CM.6679.01", "Presynaptic function of Kainate receptors"], ["TCGA.CM.6679.01", "Long-term potentiation"], ["TCGA.CM.6679.01", "Regulation of insulin secretion"], ["TCGA.CM.6679.01", "Diseases of glycosylation"], ["TCGA.CM.6679.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.CM.6679.01", "GABA B receptor activation"], ["TCGA.CM.6679.01", "Activation of GABAB receptors"], ["TCGA.CM.6679.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.CM.6679.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.CM.6679.01", "Platelet activation, signaling and aggregation"], ["TCGA.CM.6679.01", "G alpha (i) signalling events"], ["TCGA.CM.6679.01", "Collagen degradation"], ["TCGA.CM.6679.01", "Glucagon signaling in metabolic regulation"], ["TCGA.CM.6679.01", "Voltage gated Potassium channels"], ["TCGA.CM.6679.01", "Transport of small molecules"], ["TCGA.CM.6680.01", "Extracellular matrix organization"], ["TCGA.CM.6680.01", "Activation of Matrix Metalloproteinases"], ["TCGA.CM.6680.01", "Degradation of the extracellular matrix"], ["TCGA.CM.6680.01", "TNFs bind their physiological receptors"], ["TCGA.CM.6680.01", "Cytosolic sulfonation of small molecules"], ["TCGA.CM.6680.01", "Drug ADME"], ["TCGA.CM.6680.01", "Phase II - Conjugation of compounds"], ["TCGA.CM.6680.01", "Regulation of FZD by ubiquitination"], ["TCGA.CM.6680.01", "Signaling by GPCR"], ["TCGA.CM.6680.01", "Biological oxidations"], ["TCGA.CM.6680.01", "L1CAM interactions"], ["TCGA.CM.6680.01", "GPCR downstream signalling"], ["TCGA.CM.6680.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.CM.6680.01", "G alpha (i) signalling events"], ["TCGA.CM.6680.01", "SLC-mediated transmembrane transport"], ["TCGA.CM.6680.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.CM.6680.01", "Interaction between L1 and Ankyrins"], ["TCGA.CM.6680.01", "ECM proteoglycans"], ["TCGA.D5.5537.01", "Neuronal System"], ["TCGA.D5.5537.01", "Signaling by GPCR"], ["TCGA.D5.5537.01", "GPCR downstream signalling"], ["TCGA.D5.5537.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.5537.01", "Signaling Pathways"], ["TCGA.D5.5537.01", "Cardiac conduction"], ["TCGA.D5.5537.01", "Transmission across Chemical Synapses"], ["TCGA.D5.5537.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.5537.01", "G alpha (i) signalling events"], ["TCGA.D5.5537.01", "Peptide hormone metabolism"], ["TCGA.D5.5537.01", "G alpha (s) signalling events"], ["TCGA.D5.5537.01", "Extracellular matrix organization"], ["TCGA.D5.5537.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.5537.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.5537.01", "L1CAM interactions"], ["TCGA.D5.5537.01", "Transport of small molecules"], ["TCGA.D5.5537.01", "Potassium Channels"], ["TCGA.D5.5537.01", "Regulation of insulin secretion"], ["TCGA.D5.5537.01", "Muscle contraction"], ["TCGA.D5.5537.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.5537.01", "Ion channel transport"], ["TCGA.D5.5537.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.5537.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.D5.5537.01", "Leishmania parasite growth and survival"], ["TCGA.D5.5537.01", "GPCR ligand binding"], ["TCGA.D5.5537.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.5537.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.5537.01", "Signal amplification"], ["TCGA.D5.5537.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.5537.01", "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"], ["TCGA.D5.5537.01", "Ethanol oxidation"], ["TCGA.D5.5537.01", "NCAM signaling for neurite out-growth"], ["TCGA.D5.5537.01", "Integration of energy metabolism"], ["TCGA.D5.5537.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.5537.01", "Regulation of FZD by ubiquitination"], ["TCGA.D5.5537.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.D5.5537.01", "Protein-protein interactions at synapses"], ["TCGA.D5.5537.01", "Heme degradation"], ["TCGA.D5.5537.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.D5.5537.01", "Collagen chain trimerization"], ["TCGA.D5.5537.01", "Arachidonic acid metabolism"], ["TCGA.D5.5537.01", "G-protein beta:gamma signalling"], ["TCGA.D5.5537.01", "Leishmania infection"], ["TCGA.D5.5537.01", "Parasitic Infection Pathways"], ["TCGA.D5.5537.01", "NCAM1 interactions"], ["TCGA.D5.5537.01", "Signaling by Retinoic Acid"], ["TCGA.D5.5537.01", "RA biosynthesis pathway"], ["TCGA.D5.5537.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.5537.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.5537.01", "GABA receptor activation"], ["TCGA.D5.5537.01", "Platelet homeostasis"], ["TCGA.D5.5537.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.D5.5537.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.D5.5537.01", "Regulation of Complement cascade"], ["TCGA.D5.5537.01", "Glucagon-type ligand receptors"], ["TCGA.D5.5537.01", "Insulin processing"], ["TCGA.D5.5537.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.D5.5537.01", "Aquaporin-mediated transport"], ["TCGA.D5.5537.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.5537.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.5537.01", "GABA B receptor activation"], ["TCGA.D5.5537.01", "Activation of GABAB receptors"], ["TCGA.D5.5537.01", "Complement cascade"], ["TCGA.D5.5537.01", "ECM proteoglycans"], ["TCGA.D5.5537.01", "Ion homeostasis"], ["TCGA.D5.5537.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.5537.01", "Long-term potentiation"], ["TCGA.D5.5537.01", "MAPK family signaling cascades"], ["TCGA.D5.5538.01", "Neuronal System"], ["TCGA.D5.5538.01", "Transmission across Chemical Synapses"], ["TCGA.D5.5538.01", "Protein-protein interactions at synapses"], ["TCGA.D5.5538.01", "Neurexins and neuroligins"], ["TCGA.D5.5538.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.5538.01", "Extracellular matrix organization"], ["TCGA.D5.5538.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.5538.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.5538.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.5538.01", "Cardiac conduction"], ["TCGA.D5.5538.01", "Degradation of the extracellular matrix"], ["TCGA.D5.5538.01", "GPCR ligand binding"], ["TCGA.D5.5538.01", "Signaling by GPCR"], ["TCGA.D5.5538.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.D5.5538.01", "Ethanol oxidation"], ["TCGA.D5.5538.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.5538.01", "Long-term potentiation"], ["TCGA.D5.5538.01", "G alpha (s) signalling events"], ["TCGA.D5.5538.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.D5.5538.01", "L1CAM interactions"], ["TCGA.D5.5538.01", "Muscle contraction"], ["TCGA.D5.5538.01", "G alpha (i) signalling events"], ["TCGA.D5.5538.01", "Synaptic adhesion-like molecules"], ["TCGA.D5.5538.01", "GPCR downstream signalling"], ["TCGA.D5.5538.01", "Activation of NMDA receptors and postsynaptic events"], ["TCGA.D5.5538.01", "Glucagon-type ligand receptors"], ["TCGA.D5.5538.01", "Potassium Channels"], ["TCGA.D5.5538.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.5538.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.5538.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.5538.01", "Dopamine Neurotransmitter Release Cycle"], ["TCGA.D5.5538.01", "Neurotransmitter release cycle"], ["TCGA.D5.5538.01", "Biological oxidations"], ["TCGA.D5.5538.01", "O-linked glycosylation"], ["TCGA.D5.5538.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.D5.5538.01", "Drug ADME"], ["TCGA.D5.5538.01", "RA biosynthesis pathway"], ["TCGA.D5.5538.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.5538.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.D5.5538.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.5538.01", "Regulation of insulin secretion"], ["TCGA.D5.5538.01", "APAP ADME"], ["TCGA.D5.5538.01", "Trafficking of AMPA receptors"], ["TCGA.D5.5538.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.D5.5538.01", "Post NMDA receptor activation events"], ["TCGA.D5.5538.01", "Peptide ligand-binding receptors"], ["TCGA.D5.5538.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.5538.01", "Signaling Pathways"], ["TCGA.D5.5538.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.D5.5538.01", "Ion channel transport"], ["TCGA.D5.5538.01", "GABA receptor activation"], ["TCGA.D5.5538.01", "NCAM1 interactions"], ["TCGA.D5.5538.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.D5.5538.01", "Transport of small molecules"], ["TCGA.D5.5538.01", "Signaling by BMP"], ["TCGA.D5.5538.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.5538.01", "Lewis blood group biosynthesis"], ["TCGA.D5.5538.01", "Integration of energy metabolism"], ["TCGA.D5.5538.01", "Sensory perception of taste"], ["TCGA.D5.5538.01", "Peptide hormone metabolism"], ["TCGA.D5.5538.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.5538.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.D5.5538.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.D5.5538.01", "Blood group systems biosynthesis"], ["TCGA.D5.5538.01", "Signal amplification"], ["TCGA.D5.5538.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.5538.01", "Stimuli-sensing channels"], ["TCGA.D5.5538.01", "Platelet homeostasis"], ["TCGA.D5.5538.01", "ECM proteoglycans"], ["TCGA.D5.5539.01", "Extracellular matrix organization"], ["TCGA.D5.5539.01", "Drug ADME"], ["TCGA.D5.5539.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.5540.01", "Eukaryotic Translation Elongation"], ["TCGA.D5.5540.01", "Viral mRNA Translation"], ["TCGA.D5.5540.01", "Peptide chain elongation"], ["TCGA.D5.5540.01", "Eukaryotic Translation Termination"], ["TCGA.D5.5540.01", "Selenocysteine synthesis"], ["TCGA.D5.5540.01", "Response of EIF2AK4 (GCN2) to amino acid deficiency"], ["TCGA.D5.5540.01", "Selenoamino acid metabolism"], ["TCGA.D5.5540.01", "Formation of a pool of free 40S subunits"], ["TCGA.D5.5540.01", "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"], ["TCGA.D5.5540.01", "SARS-CoV-2 modulates host translation machinery"], ["TCGA.D5.5540.01", "Influenza Viral RNA Transcription and Replication"], ["TCGA.D5.5540.01", "Major pathway of rRNA processing in the nucleolus and cytosol"], ["TCGA.D5.5540.01", "Influenza Infection"], ["TCGA.D5.5540.01", "rRNA processing in the nucleus and cytosol"], ["TCGA.D5.5540.01", "L13a-mediated translational silencing of Ceruloplasmin expression"], ["TCGA.D5.5540.01", "SARS-CoV-1 modulates host translation machinery"], ["TCGA.D5.5540.01", "rRNA processing"], ["TCGA.D5.5540.01", "GTP hydrolysis and joining of the 60S ribosomal subunit"], ["TCGA.D5.5540.01", "SRP-dependent cotranslational protein targeting to membrane"], ["TCGA.D5.5540.01", "Nonsense-Mediated Decay (NMD)"], ["TCGA.D5.5540.01", "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"], ["TCGA.D5.5540.01", "Cellular response to starvation"], ["TCGA.D5.5540.01", "Eukaryotic Translation Initiation"], ["TCGA.D5.5540.01", "Cap-dependent Translation Initiation"], ["TCGA.D5.5540.01", "Formation of the ternary complex, and subsequently, the 43S complex"], ["TCGA.D5.5540.01", "Developmental Biology"], ["TCGA.D5.5540.01", "Nervous system development"], ["TCGA.D5.5540.01", "Axon guidance"], ["TCGA.D5.5540.01", "Regulation of expression of SLITs and ROBOs"], ["TCGA.D5.5540.01", "Ribosomal scanning and start codon recognition"], ["TCGA.D5.5540.01", "Translation initiation complex formation"], ["TCGA.D5.5540.01", "Extracellular matrix organization"], ["TCGA.D5.5540.01", "G0 and Early G1"], ["TCGA.D5.5540.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.5540.01", "Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S"], ["TCGA.D5.5540.01", "SARS-CoV-1-host interactions"], ["TCGA.D5.5540.01", "Cell Cycle"], ["TCGA.D5.5540.01", "Deposition of new CENPA-containing nucleosomes at the centromere"], ["TCGA.D5.5540.01", "Nucleosome assembly"], ["TCGA.D5.5540.01", "Neuronal System"], ["TCGA.D5.5540.01", "Signaling by ROBO receptors"], ["TCGA.D5.5540.01", "TP53 Regulates Transcription of Cell Cycle Genes"], ["TCGA.D5.5540.01", "Metabolism of folate and pterines"], ["TCGA.D5.5540.01", "Chromosome Maintenance"], ["TCGA.D5.5540.01", "Amino acid and derivative metabolism"], ["TCGA.D5.5540.01", "Cell Cycle, Mitotic"], ["TCGA.D5.5540.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.D5.5540.01", "SARS-CoV-1 Infection"], ["TCGA.D5.5540.01", "G1/S Transition"], ["TCGA.D5.5540.01", "Mitotic G1 phase and G1/S transition"], ["TCGA.D5.5540.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.5540.01", "Cellular responses to stress"], ["TCGA.D5.5540.01", "Cardiac conduction"], ["TCGA.D5.5540.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.D5.5540.01", "Cellular responses to stimuli"], ["TCGA.D5.5540.01", "G1/S-Specific Transcription"], ["TCGA.D5.5540.01", "Ca-dependent events"], ["TCGA.D5.5540.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.D5.5540.01", "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"], ["TCGA.D5.5540.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.5540.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.5540.01", "HDR through Homologous Recombination (HRR)"], ["TCGA.D5.5540.01", "Regulation of Complement cascade"], ["TCGA.D5.5540.01", "Biological oxidations"], ["TCGA.D5.5540.01", "Calmodulin induced events"], ["TCGA.D5.5540.01", "CaM pathway"], ["TCGA.D5.5540.01", "Regulation of insulin secretion"], ["TCGA.D5.5540.01", "Disease"], ["TCGA.D5.5540.01", "Signaling Pathways"], ["TCGA.D5.5540.01", "Carnitine metabolism"], ["TCGA.D5.5540.01", "Transcription of E2F targets under negative control by DREAM complex"], ["TCGA.D5.5540.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.5540.01", "Signaling by GPCR"], ["TCGA.D5.5540.01", "Degradation of the extracellular matrix"], ["TCGA.D5.5540.01", "Metabolism"], ["TCGA.D5.5540.01", "DNA strand elongation"], ["TCGA.D5.5540.01", "Homologous DNA Pairing and Strand Exchange"], ["TCGA.D5.5540.01", "GPCR downstream signalling"], ["TCGA.D5.5540.01", "Presynaptic phase of homologous DNA pairing and strand exchange"], ["TCGA.D5.5540.01", "Scavenging of heme from plasma"], ["TCGA.D5.5540.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.D5.5540.01", "Activation of ATR in response to replication stress"], ["TCGA.D5.5540.01", "PLC beta mediated events"], ["TCGA.D5.5540.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], ["TCGA.D5.5540.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], ["TCGA.D5.5540.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], ["TCGA.D5.5540.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], ["TCGA.D5.5540.01", "Impaired BRCA2 binding to PALB2"], ["TCGA.D5.5540.01", "S Phase"], ["TCGA.D5.5540.01", "Integration of energy metabolism"], ["TCGA.D5.5540.01", "Cell Cycle Checkpoints"], ["TCGA.D5.5540.01", "Resolution of D-Loop Structures"], ["TCGA.D5.5540.01", "L1CAM interactions"], ["TCGA.D5.5540.01", "SARS-CoV-2-host interactions"], ["TCGA.D5.5540.01", "Transmission across Chemical Synapses"], ["TCGA.D5.5540.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], ["TCGA.D5.5540.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.D5.5540.01", "Resolution of Sister Chromatid Cohesion"], ["TCGA.D5.5540.01", "Cyclin D associated events in G1"], ["TCGA.D5.5540.01", "G1 Phase"], ["TCGA.D5.5540.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.D5.5540.01", "mRNA decay by 3' to 5' exoribonuclease"], ["TCGA.D5.5540.01", "G alpha (s) signalling events"], ["TCGA.D5.5540.01", "Potassium Channels"], ["TCGA.D5.5540.01", "Activation of the pre-replicative complex"], ["TCGA.D5.5540.01", "Glucagon-type ligand receptors"], ["TCGA.D5.5540.01", "Diseases of DNA repair"], ["TCGA.D5.5540.01", "Diseases of DNA Double-Strand Break Repair"], ["TCGA.D5.5540.01", "Defective homologous recombination repair (HRR) due to BRCA2 loss of function"], ["TCGA.D5.5540.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.5540.01", "NCAM signaling for neurite out-growth"], ["TCGA.D5.5540.01", "NCAM1 interactions"], ["TCGA.D5.5540.01", "G alpha (i) signalling events"], ["TCGA.D5.5540.01", "Molecules associated with elastic fibres"], ["TCGA.D5.5540.01", "Collagen chain trimerization"], ["TCGA.D5.5540.01", "Protein folding"], ["TCGA.D5.5540.01", "Translation"], ["TCGA.D5.5540.01", "Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1"], ["TCGA.D5.5540.01", "Polo-like kinase mediated events"], ["TCGA.D5.5540.01", "Blood group systems biosynthesis"], ["TCGA.D5.5540.01", "NFE2L2 regulating tumorigenic genes"], ["TCGA.D5.5540.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.5540.01", "LGI-ADAM interactions"], ["TCGA.D5.5541.01", "Extracellular matrix organization"], ["TCGA.D5.5541.01", "Neuronal System"], ["TCGA.D5.5541.01", "Biological oxidations"], ["TCGA.D5.5541.01", "Drug ADME"], ["TCGA.D5.5541.01", "Degradation of the extracellular matrix"], ["TCGA.D5.5541.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.5541.01", "Transmission across Chemical Synapses"], ["TCGA.D5.5541.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.5541.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.5541.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.5541.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.5541.01", "APAP ADME"], ["TCGA.D5.5541.01", "G alpha (i) signalling events"], ["TCGA.D5.5541.01", "Blood group systems biosynthesis"], ["TCGA.D5.5541.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.5541.01", "Cardiac conduction"], ["TCGA.D5.5541.01", "RA biosynthesis pathway"], ["TCGA.D5.5541.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.5541.01", "G alpha (s) signalling events"], ["TCGA.D5.5541.01", "Signaling by GPCR"], ["TCGA.D5.5541.01", "GABA receptor activation"], ["TCGA.D5.5541.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.5541.01", "O-linked glycosylation"], ["TCGA.D5.5541.01", "Phase I - Functionalization of compounds"], ["TCGA.D5.5541.01", "Ethanol oxidation"], ["TCGA.D5.5541.01", "Lewis blood group biosynthesis"], ["TCGA.D5.5541.01", "GPCR downstream signalling"], ["TCGA.D5.5541.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.5541.01", "ECM proteoglycans"], ["TCGA.D5.5541.01", "O-linked glycosylation of mucins"], ["TCGA.D5.5541.01", "Collagen degradation"], ["TCGA.D5.5541.01", "Regulation of insulin secretion"], ["TCGA.D5.5541.01", "Signaling by Retinoic Acid"], ["TCGA.D5.5541.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.5541.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.D5.5541.01", "Collagen formation"], ["TCGA.D5.5541.01", "Platelet homeostasis"], ["TCGA.D5.5541.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.5541.01", "Sensory perception of taste"], ["TCGA.D5.5541.01", "Signal amplification"], ["TCGA.D5.5541.01", "L1CAM interactions"], ["TCGA.D5.5541.01", "Glucuronidation"], ["TCGA.D5.5541.01", "Glucagon-type ligand receptors"], ["TCGA.D5.5541.01", "Aspirin ADME"], ["TCGA.D5.5541.01", "Transcription of E2F targets under negative control by DREAM complex"], ["TCGA.D5.5541.01", "Trafficking of AMPA receptors"], ["TCGA.D5.5541.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.D5.5541.01", "GPER1 signaling"], ["TCGA.D5.5541.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.D5.5541.01", "GABA B receptor activation"], ["TCGA.D5.5541.01", "Activation of GABAB receptors"], ["TCGA.D5.5541.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.5541.01", "Stimuli-sensing channels"], ["TCGA.D5.5541.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.5541.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.5541.01", "Metabolism"], ["TCGA.D5.5541.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.5541.01", "G protein gated Potassium channels"], ["TCGA.D5.5541.01", "G0 and Early G1"], ["TCGA.D5.5541.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.5541.01", "Opioid Signalling"], ["TCGA.D5.5541.01", "Arachidonic acid metabolism"], ["TCGA.D5.5541.01", "Activation of the phototransduction cascade"], ["TCGA.D5.5541.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.5541.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.D5.5541.01", "GPCR ligand binding"], ["TCGA.D5.6529.01", "Extracellular matrix organization"], ["TCGA.D5.6529.01", "Collagen formation"], ["TCGA.D5.6529.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6529.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6529.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6529.01", "Collagen chain trimerization"], ["TCGA.D5.6529.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6529.01", "Biological oxidations"], ["TCGA.D5.6529.01", "Neuronal System"], ["TCGA.D5.6529.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6529.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6529.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6529.01", "Regulation of insulin secretion"], ["TCGA.D5.6529.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6529.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6529.01", "Drug ADME"], ["TCGA.D5.6529.01", "Metabolism"], ["TCGA.D5.6529.01", "GABA receptor activation"], ["TCGA.D5.6529.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.6529.01", "Integration of energy metabolism"], ["TCGA.D5.6529.01", "Signal amplification"], ["TCGA.D5.6529.01", "Heme degradation"], ["TCGA.D5.6529.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6529.01", "Cardiac conduction"], ["TCGA.D5.6529.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6529.01", "Glucuronidation"], ["TCGA.D5.6529.01", "Scavenging by Class A Receptors"], ["TCGA.D5.6529.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.D5.6529.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6529.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6529.01", "NCAM1 interactions"], ["TCGA.D5.6529.01", "NCAM signaling for neurite out-growth"], ["TCGA.D5.6529.01", "O-linked glycosylation"], ["TCGA.D5.6529.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6529.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.D5.6529.01", "Collagen degradation"], ["TCGA.D5.6529.01", "Potassium Channels"], ["TCGA.D5.6529.01", "SLC-mediated transmembrane transport"], ["TCGA.D5.6529.01", "G-protein activation"], ["TCGA.D5.6529.01", "Thromboxane signalling through TP receptor"], ["TCGA.D5.6529.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.6529.01", "GABA B receptor activation"], ["TCGA.D5.6529.01", "Activation of GABAB receptors"], ["TCGA.D5.6529.01", "Bile acid and bile salt metabolism"], ["TCGA.D5.6529.01", "Interleukin-6 family signaling"], ["TCGA.D5.6529.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6529.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6529.01", "Ethanol oxidation"], ["TCGA.D5.6529.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6529.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6529.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6529.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6529.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6529.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6529.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.D5.6529.01", "L1CAM interactions"], ["TCGA.D5.6529.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6529.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6529.01", "G protein gated Potassium channels"], ["TCGA.D5.6529.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6529.01", "FGFR2 ligand binding and activation"], ["TCGA.D5.6529.01", "G beta:gamma signalling through PLC beta"], ["TCGA.D5.6529.01", "G beta:gamma signalling through CDC42"], ["TCGA.D5.6529.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6531.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6531.01", "Neuronal System"], ["TCGA.D5.6531.01", "Cardiac conduction"], ["TCGA.D5.6531.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6531.01", "Signaling by GPCR"], ["TCGA.D5.6531.01", "Muscle contraction"], ["TCGA.D5.6531.01", "G alpha (i) signalling events"], ["TCGA.D5.6531.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6531.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6531.01", "Drug ADME"], ["TCGA.D5.6531.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6531.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6531.01", "GPCR downstream signalling"], ["TCGA.D5.6531.01", "Extracellular matrix organization"], ["TCGA.D5.6531.01", "Biological oxidations"], ["TCGA.D5.6531.01", "Metabolism of vitamins and cofactors"], ["TCGA.D5.6531.01", "Regulation of insulin secretion"], ["TCGA.D5.6531.01", "Blood group systems biosynthesis"], ["TCGA.D5.6531.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.6531.01", "RA biosynthesis pathway"], ["TCGA.D5.6531.01", "Metabolism of water-soluble vitamins and cofactors"], ["TCGA.D5.6531.01", "G alpha (s) signalling events"], ["TCGA.D5.6531.01", "O-linked glycosylation"], ["TCGA.D5.6531.01", "Termination of O-glycan biosynthesis"], ["TCGA.D5.6531.01", "Integration of energy metabolism"], ["TCGA.D5.6531.01", "Potassium Channels"], ["TCGA.D5.6531.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6531.01", "Insulin processing"], ["TCGA.D5.6531.01", "APAP ADME"], ["TCGA.D5.6531.01", "IRS-related events triggered by IGF1R"], ["TCGA.D5.6531.01", "Ion homeostasis"], ["TCGA.D5.6531.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6531.01", "GPCR ligand binding"], ["TCGA.D5.6531.01", "Regulation of gene expression by Hypoxia-inducible Factor"], ["TCGA.D5.6531.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.D5.6531.01", "IGF1R signaling cascade"], ["TCGA.D5.6531.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6531.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6531.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6531.01", "Insulin receptor signalling cascade"], ["TCGA.D5.6531.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.D5.6531.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6531.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6531.01", "IRS-mediated signalling"], ["TCGA.D5.6531.01", "Signaling Pathways"], ["TCGA.D5.6531.01", "Ion channel transport"], ["TCGA.D5.6531.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6531.01", "Formation of axial mesoderm"], ["TCGA.D5.6531.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6531.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6531.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.D5.6531.01", "Peptide hormone metabolism"], ["TCGA.D5.6532.01", "Neuronal System"], ["TCGA.D5.6532.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.D5.6532.01", "Signaling Pathways"], ["TCGA.D5.6532.01", "Generation of second messenger molecules"], ["TCGA.D5.6532.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.D5.6532.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.D5.6532.01", "Potassium Channels"], ["TCGA.D5.6532.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6532.01", "G alpha (i) signalling events"], ["TCGA.D5.6532.01", "GPCR downstream signalling"], ["TCGA.D5.6532.01", "Signaling by GPCR"], ["TCGA.D5.6532.01", "PD-1 signaling"], ["TCGA.D5.6532.01", "Platelet homeostasis"], ["TCGA.D5.6532.01", "Immune System"], ["TCGA.D5.6532.01", "Cardiac conduction"], ["TCGA.D5.6532.01", "Leishmania infection"], ["TCGA.D5.6532.01", "Parasitic Infection Pathways"], ["TCGA.D5.6532.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.D5.6532.01", "Extracellular matrix organization"], ["TCGA.D5.6532.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6532.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6532.01", "Complement cascade"], ["TCGA.D5.6532.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.D5.6532.01", "Regulation of Complement cascade"], ["TCGA.D5.6532.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.D5.6532.01", "Leishmania parasite growth and survival"], ["TCGA.D5.6532.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6532.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.D5.6532.01", "Classical antibody-mediated complement activation"], ["TCGA.D5.6532.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.6532.01", "Regulation of insulin secretion"], ["TCGA.D5.6532.01", "RA biosynthesis pathway"], ["TCGA.D5.6532.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6532.01", "G-protein beta:gamma signalling"], ["TCGA.D5.6532.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6532.01", "GPCR ligand binding"], ["TCGA.D5.6532.01", "Protein-protein interactions at synapses"], ["TCGA.D5.6532.01", "Muscle contraction"], ["TCGA.D5.6532.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.D5.6532.01", "Costimulation by the CD28 family"], ["TCGA.D5.6532.01", "Peptide hormone metabolism"], ["TCGA.D5.6532.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.D5.6532.01", "Signal amplification"], ["TCGA.D5.6532.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6532.01", "G protein gated Potassium channels"], ["TCGA.D5.6532.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6532.01", "Initial triggering of complement"], ["TCGA.D5.6532.01", "G beta:gamma signalling through CDC42"], ["TCGA.D5.6532.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.D5.6532.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.D5.6532.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6532.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6532.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.6532.01", "GABA B receptor activation"], ["TCGA.D5.6532.01", "Activation of GABAB receptors"], ["TCGA.D5.6532.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6532.01", "Blood group systems biosynthesis"], ["TCGA.D5.6532.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6532.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6532.01", "Neurexins and neuroligins"], ["TCGA.D5.6532.01", "GABA receptor activation"], ["TCGA.D5.6532.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6532.01", "Biological oxidations"], ["TCGA.D5.6532.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6532.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.6532.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.D5.6532.01", "NCAM signaling for neurite out-growth"], ["TCGA.D5.6532.01", "G alpha (s) signalling events"], ["TCGA.D5.6532.01", "Ion channel transport"], ["TCGA.D5.6532.01", "L1CAM interactions"], ["TCGA.D5.6532.01", "Molecules associated with elastic fibres"], ["TCGA.D5.6532.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.D5.6532.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.D5.6532.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.D5.6532.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6532.01", "NCAM1 interactions"], ["TCGA.D5.6532.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6532.01", "Scavenging of heme from plasma"], ["TCGA.D5.6532.01", "G beta:gamma signalling through PLC beta"], ["TCGA.D5.6532.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6532.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6532.01", "CD22 mediated BCR regulation"], ["TCGA.D5.6532.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.6532.01", "Integration of energy metabolism"], ["TCGA.D5.6532.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.D5.6532.01", "Voltage gated Potassium channels"], ["TCGA.D5.6532.01", "Peptide ligand-binding receptors"], ["TCGA.D5.6532.01", "Adaptive Immune System"], ["TCGA.D5.6532.01", "Ion homeostasis"], ["TCGA.D5.6532.01", "Interleukin-10 signaling"], ["TCGA.D5.6532.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6532.01", "CD28 dependent Vav1 pathway"], ["TCGA.D5.6532.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.D5.6532.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.D5.6532.01", "Cell surface interactions at the vascular wall"], ["TCGA.D5.6532.01", "Ca2+ pathway"], ["TCGA.D5.6532.01", "Activation of the phototransduction cascade"], ["TCGA.D5.6532.01", "Aspartate and asparagine metabolism"], ["TCGA.D5.6532.01", "GPER1 signaling"], ["TCGA.D5.6532.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.D5.6532.01", "Diseases of Immune System"], ["TCGA.D5.6532.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.D5.6532.01", "Synaptic adhesion-like molecules"], ["TCGA.D5.6532.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6532.01", "Creation of C4 and C2 activators"], ["TCGA.D5.6532.01", "Innate Immune System"], ["TCGA.D5.6532.01", "Transport of small molecules"], ["TCGA.D5.6532.01", "Stimuli-sensing channels"], ["TCGA.D5.6532.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.D5.6532.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.D5.6532.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.D5.6532.01", "TCR signaling"], ["TCGA.D5.6532.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6532.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6532.01", "G-protein activation"], ["TCGA.D5.6532.01", "Thromboxane signalling through TP receptor"], ["TCGA.D5.6532.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6532.01", "Elastic fibre formation"], ["TCGA.D5.6532.01", "DAP12 signaling"], ["TCGA.D5.6532.01", "Sialic acid metabolism"], ["TCGA.D5.6532.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.D5.6532.01", "G alpha (z) signalling events"], ["TCGA.D5.6532.01", "Visual phototransduction"], ["TCGA.D5.6533.01", "Neuronal System"], ["TCGA.D5.6533.01", "Biological oxidations"], ["TCGA.D5.6533.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6533.01", "Signaling by GPCR"], ["TCGA.D5.6533.01", "Drug ADME"], ["TCGA.D5.6533.01", "G alpha (i) signalling events"], ["TCGA.D5.6533.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6533.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6533.01", "GPCR ligand binding"], ["TCGA.D5.6533.01", "Extracellular matrix organization"], ["TCGA.D5.6533.01", "GPCR downstream signalling"], ["TCGA.D5.6533.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6533.01", "Glutathione conjugation"], ["TCGA.D5.6533.01", "Regulation of insulin secretion"], ["TCGA.D5.6533.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6533.01", "Metabolism"], ["TCGA.D5.6533.01", "Aspirin ADME"], ["TCGA.D5.6533.01", "Blood group systems biosynthesis"], ["TCGA.D5.6533.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6533.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6533.01", "Neurexins and neuroligins"], ["TCGA.D5.6533.01", "RA biosynthesis pathway"], ["TCGA.D5.6533.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.6533.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6533.01", "Keratan sulfate biosynthesis"], ["TCGA.D5.6533.01", "Arachidonic acid metabolism"], ["TCGA.D5.6533.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.D5.6533.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.D5.6533.01", "Glycosaminoglycan metabolism"], ["TCGA.D5.6533.01", "Acyl chain remodelling of PE"], ["TCGA.D5.6533.01", "Ethanol oxidation"], ["TCGA.D5.6533.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.6533.01", "Potassium Channels"], ["TCGA.D5.6533.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6533.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.D5.6533.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6533.01", "Formation of axial mesoderm"], ["TCGA.D5.6533.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.6533.01", "Integration of energy metabolism"], ["TCGA.D5.6533.01", "Phase I - Functionalization of compounds"], ["TCGA.D5.6533.01", "Protein-protein interactions at synapses"], ["TCGA.D5.6533.01", "Signaling Pathways"], ["TCGA.D5.6533.01", "Acyl chain remodelling of PS"], ["TCGA.D5.6533.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6533.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6533.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6533.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6533.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.6533.01", "Interleukin-6 family signaling"], ["TCGA.D5.6533.01", "Glucuronidation"], ["TCGA.D5.6534.01", "Extracellular matrix organization"], ["TCGA.D5.6534.01", "Collagen formation"], ["TCGA.D5.6534.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6534.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6534.01", "Collagen chain trimerization"], ["TCGA.D5.6534.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6534.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6534.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6534.01", "Biological oxidations"], ["TCGA.D5.6534.01", "Drug ADME"], ["TCGA.D5.6534.01", "Integrin cell surface interactions"], ["TCGA.D5.6534.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6534.01", "Glucuronidation"], ["TCGA.D5.6534.01", "ECM proteoglycans"], ["TCGA.D5.6534.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.D5.6534.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6534.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6534.01", "APAP ADME"], ["TCGA.D5.6534.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.D5.6534.01", "Collagen degradation"], ["TCGA.D5.6534.01", "Diseases of glycosylation"], ["TCGA.D5.6534.01", "Post-translational protein phosphorylation"], ["TCGA.D5.6534.01", "Degradation of cysteine and homocysteine"], ["TCGA.D5.6534.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6534.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6534.01", "Aspirin ADME"], ["TCGA.D5.6534.01", "Visual phototransduction"], ["TCGA.D5.6534.01", "Diseases of metabolism"], ["TCGA.D5.6534.01", "Metabolism"], ["TCGA.D5.6534.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], ["TCGA.D5.6534.01", "Metabolism of fat-soluble vitamins"], ["TCGA.D5.6534.01", "Retinoid metabolism and transport"], ["TCGA.D5.6534.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.6534.01", "Chondroitin sulfate biosynthesis"], ["TCGA.D5.6534.01", "Other semaphorin interactions"], ["TCGA.D5.6534.01", "O-linked glycosylation"], ["TCGA.D5.6534.01", "Scavenging by Class A Receptors"], ["TCGA.D5.6534.01", "Glycosaminoglycan metabolism"], ["TCGA.D5.6534.01", "Peptide hormone biosynthesis"], ["TCGA.D5.6534.01", "Aflatoxin activation and detoxification"], ["TCGA.D5.6534.01", "LGI-ADAM interactions"], ["TCGA.D5.6535.01", "Neuronal System"], ["TCGA.D5.6535.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6535.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6535.01", "Platelet homeostasis"], ["TCGA.D5.6535.01", "GABA receptor activation"], ["TCGA.D5.6535.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6535.01", "Biological oxidations"], ["TCGA.D5.6535.01", "Potassium Channels"], ["TCGA.D5.6535.01", "Regulation of insulin secretion"], ["TCGA.D5.6535.01", "G alpha (i) signalling events"], ["TCGA.D5.6535.01", "G alpha (s) signalling events"], ["TCGA.D5.6535.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6535.01", "Integration of energy metabolism"], ["TCGA.D5.6535.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6535.01", "Drug ADME"], ["TCGA.D5.6535.01", "GPCR ligand binding"], ["TCGA.D5.6535.01", "GABA B receptor activation"], ["TCGA.D5.6535.01", "Activation of GABAB receptors"], ["TCGA.D5.6535.01", "Cardiac conduction"], ["TCGA.D5.6535.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.D5.6535.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6535.01", "Signal amplification"], ["TCGA.D5.6535.01", "Signaling by GPCR"], ["TCGA.D5.6535.01", "GPCR downstream signalling"], ["TCGA.D5.6535.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6535.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6535.01", "G protein gated Potassium channels"], ["TCGA.D5.6535.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6535.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6535.01", "Stimuli-sensing channels"], ["TCGA.D5.6535.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6535.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6535.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6535.01", "Ethanol oxidation"], ["TCGA.D5.6535.01", "G alpha (z) signalling events"], ["TCGA.D5.6535.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6535.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6535.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.D5.6535.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6535.01", "RA biosynthesis pathway"], ["TCGA.D5.6535.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6535.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6535.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.D5.6535.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6535.01", "Muscle contraction"], ["TCGA.D5.6535.01", "G beta:gamma signalling through PLC beta"], ["TCGA.D5.6535.01", "G beta:gamma signalling through CDC42"], ["TCGA.D5.6535.01", "APAP ADME"], ["TCGA.D5.6535.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6535.01", "L1CAM interactions"], ["TCGA.D5.6535.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6535.01", "Attenuation phase"], ["TCGA.D5.6535.01", "Transport of small molecules"], ["TCGA.D5.6535.01", "Neurexins and neuroligins"], ["TCGA.D5.6535.01", "Regulation of FZD by ubiquitination"], ["TCGA.D5.6535.01", "Aspartate and asparagine metabolism"], ["TCGA.D5.6535.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6535.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.D5.6535.01", "Opioid Signalling"], ["TCGA.D5.6535.01", "Fatty acid metabolism"], ["TCGA.D5.6535.01", "G-protein activation"], ["TCGA.D5.6535.01", "Thromboxane signalling through TP receptor"], ["TCGA.D5.6535.01", "Extracellular matrix organization"], ["TCGA.D5.6535.01", "Regulation of gene expression by Hypoxia-inducible Factor"], ["TCGA.D5.6535.01", "Sensory processing of sound"], ["TCGA.D5.6536.01", "Signaling by GPCR"], ["TCGA.D5.6536.01", "GPCR downstream signalling"], ["TCGA.D5.6536.01", "GPCR ligand binding"], ["TCGA.D5.6536.01", "Extracellular matrix organization"], ["TCGA.D5.6536.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.6536.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6536.01", "Peptide ligand-binding receptors"], ["TCGA.D5.6536.01", "G alpha (i) signalling events"], ["TCGA.D5.6536.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6536.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.D5.6536.01", "GABA receptor activation"], ["TCGA.D5.6536.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6536.01", "Neuronal System"], ["TCGA.D5.6536.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6536.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6536.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6536.01", "Collagen formation"], ["TCGA.D5.6536.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6536.01", "GABA B receptor activation"], ["TCGA.D5.6536.01", "Activation of GABAB receptors"], ["TCGA.D5.6536.01", "Signal amplification"], ["TCGA.D5.6536.01", "G alpha (s) signalling events"], ["TCGA.D5.6536.01", "G alpha (q) signalling events"], ["TCGA.D5.6536.01", "Biological oxidations"], ["TCGA.D5.6536.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6536.01", "G protein gated Potassium channels"], ["TCGA.D5.6536.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6536.01", "G-protein activation"], ["TCGA.D5.6536.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6536.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6536.01", "Generation of second messenger molecules"], ["TCGA.D5.6536.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.D5.6536.01", "Signaling Pathways"], ["TCGA.D5.6536.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6536.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6536.01", "Peptide hormone biosynthesis"], ["TCGA.D5.6536.01", "Collagen degradation"], ["TCGA.D5.6536.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6536.01", "Drug ADME"], ["TCGA.D5.6536.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.D5.6536.01", "Thromboxane signalling through TP receptor"], ["TCGA.D5.6536.01", "Regulation of insulin secretion"], ["TCGA.D5.6536.01", "G beta:gamma signalling through CDC42"], ["TCGA.D5.6536.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.D5.6536.01", "Platelet activation, signaling and aggregation"], ["TCGA.D5.6536.01", "PD-1 signaling"], ["TCGA.D5.6536.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6536.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.D5.6536.01", "Leishmania parasite growth and survival"], ["TCGA.D5.6536.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6536.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.D5.6536.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.D5.6536.01", "Peptide hormone metabolism"], ["TCGA.D5.6536.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6536.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6536.01", "G alpha (z) signalling events"], ["TCGA.D5.6536.01", "Integration of energy metabolism"], ["TCGA.D5.6536.01", "Molecules associated with elastic fibres"], ["TCGA.D5.6536.01", "Collagen chain trimerization"], ["TCGA.D5.6536.01", "Elastic fibre formation"], ["TCGA.D5.6536.01", "Opioid Signalling"], ["TCGA.D5.6536.01", "Glucuronidation"], ["TCGA.D5.6536.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.D5.6536.01", "G-protein beta:gamma signalling"], ["TCGA.D5.6536.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6536.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.6536.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.D5.6536.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.D5.6536.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.D5.6536.01", "G beta:gamma signalling through PLC beta"], ["TCGA.D5.6536.01", "SUMOylation of intracellular receptors"], ["TCGA.D5.6536.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6536.01", "Potassium Channels"], ["TCGA.D5.6536.01", "Nuclear Receptor transcription pathway"], ["TCGA.D5.6536.01", "Leishmania infection"], ["TCGA.D5.6536.01", "Parasitic Infection Pathways"], ["TCGA.D5.6536.01", "Interleukin-10 signaling"], ["TCGA.D5.6536.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.D5.6536.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6536.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6536.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.D5.6536.01", "Aquaporin-mediated transport"], ["TCGA.D5.6536.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.D5.6536.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6536.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6536.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.D5.6536.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.D5.6536.01", "GPER1 signaling"], ["TCGA.D5.6536.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.D5.6537.01", "Neuronal System"], ["TCGA.D5.6537.01", "Signaling by GPCR"], ["TCGA.D5.6537.01", "Signaling Pathways"], ["TCGA.D5.6537.01", "GPCR downstream signalling"], ["TCGA.D5.6537.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6537.01", "G alpha (i) signalling events"], ["TCGA.D5.6537.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6537.01", "Cardiac conduction"], ["TCGA.D5.6537.01", "Potassium Channels"], ["TCGA.D5.6537.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6537.01", "Complement cascade"], ["TCGA.D5.6537.01", "G-protein mediated events"], ["TCGA.D5.6537.01", "Regulation of Complement cascade"], ["TCGA.D5.6537.01", "GPCR ligand binding"], ["TCGA.D5.6537.01", "Opioid Signalling"], ["TCGA.D5.6537.01", "Muscle contraction"], ["TCGA.D5.6537.01", "PLC beta mediated events"], ["TCGA.D5.6537.01", "Ca-dependent events"], ["TCGA.D5.6537.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.D5.6537.01", "Calmodulin induced events"], ["TCGA.D5.6537.01", "CaM pathway"], ["TCGA.D5.6537.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.D5.6537.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.6537.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6537.01", "Regulation of insulin secretion"], ["TCGA.D5.6537.01", "DAG and IP3 signaling"], ["TCGA.D5.6537.01", "Integration of energy metabolism"], ["TCGA.D5.6537.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6537.01", "G alpha (s) signalling events"], ["TCGA.D5.6537.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6537.01", "Drug ADME"], ["TCGA.D5.6537.01", "GABA receptor activation"], ["TCGA.D5.6537.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.D5.6537.01", "GABA B receptor activation"], ["TCGA.D5.6537.01", "Activation of GABAB receptors"], ["TCGA.D5.6537.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.D5.6537.01", "Leishmania parasite growth and survival"], ["TCGA.D5.6537.01", "Platelet homeostasis"], ["TCGA.D5.6537.01", "Biological oxidations"], ["TCGA.D5.6537.01", "Activation of NMDA receptors and postsynaptic events"], ["TCGA.D5.6537.01", "Classical antibody-mediated complement activation"], ["TCGA.D5.6537.01", "Initial triggering of complement"], ["TCGA.D5.6537.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.D5.6537.01", "Blood group systems biosynthesis"], ["TCGA.D5.6537.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6537.01", "Signal amplification"], ["TCGA.D5.6537.01", "Ion homeostasis"], ["TCGA.D5.6537.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6537.01", "L1CAM interactions"], ["TCGA.D5.6537.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.D5.6537.01", "Generation of second messenger molecules"], ["TCGA.D5.6537.01", "G-protein beta:gamma signalling"], ["TCGA.D5.6537.01", "Extracellular matrix organization"], ["TCGA.D5.6537.01", "Ca2+ pathway"], ["TCGA.D5.6537.01", "Molecules associated with elastic fibres"], ["TCGA.D5.6537.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.D5.6537.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6537.01", "G alpha (z) signalling events"], ["TCGA.D5.6537.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6537.01", "Recycling of bile acids and salts"], ["TCGA.D5.6537.01", "Activation of the phototransduction cascade"], ["TCGA.D5.6537.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6537.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.D5.6537.01", "Post NMDA receptor activation events"], ["TCGA.D5.6537.01", "Peptide ligand-binding receptors"], ["TCGA.D5.6537.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6537.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.6537.01", "GPER1 signaling"], ["TCGA.D5.6537.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.D5.6537.01", "PD-1 signaling"], ["TCGA.D5.6537.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6537.01", "Platelet activation, signaling and aggregation"], ["TCGA.D5.6537.01", "Ion transport by P-type ATPases"], ["TCGA.D5.6537.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6537.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6537.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6537.01", "Regulation of FZD by ubiquitination"], ["TCGA.D5.6537.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.D5.6537.01", "Visual phototransduction"], ["TCGA.D5.6537.01", "Leishmania infection"], ["TCGA.D5.6537.01", "Parasitic Infection Pathways"], ["TCGA.D5.6537.01", "SUMOylation of intracellular receptors"], ["TCGA.D5.6537.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.D5.6537.01", "Trafficking of AMPA receptors"], ["TCGA.D5.6537.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.D5.6537.01", "Other semaphorin interactions"], ["TCGA.D5.6537.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.D5.6537.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.D5.6537.01", "Aquaporin-mediated transport"], ["TCGA.D5.6537.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.D5.6537.01", "Heme degradation"], ["TCGA.D5.6537.01", "Metabolism of fat-soluble vitamins"], ["TCGA.D5.6537.01", "Retinoid metabolism and transport"], ["TCGA.D5.6537.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6537.01", "G protein gated Potassium channels"], ["TCGA.D5.6537.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6537.01", "CD22 mediated BCR regulation"], ["TCGA.D5.6537.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.D5.6537.01", "G-protein activation"], ["TCGA.D5.6537.01", "Thromboxane signalling through TP receptor"], ["TCGA.D5.6537.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.D5.6537.01", "Aspirin ADME"], ["TCGA.D5.6537.01", "G beta:gamma signalling through CDC42"], ["TCGA.D5.6537.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.D5.6537.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.D5.6537.01", "Keratan sulfate biosynthesis"], ["TCGA.D5.6537.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6537.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6537.01", "Voltage gated Potassium channels"], ["TCGA.D5.6537.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6537.01", "Long-term potentiation"], ["TCGA.D5.6537.01", "Sensory processing of sound"], ["TCGA.D5.6537.01", "NCAM signaling for neurite out-growth"], ["TCGA.D5.6537.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.D5.6537.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.D5.6537.01", "Nuclear Receptor transcription pathway"], ["TCGA.D5.6537.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.D5.6537.01", "Formation of the anterior neural plate"], ["TCGA.D5.6537.01", "PKA activation in glucagon signalling"], ["TCGA.D5.6537.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.D5.6537.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.D5.6537.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6537.01", "Creation of C4 and C2 activators"], ["TCGA.D5.6537.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6537.01", "Diseases of Immune System"], ["TCGA.D5.6537.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.D5.6537.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.D5.6537.01", "Glycosaminoglycan metabolism"], ["TCGA.D5.6537.01", "NCAM1 interactions"], ["TCGA.D5.6537.01", "Other interleukin signaling"], ["TCGA.D5.6537.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.D5.6538.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.D5.6538.01", "Immune System"], ["TCGA.D5.6538.01", "Neuronal System"], ["TCGA.D5.6538.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.6538.01", "PD-1 signaling"], ["TCGA.D5.6538.01", "Generation of second messenger molecules"], ["TCGA.D5.6538.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.D5.6538.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.D5.6538.01", "Innate Immune System"], ["TCGA.D5.6538.01", "Cytokine Signaling in Immune system"], ["TCGA.D5.6538.01", "Signaling by GPCR"], ["TCGA.D5.6538.01", "GPCR downstream signalling"], ["TCGA.D5.6538.01", "G alpha (i) signalling events"], ["TCGA.D5.6538.01", "Regulation of Complement cascade"], ["TCGA.D5.6538.01", "GPCR ligand binding"], ["TCGA.D5.6538.01", "Complement cascade"], ["TCGA.D5.6538.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6538.01", "Leishmania infection"], ["TCGA.D5.6538.01", "Parasitic Infection Pathways"], ["TCGA.D5.6538.01", "Potassium Channels"], ["TCGA.D5.6538.01", "Adaptive Immune System"], ["TCGA.D5.6538.01", "Peptide ligand-binding receptors"], ["TCGA.D5.6538.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6538.01", "Signaling Pathways"], ["TCGA.D5.6538.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.D5.6538.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.D5.6538.01", "Interleukin-10 signaling"], ["TCGA.D5.6538.01", "Classical antibody-mediated complement activation"], ["TCGA.D5.6538.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.D5.6538.01", "Costimulation by the CD28 family"], ["TCGA.D5.6538.01", "Interferon gamma signaling"], ["TCGA.D5.6538.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.D5.6538.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.D5.6538.01", "Voltage gated Potassium channels"], ["TCGA.D5.6538.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6538.01", "Neurexins and neuroligins"], ["TCGA.D5.6538.01", "Diseases of Immune System"], ["TCGA.D5.6538.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.D5.6538.01", "Regulation of TLR by endogenous ligand"], ["TCGA.D5.6538.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.D5.6538.01", "Activation of the phototransduction cascade"], ["TCGA.D5.6538.01", "Binding and entry of HIV virion"], ["TCGA.D5.6538.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.D5.6538.01", "Leishmania parasite growth and survival"], ["TCGA.D5.6538.01", "Interferon alpha/beta signaling"], ["TCGA.D5.6538.01", "Signaling by Interleukins"], ["TCGA.D5.6538.01", "Trafficking and processing of endosomal TLR"], ["TCGA.D5.6538.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.D5.6538.01", "MHC class II antigen presentation"], ["TCGA.D5.6538.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.D5.6538.01", "Ion channel transport"], ["TCGA.D5.6538.01", "Platelet homeostasis"], ["TCGA.D5.6538.01", "Platelet calcium homeostasis"], ["TCGA.D5.6538.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6538.01", "Protein-protein interactions at synapses"], ["TCGA.D5.6538.01", "Defensins"], ["TCGA.D5.6538.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6538.01", "DAP12 interactions"], ["TCGA.D5.6538.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.6538.01", "Initial triggering of complement"], ["TCGA.D5.6538.01", "Ligand-dependent caspase activation"], ["TCGA.D5.6538.01", "CD22 mediated BCR regulation"], ["TCGA.D5.6538.01", "Stimuli-sensing channels"], ["TCGA.D5.6538.01", "GABA receptor activation"], ["TCGA.D5.6538.01", "Peptide hormone metabolism"], ["TCGA.D5.6538.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6538.01", "Interleukin-2 family signaling"], ["TCGA.D5.6538.01", "Cardiac conduction"], ["TCGA.D5.6538.01", "Keratan sulfate biosynthesis"], ["TCGA.D5.6538.01", "G-protein beta:gamma signalling"], ["TCGA.D5.6538.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6538.01", "Dectin-2 family"], ["TCGA.D5.6538.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.6538.01", "FCGR activation"], ["TCGA.D5.6538.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6538.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.6538.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.D5.6538.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.D5.6538.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.D5.6538.01", "Extracellular matrix organization"], ["TCGA.D5.6538.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.D5.6538.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6538.01", "Creation of C4 and C2 activators"], ["TCGA.D5.6538.01", "LGI-ADAM interactions"], ["TCGA.D5.6538.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6538.01", "Toll-like Receptor Cascades"], ["TCGA.D5.6538.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.D5.6538.01", "Other interleukin signaling"], ["TCGA.D5.6538.01", "Interferon Signaling"], ["TCGA.D5.6538.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6538.01", "G protein gated Potassium channels"], ["TCGA.D5.6538.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6538.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6538.01", "Regulation of insulin secretion"], ["TCGA.D5.6539.01", "DLGAP4"], ["TCGA.D5.6539.01", "GRIA2"], ["TCGA.D5.6539.01", "RELN"], ["TCGA.D5.6539.01", "KCNN3"], ["TCGA.D5.6539.01", "NPFFR2"], ["TCGA.D5.6539.01", "OR2AK2"], ["TCGA.D5.6539.01", "KRAS"], ["TCGA.D5.6539.01", "SYNE1"], ["TCGA.D5.6539.01", "BRD4"], ["TCGA.D5.6539.01", "OR3A1"], ["TCGA.D5.6539.01", "PIK3C2G"], ["TCGA.D5.6539.01", "DSEL"], ["TCGA.D5.6539.01", "ARRB2"], ["TCGA.D5.6539.01", "CLASP1"], ["TCGA.D5.6539.01", "MYO18B"], ["TCGA.D5.6539.01", "KERA"], ["TCGA.D5.6539.01", "NR1H4"], ["TCGA.D5.6539.01", "TP53"], ["TCGA.D5.6539.01", "MYBPC1"], ["TCGA.D5.6539.01", "TBP"], ["TCGA.D5.6539.01", "EIF2AK1"], ["TCGA.D5.6539.01", "PTEN"], ["TCGA.D5.6539.01", "OR6C4"], ["TCGA.D5.6539.01", "SEMA3D"], ["TCGA.D5.6539.01", "KDR"], ["TCGA.D5.6540.01", "Neuronal System"], ["TCGA.D5.6540.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6540.01", "GPCR downstream signalling"], ["TCGA.D5.6540.01", "Signaling by GPCR"], ["TCGA.D5.6540.01", "Biological oxidations"], ["TCGA.D5.6540.01", "Drug ADME"], ["TCGA.D5.6540.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6540.01", "GPCR ligand binding"], ["TCGA.D5.6540.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6540.01", "G alpha (i) signalling events"], ["TCGA.D5.6540.01", "Extracellular matrix organization"], ["TCGA.D5.6540.01", "Ethanol oxidation"], ["TCGA.D5.6540.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6540.01", "RA biosynthesis pathway"], ["TCGA.D5.6540.01", "Regulation of insulin secretion"], ["TCGA.D5.6540.01", "Glucuronidation"], ["TCGA.D5.6540.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.D5.6540.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6540.01", "Signaling Pathways"], ["TCGA.D5.6540.01", "NCAM1 interactions"], ["TCGA.D5.6540.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6540.01", "Potassium Channels"], ["TCGA.D5.6540.01", "G alpha (s) signalling events"], ["TCGA.D5.6540.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6540.01", "Cardiac conduction"], ["TCGA.D5.6540.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6540.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6540.01", "Phase I - Functionalization of compounds"], ["TCGA.D5.6540.01", "Integration of energy metabolism"], ["TCGA.D5.6540.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.D5.6540.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.6540.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6540.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6540.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6540.01", "Stimuli-sensing channels"], ["TCGA.D5.6540.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.D5.6540.01", "Peptide ligand-binding receptors"], ["TCGA.D5.6540.01", "Aspirin ADME"], ["TCGA.D5.6540.01", "L1CAM interactions"], ["TCGA.D5.6540.01", "Collagen formation"], ["TCGA.D5.6540.01", "Sensory processing of sound"], ["TCGA.D5.6540.01", "NCAM signaling for neurite out-growth"], ["TCGA.D5.6540.01", "Protein-protein interactions at synapses"], ["TCGA.D5.6540.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.D5.6540.01", "CD22 mediated BCR regulation"], ["TCGA.D5.6540.01", "Transport of small molecules"], ["TCGA.D5.6540.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.D5.6540.01", "Neurexins and neuroligins"], ["TCGA.D5.6540.01", "GABA receptor activation"], ["TCGA.D5.6540.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6540.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6540.01", "Activation of the phototransduction cascade"], ["TCGA.D5.6540.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6540.01", "Neurotransmitter release cycle"], ["TCGA.D5.6540.01", "Arachidonic acid metabolism"], ["TCGA.D5.6540.01", "Nicotinate metabolism"], ["TCGA.D5.6540.01", "LGI-ADAM interactions"], ["TCGA.D5.6540.01", "Collagen chain trimerization"], ["TCGA.D5.6540.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.D5.6540.01", "SLC-mediated transmembrane transport"], ["TCGA.D5.6540.01", "G alpha (q) signalling events"], ["TCGA.D5.6540.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6540.01", "G alpha (12/13) signalling events"], ["TCGA.D5.6540.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6540.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.6540.01", "G-protein beta:gamma signalling"], ["TCGA.D5.6540.01", "G beta:gamma signalling through CDC42"], ["TCGA.D5.6540.01", "APAP ADME"], ["TCGA.D5.6541.01", "Neuronal System"], ["TCGA.D5.6541.01", "Extracellular matrix organization"], ["TCGA.D5.6541.01", "Protein-protein interactions at synapses"], ["TCGA.D5.6541.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6541.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6541.01", "Signaling by GPCR"], ["TCGA.D5.6541.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6541.01", "GPCR downstream signalling"], ["TCGA.D5.6541.01", "Cardiac conduction"], ["TCGA.D5.6541.01", "NCAM1 interactions"], ["TCGA.D5.6541.01", "Collagen formation"], ["TCGA.D5.6541.01", "GPCR ligand binding"], ["TCGA.D5.6541.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6541.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6541.01", "Collagen chain trimerization"], ["TCGA.D5.6541.01", "G alpha (i) signalling events"], ["TCGA.D5.6541.01", "Neurexins and neuroligins"], ["TCGA.D5.6541.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6541.01", "G alpha (s) signalling events"], ["TCGA.D5.6541.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6541.01", "Ethanol oxidation"], ["TCGA.D5.6541.01", "O-linked glycosylation"], ["TCGA.D5.6541.01", "Potassium Channels"], ["TCGA.D5.6541.01", "Regulation of insulin secretion"], ["TCGA.D5.6541.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6541.01", "NCAM signaling for neurite out-growth"], ["TCGA.D5.6541.01", "Synaptic adhesion-like molecules"], ["TCGA.D5.6541.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6541.01", "Drug ADME"], ["TCGA.D5.6541.01", "Signal amplification"], ["TCGA.D5.6541.01", "Biological oxidations"], ["TCGA.D5.6541.01", "GABA receptor activation"], ["TCGA.D5.6541.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6541.01", "Integration of energy metabolism"], ["TCGA.D5.6541.01", "Signaling Pathways"], ["TCGA.D5.6541.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6541.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6541.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6541.01", "ECM proteoglycans"], ["TCGA.D5.6541.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6541.01", "Heme degradation"], ["TCGA.D5.6541.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.D5.6541.01", "Arachidonic acid metabolism"], ["TCGA.D5.6541.01", "Diseases of glycosylation"], ["TCGA.D5.6541.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6541.01", "Muscle contraction"], ["TCGA.D5.6541.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6541.01", "RA biosynthesis pathway"], ["TCGA.D5.6541.01", "Peptide ligand-binding receptors"], ["TCGA.D5.6541.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6541.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6541.01", "L1CAM interactions"], ["TCGA.D5.6541.01", "Phase I - Functionalization of compounds"], ["TCGA.D5.6541.01", "WNT ligand biogenesis and trafficking"], ["TCGA.D5.6541.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6541.01", "GABA B receptor activation"], ["TCGA.D5.6541.01", "Activation of GABAB receptors"], ["TCGA.D5.6541.01", "Peptide hormone metabolism"], ["TCGA.D5.6541.01", "Metabolism of amine-derived hormones"], ["TCGA.D5.6541.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.D5.6541.01", "Diseases of metabolism"], ["TCGA.D5.6898.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6898.01", "Drug ADME"], ["TCGA.D5.6898.01", "Biological oxidations"], ["TCGA.D5.6898.01", "Blood group systems biosynthesis"], ["TCGA.D5.6898.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6898.01", "Glucuronidation"], ["TCGA.D5.6898.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6898.01", "Neuronal System"], ["TCGA.D5.6898.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6898.01", "Extracellular matrix organization"], ["TCGA.D5.6898.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6898.01", "Ethanol oxidation"], ["TCGA.D5.6898.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6898.01", "GPCR ligand binding"], ["TCGA.D5.6898.01", "Cardiac conduction"], ["TCGA.D5.6898.01", "Regulation of FZD by ubiquitination"], ["TCGA.D5.6898.01", "Estrogen-dependent nuclear events downstream of ESR-membrane signaling"], ["TCGA.D5.6898.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6898.01", "Peptide ligand-binding receptors"], ["TCGA.D5.6898.01", "Potassium Channels"], ["TCGA.D5.6898.01", "Extra-nuclear estrogen signaling"], ["TCGA.D5.6920.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6920.01", "Extracellular matrix organization"], ["TCGA.D5.6920.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6920.01", "Neuronal System"], ["TCGA.D5.6920.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6920.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6920.01", "Chemokine receptors bind chemokines"], ["TCGA.D5.6920.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6920.01", "GPCR ligand binding"], ["TCGA.D5.6920.01", "GABA receptor activation"], ["TCGA.D5.6920.01", "Molecules associated with elastic fibres"], ["TCGA.D5.6920.01", "Cardiac conduction"], ["TCGA.D5.6920.01", "G alpha (i) signalling events"], ["TCGA.D5.6920.01", "L1CAM interactions"], ["TCGA.D5.6920.01", "Diseases associated with glycosaminoglycan metabolism"], ["TCGA.D5.6920.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.D5.6920.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6920.01", "Long-term potentiation"], ["TCGA.D5.6920.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6920.01", "Regulation of FZD by ubiquitination"], ["TCGA.D5.6920.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.D5.6920.01", "Biological oxidations"], ["TCGA.D5.6920.01", "Elastic fibre formation"], ["TCGA.D5.6920.01", "Glycosaminoglycan metabolism"], ["TCGA.D5.6920.01", "Peptide hormone metabolism"], ["TCGA.D5.6920.01", "Basigin interactions"], ["TCGA.D5.6920.01", "Visual phototransduction"], ["TCGA.D5.6922.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6922.01", "Glucuronidation"], ["TCGA.D5.6922.01", "Biological oxidations"], ["TCGA.D5.6922.01", "GPCR downstream signalling"], ["TCGA.D5.6922.01", "Extracellular matrix organization"], ["TCGA.D5.6922.01", "Drug ADME"], ["TCGA.D5.6922.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6922.01", "G alpha (s) signalling events"], ["TCGA.D5.6922.01", "Signaling by GPCR"], ["TCGA.D5.6922.01", "Collagen formation"], ["TCGA.D5.6922.01", "RA biosynthesis pathway"], ["TCGA.D5.6922.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6922.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.D5.6922.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6924.01", "Extracellular matrix organization"], ["TCGA.D5.6924.01", "Collagen formation"], ["TCGA.D5.6924.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6924.01", "Biological oxidations"], ["TCGA.D5.6924.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6924.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6924.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6924.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6924.01", "Drug ADME"], ["TCGA.D5.6924.01", "Neuronal System"], ["TCGA.D5.6924.01", "Metabolism"], ["TCGA.D5.6924.01", "Collagen chain trimerization"], ["TCGA.D5.6924.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6924.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6924.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6924.01", "Transport of small molecules"], ["TCGA.D5.6924.01", "Blood group systems biosynthesis"], ["TCGA.D5.6924.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6924.01", "Signal amplification"], ["TCGA.D5.6924.01", "G alpha (i) signalling events"], ["TCGA.D5.6924.01", "Heme degradation"], ["TCGA.D5.6924.01", "RA biosynthesis pathway"], ["TCGA.D5.6924.01", "SLC-mediated transmembrane transport"], ["TCGA.D5.6924.01", "Glucuronidation"], ["TCGA.D5.6924.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.6924.01", "GPCR ligand binding"], ["TCGA.D5.6924.01", "GABA receptor activation"], ["TCGA.D5.6924.01", "APAP ADME"], ["TCGA.D5.6924.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.D5.6924.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6924.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.6924.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6924.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6924.01", "FGFR4 ligand binding and activation"], ["TCGA.D5.6924.01", "Collagen degradation"], ["TCGA.D5.6924.01", "Signaling by GPCR"], ["TCGA.D5.6924.01", "PI3K events in ERBB2 signaling"], ["TCGA.D5.6924.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.D5.6924.01", "ERBB2 Regulates Cell Motility"], ["TCGA.D5.6924.01", "Lewis blood group biosynthesis"], ["TCGA.D5.6924.01", "Aspartate and asparagine metabolism"], ["TCGA.D5.6924.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.6924.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6924.01", "GRB2 events in ERBB2 signaling"], ["TCGA.D5.6924.01", "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"], ["TCGA.D5.6924.01", "Integrin cell surface interactions"], ["TCGA.D5.6924.01", "Tryptophan catabolism"], ["TCGA.D5.6924.01", "Ethanol oxidation"], ["TCGA.D5.6924.01", "activated TAK1 mediates p38 MAPK activation"], ["TCGA.D5.6924.01", "Synaptic adhesion-like molecules"], ["TCGA.D5.6924.01", "G beta:gamma signalling through BTK"], ["TCGA.D5.6924.01", "Regulation of insulin secretion"], ["TCGA.D5.6924.01", "Signaling by ERBB4"], ["TCGA.D5.6924.01", "GPCR downstream signalling"], ["TCGA.D5.6924.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.D5.6924.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.D5.6924.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.D5.6924.01", "PI-3K cascade:FGFR4"], ["TCGA.D5.6924.01", "Response to elevated platelet cytosolic Ca2+"], ["TCGA.D5.6924.01", "Integration of energy metabolism"], ["TCGA.D5.6924.01", "Scavenging by Class A Receptors"], ["TCGA.D5.6924.01", "G beta:gamma signalling through PLC beta"], ["TCGA.D5.6924.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.D5.6924.01", "G beta:gamma signalling through CDC42"], ["TCGA.D5.6924.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.D5.6924.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6924.01", "Glutathione conjugation"], ["TCGA.D5.6924.01", "Peptide ligand-binding receptors"], ["TCGA.D5.6924.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6924.01", "Defective GALNT3 causes HFTC"], ["TCGA.D5.6924.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.D5.6924.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.D5.6924.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.D5.6924.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6924.01", "SHC-mediated cascade:FGFR4"], ["TCGA.D5.6924.01", "Long-term potentiation"], ["TCGA.D5.6924.01", "IRS-related events triggered by IGF1R"], ["TCGA.D5.6924.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.D5.6924.01", "IGF1R signaling cascade"], ["TCGA.D5.6924.01", "O-linked glycosylation of mucins"], ["TCGA.D5.6924.01", "FGFR2c ligand binding and activation"], ["TCGA.D5.6924.01", "Peptide hormone biosynthesis"], ["TCGA.D5.6924.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.D5.6924.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.D5.6924.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.D5.6924.01", "Aquaporin-mediated transport"], ["TCGA.D5.6924.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.D5.6924.01", "Regulation of FZD by ubiquitination"], ["TCGA.D5.6924.01", "FRS-mediated FGFR4 signaling"], ["TCGA.D5.6924.01", "Signaling by ERBB2 TMD/JMD mutants"], ["TCGA.D5.6924.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.D5.6924.01", "Ca2+ pathway"], ["TCGA.D5.6924.01", "Peptide hormone metabolism"], ["TCGA.D5.6924.01", "GPER1 signaling"], ["TCGA.D5.6924.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.D5.6924.01", "GABA B receptor activation"], ["TCGA.D5.6924.01", "Activation of GABAB receptors"], ["TCGA.D5.6924.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.D5.6924.01", "O-linked glycosylation"], ["TCGA.D5.6924.01", "Metal ion SLC transporters"], ["TCGA.D5.6924.01", "SHC1 events in ERBB2 signaling"], ["TCGA.D5.6924.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.D5.6924.01", "Signaling Pathways"], ["TCGA.D5.6924.01", "SHC1 events in ERBB4 signaling"], ["TCGA.D5.6924.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6924.01", "GRB2:SOS provides linkage to MAPK signaling for Integrins"], ["TCGA.D5.6924.01", "p130Cas linkage to MAPK signaling for integrins"], ["TCGA.D5.6926.01", "Extracellular matrix organization"], ["TCGA.D5.6926.01", "Collagen formation"], ["TCGA.D5.6926.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6926.01", "Biological oxidations"], ["TCGA.D5.6926.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6926.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6926.01", "Collagen chain trimerization"], ["TCGA.D5.6926.01", "Signaling by GPCR"], ["TCGA.D5.6926.01", "GPCR downstream signalling"], ["TCGA.D5.6926.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6926.01", "Glucuronidation"], ["TCGA.D5.6926.01", "Drug ADME"], ["TCGA.D5.6926.01", "G alpha (i) signalling events"], ["TCGA.D5.6926.01", "RA biosynthesis pathway"], ["TCGA.D5.6926.01", "Neuronal System"], ["TCGA.D5.6926.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6926.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6926.01", "Ethanol oxidation"], ["TCGA.D5.6926.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6926.01", "Metabolism"], ["TCGA.D5.6926.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6926.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.D5.6926.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6926.01", "GPCR ligand binding"], ["TCGA.D5.6926.01", "Regulation of insulin secretion"], ["TCGA.D5.6926.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.6926.01", "G alpha (s) signalling events"], ["TCGA.D5.6926.01", "Signal amplification"], ["TCGA.D5.6926.01", "Signaling Pathways"], ["TCGA.D5.6926.01", "Platelet homeostasis"], ["TCGA.D5.6926.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6926.01", "Glutathione conjugation"], ["TCGA.D5.6926.01", "G alpha (q) signalling events"], ["TCGA.D5.6926.01", "Potassium Channels"], ["TCGA.D5.6926.01", "NCAM signaling for neurite out-growth"], ["TCGA.D5.6926.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6926.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6926.01", "Inwardly rectifying K+ channels"], ["TCGA.D5.6926.01", "Integration of energy metabolism"], ["TCGA.D5.6926.01", "APAP ADME"], ["TCGA.D5.6926.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.6926.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.D5.6926.01", "Presynaptic function of Kainate receptors"], ["TCGA.D5.6926.01", "Activation of G protein gated Potassium channels"], ["TCGA.D5.6926.01", "G protein gated Potassium channels"], ["TCGA.D5.6926.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6926.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6926.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.D5.6926.01", "Visual phototransduction"], ["TCGA.D5.6926.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6926.01", "NCAM1 interactions"], ["TCGA.D5.6926.01", "Cardiac conduction"], ["TCGA.D5.6926.01", "GABA receptor activation"], ["TCGA.D5.6926.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6926.01", "Collagen degradation"], ["TCGA.D5.6927.01", "Extracellular matrix organization"], ["TCGA.D5.6927.01", "Collagen formation"], ["TCGA.D5.6927.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6927.01", "Neuronal System"], ["TCGA.D5.6927.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6927.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6927.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6927.01", "Collagen chain trimerization"], ["TCGA.D5.6927.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6927.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6927.01", "Drug ADME"], ["TCGA.D5.6927.01", "L1CAM interactions"], ["TCGA.D5.6927.01", "RA biosynthesis pathway"], ["TCGA.D5.6927.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.6927.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6927.01", "Cardiac conduction"], ["TCGA.D5.6927.01", "Glucuronidation"], ["TCGA.D5.6927.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6927.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6927.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6927.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.D5.6927.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.D5.6927.01", "NCAM1 interactions"], ["TCGA.D5.6927.01", "Biological oxidations"], ["TCGA.D5.6927.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6927.01", "Muscle contraction"], ["TCGA.D5.6927.01", "Integrin cell surface interactions"], ["TCGA.D5.6927.01", "Interleukin-6 family signaling"], ["TCGA.D5.6927.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6927.01", "NCAM signaling for neurite out-growth"], ["TCGA.D5.6927.01", "Metabolism"], ["TCGA.D5.6927.01", "GPCR ligand binding"], ["TCGA.D5.6927.01", "Peptide hormone metabolism"], ["TCGA.D5.6927.01", "Regulation of insulin secretion"], ["TCGA.D5.6927.01", "G alpha (i) signalling events"], ["TCGA.D5.6928.01", "Drug ADME"], ["TCGA.D5.6928.01", "Biological oxidations"], ["TCGA.D5.6928.01", "Extracellular matrix organization"], ["TCGA.D5.6928.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6928.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6928.01", "Glucuronidation"], ["TCGA.D5.6928.01", "Collagen formation"], ["TCGA.D5.6928.01", "Metabolism"], ["TCGA.D5.6928.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6928.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6928.01", "Ethanol oxidation"], ["TCGA.D5.6928.01", "Potassium Channels"], ["TCGA.D5.6928.01", "Neuronal System"], ["TCGA.D5.6928.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6928.01", "Collagen chain trimerization"], ["TCGA.D5.6928.01", "RA biosynthesis pathway"], ["TCGA.D5.6928.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6928.01", "Bile acid and bile salt metabolism"], ["TCGA.D5.6928.01", "Defective GALNT3 causes HFTC"], ["TCGA.D5.6928.01", "Defective GALNT12 causes CRCS1"], ["TCGA.D5.6928.01", "Synthesis of bile acids and bile salts"], ["TCGA.D5.6928.01", "APAP ADME"], ["TCGA.D5.6928.01", "Voltage gated Potassium channels"], ["TCGA.D5.6928.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.D5.6928.01", "Dectin-2 family"], ["TCGA.D5.6928.01", "O-linked glycosylation"], ["TCGA.D5.6929.01", "Extracellular matrix organization"], ["TCGA.D5.6929.01", "Neuronal System"], ["TCGA.D5.6929.01", "Signaling Pathways"], ["TCGA.D5.6929.01", "Biological oxidations"], ["TCGA.D5.6929.01", "Signaling by GPCR"], ["TCGA.D5.6929.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6929.01", "Glucuronidation"], ["TCGA.D5.6929.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6929.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6929.01", "GPCR downstream signalling"], ["TCGA.D5.6929.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6929.01", "Collagen formation"], ["TCGA.D5.6929.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.D5.6929.01", "G alpha (i) signalling events"], ["TCGA.D5.6929.01", "Glucagon-type ligand receptors"], ["TCGA.D5.6929.01", "Aspirin ADME"], ["TCGA.D5.6929.01", "GPCR ligand binding"], ["TCGA.D5.6929.01", "Collagen chain trimerization"], ["TCGA.D5.6929.01", "G alpha (s) signalling events"], ["TCGA.D5.6929.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6929.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6929.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.D5.6929.01", "Class B/2 (Secretin family receptors)"], ["TCGA.D5.6929.01", "O-linked glycosylation"], ["TCGA.D5.6929.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6929.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6929.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6929.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.D5.6929.01", "Potassium Channels"], ["TCGA.D5.6929.01", "Peptide hormone metabolism"], ["TCGA.D5.6929.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.D5.6929.01", "Blood group systems biosynthesis"], ["TCGA.D5.6929.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.D5.6929.01", "Response to elevated platelet cytosolic Ca2+"], ["TCGA.D5.6929.01", "Diseases of glycosylation"], ["TCGA.D5.6929.01", "Metabolism"], ["TCGA.D5.6929.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.D5.6929.01", "Physiological factors"], ["TCGA.D5.6929.01", "Phase I - Functionalization of compounds"], ["TCGA.D5.6929.01", "Drug ADME"], ["TCGA.D5.6929.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6929.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6929.01", "Keratinization"], ["TCGA.D5.6929.01", "Protein-protein interactions at synapses"], ["TCGA.D5.6929.01", "YAP1- and WWTR1 (TAZ)-stimulated gene expression"], ["TCGA.D5.6929.01", "ECM proteoglycans"], ["TCGA.D5.6929.01", "Regulation of insulin secretion"], ["TCGA.D5.6929.01", "Integration of energy metabolism"], ["TCGA.D5.6929.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.D5.6929.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6929.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6929.01", "Metabolism of amine-derived hormones"], ["TCGA.D5.6929.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.D5.6930.01", "Drug ADME"], ["TCGA.D5.6930.01", "Biological oxidations"], ["TCGA.D5.6930.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6930.01", "Glucuronidation"], ["TCGA.D5.6930.01", "Extracellular matrix organization"], ["TCGA.D5.6930.01", "Neuronal System"], ["TCGA.D5.6930.01", "Collagen formation"], ["TCGA.D5.6930.01", "Metabolism"], ["TCGA.D5.6930.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6930.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6930.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.D5.6930.01", "GABA receptor activation"], ["TCGA.D5.6930.01", "G alpha (z) signalling events"], ["TCGA.D5.6930.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6930.01", "Signaling by Nuclear Receptors"], ["TCGA.D5.6930.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6930.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.D5.6930.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.D5.6930.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.D5.6930.01", "Visual phototransduction"], ["TCGA.D5.6930.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6930.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.D5.6930.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.D5.6930.01", "Extra-nuclear estrogen signaling"], ["TCGA.D5.6930.01", "Signal amplification"], ["TCGA.D5.6930.01", "O-linked glycosylation of mucins"], ["TCGA.D5.6930.01", "Integration of energy metabolism"], ["TCGA.D5.6930.01", "G alpha (s) signalling events"], ["TCGA.D5.6930.01", "GPER1 signaling"], ["TCGA.D5.6930.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.D5.6930.01", "GABA B receptor activation"], ["TCGA.D5.6930.01", "Activation of GABAB receptors"], ["TCGA.D5.6930.01", "Metabolism of vitamins and cofactors"], ["TCGA.D5.6930.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6930.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6930.01", "Phase 4 - resting membrane potential"], ["TCGA.D5.6930.01", "Ethanol oxidation"], ["TCGA.D5.6930.01", "ESR-mediated signaling"], ["TCGA.D5.6931.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6931.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6931.01", "Neuronal System"], ["TCGA.D5.6931.01", "GABA receptor activation"], ["TCGA.D5.6931.01", "Signaling by Retinoic Acid"], ["TCGA.D5.6931.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6931.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6931.01", "L1CAM interactions"], ["TCGA.D5.6931.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6931.01", "Keratinization"], ["TCGA.D5.6931.01", "Extracellular matrix organization"], ["TCGA.D5.6931.01", "Defective B3GALTL causes PpS"], ["TCGA.D5.6931.01", "Collagen formation"], ["TCGA.D5.6931.01", "Interleukin-6 family signaling"], ["TCGA.D5.6931.01", "Integration of energy metabolism"], ["TCGA.D5.6931.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.D5.6931.01", "Drug ADME"], ["TCGA.D5.6931.01", "RA biosynthesis pathway"], ["TCGA.D5.6931.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.6932.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.6932.01", "Neuronal System"], ["TCGA.D5.6932.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.6932.01", "Signaling by GPCR"], ["TCGA.D5.6932.01", "Biological oxidations"], ["TCGA.D5.6932.01", "Extracellular matrix organization"], ["TCGA.D5.6932.01", "Glucuronidation"], ["TCGA.D5.6932.01", "Drug ADME"], ["TCGA.D5.6932.01", "GPCR downstream signalling"], ["TCGA.D5.6932.01", "GPCR ligand binding"], ["TCGA.D5.6932.01", "Signaling Pathways"], ["TCGA.D5.6932.01", "G alpha (i) signalling events"], ["TCGA.D5.6932.01", "Potassium Channels"], ["TCGA.D5.6932.01", "Transmission across Chemical Synapses"], ["TCGA.D5.6932.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.6932.01", "G alpha (s) signalling events"], ["TCGA.D5.6932.01", "Peptide hormone metabolism"], ["TCGA.D5.6932.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.6932.01", "Regulation of insulin secretion"], ["TCGA.D5.6932.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.D5.6932.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.6932.01", "Aspirin ADME"], ["TCGA.D5.6932.01", "Peptide ligand-binding receptors"], ["TCGA.D5.6932.01", "L1CAM interactions"], ["TCGA.D5.6932.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.D5.6932.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.6932.01", "Ethanol oxidation"], ["TCGA.D5.6932.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.D5.6932.01", "Sensory processing of sound"], ["TCGA.D5.6932.01", "Voltage gated Potassium channels"], ["TCGA.D5.6932.01", "TNFs bind their physiological receptors"], ["TCGA.D5.6932.01", "Integration of energy metabolism"], ["TCGA.D5.6932.01", "Collagen formation"], ["TCGA.D5.6932.01", "Degradation of the extracellular matrix"], ["TCGA.D5.6932.01", "Signal amplification"], ["TCGA.D5.6932.01", "Glucagon signaling in metabolic regulation"], ["TCGA.D5.6932.01", "Cardiac conduction"], ["TCGA.D5.6932.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.D5.6932.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.D5.6932.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.D5.7000.01", "Extracellular matrix organization"], ["TCGA.D5.7000.01", "Neuronal System"], ["TCGA.D5.7000.01", "Activation of Matrix Metalloproteinases"], ["TCGA.D5.7000.01", "Transmission across Chemical Synapses"], ["TCGA.D5.7000.01", "Degradation of the extracellular matrix"], ["TCGA.D5.7000.01", "Interaction between L1 and Ankyrins"], ["TCGA.D5.7000.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.D5.7000.01", "Phase 0 - rapid depolarisation"], ["TCGA.D5.7000.01", "Cardiac conduction"], ["TCGA.D5.7000.01", "GPCR ligand binding"], ["TCGA.D5.7000.01", "L1CAM interactions"], ["TCGA.D5.7000.01", "Drug ADME"], ["TCGA.D5.7000.01", "GABA receptor activation"], ["TCGA.D5.7000.01", "Signaling by GPCR"], ["TCGA.D5.7000.01", "Cytosolic sulfonation of small molecules"], ["TCGA.D5.7000.01", "GPCR downstream signalling"], ["TCGA.D5.7000.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.D5.7000.01", "Interleukin-6 family signaling"], ["TCGA.D5.7000.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.D5.7000.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.D5.7000.01", "Trafficking of AMPA receptors"], ["TCGA.D5.7000.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.D5.7000.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.D5.7000.01", "Phase II - Conjugation of compounds"], ["TCGA.D5.7000.01", "Phase 2 - plateau phase"], ["TCGA.D5.7000.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.D5.7000.01", "Muscle contraction"], ["TCGA.D5.7000.01", "TNFs bind their physiological receptors"], ["TCGA.D5.7000.01", "G alpha (i) signalling events"], ["TCGA.D5.7000.01", "Visual phototransduction"], ["TCGA.D5.7000.01", "Peptide ligand-binding receptors"], ["TCGA.D5.7000.01", "Potassium Channels"], ["TCGA.D5.7000.01", "G alpha (s) signalling events"], ["TCGA.D5.7000.01", "Ethanol oxidation"], ["TCGA.D5.7000.01", "Transcriptional regulation of testis differentiation"], ["TCGA.D5.7000.01", "Metabolism of vitamins and cofactors"], ["TCGA.D5.7000.01", "Protein-protein interactions at synapses"], ["TCGA.D5.7000.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A0X9.01", "Neuronal System"], ["TCGA.DM.A0X9.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A0X9.01", "Potassium Channels"], ["TCGA.DM.A0X9.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A0X9.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A0X9.01", "Signaling by GPCR"], ["TCGA.DM.A0X9.01", "GPCR downstream signalling"], ["TCGA.DM.A0X9.01", "NCAM1 interactions"], ["TCGA.DM.A0X9.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A0X9.01", "NCAM signaling for neurite out-growth"], ["TCGA.DM.A0X9.01", "GPCR ligand binding"], ["TCGA.DM.A0X9.01", "G alpha (i) signalling events"], ["TCGA.DM.A0X9.01", "Cardiac conduction"], ["TCGA.DM.A0X9.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A0X9.01", "Heme degradation"], ["TCGA.DM.A0X9.01", "Neurexins and neuroligins"], ["TCGA.DM.A0X9.01", "Signaling Pathways"], ["TCGA.DM.A0X9.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A0X9.01", "Drug ADME"], ["TCGA.DM.A0X9.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A0X9.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A0X9.01", "Extracellular matrix organization"], ["TCGA.DM.A0X9.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A0X9.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A0XD.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A0XD.01", "GPCR downstream signalling"], ["TCGA.DM.A0XD.01", "Signaling by GPCR"], ["TCGA.DM.A0XD.01", "Neuronal System"], ["TCGA.DM.A0XD.01", "Drug ADME"], ["TCGA.DM.A0XD.01", "Biological oxidations"], ["TCGA.DM.A0XD.01", "G alpha (i) signalling events"], ["TCGA.DM.A0XD.01", "Generation of second messenger molecules"], ["TCGA.DM.A0XD.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A0XD.01", "Signaling Pathways"], ["TCGA.DM.A0XD.01", "Potassium Channels"], ["TCGA.DM.A0XD.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A0XD.01", "Glucuronidation"], ["TCGA.DM.A0XD.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A0XD.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A0XD.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A0XD.01", "GPCR ligand binding"], ["TCGA.DM.A0XD.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A0XD.01", "Extracellular matrix organization"], ["TCGA.DM.A0XD.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A0XD.01", "Cardiac conduction"], ["TCGA.DM.A0XD.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A0XD.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A0XD.01", "G alpha (s) signalling events"], ["TCGA.DM.A0XD.01", "Voltage gated Potassium channels"], ["TCGA.DM.A0XD.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A0XD.01", "G alpha (q) signalling events"], ["TCGA.DM.A0XD.01", "Peptide hormone metabolism"], ["TCGA.DM.A0XD.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.DM.A0XD.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A0XD.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A0XD.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A0XD.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A0XF.01", "Neuronal System"], ["TCGA.DM.A0XF.01", "GPCR downstream signalling"], ["TCGA.DM.A0XF.01", "Signaling by GPCR"], ["TCGA.DM.A0XF.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A0XF.01", "Cardiac conduction"], ["TCGA.DM.A0XF.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A0XF.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A0XF.01", "Signaling Pathways"], ["TCGA.DM.A0XF.01", "Potassium Channels"], ["TCGA.DM.A0XF.01", "G alpha (i) signalling events"], ["TCGA.DM.A0XF.01", "G alpha (s) signalling events"], ["TCGA.DM.A0XF.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A0XF.01", "Regulation of insulin secretion"], ["TCGA.DM.A0XF.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A0XF.01", "Muscle contraction"], ["TCGA.DM.A0XF.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A0XF.01", "GPCR ligand binding"], ["TCGA.DM.A0XF.01", "Signal amplification"], ["TCGA.DM.A0XF.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A0XF.01", "GABA receptor activation"], ["TCGA.DM.A0XF.01", "Extracellular matrix organization"], ["TCGA.DM.A0XF.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.DM.A0XF.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A0XF.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A0XF.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A0XF.01", "Diseases of Immune System"], ["TCGA.DM.A0XF.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A0XF.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.DM.A0XF.01", "Integration of energy metabolism"], ["TCGA.DM.A0XF.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A0XF.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A0XF.01", "G-protein mediated events"], ["TCGA.DM.A0XF.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A0XF.01", "Platelet activation, signaling and aggregation"], ["TCGA.DM.A0XF.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A0XF.01", "Regulation of TLR by endogenous ligand"], ["TCGA.DM.A0XF.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A0XF.01", "DNA strand elongation"], ["TCGA.DM.A0XF.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A0XF.01", "Opioid Signalling"], ["TCGA.DM.A0XF.01", "Blood group systems biosynthesis"], ["TCGA.DM.A0XF.01", "Peptide hormone metabolism"], ["TCGA.DM.A0XF.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.DM.A0XF.01", "Recycling of bile acids and salts"], ["TCGA.DM.A0XF.01", "O-linked glycosylation"], ["TCGA.DM.A0XF.01", "GABA B receptor activation"], ["TCGA.DM.A0XF.01", "Activation of GABAB receptors"], ["TCGA.DM.A0XF.01", "Transport of small molecules"], ["TCGA.DM.A0XF.01", "RA biosynthesis pathway"], ["TCGA.DM.A0XF.01", "Synaptic adhesion-like molecules"], ["TCGA.DM.A0XF.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A0XF.01", "PLC beta mediated events"], ["TCGA.DM.A0XF.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A0XF.01", "Platelet homeostasis"], ["TCGA.DM.A0XF.01", "G alpha (q) signalling events"], ["TCGA.DM.A0XF.01", "G0 and Early G1"], ["TCGA.DM.A0XF.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A0XF.01", "Voltage gated Potassium channels"], ["TCGA.DM.A0XF.01", "Sensory processing of sound"], ["TCGA.DM.A0XF.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A0XF.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A0XF.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A0XF.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A0XF.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.DM.A0XF.01", "Azathioprine ADME"], ["TCGA.DM.A0XF.01", "Thromboxane signalling through TP receptor"], ["TCGA.DM.A0XF.01", "GRB2:SOS provides linkage to MAPK signaling for Integrins"], ["TCGA.DM.A0XF.01", "p130Cas linkage to MAPK signaling for integrins"], ["TCGA.DM.A0XF.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.DM.A0XF.01", "Integrin cell surface interactions"], ["TCGA.DM.A1D0.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A1D0.01", "Signaling Pathways"], ["TCGA.DM.A1D0.01", "Generation of second messenger molecules"], ["TCGA.DM.A1D0.01", "PD-1 signaling"], ["TCGA.DM.A1D0.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A1D0.01", "Signaling by GPCR"], ["TCGA.DM.A1D0.01", "Immune System"], ["TCGA.DM.A1D0.01", "GPCR downstream signalling"], ["TCGA.DM.A1D0.01", "Neuronal System"], ["TCGA.DM.A1D0.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A1D0.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A1D0.01", "Extracellular matrix organization"], ["TCGA.DM.A1D0.01", "GPCR ligand binding"], ["TCGA.DM.A1D0.01", "G alpha (i) signalling events"], ["TCGA.DM.A1D0.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A1D0.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A1D0.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A1D0.01", "Complement cascade"], ["TCGA.DM.A1D0.01", "Initial triggering of complement"], ["TCGA.DM.A1D0.01", "Cardiac conduction"], ["TCGA.DM.A1D0.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A1D0.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A1D0.01", "Costimulation by the CD28 family"], ["TCGA.DM.A1D0.01", "Potassium Channels"], ["TCGA.DM.A1D0.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A1D0.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.DM.A1D0.01", "Muscle contraction"], ["TCGA.DM.A1D0.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.DM.A1D0.01", "Adaptive Immune System"], ["TCGA.DM.A1D0.01", "Regulation of Complement cascade"], ["TCGA.DM.A1D0.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A1D0.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1D0.01", "Elastic fibre formation"], ["TCGA.DM.A1D0.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1D0.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A1D0.01", "Platelet homeostasis"], ["TCGA.DM.A1D0.01", "Innate Immune System"], ["TCGA.DM.A1D0.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A1D0.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D0.01", "Peptide hormone metabolism"], ["TCGA.DM.A1D0.01", "G alpha (q) signalling events"], ["TCGA.DM.A1D0.01", "Leishmania infection"], ["TCGA.DM.A1D0.01", "Parasitic Infection Pathways"], ["TCGA.DM.A1D0.01", "Developmental Biology"], ["TCGA.DM.A1D0.01", "Integrin cell surface interactions"], ["TCGA.DM.A1D0.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A1D0.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1D0.01", "G alpha (s) signalling events"], ["TCGA.DM.A1D0.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A1D0.01", "Binding and entry of HIV virion"], ["TCGA.DM.A1D0.01", "Interleukin-10 signaling"], ["TCGA.DM.A1D0.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A1D0.01", "Stimuli-sensing channels"], ["TCGA.DM.A1D0.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A1D0.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A1D0.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A1D0.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.DM.A1D0.01", "NCAM1 interactions"], ["TCGA.DM.A1D0.01", "Long-term potentiation"], ["TCGA.DM.A1D0.01", "DAP12 signaling"], ["TCGA.DM.A1D0.01", "Nicotinate metabolism"], ["TCGA.DM.A1D0.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.DM.A1D0.01", "DAP12 interactions"], ["TCGA.DM.A1D0.01", "Trafficking and processing of endosomal TLR"], ["TCGA.DM.A1D0.01", "Ion channel transport"], ["TCGA.DM.A1D0.01", "Defective B3GALTL causes PpS"], ["TCGA.DM.A1D0.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A1D0.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A1D0.01", "Synaptic adhesion-like molecules"], ["TCGA.DM.A1D0.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1D0.01", "Cell surface interactions at the vascular wall"], ["TCGA.DM.A1D0.01", "Cytokine Signaling in Immune system"], ["TCGA.DM.A1D0.01", "Voltage gated Potassium channels"], ["TCGA.DM.A1D0.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1D0.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.DM.A1D0.01", "Signaling by Receptor Tyrosine Kinases"], ["TCGA.DM.A1D0.01", "SUMOylation of intracellular receptors"], ["TCGA.DM.A1D0.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.DM.A1D0.01", "Neurexins and neuroligins"], ["TCGA.DM.A1D0.01", "Diseases of Immune System"], ["TCGA.DM.A1D0.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A1D0.01", "Other semaphorin interactions"], ["TCGA.DM.A1D0.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.DM.A1D0.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A1D0.01", "Other interleukin signaling"], ["TCGA.DM.A1D0.01", "L1CAM interactions"], ["TCGA.DM.A1D0.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A1D0.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1D0.01", "Scavenging of heme from plasma"], ["TCGA.DM.A1D0.01", "Ion homeostasis"], ["TCGA.DM.A1D0.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.DM.A1D0.01", "Downregulation of ERBB2 signaling"], ["TCGA.DM.A1D0.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.DM.A1D0.01", "PI3K events in ERBB2 signaling"], ["TCGA.DM.A1D0.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.DM.A1D0.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.DM.A1D0.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.DM.A1D0.01", "ERBB2 Regulates Cell Motility"], ["TCGA.DM.A1D0.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1D0.01", "Negative regulation of FLT3"], ["TCGA.DM.A1D0.01", "FGFR2 ligand binding and activation"], ["TCGA.DM.A1D0.01", "Insulin processing"], ["TCGA.DM.A1D0.01", "TCR signaling"], ["TCGA.DM.A1D0.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1D0.01", "FLT3 Signaling"], ["TCGA.DM.A1D0.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.DM.A1D0.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.DM.A1D0.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A1D0.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.DM.A1D0.01", "GRB2 events in ERBB2 signaling"], ["TCGA.DM.A1D0.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.DM.A1D0.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1D0.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A1D0.01", "Dectin-2 family"], ["TCGA.DM.A1D0.01", "MHC class II antigen presentation"], ["TCGA.DM.A1D0.01", "Neurotransmitter release cycle"], ["TCGA.DM.A1D0.01", "Specification of primordial germ cells"], ["TCGA.DM.A1D4.01", "Neuronal System"], ["TCGA.DM.A1D4.01", "Signaling Pathways"], ["TCGA.DM.A1D4.01", "GPCR downstream signalling"], ["TCGA.DM.A1D4.01", "Signaling by GPCR"], ["TCGA.DM.A1D4.01", "G alpha (i) signalling events"], ["TCGA.DM.A1D4.01", "Extracellular matrix organization"], ["TCGA.DM.A1D4.01", "GPCR ligand binding"], ["TCGA.DM.A1D4.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A1D4.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A1D4.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A1D4.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A1D4.01", "Complement cascade"], ["TCGA.DM.A1D4.01", "G alpha (s) signalling events"], ["TCGA.DM.A1D4.01", "Regulation of Complement cascade"], ["TCGA.DM.A1D4.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A1D4.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A1D4.01", "Cardiac conduction"], ["TCGA.DM.A1D4.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A1D4.01", "Potassium Channels"], ["TCGA.DM.A1D4.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A1D4.01", "Elastic fibre formation"], ["TCGA.DM.A1D4.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A1D4.01", "Muscle contraction"], ["TCGA.DM.A1D4.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A1D4.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1D4.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A1D4.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A1D4.01", "Leishmania infection"], ["TCGA.DM.A1D4.01", "Parasitic Infection Pathways"], ["TCGA.DM.A1D4.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A1D4.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A1D4.01", "Neurexins and neuroligins"], ["TCGA.DM.A1D4.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A1D4.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A1D4.01", "G alpha (q) signalling events"], ["TCGA.DM.A1D4.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.DM.A1D4.01", "Interleukin-10 signaling"], ["TCGA.DM.A1D4.01", "Biological oxidations"], ["TCGA.DM.A1D4.01", "Initial triggering of complement"], ["TCGA.DM.A1D4.01", "Insulin processing"], ["TCGA.DM.A1D4.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A1D4.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.DM.A1D4.01", "Ca-dependent events"], ["TCGA.DM.A1D4.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A1D4.01", "Regulation of gene expression by Hypoxia-inducible Factor"], ["TCGA.DM.A1D4.01", "PKA activation in glucagon signalling"], ["TCGA.DM.A1D4.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.DM.A1D4.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.DM.A1D4.01", "Integrin cell surface interactions"], ["TCGA.DM.A1D4.01", "Developmental Biology"], ["TCGA.DM.A1D4.01", "Sensory processing of sound"], ["TCGA.DM.A1D4.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A1D4.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A1D4.01", "Other interleukin signaling"], ["TCGA.DM.A1D4.01", "Collagen chain trimerization"], ["TCGA.DM.A1D4.01", "Calmodulin induced events"], ["TCGA.DM.A1D4.01", "CaM pathway"], ["TCGA.DM.A1D4.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A1D4.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.DM.A1D4.01", "Aquaporin-mediated transport"], ["TCGA.DM.A1D4.01", "Peptide hormone metabolism"], ["TCGA.DM.A1D4.01", "Scavenging of heme from plasma"], ["TCGA.DM.A1D4.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1D4.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.DM.A1D4.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.DM.A1D4.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.DM.A1D4.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D4.01", "NCAM1 interactions"], ["TCGA.DM.A1D4.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.DM.A1D4.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A1D4.01", "GPER1 signaling"], ["TCGA.DM.A1D4.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.DM.A1D4.01", "GABA B receptor activation"], ["TCGA.DM.A1D4.01", "Activation of GABAB receptors"], ["TCGA.DM.A1D4.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A1D4.01", "Scavenging by Class A Receptors"], ["TCGA.DM.A1D4.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.DM.A1D4.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.DM.A1D4.01", "Netrin-1 signaling"], ["TCGA.DM.A1D4.01", "Immune System"], ["TCGA.DM.A1D4.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1D4.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.DM.A1D4.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1D4.01", "Defective B3GALTL causes PpS"], ["TCGA.DM.A1D4.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.DM.A1D4.01", "CRMPs in Sema3A signaling"], ["TCGA.DM.A1D4.01", "Cell-extracellular matrix interactions"], ["TCGA.DM.A1D4.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1D4.01", "Voltage gated Potassium channels"], ["TCGA.DM.A1D4.01", "G-protein mediated events"], ["TCGA.DM.A1D4.01", "GABA receptor activation"], ["TCGA.DM.A1D4.01", "PLC beta mediated events"], ["TCGA.DM.A1D4.01", "Signaling by BMP"], ["TCGA.DM.A1D4.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A1D4.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1D4.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.DM.A1D4.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A1D4.01", "Opioid Signalling"], ["TCGA.DM.A1D4.01", "Ion homeostasis"], ["TCGA.DM.A1D6.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A1D6.01", "Signaling by GPCR"], ["TCGA.DM.A1D6.01", "GPCR ligand binding"], ["TCGA.DM.A1D6.01", "GPCR downstream signalling"], ["TCGA.DM.A1D6.01", "G alpha (i) signalling events"], ["TCGA.DM.A1D6.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A1D6.01", "Generation of second messenger molecules"], ["TCGA.DM.A1D6.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A1D6.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A1D6.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A1D6.01", "PD-1 signaling"], ["TCGA.DM.A1D6.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A1D6.01", "Neuronal System"], ["TCGA.DM.A1D6.01", "G alpha (q) signalling events"], ["TCGA.DM.A1D6.01", "Immune System"], ["TCGA.DM.A1D6.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1D6.01", "Signaling Pathways"], ["TCGA.DM.A1D6.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A1D6.01", "Potassium Channels"], ["TCGA.DM.A1D6.01", "Complement cascade"], ["TCGA.DM.A1D6.01", "G alpha (z) signalling events"], ["TCGA.DM.A1D6.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A1D6.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A1D6.01", "Muscle contraction"], ["TCGA.DM.A1D6.01", "Biological oxidations"], ["TCGA.DM.A1D6.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.DM.A1D6.01", "G alpha (s) signalling events"], ["TCGA.DM.A1D6.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A1D6.01", "Costimulation by the CD28 family"], ["TCGA.DM.A1D6.01", "Cardiac conduction"], ["TCGA.DM.A1D6.01", "Regulation of Complement cascade"], ["TCGA.DM.A1D6.01", "G beta:gamma signalling through PLC beta"], ["TCGA.DM.A1D6.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A1D6.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A1D6.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A1D6.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A1D6.01", "G-protein activation"], ["TCGA.DM.A1D6.01", "Thromboxane signalling through TP receptor"], ["TCGA.DM.A1D6.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A1D6.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A1D6.01", "Cell surface interactions at the vascular wall"], ["TCGA.DM.A1D6.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A1D6.01", "G protein gated Potassium channels"], ["TCGA.DM.A1D6.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A1D6.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A1D6.01", "GABA receptor activation"], ["TCGA.DM.A1D6.01", "Platelet homeostasis"], ["TCGA.DM.A1D6.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A1D6.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.DM.A1D6.01", "Leishmania infection"], ["TCGA.DM.A1D6.01", "Parasitic Infection Pathways"], ["TCGA.DM.A1D6.01", "Transport of small molecules"], ["TCGA.DM.A1D6.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A1D6.01", "Regulation of insulin secretion"], ["TCGA.DM.A1D6.01", "Initial triggering of complement"], ["TCGA.DM.A1D6.01", "G beta:gamma signalling through CDC42"], ["TCGA.DM.A1D6.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.DM.A1D6.01", "Aquaporin-mediated transport"], ["TCGA.DM.A1D6.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A1D6.01", "GABA B receptor activation"], ["TCGA.DM.A1D6.01", "Activation of GABAB receptors"], ["TCGA.DM.A1D6.01", "G alpha (12/13) signalling events"], ["TCGA.DM.A1D6.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D6.01", "Adaptive Immune System"], ["TCGA.DM.A1D6.01", "Ion channel transport"], ["TCGA.DM.A1D6.01", "Phase I - Functionalization of compounds"], ["TCGA.DM.A1D6.01", "Signal amplification"], ["TCGA.DM.A1D6.01", "Extracellular matrix organization"], ["TCGA.DM.A1D6.01", "Ca2+ pathway"], ["TCGA.DM.A1D6.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1D6.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A1D6.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A1D6.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1D6.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A1D6.01", "Stimuli-sensing channels"], ["TCGA.DM.A1D6.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A1D6.01", "Integrin cell surface interactions"], ["TCGA.DM.A1D6.01", "Integration of energy metabolism"], ["TCGA.DM.A1D6.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.DM.A1D6.01", "Interleukin-10 signaling"], ["TCGA.DM.A1D6.01", "Neurexins and neuroligins"], ["TCGA.DM.A1D6.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A1D6.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A1D6.01", "Drug ADME"], ["TCGA.DM.A1D6.01", "GPER1 signaling"], ["TCGA.DM.A1D6.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.DM.A1D6.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1D6.01", "Binding and entry of HIV virion"], ["TCGA.DM.A1D6.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A1D6.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A1D6.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1D6.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A1D6.01", "Scavenging by Class A Receptors"], ["TCGA.DM.A1D6.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.DM.A1D6.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.DM.A1D6.01", "Neurotransmitter release cycle"], ["TCGA.DM.A1D6.01", "Peptide hormone metabolism"], ["TCGA.DM.A1D6.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A1D6.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1D6.01", "LGI-ADAM interactions"], ["TCGA.DM.A1D6.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A1D6.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A1D6.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A1D6.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A1D6.01", "Sensory perception of taste"], ["TCGA.DM.A1D6.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1D6.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.DM.A1D6.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.DM.A1D6.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.DM.A1D6.01", "Heme degradation"], ["TCGA.DM.A1D6.01", "Scavenging of heme from plasma"], ["TCGA.DM.A1D6.01", "Other interleukin signaling"], ["TCGA.DM.A1D6.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A1D6.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.DM.A1D6.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.DM.A1D6.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1D6.01", "Ion homeostasis"], ["TCGA.DM.A1D6.01", "FCGR activation"], ["TCGA.DM.A1D7.01", "Neuronal System"], ["TCGA.DM.A1D7.01", "Signaling by GPCR"], ["TCGA.DM.A1D7.01", "GPCR downstream signalling"], ["TCGA.DM.A1D7.01", "GPCR ligand binding"], ["TCGA.DM.A1D7.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A1D7.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A1D7.01", "G alpha (i) signalling events"], ["TCGA.DM.A1D7.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A1D7.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A1D7.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1D7.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A1D7.01", "Cardiac conduction"], ["TCGA.DM.A1D7.01", "Biological oxidations"], ["TCGA.DM.A1D7.01", "Signaling Pathways"], ["TCGA.DM.A1D7.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A1D7.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A1D7.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.DM.A1D7.01", "Synaptic adhesion-like molecules"], ["TCGA.DM.A1D7.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A1D7.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D7.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.DM.A1D7.01", "Interleukin-10 signaling"], ["TCGA.DM.A1D7.01", "Potassium Channels"], ["TCGA.DM.A1D7.01", "Interleukin-6 family signaling"], ["TCGA.DM.A1D7.01", "Drug ADME"], ["TCGA.DM.A1D7.01", "Trafficking of AMPA receptors"], ["TCGA.DM.A1D7.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.DM.A1D7.01", "G alpha (q) signalling events"], ["TCGA.DM.A1D7.01", "RA biosynthesis pathway"], ["TCGA.DM.A1D7.01", "Extracellular matrix organization"], ["TCGA.DM.A1D7.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.DM.A1D7.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1D7.01", "Complement cascade"], ["TCGA.DM.A1D7.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1D7.01", "Trafficking and processing of endosomal TLR"], ["TCGA.DM.A1D7.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A1D7.01", "Long-term potentiation"], ["TCGA.DM.A1D7.01", "G alpha (s) signalling events"], ["TCGA.DM.A1D7.01", "Regulation of Complement cascade"], ["TCGA.DM.A1D7.01", "Diseases of Immune System"], ["TCGA.DM.A1D7.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A1D7.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A1D7.01", "Heme degradation"], ["TCGA.DM.A1D7.01", "Elastic fibre formation"], ["TCGA.DM.A1D7.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A1D7.01", "Neurexins and neuroligins"], ["TCGA.DM.A1D8.01", "Neuronal System"], ["TCGA.DM.A1D8.01", "GPCR downstream signalling"], ["TCGA.DM.A1D8.01", "G alpha (i) signalling events"], ["TCGA.DM.A1D8.01", "Signaling by GPCR"], ["TCGA.DM.A1D8.01", "Signaling Pathways"], ["TCGA.DM.A1D8.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A1D8.01", "Potassium Channels"], ["TCGA.DM.A1D8.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A1D8.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A1D8.01", "GPCR ligand binding"], ["TCGA.DM.A1D8.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A1D8.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D8.01", "Cardiac conduction"], ["TCGA.DM.A1D8.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A1D8.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A1D8.01", "Complement cascade"], ["TCGA.DM.A1D8.01", "Drug ADME"], ["TCGA.DM.A1D8.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A1D8.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A1D8.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A1D8.01", "Leishmania infection"], ["TCGA.DM.A1D8.01", "Parasitic Infection Pathways"], ["TCGA.DM.A1D8.01", "Regulation of Complement cascade"], ["TCGA.DM.A1D8.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1D8.01", "G alpha (q) signalling events"], ["TCGA.DM.A1D8.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A1D8.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A1D8.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.DM.A1D8.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A1D8.01", "GABA receptor activation"], ["TCGA.DM.A1D8.01", "Biological oxidations"], ["TCGA.DM.A1D8.01", "L1CAM interactions"], ["TCGA.DM.A1D8.01", "Peptide hormone metabolism"], ["TCGA.DM.A1D8.01", "Cell surface interactions at the vascular wall"], ["TCGA.DM.A1D8.01", "G alpha (s) signalling events"], ["TCGA.DM.A1D8.01", "Voltage gated Potassium channels"], ["TCGA.DM.A1D8.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A1D8.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A1D8.01", "Platelet homeostasis"], ["TCGA.DM.A1D8.01", "Nuclear signaling by ERBB4"], ["TCGA.DM.A1D8.01", "Signaling by ERBB4"], ["TCGA.DM.A1D8.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.DM.A1D8.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A1D8.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1D8.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A1D8.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1D8.01", "Extracellular matrix organization"], ["TCGA.DM.A1D8.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A1D8.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.DM.A1D8.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1D8.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A1D8.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A1D8.01", "Muscle contraction"], ["TCGA.DM.A1D8.01", "Sensory processing of sound"], ["TCGA.DM.A1D8.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A1D8.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.DM.A1D8.01", "Diseases of Immune System"], ["TCGA.DM.A1D8.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A1D8.01", "Glucuronidation"], ["TCGA.DM.A1D8.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.DM.A1D8.01", "Regulation of insulin secretion"], ["TCGA.DM.A1D8.01", "Platelet activation, signaling and aggregation"], ["TCGA.DM.A1D8.01", "Signal amplification"], ["TCGA.DM.A1D8.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.DM.A1D8.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.DM.A1D8.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1D8.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1D8.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A1D8.01", "Aspirin ADME"], ["TCGA.DM.A1D8.01", "PI3K events in ERBB2 signaling"], ["TCGA.DM.A1D8.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.DM.A1D8.01", "ERBB2 Regulates Cell Motility"], ["TCGA.DM.A1D8.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1D8.01", "Initial triggering of complement"], ["TCGA.DM.A1D8.01", "Insulin processing"], ["TCGA.DM.A1D8.01", "Transport of small molecules"], ["TCGA.DM.A1D8.01", "Sialic acid metabolism"], ["TCGA.DM.A1D8.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.DM.A1D8.01", "Integrin cell surface interactions"], ["TCGA.DM.A1D8.01", "ERK1/ERK2 pathway"], ["TCGA.DM.A1D8.01", "Phase I - Functionalization of compounds"], ["TCGA.DM.A1D8.01", "Sensory perception of taste"], ["TCGA.DM.A1D8.01", "MAPK family signaling cascades"], ["TCGA.DM.A1D8.01", "Dectin-2 family"], ["TCGA.DM.A1D8.01", "GRB2 events in ERBB2 signaling"], ["TCGA.DM.A1D8.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.DM.A1D8.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A1D8.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1D8.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.DM.A1D8.01", "Signaling by Receptor Tyrosine Kinases"], ["TCGA.DM.A1D8.01", "Integration of energy metabolism"], ["TCGA.DM.A1D8.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A1D8.01", "Immune System"], ["TCGA.DM.A1D8.01", "SUMOylation of intracellular receptors"], ["TCGA.DM.A1D8.01", "Nuclear Receptor transcription pathway"], ["TCGA.DM.A1D8.01", "Intrinsic Pathway of Fibrin Clot Formation"], ["TCGA.DM.A1D8.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A1D8.01", "Regulation of FZD by ubiquitination"], ["TCGA.DM.A1D8.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A1D8.01", "Ion channel transport"], ["TCGA.DM.A1D8.01", "RAF/MAP kinase cascade"], ["TCGA.DM.A1D8.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.DM.A1D8.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A1D8.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A1D8.01", "Trafficking of AMPA receptors"], ["TCGA.DM.A1D8.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.DM.A1D8.01", "GABA B receptor activation"], ["TCGA.DM.A1D8.01", "Activation of GABAB receptors"], ["TCGA.DM.A1D8.01", "Visual phototransduction"], ["TCGA.DM.A1D9.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A1D9.01", "GPCR downstream signalling"], ["TCGA.DM.A1D9.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A1D9.01", "Signaling by GPCR"], ["TCGA.DM.A1D9.01", "Neuronal System"], ["TCGA.DM.A1D9.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A1D9.01", "Generation of second messenger molecules"], ["TCGA.DM.A1D9.01", "PD-1 signaling"], ["TCGA.DM.A1D9.01", "G alpha (i) signalling events"], ["TCGA.DM.A1D9.01", "Signaling Pathways"], ["TCGA.DM.A1D9.01", "Immune System"], ["TCGA.DM.A1D9.01", "GPCR ligand binding"], ["TCGA.DM.A1D9.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A1D9.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A1D9.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A1D9.01", "Potassium Channels"], ["TCGA.DM.A1D9.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A1D9.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A1D9.01", "G alpha (s) signalling events"], ["TCGA.DM.A1D9.01", "G alpha (q) signalling events"], ["TCGA.DM.A1D9.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1D9.01", "Biological oxidations"], ["TCGA.DM.A1D9.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A1D9.01", "Adaptive Immune System"], ["TCGA.DM.A1D9.01", "Phase I - Functionalization of compounds"], ["TCGA.DM.A1D9.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1D9.01", "Cardiac conduction"], ["TCGA.DM.A1D9.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A1D9.01", "Leishmania infection"], ["TCGA.DM.A1D9.01", "Parasitic Infection Pathways"], ["TCGA.DM.A1D9.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A1D9.01", "GABA receptor activation"], ["TCGA.DM.A1D9.01", "Cell surface interactions at the vascular wall"], ["TCGA.DM.A1D9.01", "Costimulation by the CD28 family"], ["TCGA.DM.A1D9.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A1D9.01", "Complement cascade"], ["TCGA.DM.A1D9.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A1D9.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A1D9.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1D9.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A1D9.01", "G-protein activation"], ["TCGA.DM.A1D9.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A1D9.01", "G beta:gamma signalling through CDC42"], ["TCGA.DM.A1D9.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A1D9.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A1D9.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A1D9.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1D9.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A1D9.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A1D9.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.DM.A1D9.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A1D9.01", "Extracellular matrix organization"], ["TCGA.DM.A1D9.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1D9.01", "Regulation of insulin secretion"], ["TCGA.DM.A1D9.01", "G alpha (z) signalling events"], ["TCGA.DM.A1D9.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A1D9.01", "Platelet homeostasis"], ["TCGA.DM.A1D9.01", "Ca2+ pathway"], ["TCGA.DM.A1D9.01", "Signal amplification"], ["TCGA.DM.A1D9.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.DM.A1D9.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A1D9.01", "G protein gated Potassium channels"], ["TCGA.DM.A1D9.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A1D9.01", "Drug ADME"], ["TCGA.DM.A1D9.01", "Integration of energy metabolism"], ["TCGA.DM.A1D9.01", "Thromboxane signalling through TP receptor"], ["TCGA.DM.A1D9.01", "Initial triggering of complement"], ["TCGA.DM.A1D9.01", "G beta:gamma signalling through PLC beta"], ["TCGA.DM.A1D9.01", "Regulation of Complement cascade"], ["TCGA.DM.A1D9.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A1D9.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1D9.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1D9.01", "Caspase-mediated cleavage of cytoskeletal proteins"], ["TCGA.DM.A1D9.01", "Signal regulatory protein family interactions"], ["TCGA.DM.A1D9.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.DM.A1D9.01", "Peptide hormone metabolism"], ["TCGA.DM.A1D9.01", "GABA B receptor activation"], ["TCGA.DM.A1D9.01", "Activation of GABAB receptors"], ["TCGA.DM.A1D9.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A1D9.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A1D9.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.DM.A1D9.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A1D9.01", "Other interleukin signaling"], ["TCGA.DM.A1D9.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A1D9.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A1D9.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A1D9.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A1D9.01", "Muscle contraction"], ["TCGA.DM.A1D9.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.DM.A1D9.01", "Ethanol oxidation"], ["TCGA.DM.A1DA.01", "Neuronal System"], ["TCGA.DM.A1DA.01", "GPCR downstream signalling"], ["TCGA.DM.A1DA.01", "Signaling by GPCR"], ["TCGA.DM.A1DA.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A1DA.01", "Signaling Pathways"], ["TCGA.DM.A1DA.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A1DA.01", "G alpha (i) signalling events"], ["TCGA.DM.A1DA.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A1DA.01", "PD-1 signaling"], ["TCGA.DM.A1DA.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A1DA.01", "Generation of second messenger molecules"], ["TCGA.DM.A1DA.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1DA.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A1DA.01", "Cardiac conduction"], ["TCGA.DM.A1DA.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A1DA.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A1DA.01", "Complement cascade"], ["TCGA.DM.A1DA.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A1DA.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A1DA.01", "GPCR ligand binding"], ["TCGA.DM.A1DA.01", "Regulation of Complement cascade"], ["TCGA.DM.A1DA.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1DA.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A1DA.01", "G alpha (s) signalling events"], ["TCGA.DM.A1DA.01", "Phospholipase C-mediated cascade: FGFR1"], ["TCGA.DM.A1DA.01", "FGFR2 ligand binding and activation"], ["TCGA.DM.A1DA.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A1DA.01", "Muscle contraction"], ["TCGA.DM.A1DA.01", "Signaling by activated point mutants of FGFR1"], ["TCGA.DM.A1DA.01", "Potassium Channels"], ["TCGA.DM.A1DA.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1DA.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.DM.A1DA.01", "FGFR1 ligand binding and activation"], ["TCGA.DM.A1DA.01", "Activated point mutants of FGFR2"], ["TCGA.DM.A1DA.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A1DA.01", "Phospholipase C-mediated cascade; FGFR2"], ["TCGA.DM.A1DA.01", "Interleukin-10 signaling"], ["TCGA.DM.A1DA.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.DM.A1DA.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A1DA.01", "Costimulation by the CD28 family"], ["TCGA.DM.A1DA.01", "Immune System"], ["TCGA.DM.A1DA.01", "PI-3K cascade:FGFR1"], ["TCGA.DM.A1DA.01", "FGFR1c ligand binding and activation"], ["TCGA.DM.A1DA.01", "FGFR2c ligand binding and activation"], ["TCGA.DM.A1DA.01", "Nicotinate metabolism"], ["TCGA.DM.A1DA.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A1DA.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A1DA.01", "FGFR4 ligand binding and activation"], ["TCGA.DM.A1DA.01", "Calmodulin induced events"], ["TCGA.DM.A1DA.01", "CaM pathway"], ["TCGA.DM.A1DA.01", "Neurotransmitter release cycle"], ["TCGA.DM.A1DA.01", "Intrinsic Pathway of Fibrin Clot Formation"], ["TCGA.DM.A1DA.01", "SHC-mediated cascade:FGFR1"], ["TCGA.DM.A1DA.01", "PI-3K cascade:FGFR2"], ["TCGA.DM.A1DA.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A1DA.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A1DA.01", "Leishmania infection"], ["TCGA.DM.A1DA.01", "Parasitic Infection Pathways"], ["TCGA.DM.A1DA.01", "Platelet homeostasis"], ["TCGA.DM.A1DA.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.DM.A1DA.01", "Downstream signaling of activated FGFR1"], ["TCGA.DM.A1DA.01", "Signaling by activated point mutants of FGFR3"], ["TCGA.DM.A1DA.01", "FGFR3 mutant receptor activation"], ["TCGA.DM.A1DA.01", "G-protein mediated events"], ["TCGA.DM.A1DA.01", "Neurexins and neuroligins"], ["TCGA.DM.A1DA.01", "G alpha (q) signalling events"], ["TCGA.DM.A1DA.01", "IRS-related events triggered by IGF1R"], ["TCGA.DM.A1DA.01", "Ion homeostasis"], ["TCGA.DM.A1DA.01", "FRS-mediated FGFR1 signaling"], ["TCGA.DM.A1DA.01", "IRS-mediated signalling"], ["TCGA.DM.A1DA.01", "Ca-dependent events"], ["TCGA.DM.A1DA.01", "DAG and IP3 signaling"], ["TCGA.DM.A1DA.01", "Regulation of insulin secretion"], ["TCGA.DM.A1DA.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.DM.A1DA.01", "IGF1R signaling cascade"], ["TCGA.DM.A1DA.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1DA.01", "Metabolism of vitamins and cofactors"], ["TCGA.DM.A1DA.01", "SHC-mediated cascade:FGFR2"], ["TCGA.DM.A1DA.01", "Integration of energy metabolism"], ["TCGA.DM.A1DA.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A1DA.01", "FGFR3 ligand binding and activation"], ["TCGA.DM.A1DA.01", "FGFR3c ligand binding and activation"], ["TCGA.DM.A1DA.01", "Phospholipase C-mediated cascade; FGFR3"], ["TCGA.DM.A1DA.01", "Voltage gated Potassium channels"], ["TCGA.DM.A1DA.01", "Metabolism of water-soluble vitamins and cofactors"], ["TCGA.DM.A1DA.01", "PLC beta mediated events"], ["TCGA.DM.A1DA.01", "Activation of NMDA receptors and postsynaptic events"], ["TCGA.DM.A1DA.01", "FRS-mediated FGFR2 signaling"], ["TCGA.DM.A1DA.01", "G alpha (z) signalling events"], ["TCGA.DM.A1DA.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.DM.A1DA.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A1DA.01", "L1CAM interactions"], ["TCGA.DM.A1DA.01", "GABA receptor activation"], ["TCGA.DM.A1DA.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1DB.01", "Neuronal System"], ["TCGA.DM.A1DB.01", "Signaling by GPCR"], ["TCGA.DM.A1DB.01", "Signaling Pathways"], ["TCGA.DM.A1DB.01", "GPCR downstream signalling"], ["TCGA.DM.A1DB.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A1DB.01", "GPCR ligand binding"], ["TCGA.DM.A1DB.01", "G alpha (q) signalling events"], ["TCGA.DM.A1DB.01", "G alpha (i) signalling events"], ["TCGA.DM.A1DB.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A1DB.01", "Cardiac conduction"], ["TCGA.DM.A1DB.01", "Potassium Channels"], ["TCGA.DM.A1DB.01", "Extracellular matrix organization"], ["TCGA.DM.A1DB.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A1DB.01", "Long-term potentiation"], ["TCGA.DM.A1DB.01", "G alpha (s) signalling events"], ["TCGA.DM.A1DB.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A1DB.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A1DB.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.DM.A1DB.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.DM.A1DB.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1DB.01", "Elastic fibre formation"], ["TCGA.DM.A1DB.01", "Regulation of insulin secretion"], ["TCGA.DM.A1DB.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.DM.A1DB.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A1DB.01", "Regulation of Complement cascade"], ["TCGA.DM.A1DB.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A1DB.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1DB.01", "Activation of NMDA receptors and postsynaptic events"], ["TCGA.DM.A1DB.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.DM.A1DB.01", "Muscle contraction"], ["TCGA.DM.A1DB.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A1DB.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1DB.01", "Neurexins and neuroligins"], ["TCGA.DM.A1DB.01", "Integration of energy metabolism"], ["TCGA.DM.A1DB.01", "Complement cascade"], ["TCGA.DM.A1DB.01", "Opioid Signalling"], ["TCGA.DM.A1DB.01", "Ca-dependent events"], ["TCGA.DM.A1DB.01", "Ion transport by P-type ATPases"], ["TCGA.DM.A1DB.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A1DB.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A1DB.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.DM.A1DB.01", "Glycosaminoglycan metabolism"], ["TCGA.DM.A1DB.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A1DB.01", "E2F mediated regulation of DNA replication"], ["TCGA.DM.A1DB.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.DM.A1DB.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1DB.01", "Neurotransmitter release cycle"], ["TCGA.DM.A1DB.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A1DB.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A1DB.01", "Calmodulin induced events"], ["TCGA.DM.A1DB.01", "CaM pathway"], ["TCGA.DM.A1DB.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A1DB.01", "G protein gated Potassium channels"], ["TCGA.DM.A1DB.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A1DB.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.DM.A1DB.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1DB.01", "GABA receptor activation"], ["TCGA.DM.A1DB.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A1DB.01", "Ion homeostasis"], ["TCGA.DM.A1DB.01", "NCAM1 interactions"], ["TCGA.DM.A1DB.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A1DB.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A1DB.01", "Platelet homeostasis"], ["TCGA.DM.A1DB.01", "Post NMDA receptor activation events"], ["TCGA.DM.A1DB.01", "Acyl chain remodelling of PE"], ["TCGA.DM.A1DB.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A1DB.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A1DB.01", "GABA B receptor activation"], ["TCGA.DM.A1DB.01", "Activation of GABAB receptors"], ["TCGA.DM.A1DB.01", "O-linked glycosylation of mucins"], ["TCGA.DM.A1DB.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A1DB.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A1DB.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A1DB.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A1DB.01", "Dopamine Neurotransmitter Release Cycle"], ["TCGA.DM.A1DB.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A1DB.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A1DB.01", "SLC-mediated transmembrane transport"], ["TCGA.DM.A1DB.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A1DB.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1DB.01", "Ras activation upon Ca2+ influx through NMDA receptor"], ["TCGA.DM.A1DB.01", "Termination of O-glycan biosynthesis"], ["TCGA.DM.A1DB.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A1DB.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.DM.A1DB.01", "Defective pyroptosis"], ["TCGA.DM.A1DB.01", "Diseases of Immune System"], ["TCGA.DM.A1DB.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A1DB.01", "PLC beta mediated events"], ["TCGA.DM.A1DB.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A1DB.01", "Regulation of signaling by NODAL"], ["TCGA.DM.A1DB.01", "O-linked glycosylation"], ["TCGA.DM.A1DB.01", "Signal amplification"], ["TCGA.DM.A1DB.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1DB.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A1DB.01", "Initial triggering of complement"], ["TCGA.DM.A1DB.01", "G beta:gamma signalling through CDC42"], ["TCGA.DM.A1DB.01", "G-protein activation"], ["TCGA.DM.A1DB.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], ["TCGA.DM.A1DB.01", "Metabolism of fat-soluble vitamins"], ["TCGA.DM.A1DB.01", "Retinoid metabolism and transport"], ["TCGA.DM.A1DB.01", "NCAM signaling for neurite out-growth"], ["TCGA.DM.A1DB.01", "DAG and IP3 signaling"], ["TCGA.DM.A1DB.01", "Inhibition of replication initiation of damaged DNA by RB1/E2F1"], ["TCGA.DM.A1DB.01", "Caspase-mediated cleavage of cytoskeletal proteins"], ["TCGA.DM.A1DB.01", "Defective GALNT12 causes CRCS1"], ["TCGA.DM.A1DB.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.DM.A1DB.01", "Ion channel transport"], ["TCGA.DM.A1HA.01", "Signaling by GPCR"], ["TCGA.DM.A1HA.01", "GPCR downstream signalling"], ["TCGA.DM.A1HA.01", "Neuronal System"], ["TCGA.DM.A1HA.01", "Signaling Pathways"], ["TCGA.DM.A1HA.01", "Extracellular matrix organization"], ["TCGA.DM.A1HA.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A1HA.01", "G alpha (i) signalling events"], ["TCGA.DM.A1HA.01", "Biological oxidations"], ["TCGA.DM.A1HA.01", "GPCR ligand binding"], ["TCGA.DM.A1HA.01", "Potassium Channels"], ["TCGA.DM.A1HA.01", "Regulation of insulin secretion"], ["TCGA.DM.A1HA.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A1HA.01", "Arachidonic acid metabolism"], ["TCGA.DM.A1HA.01", "Generation of second messenger molecules"], ["TCGA.DM.A1HA.01", "Leishmania infection"], ["TCGA.DM.A1HA.01", "Parasitic Infection Pathways"], ["TCGA.DM.A1HA.01", "G alpha (q) signalling events"], ["TCGA.DM.A1HA.01", "Drug ADME"], ["TCGA.DM.A1HA.01", "NCAM1 interactions"], ["TCGA.DM.A1HA.01", "Sialic acid metabolism"], ["TCGA.DM.A1HA.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A1HA.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.DM.A1HA.01", "Aspirin ADME"], ["TCGA.DM.A1HA.01", "Muscle contraction"], ["TCGA.DM.A1HA.01", "Integration of energy metabolism"], ["TCGA.DM.A1HA.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A1HA.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A1HA.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A1HA.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A1HA.01", "Integrin cell surface interactions"], ["TCGA.DM.A1HA.01", "Cardiac conduction"], ["TCGA.DM.A1HA.01", "Neurotransmitter release cycle"], ["TCGA.DM.A1HA.01", "Biosynthesis of DHA-derived SPMs"], ["TCGA.DM.A1HA.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A1HA.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A1HA.01", "Phase I - Functionalization of compounds"], ["TCGA.DM.A1HA.01", "G alpha (s) signalling events"], ["TCGA.DM.A1HA.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A1HA.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A1HA.01", "Complement cascade"], ["TCGA.DM.A1HA.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A1HA.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A1HA.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.DM.A1HA.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A1HA.01", "Regulation of Complement cascade"], ["TCGA.DM.A1HA.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A1HA.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A1HA.01", "Platelet homeostasis"], ["TCGA.DM.A1HA.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A1HA.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A1HA.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A1HA.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A1HA.01", "O-linked glycosylation"], ["TCGA.DM.A1HA.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A1HA.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.DM.A1HA.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.DM.A1HA.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A1HA.01", "L1CAM interactions"], ["TCGA.DM.A1HA.01", "Glucuronidation"], ["TCGA.DM.A1HA.01", "Termination of O-glycan biosynthesis"], ["TCGA.DM.A1HA.01", "Dopamine Neurotransmitter Release Cycle"], ["TCGA.DM.A1HA.01", "NCAM signaling for neurite out-growth"], ["TCGA.DM.A1HA.01", "Collagen formation"], ["TCGA.DM.A1HA.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A1HA.01", "Signal amplification"], ["TCGA.DM.A1HA.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A1HA.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A1HA.01", "Collagen chain trimerization"], ["TCGA.DM.A1HA.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.DM.A1HA.01", "Blood group systems biosynthesis"], ["TCGA.DM.A1HA.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A1HA.01", "Initial triggering of complement"], ["TCGA.DM.A1HA.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A1HA.01", "Interleukin-10 signaling"], ["TCGA.DM.A1HA.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A1HA.01", "Elastic fibre formation"], ["TCGA.DM.A1HA.01", "Defective B3GALTL causes PpS"], ["TCGA.DM.A1HA.01", "G-protein activation"], ["TCGA.DM.A1HA.01", "Thromboxane signalling through TP receptor"], ["TCGA.DM.A1HA.01", "PD-1 signaling"], ["TCGA.DM.A1HA.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A1HA.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A1HA.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A1HA.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A1HA.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.DM.A1HA.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A1HA.01", "Synthesis of substrates in N-glycan biosythesis"], ["TCGA.DM.A1HA.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.DM.A1HA.01", "Transport of small molecules"], ["TCGA.DM.A1HA.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.DM.A1HA.01", "ECM proteoglycans"], ["TCGA.DM.A1HA.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.DM.A1HA.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A1HA.01", "Regulation of FZD by ubiquitination"], ["TCGA.DM.A1HA.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.DM.A1HA.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.DM.A1HA.01", "Defective GALNT3 causes HFTC"], ["TCGA.DM.A1HA.01", "Defective GALNT12 causes CRCS1"], ["TCGA.DM.A1HA.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.DM.A1HA.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A1HA.01", "Fatty acid metabolism"], ["TCGA.DM.A1HA.01", "Opioid Signalling"], ["TCGA.DM.A1HA.01", "Stimuli-sensing channels"], ["TCGA.DM.A1HA.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A1HA.01", "Voltage gated Potassium channels"], ["TCGA.DM.A282.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A282.01", "Signaling by GPCR"], ["TCGA.DM.A282.01", "GPCR downstream signalling"], ["TCGA.DM.A282.01", "Immune System"], ["TCGA.DM.A282.01", "Signaling Pathways"], ["TCGA.DM.A282.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A282.01", "Generation of second messenger molecules"], ["TCGA.DM.A282.01", "G alpha (i) signalling events"], ["TCGA.DM.A282.01", "PD-1 signaling"], ["TCGA.DM.A282.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A282.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A282.01", "Adaptive Immune System"], ["TCGA.DM.A282.01", "GPCR ligand binding"], ["TCGA.DM.A282.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A282.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A282.01", "Neuronal System"], ["TCGA.DM.A282.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A282.01", "Interleukin-10 signaling"], ["TCGA.DM.A282.01", "Costimulation by the CD28 family"], ["TCGA.DM.A282.01", "Leishmania infection"], ["TCGA.DM.A282.01", "Parasitic Infection Pathways"], ["TCGA.DM.A282.01", "Complement cascade"], ["TCGA.DM.A282.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A282.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A282.01", "Regulation of Complement cascade"], ["TCGA.DM.A282.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A282.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A282.01", "Extracellular matrix organization"], ["TCGA.DM.A282.01", "Diseases of Immune System"], ["TCGA.DM.A282.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A282.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A282.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.DM.A282.01", "G alpha (s) signalling events"], ["TCGA.DM.A282.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A282.01", "Platelet homeostasis"], ["TCGA.DM.A282.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A282.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A282.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A282.01", "Cardiac conduction"], ["TCGA.DM.A282.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A282.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A282.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.DM.A282.01", "Other interleukin signaling"], ["TCGA.DM.A282.01", "G-protein mediated events"], ["TCGA.DM.A282.01", "Ca-dependent events"], ["TCGA.DM.A282.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A282.01", "PLC beta mediated events"], ["TCGA.DM.A282.01", "Signaling by Interleukins"], ["TCGA.DM.A282.01", "Cytokine Signaling in Immune system"], ["TCGA.DM.A282.01", "Initial triggering of complement"], ["TCGA.DM.A282.01", "Scavenging of heme from plasma"], ["TCGA.DM.A282.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.DM.A282.01", "Regulation of TLR by endogenous ligand"], ["TCGA.DM.A282.01", "Integrin cell surface interactions"], ["TCGA.DM.A282.01", "Calmodulin induced events"], ["TCGA.DM.A282.01", "CaM pathway"], ["TCGA.DM.A282.01", "FCERI mediated Ca+2 mobilization"], ["TCGA.DM.A282.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A282.01", "ERK1/ERK2 pathway"], ["TCGA.DM.A282.01", "DAG and IP3 signaling"], ["TCGA.DM.A282.01", "MAPK family signaling cascades"], ["TCGA.DM.A282.01", "NCAM1 interactions"], ["TCGA.DM.A282.01", "Potassium Channels"], ["TCGA.DM.A282.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A282.01", "Opioid Signalling"], ["TCGA.DM.A282.01", "Innate Immune System"], ["TCGA.DM.A282.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.DM.A282.01", "Neurotransmitter release cycle"], ["TCGA.DM.A282.01", "Parasite infection"], ["TCGA.DM.A282.01", "Leishmania phagocytosis"], ["TCGA.DM.A282.01", "FCGR3A-mediated phagocytosis"], ["TCGA.DM.A282.01", "Glycosaminoglycan metabolism"], ["TCGA.DM.A282.01", "Platelet activation, signaling and aggregation"], ["TCGA.DM.A282.01", "Platelet calcium homeostasis"], ["TCGA.DM.A282.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.DM.A282.01", "Peptide hormone metabolism"], ["TCGA.DM.A282.01", "RAF/MAP kinase cascade"], ["TCGA.DM.A282.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.DM.A282.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.DM.A282.01", "Regulation of insulin secretion"], ["TCGA.DM.A282.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A282.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A282.01", "Cargo recognition for clathrin-mediated endocytosis"], ["TCGA.DM.A282.01", "FGFR4 ligand binding and activation"], ["TCGA.DM.A282.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A282.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A282.01", "Insulin processing"], ["TCGA.DM.A282.01", "SUMOylation of intracellular receptors"], ["TCGA.DM.A282.01", "Signaling by ERBB4"], ["TCGA.DM.A282.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.DM.A282.01", "PI3K events in ERBB2 signaling"], ["TCGA.DM.A282.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.DM.A282.01", "ERBB2 Regulates Cell Motility"], ["TCGA.DM.A282.01", "Primitive streak formation"], ["TCGA.DM.A282.01", "NCAM signaling for neurite out-growth"], ["TCGA.DM.A282.01", "Nuclear signaling by ERBB4"], ["TCGA.DM.A282.01", "Platelet Aggregation (Plug Formation)"], ["TCGA.DM.A282.01", "IRS-related events triggered by IGF1R"], ["TCGA.DM.A282.01", "Ion homeostasis"], ["TCGA.DM.A282.01", "Sensory processing of sound"], ["TCGA.DM.A282.01", "Heme degradation"], ["TCGA.DM.A282.01", "Arachidonic acid metabolism"], ["TCGA.DM.A282.01", "Degradation of the extracellular matrix"], ["TCGA.DM.A282.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.DM.A282.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.DM.A282.01", "IGF1R signaling cascade"], ["TCGA.DM.A282.01", "GRB2 events in ERBB2 signaling"], ["TCGA.DM.A282.01", "Blood group systems biosynthesis"], ["TCGA.DM.A282.01", "FOXO-mediated transcription of cell death genes"], ["TCGA.DM.A282.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A282.01", "G alpha (z) signalling events"], ["TCGA.DM.A282.01", "Ion channel transport"], ["TCGA.DM.A282.01", "Regulation of actin dynamics for phagocytic cup formation"], ["TCGA.DM.A282.01", "Integration of energy metabolism"], ["TCGA.DM.A282.01", "Binding and entry of HIV virion"], ["TCGA.DM.A285.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A285.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A285.01", "Immune System"], ["TCGA.DM.A285.01", "Generation of second messenger molecules"], ["TCGA.DM.A285.01", "PD-1 signaling"], ["TCGA.DM.A285.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A285.01", "GPCR ligand binding"], ["TCGA.DM.A285.01", "Signaling by GPCR"], ["TCGA.DM.A285.01", "GPCR downstream signalling"], ["TCGA.DM.A285.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A285.01", "Adaptive Immune System"], ["TCGA.DM.A285.01", "Complement cascade"], ["TCGA.DM.A285.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A285.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A285.01", "Regulation of Complement cascade"], ["TCGA.DM.A285.01", "Neuronal System"], ["TCGA.DM.A285.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A285.01", "Costimulation by the CD28 family"], ["TCGA.DM.A285.01", "Signaling Pathways"], ["TCGA.DM.A285.01", "G alpha (i) signalling events"], ["TCGA.DM.A285.01", "Drug ADME"], ["TCGA.DM.A285.01", "G alpha (q) signalling events"], ["TCGA.DM.A285.01", "Extracellular matrix organization"], ["TCGA.DM.A285.01", "Cytokine Signaling in Immune system"], ["TCGA.DM.A285.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A285.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A285.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A285.01", "Potassium Channels"], ["TCGA.DM.A285.01", "Initial triggering of complement"], ["TCGA.DM.A285.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.DM.A285.01", "TCR signaling"], ["TCGA.DM.A285.01", "Diseases of Immune System"], ["TCGA.DM.A285.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A285.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A285.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A285.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A285.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A285.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A285.01", "Collagen chain trimerization"], ["TCGA.DM.A285.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A285.01", "G alpha (s) signalling events"], ["TCGA.DM.A285.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A285.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.DM.A285.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.DM.A285.01", "APAP ADME"], ["TCGA.DM.A285.01", "Interferon gamma signaling"], ["TCGA.DM.A285.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A285.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A285.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A285.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.DM.A285.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A285.01", "Interleukin receptor SHC signaling"], ["TCGA.DM.A285.01", "Innate Immune System"], ["TCGA.DM.A285.01", "Signaling by Interleukins"], ["TCGA.DM.A285.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A285.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A285.01", "Cardiac conduction"], ["TCGA.DM.A285.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.DM.A285.01", "Interleukin-10 signaling"], ["TCGA.DM.A285.01", "Peptide hormone metabolism"], ["TCGA.DM.A285.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A285.01", "Other interleukin signaling"], ["TCGA.DM.A28C.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A28C.01", "Signaling by GPCR"], ["TCGA.DM.A28C.01", "GPCR downstream signalling"], ["TCGA.DM.A28C.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A28C.01", "Immune System"], ["TCGA.DM.A28C.01", "G alpha (i) signalling events"], ["TCGA.DM.A28C.01", "Generation of second messenger molecules"], ["TCGA.DM.A28C.01", "PD-1 signaling"], ["TCGA.DM.A28C.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A28C.01", "GPCR ligand binding"], ["TCGA.DM.A28C.01", "Neuronal System"], ["TCGA.DM.A28C.01", "Platelet homeostasis"], ["TCGA.DM.A28C.01", "Signaling Pathways"], ["TCGA.DM.A28C.01", "Potassium Channels"], ["TCGA.DM.A28C.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A28C.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A28C.01", "Regulation of Complement cascade"], ["TCGA.DM.A28C.01", "Complement cascade"], ["TCGA.DM.A28C.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A28C.01", "Interleukin-10 signaling"], ["TCGA.DM.A28C.01", "Cardiac conduction"], ["TCGA.DM.A28C.01", "Cell surface interactions at the vascular wall"], ["TCGA.DM.A28C.01", "G alpha (q) signalling events"], ["TCGA.DM.A28C.01", "Leishmania infection"], ["TCGA.DM.A28C.01", "Parasitic Infection Pathways"], ["TCGA.DM.A28C.01", "Costimulation by the CD28 family"], ["TCGA.DM.A28C.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A28C.01", "Arachidonic acid metabolism"], ["TCGA.DM.A28C.01", "Muscle contraction"], ["TCGA.DM.A28C.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A28C.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A28C.01", "Adaptive Immune System"], ["TCGA.DM.A28C.01", "Ion homeostasis"], ["TCGA.DM.A28C.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A28C.01", "G protein gated Potassium channels"], ["TCGA.DM.A28C.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28C.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A28C.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A28C.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A28C.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A28C.01", "Extracellular matrix organization"], ["TCGA.DM.A28C.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A28C.01", "GABA B receptor activation"], ["TCGA.DM.A28C.01", "Activation of GABAB receptors"], ["TCGA.DM.A28C.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A28C.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A28C.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A28C.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A28C.01", "Ion channel transport"], ["TCGA.DM.A28C.01", "Initial triggering of complement"], ["TCGA.DM.A28C.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.DM.A28C.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A28C.01", "Peptide hormone metabolism"], ["TCGA.DM.A28C.01", "Platelet calcium homeostasis"], ["TCGA.DM.A28C.01", "G alpha (s) signalling events"], ["TCGA.DM.A28C.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A28C.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A28C.01", "Transport of small molecules"], ["TCGA.DM.A28C.01", "GABA receptor activation"], ["TCGA.DM.A28C.01", "Stimuli-sensing channels"], ["TCGA.DM.A28C.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28C.01", "L1CAM interactions"], ["TCGA.DM.A28C.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.DM.A28C.01", "Signaling by Interleukins"], ["TCGA.DM.A28C.01", "Cytokine Signaling in Immune system"], ["TCGA.DM.A28C.01", "Diseases of Immune System"], ["TCGA.DM.A28C.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A28C.01", "Regulation of insulin secretion"], ["TCGA.DM.A28C.01", "Glycosaminoglycan metabolism"], ["TCGA.DM.A28C.01", "Binding and entry of HIV virion"], ["TCGA.DM.A28C.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A28C.01", "Innate Immune System"], ["TCGA.DM.A28C.01", "G beta:gamma signalling through PLC beta"], ["TCGA.DM.A28C.01", "G beta:gamma signalling through CDC42"], ["TCGA.DM.A28C.01", "Signal amplification"], ["TCGA.DM.A28C.01", "G-protein activation"], ["TCGA.DM.A28C.01", "Integrin cell surface interactions"], ["TCGA.DM.A28C.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.DM.A28C.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A28C.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28C.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A28C.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A28C.01", "Keratan sulfate biosynthesis"], ["TCGA.DM.A28C.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A28C.01", "Nicotinate metabolism"], ["TCGA.DM.A28C.01", "Ca2+ pathway"], ["TCGA.DM.A28C.01", "Opioid Signalling"], ["TCGA.DM.A28C.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A28C.01", "TCR signaling"], ["TCGA.DM.A28C.01", "RA biosynthesis pathway"], ["TCGA.DM.A28C.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A28C.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A28C.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28C.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28C.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A28C.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.DM.A28C.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28C.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A28C.01", "O-linked glycosylation of mucins"], ["TCGA.DM.A28C.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A28C.01", "Regulation of TLR by endogenous ligand"], ["TCGA.DM.A28C.01", "Thromboxane signalling through TP receptor"], ["TCGA.DM.A28C.01", "Insulin processing"], ["TCGA.DM.A28C.01", "Scavenging by Class A Receptors"], ["TCGA.DM.A28C.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.DM.A28C.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.DM.A28C.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A28C.01", "DAP12 interactions"], ["TCGA.DM.A28C.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.DM.A28C.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.DM.A28C.01", "Integration of energy metabolism"], ["TCGA.DM.A28C.01", "FCGR activation"], ["TCGA.DM.A28C.01", "Defective GALNT12 causes CRCS1"], ["TCGA.DM.A28C.01", "Dectin-2 family"], ["TCGA.DM.A28C.01", "Biological oxidations"], ["TCGA.DM.A28C.01", "Ion transport by P-type ATPases"], ["TCGA.DM.A28C.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A28C.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A28C.01", "Phase I - Functionalization of compounds"], ["TCGA.DM.A28C.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A28C.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A28C.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.DM.A28C.01", "ECM proteoglycans"], ["TCGA.DM.A28C.01", "Sensory processing of sound"], ["TCGA.DM.A28C.01", "Regulation of FZD by ubiquitination"], ["TCGA.DM.A28C.01", "SLC-mediated transmembrane transport"], ["TCGA.DM.A28C.01", "LGI-ADAM interactions"], ["TCGA.DM.A28C.01", "Biosynthesis of DHA-derived SPMs"], ["TCGA.DM.A28E.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A28E.01", "Signaling by GPCR"], ["TCGA.DM.A28E.01", "GPCR downstream signalling"], ["TCGA.DM.A28E.01", "Neuronal System"], ["TCGA.DM.A28E.01", "GPCR ligand binding"], ["TCGA.DM.A28E.01", "Generation of second messenger molecules"], ["TCGA.DM.A28E.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A28E.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A28E.01", "G alpha (i) signalling events"], ["TCGA.DM.A28E.01", "Signaling Pathways"], ["TCGA.DM.A28E.01", "Immune System"], ["TCGA.DM.A28E.01", "PD-1 signaling"], ["TCGA.DM.A28E.01", "Extracellular matrix organization"], ["TCGA.DM.A28E.01", "Cardiac conduction"], ["TCGA.DM.A28E.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28E.01", "Cell surface interactions at the vascular wall"], ["TCGA.DM.A28E.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A28E.01", "Muscle contraction"], ["TCGA.DM.A28E.01", "Complement cascade"], ["TCGA.DM.A28E.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A28E.01", "Potassium Channels"], ["TCGA.DM.A28E.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A28E.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A28E.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A28E.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A28E.01", "G alpha (s) signalling events"], ["TCGA.DM.A28E.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A28E.01", "Regulation of Complement cascade"], ["TCGA.DM.A28E.01", "Biological oxidations"], ["TCGA.DM.A28E.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28E.01", "Initial triggering of complement"], ["TCGA.DM.A28E.01", "Elastic fibre formation"], ["TCGA.DM.A28E.01", "Glycosaminoglycan metabolism"], ["TCGA.DM.A28E.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A28E.01", "Leishmania infection"], ["TCGA.DM.A28E.01", "Parasitic Infection Pathways"], ["TCGA.DM.A28E.01", "Keratan sulfate biosynthesis"], ["TCGA.DM.A28E.01", "Costimulation by the CD28 family"], ["TCGA.DM.A28E.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A28E.01", "L1CAM interactions"], ["TCGA.DM.A28E.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A28E.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28E.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A28E.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A28E.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A28E.01", "Platelet homeostasis"], ["TCGA.DM.A28E.01", "Transport of small molecules"], ["TCGA.DM.A28E.01", "G alpha (q) signalling events"], ["TCGA.DM.A28E.01", "Regulation of insulin secretion"], ["TCGA.DM.A28E.01", "Neurexins and neuroligins"], ["TCGA.DM.A28E.01", "GABA receptor activation"], ["TCGA.DM.A28E.01", "DAP12 signaling"], ["TCGA.DM.A28E.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.DM.A28E.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28E.01", "Ion homeostasis"], ["TCGA.DM.A28E.01", "Integrin cell surface interactions"], ["TCGA.DM.A28E.01", "GABA B receptor activation"], ["TCGA.DM.A28E.01", "Activation of GABAB receptors"], ["TCGA.DM.A28E.01", "DAP12 interactions"], ["TCGA.DM.A28E.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A28E.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A28E.01", "Cytokine Signaling in Immune system"], ["TCGA.DM.A28E.01", "Ion channel transport"], ["TCGA.DM.A28E.01", "Keratan sulfate/keratin metabolism"], ["TCGA.DM.A28E.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A28E.01", "Blood group systems biosynthesis"], ["TCGA.DM.A28E.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.DM.A28E.01", "Aquaporin-mediated transport"], ["TCGA.DM.A28E.01", "ECM proteoglycans"], ["TCGA.DM.A28E.01", "Adaptive Immune System"], ["TCGA.DM.A28E.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A28E.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A28E.01", "Sialic acid metabolism"], ["TCGA.DM.A28E.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A28E.01", "Integration of energy metabolism"], ["TCGA.DM.A28E.01", "Netrin-1 signaling"], ["TCGA.DM.A28E.01", "Phase I - Functionalization of compounds"], ["TCGA.DM.A28E.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A28E.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A28E.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28E.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28E.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A28E.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A28E.01", "Signaling by Interleukins"], ["TCGA.DM.A28E.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.DM.A28E.01", "Voltage gated Potassium channels"], ["TCGA.DM.A28E.01", "Arachidonic acid metabolism"], ["TCGA.DM.A28E.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.DM.A28E.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A28E.01", "Other semaphorin interactions"], ["TCGA.DM.A28E.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.DM.A28E.01", "Diseases of Immune System"], ["TCGA.DM.A28E.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A28E.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A28E.01", "G alpha (z) signalling events"], ["TCGA.DM.A28E.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A28E.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.DM.A28E.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A28E.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A28E.01", "G protein gated Potassium channels"], ["TCGA.DM.A28E.01", "Platelet calcium homeostasis"], ["TCGA.DM.A28E.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A28E.01", "Diseases associated with glycosaminoglycan metabolism"], ["TCGA.DM.A28E.01", "Scavenging by Class A Receptors"], ["TCGA.DM.A28E.01", "G beta:gamma signalling through PLC beta"], ["TCGA.DM.A28E.01", "G beta:gamma signalling through CDC42"], ["TCGA.DM.A28E.01", "GPER1 signaling"], ["TCGA.DM.A28E.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.DM.A28E.01", "Ca2+ pathway"], ["TCGA.DM.A28E.01", "FCGR activation"], ["TCGA.DM.A28E.01", "CD28 dependent Vav1 pathway"], ["TCGA.DM.A28E.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A28E.01", "CRMPs in Sema3A signaling"], ["TCGA.DM.A28E.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A28E.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A28E.01", "Aspartate and asparagine metabolism"], ["TCGA.DM.A28F.01", "Neuronal System"], ["TCGA.DM.A28F.01", "Potassium Channels"], ["TCGA.DM.A28F.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A28F.01", "Signaling by GPCR"], ["TCGA.DM.A28F.01", "GPCR downstream signalling"], ["TCGA.DM.A28F.01", "Cardiac conduction"], ["TCGA.DM.A28F.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A28F.01", "Biological oxidations"], ["TCGA.DM.A28F.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A28F.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28F.01", "Signaling Pathways"], ["TCGA.DM.A28F.01", "G alpha (i) signalling events"], ["TCGA.DM.A28F.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A28F.01", "Voltage gated Potassium channels"], ["TCGA.DM.A28F.01", "Arachidonic acid metabolism"], ["TCGA.DM.A28F.01", "Interleukin-10 signaling"], ["TCGA.DM.A28F.01", "GABA receptor activation"], ["TCGA.DM.A28F.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A28F.01", "GPCR ligand binding"], ["TCGA.DM.A28F.01", "Muscle contraction"], ["TCGA.DM.A28F.01", "Phase 4 - resting membrane potential"], ["TCGA.DM.A28F.01", "Phase I - Functionalization of compounds"], ["TCGA.DM.A28F.01", "G alpha (s) signalling events"], ["TCGA.DM.A28F.01", "GABA B receptor activation"], ["TCGA.DM.A28F.01", "Activation of GABAB receptors"], ["TCGA.DM.A28F.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A28F.01", "Platelet homeostasis"], ["TCGA.DM.A28F.01", "L1CAM interactions"], ["TCGA.DM.A28F.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A28F.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A28F.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A28F.01", "Glucuronidation"], ["TCGA.DM.A28F.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28F.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A28F.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A28F.01", "G protein gated Potassium channels"], ["TCGA.DM.A28F.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A28F.01", "Insulin processing"], ["TCGA.DM.A28F.01", "Leishmania infection"], ["TCGA.DM.A28F.01", "Parasitic Infection Pathways"], ["TCGA.DM.A28F.01", "Extracellular matrix organization"], ["TCGA.DM.A28F.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.DM.A28F.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A28F.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A28F.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A28F.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28F.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.DM.A28F.01", "Peptide hormone metabolism"], ["TCGA.DM.A28F.01", "Complement cascade"], ["TCGA.DM.A28F.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A28F.01", "Ion channel transport"], ["TCGA.DM.A28F.01", "Phase II - Conjugation of compounds"], ["TCGA.DM.A28F.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A28F.01", "Other interleukin signaling"], ["TCGA.DM.A28F.01", "Nuclear signaling by ERBB4"], ["TCGA.DM.A28F.01", "Netrin-1 signaling"], ["TCGA.DM.A28F.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A28F.01", "Aspirin ADME"], ["TCGA.DM.A28F.01", "G alpha (q) signalling events"], ["TCGA.DM.A28F.01", "Stimuli-sensing channels"], ["TCGA.DM.A28F.01", "Neurexins and neuroligins"], ["TCGA.DM.A28F.01", "Initial triggering of complement"], ["TCGA.DM.A28F.01", "PI3K events in ERBB2 signaling"], ["TCGA.DM.A28F.01", "ERBB2 Regulates Cell Motility"], ["TCGA.DM.A28F.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A28F.01", "Elastic fibre formation"], ["TCGA.DM.A28F.01", "Regulation of Complement cascade"], ["TCGA.DM.A28F.01", "Keratan sulfate biosynthesis"], ["TCGA.DM.A28F.01", "Sensory processing of sound"], ["TCGA.DM.A28F.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A28F.01", "GRB2 events in ERBB2 signaling"], ["TCGA.DM.A28F.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A28F.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.DM.A28F.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A28F.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A28F.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A28F.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A28F.01", "NCAM1 interactions"], ["TCGA.DM.A28F.01", "RA biosynthesis pathway"], ["TCGA.DM.A28F.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A28F.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A28F.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.DM.A28F.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28F.01", "Signal amplification"], ["TCGA.DM.A28F.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.DM.A28F.01", "Drug ADME"], ["TCGA.DM.A28F.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A28F.01", "Endogenous sterols"], ["TCGA.DM.A28F.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.DM.A28F.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.DM.A28F.01", "Formation of the anterior neural plate"], ["TCGA.DM.A28F.01", "Regulation of insulin secretion"], ["TCGA.DM.A28F.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A28F.01", "Downregulation of ERBB2 signaling"], ["TCGA.DM.A28F.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A28F.01", "Signaling by ERBB4"], ["TCGA.DM.A28F.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A28F.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.DM.A28F.01", "Ion homeostasis"], ["TCGA.DM.A28F.01", "SHC1 events in ERBB4 signaling"], ["TCGA.DM.A28F.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A28F.01", "Ethanol oxidation"], ["TCGA.DM.A28F.01", "DAP12 signaling"], ["TCGA.DM.A28F.01", "NCAM signaling for neurite out-growth"], ["TCGA.DM.A28G.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A28G.01", "Signaling by GPCR"], ["TCGA.DM.A28G.01", "GPCR downstream signalling"], ["TCGA.DM.A28G.01", "G alpha (i) signalling events"], ["TCGA.DM.A28G.01", "Neuronal System"], ["TCGA.DM.A28G.01", "Signaling Pathways"], ["TCGA.DM.A28G.01", "Extracellular matrix organization"], ["TCGA.DM.A28G.01", "Cardiac conduction"], ["TCGA.DM.A28G.01", "Immune System"], ["TCGA.DM.A28G.01", "GPCR ligand binding"], ["TCGA.DM.A28G.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A28G.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28G.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A28G.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28G.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A28G.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A28G.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A28G.01", "Regulation of Complement cascade"], ["TCGA.DM.A28G.01", "Interleukin-10 signaling"], ["TCGA.DM.A28G.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28G.01", "RA biosynthesis pathway"], ["TCGA.DM.A28G.01", "Muscle contraction"], ["TCGA.DM.A28G.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A28G.01", "Complement cascade"], ["TCGA.DM.A28G.01", "Leishmania infection"], ["TCGA.DM.A28G.01", "Parasitic Infection Pathways"], ["TCGA.DM.A28G.01", "Drug ADME"], ["TCGA.DM.A28G.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A28G.01", "Peptide hormone metabolism"], ["TCGA.DM.A28G.01", "Cytosolic sulfonation of small molecules"], ["TCGA.DM.A28G.01", "Regulation of FZD by ubiquitination"], ["TCGA.DM.A28G.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A28G.01", "IRS-related events triggered by IGF1R"], ["TCGA.DM.A28G.01", "Degradation of the extracellular matrix"], ["TCGA.DM.A28G.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A28G.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A28G.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A28G.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.DM.A28G.01", "IGF1R signaling cascade"], ["TCGA.DM.A28G.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A28G.01", "Signaling by Retinoic Acid"], ["TCGA.DM.A28G.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A28G.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A28G.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28G.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A28G.01", "Physiological factors"], ["TCGA.DM.A28G.01", "Regulation of insulin secretion"], ["TCGA.DM.A28G.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.DM.A28G.01", "GABA receptor activation"], ["TCGA.DM.A28G.01", "Signal amplification"], ["TCGA.DM.A28G.01", "G alpha (q) signalling events"], ["TCGA.DM.A28G.01", "LGI-ADAM interactions"], ["TCGA.DM.A28G.01", "G alpha (s) signalling events"], ["TCGA.DM.A28G.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A28G.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28G.01", "FGFR2 ligand binding and activation"], ["TCGA.DM.A28G.01", "G beta:gamma signalling through CDC42"], ["TCGA.DM.A28G.01", "APAP ADME"], ["TCGA.DM.A28H.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A28H.01", "GPCR downstream signalling"], ["TCGA.DM.A28H.01", "Signaling by GPCR"], ["TCGA.DM.A28H.01", "Immune System"], ["TCGA.DM.A28H.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A28H.01", "Neuronal System"], ["TCGA.DM.A28H.01", "Signaling Pathways"], ["TCGA.DM.A28H.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A28H.01", "Potassium Channels"], ["TCGA.DM.A28H.01", "G alpha (i) signalling events"], ["TCGA.DM.A28H.01", "GPCR ligand binding"], ["TCGA.DM.A28H.01", "PD-1 signaling"], ["TCGA.DM.A28H.01", "Cytokine Signaling in Immune system"], ["TCGA.DM.A28H.01", "Complement cascade"], ["TCGA.DM.A28H.01", "G alpha (q) signalling events"], ["TCGA.DM.A28H.01", "Generation of second messenger molecules"], ["TCGA.DM.A28H.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A28H.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A28H.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A28H.01", "Interferon gamma signaling"], ["TCGA.DM.A28H.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28H.01", "Initial triggering of complement"], ["TCGA.DM.A28H.01", "G alpha (s) signalling events"], ["TCGA.DM.A28H.01", "DNA strand elongation"], ["TCGA.DM.A28H.01", "Extracellular matrix organization"], ["TCGA.DM.A28H.01", "Cardiac conduction"], ["TCGA.DM.A28H.01", "Regulation of insulin secretion"], ["TCGA.DM.A28H.01", "Deposition of new CENPA-containing nucleosomes at the centromere"], ["TCGA.DM.A28H.01", "Nucleosome assembly"], ["TCGA.DM.A28H.01", "Regulation of Complement cascade"], ["TCGA.DM.A28H.01", "Other interleukin signaling"], ["TCGA.DM.A28H.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28H.01", "Polo-like kinase mediated events"], ["TCGA.DM.A28H.01", "Blood group systems biosynthesis"], ["TCGA.DM.A28H.01", "MHC class II antigen presentation"], ["TCGA.DM.A28H.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28H.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A28H.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A28H.01", "Interferon alpha/beta signaling"], ["TCGA.DM.A28H.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28H.01", "Binding and entry of HIV virion"], ["TCGA.DM.A28H.01", "Inflammasomes"], ["TCGA.DM.A28H.01", "Lagging Strand Synthesis"], ["TCGA.DM.A28H.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A28H.01", "Elastic fibre formation"], ["TCGA.DM.A28H.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.DM.A28H.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A28H.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A28H.01", "Condensation of Prophase Chromosomes"], ["TCGA.DM.A28H.01", "Interleukin-35 Signalling"], ["TCGA.DM.A28H.01", "Chromosome Maintenance"], ["TCGA.DM.A28H.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.DM.A28H.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.DM.A28H.01", "Adaptive Immune System"], ["TCGA.DM.A28H.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A28H.01", "Leishmania infection"], ["TCGA.DM.A28H.01", "Parasitic Infection Pathways"], ["TCGA.DM.A28H.01", "Voltage gated Potassium channels"], ["TCGA.DM.A28H.01", "G0 and Early G1"], ["TCGA.DM.A28H.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A28H.01", "G1/S-Specific Transcription"], ["TCGA.DM.A28H.01", "Signal amplification"], ["TCGA.DM.A28H.01", "Depolymerization of the Nuclear Lamina"], ["TCGA.DM.A28H.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.DM.A28H.01", "Polymerase switching"], ["TCGA.DM.A28H.01", "Leading Strand Synthesis"], ["TCGA.DM.A28H.01", "Removal of the Flap Intermediate"], ["TCGA.DM.A28H.01", "Processive synthesis on the lagging strand"], ["TCGA.DM.A28H.01", "Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"], ["TCGA.DM.A28H.01", "Peptide hormone metabolism"], ["TCGA.DM.A28H.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A28H.01", "Resolution of Sister Chromatid Cohesion"], ["TCGA.DM.A28H.01", "G alpha (z) signalling events"], ["TCGA.DM.A28H.01", "Cyclin A/B1/B2 associated events during G2/M transition"], ["TCGA.DM.A28H.01", "Integration of energy metabolism"], ["TCGA.DM.A28H.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28H.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A28H.01", "APOBEC3G mediated resistance to HIV-1 infection"], ["TCGA.DM.A28H.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A28H.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A28H.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A28H.01", "Activation of the pre-replicative complex"], ["TCGA.DM.A28H.01", "Biological oxidations"], ["TCGA.DM.A28H.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A28H.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28H.01", "Platelet homeostasis"], ["TCGA.DM.A28H.01", "Signaling by Interleukins"], ["TCGA.DM.A28H.01", "Unwinding of DNA"], ["TCGA.DM.A28H.01", "Condensation of Prometaphase Chromosomes"], ["TCGA.DM.A28H.01", "Interleukin-27 signaling"], ["TCGA.DM.A28H.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A28H.01", "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"], ["TCGA.DM.A28K.01", "Signaling by GPCR"], ["TCGA.DM.A28K.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A28K.01", "GPCR downstream signalling"], ["TCGA.DM.A28K.01", "GPCR ligand binding"], ["TCGA.DM.A28K.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A28K.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28K.01", "Neuronal System"], ["TCGA.DM.A28K.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A28K.01", "G alpha (i) signalling events"], ["TCGA.DM.A28K.01", "Generation of second messenger molecules"], ["TCGA.DM.A28K.01", "Cardiac conduction"], ["TCGA.DM.A28K.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A28K.01", "Complement cascade"], ["TCGA.DM.A28K.01", "Drug ADME"], ["TCGA.DM.A28K.01", "Biological oxidations"], ["TCGA.DM.A28K.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A28K.01", "Regulation of Complement cascade"], ["TCGA.DM.A28K.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A28K.01", "Immune System"], ["TCGA.DM.A28K.01", "Signaling Pathways"], ["TCGA.DM.A28K.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A28K.01", "G alpha (s) signalling events"], ["TCGA.DM.A28K.01", "SUMOylation of intracellular receptors"], ["TCGA.DM.A28K.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A28K.01", "PD-1 signaling"], ["TCGA.DM.A28K.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28K.01", "Extracellular matrix organization"], ["TCGA.DM.A28K.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], ["TCGA.DM.A28K.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28K.01", "Muscle contraction"], ["TCGA.DM.A28K.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A28K.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A28K.01", "Calmodulin induced events"], ["TCGA.DM.A28K.01", "CaM pathway"], ["TCGA.DM.A28K.01", "Initial triggering of complement"], ["TCGA.DM.A28K.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.DM.A28K.01", "Aquaporin-mediated transport"], ["TCGA.DM.A28K.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A28K.01", "Phase I - Functionalization of compounds"], ["TCGA.DM.A28K.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A28K.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A28K.01", "Leishmania infection"], ["TCGA.DM.A28K.01", "Parasitic Infection Pathways"], ["TCGA.DM.A28K.01", "DAG and IP3 signaling"], ["TCGA.DM.A28K.01", "Ca-dependent events"], ["TCGA.DM.A28K.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A28K.01", "Activation of SMO"], ["TCGA.DM.A28K.01", "L1CAM interactions"], ["TCGA.DM.A28K.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.DM.A28K.01", "PLC beta mediated events"], ["TCGA.DM.A28K.01", "G-protein mediated events"], ["TCGA.DM.A28K.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A28K.01", "G alpha (z) signalling events"], ["TCGA.DM.A28K.01", "Ion homeostasis"], ["TCGA.DM.A28K.01", "Opioid Signalling"], ["TCGA.DM.A28K.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.DM.A28K.01", "Scavenging of heme from plasma"], ["TCGA.DM.A28K.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A28K.01", "Integration of energy metabolism"], ["TCGA.DM.A28K.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.DM.A28K.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28K.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A28K.01", "Elastic fibre formation"], ["TCGA.DM.A28K.01", "Transport of small molecules"], ["TCGA.DM.A28K.01", "Neurotransmitter release cycle"], ["TCGA.DM.A28K.01", "Long-term potentiation"], ["TCGA.DM.A28K.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.DM.A28K.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A28K.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28M.01", "Neuronal System"], ["TCGA.DM.A28M.01", "G alpha (i) signalling events"], ["TCGA.DM.A28M.01", "Signaling by GPCR"], ["TCGA.DM.A28M.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.DM.A28M.01", "GPCR downstream signalling"], ["TCGA.DM.A28M.01", "Signaling Pathways"], ["TCGA.DM.A28M.01", "Immune System"], ["TCGA.DM.A28M.01", "Transmission across Chemical Synapses"], ["TCGA.DM.A28M.01", "GPCR ligand binding"], ["TCGA.DM.A28M.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.DM.A28M.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.DM.A28M.01", "Leishmania parasite growth and survival"], ["TCGA.DM.A28M.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.DM.A28M.01", "G alpha (z) signalling events"], ["TCGA.DM.A28M.01", "Leishmania infection"], ["TCGA.DM.A28M.01", "Parasitic Infection Pathways"], ["TCGA.DM.A28M.01", "Cardiac conduction"], ["TCGA.DM.A28M.01", "GABA receptor activation"], ["TCGA.DM.A28M.01", "Generation of second messenger molecules"], ["TCGA.DM.A28M.01", "PD-1 signaling"], ["TCGA.DM.A28M.01", "Extracellular matrix organization"], ["TCGA.DM.A28M.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.DM.A28M.01", "GABA B receptor activation"], ["TCGA.DM.A28M.01", "Activation of GABAB receptors"], ["TCGA.DM.A28M.01", "Complement cascade"], ["TCGA.DM.A28M.01", "Potassium Channels"], ["TCGA.DM.A28M.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.DM.A28M.01", "Initial triggering of complement"], ["TCGA.DM.A28M.01", "Interleukin-10 signaling"], ["TCGA.DM.A28M.01", "Glucagon signaling in metabolic regulation"], ["TCGA.DM.A28M.01", "Muscle contraction"], ["TCGA.DM.A28M.01", "Chemokine receptors bind chemokines"], ["TCGA.DM.A28M.01", "Platelet homeostasis"], ["TCGA.DM.A28M.01", "G alpha (s) signalling events"], ["TCGA.DM.A28M.01", "Glucagon-type ligand receptors"], ["TCGA.DM.A28M.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.DM.A28M.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.DM.A28M.01", "Aquaporin-mediated transport"], ["TCGA.DM.A28M.01", "G-protein beta:gamma signalling"], ["TCGA.DM.A28M.01", "Ca-dependent events"], ["TCGA.DM.A28M.01", "Ion homeostasis"], ["TCGA.DM.A28M.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.DM.A28M.01", "Regulation of Complement cascade"], ["TCGA.DM.A28M.01", "Peptide ligand-binding receptors"], ["TCGA.DM.A28M.01", "G beta:gamma signalling through BTK"], ["TCGA.DM.A28M.01", "Activation of G protein gated Potassium channels"], ["TCGA.DM.A28M.01", "G protein gated Potassium channels"], ["TCGA.DM.A28M.01", "Interaction between L1 and Ankyrins"], ["TCGA.DM.A28M.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.DM.A28M.01", "Opioid Signalling"], ["TCGA.DM.A28M.01", "Calmodulin induced events"], ["TCGA.DM.A28M.01", "CaM pathway"], ["TCGA.DM.A28M.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.DM.A28M.01", "PLC beta mediated events"], ["TCGA.DM.A28M.01", "G-protein mediated events"], ["TCGA.DM.A28M.01", "Class B/2 (Secretin family receptors)"], ["TCGA.DM.A28M.01", "Phase 0 - rapid depolarisation"], ["TCGA.DM.A28M.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A28M.01", "Inwardly rectifying K+ channels"], ["TCGA.DM.A28M.01", "DAG and IP3 signaling"], ["TCGA.DM.A28M.01", "GPER1 signaling"], ["TCGA.DM.A28M.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.DM.A28M.01", "Cytokine Signaling in Immune system"], ["TCGA.DM.A28M.01", "G beta:gamma signalling through CDC42"], ["TCGA.DM.A28M.01", "Netrin-1 signaling"], ["TCGA.DM.A28M.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.DM.A28M.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A28M.01", "Ca2+ pathway"], ["TCGA.DM.A28M.01", "Cell surface interactions at the vascular wall"], ["TCGA.DM.A28M.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.DM.A28M.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.DM.A28M.01", "Signal amplification"], ["TCGA.DM.A28M.01", "Presynaptic function of Kainate receptors"], ["TCGA.DM.A28M.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.DM.A28M.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.DM.A28M.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.DM.A28M.01", "Signaling by Interleukins"], ["TCGA.DM.A28M.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.DM.A28M.01", "Integrin cell surface interactions"], ["TCGA.DM.A28M.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.DM.A28M.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.DM.A28M.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.DM.A28M.01", "Protein-protein interactions at synapses"], ["TCGA.DM.A28M.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.DM.A28M.01", "TNFs bind their physiological receptors"], ["TCGA.DM.A28M.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.DM.A28M.01", "Transport of small molecules"], ["TCGA.DM.A28M.01", "Molecules associated with elastic fibres"], ["TCGA.DM.A28M.01", "Regulation of TLR by endogenous ligand"], ["TCGA.DM.A28M.01", "Integration of energy metabolism"], ["TCGA.DM.A28M.01", "Diseases of Immune System"], ["TCGA.DM.A28M.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.DM.A28M.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.DM.A28M.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.DM.A28M.01", "Signal regulatory protein family interactions"], ["TCGA.DM.A28M.01", "Regulation of insulin secretion"], ["TCGA.DM.A28M.01", "G beta:gamma signalling through PLC beta"], ["TCGA.DM.A28M.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.DM.A28M.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.DM.A28M.01", "Ion channel transport"], ["TCGA.DM.A28M.01", "G-protein activation"], ["TCGA.DM.A28M.01", "Thromboxane signalling through TP receptor"], ["TCGA.DM.A28M.01", "Stimuli-sensing channels"], ["TCGA.DM.A28M.01", "Blood group systems biosynthesis"], ["TCGA.DM.A28M.01", "Costimulation by the CD28 family"], ["TCGA.DM.A28M.01", "Keratan sulfate biosynthesis"], ["TCGA.DM.A28M.01", "Transcriptional regulation of testis differentiation"], ["TCGA.DM.A28M.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.DM.A28M.01", "Elastic fibre formation"], ["TCGA.DM.A28M.01", "PKA activation in glucagon signalling"], ["TCGA.DM.A28M.01", "Adenylate cyclase inhibitory pathway"], ["TCGA.DM.A28M.01", "Arachidonic acid metabolism"], ["TCGA.DM.A28M.01", "ERK1/ERK2 pathway"], ["TCGA.DM.A28M.01", "Neurexins and neuroligins"], ["TCGA.DM.A28M.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.DM.A28M.01", "Other semaphorin interactions"], ["TCGA.DM.A28M.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.DM.A28M.01", "Inflammasomes"], ["TCGA.DM.A28M.01", "Innate Immune System"], ["TCGA.DM.A28M.01", "CD22 mediated BCR regulation"], ["TCGA.DM.A28M.01", "Other interleukin signaling"], ["TCGA.DM.A28M.01", "Defensins"], ["TCGA.DM.A28M.01", "IRS-related events triggered by IGF1R"], ["TCGA.DM.A28M.01", "Activation of Matrix Metalloproteinases"], ["TCGA.DM.A28M.01", "IRS-mediated signalling"], ["TCGA.DM.A28M.01", "G alpha (q) signalling events"], ["TCGA.DM.A28M.01", "Lewis blood group biosynthesis"], ["TCGA.DM.A28M.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.DM.A28M.01", "IGF1R signaling cascade"], ["TCGA.DM.A28M.01", "NCAM1 interactions"], ["TCGA.DM.A28M.01", "Glycosaminoglycan metabolism"], ["TCGA.DM.A28M.01", "RAF/MAP kinase cascade"], ["TCGA.DM.A28M.01", "Adaptive Immune System"], ["TCGA.DM.A28M.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.DM.A28M.01", "HSF1-dependent transactivation"], ["TCGA.DM.A28M.01", "Long-term potentiation"], ["TCGA.DM.A28M.01", "Activation of the phototransduction cascade"], ["TCGA.DM.A28M.01", "Degradation of the extracellular matrix"], ["TCGA.DM.A28M.01", "L1CAM interactions"], ["TCGA.DM.A28M.01", "Formation of the anterior neural plate"], ["TCGA.DM.A28M.01", "WNT ligand biogenesis and trafficking"], ["TCGA.F4.6459.01", "Extracellular matrix organization"], ["TCGA.F4.6459.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.F4.6459.01", "Collagen chain trimerization"], ["TCGA.F4.6459.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6459.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.F4.6459.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.F4.6459.01", "TNFs bind their physiological receptors"], ["TCGA.F4.6459.01", "Collagen formation"], ["TCGA.F4.6459.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6459.01", "Physiological factors"], ["TCGA.F4.6459.01", "Post-translational protein phosphorylation"], ["TCGA.F4.6459.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6459.01", "Blood group systems biosynthesis"], ["TCGA.F4.6460.01", "Biological oxidations"], ["TCGA.F4.6460.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6460.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6460.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6460.01", "Metabolism"], ["TCGA.F4.6460.01", "Formation of axial mesoderm"], ["TCGA.F4.6460.01", "Glucuronidation"], ["TCGA.F4.6460.01", "IRS-related events triggered by IGF1R"], ["TCGA.F4.6460.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.F4.6460.01", "IGF1R signaling cascade"], ["TCGA.F4.6460.01", "Peptide hormone metabolism"], ["TCGA.F4.6460.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6460.01", "FGFR4 ligand binding and activation"], ["TCGA.F4.6460.01", "Drug ADME"], ["TCGA.F4.6460.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.F4.6460.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.F4.6460.01", "IRS-mediated signalling"], ["TCGA.F4.6460.01", "Activated point mutants of FGFR2"], ["TCGA.F4.6460.01", "Phospholipase C-mediated cascade; FGFR2"], ["TCGA.F4.6460.01", "PI-3K cascade:FGFR4"], ["TCGA.F4.6460.01", "Insulin receptor signalling cascade"], ["TCGA.F4.6460.01", "Visual phototransduction"], ["TCGA.F4.6460.01", "FGFR2 ligand binding and activation"], ["TCGA.F4.6460.01", "Extracellular matrix organization"], ["TCGA.F4.6460.01", "SLC-mediated transmembrane transport"], ["TCGA.F4.6460.01", "PPARA activates gene expression"], ["TCGA.F4.6460.01", "SHC-mediated cascade:FGFR4"], ["TCGA.F4.6460.01", "Regulation of lipid metabolism by PPARalpha"], ["TCGA.F4.6460.01", "PI-3K cascade:FGFR2"], ["TCGA.F4.6460.01", "FRS-mediated FGFR4 signaling"], ["TCGA.F4.6460.01", "Aspirin ADME"], ["TCGA.F4.6460.01", "FGFR2c ligand binding and activation"], ["TCGA.F4.6460.01", "SHC-mediated cascade:FGFR2"], ["TCGA.F4.6460.01", "Regulation of insulin secretion"], ["TCGA.F4.6460.01", "FRS-mediated FGFR2 signaling"], ["TCGA.F4.6460.01", "Metabolism of fat-soluble vitamins"], ["TCGA.F4.6460.01", "Retinoid metabolism and transport"], ["TCGA.F4.6461.01", "Drug ADME"], ["TCGA.F4.6461.01", "Extracellular matrix organization"], ["TCGA.F4.6461.01", "Biological oxidations"], ["TCGA.F4.6461.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6461.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6461.01", "APAP ADME"], ["TCGA.F4.6461.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6461.01", "Ethanol oxidation"], ["TCGA.F4.6461.01", "Metabolism"], ["TCGA.F4.6461.01", "Chemokine receptors bind chemokines"], ["TCGA.F4.6461.01", "Aflatoxin activation and detoxification"], ["TCGA.F4.6461.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.F4.6461.01", "Metabolism of fat-soluble vitamins"], ["TCGA.F4.6461.01", "Retinoid metabolism and transport"], ["TCGA.F4.6461.01", "Glutathione conjugation"], ["TCGA.F4.6461.01", "Collagen formation"], ["TCGA.F4.6461.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6461.01", "SUMOylation of intracellular receptors"], ["TCGA.F4.6461.01", "Peptide ligand-binding receptors"], ["TCGA.F4.6461.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.F4.6461.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6463.01", "Drug ADME"], ["TCGA.F4.6463.01", "Extracellular matrix organization"], ["TCGA.F4.6463.01", "Metabolism"], ["TCGA.F4.6463.01", "Blood group systems biosynthesis"], ["TCGA.F4.6463.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6463.01", "Biological oxidations"], ["TCGA.F4.6463.01", "FGFR4 ligand binding and activation"], ["TCGA.F4.6463.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.F4.6463.01", "Lewis blood group biosynthesis"], ["TCGA.F4.6463.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6463.01", "IRS-related events triggered by IGF1R"], ["TCGA.F4.6463.01", "Activated point mutants of FGFR2"], ["TCGA.F4.6463.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.F4.6463.01", "IGF1R signaling cascade"], ["TCGA.F4.6463.01", "Insulin receptor signalling cascade"], ["TCGA.F4.6463.01", "Glucuronidation"], ["TCGA.F4.6463.01", "Phospholipase C-mediated cascade; FGFR2"], ["TCGA.F4.6463.01", "PI-3K cascade:FGFR4"], ["TCGA.F4.6463.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6463.01", "Defective GALNT12 causes CRCS1"], ["TCGA.F4.6463.01", "FGFR2 ligand binding and activation"], ["TCGA.F4.6463.01", "APAP ADME"], ["TCGA.F4.6463.01", "Peptide hormone metabolism"], ["TCGA.F4.6463.01", "IRS-mediated signalling"], ["TCGA.F4.6463.01", "FGFR2c ligand binding and activation"], ["TCGA.F4.6463.01", "Peptide hormone biosynthesis"], ["TCGA.F4.6463.01", "FGFRL1 modulation of FGFR1 signaling"], ["TCGA.F4.6463.01", "SHC-mediated cascade:FGFR4"], ["TCGA.F4.6463.01", "O-linked glycosylation"], ["TCGA.F4.6463.01", "PI-3K cascade:FGFR2"], ["TCGA.F4.6463.01", "FRS-mediated FGFR4 signaling"], ["TCGA.F4.6463.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.F4.6463.01", "Metabolism of amine-derived hormones"], ["TCGA.F4.6463.01", "Negative regulation of FGFR4 signaling"], ["TCGA.F4.6463.01", "Primitive streak formation"], ["TCGA.F4.6463.01", "O-linked glycosylation of mucins"], ["TCGA.F4.6463.01", "SHC-mediated cascade:FGFR2"], ["TCGA.F4.6463.01", "Bile acid and bile salt metabolism"], ["TCGA.F4.6463.01", "Keratinization"], ["TCGA.F4.6463.01", "Aspirin ADME"], ["TCGA.F4.6463.01", "FRS-mediated FGFR2 signaling"], ["TCGA.F4.6463.01", "Negative regulation of FGFR2 signaling"], ["TCGA.F4.6463.01", "Phase 4 - resting membrane potential"], ["TCGA.F4.6463.01", "Ethanol oxidation"], ["TCGA.F4.6463.01", "Signaling by Activin"], ["TCGA.F4.6463.01", "Downstream signaling of activated FGFR4"], ["TCGA.F4.6463.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.F4.6463.01", "Neuronal System"], ["TCGA.F4.6463.01", "Collagen formation"], ["TCGA.F4.6463.01", "Signaling by Insulin receptor"], ["TCGA.F4.6463.01", "Termination of O-glycan biosynthesis"], ["TCGA.F4.6463.01", "Defensins"], ["TCGA.F4.6463.01", "Heme degradation"], ["TCGA.F4.6463.01", "Response to elevated platelet cytosolic Ca2+"], ["TCGA.F4.6463.01", "Metabolism of fat-soluble vitamins"], ["TCGA.F4.6463.01", "Retinoid metabolism and transport"], ["TCGA.F4.6463.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.F4.6463.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6463.01", "Nucleotide catabolism"], ["TCGA.F4.6463.01", "Downstream signaling of activated FGFR2"], ["TCGA.F4.6463.01", "Signaling by activated point mutants of FGFR3"], ["TCGA.F4.6463.01", "FGFR3 mutant receptor activation"], ["TCGA.F4.6463.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.F4.6463.01", "Defective GALNT3 causes HFTC"], ["TCGA.F4.6463.01", "Signaling by FGFR4"], ["TCGA.F4.6569.01", "Extracellular matrix organization"], ["TCGA.F4.6569.01", "Collagen formation"], ["TCGA.F4.6569.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6569.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6569.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6569.01", "Collagen chain trimerization"], ["TCGA.F4.6569.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6569.01", "Transmission across Chemical Synapses"], ["TCGA.F4.6569.01", "Neuronal System"], ["TCGA.F4.6569.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.F4.6569.01", "Biological oxidations"], ["TCGA.F4.6569.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.F4.6569.01", "Collagen degradation"], ["TCGA.F4.6569.01", "RA biosynthesis pathway"], ["TCGA.F4.6569.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6569.01", "Stimuli-sensing channels"], ["TCGA.F4.6569.01", "O-linked glycosylation"], ["TCGA.F4.6569.01", "Diseases of glycosylation"], ["TCGA.F4.6569.01", "ECM proteoglycans"], ["TCGA.F4.6569.01", "Glucuronidation"], ["TCGA.F4.6569.01", "Defective GALNT12 causes CRCS1"], ["TCGA.F4.6569.01", "Inwardly rectifying K+ channels"], ["TCGA.F4.6569.01", "Defective B3GALTL causes PpS"], ["TCGA.F4.6569.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.F4.6569.01", "Integration of energy metabolism"], ["TCGA.F4.6569.01", "GABA receptor activation"], ["TCGA.F4.6569.01", "Activation of G protein gated Potassium channels"], ["TCGA.F4.6569.01", "G protein gated Potassium channels"], ["TCGA.F4.6569.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.F4.6569.01", "Presynaptic function of Kainate receptors"], ["TCGA.F4.6569.01", "Signaling by Retinoic Acid"], ["TCGA.F4.6569.01", "Signaling by GPCR"], ["TCGA.F4.6569.01", "Regulation of insulin secretion"], ["TCGA.F4.6569.01", "FGFR4 ligand binding and activation"], ["TCGA.F4.6569.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.F4.6569.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.F4.6569.01", "TNFs bind their physiological receptors"], ["TCGA.F4.6569.01", "GPCR ligand binding"], ["TCGA.F4.6569.01", "Post-translational protein phosphorylation"], ["TCGA.F4.6569.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.F4.6569.01", "Phospholipase C-mediated cascade; FGFR4"], ["TCGA.F4.6569.01", "Primitive streak formation"], ["TCGA.F4.6569.01", "Signal amplification"], ["TCGA.F4.6569.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.F4.6569.01", "Blood group systems biosynthesis"], ["TCGA.F4.6569.01", "Transport of small molecules"], ["TCGA.F4.6569.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.F4.6569.01", "G alpha (s) signalling events"], ["TCGA.F4.6569.01", "Glucagon signaling in metabolic regulation"], ["TCGA.F4.6569.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6569.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6569.01", "Ethanol oxidation"], ["TCGA.F4.6569.01", "Elastic fibre formation"], ["TCGA.F4.6569.01", "Signaling by Activin"], ["TCGA.F4.6569.01", "G beta:gamma signalling through BTK"], ["TCGA.F4.6569.01", "GPCR downstream signalling"], ["TCGA.F4.6569.01", "Diseases of metabolism"], ["TCGA.F4.6569.01", "Trafficking of AMPA receptors"], ["TCGA.F4.6569.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.F4.6569.01", "Chondroitin sulfate biosynthesis"], ["TCGA.F4.6569.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.F4.6569.01", "PI-3K cascade:FGFR4"], ["TCGA.F4.6569.01", "Ion channel transport"], ["TCGA.F4.6569.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.F4.6570.01", "Extracellular matrix organization"], ["TCGA.F4.6570.01", "Drug ADME"], ["TCGA.F4.6570.01", "Neuronal System"], ["TCGA.F4.6570.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6570.01", "GPCR ligand binding"], ["TCGA.F4.6570.01", "Collagen chain trimerization"], ["TCGA.F4.6570.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6570.01", "Biological oxidations"], ["TCGA.F4.6570.01", "Collagen formation"], ["TCGA.F4.6570.01", "Signaling by GPCR"], ["TCGA.F4.6570.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6570.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6570.01", "APAP ADME"], ["TCGA.F4.6570.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.F4.6570.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6570.01", "G alpha (s) signalling events"], ["TCGA.F4.6570.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.F4.6570.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.F4.6570.01", "G alpha (i) signalling events"], ["TCGA.F4.6570.01", "GPCR downstream signalling"], ["TCGA.F4.6570.01", "Transmission across Chemical Synapses"], ["TCGA.F4.6570.01", "ECM proteoglycans"], ["TCGA.F4.6570.01", "O-linked glycosylation"], ["TCGA.F4.6570.01", "Phase 0 - rapid depolarisation"], ["TCGA.F4.6570.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.F4.6570.01", "Glucuronidation"], ["TCGA.F4.6570.01", "Stimuli-sensing channels"], ["TCGA.F4.6570.01", "Diseases of metabolism"], ["TCGA.F4.6570.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6570.01", "Scavenging by Class A Receptors"], ["TCGA.F4.6570.01", "Peptide ligand-binding receptors"], ["TCGA.F4.6570.01", "Class B/2 (Secretin family receptors)"], ["TCGA.F4.6570.01", "Integrin cell surface interactions"], ["TCGA.F4.6570.01", "Protein-protein interactions at synapses"], ["TCGA.F4.6570.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.F4.6570.01", "Glutathione conjugation"], ["TCGA.F4.6570.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6570.01", "Metabolism"], ["TCGA.F4.6570.01", "Regulation of insulin secretion"], ["TCGA.F4.6570.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.F4.6570.01", "Diseases of glycosylation"], ["TCGA.F4.6570.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.F4.6570.01", "Defective GALNT3 causes HFTC"], ["TCGA.F4.6570.01", "Defective GALNT12 causes CRCS1"], ["TCGA.F4.6570.01", "Integration of energy metabolism"], ["TCGA.F4.6570.01", "Neurexins and neuroligins"], ["TCGA.F4.6570.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.F4.6570.01", "Termination of O-glycan biosynthesis"], ["TCGA.F4.6570.01", "Visual phototransduction"], ["TCGA.F4.6570.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.F4.6570.01", "Glycosaminoglycan metabolism"], ["TCGA.F4.6570.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6570.01", "Glucagon signaling in metabolic regulation"], ["TCGA.F4.6570.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.F4.6570.01", "Defective B3GALTL causes PpS"], ["TCGA.F4.6570.01", "Cardiac conduction"], ["TCGA.F4.6570.01", "Peptide hormone metabolism"], ["TCGA.F4.6570.01", "Phase 2 - plateau phase"], ["TCGA.F4.6570.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.F4.6570.01", "Interaction between L1 and Ankyrins"], ["TCGA.F4.6570.01", "O-linked glycosylation of mucins"], ["TCGA.F4.6703.01", "Extracellular matrix organization"], ["TCGA.F4.6703.01", "Collagen formation"], ["TCGA.F4.6703.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6703.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6703.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6703.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6703.01", "Collagen chain trimerization"], ["TCGA.F4.6703.01", "Keratinization"], ["TCGA.F4.6703.01", "Drug ADME"], ["TCGA.F4.6703.01", "Formation of the cornified envelope"], ["TCGA.F4.6703.01", "Collagen degradation"], ["TCGA.F4.6703.01", "GPCR ligand binding"], ["TCGA.F4.6703.01", "Defective GALNT12 causes CRCS1"], ["TCGA.F4.6703.01", "O-linked glycosylation"], ["TCGA.F4.6703.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6703.01", "Biological oxidations"], ["TCGA.F4.6703.01", "APAP ADME"], ["TCGA.F4.6703.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.F4.6703.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.F4.6703.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6703.01", "Stimuli-sensing channels"], ["TCGA.F4.6703.01", "Defective GALNT3 causes HFTC"], ["TCGA.F4.6703.01", "Antimicrobial peptides"], ["TCGA.F4.6703.01", "Acyl chain remodelling of PS"], ["TCGA.F4.6703.01", "Class B/2 (Secretin family receptors)"], ["TCGA.F4.6703.01", "Integrin cell surface interactions"], ["TCGA.F4.6703.01", "Peptide ligand-binding receptors"], ["TCGA.F4.6703.01", "Defective C1GALT1C1 causes TNPS"], ["TCGA.F4.6703.01", "Glucuronidation"], ["TCGA.F4.6703.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.F4.6703.01", "O-linked glycosylation of mucins"], ["TCGA.F4.6703.01", "Signaling by GPCR"], ["TCGA.F4.6703.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.F4.6703.01", "Aspirin ADME"], ["TCGA.F4.6703.01", "Metabolism"], ["TCGA.F4.6703.01", "Acyl chain remodelling of PE"], ["TCGA.F4.6703.01", "Tryptophan catabolism"], ["TCGA.F4.6703.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.F4.6703.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.F4.6703.01", "Chemokine receptors bind chemokines"], ["TCGA.F4.6703.01", "ECM proteoglycans"], ["TCGA.F4.6703.01", "Sensory processing of sound"], ["TCGA.F4.6703.01", "Signaling by Activin"], ["TCGA.F4.6703.01", "FCGR activation"], ["TCGA.F4.6703.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.F4.6703.01", "Ion channel transport"], ["TCGA.F4.6703.01", "Diseases of glycosylation"], ["TCGA.F4.6703.01", "Chondroitin sulfate biosynthesis"], ["TCGA.F4.6703.01", "Termination of O-glycan biosynthesis"], ["TCGA.F4.6703.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.F4.6703.01", "WNT ligand biogenesis and trafficking"], ["TCGA.F4.6703.01", "Dissolution of Fibrin Clot"], ["TCGA.F4.6703.01", "Transport of small molecules"], ["TCGA.F4.6703.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6703.01", "Scavenging by Class A Receptors"], ["TCGA.F4.6704.01", "Extracellular matrix organization"], ["TCGA.F4.6704.01", "Biological oxidations"], ["TCGA.F4.6704.01", "Collagen formation"], ["TCGA.F4.6704.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6704.01", "Drug ADME"], ["TCGA.F4.6704.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6704.01", "Glucuronidation"], ["TCGA.F4.6704.01", "Aspirin ADME"], ["TCGA.F4.6704.01", "Collagen chain trimerization"], ["TCGA.F4.6704.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6704.01", "Metabolism"], ["TCGA.F4.6704.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6704.01", "Ethanol oxidation"], ["TCGA.F4.6704.01", "Sensory processing of sound by outer hair cells of the cochlea"], ["TCGA.F4.6704.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.F4.6704.01", "Transmission across Chemical Synapses"], ["TCGA.F4.6704.01", "Neuronal System"], ["TCGA.F4.6704.01", "Sensory processing of sound"], ["TCGA.F4.6704.01", "Peptide hormone metabolism"], ["TCGA.F4.6704.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6704.01", "Glutathione conjugation"], ["TCGA.F4.6704.01", "Blood group systems biosynthesis"], ["TCGA.F4.6704.01", "Visual phototransduction"], ["TCGA.F4.6704.01", "Phase I - Functionalization of compounds"], ["TCGA.F4.6704.01", "GPCR ligand binding"], ["TCGA.F4.6704.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6704.01", "APAP ADME"], ["TCGA.F4.6704.01", "Peptide hormone biosynthesis"], ["TCGA.F4.6704.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.F4.6704.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6704.01", "Presynaptic function of Kainate receptors"], ["TCGA.F4.6704.01", "Neurotransmitter release cycle"], ["TCGA.F4.6704.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.F4.6805.01", "Extracellular matrix organization"], ["TCGA.F4.6805.01", "Collagen formation"], ["TCGA.F4.6805.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6805.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6805.01", "Collagen chain trimerization"], ["TCGA.F4.6805.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6805.01", "Biological oxidations"], ["TCGA.F4.6805.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6805.01", "Drug ADME"], ["TCGA.F4.6805.01", "GPCR ligand binding"], ["TCGA.F4.6805.01", "Glucuronidation"], ["TCGA.F4.6805.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6805.01", "Scavenging by Class A Receptors"], ["TCGA.F4.6805.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6805.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.F4.6805.01", "Collagen degradation"], ["TCGA.F4.6805.01", "ECM proteoglycans"], ["TCGA.F4.6805.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.F4.6805.01", "Class B/2 (Secretin family receptors)"], ["TCGA.F4.6805.01", "Metal ion SLC transporters"], ["TCGA.F4.6806.01", "Extracellular matrix organization"], ["TCGA.F4.6806.01", "Interaction between L1 and Ankyrins"], ["TCGA.F4.6806.01", "Classical antibody-mediated complement activation"], ["TCGA.F4.6806.01", "Complement cascade"], ["TCGA.F4.6806.01", "Regulation of Complement cascade"], ["TCGA.F4.6806.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6806.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6806.01", "Cardiac conduction"], ["TCGA.F4.6806.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.F4.6806.01", "Integrin cell surface interactions"], ["TCGA.F4.6806.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6806.01", "Collagen formation"], ["TCGA.F4.6806.01", "Neuronal System"], ["TCGA.F4.6806.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.F4.6806.01", "NCAM1 interactions"], ["TCGA.F4.6806.01", "Phase 0 - rapid depolarisation"], ["TCGA.F4.6806.01", "NCAM signaling for neurite out-growth"], ["TCGA.F4.6806.01", "Peptide hormone metabolism"], ["TCGA.F4.6806.01", "Collagen degradation"], ["TCGA.F4.6806.01", "Collagen chain trimerization"], ["TCGA.F4.6806.01", "Transmission across Chemical Synapses"], ["TCGA.F4.6806.01", "L1CAM interactions"], ["TCGA.F4.6806.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6806.01", "ECM proteoglycans"], ["TCGA.F4.6806.01", "Scavenging of heme from plasma"], ["TCGA.F4.6806.01", "Response to elevated platelet cytosolic Ca2+"], ["TCGA.F4.6806.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.F4.6806.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.F4.6806.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.F4.6806.01", "Interleukin-6 family signaling"], ["TCGA.F4.6806.01", "Glucuronidation"], ["TCGA.F4.6806.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.F4.6806.01", "Initial triggering of complement"], ["TCGA.F4.6806.01", "Creation of C4 and C2 activators"], ["TCGA.F4.6806.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.F4.6806.01", "Regulation of FZD by ubiquitination"], ["TCGA.F4.6806.01", "G alpha (s) signalling events"], ["TCGA.F4.6806.01", "Muscle contraction"], ["TCGA.F4.6806.01", "Regulation of TLR by endogenous ligand"], ["TCGA.F4.6806.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6806.01", "GPCR downstream signalling"], ["TCGA.F4.6806.01", "Defective B3GALTL causes PpS"], ["TCGA.F4.6806.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6806.01", "Transcriptional regulation of testis differentiation"], ["TCGA.F4.6806.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.F4.6806.01", "Diseases of Immune System"], ["TCGA.F4.6806.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.F4.6806.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.F4.6806.01", "Biological oxidations"], ["TCGA.F4.6807.01", "Biological oxidations"], ["TCGA.F4.6807.01", "Extracellular matrix organization"], ["TCGA.F4.6807.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6807.01", "Drug ADME"], ["TCGA.F4.6807.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6807.01", "Stimuli-sensing channels"], ["TCGA.F4.6807.01", "Glucuronidation"], ["TCGA.F4.6807.01", "Collagen formation"], ["TCGA.F4.6807.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6807.01", "Metabolism"], ["TCGA.F4.6807.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6807.01", "ECM proteoglycans"], ["TCGA.F4.6807.01", "Ethanol oxidation"], ["TCGA.F4.6807.01", "Cobalamin (Cbl, vitamin B12) transport and metabolism"], ["TCGA.F4.6807.01", "Ion channel transport"], ["TCGA.F4.6807.01", "Degradation of cysteine and homocysteine"], ["TCGA.F4.6807.01", "Aspirin ADME"], ["TCGA.F4.6807.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6807.01", "Collagen degradation"], ["TCGA.F4.6807.01", "Collagen chain trimerization"], ["TCGA.F4.6807.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6808.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.F4.6808.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.F4.6808.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.F4.6808.01", "Generation of second messenger molecules"], ["TCGA.F4.6808.01", "PD-1 signaling"], ["TCGA.F4.6808.01", "Immune System"], ["TCGA.F4.6808.01", "GPCR downstream signalling"], ["TCGA.F4.6808.01", "G alpha (i) signalling events"], ["TCGA.F4.6808.01", "Signaling by GPCR"], ["TCGA.F4.6808.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.F4.6808.01", "Leishmania parasite growth and survival"], ["TCGA.F4.6808.01", "Complement cascade"], ["TCGA.F4.6808.01", "Costimulation by the CD28 family"], ["TCGA.F4.6808.01", "Regulation of Complement cascade"], ["TCGA.F4.6808.01", "Signaling Pathways"], ["TCGA.F4.6808.01", "Adaptive Immune System"], ["TCGA.F4.6808.01", "Classical antibody-mediated complement activation"], ["TCGA.F4.6808.01", "G alpha (s) signalling events"], ["TCGA.F4.6808.01", "Interaction between L1 and Ankyrins"], ["TCGA.F4.6808.01", "GABA receptor activation"], ["TCGA.F4.6808.01", "Extracellular matrix organization"], ["TCGA.F4.6808.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.F4.6808.01", "Leishmania infection"], ["TCGA.F4.6808.01", "Parasitic Infection Pathways"], ["TCGA.F4.6808.01", "Neuronal System"], ["TCGA.F4.6808.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.F4.6808.01", "Initial triggering of complement"], ["TCGA.F4.6808.01", "FCGR activation"], ["TCGA.F4.6808.01", "TCR signaling"], ["TCGA.F4.6808.01", "Glucagon signaling in metabolic regulation"], ["TCGA.F4.6808.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6808.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.F4.6808.01", "Peptide ligand-binding receptors"], ["TCGA.F4.6808.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.F4.6808.01", "Cardiac conduction"], ["TCGA.F4.6808.01", "GPCR ligand binding"], ["TCGA.F4.6808.01", "G-protein beta:gamma signalling"], ["TCGA.F4.6808.01", "Phase 0 - rapid depolarisation"], ["TCGA.F4.6808.01", "Chemokine receptors bind chemokines"], ["TCGA.F4.6808.01", "G beta:gamma signalling through BTK"], ["TCGA.F4.6808.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.F4.6808.01", "Cell surface interactions at the vascular wall"], ["TCGA.F4.6808.01", "Transmission across Chemical Synapses"], ["TCGA.F4.6808.01", "Regulation of insulin secretion"], ["TCGA.F4.6808.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.F4.6808.01", "Aquaporin-mediated transport"], ["TCGA.F4.6808.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.F4.6808.01", "Integration of energy metabolism"], ["TCGA.F4.6808.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6808.01", "Signal amplification"], ["TCGA.F4.6808.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.F4.6808.01", "GPER1 signaling"], ["TCGA.F4.6808.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.F4.6808.01", "GABA B receptor activation"], ["TCGA.F4.6808.01", "Activation of GABAB receptors"], ["TCGA.F4.6808.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.F4.6808.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.F4.6808.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.F4.6808.01", "CD22 mediated BCR regulation"], ["TCGA.F4.6808.01", "Lewis blood group biosynthesis"], ["TCGA.F4.6808.01", "G beta:gamma signalling through CDC42"], ["TCGA.F4.6808.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.F4.6808.01", "Cytokine Signaling in Immune system"], ["TCGA.F4.6808.01", "Keratan sulfate biosynthesis"], ["TCGA.F4.6808.01", "Transport of small molecules"], ["TCGA.F4.6808.01", "Presynaptic function of Kainate receptors"], ["TCGA.F4.6808.01", "Recycling of bile acids and salts"], ["TCGA.F4.6808.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.F4.6808.01", "G alpha (q) signalling events"], ["TCGA.F4.6808.01", "Blood group systems biosynthesis"], ["TCGA.F4.6808.01", "G alpha (z) signalling events"], ["TCGA.F4.6808.01", "Interleukin-10 signaling"], ["TCGA.F4.6808.01", "SUMOylation of intracellular receptors"], ["TCGA.F4.6808.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.F4.6808.01", "Activation of the phototransduction cascade"], ["TCGA.F4.6808.01", "Regulation of FZD by ubiquitination"], ["TCGA.F4.6808.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.F4.6808.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.F4.6808.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.F4.6808.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.F4.6808.01", "Visual phototransduction"], ["TCGA.F4.6808.01", "Creation of C4 and C2 activators"], ["TCGA.F4.6808.01", "Diseases of Immune System"], ["TCGA.F4.6808.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.F4.6808.01", "Netrin-1 signaling"], ["TCGA.F4.6808.01", "Potassium Channels"], ["TCGA.F4.6808.01", "NCAM1 interactions"], ["TCGA.F4.6809.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6809.01", "Biological oxidations"], ["TCGA.F4.6809.01", "Glucuronidation"], ["TCGA.F4.6809.01", "Drug ADME"], ["TCGA.F4.6809.01", "Extracellular matrix organization"], ["TCGA.F4.6809.01", "Blood group systems biosynthesis"], ["TCGA.F4.6809.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6809.01", "APAP ADME"], ["TCGA.F4.6809.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.F4.6809.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.F4.6809.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.F4.6809.01", "Collagen chain trimerization"], ["TCGA.F4.6809.01", "ECM proteoglycans"], ["TCGA.F4.6809.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.F4.6809.01", "Lewis blood group biosynthesis"], ["TCGA.F4.6809.01", "Primitive streak formation"], ["TCGA.F4.6854.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6854.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6854.01", "Biological oxidations"], ["TCGA.F4.6854.01", "Drug ADME"], ["TCGA.F4.6854.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6854.01", "Digestion"], ["TCGA.F4.6854.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6854.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6854.01", "GPCR downstream signalling"], ["TCGA.F4.6854.01", "Glucuronidation"], ["TCGA.F4.6854.01", "Digestion and absorption"], ["TCGA.F4.6854.01", "APAP ADME"], ["TCGA.F4.6854.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.F4.6854.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.F4.6854.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.F4.6854.01", "Signaling by GPCR"], ["TCGA.F4.6854.01", "Extracellular matrix organization"], ["TCGA.F4.6854.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.F4.6854.01", "SLC-mediated transmembrane transport"], ["TCGA.F4.6855.01", "Extracellular matrix organization"], ["TCGA.F4.6855.01", "Collagen formation"], ["TCGA.F4.6855.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.F4.6855.01", "Collagen chain trimerization"], ["TCGA.F4.6855.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.F4.6855.01", "G alpha (i) signalling events"], ["TCGA.F4.6855.01", "Neuronal System"], ["TCGA.F4.6855.01", "GPCR downstream signalling"], ["TCGA.F4.6855.01", "Transmission across Chemical Synapses"], ["TCGA.F4.6855.01", "Signaling by GPCR"], ["TCGA.F4.6855.01", "Biological oxidations"], ["TCGA.F4.6855.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6855.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.F4.6855.01", "Glucuronidation"], ["TCGA.F4.6855.01", "Defective B3GALTL causes PpS"], ["TCGA.F4.6855.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.F4.6855.01", "Degradation of the extracellular matrix"], ["TCGA.F4.6855.01", "Drug ADME"], ["TCGA.F4.6855.01", "Phase II - Conjugation of compounds"], ["TCGA.F4.6855.01", "Ethanol oxidation"], ["TCGA.F4.6855.01", "TNFs bind their physiological receptors"], ["TCGA.F4.6855.01", "Glycosaminoglycan metabolism"], ["TCGA.F4.6855.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.F4.6855.01", "Signal amplification"], ["TCGA.F4.6855.01", "RA biosynthesis pathway"], ["TCGA.F4.6855.01", "ECM proteoglycans"], ["TCGA.F4.6855.01", "GPCR ligand binding"], ["TCGA.F4.6855.01", "Integrin cell surface interactions"], ["TCGA.F4.6855.01", "Peptide hormone metabolism"], ["TCGA.F4.6855.01", "Regulation of FZD by ubiquitination"], ["TCGA.F4.6855.01", "O-linked glycosylation"], ["TCGA.F4.6855.01", "Cardiac conduction"], ["TCGA.F4.6855.01", "Peptide ligand-binding receptors"], ["TCGA.F4.6855.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.F4.6855.01", "Glucagon signaling in metabolic regulation"], ["TCGA.F4.6855.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6855.01", "Cytosolic sulfonation of small molecules"], ["TCGA.F4.6855.01", "Phase 4 - resting membrane potential"], ["TCGA.F4.6856.01", "Interaction between L1 and Ankyrins"], ["TCGA.F4.6856.01", "Extracellular matrix organization"], ["TCGA.F4.6856.01", "Neuronal System"], ["TCGA.F4.6856.01", "Signaling by GPCR"], ["TCGA.F4.6856.01", "Transmission across Chemical Synapses"], ["TCGA.F4.6856.01", "G alpha (i) signalling events"], ["TCGA.F4.6856.01", "Phase 0 - rapid depolarisation"], ["TCGA.F4.6856.01", "L1CAM interactions"], ["TCGA.F4.6856.01", "GPCR downstream signalling"], ["TCGA.F4.6856.01", "Leishmania infection"], ["TCGA.F4.6856.01", "Parasitic Infection Pathways"], ["TCGA.F4.6856.01", "Transport of small molecules"], ["TCGA.F4.6856.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.F4.6856.01", "Activation of Matrix Metalloproteinases"], ["TCGA.F4.6856.01", "Cardiac conduction"], ["TCGA.F4.6856.01", "GPCR ligand binding"], ["TCGA.F4.6856.01", "Peptide hormone metabolism"], ["TCGA.F4.6856.01", "Classical antibody-mediated complement activation"], ["TCGA.F4.6856.01", "Protein-protein interactions at synapses"], ["TCGA.F4.6856.01", "Drug ADME"], ["TCGA.F4.6856.01", "Signaling Pathways"], ["TCGA.F4.6856.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.F4.6856.01", "Regulation of Complement cascade"], ["TCGA.F4.6856.01", "GABA receptor activation"], ["TCGA.F4.6856.01", "Ion channel transport"], ["TCGA.F4.6856.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.F4.6856.01", "Defensins"], ["TCGA.F4.6856.01", "Muscle contraction"], ["TCGA.F4.6856.01", "Antimicrobial peptides"], ["TCGA.F4.6856.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.F4.6856.01", "Leishmania parasite growth and survival"], ["TCGA.F4.6856.01", "O-linked glycosylation of mucins"], ["TCGA.F4.6856.01", "G-protein beta:gamma signalling"], ["TCGA.F4.6856.01", "Stimuli-sensing channels"], ["TCGA.F4.6856.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.F4.6856.01", "RA biosynthesis pathway"], ["TCGA.F4.6856.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.F4.6856.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.F4.6856.01", "Synaptic adhesion-like molecules"], ["TCGA.F4.6856.01", "G beta:gamma signalling through BTK"], ["TCGA.F4.6856.01", "Peptide ligand-binding receptors"], ["TCGA.F4.6856.01", "SUMOylation of intracellular receptors"], ["TCGA.F4.6856.01", "Biological oxidations"], ["TCGA.F4.6856.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.F4.6856.01", "Glucuronidation"], ["TCGA.F4.6856.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.F4.6856.01", "Termination of O-glycan biosynthesis"], ["TCGA.F4.6856.01", "Neurexins and neuroligins"], ["TCGA.F4.6856.01", "Sensory perception of taste"], ["TCGA.F4.6856.01", "Metabolism of water-soluble vitamins and cofactors"], ["TCGA.F4.6856.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.F4.6856.01", "G alpha (s) signalling events"], ["TCGA.F4.6856.01", "Nicotinate metabolism"], ["TCGA.F4.6856.01", "Glucagon signaling in metabolic regulation"], ["TCGA.F4.6856.01", "Glucagon-type ligand receptors"], ["TCGA.F4.6856.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.F4.6856.01", "G beta:gamma signalling through CDC42"], ["TCGA.G4.6293.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6293.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6293.01", "GPCR ligand binding"], ["TCGA.G4.6293.01", "Extracellular matrix organization"], ["TCGA.G4.6293.01", "L1CAM interactions"], ["TCGA.G4.6293.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.G4.6293.01", "Neuronal System"], ["TCGA.G4.6293.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6293.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6293.01", "Cardiac conduction"], ["TCGA.G4.6293.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6293.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6293.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6293.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6293.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6293.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6293.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6293.01", "Peptide hormone metabolism"], ["TCGA.G4.6293.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.G4.6293.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6293.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6293.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.G4.6293.01", "Common Pathway of Fibrin Clot Formation"], ["TCGA.G4.6293.01", "Regulation of Complement cascade"], ["TCGA.G4.6293.01", "Glycosaminoglycan metabolism"], ["TCGA.G4.6293.01", "Keratinization"], ["TCGA.G4.6293.01", "Muscle contraction"], ["TCGA.G4.6293.01", "Biological oxidations"], ["TCGA.G4.6294.01", "Signaling by GPCR"], ["TCGA.G4.6294.01", "GPCR downstream signalling"], ["TCGA.G4.6294.01", "Neuronal System"], ["TCGA.G4.6294.01", "GPCR ligand binding"], ["TCGA.G4.6294.01", "G alpha (i) signalling events"], ["TCGA.G4.6294.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6294.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6294.01", "Biological oxidations"], ["TCGA.G4.6294.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6294.01", "Signaling Pathways"], ["TCGA.G4.6294.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6294.01", "Potassium Channels"], ["TCGA.G4.6294.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6294.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6294.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6294.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6294.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6294.01", "G alpha (s) signalling events"], ["TCGA.G4.6294.01", "Regulation of insulin secretion"], ["TCGA.G4.6294.01", "RA biosynthesis pathway"], ["TCGA.G4.6294.01", "Extracellular matrix organization"], ["TCGA.G4.6294.01", "Cardiac conduction"], ["TCGA.G4.6294.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6294.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6294.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6294.01", "Complement cascade"], ["TCGA.G4.6294.01", "Scavenging of heme from plasma"], ["TCGA.G4.6294.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6294.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6294.01", "Neurotransmitter release cycle"], ["TCGA.G4.6294.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.G4.6294.01", "Synaptic adhesion-like molecules"], ["TCGA.G4.6294.01", "Sensory perception of taste"], ["TCGA.G4.6294.01", "Regulation of Complement cascade"], ["TCGA.G4.6294.01", "G alpha (q) signalling events"], ["TCGA.G4.6294.01", "Elastic fibre formation"], ["TCGA.G4.6294.01", "Integration of energy metabolism"], ["TCGA.G4.6294.01", "Sialic acid metabolism"], ["TCGA.G4.6294.01", "Glucuronidation"], ["TCGA.G4.6294.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.G4.6294.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6294.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6294.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6294.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6294.01", "Drug ADME"], ["TCGA.G4.6294.01", "Muscle contraction"], ["TCGA.G4.6294.01", "Signaling by Retinoic Acid"], ["TCGA.G4.6294.01", "Sensory processing of sound"], ["TCGA.G4.6294.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.G4.6294.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.G4.6294.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6294.01", "Voltage gated Potassium channels"], ["TCGA.G4.6294.01", "Arachidonic acid metabolism"], ["TCGA.G4.6295.01", "Neuronal System"], ["TCGA.G4.6295.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6295.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6295.01", "Neurotransmitter release cycle"], ["TCGA.G4.6295.01", "Metabolism"], ["TCGA.G4.6295.01", "Biological oxidations"], ["TCGA.G4.6295.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6295.01", "RA biosynthesis pathway"], ["TCGA.G4.6295.01", "Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects"], ["TCGA.G4.6295.01", "Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"], ["TCGA.G4.6295.01", "Cardiac conduction"], ["TCGA.G4.6295.01", "Drug ADME"], ["TCGA.G4.6295.01", "Arachidonic acid metabolism"], ["TCGA.G4.6295.01", "Blood group systems biosynthesis"], ["TCGA.G4.6295.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], ["TCGA.G4.6295.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6295.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6295.01", "Cyclin D associated events in G1"], ["TCGA.G4.6295.01", "G1 Phase"], ["TCGA.G4.6295.01", "Ethanol oxidation"], ["TCGA.G4.6295.01", "Regulation of insulin secretion"], ["TCGA.G4.6295.01", "G1/S-Specific Transcription"], ["TCGA.G4.6295.01", "G alpha (s) signalling events"], ["TCGA.G4.6295.01", "APAP ADME"], ["TCGA.G4.6295.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.G4.6295.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6295.01", "Lewis blood group biosynthesis"], ["TCGA.G4.6295.01", "Integration of energy metabolism"], ["TCGA.G4.6295.01", "Peptide hormone metabolism"], ["TCGA.G4.6295.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6295.01", "Carbohydrate metabolism"], ["TCGA.G4.6295.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6295.01", "L1CAM interactions"], ["TCGA.G4.6295.01", "Signaling by Retinoic Acid"], ["TCGA.G4.6295.01", "Dopamine Neurotransmitter Release Cycle"], ["TCGA.G4.6295.01", "Neurexins and neuroligins"], ["TCGA.G4.6295.01", "GABA synthesis, release, reuptake and degradation"], ["TCGA.G4.6295.01", "Aflatoxin activation and detoxification"], ["TCGA.G4.6295.01", "G0 and Early G1"], ["TCGA.G4.6295.01", "Fatty acid metabolism"], ["TCGA.G4.6297.01", "Extracellular matrix organization"], ["TCGA.G4.6297.01", "Collagen formation"], ["TCGA.G4.6297.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6297.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.G4.6297.01", "Collagen chain trimerization"], ["TCGA.G4.6297.01", "Biological oxidations"], ["TCGA.G4.6297.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6297.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6297.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6297.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6297.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6297.01", "Ethanol oxidation"], ["TCGA.G4.6297.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.G4.6297.01", "Drug ADME"], ["TCGA.G4.6297.01", "RA biosynthesis pathway"], ["TCGA.G4.6297.01", "Glucuronidation"], ["TCGA.G4.6297.01", "Defective GALNT12 causes CRCS1"], ["TCGA.G4.6297.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6297.01", "NCAM1 interactions"], ["TCGA.G4.6297.01", "Diseases of glycosylation"], ["TCGA.G4.6297.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.G4.6297.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.G4.6297.01", "ECM proteoglycans"], ["TCGA.G4.6297.01", "Signaling by GPCR"], ["TCGA.G4.6297.01", "Diseases of metabolism"], ["TCGA.G4.6297.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6297.01", "Defective B3GALTL causes PpS"], ["TCGA.G4.6297.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.G4.6297.01", "NCAM signaling for neurite out-growth"], ["TCGA.G4.6297.01", "GPCR ligand binding"], ["TCGA.G4.6297.01", "GPCR downstream signalling"], ["TCGA.G4.6297.01", "Signaling by Retinoic Acid"], ["TCGA.G4.6298.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6298.01", "Immune System"], ["TCGA.G4.6298.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.G4.6298.01", "Signaling by GPCR"], ["TCGA.G4.6298.01", "GPCR downstream signalling"], ["TCGA.G4.6298.01", "G alpha (i) signalling events"], ["TCGA.G4.6298.01", "Generation of second messenger molecules"], ["TCGA.G4.6298.01", "Cardiac conduction"], ["TCGA.G4.6298.01", "Biological oxidations"], ["TCGA.G4.6298.01", "Glucuronidation"], ["TCGA.G4.6298.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.G4.6298.01", "Drug ADME"], ["TCGA.G4.6298.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6298.01", "PD-1 signaling"], ["TCGA.G4.6298.01", "Neuronal System"], ["TCGA.G4.6298.01", "Adaptive Immune System"], ["TCGA.G4.6298.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6298.01", "GPCR ligand binding"], ["TCGA.G4.6298.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6298.01", "Aspirin ADME"], ["TCGA.G4.6298.01", "Extracellular matrix organization"], ["TCGA.G4.6298.01", "Potassium Channels"], ["TCGA.G4.6298.01", "Complement cascade"], ["TCGA.G4.6298.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6298.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6298.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6298.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6298.01", "Regulation of insulin secretion"], ["TCGA.G4.6298.01", "G alpha (q) signalling events"], ["TCGA.G4.6298.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6298.01", "Defensins"], ["TCGA.G4.6298.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6298.01", "GABA receptor activation"], ["TCGA.G4.6298.01", "Other interleukin signaling"], ["TCGA.G4.6298.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.G4.6298.01", "Cytokine Signaling in Immune system"], ["TCGA.G4.6298.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6298.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6298.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.G4.6298.01", "NCAM1 interactions"], ["TCGA.G4.6298.01", "Signaling Pathways"], ["TCGA.G4.6298.01", "Integration of energy metabolism"], ["TCGA.G4.6298.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6298.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6298.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6298.01", "Regulation of Complement cascade"], ["TCGA.G4.6298.01", "TNFs bind their physiological receptors"], ["TCGA.G4.6298.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.G4.6298.01", "Costimulation by the CD28 family"], ["TCGA.G4.6298.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6298.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6298.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6298.01", "Innate Immune System"], ["TCGA.G4.6298.01", "Muscle contraction"], ["TCGA.G4.6298.01", "Diseases of Immune System"], ["TCGA.G4.6298.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.G4.6298.01", "Collagen chain trimerization"], ["TCGA.G4.6298.01", "Inflammasomes"], ["TCGA.G4.6298.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6298.01", "GABA B receptor activation"], ["TCGA.G4.6298.01", "Activation of GABAB receptors"], ["TCGA.G4.6298.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.G4.6298.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.G4.6298.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6298.01", "G protein gated Potassium channels"], ["TCGA.G4.6298.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6298.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6298.01", "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"], ["TCGA.G4.6298.01", "Cell surface interactions at the vascular wall"], ["TCGA.G4.6298.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6298.01", "Interferon gamma signaling"], ["TCGA.G4.6298.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6298.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6298.01", "Initial triggering of complement"], ["TCGA.G4.6298.01", "Ligand-dependent caspase activation"], ["TCGA.G4.6298.01", "PI3K events in ERBB2 signaling"], ["TCGA.G4.6298.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.G4.6298.01", "Leishmania infection"], ["TCGA.G4.6298.01", "Parasitic Infection Pathways"], ["TCGA.G4.6298.01", "SLC-mediated transmembrane transport"], ["TCGA.G4.6298.01", "Ion homeostasis"], ["TCGA.G4.6298.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6298.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6298.01", "Interleukin-35 Signalling"], ["TCGA.G4.6298.01", "Blood group systems biosynthesis"], ["TCGA.G4.6298.01", "NCAM signaling for neurite out-growth"], ["TCGA.G4.6298.01", "Transport of small molecules"], ["TCGA.G4.6298.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.G4.6298.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6298.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.G4.6298.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6298.01", "LGI-ADAM interactions"], ["TCGA.G4.6298.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.G4.6298.01", "Signal amplification"], ["TCGA.G4.6298.01", "Peptide hormone metabolism"], ["TCGA.G4.6298.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6298.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.G4.6298.01", "Antimicrobial peptides"], ["TCGA.G4.6298.01", "Signaling by Interleukins"], ["TCGA.G4.6298.01", "DAP12 interactions"], ["TCGA.G4.6298.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6299.01", "Neuronal System"], ["TCGA.G4.6299.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6299.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6299.01", "Regulation of insulin secretion"], ["TCGA.G4.6299.01", "Biological oxidations"], ["TCGA.G4.6299.01", "GABA receptor activation"], ["TCGA.G4.6299.01", "Extracellular matrix organization"], ["TCGA.G4.6299.01", "RA biosynthesis pathway"], ["TCGA.G4.6299.01", "Ethanol oxidation"], ["TCGA.G4.6299.01", "Integration of energy metabolism"], ["TCGA.G4.6299.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6299.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6299.01", "Signaling by GPCR"], ["TCGA.G4.6299.01", "Signal amplification"], ["TCGA.G4.6299.01", "Drug ADME"], ["TCGA.G4.6299.01", "Peptide hormone metabolism"], ["TCGA.G4.6299.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6299.01", "Potassium Channels"], ["TCGA.G4.6299.01", "G alpha (i) signalling events"], ["TCGA.G4.6299.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.G4.6299.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.G4.6299.01", "GPCR downstream signalling"], ["TCGA.G4.6299.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6299.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6299.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.G4.6299.01", "GPCR ligand binding"], ["TCGA.G4.6299.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6299.01", "O-linked glycosylation"], ["TCGA.G4.6299.01", "G-protein activation"], ["TCGA.G4.6299.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6299.01", "Glucuronidation"], ["TCGA.G4.6299.01", "GABA B receptor activation"], ["TCGA.G4.6299.01", "Activation of GABAB receptors"], ["TCGA.G4.6299.01", "Signaling by Retinoic Acid"], ["TCGA.G4.6299.01", "Neurotransmitter release cycle"], ["TCGA.G4.6299.01", "O-linked glycosylation of mucins"], ["TCGA.G4.6299.01", "WNT ligand biogenesis and trafficking"], ["TCGA.G4.6299.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6299.01", "G alpha (s) signalling events"], ["TCGA.G4.6299.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6299.01", "Visual phototransduction"], ["TCGA.G4.6299.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6299.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6299.01", "Lewis blood group biosynthesis"], ["TCGA.G4.6299.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6299.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6299.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.G4.6299.01", "G-protein mediated events"], ["TCGA.G4.6299.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.G4.6299.01", "Free fatty acids regulate insulin secretion"], ["TCGA.G4.6299.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6299.01", "G protein gated Potassium channels"], ["TCGA.G4.6299.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6299.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.G4.6299.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.G4.6299.01", "Blood group systems biosynthesis"], ["TCGA.G4.6299.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.G4.6299.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6299.01", "Metabolism"], ["TCGA.G4.6299.01", "GABA synthesis, release, reuptake and degradation"], ["TCGA.G4.6299.01", "Opioid Signalling"], ["TCGA.G4.6299.01", "Defective GALNT12 causes CRCS1"], ["TCGA.G4.6299.01", "ECM proteoglycans"], ["TCGA.G4.6299.01", "Signaling by BMP"], ["TCGA.G4.6299.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6299.01", "TNFs bind their physiological receptors"], ["TCGA.G4.6299.01", "Cardiac conduction"], ["TCGA.G4.6302.01", "Extracellular matrix organization"], ["TCGA.G4.6302.01", "Collagen formation"], ["TCGA.G4.6302.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6302.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.G4.6302.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6302.01", "O-linked glycosylation"], ["TCGA.G4.6302.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6302.01", "Collagen chain trimerization"], ["TCGA.G4.6302.01", "Defective B3GALTL causes PpS"], ["TCGA.G4.6302.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.G4.6302.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.G4.6302.01", "Biological oxidations"], ["TCGA.G4.6302.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6302.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6302.01", "Post-translational protein phosphorylation"], ["TCGA.G4.6302.01", "Drug ADME"], ["TCGA.G4.6302.01", "Glucuronidation"], ["TCGA.G4.6302.01", "Stimuli-sensing channels"], ["TCGA.G4.6302.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6302.01", "Collagen degradation"], ["TCGA.G4.6302.01", "Regulation of signaling by NODAL"], ["TCGA.G4.6302.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.G4.6302.01", "Diseases of glycosylation"], ["TCGA.G4.6302.01", "Signaling by Activin"], ["TCGA.G4.6302.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6302.01", "Signaling by NODAL"], ["TCGA.G4.6302.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6302.01", "Ion channel transport"], ["TCGA.G4.6302.01", "Degradation of cysteine and homocysteine"], ["TCGA.G4.6302.01", "Regulation of beta-cell development"], ["TCGA.G4.6302.01", "Dissolution of Fibrin Clot"], ["TCGA.G4.6302.01", "FGFR4 ligand binding and activation"], ["TCGA.G4.6303.01", "Biological oxidations"], ["TCGA.G4.6303.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6303.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6303.01", "GPCR ligand binding"], ["TCGA.G4.6303.01", "Signaling by GPCR"], ["TCGA.G4.6303.01", "GPCR downstream signalling"], ["TCGA.G4.6303.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6303.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6303.01", "Extracellular matrix organization"], ["TCGA.G4.6303.01", "G alpha (s) signalling events"], ["TCGA.G4.6303.01", "Glucuronidation"], ["TCGA.G4.6303.01", "Regulation of insulin secretion"], ["TCGA.G4.6303.01", "Regulation of FZD by ubiquitination"], ["TCGA.G4.6303.01", "Ethanol oxidation"], ["TCGA.G4.6303.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6303.01", "Drug ADME"], ["TCGA.G4.6303.01", "Blood group systems biosynthesis"], ["TCGA.G4.6303.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6303.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6303.01", "Neuronal System"], ["TCGA.G4.6303.01", "Signal amplification"], ["TCGA.G4.6303.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6303.01", "Signaling Pathways"], ["TCGA.G4.6303.01", "Platelet homeostasis"], ["TCGA.G4.6303.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6303.01", "APAP ADME"], ["TCGA.G4.6303.01", "G alpha (q) signalling events"], ["TCGA.G4.6303.01", "G alpha (i) signalling events"], ["TCGA.G4.6303.01", "Glutathione conjugation"], ["TCGA.G4.6303.01", "Phase 2 - plateau phase"], ["TCGA.G4.6303.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6303.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6303.01", "Lewis blood group biosynthesis"], ["TCGA.G4.6303.01", "Collagen degradation"], ["TCGA.G4.6304.01", "Extracellular matrix organization"], ["TCGA.G4.6304.01", "Signaling by GPCR"], ["TCGA.G4.6304.01", "GPCR downstream signalling"], ["TCGA.G4.6304.01", "Signaling Pathways"], ["TCGA.G4.6304.01", "Elastic fibre formation"], ["TCGA.G4.6304.01", "GPCR ligand binding"], ["TCGA.G4.6304.01", "Biological oxidations"], ["TCGA.G4.6304.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6304.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6304.01", "L1CAM interactions"], ["TCGA.G4.6304.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6304.01", "Neuronal System"], ["TCGA.G4.6304.01", "Drug ADME"], ["TCGA.G4.6304.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6304.01", "Glucuronidation"], ["TCGA.G4.6304.01", "Muscle contraction"], ["TCGA.G4.6304.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6304.01", "G alpha (i) signalling events"], ["TCGA.G4.6304.01", "G alpha (q) signalling events"], ["TCGA.G4.6304.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6304.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6304.01", "G alpha (s) signalling events"], ["TCGA.G4.6304.01", "ECM proteoglycans"], ["TCGA.G4.6304.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6304.01", "Defensins"], ["TCGA.G4.6304.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6304.01", "Cardiac conduction"], ["TCGA.G4.6304.01", "Integrin cell surface interactions"], ["TCGA.G4.6304.01", "Complement cascade"], ["TCGA.G4.6304.01", "Keratan sulfate/keratin metabolism"], ["TCGA.G4.6304.01", "Peptide hormone metabolism"], ["TCGA.G4.6304.01", "Recycling of bile acids and salts"], ["TCGA.G4.6304.01", "Aspirin ADME"], ["TCGA.G4.6304.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.G4.6304.01", "Glycosaminoglycan metabolism"], ["TCGA.G4.6304.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6304.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6304.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6304.01", "Non-integrin membrane-ECM interactions"], ["TCGA.G4.6304.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6304.01", "Regulation of insulin secretion"], ["TCGA.G4.6304.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.G4.6304.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6304.01", "Diseases of metabolism"], ["TCGA.G4.6304.01", "Netrin-1 signaling"], ["TCGA.G4.6304.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.G4.6304.01", "Heme degradation"], ["TCGA.G4.6304.01", "Bile acid and bile salt metabolism"], ["TCGA.G4.6304.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6304.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6304.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6304.01", "Insulin processing"], ["TCGA.G4.6304.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6304.01", "Diseases of glycosylation"], ["TCGA.G4.6304.01", "Regulation of Complement cascade"], ["TCGA.G4.6304.01", "Integration of energy metabolism"], ["TCGA.G4.6304.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6304.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6304.01", "O-linked glycosylation"], ["TCGA.G4.6304.01", "Nuclear Receptor transcription pathway"], ["TCGA.G4.6306.01", "Extracellular matrix organization"], ["TCGA.G4.6306.01", "Signaling by GPCR"], ["TCGA.G4.6306.01", "Signaling Pathways"], ["TCGA.G4.6306.01", "Neuronal System"], ["TCGA.G4.6306.01", "Cardiac conduction"], ["TCGA.G4.6306.01", "GPCR downstream signalling"], ["TCGA.G4.6306.01", "Elastic fibre formation"], ["TCGA.G4.6306.01", "Muscle contraction"], ["TCGA.G4.6306.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6306.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6306.01", "G alpha (s) signalling events"], ["TCGA.G4.6306.01", "GPCR ligand binding"], ["TCGA.G4.6306.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6306.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6306.01", "Complement cascade"], ["TCGA.G4.6306.01", "Initial triggering of complement"], ["TCGA.G4.6306.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6306.01", "L1CAM interactions"], ["TCGA.G4.6306.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6306.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6306.01", "Regulation of Complement cascade"], ["TCGA.G4.6306.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6306.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6306.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6306.01", "Developmental Biology"], ["TCGA.G4.6306.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6306.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6306.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.G4.6306.01", "Potassium Channels"], ["TCGA.G4.6306.01", "Defective B3GALTL causes PpS"], ["TCGA.G4.6306.01", "Regulation of insulin secretion"], ["TCGA.G4.6306.01", "G alpha (i) signalling events"], ["TCGA.G4.6306.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6306.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.G4.6306.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6306.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6306.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.G4.6306.01", "Platelet homeostasis"], ["TCGA.G4.6306.01", "GABA receptor activation"], ["TCGA.G4.6306.01", "Nervous system development"], ["TCGA.G4.6306.01", "Signal amplification"], ["TCGA.G4.6306.01", "Cell surface interactions at the vascular wall"], ["TCGA.G4.6306.01", "GABA B receptor activation"], ["TCGA.G4.6306.01", "Activation of GABAB receptors"], ["TCGA.G4.6306.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6306.01", "CRMPs in Sema3A signaling"], ["TCGA.G4.6306.01", "Ca2+ pathway"], ["TCGA.G4.6306.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6306.01", "Integration of energy metabolism"], ["TCGA.G4.6306.01", "Nicotinate metabolism"], ["TCGA.G4.6306.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6306.01", "Integrin cell surface interactions"], ["TCGA.G4.6306.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6306.01", "Calcitonin-like ligand receptors"], ["TCGA.G4.6306.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6306.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.G4.6306.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6306.01", "Ion homeostasis"], ["TCGA.G4.6306.01", "Opioid Signalling"], ["TCGA.G4.6306.01", "Diseases of glycosylation"], ["TCGA.G4.6306.01", "Axon guidance"], ["TCGA.G4.6306.01", "Leishmania infection"], ["TCGA.G4.6306.01", "Parasitic Infection Pathways"], ["TCGA.G4.6306.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6306.01", "G protein gated Potassium channels"], ["TCGA.G4.6306.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6306.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6306.01", "G alpha (q) signalling events"], ["TCGA.G4.6306.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6306.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6306.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6306.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.G4.6306.01", "Plasma lipoprotein assembly"], ["TCGA.G4.6306.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6306.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6306.01", "G beta:gamma signalling through CDC42"], ["TCGA.G4.6306.01", "Sialic acid metabolism"], ["TCGA.G4.6306.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6306.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6306.01", "Neurexins and neuroligins"], ["TCGA.G4.6306.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6306.01", "Blood group systems biosynthesis"], ["TCGA.G4.6306.01", "RAC1 GTPase cycle"], ["TCGA.G4.6306.01", "IRS-related events triggered by IGF1R"], ["TCGA.G4.6306.01", "ECM proteoglycans"], ["TCGA.G4.6306.01", "Diseases of metabolism"], ["TCGA.G4.6306.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], ["TCGA.G4.6306.01", "IGF1R signaling cascade"], ["TCGA.G4.6306.01", "IRS-mediated signalling"], ["TCGA.G4.6306.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.G4.6306.01", "Aquaporin-mediated transport"], ["TCGA.G4.6306.01", "Regulation of FZD by ubiquitination"], ["TCGA.G4.6306.01", "Assembly and cell surface presentation of NMDA receptors"], ["TCGA.G4.6306.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6306.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6306.01", "Activation of SMO"], ["TCGA.G4.6306.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6306.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6306.01", "Formation of the anterior neural plate"], ["TCGA.G4.6306.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6306.01", "Biological oxidations"], ["TCGA.G4.6306.01", "GPER1 signaling"], ["TCGA.G4.6306.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.G4.6306.01", "NCAM1 interactions"], ["TCGA.G4.6306.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6306.01", "Other interleukin signaling"], ["TCGA.G4.6307.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6307.01", "Neuronal System"], ["TCGA.G4.6307.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.G4.6307.01", "Signaling by GPCR"], ["TCGA.G4.6307.01", "GPCR downstream signalling"], ["TCGA.G4.6307.01", "Generation of second messenger molecules"], ["TCGA.G4.6307.01", "Signaling Pathways"], ["TCGA.G4.6307.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.G4.6307.01", "Immune System"], ["TCGA.G4.6307.01", "PD-1 signaling"], ["TCGA.G4.6307.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6307.01", "GPCR ligand binding"], ["TCGA.G4.6307.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6307.01", "G alpha (i) signalling events"], ["TCGA.G4.6307.01", "Cardiac conduction"], ["TCGA.G4.6307.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6307.01", "Potassium Channels"], ["TCGA.G4.6307.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6307.01", "Initial triggering of complement"], ["TCGA.G4.6307.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6307.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6307.01", "Cytokine Signaling in Immune system"], ["TCGA.G4.6307.01", "G alpha (q) signalling events"], ["TCGA.G4.6307.01", "Platelet homeostasis"], ["TCGA.G4.6307.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6307.01", "Muscle contraction"], ["TCGA.G4.6307.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6307.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6307.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6307.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6307.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6307.01", "G alpha (s) signalling events"], ["TCGA.G4.6307.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6307.01", "Diseases of Immune System"], ["TCGA.G4.6307.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.G4.6307.01", "Regulation of TLR by endogenous ligand"], ["TCGA.G4.6307.01", "Interferon gamma signaling"], ["TCGA.G4.6307.01", "Glycosaminoglycan metabolism"], ["TCGA.G4.6307.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6307.01", "Neurexins and neuroligins"], ["TCGA.G4.6307.01", "Leishmania infection"], ["TCGA.G4.6307.01", "Parasitic Infection Pathways"], ["TCGA.G4.6307.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6307.01", "Complement cascade"], ["TCGA.G4.6307.01", "Signaling by Interleukins"], ["TCGA.G4.6307.01", "Costimulation by the CD28 family"], ["TCGA.G4.6307.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6307.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6307.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.G4.6307.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6307.01", "Role of phospholipids in phagocytosis"], ["TCGA.G4.6307.01", "Adaptive Immune System"], ["TCGA.G4.6307.01", "Voltage gated Potassium channels"], ["TCGA.G4.6307.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6307.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6307.01", "Interleukin-10 signaling"], ["TCGA.G4.6307.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.G4.6307.01", "Trafficking of AMPA receptors"], ["TCGA.G4.6307.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.G4.6307.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.G4.6307.01", "Other interleukin signaling"], ["TCGA.G4.6307.01", "Ion homeostasis"], ["TCGA.G4.6307.01", "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"], ["TCGA.G4.6307.01", "Signal amplification"], ["TCGA.G4.6307.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.G4.6307.01", "Biological oxidations"], ["TCGA.G4.6307.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6307.01", "G protein gated Potassium channels"], ["TCGA.G4.6307.01", "Platelet calcium homeostasis"], ["TCGA.G4.6307.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6307.01", "Cell surface interactions at the vascular wall"], ["TCGA.G4.6307.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.G4.6307.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6307.01", "Regulation of insulin secretion"], ["TCGA.G4.6307.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6307.01", "DAP12 interactions"], ["TCGA.G4.6307.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6307.01", "DAP12 signaling"], ["TCGA.G4.6307.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.G4.6307.01", "FCGR activation"], ["TCGA.G4.6307.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6307.01", "Elastic fibre formation"], ["TCGA.G4.6307.01", "L1CAM interactions"], ["TCGA.G4.6307.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.G4.6309.01", "Signaling by GPCR"], ["TCGA.G4.6309.01", "GPCR ligand binding"], ["TCGA.G4.6309.01", "Neuronal System"], ["TCGA.G4.6309.01", "GPCR downstream signalling"], ["TCGA.G4.6309.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6309.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6309.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6309.01", "Signaling Pathways"], ["TCGA.G4.6309.01", "Extracellular matrix organization"], ["TCGA.G4.6309.01", "G alpha (i) signalling events"], ["TCGA.G4.6309.01", "G alpha (s) signalling events"], ["TCGA.G4.6309.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6309.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6309.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6309.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6309.01", "Peptide hormone metabolism"], ["TCGA.G4.6309.01", "Stimuli-sensing channels"], ["TCGA.G4.6309.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6309.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6309.01", "Cardiac conduction"], ["TCGA.G4.6309.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.G4.6309.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6309.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6309.01", "DNA strand elongation"], ["TCGA.G4.6309.01", "Muscle contraction"], ["TCGA.G4.6309.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6309.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6309.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.G4.6309.01", "Platelet homeostasis"], ["TCGA.G4.6309.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6309.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6309.01", "Opioid Signalling"], ["TCGA.G4.6309.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6309.01", "G-protein mediated events"], ["TCGA.G4.6309.01", "GABA receptor activation"], ["TCGA.G4.6309.01", "Calmodulin induced events"], ["TCGA.G4.6309.01", "CaM pathway"], ["TCGA.G4.6309.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6309.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6309.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6309.01", "DAG and IP3 signaling"], ["TCGA.G4.6309.01", "Insulin processing"], ["TCGA.G4.6309.01", "Trafficking and processing of endosomal TLR"], ["TCGA.G4.6309.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6309.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6309.01", "PLC beta mediated events"], ["TCGA.G4.6310.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6310.01", "Immune System"], ["TCGA.G4.6310.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.G4.6310.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.G4.6310.01", "Generation of second messenger molecules"], ["TCGA.G4.6310.01", "Adaptive Immune System"], ["TCGA.G4.6310.01", "PD-1 signaling"], ["TCGA.G4.6310.01", "Costimulation by the CD28 family"], ["TCGA.G4.6310.01", "Signaling by GPCR"], ["TCGA.G4.6310.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6310.01", "Innate Immune System"], ["TCGA.G4.6310.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6310.01", "GPCR downstream signalling"], ["TCGA.G4.6310.01", "Interleukin-10 signaling"], ["TCGA.G4.6310.01", "Cytokine Signaling in Immune system"], ["TCGA.G4.6310.01", "Leishmania infection"], ["TCGA.G4.6310.01", "Parasitic Infection Pathways"], ["TCGA.G4.6310.01", "G alpha (i) signalling events"], ["TCGA.G4.6310.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.G4.6310.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6310.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6310.01", "TCR signaling"], ["TCGA.G4.6310.01", "Signaling by Interleukins"], ["TCGA.G4.6310.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.G4.6310.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.G4.6310.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6310.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6310.01", "GPCR ligand binding"], ["TCGA.G4.6310.01", "DAP12 interactions"], ["TCGA.G4.6310.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.G4.6310.01", "DAP12 signaling"], ["TCGA.G4.6310.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.G4.6310.01", "Glucuronidation"], ["TCGA.G4.6310.01", "Signaling Pathways"], ["TCGA.G4.6310.01", "TNFs bind their physiological receptors"], ["TCGA.G4.6310.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6310.01", "G alpha (q) signalling events"], ["TCGA.G4.6310.01", "Initial triggering of complement"], ["TCGA.G4.6310.01", "Complement cascade"], ["TCGA.G4.6310.01", "Binding and entry of HIV virion"], ["TCGA.G4.6310.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.G4.6310.01", "Extracellular matrix organization"], ["TCGA.G4.6310.01", "Scavenging of heme from plasma"], ["TCGA.G4.6310.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6310.01", "FCGR activation"], ["TCGA.G4.6310.01", "CD28 dependent Vav1 pathway"], ["TCGA.G4.6310.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6310.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6310.01", "Integrin cell surface interactions"], ["TCGA.G4.6310.01", "Biological oxidations"], ["TCGA.G4.6310.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6310.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6310.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6310.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6310.01", "Drug ADME"], ["TCGA.G4.6310.01", "Cell surface interactions at the vascular wall"], ["TCGA.G4.6310.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.G4.6310.01", "Diseases of Immune System"], ["TCGA.G4.6310.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.G4.6310.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6310.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6310.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.G4.6310.01", "Role of phospholipids in phagocytosis"], ["TCGA.G4.6310.01", "Metabolism of Angiotensinogen to Angiotensins"], ["TCGA.G4.6310.01", "Interferon gamma signaling"], ["TCGA.G4.6310.01", "Interleukin-2 family signaling"], ["TCGA.G4.6310.01", "GPVI-mediated activation cascade"], ["TCGA.G4.6310.01", "Fcgamma receptor (FCGR) dependent phagocytosis"], ["TCGA.G4.6310.01", "Regulation of Complement cascade"], ["TCGA.G4.6310.01", "Inflammasomes"], ["TCGA.G4.6310.01", "CD28 co-stimulation"], ["TCGA.G4.6310.01", "Downstream TCR signaling"], ["TCGA.G4.6310.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.G4.6310.01", "The role of Nef in HIV-1 replication and disease pathogenesis"], ["TCGA.G4.6310.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6310.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6310.01", "Transcriptional regulation of granulopoiesis"], ["TCGA.G4.6310.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.G4.6310.01", "CD28 dependent PI3K/Akt signaling"], ["TCGA.G4.6310.01", "The NLRP3 inflammasome"], ["TCGA.G4.6310.01", "Stimuli-sensing channels"], ["TCGA.G4.6310.01", "MHC class II antigen presentation"], ["TCGA.G4.6310.01", "Activation of the phototransduction cascade"], ["TCGA.G4.6310.01", "Specification of primordial germ cells"], ["TCGA.G4.6310.01", "RAC1 GTPase cycle"], ["TCGA.G4.6310.01", "Transport of small molecules"], ["TCGA.G4.6310.01", "Ligand-dependent caspase activation"], ["TCGA.G4.6310.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6310.01", "Regulation of TLR by endogenous ligand"], ["TCGA.G4.6311.01", "Extracellular matrix organization"], ["TCGA.G4.6311.01", "Collagen formation"], ["TCGA.G4.6311.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6311.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.G4.6311.01", "Collagen chain trimerization"], ["TCGA.G4.6311.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6311.01", "Biological oxidations"], ["TCGA.G4.6311.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6311.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6311.01", "Regulation of insulin secretion"], ["TCGA.G4.6311.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6311.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6311.01", "Integration of energy metabolism"], ["TCGA.G4.6311.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6311.01", "APAP ADME"], ["TCGA.G4.6311.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.G4.6311.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6311.01", "G alpha (s) signalling events"], ["TCGA.G4.6311.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6311.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6311.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6311.01", "Ethanol oxidation"], ["TCGA.G4.6311.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6311.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6311.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6311.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6311.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6311.01", "Neuronal System"], ["TCGA.G4.6311.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6311.01", "Drug ADME"], ["TCGA.G4.6311.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.G4.6311.01", "GABA receptor activation"], ["TCGA.G4.6311.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6311.01", "NCAM1 interactions"], ["TCGA.G4.6311.01", "NCAM signaling for neurite out-growth"], ["TCGA.G4.6311.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6311.01", "Collagen degradation"], ["TCGA.G4.6311.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6311.01", "Signal amplification"], ["TCGA.G4.6311.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.G4.6311.01", "Aquaporin-mediated transport"], ["TCGA.G4.6311.01", "Synthesis, secretion, and deacylation of Ghrelin"], ["TCGA.G4.6311.01", "GPER1 signaling"], ["TCGA.G4.6311.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.G4.6311.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6311.01", "RA biosynthesis pathway"], ["TCGA.G4.6311.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6311.01", "Metabolism"], ["TCGA.G4.6311.01", "Peptide hormone metabolism"], ["TCGA.G4.6311.01", "Glucuronidation"], ["TCGA.G4.6311.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.G4.6311.01", "Other semaphorin interactions"], ["TCGA.G4.6314.01", "Collagen formation"], ["TCGA.G4.6314.01", "Extracellular matrix organization"], ["TCGA.G4.6314.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6314.01", "Assembly of collagen fibrils and other multimeric structures"], ["TCGA.G4.6314.01", "Metabolism"], ["TCGA.G4.6314.01", "Biological oxidations"], ["TCGA.G4.6314.01", "Drug ADME"], ["TCGA.G4.6314.01", "Collagen chain trimerization"], ["TCGA.G4.6314.01", "Glucuronidation"], ["TCGA.G4.6314.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6314.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6314.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6314.01", "Collagen degradation"], ["TCGA.G4.6314.01", "Signaling by Activin"], ["TCGA.G4.6314.01", "Formation of axial mesoderm"], ["TCGA.G4.6314.01", "APAP ADME"], ["TCGA.G4.6314.01", "Peptide hormone biosynthesis"], ["TCGA.G4.6314.01", "ECM proteoglycans"], ["TCGA.G4.6314.01", "Aspirin ADME"], ["TCGA.G4.6314.01", "Arachidonic acid metabolism"], ["TCGA.G4.6314.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6314.01", "Ethanol oxidation"], ["TCGA.G4.6314.01", "RA biosynthesis pathway"], ["TCGA.G4.6315.01", "Immune System"], ["TCGA.G4.6315.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.G4.6315.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.G4.6315.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6315.01", "Generation of second messenger molecules"], ["TCGA.G4.6315.01", "PD-1 signaling"], ["TCGA.G4.6315.01", "Signaling by GPCR"], ["TCGA.G4.6315.01", "GPCR downstream signalling"], ["TCGA.G4.6315.01", "Signaling Pathways"], ["TCGA.G4.6315.01", "Neuronal System"], ["TCGA.G4.6315.01", "Complement cascade"], ["TCGA.G4.6315.01", "G alpha (i) signalling events"], ["TCGA.G4.6315.01", "Initial triggering of complement"], ["TCGA.G4.6315.01", "Leishmania infection"], ["TCGA.G4.6315.01", "Parasitic Infection Pathways"], ["TCGA.G4.6315.01", "Extracellular matrix organization"], ["TCGA.G4.6315.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6315.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6315.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6315.01", "GPCR ligand binding"], ["TCGA.G4.6315.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6315.01", "Costimulation by the CD28 family"], ["TCGA.G4.6315.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6315.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6315.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6315.01", "Potassium Channels"], ["TCGA.G4.6315.01", "Regulation of Complement cascade"], ["TCGA.G4.6315.01", "Adaptive Immune System"], ["TCGA.G4.6315.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6315.01", "Innate Immune System"], ["TCGA.G4.6315.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6315.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6315.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6315.01", "Cell surface interactions at the vascular wall"], ["TCGA.G4.6315.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6315.01", "Elastic fibre formation"], ["TCGA.G4.6315.01", "Regulation of insulin secretion"], ["TCGA.G4.6315.01", "Integrin cell surface interactions"], ["TCGA.G4.6315.01", "Interleukin-10 signaling"], ["TCGA.G4.6315.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6315.01", "G alpha (s) signalling events"], ["TCGA.G4.6315.01", "Cytokine Signaling in Immune system"], ["TCGA.G4.6315.01", "Platelet homeostasis"], ["TCGA.G4.6315.01", "GABA receptor activation"], ["TCGA.G4.6315.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.G4.6315.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6315.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6315.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.G4.6315.01", "Integration of energy metabolism"], ["TCGA.G4.6315.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.G4.6315.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6315.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6315.01", "Activation of SMO"], ["TCGA.G4.6315.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6315.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.G4.6315.01", "Other interleukin signaling"], ["TCGA.G4.6315.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.G4.6315.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.G4.6315.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6315.01", "Other semaphorin interactions"], ["TCGA.G4.6315.01", "Cardiac conduction"], ["TCGA.G4.6315.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.G4.6315.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6315.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6315.01", "G beta:gamma signalling through CDC42"], ["TCGA.G4.6315.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.G4.6315.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.G4.6315.01", "ECM proteoglycans"], ["TCGA.G4.6315.01", "G alpha (q) signalling events"], ["TCGA.G4.6315.01", "Voltage gated Potassium channels"], ["TCGA.G4.6315.01", "Arachidonic acid metabolism"], ["TCGA.G4.6315.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6315.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6315.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6315.01", "Regulation of TLR by endogenous ligand"], ["TCGA.G4.6315.01", "Negative regulation of FLT3"], ["TCGA.G4.6315.01", "Diseases of Immune System"], ["TCGA.G4.6315.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.G4.6315.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6315.01", "Signaling by Interleukins"], ["TCGA.G4.6315.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6315.01", "Formation of axial mesoderm"], ["TCGA.G4.6315.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6315.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6315.01", "Peptide hormone metabolism"], ["TCGA.G4.6315.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.G4.6315.01", "GABA B receptor activation"], ["TCGA.G4.6315.01", "Activation of GABAB receptors"], ["TCGA.G4.6315.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6315.01", "TCR signaling"], ["TCGA.G4.6315.01", "G-protein activation"], ["TCGA.G4.6315.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6315.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6315.01", "TNFs bind their physiological receptors"], ["TCGA.G4.6315.01", "Biological oxidations"], ["TCGA.G4.6315.01", "IRS-related events triggered by IGF1R"], ["TCGA.G4.6315.01", "Opioid Signalling"], ["TCGA.G4.6317.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6317.01", "Signaling by GPCR"], ["TCGA.G4.6317.01", "GPCR downstream signalling"], ["TCGA.G4.6317.01", "Signaling Pathways"], ["TCGA.G4.6317.01", "G alpha (i) signalling events"], ["TCGA.G4.6317.01", "Neuronal System"], ["TCGA.G4.6317.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.G4.6317.01", "GPCR ligand binding"], ["TCGA.G4.6317.01", "Generation of second messenger molecules"], ["TCGA.G4.6317.01", "Immune System"], ["TCGA.G4.6317.01", "Extracellular matrix organization"], ["TCGA.G4.6317.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6317.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6317.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6317.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6317.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6317.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6317.01", "Complement cascade"], ["TCGA.G4.6317.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6317.01", "G alpha (q) signalling events"], ["TCGA.G4.6317.01", "Regulation of Complement cascade"], ["TCGA.G4.6317.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6317.01", "G alpha (s) signalling events"], ["TCGA.G4.6317.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.G4.6317.01", "Cardiac conduction"], ["TCGA.G4.6317.01", "Potassium Channels"], ["TCGA.G4.6317.01", "Leishmania infection"], ["TCGA.G4.6317.01", "Parasitic Infection Pathways"], ["TCGA.G4.6317.01", "Signal amplification"], ["TCGA.G4.6317.01", "GABA B receptor activation"], ["TCGA.G4.6317.01", "Activation of GABAB receptors"], ["TCGA.G4.6317.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6317.01", "PD-1 signaling"], ["TCGA.G4.6317.01", "GABA receptor activation"], ["TCGA.G4.6317.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6317.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6317.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6317.01", "G protein gated Potassium channels"], ["TCGA.G4.6317.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6317.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6317.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6317.01", "Regulation of insulin secretion"], ["TCGA.G4.6317.01", "Muscle contraction"], ["TCGA.G4.6317.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.G4.6317.01", "PI3K/AKT Signaling in Cancer"], ["TCGA.G4.6317.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6317.01", "Negative regulation of the PI3K/AKT network"], ["TCGA.G4.6317.01", "Opioid Signalling"], ["TCGA.G4.6317.01", "G-protein activation"], ["TCGA.G4.6317.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6317.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6317.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6317.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6317.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.G4.6317.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], ["TCGA.G4.6317.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6317.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6317.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.G4.6317.01", "Platelet activation, signaling and aggregation"], ["TCGA.G4.6317.01", "Platelet homeostasis"], ["TCGA.G4.6317.01", "Interleukin-10 signaling"], ["TCGA.G4.6317.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6317.01", "Integration of energy metabolism"], ["TCGA.G4.6317.01", "Integrin cell surface interactions"], ["TCGA.G4.6317.01", "Formation of Fibrin Clot (Clotting Cascade)"], ["TCGA.G4.6317.01", "Initial triggering of complement"], ["TCGA.G4.6317.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6317.01", "G beta:gamma signalling through CDC42"], ["TCGA.G4.6317.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6317.01", "Cell surface interactions at the vascular wall"], ["TCGA.G4.6317.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.G4.6317.01", "G-protein mediated events"], ["TCGA.G4.6317.01", "Developmental Biology"], ["TCGA.G4.6317.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6317.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], ["TCGA.G4.6317.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6317.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6317.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6317.01", "Regulation of FZD by ubiquitination"], ["TCGA.G4.6317.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.G4.6317.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6317.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.G4.6317.01", "Azathioprine ADME"], ["TCGA.G4.6317.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.G4.6317.01", "Aquaporin-mediated transport"], ["TCGA.G4.6317.01", "PLC beta mediated events"], ["TCGA.G4.6317.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], ["TCGA.G4.6317.01", "FCGR activation"], ["TCGA.G4.6317.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6317.01", "Physiological factors"], ["TCGA.G4.6317.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6317.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], ["TCGA.G4.6317.01", "GPER1 signaling"], ["TCGA.G4.6317.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.G4.6317.01", "RAC1 GTPase cycle"], ["TCGA.G4.6317.01", "Diseases of Immune System"], ["TCGA.G4.6317.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.G4.6317.01", "Purinergic signaling in leishmaniasis infection"], ["TCGA.G4.6317.01", "Cell recruitment (pro-inflammatory response)"], ["TCGA.G4.6317.01", "Nervous system development"], ["TCGA.G4.6317.01", "Blood group systems biosynthesis"], ["TCGA.G4.6317.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6317.01", "Tryptophan catabolism"], ["TCGA.G4.6317.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6317.01", "Cytokine Signaling in Immune system"], ["TCGA.G4.6317.01", "Nuclear signaling by ERBB4"], ["TCGA.G4.6317.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6317.01", "Thrombin signalling through proteinase activated receptors (PARs)"], ["TCGA.G4.6317.01", "Costimulation by the CD28 family"], ["TCGA.G4.6317.01", "Long-term potentiation"], ["TCGA.G4.6317.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6317.01", "Collagen formation"], ["TCGA.G4.6317.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6317.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6317.01", "G alpha (z) signalling events"], ["TCGA.G4.6317.01", "Signaling by Interleukins"], ["TCGA.G4.6317.01", "NCAM1 interactions"], ["TCGA.G4.6317.01", "Role of phospholipids in phagocytosis"], ["TCGA.G4.6320.01", "Signaling by GPCR"], ["TCGA.G4.6320.01", "GPCR downstream signalling"], ["TCGA.G4.6320.01", "Neuronal System"], ["TCGA.G4.6320.01", "Cardiac conduction"], ["TCGA.G4.6320.01", "GPCR ligand binding"], ["TCGA.G4.6320.01", "G alpha (i) signalling events"], ["TCGA.G4.6320.01", "Muscle contraction"], ["TCGA.G4.6320.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6320.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6320.01", "Regulation of insulin secretion"], ["TCGA.G4.6320.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6320.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6320.01", "Integration of energy metabolism"], ["TCGA.G4.6320.01", "G alpha (s) signalling events"], ["TCGA.G4.6320.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6320.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.G4.6320.01", "Aquaporin-mediated transport"], ["TCGA.G4.6320.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6320.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.G4.6320.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6320.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6320.01", "Leishmania infection"], ["TCGA.G4.6320.01", "Parasitic Infection Pathways"], ["TCGA.G4.6320.01", "L1CAM interactions"], ["TCGA.G4.6320.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6320.01", "Extracellular matrix organization"], ["TCGA.G4.6320.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.G4.6320.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.G4.6320.01", "Signaling Pathways"], ["TCGA.G4.6320.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6320.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6320.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6320.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6320.01", "G alpha (q) signalling events"], ["TCGA.G4.6320.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.G4.6320.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6320.01", "PD-1 signaling"], ["TCGA.G4.6320.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6320.01", "G alpha (z) signalling events"], ["TCGA.G4.6320.01", "Creation of C4 and C2 activators"], ["TCGA.G4.6320.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6320.01", "GPER1 signaling"], ["TCGA.G4.6320.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.G4.6320.01", "GABA B receptor activation"], ["TCGA.G4.6320.01", "Activation of GABAB receptors"], ["TCGA.G4.6320.01", "GABA receptor activation"], ["TCGA.G4.6320.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6320.01", "Regulation of Complement cascade"], ["TCGA.G4.6320.01", "Initial triggering of complement"], ["TCGA.G4.6320.01", "G beta:gamma signalling through CDC42"], ["TCGA.G4.6320.01", "Complement cascade"], ["TCGA.G4.6320.01", "Ion homeostasis"], ["TCGA.G4.6320.01", "Potassium Channels"], ["TCGA.G4.6320.01", "Generation of second messenger molecules"], ["TCGA.G4.6320.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6320.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6320.01", "Opioid Signalling"], ["TCGA.G4.6320.01", "Phospholipase C-mediated cascade: FGFR1"], ["TCGA.G4.6320.01", "Calmodulin induced events"], ["TCGA.G4.6320.01", "CaM pathway"], ["TCGA.G4.6320.01", "DAG and IP3 signaling"], ["TCGA.G4.6320.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6320.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6320.01", "Signal amplification"], ["TCGA.G4.6320.01", "G-protein mediated events"], ["TCGA.G4.6320.01", "Neurexins and neuroligins"], ["TCGA.G4.6320.01", "PKA activation in glucagon signalling"], ["TCGA.G4.6320.01", "FGFR1 ligand binding and activation"], ["TCGA.G4.6320.01", "Glutamate Neurotransmitter Release Cycle"], ["TCGA.G4.6320.01", "RA biosynthesis pathway"], ["TCGA.G4.6320.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6320.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6320.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6320.01", "Generic Transcription Pathway"], ["TCGA.G4.6320.01", "PLC beta mediated events"], ["TCGA.G4.6320.01", "Ca-dependent events"], ["TCGA.G4.6320.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6320.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6320.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6320.01", "G protein gated Potassium channels"], ["TCGA.G4.6320.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6320.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6320.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6320.01", "Formation of the anterior neural plate"], ["TCGA.G4.6320.01", "Sensory processing of sound"], ["TCGA.G4.6320.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6320.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.G4.6320.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6320.01", "G-protein activation"], ["TCGA.G4.6320.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6320.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6320.01", "Receptor-type tyrosine-protein phosphatases"], ["TCGA.G4.6320.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6320.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.G4.6320.01", "Insulin processing"], ["TCGA.G4.6320.01", "Scavenging by Class A Receptors"], ["TCGA.G4.6320.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6320.01", "PI-3K cascade:FGFR1"], ["TCGA.G4.6320.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6321.01", "Extracellular matrix organization"], ["TCGA.G4.6321.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6321.01", "Glycosaminoglycan metabolism"], ["TCGA.G4.6321.01", "Diseases of glycosylation"], ["TCGA.G4.6321.01", "Diseases associated with glycosaminoglycan metabolism"], ["TCGA.G4.6321.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6321.01", "Defective B4GALT7 causes EDS, progeroid type"], ["TCGA.G4.6321.01", "Defective B3GAT3 causes JDSSDHD"], ["TCGA.G4.6321.01", "Defective B3GALT6 causes EDSP2 and SEMDJL1"], ["TCGA.G4.6321.01", "Chondroitin sulfate/dermatan sulfate metabolism"], ["TCGA.G4.6321.01", "Diseases of metabolism"], ["TCGA.G4.6321.01", "ECM proteoglycans"], ["TCGA.G4.6321.01", "Non-integrin membrane-ECM interactions"], ["TCGA.G4.6321.01", "Defective EXT2 causes exostoses 2"], ["TCGA.G4.6321.01", "Defective EXT1 causes exostoses 1, TRPS2 and CHDS"], ["TCGA.G4.6321.01", "GPCR ligand binding"], ["TCGA.G4.6321.01", "HS-GAG degradation"], ["TCGA.G4.6321.01", "RA biosynthesis pathway"], ["TCGA.G4.6321.01", "A tetrasaccharide linker sequence is required for GAG synthesis"], ["TCGA.G4.6321.01", "MET activates PTK2 signaling"], ["TCGA.G4.6322.01", "Biological oxidations"], ["TCGA.G4.6322.01", "Signaling by GPCR"], ["TCGA.G4.6322.01", "GPCR downstream signalling"], ["TCGA.G4.6322.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6322.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6322.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6322.01", "Drug ADME"], ["TCGA.G4.6322.01", "GPCR ligand binding"], ["TCGA.G4.6322.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.G4.6322.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6322.01", "L1CAM interactions"], ["TCGA.G4.6322.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6322.01", "Neuronal System"], ["TCGA.G4.6322.01", "Arachidonic acid metabolism"], ["TCGA.G4.6322.01", "Bile acid and bile salt metabolism"], ["TCGA.G4.6322.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6322.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6322.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.G4.6322.01", "G alpha (i) signalling events"], ["TCGA.G4.6322.01", "Peptide hormone metabolism"], ["TCGA.G4.6322.01", "Signaling Pathways"], ["TCGA.G4.6322.01", "Glycosaminoglycan metabolism"], ["TCGA.G4.6322.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6322.01", "Extracellular matrix organization"], ["TCGA.G4.6322.01", "Complement cascade"], ["TCGA.G4.6322.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], ["TCGA.G4.6322.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], ["TCGA.G4.6322.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6322.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts"], ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.G4.6322.01", "G alpha (q) signalling events"], ["TCGA.G4.6322.01", "Dermatan sulfate biosynthesis"], ["TCGA.G4.6322.01", "Chondroitin sulfate/dermatan sulfate metabolism"], ["TCGA.G4.6322.01", "Adherens junctions interactions"], ["TCGA.G4.6322.01", "Regulation of IGF Activity by IGFBP"], ["TCGA.G4.6322.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6322.01", "Synaptic adhesion-like molecules"], ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.G4.6322.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6322.01", "Recycling of bile acids and salts"], ["TCGA.G4.6322.01", "Cytochrome P450 - arranged by substrate type"], ["TCGA.G4.6322.01", "Diseases associated with glycosaminoglycan metabolism"], ["TCGA.G4.6322.01", "Metabolism of fat-soluble vitamins"], ["TCGA.G4.6322.01", "Retinoid metabolism and transport"], ["TCGA.G4.6323.01", "Extracellular matrix organization"], ["TCGA.G4.6323.01", "Neuronal System"], ["TCGA.G4.6323.01", "GPCR ligand binding"], ["TCGA.G4.6323.01", "G alpha (i) signalling events"], ["TCGA.G4.6323.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6323.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6323.01", "Signaling by GPCR"], ["TCGA.G4.6323.01", "Sensory perception of taste"], ["TCGA.G4.6323.01", "Complement cascade"], ["TCGA.G4.6323.01", "ECM proteoglycans"], ["TCGA.G4.6323.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6323.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], ["TCGA.G4.6323.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6323.01", "GABA receptor activation"], ["TCGA.G4.6323.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6323.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6323.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6323.01", "GPCR downstream signalling"], ["TCGA.G4.6323.01", "Regulation of Complement cascade"], ["TCGA.G4.6323.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6323.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6323.01", "L1CAM interactions"], ["TCGA.G4.6323.01", "Elastic fibre formation"], ["TCGA.G4.6323.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6323.01", "Initial triggering of complement"], ["TCGA.G4.6323.01", "FGFR2 ligand binding and activation"], ["TCGA.G4.6323.01", "Signaling Pathways"], ["TCGA.G4.6323.01", "Glycosaminoglycan metabolism"], ["TCGA.G4.6323.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6323.01", "Cardiac conduction"], ["TCGA.G4.6323.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6323.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6323.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6323.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6323.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6323.01", "Potassium Channels"], ["TCGA.G4.6323.01", "Keratan sulfate/keratin metabolism"], ["TCGA.G4.6323.01", "GABA B receptor activation"], ["TCGA.G4.6323.01", "Activation of GABAB receptors"], ["TCGA.G4.6323.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6323.01", "Trafficking and processing of endosomal TLR"], ["TCGA.G4.6323.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6323.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6323.01", "Activated point mutants of FGFR2"], ["TCGA.G4.6586.01", "Neuronal System"], ["TCGA.G4.6586.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6586.01", "Cardiac conduction"], ["TCGA.G4.6586.01", "Muscle contraction"], ["TCGA.G4.6586.01", "Signaling by GPCR"], ["TCGA.G4.6586.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6586.01", "GPCR downstream signalling"], ["TCGA.G4.6586.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6586.01", "G alpha (i) signalling events"], ["TCGA.G4.6586.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6586.01", "Extracellular matrix organization"], ["TCGA.G4.6586.01", "GPCR ligand binding"], ["TCGA.G4.6586.01", "Neurexins and neuroligins"], ["TCGA.G4.6586.01", "Potassium Channels"], ["TCGA.G4.6586.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6586.01", "Platelet homeostasis"], ["TCGA.G4.6586.01", "L1CAM interactions"], ["TCGA.G4.6586.01", "Signaling Pathways"], ["TCGA.G4.6586.01", "NCAM1 interactions"], ["TCGA.G4.6586.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6586.01", "Defective B3GALTL causes PpS"], ["TCGA.G4.6586.01", "G alpha (s) signalling events"], ["TCGA.G4.6586.01", "Integration of energy metabolism"], ["TCGA.G4.6586.01", "Collagen chain trimerization"], ["TCGA.G4.6586.01", "O-glycosylation of TSR domain-containing proteins"], ["TCGA.G4.6586.01", "Voltage gated Potassium channels"], ["TCGA.G4.6586.01", "Regulation of insulin secretion"], ["TCGA.G4.6586.01", "Biological oxidations"], ["TCGA.G4.6586.01", "GABA receptor activation"], ["TCGA.G4.6586.01", "O-linked glycosylation"], ["TCGA.G4.6586.01", "Ion homeostasis"], ["TCGA.G4.6586.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6586.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6586.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.G4.6586.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6586.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6586.01", "Drug ADME"], ["TCGA.G4.6586.01", "Glucuronidation"], ["TCGA.G4.6586.01", "G alpha (q) signalling events"], ["TCGA.G4.6586.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6586.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6586.01", "Stimuli-sensing channels"], ["TCGA.G4.6586.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6586.01", "Nervous system development"], ["TCGA.G4.6586.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6586.01", "Presynaptic depolarization and calcium channel opening"], ["TCGA.G4.6586.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6586.01", "Platelet calcium homeostasis"], ["TCGA.G4.6586.01", "NCAM signaling for neurite out-growth"], ["TCGA.G4.6586.01", "Keratan sulfate biosynthesis"], ["TCGA.G4.6586.01", "Elastic fibre formation"], ["TCGA.G4.6586.01", "Endogenous sterols"], ["TCGA.G4.6586.01", "Axon guidance"], ["TCGA.G4.6586.01", "Ion channel transport"], ["TCGA.G4.6586.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6586.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6586.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6586.01", "Sodium/Calcium exchangers"], ["TCGA.G4.6586.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6586.01", "ECM proteoglycans"], ["TCGA.G4.6586.01", "Diseases of glycosylation"], ["TCGA.G4.6586.01", "Diseases of Immune System"], ["TCGA.G4.6586.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.G4.6586.01", "Antimicrobial peptides"], ["TCGA.G4.6586.01", "Diseases of metabolism"], ["TCGA.G4.6586.01", "GPER1 signaling"], ["TCGA.G4.6586.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.G4.6586.01", "GABA B receptor activation"], ["TCGA.G4.6586.01", "Activation of GABAB receptors"], ["TCGA.G4.6586.01", "Scavenging of heme from plasma"], ["TCGA.G4.6586.01", "Developmental Biology"], ["TCGA.G4.6586.01", "Diseases associated with O-glycosylation of proteins"], ["TCGA.G4.6586.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.G4.6586.01", "Regulation of TLR by endogenous ligand"], ["TCGA.G4.6586.01", "FGFR2 ligand binding and activation"], ["TCGA.G4.6586.01", "Binding and Uptake of Ligands by Scavenger Receptors"], ["TCGA.G4.6586.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6586.01", "Transport of small molecules"], ["TCGA.G4.6586.01", "G-protein mediated events"], ["TCGA.G4.6586.01", "Opioid Signalling"], ["TCGA.G4.6586.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6586.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6586.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6586.01", "Sensory processing of sound"], ["TCGA.G4.6586.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.G4.6586.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6586.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6586.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.G4.6586.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.G4.6586.01", "Aquaporin-mediated transport"], ["TCGA.G4.6586.01", "Collagen formation"], ["TCGA.G4.6586.01", "PKA activation in glucagon signalling"], ["TCGA.G4.6586.01", "Activated point mutants of FGFR2"], ["TCGA.G4.6586.01", "IL-6-type cytokine receptor ligand interactions"], ["TCGA.G4.6586.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6586.01", "Synthesis of bile acids and bile salts"], ["TCGA.G4.6586.01", "Trafficking of AMPA receptors"], ["TCGA.G4.6586.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.G4.6586.01", "Keratan sulfate/keratin metabolism"], ["TCGA.G4.6586.01", "Signal amplification"], ["TCGA.G4.6586.01", "Metabolism of fat-soluble vitamins"], ["TCGA.G4.6586.01", "Retinoid metabolism and transport"], ["TCGA.G4.6586.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6586.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6588.01", "Neuronal System"], ["TCGA.G4.6588.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6588.01", "Biological oxidations"], ["TCGA.G4.6588.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6588.01", "Extracellular matrix organization"], ["TCGA.G4.6588.01", "GPCR ligand binding"], ["TCGA.G4.6588.01", "Signaling by GPCR"], ["TCGA.G4.6588.01", "G alpha (i) signalling events"], ["TCGA.G4.6588.01", "GPCR downstream signalling"], ["TCGA.G4.6588.01", "Post-translational modification: synthesis of GPI-anchored proteins"], ["TCGA.G4.6588.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6588.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6588.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6588.01", "Potassium Channels"], ["TCGA.G4.6588.01", "Drug ADME"], ["TCGA.G4.6588.01", "RA biosynthesis pathway"], ["TCGA.G4.6588.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6588.01", "GABA receptor activation"], ["TCGA.G4.6588.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6588.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6588.01", "Collagen formation"], ["TCGA.G4.6588.01", "NCAM1 interactions"], ["TCGA.G4.6588.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6588.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6588.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6588.01", "G alpha (s) signalling events"], ["TCGA.G4.6588.01", "Neurexins and neuroligins"], ["TCGA.G4.6588.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6588.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6588.01", "Ethanol oxidation"], ["TCGA.G4.6588.01", "Collagen chain trimerization"], ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], ["TCGA.G4.6588.01", "Trafficking of GluR2-containing AMPA receptors"], ["TCGA.G4.6588.01", "Arachidonic acid metabolism"], ["TCGA.G4.6588.01", "Unwinding of DNA"], ["TCGA.G4.6588.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.G4.6588.01", "Sensory processing of sound"], ["TCGA.G4.6588.01", "Platelet homeostasis"], ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], ["TCGA.G4.6588.01", "PI3K events in ERBB2 signaling"], ["TCGA.G4.6588.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6588.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.G4.6588.01", "Metabolism of vitamins and cofactors"], ["TCGA.G4.6588.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6588.01", "Visual phototransduction"], ["TCGA.G4.6588.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6588.01", "GABA B receptor activation"], ["TCGA.G4.6588.01", "Activation of GABAB receptors"], ["TCGA.G4.6588.01", "Regulation of insulin secretion"], ["TCGA.G4.6588.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6588.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.G4.6588.01", "Signaling by Retinoic Acid"], ["TCGA.G4.6588.01", "Metabolism of fat-soluble vitamins"], ["TCGA.G4.6588.01", "Retinoid metabolism and transport"], ["TCGA.G4.6588.01", "Degradation of the extracellular matrix"], ["TCGA.G4.6588.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6588.01", "Signal amplification"], ["TCGA.G4.6588.01", "Trafficking of AMPA receptors"], ["TCGA.G4.6588.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], ["TCGA.G4.6588.01", "Synaptic adhesion-like molecules"], ["TCGA.G4.6588.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6588.01", "Activation of the phototransduction cascade"], ["TCGA.G4.6588.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6588.01", "ERBB2 Activates PTK6 Signaling"], ["TCGA.G4.6588.01", "Cardiac conduction"], ["TCGA.G4.6588.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6588.01", "G protein gated Potassium channels"], ["TCGA.G4.6588.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6588.01", "Voltage gated Potassium channels"], ["TCGA.G4.6588.01", "NCAM signaling for neurite out-growth"], ["TCGA.G4.6588.01", "Unblocking of NMDA receptors, glutamate binding and activation"], ["TCGA.G4.6588.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6588.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6588.01", "Signaling Pathways"], ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], ["TCGA.G4.6588.01", "Metabolism of steroid hormones"], ["TCGA.G4.6588.01", "G-protein activation"], ["TCGA.G4.6588.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6588.01", "Sensory processing of sound by inner hair cells of the cochlea"], ["TCGA.G4.6588.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6588.01", "G beta:gamma signalling through CDC42"], ["TCGA.G4.6588.01", "APAP ADME"], ["TCGA.G4.6625.01", "Biological oxidations"], ["TCGA.G4.6625.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6625.01", "Glucuronidation"], ["TCGA.G4.6625.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6625.01", "Ethanol oxidation"], ["TCGA.G4.6625.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6625.01", "Collagen biosynthesis and modifying enzymes"], ["TCGA.G4.6625.01", "Collagen formation"], ["TCGA.G4.6625.01", "Formation of axial mesoderm"], ["TCGA.G4.6625.01", "Collagen chain trimerization"], ["TCGA.G4.6626.01", "Neuronal System"], ["TCGA.G4.6626.01", "GPCR downstream signalling"], ["TCGA.G4.6626.01", "Signaling by GPCR"], ["TCGA.G4.6626.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], ["TCGA.G4.6626.01", "Potassium Channels"], ["TCGA.G4.6626.01", "Signaling Pathways"], ["TCGA.G4.6626.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6626.01", "G alpha (i) signalling events"], ["TCGA.G4.6626.01", "GPCR ligand binding"], ["TCGA.G4.6626.01", "Anti-inflammatory response favouring Leishmania parasite infection"], ["TCGA.G4.6626.01", "Leishmania parasite growth and survival"], ["TCGA.G4.6626.01", "Extracellular matrix organization"], ["TCGA.G4.6626.01", "GABA B receptor activation"], ["TCGA.G4.6626.01", "Activation of GABAB receptors"], ["TCGA.G4.6626.01", "GABA receptor activation"], ["TCGA.G4.6626.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6626.01", "G alpha (q) signalling events"], ["TCGA.G4.6626.01", "Glucagon-type ligand receptors"], ["TCGA.G4.6626.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6626.01", "G alpha (z) signalling events"], ["TCGA.G4.6626.01", "Platelet homeostasis"], ["TCGA.G4.6626.01", "Inwardly rectifying K+ channels"], ["TCGA.G4.6626.01", "G alpha (s) signalling events"], ["TCGA.G4.6626.01", "Biological oxidations"], ["TCGA.G4.6626.01", "G beta:gamma signalling through BTK"], ["TCGA.G4.6626.01", "Drug ADME"], ["TCGA.G4.6626.01", "Activation of G protein gated Potassium channels"], ["TCGA.G4.6626.01", "G protein gated Potassium channels"], ["TCGA.G4.6626.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.G4.6626.01", "Class A/1 (Rhodopsin-like receptors)"], ["TCGA.G4.6626.01", "Cardiac conduction"], ["TCGA.G4.6626.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.G4.6626.01", "Glucagon signaling in metabolic regulation"], ["TCGA.G4.6626.01", "Glucuronidation"], ["TCGA.G4.6626.01", "G-protein beta:gamma signalling"], ["TCGA.G4.6626.01", "Regulation of insulin secretion"], ["TCGA.G4.6626.01", "G beta:gamma signalling through PI3Kgamma"], ["TCGA.G4.6626.01", "Other interleukin signaling"], ["TCGA.G4.6626.01", "Integration of energy metabolism"], ["TCGA.G4.6626.01", "G beta:gamma signalling through CDC42"], ["TCGA.G4.6626.01", "ADP signalling through P2Y purinoceptor 1"], ["TCGA.G4.6626.01", "Signal amplification"], ["TCGA.G4.6626.01", "MyD88 deficiency (TLR2/4)"], ["TCGA.G4.6626.01", "IRAK4 deficiency (TLR2/4)"], ["TCGA.G4.6626.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], ["TCGA.G4.6626.01", "Aquaporin-mediated transport"], ["TCGA.G4.6626.01", "Peptide ligand-binding receptors"], ["TCGA.G4.6626.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6626.01", "Unwinding of DNA"], ["TCGA.G4.6626.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], ["TCGA.G4.6626.01", "GPER1 signaling"], ["TCGA.G4.6626.01", "ADORA2B mediated anti-inflammatory cytokines production"], ["TCGA.G4.6626.01", "Muscle contraction"], ["TCGA.G4.6626.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6626.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.G4.6626.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], ["TCGA.G4.6626.01", "Leishmania infection"], ["TCGA.G4.6626.01", "Parasitic Infection Pathways"], ["TCGA.G4.6626.01", "Interleukin-4 and Interleukin-13 signaling"], ["TCGA.G4.6626.01", "Diseases of Immune System"], ["TCGA.G4.6626.01", "Defects in Toll-like Receptor Cascades"], ["TCGA.G4.6626.01", "Activation of kainate receptors upon glutamate binding"], ["TCGA.G4.6626.01", "Arachidonic acid metabolism"], ["TCGA.G4.6626.01", "Opioid Signalling"], ["TCGA.G4.6626.01", "Transcription of E2F targets under negative control by DREAM complex"], ["TCGA.G4.6626.01", "Initial triggering of complement"], ["TCGA.G4.6626.01", "G beta:gamma signalling through PLC beta"], ["TCGA.G4.6626.01", "Chemokine receptors bind chemokines"], ["TCGA.G4.6626.01", "G-protein activation"], ["TCGA.G4.6626.01", "Thromboxane signalling through TP receptor"], ["TCGA.G4.6626.01", "Activation of Matrix Metalloproteinases"], ["TCGA.G4.6626.01", "G0 and Early G1"], ["TCGA.G4.6626.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6626.01", "Complement cascade"], ["TCGA.G4.6626.01", "Presynaptic function of Kainate receptors"], ["TCGA.G4.6626.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6626.01", "Transcriptional regulation of testis differentiation"], ["TCGA.G4.6626.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6626.01", "Generation of second messenger molecules"], ["TCGA.G4.6626.01", "Transcriptional regulation of pluripotent stem cells"], ["TCGA.G4.6626.01", "Regulation of Complement cascade"], ["TCGA.G4.6626.01", "Immune System"], ["TCGA.G4.6626.01", "Voltage gated Potassium channels"], ["TCGA.G4.6626.01", "Activation of ATR in response to replication stress"], ["TCGA.G4.6626.01", "Interleukin-10 signaling"], ["TCGA.G4.6626.01", "Phosphorylation of CD3 and TCR zeta chains"], ["TCGA.G4.6626.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], ["TCGA.G4.6626.01", "CD22 mediated BCR regulation"], ["TCGA.G4.6626.01", "Molecules associated with elastic fibres"], ["TCGA.G4.6626.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], ["TCGA.G4.6626.01", "Norepinephrine Neurotransmitter Release Cycle"], ["TCGA.G4.6626.01", "Acetylcholine Neurotransmitter Release Cycle"], ["TCGA.G4.6626.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], ["TCGA.G4.6626.01", "Regulation of TLR by endogenous ligand"], ["TCGA.G4.6626.01", "NCAM1 interactions"], ["TCGA.G4.6626.01", "Insulin processing"], ["TCGA.G4.6626.01", "Aspirin ADME"], ["TCGA.G4.6626.01", "Ca2+ pathway"], ["TCGA.G4.6626.01", "FCGR3A-mediated IL10 synthesis"], ["TCGA.G4.6626.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], ["TCGA.G4.6626.01", "Caspase-mediated cleavage of cytoskeletal proteins"], ["TCGA.G4.6626.01", "Serotonin Neurotransmitter Release Cycle"], ["TCGA.G4.6626.01", "Translocation of ZAP-70 to Immunological synapse"], ["TCGA.G4.6628.01", "Biological oxidations"], ["TCGA.G4.6628.01", "Drug ADME"], ["TCGA.G4.6628.01", "Neuronal System"], ["TCGA.G4.6628.01", "Phase I - Functionalization of compounds"], ["TCGA.G4.6628.01", "Metabolism"], ["TCGA.G4.6628.01", "Phase II - Conjugation of compounds"], ["TCGA.G4.6628.01", "Ethanol oxidation"], ["TCGA.G4.6628.01", "Transmission across Chemical Synapses"], ["TCGA.G4.6628.01", "Glucuronidation"], ["TCGA.G4.6628.01", "Cardiac conduction"], ["TCGA.G4.6628.01", "APAP ADME"], ["TCGA.G4.6628.01", "Phase 0 - rapid depolarisation"], ["TCGA.G4.6628.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.G4.6628.01", "O2/CO2 exchange in erythrocytes"], ["TCGA.G4.6628.01", "Class B/2 (Secretin family receptors)"], ["TCGA.G4.6628.01", "Transport of small molecules"], ["TCGA.G4.6628.01", "Cytosolic sulfonation of small molecules"], ["TCGA.G4.6628.01", "Arachidonic acid metabolism"], ["TCGA.G4.6628.01", "G alpha (s) signalling events"], ["TCGA.G4.6628.01", "Ion channel transport"], ["TCGA.G4.6628.01", "Regulation of insulin secretion"], ["TCGA.G4.6628.01", "Integration of energy metabolism"], ["TCGA.G4.6628.01", "Aspirin ADME"], ["TCGA.G4.6628.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], ["TCGA.G4.6628.01", "Extracellular matrix organization"], ["TCGA.G4.6628.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.G4.6628.01", "Interaction between L1 and Ankyrins"], ["TCGA.G4.6628.01", "RA biosynthesis pathway"], ["TCGA.G4.6628.01", "Neurotransmitter receptors and postsynaptic signal transmission"], ["TCGA.G4.6628.01", "Protein-protein interactions at synapses"], ["TCGA.G4.6628.01", "Neurexins and neuroligins"], ["TCGA.G4.6628.01", "Nitric oxide stimulates guanylate cyclase"], ["TCGA.G4.6628.01", "Fatty acid metabolism"], ["TCGA.G4.6628.01", "Cytochrome P450 - arranged by substrate type"], ["TCGA.G4.6628.01", "Phase 4 - resting membrane potential"], ["TCGA.G4.6628.01", "Platelet homeostasis"], ["TCGA.G4.6628.01", "The canonical retinoid cycle in rods (twilight vision)"], ["TCGA.G4.6628.01", "Stimuli-sensing channels"], ["TCGA.G4.6628.01", "Glucagon-type ligand receptors"]], "chosen_edges": [["FN1", ["TCGA.A6.2671.01", "Extracellular matrix organization"], {"weight": 0.83692936993782}], ["SCN1A", ["TCGA.A6.2671.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.897505275485012}], ["SCN1A", ["TCGA.A6.2671.01", "Integration of energy metabolism"], {"weight": 0.91834761839254}], ["SCN1A", ["TCGA.A6.2671.01", "Regulation of insulin secretion"], {"weight": 0.911474861887779}], ["SCN1A", ["TCGA.A6.2671.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.899413655431742}], ["SCN1A", ["TCGA.A6.2671.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.84365372681596}], ["SCN1A", ["TCGA.A6.2671.01", "G alpha (z) signalling events"], {"weight": 0.893095255877222}], ["SCN1A", ["TCGA.A6.2671.01", "Signal amplification"], {"weight": 0.856565932045147}], ["SCN1A", ["TCGA.A6.2671.01", "G alpha (s) signalling events"], {"weight": 0.941333646076523}], ["SCN1A", ["TCGA.A6.2671.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.8810820892495}], ["SCN1A", ["TCGA.A6.2671.01", "Glucagon-type ligand receptors"], {"weight": 0.895675440187784}], ["SCN1A", ["TCGA.A6.2671.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.889455071711151}], ["SCN1A", ["TCGA.A6.2671.01", "GABA receptor activation"], {"weight": 0.882082993177581}], ["SCN1A", ["TCGA.A6.5656.01", "Cardiac conduction"], {"weight": 0.941244861209893}], ["SCN1A", ["TCGA.A6.5656.01", "Interaction between L1 and Ankyrins"], {"weight": 0.922367985299732}], ["SCN1A", ["TCGA.AA.3713.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.864743516221619}], ["SCN1A", ["TCGA.AD.6964.01", "Interaction between L1 and Ankyrins"], {"weight": 0.869039238608322}], ["SCN1A", ["TCGA.AD.6964.01", "Sensory perception of taste"], {"weight": 0.874876639595039}], ["SCN1A", ["TCGA.AZ.4615.01", "Interaction between L1 and Ankyrins"], {"weight": 0.950727917950141}], ["SCN1A", ["TCGA.CM.6171.01", "Interaction between L1 and Ankyrins"], {"weight": 0.934182752956726}], ["SCN1A", ["TCGA.CM.6171.01", "Phase 0 - rapid depolarisation"], {"weight": 0.889337368402575}], ["SCN1A", ["TCGA.D5.5538.01", "Interaction between L1 and Ankyrins"], {"weight": 0.919536983676705}], ["SCN1A", ["TCGA.D5.5538.01", "Phase 0 - rapid depolarisation"], {"weight": 0.919433824064966}], ["SCN1A", ["TCGA.D5.5538.01", "Cardiac conduction"], {"weight": 0.897481747520535}], ["SCN1A", ["TCGA.D5.5538.01", "Muscle contraction"], {"weight": 0.908366983932086}], ["SCN1A", ["TCGA.D5.5538.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.14498090470521}], ["SCN1A", ["TCGA.D5.5538.01", "Sensory perception of taste"], {"weight": 0.902134247731339}], ["SCN1A", ["TCGA.D5.5538.01", "Stimuli-sensing channels"], {"weight": 0.874905967507274}], ["SCN1A", ["TCGA.DM.A1HA.01", "Phase 0 - rapid depolarisation"], {"weight": 0.928949976008435}], ["SCN1A", ["TCGA.DM.A1HA.01", "Interaction between L1 and Ankyrins"], {"weight": 0.944183834048361}], ["SCN1A", ["TCGA.DM.A1HA.01", "Transport of small molecules"], {"weight": 0.944328621970969}], ["SCN1A", ["TCGA.G4.6322.01", "Interaction between L1 and Ankyrins"], {"weight": 0.934655085916247}], ["SCN1A", ["TCGA.G4.6322.01", "GPCR ligand binding"], {"weight": 0.925209768483664}], ["SCN1A", ["TCGA.G4.6322.01", "L1CAM interactions"], {"weight": 0.863976145015579}], ["SCN1A", ["TCGA.G4.6322.01", "G alpha (q) signalling events"], {"weight": 0.920419351320694}], ["KCNN3", ["TCGA.AA.3492.01", "Sensory processing of sound"], {"weight": 0.942243119997033}], ["KCNN3", ["TCGA.AA.3492.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.941217571746144}], ["KCNN3", ["TCGA.AA.3662.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.828234525950906}], ["KCNN3", ["TCGA.AA.3712.01", "Potassium Channels"], {"weight": 0.945234975928397}], ["KCNN3", ["TCGA.D5.6537.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.838150378452658}], ["KCNN3", ["TCGA.DM.A1D0.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.835982318863642}], ["KCNN3", ["TCGA.DM.A1D0.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.822899246539396}], ["KCNN3", ["TCGA.DM.A1D4.01", "Sensory processing of sound"], {"weight": 0.928330398890635}], ["KCNN3", ["TCGA.DM.A1D4.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.945069014346699}], ["KCNN3", ["TCGA.DM.A1D4.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.926273694308006}], ["KCNN3", ["TCGA.DM.A285.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.572623133200949}], ["KCNN3", ["TCGA.DM.A28E.01", "Signaling by GPCR"], {"weight": 0.947236216473559}], ["KCNN3", ["TCGA.DM.A28E.01", "GPCR downstream signalling"], {"weight": 0.951229184656942}], ["KCNN3", ["TCGA.DM.A28E.01", "G alpha (i) signalling events"], {"weight": 0.946619285395202}], ["KCNN3", ["TCGA.DM.A28E.01", "Interaction between L1 and Ankyrins"], {"weight": 0.939186718264442}], ["KCNN3", ["TCGA.DM.A28E.01", "Phase 0 - rapid depolarisation"], {"weight": 0.924028479209031}], ["KCNN3", ["TCGA.DM.A28E.01", "Protein-protein interactions at synapses"], {"weight": 0.930056145502196}], ["KCNN3", ["TCGA.DM.A28E.01", "Platelet homeostasis"], {"weight": 0.924203091402165}], ["KCNN3", ["TCGA.DM.A28E.01", "Neurexins and neuroligins"], {"weight": 0.93468346641668}], ["KCNN3", ["TCGA.DM.A28E.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.870884292728415}], ["KCNN3", ["TCGA.DM.A28E.01", "Ion homeostasis"], {"weight": 0.937410393401914}], ["KCNN3", ["TCGA.DM.A28E.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.848096604770915}], ["KCNN3", ["TCGA.DM.A28E.01", "Voltage gated Potassium channels"], {"weight": 0.873339577695965}], ["KCNN3", ["TCGA.DM.A28E.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.857189428690691}], ["KCNN3", ["TCGA.DM.A28E.01", "Platelet calcium homeostasis"], {"weight": 0.895254463378603}], ["KCNN3", ["TCGA.F4.6806.01", "Neuronal System"], {"weight": 0.877135438690522}], ["KCNN3", ["TCGA.G4.6322.01", "Phase 4 - resting membrane potential"], {"weight": 0.792440997807309}], ["SYNE1", ["TCGA.A6.6648.01", "Complement cascade"], {"weight": 0.873452210086089}], ["SYNE1", ["TCGA.A6.6648.01", "Regulation of Complement cascade"], {"weight": 0.806886128603727}], ["SYNE1", ["TCGA.A6.6648.01", "Initial triggering of complement"], {"weight": 0.815891719672801}], ["SYNE1", ["TCGA.A6.6648.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.831305547566081}], ["SYNE1", ["TCGA.AD.6888.01", "Complement cascade"], {"weight": 0.922922002963282}], ["SYNE1", ["TCGA.AD.6888.01", "Regulation of Complement cascade"], {"weight": 0.894475041970422}], ["SYNE1", ["TCGA.CA.6716.01", "Complement cascade"], {"weight": 0.83374655470705}], ["SYNE1", ["TCGA.CA.6716.01", "Initial triggering of complement"], {"weight": 0.829938388648614}], ["SYNE1", ["TCGA.CA.6716.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.690046649014188}], ["SYNE1", ["TCGA.CA.6716.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.690046649014188}], ["SYNE1", ["TCGA.CK.4952.01", "Complement cascade"], {"weight": 0.918682894369103}], ["SYNE1", ["TCGA.CK.4952.01", "Regulation of Complement cascade"], {"weight": 0.908937349064785}], ["SYNE1", ["TCGA.DM.A285.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.931455822878926}], ["SYNE1", ["TCGA.DM.A285.01", "Peptide ligand-binding receptors"], {"weight": 0.92963216494978}], ["SYNE1", ["TCGA.DM.A285.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.734092810648814}], ["SYNE1", ["TCGA.DM.A285.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.734092810648814}], ["SYNE1", ["TCGA.DM.A28F.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.930962344484785}], ["SYNE1", ["TCGA.DM.A28F.01", "Peptide ligand-binding receptors"], {"weight": 0.927982845132643}], ["SYNE1", ["TCGA.DM.A28F.01", "Complement cascade"], {"weight": 0.886351839304398}], ["SYNE1", ["TCGA.DM.A28F.01", "Initial triggering of complement"], {"weight": 0.802087064589148}], ["SYNE1", ["TCGA.DM.A28F.01", "Regulation of Complement cascade"], {"weight": 0.830404009618666}], ["APC", ["TCGA.A6.5656.01", "Molecules associated with elastic fibres"], {"weight": 0.770392026273476}], ["APC", ["TCGA.A6.5656.01", "Regulation of FZD by ubiquitination"], {"weight": 0.899248453996305}], ["APC", ["TCGA.A6.5656.01", "Formation of axial mesoderm"], {"weight": 0.710497505552816}], ["APC", ["TCGA.A6.5662.01", "Formation of axial mesoderm"], {"weight": 0.717010815972436}], ["APC", ["TCGA.A6.5666.01", "Molecules associated with elastic fibres"], {"weight": 0.785825970792133}], ["APC", ["TCGA.A6.6137.01", "Extracellular matrix organization"], {"weight": 0.746390137995872}], ["APC", ["TCGA.A6.6137.01", "Molecules associated with elastic fibres"], {"weight": 0.732518787255476}], ["APC", ["TCGA.A6.6138.01", "Formation of axial mesoderm"], {"weight": 0.750324102555213}], ["APC", ["TCGA.A6.6142.01", "Collagen chain trimerization"], {"weight": 0.903708918467886}], ["APC", ["TCGA.A6.6142.01", "Primitive streak formation"], {"weight": 0.808332157340128}], ["APC", ["TCGA.A6.6142.01", "Formation of axial mesoderm"], {"weight": 0.798250237603586}], ["APC", ["TCGA.A6.6650.01", "Insulin processing"], {"weight": 0.776044505552549}], ["APC", ["TCGA.A6.6652.01", "Molecules associated with elastic fibres"], {"weight": 0.803455363572621}], ["APC", ["TCGA.A6.6652.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.861666922409434}], ["APC", ["TCGA.A6.6652.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.799454230681366}], ["APC", ["TCGA.A6.6782.01", "Regulation of FZD by ubiquitination"], {"weight": 0.839485979410366}], ["APC", ["TCGA.AA.3660.01", "Ca2+ pathway"], {"weight": 0.745959068333066}], ["APC", ["TCGA.AA.3660.01", "Formation of axial mesoderm"], {"weight": 0.775411832692794}], ["APC", ["TCGA.AD.6888.01", "Molecules associated with elastic fibres"], {"weight": 0.884190771600654}], ["APC", ["TCGA.AU.3779.01", "Muscle contraction"], {"weight": 0.822575535698757}], ["APC", ["TCGA.AY.5543.01", "Molecules associated with elastic fibres"], {"weight": 0.865892496412087}], ["APC", ["TCGA.AY.5543.01", "Elastic fibre formation"], {"weight": 0.875335771061583}], ["APC", ["TCGA.AY.5543.01", "Insulin processing"], {"weight": 0.805460386727926}], ["APC", ["TCGA.AZ.6599.01", "Signaling Pathways"], {"weight": 0.914732446864492}], ["APC", ["TCGA.AZ.6605.01", "ECM proteoglycans"], {"weight": 0.65288515688093}], ["APC", ["TCGA.CA.6716.01", "Regulation of FZD by ubiquitination"], {"weight": 0.840481575438031}], ["APC", ["TCGA.CK.4950.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.547933281430051}], ["APC", ["TCGA.CK.4952.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.827040352335649}], ["APC", ["TCGA.CK.5912.01", "GABA receptor activation"], {"weight": 0.885207271002499}], ["APC", ["TCGA.CK.5912.01", "Signaling Pathways"], {"weight": 0.880777808813976}], ["APC", ["TCGA.CK.5912.01", "Keratan sulfate biosynthesis"], {"weight": 0.882539304277438}], ["APC", ["TCGA.CK.5912.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.66400045857323}], ["APC", ["TCGA.CK.5914.01", "Molecules associated with elastic fibres"], {"weight": 0.732534799247671}], ["APC", ["TCGA.CK.5915.01", "Molecules associated with elastic fibres"], {"weight": 0.831768905404543}], ["APC", ["TCGA.CK.5915.01", "Elastic fibre formation"], {"weight": 0.847639938000294}], ["APC", ["TCGA.CM.4744.01", "Molecules associated with elastic fibres"], {"weight": 0.836438423000658}], ["APC", ["TCGA.CM.4744.01", "Sialic acid metabolism"], {"weight": 0.651664999352887}], ["APC", ["TCGA.CM.5344.01", "Signaling Pathways"], {"weight": 0.860091729233784}], ["APC", ["TCGA.CM.5344.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.880208287109226}], ["APC", ["TCGA.CM.5344.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.612117245749089}], ["APC", ["TCGA.CM.5860.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.849456399846566}], ["APC", ["TCGA.CM.5860.01", "Formation of axial mesoderm"], {"weight": 0.742972900524186}], ["APC", ["TCGA.CM.5862.01", "O-linked glycosylation of mucins"], {"weight": 0.927700665072389}], ["APC", ["TCGA.CM.5862.01", "Termination of O-glycan biosynthesis"], {"weight": 0.885508465795096}], ["APC", ["TCGA.D5.5537.01", "Regulation of FZD by ubiquitination"], {"weight": 0.807647375598359}], ["APC", ["TCGA.D5.5540.01", "Molecules associated with elastic fibres"], {"weight": 0.863769619822846}], ["APC", ["TCGA.D5.5540.01", "Blood group systems biosynthesis"], {"weight": 0.840400575236192}], ["APC", ["TCGA.D5.6920.01", "Molecules associated with elastic fibres"], {"weight": 0.759265110163427}], ["APC", ["TCGA.D5.6920.01", "Regulation of FZD by ubiquitination"], {"weight": 0.767328914119322}], ["APC", ["TCGA.D5.6920.01", "Elastic fibre formation"], {"weight": 0.758157026885963}], ["APC", ["TCGA.D5.6924.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.775056225545284}], ["APC", ["TCGA.D5.6924.01", "Ca2+ pathway"], {"weight": 0.810000158286826}], ["APC", ["TCGA.DM.A0XF.01", "Blood group systems biosynthesis"], {"weight": 0.808543485261311}], ["APC", ["TCGA.DM.A1D0.01", "Molecules associated with elastic fibres"], {"weight": 0.879977242043513}], ["APC", ["TCGA.DM.A1D0.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.780504132331977}], ["APC", ["TCGA.DM.A1D6.01", "Signaling Pathways"], {"weight": 0.926785143183869}], ["APC", ["TCGA.DM.A1D6.01", "Molecules associated with elastic fibres"], {"weight": 0.82065296675777}], ["APC", ["TCGA.DM.A1D6.01", "Blood group systems biosynthesis"], {"weight": 0.729473288996351}], ["APC", ["TCGA.DM.A1D6.01", "Lewis blood group biosynthesis"], {"weight": 0.642650328772807}], ["APC", ["TCGA.DM.A1DB.01", "Molecules associated with elastic fibres"], {"weight": 0.874203843691247}], ["APC", ["TCGA.DM.A1DB.01", "E2F mediated regulation of DNA replication"], {"weight": 0.850712873739436}], ["APC", ["TCGA.DM.A1DB.01", "O-linked glycosylation of mucins"], {"weight": 0.921795764779189}], ["APC", ["TCGA.DM.A1DB.01", "Termination of O-glycan biosynthesis"], {"weight": 0.889830291246029}], ["APC", ["TCGA.DM.A1HA.01", "Molecules associated with elastic fibres"], {"weight": 0.887091478748987}], ["APC", ["TCGA.DM.A282.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.753960044899584}], ["APC", ["TCGA.DM.A28C.01", "Keratan sulfate biosynthesis"], {"weight": 0.905238806669183}], ["APC", ["TCGA.DM.A28C.01", "Ca2+ pathway"], {"weight": 0.910153060404662}], ["APC", ["TCGA.DM.A28C.01", "Molecules associated with elastic fibres"], {"weight": 0.791914421106555}], ["APC", ["TCGA.DM.A28C.01", "Regulation of FZD by ubiquitination"], {"weight": 0.879451393501903}], ["APC", ["TCGA.DM.A28E.01", "GPCR ligand binding"], {"weight": 0.928806743039071}], ["APC", ["TCGA.DM.A28E.01", "Generation of second messenger molecules"], {"weight": 0.920921646845993}], ["APC", ["TCGA.DM.A28E.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.91103568448378}], ["APC", ["TCGA.DM.A28E.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.9079251378468}], ["APC", ["TCGA.DM.A28E.01", "Signaling Pathways"], {"weight": 0.923668675176491}], ["APC", ["TCGA.DM.A28E.01", "PD-1 signaling"], {"weight": 0.910483218716714}], ["APC", ["TCGA.DM.A28E.01", "Cell surface interactions at the vascular wall"], {"weight": 0.828846965301957}], ["APC", ["TCGA.DM.A28E.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.927677746822071}], ["APC", ["TCGA.DM.A28E.01", "Peptide ligand-binding receptors"], {"weight": 0.923597396735432}], ["APC", ["TCGA.DM.A28E.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.917933875773867}], ["APC", ["TCGA.DM.A28E.01", "Molecules associated with elastic fibres"], {"weight": 0.895096187745797}], ["APC", ["TCGA.DM.A28E.01", "Elastic fibre formation"], {"weight": 0.906385206402192}], ["APC", ["TCGA.DM.A28E.01", "Glycosaminoglycan metabolism"], {"weight": 0.881055684393074}], ["APC", ["TCGA.DM.A28E.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.700367649206858}], ["APC", ["TCGA.DM.A28E.01", "Keratan sulfate biosynthesis"], {"weight": 0.918473187966597}], ["APC", ["TCGA.DM.A28E.01", "Costimulation by the CD28 family"], {"weight": 0.90511558568353}], ["APC", ["TCGA.DM.A28E.01", "Chemokine receptors bind chemokines"], {"weight": 0.928571574587595}], ["APC", ["TCGA.DM.A28E.01", "DAP12 signaling"], {"weight": 0.889328184833295}], ["APC", ["TCGA.DM.A28E.01", "Integrin cell surface interactions"], {"weight": 0.891374399339617}], ["APC", ["TCGA.DM.A28E.01", "DAP12 interactions"], {"weight": 0.899606229753595}], ["APC", ["TCGA.DM.A28E.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.879185578376234}], ["APC", ["TCGA.DM.A28E.01", "Ion channel transport"], {"weight": 0.929291075993756}], ["APC", ["TCGA.DM.A28E.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.918473187966597}], ["APC", ["TCGA.DM.A28E.01", "Blood group systems biosynthesis"], {"weight": 0.809689495656057}], ["APC", ["TCGA.DM.A28E.01", "Sialic acid metabolism"], {"weight": 0.714204914585361}], ["APC", ["TCGA.DM.A28E.01", "Netrin-1 signaling"], {"weight": 0.846155626742845}], ["APC", ["TCGA.DM.A28E.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.868392764505391}], ["APC", ["TCGA.DM.A28E.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.868392764505391}], ["APC", ["TCGA.DM.A28E.01", "TNFs bind their physiological receptors"], {"weight": 0.39275892201014}], ["APC", ["TCGA.DM.A28E.01", "Other semaphorin interactions"], {"weight": 0.647110555817688}], ["APC", ["TCGA.DM.A28E.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.8874442426863}], ["APC", ["TCGA.DM.A28E.01", "Diseases of Immune System"], {"weight": 0.826513201953811}], ["APC", ["TCGA.DM.A28E.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.826513201953811}], ["APC", ["TCGA.DM.A28E.01", "CD22 mediated BCR regulation"], {"weight": 0.724348227254419}], ["APC", ["TCGA.DM.A28E.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.826830983174465}], ["APC", ["TCGA.DM.A28E.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.730925044803089}], ["APC", ["TCGA.DM.A28E.01", "Lewis blood group biosynthesis"], {"weight": 0.79604950251933}], ["APC", ["TCGA.DM.A28E.01", "Diseases associated with glycosaminoglycan metabolism"], {"weight": 0.884071723886545}], ["APC", ["TCGA.DM.A28E.01", "FCGR activation"], {"weight": 0.829097978426054}], ["APC", ["TCGA.DM.A28E.01", "CD28 dependent Vav1 pathway"], {"weight": 0.785779611801386}], ["APC", ["TCGA.DM.A28E.01", "CRMPs in Sema3A signaling"], {"weight": 0.847323495228455}], ["APC", ["TCGA.DM.A28E.01", "Activation of the phototransduction cascade"], {"weight": 0.822422120413172}], ["APC", ["TCGA.DM.A28F.01", "Molecules associated with elastic fibres"], {"weight": 0.787359080285274}], ["APC", ["TCGA.DM.A28F.01", "Elastic fibre formation"], {"weight": 0.8103485897746}], ["APC", ["TCGA.DM.A28G.01", "Regulation of FZD by ubiquitination"], {"weight": 0.814184939154821}], ["APC", ["TCGA.DM.A28H.01", "Signaling by GPCR"], {"weight": 0.951078705658885}], ["APC", ["TCGA.DM.A28M.01", "Molecules associated with elastic fibres"], {"weight": 0.891228708392693}], ["APC", ["TCGA.F4.6460.01", "Formation of axial mesoderm"], {"weight": 0.726123608020881}], ["APC", ["TCGA.F4.6569.01", "Elastic fibre formation"], {"weight": 0.740135864802699}], ["APC", ["TCGA.F4.6808.01", "Transport of small molecules"], {"weight": 0.888688849653347}], ["APC", ["TCGA.F4.6808.01", "Regulation of FZD by ubiquitination"], {"weight": 0.845182497615681}], ["APC", ["TCGA.F4.6809.01", "Primitive streak formation"], {"weight": 0.692312631478246}], ["APC", ["TCGA.G4.6294.01", "Molecules associated with elastic fibres"], {"weight": 0.793675215933525}], ["APC", ["TCGA.G4.6294.01", "Elastic fibre formation"], {"weight": 0.793187967012995}], ["APC", ["TCGA.G4.6306.01", "Molecules associated with elastic fibres"], {"weight": 0.880529559835976}], ["APC", ["TCGA.G4.6307.01", "Molecules associated with elastic fibres"], {"weight": 0.805583952199006}], ["APC", ["TCGA.G4.6307.01", "Elastic fibre formation"], {"weight": 0.816176325947875}], ["APC", ["TCGA.G4.6315.01", "Molecules associated with elastic fibres"], {"weight": 0.762285815157646}], ["APC", ["TCGA.G4.6315.01", "Elastic fibre formation"], {"weight": 0.785083592091877}], ["APC", ["TCGA.G4.6322.01", "Adherens junctions interactions"], {"weight": 0.803803326436998}], ["APC", ["TCGA.G4.6323.01", "Molecules associated with elastic fibres"], {"weight": 0.746680013889004}], ["APC", ["TCGA.G4.6323.01", "Elastic fibre formation"], {"weight": 0.746046921197392}], ["APC", ["TCGA.G4.6323.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.740315948900026}], ["APC", ["TCGA.G4.6625.01", "Formation of axial mesoderm"], {"weight": 0.602535370872532}], ["APC", ["TCGA.G4.6626.01", "Opioid Signalling"], {"weight": 0.936266573268792}], ["SCN3A", ["TCGA.A6.5661.01", "Interaction between L1 and Ankyrins"], {"weight": 0.943139905194984}], ["SCN3A", ["TCGA.A6.5661.01", "Phase 0 - rapid depolarisation"], {"weight": 0.894283299230798}], ["SCN3A", ["TCGA.CM.6678.01", "Stimuli-sensing channels"], {"weight": 0.822319946877255}], ["SCN3A", ["TCGA.D5.6931.01", "Interaction between L1 and Ankyrins"], {"weight": 0.897744504362343}], ["MMP9", ["TCGA.AD.6899.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.936983005356996}], ["MMP9", ["TCGA.AD.6899.01", "Collagen formation"], {"weight": 0.882339109255365}], ["MMP9", ["TCGA.AD.6899.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.8486462559985}], ["MMP9", ["TCGA.AD.6899.01", "Degradation of the extracellular matrix"], {"weight": 0.856947238321791}], ["MMP9", ["TCGA.AD.6964.01", "Degradation of the extracellular matrix"], {"weight": 0.825597119080459}], ["MMP9", ["TCGA.AM.5820.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.807829310079462}], ["MMP9", ["TCGA.AZ.4615.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.827502782140284}], ["GRIK2", ["TCGA.AZ.6605.01", "Degradation of the extracellular matrix"], {"weight": 0.897902387261324}], ["GRIK2", ["TCGA.CM.4752.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.898540744228708}], ["GRIK2", ["TCGA.CM.4752.01", "Presynaptic function of Kainate receptors"], {"weight": 0.885169732503838}], ["GRIK2", ["TCGA.CM.4752.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.882562566326569}], ["GRIK2", ["TCGA.D5.6926.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.904852259671324}], ["GRIK2", ["TCGA.D5.6926.01", "Presynaptic function of Kainate receptors"], {"weight": 0.872709169968413}], ["GRIK2", ["TCGA.G4.6586.01", "Presynaptic function of Kainate receptors"], {"weight": 0.931674562914085}], ["COL12A1", ["TCGA.A6.2671.01", "Collagen formation"], {"weight": 0.914254695073006}], ["COL12A1", ["TCGA.F4.6807.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.91141643412789}], ["COL12A1", ["TCGA.F4.6807.01", "Collagen degradation"], {"weight": 0.889843441527787}], ["COL12A1", ["TCGA.F4.6807.01", "Collagen chain trimerization"], {"weight": 0.86781257764357}], ["COL12A1", ["TCGA.F4.6807.01", "Degradation of the extracellular matrix"], {"weight": 0.837574621138613}], ["TP53", ["TCGA.A6.2671.01", "Neuronal System"], {"weight": 0.909006621848659}], ["TP53", ["TCGA.A6.2675.01", "Degradation of the extracellular matrix"], {"weight": 0.896553271903832}], ["TP53", ["TCGA.A6.4105.01", "Metabolism"], {"weight": 0.895365612048554}], ["TP53", ["TCGA.A6.5656.01", "Neuronal System"], {"weight": 0.939991887887887}], ["TP53", ["TCGA.A6.5656.01", "Transmission across Chemical Synapses"], {"weight": 0.944390403212012}], ["TP53", ["TCGA.A6.5660.01", "Neuronal System"], {"weight": 0.920251086266832}], ["TP53", ["TCGA.A6.5660.01", "Transmission across Chemical Synapses"], {"weight": 0.917395447140654}], ["TP53", ["TCGA.A6.5660.01", "Drug ADME"], {"weight": 0.862724341580167}], ["TP53", ["TCGA.A6.5660.01", "Regulation of FZD by ubiquitination"], {"weight": 0.809517770927864}], ["TP53", ["TCGA.A6.5662.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.848213587126556}], ["TP53", ["TCGA.A6.5662.01", "Inflammasomes"], {"weight": 0.801838170164102}], ["TP53", ["TCGA.A6.5662.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.784328467847748}], ["TP53", ["TCGA.A6.5662.01", "TP53 Regulates Transcription of Caspase Activators and Caspases"], {"weight": 0.723045477678847}], ["TP53", ["TCGA.A6.5662.01", "Estrogen-dependent nuclear events downstream of ESR-membrane signaling"], {"weight": 0.887180432669942}], ["TP53", ["TCGA.A6.5662.01", "Extra-nuclear estrogen signaling"], {"weight": 0.923102841739396}], ["TP53", ["TCGA.A6.5667.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.639372291027928}], ["TP53", ["TCGA.A6.6137.01", "Neuronal System"], {"weight": 0.834803943121107}], ["TP53", ["TCGA.A6.6137.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.853102064043427}], ["TP53", ["TCGA.A6.6137.01", "Transmission across Chemical Synapses"], {"weight": 0.812654720229802}], ["TP53", ["TCGA.A6.6137.01", "Interleukin-6 family signaling"], {"weight": 0.853102064043427}], ["TP53", ["TCGA.A6.6137.01", "Phase II - Conjugation of compounds"], {"weight": 0.676648196700025}], ["TP53", ["TCGA.A6.6137.01", "Glutathione conjugation"], {"weight": 0.686751895385883}], ["TP53", ["TCGA.A6.6138.01", "Neuronal System"], {"weight": 0.919401469018878}], ["TP53", ["TCGA.A6.6138.01", "Phase 0 - rapid depolarisation"], {"weight": 0.824146133344342}], ["TP53", ["TCGA.A6.6138.01", "Cardiac conduction"], {"weight": 0.880843763274823}], ["TP53", ["TCGA.A6.6138.01", "Transmission across Chemical Synapses"], {"weight": 0.904167854396261}], ["TP53", ["TCGA.A6.6138.01", "Metabolism"], {"weight": 0.901045399701274}], ["TP53", ["TCGA.A6.6138.01", "APAP ADME"], {"weight": 0.72029583882939}], ["TP53", ["TCGA.A6.6142.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.63978463198613}], ["TP53", ["TCGA.A6.6142.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.926089082791752}], ["TP53", ["TCGA.A6.6142.01", "Cardiac conduction"], {"weight": 0.897746475370227}], ["TP53", ["TCGA.A6.6142.01", "Signaling Pathways"], {"weight": 0.874167062948228}], ["TP53", ["TCGA.A6.6142.01", "Phase 0 - rapid depolarisation"], {"weight": 0.868195546484685}], ["TP53", ["TCGA.A6.6142.01", "Interleukin-10 signaling"], {"weight": 0.659044947596374}], ["TP53", ["TCGA.A6.6142.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.886677460524805}], ["TP53", ["TCGA.A6.6142.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.746734585744767}], ["TP53", ["TCGA.A6.6142.01", "Interleukin-6 family signaling"], {"weight": 0.89557830113644}], ["TP53", ["TCGA.A6.6142.01", "Muscle contraction"], {"weight": 0.900483152397646}], ["TP53", ["TCGA.A6.6142.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.849950636960085}], ["TP53", ["TCGA.A6.6142.01", "Heme degradation"], {"weight": 0.594458538602647}], ["TP53", ["TCGA.A6.6142.01", "Collagen degradation"], {"weight": 0.933738860606448}], ["TP53", ["TCGA.A6.6649.01", "Interleukin-6 family signaling"], {"weight": 0.71205092367199}], ["TP53", ["TCGA.A6.6650.01", "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"], {"weight": 0.829773233783265}], ["TP53", ["TCGA.A6.6650.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.668770757199351}], ["TP53", ["TCGA.A6.6650.01", "TP53 Regulates Transcription of Cell Cycle Genes"], {"weight": 0.878943091009457}], ["TP53", ["TCGA.A6.6650.01", "Polo-like kinase mediated events"], {"weight": 0.821111154638313}], ["TP53", ["TCGA.A6.6651.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.845465936344372}], ["TP53", ["TCGA.A6.6651.01", "Post-translational protein phosphorylation"], {"weight": 0.781883800939669}], ["TP53", ["TCGA.A6.6651.01", "APAP ADME"], {"weight": 0.62366680502953}], ["TP53", ["TCGA.A6.6652.01", "Signaling Pathways"], {"weight": 0.912044148735465}], ["TP53", ["TCGA.A6.6652.01", "Cardiac conduction"], {"weight": 0.927605204597047}], ["TP53", ["TCGA.A6.6652.01", "Interaction between L1 and Ankyrins"], {"weight": 0.935810625307261}], ["TP53", ["TCGA.A6.6652.01", "Immune System"], {"weight": 0.870508673700607}], ["TP53", ["TCGA.A6.6652.01", "Metabolism of vitamins and cofactors"], {"weight": 0.782983756068871}], ["TP53", ["TCGA.A6.6652.01", "Muscle contraction"], {"weight": 0.933251384152557}], ["TP53", ["TCGA.A6.6652.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.826828803066456}], ["TP53", ["TCGA.A6.6652.01", "Regulation of FZD by ubiquitination"], {"weight": 0.860986902205559}], ["TP53", ["TCGA.A6.6654.01", "Stimuli-sensing channels"], {"weight": 0.847614746948297}], ["TP53", ["TCGA.A6.6654.01", "Signaling by PDGF"], {"weight": 0.910120349465939}], ["TP53", ["TCGA.A6.6782.01", "Metabolism"], {"weight": 0.818011066002246}], ["TP53", ["TCGA.AA.3511.01", "Biological oxidations"], {"weight": 0.801252884015786}], ["TP53", ["TCGA.AA.3655.01", "Neuronal System"], {"weight": 0.917490893975455}], ["TP53", ["TCGA.AA.3655.01", "Transmission across Chemical Synapses"], {"weight": 0.915228161743839}], ["TP53", ["TCGA.AA.3655.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.814194984666105}], ["TP53", ["TCGA.AA.3655.01", "Muscle contraction"], {"weight": 0.862762728032382}], ["TP53", ["TCGA.AA.3660.01", "Neuronal System"], {"weight": 0.893961157900561}], ["TP53", ["TCGA.AA.3660.01", "Transmission across Chemical Synapses"], {"weight": 0.880827443145647}], ["TP53", ["TCGA.AA.3660.01", "Regulation of FZD by ubiquitination"], {"weight": 0.743508584614605}], ["TP53", ["TCGA.AA.3660.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.791146184314778}], ["TP53", ["TCGA.AA.3697.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.773329673614759}], ["TP53", ["TCGA.AA.3712.01", "Interaction between L1 and Ankyrins"], {"weight": 0.928274876855359}], ["TP53", ["TCGA.AA.3712.01", "Cardiac conduction"], {"weight": 0.895700376320179}], ["TP53", ["TCGA.AA.3712.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.837391821325981}], ["TP53", ["TCGA.AA.3712.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.782201266904776}], ["TP53", ["TCGA.AA.3712.01", "TP53 Regulates Transcription of Cell Cycle Genes"], {"weight": 0.865548445404085}], ["TP53", ["TCGA.AA.3712.01", "Muscle contraction"], {"weight": 0.90198830421623}], ["TP53", ["TCGA.AD.6888.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.80670056236884}], ["TP53", ["TCGA.AD.6888.01", "Cardiac conduction"], {"weight": 0.949426696529248}], ["TP53", ["TCGA.AD.6888.01", "Muscle contraction"], {"weight": 0.949084271196075}], ["TP53", ["TCGA.AD.6888.01", "Interaction between L1 and Ankyrins"], {"weight": 0.940249525970287}], ["TP53", ["TCGA.AD.6888.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.868990351282434}], ["TP53", ["TCGA.AD.6888.01", "Phase 0 - rapid depolarisation"], {"weight": 0.914871709405181}], ["TP53", ["TCGA.AD.6888.01", "Diseases of metabolism"], {"weight": 0.845638073151347}], ["TP53", ["TCGA.AD.6888.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.830086959538554}], ["TP53", ["TCGA.AD.6901.01", "Drug ADME"], {"weight": 0.907995385700247}], ["TP53", ["TCGA.AD.6963.01", "Neuronal System"], {"weight": 0.925725672878157}], ["TP53", ["TCGA.AD.6963.01", "Transmission across Chemical Synapses"], {"weight": 0.919714534771564}], ["TP53", ["TCGA.AD.6963.01", "Drug ADME"], {"weight": 0.875618250075639}], ["TP53", ["TCGA.AD.6963.01", "Cardiac conduction"], {"weight": 0.941497946656734}], ["TP53", ["TCGA.AD.6963.01", "Muscle contraction"], {"weight": 0.929364260778856}], ["TP53", ["TCGA.AD.6963.01", "Transport of small molecules"], {"weight": 0.878176028112896}], ["TP53", ["TCGA.AD.6963.01", "Ethanol oxidation"], {"weight": 0.78557382085872}], ["TP53", ["TCGA.AM.5820.01", "Adaptive Immune System"], {"weight": 0.8822492359659}], ["TP53", ["TCGA.AY.5543.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.79737998444877}], ["TP53", ["TCGA.AY.5543.01", "Endogenous sterols"], {"weight": 0.460243331487183}], ["TP53", ["TCGA.AY.6196.01", "Drug ADME"], {"weight": 0.893639545274022}], ["TP53", ["TCGA.AY.6196.01", "Diseases of metabolism"], {"weight": 0.792292856129362}], ["TP53", ["TCGA.AY.6197.01", "Integration of energy metabolism"], {"weight": 0.910556286652275}], ["TP53", ["TCGA.AZ.4323.01", "Drug ADME"], {"weight": 0.801487530298976}], ["TP53", ["TCGA.AZ.4323.01", "Keratinization"], {"weight": 0.736578588307612}], ["TP53", ["TCGA.AZ.4323.01", "Phase II - Conjugation of compounds"], {"weight": 0.855955323484674}], ["TP53", ["TCGA.AZ.4323.01", "APAP ADME"], {"weight": 0.743317889721398}], ["TP53", ["TCGA.AZ.4323.01", "Glucuronidation"], {"weight": 0.72527412433816}], ["TP53", ["TCGA.AZ.4323.01", "Metabolism"], {"weight": 0.886083351089411}], ["TP53", ["TCGA.AZ.4323.01", "Vitamin D (calciferol) metabolism"], {"weight": 0.62170374254639}], ["TP53", ["TCGA.AZ.4323.01", "Presynaptic nicotinic acetylcholine receptors"], {"weight": 0.776613808623221}], ["TP53", ["TCGA.AZ.4616.01", "Neuronal System"], {"weight": 0.922590964397962}], ["TP53", ["TCGA.AZ.4616.01", "Transmission across Chemical Synapses"], {"weight": 0.913867452218344}], ["TP53", ["TCGA.AZ.4616.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.862136361219613}], ["TP53", ["TCGA.AZ.5403.01", "Complement cascade"], {"weight": 0.628432748328046}], ["TP53", ["TCGA.AZ.5407.01", "Neuronal System"], {"weight": 0.930283957575265}], ["TP53", ["TCGA.AZ.5407.01", "Transmission across Chemical Synapses"], {"weight": 0.910705110542958}], ["TP53", ["TCGA.AZ.5407.01", "Cardiac conduction"], {"weight": 0.93450707121869}], ["TP53", ["TCGA.AZ.6607.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.956930779542216}], ["TP53", ["TCGA.AZ.6607.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.708966626768926}], ["TP53", ["TCGA.AZ.6607.01", "Collagen degradation"], {"weight": 0.902304730081173}], ["TP53", ["TCGA.AZ.6607.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.887826350567955}], ["TP53", ["TCGA.AZ.6607.01", "Keratinization"], {"weight": 0.869110888237552}], ["TP53", ["TCGA.AZ.6607.01", "Signaling Pathways"], {"weight": 0.881000054719543}], ["TP53", ["TCGA.AZ.6607.01", "Formation of the cornified envelope"], {"weight": 0.827778669604159}], ["TP53", ["TCGA.AZ.6607.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.854266436624393}], ["TP53", ["TCGA.CA.5797.01", "Extra-nuclear estrogen signaling"], {"weight": 0.89213028823368}], ["TP53", ["TCGA.CK.4948.01", "Neuronal System"], {"weight": 0.917094570854792}], ["TP53", ["TCGA.CK.4948.01", "Transmission across Chemical Synapses"], {"weight": 0.909931729724484}], ["TP53", ["TCGA.CK.4948.01", "Cardiac conduction"], {"weight": 0.913148118663493}], ["TP53", ["TCGA.CK.4948.01", "Muscle contraction"], {"weight": 0.916185442313505}], ["TP53", ["TCGA.CK.4948.01", "Keratinization"], {"weight": 0.745684398294375}], ["TP53", ["TCGA.CK.5914.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946800533780616}], ["TP53", ["TCGA.CK.5914.01", "Phase 0 - rapid depolarisation"], {"weight": 0.928992053003174}], ["TP53", ["TCGA.CK.5914.01", "Cardiac conduction"], {"weight": 0.942110322343051}], ["TP53", ["TCGA.CK.5914.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.851069476352641}], ["TP53", ["TCGA.CK.5914.01", "Phase II - Conjugation of compounds"], {"weight": 0.795377791159151}], ["TP53", ["TCGA.CK.5914.01", "Muscle contraction"], {"weight": 0.931307022363205}], ["TP53", ["TCGA.CK.5916.01", "Transmission across Chemical Synapses"], {"weight": 0.901822333349192}], ["TP53", ["TCGA.CM.4750.01", "Transmission across Chemical Synapses"], {"weight": 0.904928677705772}], ["TP53", ["TCGA.CM.4750.01", "Neuronal System"], {"weight": 0.924045688066599}], ["TP53", ["TCGA.CM.4750.01", "Interaction between L1 and Ankyrins"], {"weight": 0.926924990691209}], ["TP53", ["TCGA.CM.4752.01", "Transmission across Chemical Synapses"], {"weight": 0.909933794529371}], ["TP53", ["TCGA.CM.4752.01", "Neuronal System"], {"weight": 0.91183668864787}], ["TP53", ["TCGA.CM.4752.01", "Interaction between L1 and Ankyrins"], {"weight": 0.877425477824319}], ["TP53", ["TCGA.CM.4752.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.673951813306721}], ["TP53", ["TCGA.CM.4752.01", "Heme degradation"], {"weight": 0.0459782707292534}], ["TP53", ["TCGA.CM.5348.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.794427435831853}], ["TP53", ["TCGA.CM.5348.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.837018909209049}], ["TP53", ["TCGA.CM.5348.01", "Integrin cell surface interactions"], {"weight": 0.828153768219446}], ["TP53", ["TCGA.CM.5860.01", "Neuronal System"], {"weight": 0.946235832520424}], ["TP53", ["TCGA.CM.5860.01", "Transmission across Chemical Synapses"], {"weight": 0.929653932153919}], ["TP53", ["TCGA.CM.5860.01", "APAP ADME"], {"weight": 0.756495918313377}], ["TP53", ["TCGA.CM.5860.01", "Cardiac conduction"], {"weight": 0.910314144009569}], ["TP53", ["TCGA.CM.5860.01", "Interaction between L1 and Ankyrins"], {"weight": 0.881661944961753}], ["TP53", ["TCGA.CM.5862.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.801271712825128}], ["TP53", ["TCGA.CM.5862.01", "Interaction between L1 and Ankyrins"], {"weight": 0.916418500132749}], ["TP53", ["TCGA.CM.5862.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.855073650679276}], ["TP53", ["TCGA.CM.5862.01", "Immune System"], {"weight": 0.879606054648636}], ["TP53", ["TCGA.CM.5862.01", "Neuronal System"], {"weight": 0.934430911497962}], ["TP53", ["TCGA.CM.5862.01", "Cardiac conduction"], {"weight": 0.940263965446298}], ["TP53", ["TCGA.CM.5862.01", "Degradation of the extracellular matrix"], {"weight": 0.872120120379551}], ["TP53", ["TCGA.CM.5862.01", "Signaling Pathways"], {"weight": 0.900759279181002}], ["TP53", ["TCGA.CM.5864.01", "Neuronal System"], {"weight": 0.92591645183182}], ["TP53", ["TCGA.CM.5864.01", "Transmission across Chemical Synapses"], {"weight": 0.928562030132337}], ["TP53", ["TCGA.CM.5868.01", "Neuronal System"], {"weight": 0.922984137941859}], ["TP53", ["TCGA.CM.5868.01", "Transmission across Chemical Synapses"], {"weight": 0.923227118912509}], ["TP53", ["TCGA.CM.5868.01", "Cell surface interactions at the vascular wall"], {"weight": 0.533927725127314}], ["TP53", ["TCGA.CM.6163.01", "Neuronal System"], {"weight": 0.799486012749863}], ["TP53", ["TCGA.CM.6163.01", "Signaling Pathways"], {"weight": 0.764437322931581}], ["TP53", ["TCGA.CM.6164.01", "Biological oxidations"], {"weight": 0.908025884443706}], ["TP53", ["TCGA.CM.6164.01", "Drug ADME"], {"weight": 0.883840389527036}], ["TP53", ["TCGA.CM.6164.01", "Metabolism"], {"weight": 0.872938952976089}], ["TP53", ["TCGA.CM.6164.01", "Glutathione conjugation"], {"weight": 0.764022756964489}], ["TP53", ["TCGA.CM.6164.01", "Heme degradation"], {"weight": 0.617071576763989}], ["TP53", ["TCGA.CM.6164.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.765904474024146}], ["TP53", ["TCGA.CM.6164.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.774172422675924}], ["TP53", ["TCGA.CM.6164.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.386601593022502}], ["TP53", ["TCGA.CM.6164.01", "Phase I - Functionalization of compounds"], {"weight": 0.884616284220567}], ["TP53", ["TCGA.CM.6165.01", "TP53 Regulates Transcription of Death Receptors and Ligands"], {"weight": 0.762243421096852}], ["TP53", ["TCGA.CM.6169.01", "Metabolism"], {"weight": 0.873723194043384}], ["TP53", ["TCGA.CM.6172.01", "Signaling Pathways"], {"weight": 0.788541357875772}], ["TP53", ["TCGA.CM.6676.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.795001068652237}], ["TP53", ["TCGA.CM.6676.01", "Immune System"], {"weight": 0.837876055922607}], ["TP53", ["TCGA.CM.6676.01", "Complement cascade"], {"weight": 0.75639076365208}], ["TP53", ["TCGA.CM.6676.01", "Ligand-dependent caspase activation"], {"weight": 0.725208481440823}], ["TP53", ["TCGA.CM.6676.01", "Cardiac conduction"], {"weight": 0.908791552286679}], ["TP53", ["TCGA.CM.6676.01", "Innate Immune System"], {"weight": 0.830886458253373}], ["TP53", ["TCGA.CM.6676.01", "Regulation of beta-cell development"], {"weight": 0.778857586915413}], ["TP53", ["TCGA.CM.6676.01", "Caspase activation via extrinsic apoptotic signalling pathway"], {"weight": 0.671480081648832}], ["TP53", ["TCGA.CM.6677.01", "Neuronal System"], {"weight": 0.919415344662416}], ["TP53", ["TCGA.CM.6677.01", "Cardiac conduction"], {"weight": 0.866310838208754}], ["TP53", ["TCGA.CM.6677.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.899830045876392}], ["TP53", ["TCGA.CM.6677.01", "Transmission across Chemical Synapses"], {"weight": 0.89968020472523}], ["TP53", ["TCGA.CM.6677.01", "Glucuronidation"], {"weight": 0.880171371639282}], ["TP53", ["TCGA.CM.6677.01", "TP53 Regulates Transcription of Cell Cycle Genes"], {"weight": 0.848325396877384}], ["TP53", ["TCGA.CM.6679.01", "Neuronal System"], {"weight": 0.896034906144537}], ["TP53", ["TCGA.CM.6679.01", "Transmission across Chemical Synapses"], {"weight": 0.880721385489114}], ["TP53", ["TCGA.CM.6679.01", "Ethanol oxidation"], {"weight": 0.667253607206549}], ["TP53", ["TCGA.D5.5538.01", "Degradation of the extracellular matrix"], {"weight": 0.716633326097731}], ["TP53", ["TCGA.D5.5540.01", "Cellular response to starvation"], {"weight": 0.926242215376941}], ["TP53", ["TCGA.D5.5540.01", "Developmental Biology"], {"weight": 0.925463773758393}], ["TP53", ["TCGA.D5.5540.01", "Nervous system development"], {"weight": 0.928477746718678}], ["TP53", ["TCGA.D5.5540.01", "Extracellular matrix organization"], {"weight": 0.931306238318114}], ["TP53", ["TCGA.D5.5540.01", "TP53 Regulates Transcription of Cell Cycle Genes"], {"weight": 0.91977975168964}], ["TP53", ["TCGA.D5.5540.01", "Amino acid and derivative metabolism"], {"weight": 0.903311396270473}], ["TP53", ["TCGA.D5.5540.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.896890028340178}], ["TP53", ["TCGA.D5.5540.01", "Cardiac conduction"], {"weight": 0.946616514712134}], ["TP53", ["TCGA.D5.5540.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.869521771135006}], ["TP53", ["TCGA.D5.5540.01", "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"], {"weight": 0.891674010240118}], ["TP53", ["TCGA.D5.5540.01", "Degradation of the extracellular matrix"], {"weight": 0.931050745962362}], ["TP53", ["TCGA.D5.5540.01", "DNA strand elongation"], {"weight": 0.914484253933438}], ["TP53", ["TCGA.D5.5540.01", "L1CAM interactions"], {"weight": 0.921241242621708}], ["TP53", ["TCGA.D5.5541.01", "Degradation of the extracellular matrix"], {"weight": 0.842452415880366}], ["TP53", ["TCGA.D5.6531.01", "Neuronal System"], {"weight": 0.91511250087808}], ["TP53", ["TCGA.D5.6531.01", "Transmission across Chemical Synapses"], {"weight": 0.908432405317717}], ["TP53", ["TCGA.D5.6531.01", "Drug ADME"], {"weight": 0.814712508433228}], ["TP53", ["TCGA.D5.6531.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.880408514598829}], ["TP53", ["TCGA.D5.6531.01", "Signaling Pathways"], {"weight": 0.890532760156416}], ["TP53", ["TCGA.D5.6532.01", "Neuronal System"], {"weight": 0.940100287475967}], ["TP53", ["TCGA.D5.6532.01", "Transmission across Chemical Synapses"], {"weight": 0.935614139214308}], ["TP53", ["TCGA.D5.6532.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.734018017405054}], ["TP53", ["TCGA.D5.6533.01", "Neuronal System"], {"weight": 0.934726494496684}], ["TP53", ["TCGA.D5.6533.01", "Transmission across Chemical Synapses"], {"weight": 0.916032869656974}], ["TP53", ["TCGA.D5.6533.01", "Metabolism"], {"weight": 0.916699596088552}], ["TP53", ["TCGA.D5.6534.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.64262946151804}], ["TP53", ["TCGA.D5.6534.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.76921296110501}], ["TP53", ["TCGA.D5.6534.01", "Aflatoxin activation and detoxification"], {"weight": 0.637355259551359}], ["TP53", ["TCGA.D5.6535.01", "Integration of energy metabolism"], {"weight": 0.887466580572912}], ["TP53", ["TCGA.D5.6538.01", "Immune System"], {"weight": 0.904023870854798}], ["TP53", ["TCGA.D5.6538.01", "Innate Immune System"], {"weight": 0.897913609566945}], ["TP53", ["TCGA.D5.6538.01", "Transmission across Chemical Synapses"], {"weight": 0.917647794161016}], ["TP53", ["TCGA.D5.6538.01", "MHC class II antigen presentation"], {"weight": 0.92964791479759}], ["TP53", ["TCGA.D5.6538.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.83652049910058}], ["TP53", ["TCGA.D5.6538.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.677684413266102}], ["TP53", ["TCGA.D5.6898.01", "Neuronal System"], {"weight": 0.780098994624386}], ["TP53", ["TCGA.D5.6924.01", "Transmission across Chemical Synapses"], {"weight": 0.909711357346451}], ["TP53", ["TCGA.D5.6924.01", "Neuronal System"], {"weight": 0.909053531927087}], ["TP53", ["TCGA.D5.6924.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.768492712930263}], ["TP53", ["TCGA.D5.6924.01", "Metal ion SLC transporters"], {"weight": 0.415991204035274}], ["TP53", ["TCGA.D5.6926.01", "Neuronal System"], {"weight": 0.908580958171688}], ["TP53", ["TCGA.D5.6926.01", "Transmission across Chemical Synapses"], {"weight": 0.902531822302453}], ["TP53", ["TCGA.D5.6926.01", "Signaling Pathways"], {"weight": 0.881023040694625}], ["TP53", ["TCGA.D5.6929.01", "Neuronal System"], {"weight": 0.926051649303388}], ["TP53", ["TCGA.D5.6929.01", "Signaling Pathways"], {"weight": 0.884634296090339}], ["TP53", ["TCGA.D5.6929.01", "Transmission across Chemical Synapses"], {"weight": 0.921015985088527}], ["TP53", ["TCGA.D5.6929.01", "Physiological factors"], {"weight": 0.798835774782022}], ["TP53", ["TCGA.D5.6929.01", "Keratinization"], {"weight": 0.788703642290251}], ["TP53", ["TCGA.D5.6929.01", "YAP1- and WWTR1 (TAZ)-stimulated gene expression"], {"weight": 0.751013355395327}], ["TP53", ["TCGA.D5.6929.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.472061872254537}], ["TP53", ["TCGA.D5.6932.01", "Neuronal System"], {"weight": 0.935561112463018}], ["TP53", ["TCGA.D5.6932.01", "Drug ADME"], {"weight": 0.873765346948168}], ["TP53", ["TCGA.D5.6932.01", "Transmission across Chemical Synapses"], {"weight": 0.919930182441548}], ["TP53", ["TCGA.D5.6932.01", "Cardiac conduction"], {"weight": 0.875818101210228}], ["TP53", ["TCGA.DM.A0XD.01", "Neuronal System"], {"weight": 0.939354055201099}], ["TP53", ["TCGA.DM.A0XD.01", "Transmission across Chemical Synapses"], {"weight": 0.929992442126271}], ["TP53", ["TCGA.DM.A0XF.01", "Cardiac conduction"], {"weight": 0.925898862053053}], ["TP53", ["TCGA.DM.A0XF.01", "Muscle contraction"], {"weight": 0.925607152696617}], ["TP53", ["TCGA.DM.A0XF.01", "Azathioprine ADME"], {"weight": 0.707895087147062}], ["TP53", ["TCGA.DM.A1D0.01", "Immune System"], {"weight": 0.914511326727671}], ["TP53", ["TCGA.DM.A1D0.01", "Cardiac conduction"], {"weight": 0.948252205568774}], ["TP53", ["TCGA.DM.A1D0.01", "Muscle contraction"], {"weight": 0.955824881180646}], ["TP53", ["TCGA.DM.A1D0.01", "Adaptive Immune System"], {"weight": 0.933931812026663}], ["TP53", ["TCGA.DM.A1D0.01", "Interaction between L1 and Ankyrins"], {"weight": 0.942153407609475}], ["TP53", ["TCGA.DM.A1D0.01", "Developmental Biology"], {"weight": 0.898357655886824}], ["TP53", ["TCGA.DM.A1D0.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.787592471870753}], ["TP53", ["TCGA.DM.A1D0.01", "TCR signaling"], {"weight": 0.957739703474686}], ["TP53", ["TCGA.DM.A1D4.01", "Cardiac conduction"], {"weight": 0.959652459357493}], ["TP53", ["TCGA.DM.A1D4.01", "Muscle contraction"], {"weight": 0.952431705852992}], ["TP53", ["TCGA.DM.A1D4.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.813917718324043}], ["TP53", ["TCGA.DM.A1D4.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.873766070270516}], ["TP53", ["TCGA.DM.A1D6.01", "Immune System"], {"weight": 0.908502622245515}], ["TP53", ["TCGA.DM.A1D6.01", "Leishmania infection"], {"weight": 0.926808277668428}], ["TP53", ["TCGA.DM.A1D6.01", "Parasitic Infection Pathways"], {"weight": 0.926808277668428}], ["TP53", ["TCGA.DM.A1D7.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.608567132861518}], ["TP53", ["TCGA.DM.A1D7.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.905943677776289}], ["TP53", ["TCGA.DM.A1D7.01", "Interleukin-6 family signaling"], {"weight": 0.910658473423258}], ["TP53", ["TCGA.DM.A1D8.01", "Neuronal System"], {"weight": 0.942134960228897}], ["TP53", ["TCGA.DM.A1D8.01", "Transmission across Chemical Synapses"], {"weight": 0.931467201085025}], ["TP53", ["TCGA.DM.A1D8.01", "Regulation of FZD by ubiquitination"], {"weight": 0.843934171529368}], ["TP53", ["TCGA.DM.A1D9.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.731010388344075}], ["TP53", ["TCGA.DM.A1DA.01", "Cardiac conduction"], {"weight": 0.950866066607609}], ["TP53", ["TCGA.DM.A1DA.01", "Muscle contraction"], {"weight": 0.945413390197445}], ["TP53", ["TCGA.DM.A1DB.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.876065524683365}], ["TP53", ["TCGA.DM.A1HA.01", "Muscle contraction"], {"weight": 0.957529558297675}], ["TP53", ["TCGA.DM.A1HA.01", "Cardiac conduction"], {"weight": 0.952782246428959}], ["TP53", ["TCGA.DM.A1HA.01", "Neurotransmitter release cycle"], {"weight": 0.892898349398091}], ["TP53", ["TCGA.DM.A1HA.01", "L1CAM interactions"], {"weight": 0.943347318672399}], ["TP53", ["TCGA.DM.A285.01", "Neuronal System"], {"weight": 0.910852755998485}], ["TP53", ["TCGA.DM.A28F.01", "Cardiac conduction"], {"weight": 0.942102673028963}], ["TP53", ["TCGA.DM.A28F.01", "Interaction between L1 and Ankyrins"], {"weight": 0.931671942121578}], ["TP53", ["TCGA.DM.A28F.01", "Muscle contraction"], {"weight": 0.934368307877746}], ["TP53", ["TCGA.DM.A28F.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.885188249000424}], ["TP53", ["TCGA.DM.A28F.01", "Endogenous sterols"], {"weight": 0.560377864301179}], ["TP53", ["TCGA.DM.A28H.01", "Cardiac conduction"], {"weight": 0.954175464017509}], ["TP53", ["TCGA.DM.A28H.01", "Deposition of new CENPA-containing nucleosomes at the centromere"], {"weight": 0.902097164356854}], ["TP53", ["TCGA.DM.A28H.01", "Nucleosome assembly"], {"weight": 0.902097164356854}], ["TP53", ["TCGA.DM.A28H.01", "Polo-like kinase mediated events"], {"weight": 0.876627436408295}], ["TP53", ["TCGA.DM.A28H.01", "Condensation of Prophase Chromosomes"], {"weight": 0.841185178293083}], ["TP53", ["TCGA.DM.A28H.01", "Chromosome Maintenance"], {"weight": 0.926491482953398}], ["TP53", ["TCGA.DM.A28H.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.874618960033136}], ["TP53", ["TCGA.DM.A28H.01", "Cyclin A/B1/B2 associated events during G2/M transition"], {"weight": 0.881464978281106}], ["TP53", ["TCGA.DM.A28H.01", "APOBEC3G mediated resistance to HIV-1 infection"], {"weight": 0.761167657974952}], ["TP53", ["TCGA.DM.A28H.01", "Condensation of Prometaphase Chromosomes"], {"weight": 0.815757752952959}], ["TP53", ["TCGA.DM.A28H.01", "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"], {"weight": 0.864613782601257}], ["TP53", ["TCGA.F4.6459.01", "Post-translational protein phosphorylation"], {"weight": 0.753305532429028}], ["TP53", ["TCGA.F4.6460.01", "IRS-mediated signalling"], {"weight": 0.779021218920075}], ["TP53", ["TCGA.F4.6460.01", "Insulin receptor signalling cascade"], {"weight": 0.778376519288248}], ["TP53", ["TCGA.F4.6805.01", "Extracellular matrix organization"], {"weight": 0.880683516689949}], ["TP53", ["TCGA.F4.6805.01", "Phase II - Conjugation of compounds"], {"weight": 0.586975494921901}], ["TP53", ["TCGA.F4.6808.01", "Neuronal System"], {"weight": 0.934684932969642}], ["TP53", ["TCGA.F4.6808.01", "Transmission across Chemical Synapses"], {"weight": 0.931247714077359}], ["TP53", ["TCGA.F4.6854.01", "APAP ADME"], {"weight": 0.753631098957954}], ["TP53", ["TCGA.G4.6294.01", "Neuronal System"], {"weight": 0.931839892603727}], ["TP53", ["TCGA.G4.6294.01", "Transmission across Chemical Synapses"], {"weight": 0.923524692530259}], ["TP53", ["TCGA.G4.6294.01", "Neurotransmitter release cycle"], {"weight": 0.9274648370024}], ["TP53", ["TCGA.G4.6294.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.843141538856544}], ["TP53", ["TCGA.G4.6295.01", "Cardiac conduction"], {"weight": 0.949751692027366}], ["TP53", ["TCGA.G4.6299.01", "Drug ADME"], {"weight": 0.93082021689399}], ["TP53", ["TCGA.G4.6299.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.809488599437575}], ["TP53", ["TCGA.G4.6299.01", "Metabolism"], {"weight": 0.920966771072834}], ["TP53", ["TCGA.G4.6303.01", "Regulation of FZD by ubiquitination"], {"weight": 0.793905061074145}], ["TP53", ["TCGA.G4.6306.01", "Cardiac conduction"], {"weight": 0.943910712113513}], ["TP53", ["TCGA.G4.6306.01", "Muscle contraction"], {"weight": 0.942677404319595}], ["TP53", ["TCGA.G4.6306.01", "Cell surface interactions at the vascular wall"], {"weight": 0.781417962280355}], ["TP53", ["TCGA.G4.6306.01", "Integration of energy metabolism"], {"weight": 0.924571894217074}], ["TP53", ["TCGA.G4.6306.01", "Diseases of metabolism"], {"weight": 0.855551431276022}], ["TP53", ["TCGA.G4.6306.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.937035329517616}], ["TP53", ["TCGA.G4.6307.01", "Signaling Pathways"], {"weight": 0.920838898305897}], ["TP53", ["TCGA.G4.6307.01", "Adaptive Immune System"], {"weight": 0.899084337309416}], ["TP53", ["TCGA.G4.6307.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.95226729812077}], ["TP53", ["TCGA.G4.6310.01", "Immune System"], {"weight": 0.896585380627011}], ["TP53", ["TCGA.G4.6310.01", "Ligand-dependent caspase activation"], {"weight": 0.760885591008525}], ["TP53", ["TCGA.G4.6314.01", "Metabolism"], {"weight": 0.87454420476105}], ["TP53", ["TCGA.G4.6315.01", "Immune System"], {"weight": 0.88050247977359}], ["TP53", ["TCGA.G4.6317.01", "Signaling Pathways"], {"weight": 0.939345870639764}], ["TP53", ["TCGA.G4.6317.01", "Immune System"], {"weight": 0.921875006827195}], ["TP53", ["TCGA.G4.6317.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946815622241584}], ["TP53", ["TCGA.G4.6317.01", "Muscle contraction"], {"weight": 0.949732494506663}], ["TP53", ["TCGA.G4.6317.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.80470767107207}], ["TP53", ["TCGA.G4.6317.01", "Cell surface interactions at the vascular wall"], {"weight": 0.826427177312222}], ["TP53", ["TCGA.G4.6320.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.823470638425218}], ["TP53", ["TCGA.G4.6626.01", "Neuronal System"], {"weight": 0.928817015044977}], ["TP53", ["TCGA.G4.6626.01", "Transmission across Chemical Synapses"], {"weight": 0.909166250742062}], ["TP53", ["TCGA.G4.6626.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.94746177561753}], ["TP53", ["TCGA.G4.6626.01", "Cardiac conduction"], {"weight": 0.940838113736331}], ["TP53", ["TCGA.G4.6626.01", "Muscle contraction"], {"weight": 0.93668731389002}], ["TP53", ["TCGA.G4.6626.01", "Complement cascade"], {"weight": 0.863533553015818}], ["TP53", ["TCGA.G4.6626.01", "Immune System"], {"weight": 0.88712998460351}], ["TP53", ["TCGA.G4.6626.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.836990723263002}], ["PLXNA4", ["TCGA.A6.5661.01", "Axon guidance"], {"weight": 0.907256035996402}], ["FN1", ["TCGA.AA.3502.01", "Molecules associated with elastic fibres"], {"weight": 0.830165521891268}], ["FN1", ["TCGA.AA.3502.01", "Elastic fibre formation"], {"weight": 0.882634693959894}], ["FN1", ["TCGA.AD.6901.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.610340662016912}], ["FN1", ["TCGA.F4.6807.01", "Extracellular matrix organization"], {"weight": 0.866759284998997}], ["FN1", ["TCGA.F4.6807.01", "ECM proteoglycans"], {"weight": 0.891264162971926}], ["CACNA1H", ["TCGA.AA.3660.01", "NCAM1 interactions"], {"weight": 0.897722106881892}], ["CACNA1H", ["TCGA.AA.3660.01", "NCAM signaling for neurite out-growth"], {"weight": 0.910956001188734}], ["CACNA1H", ["TCGA.AA.3660.01", "L1CAM interactions"], {"weight": 0.879746611520465}], ["CACNA1H", ["TCGA.AA.3660.01", "Stimuli-sensing channels"], {"weight": 0.789898866105439}], ["CACNA1H", ["TCGA.AY.6386.01", "Cardiac conduction"], {"weight": 0.932421970654044}], ["CACNA1H", ["TCGA.AY.6386.01", "Muscle contraction"], {"weight": 0.928261661432117}], ["CACNA1H", ["TCGA.AY.6386.01", "NCAM1 interactions"], {"weight": 0.922198055379071}], ["CACNA1H", ["TCGA.AY.6386.01", "NCAM signaling for neurite out-growth"], {"weight": 0.930743697953943}], ["CACNA1H", ["TCGA.AY.6386.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.81173933156504}], ["CACNA1H", ["TCGA.AY.6386.01", "LGI-ADAM interactions"], {"weight": 0.794495522640012}], ["CACNA1H", ["TCGA.AZ.5407.01", "L1CAM interactions"], {"weight": 0.91942074272845}], ["CACNA1H", ["TCGA.AZ.6601.01", "NCAM1 interactions"], {"weight": 0.911141109869888}], ["CACNA1H", ["TCGA.CM.5860.01", "Phase 0 - rapid depolarisation"], {"weight": 0.891444073673023}], ["CACNA1H", ["TCGA.CM.5860.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.919614183357699}], ["CACNA1H", ["TCGA.CM.5860.01", "Sensory processing of sound"], {"weight": 0.919614183357699}], ["CACNA1H", ["TCGA.D5.5537.01", "L1CAM interactions"], {"weight": 0.87204228442615}], ["CACNA1H", ["TCGA.D5.5537.01", "NCAM signaling for neurite out-growth"], {"weight": 0.931239289189429}], ["CACNA1H", ["TCGA.D5.5537.01", "NCAM1 interactions"], {"weight": 0.913332516749106}], ["CACNA1H", ["TCGA.F4.6808.01", "Signaling Pathways"], {"weight": 0.903531551519707}], ["CACNA1H", ["TCGA.F4.6808.01", "NCAM1 interactions"], {"weight": 0.935676676644114}], ["UQCRC2", ["TCGA.A6.2671.01", "Phase II - Conjugation of compounds"], {"weight": 0.869899258881659}], ["PTPRK", ["TCGA.CM.4743.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.914843195939044}], ["PTPRK", ["TCGA.DM.A1D8.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.912530894424442}], ["PTPRK", ["TCGA.DM.A1D8.01", "PI3K events in ERBB2 signaling"], {"weight": 0.912530894424442}], ["PTPRK", ["TCGA.DM.A1D8.01", "GRB2 events in ERBB2 signaling"], {"weight": 0.912530894424442}], ["PBRM1", ["TCGA.DM.A285.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.769107715149396}], ["LAMA3", ["TCGA.A6.2671.01", "Glucuronidation"], {"weight": 0.866572885033259}], ["LAMA3", ["TCGA.AZ.6600.01", "Extracellular matrix organization"], {"weight": 0.879880954707538}], ["LAMA3", ["TCGA.AZ.6600.01", "Collagen formation"], {"weight": 0.907086761811972}], ["LAMA3", ["TCGA.AZ.6600.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.919354069015019}], ["LAMA3", ["TCGA.AZ.6600.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.859520459931792}], ["LAMA3", ["TCGA.AZ.6600.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.867880812190904}], ["LAMA3", ["TCGA.AZ.6600.01", "Degradation of the extracellular matrix"], {"weight": 0.842476807973229}], ["LAMA3", ["TCGA.AZ.6601.01", "Collagen formation"], {"weight": 0.941114359153373}], ["LAMA3", ["TCGA.G4.6302.01", "Collagen formation"], {"weight": 0.923686447357309}], ["LAMA3", ["TCGA.G4.6302.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.896907283994475}], ["LAMA3", ["TCGA.G4.6302.01", "Degradation of the extracellular matrix"], {"weight": 0.793331367471561}], ["LAMA3", ["TCGA.G4.6302.01", "Collagen degradation"], {"weight": 0.873919209238964}], ["TTN", ["TCGA.A6.5657.01", "APAP ADME"], {"weight": 0.508978073215054}], ["TTN", ["TCGA.A6.6140.01", "Heme degradation"], {"weight": 0.685955490402689}], ["TTN", ["TCGA.CA.5796.01", "Muscle contraction"], {"weight": 0.912019951835319}], ["TTN", ["TCGA.CK.4947.01", "Cardiac conduction"], {"weight": 0.810137965264047}], ["TTN", ["TCGA.CM.6675.01", "Muscle contraction"], {"weight": 0.929368760292264}], ["TTN", ["TCGA.DM.A1DB.01", "Ion homeostasis"], {"weight": 0.931940155896452}], ["TTN", ["TCGA.DM.A1DB.01", "Caspase-mediated cleavage of cytoskeletal proteins"], {"weight": 0.664747423340205}], ["TTN", ["TCGA.F4.6460.01", "FGFR4 ligand binding and activation"], {"weight": 0.775213610093283}], ["TTN", ["TCGA.F4.6460.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.774767513652485}], ["TTN", ["TCGA.F4.6460.01", "PI-3K cascade:FGFR4"], {"weight": 0.774767513652485}], ["TTN", ["TCGA.F4.6460.01", "SHC-mediated cascade:FGFR4"], {"weight": 0.775213610093283}], ["TTN", ["TCGA.F4.6460.01", "FRS-mediated FGFR4 signaling"], {"weight": 0.775213610093283}], ["TTN", ["TCGA.F4.6704.01", "APAP ADME"], {"weight": 0.689208854170747}], ["TTN", ["TCGA.G4.6293.01", "Muscle contraction"], {"weight": 0.905776357625407}], ["TTN", ["TCGA.G4.6304.01", "Muscle contraction"], {"weight": 0.931986211151065}], ["LAMA2", ["TCGA.A6.2675.01", "Extracellular matrix organization"], {"weight": 0.856301498638679}], ["ACACB", ["TCGA.AZ.6598.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.888154891442842}], ["TNN", ["TCGA.A6.2675.01", "Collagen formation"], {"weight": 0.885570320067454}], ["TNN", ["TCGA.A6.2675.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.871741864397031}], ["TNN", ["TCGA.A6.2675.01", "Scavenging by Class A Receptors"], {"weight": 0.340979142196541}], ["TNN", ["TCGA.AY.5543.01", "Other semaphorin interactions"], {"weight": 0.667588737888835}], ["TNN", ["TCGA.DM.A1D0.01", "Extracellular matrix organization"], {"weight": 0.910864876677348}], ["TNN", ["TCGA.DM.A1D0.01", "Elastic fibre formation"], {"weight": 0.92241365036303}], ["TNN", ["TCGA.DM.A1D0.01", "Integrin cell surface interactions"], {"weight": 0.93174906018798}], ["TNN", ["TCGA.DM.A1D0.01", "Cell surface interactions at the vascular wall"], {"weight": 0.797220190504571}], ["TNN", ["TCGA.DM.A1D0.01", "Other semaphorin interactions"], {"weight": 0.673208843939923}], ["TNN", ["TCGA.DM.A1D0.01", "Lewis blood group biosynthesis"], {"weight": 0.710420741459675}], ["TNN", ["TCGA.DM.A1D0.01", "Blood group systems biosynthesis"], {"weight": 0.760615330183865}], ["TNN", ["TCGA.DM.A1D4.01", "Elastic fibre formation"], {"weight": 0.928787647296771}], ["TNN", ["TCGA.DM.A1D4.01", "Cell-extracellular matrix interactions"], {"weight": 0.833144425654138}], ["DNAH5", ["TCGA.D5.5538.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.698037552080405}], ["DNAH5", ["TCGA.DM.A28C.01", "Arachidonic acid metabolism"], {"weight": 0.919307645083238}], ["DNAH5", ["TCGA.DM.A28C.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.801408503897728}], ["RBP4", ["TCGA.A6.2675.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.644533804457441}], ["TGFBR2", ["TCGA.A6.2675.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.849705197447077}], ["TGFBR2", ["TCGA.A6.2675.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.889000593648967}], ["TGFBR2", ["TCGA.A6.2675.01", "Collagen chain trimerization"], {"weight": 0.819510180316898}], ["P2RY4", ["TCGA.D5.7000.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.936662592283921}], ["P2RY4", ["TCGA.D5.7000.01", "Peptide ligand-binding receptors"], {"weight": 0.916635064499126}], ["LAMC3", ["TCGA.AA.3662.01", "Extracellular matrix organization"], {"weight": 0.795937317754387}], ["LAMC3", ["TCGA.DM.A1D8.01", "Integrin cell surface interactions"], {"weight": 0.932845466699359}], ["LAMC3", ["TCGA.G4.6317.01", "GPCR downstream signalling"], {"weight": 0.958555065409504}], ["LAMC3", ["TCGA.G4.6317.01", "G-protein beta:gamma signalling"], {"weight": 0.942275506769679}], ["LAMC3", ["TCGA.G4.6317.01", "G beta:gamma signalling through CDC42"], {"weight": 0.918057527948926}], ["LAMC3", ["TCGA.G4.6317.01", "Collagen formation"], {"weight": 0.955206201785168}], ["ABCC8", ["TCGA.AD.6964.01", "Regulation of insulin secretion"], {"weight": 0.911205002789662}], ["ABCC8", ["TCGA.AD.6964.01", "Integration of energy metabolism"], {"weight": 0.915036339042585}], ["ABCC8", ["TCGA.DM.A1D9.01", "Potassium Channels"], {"weight": 0.862503745884847}], ["DPYD", ["TCGA.DM.A0XF.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.82339490302196}], ["DPYD", ["TCGA.DM.A0XF.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.802090292396501}], ["DPYD", ["TCGA.DM.A0XF.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.802090292396501}], ["LAMA2", ["TCGA.AY.6196.01", "Extracellular matrix organization"], {"weight": 0.867078650299226}], ["FMO2", ["TCGA.A6.2675.01", "Ethanol oxidation"], {"weight": 0.595455684353049}], ["SPATA5", ["TCGA.D5.6922.01", "Drug ADME"], {"weight": 0.739968310203981}], ["SPATA5", ["TCGA.D5.6922.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.690270439903866}], ["FMO2", ["TCGA.A6.2675.01", "RA biosynthesis pathway"], {"weight": 0.578830312858178}], ["KRAS", ["TCGA.A6.4105.01", "Extracellular matrix organization"], {"weight": 0.858429641082164}], ["DCN", ["TCGA.A6.4105.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.915365339062782}], ["COL27A1", ["TCGA.A6.4105.01", "Degradation of the extracellular matrix"], {"weight": 0.871995353578056}], ["COL27A1", ["TCGA.A6.4105.01", "Collagen formation"], {"weight": 0.924149459476469}], ["COL27A1", ["TCGA.A6.4105.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.899169272868308}], ["COL27A1", ["TCGA.A6.4105.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.933753491446059}], ["COL27A1", ["TCGA.A6.6138.01", "Degradation of the extracellular matrix"], {"weight": 0.844137682100119}], ["COL27A1", ["TCGA.A6.6653.01", "Degradation of the extracellular matrix"], {"weight": 0.867756216435641}], ["COL27A1", ["TCGA.AU.6004.01", "Diseases of glycosylation"], {"weight": 0.82023426580255}], ["COL27A1", ["TCGA.AY.6386.01", "Collagen chain trimerization"], {"weight": 0.888752408155478}], ["COL27A1", ["TCGA.AZ.6598.01", "Degradation of the extracellular matrix"], {"weight": 0.89595958660557}], ["COL27A1", ["TCGA.D5.6537.01", "NCAM1 interactions"], {"weight": 0.938879895771431}], ["COL27A1", ["TCGA.D5.6898.01", "Degradation of the extracellular matrix"], {"weight": 0.922439643940098}], ["COL27A1", ["TCGA.D5.6898.01", "Extracellular matrix organization"], {"weight": 0.900271376244572}], ["COL27A1", ["TCGA.D5.6932.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.895388716664669}], ["COL27A1", ["TCGA.D5.6932.01", "Collagen formation"], {"weight": 0.913921967455477}], ["COL27A1", ["TCGA.D5.6932.01", "Degradation of the extracellular matrix"], {"weight": 0.88292510597092}], ["COL27A1", ["TCGA.F4.6569.01", "Extracellular matrix organization"], {"weight": 0.893585871914579}], ["COL27A1", ["TCGA.F4.6569.01", "Collagen formation"], {"weight": 0.942112934765045}], ["COL27A1", ["TCGA.F4.6569.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.950581863664418}], ["COL27A1", ["TCGA.F4.6569.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.921287464121883}], ["COL27A1", ["TCGA.F4.6569.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.920769222947529}], ["COL27A1", ["TCGA.F4.6569.01", "Collagen chain trimerization"], {"weight": 0.932250806375452}], ["COL27A1", ["TCGA.F4.6569.01", "Collagen degradation"], {"weight": 0.921071709295937}], ["COL27A1", ["TCGA.F4.6703.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.953954878874103}], ["COL27A1", ["TCGA.F4.6703.01", "Degradation of the extracellular matrix"], {"weight": 0.91430469130114}], ["COL27A1", ["TCGA.G4.6625.01", "Collagen chain trimerization"], {"weight": 0.851288544001568}], ["FBN2", ["TCGA.A6.6649.01", "Extracellular matrix organization"], {"weight": 0.847874581154323}], ["FBN2", ["TCGA.AD.5900.01", "Extracellular matrix organization"], {"weight": 0.853012895379661}], ["FBN2", ["TCGA.G4.6314.01", "Extracellular matrix organization"], {"weight": 0.882990969115163}], ["FBN2", ["TCGA.G4.6321.01", "Extracellular matrix organization"], {"weight": 0.779929685566948}], ["FBN2", ["TCGA.G4.6586.01", "Molecules associated with elastic fibres"], {"weight": 0.901024515006288}], ["DOCK4", ["TCGA.A6.6140.01", "Protein-protein interactions at synapses"], {"weight": 0.886343438422325}], ["DOCK4", ["TCGA.AA.3697.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.518710061037143}], ["FZD10", ["TCGA.A6.4105.01", "GPCR ligand binding"], {"weight": 0.936484299134625}], ["FZD10", ["TCGA.A6.6781.01", "GPCR ligand binding"], {"weight": 0.933060862783283}], ["FZD10", ["TCGA.AU.6004.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.898620080630967}], ["FZD10", ["TCGA.AU.6004.01", "GPCR ligand binding"], {"weight": 0.931975529477047}], ["FZD10", ["TCGA.AU.6004.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.902456009634434}], ["FZD10", ["TCGA.D5.6898.01", "GPCR ligand binding"], {"weight": 0.905012356188791}], ["FZD10", ["TCGA.D5.6898.01", "Regulation of FZD by ubiquitination"], {"weight": 0.757725836318657}], ["TBXA2R", ["TCGA.A6.6780.01", "GABA receptor activation"], {"weight": 0.917638622022847}], ["TBXA2R", ["TCGA.CK.5916.01", "GABA receptor activation"], {"weight": 0.881425521669243}], ["KRAS", ["TCGA.A6.4105.01", "SHC-mediated cascade:FGFR4"], {"weight": 0.868019385433746}], ["KRAS", ["TCGA.A6.4105.01", "FRS-mediated FGFR4 signaling"], {"weight": 0.867977876952049}], ["KRAS", ["TCGA.A6.5662.01", "Signaling Pathways"], {"weight": 0.903629835356941}], ["KRAS", ["TCGA.A6.5662.01", "Transmission across Chemical Synapses"], {"weight": 0.90351279292128}], ["KRAS", ["TCGA.A6.5662.01", "Scavenging of heme from plasma"], {"weight": 0.533281511393385}], ["KRAS", ["TCGA.A6.5662.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.86325887981303}], ["KRAS", ["TCGA.A6.5662.01", "Platelet activation, signaling and aggregation"], {"weight": 0.898975924021996}], ["KRAS", ["TCGA.A6.5662.01", "Synaptic adhesion-like molecules"], {"weight": 0.818030729992845}], ["KRAS", ["TCGA.A6.5664.01", "FGFR4 ligand binding and activation"], {"weight": 0.885547600140141}], ["KRAS", ["TCGA.A6.5664.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.885547600140141}], ["KRAS", ["TCGA.A6.5664.01", "IRS-related events triggered by IGF1R"], {"weight": 0.820097219957405}], ["KRAS", ["TCGA.A6.5664.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.624511823848918}], ["KRAS", ["TCGA.A6.5664.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.820085454434868}], ["KRAS", ["TCGA.A6.5664.01", "IGF1R signaling cascade"], {"weight": 0.820085454434868}], ["KRAS", ["TCGA.A6.5664.01", "PI-3K cascade:FGFR4"], {"weight": 0.885547600140141}], ["KRAS", ["TCGA.A6.5664.01", "SHC-mediated cascade:FGFR4"], {"weight": 0.896146269094521}], ["KRAS", ["TCGA.A6.5664.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.911210990600677}], ["KRAS", ["TCGA.A6.5664.01", "FRS-mediated FGFR4 signaling"], {"weight": 0.896110172113154}], ["KRAS", ["TCGA.A6.5664.01", "IRS-mediated signalling"], {"weight": 0.832422776618905}], ["KRAS", ["TCGA.A6.5664.01", "FGFR2c ligand binding and activation"], {"weight": 0.854805044143447}], ["KRAS", ["TCGA.A6.5664.01", "Post-translational protein phosphorylation"], {"weight": 0.823156796246307}], ["KRAS", ["TCGA.A6.5664.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.875880551147793}], ["KRAS", ["TCGA.A6.5664.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.859362286794119}], ["KRAS", ["TCGA.A6.5664.01", "Downstream signaling of activated FGFR4"], {"weight": 0.896092253321718}], ["KRAS", ["TCGA.A6.5664.01", "Insulin receptor signalling cascade"], {"weight": 0.832090815058971}], ["KRAS", ["TCGA.A6.5666.01", "Signaling Pathways"], {"weight": 0.93086531941222}], ["KRAS", ["TCGA.A6.5666.01", "Protein-protein interactions at synapses"], {"weight": 0.917479844272039}], ["KRAS", ["TCGA.A6.5666.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.928441431250685}], ["KRAS", ["TCGA.A6.5666.01", "ERK1/ERK2 pathway"], {"weight": 0.932852877391282}], ["KRAS", ["TCGA.A6.5666.01", "Ca2+ pathway"], {"weight": 0.893577674555043}], ["KRAS", ["TCGA.A6.5666.01", "MAPK family signaling cascades"], {"weight": 0.917403705006963}], ["KRAS", ["TCGA.A6.5666.01", "Long-term potentiation"], {"weight": 0.925792019278214}], ["KRAS", ["TCGA.A6.6138.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.835624501035458}], ["KRAS", ["TCGA.A6.6138.01", "Interaction between L1 and Ankyrins"], {"weight": 0.893291488033006}], ["KRAS", ["TCGA.A6.6650.01", "Signaling Pathways"], {"weight": 0.898716093201494}], ["KRAS", ["TCGA.A6.6650.01", "Interaction between L1 and Ankyrins"], {"weight": 0.937548950140913}], ["KRAS", ["TCGA.A6.6650.01", "Phase 0 - rapid depolarisation"], {"weight": 0.918839570393348}], ["KRAS", ["TCGA.A6.6650.01", "Transport of small molecules"], {"weight": 0.917190190115228}], ["KRAS", ["TCGA.AA.3502.01", "Extracellular matrix organization"], {"weight": 0.851402327879929}], ["KRAS", ["TCGA.AA.3502.01", "Signaling Pathways"], {"weight": 0.890920201989504}], ["KRAS", ["TCGA.AA.3502.01", "Diseases of metabolism"], {"weight": 0.818190809677209}], ["KRAS", ["TCGA.AA.3502.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.518454707879866}], ["KRAS", ["TCGA.AA.3502.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.870686975315498}], ["KRAS", ["TCGA.AA.3502.01", "Protein-protein interactions at synapses"], {"weight": 0.899674268899856}], ["KRAS", ["TCGA.AA.3502.01", "FGFR1 ligand binding and activation"], {"weight": 0.890834604579343}], ["KRAS", ["TCGA.AA.3511.01", "Signaling Pathways"], {"weight": 0.83359615832511}], ["KRAS", ["TCGA.AA.3511.01", "Protein-protein interactions at synapses"], {"weight": 0.757342715824115}], ["KRAS", ["TCGA.AA.3655.01", "Interaction between L1 and Ankyrins"], {"weight": 0.908245469913461}], ["KRAS", ["TCGA.AA.3655.01", "Protein-protein interactions at synapses"], {"weight": 0.888875258050904}], ["KRAS", ["TCGA.AA.3655.01", "Synaptic adhesion-like molecules"], {"weight": 0.819954506263741}], ["KRAS", ["TCGA.AA.3655.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.679153924890036}], ["KRAS", ["TCGA.AA.3655.01", "Neurexins and neuroligins"], {"weight": 0.927373523083782}], ["KRAS", ["TCGA.AA.3655.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.892121082465902}], ["KRAS", ["TCGA.AA.3660.01", "Interaction between L1 and Ankyrins"], {"weight": 0.903711339071721}], ["KRAS", ["TCGA.AA.3660.01", "Phase 0 - rapid depolarisation"], {"weight": 0.897577932350703}], ["KRAS", ["TCGA.AA.3660.01", "FGFR4 ligand binding and activation"], {"weight": 0.864935813087567}], ["KRAS", ["TCGA.AA.3660.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.864935813087567}], ["KRAS", ["TCGA.AA.3660.01", "SHC-mediated cascade:FGFR4"], {"weight": 0.876353760928756}], ["KRAS", ["TCGA.AA.3660.01", "FRS-mediated FGFR4 signaling"], {"weight": 0.876314873644678}], ["KRAS", ["TCGA.AA.3660.01", "Phospholipase C-mediated cascade: FGFR1"], {"weight": 0.837140610472271}], ["KRAS", ["TCGA.AA.3660.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.744359161994479}], ["KRAS", ["TCGA.AA.3660.01", "FGFR1 ligand binding and activation"], {"weight": 0.837140610472271}], ["KRAS", ["TCGA.AA.3660.01", "Signaling by activated point mutants of FGFR1"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "Signaling by activated point mutants of FGFR3"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "FGFR3 mutant receptor activation"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "Negative regulation of FGFR4 signaling"], {"weight": 0.864935813087567}], ["KRAS", ["TCGA.AA.3660.01", "FGFR3 ligand binding and activation"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "FGFR3c ligand binding and activation"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "FGFR1c ligand binding and activation"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "Phospholipase C-mediated cascade; FGFR3"], {"weight": 0.80676823101983}], ["KRAS", ["TCGA.AA.3660.01", "SHC-mediated cascade:FGFR1"], {"weight": 0.85295042678104}], ["KRAS", ["TCGA.AD.6548.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.870323292201534}], ["KRAS", ["TCGA.AD.6548.01", "Phase 0 - rapid depolarisation"], {"weight": 0.863192794199598}], ["KRAS", ["TCGA.AD.6965.01", "Interaction between L1 and Ankyrins"], {"weight": 0.903614010132043}], ["KRAS", ["TCGA.AD.6965.01", "L1CAM interactions"], {"weight": 0.868841402353736}], ["KRAS", ["TCGA.AY.5543.01", "Neurexins and neuroligins"], {"weight": 0.930363732543209}], ["KRAS", ["TCGA.AZ.4616.01", "Phase 0 - rapid depolarisation"], {"weight": 0.857872237812383}], ["KRAS", ["TCGA.AZ.4616.01", "G alpha (z) signalling events"], {"weight": 0.872918143255085}], ["KRAS", ["TCGA.AZ.4616.01", "Phase 2 - plateau phase"], {"weight": 0.757114330863971}], ["KRAS", ["TCGA.AZ.4616.01", "Diseases of Immune System"], {"weight": 0.857499986591482}], ["KRAS", ["TCGA.AZ.4616.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.857499986591482}], ["KRAS", ["TCGA.AZ.5407.01", "Phase 0 - rapid depolarisation"], {"weight": 0.921906041704868}], ["KRAS", ["TCGA.AZ.5407.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.685502766866301}], ["KRAS", ["TCGA.AZ.6599.01", "Innate Immune System"], {"weight": 0.879582837902971}], ["KRAS", ["TCGA.AZ.6599.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.782991592888578}], ["KRAS", ["TCGA.AZ.6599.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.782991592888578}], ["KRAS", ["TCGA.AZ.6600.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.753894002403927}], ["KRAS", ["TCGA.CA.5796.01", "Phase 0 - rapid depolarisation"], {"weight": 0.911349776830351}], ["KRAS", ["TCGA.CA.5796.01", "Ca2+ pathway"], {"weight": 0.905944038772797}], ["KRAS", ["TCGA.CA.6716.01", "Immune System"], {"weight": 0.868525898028899}], ["KRAS", ["TCGA.CA.6716.01", "Adaptive Immune System"], {"weight": 0.904819431207728}], ["KRAS", ["TCGA.CA.6716.01", "Interaction between L1 and Ankyrins"], {"weight": 0.909683108397625}], ["KRAS", ["TCGA.CA.6716.01", "Platelet activation, signaling and aggregation"], {"weight": 0.928686779129845}], ["KRAS", ["TCGA.CK.4947.01", "Interaction between L1 and Ankyrins"], {"weight": 0.866147714288928}], ["KRAS", ["TCGA.CK.4948.01", "Phase 0 - rapid depolarisation"], {"weight": 0.926034720949575}], ["KRAS", ["TCGA.CK.4948.01", "Protein-protein interactions at synapses"], {"weight": 0.859923458151139}], ["KRAS", ["TCGA.CM.4744.01", "Interaction between L1 and Ankyrins"], {"weight": 0.958543487032982}], ["KRAS", ["TCGA.CM.4744.01", "L1CAM interactions"], {"weight": 0.929958432916874}], ["KRAS", ["TCGA.CM.4744.01", "Extracellular matrix organization"], {"weight": 0.891141083020057}], ["KRAS", ["TCGA.CM.4744.01", "Signaling Pathways"], {"weight": 0.927554948958507}], ["KRAS", ["TCGA.CM.4744.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.87822487777263}], ["KRAS", ["TCGA.CM.4747.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.912227420459472}], ["KRAS", ["TCGA.CM.4747.01", "Signaling Pathways"], {"weight": 0.872647938036708}], ["KRAS", ["TCGA.CM.4747.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.798251578157769}], ["KRAS", ["TCGA.CM.5863.01", "Response to elevated platelet cytosolic Ca2+"], {"weight": 0.800651842569664}], ["KRAS", ["TCGA.CM.6164.01", "Long-term potentiation"], {"weight": 0.888001905885746}], ["KRAS", ["TCGA.CM.6164.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.870679209628341}], ["KRAS", ["TCGA.CM.6164.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.872458814725214}], ["KRAS", ["TCGA.CM.6164.01", "Trafficking of AMPA receptors"], {"weight": 0.899328950411267}], ["KRAS", ["TCGA.CM.6164.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.899328950411267}], ["KRAS", ["TCGA.CM.6164.01", "Signaling Pathways"], {"weight": 0.863245124672936}], ["KRAS", ["TCGA.CM.6164.01", "Cardiac conduction"], {"weight": 0.85607852334748}], ["KRAS", ["TCGA.CM.6164.01", "G-protein mediated events"], {"weight": 0.854592147858093}], ["KRAS", ["TCGA.CM.6164.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.857135853196407}], ["KRAS", ["TCGA.CM.6166.01", "Immune System"], {"weight": 0.884160181657301}], ["KRAS", ["TCGA.CM.6166.01", "Signaling Pathways"], {"weight": 0.91020493383931}], ["KRAS", ["TCGA.CM.6166.01", "Phase 0 - rapid depolarisation"], {"weight": 0.909764120035912}], ["KRAS", ["TCGA.CM.6166.01", "Diseases of Immune System"], {"weight": 0.890573228692283}], ["KRAS", ["TCGA.CM.6166.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.890573228692283}], ["KRAS", ["TCGA.CM.6166.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.924166048870969}], ["KRAS", ["TCGA.CM.6166.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.924166048870969}], ["KRAS", ["TCGA.CM.6678.01", "Immune System"], {"weight": 0.84697269129523}], ["KRAS", ["TCGA.CM.6678.01", "Signaling Pathways"], {"weight": 0.884999455209683}], ["KRAS", ["TCGA.CM.6678.01", "Interaction between L1 and Ankyrins"], {"weight": 0.911064681751709}], ["KRAS", ["TCGA.CM.6678.01", "Innate Immune System"], {"weight": 0.860520158673127}], ["KRAS", ["TCGA.CM.6678.01", "Diseases of Immune System"], {"weight": 0.867067789406191}], ["KRAS", ["TCGA.CM.6678.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.867067789406191}], ["KRAS", ["TCGA.CM.6678.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.906766710492824}], ["KRAS", ["TCGA.CM.6678.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.906766710492824}], ["KRAS", ["TCGA.D5.5537.01", "Interaction between L1 and Ankyrins"], {"weight": 0.930598516654512}], ["KRAS", ["TCGA.D5.5537.01", "Signaling Pathways"], {"weight": 0.87731002233888}], ["KRAS", ["TCGA.D5.5537.01", "Protein-protein interactions at synapses"], {"weight": 0.847411582863712}], ["KRAS", ["TCGA.D5.5537.01", "MAPK family signaling cascades"], {"weight": 0.901970869074353}], ["KRAS", ["TCGA.D5.5538.01", "Protein-protein interactions at synapses"], {"weight": 0.864013752417456}], ["KRAS", ["TCGA.D5.5538.01", "Neurexins and neuroligins"], {"weight": 0.892996377056926}], ["KRAS", ["TCGA.D5.5538.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.880843416766192}], ["KRAS", ["TCGA.D5.5538.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.806973982008455}], ["KRAS", ["TCGA.D5.5538.01", "Long-term potentiation"], {"weight": 0.894688101490849}], ["KRAS", ["TCGA.D5.5538.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.884071378216682}], ["KRAS", ["TCGA.D5.5538.01", "Synaptic adhesion-like molecules"], {"weight": 0.883406995533727}], ["KRAS", ["TCGA.D5.5538.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.861742567334158}], ["KRAS", ["TCGA.D5.5538.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.790841142332094}], ["KRAS", ["TCGA.D5.5538.01", "Trafficking of AMPA receptors"], {"weight": 0.885352445109167}], ["KRAS", ["TCGA.D5.5538.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.885352445109167}], ["KRAS", ["TCGA.D5.5538.01", "Signaling Pathways"], {"weight": 0.859310794787681}], ["KRAS", ["TCGA.D5.5540.01", "Interaction between L1 and Ankyrins"], {"weight": 0.934986788196929}], ["KRAS", ["TCGA.D5.5540.01", "Signaling Pathways"], {"weight": 0.928943769540952}], ["KRAS", ["TCGA.D5.5540.01", "SARS-CoV-2-host interactions"], {"weight": 0.840620353382797}], ["KRAS", ["TCGA.D5.5540.01", "NCAM signaling for neurite out-growth"], {"weight": 0.939762390912052}], ["KRAS", ["TCGA.D5.6529.01", "Interaction between L1 and Ankyrins"], {"weight": 0.88629278229916}], ["KRAS", ["TCGA.D5.6529.01", "NCAM signaling for neurite out-growth"], {"weight": 0.757759537128489}], ["KRAS", ["TCGA.D5.6532.01", "Signaling Pathways"], {"weight": 0.912611909408377}], ["KRAS", ["TCGA.D5.6532.01", "Extracellular matrix organization"], {"weight": 0.868468929356567}], ["KRAS", ["TCGA.D5.6532.01", "G-protein beta:gamma signalling"], {"weight": 0.931685414564095}], ["KRAS", ["TCGA.D5.6532.01", "Protein-protein interactions at synapses"], {"weight": 0.908679582762461}], ["KRAS", ["TCGA.D5.6532.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.919863721287369}], ["KRAS", ["TCGA.D5.6532.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.827164147769998}], ["KRAS", ["TCGA.D5.6532.01", "Synaptic adhesion-like molecules"], {"weight": 0.913572390565109}], ["KRAS", ["TCGA.D5.6532.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.904115514752753}], ["KRAS", ["TCGA.D5.6532.01", "G alpha (z) signalling events"], {"weight": 0.911621429072891}], ["KRAS", ["TCGA.D5.6535.01", "Interaction between L1 and Ankyrins"], {"weight": 0.900886622632343}], ["KRAS", ["TCGA.D5.6535.01", "Neurexins and neuroligins"], {"weight": 0.872640829579254}], ["KRAS", ["TCGA.D5.6536.01", "Signaling Pathways"], {"weight": 0.899598956528855}], ["KRAS", ["TCGA.D5.6536.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.733559427249597}], ["KRAS", ["TCGA.D5.6536.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.733559427249597}], ["KRAS", ["TCGA.D5.6536.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.869237554412335}], ["KRAS", ["TCGA.D5.6536.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.869237554412335}], ["KRAS", ["TCGA.D5.6537.01", "Ion homeostasis"], {"weight": 0.93129413902114}], ["KRAS", ["TCGA.D5.6537.01", "L1CAM interactions"], {"weight": 0.922694624230348}], ["KRAS", ["TCGA.D5.6537.01", "NCAM signaling for neurite out-growth"], {"weight": 0.937956131830676}], ["KRAS", ["TCGA.D5.6538.01", "Signaling Pathways"], {"weight": 0.908375443730434}], ["KRAS", ["TCGA.D5.6538.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.919695456088705}], ["KRAS", ["TCGA.D5.6538.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.919695456088705}], ["KRAS", ["TCGA.D5.6538.01", "Diseases of Immune System"], {"weight": 0.892023859325695}], ["KRAS", ["TCGA.D5.6538.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.892023859325695}], ["KRAS", ["TCGA.D5.6538.01", "Extracellular matrix organization"], {"weight": 0.837824926118659}], ["KRAS", ["TCGA.D5.6541.01", "Signaling Pathways"], {"weight": 0.873791480366161}], ["KRAS", ["TCGA.D5.6932.01", "Signaling Pathways"], {"weight": 0.884898602373929}], ["KRAS", ["TCGA.D5.6932.01", "Interaction between L1 and Ankyrins"], {"weight": 0.890279834845416}], ["KRAS", ["TCGA.D5.7000.01", "Interaction between L1 and Ankyrins"], {"weight": 0.900495666465116}], ["KRAS", ["TCGA.DM.A0XD.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.91991984980384}], ["KRAS", ["TCGA.DM.A1D0.01", "Signaling Pathways"], {"weight": 0.933181866974449}], ["KRAS", ["TCGA.DM.A1D0.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.927614213262942}], ["KRAS", ["TCGA.DM.A1D0.01", "Innate Immune System"], {"weight": 0.920293944614533}], ["KRAS", ["TCGA.DM.A1D0.01", "Long-term potentiation"], {"weight": 0.931255545670013}], ["KRAS", ["TCGA.DM.A1D0.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.918328435280103}], ["KRAS", ["TCGA.DM.A1D0.01", "Synaptic adhesion-like molecules"], {"weight": 0.92495389172142}], ["KRAS", ["TCGA.DM.A1D0.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.916528843836894}], ["KRAS", ["TCGA.DM.A1D0.01", "PI3K events in ERBB2 signaling"], {"weight": 0.918328435280103}], ["KRAS", ["TCGA.DM.A1D0.01", "ERBB2 Regulates Cell Motility"], {"weight": 0.918328435280103}], ["KRAS", ["TCGA.DM.A1D0.01", "FGFR2 ligand binding and activation"], {"weight": 0.926804725487384}], ["KRAS", ["TCGA.DM.A1D0.01", "FLT3 Signaling"], {"weight": 0.909400519984901}], ["KRAS", ["TCGA.DM.A1D0.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.87257786021404}], ["KRAS", ["TCGA.DM.A1D0.01", "GRB2 events in ERBB2 signaling"], {"weight": 0.910358424378552}], ["KRAS", ["TCGA.DM.A1D0.01", "Specification of primordial germ cells"], {"weight": 0.631808118022435}], ["KRAS", ["TCGA.DM.A1D4.01", "Scavenging of heme from plasma"], {"weight": 0.868733927691534}], ["KRAS", ["TCGA.DM.A1D6.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.761082639368011}], ["KRAS", ["TCGA.DM.A1D6.01", "Transport of small molecules"], {"weight": 0.92738067906566}], ["KRAS", ["TCGA.DM.A1D6.01", "Adaptive Immune System"], {"weight": 0.91402261005345}], ["KRAS", ["TCGA.DM.A1D6.01", "Ca2+ pathway"], {"weight": 0.919863368764841}], ["KRAS", ["TCGA.DM.A1D6.01", "Protein-protein interactions at synapses"], {"weight": 0.930913702009717}], ["KRAS", ["TCGA.DM.A1D6.01", "Neurexins and neuroligins"], {"weight": 0.93202622922787}], ["KRAS", ["TCGA.DM.A1D6.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.821820578523321}], ["KRAS", ["TCGA.DM.A1D6.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.821820578523321}], ["KRAS", ["TCGA.DM.A1D6.01", "TNFs bind their physiological receptors"], {"weight": 0.478651766147721}], ["KRAS", ["TCGA.DM.A1D6.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.926077323403954}], ["KRAS", ["TCGA.DM.A1D6.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.942904050194319}], ["KRAS", ["TCGA.DM.A1D6.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.831072436599855}], ["KRAS", ["TCGA.DM.A1D6.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.881029834003632}], ["KRAS", ["TCGA.DM.A1D6.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.916029450770361}], ["KRAS", ["TCGA.DM.A1D6.01", "Scavenging of heme from plasma"], {"weight": 0.862709132220815}], ["KRAS", ["TCGA.DM.A1D6.01", "Other interleukin signaling"], {"weight": 0.767855058804569}], ["KRAS", ["TCGA.DM.A1D7.01", "Signaling Pathways"], {"weight": 0.895368469843467}], ["KRAS", ["TCGA.DM.A1D7.01", "Diseases of Immune System"], {"weight": 0.817775779984533}], ["KRAS", ["TCGA.DM.A1D7.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.817775779984533}], ["KRAS", ["TCGA.DM.A1D8.01", "Interaction between L1 and Ankyrins"], {"weight": 0.945863653643354}], ["KRAS", ["TCGA.DM.A1D8.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.792088316193517}], ["KRAS", ["TCGA.DM.A1D8.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.792088316193517}], ["KRAS", ["TCGA.DM.A1D8.01", "Platelet activation, signaling and aggregation"], {"weight": 0.939125041682158}], ["KRAS", ["TCGA.DM.A1D8.01", "Transport of small molecules"], {"weight": 0.907558444432165}], ["KRAS", ["TCGA.DM.A1D8.01", "ERK1/ERK2 pathway"], {"weight": 0.931005100505457}], ["KRAS", ["TCGA.DM.A1D8.01", "MAPK family signaling cascades"], {"weight": 0.920135523442987}], ["KRAS", ["TCGA.DM.A1D8.01", "RAF/MAP kinase cascade"], {"weight": 0.929480964969682}], ["KRAS", ["TCGA.DM.A1D9.01", "Signaling Pathways"], {"weight": 0.908015868765259}], ["KRAS", ["TCGA.DM.A1D9.01", "Adaptive Immune System"], {"weight": 0.8764097055779}], ["KRAS", ["TCGA.DM.A1D9.01", "Cardiac conduction"], {"weight": 0.949400869305427}], ["KRAS", ["TCGA.DM.A1D9.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.883761201410846}], ["KRAS", ["TCGA.DM.A1HA.01", "Neuronal System"], {"weight": 0.955760447287591}], ["KRAS", ["TCGA.DM.A1HA.01", "Sialic acid metabolism"], {"weight": 0.773582637710249}], ["KRAS", ["TCGA.DM.A1HA.01", "NCAM signaling for neurite out-growth"], {"weight": 0.95255458777508}], ["KRAS", ["TCGA.DM.A282.01", "Immune System"], {"weight": 0.874403049297352}], ["KRAS", ["TCGA.DM.A282.01", "Signaling Pathways"], {"weight": 0.920557131744712}], ["KRAS", ["TCGA.DM.A282.01", "G alpha (i) signalling events"], {"weight": 0.942674856074267}], ["KRAS", ["TCGA.DM.A282.01", "Adaptive Immune System"], {"weight": 0.886975052083055}], ["KRAS", ["TCGA.DM.A282.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.88029633623348}], ["KRAS", ["TCGA.DM.A282.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.923479382197896}], ["KRAS", ["TCGA.DM.A282.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.905620265336688}], ["KRAS", ["TCGA.DM.A282.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.905620265336688}], ["KRAS", ["TCGA.DM.A282.01", "Diseases of Immune System"], {"weight": 0.878418060627762}], ["KRAS", ["TCGA.DM.A282.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.878418060627762}], ["KRAS", ["TCGA.DM.A282.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.864765930605975}], ["KRAS", ["TCGA.DM.A282.01", "TNFs bind their physiological receptors"], {"weight": 0.508722407201703}], ["KRAS", ["TCGA.DM.A282.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.878516298180085}], ["KRAS", ["TCGA.DM.A282.01", "Interaction between L1 and Ankyrins"], {"weight": 0.929592237926161}], ["KRAS", ["TCGA.DM.A282.01", "Scavenging of heme from plasma"], {"weight": 0.725052747558069}], ["KRAS", ["TCGA.DM.A282.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.880176656826848}], ["KRAS", ["TCGA.DM.A282.01", "ERK1/ERK2 pathway"], {"weight": 0.916514097463817}], ["KRAS", ["TCGA.DM.A282.01", "MAPK family signaling cascades"], {"weight": 0.906923984225196}], ["KRAS", ["TCGA.DM.A282.01", "Innate Immune System"], {"weight": 0.887648978022583}], ["KRAS", ["TCGA.DM.A282.01", "Platelet activation, signaling and aggregation"], {"weight": 0.937382276149359}], ["KRAS", ["TCGA.DM.A282.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.865640922855557}], ["KRAS", ["TCGA.DM.A282.01", "RAF/MAP kinase cascade"], {"weight": 0.922802294238374}], ["KRAS", ["TCGA.DM.A282.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.805565810800912}], ["KRAS", ["TCGA.DM.A282.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.805565810800912}], ["KRAS", ["TCGA.DM.A282.01", "FGFR4 ligand binding and activation"], {"weight": 0.869322752246759}], ["KRAS", ["TCGA.DM.A282.01", "PI3K events in ERBB2 signaling"], {"weight": 0.865640922855557}], ["KRAS", ["TCGA.DM.A282.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.869322752246759}], ["KRAS", ["TCGA.DM.A282.01", "ERBB2 Regulates Cell Motility"], {"weight": 0.865640922855557}], ["KRAS", ["TCGA.DM.A282.01", "Platelet Aggregation (Plug Formation)"], {"weight": 0.897799075424561}], ["KRAS", ["TCGA.DM.A282.01", "IRS-related events triggered by IGF1R"], {"weight": 0.831651397030775}], ["KRAS", ["TCGA.DM.A282.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.831643119165361}], ["KRAS", ["TCGA.DM.A282.01", "IGF1R signaling cascade"], {"weight": 0.831643119165361}], ["KRAS", ["TCGA.DM.A282.01", "GRB2 events in ERBB2 signaling"], {"weight": 0.871226179523251}], ["KRAS", ["TCGA.DM.A285.01", "Immune System"], {"weight": 0.884168671576861}], ["KRAS", ["TCGA.DM.A285.01", "Adaptive Immune System"], {"weight": 0.901102391902949}], ["KRAS", ["TCGA.DM.A285.01", "Signaling Pathways"], {"weight": 0.89072946408558}], ["KRAS", ["TCGA.DM.A285.01", "Cytokine Signaling in Immune system"], {"weight": 0.844042365233268}], ["KRAS", ["TCGA.DM.A285.01", "Interaction between L1 and Ankyrins"], {"weight": 0.917400311644089}], ["KRAS", ["TCGA.DM.A28G.01", "Signaling Pathways"], {"weight": 0.884426301537631}], ["KRAS", ["TCGA.DM.A28G.01", "Phase 0 - rapid depolarisation"], {"weight": 0.921381120622236}], ["KRAS", ["TCGA.DM.A28G.01", "IRS-related events triggered by IGF1R"], {"weight": 0.83650239172357}], ["KRAS", ["TCGA.DM.A28G.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.836494239017418}], ["KRAS", ["TCGA.DM.A28G.01", "IGF1R signaling cascade"], {"weight": 0.836494239017418}], ["KRAS", ["TCGA.DM.A28G.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.891817859449629}], ["KRAS", ["TCGA.DM.A28G.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.803072950155062}], ["KRAS", ["TCGA.DM.A28G.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.803072950155062}], ["KRAS", ["TCGA.DM.A28G.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.873553524803437}], ["KRAS", ["TCGA.DM.A28G.01", "FGFR2 ligand binding and activation"], {"weight": 0.888721840749479}], ["KRAS", ["TCGA.DM.A28K.01", "Interaction between L1 and Ankyrins"], {"weight": 0.951660454686077}], ["KRAS", ["TCGA.DM.A28K.01", "Signaling Pathways"], {"weight": 0.92173683090773}], ["KRAS", ["TCGA.DM.A28K.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.930120790312013}], ["KRAS", ["TCGA.DM.A28K.01", "Extracellular matrix organization"], {"weight": 0.86400497700158}], ["KRAS", ["TCGA.DM.A28K.01", "Molecules associated with elastic fibres"], {"weight": 0.785897352599799}], ["KRAS", ["TCGA.DM.A28K.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.825273896600825}], ["KRAS", ["TCGA.DM.A28K.01", "L1CAM interactions"], {"weight": 0.900485970301739}], ["KRAS", ["TCGA.DM.A28K.01", "Protein-protein interactions at synapses"], {"weight": 0.916991086256881}], ["KRAS", ["TCGA.DM.A28K.01", "Elastic fibre formation"], {"weight": 0.803805596014905}], ["KRAS", ["TCGA.DM.A28K.01", "Transport of small molecules"], {"weight": 0.934986141964947}], ["KRAS", ["TCGA.DM.A28M.01", "Interaction between L1 and Ankyrins"], {"weight": 0.952349591403141}], ["KRAS", ["TCGA.DM.A28M.01", "Netrin-1 signaling"], {"weight": 0.881507155868221}], ["KRAS", ["TCGA.DM.A28M.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.935373702106723}], ["KRAS", ["TCGA.DM.A28M.01", "Protein-protein interactions at synapses"], {"weight": 0.931791312041169}], ["KRAS", ["TCGA.DM.A28M.01", "Transport of small molecules"], {"weight": 0.920984173693578}], ["KRAS", ["TCGA.DM.A28M.01", "ERK1/ERK2 pathway"], {"weight": 0.945367129811246}], ["KRAS", ["TCGA.DM.A28M.01", "Neurexins and neuroligins"], {"weight": 0.949892112099275}], ["KRAS", ["TCGA.DM.A28M.01", "Innate Immune System"], {"weight": 0.920591212830752}], ["KRAS", ["TCGA.DM.A28M.01", "NCAM1 interactions"], {"weight": 0.954123541200797}], ["KRAS", ["TCGA.DM.A28M.01", "RAF/MAP kinase cascade"], {"weight": 0.951005351459495}], ["KRAS", ["TCGA.F4.6806.01", "Interaction between L1 and Ankyrins"], {"weight": 0.911227879970088}], ["KRAS", ["TCGA.F4.6806.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.608322113746332}], ["KRAS", ["TCGA.F4.6806.01", "Integrin cell surface interactions"], {"weight": 0.858038419490084}], ["KRAS", ["TCGA.F4.6806.01", "Phase 0 - rapid depolarisation"], {"weight": 0.893988669232065}], ["KRAS", ["TCGA.F4.6806.01", "Scavenging of heme from plasma"], {"weight": 0.504041113409246}], ["KRAS", ["TCGA.F4.6806.01", "Response to elevated platelet cytosolic Ca2+"], {"weight": 0.912355144156973}], ["KRAS", ["TCGA.F4.6806.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.793988416326884}], ["KRAS", ["TCGA.G4.6294.01", "Signaling Pathways"], {"weight": 0.89544782748367}], ["KRAS", ["TCGA.G4.6294.01", "Interaction between L1 and Ankyrins"], {"weight": 0.932766957024159}], ["KRAS", ["TCGA.G4.6297.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.840876386547467}], ["KRAS", ["TCGA.G4.6323.01", "Interaction between L1 and Ankyrins"], {"weight": 0.907637001825916}], ["KRAS", ["TCGA.G4.6323.01", "FGFR2 ligand binding and activation"], {"weight": 0.871298742907552}], ["KRAS", ["TCGA.G4.6323.01", "Signaling Pathways"], {"weight": 0.835756864289044}], ["KRAS", ["TCGA.G4.6323.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.787290046570887}], ["KRAS", ["TCGA.G4.6323.01", "Activated point mutants of FGFR2"], {"weight": 0.83902408185689}], ["MTOR", ["TCGA.A6.4105.01", "Neuronal System"], {"weight": 0.892092728112779}], ["MTOR", ["TCGA.A6.4105.01", "Transmission across Chemical Synapses"], {"weight": 0.893478318490416}], ["MTOR", ["TCGA.A6.4105.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.882908449534453}], ["MTOR", ["TCGA.A6.6651.01", "Biological oxidations"], {"weight": 0.880427328281858}], ["MTOR", ["TCGA.A6.6651.01", "Phase II - Conjugation of compounds"], {"weight": 0.811105593671557}], ["MTOR", ["TCGA.A6.6651.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.727479140752314}], ["MTOR", ["TCGA.CM.4752.01", "Phase II - Conjugation of compounds"], {"weight": 0.59867972064256}], ["MTOR", ["TCGA.DM.A1D4.01", "CD22 mediated BCR regulation"], {"weight": 0.884960770085835}], ["MTOR", ["TCGA.F4.6806.01", "Initial triggering of complement"], {"weight": 0.772980325023701}], ["MTOR", ["TCGA.F4.6806.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.41291819924105}], ["MTOR", ["TCGA.G4.6298.01", "Signaling by GPCR"], {"weight": 0.945371008961642}], ["MTOR", ["TCGA.G4.6298.01", "GPCR downstream signalling"], {"weight": 0.943862396901856}], ["MTOR", ["TCGA.G4.6298.01", "Inflammasomes"], {"weight": 0.779376821162194}], ["MTOR", ["TCGA.G4.6298.01", "CD22 mediated BCR regulation"], {"weight": 0.848857897267303}], ["MTOR", ["TCGA.G4.6322.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.857906164329633}], ["MTOR", ["TCGA.G4.6322.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.835924906789743}], ["MTOR", ["TCGA.G4.6322.01", "Glycosaminoglycan metabolism"], {"weight": 0.829446823323133}], ["MTOR", ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts"], {"weight": 0.784384631434446}], ["MTOR", ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.75303226344386}], ["MTOR", ["TCGA.G4.6322.01", "Phase II - Conjugation of compounds"], {"weight": 0.802025617376858}], ["MTOR", ["TCGA.G4.6322.01", "Protein-protein interactions at synapses"], {"weight": 0.844231226531759}], ["MTOR", ["TCGA.G4.6586.01", "Stimuli-sensing channels"], {"weight": 0.937815427748518}], ["NCAM1", ["TCGA.A6.4105.01", "Interaction between L1 and Ankyrins"], {"weight": 0.907363234077216}], ["NCAM1", ["TCGA.AZ.5407.01", "Interaction between L1 and Ankyrins"], {"weight": 0.930024363782303}], ["NCAM1", ["TCGA.CM.4747.01", "Cardiac conduction"], {"weight": 0.838818198536742}], ["NCAM1", ["TCGA.CM.4747.01", "Interaction between L1 and Ankyrins"], {"weight": 0.895302861183469}], ["NCAM1", ["TCGA.D5.6535.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.852793203092064}], ["NCAM1", ["TCGA.D5.6535.01", "Degradation of the extracellular matrix"], {"weight": 0.752288252317252}], ["NCAM1", ["TCGA.D5.6535.01", "L1CAM interactions"], {"weight": 0.872926235180717}], ["NEFH", ["TCGA.A6.6142.01", "Visual phototransduction"], {"weight": 0.880019389315748}], ["NEFH", ["TCGA.A6.6142.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.891846461215288}], ["NEFH", ["TCGA.A6.6142.01", "Retinoid metabolism and transport"], {"weight": 0.891846461215288}], ["NEFH", ["TCGA.A6.6650.01", "Heme degradation"], {"weight": 0.798286586701193}], ["NEFH", ["TCGA.A6.6652.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.832668142186488}], ["NEFH", ["TCGA.A6.6652.01", "Retinoid metabolism and transport"], {"weight": 0.832668142186488}], ["NEFH", ["TCGA.A6.6652.01", "Arachidonic acid metabolism"], {"weight": 0.890610081284412}], ["NEFH", ["TCGA.AD.6890.01", "Acyl chain remodelling of PE"], {"weight": 0.777530385367888}], ["NEFH", ["TCGA.AD.6963.01", "Platelet homeostasis"], {"weight": 0.830318568496823}], ["NEFH", ["TCGA.AM.5820.01", "FOXO-mediated transcription of cell death genes"], {"weight": 0.643989769770134}], ["NEFH", ["TCGA.AZ.6603.01", "Platelet homeostasis"], {"weight": 0.709980157329227}], ["NEFH", ["TCGA.CK.4948.01", "Platelet homeostasis"], {"weight": 0.805233846816276}], ["NEFH", ["TCGA.CM.6170.01", "Platelet homeostasis"], {"weight": 0.736196554353211}], ["NEFH", ["TCGA.CM.6170.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.562765089685938}], ["NEFH", ["TCGA.CM.6170.01", "Metabolism of amine-derived hormones"], {"weight": 0.449864425556487}], ["NEFH", ["TCGA.D5.5537.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.555556328702614}], ["NEFH", ["TCGA.DM.A1D0.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.896362526153716}], ["NEFH", ["TCGA.DM.A1D0.01", "Arachidonic acid metabolism"], {"weight": 0.900138528475542}], ["NEFH", ["TCGA.DM.A1D8.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.805123554215652}], ["NEFH", ["TCGA.DM.A1DB.01", "Glycosaminoglycan metabolism"], {"weight": 0.837379400796012}], ["NEFH", ["TCGA.DM.A1DB.01", "Acyl chain remodelling of PE"], {"weight": 0.84050698334722}], ["NEFH", ["TCGA.DM.A1DB.01", "SLC-mediated transmembrane transport"], {"weight": 0.907174314485437}], ["NEFH", ["TCGA.G4.6310.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.795274360986056}], ["NEFH", ["TCGA.G4.6317.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.913160879649587}], ["NEFH", ["TCGA.G4.6317.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.913160879649587}], ["NEFH", ["TCGA.G4.6317.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.804199143058672}], ["NEFH", ["TCGA.G4.6317.01", "Diseases of Immune System"], {"weight": 0.896099737422621}], ["NEFH", ["TCGA.G4.6317.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.896099737422621}], ["FLT4", ["TCGA.A6.4105.01", "FGFR4 ligand binding and activation"], {"weight": 0.858995156767019}], ["FLT4", ["TCGA.A6.4105.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.858995156767019}], ["FLT4", ["TCGA.A6.4105.01", "FGFR2 ligand binding and activation"], {"weight": 0.874954272153203}], ["FLT4", ["TCGA.A6.4105.01", "FGFR2c ligand binding and activation"], {"weight": 0.85171997469939}], ["FLT4", ["TCGA.A6.6780.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.892729273727071}], ["FLT4", ["TCGA.CA.5796.01", "Signaling by GPCR"], {"weight": 0.938513011120993}], ["FLT4", ["TCGA.CA.5796.01", "GPCR downstream signalling"], {"weight": 0.944007305204407}], ["FLT4", ["TCGA.CA.5796.01", "Integration of energy metabolism"], {"weight": 0.887360423171943}], ["FLT4", ["TCGA.CA.5796.01", "G alpha (i) signalling events"], {"weight": 0.943709316334525}], ["FLT4", ["TCGA.CA.5796.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.828783372414783}], ["FLT4", ["TCGA.CA.5796.01", "Sensory perception of taste"], {"weight": 0.87154730352486}], ["FLT4", ["TCGA.CA.5796.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.86377385597274}], ["FLT4", ["TCGA.CA.5796.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.847962512246445}], ["FLT4", ["TCGA.CA.5796.01", "Presynaptic function of Kainate receptors"], {"weight": 0.86377385597274}], ["FLT4", ["TCGA.D5.6541.01", "Collagen formation"], {"weight": 0.930625471863842}], ["FLT4", ["TCGA.D5.6541.01", "Collagen chain trimerization"], {"weight": 0.92364449231839}], ["FLT4", ["TCGA.D5.6541.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.902685647077491}], ["FLT4", ["TCGA.F4.6805.01", "Collagen formation"], {"weight": 0.906058993846037}], ["FLT4", ["TCGA.F4.6805.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.932613964506198}], ["FLT4", ["TCGA.F4.6805.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.879094568051508}], ["FLT4", ["TCGA.F4.6805.01", "Collagen chain trimerization"], {"weight": 0.903074315735304}], ["FLT4", ["TCGA.F4.6805.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.589972703423975}], ["EGLN3", ["TCGA.A6.4105.01", "APAP ADME"], {"weight": 0.787285012312891}], ["SPTB", ["TCGA.A6.4105.01", "Phase 0 - rapid depolarisation"], {"weight": 0.863531398232448}], ["SPTB", ["TCGA.A6.4105.01", "GABA receptor activation"], {"weight": 0.830634450767143}], ["SPTB", ["TCGA.D5.6541.01", "Phase 4 - resting membrane potential"], {"weight": 0.766736804409508}], ["ATP2A1", ["TCGA.A6.4105.01", "Cardiac conduction"], {"weight": 0.916736509018308}], ["ATP2A1", ["TCGA.AU.6004.01", "Cardiac conduction"], {"weight": 0.943566832633108}], ["CUBN", ["TCGA.G4.6295.01", "Metabolism"], {"weight": 0.930702739555531}], ["CUBN", ["TCGA.G4.6309.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.701032576687837}], ["CUBN", ["TCGA.G4.6309.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.701032576687837}], ["TUBB1", ["TCGA.A6.4105.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.611327400894507}], ["ATM", ["TCGA.DM.A0XF.01", "DNA strand elongation"], {"weight": 0.877507011305597}], ["ATM", ["TCGA.DM.A0XF.01", "G0 and Early G1"], {"weight": 0.876019398436004}], ["POLA2", ["TCGA.A6.4105.01", "Drug ADME"], {"weight": 0.880906505491194}], ["POLA2", ["TCGA.A6.4105.01", "Transcription of E2F targets under negative control by DREAM complex"], {"weight": 0.809725734156834}], ["POLA2", ["TCGA.CK.4952.01", "Unwinding of DNA"], {"weight": 0.894537139459551}], ["POLA2", ["TCGA.CK.4952.01", "Activation of the pre-replicative complex"], {"weight": 0.910381138584246}], ["POLA2", ["TCGA.CK.4952.01", "DNA strand elongation"], {"weight": 0.903701948384052}], ["POLA2", ["TCGA.CK.4952.01", "Activation of ATR in response to replication stress"], {"weight": 0.899887087658295}], ["SOX9", ["TCGA.A6.6652.01", "Signaling by GPCR"], {"weight": 0.946809244254723}], ["SOX9", ["TCGA.A6.6652.01", "GPCR downstream signalling"], {"weight": 0.949479831396626}], ["SOX9", ["TCGA.A6.6652.01", "Neuronal System"], {"weight": 0.933751152235317}], ["SOX9", ["TCGA.A6.6652.01", "G alpha (i) signalling events"], {"weight": 0.957636850830838}], ["SOX9", ["TCGA.A6.6652.01", "Transmission across Chemical Synapses"], {"weight": 0.920548892792207}], ["SOX9", ["TCGA.A6.6652.01", "Regulation of insulin secretion"], {"weight": 0.932838449303029}], ["SOX9", ["TCGA.A6.6652.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.916261355153929}], ["SOX9", ["TCGA.A6.6652.01", "G alpha (s) signalling events"], {"weight": 0.962757270736792}], ["SOX9", ["TCGA.A6.6652.01", "Voltage gated Potassium channels"], {"weight": 0.921122199547541}], ["SOX9", ["TCGA.A6.6652.01", "Ca-dependent events"], {"weight": 0.855454121649096}], ["SOX9", ["TCGA.A6.6652.01", "Opioid Signalling"], {"weight": 0.921194895605858}], ["SOX9", ["TCGA.A6.6652.01", "Calmodulin induced events"], {"weight": 0.881231178346448}], ["SOX9", ["TCGA.A6.6652.01", "CaM pathway"], {"weight": 0.881231178346448}], ["SOX9", ["TCGA.A6.6652.01", "Visual phototransduction"], {"weight": 0.89183213828553}], ["SOX9", ["TCGA.A6.6652.01", "DAG and IP3 signaling"], {"weight": 0.881231178346448}], ["SOX9", ["TCGA.A6.6652.01", "Cell surface interactions at the vascular wall"], {"weight": 0.688919035058174}], ["SOX9", ["TCGA.A6.6652.01", "Stimuli-sensing channels"], {"weight": 0.894518431959703}], ["SOX9", ["TCGA.AA.3492.01", "G alpha (s) signalling events"], {"weight": 0.954951963794108}], ["SOX9", ["TCGA.AA.3492.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.924055259579407}], ["SOX9", ["TCGA.AD.6889.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.935473341420277}], ["SOX9", ["TCGA.AD.6889.01", "PLC beta mediated events"], {"weight": 0.904928010746446}], ["SOX9", ["TCGA.AD.6889.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.920592500194005}], ["SOX9", ["TCGA.AD.6889.01", "Leishmania parasite growth and survival"], {"weight": 0.920592500194005}], ["SOX9", ["TCGA.AD.6889.01", "Calmodulin induced events"], {"weight": 0.898988952906308}], ["SOX9", ["TCGA.AD.6889.01", "CaM pathway"], {"weight": 0.898988952906308}], ["SOX9", ["TCGA.AD.6889.01", "DAG and IP3 signaling"], {"weight": 0.900418648175555}], ["SOX9", ["TCGA.AD.6889.01", "Ca-dependent events"], {"weight": 0.898988952906308}], ["SOX9", ["TCGA.AD.6890.01", "Interaction between L1 and Ankyrins"], {"weight": 0.910844469131137}], ["SOX9", ["TCGA.AD.6890.01", "Neuronal System"], {"weight": 0.915272673481239}], ["SOX9", ["TCGA.AD.6890.01", "GPCR downstream signalling"], {"weight": 0.931500039664701}], ["SOX9", ["TCGA.AD.6890.01", "Signaling by GPCR"], {"weight": 0.92699969922634}], ["SOX9", ["TCGA.AD.6890.01", "G alpha (s) signalling events"], {"weight": 0.948777385539265}], ["SOX9", ["TCGA.AD.6890.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.883122419899882}], ["SOX9", ["TCGA.AD.6890.01", "Transmission across Chemical Synapses"], {"weight": 0.897266825600953}], ["SOX9", ["TCGA.AD.6890.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.894485167307699}], ["SOX9", ["TCGA.AD.6890.01", "G alpha (i) signalling events"], {"weight": 0.910838478542242}], ["SOX9", ["TCGA.AD.6890.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.896365190641043}], ["SOX9", ["TCGA.AD.6890.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.861239468673}], ["SOX9", ["TCGA.AD.6890.01", "Ion homeostasis"], {"weight": 0.817208140149299}], ["SOX9", ["TCGA.AD.6890.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.884818531252199}], ["SOX9", ["TCGA.AD.6890.01", "Aquaporin-mediated transport"], {"weight": 0.884818531252199}], ["SOX9", ["TCGA.AD.6890.01", "GPER1 signaling"], {"weight": 0.884818531252199}], ["SOX9", ["TCGA.AD.6890.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.884818531252199}], ["SOX9", ["TCGA.AY.6386.01", "Phase 0 - rapid depolarisation"], {"weight": 0.898200525557976}], ["SOX9", ["TCGA.AY.6386.01", "Developmental Biology"], {"weight": 0.872549762590334}], ["SOX9", ["TCGA.AY.6386.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.733708194642252}], ["SOX9", ["TCGA.CM.4744.01", "Neuronal System"], {"weight": 0.944187458678652}], ["SOX9", ["TCGA.CM.4744.01", "GPCR downstream signalling"], {"weight": 0.948937222461264}], ["SOX9", ["TCGA.CM.4744.01", "G alpha (i) signalling events"], {"weight": 0.951782581190078}], ["SOX9", ["TCGA.CM.4744.01", "DAG and IP3 signaling"], {"weight": 0.911636055303147}], ["SOX9", ["TCGA.CM.4744.01", "Integration of energy metabolism"], {"weight": 0.94089526953769}], ["SOX9", ["TCGA.CM.4744.01", "G-protein mediated events"], {"weight": 0.918608215626003}], ["SOX9", ["TCGA.CM.4744.01", "Calmodulin induced events"], {"weight": 0.906842145655608}], ["SOX9", ["TCGA.CM.4744.01", "CaM pathway"], {"weight": 0.906842145655608}], ["SOX9", ["TCGA.CM.4744.01", "PLC beta mediated events"], {"weight": 0.890093745390742}], ["SOX9", ["TCGA.CM.4744.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.930910254329093}], ["SOX9", ["TCGA.CM.4744.01", "Regulation of insulin secretion"], {"weight": 0.936332196966301}], ["SOX9", ["TCGA.CM.4744.01", "Ca-dependent events"], {"weight": 0.906842145655608}], ["SOX9", ["TCGA.CM.4744.01", "PKA activation in glucagon signalling"], {"weight": 0.909973040609963}], ["SOX9", ["TCGA.CM.4748.01", "Transmission across Chemical Synapses"], {"weight": 0.910726253563688}], ["SOX9", ["TCGA.CM.4748.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.908000603058278}], ["SOX9", ["TCGA.CM.6677.01", "G alpha (s) signalling events"], {"weight": 0.950738941377077}], ["SOX9", ["TCGA.CM.6677.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.897654494783102}], ["SOX9", ["TCGA.CM.6677.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.902140387551601}], ["SOX9", ["TCGA.CM.6677.01", "Integration of energy metabolism"], {"weight": 0.901462322757271}], ["SOX9", ["TCGA.D5.5537.01", "Ion homeostasis"], {"weight": 0.838141970867018}], ["SOX9", ["TCGA.D5.6532.01", "G alpha (i) signalling events"], {"weight": 0.942065207724838}], ["SOX9", ["TCGA.D5.6532.01", "GPCR downstream signalling"], {"weight": 0.946100509615785}], ["SOX9", ["TCGA.D5.6532.01", "Signaling by GPCR"], {"weight": 0.943344426938426}], ["SOX9", ["TCGA.D5.6532.01", "Leishmania infection"], {"weight": 0.878303523683378}], ["SOX9", ["TCGA.D5.6532.01", "Parasitic Infection Pathways"], {"weight": 0.878303523683378}], ["SOX9", ["TCGA.D5.6532.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.934009963500409}], ["SOX9", ["TCGA.D5.6532.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.904773182853231}], ["SOX9", ["TCGA.D5.6532.01", "Leishmania parasite growth and survival"], {"weight": 0.904773182853231}], ["SOX9", ["TCGA.D5.6532.01", "Regulation of insulin secretion"], {"weight": 0.928907210704863}], ["SOX9", ["TCGA.D5.6532.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.930074458915511}], ["SOX9", ["TCGA.D5.6532.01", "Phase 0 - rapid depolarisation"], {"weight": 0.90713425988999}], ["SOX9", ["TCGA.D5.6532.01", "G alpha (s) signalling events"], {"weight": 0.962032015984642}], ["SOX9", ["TCGA.D5.6532.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.923512800821574}], ["SOX9", ["TCGA.D5.6532.01", "Integration of energy metabolism"], {"weight": 0.931697756220814}], ["SOX9", ["TCGA.D5.6532.01", "Voltage gated Potassium channels"], {"weight": 0.912662247805127}], ["SOX9", ["TCGA.D5.6532.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.782892277908084}], ["SOX9", ["TCGA.D5.6532.01", "GPER1 signaling"], {"weight": 0.917010190563596}], ["SOX9", ["TCGA.D5.6532.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.917010190563596}], ["SOX9", ["TCGA.D5.6532.01", "Transport of small molecules"], {"weight": 0.907558687085485}], ["SOX9", ["TCGA.D5.6532.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.86401475902907}], ["SOX9", ["TCGA.D5.6929.01", "Potassium Channels"], {"weight": 0.86415686297145}], ["SOX9", ["TCGA.D5.6929.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.798752371081612}], ["SOX9", ["TCGA.D5.6931.01", "Transmission across Chemical Synapses"], {"weight": 0.828014997211704}], ["SOX9", ["TCGA.D5.6931.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.83010561841854}], ["SOX9", ["TCGA.DM.A0XD.01", "GPCR downstream signalling"], {"weight": 0.957433691803322}], ["SOX9", ["TCGA.DM.A0XD.01", "Signaling by GPCR"], {"weight": 0.957094773022759}], ["SOX9", ["TCGA.DM.A0XD.01", "G alpha (i) signalling events"], {"weight": 0.963989171571232}], ["SOX9", ["TCGA.DM.A0XD.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.905515027503893}], ["SOX9", ["TCGA.DM.A28K.01", "Signaling by GPCR"], {"weight": 0.950139484928767}], ["SOX9", ["TCGA.DM.A28K.01", "Chemokine receptors bind chemokines"], {"weight": 0.930332904565246}], ["SOX9", ["TCGA.DM.A28K.01", "Transmission across Chemical Synapses"], {"weight": 0.926038312594563}], ["SOX9", ["TCGA.DM.A28K.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.903328945798778}], ["SOX9", ["TCGA.DM.A28K.01", "Leishmania parasite growth and survival"], {"weight": 0.903328945798778}], ["SOX9", ["TCGA.DM.A28K.01", "Calmodulin induced events"], {"weight": 0.898026388082336}], ["SOX9", ["TCGA.DM.A28K.01", "CaM pathway"], {"weight": 0.898026388082336}], ["SOX9", ["TCGA.DM.A28K.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.930276677441953}], ["SOX9", ["TCGA.DM.A28K.01", "Aquaporin-mediated transport"], {"weight": 0.930276677441953}], ["SOX9", ["TCGA.DM.A28K.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.922834885693691}], ["SOX9", ["TCGA.DM.A28K.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.919124428408133}], ["SOX9", ["TCGA.DM.A28K.01", "Leishmania infection"], {"weight": 0.901417824722287}], ["SOX9", ["TCGA.DM.A28K.01", "Parasitic Infection Pathways"], {"weight": 0.901417824722287}], ["SOX9", ["TCGA.DM.A28K.01", "DAG and IP3 signaling"], {"weight": 0.901444805395767}], ["SOX9", ["TCGA.DM.A28K.01", "Ca-dependent events"], {"weight": 0.898026388082336}], ["SOX9", ["TCGA.DM.A28K.01", "PLC beta mediated events"], {"weight": 0.878078738297668}], ["SOX9", ["TCGA.DM.A28K.01", "G-protein mediated events"], {"weight": 0.883846655827347}], ["SOX9", ["TCGA.DM.A28K.01", "Opioid Signalling"], {"weight": 0.922177988687431}], ["SOX9", ["TCGA.DM.A28K.01", "Integration of energy metabolism"], {"weight": 0.915479162550354}], ["SOX9", ["TCGA.F4.6805.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.868504786015966}], ["SOX9", ["TCGA.G4.6293.01", "Phase 0 - rapid depolarisation"], {"weight": 0.851789660011323}], ["SOX9", ["TCGA.G4.6306.01", "Neuronal System"], {"weight": 0.945578145776631}], ["SOX9", ["TCGA.G4.6306.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.890236713654998}], ["SOX9", ["TCGA.G4.6306.01", "Leishmania parasite growth and survival"], {"weight": 0.890236713654998}], ["SOX9", ["TCGA.G4.6306.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.924849275735108}], ["SOX9", ["TCGA.G4.6306.01", "Regulation of insulin secretion"], {"weight": 0.904307348539108}], ["SOX9", ["TCGA.G4.6306.01", "Chemokine receptors bind chemokines"], {"weight": 0.922057644980066}], ["SOX9", ["TCGA.G4.6306.01", "Nervous system development"], {"weight": 0.908538929038986}], ["SOX9", ["TCGA.G4.6306.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.920980791407575}], ["SOX9", ["TCGA.G4.6306.01", "Axon guidance"], {"weight": 0.913705435921433}], ["SOX9", ["TCGA.G4.6306.01", "Leishmania infection"], {"weight": 0.90906410952141}], ["SOX9", ["TCGA.G4.6306.01", "Parasitic Infection Pathways"], {"weight": 0.90906410952141}], ["SOX9", ["TCGA.G4.6306.01", "Plasma lipoprotein assembly"], {"weight": 0.797060816591057}], ["SOX9", ["TCGA.G4.6306.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.921359555355457}], ["SOX9", ["TCGA.G4.6306.01", "Aquaporin-mediated transport"], {"weight": 0.921359555355457}], ["SOX9", ["TCGA.G4.6306.01", "GPER1 signaling"], {"weight": 0.922063205179186}], ["SOX9", ["TCGA.G4.6306.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.922063205179186}], ["SOX9", ["TCGA.G4.6314.01", "Collagen degradation"], {"weight": 0.862261089255355}], ["SOX3", ["TCGA.D5.5538.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.855528814179066}], ["IRF5", ["TCGA.A6.6648.01", "L1CAM interactions"], {"weight": 0.819810360023637}], ["IRF5", ["TCGA.A6.6650.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.897127016803788}], ["IRF5", ["TCGA.A6.6650.01", "PD-1 signaling"], {"weight": 0.904832507425054}], ["IRF5", ["TCGA.A6.6650.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.897127016803788}], ["IRF5", ["TCGA.A6.6650.01", "Generation of second messenger molecules"], {"weight": 0.851425953136058}], ["IRF5", ["TCGA.A6.6652.01", "Extracellular matrix organization"], {"weight": 0.867096386100773}], ["IRF5", ["TCGA.AD.6963.01", "Aspirin ADME"], {"weight": 0.829359403371554}], ["IRF5", ["TCGA.AD.6963.01", "Glucuronidation"], {"weight": 0.855513660881008}], ["IRF5", ["TCGA.CA.6716.01", "Interleukin-10 signaling"], {"weight": 0.937852670113919}], ["IRF5", ["TCGA.CA.6719.01", "Collagen chain trimerization"], {"weight": 0.862850527107719}], ["IRF5", ["TCGA.CA.6719.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.898111719530553}], ["IRF5", ["TCGA.CK.4952.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.807830475824766}], ["IRF5", ["TCGA.CK.4952.01", "Extracellular matrix organization"], {"weight": 0.864522110003235}], ["IRF5", ["TCGA.CK.5912.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.751945012797145}], ["IRF5", ["TCGA.CK.5912.01", "Heme degradation"], {"weight": 0.638468074990693}], ["IRF5", ["TCGA.CK.5914.01", "Drug ADME"], {"weight": 0.810237033292838}], ["IRF5", ["TCGA.CK.5915.01", "NCAM1 interactions"], {"weight": 0.930307811105511}], ["IRF5", ["TCGA.CK.5915.01", "Drug ADME"], {"weight": 0.865388845192509}], ["IRF5", ["TCGA.CM.4747.01", "Interleukin-10 signaling"], {"weight": 0.919220696907666}], ["IRF5", ["TCGA.CM.4747.01", "Physiological factors"], {"weight": 0.586451030795067}], ["IRF5", ["TCGA.CM.5860.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.808666030059419}], ["IRF5", ["TCGA.CM.5862.01", "Costimulation by the CD28 family"], {"weight": 0.907244690210543}], ["IRF5", ["TCGA.CM.5862.01", "Extracellular matrix organization"], {"weight": 0.879713872455459}], ["IRF5", ["TCGA.CM.6166.01", "Cardiac conduction"], {"weight": 0.889726911064983}], ["IRF5", ["TCGA.D5.6529.01", "Scavenging by Class A Receptors"], {"weight": 0.467674322362396}], ["IRF5", ["TCGA.D5.6537.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.924854885465462}], ["IRF5", ["TCGA.D5.6537.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.925516762938705}], ["IRF5", ["TCGA.D5.6537.01", "Generation of second messenger molecules"], {"weight": 0.858767900435667}], ["IRF5", ["TCGA.D5.6537.01", "PD-1 signaling"], {"weight": 0.925516762938705}], ["IRF5", ["TCGA.DM.A1D0.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.911630285868158}], ["IRF5", ["TCGA.DM.A1D0.01", "Interleukin-10 signaling"], {"weight": 0.925089537866882}], ["IRF5", ["TCGA.DM.A1D0.01", "Other interleukin signaling"], {"weight": 0.769066829242667}], ["IRF5", ["TCGA.DM.A1D0.01", "MHC class II antigen presentation"], {"weight": 0.936644691756717}], ["IRF5", ["TCGA.DM.A282.01", "Integrin cell surface interactions"], {"weight": 0.930698281315963}], ["IRF5", ["TCGA.DM.A28C.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.946798854649134}], ["IRF5", ["TCGA.DM.A28C.01", "Generation of second messenger molecules"], {"weight": 0.947549510139391}], ["IRF5", ["TCGA.DM.A28C.01", "PD-1 signaling"], {"weight": 0.946919516169823}], ["IRF5", ["TCGA.DM.A28C.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.944355940478946}], ["IRF5", ["TCGA.DM.A28C.01", "Interleukin-10 signaling"], {"weight": 0.933248639512808}], ["IRF5", ["TCGA.DM.A28C.01", "Integrin cell surface interactions"], {"weight": 0.929985033922815}], ["IRF5", ["TCGA.DM.A28F.01", "Other interleukin signaling"], {"weight": 0.702615109715549}], ["IRF5", ["TCGA.DM.A28H.01", "Interferon alpha/beta signaling"], {"weight": 0.923865489152098}], ["IRF5", ["TCGA.F4.6806.01", "L1CAM interactions"], {"weight": 0.889612598669048}], ["IRF5", ["TCGA.F4.6807.01", "Glucuronidation"], {"weight": 0.777212487194128}], ["IRF5", ["TCGA.F4.6807.01", "Aspirin ADME"], {"weight": 0.832054835286107}], ["IRF5", ["TCGA.F4.6808.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.831072089090974}], ["IRF5", ["TCGA.F4.6808.01", "Costimulation by the CD28 family"], {"weight": 0.910687617140364}], ["PIK3CA", ["TCGA.A6.4105.01", "PI-3K cascade:FGFR4"], {"weight": 0.870518414164939}], ["PIK3CA", ["TCGA.A6.5657.01", "Metabolism"], {"weight": 0.866350768731365}], ["PIK3CA", ["TCGA.A6.5659.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.69721448141704}], ["PIK3CA", ["TCGA.A6.5659.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.876241251685336}], ["PIK3CA", ["TCGA.A6.5659.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.876241251685336}], ["PIK3CA", ["TCGA.A6.5659.01", "Diseases of Immune System"], {"weight": 0.883834368553459}], ["PIK3CA", ["TCGA.A6.5659.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.883834368553459}], ["PIK3CA", ["TCGA.A6.5666.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.856428498454805}], ["PIK3CA", ["TCGA.A6.5666.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.949521247548913}], ["PIK3CA", ["TCGA.A6.5666.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.949520205271623}], ["PIK3CA", ["TCGA.A6.5666.01", "Extracellular matrix organization"], {"weight": 0.900119564154423}], ["PIK3CA", ["TCGA.A6.5666.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.814003607537753}], ["PIK3CA", ["TCGA.A6.5666.01", "Drug ADME"], {"weight": 0.880799870818254}], ["PIK3CA", ["TCGA.A6.5666.01", "Platelet homeostasis"], {"weight": 0.908478042671803}], ["PIK3CA", ["TCGA.A6.5666.01", "Peptide hormone metabolism"], {"weight": 0.761392555263663}], ["PIK3CA", ["TCGA.A6.5666.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.902961221896893}], ["PIK3CA", ["TCGA.A6.5666.01", "Developmental Biology"], {"weight": 0.916391487991332}], ["PIK3CA", ["TCGA.A6.5666.01", "CD22 mediated BCR regulation"], {"weight": 0.863807133211761}], ["PIK3CA", ["TCGA.A6.5666.01", "L1CAM interactions"], {"weight": 0.933504317115873}], ["PIK3CA", ["TCGA.A6.5666.01", "PI3K events in ERBB2 signaling"], {"weight": 0.900153017481267}], ["PIK3CA", ["TCGA.A6.5666.01", "PI-3K cascade:FGFR1"], {"weight": 0.918181973781073}], ["PIK3CA", ["TCGA.A6.6780.01", "Axon guidance"], {"weight": 0.916395960418353}], ["PIK3CA", ["TCGA.A6.6780.01", "Nervous system development"], {"weight": 0.916588957405916}], ["PIK3CA", ["TCGA.AA.3660.01", "Extracellular matrix organization"], {"weight": 0.770196950891088}], ["PIK3CA", ["TCGA.AA.3660.01", "IRS-related events triggered by IGF1R"], {"weight": 0.85587481237494}], ["PIK3CA", ["TCGA.AA.3660.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.855642931497435}], ["PIK3CA", ["TCGA.AA.3660.01", "IGF1R signaling cascade"], {"weight": 0.855642931497435}], ["PIK3CA", ["TCGA.AA.3660.01", "PI-3K cascade:FGFR4"], {"weight": 0.878694979788499}], ["PIK3CA", ["TCGA.AA.3660.01", "Peptide hormone metabolism"], {"weight": 0.653381349359912}], ["PIK3CA", ["TCGA.AA.3660.01", "IRS-mediated signalling"], {"weight": 0.851658062311948}], ["PIK3CA", ["TCGA.AA.3660.01", "Insulin receptor signalling cascade"], {"weight": 0.851407074015115}], ["PIK3CA", ["TCGA.AA.3660.01", "Downstream signaling of activated FGFR4"], {"weight": 0.878694979788499}], ["PIK3CA", ["TCGA.AA.3660.01", "PI-3K cascade:FGFR1"], {"weight": 0.848054464084847}], ["PIK3CA", ["TCGA.AA.3660.01", "Developmental Biology"], {"weight": 0.799415473575268}], ["PIK3CA", ["TCGA.AA.3660.01", "Signaling by WNT"], {"weight": 0.91290776222751}], ["PIK3CA", ["TCGA.AA.3660.01", "PI-3K cascade:FGFR2"], {"weight": 0.847679377561732}], ["PIK3CA", ["TCGA.AA.3712.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.921140565288511}], ["PIK3CA", ["TCGA.AA.3712.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.889974112998412}], ["PIK3CA", ["TCGA.AA.3712.01", "Leishmania parasite growth and survival"], {"weight": 0.889974112998412}], ["PIK3CA", ["TCGA.AD.6890.01", "G alpha (q) signalling events"], {"weight": 0.875399604792352}], ["PIK3CA", ["TCGA.AD.6890.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.852222162902433}], ["PIK3CA", ["TCGA.AD.6890.01", "Leishmania parasite growth and survival"], {"weight": 0.852222162902433}], ["PIK3CA", ["TCGA.AD.6890.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.92537624145814}], ["PIK3CA", ["TCGA.AD.6890.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.781755590544458}], ["PIK3CA", ["TCGA.AD.6890.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.889695773773189}], ["PIK3CA", ["TCGA.AD.6890.01", "SUMOylation of intracellular receptors"], {"weight": 0.705256738309438}], ["PIK3CA", ["TCGA.AD.6890.01", "Diseases of Immune System"], {"weight": 0.755407812806081}], ["PIK3CA", ["TCGA.AD.6890.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.755407812806081}], ["PIK3CA", ["TCGA.AD.6965.01", "Peptide hormone metabolism"], {"weight": 0.705051034105009}], ["PIK3CA", ["TCGA.AD.6965.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.633610703528142}], ["PIK3CA", ["TCGA.AM.5820.01", "Costimulation by the CD28 family"], {"weight": 0.891598829331735}], ["PIK3CA", ["TCGA.AM.5820.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.930483405438023}], ["PIK3CA", ["TCGA.AM.5820.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.929724959958914}], ["PIK3CA", ["TCGA.AY.5543.01", "Extracellular matrix organization"], {"weight": 0.890289665459328}], ["PIK3CA", ["TCGA.AY.6386.01", "Extracellular matrix organization"], {"weight": 0.856907628941801}], ["PIK3CA", ["TCGA.AY.6386.01", "Potassium Channels"], {"weight": 0.950796108687823}], ["PIK3CA", ["TCGA.AZ.4616.01", "Drug ADME"], {"weight": 0.838828013819616}], ["PIK3CA", ["TCGA.AZ.4616.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.902957005178343}], ["PIK3CA", ["TCGA.AZ.4616.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.90360200776146}], ["PIK3CA", ["TCGA.AZ.4616.01", "Platelet homeostasis"], {"weight": 0.868672727502693}], ["PIK3CA", ["TCGA.AZ.4616.01", "Integration of energy metabolism"], {"weight": 0.908805481275927}], ["PIK3CA", ["TCGA.AZ.4616.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.89695996476186}], ["PIK3CA", ["TCGA.AZ.4616.01", "Aquaporin-mediated transport"], {"weight": 0.89695996476186}], ["PIK3CA", ["TCGA.AZ.4616.01", "GPER1 signaling"], {"weight": 0.89695996476186}], ["PIK3CA", ["TCGA.AZ.4616.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.89695996476186}], ["PIK3CA", ["TCGA.AZ.4616.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.894829472568836}], ["PIK3CA", ["TCGA.AZ.4616.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.918167913905619}], ["PIK3CA", ["TCGA.AZ.4616.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.568572316281806}], ["PIK3CA", ["TCGA.AZ.4616.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.897635452642906}], ["PIK3CA", ["TCGA.AZ.4616.01", "Glucagon-type ligand receptors"], {"weight": 0.897944905391596}], ["PIK3CA", ["TCGA.CA.6718.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.923561164957632}], ["PIK3CA", ["TCGA.CM.4747.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.617891328789647}], ["PIK3CA", ["TCGA.CM.4747.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.914210867214075}], ["PIK3CA", ["TCGA.CM.4747.01", "Peptide hormone metabolism"], {"weight": 0.715330978952921}], ["PIK3CA", ["TCGA.CM.4747.01", "Drug ADME"], {"weight": 0.738675482174233}], ["PIK3CA", ["TCGA.CM.4747.01", "IRS-related events triggered by IGF1R"], {"weight": 0.856944199021516}], ["PIK3CA", ["TCGA.CM.4747.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.856719553544014}], ["PIK3CA", ["TCGA.CM.4747.01", "IGF1R signaling cascade"], {"weight": 0.856719553544014}], ["PIK3CA", ["TCGA.CM.4752.01", "Nervous system development"], {"weight": 0.833590616036584}], ["PIK3CA", ["TCGA.CM.4752.01", "Axon guidance"], {"weight": 0.850460758124023}], ["PIK3CA", ["TCGA.CM.5860.01", "Extracellular matrix organization"], {"weight": 0.892888216153047}], ["PIK3CA", ["TCGA.CM.5860.01", "Drug ADME"], {"weight": 0.909072959602388}], ["PIK3CA", ["TCGA.CM.5860.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.839956508125264}], ["PIK3CA", ["TCGA.CM.5860.01", "Platelet activation, signaling and aggregation"], {"weight": 0.856649582392858}], ["PIK3CA", ["TCGA.CM.5860.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.909961810227151}], ["PIK3CA", ["TCGA.CM.5860.01", "Peptide hormone biosynthesis"], {"weight": 0.516283844597517}], ["PIK3CA", ["TCGA.CM.5860.01", "Complement cascade"], {"weight": 0.744598731117466}], ["PIK3CA", ["TCGA.CM.5860.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.910880587470752}], ["PIK3CA", ["TCGA.CM.5860.01", "Signaling Pathways"], {"weight": 0.861556882096938}], ["PIK3CA", ["TCGA.CM.6678.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.816389435341391}], ["PIK3CA", ["TCGA.CM.6678.01", "Complement cascade"], {"weight": 0.809259294486216}], ["PIK3CA", ["TCGA.CM.6678.01", "Regulation of Complement cascade"], {"weight": 0.751994393246374}], ["PIK3CA", ["TCGA.CM.6678.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.9366261249617}], ["PIK3CA", ["TCGA.CM.6678.01", "CD22 mediated BCR regulation"], {"weight": 0.80855915043448}], ["PIK3CA", ["TCGA.CM.6678.01", "Chemokine receptors bind chemokines"], {"weight": 0.911609865846077}], ["PIK3CA", ["TCGA.CM.6678.01", "Peptide ligand-binding receptors"], {"weight": 0.920341201167385}], ["PIK3CA", ["TCGA.CM.6678.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.927429663251916}], ["PIK3CA", ["TCGA.CM.6678.01", "SUMOylation of intracellular receptors"], {"weight": 0.684931282781107}], ["PIK3CA", ["TCGA.CM.6678.01", "Other semaphorin interactions"], {"weight": 0.511054625834605}], ["PIK3CA", ["TCGA.D5.5540.01", "Axon guidance"], {"weight": 0.936823305040358}], ["PIK3CA", ["TCGA.D5.6529.01", "Extracellular matrix organization"], {"weight": 0.882370544301829}], ["PIK3CA", ["TCGA.D5.6529.01", "Interleukin-6 family signaling"], {"weight": 0.848413320631044}], ["PIK3CA", ["TCGA.D5.6529.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.844822735425772}], ["PIK3CA", ["TCGA.D5.6532.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.80967470086394}], ["PIK3CA", ["TCGA.D5.6532.01", "Potassium Channels"], {"weight": 0.955818411598841}], ["PIK3CA", ["TCGA.D5.6532.01", "Platelet homeostasis"], {"weight": 0.903337966925943}], ["PIK3CA", ["TCGA.D5.6532.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.936483128433283}], ["PIK3CA", ["TCGA.D5.6532.01", "Classical antibody-mediated complement activation"], {"weight": 0.658876391217506}], ["PIK3CA", ["TCGA.D5.6532.01", "G beta:gamma signalling through BTK"], {"weight": 0.916616010557706}], ["PIK3CA", ["TCGA.D5.6532.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.908714595146502}], ["PIK3CA", ["TCGA.D5.6532.01", "GPCR ligand binding"], {"weight": 0.942181482097902}], ["PIK3CA", ["TCGA.D5.6532.01", "Peptide hormone metabolism"], {"weight": 0.767038307076744}], ["PIK3CA", ["TCGA.D5.6532.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.920590478316247}], ["PIK3CA", ["TCGA.D5.6532.01", "Activation of G protein gated Potassium channels"], {"weight": 0.931071246538684}], ["PIK3CA", ["TCGA.D5.6532.01", "G protein gated Potassium channels"], {"weight": 0.931071246538684}], ["PIK3CA", ["TCGA.D5.6532.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.931071246538684}], ["PIK3CA", ["TCGA.D5.6532.01", "G beta:gamma signalling through CDC42"], {"weight": 0.913665405324947}], ["PIK3CA", ["TCGA.D5.6532.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.86760187084825}], ["PIK3CA", ["TCGA.D5.6532.01", "GABA B receptor activation"], {"weight": 0.934710275723479}], ["PIK3CA", ["TCGA.D5.6532.01", "Activation of GABAB receptors"], {"weight": 0.934710275723479}], ["PIK3CA", ["TCGA.D5.6532.01", "Glucagon-type ligand receptors"], {"weight": 0.919487563485548}], ["PIK3CA", ["TCGA.D5.6532.01", "Presynaptic function of Kainate receptors"], {"weight": 0.90233262028423}], ["PIK3CA", ["TCGA.D5.6532.01", "Inwardly rectifying K+ channels"], {"weight": 0.93708810116064}], ["PIK3CA", ["TCGA.D5.6532.01", "GABA receptor activation"], {"weight": 0.891681788891826}], ["PIK3CA", ["TCGA.D5.6532.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.911132376608984}], ["PIK3CA", ["TCGA.D5.6532.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.936473402188947}], ["PIK3CA", ["TCGA.D5.6532.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.884729482493615}], ["PIK3CA", ["TCGA.D5.6532.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.920739603947317}], ["PIK3CA", ["TCGA.D5.6532.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.946847433660831}], ["PIK3CA", ["TCGA.D5.6532.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.884729482493615}], ["PIK3CA", ["TCGA.D5.6532.01", "CD22 mediated BCR regulation"], {"weight": 0.807798079636154}], ["PIK3CA", ["TCGA.D5.6532.01", "Chemokine receptors bind chemokines"], {"weight": 0.919316530473732}], ["PIK3CA", ["TCGA.D5.6532.01", "Peptide ligand-binding receptors"], {"weight": 0.934623107219562}], ["PIK3CA", ["TCGA.D5.6532.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.806308218113707}], ["PIK3CA", ["TCGA.D5.6532.01", "Cell surface interactions at the vascular wall"], {"weight": 0.758798645382746}], ["PIK3CA", ["TCGA.D5.6532.01", "Diseases of Immune System"], {"weight": 0.856739829302979}], ["PIK3CA", ["TCGA.D5.6532.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.856739829302979}], ["PIK3CA", ["TCGA.D5.6532.01", "Creation of C4 and C2 activators"], {"weight": 0.625773000328616}], ["PIK3CA", ["TCGA.D5.6532.01", "G-protein activation"], {"weight": 0.884729482493615}], ["PIK3CA", ["TCGA.D5.6532.01", "Thromboxane signalling through TP receptor"], {"weight": 0.884729482493615}], ["PIK3CA", ["TCGA.D5.6537.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.938835858073916}], ["PIK3CA", ["TCGA.D5.6537.01", "Other semaphorin interactions"], {"weight": 0.730819127557054}], ["PIK3CA", ["TCGA.D5.6537.01", "CD22 mediated BCR regulation"], {"weight": 0.880989362029512}], ["PIK3CA", ["TCGA.D5.6537.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.749209052780763}], ["PIK3CA", ["TCGA.D5.6537.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.939357765608491}], ["PIK3CA", ["TCGA.D5.6537.01", "Long-term potentiation"], {"weight": 0.91804008152918}], ["PIK3CA", ["TCGA.D5.6537.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.906655254714869}], ["PIK3CA", ["TCGA.D5.6537.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.906655254714869}], ["PIK3CA", ["TCGA.D5.6537.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.908586794234369}], ["PIK3CA", ["TCGA.D5.6537.01", "Diseases of Immune System"], {"weight": 0.875687799685665}], ["PIK3CA", ["TCGA.D5.6537.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.875687799685665}], ["PIK3CA", ["TCGA.D5.6537.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.938081530775681}], ["PIK3CA", ["TCGA.D5.6537.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.938834189460798}], ["PIK3CA", ["TCGA.D5.6541.01", "Peptide ligand-binding receptors"], {"weight": 0.943690484574234}], ["PIK3CA", ["TCGA.D5.6920.01", "Peptide hormone metabolism"], {"weight": 0.701251306003336}], ["PIK3CA", ["TCGA.DM.A0X9.01", "CD22 mediated BCR regulation"], {"weight": 0.81105409055727}], ["PIK3CA", ["TCGA.DM.A0XD.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.783418004183413}], ["PIK3CA", ["TCGA.DM.A0XD.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.93914319053998}], ["PIK3CA", ["TCGA.DM.A0XD.01", "Peptide hormone metabolism"], {"weight": 0.75743622971149}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.73339554474299}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.943660803081229}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Complement cascade"], {"weight": 0.888807947821135}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Drug ADME"], {"weight": 0.888455074519921}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Regulation of Complement cascade"], {"weight": 0.866698622332636}], ["PIK3CA", ["TCGA.DM.A1D8.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.93003076859063}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Cell surface interactions at the vascular wall"], {"weight": 0.796964729388128}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Platelet homeostasis"], {"weight": 0.908366986458246}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Nuclear signaling by ERBB4"], {"weight": 0.831588246654966}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Signaling by ERBB4"], {"weight": 0.887642139130812}], ["PIK3CA", ["TCGA.DM.A1D8.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.930639060197932}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.919684353578653}], ["PIK3CA", ["TCGA.DM.A1D8.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.922927591452522}], ["PIK3CA", ["TCGA.DM.A1D8.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.922927591452522}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Diseases of Immune System"], {"weight": 0.895366793273106}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.895366793273106}], ["PIK3CA", ["TCGA.DM.A1D8.01", "CD22 mediated BCR regulation"], {"weight": 0.877168075332153}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.779586118216546}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Signaling by Receptor Tyrosine Kinases"], {"weight": 0.910682671243154}], ["PIK3CA", ["TCGA.DM.A1D8.01", "SUMOylation of intracellular receptors"], {"weight": 0.778686997395555}], ["PIK3CA", ["TCGA.DM.A1D8.01", "Nuclear Receptor transcription pathway"], {"weight": 0.851498124443401}], ["PIK3CA", ["TCGA.DM.A285.01", "G alpha (q) signalling events"], {"weight": 0.92363385930225}], ["PIK3CA", ["TCGA.DM.A285.01", "Diseases of Immune System"], {"weight": 0.875134794155792}], ["PIK3CA", ["TCGA.DM.A285.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.875134794155792}], ["PIK3CA", ["TCGA.DM.A285.01", "CD22 mediated BCR regulation"], {"weight": 0.845128596843427}], ["PIK3CA", ["TCGA.DM.A285.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.892309247154489}], ["PIK3CA", ["TCGA.DM.A285.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.892309247154489}], ["PIK3CA", ["TCGA.DM.A285.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.931356069200044}], ["PIK3CA", ["TCGA.DM.A28C.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.828147533220389}], ["PIK3CA", ["TCGA.DM.A28C.01", "GPCR downstream signalling"], {"weight": 0.95324182484152}], ["PIK3CA", ["TCGA.DM.A28C.01", "Immune System"], {"weight": 0.902664607353925}], ["PIK3CA", ["TCGA.DM.A28C.01", "Platelet homeostasis"], {"weight": 0.954611172108111}], ["PIK3CA", ["TCGA.DM.A28C.01", "Chemokine receptors bind chemokines"], {"weight": 0.939913335434251}], ["PIK3CA", ["TCGA.DM.A28C.01", "Regulation of Complement cascade"], {"weight": 0.903412533218345}], ["PIK3CA", ["TCGA.DM.A28C.01", "Complement cascade"], {"weight": 0.910406051341436}], ["PIK3CA", ["TCGA.DM.A28C.01", "Cell surface interactions at the vascular wall"], {"weight": 0.81543870531598}], ["PIK3CA", ["TCGA.DM.A28C.01", "Costimulation by the CD28 family"], {"weight": 0.934429091265496}], ["PIK3CA", ["TCGA.DM.A28C.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.812891717220053}], ["PIK3CA", ["TCGA.DM.A28C.01", "Extracellular matrix organization"], {"weight": 0.88168149538}], ["PIK3CA", ["TCGA.DM.A28C.01", "Peptide hormone metabolism"], {"weight": 0.874886616227834}], ["PIK3CA", ["TCGA.DM.A28C.01", "L1CAM interactions"], {"weight": 0.890124496941571}], ["PIK3CA", ["TCGA.DM.A28C.01", "Diseases of Immune System"], {"weight": 0.903793752331415}], ["PIK3CA", ["TCGA.DM.A28C.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.903793752331415}], ["PIK3CA", ["TCGA.DM.A28C.01", "Regulation of insulin secretion"], {"weight": 0.910986703712728}], ["PIK3CA", ["TCGA.DM.A28C.01", "Innate Immune System"], {"weight": 0.904492863034006}], ["PIK3CA", ["TCGA.DM.A28C.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.944283770180213}], ["PIK3CA", ["TCGA.DM.A28C.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.934075866059922}], ["PIK3CA", ["TCGA.DM.A28C.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.934075866059922}], ["PIK3CA", ["TCGA.DM.A28C.01", "TNFs bind their physiological receptors"], {"weight": 0.440728526007818}], ["PIK3CA", ["TCGA.DM.A28C.01", "Insulin processing"], {"weight": 0.909381472588622}], ["PIK3CA", ["TCGA.DM.A28C.01", "FCGR activation"], {"weight": 0.897444870094344}], ["PIK3CA", ["TCGA.DM.A28M.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.830447894229465}], ["PIK3CA", ["TCGA.DM.A28M.01", "Extracellular matrix organization"], {"weight": 0.918880523325309}], ["PIK3CA", ["TCGA.DM.A28M.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.947859207184784}], ["PIK3CA", ["TCGA.DM.A28M.01", "Platelet homeostasis"], {"weight": 0.926546178111772}], ["PIK3CA", ["TCGA.DM.A28M.01", "Classical antibody-mediated complement activation"], {"weight": 0.768829619920724}], ["PIK3CA", ["TCGA.DM.A28M.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.939255222098915}], ["PIK3CA", ["TCGA.DM.A28M.01", "Creation of C4 and C2 activators"], {"weight": 0.820637695377356}], ["PIK3CA", ["TCGA.DM.A28M.01", "Cell surface interactions at the vascular wall"], {"weight": 0.807005784822192}], ["PIK3CA", ["TCGA.DM.A28M.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.820366237491978}], ["PIK3CA", ["TCGA.DM.A28M.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.937720104516363}], ["PIK3CA", ["TCGA.DM.A28M.01", "Integrin cell surface interactions"], {"weight": 0.924207150799746}], ["PIK3CA", ["TCGA.DM.A28M.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.947858014604659}], ["PIK3CA", ["TCGA.DM.A28M.01", "Signal regulatory protein family interactions"], {"weight": 0.806734988792614}], ["PIK3CA", ["TCGA.DM.A28M.01", "Other semaphorin interactions"], {"weight": 0.71811195314349}], ["PIK3CA", ["TCGA.DM.A28M.01", "CD22 mediated BCR regulation"], {"weight": 0.895671957840029}], ["PIK3CA", ["TCGA.DM.A28M.01", "IRS-related events triggered by IGF1R"], {"weight": 0.914807867795248}], ["PIK3CA", ["TCGA.DM.A28M.01", "IRS-mediated signalling"], {"weight": 0.903938540600666}], ["PIK3CA", ["TCGA.DM.A28M.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.914699946658432}], ["PIK3CA", ["TCGA.DM.A28M.01", "IGF1R signaling cascade"], {"weight": 0.914699946658432}], ["PIK3CA", ["TCGA.F4.6461.01", "Drug ADME"], {"weight": 0.865231605304998}], ["PIK3CA", ["TCGA.F4.6569.01", "FGFR4 ligand binding and activation"], {"weight": 0.858284515545222}], ["PIK3CA", ["TCGA.F4.6569.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.858284515545222}], ["PIK3CA", ["TCGA.F4.6569.01", "PI-3K cascade:FGFR4"], {"weight": 0.871230660609754}], ["PIK3CA", ["TCGA.F4.6805.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.721837500162699}], ["PIK3CA", ["TCGA.F4.6855.01", "TNFs bind their physiological receptors"], {"weight": 0.275506483003419}], ["PIK3CA", ["TCGA.F4.6855.01", "Peptide ligand-binding receptors"], {"weight": 0.889544539314098}], ["PIK3CA", ["TCGA.F4.6855.01", "Phase 4 - resting membrane potential"], {"weight": 0.645593475082408}], ["PIK3CA", ["TCGA.G4.6304.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.782939000949743}], ["PIK3CA", ["TCGA.G4.6304.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.942135280777502}], ["PIK3CA", ["TCGA.G4.6304.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.79531873310678}], ["PIK3CA", ["TCGA.G4.6311.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.531918995075698}], ["PIK3CA", ["TCGA.G4.6586.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.943875589972561}], ["OR52D1", ["TCGA.A6.4105.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.910796191129283}], ["GDNF", ["TCGA.A6.4105.01", "NCAM1 interactions"], {"weight": 0.886905743903729}], ["MYH9", ["TCGA.A6.5665.01", "Sensory processing of sound"], {"weight": 0.916528183179926}], ["MYH9", ["TCGA.A6.5665.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.913108558636759}], ["MYH9", ["TCGA.A6.6652.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.78921165283288}], ["MYH9", ["TCGA.A6.6652.01", "Generation of second messenger molecules"], {"weight": 0.94078845916347}], ["MYH9", ["TCGA.A6.6652.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.938205839761318}], ["MYH9", ["TCGA.A6.6652.01", "PD-1 signaling"], {"weight": 0.938554557042145}], ["MYH9", ["TCGA.A6.6652.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.938205839761318}], ["MYH9", ["TCGA.A6.6652.01", "Leishmania infection"], {"weight": 0.88715741042753}], ["MYH9", ["TCGA.A6.6652.01", "Parasitic Infection Pathways"], {"weight": 0.88715741042753}], ["MYH9", ["TCGA.A6.6652.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.90906046007167}], ["MYH9", ["TCGA.A6.6652.01", "Leishmania parasite growth and survival"], {"weight": 0.90906046007167}], ["MYH9", ["TCGA.A6.6652.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.857297208524595}], ["MYH9", ["TCGA.A6.6653.01", "G alpha (i) signalling events"], {"weight": 0.952568180556011}], ["MYH9", ["TCGA.CM.5861.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.902666403060643}], ["MYH9", ["TCGA.CM.5861.01", "Leishmania parasite growth and survival"], {"weight": 0.902666403060643}], ["MYH9", ["TCGA.DM.A1DA.01", "Generation of second messenger molecules"], {"weight": 0.943960789171816}], ["MYH9", ["TCGA.DM.A1DA.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.933308240250187}], ["MYH9", ["TCGA.DM.A1DA.01", "Leishmania parasite growth and survival"], {"weight": 0.933308240250187}], ["MYH9", ["TCGA.DM.A1DA.01", "Leishmania infection"], {"weight": 0.906814286015133}], ["MYH9", ["TCGA.DM.A1DA.01", "Parasitic Infection Pathways"], {"weight": 0.906814286015133}], ["MYH9", ["TCGA.F4.6856.01", "Leishmania infection"], {"weight": 0.818853802615754}], ["MYH9", ["TCGA.F4.6856.01", "Parasitic Infection Pathways"], {"weight": 0.818853802615754}], ["NRBP1", ["TCGA.A6.4105.01", "Phase II - Conjugation of compounds"], {"weight": 0.734429508313015}], ["NRBP1", ["TCGA.A6.4105.01", "Biological oxidations"], {"weight": 0.856660299221078}], ["NRBP1", ["TCGA.A6.4105.01", "Glucuronidation"], {"weight": 0.711188069320463}], ["NRBP1", ["TCGA.CA.6718.01", "Nuclear Receptor transcription pathway"], {"weight": 0.778995124057481}], ["OR5M8", ["TCGA.A6.5656.01", "Signaling by GPCR"], {"weight": 0.946859200601636}], ["EXT1", ["TCGA.A6.5656.01", "TNFs bind their physiological receptors"], {"weight": 0.426936311088736}], ["EXT1", ["TCGA.AD.6963.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.88495601388515}], ["EXT1", ["TCGA.AY.6197.01", "Diseases associated with glycosaminoglycan metabolism"], {"weight": 0.885889450025134}], ["TBX3", ["TCGA.A6.5656.01", "Peptide hormone metabolism"], {"weight": 0.810829036710865}], ["TBX3", ["TCGA.G4.6295.01", "Peptide hormone metabolism"], {"weight": 0.773998800381375}], ["TBX3", ["TCGA.G4.6295.01", "Signaling by Retinoic Acid"], {"weight": 0.776766338685517}], ["DST", ["TCGA.A6.6651.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.93863951155561}], ["DST", ["TCGA.A6.6651.01", "Degradation of the extracellular matrix"], {"weight": 0.668558880036065}], ["DST", ["TCGA.AD.6964.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.943346488071663}], ["DST", ["TCGA.AD.6964.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.923072461563007}], ["DST", ["TCGA.CM.5861.01", "MET activates PTK2 signaling"], {"weight": 0.917943511924388}], ["DST", ["TCGA.G4.6310.01", "Extracellular matrix organization"], {"weight": 0.793593722468051}], ["DST", ["TCGA.G4.6588.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.95553423451616}], ["F10", ["TCGA.G4.6315.01", "Cytokine Signaling in Immune system"], {"weight": 0.858111997685513}], ["F10", ["TCGA.G4.6315.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.665379677113078}], ["OR5T2", ["TCGA.A6.5656.01", "GPCR ligand binding"], {"weight": 0.925657824982981}], ["OR5T2", ["TCGA.A6.5656.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.905682859129635}], ["OR5T2", ["TCGA.A6.5656.01", "Leishmania parasite growth and survival"], {"weight": 0.905682859129635}], ["OR5T2", ["TCGA.A6.5656.01", "Parasitic Infection Pathways"], {"weight": 0.878511358678821}], ["OR5T2", ["TCGA.A6.5656.01", "Phase 4 - resting membrane potential"], {"weight": 0.855321039167206}], ["OR5T2", ["TCGA.A6.5656.01", "G beta:gamma signalling through BTK"], {"weight": 0.913646549943431}], ["OR5T2", ["TCGA.A6.5656.01", "Activation of G protein gated Potassium channels"], {"weight": 0.926828067961989}], ["OR5T2", ["TCGA.A6.5656.01", "G-protein activation"], {"weight": 0.919198291626882}], ["OR5T2", ["TCGA.AZ.6600.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.819025064450348}], ["OR5T2", ["TCGA.D5.6932.01", "Signaling by GPCR"], {"weight": 0.943339991633012}], ["OR5T2", ["TCGA.D5.6932.01", "G alpha (s) signalling events"], {"weight": 0.953526715815957}], ["OR5T2", ["TCGA.D5.6932.01", "Peptide hormone metabolism"], {"weight": 0.751581278084736}], ["RXFP3", ["TCGA.A6.5656.01", "Biological oxidations"], {"weight": 0.901681586534027}], ["RXFP3", ["TCGA.A6.5656.01", "Chemokine receptors bind chemokines"], {"weight": 0.932438031671725}], ["RXFP3", ["TCGA.A6.5656.01", "Defective B3GALTL causes PpS"], {"weight": 0.865850791401954}], ["RXFP3", ["TCGA.A6.5656.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.865850791401954}], ["RXFP3", ["TCGA.A6.5656.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.774242679645793}], ["RXFP3", ["TCGA.A6.5656.01", "Defensins"], {"weight": 0.58700546939169}], ["RXFP3", ["TCGA.D5.6538.01", "Chemokine receptors bind chemokines"], {"weight": 0.93704615298733}], ["RXFP3", ["TCGA.D5.6538.01", "Regulation of Complement cascade"], {"weight": 0.869708386111757}], ["RXFP3", ["TCGA.D5.6538.01", "Complement cascade"], {"weight": 0.888264199033155}], ["RXFP3", ["TCGA.D5.6538.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.803496139793563}], ["RXFP3", ["TCGA.D5.6538.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.803496139793563}], ["RXFP3", ["TCGA.D5.6538.01", "Activation of the phototransduction cascade"], {"weight": 0.899449297503316}], ["RXFP3", ["TCGA.D5.6538.01", "Initial triggering of complement"], {"weight": 0.841520433052574}], ["RXFP3", ["TCGA.D5.6538.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.790988865690254}], ["SERPIND1", ["TCGA.AY.6197.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.911753069328178}], ["SERPIND1", ["TCGA.D5.6924.01", "GPCR ligand binding"], {"weight": 0.935992775575802}], ["SERPIND1", ["TCGA.D5.6924.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.761768755150437}], ["SERPIND1", ["TCGA.D5.6924.01", "PI3K events in ERBB2 signaling"], {"weight": 0.761768755150437}], ["SERPIND1", ["TCGA.D5.6924.01", "GRB2 events in ERBB2 signaling"], {"weight": 0.761768755150437}], ["SERPIND1", ["TCGA.D5.6924.01", "Integrin cell surface interactions"], {"weight": 0.856857273893122}], ["SERPIND1", ["TCGA.D5.6924.01", "Response to elevated platelet cytosolic Ca2+"], {"weight": 0.884937362855069}], ["SERPIND1", ["TCGA.D5.6924.01", "Peptide ligand-binding receptors"], {"weight": 0.931525999949202}], ["SERPIND1", ["TCGA.D5.6924.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.896630046128045}], ["SERPIND1", ["TCGA.D5.6924.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.910395741535345}], ["SERPIND1", ["TCGA.D5.6924.01", "Signaling by ERBB2 TMD/JMD mutants"], {"weight": 0.761768755150437}], ["SERPIND1", ["TCGA.D5.6924.01", "SHC1 events in ERBB2 signaling"], {"weight": 0.761768755150437}], ["SERPIND1", ["TCGA.D5.6924.01", "GRB2:SOS provides linkage to MAPK signaling for Integrins"], {"weight": 0.884937362855069}], ["SERPIND1", ["TCGA.D5.6924.01", "p130Cas linkage to MAPK signaling for integrins"], {"weight": 0.884937362855069}], ["SP100", ["TCGA.A6.5656.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.761863647094555}], ["SP100", ["TCGA.A6.5656.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.915836355218683}], ["SP100", ["TCGA.A6.5656.01", "PD-1 signaling"], {"weight": 0.916819658761825}], ["SP100", ["TCGA.A6.5656.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.915836355218683}], ["SP100", ["TCGA.A6.5656.01", "Extracellular matrix organization"], {"weight": 0.845599807101066}], ["SP100", ["TCGA.A6.5656.01", "Costimulation by the CD28 family"], {"weight": 0.870020139799051}], ["SP100", ["TCGA.A6.5656.01", "Interleukin-10 signaling"], {"weight": 0.932385771461011}], ["SP100", ["TCGA.CM.5348.01", "Glucuronidation"], {"weight": 0.844300807168533}], ["COL5A3", ["TCGA.A6.5656.01", "O-linked glycosylation"], {"weight": 0.903065506732039}], ["COL5A3", ["TCGA.D5.6540.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.950580719713551}], ["COL5A3", ["TCGA.F4.6855.01", "Collagen formation"], {"weight": 0.921612096012461}], ["COL5A3", ["TCGA.F4.6855.01", "Collagen chain trimerization"], {"weight": 0.933464292015039}], ["COL5A3", ["TCGA.F4.6855.01", "Integrin cell surface interactions"], {"weight": 0.920997152940272}], ["COL5A3", ["TCGA.F4.6855.01", "O-linked glycosylation"], {"weight": 0.85506787891709}], ["COL5A3", ["TCGA.G4.6297.01", "Scavenging by Class A Receptors"], {"weight": 0.609642175808723}], ["COL5A3", ["TCGA.G4.6297.01", "NCAM1 interactions"], {"weight": 0.892872005025662}], ["COL5A3", ["TCGA.G4.6297.01", "NCAM signaling for neurite out-growth"], {"weight": 0.905484345636992}], ["COL5A3", ["TCGA.G4.6586.01", "NCAM1 interactions"], {"weight": 0.95082859467662}], ["COL5A3", ["TCGA.G4.6586.01", "NCAM signaling for neurite out-growth"], {"weight": 0.952740827518114}], ["TNXB", ["TCGA.CK.5915.01", "Other semaphorin interactions"], {"weight": 0.661646700778564}], ["TNXB", ["TCGA.CM.6170.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.718957140050869}], ["TNXB", ["TCGA.CM.6170.01", "Blood group systems biosynthesis"], {"weight": 0.589009727574489}], ["TNXB", ["TCGA.CM.6170.01", "Lewis blood group biosynthesis"], {"weight": 0.542210817346572}], ["TNXB", ["TCGA.D5.6538.01", "Keratan sulfate biosynthesis"], {"weight": 0.868346989170391}], ["TNXB", ["TCGA.DM.A282.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.81288910976155}], ["NEDD4L", ["TCGA.A6.5656.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.929246479613101}], ["NEDD4L", ["TCGA.A6.5656.01", "Peptide ligand-binding receptors"], {"weight": 0.926062642011499}], ["NEDD4L", ["TCGA.A6.5656.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.880156602361303}], ["NEDD4L", ["TCGA.A6.5656.01", "Immune System"], {"weight": 0.864841192121558}], ["NEDD4L", ["TCGA.AU.6004.01", "Stimuli-sensing channels"], {"weight": 0.91644115355641}], ["GALNT6", ["TCGA.A6.5656.01", "Blood group systems biosynthesis"], {"weight": 0.778079541347123}], ["GALNT6", ["TCGA.A6.5656.01", "Lewis blood group biosynthesis"], {"weight": 0.75513501466345}], ["GALNT6", ["TCGA.A6.5656.01", "Sialic acid metabolism"], {"weight": 0.764154254074004}], ["NEFM", ["TCGA.A6.5656.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.812549739486847}], ["NEFM", ["TCGA.A6.5656.01", "Heme degradation"], {"weight": 0.750913656080908}], ["TNS1", ["TCGA.AD.6901.01", "Extracellular matrix organization"], {"weight": 0.85324863430844}], ["TBP", ["TCGA.DM.A0X9.01", "Signaling Pathways"], {"weight": 0.88968533700806}], ["TBP", ["TCGA.DM.A1DB.01", "Defective pyroptosis"], {"weight": 0.721086283089759}], ["TBP", ["TCGA.F4.6460.01", "Aspirin ADME"], {"weight": 0.675930906327872}], ["TNRC6A", ["TCGA.A6.5656.01", "Signaling Pathways"], {"weight": 0.901218399097202}], ["TNRC6A", ["TCGA.A6.5656.01", "Glucuronidation"], {"weight": 0.88972646882509}], ["TNRC6A", ["TCGA.A6.5667.01", "Signaling Pathways"], {"weight": 0.855408374791111}], ["TNRC6A", ["TCGA.AD.6888.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.602466576810662}], ["TNRC6A", ["TCGA.AD.6888.01", "Blood group systems biosynthesis"], {"weight": 0.815664831082842}], ["TNRC6A", ["TCGA.CK.5914.01", "Biological oxidations"], {"weight": 0.922432997381399}], ["TNRC6A", ["TCGA.CK.5914.01", "Blood group systems biosynthesis"], {"weight": 0.792367174126899}], ["TNRC6A", ["TCGA.CK.5914.01", "Lewis blood group biosynthesis"], {"weight": 0.774242446339254}], ["TNRC6A", ["TCGA.CK.5914.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.716479576335891}], ["TNRC6A", ["TCGA.F4.6855.01", "Glycosaminoglycan metabolism"], {"weight": 0.695051707210783}], ["RYR1", ["TCGA.A6.5656.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.761719083588463}], ["RYR1", ["TCGA.AA.3502.01", "Phase 4 - resting membrane potential"], {"weight": 0.803517181793878}], ["RYR1", ["TCGA.D5.6540.01", "Nicotinate metabolism"], {"weight": 0.841485537760596}], ["RYR1", ["TCGA.DM.A0X9.01", "Cardiac conduction"], {"weight": 0.924739970427252}], ["RYR1", ["TCGA.DM.A1D0.01", "Nicotinate metabolism"], {"weight": 0.862668636600973}], ["RYR1", ["TCGA.DM.A1D0.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.913350046152938}], ["RYR1", ["TCGA.DM.A1D4.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.900787140589295}], ["ATP6V0E2", ["TCGA.A6.5656.01", "Insulin processing"], {"weight": 0.795089565108479}], ["DGKB", ["TCGA.A6.5656.01", "RA biosynthesis pathway"], {"weight": 0.851820268240797}], ["DGKB", ["TCGA.A6.5656.01", "Phase II - Conjugation of compounds"], {"weight": 0.842221449151666}], ["DGKB", ["TCGA.A6.5656.01", "Ethanol oxidation"], {"weight": 0.83764047281575}], ["DGKB", ["TCGA.A6.6138.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.836187630370597}], ["DGKB", ["TCGA.A6.6138.01", "Phase II - Conjugation of compounds"], {"weight": 0.883172948532606}], ["DGKB", ["TCGA.A6.6138.01", "Ethanol oxidation"], {"weight": 0.823558427706501}], ["DGKB", ["TCGA.A6.6138.01", "RA biosynthesis pathway"], {"weight": 0.749393796673184}], ["DGKB", ["TCGA.AY.5543.01", "GPCR downstream signalling"], {"weight": 0.932419787041719}], ["DGKB", ["TCGA.CM.6165.01", "GPCR downstream signalling"], {"weight": 0.920975615887093}], ["DGKB", ["TCGA.D5.7000.01", "Drug ADME"], {"weight": 0.756788434318561}], ["DGKB", ["TCGA.D5.7000.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.657612478870464}], ["DGKB", ["TCGA.DM.A1HA.01", "G alpha (q) signalling events"], {"weight": 0.948797052964688}], ["DGKB", ["TCGA.G4.6307.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.89785833737721}], ["DGKB", ["TCGA.G4.6307.01", "Leishmania parasite growth and survival"], {"weight": 0.89785833737721}], ["DGKB", ["TCGA.G4.6307.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.891659543682654}], ["DGKB", ["TCGA.G4.6307.01", "Role of phospholipids in phagocytosis"], {"weight": 0.902088166413292}], ["DGKB", ["TCGA.G4.6307.01", "Biological oxidations"], {"weight": 0.898377217542062}], ["DGKB", ["TCGA.G4.6307.01", "Cell surface interactions at the vascular wall"], {"weight": 0.73847274237051}], ["DGKB", ["TCGA.G4.6307.01", "Phase II - Conjugation of compounds"], {"weight": 0.803849568629333}], ["PI4K2B", ["TCGA.A6.5656.01", "GPCR downstream signalling"], {"weight": 0.952804912868859}], ["PI4K2B", ["TCGA.A6.5656.01", "Generation of second messenger molecules"], {"weight": 0.929415169745212}], ["PI4K2B", ["TCGA.A6.5656.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.923145350756818}], ["PI4K2B", ["TCGA.A6.5656.01", "DAP12 signaling"], {"weight": 0.879473061376523}], ["PI4K2B", ["TCGA.A6.5656.01", "DAP12 interactions"], {"weight": 0.838043124081791}], ["ITPR1", ["TCGA.A6.5656.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.84887132883826}], ["ITPR1", ["TCGA.A6.5656.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.861758648309961}], ["ITPR1", ["TCGA.A6.5656.01", "CD22 mediated BCR regulation"], {"weight": 0.870832410717389}], ["ITPR1", ["TCGA.A6.5656.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.881179566914572}], ["ITPR1", ["TCGA.A6.5656.01", "Diseases of Immune System"], {"weight": 0.8464205862067}], ["ITPR1", ["TCGA.A6.5656.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.8464205862067}], ["ITPR1", ["TCGA.A6.5656.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.887166979242583}], ["ITPR1", ["TCGA.A6.5656.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.887166979242583}], ["ITPR1", ["TCGA.A6.5656.01", "Platelet activation, signaling and aggregation"], {"weight": 0.932752482354334}], ["ITPR1", ["TCGA.CM.6171.01", "Ion channel transport"], {"weight": 0.939659441881136}], ["ITPR1", ["TCGA.F4.6570.01", "Interaction between L1 and Ankyrins"], {"weight": 0.888957613851506}], ["F8", ["TCGA.A6.5656.01", "Regulation of Complement cascade"], {"weight": 0.716045046669394}], ["F8", ["TCGA.A6.5656.01", "Complement cascade"], {"weight": 0.796664113729848}], ["F8", ["TCGA.A6.5656.01", "Classical antibody-mediated complement activation"], {"weight": 0.681294545692504}], ["F8", ["TCGA.A6.5656.01", "Cell surface interactions at the vascular wall"], {"weight": 0.662769759746406}], ["F8", ["TCGA.CA.5796.01", "LGI-ADAM interactions"], {"weight": 0.82519918759653}], ["F8", ["TCGA.CA.5796.01", "GABA receptor activation"], {"weight": 0.848079128221643}], ["F8", ["TCGA.CA.5796.01", "O-linked glycosylation"], {"weight": 0.844774564226381}], ["OR5M8", ["TCGA.A6.5656.01", "G alpha (i) signalling events"], {"weight": 0.95167851575129}], ["OR5M8", ["TCGA.A6.5656.01", "Potassium Channels"], {"weight": 0.960626899809818}], ["OR5M8", ["TCGA.A6.5656.01", "G alpha (s) signalling events"], {"weight": 0.958290028362826}], ["OR5M8", ["TCGA.A6.5656.01", "Leishmania infection"], {"weight": 0.878511358678821}], ["OR5M8", ["TCGA.A6.5656.01", "G alpha (q) signalling events"], {"weight": 0.939356279871153}], ["OR5M8", ["TCGA.A6.5656.01", "Signal amplification"], {"weight": 0.923469496971568}], ["OR5M8", ["TCGA.A6.5656.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.91396031129479}], ["OR5M8", ["TCGA.A6.5656.01", "Inwardly rectifying K+ channels"], {"weight": 0.93508391584043}], ["OR5M8", ["TCGA.A6.5656.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.87126087983972}], ["OR5M8", ["TCGA.A6.5656.01", "G-protein beta:gamma signalling"], {"weight": 0.931200347973012}], ["OR5M8", ["TCGA.A6.5656.01", "Regulation of insulin secretion"], {"weight": 0.91154221676303}], ["OR5M8", ["TCGA.A6.5656.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.91838251196291}], ["OR5M8", ["TCGA.A6.5656.01", "Glucagon-type ligand receptors"], {"weight": 0.926198224320708}], ["OR5M8", ["TCGA.A6.5656.01", "G protein gated Potassium channels"], {"weight": 0.926828067961989}], ["OR5M8", ["TCGA.A6.5656.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.926828067961989}], ["OR5M8", ["TCGA.A6.5656.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.914858569641324}], ["OR5M8", ["TCGA.A6.5656.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.925384839134025}], ["OR5M8", ["TCGA.A6.5656.01", "G beta:gamma signalling through CDC42"], {"weight": 0.913747300974827}], ["OR5M8", ["TCGA.A6.5656.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.898892451710174}], ["OR5M8", ["TCGA.A6.5656.01", "Presynaptic function of Kainate receptors"], {"weight": 0.896211090610393}], ["OR5M8", ["TCGA.AD.6901.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.905009634616317}], ["OR5M8", ["TCGA.AD.6901.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.889004114069072}], ["OR5M8", ["TCGA.AD.6901.01", "Signal amplification"], {"weight": 0.880370940755622}], ["OR5M8", ["TCGA.AD.6901.01", "G beta:gamma signalling through CDC42"], {"weight": 0.864097174899574}], ["OR5M8", ["TCGA.AD.6901.01", "GPCR ligand binding"], {"weight": 0.931550477954793}], ["OR5M8", ["TCGA.AD.6901.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.919529277272524}], ["OR5M8", ["TCGA.AD.6901.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.864097174899574}], ["OR5M8", ["TCGA.AD.6901.01", "Signaling by GPCR"], {"weight": 0.933458400160072}], ["OR5M8", ["TCGA.AD.6901.01", "G-protein beta:gamma signalling"], {"weight": 0.889004114069072}], ["OR5M8", ["TCGA.AD.6901.01", "Activation of the phototransduction cascade"], {"weight": 0.837629359633676}], ["OR5M8", ["TCGA.AD.6901.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.8728946076538}], ["OR5M8", ["TCGA.DM.A28F.01", "GABA receptor activation"], {"weight": 0.908387567143299}], ["B3GALT2", ["TCGA.A6.5656.01", "Glycosaminoglycan metabolism"], {"weight": 0.841366501614003}], ["HAVCR2", ["TCGA.DM.A28E.01", "Extracellular matrix organization"], {"weight": 0.918676259560051}], ["HAVCR2", ["TCGA.DM.A28E.01", "L1CAM interactions"], {"weight": 0.897130630913542}], ["HAVCR2", ["TCGA.DM.A28E.01", "ECM proteoglycans"], {"weight": 0.901268850396312}], ["RALYL", ["TCGA.A6.5657.01", "Drug ADME"], {"weight": 0.815777949458145}], ["NFATC4", ["TCGA.A6.5657.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.821424534369854}], ["CTNNA1", ["TCGA.A6.5657.01", "Collagen formation"], {"weight": 0.87282649411648}], ["CTNNA1", ["TCGA.A6.5657.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.833043378994277}], ["CTNNA1", ["TCGA.A6.5657.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.816972158590352}], ["CTNNA1", ["TCGA.F4.6570.01", "Drug ADME"], {"weight": 0.930975957109477}], ["TLN1", ["TCGA.A6.5657.01", "Extracellular matrix organization"], {"weight": 0.813840756275685}], ["TLN1", ["TCGA.CA.6716.01", "Extracellular matrix organization"], {"weight": 0.864521302828754}], ["TLN1", ["TCGA.CA.6716.01", "Degradation of the extracellular matrix"], {"weight": 0.795345244961104}], ["TLN1", ["TCGA.F4.6806.01", "Extracellular matrix organization"], {"weight": 0.859191335578939}], ["TLN1", ["TCGA.F4.6806.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.922727157937842}], ["TLN1", ["TCGA.F4.6806.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.865010493247232}], ["TLN1", ["TCGA.F4.6806.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.865010493247232}], ["TLN1", ["TCGA.F4.6806.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.925398363799427}], ["TLN1", ["TCGA.F4.6806.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.861146276995734}], ["TLN1", ["TCGA.F4.6806.01", "Diseases of Immune System"], {"weight": 0.865010493247232}], ["TLN1", ["TCGA.F4.6806.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.865010493247232}], ["TLN1", ["TCGA.G4.6628.01", "Extracellular matrix organization"], {"weight": 0.889221008172677}], ["ATP1A3", ["TCGA.G4.6294.01", "Cardiac conduction"], {"weight": 0.929143238458044}], ["ATP1A3", ["TCGA.G4.6302.01", "Ion channel transport"], {"weight": 0.863647654986654}], ["FBXW7", ["TCGA.A6.6142.01", "Peptide ligand-binding receptors"], {"weight": 0.898838022969199}], ["FBXW7", ["TCGA.A6.6142.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.898753568389936}], ["CACNA1I", ["TCGA.A6.5661.01", "NCAM1 interactions"], {"weight": 0.924802343387898}], ["CACNA1I", ["TCGA.A6.5661.01", "NCAM signaling for neurite out-growth"], {"weight": 0.932980281624465}], ["CACNA1I", ["TCGA.CK.4948.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.810387469764173}], ["CACNA1I", ["TCGA.CK.4948.01", "L1CAM interactions"], {"weight": 0.911748160686205}], ["TIAM1", ["TCGA.AA.3662.01", "Interaction between L1 and Ankyrins"], {"weight": 0.900974871025386}], ["TIAM1", ["TCGA.AA.3662.01", "L1CAM interactions"], {"weight": 0.824806607751062}], ["TIAM1", ["TCGA.CM.4743.01", "Drug ADME"], {"weight": 0.893647353792928}], ["TIAM1", ["TCGA.CM.6679.01", "Extracellular matrix organization"], {"weight": 0.878151211565056}], ["TIAM1", ["TCGA.CM.6679.01", "Signaling Pathways"], {"weight": 0.836460262029273}], ["TIAM1", ["TCGA.CM.6679.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.892377958940078}], ["TIAM1", ["TCGA.CM.6679.01", "Peptide ligand-binding receptors"], {"weight": 0.88444451979971}], ["TIAM1", ["TCGA.CM.6679.01", "Long-term potentiation"], {"weight": 0.849414969491254}], ["TIAM1", ["TCGA.D5.6538.01", "G-protein beta:gamma signalling"], {"weight": 0.929548461179945}], ["TIAM1", ["TCGA.D5.6538.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.913792053224683}], ["PKD1L1", ["TCGA.D5.6532.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.8845861017939}], ["PKD1L1", ["TCGA.D5.6532.01", "Ion homeostasis"], {"weight": 0.924186081497653}], ["PKD1L1", ["TCGA.D5.6533.01", "Phase 0 - rapid depolarisation"], {"weight": 0.882789927765565}], ["PKD1L1", ["TCGA.D5.6533.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.858007189901243}], ["PKD1L1", ["TCGA.D5.6932.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.920093903252366}], ["PKD1L1", ["TCGA.D5.6932.01", "Sensory processing of sound"], {"weight": 0.920093903252366}], ["HGF", ["TCGA.A6.5657.01", "Classical antibody-mediated complement activation"], {"weight": 0.567560003905336}], ["HGF", ["TCGA.G4.6295.01", "Blood group systems biosynthesis"], {"weight": 0.8750400842525}], ["HGF", ["TCGA.G4.6295.01", "Lewis blood group biosynthesis"], {"weight": 0.867751195677336}], ["BAX", ["TCGA.A6.5657.01", "Phase II - Conjugation of compounds"], {"weight": 0.89306608300507}], ["BAX", ["TCGA.A6.5657.01", "Biological oxidations"], {"weight": 0.91912958264878}], ["BAX", ["TCGA.A6.5657.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.855707066438381}], ["BAX", ["TCGA.A6.5657.01", "Ethanol oxidation"], {"weight": 0.586049314482946}], ["BAX", ["TCGA.A6.5657.01", "Glucuronidation"], {"weight": 0.859010570817213}], ["BAX", ["TCGA.AY.6197.01", "Glycosaminoglycan metabolism"], {"weight": 0.859429782842644}], ["OCA2", ["TCGA.A6.5657.01", "Collagen chain trimerization"], {"weight": 0.853719333927909}], ["OCA2", ["TCGA.A6.5657.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.906676541079097}], ["MUC5B", ["TCGA.A6.6780.01", "O-linked glycosylation"], {"weight": 0.923062909619059}], ["MUC5B", ["TCGA.AY.6197.01", "Sialic acid metabolism"], {"weight": 0.619121860069782}], ["MUC5B", ["TCGA.AZ.6601.01", "Termination of O-glycan biosynthesis"], {"weight": 0.909683796007302}], ["MUC5B", ["TCGA.CK.5916.01", "Termination of O-glycan biosynthesis"], {"weight": 0.918750660277499}], ["MUC5B", ["TCGA.F4.6463.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.876674030750914}], ["MUC5B", ["TCGA.F4.6463.01", "O-linked glycosylation"], {"weight": 0.89069135823393}], ["MUC5B", ["TCGA.F4.6463.01", "O-linked glycosylation of mucins"], {"weight": 0.913721448269157}], ["MUC5B", ["TCGA.F4.6463.01", "Termination of O-glycan biosynthesis"], {"weight": 0.889321108854349}], ["MUC5B", ["TCGA.F4.6463.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.466691505770839}], ["MUC5B", ["TCGA.F4.6463.01", "Defective GALNT3 causes HFTC"], {"weight": 0.863038715154733}], ["MUC5B", ["TCGA.F4.6569.01", "O-linked glycosylation"], {"weight": 0.909714059383317}], ["MUC5B", ["TCGA.F4.6569.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.893652187199383}], ["MUC5B", ["TCGA.F4.6569.01", "Blood group systems biosynthesis"], {"weight": 0.508060323503548}], ["MUC5B", ["TCGA.F4.6703.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.896480882318279}], ["MUC5B", ["TCGA.F4.6703.01", "Defective GALNT3 causes HFTC"], {"weight": 0.887180609319188}], ["MUC5B", ["TCGA.F4.6703.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.887124688769087}], ["MUC5B", ["TCGA.F4.6703.01", "O-linked glycosylation of mucins"], {"weight": 0.93946640728886}], ["MUC5B", ["TCGA.F4.6703.01", "Termination of O-glycan biosynthesis"], {"weight": 0.886807857679981}], ["GALNTL5", ["TCGA.A6.5657.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.854140510038774}], ["PPFIA2", ["TCGA.A6.5659.01", "Neuronal System"], {"weight": 0.914469382650838}], ["DLGAP2", ["TCGA.AD.6888.01", "Protein-protein interactions at synapses"], {"weight": 0.91086075476473}], ["FHOD1", ["TCGA.DM.A1D6.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.865625437389379}], ["ADCY2", ["TCGA.A6.5659.01", "GPCR downstream signalling"], {"weight": 0.920714361919181}], ["ADCY2", ["TCGA.A6.5659.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.877099632023206}], ["ADCY2", ["TCGA.A6.5659.01", "Signaling by GPCR"], {"weight": 0.915800204808847}], ["ADCY2", ["TCGA.A6.5659.01", "Transmission across Chemical Synapses"], {"weight": 0.906214385625128}], ["ADCY2", ["TCGA.AU.3779.01", "Platelet homeostasis"], {"weight": 0.855223736717949}], ["ADCY2", ["TCGA.G4.6303.01", "Neuronal System"], {"weight": 0.845734568341948}], ["ADCY2", ["TCGA.G4.6303.01", "Platelet homeostasis"], {"weight": 0.763487502540951}], ["ADCY2", ["TCGA.G4.6303.01", "Transmission across Chemical Synapses"], {"weight": 0.872419372326985}], ["KCNA1", ["TCGA.A6.5659.01", "Potassium Channels"], {"weight": 0.943187991976946}], ["KCNA1", ["TCGA.AD.6888.01", "Neuronal System"], {"weight": 0.947537156784842}], ["KCNA1", ["TCGA.AD.6888.01", "Potassium Channels"], {"weight": 0.9660245604327}], ["KCNA1", ["TCGA.AD.6888.01", "Voltage gated Potassium channels"], {"weight": 0.888517880015892}], ["KCNA1", ["TCGA.AD.6965.01", "Neuronal System"], {"weight": 0.92471709898098}], ["KCNA1", ["TCGA.AD.6965.01", "Potassium Channels"], {"weight": 0.945302628010321}], ["KCNA1", ["TCGA.D5.6928.01", "Voltage gated Potassium channels"], {"weight": 0.920882408605602}], ["KCNA1", ["TCGA.DM.A1DA.01", "Potassium Channels"], {"weight": 0.96762363635363}], ["KCNA1", ["TCGA.DM.A1DA.01", "Voltage gated Potassium channels"], {"weight": 0.911800142468203}], ["IQCA1", ["TCGA.CA.5796.01", "Chemokine receptors bind chemokines"], {"weight": 0.893564953969669}], ["NID1", ["TCGA.A6.5659.01", "Extracellular matrix organization"], {"weight": 0.795994644135603}], ["NID1", ["TCGA.A6.6140.01", "Regulation of Complement cascade"], {"weight": 0.796449109136957}], ["NID1", ["TCGA.A6.6140.01", "Complement cascade"], {"weight": 0.858544948206173}], ["NID1", ["TCGA.A6.6140.01", "L1CAM interactions"], {"weight": 0.895751617111338}], ["NID1", ["TCGA.AD.5900.01", "Metabolism of water-soluble vitamins and cofactors"], {"weight": 0.709330568838008}], ["NID1", ["TCGA.AZ.4682.01", "Signaling Pathways"], {"weight": 0.88493384667538}], ["NID1", ["TCGA.CM.4743.01", "Extracellular matrix organization"], {"weight": 0.866119425090146}], ["NID1", ["TCGA.DM.A1DB.01", "Extracellular matrix organization"], {"weight": 0.894837244126109}], ["NID1", ["TCGA.DM.A1DB.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.885902923415855}], ["NID1", ["TCGA.DM.A1DB.01", "Retinoid metabolism and transport"], {"weight": 0.885902923415855}], ["NID1", ["TCGA.G4.6307.01", "Complement cascade"], {"weight": 0.870425305661979}], ["COL6A6", ["TCGA.A6.5662.01", "TNFs bind their physiological receptors"], {"weight": 0.364467189271179}], ["COL6A6", ["TCGA.A6.5662.01", "NCAM1 interactions"], {"weight": 0.925858546213713}], ["COL6A6", ["TCGA.A6.5662.01", "NCAM signaling for neurite out-growth"], {"weight": 0.935912323072223}], ["COL6A6", ["TCGA.A6.5662.01", "Extracellular matrix organization"], {"weight": 0.826453423487202}], ["COL6A6", ["TCGA.A6.5662.01", "Collagen chain trimerization"], {"weight": 0.916742843619245}], ["COL6A6", ["TCGA.AD.6548.01", "Extracellular matrix organization"], {"weight": 0.801515800793484}], ["COL6A6", ["TCGA.AD.6548.01", "Collagen formation"], {"weight": 0.907653422173144}], ["COL6A6", ["TCGA.CK.5914.01", "L1CAM interactions"], {"weight": 0.931696957411745}], ["COL6A6", ["TCGA.CK.5914.01", "Extracellular matrix organization"], {"weight": 0.872060091431799}], ["COL6A6", ["TCGA.DM.A1D9.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.748860100928998}], ["COL6A6", ["TCGA.DM.A1D9.01", "Molecules associated with elastic fibres"], {"weight": 0.740265687300503}], ["COL6A6", ["TCGA.DM.A282.01", "NCAM1 interactions"], {"weight": 0.899986159277881}], ["COL6A6", ["TCGA.DM.A282.01", "Degradation of the extracellular matrix"], {"weight": 0.669065427804634}], ["OR5H15", ["TCGA.A6.5659.01", "G-protein beta:gamma signalling"], {"weight": 0.911170409303809}], ["OR5H15", ["TCGA.A6.5659.01", "G protein gated Potassium channels"], {"weight": 0.887702341952425}], ["OR5H15", ["TCGA.A6.5659.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.88436409283502}], ["OR5H15", ["TCGA.F4.6569.01", "Inwardly rectifying K+ channels"], {"weight": 0.838547439967985}], ["OR5H15", ["TCGA.F4.6569.01", "Signaling by GPCR"], {"weight": 0.928528621668201}], ["OR5H15", ["TCGA.F4.6569.01", "GPCR ligand binding"], {"weight": 0.924742776891012}], ["OR5H15", ["TCGA.F4.6569.01", "Transport of small molecules"], {"weight": 0.845804463404447}], ["OR5H15", ["TCGA.F4.6569.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.876908615271879}], ["OR5H15", ["TCGA.F4.6569.01", "G alpha (s) signalling events"], {"weight": 0.905401676279754}], ["OR5H15", ["TCGA.F4.6569.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.870580706656246}], ["OR5H15", ["TCGA.F4.6569.01", "Glucagon-type ligand receptors"], {"weight": 0.900127709266995}], ["OR5H15", ["TCGA.F4.6569.01", "GPCR downstream signalling"], {"weight": 0.925860086871026}], ["OR5H15", ["TCGA.G4.6297.01", "Signaling by GPCR"], {"weight": 0.914705113928323}], ["OR5H15", ["TCGA.G4.6297.01", "GPCR ligand binding"], {"weight": 0.921705903269365}], ["OR10J5", ["TCGA.A6.5659.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.90902065927388}], ["OR10J5", ["TCGA.CM.6678.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.74977879932744}], ["OR10J5", ["TCGA.CM.6678.01", "Parasitic Infection Pathways"], {"weight": 0.841703029736645}], ["OR10J5", ["TCGA.CM.6678.01", "G alpha (s) signalling events"], {"weight": 0.940435799999226}], ["OR10J5", ["TCGA.CM.6678.01", "Phase 0 - rapid depolarisation"], {"weight": 0.789293343663844}], ["OR6P1", ["TCGA.A6.5659.01", "Glucagon-type ligand receptors"], {"weight": 0.896121545307612}], ["OR6P1", ["TCGA.A6.5659.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.887702341952425}], ["OR6P1", ["TCGA.G4.6299.01", "Signal amplification"], {"weight": 0.90559054866038}], ["OR6P1", ["TCGA.G4.6299.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.90633166446705}], ["OR6P1", ["TCGA.G4.6299.01", "Thromboxane signalling through TP receptor"], {"weight": 0.877890235447836}], ["OR6P1", ["TCGA.G4.6299.01", "Glucagon-type ligand receptors"], {"weight": 0.916403125078096}], ["BAIAP2", ["TCGA.A6.5659.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.850866980183756}], ["WDFY4", ["TCGA.D5.6924.01", "Signaling by ERBB4"], {"weight": 0.802498168123013}], ["MME", ["TCGA.AA.3713.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.847597754460746}], ["MME", ["TCGA.CM.6678.01", "Extracellular matrix organization"], {"weight": 0.846190569073882}], ["MME", ["TCGA.CM.6678.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.765396714430693}], ["MME", ["TCGA.CM.6678.01", "Degradation of the extracellular matrix"], {"weight": 0.768447108010753}], ["MME", ["TCGA.D5.6532.01", "Initial triggering of complement"], {"weight": 0.80476912253537}], ["MME", ["TCGA.D5.6532.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.702880317926263}], ["MME", ["TCGA.D5.6532.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.702880317926263}], ["PAPPA", ["TCGA.A6.5660.01", "Peptide hormone metabolism"], {"weight": 0.739278109773505}], ["PAPPA", ["TCGA.A6.6780.01", "IRS-related events triggered by IGF1R"], {"weight": 0.885065615191512}], ["PAPPA", ["TCGA.A6.6780.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.884882044166957}], ["PAPPA", ["TCGA.A6.6780.01", "IGF1R signaling cascade"], {"weight": 0.884882044166957}], ["PAPPA", ["TCGA.CM.6172.01", "Complement cascade"], {"weight": 0.659902269876112}], ["PAPPA", ["TCGA.DM.A1D8.01", "Initial triggering of complement"], {"weight": 0.735144641383521}], ["PAPPA", ["TCGA.DM.A28H.01", "TNFs bind their physiological receptors"], {"weight": 0.488857006879485}], ["PAPPA", ["TCGA.DM.A28M.01", "Arachidonic acid metabolism"], {"weight": 0.933451883578409}], ["PAPPA", ["TCGA.G4.6586.01", "Diseases of glycosylation"], {"weight": 0.917704653870363}], ["CACNA2D3", ["TCGA.CM.5863.01", "LGI-ADAM interactions"], {"weight": 0.670488312779931}], ["CACNA2D3", ["TCGA.CM.5863.01", "Peptide ligand-binding receptors"], {"weight": 0.925984477753472}], ["CACNA2D3", ["TCGA.CM.5863.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.925984477753472}], ["CACNA2D3", ["TCGA.G4.6306.01", "Ion homeostasis"], {"weight": 0.926751214269297}], ["CACNA2D3", ["TCGA.G4.6306.01", "Peptide ligand-binding receptors"], {"weight": 0.947054733547027}], ["CACNA2D3", ["TCGA.G4.6306.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.947740885418847}], ["CACNA2D3", ["TCGA.G4.6588.01", "Phase 0 - rapid depolarisation"], {"weight": 0.939079566363982}], ["DLG2", ["TCGA.A6.5659.01", "Neurexins and neuroligins"], {"weight": 0.909745443901876}], ["DLG2", ["TCGA.AA.3492.01", "Protein-protein interactions at synapses"], {"weight": 0.907279257231543}], ["DLG2", ["TCGA.AA.3492.01", "Neurexins and neuroligins"], {"weight": 0.93057738711573}], ["DLG2", ["TCGA.AM.5820.01", "Neurexins and neuroligins"], {"weight": 0.904739360214572}], ["DLG2", ["TCGA.CA.6718.01", "Protein-protein interactions at synapses"], {"weight": 0.881579426696126}], ["DLG2", ["TCGA.CM.6165.01", "Neuronal System"], {"weight": 0.777150713373334}], ["DLG2", ["TCGA.CM.6171.01", "Protein-protein interactions at synapses"], {"weight": 0.906226992339213}], ["DLG2", ["TCGA.F4.6570.01", "Protein-protein interactions at synapses"], {"weight": 0.841148808282788}], ["DLG2", ["TCGA.F4.6570.01", "Neurexins and neuroligins"], {"weight": 0.914391425821662}], ["MED12L", ["TCGA.A6.5659.01", "Phase II - Conjugation of compounds"], {"weight": 0.753160807930712}], ["MED12L", ["TCGA.AY.5543.01", "Biological oxidations"], {"weight": 0.908346612516135}], ["MED12L", ["TCGA.AY.5543.01", "Phase I - Functionalization of compounds"], {"weight": 0.922392303004858}], ["MMP16", ["TCGA.CM.5860.01", "Collagen formation"], {"weight": 0.949957857925948}], ["MMP16", ["TCGA.CM.5860.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.940767456848935}], ["MMP16", ["TCGA.CM.5860.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.949126625725177}], ["MMP16", ["TCGA.CM.5860.01", "Collagen degradation"], {"weight": 0.933112076026573}], ["MMP16", ["TCGA.D5.6536.01", "Extracellular matrix organization"], {"weight": 0.837473392805168}], ["MMP16", ["TCGA.D5.6536.01", "Degradation of the extracellular matrix"], {"weight": 0.791625817979944}], ["MMP16", ["TCGA.D5.6536.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.926937094200551}], ["MMP16", ["TCGA.D5.6536.01", "Collagen formation"], {"weight": 0.928617715845099}], ["MMP16", ["TCGA.D5.6536.01", "Collagen degradation"], {"weight": 0.933093778472567}], ["MMP16", ["TCGA.D5.6536.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.910375191108261}], ["CD109", ["TCGA.A6.6781.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.873171605006068}], ["CD109", ["TCGA.CA.6716.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.880400954756734}], ["CD109", ["TCGA.D5.5540.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.781807071117248}], ["IQSEC1", ["TCGA.AZ.6598.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.921137709790977}], ["IQSEC1", ["TCGA.AZ.6598.01", "PI3K events in ERBB2 signaling"], {"weight": 0.921137709790977}], ["IQSEC1", ["TCGA.AZ.6598.01", "ERBB2 Regulates Cell Motility"], {"weight": 0.921137709790977}], ["IQSEC1", ["TCGA.AZ.6598.01", "GRB2 events in ERBB2 signaling"], {"weight": 0.921137709790977}], ["IQSEC1", ["TCGA.AZ.6598.01", "Signaling by ERBB4"], {"weight": 0.949077598485271}], ["IQSEC1", ["TCGA.AZ.6598.01", "GAB1 signalosome"], {"weight": 0.906973892091402}], ["NRXN2", ["TCGA.A6.6137.01", "Protein-protein interactions at synapses"], {"weight": 0.728573701908415}], ["NRXN2", ["TCGA.A6.6650.01", "Neurexins and neuroligins"], {"weight": 0.936099266796513}], ["NRXN2", ["TCGA.A6.6780.01", "Neurexins and neuroligins"], {"weight": 0.943856805374856}], ["NRXN2", ["TCGA.AA.3713.01", "Protein-protein interactions at synapses"], {"weight": 0.80915093159411}], ["NRXN2", ["TCGA.AU.6004.01", "Neuronal System"], {"weight": 0.916026833984371}], ["NRXN2", ["TCGA.AY.6197.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.913052957041648}], ["NRXN2", ["TCGA.AY.6197.01", "Neurexins and neuroligins"], {"weight": 0.940619857283752}], ["NRXN2", ["TCGA.CA.5797.01", "Neuronal System"], {"weight": 0.926315374662593}], ["NRXN2", ["TCGA.CA.5797.01", "Sensory processing of sound"], {"weight": 0.934396316259444}], ["NRXN2", ["TCGA.CA.5797.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.932505257008087}], ["NRXN2", ["TCGA.CM.4743.01", "Protein-protein interactions at synapses"], {"weight": 0.910362109340341}], ["NRXN2", ["TCGA.CM.4743.01", "Neurexins and neuroligins"], {"weight": 0.951445472936871}], ["IVL", ["TCGA.A6.5659.01", "Heme degradation"], {"weight": 0.68879749491474}], ["IVL", ["TCGA.AA.3662.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.859727514689004}], ["IVL", ["TCGA.CM.6168.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.885057240914784}], ["CANT1", ["TCGA.A6.5659.01", "G alpha (s) signalling events"], {"weight": 0.937433965290866}], ["CANT1", ["TCGA.A6.5659.01", "Platelet homeostasis"], {"weight": 0.889094843854196}], ["IRS1", ["TCGA.AY.6197.01", "Protein-protein interactions at synapses"], {"weight": 0.915363306626534}], ["OR2W3", ["TCGA.A6.6652.01", "GPCR ligand binding"], {"weight": 0.937094075929501}], ["OR2W3", ["TCGA.A6.6652.01", "Potassium Channels"], {"weight": 0.922379876846157}], ["OR2W3", ["TCGA.A6.6652.01", "Platelet homeostasis"], {"weight": 0.902260482464176}], ["OR2W3", ["TCGA.D5.5537.01", "Leishmania parasite growth and survival"], {"weight": 0.850896053202572}], ["OR2W3", ["TCGA.D5.5537.01", "GPCR ligand binding"], {"weight": 0.92473126374842}], ["OR2W3", ["TCGA.D5.5537.01", "Integration of energy metabolism"], {"weight": 0.876411850093041}], ["OR2W3", ["TCGA.D5.5537.01", "G-protein beta:gamma signalling"], {"weight": 0.908541718428754}], ["OR2W3", ["TCGA.D5.5537.01", "Parasitic Infection Pathways"], {"weight": 0.805386681633061}], ["OR2W3", ["TCGA.D5.5537.01", "GABA B receptor activation"], {"weight": 0.906537340698306}], ["SCN5A", ["TCGA.A6.5659.01", "Phase 0 - rapid depolarisation"], {"weight": 0.874210954319716}], ["SCN5A", ["TCGA.AD.6548.01", "Trafficking of AMPA receptors"], {"weight": 0.902453952426879}], ["SCN5A", ["TCGA.AD.6548.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.902453952426879}], ["SCN5A", ["TCGA.AD.6548.01", "L1CAM interactions"], {"weight": 0.849042921691658}], ["SCN5A", ["TCGA.AD.6548.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.856102217479799}], ["SCN5A", ["TCGA.AD.6963.01", "Interaction between L1 and Ankyrins"], {"weight": 0.945808969049114}], ["SCN5A", ["TCGA.AD.6963.01", "Phase 0 - rapid depolarisation"], {"weight": 0.936273463901315}], ["SCN5A", ["TCGA.AD.6963.01", "L1CAM interactions"], {"weight": 0.909896129325377}], ["SCN5A", ["TCGA.AY.5543.01", "Phase 0 - rapid depolarisation"], {"weight": 0.939040329249239}], ["SCN5A", ["TCGA.AY.5543.01", "Interaction between L1 and Ankyrins"], {"weight": 0.941493553472772}], ["SCN5A", ["TCGA.AY.5543.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.906713186771117}], ["SCN5A", ["TCGA.CK.5915.01", "Ca2+ pathway"], {"weight": 0.869030796778256}], ["SCN5A", ["TCGA.CK.5916.01", "Stimuli-sensing channels"], {"weight": 0.937962068729387}], ["SCN5A", ["TCGA.CK.5916.01", "Phase 0 - rapid depolarisation"], {"weight": 0.919304761493185}], ["SCN5A", ["TCGA.CK.5916.01", "Ion channel transport"], {"weight": 0.959337672767516}], ["SCN5A", ["TCGA.CM.4743.01", "Interaction between L1 and Ankyrins"], {"weight": 0.938358722407579}], ["SCN5A", ["TCGA.CM.6170.01", "Cardiac conduction"], {"weight": 0.822901505789115}], ["SCN5A", ["TCGA.CM.6170.01", "Interaction between L1 and Ankyrins"], {"weight": 0.884327055317443}], ["SCN5A", ["TCGA.CM.6170.01", "Muscle contraction"], {"weight": 0.845489276798713}], ["SCN5A", ["TCGA.CM.6170.01", "L1CAM interactions"], {"weight": 0.813771281315954}], ["SCN5A", ["TCGA.CM.6170.01", "Stimuli-sensing channels"], {"weight": 0.884463051668347}], ["SCN5A", ["TCGA.D5.6924.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.594465824958447}], ["SCN5A", ["TCGA.F4.6856.01", "Interaction between L1 and Ankyrins"], {"weight": 0.937523401530293}], ["SCN5A", ["TCGA.F4.6856.01", "Phase 0 - rapid depolarisation"], {"weight": 0.930638714355245}], ["SCN5A", ["TCGA.G4.6317.01", "Signaling by GPCR"], {"weight": 0.953153149378122}], ["SCN5A", ["TCGA.G4.6317.01", "G alpha (s) signalling events"], {"weight": 0.960663826514985}], ["SCN5A", ["TCGA.G4.6317.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.941511472584241}], ["SCN5A", ["TCGA.G4.6317.01", "Regulation of insulin secretion"], {"weight": 0.936348756653503}], ["SCN5A", ["TCGA.G4.6317.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.93395875443068}], ["SCN5A", ["TCGA.G4.6317.01", "Integration of energy metabolism"], {"weight": 0.926600521587024}], ["SCN5A", ["TCGA.G4.6317.01", "G-protein mediated events"], {"weight": 0.943649236270092}], ["SCN5A", ["TCGA.G4.6317.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.92222526165342}], ["SCN5A", ["TCGA.G4.6317.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.930813887218709}], ["SCN5A", ["TCGA.G4.6317.01", "Aquaporin-mediated transport"], {"weight": 0.930813887218709}], ["SCN5A", ["TCGA.G4.6317.01", "GPER1 signaling"], {"weight": 0.935039528511533}], ["SCN5A", ["TCGA.G4.6317.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.935039528511533}], ["SCN5A", ["TCGA.G4.6317.01", "Long-term potentiation"], {"weight": 0.929418436753126}], ["EP300", ["TCGA.A6.5659.01", "Regulation of insulin secretion"], {"weight": 0.923624795944528}], ["EP300", ["TCGA.A6.5659.01", "Integration of energy metabolism"], {"weight": 0.92529591590707}], ["EP300", ["TCGA.A6.5659.01", "Signaling Pathways"], {"weight": 0.860569240316846}], ["EP300", ["TCGA.A6.6780.01", "Developmental Biology"], {"weight": 0.898665652859432}], ["EP300", ["TCGA.A6.6780.01", "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"], {"weight": 0.819706473282579}], ["EP300", ["TCGA.AD.6889.01", "Regulation of insulin secretion"], {"weight": 0.941743835718527}], ["EP300", ["TCGA.AD.6889.01", "SUMOylation of intracellular receptors"], {"weight": 0.780046517764971}], ["EP300", ["TCGA.AD.6889.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.812008481638795}], ["EP300", ["TCGA.CA.5796.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.596888679831196}], ["EP300", ["TCGA.CA.5796.01", "Regulation of insulin secretion"], {"weight": 0.873011826281679}], ["EP300", ["TCGA.CA.5796.01", "Carnitine metabolism"], {"weight": 0.663935499633098}], ["EP300", ["TCGA.CA.5796.01", "Glycosaminoglycan metabolism"], {"weight": 0.718144048086673}], ["EP300", ["TCGA.CK.5913.01", "Drug ADME"], {"weight": 0.875499517268544}], ["EP300", ["TCGA.D5.5540.01", "Signaling by ROBO receptors"], {"weight": 0.936754678772548}], ["EP300", ["TCGA.D5.5540.01", "Regulation of insulin secretion"], {"weight": 0.946294031754305}], ["EP300", ["TCGA.D5.5540.01", "Activation of ATR in response to replication stress"], {"weight": 0.898881276625431}], ["EP300", ["TCGA.D5.5540.01", "Integration of energy metabolism"], {"weight": 0.937172307724591}], ["EP300", ["TCGA.D5.6931.01", "Integration of energy metabolism"], {"weight": 0.844549084146468}], ["EP300", ["TCGA.G4.6322.01", "Drug ADME"], {"weight": 0.851936989597681}], ["EP300", ["TCGA.G4.6322.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.770839254548312}], ["EP300", ["TCGA.G4.6322.01", "Signaling Pathways"], {"weight": 0.865062713838065}], ["EP300", ["TCGA.G4.6322.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.777595338243029}], ["EP300", ["TCGA.G4.6322.01", "Retinoid metabolism and transport"], {"weight": 0.777595338243029}], ["EP300", ["TCGA.G4.6628.01", "Transport of small molecules"], {"weight": 0.909239903659901}], ["UNC13C", ["TCGA.CA.6716.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.876230527882647}], ["UNC13C", ["TCGA.G4.6306.01", "Protein-protein interactions at synapses"], {"weight": 0.917580647764005}], ["UNC13C", ["TCGA.G4.6306.01", "Neurexins and neuroligins"], {"weight": 0.924350127066949}], ["UNC13C", ["TCGA.G4.6306.01", "Other interleukin signaling"], {"weight": 0.611228299792785}], ["PPFIA2", ["TCGA.A6.5659.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.910815609641366}], ["PPFIA2", ["TCGA.A6.5659.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.876349409719199}], ["PPFIA2", ["TCGA.A6.5665.01", "Protein-protein interactions at synapses"], {"weight": 0.93930498835168}], ["PPFIA2", ["TCGA.A6.6653.01", "Neuronal System"], {"weight": 0.927270503295611}], ["PPFIA2", ["TCGA.AZ.6598.01", "Neuronal System"], {"weight": 0.947403280986595}], ["PPFIA2", ["TCGA.AZ.6598.01", "Protein-protein interactions at synapses"], {"weight": 0.924434850134525}], ["PPFIA2", ["TCGA.CM.6170.01", "Neuronal System"], {"weight": 0.906070081304985}], ["PPFIA2", ["TCGA.CM.6170.01", "Regulation of insulin secretion"], {"weight": 0.843011086073415}], ["PPFIA2", ["TCGA.CM.6170.01", "Integration of energy metabolism"], {"weight": 0.825607158905273}], ["PPFIA2", ["TCGA.CM.6170.01", "Transport of small molecules"], {"weight": 0.860474185459401}], ["PPFIA2", ["TCGA.D5.6931.01", "Neuronal System"], {"weight": 0.817916833665673}], ["PPFIA2", ["TCGA.DM.A1D4.01", "Neurexins and neuroligins"], {"weight": 0.94934869381614}], ["PPFIA2", ["TCGA.DM.A1D4.01", "Insulin processing"], {"weight": 0.844537437834626}], ["PPFIA2", ["TCGA.G4.6628.01", "Neuronal System"], {"weight": 0.918564328740306}], ["PPFIA2", ["TCGA.G4.6628.01", "Protein-protein interactions at synapses"], {"weight": 0.907964718567004}], ["OR5D18", ["TCGA.A6.5659.01", "G beta:gamma signalling through BTK"], {"weight": 0.893492948466469}], ["OR5D18", ["TCGA.A6.5659.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.879167733169629}], ["OR5D18", ["TCGA.A6.5659.01", "Activation of G protein gated Potassium channels"], {"weight": 0.887702341952425}], ["OR5D18", ["TCGA.AD.6901.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.880370940755622}], ["OR5D18", ["TCGA.AD.6901.01", "G alpha (q) signalling events"], {"weight": 0.916804332728121}], ["OR5D18", ["TCGA.AD.6901.01", "Inwardly rectifying K+ channels"], {"weight": 0.818729224101392}], ["OR5D18", ["TCGA.AD.6901.01", "G alpha (z) signalling events"], {"weight": 0.830977751480725}], ["OR5D18", ["TCGA.AD.6901.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.879159454455647}], ["OR5D18", ["TCGA.AD.6901.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.878099755907974}], ["OR5D18", ["TCGA.F4.6704.01", "Metabolism"], {"weight": 0.892169546852792}], ["OR5D18", ["TCGA.F4.6704.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.872304361788646}], ["OR5D18", ["TCGA.F4.6704.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.850649984712693}], ["OR5D18", ["TCGA.F4.6704.01", "Sensory processing of sound"], {"weight": 0.850649984712693}], ["OR5D18", ["TCGA.F4.6704.01", "GPCR ligand binding"], {"weight": 0.857909472038875}], ["OR5D18", ["TCGA.F4.6704.01", "Glucagon-type ligand receptors"], {"weight": 0.874146495417291}], ["OR5D18", ["TCGA.F4.6704.01", "Peptide hormone biosynthesis"], {"weight": 0.623953277639085}], ["OR5D18", ["TCGA.F4.6704.01", "Presynaptic function of Kainate receptors"], {"weight": 0.862000785263456}], ["OR5D18", ["TCGA.G4.6299.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.898444577510883}], ["OR5D18", ["TCGA.G4.6299.01", "Peptide hormone metabolism"], {"weight": 0.821809727214882}], ["OR5D18", ["TCGA.G4.6299.01", "Activation of G protein gated Potassium channels"], {"weight": 0.895694126090053}], ["PLCB3", ["TCGA.A6.5659.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.69918447067541}], ["PCLO", ["TCGA.A6.5659.01", "Sensory processing of sound"], {"weight": 0.889556872730197}], ["PCLO", ["TCGA.CM.5861.01", "Sensory processing of sound"], {"weight": 0.888919270666405}], ["PCLO", ["TCGA.CM.5861.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.881902516152078}], ["PCLO", ["TCGA.DM.A1HA.01", "Dopamine Neurotransmitter Release Cycle"], {"weight": 0.89596320169444}], ["PCLO", ["TCGA.DM.A1HA.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.877387392714977}], ["PCLO", ["TCGA.DM.A1HA.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.577618183042122}], ["PCLO", ["TCGA.F4.6854.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.652431372052084}], ["PCLO", ["TCGA.F4.6854.01", "SLC-mediated transmembrane transport"], {"weight": 0.724286652755894}], ["PCLO", ["TCGA.G4.6315.01", "Regulation of insulin secretion"], {"weight": 0.898593047461809}], ["PCLO", ["TCGA.G4.6315.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.90606944825251}], ["FFAR1", ["TCGA.AA.3712.01", "G alpha (s) signalling events"], {"weight": 0.951270784222406}], ["FFAR1", ["TCGA.AZ.6603.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.908604891248413}], ["FFAR1", ["TCGA.AZ.6603.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.760019122607422}], ["FFAR1", ["TCGA.CM.5862.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.946905682312317}], ["OR5H1", ["TCGA.A6.5659.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.899567199736162}], ["OR5H1", ["TCGA.A6.5659.01", "Phase 4 - resting membrane potential"], {"weight": 0.760344937724515}], ["OR5H1", ["TCGA.A6.5659.01", "Presynaptic function of Kainate receptors"], {"weight": 0.876669319366368}], ["OR5H1", ["TCGA.A6.5659.01", "Inwardly rectifying K+ channels"], {"weight": 0.90005454593984}], ["OR5H1", ["TCGA.A6.5659.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.888797919533952}], ["OR5H1", ["TCGA.AZ.6600.01", "Signal amplification"], {"weight": 0.845101705568301}], ["OR5H1", ["TCGA.AZ.6600.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.827867358249989}], ["OR5H1", ["TCGA.CM.5341.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.92807941074374}], ["OR5H1", ["TCGA.D5.6541.01", "Neuronal System"], {"weight": 0.921532509773598}], ["OR5H1", ["TCGA.D5.6541.01", "GPCR downstream signalling"], {"weight": 0.951854789180454}], ["OR5H1", ["TCGA.D5.6541.01", "GPCR ligand binding"], {"weight": 0.947864896608874}], ["OR5H1", ["TCGA.D5.6541.01", "G alpha (i) signalling events"], {"weight": 0.948591998876735}], ["OR5H1", ["TCGA.D5.6541.01", "G alpha (s) signalling events"], {"weight": 0.947097941438263}], ["OR5H1", ["TCGA.D5.6541.01", "Peptide hormone metabolism"], {"weight": 0.781240620347404}], ["MAF", ["TCGA.A6.5659.01", "APAP ADME"], {"weight": 0.728269915034475}], ["CCDC129", ["TCGA.DM.A285.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.938324300728509}], ["CCDC129", ["TCGA.DM.A285.01", "Generation of second messenger molecules"], {"weight": 0.942649161437798}], ["CCDC129", ["TCGA.DM.A285.01", "PD-1 signaling"], {"weight": 0.93593639874588}], ["CCDC129", ["TCGA.DM.A285.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.936081509873987}], ["CCDC129", ["TCGA.DM.A285.01", "Costimulation by the CD28 family"], {"weight": 0.910655610369542}], ["CCDC129", ["TCGA.DM.A285.01", "TCR signaling"], {"weight": 0.942101071784281}], ["CCDC129", ["TCGA.DM.A285.01", "Collagen chain trimerization"], {"weight": 0.872107939929378}], ["RGS20", ["TCGA.A6.5659.01", "G alpha (i) signalling events"], {"weight": 0.918553396521678}], ["RGS20", ["TCGA.G4.6588.01", "GPCR downstream signalling"], {"weight": 0.949813016272755}], ["RGS20", ["TCGA.G4.6588.01", "GABA receptor activation"], {"weight": 0.926074305397573}], ["RGS20", ["TCGA.G4.6588.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.94118356917185}], ["RGS20", ["TCGA.G4.6588.01", "G alpha (s) signalling events"], {"weight": 0.962683880401514}], ["RGS20", ["TCGA.G4.6588.01", "GABA B receptor activation"], {"weight": 0.930640381462554}], ["RGS20", ["TCGA.G4.6588.01", "Activation of GABAB receptors"], {"weight": 0.930640381462554}], ["RGS20", ["TCGA.G4.6588.01", "Regulation of insulin secretion"], {"weight": 0.928158799697469}], ["RGS20", ["TCGA.G4.6588.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.915987776211569}], ["RGS20", ["TCGA.G4.6588.01", "Signal amplification"], {"weight": 0.915700361027229}], ["PDGFRA", ["TCGA.CA.6716.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.854123491330695}], ["PDGFRA", ["TCGA.DM.A1D9.01", "Leishmania infection"], {"weight": 0.888371395968077}], ["PDGFRA", ["TCGA.DM.A1D9.01", "Parasitic Infection Pathways"], {"weight": 0.888371395968077}], ["PDGFRA", ["TCGA.DM.A1D9.01", "Other interleukin signaling"], {"weight": 0.690096242604255}], ["UNC80", ["TCGA.D5.5538.01", "Ion channel transport"], {"weight": 0.906180619256204}], ["MYC", ["TCGA.A6.5659.01", "Ethanol oxidation"], {"weight": 0.78328194585199}], ["MYC", ["TCGA.A6.5659.01", "RA biosynthesis pathway"], {"weight": 0.734810051519819}], ["MYC", ["TCGA.A6.6781.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.770167033353226}], ["MYC", ["TCGA.A6.6781.01", "Scavenging by Class A Receptors"], {"weight": 0.727662742827646}], ["PPP2R2B", ["TCGA.A6.5659.01", "Cardiac conduction"], {"weight": 0.898392014191823}], ["PPP2R2B", ["TCGA.A6.6653.01", "Cardiac conduction"], {"weight": 0.95902564929433}], ["PPP2R2B", ["TCGA.AD.6889.01", "LGI-ADAM interactions"], {"weight": 0.910935032384556}], ["PPP2R2B", ["TCGA.D5.6927.01", "Cardiac conduction"], {"weight": 0.947975221109698}], ["PPP2R2B", ["TCGA.D5.6927.01", "Muscle contraction"], {"weight": 0.953735030219855}], ["USP42", ["TCGA.CM.6168.01", "Extracellular matrix organization"], {"weight": 0.875504239720083}], ["CHST2", ["TCGA.D5.6534.01", "Extracellular matrix organization"], {"weight": 0.897054241035184}], ["CHST2", ["TCGA.D5.6534.01", "Integrin cell surface interactions"], {"weight": 0.923897847386276}], ["CHST2", ["TCGA.D5.6537.01", "Keratan sulfate biosynthesis"], {"weight": 0.933550762667021}], ["CHST2", ["TCGA.G4.6298.01", "Blood group systems biosynthesis"], {"weight": 0.813540779305253}], ["CHST2", ["TCGA.G4.6321.01", "Glycosaminoglycan metabolism"], {"weight": 0.781250146179803}], ["CHST2", ["TCGA.G4.6321.01", "Diseases associated with glycosaminoglycan metabolism"], {"weight": 0.798833405133742}], ["PON3", ["TCGA.A6.5659.01", "Drug ADME"], {"weight": 0.866696676654586}], ["GCNT2", ["TCGA.A6.5659.01", "Blood group systems biosynthesis"], {"weight": 0.714480897811054}], ["GCNT2", ["TCGA.F4.6809.01", "Blood group systems biosynthesis"], {"weight": 0.685428474187827}], ["GCNT2", ["TCGA.F4.6809.01", "Lewis blood group biosynthesis"], {"weight": 0.426427510516246}], ["CNTN4", ["TCGA.CM.6171.01", "L1CAM interactions"], {"weight": 0.910644901025816}], ["EPHB1", ["TCGA.A6.5660.01", "Synaptic adhesion-like molecules"], {"weight": 0.876219649363945}], ["EPHB1", ["TCGA.DM.A0X9.01", "Protein-protein interactions at synapses"], {"weight": 0.89750047500907}], ["EPHB1", ["TCGA.F4.6808.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.924601082510819}], ["EPHB1", ["TCGA.G4.6307.01", "Voltage gated Potassium channels"], {"weight": 0.904387686553846}], ["EPHB1", ["TCGA.G4.6307.01", "FCGR activation"], {"weight": 0.881868108439262}], ["FASN", ["TCGA.AD.6901.01", "Integration of energy metabolism"], {"weight": 0.846393537790356}], ["FASN", ["TCGA.CM.5861.01", "Integration of energy metabolism"], {"weight": 0.934861870548917}], ["PLCB1", ["TCGA.D5.6535.01", "Platelet homeostasis"], {"weight": 0.794895483813027}], ["PLCB1", ["TCGA.D5.6535.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.811991021886447}], ["PLCB1", ["TCGA.D5.6535.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.854522564714917}], ["PLCB1", ["TCGA.D5.6535.01", "Presynaptic function of Kainate receptors"], {"weight": 0.854505166754028}], ["PLCB1", ["TCGA.DM.A1D9.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.775723541136592}], ["PLCB1", ["TCGA.DM.A1D9.01", "Presynaptic function of Kainate receptors"], {"weight": 0.917606828452698}], ["PLCB1", ["TCGA.DM.A1D9.01", "Regulation of insulin secretion"], {"weight": 0.928622883168625}], ["PLCB1", ["TCGA.DM.A1D9.01", "Platelet homeostasis"], {"weight": 0.876291060758706}], ["PLCB1", ["TCGA.DM.A1D9.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.909452672326006}], ["PLCB1", ["TCGA.DM.A1D9.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.922940837218363}], ["GNA12", ["TCGA.A6.5660.01", "G alpha (i) signalling events"], {"weight": 0.946438920521426}], ["GNA12", ["TCGA.A6.5660.01", "Platelet homeostasis"], {"weight": 0.843373922994024}], ["GNA12", ["TCGA.A6.5660.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.888187880371868}], ["TFAP2B", ["TCGA.A6.6649.01", "Peptide hormone biosynthesis"], {"weight": 0.565757068065542}], ["TFAP2B", ["TCGA.DM.A1HA.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.933970225231675}], ["TFAP2B", ["TCGA.DM.A1HA.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.966374557762674}], ["TFAP2B", ["TCGA.DM.A1HA.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.966953799901461}], ["NGFR", ["TCGA.A6.5660.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.589068365513069}], ["NGFR", ["TCGA.AY.6197.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.882688354899907}], ["NGFR", ["TCGA.AY.6197.01", "G-protein beta:gamma signalling"], {"weight": 0.890966557076452}], ["COL11A1", ["TCGA.AZ.4323.01", "O-linked glycosylation"], {"weight": 0.908175947598182}], ["COL11A1", ["TCGA.AZ.4323.01", "Defective B3GALTL causes PpS"], {"weight": 0.890083818386806}], ["COL11A1", ["TCGA.CM.5860.01", "Degradation of the extracellular matrix"], {"weight": 0.883961913499536}], ["COL11A1", ["TCGA.CM.5860.01", "NCAM1 interactions"], {"weight": 0.835412684061689}], ["COL11A1", ["TCGA.CM.5860.01", "Integrin cell surface interactions"], {"weight": 0.868276231208737}], ["COL11A1", ["TCGA.CM.5860.01", "ECM proteoglycans"], {"weight": 0.835193040129212}], ["COL11A1", ["TCGA.CM.5860.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.621708256360588}], ["COL11A1", ["TCGA.CM.5860.01", "Defective B3GALTL causes PpS"], {"weight": 0.885466520264083}], ["COL11A1", ["TCGA.CM.5860.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.885466520264083}], ["COL11A1", ["TCGA.CM.5860.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.602163736369873}], ["COL11A1", ["TCGA.CM.5860.01", "NCAM signaling for neurite out-growth"], {"weight": 0.834750940929405}], ["COL11A1", ["TCGA.CM.5860.01", "Diseases of glycosylation"], {"weight": 0.862021374475249}], ["COL11A1", ["TCGA.D5.6924.01", "O-linked glycosylation of mucins"], {"weight": 0.869789814059602}], ["COL11A1", ["TCGA.D5.6924.01", "O-linked glycosylation"], {"weight": 0.891774901856281}], ["COL11A1", ["TCGA.G4.6304.01", "Keratan sulfate biosynthesis"], {"weight": 0.935231439373854}], ["COL11A1", ["TCGA.G4.6304.01", "Degradation of the extracellular matrix"], {"weight": 0.816935879022689}], ["COL11A1", ["TCGA.G4.6304.01", "ECM proteoglycans"], {"weight": 0.916817813970262}], ["COL11A1", ["TCGA.G4.6304.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.935231439373854}], ["COL11A1", ["TCGA.G4.6304.01", "Diseases of metabolism"], {"weight": 0.862564536264157}], ["COL11A1", ["TCGA.G4.6304.01", "Diseases of glycosylation"], {"weight": 0.920242171171937}], ["COL11A1", ["TCGA.G4.6309.01", "Degradation of the extracellular matrix"], {"weight": 0.835056350296247}], ["COL22A1", ["TCGA.A6.5660.01", "NCAM1 interactions"], {"weight": 0.91542157566382}], ["COL22A1", ["TCGA.A6.5660.01", "NCAM signaling for neurite out-growth"], {"weight": 0.924507403588228}], ["COL22A1", ["TCGA.A6.5660.01", "Collagen chain trimerization"], {"weight": 0.905578371485417}], ["COL22A1", ["TCGA.AZ.4615.01", "Collagen chain trimerization"], {"weight": 0.920539205282595}], ["KIF1A", ["TCGA.DM.A282.01", "Insulin processing"], {"weight": 0.772053102725849}], ["NRG3", ["TCGA.A6.6650.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.890701541568054}], ["SLIT1", ["TCGA.A6.5660.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.650430532996281}], ["SLIT1", ["TCGA.AY.6196.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.814415687378144}], ["OR5AS1", ["TCGA.A6.5660.01", "Signaling by GPCR"], {"weight": 0.943600537909254}], ["OR5AS1", ["TCGA.A6.5660.01", "G alpha (s) signalling events"], {"weight": 0.952946376594912}], ["OR5AS1", ["TCGA.A6.5660.01", "Leishmania parasite growth and survival"], {"weight": 0.89105115683858}], ["OR5AS1", ["TCGA.AD.6964.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.890879296223167}], ["OR5AS1", ["TCGA.AD.6964.01", "Glucagon-type ligand receptors"], {"weight": 0.895199430739964}], ["NRXN1", ["TCGA.CK.5914.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.909339812047364}], ["NRXN1", ["TCGA.CK.5914.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.903888955961756}], ["NRXN1", ["TCGA.CM.4744.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.941689818270416}], ["NRXN1", ["TCGA.CM.4744.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.870332868893547}], ["NRXN1", ["TCGA.D5.6540.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.928137528652601}], ["GRIA4", ["TCGA.A6.5660.01", "Phase 0 - rapid depolarisation"], {"weight": 0.92299871885862}], ["GRIA4", ["TCGA.AA.3511.01", "Phase 0 - rapid depolarisation"], {"weight": 0.776956819539173}], ["GRIA4", ["TCGA.AA.3511.01", "Integrin cell surface interactions"], {"weight": 0.807530102092664}], ["GRIA4", ["TCGA.CM.6675.01", "Cardiac conduction"], {"weight": 0.943023305440942}], ["GRIA4", ["TCGA.CM.6675.01", "Phase 0 - rapid depolarisation"], {"weight": 0.93543516483486}], ["GRIA4", ["TCGA.CM.6675.01", "Interaction between L1 and Ankyrins"], {"weight": 0.912695501649466}], ["GRIA4", ["TCGA.CM.6675.01", "Ion homeostasis"], {"weight": 0.943660996804337}], ["GRIA4", ["TCGA.CM.6675.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.900725655225188}], ["GRIA4", ["TCGA.CM.6675.01", "LGI-ADAM interactions"], {"weight": 0.901236194467004}], ["GRIA4", ["TCGA.D5.6924.01", "Extracellular matrix organization"], {"weight": 0.863952185023363}], ["GRIA4", ["TCGA.D5.6924.01", "GABA receptor activation"], {"weight": 0.799466870941582}], ["GRIA4", ["TCGA.D5.6924.01", "Long-term potentiation"], {"weight": 0.865176997950128}], ["CACNA1B", ["TCGA.A6.5660.01", "Signaling Pathways"], {"weight": 0.879078279989521}], ["CACNA1B", ["TCGA.AZ.5403.01", "Signaling Pathways"], {"weight": 0.844456943778792}], ["CACNA1B", ["TCGA.AZ.5403.01", "Phase 0 - rapid depolarisation"], {"weight": 0.903111055381591}], ["CACNA1B", ["TCGA.AZ.5403.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.81746140630563}], ["CACNA1B", ["TCGA.AZ.5403.01", "Leishmania parasite growth and survival"], {"weight": 0.81746140630563}], ["CACNA1B", ["TCGA.AZ.6599.01", "GPCR ligand binding"], {"weight": 0.942671162557214}], ["CACNA1B", ["TCGA.AZ.6599.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.915654036636789}], ["CACNA1B", ["TCGA.CM.5862.01", "Phase 0 - rapid depolarisation"], {"weight": 0.924885609416267}], ["CACNA1B", ["TCGA.CM.6161.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.864188861417824}], ["CACNA1B", ["TCGA.CM.6165.01", "Stimuli-sensing channels"], {"weight": 0.798886375489561}], ["CACNA1B", ["TCGA.CM.6165.01", "GPCR ligand binding"], {"weight": 0.889954912246448}], ["CACNA1B", ["TCGA.CM.6680.01", "G alpha (i) signalling events"], {"weight": 0.902322017711939}], ["CACNA1B", ["TCGA.D5.5540.01", "Phase 0 - rapid depolarisation"], {"weight": 0.944153430018741}], ["CACNA1B", ["TCGA.D5.5540.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.928451509621863}], ["CACNA1B", ["TCGA.D5.5540.01", "Glucagon-type ligand receptors"], {"weight": 0.938655757256151}], ["CACNA1B", ["TCGA.D5.5540.01", "Protein folding"], {"weight": 0.934582307774617}], ["CACNA1B", ["TCGA.D5.5541.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.918220743291924}], ["CACNA1B", ["TCGA.D5.5541.01", "G alpha (s) signalling events"], {"weight": 0.948984860881267}], ["CACNA1B", ["TCGA.D5.5541.01", "GABA receptor activation"], {"weight": 0.653356315399844}], ["CACNA1B", ["TCGA.D5.5541.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.898650298120409}], ["CACNA1B", ["TCGA.D5.5541.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.898825999560573}], ["CACNA1B", ["TCGA.D5.5541.01", "Regulation of insulin secretion"], {"weight": 0.925313649708945}], ["CACNA1B", ["TCGA.D5.5541.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.837370461501116}], ["CACNA1B", ["TCGA.D5.5541.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.901453994530025}], ["CACNA1B", ["TCGA.D5.5541.01", "Platelet homeostasis"], {"weight": 0.802455200459235}], ["CACNA1B", ["TCGA.D5.5541.01", "Sensory perception of taste"], {"weight": 0.871807765388719}], ["CACNA1B", ["TCGA.D5.5541.01", "Signal amplification"], {"weight": 0.852733580932211}], ["CACNA1B", ["TCGA.D5.5541.01", "Glucagon-type ligand receptors"], {"weight": 0.905833373427736}], ["CACNA1B", ["TCGA.D5.5541.01", "GPER1 signaling"], {"weight": 0.894730592559414}], ["CACNA1B", ["TCGA.D5.5541.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.894730592559414}], ["CACNA1B", ["TCGA.D5.5541.01", "GABA B receptor activation"], {"weight": 0.916817176552203}], ["CACNA1B", ["TCGA.D5.5541.01", "Activation of GABAB receptors"], {"weight": 0.916817176552203}], ["CACNA1B", ["TCGA.D5.5541.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.902390227761423}], ["CACNA1B", ["TCGA.D5.5541.01", "Presynaptic function of Kainate receptors"], {"weight": 0.88708958861366}], ["CACNA1B", ["TCGA.D5.5541.01", "Activation of G protein gated Potassium channels"], {"weight": 0.910148035749492}], ["CACNA1B", ["TCGA.D5.5541.01", "G protein gated Potassium channels"], {"weight": 0.910148035749492}], ["CACNA1B", ["TCGA.D5.5541.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.910148035749492}], ["CACNA1B", ["TCGA.D5.5541.01", "Opioid Signalling"], {"weight": 0.874152533881652}], ["CACNA1B", ["TCGA.D5.5541.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.883065985941828}], ["CACNA1B", ["TCGA.D5.5541.01", "GPCR ligand binding"], {"weight": 0.927751386569961}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Glucagon-type ligand receptors"], {"weight": 0.943049696883349}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Potassium Channels"], {"weight": 0.962667659475245}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G alpha (z) signalling events"], {"weight": 0.918958776737002}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G beta:gamma signalling through BTK"], {"weight": 0.919720685674003}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Presynaptic function of Kainate receptors"], {"weight": 0.920357126555351}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.928925059512986}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G alpha (s) signalling events"], {"weight": 0.964451988241021}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.915473765056807}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.927566605993797}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G-protein beta:gamma signalling"], {"weight": 0.934590608888923}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G-protein activation"], {"weight": 0.940732463057914}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Thromboxane signalling through TP receptor"], {"weight": 0.911884910898526}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Inwardly rectifying K+ channels"], {"weight": 0.935460113094146}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Activation of G protein gated Potassium channels"], {"weight": 0.93057653185873}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G protein gated Potassium channels"], {"weight": 0.93057653185873}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.930040201649332}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.93057653185873}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Platelet homeostasis"], {"weight": 0.879347314733211}], ["CACNA1B", ["TCGA.DM.A1D6.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.920497466347242}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.91118518967854}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G beta:gamma signalling through CDC42"], {"weight": 0.91118518967854}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.905818221774417}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Aquaporin-mediated transport"], {"weight": 0.905818221774417}], ["CACNA1B", ["TCGA.DM.A1D6.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.911250918548935}], ["CACNA1B", ["TCGA.DM.A1D6.01", "GABA B receptor activation"], {"weight": 0.935457747105672}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Activation of GABAB receptors"], {"weight": 0.935457747105672}], ["CACNA1B", ["TCGA.DM.A1D6.01", "G alpha (12/13) signalling events"], {"weight": 0.862350893825483}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Signal amplification"], {"weight": 0.920162869972022}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.927322723858039}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.912380627941238}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.91187072351093}], ["CACNA1B", ["TCGA.DM.A1D6.01", "GPER1 signaling"], {"weight": 0.924050912191364}], ["CACNA1B", ["TCGA.DM.A1D6.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.924050912191364}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Activation of the phototransduction cascade"], {"weight": 0.915688225048624}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Peptide hormone metabolism"], {"weight": 0.857388202842147}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Sensory perception of taste"], {"weight": 0.928100408308304}], ["CACNA1B", ["TCGA.DM.A1D6.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.917922768589267}], ["CACNA1B", ["TCGA.DM.A1D8.01", "Insulin processing"], {"weight": 0.816837700765419}], ["CACNA1B", ["TCGA.DM.A1D8.01", "Sensory perception of taste"], {"weight": 0.92002337978023}], ["CACNA1B", ["TCGA.DM.A1D8.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.909191183101425}], ["CACNA1B", ["TCGA.G4.6293.01", "Phase 4 - resting membrane potential"], {"weight": 0.806750730536584}], ["CACNA1B", ["TCGA.G4.6303.01", "Phase 2 - plateau phase"], {"weight": 0.664033918777161}], ["CACNA1B", ["TCGA.G4.6315.01", "Transmission across Chemical Synapses"], {"weight": 0.914292229191704}], ["TF", ["TCGA.A6.5660.01", "Protein-protein interactions at synapses"], {"weight": 0.831448776404542}], ["TF", ["TCGA.F4.6855.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.871611221689786}], ["IL12RB1", ["TCGA.A6.5660.01", "Biological oxidations"], {"weight": 0.923343032989615}], ["IL12RB1", ["TCGA.CK.5913.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.949786941692447}], ["IL12RB1", ["TCGA.CK.5913.01", "Peptide ligand-binding receptors"], {"weight": 0.949007872637011}], ["IL12RB1", ["TCGA.CK.5913.01", "Chemokine receptors bind chemokines"], {"weight": 0.919732056608849}], ["OR5B21", ["TCGA.A6.5660.01", "GPCR downstream signalling"], {"weight": 0.943223309725207}], ["OR5B21", ["TCGA.A6.5660.01", "Potassium Channels"], {"weight": 0.884587799292979}], ["OR5B21", ["TCGA.A6.5660.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.923611799957188}], ["OR5B21", ["TCGA.A6.5660.01", "GPCR ligand binding"], {"weight": 0.948067601874251}], ["OR5B21", ["TCGA.A6.5660.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.89105115683858}], ["OR5B21", ["TCGA.A6.5660.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.919043630841975}], ["OR5B21", ["TCGA.A6.5660.01", "Glucagon-type ligand receptors"], {"weight": 0.91877894281581}], ["OR5B21", ["TCGA.A6.5660.01", "Regulation of insulin secretion"], {"weight": 0.906257198105799}], ["A2M", ["TCGA.A6.5660.01", "Extracellular matrix organization"], {"weight": 0.856368518710225}], ["A2M", ["TCGA.A6.5660.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.944587803940731}], ["A2M", ["TCGA.A6.5660.01", "Peptide ligand-binding receptors"], {"weight": 0.9438003315303}], ["A2M", ["TCGA.AA.3502.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.874691402887497}], ["A2M", ["TCGA.AA.3502.01", "Regulation of beta-cell development"], {"weight": 0.802098084712366}], ["A2M", ["TCGA.AA.3502.01", "Regulation of gene expression in beta cells"], {"weight": 0.707949187888683}], ["A2M", ["TCGA.AZ.4616.01", "Signaling by GPCR"], {"weight": 0.935352389758293}], ["A2M", ["TCGA.AZ.4616.01", "GPCR downstream signalling"], {"weight": 0.938768655241228}], ["A2M", ["TCGA.AZ.4616.01", "GPCR ligand binding"], {"weight": 0.937080075713723}], ["A2M", ["TCGA.AZ.4616.01", "Chemokine receptors bind chemokines"], {"weight": 0.930597805912907}], ["A2M", ["TCGA.AZ.4616.01", "Extracellular matrix organization"], {"weight": 0.890707828913409}], ["A2M", ["TCGA.AZ.4616.01", "Peptide ligand-binding receptors"], {"weight": 0.941739560224963}], ["A2M", ["TCGA.AZ.4616.01", "Degradation of the extracellular matrix"], {"weight": 0.882613030603282}], ["A2M", ["TCGA.AZ.4616.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.941739560224963}], ["A2M", ["TCGA.D5.5537.01", "Extracellular matrix organization"], {"weight": 0.816962045033831}], ["A2M", ["TCGA.D5.5537.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.751879990260314}], ["A2M", ["TCGA.D5.5537.01", "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"], {"weight": 0.914181141032919}], ["A2M", ["TCGA.D5.5537.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.669843373548026}], ["A2M", ["TCGA.G4.6299.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.900903126098787}], ["KCNQ2", ["TCGA.A6.5660.01", "Voltage gated Potassium channels"], {"weight": 0.891940450690269}], ["KCNQ2", ["TCGA.A6.5660.01", "Interaction between L1 and Ankyrins"], {"weight": 0.919981264184331}], ["KCNQ2", ["TCGA.AA.3492.01", "Phase 4 - resting membrane potential"], {"weight": 0.880533598372278}], ["KCNQ2", ["TCGA.AU.6004.01", "Interaction between L1 and Ankyrins"], {"weight": 0.916030618396696}], ["KCNQ2", ["TCGA.AU.6004.01", "Phase 4 - resting membrane potential"], {"weight": 0.844150013080117}], ["KCNQ2", ["TCGA.AY.6197.01", "Phase 4 - resting membrane potential"], {"weight": 0.883718176059804}], ["KCNQ2", ["TCGA.CM.6163.01", "Phase 4 - resting membrane potential"], {"weight": 0.851295397384495}], ["KCNQ2", ["TCGA.CM.6163.01", "Inwardly rectifying K+ channels"], {"weight": 0.88665567262335}], ["KCNQ2", ["TCGA.CM.6163.01", "Potassium Channels"], {"weight": 0.919695566450894}], ["KCNQ2", ["TCGA.DM.A1HA.01", "Transmission across Chemical Synapses"], {"weight": 0.950122104929399}], ["KCNQ2", ["TCGA.DM.A1HA.01", "Potassium Channels"], {"weight": 0.965777678430937}], ["KCNQ2", ["TCGA.DM.A1HA.01", "Phase 4 - resting membrane potential"], {"weight": 0.941571556135493}], ["KCNQ2", ["TCGA.DM.A1HA.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.940465151753165}], ["KCNQ2", ["TCGA.DM.A1HA.01", "Voltage gated Potassium channels"], {"weight": 0.910472907954351}], ["MYH6", ["TCGA.A6.5660.01", "Cardiac conduction"], {"weight": 0.900002684720485}], ["MYH6", ["TCGA.A6.6648.01", "Muscle contraction"], {"weight": 0.921899867035223}], ["MYH6", ["TCGA.AM.5821.01", "Muscle contraction"], {"weight": 0.949988740995169}], ["MYH6", ["TCGA.D5.6541.01", "Heme degradation"], {"weight": 0.576476937194149}], ["OR2B11", ["TCGA.A6.5660.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.901032834503314}], ["OR2B11", ["TCGA.A6.6780.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.92186129579754}], ["OR2B11", ["TCGA.A6.6780.01", "Glucagon-type ligand receptors"], {"weight": 0.933775298932609}], ["OR2B11", ["TCGA.A6.6780.01", "G alpha (z) signalling events"], {"weight": 0.898793364131973}], ["OR2B11", ["TCGA.A6.6780.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.91266058820803}], ["OR2B11", ["TCGA.A6.6780.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.878727895684509}], ["OR2B11", ["TCGA.A6.6780.01", "GABA B receptor activation"], {"weight": 0.927238088580492}], ["OR2B11", ["TCGA.A6.6780.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.924823350074569}], ["PPP2R5D", ["TCGA.A6.5661.01", "Neuronal System"], {"weight": 0.928177570135341}], ["DLGAP1", ["TCGA.A6.5661.01", "Neurexins and neuroligins"], {"weight": 0.941894944498242}], ["DLGAP1", ["TCGA.G4.6306.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.83160667142342}], ["DLGAP1", ["TCGA.G4.6309.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.900155936087386}], ["PTPN13", ["TCGA.AA.3492.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.894036972739663}], ["PRKCB", ["TCGA.D5.6932.01", "Extracellular matrix organization"], {"weight": 0.854944626246193}], ["PRKCB", ["TCGA.D5.6932.01", "G alpha (i) signalling events"], {"weight": 0.938046174131873}], ["PRKCB", ["TCGA.D5.6932.01", "Signal amplification"], {"weight": 0.886607780050592}], ["SLC18A3", ["TCGA.A6.5665.01", "Other interleukin signaling"], {"weight": 0.838750869872166}], ["SPTBN2", ["TCGA.AA.3662.01", "Phase 0 - rapid depolarisation"], {"weight": 0.872896756761718}], ["SPTBN2", ["TCGA.AA.3712.01", "GABA receptor activation"], {"weight": 0.864679137301316}], ["SPTBN2", ["TCGA.AA.3712.01", "Phase 0 - rapid depolarisation"], {"weight": 0.86747317241043}], ["SPTBN2", ["TCGA.AD.6901.01", "Phase 0 - rapid depolarisation"], {"weight": 0.78065351225742}], ["SPTBN2", ["TCGA.CM.5868.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.905580719961273}], ["SPTBN2", ["TCGA.CM.5868.01", "Generation of second messenger molecules"], {"weight": 0.917659517185435}], ["SPTBN2", ["TCGA.CM.5868.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.89741483930251}], ["SPTBN2", ["TCGA.CM.5868.01", "GABA receptor activation"], {"weight": 0.859768830131445}], ["SPTBN2", ["TCGA.CM.5868.01", "PD-1 signaling"], {"weight": 0.89741483930251}], ["SPTBN2", ["TCGA.CM.5868.01", "Costimulation by the CD28 family"], {"weight": 0.830913671564161}], ["ACTN2", ["TCGA.CK.5916.01", "Muscle contraction"], {"weight": 0.927011352704811}], ["ACTN4", ["TCGA.CM.6162.01", "Integrin cell surface interactions"], {"weight": 0.870341288746632}], ["ACTN4", ["TCGA.CM.6162.01", "Antimicrobial peptides"], {"weight": 0.380058267841295}], ["CDH23", ["TCGA.AZ.6607.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.882766014088066}], ["CDH23", ["TCGA.AZ.6607.01", "Sensory processing of sound"], {"weight": 0.882604109116711}], ["FAT1", ["TCGA.D5.7000.01", "Phase II - Conjugation of compounds"], {"weight": 0.703918170358403}], ["FAT1", ["TCGA.DM.A1D0.01", "Regulation of Complement cascade"], {"weight": 0.911056018554447}], ["NCOA2", ["TCGA.A6.5662.01", "Biological oxidations"], {"weight": 0.924454258607695}], ["NCOA2", ["TCGA.A6.5662.01", "Glucuronidation"], {"weight": 0.927709141135418}], ["NCOA2", ["TCGA.A6.5662.01", "Phase II - Conjugation of compounds"], {"weight": 0.861455307671277}], ["NCOA2", ["TCGA.A6.5662.01", "Regulation of insulin secretion"], {"weight": 0.905572349828905}], ["NCOA2", ["TCGA.A6.5662.01", "Phase I - Functionalization of compounds"], {"weight": 0.953892040090649}], ["NCOA2", ["TCGA.A6.5662.01", "Drug ADME"], {"weight": 0.859515208029911}], ["NCOA2", ["TCGA.A6.5662.01", "Integration of energy metabolism"], {"weight": 0.910052059054715}], ["NCOA2", ["TCGA.A6.5662.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.837020784958309}], ["NCOA2", ["TCGA.A6.5662.01", "Aspirin ADME"], {"weight": 0.876151230665105}], ["NCOA2", ["TCGA.A6.5662.01", "Ethanol oxidation"], {"weight": 0.8721766895377}], ["NCOA2", ["TCGA.A6.5662.01", "Signaling by Retinoic Acid"], {"weight": 0.793047668365324}], ["NCOA2", ["TCGA.A6.5662.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.818413839595972}], ["NCOA2", ["TCGA.A6.5662.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.662044387840675}], ["NCOA2", ["TCGA.A6.5662.01", "Free fatty acids regulate insulin secretion"], {"weight": 0.692128538776241}], ["NCOA2", ["TCGA.A6.5662.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.72972942306055}], ["NCOA2", ["TCGA.A6.5662.01", "RA biosynthesis pathway"], {"weight": 0.825461858959054}], ["NCOA2", ["TCGA.AU.6004.01", "Drug ADME"], {"weight": 0.84337116433072}], ["NCOA2", ["TCGA.AZ.6598.01", "Signaling Pathways"], {"weight": 0.918447336647493}], ["NCOA2", ["TCGA.D5.5541.01", "Biological oxidations"], {"weight": 0.956034947118255}], ["NCOA2", ["TCGA.D5.5541.01", "Drug ADME"], {"weight": 0.940699764811405}], ["NCOA2", ["TCGA.D5.5541.01", "RA biosynthesis pathway"], {"weight": 0.851226751967284}], ["NCOA2", ["TCGA.D5.5541.01", "Phase II - Conjugation of compounds"], {"weight": 0.82518777216626}], ["NCOA2", ["TCGA.D5.5541.01", "Phase I - Functionalization of compounds"], {"weight": 0.947100057473605}], ["NCOA2", ["TCGA.D5.5541.01", "Ethanol oxidation"], {"weight": 0.8105239203711}], ["NCOA2", ["TCGA.D5.5541.01", "Signaling by Retinoic Acid"], {"weight": 0.792939229248725}], ["NCOA2", ["TCGA.D5.5541.01", "Glucuronidation"], {"weight": 0.8428792622513}], ["NCOA2", ["TCGA.D5.5541.01", "Aspirin ADME"], {"weight": 0.919655479678314}], ["NCOA2", ["TCGA.DM.A0XD.01", "Drug ADME"], {"weight": 0.874810336965044}], ["NCOA2", ["TCGA.DM.A0XD.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.939224440812634}], ["NCOA2", ["TCGA.G4.6303.01", "Biological oxidations"], {"weight": 0.89924170199278}], ["NCOA2", ["TCGA.G4.6303.01", "Glucuronidation"], {"weight": 0.913735352567044}], ["NCOA2", ["TCGA.G4.6303.01", "Signaling Pathways"], {"weight": 0.870563454556057}], ["NCOA2", ["TCGA.G4.6588.01", "Signaling by Retinoic Acid"], {"weight": 0.837045130206942}], ["OR4D9", ["TCGA.CM.5344.01", "Signaling by GPCR"], {"weight": 0.935877162049903}], ["OR4D9", ["TCGA.CM.5344.01", "GPCR downstream signalling"], {"weight": 0.941068581712146}], ["OR4D9", ["TCGA.CM.5344.01", "G alpha (i) signalling events"], {"weight": 0.929831590051339}], ["OR4D9", ["TCGA.CM.5344.01", "GPCR ligand binding"], {"weight": 0.906576168390869}], ["OR4D9", ["TCGA.CM.5344.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.851997654103682}], ["OR4D9", ["TCGA.CM.5344.01", "Leishmania parasite growth and survival"], {"weight": 0.851997654103682}], ["OR4D9", ["TCGA.CM.5344.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.886975853987641}], ["OR4D9", ["TCGA.CM.5344.01", "Chemokine receptors bind chemokines"], {"weight": 0.867984521039958}], ["OR4D9", ["TCGA.CM.5344.01", "G alpha (q) signalling events"], {"weight": 0.924466259439254}], ["OR4D9", ["TCGA.CM.5344.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.871208230482056}], ["OR4D9", ["TCGA.CM.5344.01", "Nuclear signaling by ERBB4"], {"weight": 0.641433192310971}], ["OR4D9", ["TCGA.CM.5344.01", "Signal amplification"], {"weight": 0.885288647881272}], ["OR4D9", ["TCGA.CM.5344.01", "Neuronal System"], {"weight": 0.905916128997656}], ["OR4D9", ["TCGA.CM.5344.01", "Peptide hormone metabolism"], {"weight": 0.72574880392511}], ["OR4D5", ["TCGA.A6.6140.01", "GPCR ligand binding"], {"weight": 0.921959190773868}], ["OR4D5", ["TCGA.A6.6140.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.890548721848643}], ["OR4D5", ["TCGA.A6.6140.01", "Signal amplification"], {"weight": 0.865450413864419}], ["OR4D5", ["TCGA.A6.6140.01", "Presynaptic function of Kainate receptors"], {"weight": 0.867459092009048}], ["OR4D5", ["TCGA.A6.6140.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.899960616969836}], ["OR4D5", ["TCGA.A6.6140.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.895297981993549}], ["OR4D5", ["TCGA.A6.6140.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.908884548734507}], ["OR4D5", ["TCGA.A6.6140.01", "G beta:gamma signalling through BTK"], {"weight": 0.885414493760369}], ["OR4D5", ["TCGA.A6.6140.01", "Ca-dependent events"], {"weight": 0.819004826663928}], ["VWF", ["TCGA.D5.6534.01", "Other semaphorin interactions"], {"weight": 0.375525890443669}], ["VWF", ["TCGA.G4.6586.01", "Antimicrobial peptides"], {"weight": 0.699359192630963}], ["HS6ST3", ["TCGA.CA.6716.01", "Visual phototransduction"], {"weight": 0.855967469199432}], ["HS6ST3", ["TCGA.F4.6570.01", "Visual phototransduction"], {"weight": 0.809330402534917}], ["GRIA2", ["TCGA.A6.6141.01", "Neuronal System"], {"weight": 0.874761264363278}], ["GRIA2", ["TCGA.A6.6141.01", "Transmission across Chemical Synapses"], {"weight": 0.84346070265818}], ["GRIA2", ["TCGA.AD.5900.01", "Transmission across Chemical Synapses"], {"weight": 0.869808217250165}], ["GRIA2", ["TCGA.AD.5900.01", "Neuronal System"], {"weight": 0.851620037058086}], ["GRIA2", ["TCGA.CK.4947.01", "Neuronal System"], {"weight": 0.858116767788384}], ["GRIA2", ["TCGA.CK.4947.01", "Transmission across Chemical Synapses"], {"weight": 0.830920348220278}], ["GRIA2", ["TCGA.CK.4947.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.837588261472884}], ["GRIA2", ["TCGA.CM.6171.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.887923845691374}], ["GRIA2", ["TCGA.D5.5537.01", "GPCR downstream signalling"], {"weight": 0.945761181918919}], ["GRIA2", ["TCGA.D5.5537.01", "Cardiac conduction"], {"weight": 0.921836021050553}], ["GRIA2", ["TCGA.D5.5537.01", "Phase 0 - rapid depolarisation"], {"weight": 0.91755748760069}], ["GRIA2", ["TCGA.D5.5537.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.887189462451142}], ["GRIA2", ["TCGA.D5.5537.01", "Insulin processing"], {"weight": 0.808836584655895}], ["GRIA2", ["TCGA.D5.5537.01", "Long-term potentiation"], {"weight": 0.905074262410574}], ["GRIA2", ["TCGA.F4.6704.01", "Collagen formation"], {"weight": 0.882488976181195}], ["GRIA2", ["TCGA.F4.6704.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.923486251835336}], ["GRIA2", ["TCGA.F4.6704.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.818492317976028}], ["GRIA2", ["TCGA.F4.6704.01", "Transmission across Chemical Synapses"], {"weight": 0.871173532158168}], ["GRIA2", ["TCGA.F4.6704.01", "Neuronal System"], {"weight": 0.843415641785085}], ["DOCK1", ["TCGA.CM.6166.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.945460248814265}], ["DOCK1", ["TCGA.CM.6166.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.945460248814265}], ["DOCK1", ["TCGA.CM.6166.01", "Generation of second messenger molecules"], {"weight": 0.948326818571477}], ["DOCK1", ["TCGA.CM.6166.01", "PD-1 signaling"], {"weight": 0.946621807316041}], ["DOCK1", ["TCGA.CM.6166.01", "Leishmania infection"], {"weight": 0.886652934682394}], ["DOCK1", ["TCGA.CM.6166.01", "Parasitic Infection Pathways"], {"weight": 0.886652934682394}], ["DOCK1", ["TCGA.CM.6166.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.872985784913194}], ["EPHA8", ["TCGA.G4.6320.01", "GPCR downstream signalling"], {"weight": 0.952124504714469}], ["COL9A3", ["TCGA.F4.6570.01", "Collagen chain trimerization"], {"weight": 0.924133659220891}], ["COL9A3", ["TCGA.F4.6570.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.928103924160755}], ["COL9A3", ["TCGA.F4.6570.01", "Diseases of glycosylation"], {"weight": 0.873288896843377}], ["COL9A3", ["TCGA.G4.6626.01", "Signaling Pathways"], {"weight": 0.91559257219191}], ["COL9A3", ["TCGA.G4.6626.01", "Extracellular matrix organization"], {"weight": 0.897748025565666}], ["COL9A3", ["TCGA.G4.6626.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.925062590707712}], ["COL9A3", ["TCGA.G4.6626.01", "NCAM1 interactions"], {"weight": 0.943957388160295}], ["HK3", ["TCGA.CK.4952.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.930317585016443}], ["HK3", ["TCGA.CK.4952.01", "Retinoid metabolism and transport"], {"weight": 0.930317585016443}], ["HK3", ["TCGA.G4.6306.01", "Sialic acid metabolism"], {"weight": 0.642578885533946}], ["XBP1", ["TCGA.CM.5862.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.868212541811315}], ["RELN", ["TCGA.A6.6650.01", "Protein-protein interactions at synapses"], {"weight": 0.916373300062545}], ["RELN", ["TCGA.A6.6650.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.837733290232192}], ["RELN", ["TCGA.AD.6901.01", "Integrin cell surface interactions"], {"weight": 0.898906311580959}], ["RELN", ["TCGA.CA.5796.01", "Protein-protein interactions at synapses"], {"weight": 0.890689730068405}], ["RELN", ["TCGA.CA.5796.01", "Neurexins and neuroligins"], {"weight": 0.896899163279495}], ["RELN", ["TCGA.CA.5796.01", "L1CAM interactions"], {"weight": 0.832376781505488}], ["RELN", ["TCGA.CA.5796.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.881913793081408}], ["RELN", ["TCGA.CA.5796.01", "Long-term potentiation"], {"weight": 0.887271520832952}], ["RELN", ["TCGA.CA.5796.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.808058689397102}], ["RELN", ["TCGA.CM.6675.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.924037090592342}], ["RELN", ["TCGA.CM.6675.01", "Protein-protein interactions at synapses"], {"weight": 0.921964087330101}], ["RELN", ["TCGA.CM.6675.01", "CD22 mediated BCR regulation"], {"weight": 0.781105244045033}], ["RELN", ["TCGA.CM.6675.01", "Synaptic adhesion-like molecules"], {"weight": 0.818598284818569}], ["RELN", ["TCGA.D5.6541.01", "Protein-protein interactions at synapses"], {"weight": 0.876880053847361}], ["RELN", ["TCGA.D5.6541.01", "Synaptic adhesion-like molecules"], {"weight": 0.899551255956186}], ["RELN", ["TCGA.DM.A1D4.01", "Protein-protein interactions at synapses"], {"weight": 0.942530076614107}], ["RELN", ["TCGA.DM.A1D4.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.899967077140552}], ["RELN", ["TCGA.G4.6309.01", "Protein-protein interactions at synapses"], {"weight": 0.896486178399818}], ["RELN", ["TCGA.G4.6310.01", "Integrin cell surface interactions"], {"weight": 0.892775344630425}], ["CASQ2", ["TCGA.AZ.6598.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.886051693149137}], ["COL6A1", ["TCGA.D5.6928.01", "Collagen chain trimerization"], {"weight": 0.902506954543593}], ["COL6A5", ["TCGA.A6.5661.01", "L1CAM interactions"], {"weight": 0.933490287154116}], ["COL6A5", ["TCGA.CM.4743.01", "L1CAM interactions"], {"weight": 0.923793484196816}], ["COL6A5", ["TCGA.CM.5864.01", "NCAM1 interactions"], {"weight": 0.927818197759937}], ["COL6A5", ["TCGA.CM.6168.01", "Degradation of the extracellular matrix"], {"weight": 0.805469606033372}], ["COL6A5", ["TCGA.CM.6168.01", "Collagen chain trimerization"], {"weight": 0.892706254909396}], ["COL6A5", ["TCGA.DM.A1D0.01", "NCAM1 interactions"], {"weight": 0.948847620663656}], ["COL6A5", ["TCGA.DM.A1D0.01", "L1CAM interactions"], {"weight": 0.911219091283715}], ["COL6A5", ["TCGA.DM.A1D4.01", "Collagen chain trimerization"], {"weight": 0.902136215937288}], ["COL6A5", ["TCGA.DM.A1D4.01", "NCAM1 interactions"], {"weight": 0.937061209350678}], ["COL6A5", ["TCGA.F4.6805.01", "Degradation of the extracellular matrix"], {"weight": 0.870946701093582}], ["COL6A5", ["TCGA.F4.6805.01", "Scavenging by Class A Receptors"], {"weight": 0.631869927417779}], ["COL6A5", ["TCGA.F4.6805.01", "Collagen degradation"], {"weight": 0.839563199179269}], ["COL6A5", ["TCGA.F4.6805.01", "ECM proteoglycans"], {"weight": 0.746195349445936}], ["MUC16", ["TCGA.A6.6650.01", "Regulation of Complement cascade"], {"weight": 0.89535625756825}], ["MUC16", ["TCGA.A6.6650.01", "Complement cascade"], {"weight": 0.905996460369904}], ["MUC16", ["TCGA.A6.6650.01", "Keratan sulfate biosynthesis"], {"weight": 0.931279790995175}], ["MUC16", ["TCGA.A6.6781.01", "O-linked glycosylation"], {"weight": 0.865176777519559}], ["MUC16", ["TCGA.A6.6782.01", "Visual phototransduction"], {"weight": 0.620837114958465}], ["MUC16", ["TCGA.AA.3492.01", "Termination of O-glycan biosynthesis"], {"weight": 0.937220997444869}], ["MUC16", ["TCGA.CA.5796.01", "Complement cascade"], {"weight": 0.757071318895934}], ["MUC16", ["TCGA.CA.5796.01", "Regulation of Complement cascade"], {"weight": 0.653738975856427}], ["MUC16", ["TCGA.CA.5796.01", "Diseases of glycosylation"], {"weight": 0.855393874988849}], ["MUC16", ["TCGA.CA.6716.01", "Innate Immune System"], {"weight": 0.864672957969482}], ["MUC16", ["TCGA.CA.6716.01", "Blood group systems biosynthesis"], {"weight": 0.852316623741754}], ["MUC16", ["TCGA.CA.6716.01", "Lewis blood group biosynthesis"], {"weight": 0.846194042599415}], ["MUC16", ["TCGA.CA.6716.01", "Sialic acid metabolism"], {"weight": 0.638013040248064}], ["MUC16", ["TCGA.CA.6716.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.880734049068453}], ["MUC16", ["TCGA.CA.6719.01", "Metabolism"], {"weight": 0.896253006421765}], ["MUC16", ["TCGA.D5.6532.01", "Immune System"], {"weight": 0.878206641579297}], ["MUC16", ["TCGA.D5.6532.01", "Complement cascade"], {"weight": 0.906061119639025}], ["MUC16", ["TCGA.D5.6532.01", "Regulation of Complement cascade"], {"weight": 0.863407014004132}], ["MUC16", ["TCGA.D5.6532.01", "Blood group systems biosynthesis"], {"weight": 0.839051416165946}], ["MUC16", ["TCGA.D5.6532.01", "Lewis blood group biosynthesis"], {"weight": 0.826254147790682}], ["MUC16", ["TCGA.D5.6532.01", "Innate Immune System"], {"weight": 0.892325311128413}], ["MUC16", ["TCGA.D5.6532.01", "Sialic acid metabolism"], {"weight": 0.780777852526723}], ["MUC16", ["TCGA.D5.6537.01", "Complement cascade"], {"weight": 0.906738108360018}], ["MUC16", ["TCGA.D5.6537.01", "Regulation of Complement cascade"], {"weight": 0.890529199465011}], ["MUC16", ["TCGA.D5.6898.01", "Blood group systems biosynthesis"], {"weight": 0.84582470258422}], ["MUC16", ["TCGA.D5.6898.01", "Lewis blood group biosynthesis"], {"weight": 0.832606004767327}], ["MUC16", ["TCGA.DM.A1D4.01", "Complement cascade"], {"weight": 0.933108835284185}], ["MUC16", ["TCGA.DM.A1D4.01", "Regulation of Complement cascade"], {"weight": 0.904496306426918}], ["MUC16", ["TCGA.DM.A1D4.01", "Blood group systems biosynthesis"], {"weight": 0.810323203477734}], ["MUC16", ["TCGA.DM.A1DA.01", "Immune System"], {"weight": 0.906848145561418}], ["MUC16", ["TCGA.DM.A1DA.01", "Blood group systems biosynthesis"], {"weight": 0.873971790322689}], ["MUC16", ["TCGA.DM.A28G.01", "Immune System"], {"weight": 0.845218747439978}], ["MUC16", ["TCGA.DM.A28G.01", "Regulation of Complement cascade"], {"weight": 0.692512868904025}], ["MUC16", ["TCGA.DM.A28G.01", "Complement cascade"], {"weight": 0.767704128409044}], ["MUC16", ["TCGA.DM.A28M.01", "Complement cascade"], {"weight": 0.941628229620064}], ["MUC16", ["TCGA.DM.A28M.01", "Regulation of Complement cascade"], {"weight": 0.931159410812175}], ["MUC16", ["TCGA.DM.A28M.01", "Blood group systems biosynthesis"], {"weight": 0.759685151124698}], ["MUC16", ["TCGA.DM.A28M.01", "Keratan sulfate biosynthesis"], {"weight": 0.934729877392421}], ["MUC16", ["TCGA.DM.A28M.01", "Lewis blood group biosynthesis"], {"weight": 0.717888604865144}], ["MUC16", ["TCGA.DM.A28M.01", "Glycosaminoglycan metabolism"], {"weight": 0.871389548446886}], ["MUC16", ["TCGA.F4.6461.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.855955971957935}], ["MUC16", ["TCGA.F4.6461.01", "Retinoid metabolism and transport"], {"weight": 0.855955971957935}], ["MUC16", ["TCGA.G4.6299.01", "O-linked glycosylation"], {"weight": 0.912928600808892}], ["MUC16", ["TCGA.G4.6299.01", "O-linked glycosylation of mucins"], {"weight": 0.938416938919212}], ["MUC16", ["TCGA.G4.6299.01", "Lewis blood group biosynthesis"], {"weight": 0.756856619793839}], ["MUC16", ["TCGA.G4.6299.01", "Blood group systems biosynthesis"], {"weight": 0.756856619793839}], ["MUC16", ["TCGA.G4.6299.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.86319829007936}], ["MUC16", ["TCGA.G4.6307.01", "Immune System"], {"weight": 0.898709236112203}], ["MUC16", ["TCGA.G4.6307.01", "Glycosaminoglycan metabolism"], {"weight": 0.871979590690251}], ["MUC16", ["TCGA.G4.6307.01", "Keratan sulfate biosynthesis"], {"weight": 0.926125521828362}], ["OR52K2", ["TCGA.CM.5860.01", "GPCR ligand binding"], {"weight": 0.937381286626816}], ["OR52K2", ["TCGA.CM.5860.01", "Peptide hormone metabolism"], {"weight": 0.692651314708525}], ["OR52K2", ["TCGA.CM.5860.01", "G alpha (s) signalling events"], {"weight": 0.951185172904681}], ["OR52K2", ["TCGA.CM.5860.01", "Glucagon-type ligand receptors"], {"weight": 0.906438316929035}], ["OR52K2", ["TCGA.CM.5860.01", "Regulation of insulin secretion"], {"weight": 0.837103063336324}], ["OR52K2", ["TCGA.CM.5860.01", "Integration of energy metabolism"], {"weight": 0.836753296003341}], ["OR52K2", ["TCGA.CM.5860.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.918833933392749}], ["OR52K2", ["TCGA.CM.5860.01", "Ca2+ pathway"], {"weight": 0.827167735442745}], ["INPP4A", ["TCGA.A6.5661.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.914018421571441}], ["INPP4A", ["TCGA.DM.A0X9.01", "Signaling by GPCR"], {"weight": 0.941276814000979}], ["INPP4A", ["TCGA.DM.A0X9.01", "GPCR downstream signalling"], {"weight": 0.939094555246398}], ["CNOT1", ["TCGA.CM.6678.01", "Collagen formation"], {"weight": 0.936225408619195}], ["DOCK11", ["TCGA.A6.5661.01", "GABA receptor activation"], {"weight": 0.878755658443221}], ["SULT2A1", ["TCGA.A6.5661.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.706867356675335}], ["IL21R", ["TCGA.A6.5666.01", "TNFs bind their physiological receptors"], {"weight": 0.517508367613114}], ["IL21R", ["TCGA.A6.5666.01", "Interleukin-10 signaling"], {"weight": 0.942703578018215}], ["PRKD3", ["TCGA.DM.A1D7.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.906961321641931}], ["PRKD3", ["TCGA.DM.A1D7.01", "Trafficking of AMPA receptors"], {"weight": 0.920312647839815}], ["PRKD3", ["TCGA.DM.A1D7.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.920312647839815}], ["PRKD3", ["TCGA.DM.A1D7.01", "Heme degradation"], {"weight": 0.648743016574542}], ["PRKD3", ["TCGA.G4.6304.01", "G alpha (q) signalling events"], {"weight": 0.926923164783754}], ["MAP3K11", ["TCGA.D5.6920.01", "Visual phototransduction"], {"weight": 0.793613359193389}], ["FHL5", ["TCGA.A6.5661.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.861851714111986}], ["FLNB", ["TCGA.D5.6920.01", "Cardiac conduction"], {"weight": 0.903620004761768}], ["FLNB", ["TCGA.D5.6920.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.825463308377325}], ["FLNB", ["TCGA.D5.6920.01", "Phase 0 - rapid depolarisation"], {"weight": 0.777141160313862}], ["FLNB", ["TCGA.D5.6920.01", "Long-term potentiation"], {"weight": 0.834185658488961}], ["FLNB", ["TCGA.D5.6920.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.7221702535067}], ["RGSL1", ["TCGA.AY.6386.01", "Phase 4 - resting membrane potential"], {"weight": 0.824487572189515}], ["RGSL1", ["TCGA.F4.6461.01", "Metabolism"], {"weight": 0.876019384624468}], ["ASAP2", ["TCGA.CM.6170.01", "SHC1 events in ERBB4 signaling"], {"weight": 0.760942031605355}], ["ASAP2", ["TCGA.D5.6922.01", "Extracellular matrix organization"], {"weight": 0.782247289157147}], ["SRRM1", ["TCGA.CM.5341.01", "Influenza Viral RNA Transcription and Replication"], {"weight": 0.930180754784918}], ["SRRM1", ["TCGA.CM.5341.01", "SARS-CoV-2 modulates host translation machinery"], {"weight": 0.888706889312101}], ["KCNK1", ["TCGA.A6.5661.01", "Potassium Channels"], {"weight": 0.955629558996173}], ["KCNK1", ["TCGA.CM.6679.01", "Potassium Channels"], {"weight": 0.942009573318106}], ["KCNK1", ["TCGA.CM.6679.01", "Phase 4 - resting membrane potential"], {"weight": 0.835568338900375}], ["ACOX1", ["TCGA.AZ.6607.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.822191979393329}], ["ACOX1", ["TCGA.AZ.6607.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], {"weight": 0.82050958227161}], ["ACOX1", ["TCGA.AZ.6607.01", "Bile acid and bile salt metabolism"], {"weight": 0.820156434182842}], ["ACOX1", ["TCGA.AZ.6607.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.842921191595454}], ["ACOX1", ["TCGA.CM.6171.01", "Aspirin ADME"], {"weight": 0.847307109846555}], ["FLNC", ["TCGA.AD.6963.01", "Extracellular matrix organization"], {"weight": 0.866249196184281}], ["FLNC", ["TCGA.CK.4950.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.808804388220449}], ["FLNC", ["TCGA.DM.A0XF.01", "Phase 0 - rapid depolarisation"], {"weight": 0.938523658356369}], ["FLNC", ["TCGA.DM.A0XF.01", "O-linked glycosylation"], {"weight": 0.860701749790499}], ["FLNC", ["TCGA.DM.A0XF.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.897889169094262}], ["STAB1", ["TCGA.AA.3502.01", "Scavenging by Class A Receptors"], {"weight": 0.387023811056947}], ["STAB1", ["TCGA.AD.6901.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.782908191929486}], ["STAB1", ["TCGA.G4.6586.01", "Platelet homeostasis"], {"weight": 0.947398538156996}], ["STAB1", ["TCGA.G4.6586.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.90797507520457}], ["STAB1", ["TCGA.G4.6586.01", "Transport of small molecules"], {"weight": 0.942155805504754}], ["STAB1", ["TCGA.G4.6586.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.935989889686384}], ["STAB1", ["TCGA.G4.6586.01", "Retinoid metabolism and transport"], {"weight": 0.935989889686384}], ["TRIM29", ["TCGA.DM.A1D6.01", "Generation of second messenger molecules"], {"weight": 0.958870053621755}], ["TRIM29", ["TCGA.DM.A1D6.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.958507751715009}], ["TRIM29", ["TCGA.DM.A1D6.01", "PD-1 signaling"], {"weight": 0.956184586655019}], ["TRIM29", ["TCGA.DM.A1D6.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.956462245736554}], ["TRIM29", ["TCGA.DM.A1D6.01", "Costimulation by the CD28 family"], {"weight": 0.928816277511309}], ["TRIM29", ["TCGA.DM.A1D6.01", "Integrin cell surface interactions"], {"weight": 0.922879894189809}], ["MAPK10", ["TCGA.AD.6888.01", "G alpha (s) signalling events"], {"weight": 0.964130796240873}], ["MAPK10", ["TCGA.AD.6888.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.829443823338871}], ["MAPK10", ["TCGA.AD.6888.01", "Ca2+ pathway"], {"weight": 0.907150652696566}], ["MAPK10", ["TCGA.AD.6888.01", "ERK1/ERK2 pathway"], {"weight": 0.908666687456939}], ["MAPK10", ["TCGA.AD.6888.01", "MAPK family signaling cascades"], {"weight": 0.913297339291443}], ["AMFR", ["TCGA.AD.6888.01", "TNFs bind their physiological receptors"], {"weight": 0.443160400754883}], ["AOC2", ["TCGA.D5.6927.01", "Biological oxidations"], {"weight": 0.898970794232345}], ["CTNND1", ["TCGA.AA.3655.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.890815181678485}], ["CTNND1", ["TCGA.D5.6930.01", "Extra-nuclear estrogen signaling"], {"weight": 0.83474823377463}], ["CTNND1", ["TCGA.DM.A1D7.01", "Regulation of Complement cascade"], {"weight": 0.621224657381543}], ["NPAS3", ["TCGA.AU.3779.01", "Biological oxidations"], {"weight": 0.891299776544366}], ["NPAS3", ["TCGA.AU.3779.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.899423730606297}], ["NPAS3", ["TCGA.AU.3779.01", "Degradation of the extracellular matrix"], {"weight": 0.831983729115722}], ["NPAS3", ["TCGA.AU.3779.01", "Phase I - Functionalization of compounds"], {"weight": 0.916969009733253}], ["NPAS3", ["TCGA.AU.3779.01", "Heme degradation"], {"weight": 0.536416586046687}], ["NPAS3", ["TCGA.CA.6716.01", "Heme degradation"], {"weight": 0.723305376422839}], ["NPAS3", ["TCGA.CA.6716.01", "SLC-mediated transmembrane transport"], {"weight": 0.876537767907436}], ["NPAS3", ["TCGA.D5.6537.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.861321633739606}], ["TMX3", ["TCGA.CM.5861.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.910847385131358}], ["TMX3", ["TCGA.CM.5861.01", "Diseases of Immune System"], {"weight": 0.870146216530061}], ["TMX3", ["TCGA.CM.5861.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.870146216530061}], ["NOS1", ["TCGA.A6.5661.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.853898720609553}], ["NOS1", ["TCGA.A6.5665.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.935403474389082}], ["NOS1", ["TCGA.A6.5665.01", "Muscle contraction"], {"weight": 0.938856046372056}], ["NOS1", ["TCGA.A6.5665.01", "Platelet homeostasis"], {"weight": 0.926926452118647}], ["NOS1", ["TCGA.A6.6780.01", "Cardiac conduction"], {"weight": 0.931074096656095}], ["NOS1", ["TCGA.A6.6780.01", "Muscle contraction"], {"weight": 0.93874475122623}], ["NOS1", ["TCGA.A6.6780.01", "Platelet homeostasis"], {"weight": 0.84595109552729}], ["NOS1", ["TCGA.AD.6889.01", "Cardiac conduction"], {"weight": 0.948318102228178}], ["NOS1", ["TCGA.AD.6889.01", "Muscle contraction"], {"weight": 0.951968574503006}], ["NOS1", ["TCGA.AD.6889.01", "Ion homeostasis"], {"weight": 0.957284646401587}], ["NOS1", ["TCGA.AD.6889.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.914642064588536}], ["NOS1", ["TCGA.AZ.6599.01", "Muscle contraction"], {"weight": 0.943568302830235}], ["NOS1", ["TCGA.AZ.6599.01", "Protein-protein interactions at synapses"], {"weight": 0.917634072488593}], ["NOS1", ["TCGA.AZ.6599.01", "Neurexins and neuroligins"], {"weight": 0.924964675414548}], ["NOS1", ["TCGA.AZ.6599.01", "Platelet homeostasis"], {"weight": 0.921022431917265}], ["NOS1", ["TCGA.AZ.6599.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.908321694273966}], ["NOS1", ["TCGA.CK.5913.01", "Muscle contraction"], {"weight": 0.900782732042825}], ["NOS1", ["TCGA.CK.5913.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.855296594153993}], ["NOS1", ["TCGA.CM.4750.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.931070656284895}], ["NOS1", ["TCGA.CM.4750.01", "Cardiac conduction"], {"weight": 0.93882220529073}], ["NOS1", ["TCGA.CM.4750.01", "Platelet homeostasis"], {"weight": 0.905130676146804}], ["NOS1", ["TCGA.CM.5861.01", "Cardiac conduction"], {"weight": 0.950674620275737}], ["NOS1", ["TCGA.G4.6628.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.838535457079602}], ["COL5A2", ["TCGA.A6.6781.01", "Degradation of the extracellular matrix"], {"weight": 0.912305764665921}], ["COL5A2", ["TCGA.A6.6781.01", "Diseases of glycosylation"], {"weight": 0.882010424274685}], ["COL5A2", ["TCGA.AA.3502.01", "Diseases of glycosylation"], {"weight": 0.886092077146616}], ["COL5A2", ["TCGA.AA.3502.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.922123071584025}], ["COL5A2", ["TCGA.AA.3502.01", "Collagen formation"], {"weight": 0.933691467028854}], ["COL5A2", ["TCGA.AA.3502.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.911909581714712}], ["COL5A2", ["TCGA.AY.5543.01", "Degradation of the extracellular matrix"], {"weight": 0.837076732602869}], ["COL5A2", ["TCGA.D5.6532.01", "NCAM1 interactions"], {"weight": 0.937108096290799}], ["COL5A2", ["TCGA.DM.A1D4.01", "Defective B3GALTL causes PpS"], {"weight": 0.922484727208822}], ["COL5A2", ["TCGA.DM.A1D4.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.922484727208822}], ["COL5A2", ["TCGA.G4.6306.01", "Extracellular matrix organization"], {"weight": 0.932784834841956}], ["COL5A2", ["TCGA.G4.6306.01", "Integrin cell surface interactions"], {"weight": 0.911122554485897}], ["COL5A2", ["TCGA.G4.6306.01", "Diseases of glycosylation"], {"weight": 0.909458636791294}], ["COL5A2", ["TCGA.G4.6306.01", "Keratan sulfate biosynthesis"], {"weight": 0.931700190702754}], ["COL5A2", ["TCGA.G4.6306.01", "ECM proteoglycans"], {"weight": 0.905409015537662}], ["COL5A2", ["TCGA.G4.6306.01", "NCAM1 interactions"], {"weight": 0.931344307436575}], ["GRIK4", ["TCGA.AU.6004.01", "Transmission across Chemical Synapses"], {"weight": 0.895721730226247}], ["GRIK4", ["TCGA.CK.4950.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.811822602138394}], ["GRIK4", ["TCGA.CM.6674.01", "Neuronal System"], {"weight": 0.913600810424599}], ["GRIK4", ["TCGA.CM.6674.01", "Transmission across Chemical Synapses"], {"weight": 0.907941442232605}], ["GRIK4", ["TCGA.D5.5537.01", "Neuronal System"], {"weight": 0.918494981150404}], ["GRIK4", ["TCGA.D5.5537.01", "Transmission across Chemical Synapses"], {"weight": 0.91952588523899}], ["GRIK4", ["TCGA.D5.5537.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.913653460931903}], ["GRIK4", ["TCGA.D5.5537.01", "Presynaptic function of Kainate receptors"], {"weight": 0.886508790055568}], ["PYGB", ["TCGA.A6.5665.01", "Glucuronidation"], {"weight": 0.910293919929858}], ["PYGB", ["TCGA.AD.5900.01", "Biological oxidations"], {"weight": 0.91720103848076}], ["PYGB", ["TCGA.AD.5900.01", "Glycogen synthesis"], {"weight": 0.805083151884414}], ["PYGB", ["TCGA.AD.6888.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.824459697807345}], ["PYGB", ["TCGA.AZ.6600.01", "Glucuronidation"], {"weight": 0.713169435494464}], ["PYGB", ["TCGA.AZ.6600.01", "Phase II - Conjugation of compounds"], {"weight": 0.707568434715615}], ["PYGB", ["TCGA.AZ.6600.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.557898649678695}], ["PYGB", ["TCGA.AZ.6600.01", "Metabolism"], {"weight": 0.815448178922804}], ["PYGB", ["TCGA.AZ.6600.01", "Glycogen synthesis"], {"weight": 0.743662872537503}], ["PYGB", ["TCGA.CM.5861.01", "Glucuronidation"], {"weight": 0.8612030379498}], ["PYGB", ["TCGA.D5.6922.01", "Phase II - Conjugation of compounds"], {"weight": 0.826105848076766}], ["PYGB", ["TCGA.D5.6922.01", "Glucuronidation"], {"weight": 0.8921590548395}], ["PYGB", ["TCGA.D5.6922.01", "Biological oxidations"], {"weight": 0.884747970284631}], ["PYGB", ["TCGA.F4.6570.01", "Metabolism"], {"weight": 0.924209501510548}], ["BRAF", ["TCGA.AZ.6598.01", "Response to elevated platelet cytosolic Ca2+"], {"weight": 0.851360004887174}], ["BRAF", ["TCGA.CM.4750.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.921794763382796}], ["BRAF", ["TCGA.CM.4750.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.921794763382796}], ["BRAF", ["TCGA.CM.4750.01", "Diseases of Immune System"], {"weight": 0.924008071168577}], ["BRAF", ["TCGA.CM.4750.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.924008071168577}], ["BRAF", ["TCGA.DM.A1D7.01", "Phase 0 - rapid depolarisation"], {"weight": 0.932118638458267}], ["BRAF", ["TCGA.DM.A28C.01", "Ion homeostasis"], {"weight": 0.932209051346834}], ["BRAF", ["TCGA.DM.A28C.01", "Ion channel transport"], {"weight": 0.92990700417604}], ["BRAF", ["TCGA.DM.A28C.01", "Cytokine Signaling in Immune system"], {"weight": 0.87732947190612}], ["BRAF", ["TCGA.DM.A28C.01", "Ion transport by P-type ATPases"], {"weight": 0.862566892730931}], ["BRAF", ["TCGA.G4.6299.01", "Signaling by GPCR"], {"weight": 0.929189730489712}], ["BRAF", ["TCGA.G4.6299.01", "GPCR downstream signalling"], {"weight": 0.936458065431146}], ["NLRP4", ["TCGA.CA.5796.01", "G alpha (s) signalling events"], {"weight": 0.931913360554469}], ["NLRP4", ["TCGA.CA.5796.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.927711293606105}], ["NLRP4", ["TCGA.CA.5796.01", "Peptide ligand-binding receptors"], {"weight": 0.92841463492723}], ["GNAO1", ["TCGA.A6.6781.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.909624909474593}], ["GNAO1", ["TCGA.G4.6320.01", "Signaling by GPCR"], {"weight": 0.949181857089173}], ["GNAO1", ["TCGA.G4.6320.01", "GPCR ligand binding"], {"weight": 0.932807971371358}], ["GNAO1", ["TCGA.G4.6320.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.921725117327021}], ["GNAO1", ["TCGA.G4.6320.01", "G-protein mediated events"], {"weight": 0.926756039421952}], ["GNAO1", ["TCGA.G4.6320.01", "PLC beta mediated events"], {"weight": 0.924002480118257}], ["POFUT2", ["TCGA.A6.5661.01", "Defective B3GALTL causes PpS"], {"weight": 0.887456956651154}], ["POFUT2", ["TCGA.A6.5661.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.893843557585977}], ["POFUT2", ["TCGA.A6.6781.01", "Defective B3GALTL causes PpS"], {"weight": 0.896310634896817}], ["POFUT2", ["TCGA.A6.6781.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.913319355124045}], ["POFUT2", ["TCGA.F4.6806.01", "Defective B3GALTL causes PpS"], {"weight": 0.864222507714944}], ["POFUT2", ["TCGA.F4.6806.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.873213823838052}], ["MAP4K4", ["TCGA.A6.5661.01", "Interleukin-10 signaling"], {"weight": 0.720749433726609}], ["MAP4K4", ["TCGA.AY.6197.01", "Interleukin-10 signaling"], {"weight": 0.751252820505602}], ["MAP4K4", ["TCGA.CM.5348.01", "Drug ADME"], {"weight": 0.818888132075158}], ["NRG1", ["TCGA.A6.6138.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.833565163557757}], ["NRG1", ["TCGA.DM.A1D8.01", "Dectin-2 family"], {"weight": 0.827127965069482}], ["NRG1", ["TCGA.DM.A282.01", "Parasite infection"], {"weight": 0.890386696710792}], ["NRG1", ["TCGA.DM.A282.01", "Leishmania phagocytosis"], {"weight": 0.890386696710792}], ["NRG1", ["TCGA.DM.A282.01", "FCGR3A-mediated phagocytosis"], {"weight": 0.890386696710792}], ["SEC16A", ["TCGA.AZ.4323.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.816221374648237}], ["SEC16A", ["TCGA.AZ.4323.01", "Extracellular matrix organization"], {"weight": 0.82415195644142}], ["SEC16A", ["TCGA.AZ.6601.01", "Synaptic adhesion-like molecules"], {"weight": 0.748532743943213}], ["SEC16A", ["TCGA.CM.6165.01", "Collagen formation"], {"weight": 0.895878245344782}], ["SEC16A", ["TCGA.CM.6165.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.841396229447539}], ["ADAMTS13", ["TCGA.AZ.6599.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.952772289509946}], ["ADAMTS13", ["TCGA.F4.6855.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.944315323241809}], ["ADAMTS13", ["TCGA.F4.6855.01", "Defective B3GALTL causes PpS"], {"weight": 0.893541752949015}], ["ADAMTS13", ["TCGA.F4.6855.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.893480937243598}], ["GRM7", ["TCGA.G4.6293.01", "Chemokine receptors bind chemokines"], {"weight": 0.862539859742991}], ["GRM7", ["TCGA.G4.6293.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.909477477310559}], ["DGKD", ["TCGA.A6.6651.01", "RA biosynthesis pathway"], {"weight": 0.778639117393955}], ["DNAH3", ["TCGA.CK.4948.01", "Termination of O-glycan biosynthesis"], {"weight": 0.878921897105226}], ["DNAH3", ["TCGA.CK.4948.01", "O-linked glycosylation of mucins"], {"weight": 0.913193664172571}], ["DNAH3", ["TCGA.CK.4948.01", "Defective GALNT3 causes HFTC"], {"weight": 0.843431249702812}], ["DNAH3", ["TCGA.CK.4948.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.843431249702812}], ["DNAH3", ["TCGA.CK.4948.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.843431249702812}], ["ANK2", ["TCGA.D5.5537.01", "GABA receptor activation"], {"weight": 0.843969675896994}], ["ANK2", ["TCGA.DM.A1D6.01", "Complement cascade"], {"weight": 0.941352170361461}], ["ANK2", ["TCGA.DM.A1D6.01", "Regulation of Complement cascade"], {"weight": 0.909887258655893}], ["ANK2", ["TCGA.DM.A1D6.01", "GABA receptor activation"], {"weight": 0.913849055277455}], ["ANK2", ["TCGA.DM.A1D6.01", "CD22 mediated BCR regulation"], {"weight": 0.827545140901142}], ["ANK2", ["TCGA.DM.A1DA.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.859989182454067}], ["ANK2", ["TCGA.DM.A1DB.01", "NCAM signaling for neurite out-growth"], {"weight": 0.946689307181657}], ["ANK2", ["TCGA.DM.A1DB.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.783830952107307}], ["ANK3", ["TCGA.A6.5661.01", "Muscle contraction"], {"weight": 0.924379083206612}], ["ANK3", ["TCGA.D5.6920.01", "Interaction between L1 and Ankyrins"], {"weight": 0.905597048177452}], ["ANK3", ["TCGA.D5.6920.01", "GABA receptor activation"], {"weight": 0.785237291250972}], ["ANK3", ["TCGA.D5.6920.01", "L1CAM interactions"], {"weight": 0.792149902273678}], ["ANK3", ["TCGA.F4.6808.01", "Interaction between L1 and Ankyrins"], {"weight": 0.940608076958352}], ["LYPLA2", ["TCGA.AZ.6599.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.821052235896029}], ["ABCA3", ["TCGA.DM.A28K.01", "Complement cascade"], {"weight": 0.881845225346751}], ["ABCA3", ["TCGA.DM.A28K.01", "Regulation of Complement cascade"], {"weight": 0.875458350070112}], ["ABCA3", ["TCGA.DM.A28K.01", "SUMOylation of intracellular receptors"], {"weight": 0.710861566147063}], ["ABCA3", ["TCGA.DM.A28K.01", "Initial triggering of complement"], {"weight": 0.800428480163081}], ["ABCA3", ["TCGA.DM.A28K.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.879625504267527}], ["ABCA3", ["TCGA.G4.6298.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.917236662633821}], ["ABCA3", ["TCGA.G4.6298.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.916996825819846}], ["ABCA3", ["TCGA.G4.6298.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.915837315281156}], ["ABCA3", ["TCGA.G4.6298.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.902456816937835}], ["SCN8A", ["TCGA.A6.6653.01", "Interaction between L1 and Ankyrins"], {"weight": 0.944340535045211}], ["SCN8A", ["TCGA.A6.6653.01", "Phase 0 - rapid depolarisation"], {"weight": 0.940104885615178}], ["SCN8A", ["TCGA.CM.6161.01", "Cardiac conduction"], {"weight": 0.823927800329927}], ["SCN8A", ["TCGA.DM.A0X9.01", "Interaction between L1 and Ankyrins"], {"weight": 0.939373423606679}], ["SCN8A", ["TCGA.DM.A0X9.01", "Phase 0 - rapid depolarisation"], {"weight": 0.929388972854041}], ["FBN3", ["TCGA.A6.5661.01", "Molecules associated with elastic fibres"], {"weight": 0.747856260093738}], ["FBN3", ["TCGA.A6.6140.01", "Molecules associated with elastic fibres"], {"weight": 0.816011722100343}], ["FBN3", ["TCGA.A6.6140.01", "Elastic fibre formation"], {"weight": 0.819341361069293}], ["FBN3", ["TCGA.A6.6780.01", "Molecules associated with elastic fibres"], {"weight": 0.880027037988463}], ["FBN3", ["TCGA.AD.6889.01", "Molecules associated with elastic fibres"], {"weight": 0.880347009869511}], ["FBN3", ["TCGA.G4.6320.01", "Molecules associated with elastic fibres"], {"weight": 0.870090582912476}], ["CYP7A1", ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.881617294716564}], ["CYP7A1", ["TCGA.AM.5821.01", "Cytochrome P450 - arranged by substrate type"], {"weight": 0.890595422014527}], ["CYP7A1", ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.900911500386435}], ["CYP7A1", ["TCGA.AY.6196.01", "Biological oxidations"], {"weight": 0.897621114773207}], ["CYP7A1", ["TCGA.AY.6196.01", "APAP ADME"], {"weight": 0.894289677243481}], ["CYP7A1", ["TCGA.AY.6196.01", "Phase I - Functionalization of compounds"], {"weight": 0.888954760796024}], ["CYP7A1", ["TCGA.AY.6196.01", "Regulation of gene expression in beta cells"], {"weight": 0.580969765539651}], ["CYP7A1", ["TCGA.CM.5868.01", "Visual phototransduction"], {"weight": 0.774358837181249}], ["CYP7A1", ["TCGA.CM.5868.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.883559855778671}], ["CYP7A1", ["TCGA.CM.5868.01", "RA biosynthesis pathway"], {"weight": 0.86309622340523}], ["CYP7A1", ["TCGA.D5.6541.01", "Metabolism of amine-derived hormones"], {"weight": 0.567655295231174}], ["CYP7A1", ["TCGA.D5.6541.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.568487788090712}], ["CYP7A1", ["TCGA.G4.6586.01", "Endogenous sterols"], {"weight": 0.716962534205509}], ["PLXNA2", ["TCGA.A6.5661.01", "Nervous system development"], {"weight": 0.902631518708453}], ["PLXNA2", ["TCGA.A6.6781.01", "Other semaphorin interactions"], {"weight": 0.891702579899458}], ["PLXNA2", ["TCGA.G4.6304.01", "L1CAM interactions"], {"weight": 0.921981947355417}], ["PLXNA2", ["TCGA.G4.6307.01", "L1CAM interactions"], {"weight": 0.919478859070693}], ["IFT122", ["TCGA.A6.6140.01", "Neuronal System"], {"weight": 0.935437056554119}], ["IFT122", ["TCGA.A6.6140.01", "Transmission across Chemical Synapses"], {"weight": 0.930069373087211}], ["IFT122", ["TCGA.A6.6140.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.91541429799479}], ["IFT122", ["TCGA.A6.6140.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.812303081405582}], ["IFT122", ["TCGA.CM.4752.01", "G alpha (s) signalling events"], {"weight": 0.940312115044072}], ["IFT122", ["TCGA.CM.4752.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.887812036366012}], ["IFT122", ["TCGA.CM.4752.01", "GPER1 signaling"], {"weight": 0.888749161685905}], ["IFT122", ["TCGA.CM.4752.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.888749161685905}], ["IFT122", ["TCGA.CM.4752.01", "Integration of energy metabolism"], {"weight": 0.892108595975234}], ["IFT122", ["TCGA.CM.4752.01", "Regulation of insulin secretion"], {"weight": 0.877510942406378}], ["IFT122", ["TCGA.CM.4752.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.88663296767504}], ["IFT122", ["TCGA.CM.4752.01", "Aquaporin-mediated transport"], {"weight": 0.88663296767504}], ["IFT122", ["TCGA.CM.4752.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.874751391326435}], ["IFT122", ["TCGA.CM.4752.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.809453059546731}], ["IFT122", ["TCGA.CM.4752.01", "Leishmania parasite growth and survival"], {"weight": 0.809453059546731}], ["IFT122", ["TCGA.CM.4752.01", "G alpha (i) signalling events"], {"weight": 0.917867666661245}], ["ETV1", ["TCGA.AM.5821.01", "Free fatty acids regulate insulin secretion"], {"weight": 0.817020784748343}], ["NRXN3", ["TCGA.AD.6963.01", "Neurexins and neuroligins"], {"weight": 0.933077859148859}], ["NRXN3", ["TCGA.AD.6963.01", "Protein-protein interactions at synapses"], {"weight": 0.900187548004437}], ["NRXN3", ["TCGA.CM.5864.01", "Sensory processing of sound"], {"weight": 0.942224298893818}], ["NRXN3", ["TCGA.CM.5864.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.940177714066283}], ["NRXN3", ["TCGA.DM.A1D7.01", "Neuronal System"], {"weight": 0.920283586870279}], ["NRXN3", ["TCGA.DM.A1D7.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.894639891107427}], ["NRXN3", ["TCGA.DM.A1D7.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.881414077626142}], ["NRXN3", ["TCGA.DM.A1D7.01", "Long-term potentiation"], {"weight": 0.892086216422278}], ["NRXN3", ["TCGA.DM.A1D7.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.825841381204281}], ["NRXN3", ["TCGA.DM.A1D7.01", "Neurexins and neuroligins"], {"weight": 0.928845181117772}], ["NRXN3", ["TCGA.DM.A28C.01", "Neuronal System"], {"weight": 0.940681744618079}], ["NRXN3", ["TCGA.DM.A28C.01", "Sensory processing of sound"], {"weight": 0.94606273150425}], ["NRXN3", ["TCGA.G4.6299.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.689589874862589}], ["NRXN3", ["TCGA.G4.6299.01", "Neurotransmitter release cycle"], {"weight": 0.915323832110571}], ["NRXN3", ["TCGA.G4.6299.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.893784699389192}], ["NRXN3", ["TCGA.G4.6299.01", "GABA synthesis, release, reuptake and degradation"], {"weight": 0.921011376984537}], ["DYNC2H1", ["TCGA.A6.5662.01", "Immune System"], {"weight": 0.845080971355397}], ["DYNC2H1", ["TCGA.A6.5662.01", "Peptide hormone metabolism"], {"weight": 0.759304360873477}], ["DYNC2H1", ["TCGA.A6.5662.01", "Defective GALNT3 causes HFTC"], {"weight": 0.785190786232033}], ["DYNC2H1", ["TCGA.A6.5662.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.785190786232033}], ["DYNC2H1", ["TCGA.D5.6533.01", "Interaction between L1 and Ankyrins"], {"weight": 0.931806342716393}], ["DYNC2H1", ["TCGA.DM.A28H.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946328908625712}], ["DYNC2H1", ["TCGA.DM.A28H.01", "Resolution of Sister Chromatid Cohesion"], {"weight": 0.912118072713054}], ["NEB", ["TCGA.AA.3655.01", "Extracellular matrix organization"], {"weight": 0.829582864053323}], ["NEB", ["TCGA.AA.3655.01", "Cardiac conduction"], {"weight": 0.817887524352773}], ["NEB", ["TCGA.AZ.5403.01", "Initial triggering of complement"], {"weight": 0.553252279265674}], ["PDE4DIP", ["TCGA.A6.5661.01", "G alpha (i) signalling events"], {"weight": 0.935967256246646}], ["PDE4DIP", ["TCGA.AD.5900.01", "G alpha (s) signalling events"], {"weight": 0.941544124484772}], ["PDE4DIP", ["TCGA.AM.5821.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.932915235309305}], ["PDE4DIP", ["TCGA.AM.5821.01", "DAG and IP3 signaling"], {"weight": 0.908206321681625}], ["PDE4DIP", ["TCGA.AM.5821.01", "Ca-dependent events"], {"weight": 0.907650046491046}], ["PDE4DIP", ["TCGA.AM.5821.01", "Calmodulin induced events"], {"weight": 0.907108492931088}], ["PDE4DIP", ["TCGA.AM.5821.01", "CaM pathway"], {"weight": 0.907108492931088}], ["PDE4DIP", ["TCGA.AM.5821.01", "PKA activation in glucagon signalling"], {"weight": 0.909035640575568}], ["PDE4DIP", ["TCGA.AZ.5403.01", "Interaction between L1 and Ankyrins"], {"weight": 0.811606396690285}], ["PDE4DIP", ["TCGA.CM.5861.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.928130831031849}], ["PDE4DIP", ["TCGA.CM.6674.01", "Transport of small molecules"], {"weight": 0.906390766519265}], ["PDE4DIP", ["TCGA.CM.6674.01", "G alpha (s) signalling events"], {"weight": 0.947570018925748}], ["PDE4DIP", ["TCGA.CM.6674.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.896699516897572}], ["PDE4DIP", ["TCGA.D5.7000.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.629696777029638}], ["PDE4DIP", ["TCGA.G4.6320.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.884457243818964}], ["PDE4DIP", ["TCGA.G4.6320.01", "Leishmania parasite growth and survival"], {"weight": 0.884457243818964}], ["PDE4DIP", ["TCGA.G4.6320.01", "Regulation of insulin secretion"], {"weight": 0.920798254143115}], ["PDE4DIP", ["TCGA.G4.6320.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.897067028873039}], ["PDE4DIP", ["TCGA.G4.6320.01", "Aquaporin-mediated transport"], {"weight": 0.897067028873039}], ["PDE4DIP", ["TCGA.G4.6320.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.929070923821848}], ["PDE4DIP", ["TCGA.G4.6320.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.925457656288404}], ["PDE4DIP", ["TCGA.G4.6320.01", "GPER1 signaling"], {"weight": 0.920256253701132}], ["PDE4DIP", ["TCGA.G4.6320.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.920256253701132}], ["PDE4DIP", ["TCGA.G4.6320.01", "Calmodulin induced events"], {"weight": 0.929153810532571}], ["PDE4DIP", ["TCGA.G4.6320.01", "CaM pathway"], {"weight": 0.929153810532571}], ["PDE4DIP", ["TCGA.G4.6320.01", "DAG and IP3 signaling"], {"weight": 0.928990134205398}], ["PDE4DIP", ["TCGA.G4.6320.01", "PKA activation in glucagon signalling"], {"weight": 0.905708933574645}], ["PDE4DIP", ["TCGA.G4.6320.01", "Ca-dependent events"], {"weight": 0.929153810532571}], ["EPS8", ["TCGA.F4.6703.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.822953981666402}], ["EPS8", ["TCGA.F4.6703.01", "Sensory processing of sound"], {"weight": 0.822588786316199}], ["ADAMTSL4", ["TCGA.AY.6196.01", "Collagen formation"], {"weight": 0.91301698277229}], ["ADAMTSL4", ["TCGA.AY.6196.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.946332964634089}], ["ADAMTSL4", ["TCGA.AY.6196.01", "Defective B3GALTL causes PpS"], {"weight": 0.90177797850056}], ["ADAMTSL4", ["TCGA.AY.6196.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.901725611216235}], ["ADAMTSL4", ["TCGA.AY.6196.01", "Integrin cell surface interactions"], {"weight": 0.892253543737935}], ["ADAMTSL4", ["TCGA.D5.6534.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.943012546867367}], ["ADAMTSL4", ["TCGA.D5.6534.01", "Defective B3GALTL causes PpS"], {"weight": 0.891965365387056}], ["ADAMTSL4", ["TCGA.D5.6534.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.891903649149043}], ["ADAMTSL4", ["TCGA.D5.6534.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.804712350114932}], ["ADAMTSL4", ["TCGA.G4.6304.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.938708735820072}], ["ADAMTSL4", ["TCGA.G4.6304.01", "O-linked glycosylation"], {"weight": 0.927474145274366}], ["SARDH", ["TCGA.DM.A28F.01", "Ethanol oxidation"], {"weight": 0.820530247781825}], ["SEMA5B", ["TCGA.AZ.4615.01", "Defective B3GALTL causes PpS"], {"weight": 0.88964772596022}], ["SEMA5B", ["TCGA.F4.6459.01", "Collagen formation"], {"weight": 0.872349463039638}], ["SEMA5B", ["TCGA.F4.6459.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.9254799605978}], ["ASPG", ["TCGA.AU.3779.01", "Drug ADME"], {"weight": 0.856435019941474}], ["ASPG", ["TCGA.AU.3779.01", "Metabolism of amine-derived hormones"], {"weight": 0.51424761317867}], ["CTNNB1", ["TCGA.A6.6780.01", "Peptide hormone metabolism"], {"weight": 0.784079136571166}], ["CTNNB1", ["TCGA.A6.6780.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.743300398456564}], ["CTNNB1", ["TCGA.CM.4752.01", "Extracellular matrix organization"], {"weight": 0.821056542658935}], ["CTNNB1", ["TCGA.CM.4752.01", "Peptide hormone metabolism"], {"weight": 0.602416885137206}], ["CTNNB1", ["TCGA.CM.4752.01", "Developmental Biology"], {"weight": 0.808369538721695}], ["CTNNB1", ["TCGA.CM.4752.01", "Signaling Pathways"], {"weight": 0.852766350341702}], ["CTNNB1", ["TCGA.CM.6675.01", "Neuronal System"], {"weight": 0.936415889732793}], ["CTNNB1", ["TCGA.CM.6675.01", "Signaling by GPCR"], {"weight": 0.938102902091138}], ["CTNNB1", ["TCGA.CM.6675.01", "Transmission across Chemical Synapses"], {"weight": 0.924974383797554}], ["CTNNB1", ["TCGA.CM.6675.01", "Signaling Pathways"], {"weight": 0.924780540882951}], ["CTNNB1", ["TCGA.CM.6675.01", "Activation of NMDA receptors and postsynaptic events"], {"weight": 0.880429859995923}], ["CTNNB1", ["TCGA.D5.6541.01", "ECM proteoglycans"], {"weight": 0.854271616041706}], ["CTNNB1", ["TCGA.D5.6541.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.881215631743622}], ["CTNNB1", ["TCGA.DM.A1D4.01", "Signaling Pathways"], {"weight": 0.937392404428675}], ["CTNNB1", ["TCGA.DM.A1D4.01", "Extracellular matrix organization"], {"weight": 0.909140021009764}], ["CTNNB1", ["TCGA.DM.A1D4.01", "Developmental Biology"], {"weight": 0.919440927060936}], ["CTNNB1", ["TCGA.DM.A1D4.01", "Peptide hormone metabolism"], {"weight": 0.834465790051807}], ["CTNNB1", ["TCGA.DM.A1D4.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.727960741310274}], ["CTNNB1", ["TCGA.DM.A1D4.01", "Netrin-1 signaling"], {"weight": 0.854763208155899}], ["CTNNB1", ["TCGA.G4.6311.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.687471583989925}], ["CTNNB1", ["TCGA.G4.6311.01", "Peptide hormone metabolism"], {"weight": 0.800067163267626}], ["CTNNB1", ["TCGA.G4.6586.01", "Developmental Biology"], {"weight": 0.914739449040788}], ["ORAI2", ["TCGA.A6.5661.01", "Cardiac conduction"], {"weight": 0.908166844168428}], ["ORAI2", ["TCGA.DM.A285.01", "Cardiac conduction"], {"weight": 0.874971996244955}], ["AP3D1", ["TCGA.DM.A1DB.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.770238521349279}], ["AP3D1", ["TCGA.DM.A1DB.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.882748686761007}], ["AP3D1", ["TCGA.DM.A1DB.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.882748686761007}], ["AP3D1", ["TCGA.DM.A1DB.01", "Dopamine Neurotransmitter Release Cycle"], {"weight": 0.888361516691707}], ["EPHX1", ["TCGA.CM.6171.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.907508560456592}], ["EPHX1", ["TCGA.G4.6295.01", "Biological oxidations"], {"weight": 0.938138238883772}], ["EPHX1", ["TCGA.G4.6295.01", "RA biosynthesis pathway"], {"weight": 0.884771785903425}], ["EPHX1", ["TCGA.G4.6295.01", "Drug ADME"], {"weight": 0.904266076396159}], ["EPHX1", ["TCGA.G4.6295.01", "Arachidonic acid metabolism"], {"weight": 0.935582611434727}], ["EPHX1", ["TCGA.G4.6295.01", "Phase I - Functionalization of compounds"], {"weight": 0.934022591057047}], ["EPHX1", ["TCGA.G4.6295.01", "Ethanol oxidation"], {"weight": 0.848565637800305}], ["EPHX1", ["TCGA.G4.6295.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.901074340395486}], ["EPHX1", ["TCGA.G4.6295.01", "Aflatoxin activation and detoxification"], {"weight": 0.819720047419009}], ["CACNA1A", ["TCGA.A6.5661.01", "GPCR ligand binding"], {"weight": 0.932589029929721}], ["CACNA1A", ["TCGA.AD.6901.01", "Regulation of insulin secretion"], {"weight": 0.873491571343549}], ["CACNA1A", ["TCGA.AD.6901.01", "Phase 2 - plateau phase"], {"weight": 0.693713600482301}], ["CACNA1A", ["TCGA.AZ.6601.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.854143576359511}], ["CACNA1A", ["TCGA.G4.6294.01", "Potassium Channels"], {"weight": 0.959709089810326}], ["CACNA1A", ["TCGA.G4.6294.01", "Phase 4 - resting membrane potential"], {"weight": 0.793101046524418}], ["CACNA1A", ["TCGA.G4.6586.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.913379806051941}], ["CACNA1F", ["TCGA.CM.6163.01", "GPCR ligand binding"], {"weight": 0.882752044570646}], ["CACNA1F", ["TCGA.CM.6163.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.898102750361981}], ["EPHA2", ["TCGA.A6.6781.01", "Drug ADME"], {"weight": 0.906645612540953}], ["EPHA2", ["TCGA.DM.A1DA.01", "Phospholipase C-mediated cascade: FGFR1"], {"weight": 0.923336545390569}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR2 ligand binding and activation"], {"weight": 0.937684861308694}], ["EPHA2", ["TCGA.DM.A1DA.01", "Signaling by activated point mutants of FGFR1"], {"weight": 0.913761360844007}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR1 ligand binding and activation"], {"weight": 0.941457866139081}], ["EPHA2", ["TCGA.DM.A1DA.01", "Activated point mutants of FGFR2"], {"weight": 0.922716342481369}], ["EPHA2", ["TCGA.DM.A1DA.01", "Phospholipase C-mediated cascade; FGFR2"], {"weight": 0.922716342481369}], ["EPHA2", ["TCGA.DM.A1DA.01", "PI-3K cascade:FGFR1"], {"weight": 0.923336545390569}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR1c ligand binding and activation"], {"weight": 0.933203477391865}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR2c ligand binding and activation"], {"weight": 0.915941634314974}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR4 ligand binding and activation"], {"weight": 0.910287959859082}], ["EPHA2", ["TCGA.DM.A1DA.01", "PI-3K cascade:FGFR2"], {"weight": 0.922716342481369}], ["EPHA2", ["TCGA.DM.A1DA.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.910287959859082}], ["EPHA2", ["TCGA.DM.A1DA.01", "Signaling by activated point mutants of FGFR3"], {"weight": 0.909621033209215}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR3 mutant receptor activation"], {"weight": 0.909621033209215}], ["EPHA2", ["TCGA.DM.A1DA.01", "IRS-mediated signalling"], {"weight": 0.888258836248677}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR3 ligand binding and activation"], {"weight": 0.909621033209215}], ["EPHA2", ["TCGA.DM.A1DA.01", "FGFR3c ligand binding and activation"], {"weight": 0.909621033209215}], ["EPHA2", ["TCGA.DM.A1DA.01", "Phospholipase C-mediated cascade; FGFR3"], {"weight": 0.909621033209215}], ["CYP4F3", ["TCGA.A6.5661.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.881868475605538}], ["CYP4F3", ["TCGA.A6.5661.01", "Arachidonic acid metabolism"], {"weight": 0.902346124072307}], ["CYP4F3", ["TCGA.A6.6142.01", "Glucuronidation"], {"weight": 0.791972234405118}], ["CYP4F3", ["TCGA.A6.6142.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.791687717512332}], ["CYP4F3", ["TCGA.A6.6142.01", "Phase II - Conjugation of compounds"], {"weight": 0.817451161101683}], ["CYP4F3", ["TCGA.A6.6142.01", "APAP ADME"], {"weight": 0.581433275629535}], ["CYP4F3", ["TCGA.G4.6588.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.920708341696179}], ["CYP4F3", ["TCGA.G4.6588.01", "Arachidonic acid metabolism"], {"weight": 0.909526281338652}], ["CCNB3", ["TCGA.A6.6648.01", "Cell Cycle Checkpoints"], {"weight": 0.919749524155511}], ["AKT1", ["TCGA.CM.6166.01", "Adaptive Immune System"], {"weight": 0.909672591437296}], ["AKT1", ["TCGA.CM.6166.01", "Costimulation by the CD28 family"], {"weight": 0.923987237865412}], ["AKT1", ["TCGA.CM.6166.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.867142256840415}], ["AKT1", ["TCGA.D5.5537.01", "Ion channel transport"], {"weight": 0.869537008547787}], ["AKT1", ["TCGA.D5.5537.01", "Signaling by Retinoic Acid"], {"weight": 0.759726347964859}], ["AKT1", ["TCGA.D5.5537.01", "RA biosynthesis pathway"], {"weight": 0.796557633486437}], ["AKT1", ["TCGA.D5.5537.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.78724421597341}], ["OCRL", ["TCGA.DM.A1D9.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.935562434118941}], ["OCRL", ["TCGA.DM.A1D9.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.933166175271828}], ["OCRL", ["TCGA.DM.A1D9.01", "PD-1 signaling"], {"weight": 0.934672366540938}], ["OCRL", ["TCGA.DM.A1D9.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.951052629022528}], ["OCRL", ["TCGA.DM.A1D9.01", "Peptide ligand-binding receptors"], {"weight": 0.951269082325605}], ["OCRL", ["TCGA.F4.6807.01", "Cobalamin (Cbl, vitamin B12) transport and metabolism"], {"weight": 0.702999566876174}], ["GPR156", ["TCGA.A6.6781.01", "G alpha (i) signalling events"], {"weight": 0.922380167571649}], ["GPR156", ["TCGA.CK.5914.01", "Arachidonic acid metabolism"], {"weight": 0.913243685505748}], ["GPR156", ["TCGA.CK.5914.01", "Phase 4 - resting membrane potential"], {"weight": 0.847267823687819}], ["GPR156", ["TCGA.CM.4748.01", "Phase 4 - resting membrane potential"], {"weight": 0.785970573065045}], ["TG", ["TCGA.A6.5661.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.906149063273997}], ["TG", ["TCGA.D5.6538.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.773746285072694}], ["ELMO1", ["TCGA.CK.4952.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.916727840665551}], ["ELMO1", ["TCGA.CK.4952.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.916746061248954}], ["ELMO1", ["TCGA.CK.4952.01", "CD22 mediated BCR regulation"], {"weight": 0.87647240483464}], ["ELMO1", ["TCGA.DM.A1D0.01", "Downregulation of ERBB2 signaling"], {"weight": 0.929141605569659}], ["ELMO1", ["TCGA.G4.6306.01", "Platelet homeostasis"], {"weight": 0.907237780343568}], ["ELMO1", ["TCGA.G4.6306.01", "RAC1 GTPase cycle"], {"weight": 0.827032525378084}], ["ELMO1", ["TCGA.G4.6306.01", "IRS-related events triggered by IGF1R"], {"weight": 0.851358243619668}], ["ELMO1", ["TCGA.G4.6306.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.851226394461162}], ["ELMO1", ["TCGA.G4.6306.01", "IGF1R signaling cascade"], {"weight": 0.851226394461162}], ["ELMO1", ["TCGA.G4.6306.01", "IRS-mediated signalling"], {"weight": 0.836518155086683}], ["ELMO1", ["TCGA.G4.6306.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.876619195980551}], ["OR4K17", ["TCGA.G4.6303.01", "Regulation of insulin secretion"], {"weight": 0.879521116239058}], ["OR4K17", ["TCGA.G4.6303.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.882306425132231}], ["KALRN", ["TCGA.AZ.5403.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.930611817545622}], ["KALRN", ["TCGA.AZ.5403.01", "Peptide ligand-binding receptors"], {"weight": 0.929007557462561}], ["KALRN", ["TCGA.AZ.5403.01", "Chemokine receptors bind chemokines"], {"weight": 0.894959341516706}], ["ENPEP", ["TCGA.A6.6141.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.729407730142554}], ["ENPEP", ["TCGA.CA.5796.01", "Glucagon-type ligand receptors"], {"weight": 0.884026065126674}], ["ENPEP", ["TCGA.CA.5796.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.85386345675037}], ["ENPEP", ["TCGA.CA.5796.01", "Degradation of the extracellular matrix"], {"weight": 0.553312664927356}], ["ENPEP", ["TCGA.CA.5796.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.848819991117518}], ["ENPEP", ["TCGA.CA.5796.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.847955992880865}], ["ENPEP", ["TCGA.DM.A1D7.01", "Extracellular matrix organization"], {"weight": 0.827067315852553}], ["ENPEP", ["TCGA.DM.A1D7.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.760050614517106}], ["COL28A1", ["TCGA.A6.5661.01", "Collagen chain trimerization"], {"weight": 0.894640722758026}], ["ROBO1", ["TCGA.DM.A282.01", "CD22 mediated BCR regulation"], {"weight": 0.774042545020561}], ["ROBO1", ["TCGA.DM.A28F.01", "Netrin-1 signaling"], {"weight": 0.891239665004803}], ["TRAF3", ["TCGA.AZ.5403.01", "TNFs bind their physiological receptors"], {"weight": 0.467967299831389}], ["TRAF3", ["TCGA.AZ.5403.01", "Immune System"], {"weight": 0.805170573512546}], ["TRAF3", ["TCGA.AZ.5403.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.863994066332278}], ["COLEC12", ["TCGA.AD.6888.01", "Regulation of insulin secretion"], {"weight": 0.933695220685679}], ["COLEC12", ["TCGA.AD.6888.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.928381094762744}], ["COLEC12", ["TCGA.AD.6888.01", "FCGR activation"], {"weight": 0.824359164107028}], ["AKAP13", ["TCGA.CK.5915.01", "G alpha (i) signalling events"], {"weight": 0.941685197286556}], ["AKAP13", ["TCGA.CK.5915.01", "G alpha (q) signalling events"], {"weight": 0.923356343282329}], ["AKAP13", ["TCGA.CK.5915.01", "Integration of energy metabolism"], {"weight": 0.907430972582153}], ["AKAP13", ["TCGA.CK.5915.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.919335168126961}], ["AKAP13", ["TCGA.CK.5915.01", "Opioid Signalling"], {"weight": 0.916492522832419}], ["AKAP13", ["TCGA.CK.5915.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.897223189437816}], ["AKAP13", ["TCGA.CK.5915.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.840414161508575}], ["AKAP13", ["TCGA.CK.5915.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.927584725289344}], ["AKAP13", ["TCGA.CK.5915.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.915024317877535}], ["AKAP13", ["TCGA.CK.5915.01", "Aquaporin-mediated transport"], {"weight": 0.915024317877535}], ["AKAP13", ["TCGA.CK.5915.01", "GPER1 signaling"], {"weight": 0.915024317877535}], ["AKAP13", ["TCGA.CK.5915.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.915024317877535}], ["AKAP13", ["TCGA.CK.5915.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.889009588251693}], ["AKAP13", ["TCGA.CK.5915.01", "Ca-dependent events"], {"weight": 0.857059016054686}], ["AKAP13", ["TCGA.D5.6924.01", "Signaling Pathways"], {"weight": 0.839936106317069}], ["TNRC6B", ["TCGA.A6.6653.01", "Signaling Pathways"], {"weight": 0.901071491844949}], ["TNRC6B", ["TCGA.AD.6901.01", "Glucuronidation"], {"weight": 0.850918459289514}], ["TNRC6B", ["TCGA.CA.6716.01", "Signaling Pathways"], {"weight": 0.899258791094417}], ["TNRC6B", ["TCGA.CA.6716.01", "CD22 mediated BCR regulation"], {"weight": 0.742058957690944}], ["TNRC6B", ["TCGA.CM.5861.01", "Signaling Pathways"], {"weight": 0.916210402820623}], ["TNRC6B", ["TCGA.D5.6924.01", "Blood group systems biosynthesis"], {"weight": 0.464975694455757}], ["TNRC6B", ["TCGA.D5.6924.01", "Lewis blood group biosynthesis"], {"weight": 0.386419397425981}], ["TNRC6B", ["TCGA.G4.6320.01", "Signaling Pathways"], {"weight": 0.912295470214333}], ["TNRC6B", ["TCGA.G4.6320.01", "Generic Transcription Pathway"], {"weight": 0.898886568562927}], ["USP28", ["TCGA.D5.6922.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.72175660656439}], ["ADAMTS4", ["TCGA.A6.5661.01", "Diseases of metabolism"], {"weight": 0.712021987965176}], ["ADAMTS4", ["TCGA.A6.5661.01", "Diseases of glycosylation"], {"weight": 0.819241792741073}], ["ADAMTS4", ["TCGA.AA.3660.01", "Collagen formation"], {"weight": 0.871263249897992}], ["ARHGEF6", ["TCGA.DM.A28C.01", "ECM proteoglycans"], {"weight": 0.895156457960323}], ["CDH1", ["TCGA.A6.5661.01", "Extracellular matrix organization"], {"weight": 0.871872417089907}], ["CDH1", ["TCGA.A6.5661.01", "Degradation of the extracellular matrix"], {"weight": 0.856452307334802}], ["CDH1", ["TCGA.A6.6780.01", "Extracellular matrix organization"], {"weight": 0.88111060868232}], ["CDH1", ["TCGA.A6.6780.01", "Degradation of the extracellular matrix"], {"weight": 0.829528123294923}], ["MYO3A", ["TCGA.D5.6535.01", "Sensory processing of sound"], {"weight": 0.866448139282802}], ["GRM4", ["TCGA.DM.A1D4.01", "Chemokine receptors bind chemokines"], {"weight": 0.941398740731215}], ["RNF213", ["TCGA.DM.A1D6.01", "GPCR ligand binding"], {"weight": 0.94926828977134}], ["RNF213", ["TCGA.DM.A1D6.01", "Peptide ligand-binding receptors"], {"weight": 0.947200320141341}], ["RNF213", ["TCGA.DM.A1D6.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.948281274151912}], ["ALDH4A1", ["TCGA.AD.6964.01", "APAP ADME"], {"weight": 0.696227121874403}], ["ALDH4A1", ["TCGA.AD.6964.01", "GABA synthesis, release, reuptake and degradation"], {"weight": 0.762011115752063}], ["PDE6C", ["TCGA.CM.4743.01", "G alpha (i) signalling events"], {"weight": 0.945724668053741}], ["SLC1A6", ["TCGA.G4.6317.01", "Neuronal System"], {"weight": 0.954789373765196}], ["SLC1A6", ["TCGA.G4.6317.01", "Transmission across Chemical Synapses"], {"weight": 0.952831560785786}], ["ABCC3", ["TCGA.AM.5821.01", "Bile acid and bile salt metabolism"], {"weight": 0.880440345650708}], ["ABCC3", ["TCGA.F4.6703.01", "APAP ADME"], {"weight": 0.899834399326016}], ["ABCC3", ["TCGA.F4.6703.01", "Aspirin ADME"], {"weight": 0.947089147885917}], ["ABCC3", ["TCGA.G4.6588.01", "APAP ADME"], {"weight": 0.79834257651744}], ["RYR3", ["TCGA.A6.5662.01", "Transport of small molecules"], {"weight": 0.921565428007862}], ["RYR3", ["TCGA.A6.5662.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.839022757916354}], ["RYR3", ["TCGA.A6.5662.01", "Stimuli-sensing channels"], {"weight": 0.887676797653294}], ["RYR3", ["TCGA.A6.5662.01", "Metabolism"], {"weight": 0.920156941087831}], ["RYR3", ["TCGA.AA.3663.01", "Cardiac conduction"], {"weight": 0.964249975539358}], ["RYR3", ["TCGA.AY.6197.01", "Stimuli-sensing channels"], {"weight": 0.887826144153025}], ["RYR3", ["TCGA.D5.6926.01", "Cardiac conduction"], {"weight": 0.864591035364039}], ["RYR3", ["TCGA.F4.6703.01", "Stimuli-sensing channels"], {"weight": 0.93457967493057}], ["RYR3", ["TCGA.F4.6856.01", "Nicotinate metabolism"], {"weight": 0.64940815512228}], ["RYR3", ["TCGA.G4.6322.01", "Synaptic adhesion-like molecules"], {"weight": 0.814426706286618}], ["RYR2", ["TCGA.AA.3663.01", "Ion homeostasis"], {"weight": 0.894519829329958}], ["RYR2", ["TCGA.AZ.4682.01", "Phase 0 - rapid depolarisation"], {"weight": 0.919932317159497}], ["RYR2", ["TCGA.AZ.4682.01", "LGI-ADAM interactions"], {"weight": 0.81015952889113}], ["RYR2", ["TCGA.AZ.4682.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.75363519626537}], ["RYR2", ["TCGA.AZ.5403.01", "NCAM1 interactions"], {"weight": 0.759504797243964}], ["RYR2", ["TCGA.AZ.5403.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.867944560867862}], ["RYR2", ["TCGA.AZ.5403.01", "Trafficking of AMPA receptors"], {"weight": 0.901910674566145}], ["RYR2", ["TCGA.AZ.5403.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.901910674566145}], ["RYR2", ["TCGA.AZ.5403.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.758863515258698}], ["RYR2", ["TCGA.AZ.5403.01", "Ca-dependent events"], {"weight": 0.810610292936495}], ["RYR2", ["TCGA.AZ.5403.01", "PLC beta mediated events"], {"weight": 0.820865586930417}], ["RYR2", ["TCGA.CK.4950.01", "Cardiac conduction"], {"weight": 0.845283461324149}], ["RYR2", ["TCGA.CM.4750.01", "Phase 0 - rapid depolarisation"], {"weight": 0.935949821402232}], ["RYR2", ["TCGA.CM.6171.01", "Ion homeostasis"], {"weight": 0.912320679134761}], ["RYR2", ["TCGA.DM.A1D8.01", "Phase 0 - rapid depolarisation"], {"weight": 0.937008740713068}], ["RYR2", ["TCGA.DM.A1D8.01", "Ion channel transport"], {"weight": 0.939482275644434}], ["RYR2", ["TCGA.DM.A282.01", "Cardiac conduction"], {"weight": 0.928307449154474}], ["RYR2", ["TCGA.DM.A282.01", "Ca-dependent events"], {"weight": 0.918296383325604}], ["RYR2", ["TCGA.DM.A282.01", "PLC beta mediated events"], {"weight": 0.919878560012873}], ["RYR2", ["TCGA.DM.A282.01", "Calmodulin induced events"], {"weight": 0.91411430691523}], ["RYR2", ["TCGA.DM.A282.01", "CaM pathway"], {"weight": 0.91411430691523}], ["RYR2", ["TCGA.DM.A282.01", "DAG and IP3 signaling"], {"weight": 0.915600288002563}], ["RYR2", ["TCGA.DM.A282.01", "Ion homeostasis"], {"weight": 0.898334467945084}], ["RYR2", ["TCGA.DM.A282.01", "Ion channel transport"], {"weight": 0.925886688485081}], ["RYR2", ["TCGA.DM.A28F.01", "Ion homeostasis"], {"weight": 0.915564272357922}], ["RYR2", ["TCGA.F4.6808.01", "Phase 0 - rapid depolarisation"], {"weight": 0.932880438824976}], ["RYR2", ["TCGA.G4.6293.01", "Cardiac conduction"], {"weight": 0.924193722929887}], ["RYR2", ["TCGA.G4.6293.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.835358770507508}], ["RYR2", ["TCGA.G4.6317.01", "Phase 0 - rapid depolarisation"], {"weight": 0.950126222614335}], ["RYR2", ["TCGA.G4.6320.01", "Ion homeostasis"], {"weight": 0.891183384901089}], ["GOLGA2", ["TCGA.A6.5661.01", "Metabolism of water-soluble vitamins and cofactors"], {"weight": 0.739579105894132}], ["RAD23A", ["TCGA.CM.5341.01", "Amino acid and derivative metabolism"], {"weight": 0.886763907034481}], ["COL4A6", ["TCGA.A6.5661.01", "Glycosaminoglycan metabolism"], {"weight": 0.834886204318982}], ["COL4A6", ["TCGA.DM.A0XD.01", "Glucuronidation"], {"weight": 0.885008791867851}], ["EIF2AK4", ["TCGA.D5.6534.01", "LGI-ADAM interactions"], {"weight": 0.694089711605358}], ["AKAP9", ["TCGA.A6.6140.01", "Cardiac conduction"], {"weight": 0.956553780229111}], ["AKAP9", ["TCGA.A6.6140.01", "Phase 0 - rapid depolarisation"], {"weight": 0.91898033380711}], ["AKAP9", ["TCGA.A6.6140.01", "Neurexins and neuroligins"], {"weight": 0.921102886309028}], ["AKAP9", ["TCGA.A6.6140.01", "Muscle contraction"], {"weight": 0.925909987526009}], ["AKAP9", ["TCGA.A6.6140.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.885150279019025}], ["AKAP9", ["TCGA.A6.6140.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.885150279019025}], ["AKAP9", ["TCGA.A6.6142.01", "Phase 2 - plateau phase"], {"weight": 0.795915163999571}], ["AKAP9", ["TCGA.AA.3492.01", "GPCR ligand binding"], {"weight": 0.924188630492941}], ["AKAP9", ["TCGA.AD.6964.01", "GPCR ligand binding"], {"weight": 0.882379089183887}], ["AKAP9", ["TCGA.CM.4743.01", "GPCR ligand binding"], {"weight": 0.937788274677973}], ["AKAP9", ["TCGA.F4.6570.01", "Phase 2 - plateau phase"], {"weight": 0.762479836820047}], ["TAS2R4", ["TCGA.A6.6140.01", "Initial triggering of complement"], {"weight": 0.825762655871216}], ["CLTC", ["TCGA.AD.6895.01", "Voltage gated Potassium channels"], {"weight": 0.886501570072867}], ["PPP2R5D", ["TCGA.AZ.6603.01", "NCAM signaling for neurite out-growth"], {"weight": 0.686207762793186}], ["LTBP1", ["TCGA.CM.6162.01", "Elastic fibre formation"], {"weight": 0.7628671289703}], ["DGKZ", ["TCGA.AD.6899.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.607848415190747}], ["PIK3CD", ["TCGA.CM.4744.01", "Developmental Biology"], {"weight": 0.919264220315377}], ["PIK3CD", ["TCGA.CM.4744.01", "Drug ADME"], {"weight": 0.907345235904957}], ["PIK3CD", ["TCGA.CM.4744.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.884210077754665}], ["PIK3CD", ["TCGA.CM.4744.01", "Leishmania parasite growth and survival"], {"weight": 0.884210077754665}], ["PIK3CD", ["TCGA.G4.6304.01", "CD22 mediated BCR regulation"], {"weight": 0.884811780949319}], ["PIK3CD", ["TCGA.G4.6304.01", "Nuclear Receptor transcription pathway"], {"weight": 0.859650934356853}], ["KCNG2", ["TCGA.AY.6386.01", "Voltage gated Potassium channels"], {"weight": 0.850379716544859}], ["ATP12A", ["TCGA.A6.6140.01", "Ion channel transport"], {"weight": 0.925606053977204}], ["ATP12A", ["TCGA.A6.6140.01", "Ion transport by P-type ATPases"], {"weight": 0.912504904396667}], ["AMPH", ["TCGA.A6.6650.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.927063456360427}], ["AMPH", ["TCGA.AU.3779.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.911010306116656}], ["AMPH", ["TCGA.AU.3779.01", "Peptide ligand-binding receptors"], {"weight": 0.909502770598158}], ["AMPH", ["TCGA.AU.3779.01", "GABA receptor activation"], {"weight": 0.849473535997822}], ["AMPH", ["TCGA.D5.6538.01", "Binding and entry of HIV virion"], {"weight": 0.824084951532556}], ["AMPH", ["TCGA.D5.6538.01", "Protein-protein interactions at synapses"], {"weight": 0.905405192802383}], ["AMPH", ["TCGA.DM.A0XD.01", "Generation of second messenger molecules"], {"weight": 0.929620085723291}], ["AMPH", ["TCGA.DM.A0XD.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.921736950877625}], ["AMPH", ["TCGA.DM.A0XD.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.918085090894292}], ["TEK", ["TCGA.AZ.6598.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.884868609793244}], ["TEK", ["TCGA.DM.A1D4.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.890685832698744}], ["TEK", ["TCGA.DM.A1D4.01", "Interleukin-10 signaling"], {"weight": 0.945524767222807}], ["TEK", ["TCGA.DM.A1D4.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.821472538724036}], ["TEK", ["TCGA.DM.A1D4.01", "Regulation of gene expression by Hypoxia-inducible Factor"], {"weight": 0.894344227778926}], ["TEK", ["TCGA.DM.A1D4.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.898632998093029}], ["TEK", ["TCGA.G4.6315.01", "Integration of energy metabolism"], {"weight": 0.905319827822273}], ["IL6", ["TCGA.DM.A1HA.01", "GPCR downstream signalling"], {"weight": 0.963425311608595}], ["IL6", ["TCGA.DM.A1HA.01", "Drug ADME"], {"weight": 0.941015495205449}], ["PGR", ["TCGA.A6.5661.01", "Chemokine receptors bind chemokines"], {"weight": 0.916312445981259}], ["PGR", ["TCGA.A6.5661.01", "Peptide ligand-binding receptors"], {"weight": 0.940500456572046}], ["PGR", ["TCGA.A6.5661.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.940857165473726}], ["PGR", ["TCGA.D5.6540.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.94881830884497}], ["PGR", ["TCGA.D5.6540.01", "Peptide ligand-binding receptors"], {"weight": 0.948327343123977}], ["PGR", ["TCGA.F4.6856.01", "Peptide ligand-binding receptors"], {"weight": 0.935717666236689}], ["PGR", ["TCGA.F4.6856.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.93572563292588}], ["SLC9A1", ["TCGA.CM.6162.01", "Peptide ligand-binding receptors"], {"weight": 0.91560328931295}], ["SLC9A1", ["TCGA.CM.6162.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.91560328931295}], ["SLC9A1", ["TCGA.CM.6162.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.722337754315832}], ["SLC9A1", ["TCGA.CM.6674.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.854221092401098}], ["SLC9A1", ["TCGA.CM.6674.01", "SLC-mediated transmembrane transport"], {"weight": 0.853081058731423}], ["AR", ["TCGA.A6.5667.01", "Inwardly rectifying K+ channels"], {"weight": 0.899268362899883}], ["AR", ["TCGA.A6.5667.01", "Activation of G protein gated Potassium channels"], {"weight": 0.890391950382258}], ["AR", ["TCGA.A6.5667.01", "G protein gated Potassium channels"], {"weight": 0.890391950382258}], ["AR", ["TCGA.A6.5667.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.890391950382258}], ["AR", ["TCGA.A6.5667.01", "GABA receptor activation"], {"weight": 0.824448310798349}], ["AR", ["TCGA.A6.5667.01", "GABA B receptor activation"], {"weight": 0.892112849780592}], ["AR", ["TCGA.A6.5667.01", "Activation of GABAB receptors"], {"weight": 0.892112849780592}], ["AR", ["TCGA.A6.5667.01", "Platelet homeostasis"], {"weight": 0.722554064590769}], ["AR", ["TCGA.A6.6650.01", "Platelet homeostasis"], {"weight": 0.799443515589192}], ["AR", ["TCGA.AA.3662.01", "Formation of axial mesoderm"], {"weight": 0.705642037805986}], ["AR", ["TCGA.AA.3697.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.891944716410984}], ["AR", ["TCGA.AA.3697.01", "GABA B receptor activation"], {"weight": 0.897846317911832}], ["AR", ["TCGA.AA.3697.01", "Activation of GABAB receptors"], {"weight": 0.897846317911832}], ["AR", ["TCGA.AD.6965.01", "Phase 4 - resting membrane potential"], {"weight": 0.782149681480799}], ["AR", ["TCGA.D5.6537.01", "Potassium Channels"], {"weight": 0.960545972986323}], ["AR", ["TCGA.D5.6537.01", "GABA receptor activation"], {"weight": 0.906479283300516}], ["AR", ["TCGA.D5.6537.01", "GABA B receptor activation"], {"weight": 0.933454212064421}], ["AR", ["TCGA.D5.6537.01", "Activation of GABAB receptors"], {"weight": 0.933454212064421}], ["AR", ["TCGA.D5.6537.01", "Platelet homeostasis"], {"weight": 0.885267477599402}], ["AR", ["TCGA.D5.6537.01", "Inwardly rectifying K+ channels"], {"weight": 0.929376073781691}], ["AR", ["TCGA.D5.6537.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.902841397044377}], ["AR", ["TCGA.D5.6537.01", "Activation of G protein gated Potassium channels"], {"weight": 0.920370001202518}], ["AR", ["TCGA.D5.6537.01", "G protein gated Potassium channels"], {"weight": 0.920370001202518}], ["AR", ["TCGA.D5.6537.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.920370001202518}], ["AR", ["TCGA.D5.6538.01", "G alpha (i) signalling events"], {"weight": 0.934716453994239}], ["AR", ["TCGA.D5.6538.01", "Platelet homeostasis"], {"weight": 0.853406178536284}], ["AR", ["TCGA.D5.6538.01", "Glucagon-type ligand receptors"], {"weight": 0.918482654104002}], ["AR", ["TCGA.D5.6538.01", "Inwardly rectifying K+ channels"], {"weight": 0.927940086153379}], ["AR", ["TCGA.D5.6538.01", "G beta:gamma signalling through BTK"], {"weight": 0.912611818622571}], ["AR", ["TCGA.D5.6538.01", "Activation of G protein gated Potassium channels"], {"weight": 0.922004343135826}], ["AR", ["TCGA.D5.6538.01", "G protein gated Potassium channels"], {"weight": 0.922004343135826}], ["AR", ["TCGA.D5.6538.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.923088968972691}], ["AR", ["TCGA.D5.6538.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.922004343135826}], ["AR", ["TCGA.D5.6538.01", "Regulation of insulin secretion"], {"weight": 0.899377055827201}], ["AR", ["TCGA.DM.A1DB.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.84882811585569}], ["AR", ["TCGA.DM.A1DB.01", "Platelet homeostasis"], {"weight": 0.880425917324695}], ["AR", ["TCGA.DM.A1DB.01", "Phase II - Conjugation of compounds"], {"weight": 0.762544971129805}], ["AR", ["TCGA.G4.6306.01", "Potassium Channels"], {"weight": 0.950490179809554}], ["AR", ["TCGA.G4.6306.01", "G beta:gamma signalling through BTK"], {"weight": 0.894666564875903}], ["AR", ["TCGA.G4.6306.01", "Activation of G protein gated Potassium channels"], {"weight": 0.900705714101397}], ["AR", ["TCGA.G4.6306.01", "G protein gated Potassium channels"], {"weight": 0.900705714101397}], ["AR", ["TCGA.G4.6306.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.900705714101397}], ["AR", ["TCGA.G4.6306.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.897267503458958}], ["AR", ["TCGA.G4.6306.01", "Thromboxane signalling through TP receptor"], {"weight": 0.889881458797709}], ["AR", ["TCGA.G4.6306.01", "Glucagon-type ligand receptors"], {"weight": 0.924627231407222}], ["AR", ["TCGA.G4.6306.01", "G beta:gamma signalling through CDC42"], {"weight": 0.890948055004914}], ["AR", ["TCGA.G4.6314.01", "Formation of axial mesoderm"], {"weight": 0.713616550497541}], ["AR", ["TCGA.G4.6314.01", "Peptide hormone biosynthesis"], {"weight": 0.666762836932148}], ["MYOF", ["TCGA.DM.A285.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.617072323719739}], ["GLI3", ["TCGA.A6.5661.01", "Signaling by GPCR"], {"weight": 0.930166581107216}], ["GLI3", ["TCGA.AD.6889.01", "Signaling Pathways"], {"weight": 0.915082872002122}], ["GLI3", ["TCGA.CK.5915.01", "Netrin-1 signaling"], {"weight": 0.768536669408253}], ["C2CD3", ["TCGA.CM.4744.01", "Transmission across Chemical Synapses"], {"weight": 0.932866436759043}], ["PLB1", ["TCGA.A6.5661.01", "Biological oxidations"], {"weight": 0.91378626110064}], ["PLB1", ["TCGA.A6.5661.01", "Phase II - Conjugation of compounds"], {"weight": 0.764842285317328}], ["PLB1", ["TCGA.A6.6140.01", "Phase II - Conjugation of compounds"], {"weight": 0.763483346245084}], ["PLB1", ["TCGA.AM.5821.01", "Neurotransmitter release cycle"], {"weight": 0.881512779565957}], ["PLB1", ["TCGA.AY.6197.01", "Phase II - Conjugation of compounds"], {"weight": 0.754653175218679}], ["PLB1", ["TCGA.CM.5868.01", "Scavenging of heme from plasma"], {"weight": 0.780327106401578}], ["PLB1", ["TCGA.CM.6161.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.821446489945706}], ["PLB1", ["TCGA.D5.6540.01", "Drug ADME"], {"weight": 0.927763107118177}], ["PLB1", ["TCGA.D5.6540.01", "Aspirin ADME"], {"weight": 0.916661305084801}], ["NLK", ["TCGA.AZ.4615.01", "GABA receptor activation"], {"weight": 0.903726653071536}], ["NLK", ["TCGA.F4.6805.01", "Glucuronidation"], {"weight": 0.606049326119457}], ["WIPF3", ["TCGA.CM.4747.01", "Leishmania infection"], {"weight": 0.821123202123554}], ["WIPF3", ["TCGA.CM.4747.01", "Parasitic Infection Pathways"], {"weight": 0.821123202123554}], ["WIPF3", ["TCGA.CM.4747.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.899967210375678}], ["WIPF3", ["TCGA.CM.4747.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.899967210375678}], ["WIPF3", ["TCGA.CM.4747.01", "Diseases of Immune System"], {"weight": 0.851352571861552}], ["WIPF3", ["TCGA.CM.4747.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.851352571861552}], ["WIPF3", ["TCGA.F4.6703.01", "FCGR activation"], {"weight": 0.827959953788302}], ["CP", ["TCGA.D5.6926.01", "Drug ADME"], {"weight": 0.891660826957581}], ["CP", ["TCGA.D5.6926.01", "APAP ADME"], {"weight": 0.65103306521522}], ["CP", ["TCGA.F4.6806.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.615521460986439}], ["CP", ["TCGA.G4.6304.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.877795806329851}], ["CP", ["TCGA.G4.6315.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.798068225179766}], ["PPP1CB", ["TCGA.A6.5661.01", "Transmission across Chemical Synapses"], {"weight": 0.923374387721714}], ["PPP1CB", ["TCGA.A6.5661.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.919565907227646}], ["PPP1CB", ["TCGA.A6.5661.01", "Activation of NMDA receptors and postsynaptic events"], {"weight": 0.877138764644498}], ["VWCE", ["TCGA.CM.6166.01", "Phase 4 - resting membrane potential"], {"weight": 0.772777606647961}], ["TAS1R1", ["TCGA.A6.5661.01", "Glucagon-type ligand receptors"], {"weight": 0.92118911512021}], ["TAS1R1", ["TCGA.A6.5661.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.932670797804674}], ["TAS1R1", ["TCGA.A6.5661.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.913890477028597}], ["TAS1R1", ["TCGA.AM.5821.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.928992543268652}], ["TAS1R1", ["TCGA.AM.5821.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.94717216274999}], ["TAS1R1", ["TCGA.AM.5821.01", "Signal amplification"], {"weight": 0.933106595536028}], ["TAS1R1", ["TCGA.AM.5821.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.926567632338218}], ["TAS1R1", ["TCGA.G4.6320.01", "G-protein beta:gamma signalling"], {"weight": 0.92046776842692}], ["TAS1R1", ["TCGA.G4.6320.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.913608949332009}], ["TAS1R1", ["TCGA.G4.6320.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.922829934904724}], ["TAS1R1", ["TCGA.G4.6320.01", "G alpha (q) signalling events"], {"weight": 0.938407332821182}], ["TAS1R1", ["TCGA.G4.6320.01", "G alpha (z) signalling events"], {"weight": 0.904965314404904}], ["TAS1R1", ["TCGA.G4.6320.01", "G beta:gamma signalling through BTK"], {"weight": 0.891525200064611}], ["TAS1R1", ["TCGA.G4.6320.01", "GABA B receptor activation"], {"weight": 0.929110078417948}], ["TAS1R1", ["TCGA.G4.6320.01", "Activation of GABAB receptors"], {"weight": 0.929110078417948}], ["TAS1R1", ["TCGA.G4.6320.01", "GABA receptor activation"], {"weight": 0.887781809757317}], ["TAS1R1", ["TCGA.G4.6320.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.900395678776031}], ["TAS1R1", ["TCGA.G4.6320.01", "G beta:gamma signalling through CDC42"], {"weight": 0.892986133086686}], ["TAS1R1", ["TCGA.G4.6320.01", "Potassium Channels"], {"weight": 0.94976784841869}], ["TAS1R1", ["TCGA.G4.6320.01", "Presynaptic function of Kainate receptors"], {"weight": 0.899838506415578}], ["TAS1R1", ["TCGA.G4.6320.01", "Opioid Signalling"], {"weight": 0.941908469114752}], ["TAS1R1", ["TCGA.G4.6320.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.889715813408957}], ["TAS1R1", ["TCGA.G4.6320.01", "Signal amplification"], {"weight": 0.903675535466994}], ["TAS1R1", ["TCGA.G4.6320.01", "Glucagon-type ligand receptors"], {"weight": 0.918532357307054}], ["TAS1R1", ["TCGA.G4.6320.01", "Activation of G protein gated Potassium channels"], {"weight": 0.909886612359027}], ["TAS1R1", ["TCGA.G4.6320.01", "G protein gated Potassium channels"], {"weight": 0.909886612359027}], ["TAS1R1", ["TCGA.G4.6320.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.909886612359027}], ["TAS1R1", ["TCGA.G4.6320.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.883037503891664}], ["TAS1R1", ["TCGA.G4.6320.01", "Inwardly rectifying K+ channels"], {"weight": 0.914537515551915}], ["TAS1R1", ["TCGA.G4.6320.01", "G-protein activation"], {"weight": 0.915576418175793}], ["TAS1R1", ["TCGA.G4.6320.01", "Thromboxane signalling through TP receptor"], {"weight": 0.888514302963472}], ["TAS1R1", ["TCGA.G4.6320.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.883037503891664}], ["TNPO1", ["TCGA.CK.5914.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.83042006764909}], ["TNPO1", ["TCGA.CK.5914.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.844175808496304}], ["MOV10L1", ["TCGA.G4.6311.01", "Other semaphorin interactions"], {"weight": 0.601613971356306}], ["CNGA1", ["TCGA.CM.6164.01", "Ca2+ pathway"], {"weight": 0.812462396356356}], ["FBXO21", ["TCGA.CK.4952.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.936665975786618}], ["FBXO21", ["TCGA.CK.4952.01", "Peptide ligand-binding receptors"], {"weight": 0.934972357633978}], ["BMPR2", ["TCGA.AZ.4615.01", "Cardiac conduction"], {"weight": 0.932868886828135}], ["BMPR2", ["TCGA.F4.6808.01", "Netrin-1 signaling"], {"weight": 0.785700661875431}], ["BMPR2", ["TCGA.G4.6304.01", "Netrin-1 signaling"], {"weight": 0.84907732730573}], ["TSPAN7", ["TCGA.A6.5661.01", "Protein-protein interactions at synapses"], {"weight": 0.907899738527109}], ["TSPAN7", ["TCGA.A6.5661.01", "Synaptic adhesion-like molecules"], {"weight": 0.90907658536859}], ["TSPAN7", ["TCGA.A6.5661.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.898446529458739}], ["PPP2R2C", ["TCGA.D5.5540.01", "NFE2L2 regulating tumorigenic genes"], {"weight": 0.884319875760529}], ["PPP2R2C", ["TCGA.D5.6540.01", "LGI-ADAM interactions"], {"weight": 0.90130511239847}], ["IBTK", ["TCGA.AZ.6598.01", "CD22 mediated BCR regulation"], {"weight": 0.843829035458705}], ["IBTK", ["TCGA.DM.A1D0.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.941652816377266}], ["IBTK", ["TCGA.DM.A1D0.01", "DAP12 signaling"], {"weight": 0.916355323499215}], ["IBTK", ["TCGA.DM.A1D0.01", "DAP12 interactions"], {"weight": 0.924336907875649}], ["IBTK", ["TCGA.DM.A1D0.01", "CD22 mediated BCR regulation"], {"weight": 0.905114510296673}], ["IBTK", ["TCGA.DM.A1D0.01", "Dectin-2 family"], {"weight": 0.842787830427356}], ["SHROOM4", ["TCGA.CA.5796.01", "Sensory processing of sound"], {"weight": 0.895141227136278}], ["SHROOM4", ["TCGA.CA.5796.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.889344750718815}], ["SHROOM4", ["TCGA.CK.5912.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.770436122750616}], ["SHROOM4", ["TCGA.CK.5912.01", "Neurexins and neuroligins"], {"weight": 0.87213446386278}], ["RGMA", ["TCGA.DM.A1D4.01", "Signaling by BMP"], {"weight": 0.940482873270411}], ["RGMA", ["TCGA.DM.A28H.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.848312178845418}], ["DPP7", ["TCGA.AA.3697.01", "G alpha (s) signalling events"], {"weight": 0.942015436206403}], ["DPP7", ["TCGA.AA.3697.01", "GPCR downstream signalling"], {"weight": 0.932027386751955}], ["KCNQ1", ["TCGA.A6.5661.01", "G alpha (s) signalling events"], {"weight": 0.959062459172569}], ["KCNQ1", ["TCGA.CK.4948.01", "GPCR downstream signalling"], {"weight": 0.945634733535702}], ["KCNQ1", ["TCGA.CK.4948.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.891432712255197}], ["KCNQ1", ["TCGA.G4.6628.01", "Phase 4 - resting membrane potential"], {"weight": 0.870081326826837}], ["CAPN6", ["TCGA.D5.6533.01", "Extracellular matrix organization"], {"weight": 0.883043948145859}], ["CAPN6", ["TCGA.D5.6533.01", "Degradation of the extracellular matrix"], {"weight": 0.857874236066065}], ["AVPR1B", ["TCGA.CM.6172.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.915989834760914}], ["AVPR1B", ["TCGA.CM.6172.01", "Peptide hormone metabolism"], {"weight": 0.66151057063457}], ["AVPR1B", ["TCGA.CM.6172.01", "Peptide ligand-binding receptors"], {"weight": 0.910751849296195}], ["MCHR2", ["TCGA.A6.6652.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.936584451396278}], ["MCHR2", ["TCGA.A6.6652.01", "Complement cascade"], {"weight": 0.865119530209341}], ["MCHR2", ["TCGA.A6.6652.01", "Peptide ligand-binding receptors"], {"weight": 0.934361277825688}], ["MCHR2", ["TCGA.A6.6652.01", "Regulation of Complement cascade"], {"weight": 0.810693614501491}], ["MCHR2", ["TCGA.A6.6652.01", "Chemokine receptors bind chemokines"], {"weight": 0.938595983770373}], ["MCHR2", ["TCGA.A6.6652.01", "PLC beta mediated events"], {"weight": 0.882738623871528}], ["MCHR2", ["TCGA.A6.6652.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.941431463056667}], ["MCHR2", ["TCGA.AA.3492.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.918746368420934}], ["MCHR2", ["TCGA.AA.3492.01", "Peptide ligand-binding receptors"], {"weight": 0.916999654828002}], ["NR5A2", ["TCGA.G4.6304.01", "Biological oxidations"], {"weight": 0.94820626618225}], ["NR5A2", ["TCGA.G4.6304.01", "Phase I - Functionalization of compounds"], {"weight": 0.961659242455439}], ["NR5A2", ["TCGA.G4.6304.01", "Recycling of bile acids and salts"], {"weight": 0.937944927190326}], ["NR5A2", ["TCGA.G4.6304.01", "Bile acid and bile salt metabolism"], {"weight": 0.92506532558311}], ["SERPINB13", ["TCGA.A6.5661.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.916491025684064}], ["SERPINB13", ["TCGA.CA.6718.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.932874804761847}], ["GREB1L", ["TCGA.A6.5661.01", "Complement cascade"], {"weight": 0.822650989489583}], ["GREB1L", ["TCGA.A6.5661.01", "Regulation of Complement cascade"], {"weight": 0.744584131985312}], ["DISP1", ["TCGA.DM.A1D6.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.934354976105966}], ["DISP1", ["TCGA.G4.6628.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.921639490240322}], ["MUC17", ["TCGA.A6.6782.01", "Defective GALNT3 causes HFTC"], {"weight": 0.800852221030508}], ["MUC17", ["TCGA.A6.6782.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.800852221030508}], ["MUC17", ["TCGA.CK.5916.01", "O-linked glycosylation of mucins"], {"weight": 0.939129695773196}], ["MUC17", ["TCGA.CM.6161.01", "Lewis blood group biosynthesis"], {"weight": 0.831446965426477}], ["MUC17", ["TCGA.CM.6161.01", "Blood group systems biosynthesis"], {"weight": 0.831446965426477}], ["MUC17", ["TCGA.CM.6161.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.862960176813747}], ["BPI", ["TCGA.A6.6140.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.815463924043357}], ["BPI", ["TCGA.A6.6140.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.815463924043357}], ["MANEAL", ["TCGA.AY.6197.01", "Blood group systems biosynthesis"], {"weight": 0.776490651448014}], ["MANEAL", ["TCGA.AY.6197.01", "Termination of O-glycan biosynthesis"], {"weight": 0.884622937894562}], ["MANEAL", ["TCGA.AY.6197.01", "Keratan sulfate biosynthesis"], {"weight": 0.932894321131798}], ["CNTN5", ["TCGA.A6.6780.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.874019925179843}], ["DAGLB", ["TCGA.A6.5661.01", "GPCR downstream signalling"], {"weight": 0.936543005048589}], ["HEPH", ["TCGA.D5.5538.01", "Transport of small molecules"], {"weight": 0.825252406096705}], ["HEPH", ["TCGA.F4.6856.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.634123381165182}], ["DMXL1", ["TCGA.CM.5344.01", "Immune System"], {"weight": 0.806819876284211}], ["NTNG1", ["TCGA.A6.5661.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.850230088370004}], ["CD1B", ["TCGA.A6.5662.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.722293736016382}], ["SHANK1", ["TCGA.A6.5662.01", "Neuronal System"], {"weight": 0.919745079026057}], ["SHANK1", ["TCGA.A6.5662.01", "G-protein beta:gamma signalling"], {"weight": 0.900022713676608}], ["SHANK1", ["TCGA.AZ.5407.01", "Neurexins and neuroligins"], {"weight": 0.946851136697935}], ["SHANK1", ["TCGA.D5.6537.01", "Neuronal System"], {"weight": 0.947195474450945}], ["SHANK1", ["TCGA.D5.6537.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.936871027699763}], ["IGSF11", ["TCGA.G4.6307.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.865364708349263}], ["IGSF11", ["TCGA.G4.6307.01", "Cytokine Signaling in Immune system"], {"weight": 0.877316938705412}], ["IGSF11", ["TCGA.G4.6307.01", "Interferon gamma signaling"], {"weight": 0.911692580003334}], ["IGSF11", ["TCGA.G4.6307.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.858289598285096}], ["IGSF11", ["TCGA.G4.6307.01", "DAP12 interactions"], {"weight": 0.920788551901683}], ["IGSF11", ["TCGA.G4.6307.01", "DAP12 signaling"], {"weight": 0.91265277842692}], ["VCAM1", ["TCGA.A6.5662.01", "G alpha (z) signalling events"], {"weight": 0.918169998362571}], ["VCAM1", ["TCGA.A6.5662.01", "Trafficking of AMPA receptors"], {"weight": 0.921873082197268}], ["VCAM1", ["TCGA.A6.5662.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.921873082197268}], ["VCAM1", ["TCGA.A6.5662.01", "Interleukin-35 Signalling"], {"weight": 0.772837691269705}], ["VCAM1", ["TCGA.G4.6307.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.935352528888688}], ["VCAM1", ["TCGA.G4.6307.01", "Signaling by GPCR"], {"weight": 0.951184452860499}], ["VCAM1", ["TCGA.G4.6307.01", "GPCR downstream signalling"], {"weight": 0.950985085918167}], ["VCAM1", ["TCGA.G4.6307.01", "Generation of second messenger molecules"], {"weight": 0.938776277020696}], ["VCAM1", ["TCGA.G4.6307.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.935352528888688}], ["VCAM1", ["TCGA.G4.6307.01", "PD-1 signaling"], {"weight": 0.937151594626889}], ["VCAM1", ["TCGA.G4.6307.01", "Costimulation by the CD28 family"], {"weight": 0.940160710894893}], ["VCAM1", ["TCGA.G4.6307.01", "Interleukin-10 signaling"], {"weight": 0.918150619187054}], ["RB1", ["TCGA.A6.5662.01", "Heme degradation"], {"weight": 0.7157720284419}], ["TCTN3", ["TCGA.A6.5662.01", "G alpha (s) signalling events"], {"weight": 0.946242037603799}], ["TCTN3", ["TCGA.A6.5662.01", "G-protein mediated events"], {"weight": 0.911836275595843}], ["TCTN3", ["TCGA.A6.5662.01", "PLC beta mediated events"], {"weight": 0.907892836432673}], ["TCTN3", ["TCGA.A6.5662.01", "Opioid Signalling"], {"weight": 0.92213167717751}], ["TCTN3", ["TCGA.A6.5662.01", "Activation of the phototransduction cascade"], {"weight": 0.784410128466416}], ["TCTN3", ["TCGA.A6.5662.01", "DAG and IP3 signaling"], {"weight": 0.905249822999508}], ["TCTN3", ["TCGA.A6.5662.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.89798114384083}], ["TCTN3", ["TCGA.A6.5662.01", "Calmodulin induced events"], {"weight": 0.904513397010032}], ["TCTN3", ["TCGA.A6.5662.01", "CaM pathway"], {"weight": 0.904513397010032}], ["TCTN3", ["TCGA.A6.5662.01", "Ca-dependent events"], {"weight": 0.904513397010032}], ["TCTN3", ["TCGA.A6.5662.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.88788971661151}], ["TCTN3", ["TCGA.A6.5662.01", "GPER1 signaling"], {"weight": 0.887487527000071}], ["TCTN3", ["TCGA.A6.5662.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.887487527000071}], ["GRIK1", ["TCGA.A6.5662.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.877676551938832}], ["GRIK1", ["TCGA.A6.5662.01", "Presynaptic function of Kainate receptors"], {"weight": 0.862934241279313}], ["GRIK1", ["TCGA.CM.5864.01", "Presynaptic function of Kainate receptors"], {"weight": 0.895865650084658}], ["ZFYVE28", ["TCGA.A6.5662.01", "Signaling by GPCR"], {"weight": 0.948191187758405}], ["ZFYVE28", ["TCGA.A6.5662.01", "GPCR downstream signalling"], {"weight": 0.951435179774607}], ["ZFYVE28", ["TCGA.A6.5662.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.850215201436356}], ["ZFYVE28", ["TCGA.A6.5662.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.833966904284052}], ["ZFYVE28", ["TCGA.A6.5662.01", "G alpha (q) signalling events"], {"weight": 0.928470268896187}], ["ZFYVE28", ["TCGA.D5.6928.01", "Dectin-2 family"], {"weight": 0.768823746643491}], ["ZFYVE28", ["TCGA.G4.6315.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.697790234523863}], ["ZFYVE28", ["TCGA.G4.6315.01", "Arachidonic acid metabolism"], {"weight": 0.8479346695054}], ["ZFYVE28", ["TCGA.G4.6315.01", "Negative regulation of FLT3"], {"weight": 0.793628835852702}], ["ZFYVE28", ["TCGA.G4.6588.01", "PI3K events in ERBB2 signaling"], {"weight": 0.89364324945453}], ["ZFYVE28", ["TCGA.G4.6588.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.892904624475691}], ["CR1", ["TCGA.A6.5662.01", "G alpha (i) signalling events"], {"weight": 0.954370578751067}], ["CR1", ["TCGA.A6.5662.01", "GPCR ligand binding"], {"weight": 0.930908200375343}], ["CR1", ["TCGA.A6.5662.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.943711227223832}], ["CR1", ["TCGA.A6.5662.01", "Peptide ligand-binding receptors"], {"weight": 0.931520359235302}], ["CR1", ["TCGA.A6.5662.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.779808895599793}], ["CR1", ["TCGA.A6.5662.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.779808895599793}], ["CR1", ["TCGA.A6.5662.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.859938367037684}], ["CR1", ["TCGA.AZ.4616.01", "Defensins"], {"weight": 0.668396146851196}], ["CD1B", ["TCGA.A6.5662.01", "Generation of second messenger molecules"], {"weight": 0.9347477187449}], ["CD1B", ["TCGA.A6.5662.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.924411932928663}], ["CD1B", ["TCGA.A6.5662.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.921518109132659}], ["CD1B", ["TCGA.A6.5662.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.876496107879075}], ["CD1B", ["TCGA.A6.5662.01", "Leishmania parasite growth and survival"], {"weight": 0.876496107879075}], ["CD1B", ["TCGA.A6.5662.01", "Leishmania infection"], {"weight": 0.874778537959016}], ["CD1B", ["TCGA.A6.5662.01", "Parasitic Infection Pathways"], {"weight": 0.874778537959016}], ["CD1B", ["TCGA.A6.5662.01", "PD-1 signaling"], {"weight": 0.922291799636022}], ["CD1B", ["TCGA.A6.5662.01", "Costimulation by the CD28 family"], {"weight": 0.84153228844761}], ["ADAMTS8", ["TCGA.A6.5662.01", "O-linked glycosylation"], {"weight": 0.90569751509471}], ["CCR7", ["TCGA.A6.5662.01", "Chemokine receptors bind chemokines"], {"weight": 0.917056723005542}], ["CCR7", ["TCGA.A6.5662.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.906863737879419}], ["CCR7", ["TCGA.A6.5662.01", "Signal amplification"], {"weight": 0.88270910401525}], ["CCR7", ["TCGA.A6.5662.01", "Complement cascade"], {"weight": 0.823882837352601}], ["CCR7", ["TCGA.A6.5662.01", "Regulation of Complement cascade"], {"weight": 0.83177692896087}], ["CCR7", ["TCGA.A6.5662.01", "Potassium Channels"], {"weight": 0.94012672183929}], ["CCR7", ["TCGA.A6.5662.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.860426286271371}], ["CCR7", ["TCGA.A6.5662.01", "Defensins"], {"weight": 0.507749201272078}], ["CCR7", ["TCGA.A6.5662.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.871488471146409}], ["CCR7", ["TCGA.A6.5662.01", "Interleukin-10 signaling"], {"weight": 0.818451093285567}], ["CCR7", ["TCGA.A6.5662.01", "G beta:gamma signalling through BTK"], {"weight": 0.85247565559569}], ["CCR7", ["TCGA.A6.5662.01", "Binding and entry of HIV virion"], {"weight": 0.695740821269213}], ["CCR7", ["TCGA.A6.5662.01", "G-protein activation"], {"weight": 0.864256531066376}], ["CCR7", ["TCGA.A6.5662.01", "Thromboxane signalling through TP receptor"], {"weight": 0.837252678767935}], ["CCR7", ["TCGA.A6.5662.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.875294297919007}], ["MYL1", ["TCGA.CK.5915.01", "Signaling Pathways"], {"weight": 0.930719029763476}], ["MYL1", ["TCGA.D5.5540.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.926697113952625}], ["KCNQ5", ["TCGA.A6.5662.01", "GABA receptor activation"], {"weight": 0.866599441659667}], ["KCNQ5", ["TCGA.A6.5662.01", "GABA B receptor activation"], {"weight": 0.897003422044727}], ["KCNQ5", ["TCGA.A6.5662.01", "Activation of GABAB receptors"], {"weight": 0.897003422044727}], ["KCNQ5", ["TCGA.A6.5662.01", "Phase 4 - resting membrane potential"], {"weight": 0.880328934502706}], ["KCNQ5", ["TCGA.A6.5662.01", "Activation of G protein gated Potassium channels"], {"weight": 0.877136240819482}], ["KCNQ5", ["TCGA.A6.5662.01", "G protein gated Potassium channels"], {"weight": 0.877136240819482}], ["KCNQ5", ["TCGA.A6.5662.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.877136240819482}], ["KCNQ5", ["TCGA.A6.5662.01", "Inwardly rectifying K+ channels"], {"weight": 0.890437100901392}], ["KCNQ5", ["TCGA.CM.6170.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.902853753616661}], ["KCNQ5", ["TCGA.CM.6170.01", "Transmission across Chemical Synapses"], {"weight": 0.898982796546863}], ["KCNQ5", ["TCGA.CM.6170.01", "Inwardly rectifying K+ channels"], {"weight": 0.915075817692186}], ["KCNQ5", ["TCGA.CM.6170.01", "GABA receptor activation"], {"weight": 0.613488861741574}], ["KCNQ5", ["TCGA.CM.6170.01", "Phase 4 - resting membrane potential"], {"weight": 0.868373109874984}], ["KCNQ5", ["TCGA.CM.6170.01", "Activation of G protein gated Potassium channels"], {"weight": 0.900041328907449}], ["KCNQ5", ["TCGA.CM.6170.01", "G protein gated Potassium channels"], {"weight": 0.900041328907449}], ["KCNQ5", ["TCGA.CM.6170.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.900041328907449}], ["KCNQ5", ["TCGA.CM.6170.01", "GABA B receptor activation"], {"weight": 0.906895748680914}], ["KCNQ5", ["TCGA.CM.6170.01", "Activation of GABAB receptors"], {"weight": 0.906895748680914}], ["KCNQ5", ["TCGA.D5.6529.01", "Phase 4 - resting membrane potential"], {"weight": 0.835331166557301}], ["KCNQ5", ["TCGA.G4.6307.01", "Cardiac conduction"], {"weight": 0.936914797813529}], ["KCNQ5", ["TCGA.G4.6307.01", "Muscle contraction"], {"weight": 0.940764004273979}], ["LCT", ["TCGA.CM.6677.01", "Ethanol oxidation"], {"weight": 0.754040760087796}], ["LCT", ["TCGA.G4.6588.01", "Metabolism of steroid hormones"], {"weight": 0.913320538292899}], ["SMAD4", ["TCGA.A6.5664.01", "Extracellular matrix organization"], {"weight": 0.802413645372226}], ["POU4F2", ["TCGA.CM.4744.01", "Biological oxidations"], {"weight": 0.915756307696255}], ["POU4F2", ["TCGA.CM.4744.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.774810002048279}], ["POU4F2", ["TCGA.CM.4744.01", "Endogenous sterols"], {"weight": 0.647973196725648}], ["NOTCH3", ["TCGA.A6.5665.01", "Signaling Pathways"], {"weight": 0.923977793663095}], ["NOTCH3", ["TCGA.D5.6536.01", "Molecules associated with elastic fibres"], {"weight": 0.741163368477666}], ["NOTCH3", ["TCGA.D5.6536.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.726127742710348}], ["NOTCH3", ["TCGA.D5.6537.01", "Signaling Pathways"], {"weight": 0.925967919474628}], ["NOTCH3", ["TCGA.D5.6537.01", "Cardiac conduction"], {"weight": 0.948984833083102}], ["NOTCH3", ["TCGA.D5.6537.01", "Muscle contraction"], {"weight": 0.95215870679559}], ["NOTCH3", ["TCGA.D5.6537.01", "Molecules associated with elastic fibres"], {"weight": 0.831907352837187}], ["RBP1", ["TCGA.CA.6716.01", "RA biosynthesis pathway"], {"weight": 0.928709428601658}], ["RBP1", ["TCGA.CA.6716.01", "Signaling by Retinoic Acid"], {"weight": 0.852651776047006}], ["RBP1", ["TCGA.CA.6716.01", "Ethanol oxidation"], {"weight": 0.862484150392294}], ["RBP1", ["TCGA.CM.5864.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.568709740105815}], ["RBP1", ["TCGA.D5.7000.01", "Visual phototransduction"], {"weight": 0.798451688539314}], ["RBP1", ["TCGA.D5.7000.01", "Ethanol oxidation"], {"weight": 0.733790135648367}], ["RBP1", ["TCGA.D5.7000.01", "Metabolism of vitamins and cofactors"], {"weight": 0.684193109578879}], ["RBP1", ["TCGA.G4.6311.01", "Ethanol oxidation"], {"weight": 0.810410165008524}], ["RBP1", ["TCGA.G4.6311.01", "RA biosynthesis pathway"], {"weight": 0.679666001406259}], ["RBP1", ["TCGA.G4.6321.01", "Defective EXT2 causes exostoses 2"], {"weight": 0.820169722591037}], ["RBP1", ["TCGA.G4.6321.01", "Defective EXT1 causes exostoses 1, TRPS2 and CHDS"], {"weight": 0.820169722591037}], ["RBP1", ["TCGA.G4.6321.01", "HS-GAG degradation"], {"weight": 0.872539202581458}], ["RBP1", ["TCGA.G4.6321.01", "RA biosynthesis pathway"], {"weight": 0.703216362982924}], ["MYLK", ["TCGA.AA.3663.01", "Muscle contraction"], {"weight": 0.952302033203532}], ["SP5", ["TCGA.A6.5664.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.856610159408713}], ["SP5", ["TCGA.AZ.5403.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.925897893472944}], ["SP5", ["TCGA.AZ.5403.01", "Collagen formation"], {"weight": 0.9098683489622}], ["SP5", ["TCGA.AZ.5403.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.877259410302981}], ["SP5", ["TCGA.CM.6680.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.880194587184791}], ["SMAD4", ["TCGA.A6.5664.01", "Collagen formation"], {"weight": 0.929792881776813}], ["SMAD4", ["TCGA.A6.5664.01", "Collagen chain trimerization"], {"weight": 0.898111409404793}], ["SMAD4", ["TCGA.A6.5664.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.91667054153072}], ["SMAD4", ["TCGA.A6.5664.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.920976203770861}], ["SMAD4", ["TCGA.A6.5664.01", "Formation of axial mesoderm"], {"weight": 0.630006276945657}], ["SMAD4", ["TCGA.A6.5664.01", "Peptide hormone biosynthesis"], {"weight": 0.814007362198879}], ["SMAD4", ["TCGA.A6.5664.01", "Primitive streak formation"], {"weight": 0.58429383765844}], ["SMAD4", ["TCGA.AZ.4616.01", "Signaling Pathways"], {"weight": 0.887771120992341}], ["SMAD4", ["TCGA.AZ.4616.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.760038000938021}], ["SMAD4", ["TCGA.AZ.4616.01", "Regulation of gene expression by Hypoxia-inducible Factor"], {"weight": 0.882145917076813}], ["SMAD4", ["TCGA.AZ.4616.01", "Peptide hormone metabolism"], {"weight": 0.732919555371387}], ["SMAD4", ["TCGA.AZ.4616.01", "Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3"], {"weight": 0.810140064804886}], ["SMAD4", ["TCGA.AZ.4616.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.863133401826512}], ["SMAD4", ["TCGA.AZ.6598.01", "Peptide hormone metabolism"], {"weight": 0.916891684364755}], ["SMAD4", ["TCGA.CA.5796.01", "Cardiac conduction"], {"weight": 0.919137902189198}], ["SMAD4", ["TCGA.CA.5796.01", "Scavenging by Class A Receptors"], {"weight": 0.280302837894881}], ["SMAD4", ["TCGA.CK.4950.01", "Signaling by BMP"], {"weight": 0.674668860080479}], ["SMAD4", ["TCGA.CK.5916.01", "Peptide hormone metabolism"], {"weight": 0.759069390764871}], ["SMAD4", ["TCGA.CM.5868.01", "Signaling Pathways"], {"weight": 0.877197786423926}], ["SMAD4", ["TCGA.CM.5868.01", "Cardiac conduction"], {"weight": 0.890627984817643}], ["SMAD4", ["TCGA.CM.5868.01", "Peptide hormone metabolism"], {"weight": 0.772651858999175}], ["SMAD4", ["TCGA.CM.6170.01", "Glucuronidation"], {"weight": 0.880027650293872}], ["SMAD4", ["TCGA.CM.6170.01", "Heme degradation"], {"weight": 0.621544430032057}], ["SMAD4", ["TCGA.CM.6170.01", "Aspirin ADME"], {"weight": 0.801043911878815}], ["SMAD4", ["TCGA.CM.6170.01", "Nuclear signaling by ERBB4"], {"weight": 0.806865813194729}], ["SMAD4", ["TCGA.CM.6170.01", "APAP ADME"], {"weight": 0.641966299865396}], ["SMAD4", ["TCGA.CM.6170.01", "Physiological factors"], {"weight": 0.514383647866297}], ["SMAD4", ["TCGA.D5.5538.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.866229537789007}], ["SMAD4", ["TCGA.D5.5538.01", "APAP ADME"], {"weight": 0.628348447920604}], ["SMAD4", ["TCGA.D5.5538.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.892658009972704}], ["SMAD4", ["TCGA.D5.6532.01", "Interleukin-10 signaling"], {"weight": 0.929731993933827}], ["SMAD4", ["TCGA.D5.6532.01", "Ca2+ pathway"], {"weight": 0.873501513891649}], ["SMAD4", ["TCGA.DM.A1D8.01", "Peptide hormone metabolism"], {"weight": 0.809514931352228}], ["SMAD4", ["TCGA.DM.A1D8.01", "Immune System"], {"weight": 0.879328125011605}], ["SMAD4", ["TCGA.DM.A1D9.01", "Ca2+ pathway"], {"weight": 0.873787736377432}], ["SMAD4", ["TCGA.DM.A1D9.01", "Peptide hormone metabolism"], {"weight": 0.809750056760953}], ["SMAD4", ["TCGA.DM.A285.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.872798073690957}], ["SMAD4", ["TCGA.DM.A285.01", "Signaling by Interleukins"], {"weight": 0.864912739231451}], ["SMAD4", ["TCGA.DM.A285.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.888756888511459}], ["SMAD4", ["TCGA.DM.A285.01", "Interleukin-10 signaling"], {"weight": 0.9284846689274}], ["SMAD4", ["TCGA.DM.A285.01", "Peptide hormone metabolism"], {"weight": 0.794080444436134}], ["SMAD4", ["TCGA.DM.A28H.01", "Cytokine Signaling in Immune system"], {"weight": 0.894729210781235}], ["SMAD4", ["TCGA.DM.A28H.01", "Interferon gamma signaling"], {"weight": 0.926782139603084}], ["SMAD4", ["TCGA.DM.A28H.01", "Molecules associated with elastic fibres"], {"weight": 0.893482020662623}], ["SMAD4", ["TCGA.DM.A28H.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.828208718901806}], ["SMAD4", ["TCGA.DM.A28H.01", "Elastic fibre formation"], {"weight": 0.900419419466822}], ["SMAD4", ["TCGA.DM.A28H.01", "Peptide hormone metabolism"], {"weight": 0.857447580578873}], ["SMAD4", ["TCGA.DM.A28H.01", "Signaling by Interleukins"], {"weight": 0.888494597068514}], ["SMAD4", ["TCGA.F4.6569.01", "Stimuli-sensing channels"], {"weight": 0.880317459563144}], ["SMAD4", ["TCGA.F4.6569.01", "Primitive streak formation"], {"weight": 0.749905187268663}], ["SMAD4", ["TCGA.F4.6569.01", "Signaling by Activin"], {"weight": 0.875269789878774}], ["SMAD4", ["TCGA.F4.6569.01", "Ion channel transport"], {"weight": 0.872645486996155}], ["SMAD4", ["TCGA.F4.6805.01", "Metal ion SLC transporters"], {"weight": 0.285312494488389}], ["SMAD4", ["TCGA.F4.6855.01", "Extracellular matrix organization"], {"weight": 0.863491264834662}], ["SMAD4", ["TCGA.F4.6855.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.898117222889611}], ["SMAD4", ["TCGA.G4.6309.01", "Peptide hormone metabolism"], {"weight": 0.760494240613096}], ["SMAD4", ["TCGA.G4.6322.01", "Biological oxidations"], {"weight": 0.925937662806653}], ["SMAD4", ["TCGA.G4.6322.01", "Peptide hormone metabolism"], {"weight": 0.818840769603414}], ["SMAD4", ["TCGA.G4.6322.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.415291575988961}], ["SMAD4", ["TCGA.G4.6322.01", "Recycling of bile acids and salts"], {"weight": 0.641547171890093}], ["SMAD4", ["TCGA.G4.6322.01", "Cytochrome P450 - arranged by substrate type"], {"weight": 0.692302690845912}], ["CATSPERD", ["TCGA.CM.5864.01", "Phase 0 - rapid depolarisation"], {"weight": 0.882028930440081}], ["SLC12A2", ["TCGA.AZ.6607.01", "NCAM signaling for neurite out-growth"], {"weight": 0.745513981395568}], ["SLC12A2", ["TCGA.AZ.6607.01", "APAP ADME"], {"weight": 0.738503620735065}], ["SLC12A2", ["TCGA.AZ.6607.01", "Neuronal System"], {"weight": 0.904575710321995}], ["SLC12A2", ["TCGA.AZ.6607.01", "Potassium Channels"], {"weight": 0.861187411964874}], ["SLC12A2", ["TCGA.D5.6898.01", "Phase 4 - resting membrane potential"], {"weight": 0.748688338270258}], ["SLC12A2", ["TCGA.DM.A0XD.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.816632201192015}], ["AKR1D1", ["TCGA.A6.5664.01", "Glucuronidation"], {"weight": 0.794630091606305}], ["AKR1D1", ["TCGA.A6.5664.01", "Biological oxidations"], {"weight": 0.817805953018196}], ["AKR1D1", ["TCGA.A6.5664.01", "Phase II - Conjugation of compounds"], {"weight": 0.733607762793309}], ["AKR1D1", ["TCGA.A6.5664.01", "Drug ADME"], {"weight": 0.815912208374106}], ["AKR1D1", ["TCGA.A6.6653.01", "Glucuronidation"], {"weight": 0.876501609622275}], ["AKR1D1", ["TCGA.DM.A28G.01", "Drug ADME"], {"weight": 0.822980430375419}], ["AKR1D1", ["TCGA.DM.A28G.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.563182223038307}], ["AKR1D1", ["TCGA.DM.A28G.01", "APAP ADME"], {"weight": 0.74919807443364}], ["AKR1D1", ["TCGA.G4.6586.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.918371410191919}], ["AKR1D1", ["TCGA.G4.6586.01", "Synthesis of bile acids and bile salts"], {"weight": 0.927594713712748}], ["NBEA", ["TCGA.A6.5665.01", "Neuronal System"], {"weight": 0.940156284906209}], ["ITGA1", ["TCGA.A6.5665.01", "Other semaphorin interactions"], {"weight": 0.646812618472531}], ["ITGA1", ["TCGA.CK.4948.01", "Extracellular matrix organization"], {"weight": 0.873796902401687}], ["ITGA1", ["TCGA.CK.5916.01", "Degradation of the extracellular matrix"], {"weight": 0.807653703200618}], ["ITGA1", ["TCGA.CM.4743.01", "Muscle contraction"], {"weight": 0.946796950663507}], ["ITGA2", ["TCGA.A6.5665.01", "L1CAM interactions"], {"weight": 0.915897941739953}], ["ITGA2", ["TCGA.A6.6780.01", "L1CAM interactions"], {"weight": 0.920888183258429}], ["ITGA2", ["TCGA.CM.6674.01", "L1CAM interactions"], {"weight": 0.881065307535884}], ["CHST3", ["TCGA.G4.6321.01", "Defective B4GALT7 causes EDS, progeroid type"], {"weight": 0.843315851152095}], ["CHST3", ["TCGA.G4.6321.01", "Defective B3GAT3 causes JDSSDHD"], {"weight": 0.843315851152095}], ["CHST3", ["TCGA.G4.6321.01", "Defective B3GALT6 causes EDSP2 and SEMDJL1"], {"weight": 0.843315851152095}], ["CHST3", ["TCGA.G4.6321.01", "Chondroitin sulfate/dermatan sulfate metabolism"], {"weight": 0.754499957291314}], ["CHST3", ["TCGA.G4.6321.01", "A tetrasaccharide linker sequence is required for GAG synthesis"], {"weight": 0.843315851152095}], ["DLGAP3", ["TCGA.A6.5665.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.930916405390288}], ["DLGAP3", ["TCGA.A6.5665.01", "Long-term potentiation"], {"weight": 0.929689716978174}], ["DLGAP3", ["TCGA.A6.5665.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.924141908256688}], ["DLGAP3", ["TCGA.AA.3663.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.937989999162436}], ["SNAP91", ["TCGA.DM.A285.01", "Other interleukin signaling"], {"weight": 0.6892347772541}], ["OBSCN", ["TCGA.CA.6716.01", "GPCR downstream signalling"], {"weight": 0.948578087365718}], ["OBSCN", ["TCGA.DM.A28C.01", "SLC-mediated transmembrane transport"], {"weight": 0.895456103392597}], ["OBSCN", ["TCGA.G4.6626.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.739549691474747}], ["UNC5C", ["TCGA.CK.4948.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.906665421171964}], ["EPB41L5", ["TCGA.G4.6317.01", "Extracellular matrix organization"], {"weight": 0.91813369624695}], ["EPB41L5", ["TCGA.G4.6317.01", "Protein-protein interactions at synapses"], {"weight": 0.914866983839926}], ["HAGH", ["TCGA.AZ.4682.01", "Biological oxidations"], {"weight": 0.884472075522578}], ["OR2K2", ["TCGA.A6.5665.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.908194350968731}], ["AHRR", ["TCGA.CM.5864.01", "Heme degradation"], {"weight": 0.73308174288044}], ["ADCY10", ["TCGA.AY.6386.01", "Platelet homeostasis"], {"weight": 0.840648540668385}], ["ADCY10", ["TCGA.AY.6386.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.798331392335488}], ["PLA2G2E", ["TCGA.A6.5665.01", "Biological oxidations"], {"weight": 0.939392134013246}], ["PLA2G2E", ["TCGA.A6.5665.01", "Drug ADME"], {"weight": 0.867834527011125}], ["PLA2G2E", ["TCGA.A6.5665.01", "Phase II - Conjugation of compounds"], {"weight": 0.850545692839786}], ["PLA2G2E", ["TCGA.AD.6889.01", "Biological oxidations"], {"weight": 0.932403606823866}], ["PLA2G2E", ["TCGA.AD.6889.01", "Drug ADME"], {"weight": 0.832708469297618}], ["SERPINB1", ["TCGA.CK.5913.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.918749479690187}], ["SERPINB1", ["TCGA.CK.5913.01", "Degradation of the extracellular matrix"], {"weight": 0.847097945665511}], ["SERPINB1", ["TCGA.F4.6704.01", "Extracellular matrix organization"], {"weight": 0.876369652748894}], ["SERPINB1", ["TCGA.F4.6704.01", "Peptide hormone metabolism"], {"weight": 0.721555666514037}], ["SERPINB1", ["TCGA.F4.6704.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.814348440775863}], ["SERPINB1", ["TCGA.F4.6704.01", "Visual phototransduction"], {"weight": 0.775522470389337}], ["SERPINB1", ["TCGA.F4.6704.01", "Degradation of the extracellular matrix"], {"weight": 0.76207379315052}], ["SERPINB1", ["TCGA.G4.6304.01", "Peptide hormone metabolism"], {"weight": 0.896647432097568}], ["SERPINB1", ["TCGA.G4.6304.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.948972569968615}], ["SERPINB1", ["TCGA.G4.6304.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.793333158213753}], ["USP9X", ["TCGA.AZ.4682.01", "GABA receptor activation"], {"weight": 0.877198984050699}], ["USP9X", ["TCGA.CK.5912.01", "Biological oxidations"], {"weight": 0.921373277485495}], ["USP9X", ["TCGA.CK.5912.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.799611103688708}], ["USP9X", ["TCGA.CM.6680.01", "Phase II - Conjugation of compounds"], {"weight": 0.666369177877569}], ["RGS2", ["TCGA.AD.6964.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.852369202990401}], ["RGS2", ["TCGA.AD.6964.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.838673509244078}], ["NCOA1", ["TCGA.AM.5820.01", "Signaling Pathways"], {"weight": 0.890926867272425}], ["NCOA1", ["TCGA.AM.5820.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.950237497607334}], ["NCOA1", ["TCGA.CK.5916.01", "Drug ADME"], {"weight": 0.927216022517048}], ["PDE1B", ["TCGA.AM.5820.01", "Activation of G protein gated Potassium channels"], {"weight": 0.914087442126165}], ["PDE1B", ["TCGA.AM.5820.01", "G protein gated Potassium channels"], {"weight": 0.914087442126165}], ["PDE1B", ["TCGA.AM.5820.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.914087442126165}], ["PDE1B", ["TCGA.AM.5820.01", "Inwardly rectifying K+ channels"], {"weight": 0.921203624309732}], ["PDE1B", ["TCGA.AM.5820.01", "Potassium Channels"], {"weight": 0.945219812302328}], ["PDE1B", ["TCGA.D5.6926.01", "Glucagon-type ligand receptors"], {"weight": 0.901370721299607}], ["PDE1B", ["TCGA.D5.6926.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.876487767949748}], ["PDE1B", ["TCGA.D5.6926.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.920059716922241}], ["PDE1B", ["TCGA.D5.6926.01", "Inwardly rectifying K+ channels"], {"weight": 0.841449243637426}], ["PDE1B", ["TCGA.D5.6926.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.881697590101119}], ["PDE1B", ["TCGA.D5.6926.01", "Activation of G protein gated Potassium channels"], {"weight": 0.886274180813202}], ["PDE1B", ["TCGA.D5.6926.01", "G protein gated Potassium channels"], {"weight": 0.886274180813202}], ["PDE1B", ["TCGA.D5.6926.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.883550623866146}], ["PDE1B", ["TCGA.D5.6926.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.886274180813202}], ["PDE1B", ["TCGA.D5.6926.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.875855314355271}], ["PDE1B", ["TCGA.D5.6926.01", "GABA receptor activation"], {"weight": 0.556636718347101}], ["DOCK7", ["TCGA.AD.6963.01", "Chemokine receptors bind chemokines"], {"weight": 0.902634628379522}], ["PLCL1", ["TCGA.D5.6538.01", "GABA receptor activation"], {"weight": 0.915594869074082}], ["ITGB2", ["TCGA.DM.A285.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.870511184757895}], ["ITGB2", ["TCGA.DM.A285.01", "Extracellular matrix organization"], {"weight": 0.837588164073792}], ["ITGB2", ["TCGA.DM.A285.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.916541767169059}], ["ITGB2", ["TCGA.DM.A285.01", "Interleukin receptor SHC signaling"], {"weight": 0.894533360135176}], ["ITGB2", ["TCGA.DM.A285.01", "Innate Immune System"], {"weight": 0.878796569251232}], ["ABCB1", ["TCGA.D5.6927.01", "Drug ADME"], {"weight": 0.8623052348417}], ["ABCB1", ["TCGA.G4.6299.01", "Visual phototransduction"], {"weight": 0.828903159773779}], ["ABCB1", ["TCGA.G4.6314.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.929484885888357}], ["ABCB1", ["TCGA.G4.6314.01", "Drug ADME"], {"weight": 0.871091863982997}], ["ABCB1", ["TCGA.G4.6314.01", "Collagen chain trimerization"], {"weight": 0.900224519387377}], ["ABCB1", ["TCGA.G4.6314.01", "Degradation of the extracellular matrix"], {"weight": 0.830500970890962}], ["HERC1", ["TCGA.CA.5797.01", "GPCR ligand binding"], {"weight": 0.9132132051231}], ["HERC1", ["TCGA.CA.5797.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.912371320344054}], ["HERC1", ["TCGA.CA.5797.01", "Peptide ligand-binding receptors"], {"weight": 0.906489780983215}], ["LRP2", ["TCGA.A6.5665.01", "Metabolism of vitamins and cofactors"], {"weight": 0.812096139087378}], ["LRP2", ["TCGA.A6.5666.01", "Neuronal System"], {"weight": 0.941943515482174}], ["LRP2", ["TCGA.A6.5666.01", "Signaling by GPCR"], {"weight": 0.958266872555366}], ["LRP2", ["TCGA.A6.5666.01", "GPCR downstream signalling"], {"weight": 0.959024519543195}], ["LRP2", ["TCGA.A6.5666.01", "GPCR ligand binding"], {"weight": 0.954606902246403}], ["LRP2", ["TCGA.A6.5666.01", "G alpha (s) signalling events"], {"weight": 0.964125355127214}], ["LRP2", ["TCGA.A6.5666.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.952038990288342}], ["LRP2", ["TCGA.A6.5666.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.929285314186907}], ["LRP2", ["TCGA.A6.5666.01", "Peptide ligand-binding receptors"], {"weight": 0.950933735985708}], ["LRP2", ["TCGA.A6.5666.01", "Generation of second messenger molecules"], {"weight": 0.91227830038932}], ["LRP2", ["TCGA.A6.5666.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.926956091276053}], ["LRP2", ["TCGA.A6.5666.01", "Blood group systems biosynthesis"], {"weight": 0.814825020336586}], ["LRP2", ["TCGA.A6.5666.01", "PD-1 signaling"], {"weight": 0.929155009499493}], ["LRP2", ["TCGA.A6.5666.01", "Lewis blood group biosynthesis"], {"weight": 0.801692797959435}], ["LRP2", ["TCGA.A6.5666.01", "Neurexins and neuroligins"], {"weight": 0.938529113214705}], ["LRP2", ["TCGA.A6.5666.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.908414027219033}], ["LRP2", ["TCGA.A6.5666.01", "Aquaporin-mediated transport"], {"weight": 0.908414027219033}], ["LRP2", ["TCGA.A6.6780.01", "GPCR ligand binding"], {"weight": 0.947900733499985}], ["LRP2", ["TCGA.AM.5821.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.951923549315006}], ["LRP2", ["TCGA.CM.4747.01", "Signaling by GPCR"], {"weight": 0.943838861947321}], ["LRP2", ["TCGA.CM.4747.01", "GPCR ligand binding"], {"weight": 0.936383253759456}], ["LRP2", ["TCGA.CM.5341.01", "Viral Infection Pathways"], {"weight": 0.891670536426166}], ["LRP2", ["TCGA.CM.5341.01", "Infectious disease"], {"weight": 0.908542054507951}], ["LRP2", ["TCGA.D5.6529.01", "O-linked glycosylation"], {"weight": 0.863084246325947}], ["LRP2", ["TCGA.D5.6529.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.788596164333432}], ["LRP2", ["TCGA.DM.A1HA.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.861231768028133}], ["LRP2", ["TCGA.DM.A1HA.01", "Termination of O-glycan biosynthesis"], {"weight": 0.954055331726997}], ["LRP2", ["TCGA.DM.A1HA.01", "Defective GALNT3 causes HFTC"], {"weight": 0.938833098987758}], ["LRP2", ["TCGA.DM.A1HA.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.938833098987758}], ["LRP2", ["TCGA.DM.A28G.01", "Peptide ligand-binding receptors"], {"weight": 0.935993123701448}], ["LRP2", ["TCGA.DM.A28G.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.93576548980286}], ["LRP2", ["TCGA.DM.A28H.01", "Signaling Pathways"], {"weight": 0.924039810031494}], ["LRP2", ["TCGA.DM.A28H.01", "Binding and entry of HIV virion"], {"weight": 0.792912736932736}], ["LRP2", ["TCGA.DM.A28H.01", "Activation of the pre-replicative complex"], {"weight": 0.888770312147345}], ["LRP2", ["TCGA.G4.6304.01", "G alpha (s) signalling events"], {"weight": 0.959279313867273}], ["CHRNA4", ["TCGA.AD.6964.01", "Transmission across Chemical Synapses"], {"weight": 0.908655560654239}], ["CHRNA1", ["TCGA.DM.A285.01", "Phase 4 - resting membrane potential"], {"weight": 0.754495361381633}], ["TEX15", ["TCGA.CK.4952.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], {"weight": 0.880471687970793}], ["TEX15", ["TCGA.CK.4952.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], {"weight": 0.880471687970793}], ["TEX15", ["TCGA.CK.4952.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], {"weight": 0.880471687970793}], ["TEX15", ["TCGA.CK.4952.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], {"weight": 0.880471687970793}], ["TEX15", ["TCGA.CK.4952.01", "Impaired BRCA2 binding to PALB2"], {"weight": 0.880471687970793}], ["TEX15", ["TCGA.CK.4952.01", "Homologous DNA Pairing and Strand Exchange"], {"weight": 0.894429060873117}], ["SLCO1A2", ["TCGA.CM.5868.01", "Drug ADME"], {"weight": 0.801983260274557}], ["SLCO1A2", ["TCGA.F4.6856.01", "Drug ADME"], {"weight": 0.880375950469201}], ["EGR1", ["TCGA.CM.4743.01", "Signaling Pathways"], {"weight": 0.921282914412859}], ["COL6A3", ["TCGA.AY.6386.01", "L1CAM interactions"], {"weight": 0.931428553335558}], ["COL6A3", ["TCGA.AZ.6603.01", "NCAM1 interactions"], {"weight": 0.683028116816256}], ["COL6A3", ["TCGA.D5.6920.01", "Glycosaminoglycan metabolism"], {"weight": 0.716234355370713}], ["COL6A3", ["TCGA.D5.6929.01", "Diseases of glycosylation"], {"weight": 0.822760865027368}], ["COL6A3", ["TCGA.DM.A28F.01", "NCAM1 interactions"], {"weight": 0.930012572292639}], ["COL6A3", ["TCGA.DM.A28F.01", "NCAM signaling for neurite out-growth"], {"weight": 0.935766088577007}], ["COL6A3", ["TCGA.G4.6298.01", "NCAM1 interactions"], {"weight": 0.939592921913106}], ["COL6A3", ["TCGA.G4.6298.01", "Collagen chain trimerization"], {"weight": 0.934840929172608}], ["COL6A3", ["TCGA.G4.6298.01", "NCAM signaling for neurite out-growth"], {"weight": 0.94559799710209}], ["NFATC1", ["TCGA.A6.6651.01", "Glucuronidation"], {"weight": 0.5742072901463}], ["NFATC1", ["TCGA.AD.6965.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.871922934740203}], ["NFATC1", ["TCGA.AD.6965.01", "Phase II - Conjugation of compounds"], {"weight": 0.74756524594205}], ["NFATC1", ["TCGA.AD.6965.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.726482780224327}], ["NFATC1", ["TCGA.AD.6965.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.907435318877594}], ["NFATC1", ["TCGA.AD.6965.01", "Other interleukin signaling"], {"weight": 0.537627698835082}], ["NFATC1", ["TCGA.CM.4743.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.938058833212316}], ["NFATC1", ["TCGA.CM.4743.01", "Peptide ligand-binding receptors"], {"weight": 0.937204338665957}], ["DCAF5", ["TCGA.CM.6675.01", "Voltage gated Potassium channels"], {"weight": 0.914162758668784}], ["ERCC6", ["TCGA.DM.A28H.01", "DNA strand elongation"], {"weight": 0.896014781316698}], ["ERCC6", ["TCGA.DM.A28H.01", "Lagging Strand Synthesis"], {"weight": 0.869321834960286}], ["ERCC6", ["TCGA.DM.A28H.01", "G1/S-Specific Transcription"], {"weight": 0.89564168087367}], ["ERCC6", ["TCGA.DM.A28H.01", "Polymerase switching"], {"weight": 0.840316173528888}], ["ERCC6", ["TCGA.DM.A28H.01", "Leading Strand Synthesis"], {"weight": 0.840316173528888}], ["ERCC6", ["TCGA.DM.A28H.01", "Removal of the Flap Intermediate"], {"weight": 0.850293736942721}], ["ERCC6", ["TCGA.DM.A28H.01", "Processive synthesis on the lagging strand"], {"weight": 0.850293736942721}], ["NPHS1", ["TCGA.CM.5868.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.712395835667659}], ["NPHS1", ["TCGA.CM.6678.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.93822979699301}], ["NPHS1", ["TCGA.CM.6678.01", "Generation of second messenger molecules"], {"weight": 0.937338849611363}], ["NPHS1", ["TCGA.CM.6678.01", "PD-1 signaling"], {"weight": 0.935024891720142}], ["NPHS1", ["TCGA.CM.6678.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.936054232908804}], ["NPHS1", ["TCGA.CM.6678.01", "Costimulation by the CD28 family"], {"weight": 0.885678064802123}], ["NPHS1", ["TCGA.CM.6678.01", "TCR signaling"], {"weight": 0.942606001484738}], ["CAMK2G", ["TCGA.AD.6889.01", "Stimuli-sensing channels"], {"weight": 0.908719662044813}], ["CAMK2G", ["TCGA.AZ.4682.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.87579966833455}], ["CAMK2G", ["TCGA.AZ.4682.01", "Leishmania parasite growth and survival"], {"weight": 0.87579966833455}], ["CAMK2G", ["TCGA.AZ.4682.01", "Leishmania infection"], {"weight": 0.860020659307156}], ["CAMK2G", ["TCGA.AZ.4682.01", "Parasitic Infection Pathways"], {"weight": 0.860020659307156}], ["CAMK2G", ["TCGA.AZ.4682.01", "Interaction between L1 and Ankyrins"], {"weight": 0.93324258694862}], ["CAMK2G", ["TCGA.CK.5913.01", "Cardiac conduction"], {"weight": 0.904381494061144}], ["CAMK2G", ["TCGA.CK.5913.01", "Phase 0 - rapid depolarisation"], {"weight": 0.93442698275024}], ["CAMK2G", ["TCGA.CK.5913.01", "Synaptic adhesion-like molecules"], {"weight": 0.82163304334724}], ["JAK1", ["TCGA.A6.5665.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.667229553667586}], ["JAK1", ["TCGA.CM.4743.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.715355621672462}], ["TLL1", ["TCGA.A6.5665.01", "Collagen chain trimerization"], {"weight": 0.899682832237207}], ["EPRS", ["TCGA.DM.A0XF.01", "TNFs bind their physiological receptors"], {"weight": 0.405591398590964}], ["CXCR3", ["TCGA.D5.6929.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.792812624071396}], ["CXCR3", ["TCGA.D5.6929.01", "Degradation of the extracellular matrix"], {"weight": 0.745748371638594}], ["CXCR3", ["TCGA.D5.6929.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.912569345693533}], ["FLNA", ["TCGA.D5.7000.01", "Phase 0 - rapid depolarisation"], {"weight": 0.887652201788434}], ["CTNNA2", ["TCGA.D5.6922.01", "Collagen formation"], {"weight": 0.85221432919206}], ["CTNNA2", ["TCGA.DM.A282.01", "NCAM signaling for neurite out-growth"], {"weight": 0.856697313662996}], ["SMAD1", ["TCGA.CM.5864.01", "Peptide hormone metabolism"], {"weight": 0.726345669707973}], ["PKD2", ["TCGA.CA.5796.01", "GPCR ligand binding"], {"weight": 0.917230391311305}], ["PKD2", ["TCGA.CA.5796.01", "Interaction between L1 and Ankyrins"], {"weight": 0.872784146852467}], ["PKD2", ["TCGA.DM.A28M.01", "Activation of the phototransduction cascade"], {"weight": 0.912161460113013}], ["LLGL1", ["TCGA.A6.5665.01", "Neurexins and neuroligins"], {"weight": 0.949840656861693}], ["SPTBN5", ["TCGA.AA.3697.01", "GABA receptor activation"], {"weight": 0.843682326085791}], ["SPTBN5", ["TCGA.CK.4950.01", "Phase 0 - rapid depolarisation"], {"weight": 0.667829960415444}], ["SPTBN5", ["TCGA.CM.5863.01", "GPCR ligand binding"], {"weight": 0.901178388520766}], ["SPTBN5", ["TCGA.G4.6294.01", "Phase 0 - rapid depolarisation"], {"weight": 0.899852759916387}], ["APOB", ["TCGA.A6.6650.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.727357839700806}], ["APOB", ["TCGA.A6.6650.01", "Classical antibody-mediated complement activation"], {"weight": 0.696614533550667}], ["APOB", ["TCGA.A6.6650.01", "Immune System"], {"weight": 0.85669632782715}], ["APOB", ["TCGA.A6.6650.01", "Adaptive Immune System"], {"weight": 0.86440062169305}], ["APOB", ["TCGA.A6.6650.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.71466911182759}], ["APOB", ["TCGA.A6.6650.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.699773550026767}], ["APOB", ["TCGA.A6.6650.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.699773550026767}], ["APOB", ["TCGA.A6.6650.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.878167295006401}], ["APOB", ["TCGA.AA.3489.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.661792603035221}], ["APOB", ["TCGA.AA.3489.01", "Glycosaminoglycan metabolism"], {"weight": 0.757282407448187}], ["APOB", ["TCGA.AA.3713.01", "Glycosaminoglycan metabolism"], {"weight": 0.830525530795994}], ["APOB", ["TCGA.AD.6964.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.766457250561903}], ["APOB", ["TCGA.AD.6964.01", "Visual phototransduction"], {"weight": 0.804806610276697}], ["APOB", ["TCGA.AZ.6598.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.757661393324132}], ["APOB", ["TCGA.AZ.6607.01", "Metabolism"], {"weight": 0.922653536562521}], ["APOB", ["TCGA.AZ.6607.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.857509851726489}], ["APOB", ["TCGA.AZ.6607.01", "Retinoid metabolism and transport"], {"weight": 0.857509851726489}], ["APOB", ["TCGA.AZ.6607.01", "Metabolism of vitamins and cofactors"], {"weight": 0.700337458072262}], ["APOB", ["TCGA.CA.6716.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.860306201742812}], ["APOB", ["TCGA.CA.6716.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.743018514707161}], ["APOB", ["TCGA.CA.6716.01", "Cytokine Signaling in Immune system"], {"weight": 0.846401195291006}], ["APOB", ["TCGA.CA.6716.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.750325920321491}], ["APOB", ["TCGA.CA.6716.01", "Classical antibody-mediated complement activation"], {"weight": 0.692068598929241}], ["APOB", ["TCGA.CA.6716.01", "Creation of C4 and C2 activators"], {"weight": 0.645959744649947}], ["APOB", ["TCGA.CA.6716.01", "Cell surface interactions at the vascular wall"], {"weight": 0.622081394794016}], ["APOB", ["TCGA.CA.6716.01", "Scavenging by Class A Receptors"], {"weight": 0.533360290549124}], ["APOB", ["TCGA.CA.6716.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.866359444206928}], ["APOB", ["TCGA.CA.6716.01", "FCGR activation"], {"weight": 0.857502851073271}], ["APOB", ["TCGA.CM.4743.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.792656380680131}], ["APOB", ["TCGA.CM.5861.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.688469481345294}], ["APOB", ["TCGA.D5.6931.01", "Drug ADME"], {"weight": 0.827660823567732}], ["APOB", ["TCGA.D5.6931.01", "RA biosynthesis pathway"], {"weight": 0.719215451073886}], ["APOB", ["TCGA.F4.6460.01", "Visual phototransduction"], {"weight": 0.802245246625461}], ["APOB", ["TCGA.F4.6460.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.890994777290092}], ["APOB", ["TCGA.F4.6460.01", "Retinoid metabolism and transport"], {"weight": 0.890994777290092}], ["APOB", ["TCGA.F4.6855.01", "Neuronal System"], {"weight": 0.858807726630476}], ["APOB", ["TCGA.F4.6855.01", "Transmission across Chemical Synapses"], {"weight": 0.86256566673025}], ["TRIP6", ["TCGA.AD.5900.01", "Drug ADME"], {"weight": 0.921862351738048}], ["TRIP6", ["TCGA.AD.6895.01", "Drug ADME"], {"weight": 0.889293499593527}], ["TRIP6", ["TCGA.AD.6895.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.903453134399195}], ["TRIP6", ["TCGA.AD.6895.01", "APAP ADME"], {"weight": 0.799476646174635}], ["TRIP6", ["TCGA.CA.6718.01", "Drug ADME"], {"weight": 0.937614085703381}], ["TRIP6", ["TCGA.G4.6628.01", "Drug ADME"], {"weight": 0.916537293871672}], ["TRIP6", ["TCGA.G4.6628.01", "APAP ADME"], {"weight": 0.818613148006926}], ["TRIP6", ["TCGA.G4.6628.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.751618625420407}], ["EVC2", ["TCGA.AA.3502.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.754854368135266}], ["EVC2", ["TCGA.DM.A28C.01", "Binding and entry of HIV virion"], {"weight": 0.708444640873267}], ["EVC2", ["TCGA.DM.A28C.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.811926307598791}], ["IL13RA1", ["TCGA.DM.A1D8.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.906276175643309}], ["OR2T10", ["TCGA.A6.5665.01", "Glucagon-type ligand receptors"], {"weight": 0.927768879093478}], ["OR2T10", ["TCGA.G4.6309.01", "Glucagon-type ligand receptors"], {"weight": 0.925910774425838}], ["OR2T10", ["TCGA.G4.6309.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.941165407316933}], ["OR2T10", ["TCGA.G4.6309.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.910480746788197}], ["OR2T10", ["TCGA.G4.6309.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.859390000560481}], ["OR2T10", ["TCGA.G4.6309.01", "Leishmania parasite growth and survival"], {"weight": 0.859390000560481}], ["KRT14", ["TCGA.AZ.4682.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.706322220351932}], ["KRT14", ["TCGA.AZ.4682.01", "Ca2+ pathway"], {"weight": 0.882881602509783}], ["KRT14", ["TCGA.AZ.4682.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.8057280948266}], ["KRT14", ["TCGA.AZ.4682.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.8057280948266}], ["ARFGEF1", ["TCGA.CK.5912.01", "Phase 0 - rapid depolarisation"], {"weight": 0.895110907364506}], ["ARFGEF1", ["TCGA.CK.5912.01", "Cardiac conduction"], {"weight": 0.915122663982176}], ["ARFGEF1", ["TCGA.CK.5912.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.867574361034689}], ["ARFGEF1", ["TCGA.CK.5912.01", "Interaction between L1 and Ankyrins"], {"weight": 0.890610408526657}], ["ARFGEF1", ["TCGA.CK.5912.01", "Arachidonic acid metabolism"], {"weight": 0.910826063601663}], ["ARFGEF1", ["TCGA.CK.5912.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.731118081888469}], ["ARFGEF1", ["TCGA.CK.5912.01", "Platelet calcium homeostasis"], {"weight": 0.880051421523796}], ["ARFGEF1", ["TCGA.CK.5912.01", "Phase 2 - plateau phase"], {"weight": 0.690639562823608}], ["ARFGEF1", ["TCGA.CK.5912.01", "Phase 4 - resting membrane potential"], {"weight": 0.819334543819008}], ["ARFGEF1", ["TCGA.CK.5912.01", "Fatty acid metabolism"], {"weight": 0.878003553866222}], ["ARFGEF1", ["TCGA.D5.6531.01", "Extracellular matrix organization"], {"weight": 0.824898912572115}], ["ARFGEF1", ["TCGA.D5.6531.01", "Insulin processing"], {"weight": 0.719209924484592}], ["KIF4B", ["TCGA.AD.6965.01", "PD-1 signaling"], {"weight": 0.884129270807972}], ["KIF4B", ["TCGA.AD.6965.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.875302980399615}], ["KIF4B", ["TCGA.AD.6965.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.875302980399615}], ["KIF4B", ["TCGA.AZ.4615.01", "L1CAM interactions"], {"weight": 0.93405245906973}], ["KIF4B", ["TCGA.D5.6929.01", "Interaction between L1 and Ankyrins"], {"weight": 0.91402065762624}], ["KIF4B", ["TCGA.DM.A1D7.01", "Interaction between L1 and Ankyrins"], {"weight": 0.933870759664504}], ["AGRN", ["TCGA.A6.5665.01", "ECM proteoglycans"], {"weight": 0.90189677160494}], ["AGRN", ["TCGA.A6.6780.01", "ECM proteoglycans"], {"weight": 0.898868520226495}], ["AGRN", ["TCGA.AA.3492.01", "Extracellular matrix organization"], {"weight": 0.826064979041514}], ["AGRN", ["TCGA.AU.6004.01", "NCAM1 interactions"], {"weight": 0.904542445146332}], ["AGRN", ["TCGA.AU.6004.01", "NCAM signaling for neurite out-growth"], {"weight": 0.921401832358695}], ["AGRN", ["TCGA.AU.6004.01", "ECM proteoglycans"], {"weight": 0.892689158285064}], ["AGRN", ["TCGA.AZ.6600.01", "Integrin cell surface interactions"], {"weight": 0.863321889108558}], ["AGRN", ["TCGA.D5.6540.01", "L1CAM interactions"], {"weight": 0.925598625108814}], ["AGRN", ["TCGA.F4.6570.01", "ECM proteoglycans"], {"weight": 0.92046246809877}], ["AGRN", ["TCGA.F4.6570.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.834889869745858}], ["AGRN", ["TCGA.F4.6856.01", "Extracellular matrix organization"], {"weight": 0.853442926686442}], ["AGRN", ["TCGA.F4.6856.01", "L1CAM interactions"], {"weight": 0.905118639826155}], ["AGRN", ["TCGA.G4.6586.01", "ECM proteoglycans"], {"weight": 0.922815066481817}], ["FZD6", ["TCGA.AM.5820.01", "Signaling by GPCR"], {"weight": 0.936625083043569}], ["FZD6", ["TCGA.AM.5820.01", "GPCR ligand binding"], {"weight": 0.925767264734581}], ["FZD6", ["TCGA.AY.6197.01", "GPCR ligand binding"], {"weight": 0.943625442231204}], ["FZD6", ["TCGA.AY.6197.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.908137739456115}], ["FZD6", ["TCGA.AY.6197.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.912766423465713}], ["FZD6", ["TCGA.CA.6718.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.916464540132818}], ["FZD6", ["TCGA.CM.6170.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.810233482211303}], ["FZD6", ["TCGA.CM.6170.01", "G alpha (s) signalling events"], {"weight": 0.937741568956064}], ["FZD6", ["TCGA.CM.6170.01", "Signal amplification"], {"weight": 0.832399740728378}], ["FZD6", ["TCGA.CM.6170.01", "Signaling by GPCR"], {"weight": 0.911254700576203}], ["FZD6", ["TCGA.CM.6170.01", "Extra-nuclear estrogen signaling"], {"weight": 0.861178583064764}], ["FZD6", ["TCGA.CM.6170.01", "GPCR ligand binding"], {"weight": 0.919135015838156}], ["FZD6", ["TCGA.CM.6170.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.879592737071155}], ["FZD6", ["TCGA.CM.6170.01", "Presynaptic function of Kainate receptors"], {"weight": 0.871147963848654}], ["FZD6", ["TCGA.CM.6170.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.874895444258726}], ["FZD6", ["TCGA.CM.6170.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.884550191439521}], ["FZD6", ["TCGA.CM.6170.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.878144646194118}], ["FZD6", ["TCGA.CM.6170.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.872594395408693}], ["FZD6", ["TCGA.CM.6170.01", "Glucagon-type ligand receptors"], {"weight": 0.883288502627081}], ["FZD6", ["TCGA.CM.6170.01", "G alpha (i) signalling events"], {"weight": 0.884402557101677}], ["FZD6", ["TCGA.CM.6170.01", "G beta:gamma signalling through BTK"], {"weight": 0.837674923180474}], ["FZD6", ["TCGA.CM.6170.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.837674923180474}], ["FZD6", ["TCGA.CM.6170.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.837674923180474}], ["FZD6", ["TCGA.CM.6170.01", "G beta:gamma signalling through CDC42"], {"weight": 0.837674923180474}], ["FZD6", ["TCGA.CM.6170.01", "Signaling Pathways"], {"weight": 0.851057963070455}], ["LRRFIP1", ["TCGA.D5.6538.01", "Classical antibody-mediated complement activation"], {"weight": 0.715914885921911}], ["LRRFIP1", ["TCGA.D5.6538.01", "Creation of C4 and C2 activators"], {"weight": 0.70339886707425}], ["HLA-B", ["TCGA.AZ.4615.01", "Extracellular matrix organization"], {"weight": 0.855786920666198}], ["HLA-A", ["TCGA.AD.6889.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.705358133307492}], ["SLITRK1", ["TCGA.A6.5665.01", "Synaptic adhesion-like molecules"], {"weight": 0.837320933167049}], ["SLITRK1", ["TCGA.AZ.6598.01", "Synaptic adhesion-like molecules"], {"weight": 0.848921182715117}], ["CEP170", ["TCGA.AD.6963.01", "Ca-dependent events"], {"weight": 0.834532199577551}], ["CEP170", ["TCGA.AD.6963.01", "G-protein mediated events"], {"weight": 0.853965000617576}], ["CEP170", ["TCGA.AD.6963.01", "Calmodulin induced events"], {"weight": 0.861727024705934}], ["CEP170", ["TCGA.AD.6963.01", "CaM pathway"], {"weight": 0.861727024705934}], ["TICAM1", ["TCGA.CM.5860.01", "TNFs bind their physiological receptors"], {"weight": 0.571089460452318}], ["DSEL", ["TCGA.D5.6534.01", "ECM proteoglycans"], {"weight": 0.924224411671627}], ["DSEL", ["TCGA.D5.6534.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.853140727893743}], ["DSEL", ["TCGA.F4.6808.01", "Extracellular matrix organization"], {"weight": 0.872366309793726}], ["KCNH1", ["TCGA.AA.3713.01", "Potassium Channels"], {"weight": 0.936872383674503}], ["KCNH1", ["TCGA.DM.A0XD.01", "Potassium Channels"], {"weight": 0.959374861335038}], ["KCNH1", ["TCGA.DM.A0XD.01", "Voltage gated Potassium channels"], {"weight": 0.915857748195373}], ["KCNH3", ["TCGA.AA.3492.01", "Potassium Channels"], {"weight": 0.960845333350614}], ["ACAN", ["TCGA.A6.6649.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.895969019390039}], ["ACAN", ["TCGA.A6.6649.01", "Collagen formation"], {"weight": 0.906301268941257}], ["ACAN", ["TCGA.A6.6649.01", "Degradation of the extracellular matrix"], {"weight": 0.795853948272452}], ["ACAN", ["TCGA.AA.3492.01", "O-linked glycosylation"], {"weight": 0.926487560765988}], ["ACAN", ["TCGA.AD.6965.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.741159669099435}], ["ACAN", ["TCGA.AD.6965.01", "Degradation of the extracellular matrix"], {"weight": 0.671135097967277}], ["ACAN", ["TCGA.AD.6965.01", "Collagen formation"], {"weight": 0.911504980932378}], ["ACAN", ["TCGA.AM.5821.01", "O-linked glycosylation"], {"weight": 0.94641230485658}], ["ACAN", ["TCGA.AZ.4616.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.949689866538877}], ["ACAN", ["TCGA.AZ.4616.01", "Blood group systems biosynthesis"], {"weight": 0.677910264143448}], ["ACAN", ["TCGA.AZ.4616.01", "Lewis blood group biosynthesis"], {"weight": 0.630024633739096}], ["ACAN", ["TCGA.D5.6534.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.935565992458781}], ["ACAN", ["TCGA.D5.6534.01", "Collagen degradation"], {"weight": 0.913536402800488}], ["ACAN", ["TCGA.D5.6534.01", "Diseases of glycosylation"], {"weight": 0.840101401352449}], ["ACAN", ["TCGA.D5.6534.01", "Diseases of metabolism"], {"weight": 0.814381449511796}], ["ACAN", ["TCGA.D5.6534.01", "O-linked glycosylation"], {"weight": 0.814434130734177}], ["ACAN", ["TCGA.D5.6534.01", "Glycosaminoglycan metabolism"], {"weight": 0.753000181656012}], ["ACAN", ["TCGA.D5.6537.01", "Blood group systems biosynthesis"], {"weight": 0.920715297821911}], ["ACAN", ["TCGA.D5.6537.01", "Lewis blood group biosynthesis"], {"weight": 0.918308287340348}], ["ACAN", ["TCGA.D5.6537.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.93200659841518}], ["ACAN", ["TCGA.D5.6541.01", "Defective B3GALTL causes PpS"], {"weight": 0.899593262031032}], ["ACAN", ["TCGA.D5.6541.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.899593262031032}], ["ACAN", ["TCGA.D5.6541.01", "O-linked glycosylation"], {"weight": 0.92979561524624}], ["ACAN", ["TCGA.D5.6541.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.874372434818607}], ["ACAN", ["TCGA.D5.6541.01", "Diseases of glycosylation"], {"weight": 0.893249323715683}], ["ACAN", ["TCGA.D5.6541.01", "Diseases of metabolism"], {"weight": 0.834270354345351}], ["ACAN", ["TCGA.G4.6302.01", "O-linked glycosylation"], {"weight": 0.885892451371741}], ["ACAN", ["TCGA.G4.6302.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.833395126353171}], ["ACAN", ["TCGA.G4.6302.01", "Diseases of glycosylation"], {"weight": 0.800655210193416}], ["ACAN", ["TCGA.G4.6322.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.931998713814319}], ["ACAN", ["TCGA.G4.6322.01", "Degradation of the extracellular matrix"], {"weight": 0.883570611037395}], ["ACAN", ["TCGA.G4.6322.01", "Extracellular matrix organization"], {"weight": 0.888559735385905}], ["ACAN", ["TCGA.G4.6322.01", "Chondroitin sulfate/dermatan sulfate metabolism"], {"weight": 0.782080624279767}], ["ACAN", ["TCGA.G4.6322.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.849018172464612}], ["ACAN", ["TCGA.G4.6322.01", "Diseases associated with glycosaminoglycan metabolism"], {"weight": 0.877463387145727}], ["KCNK10", ["TCGA.A6.5665.01", "Potassium Channels"], {"weight": 0.961084688730147}], ["TRAPPC6A", ["TCGA.A6.6780.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.915919548001567}], ["SUCLA2", ["TCGA.CK.5916.01", "Ethanol oxidation"], {"weight": 0.90996980500607}], ["OR1L3", ["TCGA.A6.6648.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.886725958685824}], ["OR1L3", ["TCGA.A6.6648.01", "Neurexins and neuroligins"], {"weight": 0.866668794209247}], ["OR1L3", ["TCGA.A6.6648.01", "GABA receptor activation"], {"weight": 0.838469932212398}], ["OR1L3", ["TCGA.A6.6648.01", "Inwardly rectifying K+ channels"], {"weight": 0.906779502179125}], ["OR1L3", ["TCGA.A6.6648.01", "Potassium Channels"], {"weight": 0.937977247205283}], ["OR1L3", ["TCGA.A6.6648.01", "GABA B receptor activation"], {"weight": 0.911777767382452}], ["OR1L3", ["TCGA.A6.6648.01", "Activation of GABAB receptors"], {"weight": 0.911777767382452}], ["OR1L3", ["TCGA.A6.6648.01", "Phase 4 - resting membrane potential"], {"weight": 0.777753259657588}], ["OR1L3", ["TCGA.A6.6648.01", "LGI-ADAM interactions"], {"weight": 0.649830499859756}], ["OR1L3", ["TCGA.A6.6648.01", "Activation of G protein gated Potassium channels"], {"weight": 0.895125328086948}], ["OR1L3", ["TCGA.A6.6648.01", "G protein gated Potassium channels"], {"weight": 0.895125328086948}], ["OR1L3", ["TCGA.A6.6648.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.895125328086948}], ["RNF220", ["TCGA.F4.6461.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.848826335633507}], ["AMPD3", ["TCGA.D5.6532.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.890889375012396}], ["CD38", ["TCGA.CM.6172.01", "Signaling by GPCR"], {"weight": 0.915019288419859}], ["CD38", ["TCGA.CM.6172.01", "GPCR downstream signalling"], {"weight": 0.912761155566202}], ["CD38", ["TCGA.CM.6172.01", "Platelet homeostasis"], {"weight": 0.734263242364058}], ["CD38", ["TCGA.CM.6172.01", "G alpha (z) signalling events"], {"weight": 0.840396073074071}], ["NPR2", ["TCGA.CK.4948.01", "Drug ADME"], {"weight": 0.808038773992693}], ["NPR2", ["TCGA.CK.4948.01", "Azathioprine ADME"], {"weight": 0.690607670403625}], ["NPR2", ["TCGA.CM.6171.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.813444408824154}], ["GRM5", ["TCGA.A6.5666.01", "GABA B receptor activation"], {"weight": 0.944304306728737}], ["GRM5", ["TCGA.A6.5666.01", "Activation of GABAB receptors"], {"weight": 0.944304306728737}], ["GRM6", ["TCGA.AD.6890.01", "Chemokine receptors bind chemokines"], {"weight": 0.893496352260493}], ["TPO", ["TCGA.AD.6901.01", "Metabolism"], {"weight": 0.898113274534755}], ["TPO", ["TCGA.G4.6317.01", "Tryptophan catabolism"], {"weight": 0.800912374660467}], ["SNAI1", ["TCGA.A6.6782.01", "Physiological factors"], {"weight": 0.552162658627917}], ["PPP4R4", ["TCGA.CM.6677.01", "Phase II - Conjugation of compounds"], {"weight": 0.800941200242855}], ["PPP4R4", ["TCGA.CM.6677.01", "Biological oxidations"], {"weight": 0.880140852905476}], ["PPP4R4", ["TCGA.CM.6677.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.8149597226201}], ["PPP4R4", ["TCGA.DM.A28C.01", "Glycosaminoglycan metabolism"], {"weight": 0.889424787434562}], ["SETD2", ["TCGA.AD.6548.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.78824478057481}], ["COL2A1", ["TCGA.CM.6679.01", "Collagen formation"], {"weight": 0.942151005917972}], ["COL2A1", ["TCGA.CM.6679.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.93635482276295}], ["COL2A1", ["TCGA.CM.6679.01", "O-linked glycosylation"], {"weight": 0.900046433638321}], ["COL2A1", ["TCGA.CM.6679.01", "Degradation of the extracellular matrix"], {"weight": 0.878688290640826}], ["COL2A1", ["TCGA.CM.6679.01", "NCAM signaling for neurite out-growth"], {"weight": 0.66917062371656}], ["COL2A1", ["TCGA.CM.6679.01", "Diseases of glycosylation"], {"weight": 0.841332783011945}], ["COL2A1", ["TCGA.F4.6570.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.942124380252066}], ["COL2A1", ["TCGA.F4.6570.01", "Collagen formation"], {"weight": 0.945052631662751}], ["EXOC1", ["TCGA.AA.3660.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.658524084974498}], ["MALT1", ["TCGA.AD.6901.01", "Trafficking of AMPA receptors"], {"weight": 0.868084431484648}], ["MALT1", ["TCGA.AD.6901.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.868084431484648}], ["GREB1", ["TCGA.CK.4952.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.89464008290005}], ["GREB1", ["TCGA.CK.4952.01", "SUMOylation of intracellular receptors"], {"weight": 0.78996520620915}], ["GREB1", ["TCGA.DM.A1D4.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.901559330053588}], ["GREB1", ["TCGA.DM.A1D4.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.894367217097158}], ["GREB1", ["TCGA.DM.A1D4.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.888470026744711}], ["GREB1", ["TCGA.DM.A1D9.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.940533903582357}], ["DCLRE1C", ["TCGA.D5.5540.01", "Carnitine metabolism"], {"weight": 0.775041533542659}], ["DCLRE1C", ["TCGA.D5.5540.01", "Homologous DNA Pairing and Strand Exchange"], {"weight": 0.914543440625331}], ["DCLRE1C", ["TCGA.D5.5540.01", "Presynaptic phase of homologous DNA pairing and strand exchange"], {"weight": 0.91159065356201}], ["DCLRE1C", ["TCGA.D5.5540.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.906276457248915}], ["DCLRE1C", ["TCGA.D5.5540.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], {"weight": 0.898370859187839}], ["DCLRE1C", ["TCGA.D5.5540.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], {"weight": 0.898370859187839}], ["DCLRE1C", ["TCGA.D5.5540.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], {"weight": 0.898370859187839}], ["DCLRE1C", ["TCGA.D5.5540.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], {"weight": 0.898370859187839}], ["DCLRE1C", ["TCGA.D5.5540.01", "Impaired BRCA2 binding to PALB2"], {"weight": 0.898370859187839}], ["DCLRE1C", ["TCGA.D5.5540.01", "Resolution of D-Loop Structures"], {"weight": 0.906276457248915}], ["DCLRE1C", ["TCGA.D5.5540.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], {"weight": 0.904764880800297}], ["DCLRE1C", ["TCGA.D5.5540.01", "Activation of the pre-replicative complex"], {"weight": 0.893488451594754}], ["DCLRE1C", ["TCGA.D5.5540.01", "Diseases of DNA repair"], {"weight": 0.910225870122429}], ["DCLRE1C", ["TCGA.D5.5540.01", "Diseases of DNA Double-Strand Break Repair"], {"weight": 0.910225870122429}], ["DCLRE1C", ["TCGA.D5.5540.01", "Defective homologous recombination repair (HRR) due to BRCA2 loss of function"], {"weight": 0.910225870122429}], ["KCNU1", ["TCGA.AM.5821.01", "Phase 2 - plateau phase"], {"weight": 0.851337807249121}], ["KCNU1", ["TCGA.D5.6535.01", "Attenuation phase"], {"weight": 0.704545136354889}], ["KCNU1", ["TCGA.DM.A1D7.01", "GPCR downstream signalling"], {"weight": 0.941035531241532}], ["KCNU1", ["TCGA.DM.A1D7.01", "Peptide ligand-binding receptors"], {"weight": 0.933278871029613}], ["LUZP1", ["TCGA.DM.A28G.01", "Leishmania infection"], {"weight": 0.806363191815062}], ["LUZP1", ["TCGA.DM.A28G.01", "Parasitic Infection Pathways"], {"weight": 0.806363191815062}], ["PBX1", ["TCGA.D5.6531.01", "Regulation of gene expression by Hypoxia-inducible Factor"], {"weight": 0.89754945292443}], ["PBX1", ["TCGA.D5.6531.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.637312049567091}], ["MYO1A", ["TCGA.G4.6586.01", "Sensory processing of sound"], {"weight": 0.955045221545403}], ["MYO1A", ["TCGA.G4.6586.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.954537546464948}], ["MPO", ["TCGA.A6.5665.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.914570703330781}], ["MPO", ["TCGA.A6.5665.01", "Arachidonic acid metabolism"], {"weight": 0.905945511154833}], ["MPO", ["TCGA.DM.A28M.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.883954235457625}], ["MPO", ["TCGA.DM.A28M.01", "Other interleukin signaling"], {"weight": 0.786823963331889}], ["CDK14", ["TCGA.CM.4743.01", "Regulation of signaling by NODAL"], {"weight": 0.864605346503301}], ["PTK2", ["TCGA.A6.5665.01", "Extracellular matrix organization"], {"weight": 0.887999116500909}], ["PTK2", ["TCGA.AZ.6601.01", "Extracellular matrix organization"], {"weight": 0.860284529849265}], ["PTK2", ["TCGA.AZ.6601.01", "Degradation of the extracellular matrix"], {"weight": 0.859540496761522}], ["PTK2", ["TCGA.AZ.6601.01", "ECM proteoglycans"], {"weight": 0.914075098570888}], ["PTK2", ["TCGA.AZ.6601.01", "Developmental Biology"], {"weight": 0.826593566140588}], ["PTK2", ["TCGA.CA.6718.01", "Extracellular matrix organization"], {"weight": 0.858795823982895}], ["PTK2", ["TCGA.CA.6718.01", "Degradation of the extracellular matrix"], {"weight": 0.846013926069967}], ["PTK2", ["TCGA.CM.5861.01", "L1CAM interactions"], {"weight": 0.922347281163494}], ["PTK2", ["TCGA.CM.5861.01", "Degradation of the extracellular matrix"], {"weight": 0.84769918880074}], ["PTK2", ["TCGA.CM.6171.01", "Extracellular matrix organization"], {"weight": 0.849068570814732}], ["PTK2", ["TCGA.G4.6299.01", "Extracellular matrix organization"], {"weight": 0.880238388458466}], ["PTK2", ["TCGA.G4.6299.01", "Interaction between L1 and Ankyrins"], {"weight": 0.910066169674095}], ["PTK2", ["TCGA.G4.6299.01", "ECM proteoglycans"], {"weight": 0.931225144460376}], ["PTK2", ["TCGA.G4.6320.01", "L1CAM interactions"], {"weight": 0.906716323698132}], ["SCNN1G", ["TCGA.A6.5665.01", "Interaction between L1 and Ankyrins"], {"weight": 0.948734528104811}], ["COL15A1", ["TCGA.A6.5665.01", "Collagen formation"], {"weight": 0.945921643723977}], ["COL15A1", ["TCGA.AM.5821.01", "Collagen formation"], {"weight": 0.96182730443204}], ["COL15A1", ["TCGA.AM.5821.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.947731021383125}], ["COL15A1", ["TCGA.AU.6004.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.91813863843682}], ["COL15A1", ["TCGA.AU.6004.01", "Collagen formation"], {"weight": 0.952405820735193}], ["COL15A1", ["TCGA.AU.6004.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.937295161900672}], ["COL15A1", ["TCGA.AZ.4615.01", "Collagen formation"], {"weight": 0.942464915650337}], ["COL15A1", ["TCGA.CM.6172.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.73088874545928}], ["COL15A1", ["TCGA.CM.6172.01", "Extracellular matrix organization"], {"weight": 0.664005836119453}], ["COL15A1", ["TCGA.D5.6535.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.789276697725121}], ["COL15A1", ["TCGA.D5.6930.01", "Collagen formation"], {"weight": 0.947859493855093}], ["COL15A1", ["TCGA.D5.6930.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.934050825571837}], ["PELP1", ["TCGA.F4.6463.01", "APAP ADME"], {"weight": 0.703118606793955}], ["PELP1", ["TCGA.F4.6463.01", "Heme degradation"], {"weight": 0.474432838574875}], ["MAD1L1", ["TCGA.DM.A1D9.01", "Muscle contraction"], {"weight": 0.938200235795718}], ["KLKB1", ["TCGA.A6.5665.01", "GPCR downstream signalling"], {"weight": 0.939080166157298}], ["KLKB1", ["TCGA.AD.5900.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.942685830952279}], ["KLKB1", ["TCGA.AD.5900.01", "Degradation of the extracellular matrix"], {"weight": 0.866474672927828}], ["KLKB1", ["TCGA.AM.5821.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.956956188958222}], ["KLKB1", ["TCGA.CM.6171.01", "Signaling by GPCR"], {"weight": 0.930103865614617}], ["KLKB1", ["TCGA.CM.6171.01", "GPCR downstream signalling"], {"weight": 0.946819822886523}], ["KLKB1", ["TCGA.CM.6171.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.751824330641816}], ["KLKB1", ["TCGA.D5.6927.01", "Collagen formation"], {"weight": 0.950191166222368}], ["KLKB1", ["TCGA.D5.6927.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.942763962715495}], ["KLKB1", ["TCGA.D5.6927.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.921469882068327}], ["KLKB1", ["TCGA.G4.6588.01", "Peptide ligand-binding receptors"], {"weight": 0.946815939925825}], ["AOX1", ["TCGA.A6.5665.01", "Neurotransmitter release cycle"], {"weight": 0.868951686169462}], ["AOX1", ["TCGA.A6.5667.01", "Phase II - Conjugation of compounds"], {"weight": 0.696429653959934}], ["AOX1", ["TCGA.A6.5667.01", "Ethanol oxidation"], {"weight": 0.888746267104066}], ["AOX1", ["TCGA.A6.5667.01", "RA biosynthesis pathway"], {"weight": 0.890814218399107}], ["AOX1", ["TCGA.A6.5667.01", "Glucuronidation"], {"weight": 0.824747098789206}], ["ADAMTS20", ["TCGA.AA.3502.01", "Defective B3GALTL causes PpS"], {"weight": 0.917819941949742}], ["ADAMTS20", ["TCGA.AA.3502.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.917785356744038}], ["ADAMTS20", ["TCGA.AA.3502.01", "O-linked glycosylation"], {"weight": 0.857568259925614}], ["ADAMTS20", ["TCGA.AA.3502.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.917819941949742}], ["ADAMTS20", ["TCGA.CM.6679.01", "Defective B3GALTL causes PpS"], {"weight": 0.883830707247413}], ["ADAMTS20", ["TCGA.CM.6679.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.883759234926206}], ["ADAMTS20", ["TCGA.CM.6679.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.812707228522406}], ["OR4C15", ["TCGA.AZ.5403.01", "Signaling by GPCR"], {"weight": 0.928758897868457}], ["OR4C15", ["TCGA.AZ.5403.01", "Transmission across Chemical Synapses"], {"weight": 0.926309386501651}], ["OR4C15", ["TCGA.AZ.5403.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.912925349816594}], ["OR4C15", ["TCGA.AZ.5403.01", "G alpha (i) signalling events"], {"weight": 0.917432672711927}], ["OR4C15", ["TCGA.AZ.5403.01", "GABA receptor activation"], {"weight": 0.676537293010965}], ["OR4C15", ["TCGA.AZ.5403.01", "Neuronal System"], {"weight": 0.932281479869196}], ["OR4C15", ["TCGA.AZ.5403.01", "GPCR ligand binding"], {"weight": 0.936215653108784}], ["OR4C15", ["TCGA.AZ.5403.01", "Activation of GABAB receptors"], {"weight": 0.910871011511906}], ["OR4C15", ["TCGA.AZ.5403.01", "G alpha (q) signalling events"], {"weight": 0.913727565341413}], ["OR4C15", ["TCGA.AZ.5403.01", "G alpha (s) signalling events"], {"weight": 0.945135704360556}], ["OR4C15", ["TCGA.AZ.5403.01", "G protein gated Potassium channels"], {"weight": 0.90706097882397}], ["OR4C15", ["TCGA.AZ.5403.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.883054392979721}], ["OR4C15", ["TCGA.D5.6920.01", "G alpha (i) signalling events"], {"weight": 0.883987368535863}], ["TUB", ["TCGA.A6.5665.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.945785412893529}], ["TUB", ["TCGA.A6.5665.01", "Peptide ligand-binding receptors"], {"weight": 0.944929650885901}], ["TUB", ["TCGA.A6.5665.01", "Chemokine receptors bind chemokines"], {"weight": 0.919973483379997}], ["TUB", ["TCGA.AA.3663.01", "Chemokine receptors bind chemokines"], {"weight": 0.928514493671221}], ["TUB", ["TCGA.AZ.6598.01", "Chemokine receptors bind chemokines"], {"weight": 0.930026790644185}], ["TUB", ["TCGA.DM.A1DA.01", "Chemokine receptors bind chemokines"], {"weight": 0.939646796192049}], ["TUB", ["TCGA.DM.A1DA.01", "Peptide ligand-binding receptors"], {"weight": 0.935382435806881}], ["TUB", ["TCGA.F4.6460.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.910494078089811}], ["TUB", ["TCGA.F4.6460.01", "IRS-related events triggered by IGF1R"], {"weight": 0.789517716652013}], ["TUB", ["TCGA.F4.6460.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.789517716652013}], ["TUB", ["TCGA.F4.6460.01", "IGF1R signaling cascade"], {"weight": 0.789517716652013}], ["TUB", ["TCGA.F4.6460.01", "Peptide hormone metabolism"], {"weight": 0.786777748872577}], ["TUB", ["TCGA.F4.6460.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.691797101441117}], ["TUB", ["TCGA.F4.6460.01", "Extracellular matrix organization"], {"weight": 0.753013643752186}], ["TUB", ["TCGA.F4.6460.01", "PPARA activates gene expression"], {"weight": 0.856961211089486}], ["TUB", ["TCGA.F4.6460.01", "Regulation of lipid metabolism by PPARalpha"], {"weight": 0.856961211089486}], ["RDH12", ["TCGA.A6.5665.01", "RA biosynthesis pathway"], {"weight": 0.922807360768459}], ["RDH12", ["TCGA.A6.5665.01", "Ethanol oxidation"], {"weight": 0.91290413509343}], ["NALCN", ["TCGA.A6.5665.01", "Stimuli-sensing channels"], {"weight": 0.872396242714921}], ["NALCN", ["TCGA.CK.5914.01", "Neurexins and neuroligins"], {"weight": 0.931340430956918}], ["NALCN", ["TCGA.D5.5541.01", "Interaction between L1 and Ankyrins"], {"weight": 0.881981408537338}], ["NALCN", ["TCGA.D5.5541.01", "Stimuli-sensing channels"], {"weight": 0.884270693601999}], ["NALCN", ["TCGA.DM.A0XF.01", "Transport of small molecules"], {"weight": 0.876359690683669}], ["NALCN", ["TCGA.DM.A0XF.01", "Synaptic adhesion-like molecules"], {"weight": 0.757367459768518}], ["NALCN", ["TCGA.F4.6569.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.712911054200599}], ["CACNB1", ["TCGA.A6.5665.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.879033995539976}], ["OR13C5", ["TCGA.A6.5665.01", "G-protein beta:gamma signalling"], {"weight": 0.924067797857703}], ["OR13C5", ["TCGA.CM.6171.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.946221320803712}], ["OR13C5", ["TCGA.G4.6298.01", "G alpha (q) signalling events"], {"weight": 0.929197950062486}], ["OR13C5", ["TCGA.G4.6298.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.936360628421743}], ["OR13C5", ["TCGA.G4.6298.01", "Ion homeostasis"], {"weight": 0.852310424470606}], ["OR13C5", ["TCGA.G4.6298.01", "G-protein beta:gamma signalling"], {"weight": 0.941609131614603}], ["OR13C5", ["TCGA.G4.6298.01", "Signal amplification"], {"weight": 0.916918038016539}], ["OR13C5", ["TCGA.G4.6298.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.930210657722142}], ["NOTUM", ["TCGA.A6.5665.01", "GPCR ligand binding"], {"weight": 0.936101982127353}], ["NOTUM", ["TCGA.A6.5665.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.910308454029904}], ["NOTUM", ["TCGA.A6.5665.01", "Activation of SMO"], {"weight": 0.900976909416723}], ["NOTUM", ["TCGA.AZ.6601.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.878805121656301}], ["FCGRT", ["TCGA.CA.6716.01", "Interferon gamma signaling"], {"weight": 0.924774527079723}], ["FCGRT", ["TCGA.CA.6716.01", "The role of Nef in HIV-1 replication and disease pathogenesis"], {"weight": 0.819353466092092}], ["FCGRT", ["TCGA.CA.6716.01", "DAP12 interactions"], {"weight": 0.907411035723074}], ["FCGRT", ["TCGA.CA.6716.01", "DAP12 signaling"], {"weight": 0.890040448615636}], ["FCGRT", ["TCGA.G4.6298.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.860159263369658}], ["FCGRT", ["TCGA.G4.6298.01", "DAP12 interactions"], {"weight": 0.922183455259059}], ["FGFR4", ["TCGA.DM.A28F.01", "Interleukin-10 signaling"], {"weight": 0.941211059305622}], ["FGFR4", ["TCGA.DM.A28F.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.888856569072021}], ["FGFR4", ["TCGA.DM.A28F.01", "PI3K events in ERBB2 signaling"], {"weight": 0.888856569072021}], ["FGFR4", ["TCGA.DM.A28F.01", "ERBB2 Regulates Cell Motility"], {"weight": 0.888856569072021}], ["FGFR4", ["TCGA.DM.A28F.01", "GRB2 events in ERBB2 signaling"], {"weight": 0.888856569072021}], ["FGFR4", ["TCGA.DM.A28F.01", "Downregulation of ERBB2 signaling"], {"weight": 0.880404333523535}], ["FGFR3", ["TCGA.AD.6889.01", "G-protein mediated events"], {"weight": 0.909452692342197}], ["FGFR3", ["TCGA.DM.A1D7.01", "Interleukin-10 signaling"], {"weight": 0.926811881897068}], ["PDE3A", ["TCGA.A6.5665.01", "Cardiac conduction"], {"weight": 0.952587926967852}], ["PDE3A", ["TCGA.DM.A1DB.01", "Cardiac conduction"], {"weight": 0.940295804715996}], ["PDE3A", ["TCGA.DM.A1DB.01", "Long-term potentiation"], {"weight": 0.930568401309272}], ["PDE3A", ["TCGA.DM.A1DB.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.897665591294929}], ["PDE3A", ["TCGA.DM.A1DB.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.923447594281471}], ["PDE3A", ["TCGA.DM.A1DB.01", "Muscle contraction"], {"weight": 0.942563603932192}], ["PDE3A", ["TCGA.DM.A1DB.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.911260080514641}], ["PDE3A", ["TCGA.G4.6586.01", "Cardiac conduction"], {"weight": 0.956399942562658}], ["PDE3A", ["TCGA.G4.6586.01", "Muscle contraction"], {"weight": 0.959242358930678}], ["PLXNB3", ["TCGA.AD.5900.01", "O-linked glycosylation"], {"weight": 0.86723163111719}], ["PLXNB3", ["TCGA.AD.6895.01", "O-linked glycosylation"], {"weight": 0.864141573185856}], ["PLXNB3", ["TCGA.AU.6004.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.562339973687439}], ["PLXNB3", ["TCGA.G4.6586.01", "Defective B3GALTL causes PpS"], {"weight": 0.926060061482565}], ["PLXNB3", ["TCGA.G4.6586.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.926060061482565}], ["OR4S1", ["TCGA.A6.6780.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.9047621979577}], ["ASPN", ["TCGA.AY.6196.01", "ECM proteoglycans"], {"weight": 0.835395297318798}], ["SSTR4", ["TCGA.CM.4747.01", "Chemokine receptors bind chemokines"], {"weight": 0.89639390010621}], ["MED12", ["TCGA.CM.6161.01", "Drug ADME"], {"weight": 0.914951745676662}], ["MED12", ["TCGA.CM.6678.01", "Regulation of FZD by ubiquitination"], {"weight": 0.84169323701184}], ["MUSK", ["TCGA.DM.A1DA.01", "Metabolism of water-soluble vitamins and cofactors"], {"weight": 0.782483869762397}], ["TRIO", ["TCGA.G4.6299.01", "Free fatty acids regulate insulin secretion"], {"weight": 0.657373352907533}], ["CACNA1E", ["TCGA.A6.5665.01", "LGI-ADAM interactions"], {"weight": 0.907312066446143}], ["CACNA1E", ["TCGA.A6.5666.01", "Transmission across Chemical Synapses"], {"weight": 0.936551768967944}], ["CACNA1E", ["TCGA.A6.5666.01", "Immune System"], {"weight": 0.892533828071135}], ["CACNA1E", ["TCGA.A6.5666.01", "Integration of energy metabolism"], {"weight": 0.951313661026324}], ["CACNA1E", ["TCGA.A6.5666.01", "Regulation of insulin secretion"], {"weight": 0.938613265474124}], ["CACNA1E", ["TCGA.A6.5666.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.941894367519868}], ["CACNA1E", ["TCGA.CM.5861.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.90800773162679}], ["CACNA1E", ["TCGA.CM.6676.01", "Trafficking of AMPA receptors"], {"weight": 0.914492322437744}], ["CACNA1E", ["TCGA.CM.6676.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.914492322437744}], ["CACNA1E", ["TCGA.CM.6676.01", "Insulin processing"], {"weight": 0.790228466976209}], ["CACNA1E", ["TCGA.D5.6541.01", "Regulation of insulin secretion"], {"weight": 0.871643156374483}], ["CACNA1E", ["TCGA.DM.A28F.01", "Sensory processing of sound"], {"weight": 0.943477950327866}], ["CACNA1E", ["TCGA.DM.A28F.01", "Regulation of insulin secretion"], {"weight": 0.902917247516946}], ["PAX5", ["TCGA.DM.A1DA.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.90131496173995}], ["PDE7A", ["TCGA.AZ.4615.01", "G alpha (s) signalling events"], {"weight": 0.962095626316955}], ["NCOR2", ["TCGA.A6.6651.01", "Drug ADME"], {"weight": 0.7946213921674}], ["NCOR2", ["TCGA.AA.3492.01", "Nuclear Receptor transcription pathway"], {"weight": 0.936713276902074}], ["NCOR2", ["TCGA.AD.6895.01", "Nuclear Receptor transcription pathway"], {"weight": 0.928614524526202}], ["NCOR2", ["TCGA.AD.6895.01", "SUMOylation of intracellular receptors"], {"weight": 0.673026897322701}], ["NCOR2", ["TCGA.CM.6674.01", "Drug ADME"], {"weight": 0.787426021177236}], ["NCOR2", ["TCGA.D5.6928.01", "Drug ADME"], {"weight": 0.907123727800388}], ["NCOR2", ["TCGA.F4.6808.01", "Recycling of bile acids and salts"], {"weight": 0.852136554517331}], ["NCOR2", ["TCGA.F4.6808.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.903946878191279}], ["NCOR2", ["TCGA.F4.6808.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.903946878191279}], ["NCOR1", ["TCGA.AM.5821.01", "Nuclear Receptor transcription pathway"], {"weight": 0.955089398267016}], ["NCOR1", ["TCGA.F4.6856.01", "SUMOylation of intracellular receptors"], {"weight": 0.733549308762941}], ["NME1", ["TCGA.A6.5665.01", "G alpha (s) signalling events"], {"weight": 0.957831946770446}], ["NME1", ["TCGA.A6.5665.01", "GABA receptor activation"], {"weight": 0.909138213828902}], ["NME1", ["TCGA.A6.5665.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.926187801738718}], ["OR10A5", ["TCGA.A6.5665.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.916681602877725}], ["OR10A5", ["TCGA.A6.5665.01", "G beta:gamma signalling through BTK"], {"weight": 0.914221880583961}], ["OR2T27", ["TCGA.CM.4747.01", "GPCR downstream signalling"], {"weight": 0.945909074456269}], ["OR2T27", ["TCGA.CM.4747.01", "G alpha (i) signalling events"], {"weight": 0.921285759810982}], ["OR2T27", ["TCGA.CM.4747.01", "Transmission across Chemical Synapses"], {"weight": 0.867186015108176}], ["OR2T27", ["TCGA.CM.4747.01", "G-protein beta:gamma signalling"], {"weight": 0.912536672284757}], ["OR2T27", ["TCGA.CM.4747.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.867564335984892}], ["OR2T27", ["TCGA.CM.4747.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.893671548878403}], ["OR2T27", ["TCGA.CM.4747.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.847243799342436}], ["OR2T27", ["TCGA.CM.4747.01", "Leishmania parasite growth and survival"], {"weight": 0.847243799342436}], ["OR2T27", ["TCGA.CM.4747.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.888491643753239}], ["OR2T27", ["TCGA.CM.4747.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.822188944561814}], ["OR2T27", ["TCGA.CM.4747.01", "G beta:gamma signalling through BTK"], {"weight": 0.882818940005451}], ["OR2T27", ["TCGA.CM.4747.01", "G alpha (s) signalling events"], {"weight": 0.950346509812479}], ["OR2T27", ["TCGA.CM.4747.01", "GABA receptor activation"], {"weight": 0.846141070557979}], ["OR2T27", ["TCGA.CM.4747.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.885718988915327}], ["OR2T27", ["TCGA.CM.4747.01", "G beta:gamma signalling through CDC42"], {"weight": 0.8766725291138}], ["OR2T27", ["TCGA.CM.4747.01", "Inwardly rectifying K+ channels"], {"weight": 0.917495600060479}], ["OR2T27", ["TCGA.CM.4747.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.892749718732395}], ["OR2T27", ["TCGA.CM.4747.01", "GABA B receptor activation"], {"weight": 0.910502971920555}], ["OR2T27", ["TCGA.CM.4747.01", "Activation of GABAB receptors"], {"weight": 0.910502971920555}], ["OR2T27", ["TCGA.CM.4747.01", "Presynaptic function of Kainate receptors"], {"weight": 0.872006406431034}], ["OR2T27", ["TCGA.CM.4747.01", "Activation of G protein gated Potassium channels"], {"weight": 0.904894457634318}], ["OR2T27", ["TCGA.CM.4747.01", "G protein gated Potassium channels"], {"weight": 0.904894457634318}], ["OR2T27", ["TCGA.CM.4747.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.904894457634318}], ["OR2T27", ["TCGA.CM.4747.01", "Regulation of insulin secretion"], {"weight": 0.84644597768872}], ["KCNB1", ["TCGA.AA.3492.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.925141228705304}], ["KCNB1", ["TCGA.AA.3502.01", "Opioid Signalling"], {"weight": 0.937546955402798}], ["KCNB1", ["TCGA.CM.4750.01", "Regulation of insulin secretion"], {"weight": 0.919958789269628}], ["KCNB1", ["TCGA.CM.4750.01", "G alpha (s) signalling events"], {"weight": 0.953904794740069}], ["KCNB1", ["TCGA.CM.4750.01", "Potassium Channels"], {"weight": 0.94891316349295}], ["KCNB1", ["TCGA.F4.6570.01", "Regulation of insulin secretion"], {"weight": 0.925132125227889}], ["KCNB1", ["TCGA.G4.6309.01", "Phase 0 - rapid depolarisation"], {"weight": 0.89388949441125}], ["CNTNAP2", ["TCGA.AA.3712.01", "L1CAM interactions"], {"weight": 0.900112688412043}], ["CNTNAP2", ["TCGA.CM.4743.01", "NCAM1 interactions"], {"weight": 0.941059868084579}], ["CNTNAP2", ["TCGA.D5.6540.01", "NCAM1 interactions"], {"weight": 0.945230353904655}], ["CNTNAP2", ["TCGA.D5.6540.01", "NCAM signaling for neurite out-growth"], {"weight": 0.947755867725433}], ["CNTNAP2", ["TCGA.D5.6927.01", "NCAM1 interactions"], {"weight": 0.929005279657631}], ["CNTNAP2", ["TCGA.D5.6927.01", "NCAM signaling for neurite out-growth"], {"weight": 0.937840590458967}], ["CNTNAP2", ["TCGA.G4.6588.01", "NCAM1 interactions"], {"weight": 0.945934829499652}], ["CNTNAP2", ["TCGA.G4.6588.01", "NCAM signaling for neurite out-growth"], {"weight": 0.947882644554626}], ["OR2B6", ["TCGA.A6.5665.01", "G beta:gamma signalling through CDC42"], {"weight": 0.911842724057119}], ["OR2B6", ["TCGA.CA.6718.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.908533360161891}], ["OR4K13", ["TCGA.DM.A0XD.01", "G alpha (s) signalling events"], {"weight": 0.95969260507731}], ["OR4K13", ["TCGA.DM.A0XD.01", "G alpha (q) signalling events"], {"weight": 0.936192296850028}], ["NDST1", ["TCGA.D5.5541.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.909305726751511}], ["NDST1", ["TCGA.G4.6304.01", "Molecules associated with elastic fibres"], {"weight": 0.893578895937833}], ["NDST1", ["TCGA.G4.6304.01", "Glycosaminoglycan metabolism"], {"weight": 0.873690761952909}], ["GFRA1", ["TCGA.CM.4744.01", "Azathioprine ADME"], {"weight": 0.744656500918187}], ["NBEA", ["TCGA.A6.5665.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.933332426687127}], ["NBEA", ["TCGA.A6.6653.01", "Transmission across Chemical Synapses"], {"weight": 0.91901925172059}], ["NBEA", ["TCGA.CA.6718.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.877713642313092}], ["NBEA", ["TCGA.CM.5348.01", "Neuronal System"], {"weight": 0.87186558310761}], ["NBEA", ["TCGA.CM.5860.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.812863088723244}], ["NBEA", ["TCGA.D5.6927.01", "Neuronal System"], {"weight": 0.900708103211889}], ["NBEA", ["TCGA.D5.6927.01", "Transmission across Chemical Synapses"], {"weight": 0.899130695415995}], ["NBEA", ["TCGA.D5.6927.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.854626378910292}], ["NBEA", ["TCGA.F4.6569.01", "Transmission across Chemical Synapses"], {"weight": 0.846433669331172}], ["NBEA", ["TCGA.F4.6569.01", "Neuronal System"], {"weight": 0.860919187438138}], ["NBEA", ["TCGA.F4.6569.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.861672473856992}], ["PPARGC1A", ["TCGA.A6.5665.01", "Integration of energy metabolism"], {"weight": 0.92854558542958}], ["PPARGC1A", ["TCGA.AD.6889.01", "Integration of energy metabolism"], {"weight": 0.934372925709711}], ["PPARGC1A", ["TCGA.AM.5821.01", "Integration of energy metabolism"], {"weight": 0.942393212558982}], ["PPARGC1A", ["TCGA.AM.5821.01", "Fatty acid metabolism"], {"weight": 0.945068211242254}], ["PPARGC1A", ["TCGA.D5.6537.01", "Integration of energy metabolism"], {"weight": 0.943577232642714}], ["PPARGC1A", ["TCGA.D5.6537.01", "Recycling of bile acids and salts"], {"weight": 0.884499305732994}], ["PPARGC1A", ["TCGA.D5.6537.01", "SUMOylation of intracellular receptors"], {"weight": 0.821723059128064}], ["PPARGC1A", ["TCGA.D5.6537.01", "Nuclear Receptor transcription pathway"], {"weight": 0.871253072280785}], ["CHRNG", ["TCGA.AD.6888.01", "Transmission across Chemical Synapses"], {"weight": 0.935106726097103}], ["ADAMTS3", ["TCGA.AA.3489.01", "Collagen chain trimerization"], {"weight": 0.90992092358545}], ["ADAMTS3", ["TCGA.AA.3489.01", "O-linked glycosylation"], {"weight": 0.88367317322008}], ["ADAMTS3", ["TCGA.AA.3489.01", "Defective B3GALTL causes PpS"], {"weight": 0.866836273209179}], ["ADAMTS3", ["TCGA.AA.3489.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.866765790404564}], ["ADAMTS3", ["TCGA.AU.6004.01", "Collagen chain trimerization"], {"weight": 0.905676025794333}], ["ADAMTS3", ["TCGA.CM.5348.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.945409521856034}], ["ADAMTS3", ["TCGA.CM.5348.01", "Collagen chain trimerization"], {"weight": 0.901669771019627}], ["ADAMTS3", ["TCGA.D5.6927.01", "Collagen chain trimerization"], {"weight": 0.926372140120573}], ["CARD11", ["TCGA.CA.5796.01", "Neuronal System"], {"weight": 0.924765557475951}], ["CARD11", ["TCGA.CA.5796.01", "Transmission across Chemical Synapses"], {"weight": 0.91331747183101}], ["CARD11", ["TCGA.CA.5796.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.889505487669223}], ["CARD11", ["TCGA.CA.5796.01", "Trafficking of AMPA receptors"], {"weight": 0.902627339488982}], ["CARD11", ["TCGA.CA.5796.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.902627339488982}], ["CARD11", ["TCGA.CA.5796.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.861173855017625}], ["SLC6A3", ["TCGA.A6.5665.01", "Transmission across Chemical Synapses"], {"weight": 0.93127004807292}], ["SLC6A3", ["TCGA.A6.5665.01", "Phase 0 - rapid depolarisation"], {"weight": 0.942192761941752}], ["SLC6A3", ["TCGA.A6.5665.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.920675530175408}], ["SLC6A3", ["TCGA.A6.5665.01", "Trafficking of AMPA receptors"], {"weight": 0.934199598469682}], ["SLC6A3", ["TCGA.A6.5665.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.934199598469682}], ["SLC6A3", ["TCGA.AA.3712.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.879181169204403}], ["SLC6A3", ["TCGA.AA.3712.01", "Degradation of the extracellular matrix"], {"weight": 0.854293181674592}], ["SLC6A3", ["TCGA.DM.A1D0.01", "Neuronal System"], {"weight": 0.950324838295584}], ["SLC6A3", ["TCGA.DM.A1D0.01", "Transmission across Chemical Synapses"], {"weight": 0.947032296708425}], ["SLC6A3", ["TCGA.DM.A1D0.01", "Signaling by Receptor Tyrosine Kinases"], {"weight": 0.918628461799427}], ["SLC6A3", ["TCGA.F4.6855.01", "Degradation of the extracellular matrix"], {"weight": 0.776202348293821}], ["SLC6A3", ["TCGA.F4.6855.01", "Cardiac conduction"], {"weight": 0.885311990860233}], ["ALB", ["TCGA.D5.6898.01", "Drug ADME"], {"weight": 0.846499697951934}], ["ALB", ["TCGA.D5.6898.01", "Phase II - Conjugation of compounds"], {"weight": 0.72816307264495}], ["ALB", ["TCGA.D5.6898.01", "Glucuronidation"], {"weight": 0.713243753089241}], ["ALB", ["TCGA.D5.6898.01", "Estrogen-dependent nuclear events downstream of ESR-membrane signaling"], {"weight": 0.690870263761041}], ["CRTC1", ["TCGA.A6.6653.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.92262957363323}], ["CRTC1", ["TCGA.A6.6653.01", "Aspartate and asparagine metabolism"], {"weight": 0.593608839933167}], ["CRTC1", ["TCGA.A6.6780.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.770526769875141}], ["CRTC1", ["TCGA.AZ.6601.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.892846479044386}], ["CRTC1", ["TCGA.D5.6930.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.924307505060268}], ["TSHR", ["TCGA.DM.A0XF.01", "PLC beta mediated events"], {"weight": 0.875157240638386}], ["TSHR", ["TCGA.G4.6626.01", "Peptide ligand-binding receptors"], {"weight": 0.946787386384692}], ["TSHR", ["TCGA.G4.6626.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.813100977842709}], ["COL7A1", ["TCGA.A6.6780.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.931094796374089}], ["COL7A1", ["TCGA.F4.6809.01", "Collagen chain trimerization"], {"weight": 0.861487329219474}], ["COL7A1", ["TCGA.G4.6317.01", "Degradation of the extracellular matrix"], {"weight": 0.881994432839258}], ["HRH2", ["TCGA.D5.6535.01", "G alpha (s) signalling events"], {"weight": 0.944732375312437}], ["HRH2", ["TCGA.D5.6541.01", "Cardiac conduction"], {"weight": 0.903684220591961}], ["HRH2", ["TCGA.D5.6541.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.944151982457995}], ["HRH2", ["TCGA.D5.6541.01", "Muscle contraction"], {"weight": 0.87193981444136}], ["COL4A3", ["TCGA.D5.6533.01", "Glycosaminoglycan metabolism"], {"weight": 0.83776873758506}], ["COL4A3", ["TCGA.D5.6537.01", "Glycosaminoglycan metabolism"], {"weight": 0.864103127676439}], ["COL4A2", ["TCGA.A6.6781.01", "Glycosaminoglycan metabolism"], {"weight": 0.884435671959564}], ["COL4A2", ["TCGA.F4.6570.01", "Glycosaminoglycan metabolism"], {"weight": 0.815883255737273}], ["COL4A2", ["TCGA.G4.6311.01", "Glucuronidation"], {"weight": 0.460366319046627}], ["COL4A2", ["TCGA.G4.6315.01", "Integrin cell surface interactions"], {"weight": 0.920508930569389}], ["COL4A2", ["TCGA.G4.6315.01", "Other semaphorin interactions"], {"weight": 0.658217932250537}], ["COL4A2", ["TCGA.G4.6315.01", "ECM proteoglycans"], {"weight": 0.888419010865967}], ["COL4A2", ["TCGA.G4.6315.01", "TNFs bind their physiological receptors"], {"weight": 0.496656407416206}], ["LHCGR", ["TCGA.CM.5860.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.93049393819593}], ["LHCGR", ["TCGA.CM.5860.01", "Peptide ligand-binding receptors"], {"weight": 0.927031328199024}], ["IFT140", ["TCGA.D5.6927.01", "Phase 0 - rapid depolarisation"], {"weight": 0.863519945488702}], ["NTRK2", ["TCGA.D5.6541.01", "Signaling by GPCR"], {"weight": 0.954277916141119}], ["AKAP7", ["TCGA.A6.5665.01", "G alpha (i) signalling events"], {"weight": 0.942057410644439}], ["AKAP7", ["TCGA.A6.5665.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.92901482380417}], ["AKAP7", ["TCGA.A6.5665.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.922612250754958}], ["AKAP7", ["TCGA.A6.5665.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.892610506096198}], ["AKAP7", ["TCGA.A6.5665.01", "Aquaporin-mediated transport"], {"weight": 0.892610506096198}], ["AKAP7", ["TCGA.AZ.4615.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.921174016777007}], ["ATP6V1B1", ["TCGA.AD.6548.01", "Signaling Pathways"], {"weight": 0.812066123173037}], ["ATP6V1B1", ["TCGA.CK.5916.01", "Transport of small molecules"], {"weight": 0.926329975733981}], ["TBK1", ["TCGA.D5.6922.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.88028044267729}], ["TBK1", ["TCGA.G4.6309.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.844657089763522}], ["ERBB4", ["TCGA.A6.6650.01", "MHC class II antigen presentation"], {"weight": 0.922264277979098}], ["ERBB4", ["TCGA.A6.6650.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.89235420737687}], ["ERBB4", ["TCGA.D5.6932.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.823295184416262}], ["ERBB4", ["TCGA.D5.6932.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.87796602857698}], ["ERBB4", ["TCGA.DM.A1DA.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.921079250314706}], ["ERBB4", ["TCGA.DM.A1DA.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.910469419385641}], ["CAPN12", ["TCGA.CM.5864.01", "Extracellular matrix organization"], {"weight": 0.874495720580273}], ["LRP12", ["TCGA.AD.6964.01", "Scavenging by Class A Receptors"], {"weight": 0.697470228445094}], ["LRP12", ["TCGA.AD.6964.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.552389465642259}], ["LRP12", ["TCGA.AD.6964.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.552389465642259}], ["NPHP4", ["TCGA.D5.6531.01", "IRS-mediated signalling"], {"weight": 0.861049814535163}], ["KCNG4", ["TCGA.A6.6140.01", "Potassium Channels"], {"weight": 0.946987102947329}], ["KCNG4", ["TCGA.AD.6889.01", "Voltage gated Potassium channels"], {"weight": 0.949858764958649}], ["KCNG4", ["TCGA.DM.A1D4.01", "Potassium Channels"], {"weight": 0.96469324632102}], ["KCNG4", ["TCGA.DM.A1D4.01", "Voltage gated Potassium channels"], {"weight": 0.882338817329289}], ["KCNG4", ["TCGA.DM.A1D7.01", "Potassium Channels"], {"weight": 0.892560093639937}], ["OR8D1", ["TCGA.CK.5914.01", "Potassium Channels"], {"weight": 0.956379495363985}], ["OR8D1", ["TCGA.CK.5914.01", "G alpha (s) signalling events"], {"weight": 0.960514407855896}], ["OR8D1", ["TCGA.CK.5914.01", "GABA receptor activation"], {"weight": 0.698101793741842}], ["OR8D1", ["TCGA.CK.5914.01", "G alpha (z) signalling events"], {"weight": 0.927378600808712}], ["OR8D1", ["TCGA.CK.5914.01", "Regulation of insulin secretion"], {"weight": 0.92099534501284}], ["OR8D1", ["TCGA.CK.5914.01", "Platelet homeostasis"], {"weight": 0.83861435236101}], ["OR8D1", ["TCGA.CK.5914.01", "GABA B receptor activation"], {"weight": 0.926079994618719}], ["OR8D1", ["TCGA.CK.5914.01", "Activation of GABAB receptors"], {"weight": 0.926079994618719}], ["OR8D1", ["TCGA.CK.5914.01", "Signal amplification"], {"weight": 0.917803265289583}], ["OR8D1", ["TCGA.CK.5914.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.926435464334998}], ["OR8D1", ["TCGA.CK.5914.01", "Platelet activation, signaling and aggregation"], {"weight": 0.884406285298406}], ["OR8D1", ["TCGA.CK.5914.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.917365416536287}], ["OR8D1", ["TCGA.CK.5914.01", "G beta:gamma signalling through BTK"], {"weight": 0.902205012148399}], ["OR8D1", ["TCGA.CK.5914.01", "Sensory perception of taste"], {"weight": 0.905805897065931}], ["OR8D1", ["TCGA.CK.5914.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.89229169314935}], ["OR8D1", ["TCGA.CK.5914.01", "G-protein beta:gamma signalling"], {"weight": 0.914518230080252}], ["OR8D1", ["TCGA.CK.5914.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.942824555776175}], ["ACVR2A", ["TCGA.A6.6780.01", "Signaling by BMP"], {"weight": 0.850000350875992}], ["ACVR2A", ["TCGA.CM.6677.01", "Peptide hormone metabolism"], {"weight": 0.72766809617797}], ["ACVR2A", ["TCGA.F4.6856.01", "Peptide hormone metabolism"], {"weight": 0.705745410856609}], ["HCN4", ["TCGA.AD.6889.01", "Potassium Channels"], {"weight": 0.962515336099233}], ["HCN4", ["TCGA.CM.6171.01", "Potassium Channels"], {"weight": 0.961627345227516}], ["HCN4", ["TCGA.D5.6540.01", "Potassium Channels"], {"weight": 0.959937956179755}], ["HCN4", ["TCGA.D5.6928.01", "Potassium Channels"], {"weight": 0.91082617984623}], ["HCN4", ["TCGA.G4.6295.01", "Neuronal System"], {"weight": 0.922199191998135}], ["HCN4", ["TCGA.G4.6295.01", "Interaction between L1 and Ankyrins"], {"weight": 0.945006426149897}], ["HCN4", ["TCGA.G4.6295.01", "Phase 0 - rapid depolarisation"], {"weight": 0.938913699465388}], ["HCN4", ["TCGA.G4.6295.01", "L1CAM interactions"], {"weight": 0.898671918907724}], ["UBE4B", ["TCGA.AY.6196.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.87660725002446}], ["UBE4B", ["TCGA.G4.6298.01", "Adaptive Immune System"], {"weight": 0.901897793220639}], ["RB1CC1", ["TCGA.AA.3663.01", "Transmission across Chemical Synapses"], {"weight": 0.924231605562641}], ["RB1CC1", ["TCGA.AA.3663.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.920703307520205}], ["RB1CC1", ["TCGA.AD.6895.01", "Integration of energy metabolism"], {"weight": 0.910586437789128}], ["RB1CC1", ["TCGA.AY.6197.01", "GPCR downstream signalling"], {"weight": 0.921001535467032}], ["RB1CC1", ["TCGA.AZ.6598.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.931505173291301}], ["RB1CC1", ["TCGA.AZ.6598.01", "Activation of NMDA receptors and postsynaptic events"], {"weight": 0.892678603889057}], ["RB1CC1", ["TCGA.CA.6718.01", "Neuronal System"], {"weight": 0.909900345041359}], ["RB1CC1", ["TCGA.CA.6718.01", "Transmission across Chemical Synapses"], {"weight": 0.89775172664609}], ["ESR1", ["TCGA.CM.5861.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.927649504971606}], ["SCN7A", ["TCGA.AD.6889.01", "Transport of small molecules"], {"weight": 0.92219199466673}], ["SCN7A", ["TCGA.AD.6965.01", "G alpha (s) signalling events"], {"weight": 0.952228837109471}], ["SCN7A", ["TCGA.AD.6965.01", "Regulation of insulin secretion"], {"weight": 0.861796183216459}], ["SCN7A", ["TCGA.AD.6965.01", "G alpha (i) signalling events"], {"weight": 0.938202151520053}], ["SCN7A", ["TCGA.CM.6674.01", "Interaction between L1 and Ankyrins"], {"weight": 0.908138215947767}], ["SCN7A", ["TCGA.DM.A1DA.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.897703394883399}], ["SCN7A", ["TCGA.DM.A1DA.01", "Ion homeostasis"], {"weight": 0.936762166299904}], ["CREB3L2", ["TCGA.A6.5665.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.905064666304489}], ["CREB3L2", ["TCGA.A6.5665.01", "Activation of NMDA receptors and postsynaptic events"], {"weight": 0.923860465099503}], ["RASAL3", ["TCGA.DM.A28C.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.808106804988241}], ["RASAL3", ["TCGA.DM.A28C.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.808106804988241}], ["MRVI1", ["TCGA.AZ.6598.01", "DAG and IP3 signaling"], {"weight": 0.899843589891997}], ["FURIN", ["TCGA.A6.5665.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.810682143846604}], ["FURIN", ["TCGA.A6.6780.01", "G alpha (q) signalling events"], {"weight": 0.929803261997879}], ["ATP2B3", ["TCGA.AU.3779.01", "Cardiac conduction"], {"weight": 0.841576228311864}], ["ATP2B3", ["TCGA.AU.3779.01", "Phase 0 - rapid depolarisation"], {"weight": 0.807147751442056}], ["ATP2B3", ["TCGA.AY.6197.01", "Ion homeostasis"], {"weight": 0.912436210545991}], ["ATP2B3", ["TCGA.CA.5797.01", "Cardiac conduction"], {"weight": 0.904352875803348}], ["ATP2B3", ["TCGA.CA.5797.01", "Interaction between L1 and Ankyrins"], {"weight": 0.858427273570232}], ["ATP2B3", ["TCGA.CA.5797.01", "Muscle contraction"], {"weight": 0.90570305289685}], ["ATP2B3", ["TCGA.CA.5797.01", "L1CAM interactions"], {"weight": 0.812636228078071}], ["ATP2B3", ["TCGA.CA.5797.01", "Platelet homeostasis"], {"weight": 0.893886833862539}], ["ATP2B3", ["TCGA.CA.5797.01", "Sensory perception of taste"], {"weight": 0.858130620396013}], ["ATP2B3", ["TCGA.CA.5797.01", "Chemokine receptors bind chemokines"], {"weight": 0.862438170690302}], ["ATP2B3", ["TCGA.CA.5797.01", "Phase 2 - plateau phase"], {"weight": 0.679847606609901}], ["ATP2B3", ["TCGA.CM.6171.01", "Cardiac conduction"], {"weight": 0.936341140683435}], ["ATP2B3", ["TCGA.CM.6171.01", "G alpha (s) signalling events"], {"weight": 0.953409250273864}], ["ATP2B3", ["TCGA.G4.6586.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.934040440295778}], ["ATP2B3", ["TCGA.G4.6586.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.936725523056683}], ["ATP2B3", ["TCGA.G4.6586.01", "Sodium/Calcium exchangers"], {"weight": 0.71362990553639}], ["ATP2B3", ["TCGA.G4.6586.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.929552491384861}], ["ATP2B3", ["TCGA.G4.6586.01", "Aquaporin-mediated transport"], {"weight": 0.929552491384861}], ["ATP2B3", ["TCGA.G4.6586.01", "PKA activation in glucagon signalling"], {"weight": 0.907436946261036}], ["ATP2B4", ["TCGA.AZ.5403.01", "Cardiac conduction"], {"weight": 0.884611739931075}], ["ATP2B4", ["TCGA.CK.5915.01", "Cardiac conduction"], {"weight": 0.94897992727422}], ["ATP2B4", ["TCGA.CK.5915.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.770372209525533}], ["ATP2B4", ["TCGA.CK.5915.01", "Ion homeostasis"], {"weight": 0.931846749981341}], ["ATP2B4", ["TCGA.CK.5915.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.828897535783283}], ["ATP2B4", ["TCGA.CM.6165.01", "Ion channel transport"], {"weight": 0.815379220203361}], ["ATP2B4", ["TCGA.F4.6856.01", "Cardiac conduction"], {"weight": 0.93650617835176}], ["ATP2B4", ["TCGA.F4.6856.01", "Muscle contraction"], {"weight": 0.946271952660131}], ["ORC2", ["TCGA.G4.6317.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.924959598659915}], ["ORC2", ["TCGA.G4.6317.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.925026834466731}], ["ORC2", ["TCGA.G4.6317.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.918626883759493}], ["ORC2", ["TCGA.G4.6317.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.91579584114202}], ["RGS22", ["TCGA.AZ.6598.01", "GABA receptor activation"], {"weight": 0.926315851910195}], ["RGS22", ["TCGA.AZ.6598.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.940974397088739}], ["RGS22", ["TCGA.AZ.6598.01", "G-protein mediated events"], {"weight": 0.904309258027807}], ["RGS22", ["TCGA.AZ.6598.01", "G alpha (s) signalling events"], {"weight": 0.962365803283018}], ["RGS22", ["TCGA.AZ.6598.01", "G alpha (z) signalling events"], {"weight": 0.93620058819809}], ["RGS22", ["TCGA.AZ.6598.01", "Opioid Signalling"], {"weight": 0.919743554942658}], ["RGS22", ["TCGA.AZ.6598.01", "GABA B receptor activation"], {"weight": 0.941362943173227}], ["RGS22", ["TCGA.AZ.6598.01", "Activation of GABAB receptors"], {"weight": 0.941362943173227}], ["RGS22", ["TCGA.D5.5537.01", "G alpha (i) signalling events"], {"weight": 0.937458013254049}], ["RGS22", ["TCGA.D5.5537.01", "Arachidonic acid metabolism"], {"weight": 0.829737680568784}], ["RGS22", ["TCGA.D5.5537.01", "Regulation of Complement cascade"], {"weight": 0.741282316816869}], ["RGS22", ["TCGA.D5.5537.01", "Complement cascade"], {"weight": 0.79457597359248}], ["RGS22", ["TCGA.D5.6930.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.887300711474483}], ["RGS22", ["TCGA.D5.6930.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.859742244915204}], ["RGS22", ["TCGA.D5.6930.01", "Signal amplification"], {"weight": 0.866056142697046}], ["RGS22", ["TCGA.D5.6930.01", "GPER1 signaling"], {"weight": 0.872963089976175}], ["RGS22", ["TCGA.G4.6298.01", "G alpha (i) signalling events"], {"weight": 0.935658827818139}], ["RGS22", ["TCGA.G4.6586.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.948315607281015}], ["RGS22", ["TCGA.G4.6586.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.934927913748291}], ["RGS22", ["TCGA.G4.6586.01", "GABA B receptor activation"], {"weight": 0.943714716898519}], ["RGS22", ["TCGA.G4.6586.01", "Activation of GABAB receptors"], {"weight": 0.943714716898519}], ["RGS22", ["TCGA.G4.6586.01", "G-protein mediated events"], {"weight": 0.941323699828442}], ["RGS22", ["TCGA.G4.6586.01", "Opioid Signalling"], {"weight": 0.951600597062848}], ["RGS22", ["TCGA.G4.6586.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.932674071845909}], ["RGS22", ["TCGA.G4.6586.01", "Signal amplification"], {"weight": 0.922175109957507}], ["ST3GAL3", ["TCGA.G4.6311.01", "Metabolism"], {"weight": 0.872297265293589}], ["C3", ["TCGA.A6.5665.01", "Signaling by GPCR"], {"weight": 0.936580419837999}], ["PPP2CB", ["TCGA.AY.6197.01", "Muscle contraction"], {"weight": 0.93002500677677}], ["PPP2CB", ["TCGA.AY.6197.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.912166090465291}], ["PPP2CB", ["TCGA.AY.6197.01", "Regulation of insulin secretion"], {"weight": 0.886767943840777}], ["CHSY3", ["TCGA.D5.6529.01", "Collagen chain trimerization"], {"weight": 0.883712780663736}], ["CHSY3", ["TCGA.D5.6529.01", "Collagen degradation"], {"weight": 0.867333696378487}], ["THSD7A", ["TCGA.AZ.4615.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.889584685739514}], ["THSD7A", ["TCGA.CA.5797.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.476784418341691}], ["CSF1", ["TCGA.G4.6304.01", "Integrin cell surface interactions"], {"weight": 0.906206756150591}], ["CNTN2", ["TCGA.F4.6704.01", "Neurotransmitter release cycle"], {"weight": 0.841144185040212}], ["CNTN2", ["TCGA.F4.6856.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.873846701307293}], ["CNTN6", ["TCGA.AD.6890.01", "Blood group systems biosynthesis"], {"weight": 0.78826156012657}], ["CNTN6", ["TCGA.AD.6890.01", "L1CAM interactions"], {"weight": 0.882798452470473}], ["CNTN6", ["TCGA.AD.6890.01", "Lewis blood group biosynthesis"], {"weight": 0.776754129370455}], ["CNTN6", ["TCGA.AD.6895.01", "L1CAM interactions"], {"weight": 0.900299222130971}], ["CNTN6", ["TCGA.AD.6965.01", "Blood group systems biosynthesis"], {"weight": 0.693732072364954}], ["CNTN6", ["TCGA.G4.6320.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.860782020451609}], ["IQGAP1", ["TCGA.A6.5665.01", "Voltage gated Potassium channels"], {"weight": 0.90237272867737}], ["IQGAP1", ["TCGA.F4.6570.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.915252688150109}], ["PCCB", ["TCGA.D5.6532.01", "Signaling by Retinoic Acid"], {"weight": 0.805475626357299}], ["GPSM1", ["TCGA.CM.5862.01", "Regulation of Complement cascade"], {"weight": 0.82537551909034}], ["GPSM1", ["TCGA.D5.6540.01", "GPCR ligand binding"], {"weight": 0.944283773339463}], ["GPSM1", ["TCGA.D5.6540.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.918949069967312}], ["GATA3", ["TCGA.AY.6197.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.83963997708148}], ["LAMA1", ["TCGA.A6.6780.01", "Collagen formation"], {"weight": 0.94276514157153}], ["LAMA1", ["TCGA.D5.5540.01", "NCAM1 interactions"], {"weight": 0.94269922847464}], ["LAMA4", ["TCGA.CK.5913.01", "Extracellular matrix organization"], {"weight": 0.880778755393128}], ["LAMA4", ["TCGA.DM.A282.01", "Extracellular matrix organization"], {"weight": 0.819025990117831}], ["LAMA4", ["TCGA.DM.A282.01", "Regulation of actin dynamics for phagocytic cup formation"], {"weight": 0.881554080078878}], ["LAMA4", ["TCGA.G4.6321.01", "ECM proteoglycans"], {"weight": 0.886870864881683}], ["LAMA5", ["TCGA.A6.6780.01", "Glycosaminoglycan metabolism"], {"weight": 0.847102434459905}], ["LAMA5", ["TCGA.A6.6781.01", "Extracellular matrix organization"], {"weight": 0.933886497606023}], ["LAMA5", ["TCGA.AA.3511.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.355922481677449}], ["LAMA5", ["TCGA.AA.3511.01", "ECM proteoglycans"], {"weight": 0.854898760122423}], ["LAMA5", ["TCGA.AA.3697.01", "Presynaptic nicotinic acetylcholine receptors"], {"weight": 0.781443573214263}], ["LAMA5", ["TCGA.AA.3697.01", "Acetylcholine binding and downstream events"], {"weight": 0.781443573214263}], ["LAMA5", ["TCGA.AA.3697.01", "Postsynaptic nicotinic acetylcholine receptors"], {"weight": 0.781443573214263}], ["LAMA5", ["TCGA.AA.3697.01", "Glycosaminoglycan metabolism"], {"weight": 0.824307247783205}], ["LAMA5", ["TCGA.AD.6901.01", "Glycosaminoglycan metabolism"], {"weight": 0.70350490086934}], ["LAMA5", ["TCGA.AZ.6603.01", "Biological oxidations"], {"weight": 0.898897644859018}], ["LAMA5", ["TCGA.AZ.6603.01", "Phase II - Conjugation of compounds"], {"weight": 0.832016986952992}], ["LAMA5", ["TCGA.AZ.6603.01", "Glucuronidation"], {"weight": 0.835765402716809}], ["LAMA5", ["TCGA.AZ.6603.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.756644821692533}], ["LAMA5", ["TCGA.CM.6162.01", "Extracellular matrix organization"], {"weight": 0.900261545770062}], ["LAMA5", ["TCGA.CM.6169.01", "Glycosaminoglycan metabolism"], {"weight": 0.730955177785429}], ["LAMA5", ["TCGA.G4.6297.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.919357980956534}], ["LAMA5", ["TCGA.G4.6297.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.525798166032352}], ["LAMA5", ["TCGA.G4.6297.01", "ECM proteoglycans"], {"weight": 0.848106435144578}], ["F2", ["TCGA.CM.4750.01", "GABA B receptor activation"], {"weight": 0.914483260879041}], ["F2", ["TCGA.CM.4750.01", "Activation of GABAB receptors"], {"weight": 0.914483260879041}], ["F2", ["TCGA.CM.4750.01", "Peptide hormone metabolism"], {"weight": 0.76362161244506}], ["F2", ["TCGA.D5.6927.01", "Peptide hormone metabolism"], {"weight": 0.713550819064659}], ["F2", ["TCGA.DM.A1DA.01", "Intrinsic Pathway of Fibrin Clot Formation"], {"weight": 0.909971814796451}], ["F2", ["TCGA.DM.A1DA.01", "IRS-related events triggered by IGF1R"], {"weight": 0.896000535481971}], ["F2", ["TCGA.DM.A1DA.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.896000535481971}], ["F2", ["TCGA.DM.A1DA.01", "IGF1R signaling cascade"], {"weight": 0.896000535481971}], ["F2", ["TCGA.DM.A1DA.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.753568184313546}], ["KCND2", ["TCGA.D5.6538.01", "Potassium Channels"], {"weight": 0.957892003064303}], ["KCND2", ["TCGA.D5.6538.01", "Voltage gated Potassium channels"], {"weight": 0.890828576556102}], ["KCND2", ["TCGA.G4.6323.01", "Neuronal System"], {"weight": 0.779716782744424}], ["KCND2", ["TCGA.G4.6323.01", "Cardiac conduction"], {"weight": 0.892672518733516}], ["KCND2", ["TCGA.G4.6323.01", "Potassium Channels"], {"weight": 0.936201142166902}], ["SERPING1", ["TCGA.G4.6297.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.545002547178613}], ["SERPING1", ["TCGA.G4.6297.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.812939079122109}], ["SERPING1", ["TCGA.G4.6297.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.691835788224216}], ["THBS2", ["TCGA.A6.6650.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.884956136095844}], ["THBS2", ["TCGA.A6.6650.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.884956136095844}], ["THBS2", ["TCGA.CM.6165.01", "Extracellular matrix organization"], {"weight": 0.856929536801214}], ["THBS2", ["TCGA.CM.6165.01", "TNFs bind their physiological receptors"], {"weight": 0.275952135985091}], ["THBS2", ["TCGA.DM.A1HA.01", "Integrin cell surface interactions"], {"weight": 0.926837559983063}], ["THBS2", ["TCGA.DM.A1HA.01", "O-linked glycosylation"], {"weight": 0.945660172928454}], ["THBS2", ["TCGA.DM.A1HA.01", "Collagen formation"], {"weight": 0.937184098221421}], ["THBS2", ["TCGA.DM.A1HA.01", "Elastic fibre formation"], {"weight": 0.922261871721797}], ["THBS2", ["TCGA.DM.A1HA.01", "Defective B3GALTL causes PpS"], {"weight": 0.932453559455844}], ["THBS2", ["TCGA.DM.A1HA.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.932436205921479}], ["THBS2", ["TCGA.DM.A1HA.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.935566873737467}], ["THBS2", ["TCGA.G4.6298.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.905446137809102}], ["THBS2", ["TCGA.G4.6298.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.905446137809102}], ["THBS2", ["TCGA.G4.6298.01", "Diseases of Immune System"], {"weight": 0.885213576605372}], ["THBS2", ["TCGA.G4.6298.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.885213576605372}], ["THBS2", ["TCGA.G4.6303.01", "Extracellular matrix organization"], {"weight": 0.838827098623668}], ["RNF165", ["TCGA.CK.4952.01", "Neurexins and neuroligins"], {"weight": 0.93645351691057}], ["PELI1", ["TCGA.A6.6654.01", "TNFs bind their physiological receptors"], {"weight": 0.0132859173653149}], ["CREBBP", ["TCGA.A6.5665.01", "Regulation of insulin secretion"], {"weight": 0.938500610316351}], ["CREBBP", ["TCGA.AM.5820.01", "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"], {"weight": 0.844318098082479}], ["CREBBP", ["TCGA.AM.5820.01", "FOXO-mediated transcription"], {"weight": 0.798526506738791}], ["CREBBP", ["TCGA.AU.6004.01", "Integration of energy metabolism"], {"weight": 0.919605606644584}], ["CREBBP", ["TCGA.AU.6004.01", "Regulation of insulin secretion"], {"weight": 0.907353476519462}], ["CREBBP", ["TCGA.AZ.6599.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.797673134185867}], ["CREBBP", ["TCGA.AZ.6599.01", "Drug ADME"], {"weight": 0.893945673171632}], ["CREBBP", ["TCGA.AZ.6599.01", "Regulation of insulin secretion"], {"weight": 0.885597527654691}], ["CREBBP", ["TCGA.AZ.6599.01", "Diseases of Immune System"], {"weight": 0.856579908050471}], ["CREBBP", ["TCGA.AZ.6599.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.856579908050471}], ["CREBBP", ["TCGA.AZ.6599.01", "Cytokine Signaling in Immune system"], {"weight": 0.885796660095352}], ["CREBBP", ["TCGA.AZ.6599.01", "Signaling by Interleukins"], {"weight": 0.881167632367546}], ["CREBBP", ["TCGA.CM.6168.01", "Ethanol oxidation"], {"weight": -0.0316437503580192}], ["CREBBP", ["TCGA.CM.6171.01", "Post-translational protein phosphorylation"], {"weight": 0.789385276763041}], ["CREBBP", ["TCGA.D5.6540.01", "Regulation of insulin secretion"], {"weight": 0.943355922213714}], ["CREBBP", ["TCGA.D5.6540.01", "Cardiac conduction"], {"weight": 0.958315666362032}], ["CREBBP", ["TCGA.D5.6540.01", "Integration of energy metabolism"], {"weight": 0.931102753737338}], ["CREBBP", ["TCGA.F4.6808.01", "Adaptive Immune System"], {"weight": 0.908843207973852}], ["CREBBP", ["TCGA.F4.6808.01", "Cardiac conduction"], {"weight": 0.944106984399568}], ["CREBBP", ["TCGA.F4.6808.01", "Regulation of insulin secretion"], {"weight": 0.93166162572657}], ["CREBBP", ["TCGA.F4.6808.01", "Integration of energy metabolism"], {"weight": 0.933606338982223}], ["CREBBP", ["TCGA.F4.6808.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.906371496936794}], ["CREBBP", ["TCGA.F4.6808.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.859777864921245}], ["CREBBP", ["TCGA.F4.6808.01", "Diseases of Immune System"], {"weight": 0.879152565619225}], ["CREBBP", ["TCGA.F4.6808.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.879152565619225}], ["CREBBP", ["TCGA.G4.6311.01", "Regulation of insulin secretion"], {"weight": 0.906566506122363}], ["CREBBP", ["TCGA.G4.6311.01", "Integration of energy metabolism"], {"weight": 0.884996771890978}], ["CREBBP", ["TCGA.G4.6625.01", "Phase II - Conjugation of compounds"], {"weight": 0.85465532711998}], ["CREBBP", ["TCGA.G4.6628.01", "Metabolism"], {"weight": 0.911330396311831}], ["CREBBP", ["TCGA.G4.6628.01", "Regulation of insulin secretion"], {"weight": 0.92965765908662}], ["CREBBP", ["TCGA.G4.6628.01", "Integration of energy metabolism"], {"weight": 0.935821044412275}], ["OR51E1", ["TCGA.A6.6140.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.83010558118453}], ["OR51E1", ["TCGA.CK.5913.01", "GPCR ligand binding"], {"weight": 0.951054775028927}], ["OR51E1", ["TCGA.DM.A28F.01", "G alpha (i) signalling events"], {"weight": 0.940966812859684}], ["OR51E1", ["TCGA.DM.A28F.01", "GPCR ligand binding"], {"weight": 0.930226399651397}], ["OR51E1", ["TCGA.DM.A28F.01", "Leishmania parasite growth and survival"], {"weight": 0.902478488520922}], ["OR51E1", ["TCGA.DM.A28F.01", "Activation of G protein gated Potassium channels"], {"weight": 0.927969131464439}], ["OR51E1", ["TCGA.DM.A28F.01", "G protein gated Potassium channels"], {"weight": 0.927969131464439}], ["OR51E1", ["TCGA.DM.A28F.01", "G-protein beta:gamma signalling"], {"weight": 0.925583518224542}], ["OR51E1", ["TCGA.DM.A28F.01", "G beta:gamma signalling through BTK"], {"weight": 0.901472453112831}], ["OR51E1", ["TCGA.G4.6299.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.927683643358549}], ["ACTA1", ["TCGA.DM.A0XD.01", "Extracellular matrix organization"], {"weight": 0.890644914770152}], ["ACTA1", ["TCGA.F4.6460.01", "Glucuronidation"], {"weight": 0.643750523985458}], ["ACTA1", ["TCGA.F4.6704.01", "Phase II - Conjugation of compounds"], {"weight": 0.867041066654815}], ["ACTA1", ["TCGA.F4.6704.01", "Drug ADME"], {"weight": 0.904850171868592}], ["ACTA1", ["TCGA.F4.6704.01", "Glucuronidation"], {"weight": 0.774556746284614}], ["ACTA1", ["TCGA.F4.6704.01", "Aspirin ADME"], {"weight": 0.893446561191831}], ["ACTA1", ["TCGA.F4.6704.01", "Collagen chain trimerization"], {"weight": 0.874390511749538}], ["ACTA1", ["TCGA.F4.6704.01", "Glutathione conjugation"], {"weight": 0.820631731369902}], ["HLA-DRA", ["TCGA.A6.6142.01", "Interaction between L1 and Ankyrins"], {"weight": 0.922497351671697}], ["HLA-DRA", ["TCGA.A6.6142.01", "ECM proteoglycans"], {"weight": 0.931917763825842}], ["HLA-DRA", ["TCGA.A6.6142.01", "L1CAM interactions"], {"weight": 0.87559365407774}], ["HLA-DRA", ["TCGA.A6.6142.01", "NCAM1 interactions"], {"weight": 0.917732771824313}], ["HLA-DRA", ["TCGA.A6.6142.01", "NCAM signaling for neurite out-growth"], {"weight": 0.927876267644439}], ["HLA-DRA", ["TCGA.D5.6927.01", "L1CAM interactions"], {"weight": 0.87105882278242}], ["MYH2", ["TCGA.CM.4750.01", "Insulin processing"], {"weight": 0.765498188541666}], ["CADM1", ["TCGA.A6.6137.01", "Transcriptional Regulation by MECP2"], {"weight": 0.501586330421186}], ["PIP5K1C", ["TCGA.G4.6306.01", "Signaling Pathways"], {"weight": 0.91928135242895}], ["PIP5K1C", ["TCGA.G4.6306.01", "G-protein beta:gamma signalling"], {"weight": 0.922318744934069}], ["PIP5K1C", ["TCGA.G4.6306.01", "Developmental Biology"], {"weight": 0.902192752324358}], ["PIP5K1C", ["TCGA.G4.6306.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.908337448479246}], ["PIP5K1C", ["TCGA.G4.6306.01", "CRMPs in Sema3A signaling"], {"weight": 0.91744901048541}], ["PIP5K1C", ["TCGA.G4.6306.01", "Presynaptic function of Kainate receptors"], {"weight": 0.892967436537643}], ["PIP5K1C", ["TCGA.G4.6306.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.905822580867487}], ["PIP5K1C", ["TCGA.G4.6306.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.886593774081191}], ["ARID1A", ["TCGA.AZ.4616.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.782208471971991}], ["ARID1A", ["TCGA.CA.5797.01", "Glucuronidation"], {"weight": 0.83707783866172}], ["ARID1A", ["TCGA.CK.5915.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.781309891732671}], ["USP5", ["TCGA.CM.5860.01", "Biological oxidations"], {"weight": 0.942325893855103}], ["USP5", ["TCGA.CM.5860.01", "Phase II - Conjugation of compounds"], {"weight": 0.859495946470624}], ["CPS1", ["TCGA.D5.5541.01", "APAP ADME"], {"weight": 0.752682600732888}], ["CPS1", ["TCGA.D5.5541.01", "Metabolism"], {"weight": 0.900399807826366}], ["CPS1", ["TCGA.D5.5541.01", "Arachidonic acid metabolism"], {"weight": 0.809916734805028}], ["GALNTL6", ["TCGA.AY.6196.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.87824511250935}], ["GALNTL6", ["TCGA.AZ.6601.01", "Defective GALNT3 causes HFTC"], {"weight": 0.883034242632463}], ["GALNTL6", ["TCGA.AZ.6601.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.883034242632463}], ["GALNTL6", ["TCGA.AZ.6601.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.883034242632463}], ["MATN3", ["TCGA.A6.6781.01", "Integrin cell surface interactions"], {"weight": 0.929470927255562}], ["KRT2", ["TCGA.CM.4748.01", "Keratinization"], {"weight": 0.464377792816889}], ["KRT2", ["TCGA.DM.A0X9.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.76504337738859}], ["CES5A", ["TCGA.A6.5665.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.92280362403851}], ["CES5A", ["TCGA.A6.5665.01", "Retinoid metabolism and transport"], {"weight": 0.92280362403851}], ["CES5A", ["TCGA.AZ.6600.01", "Aspirin ADME"], {"weight": 0.895935511624242}], ["CES5A", ["TCGA.AZ.6600.01", "Biological oxidations"], {"weight": 0.814678770225795}], ["CES5A", ["TCGA.AZ.6600.01", "Drug ADME"], {"weight": 0.910794179395287}], ["CES5A", ["TCGA.D5.6535.01", "Biological oxidations"], {"weight": 0.91414119934322}], ["CES5A", ["TCGA.D5.6535.01", "Drug ADME"], {"weight": 0.898755229926288}], ["CES5A", ["TCGA.D5.6535.01", "Ethanol oxidation"], {"weight": 0.802399004662434}], ["CES5A", ["TCGA.D5.6535.01", "RA biosynthesis pathway"], {"weight": 0.801990014430094}], ["NAGA", ["TCGA.A6.5665.01", "Blood group systems biosynthesis"], {"weight": 0.896906679627633}], ["MUC4", ["TCGA.AZ.4615.01", "O-linked glycosylation"], {"weight": 0.918262270492393}], ["MUC4", ["TCGA.AZ.4615.01", "O-linked glycosylation of mucins"], {"weight": 0.940462175376124}], ["MUC4", ["TCGA.CK.5915.01", "Blood group systems biosynthesis"], {"weight": 0.93259005946694}], ["MUC4", ["TCGA.CK.5915.01", "Lewis blood group biosynthesis"], {"weight": 0.934289713196481}], ["MUC4", ["TCGA.CK.5915.01", "Sialic acid metabolism"], {"weight": 0.611889683183905}], ["MUC4", ["TCGA.CK.5915.01", "Keratan sulfate biosynthesis"], {"weight": 0.946274920903949}], ["MUC4", ["TCGA.CM.5868.01", "Blood group systems biosynthesis"], {"weight": 0.591715643888227}], ["MUC4", ["TCGA.D5.6531.01", "Blood group systems biosynthesis"], {"weight": 0.770996977477653}], ["MUC4", ["TCGA.D5.6531.01", "Lewis blood group biosynthesis"], {"weight": 0.820308656367763}], ["MUC4", ["TCGA.DM.A28H.01", "Blood group systems biosynthesis"], {"weight": 0.939054281083117}], ["MUC4", ["TCGA.DM.A28H.01", "Lewis blood group biosynthesis"], {"weight": 0.939759831651656}], ["MUC4", ["TCGA.G4.6294.01", "Sialic acid metabolism"], {"weight": 0.6404741003481}], ["MUC4", ["TCGA.G4.6294.01", "Keratan sulfate biosynthesis"], {"weight": 0.93400389413001}], ["MUC4", ["TCGA.G4.6323.01", "Keratan sulfate biosynthesis"], {"weight": 0.883792115856475}], ["MUC4", ["TCGA.G4.6323.01", "Glycosaminoglycan metabolism"], {"weight": 0.702428755699883}], ["MUC4", ["TCGA.G4.6323.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.883792115856475}], ["COLEC11", ["TCGA.G4.6298.01", "Classical antibody-mediated complement activation"], {"weight": 0.740974929904271}], ["COLEC11", ["TCGA.G4.6298.01", "Initial triggering of complement"], {"weight": 0.783860780694962}], ["COLEC11", ["TCGA.G4.6298.01", "Creation of C4 and C2 activators"], {"weight": 0.835567010969344}], ["CES3", ["TCGA.CM.5861.01", "Aspirin ADME"], {"weight": 0.952291720220665}], ["DLK1", ["TCGA.G4.6306.01", "Blood group systems biosynthesis"], {"weight": 0.781374779838953}], ["ADD3", ["TCGA.CM.6676.01", "Signaling Pathways"], {"weight": 0.867526791375572}], ["CYP7B1", ["TCGA.A6.5665.01", "Phase I - Functionalization of compounds"], {"weight": 0.954298561505037}], ["CYP7B1", ["TCGA.A6.5665.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.852797259221355}], ["CYP7B1", ["TCGA.A6.5665.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.753136046949291}], ["CYP7B1", ["TCGA.CA.6718.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.928186358322174}], ["CYP7B1", ["TCGA.CA.6718.01", "Phase I - Functionalization of compounds"], {"weight": 0.952824662226043}], ["CYP7B1", ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.914249533772203}], ["CYP7B1", ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.84933982436778}], ["CYP7B1", ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.916604634587442}], ["CYP7B1", ["TCGA.CK.5916.01", "Biological oxidations"], {"weight": 0.916085200045598}], ["CYP7B1", ["TCGA.D5.6931.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.673423269098129}], ["CYP7B1", ["TCGA.G4.6320.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.767058867921636}], ["CYP27B1", ["TCGA.F4.6807.01", "Biological oxidations"], {"weight": 0.893135364983846}], ["FUT1", ["TCGA.AY.6197.01", "Lewis blood group biosynthesis"], {"weight": 0.818038441712944}], ["FUT1", ["TCGA.CK.5916.01", "Keratan sulfate biosynthesis"], {"weight": 0.893730675195688}], ["SRCAP", ["TCGA.AY.6196.01", "Triglyceride biosynthesis"], {"weight": 0.764329161349574}], ["ASIC2", ["TCGA.CM.4744.01", "Ion channel transport"], {"weight": 0.95704682004586}], ["ADCY7", ["TCGA.A6.5666.01", "Complement cascade"], {"weight": 0.921306326868632}], ["ADCY7", ["TCGA.A6.5666.01", "Regulation of Complement cascade"], {"weight": 0.898064714264417}], ["ADCY7", ["TCGA.A6.5666.01", "Initial triggering of complement"], {"weight": 0.934787844976771}], ["ADCY7", ["TCGA.A6.5666.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.906329186418223}], ["ADCY7", ["TCGA.A6.5666.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.928171857587316}], ["ADCY7", ["TCGA.A6.5666.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.798571077278152}], ["ADCY7", ["TCGA.AZ.6605.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.543937258834437}], ["NRCAM", ["TCGA.A6.5666.01", "Interaction between L1 and Ankyrins"], {"weight": 0.945177436449654}], ["NRCAM", ["TCGA.A6.5666.01", "Cardiac conduction"], {"weight": 0.91665740485818}], ["NRCAM", ["TCGA.A6.5666.01", "NCAM1 interactions"], {"weight": 0.947455115711954}], ["NRCAM", ["TCGA.A6.5666.01", "Phase 0 - rapid depolarisation"], {"weight": 0.946785271420293}], ["NRCAM", ["TCGA.A6.5666.01", "NCAM signaling for neurite out-growth"], {"weight": 0.948951421972503}], ["NRCAM", ["TCGA.A6.5666.01", "Other interleukin signaling"], {"weight": 0.872733539896507}], ["CHST15", ["TCGA.A6.5666.01", "Keratan sulfate biosynthesis"], {"weight": 0.891370090607327}], ["CHST15", ["TCGA.F4.6459.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.769155647028678}], ["CHST15", ["TCGA.F4.6459.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.757350251275274}], ["SALL4", ["TCGA.A6.5666.01", "Classical antibody-mediated complement activation"], {"weight": 0.706535899522259}], ["SALL4", ["TCGA.A6.5666.01", "Creation of C4 and C2 activators"], {"weight": 0.752695407805626}], ["SALL4", ["TCGA.CM.6166.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.798723114527402}], ["SALL4", ["TCGA.CM.6166.01", "Classical antibody-mediated complement activation"], {"weight": 0.669755985884183}], ["SALL4", ["TCGA.CM.6678.01", "Classical antibody-mediated complement activation"], {"weight": 0.57899327680909}], ["HTR2C", ["TCGA.A6.5666.01", "Chemokine receptors bind chemokines"], {"weight": 0.942545227709562}], ["HTR2C", ["TCGA.A6.5666.01", "Glucagon-type ligand receptors"], {"weight": 0.942752371172416}], ["HTR2C", ["TCGA.A6.5666.01", "GABA receptor activation"], {"weight": 0.931230312645611}], ["HTR2C", ["TCGA.A6.5666.01", "Regulation of FZD by ubiquitination"], {"weight": 0.894824704337993}], ["HTR2C", ["TCGA.A6.5666.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.921266777440809}], ["HTR2C", ["TCGA.A6.5666.01", "Signal amplification"], {"weight": 0.928924825918569}], ["HTR2C", ["TCGA.A6.5666.01", "G alpha (z) signalling events"], {"weight": 0.934930415297959}], ["HTR2C", ["TCGA.A6.5666.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.931205842830729}], ["HTR2C", ["TCGA.A6.5666.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.937090002138189}], ["HTR2C", ["TCGA.A6.5666.01", "G beta:gamma signalling through BTK"], {"weight": 0.931444706372826}], ["HTR2C", ["TCGA.A6.5666.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.928468212146744}], ["HTR2C", ["TCGA.A6.5666.01", "G beta:gamma signalling through CDC42"], {"weight": 0.929855939933306}], ["HTR2C", ["TCGA.A6.5666.01", "GPER1 signaling"], {"weight": 0.934349385333047}], ["HTR2C", ["TCGA.A6.5666.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.934349385333047}], ["HTR2C", ["TCGA.DM.A28F.01", "Chemokine receptors bind chemokines"], {"weight": 0.924768524437929}], ["COL5A1", ["TCGA.A6.5666.01", "Integrin cell surface interactions"], {"weight": 0.930958185889896}], ["COL5A1", ["TCGA.CK.4948.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.900566801896234}], ["COL5A1", ["TCGA.CK.4948.01", "Collagen formation"], {"weight": 0.915040113891249}], ["COL5A1", ["TCGA.CK.4948.01", "Collagen chain trimerization"], {"weight": 0.925664439004031}], ["COL5A1", ["TCGA.CK.4948.01", "O-linked glycosylation"], {"weight": 0.915712173403961}], ["COL5A1", ["TCGA.CK.4948.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.938401019180663}], ["COL5A1", ["TCGA.CM.6163.01", "Collagen chain trimerization"], {"weight": 0.875799303390273}], ["COL5A1", ["TCGA.CM.6163.01", "Collagen formation"], {"weight": 0.884924362524868}], ["COL5A1", ["TCGA.D5.6540.01", "Collagen formation"], {"weight": 0.951833378368082}], ["EFEMP2", ["TCGA.A6.5666.01", "Elastic fibre formation"], {"weight": 0.89321205617923}], ["DSCAM", ["TCGA.A6.5666.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.965000884501559}], ["DSCAM", ["TCGA.A6.5666.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.965000884501559}], ["DSCAM", ["TCGA.A6.5666.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.938857345561912}], ["DSCAM", ["TCGA.A6.5666.01", "Heme degradation"], {"weight": 0.776933977648628}], ["DSCAM", ["TCGA.AA.3712.01", "Formation of axial mesoderm"], {"weight": 0.742923179167379}], ["DSCAM", ["TCGA.AZ.4682.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.886735008227367}], ["DSCAM", ["TCGA.AZ.6603.01", "Drug ADME"], {"weight": 0.809027536274964}], ["DSCAM", ["TCGA.D5.6537.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.690042962577536}], ["DSCAM", ["TCGA.DM.A28F.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.795895192617899}], ["DSCAM", ["TCGA.DM.A28F.01", "Nuclear signaling by ERBB4"], {"weight": 0.810420480178883}], ["DSCAM", ["TCGA.DM.A28F.01", "Signaling by ERBB4"], {"weight": 0.867146771894007}], ["DSCAM", ["TCGA.F4.6809.01", "Drug ADME"], {"weight": 0.795685331473104}], ["DSCAM", ["TCGA.G4.6320.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.69824254466792}], ["TRPV6", ["TCGA.A6.5666.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.939080467931703}], ["TRPV6", ["TCGA.A6.5666.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.917388900940484}], ["TRPV6", ["TCGA.A6.5666.01", "Leishmania parasite growth and survival"], {"weight": 0.917388900940484}], ["TRPV6", ["TCGA.A6.5666.01", "Cytokine Signaling in Immune system"], {"weight": 0.873892877161325}], ["TRPV6", ["TCGA.A6.5666.01", "Leishmania infection"], {"weight": 0.893189533366808}], ["TRPV6", ["TCGA.A6.5666.01", "Parasitic Infection Pathways"], {"weight": 0.893189533366808}], ["FGFR2", ["TCGA.A6.5666.01", "G alpha (i) signalling events"], {"weight": 0.958325772820984}], ["FGFR2", ["TCGA.A6.5666.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.944858280093219}], ["FGFR2", ["TCGA.A6.5666.01", "G-protein beta:gamma signalling"], {"weight": 0.943593622395717}], ["FGFR2", ["TCGA.A6.5666.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.925812033440798}], ["FGFR2", ["TCGA.A6.5666.01", "Presynaptic function of Kainate receptors"], {"weight": 0.91379967392745}], ["FGFR2", ["TCGA.A6.5666.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.924974801339316}], ["FGFR2", ["TCGA.A6.5666.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.929734708367999}], ["FGFR2", ["TCGA.A6.5666.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.905834861889673}], ["FGFR2", ["TCGA.A6.5666.01", "IRS-related events triggered by IGF1R"], {"weight": 0.939070086483155}], ["FGFR2", ["TCGA.A6.5666.01", "IRS-mediated signalling"], {"weight": 0.937420999512909}], ["FGFR2", ["TCGA.A6.5666.01", "G alpha (q) signalling events"], {"weight": 0.941530457042554}], ["FGFR2", ["TCGA.A6.5666.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.939070086483155}], ["FGFR2", ["TCGA.A6.5666.01", "IGF1R signaling cascade"], {"weight": 0.939070086483155}], ["FGFR2", ["TCGA.A6.5666.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.911028773944442}], ["FGFR2", ["TCGA.A6.5666.01", "Phospholipase C-mediated cascade: FGFR1"], {"weight": 0.90281777181906}], ["FGFR2", ["TCGA.AZ.6598.01", "L1CAM interactions"], {"weight": 0.924376880951515}], ["COL4A1", ["TCGA.D5.5537.01", "Collagen chain trimerization"], {"weight": 0.905092975286412}], ["CATSPER1", ["TCGA.A6.5666.01", "Muscle contraction"], {"weight": 0.925896145516105}], ["SEMA3A", ["TCGA.DM.A0XF.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.914284971598361}], ["KLF5", ["TCGA.A6.5666.01", "Biological oxidations"], {"weight": 0.937629774484539}], ["KLF5", ["TCGA.A6.5666.01", "Glucuronidation"], {"weight": 0.821923682862976}], ["KLF5", ["TCGA.A6.5666.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.849549585031453}], ["KLF5", ["TCGA.CM.6161.01", "Glucuronidation"], {"weight": 0.89235986982987}], ["KLF5", ["TCGA.CM.6161.01", "Biological oxidations"], {"weight": 0.944124931850089}], ["KLF5", ["TCGA.CM.6161.01", "Phase II - Conjugation of compounds"], {"weight": 0.89684156810266}], ["KLF5", ["TCGA.CM.6161.01", "Aspirin ADME"], {"weight": 0.905490808611472}], ["KLF5", ["TCGA.F4.6569.01", "Phase II - Conjugation of compounds"], {"weight": 0.800434717992406}], ["KLF5", ["TCGA.F4.6569.01", "Glucuronidation"], {"weight": 0.762881397147031}], ["ASAH1", ["TCGA.A6.5666.01", "Sialic acid metabolism"], {"weight": 0.618091835344129}], ["KCNH5", ["TCGA.A6.5666.01", "Potassium Channels"], {"weight": 0.923181258662537}], ["KCNH5", ["TCGA.A6.5666.01", "Voltage gated Potassium channels"], {"weight": 0.94752260529386}], ["KCNH5", ["TCGA.AA.3697.01", "Neuronal System"], {"weight": 0.905583841027006}], ["KCNH5", ["TCGA.AY.6197.01", "Potassium Channels"], {"weight": 0.944363871103447}], ["KCNH5", ["TCGA.D5.5540.01", "Potassium Channels"], {"weight": 0.965139140187779}], ["KCNH5", ["TCGA.DM.A282.01", "Potassium Channels"], {"weight": 0.895425487249391}], ["KCNH5", ["TCGA.DM.A282.01", "Sensory processing of sound"], {"weight": 0.881887975045239}], ["SCAF8", ["TCGA.A6.5666.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.869838112204201}], ["DNMT3B", ["TCGA.A6.5666.01", "Phase II - Conjugation of compounds"], {"weight": 0.862171920553516}], ["DNMT3B", ["TCGA.D5.6924.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.832185734478417}], ["DNMT3B", ["TCGA.D5.6924.01", "SLC-mediated transmembrane transport"], {"weight": 0.880966906014497}], ["DNMT3B", ["TCGA.D5.6924.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.810530039518247}], ["DNMT3B", ["TCGA.F4.6809.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.636449395136214}], ["ANKHD1", ["TCGA.A6.5666.01", "Signaling by Interleukins"], {"weight": 0.887720438968737}], ["TRPM7", ["TCGA.A6.5666.01", "Ion channel transport"], {"weight": 0.921128061385761}], ["TRPM7", ["TCGA.A6.5666.01", "Transport of small molecules"], {"weight": 0.907442890864721}], ["PDK2", ["TCGA.DM.A1D8.01", "GPCR downstream signalling"], {"weight": 0.954927253765208}], ["PDK2", ["TCGA.DM.A1D8.01", "Signaling by GPCR"], {"weight": 0.952430371469962}], ["PDK2", ["TCGA.DM.A1D8.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.927056822712027}], ["PDK2", ["TCGA.DM.A1D8.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.933134688529596}], ["PDK2", ["TCGA.DM.A1D8.01", "Trafficking of AMPA receptors"], {"weight": 0.940688218550491}], ["PDK2", ["TCGA.DM.A1D8.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.940688218550491}], ["DOCK9", ["TCGA.A6.6653.01", "GABA receptor activation"], {"weight": 0.911961391737677}], ["DOCK9", ["TCGA.DM.A28M.01", "HSF1-dependent transactivation"], {"weight": 0.815105730826293}], ["DOCK9", ["TCGA.DM.A28M.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.879199972515231}], ["DOCK9", ["TCGA.F4.6704.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.790961237908694}], ["EPHA3", ["TCGA.A6.5667.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.87500739437672}], ["EPHA3", ["TCGA.DM.A1D0.01", "Generation of second messenger molecules"], {"weight": 0.958205352446975}], ["EPHA3", ["TCGA.DM.A1D0.01", "PD-1 signaling"], {"weight": 0.955343198543189}], ["EPHA3", ["TCGA.DM.A1D0.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.958057957046367}], ["EPHA3", ["TCGA.DM.A1D0.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.956031908758636}], ["EPHA3", ["TCGA.DM.A1D0.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.966376690802839}], ["EPHA3", ["TCGA.DM.A1D0.01", "Costimulation by the CD28 family"], {"weight": 0.944825561221512}], ["EPHA3", ["TCGA.DM.A1D0.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.93029249737971}], ["EPHA3", ["TCGA.DM.A1D0.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.919493933238596}], ["EPHA3", ["TCGA.DM.A1D7.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.885795488051498}], ["OBSL1", ["TCGA.AA.3662.01", "Ethanol oxidation"], {"weight": 0.801291966202714}], ["OBSL1", ["TCGA.AA.3662.01", "RA biosynthesis pathway"], {"weight": 0.799292349491639}], ["OBSL1", ["TCGA.CM.6161.01", "RA biosynthesis pathway"], {"weight": 0.779916902538605}], ["OBSL1", ["TCGA.CM.6161.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.734514609328229}], ["GRIN3B", ["TCGA.A6.5667.01", "G alpha (s) signalling events"], {"weight": 0.949871271918452}], ["GRIN3B", ["TCGA.AA.3662.01", "Neuronal System"], {"weight": 0.864086468964388}], ["GRIN3B", ["TCGA.AA.3662.01", "Transmission across Chemical Synapses"], {"weight": 0.848011782445695}], ["GRIN3B", ["TCGA.AA.3662.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.726464247653676}], ["GRIN3B", ["TCGA.AA.3697.01", "Transmission across Chemical Synapses"], {"weight": 0.894181832823351}], ["GRIN3B", ["TCGA.AA.3697.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.905934307018484}], ["GRIN3B", ["TCGA.AA.3697.01", "Regulation of insulin secretion"], {"weight": 0.89483908115289}], ["GRIN3B", ["TCGA.AA.3697.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.874243677318078}], ["GRIN3B", ["TCGA.AY.6386.01", "Neuronal System"], {"weight": 0.92127644632276}], ["GRIN3B", ["TCGA.AY.6386.01", "Transmission across Chemical Synapses"], {"weight": 0.907400624517328}], ["GRIN3B", ["TCGA.AY.6386.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.883972293939002}], ["GRIN3B", ["TCGA.AY.6386.01", "Neurexins and neuroligins"], {"weight": 0.926480511718633}], ["GRIN3B", ["TCGA.AZ.5407.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.924147102920095}], ["GRIN3B", ["TCGA.AZ.5407.01", "Long-term potentiation"], {"weight": 0.917081604647254}], ["GRIN3B", ["TCGA.AZ.5407.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.908041199328579}], ["GRIN3B", ["TCGA.AZ.5407.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.915101023987881}], ["GRIN3B", ["TCGA.AZ.6598.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.842458942596737}], ["GRIN3B", ["TCGA.D5.6537.01", "G alpha (s) signalling events"], {"weight": 0.960055155555339}], ["GRIN3B", ["TCGA.D5.6537.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.846091541316907}], ["GRIN3B", ["TCGA.D5.6537.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.890097935861755}], ["GRIN3B", ["TCGA.D5.7000.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.885943696906742}], ["GRIN3B", ["TCGA.D5.7000.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.884393894931318}], ["GRIN3B", ["TCGA.D5.7000.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.822786928778538}], ["GRIN3B", ["TCGA.G4.6294.01", "G alpha (i) signalling events"], {"weight": 0.945268940413058}], ["GRIN3B", ["TCGA.G4.6294.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.904448222897124}], ["GRIN3B", ["TCGA.G4.6294.01", "Synaptic adhesion-like molecules"], {"weight": 0.898901163954062}], ["GRIN3B", ["TCGA.G4.6294.01", "Sensory perception of taste"], {"weight": 0.899785080680757}], ["GRIN3B", ["TCGA.G4.6294.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.885719090135022}], ["GRIN3B", ["TCGA.G4.6311.01", "G alpha (s) signalling events"], {"weight": 0.935238669244367}], ["RHOT2", ["TCGA.A6.5667.01", "Signaling by GPCR"], {"weight": 0.934721713789804}], ["RHOT2", ["TCGA.A6.5667.01", "GPCR downstream signalling"], {"weight": 0.939447569701794}], ["RHOT2", ["TCGA.AM.5821.01", "Signaling by GPCR"], {"weight": 0.949906773407993}], ["RHOT2", ["TCGA.AM.5821.01", "GPCR downstream signalling"], {"weight": 0.949418855103937}], ["RHOT2", ["TCGA.D5.6540.01", "GPCR downstream signalling"], {"weight": 0.948044786009186}], ["RHOT2", ["TCGA.D5.6540.01", "Signaling by GPCR"], {"weight": 0.946749605450788}], ["RHOT2", ["TCGA.D5.6540.01", "G alpha (12/13) signalling events"], {"weight": 0.916503314994494}], ["KCNJ16", ["TCGA.A6.5667.01", "G alpha (i) signalling events"], {"weight": 0.926141748179695}], ["KCNJ16", ["TCGA.A6.5667.01", "GPCR ligand binding"], {"weight": 0.902408160151172}], ["KCNJ16", ["TCGA.A6.5667.01", "Signal amplification"], {"weight": 0.847026259525696}], ["KCNJ16", ["TCGA.A6.5667.01", "Glucagon-type ligand receptors"], {"weight": 0.889391428117967}], ["KCNJ16", ["TCGA.A6.5667.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.887663252874977}], ["KCNJ16", ["TCGA.A6.5667.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.881474092824304}], ["KCNJ16", ["TCGA.A6.5667.01", "G-protein beta:gamma signalling"], {"weight": 0.903076109463256}], ["KCNJ16", ["TCGA.A6.5667.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.821378706257096}], ["KCNJ16", ["TCGA.A6.5667.01", "G beta:gamma signalling through BTK"], {"weight": 0.885681142382958}], ["KCNJ16", ["TCGA.A6.5667.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.865331412353353}], ["KCNJ16", ["TCGA.A6.5667.01", "Leishmania parasite growth and survival"], {"weight": 0.865331412353353}], ["KCNJ16", ["TCGA.A6.5667.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.880427383152831}], ["KCNJ16", ["TCGA.A6.5667.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.882227515683483}], ["KCNJ16", ["TCGA.A6.5667.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.883441355431716}], ["KCNJ16", ["TCGA.AD.6895.01", "Potassium Channels"], {"weight": 0.890675420873678}], ["GRP", ["TCGA.A6.5667.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.791862871657635}], ["GRP", ["TCGA.CM.6680.01", "Signaling by GPCR"], {"weight": 0.893792580796757}], ["GRP", ["TCGA.CM.6680.01", "GPCR downstream signalling"], {"weight": 0.912306755134022}], ["TGFB1", ["TCGA.A6.5667.01", "Extracellular matrix organization"], {"weight": 0.801472663461788}], ["TGFB1", ["TCGA.AY.6386.01", "Regulation of Complement cascade"], {"weight": 0.84320438869256}], ["TGFB1", ["TCGA.AY.6386.01", "Complement cascade"], {"weight": 0.855539411520577}], ["TGFB1", ["TCGA.AY.6386.01", "Peptide ligand-binding receptors"], {"weight": 0.94869515858495}], ["TGFB1", ["TCGA.AY.6386.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.94842966914305}], ["TGFB1", ["TCGA.F4.6703.01", "Keratinization"], {"weight": 0.883150307127094}], ["TGFB1", ["TCGA.F4.6703.01", "Formation of the cornified envelope"], {"weight": 0.780942750884443}], ["TGFB1", ["TCGA.F4.6703.01", "Integrin cell surface interactions"], {"weight": 0.898577381369248}], ["TGFB1", ["TCGA.F4.6703.01", "Signaling by Activin"], {"weight": 0.822406191037087}], ["TGFB1", ["TCGA.F4.6703.01", "Diseases of glycosylation"], {"weight": 0.884635958191862}], ["TGFB1", ["TCGA.F4.6703.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.890947646418541}], ["TGFB1", ["TCGA.G4.6321.01", "Diseases of glycosylation"], {"weight": 0.803739841853885}], ["TGFB1", ["TCGA.G4.6321.01", "Diseases of metabolism"], {"weight": 0.792230163634647}], ["SLC16A8", ["TCGA.AA.3712.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.912898317853633}], ["SLC16A8", ["TCGA.AM.5821.01", "Amino acid transport across the plasma membrane"], {"weight": 0.87581910761209}], ["SLC16A8", ["TCGA.AM.5821.01", "SLC-mediated transmembrane transport"], {"weight": 0.914729681727875}], ["SLC16A8", ["TCGA.D5.5541.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.888652905848262}], ["MTDH", ["TCGA.A6.5667.01", "G0 and Early G1"], {"weight": 0.853303875953866}], ["MTDH", ["TCGA.AA.3712.01", "G0 and Early G1"], {"weight": 0.863130239861718}], ["CD7", ["TCGA.AD.6890.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.437181863760399}], ["DTX1", ["TCGA.A6.5667.01", "Blood group systems biosynthesis"], {"weight": 0.801536552111808}], ["DTX1", ["TCGA.A6.5667.01", "Lewis blood group biosynthesis"], {"weight": 0.791754502753403}], ["IGF1R", ["TCGA.AD.6889.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.886305762064636}], ["PHF2", ["TCGA.AZ.5403.01", "Signaling by Retinoic Acid"], {"weight": 0.671350107271905}], ["PHF2", ["TCGA.AZ.5403.01", "Biological oxidations"], {"weight": 0.832007751897435}], ["PHF2", ["TCGA.D5.6929.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.851343102429378}], ["PHF2", ["TCGA.DM.A28E.01", "Cardiac conduction"], {"weight": 0.944145921641307}], ["PHF2", ["TCGA.DM.A28E.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.765768510429359}], ["PHF2", ["TCGA.DM.A28E.01", "Arachidonic acid metabolism"], {"weight": 0.876663023100806}], ["HAP1", ["TCGA.CM.5860.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.918887295352975}], ["ESRRA", ["TCGA.A6.5667.01", "Biological oxidations"], {"weight": 0.843997212460183}], ["OR51S1", ["TCGA.A6.6137.01", "GPCR ligand binding"], {"weight": 0.906704220973169}], ["OR51S1", ["TCGA.A6.6137.01", "G alpha (i) signalling events"], {"weight": 0.82221648466767}], ["OR51S1", ["TCGA.A6.6137.01", "Signaling by GPCR"], {"weight": 0.854177872578248}], ["OR51S1", ["TCGA.A6.6137.01", "GPCR downstream signalling"], {"weight": 0.861860144259177}], ["OR51S1", ["TCGA.A6.6137.01", "Glucagon-type ligand receptors"], {"weight": 0.873244767770455}], ["OR51S1", ["TCGA.A6.6137.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.79631202814854}], ["OR51S1", ["TCGA.A6.6137.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.853111521496979}], ["COL1A2", ["TCGA.A6.6140.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.930453098457605}], ["COL1A2", ["TCGA.A6.6140.01", "Peptide ligand-binding receptors"], {"weight": 0.910757669449038}], ["LRRK2", ["TCGA.A6.6137.01", "Regulation of FZD by ubiquitination"], {"weight": 0.722397472046186}], ["LRRK2", ["TCGA.A6.6648.01", "Regulation of FZD by ubiquitination"], {"weight": 0.825454153540105}], ["LRRK2", ["TCGA.CM.4744.01", "Signaling by GPCR"], {"weight": 0.949513365097405}], ["HOXD4", ["TCGA.A6.6137.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.411152106796596}], ["TCF7L2", ["TCGA.A6.6137.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.70239949558231}], ["TCF7L2", ["TCGA.AU.6004.01", "Peptide hormone metabolism"], {"weight": 0.722887529392897}], ["TCF7L2", ["TCGA.AU.6004.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.713160787334443}], ["TCF7L2", ["TCGA.AZ.5403.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.770812078985427}], ["TCF7L2", ["TCGA.AZ.5403.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.780838476580345}], ["TCF7L2", ["TCGA.CK.4950.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.777591816365152}], ["TCF7L2", ["TCGA.CK.5915.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.934413058886822}], ["TCF7L2", ["TCGA.CK.5915.01", "Glucagon-type ligand receptors"], {"weight": 0.936868109592331}], ["TCF7L2", ["TCGA.CK.5915.01", "Regulation of insulin secretion"], {"weight": 0.913312633302007}], ["TCF7L2", ["TCGA.CM.5349.01", "Phase II - Conjugation of compounds"], {"weight": 0.781469067685038}], ["TCF7L2", ["TCGA.DM.A282.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.713327312389291}], ["TCF7L2", ["TCGA.DM.A282.01", "Peptide hormone metabolism"], {"weight": 0.773786831449604}], ["TCF7L2", ["TCGA.DM.A282.01", "SUMOylation of intracellular receptors"], {"weight": 0.697310992848906}], ["TCF7L2", ["TCGA.DM.A28F.01", "Signaling Pathways"], {"weight": 0.906401382175596}], ["TCF7L2", ["TCGA.DM.A28F.01", "Peptide hormone metabolism"], {"weight": 0.813657204982177}], ["TCF7L2", ["TCGA.F4.6855.01", "Regulation of FZD by ubiquitination"], {"weight": 0.814543030770354}], ["TCF7L2", ["TCGA.F4.6855.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.753838564256857}], ["TCF7L2", ["TCGA.G4.6293.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.855978273385153}], ["TCF7L2", ["TCGA.G4.6293.01", "Keratinization"], {"weight": 0.757686359051558}], ["TCF7L2", ["TCGA.G4.6298.01", "Peptide hormone metabolism"], {"weight": 0.781663850670072}], ["SCN2A", ["TCGA.A6.6137.01", "Interaction between L1 and Ankyrins"], {"weight": 0.878758275787841}], ["SCN2A", ["TCGA.AA.3663.01", "Phase 0 - rapid depolarisation"], {"weight": 0.939170658240929}], ["SCN2A", ["TCGA.AU.3779.01", "Interaction between L1 and Ankyrins"], {"weight": 0.875512973143786}], ["SCN2A", ["TCGA.AU.3779.01", "Phase 4 - resting membrane potential"], {"weight": 0.596292341139515}], ["SCN2A", ["TCGA.CM.4743.01", "Phase 0 - rapid depolarisation"], {"weight": 0.939516030607207}], ["SCN2A", ["TCGA.CM.5861.01", "Phase 0 - rapid depolarisation"], {"weight": 0.945120407311791}], ["SCN2A", ["TCGA.D5.6540.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946920315400741}], ["SCN2A", ["TCGA.G4.6306.01", "Interaction between L1 and Ankyrins"], {"weight": 0.9531918494413}], ["SCN2A", ["TCGA.G4.6306.01", "Phase 0 - rapid depolarisation"], {"weight": 0.947717062034201}], ["SCN2A", ["TCGA.G4.6306.01", "L1CAM interactions"], {"weight": 0.895928374017545}], ["SCN2A", ["TCGA.G4.6315.01", "Interaction between L1 and Ankyrins"], {"weight": 0.942496533537451}], ["SCN2A", ["TCGA.G4.6315.01", "Cardiac conduction"], {"weight": 0.921402346925623}], ["SCN2A", ["TCGA.G4.6315.01", "Phase 0 - rapid depolarisation"], {"weight": 0.927520981666318}], ["SCN2A", ["TCGA.G4.6628.01", "Stimuli-sensing channels"], {"weight": 0.921630867228014}], ["TFEC", ["TCGA.A6.6137.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.840222433596833}], ["TFEC", ["TCGA.A6.6137.01", "Degradation of the extracellular matrix"], {"weight": 0.791662778913608}], ["OPN4", ["TCGA.A6.6137.01", "Peptide ligand-binding receptors"], {"weight": 0.879500355887042}], ["OPN4", ["TCGA.A6.6137.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.879500355887042}], ["OPN4", ["TCGA.AA.3655.01", "Peptide ligand-binding receptors"], {"weight": 0.920376685526893}], ["OPN4", ["TCGA.AA.3655.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.935973754231244}], ["OPN4", ["TCGA.AA.3655.01", "Chemokine receptors bind chemokines"], {"weight": 0.906567031782137}], ["COL3A1", ["TCGA.CM.6164.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.929238229864467}], ["COL3A1", ["TCGA.CM.6164.01", "Glycosaminoglycan metabolism"], {"weight": 0.461849827322255}], ["COL3A1", ["TCGA.CM.6164.01", "Collagen formation"], {"weight": 0.910218128935631}], ["COL3A1", ["TCGA.CM.6164.01", "Degradation of the extracellular matrix"], {"weight": 0.732533897550036}], ["SELP", ["TCGA.CM.6677.01", "Drug ADME"], {"weight": 0.8559456013636}], ["SELP", ["TCGA.CM.6677.01", "Nucleotide catabolism"], {"weight": 0.554665170053515}], ["SELP", ["TCGA.G4.6320.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.896999627596049}], ["SELP", ["TCGA.G4.6320.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.896999627596049}], ["GLRA1", ["TCGA.D5.6538.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.90672069258811}], ["CHIT1", ["TCGA.DM.A1HA.01", "Blood group systems biosynthesis"], {"weight": 0.925137368281979}], ["CHIT1", ["TCGA.DM.A1HA.01", "Synthesis of substrates in N-glycan biosythesis"], {"weight": 0.77314549648995}], ["CHIT1", ["TCGA.DM.A1HA.01", "Lewis blood group biosynthesis"], {"weight": 0.925028188525257}], ["UCKL1", ["TCGA.A6.6138.01", "Biological oxidations"], {"weight": 0.939777919313073}], ["OR2C1", ["TCGA.A6.6138.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.920078446632737}], ["OR2C1", ["TCGA.A6.6138.01", "Potassium Channels"], {"weight": 0.94933414421137}], ["OR2C1", ["TCGA.A6.6138.01", "Regulation of insulin secretion"], {"weight": 0.901732840583945}], ["OR2C1", ["TCGA.A6.6138.01", "Phase 4 - resting membrane potential"], {"weight": 0.809361049397848}], ["OR2C1", ["TCGA.A6.6138.01", "Integration of energy metabolism"], {"weight": 0.879184554493758}], ["OR2C1", ["TCGA.A6.6138.01", "G alpha (i) signalling events"], {"weight": 0.914238575548133}], ["OR2C1", ["TCGA.A6.6138.01", "GPCR ligand binding"], {"weight": 0.918008034090947}], ["NRP2", ["TCGA.AA.3663.01", "Interaction between L1 and Ankyrins"], {"weight": 0.941562946204247}], ["UCKL1", ["TCGA.A6.6138.01", "Phase I - Functionalization of compounds"], {"weight": 0.89030480477346}], ["PLCG2", ["TCGA.AZ.6598.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.899761654588537}], ["PLCG2", ["TCGA.AZ.6598.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.885992669858034}], ["PLCG2", ["TCGA.F4.6463.01", "Activated point mutants of FGFR2"], {"weight": 0.912924080870534}], ["PLCG2", ["TCGA.F4.6463.01", "Phospholipase C-mediated cascade; FGFR2"], {"weight": 0.912924080870534}], ["PLCG2", ["TCGA.F4.6463.01", "FGFR2 ligand binding and activation"], {"weight": 0.912924080870534}], ["PLCG2", ["TCGA.F4.6463.01", "FGFR2c ligand binding and activation"], {"weight": 0.909021987468353}], ["PLCG2", ["TCGA.F4.6463.01", "PI-3K cascade:FGFR2"], {"weight": 0.912924080870534}], ["PLCG2", ["TCGA.F4.6463.01", "SHC-mediated cascade:FGFR2"], {"weight": 0.912924080870534}], ["PLCG2", ["TCGA.F4.6463.01", "FRS-mediated FGFR2 signaling"], {"weight": 0.912924080870534}], ["PLCG2", ["TCGA.F4.6463.01", "Downstream signaling of activated FGFR2"], {"weight": 0.912924080870534}], ["PLCG2", ["TCGA.G4.6586.01", "Neuronal System"], {"weight": 0.953818447876849}], ["PLCG2", ["TCGA.G4.6586.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.939455119283507}], ["ZNF217", ["TCGA.A6.6138.01", "Drug ADME"], {"weight": 0.875923963657643}], ["PAX6", ["TCGA.DM.A28F.01", "Formation of the anterior neural plate"], {"weight": 0.716281676302947}], ["PAX6", ["TCGA.DM.A28K.01", "GPCR ligand binding"], {"weight": 0.947262232396166}], ["PAX6", ["TCGA.DM.A28K.01", "CD22 mediated BCR regulation"], {"weight": 0.824642870175469}], ["RANBP3", ["TCGA.A6.6138.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.868307982095153}], ["RANBP3", ["TCGA.A6.6138.01", "Signaling by Retinoic Acid"], {"weight": 0.60348436233649}], ["TSC2", ["TCGA.A6.6138.01", "Glucuronidation"], {"weight": 0.848628401243995}], ["TSC2", ["TCGA.A6.6138.01", "Carnitine metabolism"], {"weight": 0.622135801403448}], ["TSC2", ["TCGA.G4.6320.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.906906311405319}], ["NLGN4Y", ["TCGA.A6.6138.01", "Neurexins and neuroligins"], {"weight": 0.889799818156845}], ["NLGN4Y", ["TCGA.A6.6138.01", "Protein-protein interactions at synapses"], {"weight": 0.861590252901182}], ["NLGN4Y", ["TCGA.A6.6138.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.853768455861305}], ["NLGN4Y", ["TCGA.AA.3663.01", "Neurexins and neuroligins"], {"weight": 0.95128190270249}], ["NLGN4Y", ["TCGA.AD.6890.01", "Neurexins and neuroligins"], {"weight": 0.881595267329246}], ["MAP1B", ["TCGA.D5.6924.01", "Synaptic adhesion-like molecules"], {"weight": 0.779963997689183}], ["MAP1B", ["TCGA.G4.6317.01", "Developmental Biology"], {"weight": 0.92221338997465}], ["MAP1B", ["TCGA.G4.6317.01", "Nervous system development"], {"weight": 0.922585590807292}], ["PARP3", ["TCGA.G4.6626.01", "Other interleukin signaling"], {"weight": 0.714392070336669}], ["PARP3", ["TCGA.G4.6626.01", "Caspase-mediated cleavage of cytoskeletal proteins"], {"weight": 0.853707898413717}], ["MYH15", ["TCGA.D5.6532.01", "Activation of the phototransduction cascade"], {"weight": 0.828317507354101}], ["SELL", ["TCGA.A6.6138.01", "Extracellular matrix organization"], {"weight": 0.80705605745065}], ["GLI2", ["TCGA.A6.6140.01", "Signaling by GPCR"], {"weight": 0.937335182520785}], ["B3GAT2", ["TCGA.A6.6140.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.824803182472524}], ["ZNF429", ["TCGA.DM.A28F.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.895424385172999}], ["ZNF429", ["TCGA.DM.A28F.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.895424385172999}], ["MAMLD1", ["TCGA.A6.6648.01", "Molecules associated with elastic fibres"], {"weight": 0.704296586626822}], ["MAMLD1", ["TCGA.DM.A1D8.01", "Signaling Pathways"], {"weight": 0.917090793964093}], ["MAMLD1", ["TCGA.DM.A28K.01", "Cardiac conduction"], {"weight": 0.947226474613183}], ["MAMLD1", ["TCGA.DM.A28K.01", "Muscle contraction"], {"weight": 0.942389160052058}], ["POLR3E", ["TCGA.AD.6965.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.883020167453171}], ["POLR3E", ["TCGA.G4.6588.01", "Metabolism of vitamins and cofactors"], {"weight": 0.827918059020732}], ["CD82", ["TCGA.A6.6140.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.865147928570918}], ["SERPINB10", ["TCGA.A6.6140.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.794711953011339}], ["SERPINB10", ["TCGA.A6.6140.01", "Leishmania infection"], {"weight": 0.861222301764572}], ["SERPINB10", ["TCGA.A6.6140.01", "Parasitic Infection Pathways"], {"weight": 0.861222301764572}], ["GP6", ["TCGA.CK.5913.01", "Collagen chain trimerization"], {"weight": 0.927696621541243}], ["GP6", ["TCGA.CM.5868.01", "Collagen chain trimerization"], {"weight": 0.91885839731927}], ["GP6", ["TCGA.CM.5868.01", "NCAM1 interactions"], {"weight": 0.928768850978995}], ["GP6", ["TCGA.CM.5868.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.933767540036591}], ["GP6", ["TCGA.CM.5868.01", "Integrin cell surface interactions"], {"weight": 0.920504972507804}], ["GP6", ["TCGA.CM.5868.01", "NCAM signaling for neurite out-growth"], {"weight": 0.930910282754137}], ["GP6", ["TCGA.D5.6924.01", "Collagen formation"], {"weight": 0.930348030508524}], ["GP6", ["TCGA.D5.6924.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.941320408728281}], ["GP6", ["TCGA.D5.6924.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.91086104827762}], ["GP6", ["TCGA.D5.6924.01", "Collagen chain trimerization"], {"weight": 0.912396721740759}], ["GP6", ["TCGA.D5.6924.01", "Collagen degradation"], {"weight": 0.910171390872394}], ["GP6", ["TCGA.D5.6924.01", "Scavenging by Class A Receptors"], {"weight": 0.644291278179763}], ["PRKACG", ["TCGA.A6.6140.01", "Interaction between L1 and Ankyrins"], {"weight": 0.932424677969895}], ["PRKACG", ["TCGA.A6.6140.01", "Ion homeostasis"], {"weight": 0.930315489512234}], ["PRKACG", ["TCGA.A6.6140.01", "Ca2+ pathway"], {"weight": 0.855943006378797}], ["PRKACG", ["TCGA.AD.5900.01", "Phase 0 - rapid depolarisation"], {"weight": 0.875849516515846}], ["PRKACG", ["TCGA.AY.5543.01", "Cardiac conduction"], {"weight": 0.93968211536068}], ["PRKACG", ["TCGA.AY.5543.01", "Muscle contraction"], {"weight": 0.942312730181609}], ["PRKACG", ["TCGA.AY.5543.01", "Signaling Pathways"], {"weight": 0.893332098153531}], ["PRKACG", ["TCGA.AY.5543.01", "L1CAM interactions"], {"weight": 0.913629241921435}], ["PRKACG", ["TCGA.AY.5543.01", "Ion homeostasis"], {"weight": 0.936135584611475}], ["OR6C74", ["TCGA.A6.6140.01", "GPCR downstream signalling"], {"weight": 0.941032430609837}], ["OR6C74", ["TCGA.A6.6140.01", "G alpha (s) signalling events"], {"weight": 0.952729603488292}], ["OR6C74", ["TCGA.A6.6140.01", "GABA receptor activation"], {"weight": 0.83370531121991}], ["OR6C74", ["TCGA.AZ.5403.01", "GABA B receptor activation"], {"weight": 0.910871011511906}], ["OR6C74", ["TCGA.AZ.5403.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.911220381523339}], ["OR6C74", ["TCGA.AZ.5403.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.889078208477093}], ["OR6C74", ["TCGA.AZ.5403.01", "Signal amplification"], {"weight": 0.898396178479842}], ["OR6C74", ["TCGA.AZ.5403.01", "Activation of G protein gated Potassium channels"], {"weight": 0.90706097882397}], ["OR6C74", ["TCGA.AZ.5403.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.90706097882397}], ["OR6C74", ["TCGA.AZ.5403.01", "G-protein beta:gamma signalling"], {"weight": 0.903232258276314}], ["TYK2", ["TCGA.A6.6140.01", "Interleukin-10 signaling"], {"weight": 0.775189019877103}], ["TYK2", ["TCGA.A6.6140.01", "Chemokine receptors bind chemokines"], {"weight": 0.908379690060609}], ["TNFRSF10A", ["TCGA.A6.6140.01", "Porphyrin metabolism"], {"weight": 0.598507624604088}], ["PYGL", ["TCGA.A6.6140.01", "Glucuronidation"], {"weight": 0.836992499323366}], ["PYGL", ["TCGA.CM.5862.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.882254310177675}], ["TAS2R16", ["TCGA.DM.A1D8.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.953489524925638}], ["TAS2R16", ["TCGA.DM.A1D8.01", "Peptide ligand-binding receptors"], {"weight": 0.953008421424681}], ["TAS2R16", ["TCGA.DM.A1D8.01", "Chemokine receptors bind chemokines"], {"weight": 0.93293458837481}], ["HSP90B1", ["TCGA.A6.6140.01", "Classical antibody-mediated complement activation"], {"weight": 0.705814977725024}], ["HSP90B1", ["TCGA.A6.6140.01", "Creation of C4 and C2 activators"], {"weight": 0.705814977725024}], ["TFRC", ["TCGA.CA.6718.01", "Transport of small molecules"], {"weight": 0.956356649560645}], ["ARHGAP35", ["TCGA.A6.6140.01", "Signaling Pathways"], {"weight": 0.891314897189912}], ["GSTM4", ["TCGA.A6.6140.01", "Arachidonic acid metabolism"], {"weight": 0.859708267988957}], ["GSTM4", ["TCGA.A6.6140.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.873145256346208}], ["ADAMTS9", ["TCGA.D5.6931.01", "Defective B3GALTL causes PpS"], {"weight": 0.865296578653892}], ["ADAMTS9", ["TCGA.D5.6931.01", "Collagen formation"], {"weight": 0.879886993673546}], ["ADAMTS9", ["TCGA.F4.6808.01", "Lewis blood group biosynthesis"], {"weight": 0.713498530598862}], ["ADAMTS9", ["TCGA.F4.6808.01", "Blood group systems biosynthesis"], {"weight": 0.763018253401876}], ["EPN3", ["TCGA.A6.6140.01", "Phospholipase C-mediated cascade; FGFR2"], {"weight": 0.893095255692532}], ["EPN3", ["TCGA.A6.6140.01", "FGFR2 ligand binding and activation"], {"weight": 0.904488969224476}], ["EPN3", ["TCGA.A6.6140.01", "Activated point mutants of FGFR2"], {"weight": 0.872013728336216}], ["PLEC", ["TCGA.CK.5915.01", "Extracellular matrix organization"], {"weight": 0.896791599460902}], ["PDE6A", ["TCGA.A6.6780.01", "Signaling by GPCR"], {"weight": 0.946584760306965}], ["PDE6A", ["TCGA.A6.6780.01", "GPCR downstream signalling"], {"weight": 0.948293786516912}], ["PDE6A", ["TCGA.A6.6780.01", "G alpha (i) signalling events"], {"weight": 0.943540165150018}], ["PDE6A", ["TCGA.AA.3663.01", "G alpha (i) signalling events"], {"weight": 0.94594706449369}], ["PDE6A", ["TCGA.G4.6304.01", "GPCR ligand binding"], {"weight": 0.954250542554256}], ["PDE6A", ["TCGA.G4.6304.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.944574773905136}], ["PDE6A", ["TCGA.G4.6304.01", "Glucagon-type ligand receptors"], {"weight": 0.931543105925988}], ["COL4A4", ["TCGA.A6.6782.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.63766154805594}], ["COL4A4", ["TCGA.AZ.6601.01", "Collagen chain trimerization"], {"weight": 0.916905375504068}], ["COL4A4", ["TCGA.AZ.6601.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.918656662263057}], ["OR2A5", ["TCGA.A6.6140.01", "G alpha (i) signalling events"], {"weight": 0.938335349152727}], ["OR2A5", ["TCGA.A6.6140.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.863218289493157}], ["OR2A5", ["TCGA.A6.6140.01", "Leishmania parasite growth and survival"], {"weight": 0.863218289493157}], ["OR2A5", ["TCGA.A6.6140.01", "Regulation of insulin secretion"], {"weight": 0.899192216623802}], ["OR2A5", ["TCGA.A6.6140.01", "G alpha (q) signalling events"], {"weight": 0.911135841221836}], ["OR2A5", ["TCGA.A6.6140.01", "Phase 4 - resting membrane potential"], {"weight": 0.794468564609379}], ["OR2A5", ["TCGA.A6.6140.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.894943388847553}], ["OR2A5", ["TCGA.A6.6140.01", "G-protein mediated events"], {"weight": 0.840048259762129}], ["OR2A5", ["TCGA.A6.6140.01", "Opioid Signalling"], {"weight": 0.862389283222695}], ["OR2A5", ["TCGA.A6.6650.01", "GPCR downstream signalling"], {"weight": 0.930513143937353}], ["OR2A5", ["TCGA.A6.6650.01", "G alpha (i) signalling events"], {"weight": 0.932953707820134}], ["OR2A5", ["TCGA.A6.6650.01", "GPCR ligand binding"], {"weight": 0.921974496156975}], ["OR2A5", ["TCGA.A6.6650.01", "G alpha (s) signalling events"], {"weight": 0.949965020897737}], ["OR2A5", ["TCGA.A6.6650.01", "Glucagon-type ligand receptors"], {"weight": 0.925205932190356}], ["OR2A5", ["TCGA.A6.6650.01", "Regulation of insulin secretion"], {"weight": 0.914207403453684}], ["OR2A5", ["TCGA.A6.6650.01", "Potassium Channels"], {"weight": 0.93467541621728}], ["OR2A5", ["TCGA.A6.6650.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.896029285994626}], ["OR2A5", ["TCGA.A6.6650.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.910400123105745}], ["OR2A5", ["TCGA.A6.6650.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.873941677212017}], ["OR2A5", ["TCGA.A6.6650.01", "Leishmania parasite growth and survival"], {"weight": 0.873941677212017}], ["OR2A5", ["TCGA.A6.6650.01", "Peptide hormone metabolism"], {"weight": 0.751553944950306}], ["OR2A5", ["TCGA.A6.6650.01", "Signal amplification"], {"weight": 0.8606428198829}], ["OR2A5", ["TCGA.A6.6650.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.897230206258559}], ["OR2A5", ["TCGA.A6.6650.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.905417300056422}], ["OR2A5", ["TCGA.A6.6650.01", "G beta:gamma signalling through BTK"], {"weight": 0.90076404686036}], ["OR2A5", ["TCGA.A6.6650.01", "G alpha (z) signalling events"], {"weight": 0.898755958341888}], ["OR2A5", ["TCGA.A6.6650.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.902034199740361}], ["OR2A5", ["TCGA.A6.6650.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.837227115803549}], ["OR2A5", ["TCGA.A6.6650.01", "G-protein beta:gamma signalling"], {"weight": 0.912162546750077}], ["OR2A5", ["TCGA.A6.6650.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.905212780670017}], ["OR2A5", ["TCGA.A6.6650.01", "Leishmania infection"], {"weight": 0.865007168989913}], ["OR2A5", ["TCGA.A6.6650.01", "Parasitic Infection Pathways"], {"weight": 0.865007168989913}], ["OR2A5", ["TCGA.A6.6650.01", "Opioid Signalling"], {"weight": 0.870531962827205}], ["OAS1", ["TCGA.A6.6140.01", "Extracellular matrix organization"], {"weight": 0.752966256950554}], ["LDHAL6B", ["TCGA.D5.6529.01", "Metabolism"], {"weight": 0.879896020744044}], ["LDHAL6B", ["TCGA.D5.6529.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.691743854872337}], ["MTMR6", ["TCGA.A6.6140.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.597987097670668}], ["MTMR6", ["TCGA.A6.6651.01", "Metabolism"], {"weight": 0.852970532847809}], ["GMPR", ["TCGA.A6.6140.01", "Platelet homeostasis"], {"weight": 0.819397942556365}], ["GMPR", ["TCGA.A6.6140.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.808682098829344}], ["TRPA1", ["TCGA.AD.6889.01", "Ion channel transport"], {"weight": 0.94226598796473}], ["TRPA1", ["TCGA.AY.6196.01", "SLC-mediated transmembrane transport"], {"weight": 0.746837235362494}], ["AHCYL2", ["TCGA.A6.6140.01", "Biological oxidations"], {"weight": 0.877283879910858}], ["MYO5A", ["TCGA.D5.6532.01", "Generation of second messenger molecules"], {"weight": 0.934565768985754}], ["MYO5A", ["TCGA.D5.6532.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.928310836890526}], ["MYO5A", ["TCGA.D5.6532.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.927298787567862}], ["MYO5A", ["TCGA.D5.6532.01", "PD-1 signaling"], {"weight": 0.928889417418517}], ["MYO5A", ["TCGA.D5.6532.01", "TCR signaling"], {"weight": 0.935633080212164}], ["ARSF", ["TCGA.DM.A0XD.01", "Phase II - Conjugation of compounds"], {"weight": 0.873561934699264}], ["ARSF", ["TCGA.DM.A0XD.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.865299215435438}], ["RNF17", ["TCGA.A6.6652.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.655077072236728}], ["RNF17", ["TCGA.A6.6652.01", "Transport of small molecules"], {"weight": 0.919024510389121}], ["RNF17", ["TCGA.CA.6718.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.908421234614233}], ["RNF17", ["TCGA.CA.6718.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.908421234614233}], ["RNF17", ["TCGA.DM.A28F.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.905357269600748}], ["RNF17", ["TCGA.DM.A28F.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.905357269600748}], ["RNF17", ["TCGA.G4.6628.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.897051631992865}], ["RNF17", ["TCGA.G4.6628.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.897051631992865}], ["ITGAX", ["TCGA.CM.4744.01", "Elastic fibre formation"], {"weight": 0.885997245657288}], ["CFI", ["TCGA.G4.6310.01", "Initial triggering of complement"], {"weight": 0.804215093263844}], ["CFI", ["TCGA.G4.6310.01", "Classical antibody-mediated complement activation"], {"weight": 0.759690605891325}], ["CFI", ["TCGA.G4.6310.01", "Creation of C4 and C2 activators"], {"weight": 0.760994191116776}], ["CFI", ["TCGA.G4.6310.01", "Regulation of Complement cascade"], {"weight": 0.805365981173037}], ["UNC5D", ["TCGA.CK.4948.01", "Degradation of the extracellular matrix"], {"weight": 0.844762892101355}], ["UNC5D", ["TCGA.F4.6569.01", "Degradation of the extracellular matrix"], {"weight": 0.870761663467475}], ["UNC5D", ["TCGA.F4.6569.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.742969184026528}], ["UNC5D", ["TCGA.F4.6569.01", "Trafficking of AMPA receptors"], {"weight": 0.774195254179027}], ["UNC5D", ["TCGA.F4.6569.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.774195254179027}], ["OR8J3", ["TCGA.AA.3502.01", "Signaling by GPCR"], {"weight": 0.934451614199872}], ["OR8J3", ["TCGA.AA.3502.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.902582731916056}], ["OR8J3", ["TCGA.AA.3502.01", "GPCR downstream signalling"], {"weight": 0.940998363573687}], ["OR8J3", ["TCGA.AA.3502.01", "Potassium Channels"], {"weight": 0.957737454388117}], ["OR8J3", ["TCGA.AA.3502.01", "G alpha (z) signalling events"], {"weight": 0.940317156811145}], ["OR8J3", ["TCGA.AA.3502.01", "GABA B receptor activation"], {"weight": 0.937291553260794}], ["OR8J3", ["TCGA.AA.3502.01", "Activation of GABAB receptors"], {"weight": 0.937291553260794}], ["OR8J3", ["TCGA.AA.3502.01", "Signal amplification"], {"weight": 0.91183620263125}], ["OR8J3", ["TCGA.AA.3502.01", "G alpha (i) signalling events"], {"weight": 0.952072720690188}], ["OR8J3", ["TCGA.AA.3502.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.918008127742941}], ["OR8J3", ["TCGA.AA.3502.01", "GABA receptor activation"], {"weight": 0.889914061347595}], ["OR8J3", ["TCGA.AA.3502.01", "Integration of energy metabolism"], {"weight": 0.908844747168833}], ["OR8J3", ["TCGA.AA.3502.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.929330346327554}], ["OR8J3", ["TCGA.AA.3502.01", "GPCR ligand binding"], {"weight": 0.929777773287488}], ["OR8J3", ["TCGA.AA.3502.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.906994538938716}], ["OR8J3", ["TCGA.AA.3502.01", "Inwardly rectifying K+ channels"], {"weight": 0.933834500526555}], ["OR8J3", ["TCGA.AA.3502.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.890967000913417}], ["OR8J3", ["TCGA.AA.3502.01", "Thromboxane signalling through TP receptor"], {"weight": 0.891418265231541}], ["OR8J3", ["TCGA.AA.3502.01", "Regulation of insulin secretion"], {"weight": 0.916731840563692}], ["OR8J3", ["TCGA.AA.3502.01", "Presynaptic function of Kainate receptors"], {"weight": 0.896378553553418}], ["OR8J3", ["TCGA.AA.3502.01", "G alpha (12/13) signalling events"], {"weight": 0.841094361022107}], ["OR8J3", ["TCGA.AA.3502.01", "Activation of G protein gated Potassium channels"], {"weight": 0.927072598178895}], ["OR8J3", ["TCGA.AA.3502.01", "G protein gated Potassium channels"], {"weight": 0.927072598178895}], ["OR8J3", ["TCGA.AA.3502.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.927072598178895}], ["OR8J3", ["TCGA.AA.3502.01", "G beta:gamma signalling through BTK"], {"weight": 0.882223083535854}], ["OR8J3", ["TCGA.AA.3502.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.890239918806349}], ["OR8J3", ["TCGA.AA.3502.01", "Platelet homeostasis"], {"weight": 0.910272286231646}], ["OR8J3", ["TCGA.AA.3502.01", "G-protein activation"], {"weight": 0.912986778985543}], ["OR8J3", ["TCGA.AA.3502.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.899121109398781}], ["OR8J3", ["TCGA.AA.3502.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.882223083535854}], ["OR8J3", ["TCGA.AA.3502.01", "G beta:gamma signalling through CDC42"], {"weight": 0.882223083535854}], ["OR8J3", ["TCGA.AA.3502.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.905805890999143}], ["OR8J3", ["TCGA.AA.3502.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.896482787327214}], ["OR8J3", ["TCGA.AA.3502.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.890909824421784}], ["OR8J3", ["TCGA.AA.3502.01", "G-protein mediated events"], {"weight": 0.887206033107714}], ["OR8J3", ["TCGA.AA.3502.01", "G alpha (q) signalling events"], {"weight": 0.931397986901701}], ["OR8J3", ["TCGA.AA.3502.01", "G-protein beta:gamma signalling"], {"weight": 0.890239918806349}], ["RASA2", ["TCGA.AD.6964.01", "Scavenging of heme from plasma"], {"weight": 0.714631397759931}], ["RGS3", ["TCGA.F4.6856.01", "G alpha (i) signalling events"], {"weight": 0.926922310191544}], ["HIST1H1A", ["TCGA.F4.6855.01", "ECM proteoglycans"], {"weight": 0.752704000003719}], ["UBA6", ["TCGA.F4.6854.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.577102620037726}], ["GOLGB1", ["TCGA.A6.6780.01", "Interaction between L1 and Ankyrins"], {"weight": 0.939614480438065}], ["GOLGB1", ["TCGA.AA.3502.01", "Interaction between L1 and Ankyrins"], {"weight": 0.92388765270624}], ["GOLGB1", ["TCGA.AA.3502.01", "L1CAM interactions"], {"weight": 0.834164696894489}], ["GOLGB1", ["TCGA.D5.6541.01", "Interaction between L1 and Ankyrins"], {"weight": 0.927339098310229}], ["GOLGB1", ["TCGA.D5.6541.01", "GABA receptor activation"], {"weight": 0.858145458324849}], ["GOLGB1", ["TCGA.D5.6541.01", "L1CAM interactions"], {"weight": 0.916771819476376}], ["GOLGB1", ["TCGA.D5.6927.01", "Interaction between L1 and Ankyrins"], {"weight": 0.920800144156834}], ["GOLGB1", ["TCGA.DM.A0XF.01", "Interaction between L1 and Ankyrins"], {"weight": 0.941901447118171}], ["MSR1", ["TCGA.CM.4743.01", "Classical antibody-mediated complement activation"], {"weight": 0.618558661779781}], ["GRIN3A", ["TCGA.AZ.6603.01", "Neuronal System"], {"weight": 0.844951893816661}], ["GRIN3A", ["TCGA.AZ.6603.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.836265180430434}], ["GRIN3A", ["TCGA.AZ.6603.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.836265180430434}], ["GRIN3A", ["TCGA.AZ.6603.01", "Long-term potentiation"], {"weight": 0.836265180430434}], ["GRIN3A", ["TCGA.AZ.6603.01", "Neurexins and neuroligins"], {"weight": 0.819616006122858}], ["GRIN3A", ["TCGA.AZ.6603.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.835642262388681}], ["GRIN3A", ["TCGA.D5.6529.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.85059494926171}], ["GRIN3A", ["TCGA.DM.A1DA.01", "Phase 0 - rapid depolarisation"], {"weight": 0.945608207643663}], ["GRIN3A", ["TCGA.DM.A1DA.01", "Protein-protein interactions at synapses"], {"weight": 0.916082444464677}], ["GRIN3A", ["TCGA.DM.A1DA.01", "Neurexins and neuroligins"], {"weight": 0.934967253634269}], ["OR2L3", ["TCGA.AU.6004.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.889803267852027}], ["OR2L3", ["TCGA.CK.5912.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.917036106025615}], ["OR2L3", ["TCGA.CK.5912.01", "Transmission across Chemical Synapses"], {"weight": 0.909860956671989}], ["OR2L3", ["TCGA.CK.5912.01", "Potassium Channels"], {"weight": 0.957252143364412}], ["OR2L3", ["TCGA.CK.5912.01", "Signaling by GPCR"], {"weight": 0.942354722979441}], ["OR2L3", ["TCGA.CK.5912.01", "GPCR downstream signalling"], {"weight": 0.938589387149803}], ["OR2L3", ["TCGA.CK.5912.01", "G alpha (i) signalling events"], {"weight": 0.940335885490915}], ["OR2L3", ["TCGA.CK.5912.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.91899420350142}], ["OR2L3", ["TCGA.CK.5912.01", "Leishmania parasite growth and survival"], {"weight": 0.91899420350142}], ["OR2L3", ["TCGA.CK.5912.01", "Platelet homeostasis"], {"weight": 0.881120739572009}], ["OR2L3", ["TCGA.CK.5912.01", "Peptide hormone metabolism"], {"weight": 0.781626027660734}], ["OR2L3", ["TCGA.CK.5912.01", "GPCR ligand binding"], {"weight": 0.946754838489346}], ["OR2L3", ["TCGA.CK.5912.01", "Carnitine metabolism"], {"weight": 0.67228416542985}], ["OR2L3", ["TCGA.CK.5912.01", "Voltage gated Potassium channels"], {"weight": 0.865287441656554}], ["OR2L3", ["TCGA.CK.5912.01", "Leishmania infection"], {"weight": 0.865462073431175}], ["OR2L3", ["TCGA.CK.5912.01", "Parasitic Infection Pathways"], {"weight": 0.865462073431175}], ["OR2L3", ["TCGA.CK.5912.01", "Activation of G protein gated Potassium channels"], {"weight": 0.930566683195436}], ["OR2L3", ["TCGA.CK.5912.01", "G protein gated Potassium channels"], {"weight": 0.930566683195436}], ["OR2L3", ["TCGA.CK.5912.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.930566683195436}], ["OR2L3", ["TCGA.CK.5912.01", "Inwardly rectifying K+ channels"], {"weight": 0.936179114432457}], ["OR2L3", ["TCGA.CK.5912.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.903695600346146}], ["OR2L3", ["TCGA.CK.5912.01", "Opioid Signalling"], {"weight": 0.903745826505177}], ["OR2L3", ["TCGA.CK.5912.01", "G-protein beta:gamma signalling"], {"weight": 0.912819547123256}], ["OR2L3", ["TCGA.CK.5912.01", "GABA B receptor activation"], {"weight": 0.93178006406288}], ["OR2L3", ["TCGA.CK.5912.01", "Activation of GABAB receptors"], {"weight": 0.93178006406288}], ["OR2L3", ["TCGA.CK.5912.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.87026539753561}], ["OR2L3", ["TCGA.CK.5912.01", "Signal amplification"], {"weight": 0.907887506434099}], ["OR2L3", ["TCGA.CK.5912.01", "G alpha (q) signalling events"], {"weight": 0.924075851783677}], ["OR2L3", ["TCGA.CK.5912.01", "Glucagon-type ligand receptors"], {"weight": 0.928368835759832}], ["OR2L3", ["TCGA.CK.5912.01", "Ca2+ pathway"], {"weight": 0.843208029382937}], ["OR2L3", ["TCGA.CK.5912.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.91661838977805}], ["DMD", ["TCGA.CM.6675.01", "G alpha (q) signalling events"], {"weight": 0.924001043706525}], ["DMD", ["TCGA.CM.6675.01", "G beta:gamma signalling through CDC42"], {"weight": 0.922229538465068}], ["PAX3", ["TCGA.AD.6890.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.681096667785422}], ["PAX3", ["TCGA.AD.6890.01", "Phase II - Conjugation of compounds"], {"weight": 0.701179691532579}], ["PAX3", ["TCGA.D5.6529.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.49627357006249}], ["PAX3", ["TCGA.D5.6529.01", "Signaling by Retinoic Acid"], {"weight": 0.570653780031378}], ["PAX3", ["TCGA.DM.A28G.01", "Interleukin-10 signaling"], {"weight": 0.835616957837322}], ["PAX3", ["TCGA.DM.A28G.01", "Muscle contraction"], {"weight": 0.902083073995618}], ["PAX3", ["TCGA.DM.A28G.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.744808626628713}], ["OTUD7A", ["TCGA.D5.5540.01", "Eukaryotic Translation Elongation"], {"weight": 0.912620611501088}], ["OTUD7A", ["TCGA.D5.5540.01", "Viral mRNA Translation"], {"weight": 0.919881437680884}], ["OTUD7A", ["TCGA.D5.5540.01", "Peptide chain elongation"], {"weight": 0.919881437680884}], ["OTUD7A", ["TCGA.D5.5540.01", "Eukaryotic Translation Termination"], {"weight": 0.908686286540255}], ["OTUD7A", ["TCGA.D5.5540.01", "Selenocysteine synthesis"], {"weight": 0.919881437680884}], ["OTUD7A", ["TCGA.D5.5540.01", "Response of EIF2AK4 (GCN2) to amino acid deficiency"], {"weight": 0.923213955364332}], ["OTUD7A", ["TCGA.D5.5540.01", "Selenoamino acid metabolism"], {"weight": 0.894174744373768}], ["OTUD7A", ["TCGA.D5.5540.01", "Formation of a pool of free 40S subunits"], {"weight": 0.9213150972148}], ["OTUD7A", ["TCGA.D5.5540.01", "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"], {"weight": 0.919881437680884}], ["OTUD7A", ["TCGA.D5.5540.01", "SARS-CoV-2 modulates host translation machinery"], {"weight": 0.904592624187657}], ["OTUD7A", ["TCGA.D5.5540.01", "Influenza Viral RNA Transcription and Replication"], {"weight": 0.924924906660978}], ["OTUD7A", ["TCGA.D5.5540.01", "Major pathway of rRNA processing in the nucleolus and cytosol"], {"weight": 0.935137855526286}], ["OTUD7A", ["TCGA.D5.5540.01", "Influenza Infection"], {"weight": 0.927312911176043}], ["OTUD7A", ["TCGA.D5.5540.01", "rRNA processing in the nucleus and cytosol"], {"weight": 0.928044989301229}], ["OTUD7A", ["TCGA.D5.5540.01", "L13a-mediated translational silencing of Ceruloplasmin expression"], {"weight": 0.932587681553411}], ["OTUD7A", ["TCGA.D5.5540.01", "SARS-CoV-1 modulates host translation machinery"], {"weight": 0.914750838182782}], ["OTUD7A", ["TCGA.D5.5540.01", "rRNA processing"], {"weight": 0.928044989301229}], ["OTUD7A", ["TCGA.D5.5540.01", "GTP hydrolysis and joining of the 60S ribosomal subunit"], {"weight": 0.921178127574127}], ["OTUD7A", ["TCGA.D5.5540.01", "SRP-dependent cotranslational protein targeting to membrane"], {"weight": 0.921030761715922}], ["OTUD7A", ["TCGA.D5.5540.01", "Nonsense-Mediated Decay (NMD)"], {"weight": 0.920987599856742}], ["OTUD7A", ["TCGA.D5.5540.01", "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"], {"weight": 0.920987599856742}], ["OTUD7A", ["TCGA.D5.5540.01", "Eukaryotic Translation Initiation"], {"weight": 0.921178127574127}], ["OTUD7A", ["TCGA.D5.5540.01", "Cap-dependent Translation Initiation"], {"weight": 0.921178127574127}], ["OTUD7A", ["TCGA.D5.5540.01", "Formation of the ternary complex, and subsequently, the 43S complex"], {"weight": 0.917905799706501}], ["OTUD7A", ["TCGA.D5.5540.01", "Regulation of expression of SLITs and ROBOs"], {"weight": 0.915908480695051}], ["OTUD7A", ["TCGA.D5.5540.01", "Ribosomal scanning and start codon recognition"], {"weight": 0.917905799706501}], ["OTUD7A", ["TCGA.D5.5540.01", "Translation initiation complex formation"], {"weight": 0.917905799706501}], ["OTUD7A", ["TCGA.D5.5540.01", "Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S"], {"weight": 0.917905799706501}], ["OTUD7A", ["TCGA.D5.5540.01", "SARS-CoV-1-host interactions"], {"weight": 0.891775554054952}], ["OTUD7A", ["TCGA.D5.5540.01", "Cell Cycle, Mitotic"], {"weight": 0.936987716388009}], ["OTUD7A", ["TCGA.D5.5540.01", "SARS-CoV-1 Infection"], {"weight": 0.873927905503773}], ["OTUD7A", ["TCGA.D5.5540.01", "Mitotic G1 phase and G1/S transition"], {"weight": 0.941077031391657}], ["OTUD7A", ["TCGA.D5.5540.01", "Cellular responses to stress"], {"weight": 0.934057204702937}], ["OTUD7A", ["TCGA.D5.5540.01", "Cellular responses to stimuli"], {"weight": 0.934057204702937}], ["OTUD7A", ["TCGA.D5.5540.01", "HDR through Homologous Recombination (HRR)"], {"weight": 0.932571129157804}], ["OTUD7A", ["TCGA.D5.5540.01", "Cell Cycle Checkpoints"], {"weight": 0.938962894485679}], ["OTUD7A", ["TCGA.D5.5540.01", "Cyclin D associated events in G1"], {"weight": 0.929789683757318}], ["OTUD7A", ["TCGA.D5.5540.01", "G1 Phase"], {"weight": 0.929789683757318}], ["OTUD7A", ["TCGA.D5.5540.01", "Translation"], {"weight": 0.911248143462578}], ["MAPK12", ["TCGA.DM.A1D4.01", "Neuronal System"], {"weight": 0.941908852033785}], ["MAPK12", ["TCGA.DM.A1D4.01", "Transmission across Chemical Synapses"], {"weight": 0.924914123836354}], ["MAPK12", ["TCGA.DM.A1D4.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.773800304856653}], ["MAPK12", ["TCGA.DM.A1D4.01", "Immune System"], {"weight": 0.898223084188281}], ["MAPK12", ["TCGA.DM.A1D4.01", "CRMPs in Sema3A signaling"], {"weight": 0.901626096778223}], ["MAPK12", ["TCGA.G4.6588.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.904889325273309}], ["CHRM2", ["TCGA.D5.6931.01", "GABA receptor activation"], {"weight": 0.854601863258665}], ["CHRM2", ["TCGA.DM.A1HA.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.777919950259247}], ["NPAS4", ["TCGA.DM.A0XF.01", "Chemokine receptors bind chemokines"], {"weight": 0.901744331115431}], ["NOS3", ["TCGA.AY.6197.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.843711523421452}], ["NOS3", ["TCGA.F4.6856.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.850788309289935}], ["NOS3", ["TCGA.F4.6856.01", "Leishmania parasite growth and survival"], {"weight": 0.850788309289935}], ["CACNA2D1", ["TCGA.AA.3489.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.841602705127183}], ["ANKRD1", ["TCGA.F4.6854.01", "Phase II - Conjugation of compounds"], {"weight": 0.706918623823233}], ["ANKRD1", ["TCGA.F4.6854.01", "Glucuronidation"], {"weight": 0.771948400911568}], ["KCNH7", ["TCGA.AU.3779.01", "Neuronal System"], {"weight": 0.919042102812314}], ["KCNH7", ["TCGA.AU.3779.01", "Potassium Channels"], {"weight": 0.867416966446384}], ["KCNH7", ["TCGA.AZ.4615.01", "Voltage gated Potassium channels"], {"weight": 0.902060664935811}], ["KCNH7", ["TCGA.CM.6170.01", "Potassium Channels"], {"weight": 0.950040192628206}], ["KCNH7", ["TCGA.CM.6674.01", "Potassium Channels"], {"weight": 0.949706813247191}], ["KCNH7", ["TCGA.D5.6535.01", "Potassium Channels"], {"weight": 0.868590676516655}], ["KCNH7", ["TCGA.DM.A1D0.01", "Potassium Channels"], {"weight": 0.96550166518648}], ["KCNH7", ["TCGA.DM.A1D0.01", "Voltage gated Potassium channels"], {"weight": 0.870554379309615}], ["KCNH7", ["TCGA.G4.6586.01", "Voltage gated Potassium channels"], {"weight": 0.951504833655192}], ["UBR5", ["TCGA.D5.5538.01", "Dopamine Neurotransmitter Release Cycle"], {"weight": 0.823437515144716}], ["UBR5", ["TCGA.D5.5538.01", "Neurotransmitter release cycle"], {"weight": 0.880749806745792}], ["UBR5", ["TCGA.D5.5538.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.77288339181299}], ["TGM2", ["TCGA.CM.5864.01", "Potassium Channels"], {"weight": 0.955478904789891}], ["TGM2", ["TCGA.CM.5864.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.912808512356386}], ["TGM2", ["TCGA.CM.5864.01", "G alpha (s) signalling events"], {"weight": 0.952260574039354}], ["TGM2", ["TCGA.CM.5864.01", "G-protein beta:gamma signalling"], {"weight": 0.92670976690433}], ["TGM2", ["TCGA.CM.5864.01", "Ca2+ pathway"], {"weight": 0.86093493863491}], ["TGM2", ["TCGA.CM.5864.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.913365659621476}], ["TGM2", ["TCGA.CM.5864.01", "Glucagon-type ligand receptors"], {"weight": 0.916902062877283}], ["TGM2", ["TCGA.CM.5864.01", "GABA receptor activation"], {"weight": 0.880501798540971}], ["TGM2", ["TCGA.CM.5864.01", "GABA B receptor activation"], {"weight": 0.933745032477251}], ["TGM2", ["TCGA.CM.5864.01", "Activation of GABAB receptors"], {"weight": 0.933745032477251}], ["TGM2", ["TCGA.CM.5864.01", "GPCR ligand binding"], {"weight": 0.941132920782844}], ["TGM2", ["TCGA.CM.5864.01", "Regulation of insulin secretion"], {"weight": 0.909581758528094}], ["TGM2", ["TCGA.CM.5864.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.911422448360415}], ["TGM2", ["TCGA.CM.5864.01", "Activation of G protein gated Potassium channels"], {"weight": 0.927429928131357}], ["TGM2", ["TCGA.CM.5864.01", "G protein gated Potassium channels"], {"weight": 0.927429928131357}], ["TGM2", ["TCGA.CM.5864.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.929421217420546}], ["TGM2", ["TCGA.CM.5864.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.927429928131357}], ["TGM2", ["TCGA.CM.5864.01", "G beta:gamma signalling through BTK"], {"weight": 0.909986040850172}], ["TGM2", ["TCGA.CM.5864.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.906899044931998}], ["TGM2", ["TCGA.CM.5864.01", "Inwardly rectifying K+ channels"], {"weight": 0.931979792667126}], ["TGM2", ["TCGA.CM.5864.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.93045226473765}], ["TGM2", ["TCGA.CM.5864.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.893881268660177}], ["TGM2", ["TCGA.CM.5864.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.884450444297889}], ["TGM2", ["TCGA.CM.5864.01", "G beta:gamma signalling through CDC42"], {"weight": 0.905376443395296}], ["TGM2", ["TCGA.CM.5864.01", "Phase 4 - resting membrane potential"], {"weight": 0.827279045786901}], ["TGM2", ["TCGA.CM.5864.01", "Platelet homeostasis"], {"weight": 0.831414161033174}], ["LPA", ["TCGA.DM.A0XF.01", "Regulation of insulin secretion"], {"weight": 0.903071015551581}], ["LPA", ["TCGA.DM.A0XF.01", "Integration of energy metabolism"], {"weight": 0.888899856821949}], ["LPA", ["TCGA.DM.A0XF.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.821634503083097}], ["LPA", ["TCGA.DM.A0XF.01", "Peptide hormone metabolism"], {"weight": 0.863492001661191}], ["LPA", ["TCGA.DM.A0XF.01", "GRB2:SOS provides linkage to MAPK signaling for Integrins"], {"weight": 0.806757850379617}], ["LPA", ["TCGA.DM.A0XF.01", "p130Cas linkage to MAPK signaling for integrins"], {"weight": 0.806112961465168}], ["LPA", ["TCGA.G4.6586.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.755508306944829}], ["AMPD1", ["TCGA.AY.5543.01", "Signaling by GPCR"], {"weight": 0.928791392794957}], ["AMPD1", ["TCGA.AY.5543.01", "Glutathione conjugation"], {"weight": 0.792451365162727}], ["AMPD1", ["TCGA.AY.5543.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.799933932516705}], ["AMPD1", ["TCGA.AZ.4616.01", "G alpha (i) signalling events"], {"weight": 0.935463601072956}], ["AMPD1", ["TCGA.AZ.4616.01", "G alpha (s) signalling events"], {"weight": 0.953257321038762}], ["AMPD1", ["TCGA.AZ.4616.01", "Calmodulin induced events"], {"weight": 0.919222876299551}], ["AMPD1", ["TCGA.AZ.4616.01", "CaM pathway"], {"weight": 0.919222876299551}], ["AMPD1", ["TCGA.AZ.4616.01", "DAG and IP3 signaling"], {"weight": 0.91950584273144}], ["AMPD1", ["TCGA.AZ.4616.01", "G-protein mediated events"], {"weight": 0.895468401740496}], ["AMPD1", ["TCGA.AZ.4616.01", "PLC beta mediated events"], {"weight": 0.88871964859382}], ["AMPD1", ["TCGA.AZ.4616.01", "Ca-dependent events"], {"weight": 0.919222876299551}], ["AMPD1", ["TCGA.AZ.4616.01", "Azathioprine ADME"], {"weight": 0.668945252918149}], ["AMPD1", ["TCGA.AZ.4616.01", "Opioid Signalling"], {"weight": 0.931825054832474}], ["MYO18B", ["TCGA.D5.6538.01", "LGI-ADAM interactions"], {"weight": 0.820928392197005}], ["OR51A7", ["TCGA.D5.6929.01", "Glucagon-type ligand receptors"], {"weight": 0.920225619293194}], ["OR51A7", ["TCGA.D5.6929.01", "GPCR ligand binding"], {"weight": 0.942973351319882}], ["OR51A7", ["TCGA.D5.6929.01", "G alpha (s) signalling events"], {"weight": 0.952323576334081}], ["OR51A7", ["TCGA.D5.6929.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.934288149974943}], ["OR51A7", ["TCGA.D5.6929.01", "Peptide hormone metabolism"], {"weight": 0.816351527000949}], ["OR51A7", ["TCGA.D5.6929.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.896857832505485}], ["OR51A7", ["TCGA.D5.6929.01", "Regulation of insulin secretion"], {"weight": 0.861903867745118}], ["OR51A7", ["TCGA.D5.6929.01", "Integration of energy metabolism"], {"weight": 0.851109148323986}], ["OR51A7", ["TCGA.D5.6929.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.905659649917285}], ["GAD2", ["TCGA.A6.6654.01", "Drug ADME"], {"weight": 0.898091307400309}], ["GAD2", ["TCGA.A6.6654.01", "APAP ADME"], {"weight": 0.780145709514604}], ["GAD2", ["TCGA.A6.6654.01", "Phase II - Conjugation of compounds"], {"weight": 0.778599817650985}], ["GAD2", ["TCGA.A6.6654.01", "Degradation of cysteine and homocysteine"], {"weight": 0.696774978206499}], ["GAD2", ["TCGA.A6.6654.01", "Sulfur amino acid metabolism"], {"weight": 0.828299650451598}], ["GAD2", ["TCGA.CM.6165.01", "RA biosynthesis pathway"], {"weight": 0.649981836673093}], ["GAD2", ["TCGA.D5.6931.01", "Signaling by Retinoic Acid"], {"weight": 0.665081162718676}], ["GYS2", ["TCGA.D5.6930.01", "Integration of energy metabolism"], {"weight": 0.877313974136922}], ["CDK13", ["TCGA.CK.5914.01", "Transmission across Chemical Synapses"], {"weight": 0.929026074184336}], ["CDK13", ["TCGA.CK.5914.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.932156791664429}], ["CDK13", ["TCGA.CK.5914.01", "Activation of NMDA receptors and postsynaptic events"], {"weight": 0.890691337614124}], ["GNAS", ["TCGA.AA.3489.01", "APAP ADME"], {"weight": 0.525192369995755}], ["GNAS", ["TCGA.AA.3502.01", "G alpha (s) signalling events"], {"weight": 0.955983606484814}], ["GNAS", ["TCGA.AA.3502.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.886517984816272}], ["GNAS", ["TCGA.AA.3502.01", "Aquaporin-mediated transport"], {"weight": 0.886517984816272}], ["GNAS", ["TCGA.AA.3502.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.895086710102362}], ["GNAS", ["TCGA.AA.3502.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.921316739782394}], ["GNAS", ["TCGA.AA.3502.01", "Glucagon-type ligand receptors"], {"weight": 0.925482458679393}], ["GNAS", ["TCGA.AA.3502.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.928007224721764}], ["GNAS", ["TCGA.AA.3502.01", "GPER1 signaling"], {"weight": 0.92933074844299}], ["GNAS", ["TCGA.AA.3502.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.92933074844299}], ["GNAS", ["TCGA.AA.3502.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.9026315376639}], ["GNAS", ["TCGA.AA.3502.01", "Leishmania parasite growth and survival"], {"weight": 0.9026315376639}], ["GNAS", ["TCGA.AA.3660.01", "G alpha (s) signalling events"], {"weight": 0.935212581565964}], ["GNAS", ["TCGA.AA.3660.01", "GPER1 signaling"], {"weight": 0.883066212790579}], ["GNAS", ["TCGA.AA.3660.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.883066212790579}], ["GNAS", ["TCGA.AA.3660.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.877246399176083}], ["GNAS", ["TCGA.AA.3660.01", "Glucagon-type ligand receptors"], {"weight": 0.890323748615832}], ["GNAS", ["TCGA.AA.3660.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.893460481881553}], ["GNAS", ["TCGA.AA.3660.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.840589688905785}], ["GNAS", ["TCGA.AA.3660.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.877175151003393}], ["GNAS", ["TCGA.AA.3660.01", "Aquaporin-mediated transport"], {"weight": 0.877175151003393}], ["GNAS", ["TCGA.AA.3660.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.87731894429847}], ["GNAS", ["TCGA.AA.3660.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.738430359558704}], ["GNAS", ["TCGA.AA.3663.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.924319375117476}], ["GNAS", ["TCGA.AA.3663.01", "Glucagon-type ligand receptors"], {"weight": 0.930864259815897}], ["GNAS", ["TCGA.AA.3697.01", "Cardiac conduction"], {"weight": 0.906614955787619}], ["GNAS", ["TCGA.AA.3697.01", "Signal amplification"], {"weight": 0.900367640749088}], ["GNAS", ["TCGA.AA.3697.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.902492163370162}], ["GNAS", ["TCGA.AA.3697.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.885623664712572}], ["GNAS", ["TCGA.AA.3697.01", "G alpha (i) signalling events"], {"weight": 0.943291860893854}], ["GNAS", ["TCGA.AA.3697.01", "Glucagon-type ligand receptors"], {"weight": 0.902732486721449}], ["GNAS", ["TCGA.AA.3697.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.902540524373403}], ["GNAS", ["TCGA.AA.3697.01", "GPER1 signaling"], {"weight": 0.898738929810088}], ["GNAS", ["TCGA.AA.3697.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.898738929810088}], ["GNAS", ["TCGA.AA.3697.01", "GPCR ligand binding"], {"weight": 0.931713232886813}], ["GNAS", ["TCGA.AA.3697.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.89701750703214}], ["GNAS", ["TCGA.AA.3697.01", "Aquaporin-mediated transport"], {"weight": 0.89701750703214}], ["GNAS", ["TCGA.AD.5900.01", "GPCR ligand binding"], {"weight": 0.934672447425732}], ["GNAS", ["TCGA.AD.5900.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.921198580785646}], ["GNAS", ["TCGA.AD.6889.01", "G alpha (s) signalling events"], {"weight": 0.963176205672368}], ["GNAS", ["TCGA.AD.6889.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.937853424416927}], ["GNAS", ["TCGA.AD.6889.01", "Leishmania infection"], {"weight": 0.91453831148037}], ["GNAS", ["TCGA.AD.6889.01", "Parasitic Infection Pathways"], {"weight": 0.91453831148037}], ["GNAS", ["TCGA.AU.6004.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.896731293023567}], ["GNAS", ["TCGA.AU.6004.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.890306312747718}], ["GNAS", ["TCGA.AU.6004.01", "Glucagon-type ligand receptors"], {"weight": 0.897468239322054}], ["GNAS", ["TCGA.AY.6386.01", "G alpha (s) signalling events"], {"weight": 0.950102063592112}], ["GNAS", ["TCGA.AY.6386.01", "GPCR downstream signalling"], {"weight": 0.938044310398357}], ["GNAS", ["TCGA.AY.6386.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.911759006861132}], ["GNAS", ["TCGA.AY.6386.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.885648660878536}], ["GNAS", ["TCGA.AY.6386.01", "G alpha (i) signalling events"], {"weight": 0.927777259946655}], ["GNAS", ["TCGA.AY.6386.01", "Signal amplification"], {"weight": 0.890905644174224}], ["GNAS", ["TCGA.AZ.6598.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.948193068725579}], ["GNAS", ["TCGA.AZ.6598.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.933330800687551}], ["GNAS", ["TCGA.AZ.6598.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.929586232390227}], ["GNAS", ["TCGA.AZ.6598.01", "Glucagon-type ligand receptors"], {"weight": 0.942132698554461}], ["GNAS", ["TCGA.AZ.6598.01", "GPER1 signaling"], {"weight": 0.926482826571775}], ["GNAS", ["TCGA.AZ.6599.01", "GPCR downstream signalling"], {"weight": 0.947207808435977}], ["GNAS", ["TCGA.AZ.6599.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.911523922818296}], ["GNAS", ["TCGA.AZ.6599.01", "Leishmania parasite growth and survival"], {"weight": 0.911523922818296}], ["GNAS", ["TCGA.AZ.6599.01", "Peptide ligand-binding receptors"], {"weight": 0.946941546087397}], ["GNAS", ["TCGA.AZ.6599.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.947179569555585}], ["GNAS", ["TCGA.AZ.6599.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.920546885297439}], ["GNAS", ["TCGA.CM.6161.01", "Metabolism"], {"weight": 0.897779808325712}], ["GNAS", ["TCGA.CM.6675.01", "GPCR downstream signalling"], {"weight": 0.938299481205925}], ["GNAS", ["TCGA.CM.6675.01", "Potassium Channels"], {"weight": 0.959149510468019}], ["GNAS", ["TCGA.CM.6675.01", "GPCR ligand binding"], {"weight": 0.949842844567637}], ["GNAS", ["TCGA.CM.6675.01", "G alpha (i) signalling events"], {"weight": 0.944020751405425}], ["GNAS", ["TCGA.CM.6675.01", "Chemokine receptors bind chemokines"], {"weight": 0.937613377517531}], ["GNAS", ["TCGA.CM.6675.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.933583117841421}], ["GNAS", ["TCGA.CM.6675.01", "Platelet homeostasis"], {"weight": 0.894700324791699}], ["GNAS", ["TCGA.CM.6675.01", "G beta:gamma signalling through BTK"], {"weight": 0.922534447347602}], ["GNAS", ["TCGA.CM.6675.01", "G alpha (s) signalling events"], {"weight": 0.96400761137782}], ["GNAS", ["TCGA.CM.6675.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.936575068217111}], ["GNAS", ["TCGA.CM.6675.01", "Activation of G protein gated Potassium channels"], {"weight": 0.918670841863315}], ["GNAS", ["TCGA.CM.6675.01", "G protein gated Potassium channels"], {"weight": 0.918670841863315}], ["GNAS", ["TCGA.CM.6675.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.918670841863315}], ["GNAS", ["TCGA.CM.6675.01", "Glucagon-type ligand receptors"], {"weight": 0.937102566428865}], ["GNAS", ["TCGA.CM.6675.01", "GABA receptor activation"], {"weight": 0.921327829344778}], ["GNAS", ["TCGA.CM.6675.01", "Inwardly rectifying K+ channels"], {"weight": 0.924794286707413}], ["GNAS", ["TCGA.CM.6675.01", "Presynaptic function of Kainate receptors"], {"weight": 0.912406159173965}], ["GNAS", ["TCGA.CM.6675.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.915759186719964}], ["GNAS", ["TCGA.D5.6930.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.864484109547389}], ["GNAS", ["TCGA.G4.6298.01", "GPCR ligand binding"], {"weight": 0.94448280258481}], ["GNAS", ["TCGA.G4.6298.01", "Chemokine receptors bind chemokines"], {"weight": 0.932749703411644}], ["GNAS", ["TCGA.G4.6298.01", "Peptide ligand-binding receptors"], {"weight": 0.947721774900712}], ["GNAS", ["TCGA.G4.6298.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.947496441339203}], ["GNAS", ["TCGA.G4.6298.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.907824454237724}], ["GNAS", ["TCGA.G4.6298.01", "Leishmania parasite growth and survival"], {"weight": 0.907824454237724}], ["GNAS", ["TCGA.G4.6298.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.930332096005515}], ["GNAS", ["TCGA.G4.6298.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.926576274362042}], ["GNAS", ["TCGA.G4.6320.01", "Leishmania infection"], {"weight": 0.888110054382505}], ["GNAS", ["TCGA.G4.6320.01", "Parasitic Infection Pathways"], {"weight": 0.888110054382505}], ["CPSF3", ["TCGA.G4.6310.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.632156388267196}], ["RLN2", ["TCGA.A6.6142.01", "Signal amplification"], {"weight": 0.893963313605449}], ["RLN2", ["TCGA.A6.6142.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.873242854925826}], ["GUCY2F", ["TCGA.D5.6927.01", "G alpha (i) signalling events"], {"weight": 0.945508232796823}], ["GUCY2F", ["TCGA.G4.6320.01", "G alpha (s) signalling events"], {"weight": 0.960780164580987}], ["TRPV5", ["TCGA.DM.A1D6.01", "Stimuli-sensing channels"], {"weight": 0.908854121115088}], ["TRPV5", ["TCGA.DM.A1D6.01", "FCGR activation"], {"weight": 0.825829435881185}], ["TRPV5", ["TCGA.DM.A28F.01", "Ion channel transport"], {"weight": 0.942633346610618}], ["TRPV5", ["TCGA.DM.A28F.01", "Stimuli-sensing channels"], {"weight": 0.907240374439073}], ["TRPV5", ["TCGA.F4.6570.01", "Stimuli-sensing channels"], {"weight": 0.919846660730248}], ["ARHGEF10", ["TCGA.DM.A28M.01", "Degradation of the extracellular matrix"], {"weight": 0.824678521977164}], ["ASB15", ["TCGA.F4.6461.01", "Peptide ligand-binding receptors"], {"weight": 0.822763744577556}], ["DICER1", ["TCGA.A6.6652.01", "Glucuronidation"], {"weight": 0.90603524126953}], ["DICER1", ["TCGA.A6.6652.01", "Phase II - Conjugation of compounds"], {"weight": 0.855989144147192}], ["DICER1", ["TCGA.A6.6652.01", "Aspirin ADME"], {"weight": 0.837129296628659}], ["OR4K5", ["TCGA.G4.6299.01", "Regulation of insulin secretion"], {"weight": 0.919393152257507}], ["OR4K5", ["TCGA.G4.6299.01", "GABA receptor activation"], {"weight": 0.907898201494809}], ["OR4K5", ["TCGA.G4.6299.01", "Integration of energy metabolism"], {"weight": 0.923348204128987}], ["OR4K5", ["TCGA.G4.6299.01", "Activation of GABAB receptors"], {"weight": 0.914521189618431}], ["OR4K5", ["TCGA.G4.6299.01", "Phase 4 - resting membrane potential"], {"weight": 0.766173319589526}], ["OR4K5", ["TCGA.G4.6299.01", "G protein gated Potassium channels"], {"weight": 0.895694126090053}], ["OR4K5", ["TCGA.G4.6299.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.895694126090053}], ["OR2AG1", ["TCGA.CM.5861.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.940967776740116}], ["UNC13B", ["TCGA.CM.5861.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.919877236529587}], ["UNC13B", ["TCGA.DM.A1D0.01", "Protein-protein interactions at synapses"], {"weight": 0.921188747190466}], ["UNC13B", ["TCGA.DM.A1D0.01", "Neurexins and neuroligins"], {"weight": 0.943306908188375}], ["UNC13B", ["TCGA.DM.A1D0.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.808029876141181}], ["UNC13B", ["TCGA.DM.A1D0.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.742017202599767}], ["UNC13B", ["TCGA.DM.A1D0.01", "Insulin processing"], {"weight": 0.841014676098805}], ["UNC13B", ["TCGA.DM.A1D0.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.89896942297994}], ["UNC13B", ["TCGA.DM.A1D0.01", "Neurotransmitter release cycle"], {"weight": 0.809062279062874}], ["CD163", ["TCGA.CM.6674.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.858704676444898}], ["CD163", ["TCGA.CM.6674.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.858704676444898}], ["CYP2E1", ["TCGA.A6.6141.01", "Drug ADME"], {"weight": 0.845401339703436}], ["HTT", ["TCGA.AD.6899.01", "Drug ADME"], {"weight": 0.746211013331}], ["HTT", ["TCGA.CA.6719.01", "Glucuronidation"], {"weight": 0.874367467476135}], ["HTT", ["TCGA.G4.6323.01", "Phase 0 - rapid depolarisation"], {"weight": 0.843371122161143}], ["HDC", ["TCGA.CM.6680.01", "Biological oxidations"], {"weight": 0.863540734344536}], ["MAPRE3", ["TCGA.AD.6889.01", "Classical antibody-mediated complement activation"], {"weight": 0.716863062949229}], ["BCAR3", ["TCGA.G4.6309.01", "Insulin processing"], {"weight": 0.772129807057213}], ["AGTR1", ["TCGA.CK.5913.01", "GABA receptor activation"], {"weight": 0.90773167777567}], ["AGTR1", ["TCGA.CM.4744.01", "Complement cascade"], {"weight": 0.860119402755204}], ["AGTR1", ["TCGA.CM.4744.01", "Regulation of Complement cascade"], {"weight": 0.821658042614704}], ["AGTR1", ["TCGA.CM.4744.01", "Defective B3GALTL causes PpS"], {"weight": 0.88989059850944}], ["AGTR1", ["TCGA.CM.4744.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.88989059850944}], ["AGTR1", ["TCGA.CM.5861.01", "Regulation of Complement cascade"], {"weight": 0.763652748982093}], ["CAPN11", ["TCGA.AU.6004.01", "Extracellular matrix organization"], {"weight": 0.849761581808067}], ["CAPN11", ["TCGA.AU.6004.01", "Degradation of the extracellular matrix"], {"weight": 0.874604766386528}], ["OAS2", ["TCGA.G4.6310.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.949057340728184}], ["OAS2", ["TCGA.G4.6310.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.946925832445741}], ["OAS2", ["TCGA.G4.6310.01", "Generation of second messenger molecules"], {"weight": 0.953041623005619}], ["OAS2", ["TCGA.G4.6310.01", "PD-1 signaling"], {"weight": 0.94705749675412}], ["OAS2", ["TCGA.G4.6310.01", "Interleukin-10 signaling"], {"weight": 0.95036489808435}], ["OAS2", ["TCGA.G4.6310.01", "TCR signaling"], {"weight": 0.953673995032271}], ["OAS2", ["TCGA.G4.6310.01", "G alpha (q) signalling events"], {"weight": 0.936380873837653}], ["OAS2", ["TCGA.G4.6310.01", "Interferon gamma signaling"], {"weight": 0.923978056853435}], ["OAS2", ["TCGA.G4.6310.01", "Downstream TCR signaling"], {"weight": 0.949531854044179}], ["OAS2", ["TCGA.G4.6310.01", "MHC class II antigen presentation"], {"weight": 0.926685366494413}], ["PTPRG", ["TCGA.AA.3663.01", "L1CAM interactions"], {"weight": 0.896820184828979}], ["PTPRG", ["TCGA.AD.6889.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.906799976411729}], ["PTPRG", ["TCGA.AD.6889.01", "L1CAM interactions"], {"weight": 0.912904089555573}], ["PTPRG", ["TCGA.DM.A1D6.01", "Interaction between L1 and Ankyrins"], {"weight": 0.949722005851546}], ["PTPRM", ["TCGA.D5.6537.01", "Formation of the anterior neural plate"], {"weight": 0.590767813333001}], ["IFIT1", ["TCGA.D5.5540.01", "Disease"], {"weight": 0.921593358876062}], ["IFIT1", ["TCGA.D5.5540.01", "Transmission across Chemical Synapses"], {"weight": 0.940978815318607}], ["ITK", ["TCGA.CM.4747.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.91403244423339}], ["ITK", ["TCGA.CM.4747.01", "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"], {"weight": 0.831991201629886}], ["ITK", ["TCGA.CM.4747.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.937287353453067}], ["ITK", ["TCGA.CM.4747.01", "Signaling by Erythropoietin"], {"weight": 0.881824245610217}], ["FNTA", ["TCGA.AA.3697.01", "Phase 4 - resting membrane potential"], {"weight": 0.770872212655894}], ["IL31RA", ["TCGA.CM.5861.01", "Generation of second messenger molecules"], {"weight": 0.929302559833875}], ["IL31RA", ["TCGA.CM.5861.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.919145508545159}], ["IL31RA", ["TCGA.CM.5861.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.908006664499009}], ["IL31RA", ["TCGA.CM.6679.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.709858339085271}], ["IL31RA", ["TCGA.DM.A282.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.940860351078949}], ["IL31RA", ["TCGA.DM.A282.01", "Generation of second messenger molecules"], {"weight": 0.941234636290993}], ["IL31RA", ["TCGA.DM.A282.01", "PD-1 signaling"], {"weight": 0.939026547462671}], ["IL31RA", ["TCGA.DM.A282.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.938183332728295}], ["IL31RA", ["TCGA.DM.A282.01", "Costimulation by the CD28 family"], {"weight": 0.896295741028027}], ["IL31RA", ["TCGA.DM.A282.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.870868613025427}], ["IL31RA", ["TCGA.DM.A282.01", "Other interleukin signaling"], {"weight": 0.684278008881192}], ["IL31RA", ["TCGA.DM.A282.01", "Signaling by Interleukins"], {"weight": 0.856172159478549}], ["IL31RA", ["TCGA.DM.A282.01", "Cytokine Signaling in Immune system"], {"weight": 0.855790306186299}], ["IL31RA", ["TCGA.DM.A282.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.683033004009268}], ["IL31RA", ["TCGA.DM.A282.01", "FCERI mediated Ca+2 mobilization"], {"weight": 0.812879388480678}], ["IL31RA", ["TCGA.DM.A282.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.819544744361777}], ["IL31RA", ["TCGA.DM.A282.01", "Cargo recognition for clathrin-mediated endocytosis"], {"weight": 0.912583019926296}], ["IL31RA", ["TCGA.DM.A282.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.664072001036308}], ["IL31RA", ["TCGA.DM.A282.01", "Binding and entry of HIV virion"], {"weight": 0.739739690415291}], ["FYN", ["TCGA.A6.6653.01", "CD22 mediated BCR regulation"], {"weight": 0.847021018812253}], ["FYN", ["TCGA.A6.6653.01", "Integration of energy metabolism"], {"weight": 0.915487779053037}], ["FYN", ["TCGA.CM.5341.01", "Signaling by ROBO receptors"], {"weight": 0.882662230275037}], ["FYN", ["TCGA.CM.5341.01", "Axon guidance"], {"weight": 0.932606142555666}], ["FYN", ["TCGA.CM.5341.01", "Developmental Biology"], {"weight": 0.913040755026657}], ["FYN", ["TCGA.CM.5341.01", "Nervous system development"], {"weight": 0.925020721639046}], ["FYN", ["TCGA.CM.5341.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.908270426745566}], ["FYN", ["TCGA.CM.5341.01", "Interaction between L1 and Ankyrins"], {"weight": 0.907603199812789}], ["FYN", ["TCGA.CM.5341.01", "Degradation of the extracellular matrix"], {"weight": 0.875325922531414}], ["FYN", ["TCGA.CM.5341.01", "Extracellular matrix organization"], {"weight": 0.887876345134098}], ["FYN", ["TCGA.CM.5341.01", "TNFs bind their physiological receptors"], {"weight": 0.361577277671819}], ["FYN", ["TCGA.CM.5341.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.790572867895066}], ["FYN", ["TCGA.CM.5341.01", "L1CAM interactions"], {"weight": 0.873379355189583}], ["PRKCI", ["TCGA.D5.5540.01", "LGI-ADAM interactions"], {"weight": 0.86483947424644}], ["RANBP2", ["TCGA.CM.4744.01", "Eukaryotic Translation Elongation"], {"weight": 0.888974545732619}], ["GUCY1A2", ["TCGA.AA.3712.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.88934144812369}], ["GUCY1A2", ["TCGA.AA.3712.01", "Platelet homeostasis"], {"weight": 0.873061311077494}], ["GUCY1A2", ["TCGA.AA.3712.01", "Visual phototransduction"], {"weight": 0.82028911143656}], ["PTK2B", ["TCGA.AY.6197.01", "Response to elevated platelet cytosolic Ca2+"], {"weight": 0.87656916197654}], ["PTK2B", ["TCGA.AY.6197.01", "ECM proteoglycans"], {"weight": 0.740824441137969}], ["PTK2B", ["TCGA.D5.5537.01", "ECM proteoglycans"], {"weight": 0.882051852013348}], ["PCCA", ["TCGA.D5.6534.01", "APAP ADME"], {"weight": 0.540588041013828}], ["UGT2B4", ["TCGA.G4.6625.01", "Biological oxidations"], {"weight": 0.892882209594121}], ["UGT2B4", ["TCGA.G4.6625.01", "Glucuronidation"], {"weight": 0.855966011071594}], ["UGT2B4", ["TCGA.G4.6625.01", "Ethanol oxidation"], {"weight": 0.783330120642788}], ["LIFR", ["TCGA.G4.6315.01", "Other interleukin signaling"], {"weight": 0.646726466997516}], ["SLC25A3", ["TCGA.F4.6459.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.825880407136201}], ["KIF5A", ["TCGA.G4.6626.01", "Generation of second messenger molecules"], {"weight": 0.87130866475377}], ["KIF5A", ["TCGA.G4.6626.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.889649066380864}], ["KIF5A", ["TCGA.G4.6626.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.884418326550481}], ["CDK1", ["TCGA.AZ.6603.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.708974918116139}], ["CDK1", ["TCGA.AZ.6603.01", "Signaling Pathways"], {"weight": 0.808092212993846}], ["FMO5", ["TCGA.D5.6531.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.906172374055896}], ["FMO5", ["TCGA.D5.6531.01", "Phase II - Conjugation of compounds"], {"weight": 0.907495170212741}], ["FMO5", ["TCGA.D5.6531.01", "RA biosynthesis pathway"], {"weight": 0.79015871001356}], ["FMO5", ["TCGA.D5.6531.01", "APAP ADME"], {"weight": 0.68282593406299}], ["FMO5", ["TCGA.F4.6703.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.852184343243535}], ["COL24A1", ["TCGA.AD.6895.01", "Collagen formation"], {"weight": 0.947190518171186}], ["COL24A1", ["TCGA.AD.6895.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.94577945891941}], ["COL24A1", ["TCGA.D5.6534.01", "Collagen formation"], {"weight": 0.943327846662625}], ["COL24A1", ["TCGA.D5.6534.01", "Collagen chain trimerization"], {"weight": 0.921906862608247}], ["COL24A1", ["TCGA.F4.6854.01", "Degradation of the extracellular matrix"], {"weight": 0.863732483333983}], ["SPTAN1", ["TCGA.CM.5861.01", "Extracellular matrix organization"], {"weight": 0.906630390239694}], ["PLG", ["TCGA.AD.6889.01", "Regulation of Complement cascade"], {"weight": 0.870457145396664}], ["PLG", ["TCGA.F4.6856.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.891029035327149}], ["SLC12A7", ["TCGA.AU.6004.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.850558773358386}], ["SLC12A7", ["TCGA.AU.6004.01", "SLC-mediated transmembrane transport"], {"weight": 0.905383008471055}], ["ABCC2", ["TCGA.CK.5916.01", "APAP ADME"], {"weight": 0.819070090186612}], ["DEF6", ["TCGA.A6.6142.01", "Extracellular matrix organization"], {"weight": 0.9215501411285}], ["PDE7B", ["TCGA.A6.6142.01", "G alpha (i) signalling events"], {"weight": 0.946943593893823}], ["PDE7B", ["TCGA.A6.6142.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.91223538331687}], ["PDE7B", ["TCGA.A6.6142.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.83066756095229}], ["PDE7B", ["TCGA.A6.6142.01", "Leishmania parasite growth and survival"], {"weight": 0.83066756095229}], ["PDE7B", ["TCGA.A6.6142.01", "Drug ADME"], {"weight": 0.860490668584284}], ["PDE7B", ["TCGA.A6.6142.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.873341357528179}], ["PDE7B", ["TCGA.A6.6142.01", "Transmission across Chemical Synapses"], {"weight": 0.859154258775437}], ["PDE7B", ["TCGA.A6.6142.01", "G alpha (z) signalling events"], {"weight": 0.900954319559471}], ["IGFALS", ["TCGA.A6.6142.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.948598841252977}], ["IGFALS", ["TCGA.A6.6142.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.855462730184046}], ["IGFALS", ["TCGA.A6.6142.01", "Degradation of the extracellular matrix"], {"weight": 0.903978895806312}], ["IGFALS", ["TCGA.A6.6142.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.855462730184046}], ["IGFALS", ["TCGA.A6.6142.01", "FGFR2 ligand binding and activation"], {"weight": 0.833375364403649}], ["IGFALS", ["TCGA.A6.6142.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.818919362756976}], ["IGFALS", ["TCGA.A6.6781.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.950635284861684}], ["IGFALS", ["TCGA.G4.6298.01", "Complement cascade"], {"weight": 0.819635490307485}], ["IGFALS", ["TCGA.G4.6298.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.91587865425372}], ["IGFALS", ["TCGA.G4.6298.01", "Regulation of Complement cascade"], {"weight": 0.726049349988499}], ["IGFALS", ["TCGA.G4.6298.01", "Cell surface interactions at the vascular wall"], {"weight": 0.79765653097501}], ["IGFALS", ["TCGA.G4.6309.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.886977861227975}], ["EIF3A", ["TCGA.CM.4744.01", "Viral mRNA Translation"], {"weight": 0.896990221204614}], ["EIF3A", ["TCGA.CM.4744.01", "Peptide chain elongation"], {"weight": 0.896990221204614}], ["EIF3A", ["TCGA.CM.4744.01", "Selenoamino acid metabolism"], {"weight": 0.907314812456113}], ["EIF3A", ["TCGA.CM.4744.01", "Selenocysteine synthesis"], {"weight": 0.896990221204614}], ["EIF3A", ["TCGA.CM.4744.01", "Eukaryotic Translation Termination"], {"weight": 0.896990221204614}], ["ADAMTS18", ["TCGA.A6.6142.01", "Collagen formation"], {"weight": 0.951826405211385}], ["ADAMTS18", ["TCGA.A6.6142.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.958079551112546}], ["ADAMTS18", ["TCGA.AU.6004.01", "O-linked glycosylation"], {"weight": 0.888011322862464}], ["ADAMTS18", ["TCGA.CA.5797.01", "O-linked glycosylation"], {"weight": 0.917378833436389}], ["ADAMTS18", ["TCGA.CA.5797.01", "O-linked glycosylation of mucins"], {"weight": 0.905420534203059}], ["ADAMTS18", ["TCGA.CK.5916.01", "O-linked glycosylation"], {"weight": 0.916076133613036}], ["DEF6", ["TCGA.A6.6142.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.860718193122666}], ["DEF6", ["TCGA.A6.6142.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.765293165416965}], ["LRFN4", ["TCGA.AD.6895.01", "Protein-protein interactions at synapses"], {"weight": 0.851286345577907}], ["LRFN4", ["TCGA.AZ.5407.01", "Protein-protein interactions at synapses"], {"weight": 0.911267790862563}], ["LRFN4", ["TCGA.CK.5916.01", "Protein-protein interactions at synapses"], {"weight": 0.788253626322317}], ["ST3GAL4", ["TCGA.A6.6142.01", "Glycosaminoglycan metabolism"], {"weight": 0.743975640156379}], ["ST3GAL4", ["TCGA.CM.6677.01", "Blood group systems biosynthesis"], {"weight": 0.732598022847939}], ["ST3GAL4", ["TCGA.CM.6677.01", "Metabolism"], {"weight": 0.893256372401244}], ["ST3GAL4", ["TCGA.CM.6677.01", "Lewis blood group biosynthesis"], {"weight": 0.69805245921499}], ["DPP4", ["TCGA.A6.6142.01", "Signaling by GPCR"], {"weight": 0.925344088904631}], ["DPP4", ["TCGA.A6.6142.01", "Regulation of insulin secretion"], {"weight": 0.905903166442865}], ["DPP4", ["TCGA.A6.6142.01", "GPCR downstream signalling"], {"weight": 0.93351803924022}], ["DPP4", ["TCGA.A6.6142.01", "GPCR ligand binding"], {"weight": 0.915247225291768}], ["DPP4", ["TCGA.A6.6142.01", "Integration of energy metabolism"], {"weight": 0.90570772717798}], ["DPP4", ["TCGA.A6.6142.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.782264899446714}], ["DPP4", ["TCGA.A6.6142.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.908916678468412}], ["DPP4", ["TCGA.A6.6142.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.889061491903908}], ["DPP4", ["TCGA.A6.6142.01", "Glucagon-type ligand receptors"], {"weight": 0.912114027019788}], ["DPP4", ["TCGA.AZ.4615.01", "Peptide hormone metabolism"], {"weight": 0.806902830353199}], ["DPP4", ["TCGA.AZ.4615.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.764024222602222}], ["KCNJ1", ["TCGA.A6.6142.01", "Neuronal System"], {"weight": 0.89860905443006}], ["KCNJ1", ["TCGA.A6.6142.01", "Potassium Channels"], {"weight": 0.855947753755197}], ["KCNJ1", ["TCGA.AZ.6598.01", "Potassium Channels"], {"weight": 0.959458232336059}], ["KCNJ1", ["TCGA.G4.6588.01", "Potassium Channels"], {"weight": 0.958057833358776}], ["KCNJ1", ["TCGA.G4.6588.01", "Inwardly rectifying K+ channels"], {"weight": 0.928925243291854}], ["KCNC4", ["TCGA.CM.6171.01", "Voltage gated Potassium channels"], {"weight": 0.917797061425989}], ["GABRA5", ["TCGA.A6.6648.01", "Neuronal System"], {"weight": 0.899540120422533}], ["ADCY8", ["TCGA.A6.6648.01", "Cardiac conduction"], {"weight": 0.928889713472229}], ["ADCY8", ["TCGA.A6.6648.01", "Phase 0 - rapid depolarisation"], {"weight": 0.887497047222849}], ["ADCY8", ["TCGA.A6.6653.01", "Signaling by GPCR"], {"weight": 0.944206848986218}], ["ADCY8", ["TCGA.AD.6890.01", "Platelet homeostasis"], {"weight": 0.863707555993946}], ["ADCY8", ["TCGA.AD.6890.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.818603185980776}], ["ADCY8", ["TCGA.AD.6890.01", "Drug ADME"], {"weight": 0.735366343305467}], ["ADCY8", ["TCGA.F4.6856.01", "Metabolism of water-soluble vitamins and cofactors"], {"weight": 0.72514538468298}], ["ADCY8", ["TCGA.F4.6856.01", "G alpha (s) signalling events"], {"weight": 0.948754121444979}], ["ADCY8", ["TCGA.G4.6628.01", "Platelet homeostasis"], {"weight": 0.870719077978532}], ["ALDH5A1", ["TCGA.CM.4743.01", "Neuronal System"], {"weight": 0.937790946452}], ["ALDH5A1", ["TCGA.CM.4743.01", "Transmission across Chemical Synapses"], {"weight": 0.935339586665656}], ["JAK3", ["TCGA.A6.6648.01", "Classical antibody-mediated complement activation"], {"weight": 0.469751696318161}], ["JAK3", ["TCGA.A6.6648.01", "Cell Cycle"], {"weight": 0.918099020393205}], ["JAK3", ["TCGA.A6.6648.01", "Cell Cycle, Mitotic"], {"weight": 0.909576824126626}], ["JAK3", ["TCGA.G4.6310.01", "Chemokine receptors bind chemokines"], {"weight": 0.930244740736891}], ["JAK3", ["TCGA.G4.6310.01", "Peptide ligand-binding receptors"], {"weight": 0.938645923500325}], ["JAK3", ["TCGA.G4.6310.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.938645923500325}], ["JAK3", ["TCGA.G4.6310.01", "GPCR ligand binding"], {"weight": 0.930939669477417}], ["JAK3", ["TCGA.G4.6310.01", "DAP12 interactions"], {"weight": 0.919861318051333}], ["JAK3", ["TCGA.G4.6310.01", "DAP12 signaling"], {"weight": 0.910225824234954}], ["JAK3", ["TCGA.G4.6310.01", "Binding and entry of HIV virion"], {"weight": 0.849513008087595}], ["JAK3", ["TCGA.G4.6310.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.879291010041406}], ["JAK3", ["TCGA.G4.6310.01", "The role of Nef in HIV-1 replication and disease pathogenesis"], {"weight": 0.851581217894695}], ["JAK3", ["TCGA.G4.6310.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.852165690832147}], ["JAK3", ["TCGA.G4.6310.01", "CD28 dependent PI3K/Akt signaling"], {"weight": 0.812367637361479}], ["JAK3", ["TCGA.G4.6310.01", "Specification of primordial germ cells"], {"weight": 0.548286182576177}], ["SUPT16H", ["TCGA.A6.6648.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], {"weight": 0.880758240709693}], ["SUPT16H", ["TCGA.A6.6648.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], {"weight": 0.880758240709693}], ["SUPT16H", ["TCGA.A6.6648.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], {"weight": 0.880758240709693}], ["SUPT16H", ["TCGA.A6.6648.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], {"weight": 0.880758240709693}], ["SUPT16H", ["TCGA.A6.6648.01", "Impaired BRCA2 binding to PALB2"], {"weight": 0.880758240709693}], ["SUPT16H", ["TCGA.A6.6648.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.888883011075823}], ["SUPT16H", ["TCGA.A6.6648.01", "Resolution of D-Loop Structures"], {"weight": 0.888883011075823}], ["SUPT16H", ["TCGA.A6.6648.01", "Presynaptic phase of homologous DNA pairing and strand exchange"], {"weight": 0.897519334078503}], ["SUPT16H", ["TCGA.A6.6648.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], {"weight": 0.880758240709693}], ["SUPT16H", ["TCGA.A6.6648.01", "Homologous DNA Pairing and Strand Exchange"], {"weight": 0.897519334078503}], ["SUPT16H", ["TCGA.A6.6648.01", "Diseases of DNA repair"], {"weight": 0.895495343998673}], ["SUPT16H", ["TCGA.A6.6648.01", "Diseases of DNA Double-Strand Break Repair"], {"weight": 0.895495343998673}], ["SUPT16H", ["TCGA.A6.6648.01", "Defective homologous recombination repair (HRR) due to BRCA2 loss of function"], {"weight": 0.895495343998673}], ["SUPT16H", ["TCGA.CK.4952.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.900766055806696}], ["SUPT16H", ["TCGA.CK.4952.01", "Resolution of D-Loop Structures"], {"weight": 0.900766055806696}], ["SUPT16H", ["TCGA.CK.4952.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], {"weight": 0.885458420619174}], ["MYCT1", ["TCGA.A6.6648.01", "G0 and Early G1"], {"weight": 0.877064471902912}], ["MYCT1", ["TCGA.A6.6648.01", "Transcription of E2F targets under negative control by DREAM complex"], {"weight": 0.862489652733484}], ["CYP1A2", ["TCGA.A6.6648.01", "Arachidonic acid metabolism"], {"weight": 0.840681907797808}], ["CYP1A2", ["TCGA.A6.6648.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.622791628228752}], ["CYP1A2", ["TCGA.AZ.6598.01", "Phase II - Conjugation of compounds"], {"weight": 0.897762370156623}], ["CYP1A2", ["TCGA.CK.5915.01", "Immune System"], {"weight": 0.904509692975399}], ["CYP1A2", ["TCGA.CK.5915.01", "Adaptive Immune System"], {"weight": 0.91920866381441}], ["CYP1A2", ["TCGA.CK.5915.01", "Arachidonic acid metabolism"], {"weight": 0.932462229902522}], ["CYP1A2", ["TCGA.CK.5915.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.926434958414519}], ["CYP1A2", ["TCGA.CK.5915.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.917486659823822}], ["CYP1A2", ["TCGA.CK.5915.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.939195698307791}], ["CYP1A2", ["TCGA.CK.5915.01", "Biological oxidations"], {"weight": 0.920560487974331}], ["CYP1A2", ["TCGA.CK.5915.01", "Signal amplification"], {"weight": 0.921503784907325}], ["CYP1A2", ["TCGA.CK.5915.01", "Aspirin ADME"], {"weight": 0.826328293740552}], ["CYP1A2", ["TCGA.CK.5915.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.887406606768414}], ["CYP1A2", ["TCGA.CK.5915.01", "Biosynthesis of DHA-derived SPMs"], {"weight": 0.900872640463948}], ["CYP1A2", ["TCGA.CM.6169.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.897390632710506}], ["CYP1A2", ["TCGA.CM.6169.01", "Phase II - Conjugation of compounds"], {"weight": 0.922612797088302}], ["CYP1A2", ["TCGA.CM.6169.01", "Biological oxidations"], {"weight": 0.943322957131451}], ["CYP1A2", ["TCGA.CM.6169.01", "Ethanol oxidation"], {"weight": 0.858481687942741}], ["CYP1A2", ["TCGA.G4.6314.01", "Biological oxidations"], {"weight": 0.934755921726367}], ["CYP1A2", ["TCGA.G4.6314.01", "Glucuronidation"], {"weight": 0.865279971835236}], ["CYP1A2", ["TCGA.G4.6314.01", "Phase II - Conjugation of compounds"], {"weight": 0.878851096627641}], ["CYP1A2", ["TCGA.G4.6314.01", "APAP ADME"], {"weight": 0.769919571241719}], ["CYP1A2", ["TCGA.G4.6314.01", "Aspirin ADME"], {"weight": 0.915562694258478}], ["CYP1A2", ["TCGA.G4.6314.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.724703637431179}], ["CYP1A2", ["TCGA.G4.6314.01", "Ethanol oxidation"], {"weight": 0.514992927763836}], ["CYP1A2", ["TCGA.G4.6314.01", "RA biosynthesis pathway"], {"weight": 0.883336252877436}], ["TEC", ["TCGA.A6.6648.01", "Protein-protein interactions at synapses"], {"weight": 0.844746339642836}], ["GABRA5", ["TCGA.A6.6648.01", "Transmission across Chemical Synapses"], {"weight": 0.884513549687833}], ["GABRA5", ["TCGA.CK.5915.01", "Transmission across Chemical Synapses"], {"weight": 0.911841345929403}], ["GABRA5", ["TCGA.CK.5915.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.915758390909591}], ["GABRA5", ["TCGA.CK.5915.01", "GABA receptor activation"], {"weight": 0.927722183146884}], ["GABRA5", ["TCGA.D5.6920.01", "Transmission across Chemical Synapses"], {"weight": 0.85552333234807}], ["GABRA5", ["TCGA.G4.6322.01", "Neuronal System"], {"weight": 0.900436174015353}], ["CDK5R1", ["TCGA.A6.6648.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.860276230518249}], ["CDK5R1", ["TCGA.A6.6648.01", "Interaction between L1 and Ankyrins"], {"weight": 0.857868268557767}], ["CDK5R1", ["TCGA.A6.6648.01", "TP53 Regulates Transcription of Cell Cycle Genes"], {"weight": 0.879359235972978}], ["OPRM1", ["TCGA.G4.6295.01", "G alpha (s) signalling events"], {"weight": 0.954406905635327}], ["ST6GALNAC2", ["TCGA.G4.6586.01", "O-linked glycosylation"], {"weight": 0.932720386442367}], ["ST6GALNAC2", ["TCGA.G4.6586.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.884017337213374}], ["FSHR", ["TCGA.CM.6164.01", "G alpha (i) signalling events"], {"weight": 0.925663238747011}], ["FSHR", ["TCGA.CM.6164.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.923291432195154}], ["FSHR", ["TCGA.CM.6164.01", "Transmission across Chemical Synapses"], {"weight": 0.906017579854692}], ["FSHR", ["TCGA.CM.6164.01", "GABA receptor activation"], {"weight": 0.867354277089027}], ["FSHR", ["TCGA.CM.6164.01", "Signal amplification"], {"weight": 0.868952883090169}], ["FSHR", ["TCGA.CM.6164.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.888883220387385}], ["FSHR", ["TCGA.CM.6164.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.895964463716329}], ["FSHR", ["TCGA.CM.6164.01", "Regulation of insulin secretion"], {"weight": 0.84883174782915}], ["FSHR", ["TCGA.CM.6164.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.844464376219985}], ["FSHR", ["TCGA.CM.6164.01", "G beta:gamma signalling through BTK"], {"weight": 0.883076216445176}], ["FSHR", ["TCGA.CM.6164.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.8811088817014}], ["FSHR", ["TCGA.CM.6164.01", "Peptide hormone metabolism"], {"weight": 0.715084517897926}], ["FSHR", ["TCGA.CM.6164.01", "Transport of small molecules"], {"weight": 0.930795166847444}], ["FSHR", ["TCGA.CM.6164.01", "Integration of energy metabolism"], {"weight": 0.836890420699399}], ["FSHR", ["TCGA.CM.6164.01", "Inwardly rectifying K+ channels"], {"weight": 0.845702792473197}], ["FSHR", ["TCGA.CM.6164.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.888185388790254}], ["FSHR", ["TCGA.CM.6164.01", "GABA B receptor activation"], {"weight": 0.894954575346703}], ["FSHR", ["TCGA.CM.6164.01", "Activation of GABAB receptors"], {"weight": 0.894954575346703}], ["FSHR", ["TCGA.CM.6164.01", "Opioid Signalling"], {"weight": 0.880216521555368}], ["FSHR", ["TCGA.CM.6164.01", "Platelet homeostasis"], {"weight": 0.74941104372775}], ["FSHR", ["TCGA.CM.6164.01", "Presynaptic function of Kainate receptors"], {"weight": 0.870481570100553}], ["FSHR", ["TCGA.CM.6164.01", "G alpha (s) signalling events"], {"weight": 0.94187451127213}], ["FSHR", ["TCGA.CM.6164.01", "Potassium Channels"], {"weight": 0.836001965809039}], ["FSHR", ["TCGA.CM.6164.01", "G-protein beta:gamma signalling"], {"weight": 0.896644627465991}], ["FSHR", ["TCGA.CM.6164.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.824859094813679}], ["FSHR", ["TCGA.CM.6164.01", "Leishmania parasite growth and survival"], {"weight": 0.824859094813679}], ["FSHR", ["TCGA.CM.6164.01", "Ca-dependent events"], {"weight": 0.833374960514641}], ["FSHR", ["TCGA.CM.6164.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.876506019937808}], ["ATP2B2", ["TCGA.AD.6964.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.89605557270189}], ["ATP2B2", ["TCGA.CM.4750.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.887555067595691}], ["ATP2B2", ["TCGA.CM.4750.01", "Opioid Signalling"], {"weight": 0.895804909656796}], ["ATP2B2", ["TCGA.CM.4750.01", "GPCR downstream signalling"], {"weight": 0.936774390336707}], ["ATP2B2", ["TCGA.CM.4750.01", "Signaling by GPCR"], {"weight": 0.934311342027441}], ["ATP2B2", ["TCGA.CM.4750.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.908221711159022}], ["ATP2B2", ["TCGA.CM.4750.01", "G-protein mediated events"], {"weight": 0.890967028487181}], ["ATP2B2", ["TCGA.CM.4750.01", "G alpha (i) signalling events"], {"weight": 0.933709244124129}], ["ATP2B2", ["TCGA.D5.6541.01", "Phase 0 - rapid depolarisation"], {"weight": 0.887686967583083}], ["ATP2B2", ["TCGA.D5.6898.01", "Cardiac conduction"], {"weight": 0.792863660587272}], ["ATP2B2", ["TCGA.D5.6898.01", "Peptide ligand-binding receptors"], {"weight": 0.89049142777884}], ["ATP2B2", ["TCGA.DM.A28G.01", "Cardiac conduction"], {"weight": 0.912650096857426}], ["ATP2B2", ["TCGA.DM.A28G.01", "LGI-ADAM interactions"], {"weight": 0.639541481835188}], ["ATP2B2", ["TCGA.F4.6856.01", "Sensory perception of taste"], {"weight": 0.896922836069872}], ["ATP2B2", ["TCGA.G4.6588.01", "Sensory processing of sound"], {"weight": 0.943409094609076}], ["ATP2B2", ["TCGA.G4.6588.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.941805430429109}], ["B4GALT6", ["TCGA.AZ.6607.01", "ECM proteoglycans"], {"weight": 0.937950750941954}], ["B4GALT6", ["TCGA.AZ.6607.01", "Integrin cell surface interactions"], {"weight": 0.887281079170517}], ["B4GALT6", ["TCGA.AZ.6607.01", "Glycosaminoglycan metabolism"], {"weight": 0.780853566498453}], ["CCT6A", ["TCGA.AM.5820.01", "GPCR downstream signalling"], {"weight": 0.941087691344466}], ["CCT6A", ["TCGA.AM.5820.01", "G alpha (i) signalling events"], {"weight": 0.930333069107693}], ["ADAMTSL3", ["TCGA.F4.6569.01", "Diseases of glycosylation"], {"weight": 0.83748130990441}], ["ADAMTSL3", ["TCGA.F4.6569.01", "Defective B3GALTL causes PpS"], {"weight": 0.897228206554743}], ["ADAMTSL3", ["TCGA.F4.6569.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.897164976948553}], ["ADAMTSL3", ["TCGA.F4.6569.01", "Diseases of metabolism"], {"weight": 0.83748130990441}], ["OR1A1", ["TCGA.D5.6533.01", "Regulation of insulin secretion"], {"weight": 0.916164983606135}], ["OR1A1", ["TCGA.D5.6533.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.922403817691441}], ["OR1A1", ["TCGA.D5.6533.01", "Integration of energy metabolism"], {"weight": 0.897470769573092}], ["OR1A1", ["TCGA.D5.6533.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.905261665089574}], ["TNFRSF13B", ["TCGA.G4.6322.01", "Molecules associated with elastic fibres"], {"weight": 0.745004139776326}], ["TNFRSF13B", ["TCGA.G4.6322.01", "Dermatan sulfate biosynthesis"], {"weight": 0.745278055196501}], ["FBN1", ["TCGA.A6.6650.01", "Molecules associated with elastic fibres"], {"weight": 0.822700350566193}], ["FBN1", ["TCGA.A6.6650.01", "Extracellular matrix organization"], {"weight": 0.780643153401637}], ["FBN1", ["TCGA.CA.5796.01", "Elastic fibre formation"], {"weight": 0.889383704565688}], ["FBN1", ["TCGA.CA.5796.01", "Molecules associated with elastic fibres"], {"weight": 0.871860340772479}], ["FBN1", ["TCGA.CM.6169.01", "Extracellular matrix organization"], {"weight": 0.786550694986329}], ["FBN1", ["TCGA.D5.6532.01", "Molecules associated with elastic fibres"], {"weight": 0.809355445676321}], ["FBN1", ["TCGA.D5.6532.01", "Elastic fibre formation"], {"weight": 0.824937499283549}], ["FBN1", ["TCGA.DM.A1D7.01", "Molecules associated with elastic fibres"], {"weight": 0.793969776265082}], ["FBN1", ["TCGA.DM.A1D7.01", "Elastic fibre formation"], {"weight": 0.795027833330147}], ["FBN1", ["TCGA.G4.6309.01", "Molecules associated with elastic fibres"], {"weight": 0.858637782842019}], ["MLXIPL", ["TCGA.A6.6650.01", "Signaling by GPCR"], {"weight": 0.927782794462226}], ["MLXIPL", ["TCGA.A6.6650.01", "Neuronal System"], {"weight": 0.938994534818005}], ["MLXIPL", ["TCGA.A6.6650.01", "Transmission across Chemical Synapses"], {"weight": 0.928408410168767}], ["MLXIPL", ["TCGA.A6.6650.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.918252051295365}], ["MLXIPL", ["TCGA.AY.6197.01", "Neuronal System"], {"weight": 0.938747676442361}], ["MLXIPL", ["TCGA.AY.6197.01", "Transmission across Chemical Synapses"], {"weight": 0.93562712603296}], ["MLXIPL", ["TCGA.AZ.4615.01", "Transmission across Chemical Synapses"], {"weight": 0.941746151147937}], ["MLXIPL", ["TCGA.AZ.4615.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.921573098057775}], ["MLXIPL", ["TCGA.AZ.4615.01", "Integration of energy metabolism"], {"weight": 0.926381250667113}], ["TAS2R46", ["TCGA.A6.6650.01", "Initial triggering of complement"], {"weight": 0.886852683045842}], ["TAS2R46", ["TCGA.DM.A1DB.01", "Initial triggering of complement"], {"weight": 0.814051736084965}], ["APOBR", ["TCGA.D5.6533.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.701836592551122}], ["IRS2", ["TCGA.A6.6650.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.670871987565277}], ["IRS2", ["TCGA.AY.6386.01", "FGFR1 ligand binding and activation"], {"weight": 0.907828577942563}], ["IRS2", ["TCGA.G4.6314.01", "Signaling by Activin"], {"weight": 0.79733214125228}], ["WNK1", ["TCGA.A6.6650.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.651540844355163}], ["WNK1", ["TCGA.F4.6703.01", "Transport of small molecules"], {"weight": 0.932141726200353}], ["WNK1", ["TCGA.F4.6806.01", "Regulation of FZD by ubiquitination"], {"weight": 0.76789911659451}], ["MED15", ["TCGA.A6.6650.01", "Diseases of Immune System"], {"weight": 0.855382297457056}], ["MED15", ["TCGA.A6.6650.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.855382297457056}], ["MED15", ["TCGA.A6.6650.01", "Integration of energy metabolism"], {"weight": 0.920561690050237}], ["MED15", ["TCGA.A6.6650.01", "Glucuronidation"], {"weight": 0.818908854394937}], ["MED15", ["TCGA.G4.6321.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.418567252331402}], ["TUBA3C", ["TCGA.A6.6654.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.799524101884286}], ["TUBA3C", ["TCGA.AZ.6607.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.845116962699029}], ["TUBA3C", ["TCGA.AZ.6607.01", "Phase II - Conjugation of compounds"], {"weight": 0.835178504289497}], ["TYRO3", ["TCGA.A6.6650.01", "Costimulation by the CD28 family"], {"weight": 0.847690552787924}], ["TYRO3", ["TCGA.A6.6650.01", "Ethanol oxidation"], {"weight": 0.791841702979709}], ["TYRO3", ["TCGA.A6.6650.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.746746214070218}], ["TYRO3", ["TCGA.AA.3662.01", "IRS-related events triggered by IGF1R"], {"weight": 0.839786461579155}], ["TYRO3", ["TCGA.AA.3662.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.839786461579155}], ["TYRO3", ["TCGA.AA.3662.01", "IGF1R signaling cascade"], {"weight": 0.839786461579155}], ["TYRO3", ["TCGA.AA.3662.01", "IRS-mediated signalling"], {"weight": 0.835308586139755}], ["TYRO3", ["TCGA.AZ.5403.01", "Ethanol oxidation"], {"weight": 0.610788652575631}], ["TYRO3", ["TCGA.CM.5862.01", "Biological oxidations"], {"weight": 0.928426990069201}], ["TYRO3", ["TCGA.G4.6294.01", "Biological oxidations"], {"weight": 0.914157422065234}], ["TYRO3", ["TCGA.G4.6320.01", "Integration of energy metabolism"], {"weight": 0.927804744433623}], ["KCNAB2", ["TCGA.A6.6650.01", "Cardiac conduction"], {"weight": 0.940493778112926}], ["KCNAB2", ["TCGA.A6.6650.01", "Phase 4 - resting membrane potential"], {"weight": 0.812966666918011}], ["PRDM9", ["TCGA.CK.5912.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.826997957546529}], ["CYP51A1", ["TCGA.A6.6650.01", "Biological oxidations"], {"weight": 0.909716235666856}], ["COL18A1", ["TCGA.A6.6651.01", "Extracellular matrix organization"], {"weight": 0.817977812930936}], ["FUBP1", ["TCGA.A6.6651.01", "Nucleotide catabolism"], {"weight": 0.689923947710318}], ["ZFPM1", ["TCGA.CK.5914.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.897263193439845}], ["ZFPM1", ["TCGA.CM.5868.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.80844510355151}], ["COL18A1", ["TCGA.A6.6651.01", "Collagen formation"], {"weight": 0.927249596323682}], ["COL18A1", ["TCGA.A6.6651.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.904486779302933}], ["COL18A1", ["TCGA.A6.6651.01", "Collagen chain trimerization"], {"weight": 0.910212781118108}], ["COL18A1", ["TCGA.A6.6651.01", "Collagen degradation"], {"weight": 0.909349481346601}], ["COL18A1", ["TCGA.A6.6651.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.853033629759128}], ["COL18A1", ["TCGA.A6.6651.01", "Integrin cell surface interactions"], {"weight": 0.837377653152912}], ["COL18A1", ["TCGA.A6.6651.01", "Scavenging by Class A Receptors"], {"weight": 0.587222279208818}], ["COL18A1", ["TCGA.A6.6782.01", "Collagen formation"], {"weight": 0.925660857465313}], ["COL18A1", ["TCGA.A6.6782.01", "Formation of axial mesoderm"], {"weight": 0.670223622371673}], ["COL18A1", ["TCGA.AA.3489.01", "Collagen formation"], {"weight": 0.932559678871069}], ["COL18A1", ["TCGA.AA.3489.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.94391945338675}], ["COL18A1", ["TCGA.AA.3489.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.903203324666073}], ["COL18A1", ["TCGA.AA.3489.01", "ECM proteoglycans"], {"weight": 0.811107939790776}], ["COL18A1", ["TCGA.AA.3489.01", "Collagen degradation"], {"weight": 0.906671747642093}], ["COL18A1", ["TCGA.AA.3511.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.932232057332309}], ["COL18A1", ["TCGA.AA.3511.01", "Collagen formation"], {"weight": 0.937776339668089}], ["COL18A1", ["TCGA.AA.3511.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.918035842359871}], ["COL18A1", ["TCGA.AA.3511.01", "Collagen chain trimerization"], {"weight": 0.897658332689867}], ["COL18A1", ["TCGA.AA.3511.01", "Formation of axial mesoderm"], {"weight": 0.656580502795692}], ["COL18A1", ["TCGA.AD.6964.01", "Collagen formation"], {"weight": 0.9466334896242}], ["COL18A1", ["TCGA.AD.6964.01", "Collagen degradation"], {"weight": 0.899586849010204}], ["COL18A1", ["TCGA.AZ.4615.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.930583498449182}], ["COL18A1", ["TCGA.AZ.6598.01", "Collagen formation"], {"weight": 0.951931013189386}], ["COL18A1", ["TCGA.AZ.6598.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.9402781558274}], ["COL18A1", ["TCGA.CA.6716.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.791509000404363}], ["COL18A1", ["TCGA.CM.5863.01", "Extracellular matrix organization"], {"weight": 0.890081596386554}], ["COL18A1", ["TCGA.CM.5863.01", "Collagen formation"], {"weight": 0.923576172385214}], ["COL18A1", ["TCGA.CM.5863.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.904638726171471}], ["COL18A1", ["TCGA.CM.5863.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.924337091983747}], ["COL18A1", ["TCGA.CM.5863.01", "Degradation of the extracellular matrix"], {"weight": 0.926294569531743}], ["COL18A1", ["TCGA.CM.5863.01", "Signaling by GPCR"], {"weight": 0.89577077358256}], ["COL18A1", ["TCGA.CM.5863.01", "Collagen chain trimerization"], {"weight": 0.886745798251419}], ["COL18A1", ["TCGA.CM.5868.01", "Extracellular matrix organization"], {"weight": 0.859087536415872}], ["COL18A1", ["TCGA.CM.5868.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.78041653840695}], ["COL18A1", ["TCGA.CM.5868.01", "L1CAM interactions"], {"weight": 0.863910371154263}], ["COL18A1", ["TCGA.CM.5868.01", "Collagen formation"], {"weight": 0.94196048736474}], ["COL18A1", ["TCGA.CM.5868.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.928766737573528}], ["COL18A1", ["TCGA.CM.6162.01", "Collagen formation"], {"weight": 0.936582362289352}], ["COL18A1", ["TCGA.CM.6162.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.923923273374918}], ["COL18A1", ["TCGA.CM.6162.01", "Collagen degradation"], {"weight": 0.915816396461505}], ["COL18A1", ["TCGA.CM.6169.01", "Formation of axial mesoderm"], {"weight": 0.652164533871589}], ["COL18A1", ["TCGA.CM.6674.01", "Collagen formation"], {"weight": 0.952281425138213}], ["COL18A1", ["TCGA.CM.6674.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.937963028341947}], ["COL18A1", ["TCGA.D5.6537.01", "Extracellular matrix organization"], {"weight": 0.908200639382602}], ["COL18A1", ["TCGA.F4.6806.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.910169096301473}], ["COL18A1", ["TCGA.F4.6806.01", "Degradation of the extracellular matrix"], {"weight": 0.847334127837022}], ["COL18A1", ["TCGA.F4.6806.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.933207343875373}], ["COL18A1", ["TCGA.F4.6806.01", "Collagen formation"], {"weight": 0.950219065284184}], ["COL18A1", ["TCGA.F4.6806.01", "Collagen degradation"], {"weight": 0.929923971502832}], ["COL18A1", ["TCGA.F4.6806.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.935521358315383}], ["COL18A1", ["TCGA.F4.6806.01", "GPCR downstream signalling"], {"weight": 0.934566131472863}], ["COL18A1", ["TCGA.G4.6297.01", "Collagen formation"], {"weight": 0.935822576662835}], ["COL18A1", ["TCGA.G4.6297.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.948560400966682}], ["COL18A1", ["TCGA.G4.6297.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.91015771776672}], ["COL18A1", ["TCGA.G4.6297.01", "Collagen chain trimerization"], {"weight": 0.922445536198394}], ["COL18A1", ["TCGA.G4.6588.01", "Collagen formation"], {"weight": 0.95442977833153}], ["TRIM26", ["TCGA.CK.4948.01", "Metal ion SLC transporters"], {"weight": 0.564617998047304}], ["TRIM26", ["TCGA.DM.A1D8.01", "L1CAM interactions"], {"weight": 0.870240508372951}], ["SYT5", ["TCGA.A6.6652.01", "Phase 0 - rapid depolarisation"], {"weight": 0.938533599108742}], ["SYT5", ["TCGA.A6.6652.01", "Neurexins and neuroligins"], {"weight": 0.938477751703716}], ["SYT5", ["TCGA.A6.6652.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.898614623557971}], ["SYT5", ["TCGA.A6.6652.01", "CD22 mediated BCR regulation"], {"weight": 0.831933551379361}], ["SYT5", ["TCGA.D5.6540.01", "Phase 0 - rapid depolarisation"], {"weight": 0.94347297275619}], ["SYT5", ["TCGA.D5.6540.01", "Sensory processing of sound"], {"weight": 0.94068217926927}], ["OR14J1", ["TCGA.A6.6652.01", "Integration of energy metabolism"], {"weight": 0.93309665070635}], ["OR14J1", ["TCGA.A6.6652.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.939114672927045}], ["OR14J1", ["TCGA.A6.6652.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.920602390384011}], ["OR14J1", ["TCGA.A6.6652.01", "GABA receptor activation"], {"weight": 0.91504086990938}], ["OR14J1", ["TCGA.A6.6652.01", "G-protein beta:gamma signalling"], {"weight": 0.937135452330006}], ["OR14J1", ["TCGA.A6.6652.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.92342189583514}], ["OR56A1", ["TCGA.A6.6652.01", "G-protein mediated events"], {"weight": 0.89699290009345}], ["OR56A1", ["TCGA.A6.6652.01", "Peptide hormone metabolism"], {"weight": 0.840679332602138}], ["DHTKD1", ["TCGA.A6.6652.01", "Biological oxidations"], {"weight": 0.925680394005555}], ["DHTKD1", ["TCGA.A6.6652.01", "Drug ADME"], {"weight": 0.878211620454316}], ["HERPUD1", ["TCGA.A6.6652.01", "Long-term potentiation"], {"weight": 0.862468851283046}], ["HERPUD1", ["TCGA.A6.6652.01", "Ion channel transport"], {"weight": 0.91843623331623}], ["DIRAS1", ["TCGA.A6.6652.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.842087453836901}], ["OR6F1", ["TCGA.A6.6652.01", "Signal amplification"], {"weight": 0.928500556167725}], ["OR6F1", ["TCGA.A6.6652.01", "G alpha (q) signalling events"], {"weight": 0.92542065477901}], ["OR6F1", ["TCGA.A6.6652.01", "Activation of the phototransduction cascade"], {"weight": 0.834312807369114}], ["KCNH8", ["TCGA.A6.6780.01", "Potassium Channels"], {"weight": 0.948715168459352}], ["KCNH8", ["TCGA.CM.4744.01", "Potassium Channels"], {"weight": 0.96085059886792}], ["KCNH8", ["TCGA.CM.4744.01", "Voltage gated Potassium channels"], {"weight": 0.948087005210933}], ["KCNH8", ["TCGA.D5.6531.01", "Potassium Channels"], {"weight": 0.947391157401348}], ["ITGAL", ["TCGA.AM.5821.01", "Extracellular matrix organization"], {"weight": 0.918695376509111}], ["ITGAL", ["TCGA.CM.6676.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.898786950287243}], ["ITGAL", ["TCGA.CM.6676.01", "Drug ADME"], {"weight": 0.846136286890019}], ["ITGAL", ["TCGA.CM.6676.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.880836602696267}], ["ITGAL", ["TCGA.G4.6626.01", "Molecules associated with elastic fibres"], {"weight": 0.884862200059148}], ["EPB41L1", ["TCGA.AZ.4615.01", "Protein-protein interactions at synapses"], {"weight": 0.906170404071275}], ["EPB41L1", ["TCGA.G4.6309.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.911827662083092}], ["EPB41L3", ["TCGA.A6.6653.01", "Extracellular matrix organization"], {"weight": 0.899291218911742}], ["LAMB2", ["TCGA.CM.6680.01", "L1CAM interactions"], {"weight": 0.791480244787227}], ["ADCY5", ["TCGA.G4.6309.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.860811894668869}], ["ADCY5", ["TCGA.G4.6309.01", "Platelet homeostasis"], {"weight": 0.902983005073723}], ["ADCY5", ["TCGA.G4.6586.01", "Peptide ligand-binding receptors"], {"weight": 0.955419401328984}], ["ADCY5", ["TCGA.G4.6588.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.85669687768659}], ["ADCY6", ["TCGA.AA.3492.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.843956304882894}], ["ADCY6", ["TCGA.AA.3492.01", "Platelet homeostasis"], {"weight": 0.912428158736609}], ["ADCY9", ["TCGA.F4.6703.01", "Peptide ligand-binding receptors"], {"weight": 0.939105875277703}], ["ADCY9", ["TCGA.F4.6703.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.939105875277703}], ["RAPGEF3", ["TCGA.AY.6386.01", "Integration of energy metabolism"], {"weight": 0.916936037526712}], ["RAPGEF3", ["TCGA.AY.6386.01", "Regulation of insulin secretion"], {"weight": 0.889301418177242}], ["NCOA3", ["TCGA.A6.6653.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.451965385050428}], ["NCOA3", ["TCGA.AY.6196.01", "Triglyceride metabolism"], {"weight": 0.837650218129525}], ["NCOA3", ["TCGA.F4.6569.01", "Signaling by Retinoic Acid"], {"weight": 0.775177691813232}], ["NCOA3", ["TCGA.F4.6856.01", "Signaling Pathways"], {"weight": 0.878550728002065}], ["NCOA7", ["TCGA.CM.5861.01", "SUMOylation of intracellular receptors"], {"weight": 0.689372057609535}], ["NCOA7", ["TCGA.CM.5861.01", "Nuclear Receptor transcription pathway"], {"weight": 0.821166667808476}], ["F13B", ["TCGA.CA.5797.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.77128827012821}], ["F13B", ["TCGA.G4.6315.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.892966158890201}], ["F13B", ["TCGA.G4.6315.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.892966158890201}], ["F13B", ["TCGA.G4.6315.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.793922446289627}], ["F13B", ["TCGA.G4.6315.01", "Diseases of Immune System"], {"weight": 0.892966158890201}], ["F13B", ["TCGA.G4.6315.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.892966158890201}], ["SCRIB", ["TCGA.A6.6780.01", "Long-term potentiation"], {"weight": 0.920101883872861}], ["SCRIB", ["TCGA.AA.3697.01", "Neurexins and neuroligins"], {"weight": 0.904354570644567}], ["SCRIB", ["TCGA.AA.3712.01", "GPCR ligand binding"], {"weight": 0.935011627168629}], ["SCRIB", ["TCGA.AA.3712.01", "Protein-protein interactions at synapses"], {"weight": 0.890246159956987}], ["SCRIB", ["TCGA.AA.3712.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.890097868882656}], ["SCRIB", ["TCGA.AA.3712.01", "Neurexins and neuroligins"], {"weight": 0.934315954479175}], ["SCRIB", ["TCGA.CM.4750.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.844278658192315}], ["CTSC", ["TCGA.A6.6653.01", "Collagen formation"], {"weight": 0.944800179064221}], ["CTSC", ["TCGA.AM.5821.01", "Protein-protein interactions at synapses"], {"weight": 0.936194944941218}], ["CTSC", ["TCGA.AM.5821.01", "Synaptic adhesion-like molecules"], {"weight": 0.835901324227836}], ["CTSC", ["TCGA.G4.6625.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.897129228156248}], ["CTSC", ["TCGA.G4.6625.01", "Collagen formation"], {"weight": 0.862329324926551}], ["NR5A1", ["TCGA.AZ.6598.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.839976751348026}], ["NR5A1", ["TCGA.CM.6171.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.860987390146239}], ["NR5A1", ["TCGA.CM.6171.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.901370456198574}], ["NFATC3", ["TCGA.D5.6540.01", "Arachidonic acid metabolism"], {"weight": 0.900571556302592}], ["NFATC3", ["TCGA.G4.6320.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.931962292983362}], ["NFATC3", ["TCGA.G4.6320.01", "Peptide ligand-binding receptors"], {"weight": 0.928962715233931}], ["DRD5", ["TCGA.CM.4752.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.836088897354072}], ["DRD5", ["TCGA.CM.4752.01", "Signal amplification"], {"weight": 0.846507019832595}], ["DRD5", ["TCGA.CM.4752.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.898813372517742}], ["DRD5", ["TCGA.CM.4752.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.883178445467296}], ["DRD5", ["TCGA.CM.4752.01", "G beta:gamma signalling through BTK"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "G beta:gamma signalling through CDC42"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "GPCR ligand binding"], {"weight": 0.916326116123283}], ["DRD5", ["TCGA.CM.4752.01", "G-protein activation"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "Thromboxane signalling through TP receptor"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "Glucagon-type ligand receptors"], {"weight": 0.878377916672161}], ["DRD5", ["TCGA.CM.4752.01", "Activation of G protein gated Potassium channels"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "G protein gated Potassium channels"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.860738445238141}], ["DRD5", ["TCGA.CM.4752.01", "Potassium Channels"], {"weight": 0.80321908807949}], ["ENTPD2", ["TCGA.DM.A28C.01", "Nicotinate metabolism"], {"weight": 0.673122660892282}], ["UGT2B11", ["TCGA.A6.6653.01", "RA biosynthesis pathway"], {"weight": 0.861480198433482}], ["UGT2B11", ["TCGA.AZ.4615.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.876080424133371}], ["UGT2B11", ["TCGA.AZ.4615.01", "RA biosynthesis pathway"], {"weight": 0.909564539422741}], ["UGT2B11", ["TCGA.CM.6675.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.924428702029683}], ["RARB", ["TCGA.A6.6780.01", "Formation of the anterior neural plate"], {"weight": 0.68479159555888}], ["EXOC3L2", ["TCGA.D5.6537.01", "Activation of the phototransduction cascade"], {"weight": 0.837595689564158}], ["OR2M4", ["TCGA.A6.6653.01", "G alpha (s) signalling events"], {"weight": 0.960168776072696}], ["OR2M4", ["TCGA.DM.A0XF.01", "Neuronal System"], {"weight": 0.9342449457732}], ["OR2M4", ["TCGA.DM.A0XF.01", "Transmission across Chemical Synapses"], {"weight": 0.921394598629653}], ["OR2M4", ["TCGA.DM.A0XF.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.928197684127545}], ["OR2M4", ["TCGA.DM.A0XF.01", "Signaling Pathways"], {"weight": 0.903842153867159}], ["OR2M4", ["TCGA.DM.A0XF.01", "Potassium Channels"], {"weight": 0.960448771850045}], ["OR2M4", ["TCGA.DM.A0XF.01", "G alpha (i) signalling events"], {"weight": 0.946026520042346}], ["OR2M4", ["TCGA.DM.A0XF.01", "Phase 4 - resting membrane potential"], {"weight": 0.861869284695899}], ["OR2M4", ["TCGA.DM.A0XF.01", "Signal amplification"], {"weight": 0.919706138125876}], ["OR2M4", ["TCGA.DM.A0XF.01", "GABA receptor activation"], {"weight": 0.915528009099176}], ["OR2M4", ["TCGA.DM.A0XF.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.906722999402263}], ["OR2M4", ["TCGA.DM.A0XF.01", "Glucagon-type ligand receptors"], {"weight": 0.923507240492741}], ["OR2M4", ["TCGA.DM.A0XF.01", "G-protein mediated events"], {"weight": 0.886429775381609}], ["OR2M4", ["TCGA.DM.A0XF.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.90904811863352}], ["OR2M4", ["TCGA.DM.A0XF.01", "Platelet activation, signaling and aggregation"], {"weight": 0.90429212911341}], ["OR2M4", ["TCGA.DM.A0XF.01", "Opioid Signalling"], {"weight": 0.907670980878775}], ["OR2M4", ["TCGA.DM.A0XF.01", "GABA B receptor activation"], {"weight": 0.927779873695806}], ["OR2M4", ["TCGA.DM.A0XF.01", "Activation of GABAB receptors"], {"weight": 0.927779873695806}], ["OR2M4", ["TCGA.DM.A0XF.01", "Activation of the phototransduction cascade"], {"weight": 0.776454441574848}], ["OR2M4", ["TCGA.DM.A0XF.01", "Platelet homeostasis"], {"weight": 0.860059310169105}], ["OR2M4", ["TCGA.DM.A0XF.01", "G alpha (q) signalling events"], {"weight": 0.926290116782613}], ["OR2M4", ["TCGA.DM.A0XF.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.919196932649048}], ["OR2M4", ["TCGA.DM.A0XF.01", "Voltage gated Potassium channels"], {"weight": 0.886192716308493}], ["OR2M4", ["TCGA.DM.A0XF.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.873037925953113}], ["OR2M4", ["TCGA.DM.A0XF.01", "Leishmania parasite growth and survival"], {"weight": 0.873037925953113}], ["OR2M4", ["TCGA.DM.A0XF.01", "Thromboxane signalling through TP receptor"], {"weight": 0.89560070692546}], ["OR2M4", ["TCGA.G4.6309.01", "G-protein beta:gamma signalling"], {"weight": 0.916860884840715}], ["UBQLN2", ["TCGA.D5.6920.01", "Extracellular matrix organization"], {"weight": 0.831680599633731}], ["PLCG1", ["TCGA.A6.6781.01", "Signaling by GPCR"], {"weight": 0.928924702780675}], ["PLCG1", ["TCGA.A6.6781.01", "GPCR downstream signalling"], {"weight": 0.924770672410836}], ["PLCG1", ["TCGA.AA.3663.01", "Neuronal System"], {"weight": 0.931022684398385}], ["PLCG1", ["TCGA.F4.6856.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.86165575094052}], ["PLCG1", ["TCGA.F4.6856.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.86165575094052}], ["PREX2", ["TCGA.CK.5913.01", "GPCR downstream signalling"], {"weight": 0.939768741370666}], ["PREX2", ["TCGA.CK.5916.01", "GPCR ligand binding"], {"weight": 0.906788031730059}], ["PREX2", ["TCGA.D5.6538.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.804245566549876}], ["RGS12", ["TCGA.A6.6653.01", "G-protein mediated events"], {"weight": 0.920182333518685}], ["RGS12", ["TCGA.A6.6653.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.889755357639761}], ["RGS12", ["TCGA.AA.3492.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.929012344892372}], ["RGS12", ["TCGA.AA.3492.01", "Signal amplification"], {"weight": 0.886416829801234}], ["RGS12", ["TCGA.AA.3492.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.918462939470163}], ["RGS12", ["TCGA.AA.3492.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.906045524399145}], ["RGS12", ["TCGA.AA.3492.01", "GABA B receptor activation"], {"weight": 0.935585421544267}], ["RGS12", ["TCGA.AA.3492.01", "Activation of GABAB receptors"], {"weight": 0.935585421544267}], ["RGS12", ["TCGA.AA.3660.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.860450426170202}], ["RGS12", ["TCGA.AA.3660.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.893957551943815}], ["RGS12", ["TCGA.AA.3660.01", "Integration of energy metabolism"], {"weight": 0.817446808224761}], ["RGS12", ["TCGA.AA.3660.01", "G alpha (z) signalling events"], {"weight": 0.881809832831366}], ["RGS12", ["TCGA.AA.3660.01", "Regulation of insulin secretion"], {"weight": 0.821502458221479}], ["RGS12", ["TCGA.AA.3660.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.871258563426956}], ["RGS12", ["TCGA.AA.3660.01", "G alpha (i) signalling events"], {"weight": 0.934142214559581}], ["RGS12", ["TCGA.AA.3660.01", "GABA B receptor activation"], {"weight": 0.867006028731865}], ["RGS12", ["TCGA.AA.3660.01", "Activation of GABAB receptors"], {"weight": 0.867006028731865}], ["RGS12", ["TCGA.AA.3660.01", "Signal amplification"], {"weight": 0.871258563426956}], ["RGS12", ["TCGA.AZ.4615.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.905115107931528}], ["RGS12", ["TCGA.CM.6162.01", "G alpha (i) signalling events"], {"weight": 0.896158773831514}], ["RGS12", ["TCGA.D5.6927.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.914009885327353}], ["RGS12", ["TCGA.D5.6927.01", "Regulation of insulin secretion"], {"weight": 0.894307070061598}], ["RGS12", ["TCGA.G4.6304.01", "Signaling by GPCR"], {"weight": 0.951870438241969}], ["RGS12", ["TCGA.G4.6304.01", "GPCR downstream signalling"], {"weight": 0.951040149472753}], ["RGS12", ["TCGA.G4.6304.01", "G alpha (i) signalling events"], {"weight": 0.956543689477889}], ["GRIN1", ["TCGA.A6.6653.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.895211839336063}], ["GRIN1", ["TCGA.CM.4743.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.933834988935929}], ["GRIN1", ["TCGA.G4.6586.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.945925401378794}], ["GRIN1", ["TCGA.G4.6588.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.93769026291517}], ["ARHGAP22", ["TCGA.CK.4952.01", "Generation of second messenger molecules"], {"weight": 0.896502909866506}], ["ARHGAP22", ["TCGA.CM.5860.01", "Neurexins and neuroligins"], {"weight": 0.869061358740622}], ["PKD1", ["TCGA.CM.6675.01", "Activation of the phototransduction cascade"], {"weight": 0.886270384231244}], ["PKD1", ["TCGA.D5.6540.01", "Activation of the phototransduction cascade"], {"weight": 0.885483669699187}], ["PKD1", ["TCGA.G4.6588.01", "Activation of the phototransduction cascade"], {"weight": 0.895112437749102}], ["APBA1", ["TCGA.CM.6676.01", "Neuronal System"], {"weight": 0.932878436328018}], ["APBA1", ["TCGA.CM.6676.01", "Initial triggering of complement"], {"weight": 0.600271058691538}], ["APBA1", ["TCGA.CM.6676.01", "Extracellular matrix organization"], {"weight": 0.837043825185775}], ["APBA1", ["TCGA.CM.6676.01", "Peptide ligand-binding receptors"], {"weight": 0.911842255330798}], ["APBA1", ["TCGA.G4.6320.01", "Neuronal System"], {"weight": 0.934284202555297}], ["APBA1", ["TCGA.G4.6320.01", "Transmission across Chemical Synapses"], {"weight": 0.922481395232771}], ["APBA2", ["TCGA.A6.6653.01", "Neurexins and neuroligins"], {"weight": 0.950890564202467}], ["APBA2", ["TCGA.AZ.4615.01", "Neurexins and neuroligins"], {"weight": 0.914442575992183}], ["APBA2", ["TCGA.CM.4748.01", "Neuronal System"], {"weight": 0.922640592298474}], ["APBA2", ["TCGA.CM.5348.01", "LGI-ADAM interactions"], {"weight": 0.813891674887926}], ["APBA2", ["TCGA.CM.6164.01", "Neuronal System"], {"weight": 0.91362629161961}], ["APBA2", ["TCGA.CM.6164.01", "Extracellular matrix organization"], {"weight": 0.819752229972283}], ["APBA2", ["TCGA.CM.6164.01", "Complement cascade"], {"weight": 0.659984881720323}], ["APBA2", ["TCGA.CM.6164.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.784732515983599}], ["APBA2", ["TCGA.CM.6164.01", "Regulation of Complement cascade"], {"weight": 0.640396444279337}], ["APBA2", ["TCGA.CM.6164.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.646748252234825}], ["APBA2", ["TCGA.D5.6532.01", "Neurexins and neuroligins"], {"weight": 0.937735343863994}], ["APBA2", ["TCGA.D5.6532.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.718559473091947}], ["APBA2", ["TCGA.D5.6929.01", "Protein-protein interactions at synapses"], {"weight": 0.84067828423555}], ["APBA2", ["TCGA.G4.6298.01", "Defensins"], {"weight": 0.697363211120478}], ["APBA2", ["TCGA.G4.6298.01", "Other interleukin signaling"], {"weight": 0.74516033518452}], ["APBA2", ["TCGA.G4.6298.01", "LGI-ADAM interactions"], {"weight": 0.784116822333187}], ["APBA2", ["TCGA.G4.6298.01", "Antimicrobial peptides"], {"weight": 0.673253865333627}], ["PTPRZ1", ["TCGA.A6.6653.01", "L1CAM interactions"], {"weight": 0.916382920900321}], ["PTPRZ1", ["TCGA.AD.5900.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.899305209582385}], ["PTPRZ1", ["TCGA.AD.6901.01", "NCAM1 interactions"], {"weight": 0.909449917659477}], ["PTPRZ1", ["TCGA.AD.6901.01", "NCAM signaling for neurite out-growth"], {"weight": 0.922437095434874}], ["PTPRZ1", ["TCGA.AM.5821.01", "L1CAM interactions"], {"weight": 0.944877142722589}], ["PTPRZ1", ["TCGA.CK.4950.01", "Interaction between L1 and Ankyrins"], {"weight": 0.861748992806565}], ["PTPRZ1", ["TCGA.CK.4950.01", "L1CAM interactions"], {"weight": 0.823316365295494}], ["PTPRZ1", ["TCGA.D5.6930.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.834138250885628}], ["PTPRZ1", ["TCGA.G4.6293.01", "Interaction between L1 and Ankyrins"], {"weight": 0.914466150746983}], ["PTPRZ1", ["TCGA.G4.6293.01", "L1CAM interactions"], {"weight": 0.884122031037184}], ["PTPRZ1", ["TCGA.G4.6293.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.831555921078669}], ["PTPRZ1", ["TCGA.G4.6311.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.81559712278669}], ["TGFB3", ["TCGA.A6.6653.01", "Peptide hormone metabolism"], {"weight": 0.905163487316617}], ["TGFB3", ["TCGA.CM.6674.01", "Extracellular matrix organization"], {"weight": 0.876229046740582}], ["TGFB3", ["TCGA.CM.6674.01", "Peptide hormone metabolism"], {"weight": 0.764063161434002}], ["KEL", ["TCGA.DM.A1DA.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.937273424187895}], ["KEL", ["TCGA.DM.A1DA.01", "GPCR ligand binding"], {"weight": 0.939252735482448}], ["KEL", ["TCGA.DM.A1DA.01", "G alpha (q) signalling events"], {"weight": 0.935231399730058}], ["STAB2", ["TCGA.DM.A28K.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.754495181293007}], ["STAB2", ["TCGA.DM.A28K.01", "Scavenging of heme from plasma"], {"weight": 0.619548489008133}], ["STAB2", ["TCGA.DM.A28K.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.703302302548108}], ["STAB2", ["TCGA.DM.A28K.01", "Neurotransmitter release cycle"], {"weight": 0.895258877518314}], ["STAB2", ["TCGA.DM.A28K.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.850942198372728}], ["HIP1", ["TCGA.AA.3489.01", "Extracellular matrix organization"], {"weight": 0.844515236706521}], ["NDOR1", ["TCGA.CK.5914.01", "Nucleotide catabolism"], {"weight": 0.732167248877611}], ["WDFY3", ["TCGA.CM.6166.01", "Interferon gamma signaling"], {"weight": 0.913522311357856}], ["KCNJ11", ["TCGA.A6.6653.01", "DAG and IP3 signaling"], {"weight": 0.913709610248082}], ["KCNJ11", ["TCGA.A6.6653.01", "Calmodulin induced events"], {"weight": 0.913098588370456}], ["KCNJ11", ["TCGA.A6.6653.01", "CaM pathway"], {"weight": 0.913098588370456}], ["KCNJ11", ["TCGA.A6.6653.01", "Regulation of insulin secretion"], {"weight": 0.908523440754196}], ["KCNJ11", ["TCGA.A6.6653.01", "Ca-dependent events"], {"weight": 0.913098588370456}], ["KCNJ11", ["TCGA.G4.6299.01", "Potassium Channels"], {"weight": 0.951701700841661}], ["KCNJ11", ["TCGA.G4.6299.01", "G alpha (i) signalling events"], {"weight": 0.950774736390734}], ["KCNJ11", ["TCGA.G4.6299.01", "Inwardly rectifying K+ channels"], {"weight": 0.914902729409944}], ["KCNJ11", ["TCGA.G4.6299.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.909230750359353}], ["KCNJ11", ["TCGA.G4.6299.01", "G-protein mediated events"], {"weight": 0.923366608517696}], ["KCNJ11", ["TCGA.G4.6299.01", "Opioid Signalling"], {"weight": 0.936452888704487}], ["KCNJ11", ["TCGA.G4.6299.01", "Phase 0 - rapid depolarisation"], {"weight": 0.851376886161896}], ["KCNJ11", ["TCGA.G4.6299.01", "Cardiac conduction"], {"weight": 0.88093964664954}], ["HIF3A", ["TCGA.CM.5349.01", "Glucuronidation"], {"weight": 0.796594304229595}], ["HIF3A", ["TCGA.CM.5349.01", "Drug ADME"], {"weight": 0.830704244308103}], ["B2M", ["TCGA.D5.5538.01", "NCAM1 interactions"], {"weight": 0.913395466800652}], ["B2M", ["TCGA.DM.A28F.01", "G alpha (q) signalling events"], {"weight": 0.918916760217222}], ["B2M", ["TCGA.DM.A28F.01", "Classical antibody-mediated complement activation"], {"weight": 0.66380088607278}], ["B2M", ["TCGA.DM.A28F.01", "Creation of C4 and C2 activators"], {"weight": 0.745728933248473}], ["DCC", ["TCGA.D5.6538.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.933019997108683}], ["DCC", ["TCGA.D5.6538.01", "DAP12 interactions"], {"weight": 0.914900787015565}], ["DCC", ["TCGA.D5.6538.01", "Dectin-2 family"], {"weight": 0.809805758061417}], ["C9orf3", ["TCGA.A6.6653.01", "GPCR downstream signalling"], {"weight": 0.94443672202465}], ["C9orf3", ["TCGA.A6.6653.01", "GPCR ligand binding"], {"weight": 0.950064684273308}], ["C9orf3", ["TCGA.A6.6653.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.948997128317142}], ["C9orf3", ["TCGA.A6.6653.01", "Peptide ligand-binding receptors"], {"weight": 0.950253658474221}], ["C9orf3", ["TCGA.A6.6653.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.935169661531693}], ["DBT", ["TCGA.D5.6540.01", "Biological oxidations"], {"weight": 0.938929384710153}], ["DBT", ["TCGA.D5.6540.01", "Phase II - Conjugation of compounds"], {"weight": 0.881816228938543}], ["DBT", ["TCGA.D5.6540.01", "Signaling by Retinoic Acid"], {"weight": 0.82742935194771}], ["AMPD2", ["TCGA.G4.6320.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.826998137562009}], ["OR51A2", ["TCGA.A6.6653.01", "GABA B receptor activation"], {"weight": 0.921851317154255}], ["OR51A2", ["TCGA.A6.6653.01", "Activation of GABAB receptors"], {"weight": 0.921851317154255}], ["SDC1", ["TCGA.CM.6162.01", "Metabolism"], {"weight": 0.825364668924645}], ["PCDH7", ["TCGA.CM.5862.01", "APAP ADME"], {"weight": 0.828037362132992}], ["PCDH7", ["TCGA.D5.6540.01", "APAP ADME"], {"weight": 0.908415990503263}], ["PCDH7", ["TCGA.G4.6294.01", "Regulation of insulin secretion"], {"weight": 0.91861224994595}], ["PCDH7", ["TCGA.G4.6294.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.790969696436975}], ["PCDH7", ["TCGA.G4.6294.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.790969696436975}], ["PCDH7", ["TCGA.G4.6294.01", "Drug ADME"], {"weight": 0.867006019566083}], ["DHX30", ["TCGA.DM.A0XF.01", "CD22 mediated BCR regulation"], {"weight": 0.770214387980741}], ["CHRNB2", ["TCGA.CM.6674.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.886998482472048}], ["BEGAIN", ["TCGA.AZ.6598.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.911408095264122}], ["BEGAIN", ["TCGA.G4.6628.01", "Neurexins and neuroligins"], {"weight": 0.895358165306953}], ["PTGS1", ["TCGA.AD.6895.01", "Glutathione conjugation"], {"weight": 0.88387847748472}], ["PTGS1", ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts"], {"weight": 0.903458648887985}], ["PTGS1", ["TCGA.AM.5821.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.878103545113853}], ["PTGS1", ["TCGA.AM.5821.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.822441011873879}], ["BMP1", ["TCGA.A6.6653.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.935930382405667}], ["BMP1", ["TCGA.A6.6781.01", "Collagen chain trimerization"], {"weight": 0.93943424825203}], ["BMP1", ["TCGA.AD.6895.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.930319781957174}], ["BMP1", ["TCGA.AZ.6598.01", "Collagen chain trimerization"], {"weight": 0.931442463841028}], ["BMP1", ["TCGA.CM.6674.01", "Collagen chain trimerization"], {"weight": 0.91914314794567}], ["CYP26A1", ["TCGA.AZ.6598.01", "RA biosynthesis pathway"], {"weight": 0.922342449497293}], ["ACAT1", ["TCGA.A6.6653.01", "Biological oxidations"], {"weight": 0.912330710049086}], ["ACAT1", ["TCGA.AA.3697.01", "Biological oxidations"], {"weight": 0.893380948812512}], ["ACAT1", ["TCGA.G4.6297.01", "Biological oxidations"], {"weight": 0.895898821857657}], ["ACAT1", ["TCGA.G4.6297.01", "Ethanol oxidation"], {"weight": 0.775326609455231}], ["CPSF6", ["TCGA.DM.A1D8.01", "Classical antibody-mediated complement activation"], {"weight": 0.634897731603275}], ["CPSF6", ["TCGA.DM.A1D8.01", "TNFs bind their physiological receptors"], {"weight": 0.377869305588796}], ["CPSF6", ["TCGA.DM.A1D8.01", "Creation of C4 and C2 activators"], {"weight": 0.703505035859914}], ["SLCO1B1", ["TCGA.AA.3697.01", "Drug ADME"], {"weight": 0.909638767844413}], ["TJP2", ["TCGA.CK.5916.01", "Neurexins and neuroligins"], {"weight": 0.772279128320944}], ["TJP2", ["TCGA.D5.6541.01", "Neurexins and neuroligins"], {"weight": 0.8943096936587}], ["NR2C2", ["TCGA.D5.6920.01", "Diseases associated with glycosaminoglycan metabolism"], {"weight": 0.7851702989567}], ["WLS", ["TCGA.A6.6653.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.817972898888433}], ["GRIA1", ["TCGA.AD.6890.01", "Phase 0 - rapid depolarisation"], {"weight": 0.921925650863732}], ["GRIA1", ["TCGA.AD.6890.01", "Insulin processing"], {"weight": 0.611044661349741}], ["GRIA1", ["TCGA.CM.5349.01", "Extracellular matrix organization"], {"weight": 0.845552691614672}], ["GRIA1", ["TCGA.F4.6461.01", "Extracellular matrix organization"], {"weight": 0.864177597271464}], ["GRIA1", ["TCGA.F4.6461.01", "Collagen formation"], {"weight": 0.932633425455197}], ["GRIA1", ["TCGA.F4.6461.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.92159184101759}], ["MED13", ["TCGA.D5.6932.01", "Glucuronidation"], {"weight": 0.87806036311788}], ["MED13", ["TCGA.D5.6932.01", "Aspirin ADME"], {"weight": 0.790009140327312}], ["MED13", ["TCGA.G4.6626.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.916182547394539}], ["MED13", ["TCGA.G4.6626.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.916182547394539}], ["MED13", ["TCGA.G4.6626.01", "Diseases of Immune System"], {"weight": 0.898242192626512}], ["MED13", ["TCGA.G4.6626.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.898242192626512}], ["MED13", ["TCGA.G4.6626.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.905323690793335}], ["CACNA1C", ["TCGA.AD.6890.01", "Cardiac conduction"], {"weight": 0.899783657848075}], ["CACNA1C", ["TCGA.AD.6890.01", "Extracellular matrix organization"], {"weight": 0.848672090369593}], ["CACNA1C", ["TCGA.AD.6890.01", "Signaling Pathways"], {"weight": 0.873150028970686}], ["CACNA1C", ["TCGA.AD.6890.01", "Muscle contraction"], {"weight": 0.904625442221798}], ["CACNA1C", ["TCGA.AD.6890.01", "Peptide hormone metabolism"], {"weight": 0.692555288970862}], ["CACNA1C", ["TCGA.AD.6890.01", "Regulation of insulin secretion"], {"weight": 0.891204989907117}], ["CACNA1C", ["TCGA.AD.6890.01", "Integration of energy metabolism"], {"weight": 0.896374692877786}], ["CACNA1C", ["TCGA.AD.6890.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.914936775335756}], ["CACNA1C", ["TCGA.AD.6890.01", "Sensory processing of sound"], {"weight": 0.914936775335756}], ["CACNA1C", ["TCGA.AD.6899.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.889213283888308}], ["CACNA1C", ["TCGA.CM.6171.01", "LGI-ADAM interactions"], {"weight": 0.899193426160686}], ["CACNA1C", ["TCGA.F4.6460.01", "Regulation of insulin secretion"], {"weight": 0.809858245761716}], ["CACNA1D", ["TCGA.DM.A0XD.01", "Signaling Pathways"], {"weight": 0.914272902672544}], ["CACNA1D", ["TCGA.DM.A1DA.01", "Platelet homeostasis"], {"weight": 0.921643033154895}], ["CACNA1S", ["TCGA.AA.3655.01", "LGI-ADAM interactions"], {"weight": 0.738505559087164}], ["CACNA1S", ["TCGA.D5.5540.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.893161843108147}], ["CACNA1S", ["TCGA.DM.A28K.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.952121756673653}], ["CACNA1S", ["TCGA.DM.A28K.01", "Immune System"], {"weight": 0.886887253655605}], ["CACNA1S", ["TCGA.DM.A28K.01", "Peptide ligand-binding receptors"], {"weight": 0.951149151297709}], ["CACNA1S", ["TCGA.DM.A28K.01", "Phase 0 - rapid depolarisation"], {"weight": 0.944567729068336}], ["CACNA1S", ["TCGA.DM.A28K.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.876057179651119}], ["CACNA1S", ["TCGA.DM.A28K.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.877417604754791}], ["CACNA1S", ["TCGA.DM.A28K.01", "Ion homeostasis"], {"weight": 0.955895900176648}], ["CACNA1S", ["TCGA.DM.A28K.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.909001073657091}], ["CACNA1S", ["TCGA.DM.A28K.01", "Long-term potentiation"], {"weight": 0.91241723246929}], ["KCNJ4", ["TCGA.A6.6653.01", "Phase 4 - resting membrane potential"], {"weight": 0.883546009989713}], ["KCNJ4", ["TCGA.CK.5916.01", "Potassium Channels"], {"weight": 0.948564920778547}], ["KCNJ4", ["TCGA.D5.5538.01", "Transmission across Chemical Synapses"], {"weight": 0.917641515483699}], ["KCNJ4", ["TCGA.D5.5538.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.912179422261174}], ["KCNJ4", ["TCGA.D5.5538.01", "Phase 4 - resting membrane potential"], {"weight": 0.881370135015259}], ["KCNJ4", ["TCGA.D5.5538.01", "GABA receptor activation"], {"weight": 0.864597480854699}], ["KCNB2", ["TCGA.CM.5348.01", "Potassium Channels"], {"weight": 0.937848640438049}], ["PPFIA3", ["TCGA.A6.6653.01", "Protein-protein interactions at synapses"], {"weight": 0.938380348668642}], ["PPFIA3", ["TCGA.A6.6780.01", "Protein-protein interactions at synapses"], {"weight": 0.930971162273729}], ["PPFIA3", ["TCGA.D5.6540.01", "Neuronal System"], {"weight": 0.942857253093234}], ["PPFIA3", ["TCGA.D5.6540.01", "Protein-protein interactions at synapses"], {"weight": 0.936408690493325}], ["PPFIA3", ["TCGA.G4.6588.01", "Neuronal System"], {"weight": 0.948409231053182}], ["PPFIA3", ["TCGA.G4.6588.01", "Protein-protein interactions at synapses"], {"weight": 0.940947664947938}], ["PPFIA3", ["TCGA.G4.6588.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.919140655246094}], ["GAA", ["TCGA.AZ.4615.01", "Digestion and absorption"], {"weight": 0.717493573085748}], ["GAA", ["TCGA.AZ.4615.01", "Digestion"], {"weight": 0.745938951256309}], ["PDIA3", ["TCGA.F4.6808.01", "Classical antibody-mediated complement activation"], {"weight": 0.781260228041597}], ["PDIA3", ["TCGA.F4.6808.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.65955163594075}], ["PDIA3", ["TCGA.F4.6808.01", "Creation of C4 and C2 activators"], {"weight": 0.745051777867353}], ["ITGA10", ["TCGA.AA.3655.01", "L1CAM interactions"], {"weight": 0.910644100459509}], ["ITGA10", ["TCGA.DM.A1HA.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.948581422128565}], ["ITGA10", ["TCGA.DM.A1HA.01", "Collagen chain trimerization"], {"weight": 0.934483740828252}], ["MIA3", ["TCGA.AA.3712.01", "Collagen formation"], {"weight": 0.925322130635843}], ["MIA3", ["TCGA.AA.3712.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.940586572755894}], ["MIA3", ["TCGA.AA.3712.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.901917695291893}], ["FGD2", ["TCGA.G4.6307.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.792310982596948}], ["FGD2", ["TCGA.G4.6307.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.710063951158609}], ["CD9", ["TCGA.AY.6197.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.918491889077142}], ["CD9", ["TCGA.AY.6197.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.918491889077142}], ["CD9", ["TCGA.AY.6197.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.910016089531203}], ["CD9", ["TCGA.AY.6197.01", "Diseases of Immune System"], {"weight": 0.874711548962043}], ["CD9", ["TCGA.AY.6197.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.874711548962043}], ["COL4A5", ["TCGA.DM.A1D9.01", "Cell surface interactions at the vascular wall"], {"weight": 0.72355163232123}], ["COL4A5", ["TCGA.F4.6569.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.721699492948152}], ["SLCO1B3", ["TCGA.F4.6459.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.831486414570529}], ["SLCO1B3", ["TCGA.F4.6459.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.836606909471845}], ["GBE1", ["TCGA.AZ.6598.01", "Glycogen synthesis"], {"weight": 0.792220565404587}], ["PPP2R5A", ["TCGA.D5.6536.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.765405119978201}], ["PPP2R5A", ["TCGA.D5.6536.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.842692306993163}], ["MBD6", ["TCGA.CM.5341.01", "rRNA processing in the nucleus and cytosol"], {"weight": 0.933860983616314}], ["MBD6", ["TCGA.CM.5341.01", "rRNA processing"], {"weight": 0.933860983616314}], ["PANX2", ["TCGA.AD.6964.01", "Neuronal System"], {"weight": 0.908349300551897}], ["PIK3CG", ["TCGA.AA.3660.01", "Signaling Pathways"], {"weight": 0.870230938944371}], ["PIK3CG", ["TCGA.AA.3660.01", "FGFR2 ligand binding and activation"], {"weight": 0.861496561709756}], ["PIK3CG", ["TCGA.AA.3660.01", "FGFR2c ligand binding and activation"], {"weight": 0.837608082623029}], ["PIK3CG", ["TCGA.AA.3660.01", "Activated point mutants of FGFR2"], {"weight": 0.837608082623029}], ["PIK3CG", ["TCGA.AA.3660.01", "Phospholipase C-mediated cascade; FGFR2"], {"weight": 0.837608082623029}], ["PIK3CG", ["TCGA.AA.3660.01", "Signaling by GPCR"], {"weight": 0.927791436798001}], ["PIK3CG", ["TCGA.AA.3660.01", "GPCR downstream signalling"], {"weight": 0.929726433204598}], ["PIK3CG", ["TCGA.AM.5820.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.812350842682627}], ["PIK3CG", ["TCGA.AM.5821.01", "SUMOylation of intracellular receptors"], {"weight": 0.852008090882843}], ["PIK3CG", ["TCGA.CK.5915.01", "Platelet homeostasis"], {"weight": 0.903590252702641}], ["PIK3CG", ["TCGA.CK.5915.01", "Cell surface interactions at the vascular wall"], {"weight": 0.779193870553705}], ["PIK3CG", ["TCGA.CM.6166.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.890876473663295}], ["PIK3CG", ["TCGA.CM.6166.01", "Regulation of Complement cascade"], {"weight": 0.801458785592432}], ["PIK3CG", ["TCGA.CM.6166.01", "Complement cascade"], {"weight": 0.82738526442083}], ["PIK3CG", ["TCGA.CM.6166.01", "Platelet homeostasis"], {"weight": 0.931817057522869}], ["PIK3CG", ["TCGA.D5.6533.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.890616625536242}], ["PIK3CG", ["TCGA.D5.6533.01", "Interleukin-6 family signaling"], {"weight": 0.89245489670905}], ["ESR2", ["TCGA.D5.6926.01", "Phase II - Conjugation of compounds"], {"weight": 0.872592397699113}], ["ESR2", ["TCGA.D5.6926.01", "Glucuronidation"], {"weight": 0.885480700061353}], ["ESR2", ["TCGA.D5.6926.01", "G alpha (i) signalling events"], {"weight": 0.928545914694133}], ["ESR2", ["TCGA.D5.6926.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.893505835567368}], ["ESR2", ["TCGA.D5.6926.01", "Regulation of insulin secretion"], {"weight": 0.891166419134435}], ["ESR2", ["TCGA.D5.6926.01", "Signal amplification"], {"weight": 0.904110487632085}], ["ESR2", ["TCGA.D5.6926.01", "Integration of energy metabolism"], {"weight": 0.895170613473069}], ["C6", ["TCGA.CK.4952.01", "Molecules associated with elastic fibres"], {"weight": 0.866699346144813}], ["RBMS1", ["TCGA.A6.6654.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.730572759008548}], ["SH3BP2", ["TCGA.A6.6653.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.913538794268459}], ["SH3BP2", ["TCGA.D5.6540.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.919591746234032}], ["SH3BP2", ["TCGA.G4.6320.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.910120516093738}], ["SH3BP2", ["TCGA.G4.6320.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.907616329235375}], ["SH3BP2", ["TCGA.G4.6320.01", "PD-1 signaling"], {"weight": 0.910003894458868}], ["SH3BP2", ["TCGA.G4.6320.01", "Generation of second messenger molecules"], {"weight": 0.9181438859984}], ["MAGI1", ["TCGA.AZ.4323.01", "Neuronal System"], {"weight": 0.922237841820743}], ["MAGI1", ["TCGA.AZ.4323.01", "Transmission across Chemical Synapses"], {"weight": 0.914503885227606}], ["MAGI1", ["TCGA.AZ.4323.01", "Muscle contraction"], {"weight": 0.928610263003896}], ["MAGI1", ["TCGA.AZ.4323.01", "Long-term potentiation"], {"weight": 0.896225395994482}], ["MAGI1", ["TCGA.AZ.4323.01", "Protein-protein interactions at synapses"], {"weight": 0.768414654769884}], ["MAGI1", ["TCGA.AZ.4323.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.903505221734285}], ["MAGI1", ["TCGA.CM.5862.01", "Initial triggering of complement"], {"weight": 0.823686525953265}], ["MAGI1", ["TCGA.F4.6570.01", "Integrin cell surface interactions"], {"weight": 0.815647715603368}], ["NGEF", ["TCGA.D5.6536.01", "PD-1 signaling"], {"weight": 0.922953184816831}], ["KCNQ3", ["TCGA.AA.3663.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.930073904226803}], ["KCNQ3", ["TCGA.AD.6901.01", "Potassium Channels"], {"weight": 0.900339311317097}], ["KCNQ3", ["TCGA.AD.6901.01", "Interaction between L1 and Ankyrins"], {"weight": 0.879347828338314}], ["KCNQ3", ["TCGA.AD.6901.01", "Cardiac conduction"], {"weight": 0.780375782874468}], ["KCNQ3", ["TCGA.AZ.4616.01", "Interaction between L1 and Ankyrins"], {"weight": 0.929708494102791}], ["KCNQ3", ["TCGA.AZ.4616.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.884488337705552}], ["KCNQ3", ["TCGA.AZ.4616.01", "L1CAM interactions"], {"weight": 0.906370151845504}], ["KCNQ3", ["TCGA.AZ.4616.01", "GABA B receptor activation"], {"weight": 0.915583634626182}], ["KCNQ3", ["TCGA.AZ.4616.01", "Activation of GABAB receptors"], {"weight": 0.915583634626182}], ["KCNQ3", ["TCGA.AZ.4616.01", "GABA receptor activation"], {"weight": 0.857124874120782}], ["KCNQ3", ["TCGA.AZ.4616.01", "Muscle contraction"], {"weight": 0.918272486787674}], ["KCNQ3", ["TCGA.AZ.4616.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.806099780843184}], ["KCNQ3", ["TCGA.D5.6531.01", "Phase 4 - resting membrane potential"], {"weight": 0.892351090313579}], ["KCNQ3", ["TCGA.D5.6531.01", "Interaction between L1 and Ankyrins"], {"weight": 0.906401568638499}], ["KCNQ3", ["TCGA.D5.6926.01", "NCAM signaling for neurite out-growth"], {"weight": 0.727174367362637}], ["KCNQ3", ["TCGA.D5.6926.01", "Interaction between L1 and Ankyrins"], {"weight": 0.891660657241485}], ["KCNQ3", ["TCGA.G4.6309.01", "Interaction between L1 and Ankyrins"], {"weight": 0.939068578197971}], ["PLEKHA7", ["TCGA.F4.6809.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.765765503832273}], ["PLEKHA7", ["TCGA.F4.6809.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.795580442715394}], ["PLEKHA7", ["TCGA.F4.6809.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.487795049790199}], ["GPR32", ["TCGA.CA.6716.01", "G alpha (s) signalling events"], {"weight": 0.953039404587611}], ["NFASC", ["TCGA.A6.6780.01", "Phase 0 - rapid depolarisation"], {"weight": 0.941132780597396}], ["NFASC", ["TCGA.AA.3697.01", "Interaction between L1 and Ankyrins"], {"weight": 0.914830967313035}], ["NFASC", ["TCGA.AA.3697.01", "L1CAM interactions"], {"weight": 0.864861869884418}], ["NFASC", ["TCGA.AU.6004.01", "L1CAM interactions"], {"weight": 0.902078724903517}], ["NFASC", ["TCGA.AY.6197.01", "Phase 0 - rapid depolarisation"], {"weight": 0.892831895530659}], ["NFASC", ["TCGA.CM.5341.01", "Cardiac conduction"], {"weight": 0.919334356579902}], ["NFASC", ["TCGA.CM.5341.01", "Phase 0 - rapid depolarisation"], {"weight": 0.870888295570197}], ["NFASC", ["TCGA.D5.6532.01", "Cardiac conduction"], {"weight": 0.943138389151604}], ["NFASC", ["TCGA.D5.6532.01", "Interaction between L1 and Ankyrins"], {"weight": 0.948807584031561}], ["NFASC", ["TCGA.D5.6532.01", "Muscle contraction"], {"weight": 0.926864087505386}], ["NFASC", ["TCGA.D5.6532.01", "Phase 4 - resting membrane potential"], {"weight": 0.857936527846143}], ["NFASC", ["TCGA.D5.6532.01", "L1CAM interactions"], {"weight": 0.898053994505686}], ["NFASC", ["TCGA.DM.A1D4.01", "Interaction between L1 and Ankyrins"], {"weight": 0.952909295523671}], ["NFASC", ["TCGA.DM.A28C.01", "Cardiac conduction"], {"weight": 0.956052548805795}], ["NFASC", ["TCGA.DM.A28C.01", "Stimuli-sensing channels"], {"weight": 0.873502923236729}], ["NFASC", ["TCGA.DM.A28C.01", "Signaling by Interleukins"], {"weight": 0.88403698181073}], ["NFASC", ["TCGA.DM.A28C.01", "Phase 0 - rapid depolarisation"], {"weight": 0.940227721566625}], ["NFASC", ["TCGA.DM.A28H.01", "Other interleukin signaling"], {"weight": 0.732852014849073}], ["NFASC", ["TCGA.DM.A28H.01", "Phase 0 - rapid depolarisation"], {"weight": 0.941835471824675}], ["VCAN", ["TCGA.AU.3779.01", "O-linked glycosylation of mucins"], {"weight": 0.889073170481642}], ["VCAN", ["TCGA.AU.3779.01", "Keratan sulfate biosynthesis"], {"weight": 0.82690907043973}], ["VCAN", ["TCGA.DM.A0X9.01", "Extracellular matrix organization"], {"weight": 0.830519400940616}], ["VCAN", ["TCGA.DM.A1D9.01", "Extracellular matrix organization"], {"weight": 0.854074554012179}], ["VCAN", ["TCGA.G4.6299.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.790273709827596}], ["LOXL2", ["TCGA.D5.6930.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.935527257106072}], ["LOXL2", ["TCGA.G4.6586.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.948270663148843}], ["LOXL2", ["TCGA.G4.6586.01", "Collagen formation"], {"weight": 0.937446813805431}], ["CYP8B1", ["TCGA.CK.5913.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.754934099539425}], ["SH3PXD2A", ["TCGA.A6.6654.01", "Extracellular matrix organization"], {"weight": 0.864077890175503}], ["CHST5", ["TCGA.A6.6654.01", "ECM proteoglycans"], {"weight": 0.881064722759795}], ["CHST5", ["TCGA.A6.6654.01", "Integrin cell surface interactions"], {"weight": 0.856657749813049}], ["GPC5", ["TCGA.A6.6654.01", "Metabolism"], {"weight": 0.879839282600125}], ["GPC5", ["TCGA.A6.6654.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.856650837012626}], ["GPC5", ["TCGA.A6.6654.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.787821016063936}], ["GPC5", ["TCGA.A6.6654.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.770095096478641}], ["GPC5", ["TCGA.A6.6654.01", "Glycosaminoglycan metabolism"], {"weight": 0.663672090209615}], ["GPC5", ["TCGA.CA.6718.01", "Metabolism"], {"weight": 0.927095790083573}], ["GPC5", ["TCGA.CA.6718.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.910436320436184}], ["GPC5", ["TCGA.CA.6718.01", "Retinoid metabolism and transport"], {"weight": 0.910436320436184}], ["GPC5", ["TCGA.CA.6718.01", "Metabolism of vitamins and cofactors"], {"weight": 0.849180300265993}], ["GPC5", ["TCGA.CA.6718.01", "Visual phototransduction"], {"weight": 0.909194091770345}], ["OR2M2", ["TCGA.A6.6654.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.836116486409071}], ["OR2M2", ["TCGA.AD.6895.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.91897592126159}], ["OR2M2", ["TCGA.CA.5797.01", "Transmission across Chemical Synapses"], {"weight": 0.924362113428869}], ["OR2M2", ["TCGA.CA.5797.01", "GPCR downstream signalling"], {"weight": 0.944551977680102}], ["OR2M2", ["TCGA.CA.5797.01", "Signaling by GPCR"], {"weight": 0.939637258610365}], ["OR2M2", ["TCGA.CA.5797.01", "Regulation of insulin secretion"], {"weight": 0.89473304214031}], ["OR2M2", ["TCGA.CA.5797.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.923305181564047}], ["OR2M2", ["TCGA.CA.5797.01", "G alpha (i) signalling events"], {"weight": 0.935405015526813}], ["OR2M2", ["TCGA.CA.5797.01", "Integration of energy metabolism"], {"weight": 0.881803139356968}], ["OR2M2", ["TCGA.CA.5797.01", "GABA receptor activation"], {"weight": 0.880275830484608}], ["OR2M2", ["TCGA.CA.5797.01", "Potassium Channels"], {"weight": 0.952479018284414}], ["OR2M2", ["TCGA.CA.5797.01", "G alpha (s) signalling events"], {"weight": 0.94729772731926}], ["OR2M2", ["TCGA.CA.5797.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.918841525849826}], ["OR2M2", ["TCGA.CA.5797.01", "Signal amplification"], {"weight": 0.912062493081919}], ["OR2M2", ["TCGA.CA.5797.01", "G alpha (q) signalling events"], {"weight": 0.939052818160928}], ["OR2M2", ["TCGA.CA.5797.01", "Glucagon-type ligand receptors"], {"weight": 0.905601011711933}], ["OR2M2", ["TCGA.CA.5797.01", "Inwardly rectifying K+ channels"], {"weight": 0.922893913684958}], ["OR2M2", ["TCGA.CA.5797.01", "Phase 4 - resting membrane potential"], {"weight": 0.840607162463123}], ["OR2M2", ["TCGA.CA.5797.01", "Activation of G protein gated Potassium channels"], {"weight": 0.91317388600628}], ["OR2M2", ["TCGA.CA.5797.01", "G protein gated Potassium channels"], {"weight": 0.91317388600628}], ["OR2M2", ["TCGA.CA.5797.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.91317388600628}], ["OR2M2", ["TCGA.CA.5797.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.899395105229916}], ["OR2M2", ["TCGA.CA.5797.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.901045228408967}], ["OR2M2", ["TCGA.CA.5797.01", "GABA B receptor activation"], {"weight": 0.914861247904777}], ["OR2M2", ["TCGA.CA.5797.01", "Activation of GABAB receptors"], {"weight": 0.914861247904777}], ["OR2M2", ["TCGA.CA.5797.01", "NCAM1 interactions"], {"weight": 0.871454567897808}], ["OR2M2", ["TCGA.CA.5797.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.903827691640607}], ["OR2M2", ["TCGA.CA.5797.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.909154526936635}], ["OR2M2", ["TCGA.CA.5797.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.902683551872679}], ["OR2M2", ["TCGA.CA.5797.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.895233611183025}], ["OR2M2", ["TCGA.CA.5797.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.828590369613706}], ["OR2M2", ["TCGA.CA.5797.01", "Leishmania parasite growth and survival"], {"weight": 0.828590369613706}], ["OR2M2", ["TCGA.CA.5797.01", "Presynaptic function of Kainate receptors"], {"weight": 0.8910493923531}], ["OR2M2", ["TCGA.CA.5797.01", "Opioid Signalling"], {"weight": 0.879084900716342}], ["OR2M2", ["TCGA.CA.5797.01", "Signaling by Nuclear Receptors"], {"weight": 0.84536768658051}], ["LEO1", ["TCGA.A6.6782.01", "Nucleotide catabolism"], {"weight": 0.540659190506615}], ["ELANE", ["TCGA.A6.6654.01", "Collagen formation"], {"weight": 0.937597034678399}], ["ELANE", ["TCGA.A6.6654.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.936375519624886}], ["ELANE", ["TCGA.A6.6654.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.923915646116508}], ["ELANE", ["TCGA.A6.6654.01", "Collagen chain trimerization"], {"weight": 0.902974193706029}], ["ELANE", ["TCGA.A6.6654.01", "Degradation of the extracellular matrix"], {"weight": 0.789216645602121}], ["ELANE", ["TCGA.A6.6654.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.945121077253577}], ["ELANE", ["TCGA.A6.6654.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.730357894046806}], ["ELANE", ["TCGA.A6.6654.01", "Collagen degradation"], {"weight": 0.92987853363906}], ["PDGFRB", ["TCGA.A6.6654.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.544212476106517}], ["IFNG", ["TCGA.A6.6654.01", "Interleukin-6 family signaling"], {"weight": 0.853152122978159}], ["IFNG", ["TCGA.A6.6654.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.838655079367759}], ["GABBR1", ["TCGA.CM.6674.01", "Phase 4 - resting membrane potential"], {"weight": 0.859405981848869}], ["PDLIM5", ["TCGA.AM.5821.01", "Neurexins and neuroligins"], {"weight": 0.956427631397803}], ["PDLIM5", ["TCGA.CM.5861.01", "Protein-protein interactions at synapses"], {"weight": 0.912737800258978}], ["PDLIM5", ["TCGA.CM.5861.01", "Neurexins and neuroligins"], {"weight": 0.93645446333047}], ["PDLIM5", ["TCGA.DM.A1D8.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.828906743641872}], ["PASK", ["TCGA.A6.6654.01", "Biological oxidations"], {"weight": 0.888426111763766}], ["PASK", ["TCGA.AD.6964.01", "Biological oxidations"], {"weight": 0.925216363554588}], ["PASK", ["TCGA.AM.5821.01", "Glucuronidation"], {"weight": 0.944338783715898}], ["PASK", ["TCGA.DM.A1D8.01", "Integration of energy metabolism"], {"weight": 0.932062854653978}], ["REG3A", ["TCGA.A6.6654.01", "Defective B3GALTL causes PpS"], {"weight": 0.847731125606404}], ["REG3A", ["TCGA.A6.6654.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.847731125606404}], ["SH3PXD2A", ["TCGA.D5.5538.01", "Extracellular matrix organization"], {"weight": 0.784842407886561}], ["CALCR", ["TCGA.D5.5540.01", "Signaling by GPCR"], {"weight": 0.94135110843242}], ["TBL1XR1", ["TCGA.A6.6654.01", "Signaling by Retinoic Acid"], {"weight": 0.802166886455977}], ["TBL1XR1", ["TCGA.A6.6654.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.650289289545648}], ["TBL1XR1", ["TCGA.D5.6927.01", "Signaling by Retinoic Acid"], {"weight": 0.707095597477975}], ["ALDH1A3", ["TCGA.A6.6654.01", "Ethanol oxidation"], {"weight": 0.882512544862972}], ["ALDH1A3", ["TCGA.A6.6654.01", "RA biosynthesis pathway"], {"weight": 0.907542869009298}], ["ALDH1A3", ["TCGA.A6.6654.01", "Phase I - Functionalization of compounds"], {"weight": 0.890124817662644}], ["ALDH1A3", ["TCGA.AA.3655.01", "RA biosynthesis pathway"], {"weight": 0.870467613464025}], ["ALDH1A3", ["TCGA.AA.3655.01", "Ethanol oxidation"], {"weight": 0.924079810410594}], ["ALDH1A3", ["TCGA.AA.3655.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.791652217983449}], ["ALDH1A3", ["TCGA.AA.3655.01", "Signaling by Retinoic Acid"], {"weight": 0.79558159899496}], ["ALDH1A3", ["TCGA.AA.3655.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.823289095151751}], ["ALDH1A3", ["TCGA.CK.5916.01", "Glutathione conjugation"], {"weight": 0.898555608308483}], ["ALDH1A3", ["TCGA.D5.6930.01", "Ethanol oxidation"], {"weight": 0.88223313426016}], ["ALDH1A3", ["TCGA.DM.A1D6.01", "Neuronal System"], {"weight": 0.953214335132789}], ["ALDH1A3", ["TCGA.DM.A1D6.01", "Biological oxidations"], {"weight": 0.950624959847007}], ["ALDH1A3", ["TCGA.DM.A1D6.01", "Transmission across Chemical Synapses"], {"weight": 0.943306598076425}], ["ALDH1A3", ["TCGA.DM.A1D6.01", "Neurotransmitter release cycle"], {"weight": 0.870434771636523}], ["HSD3B1", ["TCGA.A6.6654.01", "Glucuronidation"], {"weight": 0.851158493139031}], ["HSD3B1", ["TCGA.A6.6654.01", "Aspirin ADME"], {"weight": 0.916520101194775}], ["HSD3B1", ["TCGA.A6.6654.01", "Arachidonic acid metabolism"], {"weight": 0.846514561117702}], ["HSD3B1", ["TCGA.AD.6964.01", "Drug ADME"], {"weight": 0.897912233137281}], ["HSD3B1", ["TCGA.AD.6964.01", "Phase II - Conjugation of compounds"], {"weight": 0.858619070701337}], ["HSD3B1", ["TCGA.AD.6964.01", "Glucuronidation"], {"weight": 0.866629438512526}], ["GABARAPL1", ["TCGA.A6.6780.01", "Neuronal System"], {"weight": 0.925210665847617}], ["ITGA8", ["TCGA.D5.6931.01", "Extracellular matrix organization"], {"weight": 0.855244191468263}], ["ITGA8", ["TCGA.DM.A1D8.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.918459915236064}], ["ITGA8", ["TCGA.DM.A1D8.01", "Intrinsic Pathway of Fibrin Clot Formation"], {"weight": 0.891095207520024}], ["ITGA8", ["TCGA.G4.6294.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.64815482275141}], ["ITGAM", ["TCGA.CM.6675.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.953118347408111}], ["ITGAM", ["TCGA.CM.6675.01", "Extracellular matrix organization"], {"weight": 0.849588793373903}], ["ITGAM", ["TCGA.CM.6675.01", "Peptide ligand-binding receptors"], {"weight": 0.952677265754504}], ["ITGAM", ["TCGA.CM.6675.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.920642088279872}], ["ITGAM", ["TCGA.CM.6675.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.664159956484716}], ["ITGAM", ["TCGA.CM.6675.01", "G-protein beta:gamma signalling"], {"weight": 0.934620698760721}], ["ITGAM", ["TCGA.CM.6675.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.922694863799473}], ["ITGAM", ["TCGA.CM.6675.01", "Complement cascade"], {"weight": 0.890618941426503}], ["ITGAM", ["TCGA.D5.6535.01", "Extracellular matrix organization"], {"weight": 0.767980146866623}], ["IGF2R", ["TCGA.AD.6901.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.550915659224235}], ["PRKAR2A", ["TCGA.G4.6309.01", "GPCR downstream signalling"], {"weight": 0.92896324338633}], ["PRKAR2A", ["TCGA.G4.6309.01", "G alpha (i) signalling events"], {"weight": 0.930025018735547}], ["PRKAR2A", ["TCGA.G4.6309.01", "Opioid Signalling"], {"weight": 0.9353728816918}], ["PRKAR2A", ["TCGA.G4.6309.01", "G-protein mediated events"], {"weight": 0.888672240866757}], ["PRKAR2A", ["TCGA.G4.6309.01", "Calmodulin induced events"], {"weight": 0.913226599906601}], ["PRKAR2A", ["TCGA.G4.6309.01", "CaM pathway"], {"weight": 0.913226599906601}], ["PRKAR2A", ["TCGA.G4.6309.01", "DAG and IP3 signaling"], {"weight": 0.914873132620777}], ["PRKAR2A", ["TCGA.G4.6309.01", "PLC beta mediated events"], {"weight": 0.881140154380401}], ["PAXIP1", ["TCGA.CM.5341.01", "Influenza Infection"], {"weight": 0.931034381635422}], ["PAXIP1", ["TCGA.CM.5341.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.909323357094243}], ["PAXIP1", ["TCGA.CM.5341.01", "Recycling of bile acids and salts"], {"weight": 0.883223401442495}], ["BCL9", ["TCGA.DM.A282.01", "Primitive streak formation"], {"weight": 0.799354562995752}], ["BCL9", ["TCGA.DM.A282.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.726846743940015}], ["MARK3", ["TCGA.D5.6536.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.918623939423356}], ["MARK3", ["TCGA.D5.6536.01", "SUMOylation of intracellular receptors"], {"weight": 0.609859595404071}], ["MARK3", ["TCGA.D5.6536.01", "Nuclear Receptor transcription pathway"], {"weight": 0.818162535363114}], ["GPC3", ["TCGA.A6.6780.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.860881577310861}], ["PDHA2", ["TCGA.A6.6780.01", "Biological oxidations"], {"weight": 0.914500024549157}], ["PDHA2", ["TCGA.A6.6780.01", "Signaling by Retinoic Acid"], {"weight": 0.812881840902429}], ["PDHA2", ["TCGA.CK.5916.01", "Signaling by Retinoic Acid"], {"weight": 0.766917329993705}], ["PDHA2", ["TCGA.G4.6310.01", "Biological oxidations"], {"weight": 0.923659331234754}], ["PIP4K2A", ["TCGA.AM.5820.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.950927142522921}], ["NCOA6", ["TCGA.CA.6716.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.929641705580686}], ["NCOA6", ["TCGA.CA.6716.01", "Biological oxidations"], {"weight": 0.908843917968361}], ["NCOA6", ["TCGA.CA.6716.01", "Aspirin ADME"], {"weight": 0.838023872791422}], ["NCOA6", ["TCGA.CA.6716.01", "Glucuronidation"], {"weight": 0.897286786867133}], ["NCOA6", ["TCGA.CA.6716.01", "Phase II - Conjugation of compounds"], {"weight": 0.837960124454612}], ["NCOA6", ["TCGA.CA.6716.01", "Drug ADME"], {"weight": 0.8456695604687}], ["NCOA6", ["TCGA.G4.6302.01", "Drug ADME"], {"weight": 0.830240813388897}], ["DOCK3", ["TCGA.AZ.4682.01", "Chemokine receptors bind chemokines"], {"weight": 0.889098985086163}], ["DOCK3", ["TCGA.AZ.4682.01", "Diseases of Immune System"], {"weight": 0.778740464579853}], ["DOCK3", ["TCGA.AZ.4682.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.778740464579853}], ["DOCK3", ["TCGA.G4.6307.01", "Peptide ligand-binding receptors"], {"weight": 0.917565925898615}], ["DOCK3", ["TCGA.G4.6307.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.919685454151296}], ["DOCK3", ["TCGA.G4.6307.01", "Leishmania infection"], {"weight": 0.887669986526689}], ["DOCK3", ["TCGA.G4.6307.01", "Parasitic Infection Pathways"], {"weight": 0.887669986526689}], ["DOCK3", ["TCGA.G4.6307.01", "Signaling by Interleukins"], {"weight": 0.872448095119237}], ["DOCK3", ["TCGA.G4.6307.01", "Chemokine receptors bind chemokines"], {"weight": 0.911230169226768}], ["DOCK3", ["TCGA.G4.6307.01", "Trafficking of AMPA receptors"], {"weight": 0.892228212197166}], ["DOCK3", ["TCGA.G4.6307.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.892228212197166}], ["DOCK3", ["TCGA.G4.6307.01", "Ion homeostasis"], {"weight": 0.894967306783944}], ["DOCK3", ["TCGA.G4.6307.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.821110400820369}], ["DOCK6", ["TCGA.G4.6320.01", "Insulin processing"], {"weight": 0.76169434334308}], ["EPHA6", ["TCGA.AZ.5403.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.906021025886179}], ["EPHA6", ["TCGA.AZ.5403.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.8785936297337}], ["EPHA6", ["TCGA.F4.6460.01", "Activated point mutants of FGFR2"], {"weight": 0.760994004528985}], ["EPHA6", ["TCGA.F4.6460.01", "Phospholipase C-mediated cascade; FGFR2"], {"weight": 0.760994004528985}], ["EPHA6", ["TCGA.F4.6460.01", "FGFR2 ligand binding and activation"], {"weight": 0.760994004528985}], ["EPHA6", ["TCGA.F4.6460.01", "PI-3K cascade:FGFR2"], {"weight": 0.760994004528985}], ["EPHA6", ["TCGA.F4.6460.01", "FGFR2c ligand binding and activation"], {"weight": 0.705689930673868}], ["EPHA6", ["TCGA.F4.6460.01", "SHC-mediated cascade:FGFR2"], {"weight": 0.760994004528985}], ["EPHA6", ["TCGA.F4.6460.01", "FRS-mediated FGFR2 signaling"], {"weight": 0.760994004528985}], ["USP34", ["TCGA.DM.A1D7.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.746847755265544}], ["USP34", ["TCGA.F4.6570.01", "APAP ADME"], {"weight": 0.892382163951221}], ["CCKBR", ["TCGA.D5.6533.01", "Chemokine receptors bind chemokines"], {"weight": 0.916435836507032}], ["MAML1", ["TCGA.A6.6780.01", "Signaling Pathways"], {"weight": 0.90695851146598}], ["LRP1", ["TCGA.A6.6781.01", "ECM proteoglycans"], {"weight": 0.896001317450896}], ["LRP1", ["TCGA.CM.5341.01", "Induction of Cell-Cell Fusion"], {"weight": 0.482167127551242}], ["LRP1", ["TCGA.CM.6166.01", "Integrin cell surface interactions"], {"weight": 0.934344110422408}], ["LRP1", ["TCGA.CM.6166.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.88866210827644}], ["LRP1", ["TCGA.CM.6166.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.88866210827644}], ["LRP1", ["TCGA.CM.6166.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.870304699145072}], ["LRP1", ["TCGA.D5.6924.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.659153725073647}], ["LRP1", ["TCGA.D5.6924.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.78637713941625}], ["LRP1", ["TCGA.D5.6924.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.78637713941625}], ["LRP1", ["TCGA.F4.6463.01", "Degradation of the extracellular matrix"], {"weight": 0.784812408214367}], ["LRP1", ["TCGA.F4.6463.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.412900567482745}], ["LRP1", ["TCGA.F4.6463.01", "Retinoid metabolism and transport"], {"weight": 0.412900567482745}], ["LRP1", ["TCGA.G4.6320.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.86593944887941}], ["LRP1", ["TCGA.G4.6320.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.86593944887941}], ["LRP1", ["TCGA.G4.6588.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.925966391708665}], ["LRP1", ["TCGA.G4.6588.01", "Retinoid metabolism and transport"], {"weight": 0.925966391708665}], ["PDHX", ["TCGA.AA.3662.01", "Metabolism"], {"weight": 0.91397790661409}], ["PDHX", ["TCGA.AA.3697.01", "Metabolism"], {"weight": 0.895206510721886}], ["COL6A2", ["TCGA.AY.6196.01", "Collagen chain trimerization"], {"weight": 0.92153520028335}], ["COL6A2", ["TCGA.AY.6196.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.872538622372627}], ["COL6A2", ["TCGA.AY.6196.01", "Degradation of the extracellular matrix"], {"weight": 0.766551723939974}], ["COL6A2", ["TCGA.AY.6196.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.567422399307864}], ["COL6A2", ["TCGA.AY.6196.01", "Scavenging by Class A Receptors"], {"weight": 0.618297118623212}], ["COL6A2", ["TCGA.AY.6196.01", "Collagen degradation"], {"weight": 0.819817615853633}], ["COL6A2", ["TCGA.AY.6197.01", "L1CAM interactions"], {"weight": 0.941507867631443}], ["COL6A2", ["TCGA.CM.6679.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.929371920290854}], ["COL6A2", ["TCGA.CM.6679.01", "Collagen chain trimerization"], {"weight": 0.914028802622461}], ["COL6A2", ["TCGA.CM.6679.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.654451690436042}], ["COL6A2", ["TCGA.CM.6679.01", "Scavenging by Class A Receptors"], {"weight": 0.692608962407184}], ["COL6A2", ["TCGA.CM.6679.01", "ECM proteoglycans"], {"weight": 0.834849958409124}], ["COL6A2", ["TCGA.CM.6679.01", "Collagen degradation"], {"weight": 0.885662181140333}], ["COL6A2", ["TCGA.D5.6541.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.944843426997673}], ["COL6A2", ["TCGA.D5.6541.01", "NCAM1 interactions"], {"weight": 0.939918039991602}], ["COL6A2", ["TCGA.D5.6541.01", "NCAM signaling for neurite out-growth"], {"weight": 0.943183027219828}], ["CYP26B1", ["TCGA.A6.6780.01", "Glucuronidation"], {"weight": 0.87072664463646}], ["CYP26B1", ["TCGA.CM.6169.01", "Drug ADME"], {"weight": 0.887601675891798}], ["CYP26B1", ["TCGA.CM.6169.01", "RA biosynthesis pathway"], {"weight": 0.851369405095421}], ["CYP26B1", ["TCGA.D5.6540.01", "RA biosynthesis pathway"], {"weight": 0.935665941547333}], ["CYP26B1", ["TCGA.D5.6540.01", "Glucuronidation"], {"weight": 0.912168166529993}], ["CYP26B1", ["TCGA.DM.A1HA.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.94866829971158}], ["CYP26B1", ["TCGA.DM.A1HA.01", "Aspirin ADME"], {"weight": 0.92693249415669}], ["CYP26B1", ["TCGA.DM.A1HA.01", "Biosynthesis of DHA-derived SPMs"], {"weight": 0.919167152321497}], ["CYP26B1", ["TCGA.DM.A1HA.01", "Glucuronidation"], {"weight": 0.928977711431686}], ["HCK", ["TCGA.CM.5349.01", "Chemokine receptors bind chemokines"], {"weight": 0.90398612443755}], ["HCK", ["TCGA.CM.5349.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.923386391204299}], ["HCK", ["TCGA.CM.5349.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.44381707715731}], ["HCK", ["TCGA.CM.5349.01", "Peptide ligand-binding receptors"], {"weight": 0.92041987117073}], ["HCK", ["TCGA.D5.6932.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.936380912041773}], ["HCK", ["TCGA.D5.6932.01", "Peptide ligand-binding receptors"], {"weight": 0.933650582838127}], ["HTR1B", ["TCGA.AD.6901.01", "Peptide hormone metabolism"], {"weight": 0.723209606192284}], ["GABARAPL1", ["TCGA.A6.6780.01", "Transmission across Chemical Synapses"], {"weight": 0.921765567532611}], ["GABARAPL1", ["TCGA.A6.6780.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.905730403758173}], ["TLL2", ["TCGA.A6.6780.01", "Collagen chain trimerization"], {"weight": 0.922630359618168}], ["TLL2", ["TCGA.A6.6780.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.939599927645809}], ["TLL2", ["TCGA.AD.6895.01", "Collagen chain trimerization"], {"weight": 0.917961576809842}], ["TLL2", ["TCGA.AD.6901.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.943744087139402}], ["TLL2", ["TCGA.AD.6901.01", "Collagen chain trimerization"], {"weight": 0.921837813952466}], ["TLL2", ["TCGA.AD.6901.01", "Collagen formation"], {"weight": 0.928844752088146}], ["TLL2", ["TCGA.AD.6901.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.898758256460371}], ["TLL2", ["TCGA.D5.6929.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.947079273447108}], ["TLL2", ["TCGA.D5.6929.01", "Collagen formation"], {"weight": 0.935217221107234}], ["TLL2", ["TCGA.D5.6929.01", "Collagen chain trimerization"], {"weight": 0.927000557660756}], ["TLL2", ["TCGA.D5.6929.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.62618020736685}], ["TLL2", ["TCGA.D5.6929.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.909169031149541}], ["TLL2", ["TCGA.DM.A1D4.01", "Molecules associated with elastic fibres"], {"weight": 0.890424964950142}], ["RIMS1", ["TCGA.CK.4950.01", "Neuronal System"], {"weight": 0.849512575737385}], ["RIMS1", ["TCGA.CK.4950.01", "Transmission across Chemical Synapses"], {"weight": 0.869846420108033}], ["RIMS1", ["TCGA.D5.6532.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.690448973521781}], ["RIMS1", ["TCGA.D5.6532.01", "Aspartate and asparagine metabolism"], {"weight": 0.814541521912663}], ["RIMS1", ["TCGA.DM.A0X9.01", "Neurexins and neuroligins"], {"weight": 0.913772146411759}], ["OR10R2", ["TCGA.A6.6780.01", "Aquaporin-mediated transport"], {"weight": 0.878727895684509}], ["OR10R2", ["TCGA.CK.4952.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.931089194701324}], ["OR10R2", ["TCGA.D5.6924.01", "Aquaporin-mediated transport"], {"weight": 0.871484717008373}], ["OR10R2", ["TCGA.D5.6932.01", "GPCR downstream signalling"], {"weight": 0.94147366565492}], ["OR10R2", ["TCGA.D5.6932.01", "Regulation of insulin secretion"], {"weight": 0.902863947083656}], ["OR10R2", ["TCGA.D5.6932.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.903992149486432}], ["SLC8A2", ["TCGA.CM.4744.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.825521402535396}], ["SLC8A2", ["TCGA.CM.4744.01", "Metabolism of vitamins and cofactors"], {"weight": 0.802842906845618}], ["KCNS3", ["TCGA.D5.5540.01", "Ca-dependent events"], {"weight": 0.905451171674577}], ["KCNS3", ["TCGA.D5.5540.01", "Calmodulin induced events"], {"weight": 0.902933182417336}], ["KCNS3", ["TCGA.D5.5540.01", "CaM pathway"], {"weight": 0.902933182417336}], ["KCNS3", ["TCGA.D5.5540.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.933426784570481}], ["KCNS3", ["TCGA.D5.5540.01", "GPCR downstream signalling"], {"weight": 0.940426652693972}], ["KCNS3", ["TCGA.D5.5540.01", "PLC beta mediated events"], {"weight": 0.908008857452333}], ["KCNS3", ["TCGA.D5.5540.01", "G alpha (s) signalling events"], {"weight": 0.965061950182454}], ["KCNS3", ["TCGA.D5.5540.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.945552820187003}], ["KCNS3", ["TCGA.D5.5540.01", "G alpha (i) signalling events"], {"weight": 0.93707670044071}], ["EFCAB6", ["TCGA.CA.5797.01", "Phase 0 - rapid depolarisation"], {"weight": 0.872851006599702}], ["EFCAB6", ["TCGA.CA.5797.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.781965877091249}], ["TUBAL3", ["TCGA.CA.5797.01", "APAP ADME"], {"weight": 0.808230088318629}], ["TUBAL3", ["TCGA.CA.5797.01", "NCAM signaling for neurite out-growth"], {"weight": 0.883628964726423}], ["TUBAL3", ["TCGA.CA.5797.01", "Drug ADME"], {"weight": 0.876075844627296}], ["NOG", ["TCGA.A6.6780.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.745791587741163}], ["SMAD2", ["TCGA.DM.A28M.01", "Signaling Pathways"], {"weight": 0.928701717053887}], ["SMAD2", ["TCGA.DM.A28M.01", "Cardiac conduction"], {"weight": 0.952404083739022}], ["SMAD2", ["TCGA.DM.A28M.01", "Muscle contraction"], {"weight": 0.955055856366679}], ["SMAD2", ["TCGA.DM.A28M.01", "Phase 0 - rapid depolarisation"], {"weight": 0.948765817405836}], ["SMAD2", ["TCGA.DM.A28M.01", "Elastic fibre formation"], {"weight": 0.924238689293412}], ["SMAD2", ["TCGA.DM.A28M.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.936580433504432}], ["SMAD2", ["TCGA.DM.A28M.01", "Long-term potentiation"], {"weight": 0.933101955493476}], ["SMAD2", ["TCGA.DM.A28M.01", "Formation of the anterior neural plate"], {"weight": 0.776342276553651}], ["IGFBP4", ["TCGA.A6.6780.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.938473279049932}], ["IGFBP4", ["TCGA.A6.6780.01", "Regulation of FZD by ubiquitination"], {"weight": 0.871481012675003}], ["IGFBP4", ["TCGA.A6.6780.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.90519065192692}], ["ARHGAP21", ["TCGA.G4.6321.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.785188268521707}], ["CAV2", ["TCGA.A6.6780.01", "Elastic fibre formation"], {"weight": 0.898777615148797}], ["PLA2G4E", ["TCGA.A6.6780.01", "G-protein mediated events"], {"weight": 0.925036005307871}], ["PLA2G4E", ["TCGA.AZ.6598.01", "PLC beta mediated events"], {"weight": 0.897379639082501}], ["HCAR3", ["TCGA.F4.6463.01", "Peptide hormone metabolism"], {"weight": 0.671001188053169}], ["F2R", ["TCGA.AA.3511.01", "Extracellular matrix organization"], {"weight": 0.872546241478678}], ["F2R", ["TCGA.AA.3511.01", "Chemokine receptors bind chemokines"], {"weight": 0.907721193884414}], ["F2R", ["TCGA.AA.3511.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.358250804865808}], ["F2R", ["TCGA.AZ.6599.01", "Leishmania infection"], {"weight": 0.911239840583967}], ["F2R", ["TCGA.AZ.6599.01", "Parasitic Infection Pathways"], {"weight": 0.911239840583967}], ["F2R", ["TCGA.CM.5861.01", "Leishmania infection"], {"weight": 0.902784745743262}], ["F2R", ["TCGA.CM.5861.01", "Parasitic Infection Pathways"], {"weight": 0.902784745743262}], ["ALDH6A1", ["TCGA.AZ.4615.01", "Signaling by Retinoic Acid"], {"weight": 0.850881751134715}], ["MMP8", ["TCGA.F4.6570.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.920049680536756}], ["KIF26A", ["TCGA.AY.6386.01", "Interaction between L1 and Ankyrins"], {"weight": 0.942449752684886}], ["KIF26A", ["TCGA.AY.6386.01", "Peptide hormone metabolism"], {"weight": 0.811619746035388}], ["KIF26A", ["TCGA.CK.4952.01", "Interaction between L1 and Ankyrins"], {"weight": 0.947186606865874}], ["KIF26A", ["TCGA.DM.A1DA.01", "Interaction between L1 and Ankyrins"], {"weight": 0.95742864568676}], ["ATP6V0D1", ["TCGA.AD.6895.01", "Ion channel transport"], {"weight": 0.939065764514367}], ["ATP6V0D1", ["TCGA.AZ.6601.01", "Ion channel transport"], {"weight": 0.906032797303039}], ["SDHA", ["TCGA.CM.5868.01", "Phase II - Conjugation of compounds"], {"weight": 0.833281604996472}], ["SDHA", ["TCGA.D5.6531.01", "Biological oxidations"], {"weight": 0.940457339102033}], ["DLG1", ["TCGA.AD.6964.01", "Synaptic adhesion-like molecules"], {"weight": 0.730970535684036}], ["DLG1", ["TCGA.AD.6964.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.890483822916945}], ["DLG1", ["TCGA.AU.6004.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.862104665861147}], ["DLG1", ["TCGA.CM.6171.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.909700057427324}], ["HMGB1", ["TCGA.DM.A28F.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.878359169217007}], ["HMGB1", ["TCGA.DM.A28F.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.907158900478997}], ["HMGB1", ["TCGA.DM.A28F.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.907158900478997}], ["GRIK3", ["TCGA.AA.3713.01", "Neuronal System"], {"weight": 0.901704879817163}], ["GRIK3", ["TCGA.AZ.6599.01", "Neuronal System"], {"weight": 0.943837377043512}], ["GRIK3", ["TCGA.AZ.6599.01", "Transmission across Chemical Synapses"], {"weight": 0.939850368485015}], ["GRIK3", ["TCGA.AZ.6599.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.920476120281371}], ["HUNK", ["TCGA.G4.6586.01", "Integration of energy metabolism"], {"weight": 0.945142903931745}], ["BPTF", ["TCGA.D5.5540.01", "Collagen chain trimerization"], {"weight": 0.895745223604564}], ["PRCP", ["TCGA.A6.6780.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.950196725330202}], ["PRCP", ["TCGA.A6.6780.01", "Peptide ligand-binding receptors"], {"weight": 0.95038270499568}], ["WDR26", ["TCGA.G4.6303.01", "Degradation of the extracellular matrix"], {"weight": 0.842914350475788}], ["WDR26", ["TCGA.G4.6303.01", "Collagen degradation"], {"weight": 0.797402351886129}], ["ADAMTS14", ["TCGA.AD.6965.01", "Collagen chain trimerization"], {"weight": 0.897068450253288}], ["ADAMTS14", ["TCGA.AD.6965.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.875591906179901}], ["ADAMTS14", ["TCGA.CM.6166.01", "Collagen chain trimerization"], {"weight": 0.92428057938368}], ["ADAMTS14", ["TCGA.G4.6302.01", "Collagen chain trimerization"], {"weight": 0.908584357438669}], ["ADAMTS14", ["TCGA.G4.6302.01", "Scavenging by Class A Receptors"], {"weight": 0.694193716960184}], ["ECHS1", ["TCGA.AA.3712.01", "Biological oxidations"], {"weight": 0.906961235856335}], ["FLT1", ["TCGA.AZ.5403.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.795143733995451}], ["FLT1", ["TCGA.AZ.5403.01", "NCAM signaling for neurite out-growth"], {"weight": 0.688304125108795}], ["FLT1", ["TCGA.AZ.5403.01", "Interleukin-10 signaling"], {"weight": 0.898024137538672}], ["ANK1", ["TCGA.AA.3492.01", "L1CAM interactions"], {"weight": 0.919134045328326}], ["ABCA1", ["TCGA.CM.6679.01", "Phase II - Conjugation of compounds"], {"weight": 0.787715474817646}], ["ABCA1", ["TCGA.CM.6679.01", "Biological oxidations"], {"weight": 0.847622061930864}], ["ABCA1", ["TCGA.CM.6679.01", "Glucuronidation"], {"weight": 0.850795893732157}], ["ABCA1", ["TCGA.CM.6679.01", "Drug ADME"], {"weight": 0.760967493570701}], ["ABCA1", ["TCGA.CM.6679.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.559358705803913}], ["ABCA1", ["TCGA.CM.6679.01", "NCAM1 interactions"], {"weight": 0.725212732155119}], ["ABCA1", ["TCGA.D5.6535.01", "Phase 0 - rapid depolarisation"], {"weight": 0.844907176718175}], ["ABCA1", ["TCGA.DM.A28F.01", "Phase 0 - rapid depolarisation"], {"weight": 0.909120197389148}], ["ABCA1", ["TCGA.DM.A28F.01", "Aspirin ADME"], {"weight": 0.834031083886833}], ["ABCA1", ["TCGA.F4.6806.01", "Glucuronidation"], {"weight": 0.662491460167844}], ["ATP2A2", ["TCGA.CM.5864.01", "Cardiac conduction"], {"weight": 0.899074200576873}], ["ATP2A2", ["TCGA.CM.5864.01", "Muscle contraction"], {"weight": 0.902176614744944}], ["TAS2R13", ["TCGA.DM.A28H.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.847433732643901}], ["TAS2R13", ["TCGA.DM.A28H.01", "Peptide ligand-binding receptors"], {"weight": 0.934140137814261}], ["TAS2R13", ["TCGA.DM.A28H.01", "Initial triggering of complement"], {"weight": 0.855400379826191}], ["TAS2R13", ["TCGA.DM.A28H.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.798288383323787}], ["TAS2R13", ["TCGA.DM.A28H.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.798288383323787}], ["C1S", ["TCGA.CM.5861.01", "Initial triggering of complement"], {"weight": 0.748288991516393}], ["C1S", ["TCGA.CM.5861.01", "Classical antibody-mediated complement activation"], {"weight": 0.812254827691754}], ["C1S", ["TCGA.CM.5861.01", "Creation of C4 and C2 activators"], {"weight": 0.724423298419793}], ["C1S", ["TCGA.DM.A1D0.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.821300085728262}], ["C1S", ["TCGA.DM.A1D0.01", "Classical antibody-mediated complement activation"], {"weight": 0.671051013466551}], ["C1S", ["TCGA.DM.A1D0.01", "Creation of C4 and C2 activators"], {"weight": 0.75066979712157}], ["C1S", ["TCGA.DM.A1D0.01", "Defective B3GALTL causes PpS"], {"weight": 0.887276411509707}], ["C1S", ["TCGA.DM.A1D0.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.887276411509707}], ["C1S", ["TCGA.DM.A1D0.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.861379687187479}], ["C1S", ["TCGA.F4.6856.01", "Classical antibody-mediated complement activation"], {"weight": 0.804813088256147}], ["C1S", ["TCGA.F4.6856.01", "Regulation of Complement cascade"], {"weight": 0.66680893378757}], ["LONRF1", ["TCGA.D5.6536.01", "GPCR ligand binding"], {"weight": 0.934503552314372}], ["LONRF1", ["TCGA.D5.6536.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.931625173436378}], ["WRN", ["TCGA.AA.3713.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], {"weight": 0.822036008032466}], ["WRN", ["TCGA.AA.3713.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], {"weight": 0.822036008032466}], ["WRN", ["TCGA.AA.3713.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], {"weight": 0.822036008032466}], ["WRN", ["TCGA.AA.3713.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], {"weight": 0.822036008032466}], ["WRN", ["TCGA.AA.3713.01", "Impaired BRCA2 binding to PALB2"], {"weight": 0.822108926899947}], ["SHF", ["TCGA.A6.6780.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.932734476179979}], ["PLK1", ["TCGA.AA.3492.01", "GPCR downstream signalling"], {"weight": 0.950186673650242}], ["TUBA1B", ["TCGA.AD.6963.01", "Biological oxidations"], {"weight": 0.92455176921174}], ["TUBA1B", ["TCGA.AD.6963.01", "Phase II - Conjugation of compounds"], {"weight": 0.852642603989355}], ["TUBA1B", ["TCGA.AD.6963.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.841494340771032}], ["CCT4", ["TCGA.AD.6895.01", "GPCR downstream signalling"], {"weight": 0.929117604441109}], ["ATP1B2", ["TCGA.F4.6463.01", "Negative regulation of FGFR4 signaling"], {"weight": 0.932854565181462}], ["ATP1B2", ["TCGA.F4.6463.01", "Negative regulation of FGFR2 signaling"], {"weight": 0.923958062892713}], ["ATP1B2", ["TCGA.F4.6463.01", "Signaling by Activin"], {"weight": 0.75413184695419}], ["ATP1B2", ["TCGA.F4.6463.01", "Signaling by FGFR4"], {"weight": 0.932854565181462}], ["LILRB5", ["TCGA.AZ.4682.01", "Regulation of Complement cascade"], {"weight": 0.805684183407115}], ["LILRB5", ["TCGA.AZ.4682.01", "CD22 mediated BCR regulation"], {"weight": 0.704582513886604}], ["LILRB5", ["TCGA.AZ.4682.01", "Arachidonic acid metabolism"], {"weight": 0.779881273715887}], ["CACNA1G", ["TCGA.A6.6780.01", "NCAM1 interactions"], {"weight": 0.935572540139174}], ["CACNA1G", ["TCGA.CM.6161.01", "Formation of axial mesoderm"], {"weight": 0.749245777558692}], ["CACNA1G", ["TCGA.F4.6570.01", "Peptide hormone metabolism"], {"weight": 0.721771970387343}], ["OR4K2", ["TCGA.A6.6780.01", "G alpha (s) signalling events"], {"weight": 0.957535984295062}], ["OR4K2", ["TCGA.A6.6780.01", "DAG and IP3 signaling"], {"weight": 0.922131109119076}], ["OR4K2", ["TCGA.A6.6780.01", "Activation of GABAB receptors"], {"weight": 0.927238088580492}], ["ADO", ["TCGA.A6.6780.01", "Neurotransmitter release cycle"], {"weight": 0.93109904971914}], ["ADO", ["TCGA.AA.3511.01", "Neuronal System"], {"weight": 0.887230739318736}], ["ADO", ["TCGA.AA.3511.01", "Transmission across Chemical Synapses"], {"weight": 0.877252524046107}], ["ADO", ["TCGA.G4.6297.01", "RA biosynthesis pathway"], {"weight": 0.694426714724892}], ["FBXL4", ["TCGA.D5.6538.01", "GPCR ligand binding"], {"weight": 0.931717014734373}], ["FBXL4", ["TCGA.D5.6538.01", "Peptide ligand-binding receptors"], {"weight": 0.932403978887212}], ["FBXL4", ["TCGA.D5.6538.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.933722143994792}], ["SOX7", ["TCGA.D5.6926.01", "Signaling by Retinoic Acid"], {"weight": 0.72081228854343}], ["COL20A1", ["TCGA.CM.5349.01", "Degradation of the extracellular matrix"], {"weight": 0.853199856010615}], ["COL20A1", ["TCGA.CM.5349.01", "Collagen formation"], {"weight": 0.93504093840725}], ["COL20A1", ["TCGA.CM.5349.01", "Collagen degradation"], {"weight": 0.919707790929062}], ["COL20A1", ["TCGA.CM.5349.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.925713596320038}], ["COL20A1", ["TCGA.CM.5349.01", "Glycosaminoglycan metabolism"], {"weight": 0.596053849794617}], ["COL20A1", ["TCGA.CM.5349.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.756910878572928}], ["COL20A1", ["TCGA.CM.5349.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.917059073081947}], ["COL20A1", ["TCGA.G4.6586.01", "Collagen chain trimerization"], {"weight": 0.931069574121761}], ["PLCZ1", ["TCGA.CA.6716.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.925129009744527}], ["PLCZ1", ["TCGA.CA.6716.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.867102810435255}], ["SHC1", ["TCGA.G4.6586.01", "GPER1 signaling"], {"weight": 0.940247836594526}], ["PTEN", ["TCGA.AZ.4616.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.893518418273036}], ["PTEN", ["TCGA.AZ.4616.01", "Leishmania parasite growth and survival"], {"weight": 0.893518418273036}], ["PTEN", ["TCGA.DM.A1DA.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.962124443074224}], ["PTEN", ["TCGA.DM.A1DA.01", "CD22 mediated BCR regulation"], {"weight": 0.84175578418436}], ["PTEN", ["TCGA.DM.A28C.01", "Signaling Pathways"], {"weight": 0.918318125295549}], ["PTEN", ["TCGA.DM.A28C.01", "Adaptive Immune System"], {"weight": 0.90119324382612}], ["PTEN", ["TCGA.DM.A28C.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.936935663072683}], ["PTEN", ["TCGA.DM.A28C.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.877236362374882}], ["PTEN", ["TCGA.DM.A28C.01", "TCR signaling"], {"weight": 0.949187517148432}], ["PTEN", ["TCGA.DM.A28C.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.896810263250499}], ["PTEN", ["TCGA.DM.A28C.01", "CD22 mediated BCR regulation"], {"weight": 0.875977372581267}], ["PTEN", ["TCGA.DM.A28C.01", "DAP12 interactions"], {"weight": 0.921542209858014}], ["PTEN", ["TCGA.DM.A28C.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.904855245161217}], ["PTEN", ["TCGA.DM.A28C.01", "Dectin-2 family"], {"weight": 0.842009884849166}], ["PTEN", ["TCGA.DM.A28C.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.945505949385659}], ["PTEN", ["TCGA.DM.A28C.01", "Biosynthesis of DHA-derived SPMs"], {"weight": 0.84813684453973}], ["LRFN2", ["TCGA.F4.6856.01", "Synaptic adhesion-like molecules"], {"weight": 0.780636925412111}], ["PTGDR2", ["TCGA.F4.6463.01", "Defensins"], {"weight": 0.681475340502921}], ["ZBTB17", ["TCGA.DM.A28H.01", "Complement cascade"], {"weight": 0.945956830652793}], ["ZBTB17", ["TCGA.DM.A28H.01", "Regulation of Complement cascade"], {"weight": 0.939702340886694}], ["ZBTB17", ["TCGA.DM.A28H.01", "Inflammasomes"], {"weight": 0.887426660922058}], ["ZBTB17", ["TCGA.DM.A28H.01", "G0 and Early G1"], {"weight": 0.889180634669348}], ["ZBTB17", ["TCGA.F4.6807.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.869243331348549}], ["RHOBTB2", ["TCGA.AZ.6598.01", "Signaling by GPCR"], {"weight": 0.956381206470602}], ["RHOBTB2", ["TCGA.AZ.6598.01", "GPCR downstream signalling"], {"weight": 0.953384652874439}], ["KCNG1", ["TCGA.CM.4748.01", "Potassium Channels"], {"weight": 0.958731791106177}], ["EEF2K", ["TCGA.G4.6323.01", "Transmission across Chemical Synapses"], {"weight": 0.722867003986793}], ["EEF2K", ["TCGA.G4.6323.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.6419373301534}], ["COG4", ["TCGA.D5.6537.01", "Interaction between L1 and Ankyrins"], {"weight": 0.944459293235974}], ["SEMA3E", ["TCGA.AY.6196.01", "Other semaphorin interactions"], {"weight": 0.685810218599176}], ["SEMA3D", ["TCGA.A6.6780.01", "Other semaphorin interactions"], {"weight": 0.764837879152882}], ["SEMA3D", ["TCGA.AD.6888.01", "L1CAM interactions"], {"weight": 0.905921067350816}], ["OSGEP", ["TCGA.AA.3489.01", "Biological oxidations"], {"weight": 0.892752687454691}], ["ITPR3", ["TCGA.CM.5861.01", "GPCR ligand binding"], {"weight": 0.94436564695478}], ["ITPR3", ["TCGA.CM.5861.01", "G alpha (q) signalling events"], {"weight": 0.917959508353326}], ["ITPR3", ["TCGA.CM.5861.01", "Immune System"], {"weight": 0.872856148343105}], ["ITPR3", ["TCGA.D5.6540.01", "CD22 mediated BCR regulation"], {"weight": 0.850702930557574}], ["FKBP9", ["TCGA.CM.6678.01", "Signaling by GPCR"], {"weight": 0.92672142126651}], ["FKBP9", ["TCGA.CM.6678.01", "G alpha (i) signalling events"], {"weight": 0.940979109475148}], ["CNGA4", ["TCGA.CM.6674.01", "Activation of the phototransduction cascade"], {"weight": 0.884970832888172}], ["KDR", ["TCGA.DM.A1D9.01", "Drug ADME"], {"weight": 0.817117053028997}], ["KDR", ["TCGA.DM.A1D9.01", "Signal regulatory protein family interactions"], {"weight": 0.752513062114294}], ["AP1G2", ["TCGA.G4.6299.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.830380776582288}], ["TRPC3", ["TCGA.AD.6889.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.932024928011988}], ["TRPC3", ["TCGA.AZ.6601.01", "Stimuli-sensing channels"], {"weight": 0.925649065533628}], ["MYH7", ["TCGA.DM.A28C.01", "Muscle contraction"], {"weight": 0.941973836352388}], ["SELE", ["TCGA.AM.5821.01", "Trafficking of AMPA receptors"], {"weight": 0.93910061363206}], ["SELE", ["TCGA.AM.5821.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.93910061363206}], ["SELE", ["TCGA.AM.5821.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.920329305568111}], ["SELE", ["TCGA.AZ.6599.01", "Cell surface interactions at the vascular wall"], {"weight": 0.805266307397937}], ["SELE", ["TCGA.AZ.6599.01", "Degradation of the extracellular matrix"], {"weight": 0.872652909668816}], ["SELE", ["TCGA.AZ.6599.01", "Glycosaminoglycan metabolism"], {"weight": 0.867172487083561}], ["SELE", ["TCGA.F4.6856.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.900614142858113}], ["MATN1", ["TCGA.CM.6680.01", "Extracellular matrix organization"], {"weight": 0.821981134595283}], ["MATN1", ["TCGA.CM.6680.01", "ECM proteoglycans"], {"weight": 0.67052330240897}], ["GIF", ["TCGA.D5.6924.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.900881340623567}], ["GIF", ["TCGA.D5.6924.01", "Transport of small molecules"], {"weight": 0.832906904611361}], ["GIF", ["TCGA.D5.6924.01", "Degradation of the extracellular matrix"], {"weight": 0.865030533350586}], ["GIF", ["TCGA.D5.6930.01", "Metabolism of vitamins and cofactors"], {"weight": 0.668528484337404}], ["PARP14", ["TCGA.AZ.6600.01", "Collagen chain trimerization"], {"weight": 0.834576499939668}], ["UGT3A1", ["TCGA.A6.6781.01", "Biological oxidations"], {"weight": 0.93324489682296}], ["UGT3A1", ["TCGA.A6.6782.01", "Biological oxidations"], {"weight": 0.882206263157509}], ["UGT3A1", ["TCGA.A6.6782.01", "Phase II - Conjugation of compounds"], {"weight": 0.780163503254258}], ["UGT3A1", ["TCGA.A6.6782.01", "Glucuronidation"], {"weight": 0.79516217690959}], ["UGT3A1", ["TCGA.A6.6782.01", "Drug ADME"], {"weight": 0.836323464267235}], ["UGT3A1", ["TCGA.AD.6964.01", "Aspirin ADME"], {"weight": 0.933336070318472}], ["UGT3A1", ["TCGA.G4.6628.01", "Aspirin ADME"], {"weight": 0.934638015102238}], ["LMX1B", ["TCGA.A6.6780.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.92396331279767}], ["ATAD5", ["TCGA.CA.6718.01", "Diseases of DNA repair"], {"weight": 0.886551345517845}], ["ATAD5", ["TCGA.CA.6718.01", "Diseases of DNA Double-Strand Break Repair"], {"weight": 0.886551345517845}], ["ATAD5", ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to BRCA2 loss of function"], {"weight": 0.886551345517845}], ["ATAD5", ["TCGA.CA.6718.01", "Presynaptic phase of homologous DNA pairing and strand exchange"], {"weight": 0.886551345517845}], ["ATAD5", ["TCGA.G4.6309.01", "DNA strand elongation"], {"weight": 0.879384835621909}], ["ATAD5", ["TCGA.G4.6626.01", "Activation of ATR in response to replication stress"], {"weight": 0.891948955955918}], ["PPL", ["TCGA.G4.6299.01", "TNFs bind their physiological receptors"], {"weight": 0.287558594125057}], ["ARSJ", ["TCGA.A6.6780.01", "RA biosynthesis pathway"], {"weight": 0.856784175832324}], ["CHST6", ["TCGA.A6.6781.01", "Keratan sulfate biosynthesis"], {"weight": 0.88594725793442}], ["CHST6", ["TCGA.A6.6781.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.88594725793442}], ["CHST6", ["TCGA.F4.6463.01", "Blood group systems biosynthesis"], {"weight": 0.737301019134878}], ["CHST6", ["TCGA.F4.6463.01", "Lewis blood group biosynthesis"], {"weight": 0.70663064410866}], ["CASP9", ["TCGA.AA.3662.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.791345410512608}], ["CASP9", ["TCGA.CK.4952.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.922950116223816}], ["CASP9", ["TCGA.CM.6170.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.780581559995063}], ["CASP9", ["TCGA.D5.6537.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.936570458844815}], ["CASP9", ["TCGA.G4.6311.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.766944310803328}], ["CASP9", ["TCGA.G4.6311.01", "Phase II - Conjugation of compounds"], {"weight": 0.713307562490466}], ["PTCH1", ["TCGA.F4.6570.01", "GPCR ligand binding"], {"weight": 0.922204107129386}], ["PTCH1", ["TCGA.F4.6570.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.910110168284588}], ["PTPN12", ["TCGA.AD.6964.01", "PI3K events in ERBB2 signaling"], {"weight": 0.863847775326646}], ["PTPN12", ["TCGA.AD.6964.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.856641993611795}], ["PTPN12", ["TCGA.AD.6964.01", "GAB1 signalosome"], {"weight": 0.842981330652301}], ["PTPN12", ["TCGA.AZ.6598.01", "SHC1 events in ERBB4 signaling"], {"weight": 0.907227110249775}], ["ADSL", ["TCGA.D5.6926.01", "Signaling by GPCR"], {"weight": 0.924504972758891}], ["ADSL", ["TCGA.D5.6926.01", "GPCR downstream signalling"], {"weight": 0.922534039332834}], ["ADSL", ["TCGA.D5.6926.01", "Ethanol oxidation"], {"weight": 0.836963718585103}], ["ADSL", ["TCGA.D5.6926.01", "Metabolism"], {"weight": 0.886601924735434}], ["ADSL", ["TCGA.D5.6926.01", "G alpha (s) signalling events"], {"weight": 0.939369924094683}], ["ADSL", ["TCGA.F4.6856.01", "GPCR downstream signalling"], {"weight": 0.939112665879432}], ["ACTN1", ["TCGA.D5.6929.01", "Extracellular matrix organization"], {"weight": 0.827495863084657}], ["ACTN1", ["TCGA.D5.6929.01", "ECM proteoglycans"], {"weight": 0.84736898717761}], ["SIPA1L1", ["TCGA.AM.5820.01", "Synaptic adhesion-like molecules"], {"weight": 0.886236739337191}], ["SIPA1L1", ["TCGA.CM.5861.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.906824361018093}], ["SIPA1L1", ["TCGA.CM.5861.01", "Synaptic adhesion-like molecules"], {"weight": 0.919654841600454}], ["SIPA1L1", ["TCGA.CM.5861.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.899677097457572}], ["SIPA1L1", ["TCGA.DM.A28C.01", "Transmission across Chemical Synapses"], {"weight": 0.93182528843915}], ["SIPA1L1", ["TCGA.DM.A28C.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.930929145538292}], ["RTN1", ["TCGA.CK.5912.01", "Muscle contraction"], {"weight": 0.893266635586595}], ["RTN1", ["TCGA.CK.5912.01", "Scavenging of heme from plasma"], {"weight": 0.617121811516012}], ["NOTCH2", ["TCGA.D5.6536.01", "Elastic fibre formation"], {"weight": 0.77835267740449}], ["NOTCH2", ["TCGA.G4.6628.01", "Cardiac conduction"], {"weight": 0.953602884172154}], ["MRPS9", ["TCGA.CM.5341.01", "SRP-dependent cotranslational protein targeting to membrane"], {"weight": 0.929279327354175}], ["NLGN4X", ["TCGA.CK.4948.01", "Neurexins and neuroligins"], {"weight": 0.885945983415558}], ["NLGN4X", ["TCGA.CM.5868.01", "Neurexins and neuroligins"], {"weight": 0.882893618865898}], ["CTSF", ["TCGA.CA.6716.01", "Generation of second messenger molecules"], {"weight": 0.940763167932482}], ["CTSF", ["TCGA.CA.6716.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.938881240334537}], ["CTSF", ["TCGA.CA.6716.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.939622943151659}], ["CTSF", ["TCGA.CA.6716.01", "PD-1 signaling"], {"weight": 0.939720334905159}], ["CTSF", ["TCGA.CA.6716.01", "Costimulation by the CD28 family"], {"weight": 0.890014595933149}], ["CTSF", ["TCGA.CA.6716.01", "TCR signaling"], {"weight": 0.922711281565583}], ["JARID2", ["TCGA.F4.6704.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.735554386769352}], ["VAV2", ["TCGA.CM.5861.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.778890910079611}], ["VAV2", ["TCGA.CM.5861.01", "Cell surface interactions at the vascular wall"], {"weight": 0.64579095620165}], ["FGA", ["TCGA.G4.6294.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.724702462400935}], ["CEL", ["TCGA.AZ.6598.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.783702373032831}], ["CEL", ["TCGA.CM.6171.01", "Biological oxidations"], {"weight": 0.928481120266981}], ["CEL", ["TCGA.CM.6171.01", "Phase I - Functionalization of compounds"], {"weight": 0.94403339928409}], ["CEL", ["TCGA.G4.6628.01", "Biological oxidations"], {"weight": 0.928451046294972}], ["CEL", ["TCGA.G4.6628.01", "Phase I - Functionalization of compounds"], {"weight": 0.920258303243294}], ["SCARF1", ["TCGA.D5.6537.01", "Classical antibody-mediated complement activation"], {"weight": 0.76715345287281}], ["SCARF1", ["TCGA.D5.6537.01", "Creation of C4 and C2 activators"], {"weight": 0.731284327254005}], ["DIAPH1", ["TCGA.AD.6964.01", "ERBB2 Regulates Cell Motility"], {"weight": 0.88048025090055}], ["DIAPH1", ["TCGA.DM.A1D8.01", "ERBB2 Regulates Cell Motility"], {"weight": 0.93141361307408}], ["DVL3", ["TCGA.D5.6535.01", "Phase 4 - resting membrane potential"], {"weight": 0.726016355818149}], ["DVL3", ["TCGA.D5.6535.01", "Regulation of FZD by ubiquitination"], {"weight": 0.804131110172866}], ["DVL3", ["TCGA.D5.6537.01", "Regulation of FZD by ubiquitination"], {"weight": 0.921169273929465}], ["ADAM9", ["TCGA.A6.6781.01", "Collagen formation"], {"weight": 0.961624988416888}], ["ADAM9", ["TCGA.A6.6781.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.960385161546217}], ["ADAM9", ["TCGA.A6.6781.01", "Collagen degradation"], {"weight": 0.932981059569832}], ["ADAM9", ["TCGA.AZ.6598.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.949096791256814}], ["ADAM9", ["TCGA.CA.6718.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.945044215373002}], ["KRT1", ["TCGA.AZ.5407.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.917944064072148}], ["KRT1", ["TCGA.AZ.5407.01", "Degradation of the extracellular matrix"], {"weight": 0.830306026880193}], ["KRT1", ["TCGA.CK.4950.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.916000901888254}], ["KRT1", ["TCGA.D5.6533.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.891261283444424}], ["KRT1", ["TCGA.D5.6534.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.937056609812802}], ["KRT1", ["TCGA.D5.6534.01", "Degradation of the extracellular matrix"], {"weight": 0.882346101242094}], ["KRT1", ["TCGA.D5.6931.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.897482516198721}], ["KRT1", ["TCGA.D5.6931.01", "Keratinization"], {"weight": 0.833117285939578}], ["KRT1", ["TCGA.D5.7000.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.903422232087948}], ["KRT1", ["TCGA.DM.A1D4.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.863117027394347}], ["KRT1", ["TCGA.F4.6463.01", "Keratinization"], {"weight": 0.876498030792129}], ["KRT1", ["TCGA.G4.6306.01", "Ca2+ pathway"], {"weight": 0.872493574384573}], ["OR6C75", ["TCGA.AU.6004.01", "Inwardly rectifying K+ channels"], {"weight": 0.908834863604624}], ["KRT16", ["TCGA.CM.5344.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.876022071968161}], ["KRT16", ["TCGA.CM.5344.01", "Degradation of the extracellular matrix"], {"weight": 0.772316910989442}], ["FZD2", ["TCGA.CM.6171.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.897540969207105}], ["LPAR3", ["TCGA.G4.6317.01", "Regulation of Complement cascade"], {"weight": 0.921331585347693}], ["LPAR3", ["TCGA.G4.6317.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.794685736591696}], ["LPAR3", ["TCGA.G4.6317.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.794685736591696}], ["LPAR3", ["TCGA.G4.6317.01", "Nuclear signaling by ERBB4"], {"weight": 0.863978572258859}], ["FADS2", ["TCGA.G4.6317.01", "G alpha (i) signalling events"], {"weight": 0.959502999035012}], ["FADS2", ["TCGA.G4.6317.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.933433099886196}], ["FADS2", ["TCGA.G4.6317.01", "Signal amplification"], {"weight": 0.938401656422094}], ["FADS2", ["TCGA.G4.6317.01", "Opioid Signalling"], {"weight": 0.954277396546445}], ["FADS2", ["TCGA.G4.6317.01", "Platelet homeostasis"], {"weight": 0.915651152629388}], ["FADS2", ["TCGA.G4.6317.01", "PLC beta mediated events"], {"weight": 0.936587317019344}], ["FADS2", ["TCGA.G4.6317.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.879870144508175}], ["OR1J1", ["TCGA.CM.6678.01", "GPCR downstream signalling"], {"weight": 0.932689161520359}], ["OR1J1", ["TCGA.CM.6678.01", "Leishmania infection"], {"weight": 0.841703029736645}], ["OR1J1", ["TCGA.CM.6678.01", "GPCR ligand binding"], {"weight": 0.928344329510084}], ["OR1J1", ["TCGA.CM.6678.01", "G alpha (q) signalling events"], {"weight": 0.885620564361054}], ["OR1J1", ["TCGA.CM.6678.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.857973412560748}], ["OR1J1", ["TCGA.CM.6678.01", "Leishmania parasite growth and survival"], {"weight": 0.857973412560748}], ["OR1J1", ["TCGA.CM.6678.01", "Potassium Channels"], {"weight": 0.941381075140804}], ["SMOX", ["TCGA.CM.5868.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.63216594277393}], ["SLC8A1", ["TCGA.AD.5900.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.822168312085}], ["SLC8A1", ["TCGA.AD.6895.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.887677378809421}], ["SLC8A1", ["TCGA.CA.6718.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.919745084843858}], ["SLC8A1", ["TCGA.D5.6531.01", "Cardiac conduction"], {"weight": 0.894558081417297}], ["SLC8A1", ["TCGA.D5.6531.01", "Muscle contraction"], {"weight": 0.923484656015268}], ["SLC8A1", ["TCGA.D5.6531.01", "Metabolism of vitamins and cofactors"], {"weight": 0.736056811498085}], ["SLC8A1", ["TCGA.D5.6531.01", "Regulation of insulin secretion"], {"weight": 0.905207014704317}], ["SLC8A1", ["TCGA.D5.6531.01", "Integration of energy metabolism"], {"weight": 0.911054265116583}], ["SLC8A1", ["TCGA.D5.6531.01", "Ion homeostasis"], {"weight": 0.873648372762694}], ["SLC8A1", ["TCGA.D5.6531.01", "Insulin receptor signalling cascade"], {"weight": 0.86662660793123}], ["SLC8A1", ["TCGA.D5.6531.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.899407953222805}], ["SLC8A1", ["TCGA.F4.6570.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.896903266718702}], ["CACNA2D2", ["TCGA.G4.6304.01", "Peptide ligand-binding receptors"], {"weight": 0.951866089628787}], ["CACNA2D2", ["TCGA.G4.6304.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.952197994164225}], ["TAS1R3", ["TCGA.A6.6781.01", "Glucagon-type ligand receptors"], {"weight": 0.914590399053464}], ["TAS1R3", ["TCGA.AM.5821.01", "G alpha (s) signalling events"], {"weight": 0.95913416696086}], ["TAS1R3", ["TCGA.AM.5821.01", "GABA B receptor activation"], {"weight": 0.947569567519483}], ["TAS1R3", ["TCGA.AM.5821.01", "Activation of GABAB receptors"], {"weight": 0.947569567519483}], ["TAS1R3", ["TCGA.AY.6197.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.916846103439295}], ["TAS1R3", ["TCGA.AY.6197.01", "Glucagon-type ligand receptors"], {"weight": 0.91523032552086}], ["TAS1R3", ["TCGA.AY.6197.01", "Activation of G protein gated Potassium channels"], {"weight": 0.897370273867459}], ["TAS1R3", ["TCGA.AY.6197.01", "G protein gated Potassium channels"], {"weight": 0.897370273867459}], ["TAS1R3", ["TCGA.AY.6197.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.897370273867459}], ["TAS1R3", ["TCGA.AY.6197.01", "G beta:gamma signalling through BTK"], {"weight": 0.873422618969523}], ["TAS1R3", ["TCGA.AY.6197.01", "GABA receptor activation"], {"weight": 0.866708338458193}], ["TAS1R3", ["TCGA.AY.6197.01", "GABA B receptor activation"], {"weight": 0.916964689444051}], ["TAS1R3", ["TCGA.AY.6197.01", "Activation of GABAB receptors"], {"weight": 0.916964689444051}], ["TAS1R3", ["TCGA.AY.6197.01", "G alpha (z) signalling events"], {"weight": 0.87670289250054}], ["TAS1R3", ["TCGA.AY.6197.01", "Presynaptic function of Kainate receptors"], {"weight": 0.878988644046323}], ["TAS1R3", ["TCGA.AY.6197.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.87954446350637}], ["TAS1R3", ["TCGA.AY.6197.01", "Inwardly rectifying K+ channels"], {"weight": 0.897370273867459}], ["TAS1R3", ["TCGA.AY.6197.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.911151160420009}], ["TAS1R3", ["TCGA.AY.6197.01", "Aquaporin-mediated transport"], {"weight": 0.911151160420009}], ["TAS1R3", ["TCGA.AY.6197.01", "GPER1 signaling"], {"weight": 0.911151160420009}], ["TAS1R3", ["TCGA.AY.6197.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.911151160420009}], ["TAS1R3", ["TCGA.AY.6197.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.861014132084234}], ["TAS1R3", ["TCGA.AY.6197.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.88800749978065}], ["TAS1R3", ["TCGA.CM.4743.01", "G alpha (s) signalling events"], {"weight": 0.959947629828347}], ["TAS1R3", ["TCGA.CM.6679.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.854598555039686}], ["TAS1R3", ["TCGA.CM.6679.01", "Signaling by GPCR"], {"weight": 0.940677545906}], ["TAS1R3", ["TCGA.CM.6679.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.874947910519558}], ["TAS1R3", ["TCGA.CM.6679.01", "Signal amplification"], {"weight": 0.882582413184498}], ["TAS1R3", ["TCGA.CM.6679.01", "GPCR ligand binding"], {"weight": 0.914172561421311}], ["TAS1R3", ["TCGA.CM.6679.01", "GPCR downstream signalling"], {"weight": 0.939406238950391}], ["TAS1R3", ["TCGA.CM.6679.01", "G alpha (q) signalling events"], {"weight": 0.914267519626039}], ["TAS1R3", ["TCGA.CM.6679.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.856745971202797}], ["TAS1R3", ["TCGA.CM.6679.01", "GABA receptor activation"], {"weight": 0.794336546557102}], ["TAS1R3", ["TCGA.CM.6679.01", "Inwardly rectifying K+ channels"], {"weight": 0.902609956890237}], ["TAS1R3", ["TCGA.CM.6679.01", "Activation of G protein gated Potassium channels"], {"weight": 0.884731068950339}], ["TAS1R3", ["TCGA.CM.6679.01", "G protein gated Potassium channels"], {"weight": 0.884731068950339}], ["TAS1R3", ["TCGA.CM.6679.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.863808296932605}], ["TAS1R3", ["TCGA.CM.6679.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.884731068950339}], ["TAS1R3", ["TCGA.CM.6679.01", "G alpha (s) signalling events"], {"weight": 0.929521943946639}], ["TAS1R3", ["TCGA.CM.6679.01", "Presynaptic function of Kainate receptors"], {"weight": 0.857844390688463}], ["TAS1R3", ["TCGA.CM.6679.01", "Regulation of insulin secretion"], {"weight": 0.79670013525575}], ["TAS1R3", ["TCGA.CM.6679.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.871114379221288}], ["TAS1R3", ["TCGA.CM.6679.01", "GABA B receptor activation"], {"weight": 0.88951548550854}], ["TAS1R3", ["TCGA.CM.6679.01", "Activation of GABAB receptors"], {"weight": 0.88951548550854}], ["TAS1R3", ["TCGA.CM.6679.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.856405678673122}], ["TAS1R3", ["TCGA.CM.6679.01", "Platelet activation, signaling and aggregation"], {"weight": 0.904498479707938}], ["TAS1R3", ["TCGA.CM.6679.01", "G alpha (i) signalling events"], {"weight": 0.908057545857261}], ["TAS1R3", ["TCGA.CM.6679.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.845082051873649}], ["TAS1R3", ["TCGA.CM.6679.01", "Transport of small molecules"], {"weight": 0.820293392893134}], ["TAS1R3", ["TCGA.G4.6588.01", "Glucagon-type ligand receptors"], {"weight": 0.93074037014278}], ["TAS1R3", ["TCGA.G4.6588.01", "G beta:gamma signalling through BTK"], {"weight": 0.913266326087461}], ["TAS1R3", ["TCGA.G4.6588.01", "Activation of G protein gated Potassium channels"], {"weight": 0.922226650798351}], ["TAS1R3", ["TCGA.G4.6588.01", "G protein gated Potassium channels"], {"weight": 0.922226650798351}], ["TAS1R3", ["TCGA.G4.6588.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.922226650798351}], ["TAS1R3", ["TCGA.G4.6588.01", "G-protein activation"], {"weight": 0.91426715360113}], ["TAS1R3", ["TCGA.G4.6588.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.903351712285217}], ["TAS1R3", ["TCGA.G4.6588.01", "G-protein beta:gamma signalling"], {"weight": 0.921849409148859}], ["TAS1R3", ["TCGA.G4.6588.01", "G beta:gamma signalling through CDC42"], {"weight": 0.90926472995117}], ["MAPK8IP3", ["TCGA.AZ.6598.01", "Long-term potentiation"], {"weight": 0.940052557191363}], ["MAPK8IP3", ["TCGA.AZ.6598.01", "RET signaling"], {"weight": 0.942914579863816}], ["DGAT1", ["TCGA.G4.6294.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.834719224186922}], ["DGAT1", ["TCGA.G4.6294.01", "Phase I - Functionalization of compounds"], {"weight": 0.9510096932075}], ["PPP1R3D", ["TCGA.G4.6295.01", "Transmission across Chemical Synapses"], {"weight": 0.913897785436687}], ["PPP1R3D", ["TCGA.G4.6295.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.892950857713045}], ["VPS37B", ["TCGA.D5.6531.01", "Ion channel transport"], {"weight": 0.930255092997057}], ["GRIP1", ["TCGA.DM.A28G.01", "Neuronal System"], {"weight": 0.88940017863398}], ["GRIP1", ["TCGA.DM.A28G.01", "Transmission across Chemical Synapses"], {"weight": 0.884947686255485}], ["GRIP1", ["TCGA.DM.A28G.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.886168961347452}], ["GRIP1", ["TCGA.DM.A28G.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.753833564261499}], ["GRIP1", ["TCGA.DM.A28G.01", "GABA receptor activation"], {"weight": 0.818432532476995}], ["SETD1B", ["TCGA.AU.6004.01", "Integrin cell surface interactions"], {"weight": 0.781109215454432}], ["GALNT3", ["TCGA.CK.5916.01", "Defective GALNT3 causes HFTC"], {"weight": 0.900038265272307}], ["GALNT3", ["TCGA.CK.5916.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.896890464534256}], ["GALNT3", ["TCGA.D5.6930.01", "O-linked glycosylation of mucins"], {"weight": 0.932132167973388}], ["LOXL1", ["TCGA.AA.3697.01", "Molecules associated with elastic fibres"], {"weight": 0.754635776329724}], ["LOXL1", ["TCGA.AA.3697.01", "Extracellular matrix organization"], {"weight": 0.776186527577672}], ["LOXL1", ["TCGA.AY.6386.01", "Collagen formation"], {"weight": 0.945965176094883}], ["LOXL1", ["TCGA.AY.6386.01", "Molecules associated with elastic fibres"], {"weight": 0.822081522067777}], ["LOXL1", ["TCGA.AZ.6603.01", "Extracellular matrix organization"], {"weight": 0.711744151696313}], ["LOXL1", ["TCGA.G4.6293.01", "Extracellular matrix organization"], {"weight": 0.793286809462064}], ["LOXL1", ["TCGA.G4.6293.01", "Degradation of the extracellular matrix"], {"weight": 0.829227828299442}], ["LOXL1", ["TCGA.G4.6298.01", "Extracellular matrix organization"], {"weight": 0.902489490598737}], ["LOXL1", ["TCGA.G4.6298.01", "Degradation of the extracellular matrix"], {"weight": 0.837216408289929}], ["LOXL1", ["TCGA.G4.6298.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.925281446252118}], ["LOXL1", ["TCGA.G4.6298.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.950829604774522}], ["LOXL1", ["TCGA.G4.6314.01", "Collagen formation"], {"weight": 0.917168464812616}], ["LOXL1", ["TCGA.G4.6314.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.894008108841853}], ["LOXL4", ["TCGA.A6.6781.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.948817542655815}], ["LOXL4", ["TCGA.A6.6781.01", "Elastic fibre formation"], {"weight": 0.906121271412214}], ["LOXL4", ["TCGA.CM.4747.01", "Extracellular matrix organization"], {"weight": 0.847150539680155}], ["APOA5", ["TCGA.AA.3502.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.796164050142013}], ["APOA5", ["TCGA.AA.3502.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.796164050142013}], ["CABIN1", ["TCGA.AD.6895.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.897516904520438}], ["ABCC1", ["TCGA.A6.6781.01", "APAP ADME"], {"weight": 0.815252202906555}], ["ABCC1", ["TCGA.AD.6889.01", "Arachidonic acid metabolism"], {"weight": 0.944313385282148}], ["ABCC1", ["TCGA.CM.6171.01", "APAP ADME"], {"weight": 0.932866271997686}], ["ABCC1", ["TCGA.G4.6310.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.838309270075815}], ["ABCC1", ["TCGA.G4.6310.01", "Transport of small molecules"], {"weight": 0.913510404560262}], ["ABCC1", ["TCGA.G4.6322.01", "Arachidonic acid metabolism"], {"weight": 0.897687781189962}], ["ABCC1", ["TCGA.G4.6322.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.815190416931323}], ["OSMR", ["TCGA.AY.6197.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.908730647464942}], ["OSMR", ["TCGA.AY.6197.01", "Interleukin-6 family signaling"], {"weight": 0.910489459448743}], ["IL2RG", ["TCGA.AM.5820.01", "TNFs bind their physiological receptors"], {"weight": 0.61315159099939}], ["GATA4", ["TCGA.CK.4950.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.836177645165786}], ["KIF2B", ["TCGA.AZ.4323.01", "Interaction between L1 and Ankyrins"], {"weight": 0.926746355271612}], ["KIF2B", ["TCGA.AZ.4323.01", "Receptor-type tyrosine-protein phosphatases"], {"weight": 0.625818111757801}], ["KIF2B", ["TCGA.AZ.4323.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.588404221057766}], ["KIF2B", ["TCGA.D5.5540.01", "G0 and Early G1"], {"weight": 0.909113172958976}], ["KIF2B", ["TCGA.D5.5540.01", "Deposition of new CENPA-containing nucleosomes at the centromere"], {"weight": 0.921900822798193}], ["KIF2B", ["TCGA.D5.5540.01", "Nucleosome assembly"], {"weight": 0.921900822798193}], ["KIF2B", ["TCGA.D5.5540.01", "G1/S-Specific Transcription"], {"weight": 0.910695853583543}], ["KIF2B", ["TCGA.D5.5540.01", "Resolution of Sister Chromatid Cohesion"], {"weight": 0.943249925436819}], ["KIF2B", ["TCGA.D5.5540.01", "Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1"], {"weight": 0.878384711605467}], ["KIF2B", ["TCGA.D5.5540.01", "Polo-like kinase mediated events"], {"weight": 0.880000521522141}], ["PKN1", ["TCGA.CM.6166.01", "Recycling of bile acids and salts"], {"weight": 0.893817697621755}], ["PKN1", ["TCGA.CM.6166.01", "Ca-dependent events"], {"weight": 0.827817230098556}], ["CRIM1", ["TCGA.CM.5868.01", "Interaction between L1 and Ankyrins"], {"weight": 0.88186817616035}], ["SSTR2", ["TCGA.A6.6781.01", "Peptide ligand-binding receptors"], {"weight": 0.931112696369759}], ["SSTR2", ["TCGA.A6.6781.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.930539006157432}], ["SCNN1B", ["TCGA.CM.6679.01", "Interaction between L1 and Ankyrins"], {"weight": 0.846477444140646}], ["SCNN1B", ["TCGA.D5.6538.01", "Interaction between L1 and Ankyrins"], {"weight": 0.921540086159049}], ["LILRB2", ["TCGA.CK.4952.01", "DAP12 interactions"], {"weight": 0.904910817529101}], ["LILRB2", ["TCGA.CK.4952.01", "DAP12 signaling"], {"weight": 0.929577986430516}], ["LILRB2", ["TCGA.D5.6926.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.45913911498886}], ["CPT1B", ["TCGA.AA.3697.01", "Integration of energy metabolism"], {"weight": 0.900737923448226}], ["OPRD1", ["TCGA.AY.5543.01", "GPCR ligand binding"], {"weight": 0.92040582058731}], ["OPRD1", ["TCGA.AY.5543.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.840244394127064}], ["OPRD1", ["TCGA.AY.5543.01", "Chemokine receptors bind chemokines"], {"weight": 0.925412723857794}], ["OPRD1", ["TCGA.AY.5543.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.925754432771023}], ["OPRD1", ["TCGA.AY.5543.01", "Peptide ligand-binding receptors"], {"weight": 0.924692623294547}], ["OPRD1", ["TCGA.CK.5915.01", "Initial triggering of complement"], {"weight": 0.868245977898746}], ["OPRD1", ["TCGA.CM.5860.01", "Chemokine receptors bind chemokines"], {"weight": 0.912280008824507}], ["OPRD1", ["TCGA.CM.5862.01", "Complement cascade"], {"weight": 0.862345544212855}], ["OPRD1", ["TCGA.D5.5541.01", "G alpha (i) signalling events"], {"weight": 0.934018232403984}], ["OPRD1", ["TCGA.D5.5541.01", "Signaling by GPCR"], {"weight": 0.939917258153054}], ["OPRD1", ["TCGA.D5.5541.01", "GPCR downstream signalling"], {"weight": 0.944724361952421}], ["OPRD1", ["TCGA.F4.6855.01", "Signaling by GPCR"], {"weight": 0.9235124157863}], ["OPRD1", ["TCGA.F4.6855.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.855595155187266}], ["ALOX15B", ["TCGA.D5.6540.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.910990462336087}], ["TRPC6", ["TCGA.AA.3662.01", "Phase 4 - resting membrane potential"], {"weight": 0.774315960974191}], ["TRPC6", ["TCGA.AD.6963.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.790477032377529}], ["TRPC6", ["TCGA.CM.6676.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.926248848200581}], ["TRPC6", ["TCGA.F4.6807.01", "Stimuli-sensing channels"], {"weight": 0.834743863971426}], ["TRPC6", ["TCGA.F4.6807.01", "Ion channel transport"], {"weight": 0.896661257161969}], ["LAMC2", ["TCGA.AA.3663.01", "Extracellular matrix organization"], {"weight": 0.870475067792139}], ["LAMC2", ["TCGA.CM.6162.01", "Degradation of the extracellular matrix"], {"weight": 0.921056878427741}], ["LAMC2", ["TCGA.D5.6926.01", "Extracellular matrix organization"], {"weight": 0.888070209216917}], ["LAMC2", ["TCGA.D5.6926.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.945433203776331}], ["LAMC2", ["TCGA.D5.6926.01", "G alpha (q) signalling events"], {"weight": 0.904168452169776}], ["PRODH2", ["TCGA.F4.6806.01", "Biological oxidations"], {"weight": 0.858871880971435}], ["GAK", ["TCGA.DM.A1D4.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.777114782217842}], ["GAK", ["TCGA.DM.A1D4.01", "Scavenging by Class A Receptors"], {"weight": 0.535042234251627}], ["MOV10", ["TCGA.CK.4947.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.475364329221636}], ["MOV10", ["TCGA.CK.4947.01", "Phase II - Conjugation of compounds"], {"weight": 0.704541982792565}], ["CD19", ["TCGA.AZ.6599.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.93429266900059}], ["CD19", ["TCGA.AZ.6599.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.899343985194373}], ["CD19", ["TCGA.AZ.6599.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.899343985194373}], ["CD19", ["TCGA.AZ.6599.01", "FCERI mediated Ca+2 mobilization"], {"weight": 0.865180242362084}], ["CD19", ["TCGA.AZ.6599.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.897618041410298}], ["CD19", ["TCGA.AZ.6599.01", "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"], {"weight": 0.873122604664219}], ["CD19", ["TCGA.AZ.6599.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.867838217651445}], ["CD19", ["TCGA.AZ.6599.01", "Costimulation by the CD28 family"], {"weight": 0.914692632681943}], ["CD19", ["TCGA.AZ.6599.01", "Role of phospholipids in phagocytosis"], {"weight": 0.838166855835305}], ["CD19", ["TCGA.AZ.6599.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.916727695556523}], ["CD19", ["TCGA.AZ.6599.01", "DAP12 interactions"], {"weight": 0.927500338568475}], ["CD19", ["TCGA.CM.4743.01", "CD22 mediated BCR regulation"], {"weight": 0.843273243317653}], ["INPPL1", ["TCGA.G4.6626.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.878429528211675}], ["LRP4", ["TCGA.AD.6895.01", "NCAM1 interactions"], {"weight": 0.921958500148311}], ["LRP4", ["TCGA.AD.6895.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.872659118548953}], ["LRP4", ["TCGA.AD.6895.01", "Retinoid metabolism and transport"], {"weight": 0.872659118548953}], ["LRP4", ["TCGA.AD.6895.01", "Visual phototransduction"], {"weight": 0.853717185459851}], ["LRP4", ["TCGA.AD.6895.01", "NCAM signaling for neurite out-growth"], {"weight": 0.932146701751964}], ["LRP4", ["TCGA.AD.6895.01", "ECM proteoglycans"], {"weight": 0.927782731015002}], ["LRP4", ["TCGA.G4.6314.01", "ECM proteoglycans"], {"weight": 0.776329117198381}], ["LRP5", ["TCGA.A6.6781.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.905867989189492}], ["ADAMTS7", ["TCGA.G4.6306.01", "Defective B3GALTL causes PpS"], {"weight": 0.917800499005763}], ["ADAMTS7", ["TCGA.G4.6306.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.917763982625476}], ["ADAMTS7", ["TCGA.G4.6306.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.722524224611338}], ["VTN", ["TCGA.G4.6302.01", "Extracellular matrix organization"], {"weight": 0.87603536144966}], ["VTN", ["TCGA.G4.6302.01", "Dissolution of Fibrin Clot"], {"weight": 0.81539096269291}], ["MED25", ["TCGA.G4.6306.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.918877077141755}], ["MED25", ["TCGA.G4.6306.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.918877077141755}], ["MED25", ["TCGA.G4.6306.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.655608567501225}], ["MED25", ["TCGA.G4.6306.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.655608567501225}], ["ST14", ["TCGA.DM.A1D7.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.934686250759241}], ["INF2", ["TCGA.DM.A1D0.01", "Binding and entry of HIV virion"], {"weight": 0.749987617494524}], ["INF2", ["TCGA.DM.A1D0.01", "Scavenging of heme from plasma"], {"weight": 0.873503453062728}], ["INF2", ["TCGA.G4.6294.01", "Scavenging of heme from plasma"], {"weight": 0.670513383008496}], ["INF2", ["TCGA.G4.6294.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.833263627214064}], ["INF2", ["TCGA.G4.6294.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.839717292019681}], ["ANGPT1", ["TCGA.CM.6162.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.934870760426004}], ["TXLNA", ["TCGA.G4.6317.01", "Signaling by Interleukins"], {"weight": 0.904103010723234}], ["GSPT1", ["TCGA.AZ.6603.01", "Regulation of FZD by ubiquitination"], {"weight": 0.731931400866795}], ["KIT", ["TCGA.CM.4752.01", "L1CAM interactions"], {"weight": 0.814801391147164}], ["KIT", ["TCGA.CM.5862.01", "Drug ADME"], {"weight": 0.85830152459102}], ["KIT", ["TCGA.CM.6164.01", "Phase II - Conjugation of compounds"], {"weight": 0.825806255878127}], ["KIT", ["TCGA.CM.6164.01", "GPCR downstream signalling"], {"weight": 0.937189973175553}], ["KIT", ["TCGA.CM.6164.01", "Glucuronidation"], {"weight": 0.851926119753995}], ["KIT", ["TCGA.CM.6164.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.74626061049921}], ["KIT", ["TCGA.CM.6164.01", "Ethanol oxidation"], {"weight": 0.769470793769459}], ["KIT", ["TCGA.CM.6164.01", "Aspirin ADME"], {"weight": 0.733682065621188}], ["KIT", ["TCGA.CM.6164.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.779303106023422}], ["KIT", ["TCGA.CM.6164.01", "Regulation of beta-cell development"], {"weight": 0.769660796407018}], ["KIT", ["TCGA.D5.5541.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.735648596366647}], ["MTMR1", ["TCGA.CK.5915.01", "Signaling by GPCR"], {"weight": 0.943251844736402}], ["MTMR1", ["TCGA.CK.5915.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.911238536740691}], ["MTMR1", ["TCGA.CK.5915.01", "Leishmania parasite growth and survival"], {"weight": 0.911238536740691}], ["MTMR1", ["TCGA.CK.5915.01", "Leishmania infection"], {"weight": 0.906945808793433}], ["MTMR1", ["TCGA.CK.5915.01", "Parasitic Infection Pathways"], {"weight": 0.906945808793433}], ["MTMR1", ["TCGA.CK.5915.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.94228565158103}], ["MTMR1", ["TCGA.CK.5915.01", "G-protein beta:gamma signalling"], {"weight": 0.928848676189244}], ["MTMR1", ["TCGA.CK.5915.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.919318573450949}], ["MTMR1", ["TCGA.CK.5915.01", "DAP12 signaling"], {"weight": 0.92316525868828}], ["MTMR1", ["TCGA.CK.5915.01", "Cytokine Signaling in Immune system"], {"weight": 0.862135067256516}], ["MTMR1", ["TCGA.CK.5915.01", "CD22 mediated BCR regulation"], {"weight": 0.829291192169315}], ["RAB8A", ["TCGA.AZ.6599.01", "Activation of the phototransduction cascade"], {"weight": 0.861505395798776}], ["PAK2", ["TCGA.CM.5868.01", "ECM proteoglycans"], {"weight": 0.886180054818851}], ["PAK2", ["TCGA.G4.6586.01", "Nervous system development"], {"weight": 0.927274885486712}], ["PAK2", ["TCGA.G4.6586.01", "Axon guidance"], {"weight": 0.935484722030369}], ["STAT5A", ["TCGA.D5.5537.01", "Chemokine receptors bind chemokines"], {"weight": 0.92397607886486}], ["STAT5A", ["TCGA.D5.5537.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.940717028089703}], ["STAT5A", ["TCGA.D5.6930.01", "ESR-mediated signaling"], {"weight": 0.803121667216575}], ["STAT5A", ["TCGA.G4.6311.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.738020250909835}], ["DOK1", ["TCGA.AZ.6607.01", "Signaling by PDGF"], {"weight": 0.931713574517525}], ["DOK1", ["TCGA.AZ.6607.01", "NCAM1 interactions"], {"weight": 0.758684196160949}], ["DOK1", ["TCGA.D5.6538.01", "Leishmania infection"], {"weight": 0.900872215532352}], ["DOK1", ["TCGA.D5.6538.01", "Parasitic Infection Pathways"], {"weight": 0.900872215532352}], ["DOK1", ["TCGA.D5.6538.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.90827771553381}], ["DOK1", ["TCGA.D5.6538.01", "Leishmania parasite growth and survival"], {"weight": 0.90827771553381}], ["DOK1", ["TCGA.D5.6538.01", "CD22 mediated BCR regulation"], {"weight": 0.873895443763746}], ["DOK1", ["TCGA.D5.6538.01", "FCGR activation"], {"weight": 0.892590695908498}], ["DOK4", ["TCGA.CM.6674.01", "NCAM1 interactions"], {"weight": 0.928336148921691}], ["DOK4", ["TCGA.CM.6674.01", "NCAM signaling for neurite out-growth"], {"weight": 0.931623356531803}], ["CYP2B6", ["TCGA.AM.5821.01", "Phase II - Conjugation of compounds"], {"weight": 0.927369176538864}], ["CYP2B6", ["TCGA.AM.5821.01", "Biosynthesis of DHA-derived SPMs"], {"weight": 0.840676003411403}], ["PANK4", ["TCGA.CM.6674.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.793656232878139}], ["KIF13A", ["TCGA.G4.6322.01", "Signaling by GPCR"], {"weight": 0.93188116871906}], ["KIF13A", ["TCGA.G4.6322.01", "GPCR downstream signalling"], {"weight": 0.936021410701348}], ["KIF13A", ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.710599706268184}], ["KIF13A", ["TCGA.G4.6322.01", "Bile acid and bile salt metabolism"], {"weight": 0.747900188886373}], ["KIF13A", ["TCGA.G4.6322.01", "G alpha (i) signalling events"], {"weight": 0.9391746706349}], ["KIF13A", ["TCGA.G4.6322.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.727536084786026}], ["EFNB3", ["TCGA.CM.5861.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.915868675694679}], ["MYO5C", ["TCGA.AD.6888.01", "Leishmania infection"], {"weight": 0.915129980690781}], ["MYO5C", ["TCGA.AD.6888.01", "Parasitic Infection Pathways"], {"weight": 0.915129980690781}], ["MYO5C", ["TCGA.AD.6888.01", "Insulin processing"], {"weight": 0.822164104156027}], ["MYO5C", ["TCGA.AD.6888.01", "Activation of the phototransduction cascade"], {"weight": 0.78472337115319}], ["MYO5C", ["TCGA.G4.6298.01", "Leishmania infection"], {"weight": 0.89607590730144}], ["MYO5C", ["TCGA.G4.6298.01", "Parasitic Infection Pathways"], {"weight": 0.89607590730144}], ["PDE4B", ["TCGA.DM.A28F.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.814279931399799}], ["SLC7A11", ["TCGA.D5.6920.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.884086741154192}], ["ISYNA1", ["TCGA.CM.6676.01", "Biological oxidations"], {"weight": 0.894704070556073}], ["ISYNA1", ["TCGA.CM.6676.01", "Phase II - Conjugation of compounds"], {"weight": 0.789432031407424}], ["ISYNA1", ["TCGA.CM.6676.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.765225331229439}], ["HSD17B2", ["TCGA.A6.6781.01", "Glucuronidation"], {"weight": 0.895676191299759}], ["HSD17B2", ["TCGA.AZ.6599.01", "Glucuronidation"], {"weight": 0.881580171135358}], ["CARNS1", ["TCGA.F4.6703.01", "Tryptophan catabolism"], {"weight": 0.689924428850164}], ["CARNS1", ["TCGA.G4.6293.01", "Transmission across Chemical Synapses"], {"weight": 0.855775678419606}], ["TBXAS1", ["TCGA.A6.6781.01", "Fatty acid metabolism"], {"weight": 0.889143260636359}], ["TBXAS1", ["TCGA.AD.6899.01", "Biological oxidations"], {"weight": 0.852793331693883}], ["TBXAS1", ["TCGA.AD.6899.01", "Phase II - Conjugation of compounds"], {"weight": 0.73998283073572}], ["TBXAS1", ["TCGA.AD.6899.01", "Ethanol oxidation"], {"weight": 0.676570567274169}], ["TBXAS1", ["TCGA.AD.6964.01", "Glutathione conjugation"], {"weight": 0.845930802277087}], ["TBXAS1", ["TCGA.CM.6170.01", "Biological oxidations"], {"weight": 0.899657407769367}], ["TBXAS1", ["TCGA.CM.6170.01", "Phase II - Conjugation of compounds"], {"weight": 0.852827089639475}], ["TBXAS1", ["TCGA.CM.6170.01", "Ethanol oxidation"], {"weight": 0.832957570566102}], ["TBXAS1", ["TCGA.CM.6170.01", "RA biosynthesis pathway"], {"weight": 0.752882714524616}], ["TBXAS1", ["TCGA.CM.6170.01", "Signaling by Nuclear Receptors"], {"weight": 0.815565707939091}], ["TBXAS1", ["TCGA.CM.6170.01", "Arachidonic acid metabolism"], {"weight": 0.850829007255474}], ["TBXAS1", ["TCGA.CM.6170.01", "Phase I - Functionalization of compounds"], {"weight": 0.895614651458146}], ["CYP2S1", ["TCGA.A6.6781.01", "Phase II - Conjugation of compounds"], {"weight": 0.88543398819589}], ["CYP2S1", ["TCGA.D5.6529.01", "Biological oxidations"], {"weight": 0.918211425778482}], ["CYP2S1", ["TCGA.D5.6529.01", "Phase II - Conjugation of compounds"], {"weight": 0.829126593915441}], ["CYP2S1", ["TCGA.D5.6529.01", "Drug ADME"], {"weight": 0.892504609360203}], ["CYP2S1", ["TCGA.D5.6529.01", "Glucuronidation"], {"weight": 0.825087238289382}], ["CYP2S1", ["TCGA.D5.6529.01", "Bile acid and bile salt metabolism"], {"weight": 0.731490616292421}], ["CYP2S1", ["TCGA.D5.6529.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.466007400632756}], ["CYP2S1", ["TCGA.F4.6703.01", "Biological oxidations"], {"weight": 0.934655672084996}], ["CYP2S1", ["TCGA.F4.6703.01", "Phase II - Conjugation of compounds"], {"weight": 0.902578321056483}], ["CYP2S1", ["TCGA.F4.6703.01", "Glucuronidation"], {"weight": 0.924451715594432}], ["CYP2S1", ["TCGA.G4.6628.01", "Phase II - Conjugation of compounds"], {"weight": 0.856024192163825}], ["CNGA3", ["TCGA.D5.5541.01", "Activation of the phototransduction cascade"], {"weight": 0.756986303844399}], ["CNGA3", ["TCGA.G4.6297.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.692508397678194}], ["UGT2B7", ["TCGA.AA.3712.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.873987481180468}], ["FMO4", ["TCGA.CM.6162.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.632983130098722}], ["FMO4", ["TCGA.D5.6922.01", "RA biosynthesis pathway"], {"weight": 0.769168458694279}], ["PSAP", ["TCGA.D5.6531.01", "G alpha (i) signalling events"], {"weight": 0.934033098517544}], ["ADAM22", ["TCGA.AA.3662.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.861736385388916}], ["ADAM22", ["TCGA.D5.5541.01", "Neuronal System"], {"weight": 0.915997567283294}], ["ADAM22", ["TCGA.D5.5541.01", "Transmission across Chemical Synapses"], {"weight": 0.92673595186881}], ["ADAM22", ["TCGA.D5.5541.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.928432319120911}], ["ADAM22", ["TCGA.D5.5541.01", "Phase 0 - rapid depolarisation"], {"weight": 0.920148063883671}], ["ADAM22", ["TCGA.D5.5541.01", "Cardiac conduction"], {"weight": 0.892419812923577}], ["ADAM22", ["TCGA.D5.5541.01", "Trafficking of AMPA receptors"], {"weight": 0.890148441325765}], ["ADAM22", ["TCGA.D5.5541.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.890148441325765}], ["BCORL1", ["TCGA.AZ.4323.01", "Stimuli-sensing channels"], {"weight": 0.864414206587998}], ["ACOX2", ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.598425808712962}], ["ACOX2", ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.731453540499786}], ["ACOX2", ["TCGA.AA.3660.01", "Recycling of bile acids and salts"], {"weight": 0.54502919919376}], ["GALNT8", ["TCGA.AD.6964.01", "O-linked glycosylation of mucins"], {"weight": 0.928855955781198}], ["GALNT8", ["TCGA.AD.6964.01", "Defective GALNT3 causes HFTC"], {"weight": 0.813930576873357}], ["GALNT8", ["TCGA.AD.6964.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.813930576873357}], ["NCLN", ["TCGA.D5.6924.01", "Aspartate and asparagine metabolism"], {"weight": 0.687325947110917}], ["KCND1", ["TCGA.F4.6806.01", "Cardiac conduction"], {"weight": 0.896780882893154}], ["KCND1", ["TCGA.F4.6806.01", "Muscle contraction"], {"weight": 0.907125917985157}], ["KCND1", ["TCGA.G4.6309.01", "Neuronal System"], {"weight": 0.93215946932466}], ["F2RL3", ["TCGA.A6.6782.01", "Extracellular matrix organization"], {"weight": 0.786879526969911}], ["ADCY1", ["TCGA.AM.5820.01", "Neuronal System"], {"weight": 0.90268898602152}], ["ADCY1", ["TCGA.AM.5820.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.896847234753363}], ["ADCY1", ["TCGA.AM.5820.01", "Transmission across Chemical Synapses"], {"weight": 0.898021104506927}], ["ADCY1", ["TCGA.AY.6196.01", "Signaling by GPCR"], {"weight": 0.871995267639041}], ["ADCY1", ["TCGA.DM.A285.01", "Chemokine receptors bind chemokines"], {"weight": 0.920968309429751}], ["ADCY1", ["TCGA.DM.A285.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.782450973944222}], ["USP12", ["TCGA.DM.A28H.01", "Unwinding of DNA"], {"weight": 0.773583428051782}], ["PROS1", ["TCGA.DM.A1D4.01", "Classical antibody-mediated complement activation"], {"weight": 0.795754269729394}], ["PROS1", ["TCGA.DM.A1D4.01", "Initial triggering of complement"], {"weight": 0.864747253542073}], ["PROS1", ["TCGA.DM.A1D4.01", "Creation of C4 and C2 activators"], {"weight": 0.864952072377129}], ["PDGFA", ["TCGA.CK.4950.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.661864331404621}], ["COL25A1", ["TCGA.A6.6782.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.919490195727908}], ["COL25A1", ["TCGA.A6.6782.01", "ECM proteoglycans"], {"weight": 0.856471285459192}], ["COL25A1", ["TCGA.A6.6782.01", "Collagen chain trimerization"], {"weight": 0.885944840331625}], ["COL25A1", ["TCGA.A6.6782.01", "Integrin cell surface interactions"], {"weight": 0.782810376643111}], ["COL25A1", ["TCGA.A6.6782.01", "NCAM signaling for neurite out-growth"], {"weight": 0.895817575147136}], ["COL25A1", ["TCGA.D5.6926.01", "Collagen formation"], {"weight": 0.935913608416968}], ["COL25A1", ["TCGA.D5.6926.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.947509043978528}], ["COL25A1", ["TCGA.D5.6926.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.919978090302272}], ["COL25A1", ["TCGA.D5.6926.01", "Collagen chain trimerization"], {"weight": 0.927891511297085}], ["COL25A1", ["TCGA.D5.6926.01", "Degradation of the extracellular matrix"], {"weight": 0.87847431527803}], ["COL25A1", ["TCGA.D5.6926.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.663507955609252}], ["COL25A1", ["TCGA.D5.6926.01", "NCAM1 interactions"], {"weight": 0.797338525834112}], ["COL25A1", ["TCGA.D5.6926.01", "Collagen degradation"], {"weight": 0.916312530463964}], ["RPS6KA2", ["TCGA.A6.6782.01", "Surfactant metabolism"], {"weight": 0.918447192351495}], ["RPS6KA2", ["TCGA.CK.5914.01", "G alpha (q) signalling events"], {"weight": 0.917404922193975}], ["RPS6KA2", ["TCGA.CK.5914.01", "SUMOylation of intracellular receptors"], {"weight": 0.637301966449686}], ["ADAMTSL1", ["TCGA.CM.6171.01", "Defective B3GALTL causes PpS"], {"weight": 0.9035554511143}], ["ADAMTSL1", ["TCGA.CM.6171.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.903504031493364}], ["TRAM1", ["TCGA.CM.5341.01", "Eukaryotic Translation Elongation"], {"weight": 0.930159364506526}], ["TRAM1", ["TCGA.CM.5341.01", "Peptide chain elongation"], {"weight": 0.92999650143275}], ["TRAM1", ["TCGA.CM.5341.01", "Viral mRNA Translation"], {"weight": 0.929034664757487}], ["TRAM1", ["TCGA.CM.5341.01", "Eukaryotic Translation Termination"], {"weight": 0.918912700359065}], ["TRAM1", ["TCGA.CM.5341.01", "Selenoamino acid metabolism"], {"weight": 0.921602031811474}], ["TRAM1", ["TCGA.CM.5341.01", "Selenocysteine synthesis"], {"weight": 0.929034664757487}], ["TRAM1", ["TCGA.CM.5341.01", "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"], {"weight": 0.928665934012094}], ["TRAM1", ["TCGA.CM.5341.01", "Response of EIF2AK4 (GCN2) to amino acid deficiency"], {"weight": 0.922560611602413}], ["TRAM1", ["TCGA.CM.5341.01", "Formation of a pool of free 40S subunits"], {"weight": 0.930459188565895}], ["TRAM1", ["TCGA.CM.5341.01", "L13a-mediated translational silencing of Ceruloplasmin expression"], {"weight": 0.939206904116088}], ["TRAM1", ["TCGA.CM.5341.01", "GTP hydrolysis and joining of the 60S ribosomal subunit"], {"weight": 0.929816744362468}], ["TRAM1", ["TCGA.CM.5341.01", "Nonsense-Mediated Decay (NMD)"], {"weight": 0.929712339014691}], ["TRAM1", ["TCGA.CM.5341.01", "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"], {"weight": 0.929712339014691}], ["TRAM1", ["TCGA.CM.5341.01", "Eukaryotic Translation Initiation"], {"weight": 0.929816744362468}], ["TRAM1", ["TCGA.CM.5341.01", "Cap-dependent Translation Initiation"], {"weight": 0.929816744362468}], ["TRAM1", ["TCGA.CM.5341.01", "SARS-CoV-1 modulates host translation machinery"], {"weight": 0.909491385238535}], ["TRAM1", ["TCGA.CM.5341.01", "Formation of the ternary complex, and subsequently, the 43S complex"], {"weight": 0.91493697709827}], ["TRAM1", ["TCGA.CM.5341.01", "Ribosomal scanning and start codon recognition"], {"weight": 0.91477522207505}], ["TRAM1", ["TCGA.CM.5341.01", "Translation initiation complex formation"], {"weight": 0.91477522207505}], ["TRAM1", ["TCGA.CM.5341.01", "Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S"], {"weight": 0.91477522207505}], ["GABBR2", ["TCGA.CK.5913.01", "Potassium Channels"], {"weight": 0.952864140054904}], ["GABBR2", ["TCGA.CK.5913.01", "Activation of G protein gated Potassium channels"], {"weight": 0.916619334804961}], ["GABBR2", ["TCGA.CK.5913.01", "G protein gated Potassium channels"], {"weight": 0.916619334804961}], ["GABBR2", ["TCGA.CK.5913.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.916619334804961}], ["GABBR2", ["TCGA.CK.5913.01", "GABA B receptor activation"], {"weight": 0.924685631137922}], ["GABBR2", ["TCGA.CK.5913.01", "Activation of GABAB receptors"], {"weight": 0.924685631137922}], ["GABBR2", ["TCGA.DM.A1D9.01", "Arachidonic acid metabolism"], {"weight": 0.917675415282307}], ["GABBR2", ["TCGA.DM.A1D9.01", "Biological oxidations"], {"weight": 0.924684070368312}], ["GABBR2", ["TCGA.DM.A1D9.01", "Phase I - Functionalization of compounds"], {"weight": 0.922868538014667}], ["GABBR2", ["TCGA.DM.A1D9.01", "GABA receptor activation"], {"weight": 0.92392023005836}], ["GABBR2", ["TCGA.DM.A1D9.01", "Complement cascade"], {"weight": 0.8385700184558}], ["GABBR2", ["TCGA.DM.A1D9.01", "Activation of G protein gated Potassium channels"], {"weight": 0.928471637759353}], ["GABBR2", ["TCGA.DM.A1D9.01", "G protein gated Potassium channels"], {"weight": 0.928471637759353}], ["GABBR2", ["TCGA.DM.A1D9.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.928471637759353}], ["GABBR2", ["TCGA.DM.A1D9.01", "Regulation of Complement cascade"], {"weight": 0.736177398614419}], ["GABBR2", ["TCGA.DM.A1D9.01", "GABA B receptor activation"], {"weight": 0.935673587740321}], ["GABBR2", ["TCGA.DM.A1D9.01", "Activation of GABAB receptors"], {"weight": 0.935673587740321}], ["GABBR2", ["TCGA.DM.A1D9.01", "Inwardly rectifying K+ channels"], {"weight": 0.928471637759353}], ["GABBR2", ["TCGA.G4.6309.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.934024654776118}], ["GABBR2", ["TCGA.G4.6309.01", "GABA receptor activation"], {"weight": 0.901488000997967}], ["E2F2", ["TCGA.A6.6782.01", "SLC-mediated transmembrane transport"], {"weight": 0.75245452317972}], ["FARP2", ["TCGA.AD.6964.01", "Other semaphorin interactions"], {"weight": 0.725794224592552}], ["RHOBTB1", ["TCGA.A6.6782.01", "Neuronal System"], {"weight": 0.824160579368434}], ["RHOBTB1", ["TCGA.A6.6782.01", "Transmission across Chemical Synapses"], {"weight": 0.78264275602716}], ["RHOBTB1", ["TCGA.A6.6782.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.810444331054906}], ["CMA1", ["TCGA.A6.6782.01", "Negative regulation of NMDA receptor-mediated neuronal transmission"], {"weight": 0.730233391805542}], ["SLC1A7", ["TCGA.D5.6928.01", "Neuronal System"], {"weight": 0.867253351023928}], ["RIMKLB", ["TCGA.AA.3489.01", "Drug ADME"], {"weight": 0.90234402409006}], ["RIMKLB", ["TCGA.AA.3489.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], {"weight": 0.414658621521749}], ["OR8B8", ["TCGA.AA.3489.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.851436134720596}], ["OR8B8", ["TCGA.AA.3489.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.855135117613697}], ["OR8B8", ["TCGA.AA.3489.01", "Activation of G protein gated Potassium channels"], {"weight": 0.882400223743617}], ["OR8B8", ["TCGA.AA.3489.01", "G protein gated Potassium channels"], {"weight": 0.882400223743617}], ["OR8B8", ["TCGA.AA.3489.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.882400223743617}], ["OR8B8", ["TCGA.D5.6924.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.807400441656797}], ["OR8B8", ["TCGA.D5.6924.01", "Signal amplification"], {"weight": 0.822577749040858}], ["OR8B8", ["TCGA.D5.6924.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.875002262186105}], ["OR8B8", ["TCGA.D5.6924.01", "Signaling by GPCR"], {"weight": 0.897227265270582}], ["OR8B8", ["TCGA.D5.6924.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.880348088291075}], ["OR8B8", ["TCGA.D5.6924.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.871484717008373}], ["OR8B8", ["TCGA.D5.6924.01", "G beta:gamma signalling through BTK"], {"weight": 0.848361877851565}], ["OR8B8", ["TCGA.D5.6924.01", "Regulation of insulin secretion"], {"weight": 0.914488906699077}], ["OR8B8", ["TCGA.D5.6924.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.848361877851565}], ["OR8B8", ["TCGA.D5.6924.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.848361877851565}], ["OR8B8", ["TCGA.D5.6924.01", "G beta:gamma signalling through CDC42"], {"weight": 0.848361877851565}], ["OR8B8", ["TCGA.D5.6924.01", "Presynaptic function of Kainate receptors"], {"weight": 0.848361877851565}], ["OR8B8", ["TCGA.D5.6924.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.871484717008373}], ["OR8B8", ["TCGA.D5.6924.01", "GPER1 signaling"], {"weight": 0.871484717008373}], ["OR8B8", ["TCGA.D5.6924.01", "GABA B receptor activation"], {"weight": 0.872332503669951}], ["OR8B8", ["TCGA.D5.6924.01", "Activation of GABAB receptors"], {"weight": 0.872332503669951}], ["OR8B8", ["TCGA.D5.6924.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.868308774431226}], ["OR8B8", ["TCGA.D5.6924.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.848361877851565}], ["OR8B8", ["TCGA.DM.A1D8.01", "G alpha (i) signalling events"], {"weight": 0.950740030290233}], ["OR8B8", ["TCGA.DM.A1D8.01", "GPCR ligand binding"], {"weight": 0.94967993927104}], ["OR8B8", ["TCGA.DM.A1D8.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.926208149986858}], ["OR8B8", ["TCGA.DM.A1D8.01", "Leishmania parasite growth and survival"], {"weight": 0.926208149986858}], ["OR8B8", ["TCGA.DM.A1D8.01", "G alpha (q) signalling events"], {"weight": 0.950027733434982}], ["OR8B8", ["TCGA.DM.A1D8.01", "GABA receptor activation"], {"weight": 0.920660843287707}], ["OR8B8", ["TCGA.DM.A1D8.01", "G alpha (s) signalling events"], {"weight": 0.963920219845914}], ["OR8B8", ["TCGA.DM.A1D8.01", "Glucagon-type ligand receptors"], {"weight": 0.933936331836353}], ["OR8B8", ["TCGA.DM.A1D8.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.924268672102494}], ["OR8B8", ["TCGA.DM.A1D8.01", "Regulation of insulin secretion"], {"weight": 0.92145062081152}], ["OR8B8", ["TCGA.DM.A1D8.01", "Signal amplification"], {"weight": 0.91496910350347}], ["OR8B8", ["TCGA.DM.A1D8.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.891147058500362}], ["OR8B8", ["TCGA.DM.A1D8.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.864955989354431}], ["OR8B8", ["TCGA.DM.A1D8.01", "G-protein beta:gamma signalling"], {"weight": 0.920592864962462}], ["OR8B8", ["TCGA.DM.A1D8.01", "Activation of the phototransduction cascade"], {"weight": 0.818342258151036}], ["OR8B8", ["TCGA.DM.A1D8.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.908531909326202}], ["OR8B8", ["TCGA.DM.A1D8.01", "G beta:gamma signalling through BTK"], {"weight": 0.892654042888442}], ["OR8B8", ["TCGA.DM.A1D8.01", "GABA B receptor activation"], {"weight": 0.920282858613156}], ["OR8B8", ["TCGA.DM.A1D8.01", "Activation of GABAB receptors"], {"weight": 0.920282858613156}], ["HPR", ["TCGA.AZ.6598.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.871477072233686}], ["HPR", ["TCGA.AZ.6598.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.871477072233686}], ["OR11G2", ["TCGA.AA.3489.01", "Transmission across Chemical Synapses"], {"weight": 0.835159790141393}], ["OR11G2", ["TCGA.DM.A28M.01", "G alpha (z) signalling events"], {"weight": 0.897043203307896}], ["OR11G2", ["TCGA.DM.A28M.01", "GABA B receptor activation"], {"weight": 0.937423607653297}], ["OR11G2", ["TCGA.DM.A28M.01", "Activation of GABAB receptors"], {"weight": 0.937423607653297}], ["OR11G2", ["TCGA.DM.A28M.01", "Potassium Channels"], {"weight": 0.919339564580373}], ["OR11G2", ["TCGA.DM.A28M.01", "Glucagon-type ligand receptors"], {"weight": 0.940897918665961}], ["OR11G2", ["TCGA.DM.A28M.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.922182777191247}], ["OR11G2", ["TCGA.DM.A28M.01", "G-protein beta:gamma signalling"], {"weight": 0.932944362402911}], ["OR11G2", ["TCGA.DM.A28M.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.916902395716186}], ["OR11G2", ["TCGA.DM.A28M.01", "G beta:gamma signalling through BTK"], {"weight": 0.913216733161578}], ["OR11G2", ["TCGA.DM.A28M.01", "Activation of G protein gated Potassium channels"], {"weight": 0.92096387517322}], ["OR11G2", ["TCGA.DM.A28M.01", "G protein gated Potassium channels"], {"weight": 0.92096387517322}], ["OR11G2", ["TCGA.DM.A28M.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.92096387517322}], ["OR11G2", ["TCGA.DM.A28M.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.931286660664037}], ["OR11G2", ["TCGA.DM.A28M.01", "Inwardly rectifying K+ channels"], {"weight": 0.899254952777593}], ["OR11G2", ["TCGA.DM.A28M.01", "G beta:gamma signalling through CDC42"], {"weight": 0.90816060910092}], ["OR11G2", ["TCGA.DM.A28M.01", "Ca2+ pathway"], {"weight": 0.874749891034511}], ["OR11G2", ["TCGA.DM.A28M.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.922873285623094}], ["OR11G2", ["TCGA.DM.A28M.01", "Signal amplification"], {"weight": 0.922347101716658}], ["OR11G2", ["TCGA.DM.A28M.01", "Presynaptic function of Kainate receptors"], {"weight": 0.915314918250976}], ["OR11G2", ["TCGA.DM.A28M.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.909508833163183}], ["OR11G2", ["TCGA.DM.A28M.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.898861423989369}], ["OR11G2", ["TCGA.DM.A28M.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.923371206726807}], ["OR11G2", ["TCGA.DM.A28M.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.898861423989369}], ["OR11G2", ["TCGA.DM.A28M.01", "G-protein activation"], {"weight": 0.927421155190238}], ["OR11G2", ["TCGA.DM.A28M.01", "Thromboxane signalling through TP receptor"], {"weight": 0.9001279001713}], ["OR11G2", ["TCGA.DM.A28M.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.88406712112786}], ["OR11G2", ["TCGA.DM.A28M.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.920357610691052}], ["MMP11", ["TCGA.AA.3489.01", "Degradation of the extracellular matrix"], {"weight": 0.782433751736682}], ["MMP11", ["TCGA.AA.3489.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.831108262426458}], ["MMP11", ["TCGA.AA.3489.01", "Aspirin ADME"], {"weight": 0.811518475687771}], ["MMP11", ["TCGA.F4.6703.01", "Collagen formation"], {"weight": 0.94337448631791}], ["MMP11", ["TCGA.F4.6703.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.933709258299447}], ["MMP11", ["TCGA.F4.6703.01", "Collagen degradation"], {"weight": 0.90509937430546}], ["CSNK2A1", ["TCGA.AA.3489.01", "Glucuronidation"], {"weight": 0.821383190962004}], ["ENTPD4", ["TCGA.AA.3489.01", "Phase II - Conjugation of compounds"], {"weight": 0.827814198328692}], ["ENTPD4", ["TCGA.AA.3489.01", "Metabolism"], {"weight": 0.885779039254314}], ["ENTPD4", ["TCGA.AD.6889.01", "Activation of the phototransduction cascade"], {"weight": 0.886652116305227}], ["ENTPD4", ["TCGA.AD.6895.01", "Metabolism"], {"weight": 0.925106057341597}], ["ENTPD4", ["TCGA.D5.6929.01", "Metabolism"], {"weight": 0.902805735355029}], ["NRAS", ["TCGA.AA.3492.01", "Neuronal System"], {"weight": 0.943164371221639}], ["LNPEP", ["TCGA.G4.6626.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.844035197904513}], ["SLC17A7", ["TCGA.G4.6320.01", "Neurexins and neuroligins"], {"weight": 0.92220738959653}], ["SLC17A7", ["TCGA.G4.6628.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.851586312162599}], ["AP5B1", ["TCGA.G4.6306.01", "Regulation of FZD by ubiquitination"], {"weight": 0.854347657534836}], ["SMPD1", ["TCGA.AA.3662.01", "TNFs bind their physiological receptors"], {"weight": 0.503702474349617}], ["PLA2G6", ["TCGA.AA.3492.01", "Phase II - Conjugation of compounds"], {"weight": 0.84769657834873}], ["PLA2G6", ["TCGA.AA.3492.01", "Drug ADME"], {"weight": 0.847764730828728}], ["PLA2G6", ["TCGA.AA.3492.01", "Aspirin ADME"], {"weight": 0.856116639930317}], ["PLA2G6", ["TCGA.AD.6895.01", "Biological oxidations"], {"weight": 0.925610729046294}], ["PLA2G6", ["TCGA.AD.6895.01", "Signaling by Retinoic Acid"], {"weight": 0.746704326167846}], ["PLA2G6", ["TCGA.AD.6895.01", "Aspirin ADME"], {"weight": 0.873430019530113}], ["PLA2G6", ["TCGA.CM.5861.01", "Drug ADME"], {"weight": 0.911618376396069}], ["PLA2G6", ["TCGA.CM.5861.01", "Signaling by Retinoic Acid"], {"weight": 0.876556437009725}], ["OR2T33", ["TCGA.AA.3662.01", "GABA receptor activation"], {"weight": 0.825289349843436}], ["OR2T33", ["TCGA.AA.3662.01", "Integration of energy metabolism"], {"weight": 0.884915258254649}], ["OR2T33", ["TCGA.AA.3662.01", "GPER1 signaling"], {"weight": 0.88987023486262}], ["OR2T33", ["TCGA.AA.3662.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.88987023486262}], ["OR2T33", ["TCGA.AA.3662.01", "Activation of GABAB receptors"], {"weight": 0.900296824311065}], ["OR2T33", ["TCGA.AA.3662.01", "Inwardly rectifying K+ channels"], {"weight": 0.841199651880359}], ["OR2T33", ["TCGA.AA.3662.01", "Extra-nuclear estrogen signaling"], {"weight": 0.850856218498518}], ["OR2T33", ["TCGA.AA.3662.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.878415234627197}], ["OR2T33", ["TCGA.AA.3662.01", "Opioid Signalling"], {"weight": 0.872679171166731}], ["OR2T33", ["TCGA.AA.3662.01", "G-protein activation"], {"weight": 0.887562044038712}], ["OR2T33", ["TCGA.DM.A1DB.01", "Neuronal System"], {"weight": 0.94762635318239}], ["OR2T33", ["TCGA.DM.A1DB.01", "Signaling by GPCR"], {"weight": 0.949287253977447}], ["OR2T33", ["TCGA.DM.A1DB.01", "GPCR downstream signalling"], {"weight": 0.948125593884666}], ["OR2T33", ["TCGA.DM.A1DB.01", "Transmission across Chemical Synapses"], {"weight": 0.940069230798327}], ["OR2T33", ["TCGA.DM.A1DB.01", "GPCR ligand binding"], {"weight": 0.954069644284129}], ["OR2T33", ["TCGA.DM.A1DB.01", "G alpha (q) signalling events"], {"weight": 0.925460104395138}], ["OR2T33", ["TCGA.DM.A1DB.01", "G alpha (i) signalling events"], {"weight": 0.94035487994197}], ["OR2T33", ["TCGA.DM.A1DB.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.932412602029022}], ["OR2T33", ["TCGA.DM.A1DB.01", "Potassium Channels"], {"weight": 0.957585878167764}], ["OR2T33", ["TCGA.DM.A1DB.01", "G alpha (s) signalling events"], {"weight": 0.959955795202912}], ["OR2T33", ["TCGA.DM.A1DB.01", "Regulation of insulin secretion"], {"weight": 0.933376138567139}], ["OR2T33", ["TCGA.DM.A1DB.01", "Protein-protein interactions at synapses"], {"weight": 0.925765694305627}], ["OR2T33", ["TCGA.DM.A1DB.01", "Interaction between L1 and Ankyrins"], {"weight": 0.927383000208114}], ["OR2T33", ["TCGA.DM.A1DB.01", "Activation of NMDA receptors and postsynaptic events"], {"weight": 0.919426459918209}], ["OR2T33", ["TCGA.DM.A1DB.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.931045307997193}], ["OR2T33", ["TCGA.DM.A1DB.01", "Glucagon-type ligand receptors"], {"weight": 0.935616592463769}], ["OR2T33", ["TCGA.DM.A1DB.01", "Neurexins and neuroligins"], {"weight": 0.930059976339511}], ["OR2T33", ["TCGA.DM.A1DB.01", "Integration of energy metabolism"], {"weight": 0.937061768633868}], ["OR2T33", ["TCGA.DM.A1DB.01", "Opioid Signalling"], {"weight": 0.938904889068134}], ["OR2T33", ["TCGA.DM.A1DB.01", "Ca-dependent events"], {"weight": 0.917906908661584}], ["OR2T33", ["TCGA.DM.A1DB.01", "Inwardly rectifying K+ channels"], {"weight": 0.92931915940249}], ["OR2T33", ["TCGA.DM.A1DB.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.946158267860234}], ["OR2T33", ["TCGA.DM.A1DB.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.922112902599685}], ["OR2T33", ["TCGA.DM.A1DB.01", "Calmodulin induced events"], {"weight": 0.91254056035735}], ["OR2T33", ["TCGA.DM.A1DB.01", "CaM pathway"], {"weight": 0.91254056035735}], ["OR2T33", ["TCGA.DM.A1DB.01", "Activation of G protein gated Potassium channels"], {"weight": 0.917275315428432}], ["OR2T33", ["TCGA.DM.A1DB.01", "G protein gated Potassium channels"], {"weight": 0.917275315428432}], ["OR2T33", ["TCGA.DM.A1DB.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.917275315428432}], ["OR2T33", ["TCGA.DM.A1DB.01", "GABA receptor activation"], {"weight": 0.902913207554061}], ["OR2T33", ["TCGA.DM.A1DB.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.883602347107933}], ["OR2T33", ["TCGA.DM.A1DB.01", "Leishmania parasite growth and survival"], {"weight": 0.883602347107933}], ["OR2T33", ["TCGA.DM.A1DB.01", "Post NMDA receptor activation events"], {"weight": 0.922788850256895}], ["OR2T33", ["TCGA.DM.A1DB.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.931404631491428}], ["OR2T33", ["TCGA.DM.A1DB.01", "GABA B receptor activation"], {"weight": 0.931119918539852}], ["OR2T33", ["TCGA.DM.A1DB.01", "Activation of GABAB receptors"], {"weight": 0.931119918539852}], ["OR2T33", ["TCGA.DM.A1DB.01", "G beta:gamma signalling through BTK"], {"weight": 0.895157183829026}], ["OR2T33", ["TCGA.DM.A1DB.01", "G-protein beta:gamma signalling"], {"weight": 0.913780142900206}], ["OR2T33", ["TCGA.DM.A1DB.01", "PLC beta mediated events"], {"weight": 0.920679096220389}], ["OR2T33", ["TCGA.DM.A1DB.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.902393287163996}], ["OR2T33", ["TCGA.DM.A1DB.01", "Regulation of signaling by NODAL"], {"weight": 0.80896319306628}], ["OR2T33", ["TCGA.DM.A1DB.01", "Signal amplification"], {"weight": 0.924935793062018}], ["OR2T33", ["TCGA.DM.A1DB.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.9232911932325}], ["OR2T33", ["TCGA.DM.A1DB.01", "G beta:gamma signalling through CDC42"], {"weight": 0.887857266088259}], ["OR2T33", ["TCGA.DM.A1DB.01", "G-protein activation"], {"weight": 0.936788454887237}], ["OR2T33", ["TCGA.DM.A1DB.01", "DAG and IP3 signaling"], {"weight": 0.91254056035735}], ["PLA2G2C", ["TCGA.G4.6586.01", "Biological oxidations"], {"weight": 0.933680804734527}], ["PLA2G2C", ["TCGA.G4.6586.01", "Drug ADME"], {"weight": 0.87387378372366}], ["PLA2G2C", ["TCGA.G4.6586.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.908588176617528}], ["PLA2G2C", ["TCGA.G4.6586.01", "Phase II - Conjugation of compounds"], {"weight": 0.856975139743185}], ["RASA3", ["TCGA.G4.6317.01", "RAC1 GTPase cycle"], {"weight": 0.813912277593917}], ["SCNN1A", ["TCGA.AZ.6598.01", "Interaction between L1 and Ankyrins"], {"weight": 0.952144864899592}], ["OR52K1", ["TCGA.G4.6626.01", "GPCR downstream signalling"], {"weight": 0.949943067050346}], ["OR52K1", ["TCGA.G4.6626.01", "Potassium Channels"], {"weight": 0.959862599879826}], ["OR52K1", ["TCGA.G4.6626.01", "G alpha (i) signalling events"], {"weight": 0.95238288874685}], ["OR52K1", ["TCGA.G4.6626.01", "GABA B receptor activation"], {"weight": 0.934150671069613}], ["OR52K1", ["TCGA.G4.6626.01", "GABA receptor activation"], {"weight": 0.907350576279689}], ["OR52K1", ["TCGA.G4.6626.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.930275679111209}], ["OR52K1", ["TCGA.G4.6626.01", "G alpha (q) signalling events"], {"weight": 0.933578176491983}], ["OR52K1", ["TCGA.G4.6626.01", "Glucagon-type ligand receptors"], {"weight": 0.933120625667087}], ["OR52K1", ["TCGA.G4.6626.01", "G alpha (z) signalling events"], {"weight": 0.907312641812682}], ["OR52K1", ["TCGA.G4.6626.01", "Platelet homeostasis"], {"weight": 0.893369401070751}], ["OR52K1", ["TCGA.G4.6626.01", "Inwardly rectifying K+ channels"], {"weight": 0.932288968114071}], ["OR52K1", ["TCGA.G4.6626.01", "G alpha (s) signalling events"], {"weight": 0.961336922972838}], ["OR52K1", ["TCGA.G4.6626.01", "Activation of G protein gated Potassium channels"], {"weight": 0.926629677446389}], ["OR52K1", ["TCGA.G4.6626.01", "G protein gated Potassium channels"], {"weight": 0.926629677446389}], ["OR52K1", ["TCGA.G4.6626.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.926629677446389}], ["OR52K1", ["TCGA.G4.6626.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.918201101325134}], ["OR52K1", ["TCGA.G4.6626.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.926388230649895}], ["OR52K1", ["TCGA.G4.6626.01", "G-protein beta:gamma signalling"], {"weight": 0.93045419498515}], ["OR52K1", ["TCGA.G4.6626.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.922712423516857}], ["OR52K1", ["TCGA.G4.6626.01", "G beta:gamma signalling through CDC42"], {"weight": 0.911942304317249}], ["OR52K1", ["TCGA.G4.6626.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.918286942027043}], ["OR52K1", ["TCGA.G4.6626.01", "Signal amplification"], {"weight": 0.926567934051875}], ["OR52K1", ["TCGA.G4.6626.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.897123061039396}], ["OR52K1", ["TCGA.G4.6626.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.930768931740633}], ["OR52K1", ["TCGA.G4.6626.01", "GPER1 signaling"], {"weight": 0.926944590312056}], ["OR52K1", ["TCGA.G4.6626.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.926944590312056}], ["OR52K1", ["TCGA.G4.6626.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.90512335325557}], ["OR52K1", ["TCGA.G4.6626.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.90512335325557}], ["OR52K1", ["TCGA.G4.6626.01", "G-protein activation"], {"weight": 0.911305071380404}], ["OR52K1", ["TCGA.G4.6626.01", "Thromboxane signalling through TP receptor"], {"weight": 0.911305071380404}], ["OR52K1", ["TCGA.G4.6626.01", "Presynaptic function of Kainate receptors"], {"weight": 0.90512335325557}], ["OR52K1", ["TCGA.G4.6626.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.922203352291792}], ["OR52K1", ["TCGA.G4.6626.01", "Ca2+ pathway"], {"weight": 0.868545657170146}], ["OR52K1", ["TCGA.G4.6626.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.870959692232739}], ["KIF3C", ["TCGA.AD.6895.01", "Interaction between L1 and Ankyrins"], {"weight": 0.920329487228794}], ["KIF3C", ["TCGA.DM.A28G.01", "Interaction between L1 and Ankyrins"], {"weight": 0.925239071429599}], ["KIF3C", ["TCGA.DM.A28G.01", "Peptide hormone metabolism"], {"weight": 0.718363843570322}], ["KIF3C", ["TCGA.DM.A28G.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.771973107617761}], ["POLR3A", ["TCGA.CK.5912.01", "Regulation of insulin secretion"], {"weight": 0.890189288443588}], ["POLR3A", ["TCGA.CK.5912.01", "Nucleotide catabolism"], {"weight": 0.821015442815159}], ["ALDH3B2", ["TCGA.AA.3492.01", "Biological oxidations"], {"weight": 0.921530956864957}], ["ALDH3B2", ["TCGA.AA.3502.01", "Neuronal System"], {"weight": 0.921229063917912}], ["ALDH3B2", ["TCGA.AA.3502.01", "Transmission across Chemical Synapses"], {"weight": 0.908860222371453}], ["ALDH3B2", ["TCGA.AA.3502.01", "Biological oxidations"], {"weight": 0.952097149643581}], ["ALDH3B2", ["TCGA.AA.3502.01", "Phase I - Functionalization of compounds"], {"weight": 0.945295382755753}], ["ALDH3B2", ["TCGA.AA.3502.01", "Ethanol oxidation"], {"weight": 0.886865126932771}], ["ALDH3B2", ["TCGA.CA.6718.01", "Neurotransmitter release cycle"], {"weight": 0.934671413205004}], ["ALDH3B2", ["TCGA.DM.A1D7.01", "Biological oxidations"], {"weight": 0.920783048656388}], ["ALDH3B2", ["TCGA.DM.A1D7.01", "Drug ADME"], {"weight": 0.79076668079576}], ["ALDH3B2", ["TCGA.DM.A1D7.01", "RA biosynthesis pathway"], {"weight": 0.897778489110363}], ["HSPG2", ["TCGA.AD.6889.01", "Extracellular matrix organization"], {"weight": 0.932650591343347}], ["HSPG2", ["TCGA.AD.6889.01", "Antimicrobial peptides"], {"weight": 0.73004277595321}], ["HSPG2", ["TCGA.AD.6889.01", "Degradation of the extracellular matrix"], {"weight": 0.898338453193205}], ["HSPG2", ["TCGA.AM.5820.01", "Extracellular matrix organization"], {"weight": 0.814977369529861}], ["HSPG2", ["TCGA.AY.6197.01", "Extracellular matrix organization"], {"weight": 0.847021134495575}], ["HSPG2", ["TCGA.AY.6197.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.825454591095498}], ["HSPG2", ["TCGA.AY.6197.01", "Retinoid metabolism and transport"], {"weight": 0.825454591095498}], ["HSPG2", ["TCGA.AY.6386.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.755134914428134}], ["HSPG2", ["TCGA.AY.6386.01", "Degradation of the extracellular matrix"], {"weight": 0.765327638960871}], ["HSPG2", ["TCGA.AY.6386.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.922791292140803}], ["HSPG2", ["TCGA.AY.6386.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.855446623791345}], ["HSPG2", ["TCGA.AZ.4615.01", "Visual phototransduction"], {"weight": 0.875673112276196}], ["HSPG2", ["TCGA.CK.4950.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.750667806588854}], ["HSPG2", ["TCGA.CK.4950.01", "Post-translational protein phosphorylation"], {"weight": 0.768863392001948}], ["HSPG2", ["TCGA.CK.4950.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.861501789855508}], ["HSPG2", ["TCGA.CK.4950.01", "Extracellular matrix organization"], {"weight": 0.770185866566633}], ["HSPG2", ["TCGA.CK.4950.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.669402480808003}], ["HSPG2", ["TCGA.CK.4950.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.671649774086647}], ["HSPG2", ["TCGA.CK.4950.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.671649774086647}], ["HSPG2", ["TCGA.CK.5916.01", "Metabolism"], {"weight": 0.923575371450752}], ["HSPG2", ["TCGA.D5.5540.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.940980363218755}], ["HSPG2", ["TCGA.D5.5540.01", "Scavenging of heme from plasma"], {"weight": 0.774041536325572}], ["HSPG2", ["TCGA.D5.6927.01", "Degradation of the extracellular matrix"], {"weight": 0.870308260850777}], ["HSPG2", ["TCGA.D5.6927.01", "Metabolism"], {"weight": 0.886953323678395}], ["HSPG2", ["TCGA.D5.6930.01", "Extracellular matrix organization"], {"weight": 0.875355846294788}], ["HSPG2", ["TCGA.D5.6930.01", "Metabolism"], {"weight": 0.886469624785899}], ["HSPG2", ["TCGA.D5.6930.01", "Visual phototransduction"], {"weight": 0.802388405301874}], ["HSPG2", ["TCGA.F4.6808.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.814039294919007}], ["HSPG2", ["TCGA.F4.6808.01", "Visual phototransduction"], {"weight": 0.927352947521417}], ["HSPG2", ["TCGA.G4.6311.01", "Extracellular matrix organization"], {"weight": 0.899215017035061}], ["HSPG2", ["TCGA.G4.6311.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.943636606987338}], ["HSPG2", ["TCGA.G4.6311.01", "Degradation of the extracellular matrix"], {"weight": 0.897144903258205}], ["HSPG2", ["TCGA.G4.6311.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.769529450236802}], ["HSPG2", ["TCGA.G4.6320.01", "Extracellular matrix organization"], {"weight": 0.887198278566019}], ["PRKD2", ["TCGA.CM.6674.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.902080212917488}], ["PRKD2", ["TCGA.CM.6674.01", "Trafficking of AMPA receptors"], {"weight": 0.914530511331025}], ["PRKD2", ["TCGA.CM.6674.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.914530511331025}], ["KIF6", ["TCGA.DM.A28F.01", "Insulin processing"], {"weight": 0.797221954151995}], ["CEP350", ["TCGA.CM.6677.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.852418688341973}], ["CEP350", ["TCGA.DM.A28C.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.769636880642664}], ["CEP350", ["TCGA.DM.A28C.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.849150920635972}], ["CEP350", ["TCGA.DM.A28C.01", "Scavenging by Class A Receptors"], {"weight": 0.53110758087959}], ["CEP350", ["TCGA.DM.A28C.01", "LGI-ADAM interactions"], {"weight": 0.867622121035644}], ["HDAC5", ["TCGA.AZ.6598.01", "Phase 0 - rapid depolarisation"], {"weight": 0.945923739987915}], ["HDAC5", ["TCGA.G4.6298.01", "Potassium Channels"], {"weight": 0.955092441336455}], ["HDAC5", ["TCGA.G4.6298.01", "GABA receptor activation"], {"weight": 0.910171973499266}], ["HDAC5", ["TCGA.G4.6298.01", "Inwardly rectifying K+ channels"], {"weight": 0.922951081568876}], ["HDAC5", ["TCGA.G4.6298.01", "GABA B receptor activation"], {"weight": 0.923077324318354}], ["HDAC5", ["TCGA.G4.6298.01", "Activation of GABAB receptors"], {"weight": 0.923077324318354}], ["HDAC5", ["TCGA.G4.6298.01", "Activation of G protein gated Potassium channels"], {"weight": 0.915501749320714}], ["HDAC5", ["TCGA.G4.6298.01", "G protein gated Potassium channels"], {"weight": 0.915501749320714}], ["HDAC5", ["TCGA.G4.6298.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.915501749320714}], ["PHKB", ["TCGA.G4.6310.01", "Leishmania infection"], {"weight": 0.884560204296938}], ["PHKB", ["TCGA.G4.6310.01", "Parasitic Infection Pathways"], {"weight": 0.884560204296938}], ["PHKB", ["TCGA.G4.6310.01", "G alpha (i) signalling events"], {"weight": 0.934074934556671}], ["PHKB", ["TCGA.G4.6310.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.8943108550703}], ["PHKB", ["TCGA.G4.6310.01", "Leishmania parasite growth and survival"], {"weight": 0.8943108550703}], ["PHKB", ["TCGA.G4.6310.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.882132122478764}], ["THADA", ["TCGA.D5.6529.01", "Collagen formation"], {"weight": 0.918676869123302}], ["THADA", ["TCGA.D5.6529.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.92317807469359}], ["THADA", ["TCGA.D5.6529.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.893468204344875}], ["THADA", ["TCGA.D5.6529.01", "Ethanol oxidation"], {"weight": 0.75036718835518}], ["AP2A1", ["TCGA.AA.3492.01", "Transmission across Chemical Synapses"], {"weight": 0.941418686587402}], ["AP2A1", ["TCGA.AA.3492.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.932541016539346}], ["OR5T3", ["TCGA.D5.7000.01", "Neuronal System"], {"weight": 0.93225235657318}], ["OR5T3", ["TCGA.D5.7000.01", "Transmission across Chemical Synapses"], {"weight": 0.921080270861359}], ["OR5T3", ["TCGA.D5.7000.01", "GPCR ligand binding"], {"weight": 0.930569890271227}], ["OR5T3", ["TCGA.D5.7000.01", "GABA receptor activation"], {"weight": 0.501626835617306}], ["OR5T3", ["TCGA.D5.7000.01", "G alpha (i) signalling events"], {"weight": 0.951639928735989}], ["OR5T3", ["TCGA.D5.7000.01", "Potassium Channels"], {"weight": 0.940338027163333}], ["OR5T3", ["TCGA.D5.7000.01", "G alpha (s) signalling events"], {"weight": 0.940927077295272}], ["INSR", ["TCGA.AZ.6599.01", "Stimuli-sensing channels"], {"weight": 0.85665974139345}], ["INSR", ["TCGA.AZ.6599.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.887673404774103}], ["INSR", ["TCGA.AZ.6599.01", "Phospholipase C-mediated cascade: FGFR1"], {"weight": 0.881798930127778}], ["INSR", ["TCGA.AZ.6599.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.805569141053025}], ["INSR", ["TCGA.DM.A1DB.01", "Signaling Pathways"], {"weight": 0.920540287647011}], ["INSR", ["TCGA.DM.A1DB.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.890377945346372}], ["INSR", ["TCGA.DM.A1DB.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.925745182384014}], ["INSR", ["TCGA.DM.A1DB.01", "Inhibition of replication initiation of damaged DNA by RB1/E2F1"], {"weight": 0.620812469729555}], ["INSR", ["TCGA.DM.A1DB.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.870019359787871}], ["INSR", ["TCGA.DM.A1DB.01", "Ion channel transport"], {"weight": 0.953640513110399}], ["INSR", ["TCGA.F4.6703.01", "Ion channel transport"], {"weight": 0.920709778555833}], ["POR", ["TCGA.AZ.6599.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.651409623321259}], ["OR5L2", ["TCGA.AA.3663.01", "GPCR ligand binding"], {"weight": 0.948987732729575}], ["OR5L2", ["TCGA.CK.4948.01", "G alpha (i) signalling events"], {"weight": 0.925023098018159}], ["OR5L2", ["TCGA.CK.4948.01", "G alpha (s) signalling events"], {"weight": 0.946931378236339}], ["OR5L2", ["TCGA.D5.6536.01", "GABA receptor activation"], {"weight": 0.925055297254629}], ["OR5L2", ["TCGA.D5.6536.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.902611541223564}], ["OR5L2", ["TCGA.D5.6536.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.927406485270247}], ["OR5L2", ["TCGA.D5.6536.01", "GABA B receptor activation"], {"weight": 0.938324147055132}], ["OR5L2", ["TCGA.D5.6536.01", "Activation of GABAB receptors"], {"weight": 0.938324147055132}], ["OR5L2", ["TCGA.D5.6536.01", "Signal amplification"], {"weight": 0.910909393099845}], ["OR5L2", ["TCGA.D5.6536.01", "Activation of G protein gated Potassium channels"], {"weight": 0.932918852044734}], ["OR5L2", ["TCGA.D5.6536.01", "G protein gated Potassium channels"], {"weight": 0.932918852044734}], ["OR5L2", ["TCGA.D5.6536.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.932918852044734}], ["OR5L2", ["TCGA.D5.6536.01", "Inwardly rectifying K+ channels"], {"weight": 0.934885365256899}], ["OR5L2", ["TCGA.D5.6536.01", "Peptide hormone biosynthesis"], {"weight": 0.819613518518911}], ["OR5L2", ["TCGA.D5.6536.01", "Glucagon-type ligand receptors"], {"weight": 0.921121224803813}], ["OR5L2", ["TCGA.D5.6536.01", "Thromboxane signalling through TP receptor"], {"weight": 0.89209980223273}], ["OR5L2", ["TCGA.D5.6536.01", "Regulation of insulin secretion"], {"weight": 0.859801577987614}], ["OR5L2", ["TCGA.D5.6536.01", "G beta:gamma signalling through CDC42"], {"weight": 0.911850317481917}], ["OR5L2", ["TCGA.D5.6536.01", "Platelet activation, signaling and aggregation"], {"weight": 0.897602235474076}], ["OR5L2", ["TCGA.D5.6536.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.895983190616419}], ["OR5L2", ["TCGA.D5.6536.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.909503810525923}], ["OR5L2", ["TCGA.D5.6536.01", "G alpha (z) signalling events"], {"weight": 0.918591693173322}], ["OR5L2", ["TCGA.D5.6536.01", "Integration of energy metabolism"], {"weight": 0.849385489206553}], ["OR5L2", ["TCGA.D5.6536.01", "G-protein beta:gamma signalling"], {"weight": 0.916850040127398}], ["OR5L2", ["TCGA.D5.6536.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.909305756029593}], ["OR5L2", ["TCGA.D5.6536.01", "Potassium Channels"], {"weight": 0.947490622634381}], ["OR5L2", ["TCGA.D5.6536.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.922698500463869}], ["OR5L2", ["TCGA.D5.6536.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.909503810525923}], ["OR5L2", ["TCGA.D5.6536.01", "GPER1 signaling"], {"weight": 0.909503810525923}], ["OR5L2", ["TCGA.D5.6536.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.909503810525923}], ["OR5L2", ["TCGA.DM.A0X9.01", "Transmission across Chemical Synapses"], {"weight": 0.915223769869674}], ["PRKG2", ["TCGA.AZ.4682.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.90223451654222}], ["PRKG2", ["TCGA.DM.A0XD.01", "Cardiac conduction"], {"weight": 0.923408495796795}], ["NTSR2", ["TCGA.AD.6965.01", "Neurexins and neuroligins"], {"weight": 0.878550578658078}], ["NTSR2", ["TCGA.AD.6965.01", "Chemokine receptors bind chemokines"], {"weight": 0.900681313110733}], ["NTSR2", ["TCGA.DM.A1D6.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.932047665167386}], ["NTSR2", ["TCGA.G4.6293.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.908056681844721}], ["KANK1", ["TCGA.AA.3492.01", "Cardiac conduction"], {"weight": 0.920939185535765}], ["KANK1", ["TCGA.CM.4743.01", "Cardiac conduction"], {"weight": 0.93965335461825}], ["SLC27A5", ["TCGA.D5.6930.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.875844996200954}], ["SLC27A5", ["TCGA.D5.6930.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.849993039755803}], ["ADAMTS2", ["TCGA.AA.3492.01", "Collagen chain trimerization"], {"weight": 0.915547026116293}], ["ADAMTS2", ["TCGA.AZ.6599.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.765437662968012}], ["ADAMTS2", ["TCGA.AZ.6599.01", "Collagen chain trimerization"], {"weight": 0.91386009409545}], ["ADAMTS2", ["TCGA.AZ.6599.01", "Scavenging by Class A Receptors"], {"weight": 0.600190998494286}], ["ADAMTS2", ["TCGA.D5.6540.01", "Collagen chain trimerization"], {"weight": 0.923548479425592}], ["ADAMTS2", ["TCGA.G4.6588.01", "Collagen chain trimerization"], {"weight": 0.92847237583277}], ["PLOD2", ["TCGA.AA.3492.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.945064928811596}], ["PLOD2", ["TCGA.AZ.4615.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.936792818034249}], ["CEP78", ["TCGA.DM.A1D9.01", "G alpha (s) signalling events"], {"weight": 0.956656415072022}], ["CEP78", ["TCGA.DM.A1D9.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.929369214211383}], ["CEP78", ["TCGA.DM.A1D9.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.914749054669605}], ["MMP2", ["TCGA.AD.5900.01", "Signaling by GPCR"], {"weight": 0.930608176779123}], ["MMP2", ["TCGA.AD.5900.01", "GPCR downstream signalling"], {"weight": 0.927197107168012}], ["MMP2", ["TCGA.G4.6588.01", "Extracellular matrix organization"], {"weight": 0.895712391289549}], ["MMP2", ["TCGA.G4.6588.01", "Degradation of the extracellular matrix"], {"weight": 0.858085592255099}], ["MMP2", ["TCGA.G4.6588.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.909202952382508}], ["LCP2", ["TCGA.CK.4948.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.815945178296491}], ["LCP2", ["TCGA.DM.A1DA.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.940541930866352}], ["LCP2", ["TCGA.DM.A1DA.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.770185831985743}], ["LCP2", ["TCGA.DM.A1DA.01", "PD-1 signaling"], {"weight": 0.94087729249212}], ["LCP2", ["TCGA.DM.A1DA.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.940541930866352}], ["LCP2", ["TCGA.DM.A1DA.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.929455219204689}], ["LCP2", ["TCGA.DM.A1DA.01", "Costimulation by the CD28 family"], {"weight": 0.924866988352567}], ["PIK3R4", ["TCGA.CK.5916.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.897816607845347}], ["TAS1R2", ["TCGA.AA.3492.01", "Glucagon-type ligand receptors"], {"weight": 0.917875905260851}], ["TAS1R2", ["TCGA.AA.3492.01", "Activation of G protein gated Potassium channels"], {"weight": 0.930400026735751}], ["TAS1R2", ["TCGA.AA.3492.01", "G protein gated Potassium channels"], {"weight": 0.930400026735751}], ["TAS1R2", ["TCGA.AA.3492.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.930400026735751}], ["TAS1R2", ["TCGA.AA.3492.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.86699247685355}], ["TAS1R2", ["TCGA.AA.3492.01", "Leishmania parasite growth and survival"], {"weight": 0.906045524399145}], ["TAS1R2", ["TCGA.AA.3492.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.918412958024685}], ["TAS1R2", ["TCGA.AA.3492.01", "Presynaptic function of Kainate receptors"], {"weight": 0.905122717862096}], ["TAS1R2", ["TCGA.AA.3492.01", "Inwardly rectifying K+ channels"], {"weight": 0.930400026735751}], ["TAS1R2", ["TCGA.AA.3712.01", "Signaling by GPCR"], {"weight": 0.927568813466248}], ["TAS1R2", ["TCGA.AA.3712.01", "GPCR downstream signalling"], {"weight": 0.930003633605628}], ["TAS1R2", ["TCGA.AA.3712.01", "G alpha (i) signalling events"], {"weight": 0.936461382040749}], ["TAS1R2", ["TCGA.AA.3712.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.908182822899924}], ["TAS1R2", ["TCGA.AA.3712.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.909643955611754}], ["TAS1R2", ["TCGA.AA.3712.01", "Glucagon-type ligand receptors"], {"weight": 0.911428936915391}], ["TAS1R2", ["TCGA.AA.3712.01", "Regulation of insulin secretion"], {"weight": 0.90144623304846}], ["TAS1R2", ["TCGA.AA.3712.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.903202238685835}], ["TAS1R2", ["TCGA.AA.3712.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.91509621471194}], ["TAS1R2", ["TCGA.AA.3712.01", "GPER1 signaling"], {"weight": 0.907485779752422}], ["TAS1R2", ["TCGA.AA.3712.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.907485779752422}], ["TAS1R2", ["TCGA.AA.3712.01", "GABA B receptor activation"], {"weight": 0.916053820495058}], ["TAS1R2", ["TCGA.AA.3712.01", "Activation of GABAB receptors"], {"weight": 0.916053820495058}], ["TAS1R2", ["TCGA.AA.3712.01", "G beta:gamma signalling through BTK"], {"weight": 0.90404882253057}], ["TAS1R2", ["TCGA.AA.3712.01", "Ca2+ pathway"], {"weight": 0.874030048850312}], ["TAS1R2", ["TCGA.AA.3712.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.904953729979033}], ["TAS1R2", ["TCGA.AA.3712.01", "G alpha (z) signalling events"], {"weight": 0.909256243146384}], ["TAS1R2", ["TCGA.D5.6540.01", "Transmission across Chemical Synapses"], {"weight": 0.934142469379427}], ["TAS1R2", ["TCGA.D5.6540.01", "G alpha (i) signalling events"], {"weight": 0.938462620202656}], ["TAS1R2", ["TCGA.D5.6540.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.942434706894473}], ["TAS1R2", ["TCGA.D5.6540.01", "G alpha (s) signalling events"], {"weight": 0.957597278784962}], ["TAS1R2", ["TCGA.D5.6540.01", "Glucagon-type ligand receptors"], {"weight": 0.929227470073317}], ["TAS1R2", ["TCGA.D5.6540.01", "GABA receptor activation"], {"weight": 0.916808146177909}], ["TAS1R2", ["TCGA.D5.6540.01", "G beta:gamma signalling through BTK"], {"weight": 0.917854620824282}], ["TAS1R2", ["TCGA.D5.6540.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.924589515307477}], ["TAS1R2", ["TCGA.D5.6540.01", "G alpha (q) signalling events"], {"weight": 0.932204276149052}], ["TAS1R2", ["TCGA.D5.6540.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.903732107842139}], ["TAS1R2", ["TCGA.D5.6540.01", "G-protein beta:gamma signalling"], {"weight": 0.926758378197272}], ["TAS1R2", ["TCGA.D5.6540.01", "G beta:gamma signalling through CDC42"], {"weight": 0.913489510742771}], ["TAS1R2", ["TCGA.D5.6927.01", "GPCR ligand binding"], {"weight": 0.916301159208989}], ["TAS1R2", ["TCGA.D5.6930.01", "G alpha (z) signalling events"], {"weight": 0.885617845256008}], ["TAS1R2", ["TCGA.D5.6930.01", "G alpha (s) signalling events"], {"weight": 0.937025663262087}], ["TAS1R2", ["TCGA.D5.6930.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.872963089976175}], ["TAS1R2", ["TCGA.D5.6930.01", "GABA B receptor activation"], {"weight": 0.887512717220988}], ["TAS1R2", ["TCGA.D5.6930.01", "Activation of GABAB receptors"], {"weight": 0.887512717220988}], ["NCAM2", ["TCGA.AZ.4615.01", "NCAM1 interactions"], {"weight": 0.940242023606708}], ["NCAM2", ["TCGA.AZ.4615.01", "NCAM signaling for neurite out-growth"], {"weight": 0.9429177568012}], ["NCAM2", ["TCGA.CK.5916.01", "ECM proteoglycans"], {"weight": 0.888397966598494}], ["NCAM2", ["TCGA.CM.5341.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.820808566572181}], ["KCNH4", ["TCGA.AU.6004.01", "Potassium Channels"], {"weight": 0.946705077792805}], ["KCNH4", ["TCGA.CK.5915.01", "Neuronal System"], {"weight": 0.930492614883555}], ["KCNH4", ["TCGA.CK.5915.01", "Potassium Channels"], {"weight": 0.965926952651697}], ["KCNH4", ["TCGA.CK.5915.01", "Voltage gated Potassium channels"], {"weight": 0.870669250938248}], ["KCNH6", ["TCGA.AA.3492.01", "Voltage gated Potassium channels"], {"weight": 0.906889786015263}], ["FOXO1", ["TCGA.AZ.6598.01", "Transmission across Chemical Synapses"], {"weight": 0.946761036434393}], ["FOXO1", ["TCGA.AZ.6598.01", "Integration of energy metabolism"], {"weight": 0.931702683679696}], ["FOXO1", ["TCGA.F4.6570.01", "Transmission across Chemical Synapses"], {"weight": 0.894023896505856}], ["FOXO4", ["TCGA.D5.6534.01", "Peptide hormone biosynthesis"], {"weight": 0.691629022318261}], ["FOXO4", ["TCGA.F4.6806.01", "Classical antibody-mediated complement activation"], {"weight": 0.808918834289052}], ["FOXO4", ["TCGA.F4.6806.01", "Complement cascade"], {"weight": 0.779680121858545}], ["FOXO4", ["TCGA.F4.6806.01", "Creation of C4 and C2 activators"], {"weight": 0.808918834289052}], ["FOXO4", ["TCGA.F4.6806.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.736378738788646}], ["CASK", ["TCGA.AZ.4616.01", "Regulation of insulin secretion"], {"weight": 0.902275729605289}], ["CASK", ["TCGA.CM.6171.01", "Sensory processing of sound"], {"weight": 0.914219554578397}], ["CASK", ["TCGA.CM.6171.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.911118528792255}], ["CASK", ["TCGA.CM.6171.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.753056451330308}], ["CASK", ["TCGA.CM.6171.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.929980349112124}], ["TXK", ["TCGA.CM.4743.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.915606378465566}], ["TXK", ["TCGA.DM.A1D9.01", "Generation of second messenger molecules"], {"weight": 0.939413331450209}], ["TXK", ["TCGA.DM.A1D9.01", "G alpha (q) signalling events"], {"weight": 0.941491572786462}], ["TXK", ["TCGA.DM.A1D9.01", "G beta:gamma signalling through BTK"], {"weight": 0.926625488346347}], ["TXK", ["TCGA.DM.A1D9.01", "G-protein beta:gamma signalling"], {"weight": 0.939901326059078}], ["TXK", ["TCGA.DM.A1D9.01", "Costimulation by the CD28 family"], {"weight": 0.888435982317478}], ["TXK", ["TCGA.DM.A1D9.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.928641348819715}], ["TXK", ["TCGA.DM.A1D9.01", "Ethanol oxidation"], {"weight": 0.746975929871044}], ["KLHL21", ["TCGA.AZ.6607.01", "Degradation of cysteine and homocysteine"], {"weight": 0.754294755684863}], ["ICAM5", ["TCGA.G4.6315.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.762469921139538}], ["ICAM5", ["TCGA.G4.6315.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.717452868380549}], ["KAT2A", ["TCGA.AA.3660.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.480864802419487}], ["KAT2A", ["TCGA.AA.3660.01", "Drug ADME"], {"weight": 0.893174579038963}], ["KAT2A", ["TCGA.AA.3660.01", "Glucuronidation"], {"weight": 0.804438421132606}], ["KAT2A", ["TCGA.AA.3660.01", "Phase II - Conjugation of compounds"], {"weight": 0.695375232992513}], ["KAT2A", ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.616723528680284}], ["KAT2A", ["TCGA.AA.3660.01", "Signaling by Retinoic Acid"], {"weight": 0.73053175325688}], ["KAT2A", ["TCGA.F4.6704.01", "Blood group systems biosynthesis"], {"weight": 0.685445691076826}], ["ADAMTS15", ["TCGA.F4.6570.01", "Defective B3GALTL causes PpS"], {"weight": 0.88607482632873}], ["ADAMTS15", ["TCGA.F4.6570.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.886004734685636}], ["ALDH1A2", ["TCGA.AY.6197.01", "Visual phototransduction"], {"weight": 0.775609949198718}], ["ALDH1A2", ["TCGA.AY.6386.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.82519515277932}], ["ALDH1A2", ["TCGA.AY.6386.01", "Biological oxidations"], {"weight": 0.895776848697759}], ["ALDH1A2", ["TCGA.AY.6386.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.832012120420704}], ["ALDH1A2", ["TCGA.AY.6386.01", "Phase I - Functionalization of compounds"], {"weight": 0.912249362155942}], ["ALDH1A2", ["TCGA.AY.6386.01", "Arachidonic acid metabolism"], {"weight": 0.863391362884552}], ["ST8SIA2", ["TCGA.AA.3492.01", "NCAM1 interactions"], {"weight": 0.935582785642324}], ["ST8SIA2", ["TCGA.AA.3492.01", "NCAM signaling for neurite out-growth"], {"weight": 0.939443198780562}], ["ST8SIA2", ["TCGA.CM.5861.01", "NCAM1 interactions"], {"weight": 0.946394810819572}], ["ST8SIA2", ["TCGA.CM.5861.01", "ECM proteoglycans"], {"weight": 0.934278497176811}], ["ST8SIA2", ["TCGA.CM.5861.01", "NCAM signaling for neurite out-growth"], {"weight": 0.94710362287509}], ["RXFP2", ["TCGA.CK.5915.01", "GABA B receptor activation"], {"weight": 0.93461799301511}], ["RXFP2", ["TCGA.CK.5915.01", "Activation of GABAB receptors"], {"weight": 0.93461799301511}], ["RXFP2", ["TCGA.CK.5915.01", "Activation of G protein gated Potassium channels"], {"weight": 0.930928901221012}], ["RXFP2", ["TCGA.CK.5915.01", "G protein gated Potassium channels"], {"weight": 0.930928901221012}], ["RXFP2", ["TCGA.CK.5915.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.926592486118438}], ["RXFP2", ["TCGA.CK.5915.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.930928901221012}], ["RXFP2", ["TCGA.CK.5915.01", "Inwardly rectifying K+ channels"], {"weight": 0.933663401250113}], ["RXFP2", ["TCGA.CK.5915.01", "Peptide hormone metabolism"], {"weight": 0.881401881989347}], ["RXFP2", ["TCGA.CK.5915.01", "G beta:gamma signalling through BTK"], {"weight": 0.911791769909819}], ["RXFP2", ["TCGA.CK.5915.01", "G alpha (z) signalling events"], {"weight": 0.876332840914896}], ["RXFP2", ["TCGA.CK.5915.01", "G beta:gamma signalling through CDC42"], {"weight": 0.90534997286418}], ["RXFP2", ["TCGA.CK.5915.01", "G-protein activation"], {"weight": 0.912596800939268}], ["RXFP2", ["TCGA.CK.5915.01", "Phase 4 - resting membrane potential"], {"weight": 0.889531747488754}], ["RXFP2", ["TCGA.CK.5915.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.907333307236326}], ["RXFP2", ["TCGA.CK.5915.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.882480857456546}], ["RXFP2", ["TCGA.CK.5915.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.899008184802518}], ["RXFP2", ["TCGA.CK.5915.01", "Thromboxane signalling through TP receptor"], {"weight": 0.903703521734159}], ["RXFP2", ["TCGA.CK.5915.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.899008184802518}], ["RXFP2", ["TCGA.CK.5915.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.91812081878839}], ["RXFP2", ["TCGA.CK.5915.01", "Presynaptic function of Kainate receptors"], {"weight": 0.899008184802518}], ["RXRA", ["TCGA.AA.3492.01", "Signaling Pathways"], {"weight": 0.900676090786976}], ["RXRA", ["TCGA.D5.6928.01", "Bile acid and bile salt metabolism"], {"weight": 0.735493508447678}], ["PLXNA1", ["TCGA.DM.A28F.01", "L1CAM interactions"], {"weight": 0.905063604004925}], ["OR4P4", ["TCGA.D5.6536.01", "G beta:gamma signalling through BTK"], {"weight": 0.912946869802713}], ["OR4P4", ["TCGA.D5.6536.01", "Presynaptic function of Kainate receptors"], {"weight": 0.894830162803482}], ["OR4P4", ["TCGA.D5.6536.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.89940845889004}], ["OR4P4", ["TCGA.D5.6536.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.914090783471487}], ["OR4P4", ["TCGA.D5.6536.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.881394757728731}], ["OR4P4", ["TCGA.D5.6536.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.881394757728731}], ["OR4P4", ["TCGA.D5.6536.01", "Aquaporin-mediated transport"], {"weight": 0.909503810525923}], ["OR4P4", ["TCGA.D5.6536.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.881394757728731}], ["BDNF", ["TCGA.AZ.5407.01", "Complement cascade"], {"weight": 0.816816115755932}], ["PTGS2", ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.784198421517045}], ["CHD7", ["TCGA.DM.A0XF.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.880290584590279}], ["CHD7", ["TCGA.DM.A0XF.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.880290584590279}], ["CHD7", ["TCGA.DM.A0XF.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.80899398021147}], ["CHD7", ["TCGA.DM.A1DB.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.614211301059656}], ["CHD7", ["TCGA.DM.A1DB.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.843158556972259}], ["CHD7", ["TCGA.DM.A1DB.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.843158556972259}], ["CHD7", ["TCGA.DM.A1DB.01", "Diseases of Immune System"], {"weight": 0.830956719299673}], ["CHD7", ["TCGA.DM.A1DB.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.830956719299673}], ["HLA-DRB1", ["TCGA.G4.6309.01", "Extracellular matrix organization"], {"weight": 0.829269317863317}], ["MUC20", ["TCGA.DM.A1D7.01", "Complement cascade"], {"weight": 0.740573787899727}], ["HIPK2", ["TCGA.AA.3492.01", "Muscle contraction"], {"weight": 0.930840994550367}], ["HIPK2", ["TCGA.CM.5861.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.925083060560286}], ["SHB", ["TCGA.CM.5860.01", "Phase I - Functionalization of compounds"], {"weight": 0.922283260868487}], ["SHB", ["TCGA.CM.5860.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.870419326736655}], ["BRCA1", ["TCGA.CA.5797.01", "Signaling by ERBB4"], {"weight": 0.873654202032104}], ["BRCA1", ["TCGA.CA.5797.01", "Signaling Pathways"], {"weight": 0.875784464545695}], ["BRCA1", ["TCGA.CA.5797.01", "Nuclear signaling by ERBB4"], {"weight": 0.783542709431868}], ["SPP1", ["TCGA.G4.6302.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.890486417585938}], ["TJP1", ["TCGA.D5.6538.01", "Neuronal System"], {"weight": 0.933729557621089}], ["TJP1", ["TCGA.D5.6538.01", "Neurexins and neuroligins"], {"weight": 0.923363370485928}], ["ECHDC1", ["TCGA.G4.6628.01", "Ethanol oxidation"], {"weight": 0.90655888178214}], ["GPLD1", ["TCGA.CM.6679.01", "Voltage gated Potassium channels"], {"weight": 0.696637091465023}], ["GPLD1", ["TCGA.D5.6540.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.957126858529595}], ["WNK2", ["TCGA.CM.5861.01", "Stimuli-sensing channels"], {"weight": 0.9304513683189}], ["WNK2", ["TCGA.G4.6309.01", "Stimuli-sensing channels"], {"weight": 0.895937211744398}], ["ATP1B4", ["TCGA.AD.6963.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.911638755693997}], ["ATP1B4", ["TCGA.AD.6963.01", "G alpha (i) signalling events"], {"weight": 0.94169929503975}], ["ATP1B4", ["TCGA.AD.6963.01", "GPCR downstream signalling"], {"weight": 0.939612732403262}], ["ATP1B4", ["TCGA.AD.6963.01", "Signaling by GPCR"], {"weight": 0.935845506888604}], ["ATP1B4", ["TCGA.AD.6963.01", "G alpha (s) signalling events"], {"weight": 0.954334707443318}], ["ATP1B4", ["TCGA.AD.6963.01", "Signaling Pathways"], {"weight": 0.890393807887421}], ["ATP1B4", ["TCGA.AD.6963.01", "Heme degradation"], {"weight": 0.68689994940628}], ["ATP1B4", ["TCGA.D5.7000.01", "Cardiac conduction"], {"weight": 0.894551160685974}], ["ATP1B4", ["TCGA.D5.7000.01", "Phase 2 - plateau phase"], {"weight": 0.576781260253317}], ["ATP1B4", ["TCGA.D5.7000.01", "Muscle contraction"], {"weight": 0.879549915636673}], ["ATP1B4", ["TCGA.DM.A28M.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.931361325961965}], ["ATP1B4", ["TCGA.DM.A28M.01", "Aquaporin-mediated transport"], {"weight": 0.931361325961965}], ["ATP1B4", ["TCGA.DM.A28M.01", "Ca-dependent events"], {"weight": 0.919315849579481}], ["ATP1B4", ["TCGA.DM.A28M.01", "Ion homeostasis"], {"weight": 0.944153035417246}], ["ATP1B4", ["TCGA.DM.A28M.01", "Calmodulin induced events"], {"weight": 0.911362269237433}], ["ATP1B4", ["TCGA.DM.A28M.01", "CaM pathway"], {"weight": 0.911362269237433}], ["ATP1B4", ["TCGA.DM.A28M.01", "DAG and IP3 signaling"], {"weight": 0.912275354266601}], ["ATP1B4", ["TCGA.DM.A28M.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.791582101016002}], ["ATP1B4", ["TCGA.DM.A28M.01", "Adaptive Immune System"], {"weight": 0.913037008028274}], ["PLD2", ["TCGA.AA.3492.01", "G alpha (i) signalling events"], {"weight": 0.945672095701579}], ["GABRA1", ["TCGA.AA.3492.01", "GABA receptor activation"], {"weight": 0.916247008561784}], ["DOCK2", ["TCGA.F4.6808.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.911057611246512}], ["DOCK2", ["TCGA.F4.6808.01", "Leishmania parasite growth and survival"], {"weight": 0.911057611246512}], ["DOCK2", ["TCGA.F4.6808.01", "Leishmania infection"], {"weight": 0.889964196664411}], ["DOCK2", ["TCGA.F4.6808.01", "Parasitic Infection Pathways"], {"weight": 0.889964196664411}], ["DOCK2", ["TCGA.F4.6808.01", "FCGR activation"], {"weight": 0.872235980839982}], ["DOCK2", ["TCGA.F4.6808.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.887027919857865}], ["DOCK2", ["TCGA.F4.6808.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.861784710488199}], ["APEX1", ["TCGA.AM.5821.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.933440656012948}], ["TNC", ["TCGA.CM.6162.01", "ECM proteoglycans"], {"weight": 0.8193096737112}], ["TNC", ["TCGA.F4.6459.01", "Extracellular matrix organization"], {"weight": 0.846704230657254}], ["TNC", ["TCGA.F4.6459.01", "TNFs bind their physiological receptors"], {"weight": 0.188824456931489}], ["TNC", ["TCGA.F4.6459.01", "Blood group systems biosynthesis"], {"weight": 0.657465845752731}], ["TNC", ["TCGA.F4.6703.01", "ECM proteoglycans"], {"weight": 0.873917257811291}], ["KCNJ3", ["TCGA.F4.6806.01", "Transmission across Chemical Synapses"], {"weight": 0.853193670735457}], ["KCNJ8", ["TCGA.CM.5861.01", "Neuronal System"], {"weight": 0.944802812293561}], ["KCNJ8", ["TCGA.D5.6533.01", "Potassium Channels"], {"weight": 0.884440144612958}], ["EP400", ["TCGA.AD.6888.01", "G alpha (z) signalling events"], {"weight": 0.888841452716272}], ["NRAS", ["TCGA.AA.3662.01", "Protein-protein interactions at synapses"], {"weight": 0.808854393297846}], ["NRAS", ["TCGA.CM.5864.01", "Signaling Pathways"], {"weight": 0.88355773608115}], ["NRAS", ["TCGA.CM.5864.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.726221955812316}], ["NRAS", ["TCGA.CM.5864.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.65960423359824}], ["NRAS", ["TCGA.CM.6171.01", "Neuronal System"], {"weight": 0.937410754909442}], ["NRAS", ["TCGA.CM.6171.01", "Transmission across Chemical Synapses"], {"weight": 0.927405479279493}], ["NRAS", ["TCGA.CM.6171.01", "Signaling Pathways"], {"weight": 0.899534001780537}], ["NRAS", ["TCGA.CM.6680.01", "Interaction between L1 and Ankyrins"], {"weight": 0.863481926009685}], ["NRAS", ["TCGA.DM.A1D9.01", "Neuronal System"], {"weight": 0.941450448653605}], ["NRAS", ["TCGA.DM.A1D9.01", "Immune System"], {"weight": 0.871630009834498}], ["NRAS", ["TCGA.DM.A1D9.01", "Transmission across Chemical Synapses"], {"weight": 0.934013065311399}], ["NRAS", ["TCGA.DM.A1D9.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.936054774711534}], ["NRAS", ["TCGA.DM.A1D9.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.895763989660281}], ["NRAS", ["TCGA.DM.A1D9.01", "Interaction between L1 and Ankyrins"], {"weight": 0.93570179237335}], ["NRAS", ["TCGA.DM.A1D9.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.895322717158066}], ["NRAS", ["TCGA.DM.A1DA.01", "Neuronal System"], {"weight": 0.95352255919128}], ["NRAS", ["TCGA.DM.A1DA.01", "GPCR downstream signalling"], {"weight": 0.962804969413516}], ["NRAS", ["TCGA.DM.A1DA.01", "Signaling by GPCR"], {"weight": 0.958751215564566}], ["NRAS", ["TCGA.DM.A1DA.01", "Transmission across Chemical Synapses"], {"weight": 0.951485376087133}], ["NRAS", ["TCGA.DM.A1DA.01", "Signaling Pathways"], {"weight": 0.94014275212792}], ["NRAS", ["TCGA.DM.A1DA.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.953029061280118}], ["NRAS", ["TCGA.DM.A1DA.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.832411032835893}], ["NRAS", ["TCGA.DM.A1DA.01", "SHC-mediated cascade:FGFR1"], {"weight": 0.937384871666618}], ["NRAS", ["TCGA.DM.A1DA.01", "Downstream signaling of activated FGFR1"], {"weight": 0.944157714687023}], ["NRAS", ["TCGA.DM.A1DA.01", "FRS-mediated FGFR1 signaling"], {"weight": 0.93737142849153}], ["NRAS", ["TCGA.DM.A1DA.01", "SHC-mediated cascade:FGFR2"], {"weight": 0.936864766974038}], ["NRAS", ["TCGA.DM.A1DA.01", "Activation of NMDA receptors and postsynaptic events"], {"weight": 0.939402067457131}], ["NRAS", ["TCGA.DM.A1DA.01", "FRS-mediated FGFR2 signaling"], {"weight": 0.936851315645869}], ["NRAS", ["TCGA.DM.A1DA.01", "L1CAM interactions"], {"weight": 0.936565548633044}], ["NRAS", ["TCGA.G4.6298.01", "Immune System"], {"weight": 0.895629447132032}], ["NRAS", ["TCGA.G4.6298.01", "Neuronal System"], {"weight": 0.945672300950924}], ["NRAS", ["TCGA.G4.6298.01", "Transmission across Chemical Synapses"], {"weight": 0.935027727420953}], ["NRAS", ["TCGA.G4.6298.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.924955060182986}], ["NRAS", ["TCGA.G4.6298.01", "Interaction between L1 and Ankyrins"], {"weight": 0.937272689942032}], ["NRAS", ["TCGA.G4.6298.01", "Signaling Pathways"], {"weight": 0.91787513902535}], ["NRAS", ["TCGA.G4.6298.01", "Innate Immune System"], {"weight": 0.889406376595919}], ["NRAS", ["TCGA.G4.6298.01", "Interferon gamma signaling"], {"weight": 0.926891871507325}], ["NRAS", ["TCGA.G4.6315.01", "Extracellular matrix organization"], {"weight": 0.88212194378466}], ["NRAS", ["TCGA.G4.6315.01", "Innate Immune System"], {"weight": 0.885727241698556}], ["NRAS", ["TCGA.G4.6315.01", "Protein-protein interactions at synapses"], {"weight": 0.850504567720849}], ["EHD4", ["TCGA.CA.6719.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.854527490313917}], ["EHD4", ["TCGA.CA.6719.01", "Collagen formation"], {"weight": 0.893322215305855}], ["EHD4", ["TCGA.D5.6537.01", "Signaling by GPCR"], {"weight": 0.945094900000219}], ["EHD4", ["TCGA.D5.6537.01", "Platelet activation, signaling and aggregation"], {"weight": 0.896222169708876}], ["EHD4", ["TCGA.F4.6703.01", "Acyl chain remodelling of PS"], {"weight": 0.842746708049322}], ["EHD4", ["TCGA.F4.6703.01", "Acyl chain remodelling of PE"], {"weight": 0.753940083084675}], ["GLUD2", ["TCGA.DM.A0X9.01", "Drug ADME"], {"weight": 0.865692825663296}], ["GLUD2", ["TCGA.G4.6303.01", "Phase II - Conjugation of compounds"], {"weight": 0.823396020288114}], ["GLUD2", ["TCGA.G4.6303.01", "Drug ADME"], {"weight": 0.866546561590086}], ["GLUD2", ["TCGA.G4.6303.01", "APAP ADME"], {"weight": 0.718992777566046}], ["GLUD2", ["TCGA.G4.6303.01", "Glutathione conjugation"], {"weight": 0.87685961455148}], ["XDH", ["TCGA.DM.A1DA.01", "Metabolism of vitamins and cofactors"], {"weight": 0.837979585717747}], ["PPARA", ["TCGA.AA.3492.01", "Regulation of insulin secretion"], {"weight": 0.932442196892249}], ["PPARA", ["TCGA.AA.3492.01", "Integration of energy metabolism"], {"weight": 0.939638935912196}], ["PPARA", ["TCGA.AA.3492.01", "Chemokine receptors bind chemokines"], {"weight": 0.920194440996549}], ["LRRTM4", ["TCGA.F4.6856.01", "Protein-protein interactions at synapses"], {"weight": 0.908901392674575}], ["LRRTM4", ["TCGA.F4.6856.01", "Neurexins and neuroligins"], {"weight": 0.897093499131006}], ["CTRC", ["TCGA.CM.6680.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.826703506181726}], ["CTRC", ["TCGA.CM.6680.01", "Degradation of the extracellular matrix"], {"weight": 0.779642756193863}], ["JAG2", ["TCGA.D5.6531.01", "Termination of O-glycan biosynthesis"], {"weight": 0.889029038114075}], ["JAG2", ["TCGA.DM.A282.01", "Blood group systems biosynthesis"], {"weight": 0.554629741770132}], ["GRM1", ["TCGA.CM.6165.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.805792714771484}], ["GRM1", ["TCGA.D5.6529.01", "Neuronal System"], {"weight": 0.889888263056098}], ["GRM1", ["TCGA.D5.6529.01", "Cardiac conduction"], {"weight": 0.79722221512727}], ["SPOCK3", ["TCGA.CM.5864.01", "GPCR downstream signalling"], {"weight": 0.928076857881502}], ["RAP1GDS1", ["TCGA.AA.3655.01", "Signaling Pathways"], {"weight": 0.878171898123769}], ["RAP1GDS1", ["TCGA.AA.3655.01", "Degradation of the extracellular matrix"], {"weight": 0.800535434506711}], ["LILRA6", ["TCGA.AY.6386.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.925994424690224}], ["IL4I1", ["TCGA.AD.6895.01", "Transmission across Chemical Synapses"], {"weight": 0.929695281645086}], ["CRYZ", ["TCGA.G4.6310.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.689464287122516}], ["CES1", ["TCGA.AD.5900.01", "Phase II - Conjugation of compounds"], {"weight": 0.88515958875963}], ["CES1", ["TCGA.AD.5900.01", "Glucuronidation"], {"weight": 0.882283864202488}], ["CES1", ["TCGA.AD.5900.01", "Aspirin ADME"], {"weight": 0.924250067490304}], ["CES1", ["TCGA.G4.6628.01", "Glucuronidation"], {"weight": 0.879190166146396}], ["CES1", ["TCGA.G4.6628.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.82296207559032}], ["RLBP1", ["TCGA.CK.5916.01", "RA biosynthesis pathway"], {"weight": 0.867480622164259}], ["POMC", ["TCGA.AY.6196.01", "GPCR ligand binding"], {"weight": 0.891288192038048}], ["PTPRF", ["TCGA.AA.3492.01", "Synaptic adhesion-like molecules"], {"weight": 0.837158549175299}], ["PTPRF", ["TCGA.AZ.4615.01", "Synaptic adhesion-like molecules"], {"weight": 0.797062495424149}], ["PTPRF", ["TCGA.G4.6588.01", "Synaptic adhesion-like molecules"], {"weight": 0.837116547259487}], ["FGFRL1", ["TCGA.AA.3662.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.856504747044685}], ["FGFRL1", ["TCGA.AA.3662.01", "FGFR4 ligand binding and activation"], {"weight": 0.889961613112422}], ["FGFRL1", ["TCGA.AA.3662.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.889961613112422}], ["GUSB", ["TCGA.AA.3492.01", "Glucuronidation"], {"weight": 0.893411455263122}], ["CYP2F1", ["TCGA.AD.6901.01", "Biological oxidations"], {"weight": 0.931893390591051}], ["OR7C1", ["TCGA.AZ.6603.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.883522604851604}], ["OR7C1", ["TCGA.AZ.6603.01", "GPCR ligand binding"], {"weight": 0.925353309734825}], ["OR7C1", ["TCGA.AZ.6603.01", "Signal amplification"], {"weight": 0.883522604851604}], ["OR7C1", ["TCGA.AZ.6603.01", "Signaling by GPCR"], {"weight": 0.940601248943409}], ["OR7C1", ["TCGA.AZ.6603.01", "G alpha (s) signalling events"], {"weight": 0.869868275589372}], ["OR7C1", ["TCGA.AZ.6603.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.859534736534287}], ["OR7C1", ["TCGA.AZ.6603.01", "GPCR downstream signalling"], {"weight": 0.938598637124189}], ["OR6C4", ["TCGA.DM.A28K.01", "GPCR downstream signalling"], {"weight": 0.953540845374766}], ["OR6C4", ["TCGA.DM.A28K.01", "Neuronal System"], {"weight": 0.932344742251362}], ["OR6C4", ["TCGA.DM.A28K.01", "G alpha (i) signalling events"], {"weight": 0.942560701973349}], ["OR6C4", ["TCGA.DM.A28K.01", "Biological oxidations"], {"weight": 0.942759034591366}], ["OR6C4", ["TCGA.DM.A28K.01", "G alpha (s) signalling events"], {"weight": 0.959429269812067}], ["OR6C4", ["TCGA.DM.A28K.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.920766454033576}], ["OR6C4", ["TCGA.DM.A28K.01", "Activation of SMO"], {"weight": 0.773548266975183}], ["OR6C4", ["TCGA.DM.A28K.01", "G alpha (z) signalling events"], {"weight": 0.912477790676141}], ["OR6C4", ["TCGA.DM.A28K.01", "Glucagon-type ligand receptors"], {"weight": 0.928205040366806}], ["OR6C4", ["TCGA.DM.A28K.01", "G-protein beta:gamma signalling"], {"weight": 0.922640514484928}], ["LRP10", ["TCGA.CM.6676.01", "Visual phototransduction"], {"weight": 0.837436926646661}], ["LRP10", ["TCGA.CM.6676.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.874848834351336}], ["LRP10", ["TCGA.CM.6676.01", "Retinoid metabolism and transport"], {"weight": 0.874848834351336}], ["AGT", ["TCGA.AA.3492.01", "Peptide hormone metabolism"], {"weight": 0.851562470943622}], ["AGT", ["TCGA.CA.6718.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.830130294867509}], ["AGT", ["TCGA.G4.6323.01", "Sensory perception of taste"], {"weight": 0.884694380504052}], ["AGT", ["TCGA.G4.6323.01", "Complement cascade"], {"weight": 0.706645966739954}], ["AGT", ["TCGA.G4.6323.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.870810480595803}], ["AGT", ["TCGA.G4.6323.01", "Degradation of the extracellular matrix"], {"weight": 0.737712168641469}], ["AGT", ["TCGA.G4.6323.01", "Regulation of Complement cascade"], {"weight": 0.728294427275939}], ["AGT", ["TCGA.G4.6323.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.795025702597937}], ["AGT", ["TCGA.G4.6323.01", "Chemokine receptors bind chemokines"], {"weight": 0.898105162716034}], ["AGT", ["TCGA.G4.6323.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.837561509252883}], ["SCN10A", ["TCGA.AA.3492.01", "Interaction between L1 and Ankyrins"], {"weight": 0.947605654219948}], ["SCN10A", ["TCGA.AA.3492.01", "Phase 0 - rapid depolarisation"], {"weight": 0.939445954203028}], ["SCN10A", ["TCGA.AD.5900.01", "Stimuli-sensing channels"], {"weight": 0.917770407197568}], ["SCN10A", ["TCGA.CM.6677.01", "Interaction between L1 and Ankyrins"], {"weight": 0.908449017268886}], ["SCN10A", ["TCGA.CM.6677.01", "Phase 0 - rapid depolarisation"], {"weight": 0.854601974833783}], ["SCN10A", ["TCGA.G4.6586.01", "Interaction between L1 and Ankyrins"], {"weight": 0.956751599818428}], ["SCN10A", ["TCGA.G4.6586.01", "Phase 0 - rapid depolarisation"], {"weight": 0.957276137703225}], ["SMARCA2", ["TCGA.CK.5912.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.613451878096078}], ["SMARCA2", ["TCGA.CK.5912.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.834416104440728}], ["SMARCA2", ["TCGA.CK.5912.01", "Phase I - Functionalization of compounds"], {"weight": 0.904992230661837}], ["SMARCA2", ["TCGA.G4.6293.01", "Regulation of Complement cascade"], {"weight": 0.743315224031888}], ["ARHGAP5", ["TCGA.CM.5860.01", "GPCR downstream signalling"], {"weight": 0.921151025431315}], ["ARHGAP5", ["TCGA.CM.5860.01", "Signaling by GPCR"], {"weight": 0.92240872520303}], ["ARHGAP5", ["TCGA.G4.6310.01", "Costimulation by the CD28 family"], {"weight": 0.90332130872917}], ["ARHGAP5", ["TCGA.G4.6310.01", "Signaling by GPCR"], {"weight": 0.93955431605633}], ["ARHGAP5", ["TCGA.G4.6310.01", "GPCR downstream signalling"], {"weight": 0.943233877282862}], ["ARHGAP5", ["TCGA.G4.6310.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.931987698304019}], ["ARHGAP5", ["TCGA.G4.6310.01", "CD28 dependent Vav1 pathway"], {"weight": 0.896232974916773}], ["ARHGAP5", ["TCGA.G4.6310.01", "GPVI-mediated activation cascade"], {"weight": 0.913675493461106}], ["ARHGAP5", ["TCGA.G4.6310.01", "CD28 co-stimulation"], {"weight": 0.858989222149112}], ["ARHGAP5", ["TCGA.G4.6310.01", "Stimuli-sensing channels"], {"weight": 0.886922656905575}], ["ARHGAP5", ["TCGA.G4.6310.01", "RAC1 GTPase cycle"], {"weight": 0.80080582401434}], ["SNIP1", ["TCGA.CM.6163.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.733257323094544}], ["CFTR", ["TCGA.AA.3492.01", "Signaling by GPCR"], {"weight": 0.947125695204445}], ["CFTR", ["TCGA.AM.5821.01", "G alpha (i) signalling events"], {"weight": 0.954909893097337}], ["CFTR", ["TCGA.DM.A28M.01", "Neuronal System"], {"weight": 0.953175167202186}], ["CFTR", ["TCGA.DM.A28M.01", "Transmission across Chemical Synapses"], {"weight": 0.942380042469603}], ["CFTR", ["TCGA.DM.A28M.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.947391111426232}], ["CFTR", ["TCGA.DM.A28M.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.937193976383318}], ["CFTR", ["TCGA.DM.A28M.01", "Generation of second messenger molecules"], {"weight": 0.938430406871664}], ["CFTR", ["TCGA.DM.A28M.01", "PD-1 signaling"], {"weight": 0.936175241738394}], ["CFTR", ["TCGA.DM.A28M.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.933987632604519}], ["CFTR", ["TCGA.DM.A28M.01", "G alpha (s) signalling events"], {"weight": 0.966416162280571}], ["CFTR", ["TCGA.DM.A28M.01", "Integration of energy metabolism"], {"weight": 0.938787006202712}], ["CFTR", ["TCGA.DM.A28M.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.862772504395311}], ["CFTR", ["TCGA.DM.A28M.01", "G alpha (q) signalling events"], {"weight": 0.949206941144667}], ["CFTR", ["TCGA.DM.A28M.01", "L1CAM interactions"], {"weight": 0.911804524033961}], ["MYO6", ["TCGA.AA.3492.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.877936199065777}], ["MYO6", ["TCGA.CM.4744.01", "Cardiac conduction"], {"weight": 0.937756679202023}], ["MYO6", ["TCGA.CM.4744.01", "Phase 0 - rapid depolarisation"], {"weight": 0.950448780526658}], ["MYO6", ["TCGA.CM.4744.01", "Ribavirin ADME"], {"weight": 0.647881867339913}], ["MYO6", ["TCGA.CM.4744.01", "Ion homeostasis"], {"weight": 0.936864654037999}], ["MYO6", ["TCGA.CM.4744.01", "LGI-ADAM interactions"], {"weight": 0.919412737786729}], ["MYO6", ["TCGA.G4.6588.01", "Trafficking of AMPA receptors"], {"weight": 0.942642347664333}], ["MYO6", ["TCGA.G4.6588.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.942642347664333}], ["MYT1", ["TCGA.CM.6677.01", "Signaling by Retinoic Acid"], {"weight": 0.614914320371809}], ["OR10K1", ["TCGA.AD.6548.01", "Neuronal System"], {"weight": 0.846339544595833}], ["OR10K1", ["TCGA.AD.6548.01", "GPCR ligand binding"], {"weight": 0.930310072040369}], ["OR10K1", ["TCGA.AD.6548.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.919930246064285}], ["OR10K1", ["TCGA.AD.6548.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.781893387827848}], ["OR10K1", ["TCGA.AD.6548.01", "Transmission across Chemical Synapses"], {"weight": 0.855806385373005}], ["OR10K1", ["TCGA.AZ.4615.01", "GABA B receptor activation"], {"weight": 0.935070729386966}], ["OR10K1", ["TCGA.AZ.4615.01", "Activation of GABAB receptors"], {"weight": 0.935070729386966}], ["OR10K1", ["TCGA.AZ.4615.01", "G protein gated Potassium channels"], {"weight": 0.921857048731189}], ["OR10K1", ["TCGA.D5.6898.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.89033808686746}], ["OR10K1", ["TCGA.D5.6898.01", "Potassium Channels"], {"weight": 0.933791477730281}], ["OR10K1", ["TCGA.D5.6898.01", "Extra-nuclear estrogen signaling"], {"weight": 0.81197907057619}], ["BCKDHA", ["TCGA.AD.6901.01", "Degradation of cysteine and homocysteine"], {"weight": 0.821044002910595}], ["WIPF2", ["TCGA.AZ.4616.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.891789104572539}], ["WIPF2", ["TCGA.AZ.4616.01", "Leishmania infection"], {"weight": 0.89031548082148}], ["WIPF2", ["TCGA.AZ.4616.01", "Parasitic Infection Pathways"], {"weight": 0.89031548082148}], ["BEST1", ["TCGA.G4.6586.01", "Transmission across Chemical Synapses"], {"weight": 0.950971528372275}], ["CDC42BPA", ["TCGA.AA.3492.01", "Insulin processing"], {"weight": 0.804461107407586}], ["MAGI2", ["TCGA.AZ.4616.01", "Cardiac conduction"], {"weight": 0.914747273411014}], ["MAGI2", ["TCGA.AZ.4616.01", "PKA activation in glucagon signalling"], {"weight": 0.83183619312888}], ["MAGI2", ["TCGA.AZ.4616.01", "Biological oxidations"], {"weight": 0.886158760734374}], ["MAGI2", ["TCGA.CM.4747.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.752526203181691}], ["MAGI2", ["TCGA.D5.5541.01", "Collagen formation"], {"weight": 0.923304764605114}], ["MAGI2", ["TCGA.D5.5541.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.814173038091802}], ["MAGI2", ["TCGA.F4.6569.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.789319835301662}], ["MAGI2", ["TCGA.G4.6317.01", "CD22 mediated BCR regulation"], {"weight": 0.818294053579943}], ["OR5M9", ["TCGA.CM.6166.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.914179187810333}], ["OR5M9", ["TCGA.CM.6166.01", "Transmission across Chemical Synapses"], {"weight": 0.915428553762861}], ["OR5M9", ["TCGA.CM.6166.01", "GPCR ligand binding"], {"weight": 0.941678349342188}], ["OR5M9", ["TCGA.CM.6166.01", "Signal amplification"], {"weight": 0.917919336817047}], ["OR5M9", ["TCGA.CM.6166.01", "G alpha (q) signalling events"], {"weight": 0.92539233449393}], ["OR5M9", ["TCGA.CM.6166.01", "Opioid Signalling"], {"weight": 0.916051416664613}], ["OR5M9", ["TCGA.CM.6166.01", "G alpha (s) signalling events"], {"weight": 0.960211848851468}], ["OR5M9", ["TCGA.CM.6166.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.908581196397243}], ["OR5M9", ["TCGA.CM.6166.01", "Thromboxane signalling through TP receptor"], {"weight": 0.902259499309015}], ["OR5M9", ["TCGA.CM.6166.01", "GABA receptor activation"], {"weight": 0.706729036402251}], ["OR5M9", ["TCGA.CM.6166.01", "G-protein beta:gamma signalling"], {"weight": 0.939263230213279}], ["OR5M9", ["TCGA.CM.6166.01", "Platelet activation, signaling and aggregation"], {"weight": 0.907832238994414}], ["OR5M9", ["TCGA.CM.6166.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.926172362961572}], ["OR5M9", ["TCGA.CM.6166.01", "G protein gated Potassium channels"], {"weight": 0.919873805056577}], ["OR5M9", ["TCGA.CM.6166.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.919873805056577}], ["OR5M9", ["TCGA.DM.A28H.01", "Glucagon-type ligand receptors"], {"weight": 0.932898941995056}], ["OR5M9", ["TCGA.DM.A28H.01", "Integration of energy metabolism"], {"weight": 0.923084164752604}], ["OR5M9", ["TCGA.G4.6586.01", "G-protein beta:gamma signalling"], {"weight": 0.938211263700129}], ["SLC25A4", ["TCGA.AD.6888.01", "Transport of small molecules"], {"weight": 0.894420209374255}], ["KIF5C", ["TCGA.AA.3492.01", "Trafficking of AMPA receptors"], {"weight": 0.935766892428787}], ["KIF5C", ["TCGA.AA.3492.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.935766892428787}], ["KIF5C", ["TCGA.AA.3492.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.9158943771917}], ["KIF5C", ["TCGA.G4.6586.01", "Protein-protein interactions at synapses"], {"weight": 0.932278226196425}], ["KIF5C", ["TCGA.G4.6586.01", "Trafficking of AMPA receptors"], {"weight": 0.941963793355611}], ["KIF5C", ["TCGA.G4.6586.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.941963793355611}], ["SLC2A8", ["TCGA.CK.5915.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.947258457280146}], ["SLC2A8", ["TCGA.CK.5915.01", "PD-1 signaling"], {"weight": 0.944298934733546}], ["SLC2A8", ["TCGA.CK.5915.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.944814979484172}], ["SLC2A8", ["TCGA.CK.5915.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.794327990782523}], ["SLC2A8", ["TCGA.CK.5915.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.957234369078288}], ["SLC2A8", ["TCGA.CK.5915.01", "Peptide ligand-binding receptors"], {"weight": 0.9560043232943}], ["SLC2A8", ["TCGA.CK.5915.01", "Costimulation by the CD28 family"], {"weight": 0.930076086998163}], ["SLC2A8", ["TCGA.CK.5915.01", "Scavenging by Class A Receptors"], {"weight": 0.527160710815539}], ["SLC2A8", ["TCGA.CK.5915.01", "FCGR activation"], {"weight": 0.885807906337123}], ["BGN", ["TCGA.F4.6806.01", "NCAM1 interactions"], {"weight": 0.898180705374009}], ["BGN", ["TCGA.F4.6806.01", "NCAM signaling for neurite out-growth"], {"weight": 0.914864303223624}], ["BGN", ["TCGA.F4.6806.01", "Collagen chain trimerization"], {"weight": 0.896092813982455}], ["BGN", ["TCGA.F4.6806.01", "ECM proteoglycans"], {"weight": 0.822721437299817}], ["PDE4D", ["TCGA.DM.A0XF.01", "G alpha (s) signalling events"], {"weight": 0.959130484142166}], ["PDE4D", ["TCGA.DM.A0XF.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.866802572583232}], ["PDE4D", ["TCGA.DM.A0XF.01", "Sensory processing of sound"], {"weight": 0.907284566548194}], ["PDE4D", ["TCGA.DM.A0XF.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.902584816811678}], ["DAGLA", ["TCGA.CM.4752.01", "Signaling by GPCR"], {"weight": 0.921572564605539}], ["DAGLA", ["TCGA.CM.4752.01", "GPCR downstream signalling"], {"weight": 0.928635217807485}], ["DAGLA", ["TCGA.DM.A28F.01", "Signaling by GPCR"], {"weight": 0.939758744114354}], ["DAGLA", ["TCGA.DM.A28F.01", "GPCR downstream signalling"], {"weight": 0.942703327527762}], ["GALNT14", ["TCGA.AA.3492.01", "O-linked glycosylation of mucins"], {"weight": 0.952486257871656}], ["ST8SIA1", ["TCGA.F4.6460.01", "Metabolism"], {"weight": 0.885098648239698}], ["ARID5B", ["TCGA.G4.6299.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.850745038660599}], ["RPE65", ["TCGA.CM.5341.01", "Signaling by Retinoic Acid"], {"weight": 0.84494558448789}], ["MUC6", ["TCGA.CM.5864.01", "Lewis blood group biosynthesis"], {"weight": 0.784920507808151}], ["MUC6", ["TCGA.CM.6164.01", "Blood group systems biosynthesis"], {"weight": 0.618286127204081}], ["CNNM1", ["TCGA.CK.5915.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.889669406974407}], ["CNNM1", ["TCGA.CK.5915.01", "DAP12 interactions"], {"weight": 0.935344251383762}], ["CNNM1", ["TCGA.CK.5915.01", "Innate Immune System"], {"weight": 0.902416088493377}], ["CNNM1", ["TCGA.CK.5915.01", "Interferon gamma signaling"], {"weight": 0.921432726674535}], ["GATA1", ["TCGA.AA.3492.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.794223617442143}], ["GBGT1", ["TCGA.AA.3492.01", "Blood group systems biosynthesis"], {"weight": 0.827988068922869}], ["CHST13", ["TCGA.F4.6809.01", "Extracellular matrix organization"], {"weight": 0.817407008537929}], ["CHST13", ["TCGA.F4.6809.01", "ECM proteoglycans"], {"weight": 0.842222048502224}], ["MAML3", ["TCGA.AZ.6600.01", "Physiological factors"], {"weight": 0.623509373702486}], ["MAML3", ["TCGA.AZ.6600.01", "YAP1- and WWTR1 (TAZ)-stimulated gene expression"], {"weight": 0.562347246942775}], ["MAML3", ["TCGA.CM.6169.01", "Repression of WNT target genes"], {"weight": 0.769858478638896}], ["HSD17B6", ["TCGA.AA.3502.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.852943374688033}], ["HSD17B6", ["TCGA.AA.3502.01", "Bile acid and bile salt metabolism"], {"weight": 0.676912720440776}], ["HSD17B6", ["TCGA.AA.3502.01", "RA biosynthesis pathway"], {"weight": 0.846924575748466}], ["HSD17B6", ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.708167694854747}], ["HSD17B6", ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.705411084108563}], ["HSD17B6", ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts"], {"weight": 0.709680443682349}], ["HSD17B6", ["TCGA.AA.3502.01", "Fatty acid metabolism"], {"weight": 0.80568724860699}], ["HSD17B6", ["TCGA.AA.3502.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.620526536392667}], ["RARS", ["TCGA.DM.A28E.01", "Phase II - Conjugation of compounds"], {"weight": 0.730786040476903}], ["RARS", ["TCGA.DM.A28E.01", "Aspartate and asparagine metabolism"], {"weight": 0.814736909603896}], ["CPE", ["TCGA.AA.3502.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.791702309410271}], ["ROR1", ["TCGA.AA.3502.01", "Voltage gated Potassium channels"], {"weight": 0.879169871719106}], ["ROR1", ["TCGA.CK.4947.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.762626337322394}], ["ADAMTS16", ["TCGA.D5.6531.01", "O-linked glycosylation"], {"weight": 0.9188540977053}], ["ADAMTS16", ["TCGA.DM.A28C.01", "O-linked glycosylation of mucins"], {"weight": 0.931350451568676}], ["ADAMTS16", ["TCGA.G4.6303.01", "Blood group systems biosynthesis"], {"weight": 0.499271317114436}], ["ADAMTS16", ["TCGA.G4.6303.01", "Lewis blood group biosynthesis"], {"weight": 0.42088802879042}], ["MYO1F", ["TCGA.DM.A282.01", "Neurotransmitter release cycle"], {"weight": 0.753919501097252}], ["GRIN2C", ["TCGA.AA.3502.01", "Phase 0 - rapid depolarisation"], {"weight": 0.921007780991682}], ["GRIN2C", ["TCGA.AA.3502.01", "Long-term potentiation"], {"weight": 0.912214242635852}], ["GRIN2C", ["TCGA.DM.A1D6.01", "Muscle contraction"], {"weight": 0.959974346558006}], ["GRIN2C", ["TCGA.DM.A1D6.01", "Cardiac conduction"], {"weight": 0.959684921706077}], ["GRIN2C", ["TCGA.DM.A1D6.01", "Phase 0 - rapid depolarisation"], {"weight": 0.944767658650536}], ["GRIN2C", ["TCGA.DM.A1D6.01", "Ion homeostasis"], {"weight": 0.958483280517384}], ["ATP1B3", ["TCGA.AA.3502.01", "Cardiac conduction"], {"weight": 0.933287664668885}], ["ATP1B3", ["TCGA.AA.3502.01", "Muscle contraction"], {"weight": 0.91910890653847}], ["ATP1B3", ["TCGA.AA.3502.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.847081327184397}], ["PLCH2", ["TCGA.AA.3712.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.896752102993234}], ["PLCH2", ["TCGA.G4.6298.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.930974913415878}], ["PLCH2", ["TCGA.G4.6298.01", "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"], {"weight": 0.896651456645594}], ["ERBB2", ["TCGA.AA.3502.01", "Drug ADME"], {"weight": 0.896386878904278}], ["ERBB2", ["TCGA.AD.6888.01", "Extracellular matrix organization"], {"weight": 0.916582559165589}], ["ERBB2", ["TCGA.AD.6888.01", "Integrin cell surface interactions"], {"weight": 0.91245967349285}], ["ERBB2", ["TCGA.AD.6888.01", "Glycosaminoglycan metabolism"], {"weight": 0.89973486864685}], ["ERBB2", ["TCGA.AD.6888.01", "Cell surface interactions at the vascular wall"], {"weight": 0.834573787069027}], ["ERBB2", ["TCGA.AD.6888.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.913240996493567}], ["ERBB2", ["TCGA.AD.6888.01", "Degradation of the extracellular matrix"], {"weight": 0.855274463008905}], ["ERBB2", ["TCGA.AD.6888.01", "Interleukin-6 family signaling"], {"weight": 0.918695037996827}], ["ERBB2", ["TCGA.AD.6888.01", "Carbohydrate metabolism"], {"weight": 0.929981442159033}], ["ERBB2", ["TCGA.G4.6298.01", "PI3K events in ERBB2 signaling"], {"weight": 0.902683301239493}], ["ERBB2", ["TCGA.G4.6298.01", "Interleukin-35 Signalling"], {"weight": 0.870753734657143}], ["ERBB2", ["TCGA.G4.6298.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.893366172354534}], ["ERBB2", ["TCGA.G4.6298.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.902574477140332}], ["ACSBG1", ["TCGA.AA.3502.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.70841540005285}], ["ACSBG1", ["TCGA.D5.6929.01", "Phase II - Conjugation of compounds"], {"weight": 0.848797848158191}], ["RAD9A", ["TCGA.AA.3511.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.674335222388733}], ["NRK", ["TCGA.AA.3511.01", "TNFs bind their physiological receptors"], {"weight": 0.340798802238506}], ["ROBO2", ["TCGA.CM.5344.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.824839109757964}], ["OR8K5", ["TCGA.AA.3511.01", "G alpha (i) signalling events"], {"weight": 0.904758804364723}], ["OR8K5", ["TCGA.AA.3511.01", "Potassium Channels"], {"weight": 0.893389745510674}], ["OR8K5", ["TCGA.AA.3511.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.87723649421312}], ["OR8K5", ["TCGA.AA.3511.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.883818216440584}], ["OR8K5", ["TCGA.AA.3511.01", "Regulation of insulin secretion"], {"weight": 0.851379308325124}], ["OR8K5", ["TCGA.AD.6901.01", "Presynaptic function of Kainate receptors"], {"weight": 0.879159454455647}], ["OR8K5", ["TCGA.AD.6901.01", "G-protein activation"], {"weight": 0.900201169199991}], ["OR8K5", ["TCGA.AD.6901.01", "Thromboxane signalling through TP receptor"], {"weight": 0.8728946076538}], ["OR8K5", ["TCGA.AD.6901.01", "G beta:gamma signalling through BTK"], {"weight": 0.864097174899574}], ["OR8K5", ["TCGA.AD.6901.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.864097174899574}], ["OR8K5", ["TCGA.AD.6901.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.864097174899574}], ["MCCC2", ["TCGA.AA.3511.01", "Ethanol oxidation"], {"weight": 0.701117319605994}], ["HNF4A", ["TCGA.AA.3511.01", "Signaling by GPCR"], {"weight": 0.910886851470668}], ["HNF4A", ["TCGA.AA.3511.01", "GPCR downstream signalling"], {"weight": 0.917150702311764}], ["HNF4A", ["TCGA.AA.3511.01", "GPCR ligand binding"], {"weight": 0.922653846790476}], ["HNF4A", ["TCGA.AA.3511.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.933133278111666}], ["HNF4A", ["TCGA.AA.3511.01", "Peptide ligand-binding receptors"], {"weight": 0.931308267999951}], ["HNF4A", ["TCGA.AA.3511.01", "Glucuronidation"], {"weight": 0.62681720859778}], ["HNF4A", ["TCGA.AA.3511.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.901812859701111}], ["HNF4A", ["TCGA.AA.3511.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.89303485492978}], ["HNF4A", ["TCGA.AA.3511.01", "Phase II - Conjugation of compounds"], {"weight": 0.519245205427487}], ["HNF4A", ["TCGA.AA.3511.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.846177131989028}], ["AP5M1", ["TCGA.AA.3511.01", "Voltage gated Potassium channels"], {"weight": 0.768818429821765}], ["ITGA7", ["TCGA.AA.3655.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.890200272487622}], ["ITGA7", ["TCGA.AA.3655.01", "Collagen chain trimerization"], {"weight": 0.892482366139631}], ["ITGA7", ["TCGA.CM.6162.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.944221326719343}], ["ITGA7", ["TCGA.D5.6534.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.602541557233447}], ["STXBP3", ["TCGA.AA.3655.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.895049143375623}], ["CYP2D6", ["TCGA.AA.3655.01", "Biological oxidations"], {"weight": 0.901555461790508}], ["CYP2D6", ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.826231761897415}], ["CYP2D6", ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.819872749511333}], ["CYP2D6", ["TCGA.AA.3655.01", "Phase II - Conjugation of compounds"], {"weight": 0.803645340108632}], ["CYP2D6", ["TCGA.AA.3655.01", "Glucuronidation"], {"weight": 0.910623440356994}], ["CYP2D6", ["TCGA.AA.3655.01", "Phase I - Functionalization of compounds"], {"weight": 0.898651126472665}], ["CYP2D6", ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts"], {"weight": 0.78898554331003}], ["CYP2D6", ["TCGA.AA.3655.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.77068223938239}], ["CYP2D6", ["TCGA.AA.3655.01", "Drug ADME"], {"weight": 0.839678350856279}], ["CYP2D6", ["TCGA.AA.3655.01", "Bile acid and bile salt metabolism"], {"weight": 0.788791994987324}], ["CYP2D6", ["TCGA.AA.3655.01", "Aspirin ADME"], {"weight": 0.823383334938752}], ["CYP2D6", ["TCGA.AA.3655.01", "Visual phototransduction"], {"weight": 0.800187930016499}], ["CYP2D6", ["TCGA.AA.3655.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.799154645896206}], ["CYP2D6", ["TCGA.AA.3655.01", "Retinoid metabolism and transport"], {"weight": 0.799154645896206}], ["CYP2D6", ["TCGA.CM.6162.01", "Phase II - Conjugation of compounds"], {"weight": 0.790011772666483}], ["CYP2D6", ["TCGA.CM.6162.01", "Biological oxidations"], {"weight": 0.895810212380767}], ["CYP2D6", ["TCGA.CM.6674.01", "Glucuronidation"], {"weight": 0.866144949711076}], ["DGAT2", ["TCGA.AA.3655.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.643682007636386}], ["AKAP1", ["TCGA.AA.3655.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.905517281206798}], ["AKAP1", ["TCGA.AA.3655.01", "G alpha (i) signalling events"], {"weight": 0.902714723618576}], ["AKAP1", ["TCGA.AA.3655.01", "Signaling by GPCR"], {"weight": 0.913495054703185}], ["AKAP1", ["TCGA.AA.3655.01", "GPCR downstream signalling"], {"weight": 0.915688792960282}], ["AKAP1", ["TCGA.AA.3655.01", "Regulation of gene expression by Hypoxia-inducible Factor"], {"weight": 0.815910960358533}], ["AKAP1", ["TCGA.AA.3655.01", "Phase 0 - rapid depolarisation"], {"weight": 0.860384730183426}], ["DMTF1", ["TCGA.AA.3655.01", "Signaling by BMP"], {"weight": 0.769551854143145}], ["DOK2", ["TCGA.AD.6888.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.935454702270147}], ["DOK2", ["TCGA.AD.6888.01", "Generation of second messenger molecules"], {"weight": 0.941952367035586}], ["DOK2", ["TCGA.AD.6888.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.933167301306784}], ["DOK2", ["TCGA.AD.6888.01", "PD-1 signaling"], {"weight": 0.937150357744159}], ["DOK2", ["TCGA.AD.6888.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.917224057675295}], ["DOK2", ["TCGA.AD.6888.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.91333820914147}], ["DOK2", ["TCGA.AD.6888.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.924126293283263}], ["DOK2", ["TCGA.AD.6888.01", "NCAM1 interactions"], {"weight": 0.941920200326176}], ["DOK2", ["TCGA.AD.6888.01", "DAP12 signaling"], {"weight": 0.914206079151907}], ["DOK2", ["TCGA.AD.6888.01", "Costimulation by the CD28 family"], {"weight": 0.907967057391981}], ["DOK2", ["TCGA.AD.6888.01", "DAP12 interactions"], {"weight": 0.924643958970185}], ["DOK2", ["TCGA.AD.6888.01", "NCAM signaling for neurite out-growth"], {"weight": 0.946860445058524}], ["DOK2", ["TCGA.AD.6888.01", "Other interleukin signaling"], {"weight": 0.789165546294437}], ["OR10H2", ["TCGA.AA.3655.01", "GPCR ligand binding"], {"weight": 0.932220602877654}], ["OR10H2", ["TCGA.AA.3655.01", "Potassium Channels"], {"weight": 0.944384348028538}], ["OR10H2", ["TCGA.AA.3655.01", "Peptide hormone metabolism"], {"weight": 0.714673542938134}], ["OR6N2", ["TCGA.AA.3655.01", "GABA receptor activation"], {"weight": 0.545077900998867}], ["OR6N2", ["TCGA.AA.3655.01", "Phase 4 - resting membrane potential"], {"weight": 0.776447931260798}], ["OR5I1", ["TCGA.AA.3660.01", "Presynaptic function of Kainate receptors"], {"weight": 0.856132482671739}], ["OR5I1", ["TCGA.AA.3660.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.872269290495391}], ["OR5I1", ["TCGA.AA.3660.01", "G beta:gamma signalling through BTK"], {"weight": 0.827887576952549}], ["OR5I1", ["TCGA.AA.3660.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.827887576952549}], ["OR5I1", ["TCGA.AA.3660.01", "G beta:gamma signalling through CDC42"], {"weight": 0.827887576952549}], ["OR5I1", ["TCGA.AA.3660.01", "LGI-ADAM interactions"], {"weight": 0.625025645413137}], ["OR5I1", ["TCGA.CK.4948.01", "GPCR ligand binding"], {"weight": 0.934153145419485}], ["OR5I1", ["TCGA.CK.4948.01", "Glucagon-type ligand receptors"], {"weight": 0.9094108247162}], ["OR5I1", ["TCGA.CK.4948.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.873779372842884}], ["OR5I1", ["TCGA.CK.4948.01", "Signal amplification"], {"weight": 0.892503127012959}], ["OR5I1", ["TCGA.CK.4948.01", "Regulation of insulin secretion"], {"weight": 0.848267258592286}], ["OR5I1", ["TCGA.CK.4948.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.886260818893049}], ["CX3CR1", ["TCGA.F4.6570.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.916084195950856}], ["CX3CR1", ["TCGA.F4.6570.01", "Peptide ligand-binding receptors"], {"weight": 0.914261146860236}], ["CHL1", ["TCGA.AA.3660.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.883355423308842}], ["CHL1", ["TCGA.AA.3660.01", "Collagen chain trimerization"], {"weight": 0.796975213129697}], ["CHL1", ["TCGA.AY.6197.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.870933328046609}], ["CHL1", ["TCGA.CA.6718.01", "Interaction between L1 and Ankyrins"], {"weight": 0.90912041425843}], ["CHL1", ["TCGA.DM.A1D6.01", "LGI-ADAM interactions"], {"weight": 0.884975236837391}], ["CHL1", ["TCGA.G4.6321.01", "Non-integrin membrane-ECM interactions"], {"weight": 0.7920899038636}], ["CHL1", ["TCGA.G4.6321.01", "MET activates PTK2 signaling"], {"weight": 0.8266976522767}], ["MCCC1", ["TCGA.AA.3660.01", "Biological oxidations"], {"weight": 0.835901597660978}], ["MCCC1", ["TCGA.AA.3660.01", "Bile acid and bile salt metabolism"], {"weight": 0.651231780405519}], ["MCCC1", ["TCGA.AA.3660.01", "Synthesis of bile acids and bile salts"], {"weight": 0.662756629560556}], ["MCCC1", ["TCGA.AA.3660.01", "Ethanol oxidation"], {"weight": 0.638751310601171}], ["INHBA", ["TCGA.AD.6901.01", "ECM proteoglycans"], {"weight": 0.898073936541121}], ["OR2A14", ["TCGA.CM.5348.01", "GPCR ligand binding"], {"weight": 0.875204601095172}], ["OR2A14", ["TCGA.CM.5348.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.839698059807074}], ["PTDSS1", ["TCGA.CM.4747.01", "Arachidonic acid metabolism"], {"weight": 0.826767858462649}], ["PTDSS1", ["TCGA.CM.4747.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.763359187354881}], ["PTDSS1", ["TCGA.CM.6675.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.839734231402906}], ["PTDSS1", ["TCGA.CM.6675.01", "Nicotinate metabolism"], {"weight": 0.749120414815788}], ["TCEA3", ["TCGA.AA.3660.01", "Physiological factors"], {"weight": 0.66168080205177}], ["ATP1A4", ["TCGA.AA.3660.01", "Cardiac conduction"], {"weight": 0.875144316127671}], ["ATP1A4", ["TCGA.AA.3660.01", "Muscle contraction"], {"weight": 0.878598302788671}], ["PLA2G4D", ["TCGA.AA.3662.01", "Biological oxidations"], {"weight": 0.92047448070413}], ["INSL3", ["TCGA.AA.3697.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.831815737793086}], ["INSL3", ["TCGA.AA.3697.01", "Activation of G protein gated Potassium channels"], {"weight": 0.886353313298266}], ["INSL3", ["TCGA.AA.3697.01", "G protein gated Potassium channels"], {"weight": 0.886353313298266}], ["UBXN11", ["TCGA.F4.6463.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.56675993660349}], ["TAAR5", ["TCGA.AD.6965.01", "GPCR ligand binding"], {"weight": 0.919274937425336}], ["SMAD9", ["TCGA.G4.6320.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.72495777817558}], ["PLA2G4D", ["TCGA.AA.3662.01", "Phase II - Conjugation of compounds"], {"weight": 0.760741579463961}], ["PLA2G4D", ["TCGA.AA.3662.01", "Phase I - Functionalization of compounds"], {"weight": 0.939187266530185}], ["PLA2G4D", ["TCGA.AZ.4615.01", "Drug ADME"], {"weight": 0.852830552726306}], ["PLA2G4D", ["TCGA.AZ.4615.01", "Biological oxidations"], {"weight": 0.945450425369932}], ["PLA2G4D", ["TCGA.CM.4743.01", "Biological oxidations"], {"weight": 0.925482998094038}], ["PLA2G4D", ["TCGA.CM.6166.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.931979607260491}], ["PLA2G4D", ["TCGA.CM.6166.01", "PLC beta mediated events"], {"weight": 0.849031510141881}], ["PLA2G4D", ["TCGA.CM.6166.01", "Drug ADME"], {"weight": 0.91181290905375}], ["PLA2G4D", ["TCGA.CM.6166.01", "Biological oxidations"], {"weight": 0.947174334155292}], ["PLA2G4D", ["TCGA.CM.6166.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.915455010481513}], ["PLA2G4D", ["TCGA.CM.6166.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.829575179575151}], ["PLA2G4D", ["TCGA.CM.6166.01", "Acyl chain remodelling of PE"], {"weight": 0.851150060710959}], ["PLA2G4D", ["TCGA.G4.6298.01", "Biological oxidations"], {"weight": 0.958154110419421}], ["PLA2G4D", ["TCGA.G4.6298.01", "Drug ADME"], {"weight": 0.92021310223969}], ["PLA2G4D", ["TCGA.G4.6298.01", "Phase II - Conjugation of compounds"], {"weight": 0.915329182549292}], ["PLA2G4D", ["TCGA.G4.6298.01", "Aspirin ADME"], {"weight": 0.933121057005296}], ["PLA2G4D", ["TCGA.G4.6298.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.907839443804074}], ["PLA2G4D", ["TCGA.G4.6311.01", "Biological oxidations"], {"weight": 0.924919587396534}], ["PLA2G4D", ["TCGA.G4.6311.01", "APAP ADME"], {"weight": 0.820699824223515}], ["PLA2G4D", ["TCGA.G4.6311.01", "Phase I - Functionalization of compounds"], {"weight": 0.937912996280036}], ["PLA2G4D", ["TCGA.G4.6311.01", "Drug ADME"], {"weight": 0.848116701014604}], ["NPW", ["TCGA.D5.6537.01", "Initial triggering of complement"], {"weight": 0.915356171218789}], ["TRIB2", ["TCGA.AZ.6607.01", "Ethanol oxidation"], {"weight": 0.790760491817272}], ["TRIB2", ["TCGA.AZ.6607.01", "IRS-related events triggered by IGF1R"], {"weight": 0.790064471292993}], ["TRIB2", ["TCGA.AZ.6607.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.789864203290612}], ["TRIB2", ["TCGA.AZ.6607.01", "IGF1R signaling cascade"], {"weight": 0.789864203290612}], ["SPHK1", ["TCGA.AA.3697.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.851848888591724}], ["SPHK1", ["TCGA.CK.4950.01", "Response to elevated platelet cytosolic Ca2+"], {"weight": 0.693447879532797}], ["SPHK1", ["TCGA.F4.6463.01", "Response to elevated platelet cytosolic Ca2+"], {"weight": 0.607920756928623}], ["GFI1", ["TCGA.AZ.4682.01", "Complement cascade"], {"weight": 0.835567695391204}], ["GFI1", ["TCGA.AZ.4682.01", "Phase II - Conjugation of compounds"], {"weight": 0.713990784610762}], ["OR5F1", ["TCGA.AA.3662.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.90592109608334}], ["OR5F1", ["TCGA.AA.3662.01", "Regulation of insulin secretion"], {"weight": 0.877306418138806}], ["OR5F1", ["TCGA.AA.3662.01", "Visual phototransduction"], {"weight": 0.881538533331327}], ["OR5F1", ["TCGA.AA.3662.01", "G alpha (z) signalling events"], {"weight": 0.896277885567098}], ["OR5F1", ["TCGA.AA.3662.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.877917816089502}], ["OR5F1", ["TCGA.AA.3662.01", "Signal amplification"], {"weight": 0.887809168998263}], ["OR5F1", ["TCGA.AA.3662.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.828646161053722}], ["OR5F1", ["TCGA.AA.3662.01", "Aquaporin-mediated transport"], {"weight": 0.828646161053722}], ["OR5F1", ["TCGA.AA.3662.01", "GABA B receptor activation"], {"weight": 0.900296824311065}], ["OR5F1", ["TCGA.AA.3662.01", "Peptide hormone metabolism"], {"weight": 0.664315822930935}], ["OR5F1", ["TCGA.AA.3662.01", "G alpha (s) signalling events"], {"weight": 0.935537263813936}], ["OR5F1", ["TCGA.AA.3662.01", "Thromboxane signalling through TP receptor"], {"weight": 0.861525370497121}], ["OR5F1", ["TCGA.DM.A1D0.01", "Signaling by GPCR"], {"weight": 0.956549336428752}], ["OR5F1", ["TCGA.DM.A1D0.01", "GPCR downstream signalling"], {"weight": 0.962208757553675}], ["OR5F1", ["TCGA.DM.A1D0.01", "G alpha (i) signalling events"], {"weight": 0.947513259492515}], ["OR5F1", ["TCGA.DM.A1D0.01", "Initial triggering of complement"], {"weight": 0.919202260472526}], ["OR5F1", ["TCGA.DM.A1D0.01", "Peptide hormone metabolism"], {"weight": 0.824536182353458}], ["OR5F1", ["TCGA.DM.A1D0.01", "G alpha (q) signalling events"], {"weight": 0.95218512495005}], ["OR5F1", ["TCGA.DM.A1D0.01", "Leishmania infection"], {"weight": 0.915405427272907}], ["OR5F1", ["TCGA.DM.A1D0.01", "Parasitic Infection Pathways"], {"weight": 0.915405427272907}], ["OR5F1", ["TCGA.DM.A1D0.01", "G-protein beta:gamma signalling"], {"weight": 0.940673590507181}], ["OR5F1", ["TCGA.DM.A1D0.01", "G alpha (s) signalling events"], {"weight": 0.964913898796117}], ["OR5F1", ["TCGA.DM.A1D0.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.919150456230639}], ["OR5F1", ["TCGA.DM.A1D0.01", "Leishmania parasite growth and survival"], {"weight": 0.919150456230639}], ["OR5F1", ["TCGA.DM.A1D0.01", "Phase 0 - rapid depolarisation"], {"weight": 0.929726124487453}], ["OR5F1", ["TCGA.DM.A1D0.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.931981116043725}], ["OR5F1", ["TCGA.DM.A1D0.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.928710938691752}], ["OR5F1", ["TCGA.DM.A1D0.01", "Glucagon-type ligand receptors"], {"weight": 0.940370207426462}], ["OR5F1", ["TCGA.DM.A1D0.01", "Inwardly rectifying K+ channels"], {"weight": 0.92886823322592}], ["OR5F1", ["TCGA.DM.A1D0.01", "Presynaptic function of Kainate receptors"], {"weight": 0.911231419709096}], ["AMY1A", ["TCGA.AA.3662.01", "Glucuronidation"], {"weight": 0.68420778192904}], ["TGIF1", ["TCGA.D5.6541.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.846093361748629}], ["KCNA5", ["TCGA.AD.6890.01", "Potassium Channels"], {"weight": 0.945735271606446}], ["KCNA5", ["TCGA.CM.4747.01", "Neuronal System"], {"weight": 0.877546191228764}], ["KCNA5", ["TCGA.CM.4747.01", "Potassium Channels"], {"weight": 0.946587767093955}], ["KCNA5", ["TCGA.CM.5860.01", "Potassium Channels"], {"weight": 0.954271344305514}], ["KCNA5", ["TCGA.CM.5860.01", "Voltage gated Potassium channels"], {"weight": 0.890371447629804}], ["KCNA5", ["TCGA.D5.6529.01", "Potassium Channels"], {"weight": 0.93281608352521}], ["TRAPPC5", ["TCGA.AY.6386.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.936913512265357}], ["TRAPPC5", ["TCGA.CK.4952.01", "Protein-protein interactions at synapses"], {"weight": 0.934125041090099}], ["TRAPPC5", ["TCGA.CK.4952.01", "Synaptic adhesion-like molecules"], {"weight": 0.869599851224075}], ["TRAPPC5", ["TCGA.CK.4952.01", "Intrinsic Pathway of Fibrin Clot Formation"], {"weight": 0.900227426702271}], ["ITGAV", ["TCGA.CK.4948.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.56548748588263}], ["NUP107", ["TCGA.D5.5540.01", "Metabolism of folate and pterines"], {"weight": 0.884332066881765}], ["NUP107", ["TCGA.D5.5540.01", "Chromosome Maintenance"], {"weight": 0.942793400598116}], ["NUP107", ["TCGA.D5.5540.01", "Transcription of E2F targets under negative control by DREAM complex"], {"weight": 0.883721999453363}], ["NUP107", ["TCGA.D5.5540.01", "S Phase"], {"weight": 0.924839357365837}], ["ALPL", ["TCGA.CA.6718.01", "Collagen chain trimerization"], {"weight": 0.925614475182053}], ["ALPL", ["TCGA.CM.6162.01", "Collagen chain trimerization"], {"weight": 0.928640649106139}], ["ALPL", ["TCGA.DM.A28F.01", "Glucuronidation"], {"weight": 0.896774451311869}], ["ALPL", ["TCGA.F4.6463.01", "Glucuronidation"], {"weight": 0.691308746441258}], ["ALPL", ["TCGA.F4.6463.01", "Collagen formation"], {"weight": 0.937648027901105}], ["ALPL", ["TCGA.F4.6463.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.929949324786142}], ["ZFYVE19", ["TCGA.G4.6298.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.901271707656156}], ["KIDINS220", ["TCGA.DM.A1D0.01", "Negative regulation of FLT3"], {"weight": 0.866413656242489}], ["PCSK1", ["TCGA.D5.6536.01", "Chemokine receptors bind chemokines"], {"weight": 0.926647580498277}], ["PCSK1", ["TCGA.D5.6536.01", "Peptide ligand-binding receptors"], {"weight": 0.927802177396548}], ["PCSK1", ["TCGA.D5.6536.01", "G alpha (i) signalling events"], {"weight": 0.933799518032614}], ["PCSK1", ["TCGA.D5.6536.01", "G alpha (s) signalling events"], {"weight": 0.954727048977973}], ["PCSK1", ["TCGA.D5.6536.01", "Biological oxidations"], {"weight": 0.921178198298732}], ["PCSK1", ["TCGA.D5.6536.01", "G-protein activation"], {"weight": 0.924090714968937}], ["PCSK1", ["TCGA.D5.6536.01", "Opioid Signalling"], {"weight": 0.936068571721964}], ["PCSK1", ["TCGA.G4.6628.01", "Glucagon-type ligand receptors"], {"weight": 0.920344757903621}], ["ADCY4", ["TCGA.CM.4752.01", "GABA receptor activation"], {"weight": 0.876700104413054}], ["ADCY4", ["TCGA.CM.4752.01", "Platelet homeostasis"], {"weight": 0.747639713375184}], ["ADCY4", ["TCGA.CM.4752.01", "GABA B receptor activation"], {"weight": 0.881862316701866}], ["ADCY4", ["TCGA.CM.4752.01", "Activation of GABAB receptors"], {"weight": 0.881862316701866}], ["ADCY4", ["TCGA.CM.4752.01", "Opioid Signalling"], {"weight": 0.855376329757189}], ["ADCY4", ["TCGA.CM.4752.01", "G alpha (z) signalling events"], {"weight": 0.881854480000438}], ["BPNT1", ["TCGA.AA.3663.01", "Phase II - Conjugation of compounds"], {"weight": 0.793082571561047}], ["BPNT1", ["TCGA.AM.5820.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.917086271840804}], ["BPNT1", ["TCGA.AY.6197.01", "Biological oxidations"], {"weight": 0.899984621391495}], ["BCL6", ["TCGA.CM.5861.01", "Interleukin-10 signaling"], {"weight": 0.905531597809542}], ["SERPINB3", ["TCGA.G4.6320.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.759820858956925}], ["ANAPC7", ["TCGA.G4.6317.01", "GPCR ligand binding"], {"weight": 0.944996324334495}], ["ANAPC7", ["TCGA.G4.6317.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.94753836633502}], ["ANAPC7", ["TCGA.G4.6317.01", "Peptide ligand-binding receptors"], {"weight": 0.946341284575245}], ["WNT9A", ["TCGA.AD.5900.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.870319439066006}], ["WNT9A", ["TCGA.CM.5349.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.789300987429351}], ["WNT9A", ["TCGA.CM.5349.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.887188739850166}], ["WNT9A", ["TCGA.CM.5349.01", "Retinoid metabolism and transport"], {"weight": 0.887188739850166}], ["WNT9A", ["TCGA.CM.5349.01", "Visual phototransduction"], {"weight": 0.774008155965236}], ["WNT9A", ["TCGA.CM.6164.01", "Signaling by GPCR"], {"weight": 0.938788565905788}], ["WNT9A", ["TCGA.CM.6164.01", "GPCR ligand binding"], {"weight": 0.904284455422337}], ["WNT9A", ["TCGA.CM.6164.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.914994970654502}], ["SKIL", ["TCGA.CM.6675.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.857761221682273}], ["FLRT1", ["TCGA.CM.6170.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.835113622678063}], ["FLRT1", ["TCGA.F4.6570.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.882908758369509}], ["FLRT1", ["TCGA.F4.6570.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.84316021523138}], ["SCN1B", ["TCGA.AZ.6599.01", "Cardiac conduction"], {"weight": 0.93613999218802}], ["SCN1B", ["TCGA.AZ.6599.01", "Interaction between L1 and Ankyrins"], {"weight": 0.935011421196598}], ["SCN1B", ["TCGA.AZ.6599.01", "Phase 0 - rapid depolarisation"], {"weight": 0.934072620544152}], ["SCN1B", ["TCGA.AZ.6599.01", "L1CAM interactions"], {"weight": 0.871857469076965}], ["SCN1B", ["TCGA.AZ.6599.01", "Transport of small molecules"], {"weight": 0.936169451579303}], ["SCN1B", ["TCGA.AZ.6599.01", "NCAM signaling for neurite out-growth"], {"weight": 0.9408226095091}], ["PNMT", ["TCGA.D5.6540.01", "Phase I - Functionalization of compounds"], {"weight": 0.94543532777015}], ["PNMT", ["TCGA.D5.6540.01", "Neurotransmitter release cycle"], {"weight": 0.914638149086418}], ["DOCK8", ["TCGA.AA.3663.01", "Peptide ligand-binding receptors"], {"weight": 0.947231940757449}], ["DOCK8", ["TCGA.AA.3663.01", "Complement cascade"], {"weight": 0.87215907766882}], ["DOCK8", ["TCGA.AY.6197.01", "Peptide ligand-binding receptors"], {"weight": 0.94497581163573}], ["DOCK8", ["TCGA.AY.6197.01", "G alpha (i) signalling events"], {"weight": 0.922626190437511}], ["DOCK8", ["TCGA.AY.6197.01", "Complement cascade"], {"weight": 0.801296785048341}], ["DOCK8", ["TCGA.AY.6197.01", "Regulation of Complement cascade"], {"weight": 0.773655205963696}], ["DOCK8", ["TCGA.G4.6309.01", "Peptide ligand-binding receptors"], {"weight": 0.926621604156198}], ["DOCK8", ["TCGA.G4.6309.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.926813027627572}], ["COL9A1", ["TCGA.DM.A28G.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.696507085485017}], ["COL9A1", ["TCGA.DM.A28G.01", "Molecules associated with elastic fibres"], {"weight": 0.743088405954665}], ["COL9A1", ["TCGA.DM.A28G.01", "Degradation of the extracellular matrix"], {"weight": 0.768521183679016}], ["IFNB1", ["TCGA.DM.A1D4.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.919250264416341}], ["IFNB1", ["TCGA.DM.A1D4.01", "Other interleukin signaling"], {"weight": 0.780897643051768}], ["IFNB1", ["TCGA.DM.A1D4.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.730027858637555}], ["IFNB1", ["TCGA.DM.A1D4.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.730027858637555}], ["C8B", ["TCGA.AA.3663.01", "Regulation of Complement cascade"], {"weight": 0.861837577067176}], ["LIN7A", ["TCGA.D5.6931.01", "L1CAM interactions"], {"weight": 0.914799623260108}], ["RASGRP2", ["TCGA.AZ.6598.01", "LGI-ADAM interactions"], {"weight": 0.912311646480632}], ["ITSN2", ["TCGA.AM.5821.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.934816983165587}], ["CTBP2", ["TCGA.AU.3779.01", "Sensory processing of sound"], {"weight": 0.929285393023369}], ["CTBP2", ["TCGA.AU.3779.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.927003765235289}], ["CTBP2", ["TCGA.AU.3779.01", "Formation of axial mesoderm"], {"weight": 0.602323424163283}], ["CTBP2", ["TCGA.D5.6537.01", "Ca2+ pathway"], {"weight": 0.863427357319081}], ["CTBP2", ["TCGA.D5.6537.01", "Sensory processing of sound"], {"weight": 0.921345561186873}], ["CTBP2", ["TCGA.D5.6537.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.919010663951461}], ["WDHD1", ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to BRCA1 loss of function"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Defective homologous recombination repair (HRR) due to PALB2 loss of function"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Impaired BRCA2 binding to PALB2"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.892948162587031}], ["WDHD1", ["TCGA.CA.6718.01", "Resolution of D-Loop Structures"], {"weight": 0.892948162587031}], ["WDHD1", ["TCGA.CA.6718.01", "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"], {"weight": 0.877725901354099}], ["WDHD1", ["TCGA.CA.6718.01", "Unwinding of DNA"], {"weight": 0.819419023775437}], ["WDHD1", ["TCGA.D5.6541.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.785896362962158}], ["WDHD1", ["TCGA.D5.6541.01", "Degradation of the extracellular matrix"], {"weight": 0.756055205953953}], ["SLC32A1", ["TCGA.D5.6537.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.729279112809573}], ["SLC32A1", ["TCGA.D5.6537.01", "Other interleukin signaling"], {"weight": 0.803913943442123}], ["SLC32A1", ["TCGA.F4.6460.01", "Biological oxidations"], {"weight": 0.871010434804403}], ["SLC32A1", ["TCGA.F4.6460.01", "Phase II - Conjugation of compounds"], {"weight": 0.78015826507963}], ["SLC32A1", ["TCGA.F4.6460.01", "Drug ADME"], {"weight": 0.793864954661525}], ["SLC32A1", ["TCGA.F4.6460.01", "SLC-mediated transmembrane transport"], {"weight": 0.675184910372788}], ["SLC32A1", ["TCGA.G4.6626.01", "Integration of energy metabolism"], {"weight": 0.932968125223957}], ["SLC32A1", ["TCGA.G4.6626.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.785476698963198}], ["SLC32A1", ["TCGA.G4.6626.01", "Acetylcholine Neurotransmitter Release Cycle"], {"weight": 0.746528245299463}], ["SLC32A1", ["TCGA.G4.6626.01", "Insulin processing"], {"weight": 0.854811598718971}], ["SLC32A1", ["TCGA.G4.6626.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.892075365644969}], ["CAMK2D", ["TCGA.DM.A1D7.01", "Transmission across Chemical Synapses"], {"weight": 0.902647232448069}], ["CAMK2D", ["TCGA.DM.A1D7.01", "Protein-protein interactions at synapses"], {"weight": 0.878613293623332}], ["CAMK2D", ["TCGA.DM.A1D7.01", "Synaptic adhesion-like molecules"], {"weight": 0.810622044587019}], ["CAMK2D", ["TCGA.G4.6302.01", "Stimuli-sensing channels"], {"weight": 0.885894536687012}], ["MAP3K10", ["TCGA.DM.A1D6.01", "Regulation of insulin secretion"], {"weight": 0.894397784520632}], ["MAP3K10", ["TCGA.DM.A1D6.01", "Integration of energy metabolism"], {"weight": 0.900388112904715}], ["PHACTR2", ["TCGA.CM.5861.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.904049940794294}], ["PHACTR2", ["TCGA.CM.5861.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.910847385131358}], ["NET1", ["TCGA.AZ.6599.01", "GPVI-mediated activation cascade"], {"weight": 0.920364734607232}], ["RGS10", ["TCGA.G4.6586.01", "Regulation of insulin secretion"], {"weight": 0.939403420440084}], ["AP2A2", ["TCGA.AD.6889.01", "Transmission across Chemical Synapses"], {"weight": 0.949258561247481}], ["AP2A2", ["TCGA.AD.6889.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.941877104604892}], ["AP2A2", ["TCGA.AD.6901.01", "Neuronal System"], {"weight": 0.909286750053392}], ["AP2A2", ["TCGA.AD.6901.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.915533763482113}], ["AP2A2", ["TCGA.AD.6901.01", "Transmission across Chemical Synapses"], {"weight": 0.902678084504719}], ["AP2A2", ["TCGA.F4.6856.01", "Neuronal System"], {"weight": 0.93517594627566}], ["AP2A2", ["TCGA.F4.6856.01", "Transmission across Chemical Synapses"], {"weight": 0.926468929978946}], ["AP2A2", ["TCGA.F4.6856.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.924616524868468}], ["TFAP2C", ["TCGA.DM.A1D8.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.678111808328129}], ["EDNRB", ["TCGA.D5.6926.01", "GPCR ligand binding"], {"weight": 0.928985810225049}], ["EDNRB", ["TCGA.G4.6323.01", "GPCR ligand binding"], {"weight": 0.8931688559046}], ["EDNRB", ["TCGA.G4.6323.01", "G alpha (i) signalling events"], {"weight": 0.940268546630825}], ["EDNRB", ["TCGA.G4.6323.01", "Signaling by GPCR"], {"weight": 0.914923984665149}], ["EDNRB", ["TCGA.G4.6323.01", "GABA receptor activation"], {"weight": 0.547748913982431}], ["EDNRB", ["TCGA.G4.6323.01", "GPCR downstream signalling"], {"weight": 0.932798036739502}], ["EDNRB", ["TCGA.G4.6323.01", "Peptide ligand-binding receptors"], {"weight": 0.931985201790033}], ["EDNRB", ["TCGA.G4.6323.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.931985201790033}], ["EDNRB", ["TCGA.G4.6323.01", "GABA B receptor activation"], {"weight": 0.882850129118799}], ["EDNRB", ["TCGA.G4.6323.01", "Activation of GABAB receptors"], {"weight": 0.882850129118799}], ["EDNRB", ["TCGA.G4.6323.01", "Glucagon-type ligand receptors"], {"weight": 0.885181771902982}], ["PKLR", ["TCGA.AA.3663.01", "Drug ADME"], {"weight": 0.864566009410379}], ["PKLR", ["TCGA.AD.6889.01", "Metabolism of vitamins and cofactors"], {"weight": 0.718405043387189}], ["KCNC3", ["TCGA.AA.3663.01", "Potassium Channels"], {"weight": 0.959202954556746}], ["KCNC3", ["TCGA.DM.A1D8.01", "Potassium Channels"], {"weight": 0.960383632595227}], ["KCNC3", ["TCGA.DM.A1D8.01", "Voltage gated Potassium channels"], {"weight": 0.902976217337548}], ["KCNC3", ["TCGA.G4.6588.01", "Voltage gated Potassium channels"], {"weight": 0.910161843306515}], ["KPNA3", ["TCGA.CM.5348.01", "Apoptotic cleavage of cell adhesion  proteins"], {"weight": 0.686834716160194}], ["IL1RAP", ["TCGA.D5.6538.01", "Cytokine Signaling in Immune system"], {"weight": 0.898450309565357}], ["IL1RAP", ["TCGA.D5.6538.01", "Interleukin-10 signaling"], {"weight": 0.946090486498706}], ["IL1RAP", ["TCGA.D5.6538.01", "Signaling by Interleukins"], {"weight": 0.890573331599541}], ["IL1RAP", ["TCGA.F4.6808.01", "Immune System"], {"weight": 0.898101553193014}], ["IL1RAP", ["TCGA.F4.6808.01", "Cytokine Signaling in Immune system"], {"weight": 0.885561288707075}], ["IL1RAP", ["TCGA.F4.6808.01", "Interleukin-10 signaling"], {"weight": 0.937511122545504}], ["FZD7", ["TCGA.DM.A1HA.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.941381479391175}], ["FZD7", ["TCGA.DM.A1HA.01", "Regulation of FZD by ubiquitination"], {"weight": 0.917541027312821}], ["PTGDS", ["TCGA.AA.3663.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.861722098085724}], ["PTGDS", ["TCGA.AZ.6601.01", "Phase II - Conjugation of compounds"], {"weight": 0.911624758598395}], ["PTGDS", ["TCGA.AZ.6601.01", "Biological oxidations"], {"weight": 0.949656804015798}], ["USP20", ["TCGA.AA.3663.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.947473665764842}], ["USP20", ["TCGA.AY.6197.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.944791786785069}], ["GSK3B", ["TCGA.DM.A285.01", "Phase II - Conjugation of compounds"], {"weight": 0.78965225946594}], ["NOS2", ["TCGA.AM.5821.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.887829325241248}], ["NOS2", ["TCGA.CM.5861.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.860342199830273}], ["NOS2", ["TCGA.DM.A0X9.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.855709613445557}], ["ALDH2", ["TCGA.AA.3663.01", "Biological oxidations"], {"weight": 0.929483621305151}], ["ALDH2", ["TCGA.D5.6928.01", "Biological oxidations"], {"weight": 0.943053592804054}], ["ALDH2", ["TCGA.D5.6928.01", "Ethanol oxidation"], {"weight": 0.781094089381102}], ["EPN2", ["TCGA.CM.6166.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.946923711477771}], ["EPN2", ["TCGA.CM.6166.01", "Peptide ligand-binding receptors"], {"weight": 0.936195793918736}], ["EPN2", ["TCGA.CM.6166.01", "Other interleukin signaling"], {"weight": 0.770408313084098}], ["CACNA2D4", ["TCGA.CM.4747.01", "Phase 0 - rapid depolarisation"], {"weight": 0.850323291221512}], ["CACNA2D4", ["TCGA.CM.4747.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.931927802733406}], ["CACNA2D4", ["TCGA.CM.4747.01", "Peptide ligand-binding receptors"], {"weight": 0.911331328249165}], ["CACNA2D4", ["TCGA.D5.6532.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.925460611967686}], ["CACNA2D4", ["TCGA.D5.6532.01", "Adaptive Immune System"], {"weight": 0.882353168820984}], ["COL21A1", ["TCGA.G4.6311.01", "Collagen formation"], {"weight": 0.946574866571536}], ["COL21A1", ["TCGA.G4.6311.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.941020730554454}], ["COL21A1", ["TCGA.G4.6311.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.936847234233317}], ["COL21A1", ["TCGA.G4.6311.01", "Collagen chain trimerization"], {"weight": 0.915788058329135}], ["COL21A1", ["TCGA.G4.6311.01", "NCAM1 interactions"], {"weight": 0.899217518436417}], ["COL21A1", ["TCGA.G4.6311.01", "Collagen degradation"], {"weight": 0.911827652384044}], ["PTPN5", ["TCGA.DM.A28F.01", "Arachidonic acid metabolism"], {"weight": 0.903351435743567}], ["FOXO3", ["TCGA.AD.6895.01", "Stimuli-sensing channels"], {"weight": 0.909908620449412}], ["TTC38", ["TCGA.G4.6626.01", "CD22 mediated BCR regulation"], {"weight": 0.755116622471496}], ["GGH", ["TCGA.AZ.4615.01", "Glutathione conjugation"], {"weight": 0.919469026372525}], ["EPS15", ["TCGA.AM.5820.01", "Protein-protein interactions at synapses"], {"weight": 0.859919901849443}], ["EPS15", ["TCGA.D5.6529.01", "L1CAM interactions"], {"weight": 0.793630311440357}], ["EPS15", ["TCGA.D5.6529.01", "FGFR2 ligand binding and activation"], {"weight": 0.856033533905661}], ["XK", ["TCGA.G4.6293.01", "GPCR ligand binding"], {"weight": 0.910393290526247}], ["XK", ["TCGA.G4.6293.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.916309112559397}], ["XK", ["TCGA.G4.6293.01", "Peptide ligand-binding receptors"], {"weight": 0.914090353922485}], ["AFP", ["TCGA.G4.6315.01", "Activation of SMO"], {"weight": 0.766650304773139}], ["AFP", ["TCGA.G4.6315.01", "Formation of axial mesoderm"], {"weight": 0.7328595798047}], ["HOXB1", ["TCGA.D5.6927.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.882863172235984}], ["PRKX", ["TCGA.AZ.5407.01", "G alpha (s) signalling events"], {"weight": 0.94904477171076}], ["PRKX", ["TCGA.AZ.5407.01", "Signaling by GPCR"], {"weight": 0.951496773518571}], ["PRKX", ["TCGA.AZ.5407.01", "GPCR downstream signalling"], {"weight": 0.952394371480553}], ["PRKX", ["TCGA.CK.4952.01", "Transmission across Chemical Synapses"], {"weight": 0.929918220716052}], ["PRKX", ["TCGA.CK.4952.01", "Signaling by GPCR"], {"weight": 0.956249795012306}], ["PRKX", ["TCGA.CK.4952.01", "GPCR downstream signalling"], {"weight": 0.956634048544381}], ["PRKX", ["TCGA.CK.4952.01", "G alpha (i) signalling events"], {"weight": 0.945201373741135}], ["PRKX", ["TCGA.CK.5914.01", "Neuronal System"], {"weight": 0.937664658313454}], ["PRKX", ["TCGA.CK.5914.01", "GPCR downstream signalling"], {"weight": 0.947648660598245}], ["PRKX", ["TCGA.CK.5914.01", "Signaling by GPCR"], {"weight": 0.948294090013829}], ["PRKX", ["TCGA.CK.5914.01", "G alpha (i) signalling events"], {"weight": 0.948440874716121}], ["PRKX", ["TCGA.CK.5914.01", "Ca-dependent events"], {"weight": 0.896016776587266}], ["PRKX", ["TCGA.CK.5914.01", "G-protein mediated events"], {"weight": 0.904710867544596}], ["PRKX", ["TCGA.CK.5914.01", "Calmodulin induced events"], {"weight": 0.891385096604316}], ["PRKX", ["TCGA.CK.5914.01", "CaM pathway"], {"weight": 0.891385096604316}], ["PRKX", ["TCGA.CK.5914.01", "DAG and IP3 signaling"], {"weight": 0.892233920322747}], ["PRKX", ["TCGA.CK.5914.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.921783953079068}], ["PRKX", ["TCGA.CK.5914.01", "Opioid Signalling"], {"weight": 0.917766209292204}], ["PRKX", ["TCGA.CK.5914.01", "Integration of energy metabolism"], {"weight": 0.92263774385705}], ["PRKX", ["TCGA.CK.5914.01", "PLC beta mediated events"], {"weight": 0.896882108074014}], ["PRKX", ["TCGA.CK.5914.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.936499990117663}], ["PRKX", ["TCGA.CK.5914.01", "Leishmania parasite growth and survival"], {"weight": 0.936499990117663}], ["PRKX", ["TCGA.CK.5914.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.923004614700591}], ["PRKX", ["TCGA.CK.5914.01", "Transport of small molecules"], {"weight": 0.871072784432693}], ["PRKX", ["TCGA.CK.5914.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.918602850789331}], ["PRKX", ["TCGA.CK.5914.01", "Aquaporin-mediated transport"], {"weight": 0.918602850789331}], ["PRKX", ["TCGA.CK.5914.01", "GPER1 signaling"], {"weight": 0.920957076785076}], ["PRKX", ["TCGA.CK.5914.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.920648354765863}], ["PRKX", ["TCGA.CK.5914.01", "Post NMDA receptor activation events"], {"weight": 0.928967096104882}], ["PRKX", ["TCGA.D5.6537.01", "GPCR downstream signalling"], {"weight": 0.943685787379382}], ["PRKX", ["TCGA.D5.6537.01", "Transmission across Chemical Synapses"], {"weight": 0.942810008130939}], ["PRKX", ["TCGA.D5.6537.01", "G alpha (i) signalling events"], {"weight": 0.949105742727465}], ["PRKX", ["TCGA.D5.6537.01", "G-protein mediated events"], {"weight": 0.918166218942098}], ["PRKX", ["TCGA.D5.6537.01", "Opioid Signalling"], {"weight": 0.93231447773925}], ["PRKX", ["TCGA.D5.6537.01", "PLC beta mediated events"], {"weight": 0.913242058651937}], ["PRKX", ["TCGA.D5.6537.01", "Ca-dependent events"], {"weight": 0.911320372315039}], ["PRKX", ["TCGA.D5.6537.01", "Calmodulin induced events"], {"weight": 0.910154872559441}], ["PRKX", ["TCGA.D5.6537.01", "CaM pathway"], {"weight": 0.910154872559441}], ["PRKX", ["TCGA.D5.6537.01", "Regulation of insulin secretion"], {"weight": 0.933411758980375}], ["PRKX", ["TCGA.D5.6537.01", "DAG and IP3 signaling"], {"weight": 0.911898898842336}], ["PRKX", ["TCGA.D5.6537.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.927378961641378}], ["PRKX", ["TCGA.D5.6537.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.891400735451628}], ["PRKX", ["TCGA.D5.6537.01", "Leishmania parasite growth and survival"], {"weight": 0.891400735451628}], ["PRKX", ["TCGA.D5.6537.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.930670255747592}], ["PRKX", ["TCGA.D5.6537.01", "GPER1 signaling"], {"weight": 0.928537381023505}], ["PRKX", ["TCGA.D5.6537.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.928283048323868}], ["PRKX", ["TCGA.D5.6537.01", "Leishmania infection"], {"weight": 0.89631634601854}], ["PRKX", ["TCGA.D5.6537.01", "Parasitic Infection Pathways"], {"weight": 0.89631634601854}], ["PRKX", ["TCGA.D5.6537.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.921413557398266}], ["PRKX", ["TCGA.D5.6537.01", "Aquaporin-mediated transport"], {"weight": 0.921413557398266}], ["PRKX", ["TCGA.D5.6537.01", "PKA activation in glucagon signalling"], {"weight": 0.897363550046798}], ["SOD3", ["TCGA.D5.6537.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.861569502056444}], ["ATP1A1", ["TCGA.G4.6628.01", "Ion channel transport"], {"weight": 0.920837703844029}], ["ACOT12", ["TCGA.CK.4947.01", "RA biosynthesis pathway"], {"weight": 0.847907956423825}], ["ACOT12", ["TCGA.CK.4947.01", "Signaling by Retinoic Acid"], {"weight": 0.74177409412635}], ["ACOT12", ["TCGA.CK.4947.01", "Ethanol oxidation"], {"weight": 0.733452308291553}], ["GRIN2A", ["TCGA.D5.6532.01", "Visual phototransduction"], {"weight": 0.800180577445601}], ["GRIN2A", ["TCGA.D5.6537.01", "Phase 0 - rapid depolarisation"], {"weight": 0.938546983157623}], ["GRIN2A", ["TCGA.D5.6537.01", "Ion transport by P-type ATPases"], {"weight": 0.905370229464004}], ["GRIN2A", ["TCGA.D5.6537.01", "Visual phototransduction"], {"weight": 0.924397670364153}], ["GRIN2A", ["TCGA.D5.6537.01", "Trafficking of AMPA receptors"], {"weight": 0.9333798838276}], ["GRIN2A", ["TCGA.D5.6537.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.9333798838276}], ["GRIN2A", ["TCGA.DM.A1DB.01", "Phase 0 - rapid depolarisation"], {"weight": 0.93940101941014}], ["GRIN2A", ["TCGA.DM.A1DB.01", "Ion transport by P-type ATPases"], {"weight": 0.906377907052717}], ["GRIN2A", ["TCGA.DM.A1DB.01", "CD22 mediated BCR regulation"], {"weight": 0.75813502255463}], ["GRIN2A", ["TCGA.DM.A1DB.01", "Ras activation upon Ca2+ influx through NMDA receptor"], {"weight": 0.90045347836387}], ["PTK7", ["TCGA.AD.6965.01", "Biological oxidations"], {"weight": 0.884299968904066}], ["DLL1", ["TCGA.G4.6317.01", "Molecules associated with elastic fibres"], {"weight": 0.862685554079428}], ["DLL1", ["TCGA.G4.6317.01", "Blood group systems biosynthesis"], {"weight": 0.861070231184811}], ["DLL1", ["TCGA.G4.6317.01", "Keratan sulfate biosynthesis"], {"weight": 0.90895037966534}], ["PTGER4", ["TCGA.D5.6533.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.943974425547939}], ["TRPV1", ["TCGA.D5.6538.01", "Ion channel transport"], {"weight": 0.92165369117779}], ["TRPV1", ["TCGA.D5.6538.01", "Stimuli-sensing channels"], {"weight": 0.905205530209639}], ["NDUFA9", ["TCGA.AZ.6605.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.471001027591457}], ["NDUFA9", ["TCGA.AZ.6605.01", "Glycosaminoglycan metabolism"], {"weight": 0.59987119477789}], ["SLC39A3", ["TCGA.CM.6162.01", "SLC-mediated transmembrane transport"], {"weight": 0.76253752369058}], ["RET", ["TCGA.DM.A28F.01", "Protein-protein interactions at synapses"], {"weight": 0.91416247191678}], ["WASF3", ["TCGA.CK.5914.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.928249204068211}], ["WASF3", ["TCGA.CK.5914.01", "Protein-protein interactions at synapses"], {"weight": 0.901904689085189}], ["ASPH", ["TCGA.AY.6196.01", "Stimuli-sensing channels"], {"weight": 0.833519593257717}], ["GABRA6", ["TCGA.AA.3663.01", "GABA receptor activation"], {"weight": 0.920982151283166}], ["GABRA6", ["TCGA.G4.6304.01", "Transmission across Chemical Synapses"], {"weight": 0.941732270555188}], ["CDC42", ["TCGA.AA.3663.01", "Signaling by GPCR"], {"weight": 0.944384634168037}], ["CDC42", ["TCGA.AA.3663.01", "GPCR downstream signalling"], {"weight": 0.943673207907859}], ["CDC42", ["TCGA.AA.3663.01", "Signaling Pathways"], {"weight": 0.904047702812758}], ["MEF2A", ["TCGA.CK.4952.01", "Cardiac conduction"], {"weight": 0.943412790718361}], ["MEF2A", ["TCGA.CK.4952.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.889779680882158}], ["MEF2A", ["TCGA.CK.4952.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.930177993516055}], ["MEF2A", ["TCGA.CK.4952.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.91503602374561}], ["MEF2A", ["TCGA.G4.6298.01", "Cardiac conduction"], {"weight": 0.919604252506123}], ["MEF2A", ["TCGA.G4.6298.01", "Glucuronidation"], {"weight": 0.925877575358798}], ["MEF2A", ["TCGA.G4.6298.01", "Phase 0 - rapid depolarisation"], {"weight": 0.929508129491021}], ["MEF2A", ["TCGA.G4.6298.01", "Muscle contraction"], {"weight": 0.931213406264663}], ["MEF2A", ["TCGA.G4.6298.01", "Transport of small molecules"], {"weight": 0.916006262110184}], ["KCNJ2", ["TCGA.AA.3663.01", "Phase 4 - resting membrane potential"], {"weight": 0.917597993814496}], ["KCNJ2", ["TCGA.CM.6172.01", "GPCR ligand binding"], {"weight": 0.925699486154144}], ["KCNJ2", ["TCGA.CM.6172.01", "G alpha (s) signalling events"], {"weight": 0.932324938851103}], ["KCNJ2", ["TCGA.CM.6172.01", "G alpha (i) signalling events"], {"weight": 0.897979780093166}], ["KCNJ2", ["TCGA.CM.6172.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.872443642720565}], ["KCNJ2", ["TCGA.CM.6172.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.877903227192149}], ["KCNJ2", ["TCGA.CM.6172.01", "GABA receptor activation"], {"weight": 0.539882857887445}], ["KCNJ2", ["TCGA.CM.6172.01", "Glucagon-type ligand receptors"], {"weight": 0.875096188430535}], ["KCNJ2", ["TCGA.CM.6172.01", "G-protein activation"], {"weight": 0.879822650357995}], ["KCNJ2", ["TCGA.CM.6172.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.904277561579976}], ["KCNJ2", ["TCGA.CM.6172.01", "G beta:gamma signalling through BTK"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.888082264905641}], ["KCNJ2", ["TCGA.CM.6172.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Potassium Channels"], {"weight": 0.920713922955689}], ["KCNJ2", ["TCGA.CM.6172.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "G beta:gamma signalling through CDC42"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Signaling by Nuclear Receptors"], {"weight": 0.808808129339132}], ["KCNJ2", ["TCGA.CM.6172.01", "Presynaptic function of Kainate receptors"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.771837479896179}], ["KCNJ2", ["TCGA.CM.6172.01", "Signal amplification"], {"weight": 0.872443642720565}], ["KCNJ2", ["TCGA.CM.6172.01", "Neuronal System"], {"weight": 0.740500940086099}], ["KCNJ2", ["TCGA.CM.6172.01", "Extra-nuclear estrogen signaling"], {"weight": 0.848744877248812}], ["KCNJ2", ["TCGA.CM.6172.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.862855951272448}], ["KCNJ2", ["TCGA.CM.6172.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Inwardly rectifying K+ channels"], {"weight": 0.868254348669343}], ["KCNJ2", ["TCGA.CM.6172.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.CM.6172.01", "Thromboxane signalling through TP receptor"], {"weight": 0.842087127384903}], ["KCNJ2", ["TCGA.D5.6930.01", "Phase 4 - resting membrane potential"], {"weight": 0.816015279796109}], ["MATK", ["TCGA.AA.3663.01", "Protein-protein interactions at synapses"], {"weight": 0.923057952444183}], ["MATK", ["TCGA.AM.5821.01", "Neuronal System"], {"weight": 0.951348105191886}], ["CTGF", ["TCGA.AZ.6599.01", "FGFR1 ligand binding and activation"], {"weight": 0.914554890458412}], ["CTGF", ["TCGA.AZ.6599.01", "FGFR1c ligand binding and activation"], {"weight": 0.89059695952686}], ["DUSP16", ["TCGA.F4.6854.01", "Drug ADME"], {"weight": 0.784943859173465}], ["SPRY1", ["TCGA.D5.6932.01", "L1CAM interactions"], {"weight": 0.849353517822852}], ["ALOX12", ["TCGA.AA.3663.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.88059870508825}], ["AKAP11", ["TCGA.AD.6895.01", "Regulation of insulin secretion"], {"weight": 0.905432955617515}], ["AKAP11", ["TCGA.AD.6895.01", "G alpha (s) signalling events"], {"weight": 0.952907041677782}], ["AKAP11", ["TCGA.CK.5916.01", "G alpha (i) signalling events"], {"weight": 0.94406255945806}], ["AKAP11", ["TCGA.CK.5916.01", "Regulation of insulin secretion"], {"weight": 0.891895770891247}], ["AKAP11", ["TCGA.DM.A1DA.01", "G alpha (i) signalling events"], {"weight": 0.966843705435268}], ["AKAP11", ["TCGA.DM.A1DA.01", "G alpha (s) signalling events"], {"weight": 0.967800460469272}], ["AKAP11", ["TCGA.DM.A1DA.01", "Calmodulin induced events"], {"weight": 0.940009303925766}], ["AKAP11", ["TCGA.DM.A1DA.01", "CaM pathway"], {"weight": 0.940009303925766}], ["AKAP11", ["TCGA.DM.A1DA.01", "G-protein mediated events"], {"weight": 0.94486298522005}], ["AKAP11", ["TCGA.DM.A1DA.01", "Ca-dependent events"], {"weight": 0.940009303925766}], ["AKAP11", ["TCGA.DM.A1DA.01", "DAG and IP3 signaling"], {"weight": 0.940926847755625}], ["AKAP11", ["TCGA.DM.A1DA.01", "Integration of energy metabolism"], {"weight": 0.947833006460623}], ["AKAP11", ["TCGA.DM.A1DA.01", "PLC beta mediated events"], {"weight": 0.93966658693463}], ["AKAP11", ["TCGA.DM.A1DA.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.898360890706136}], ["AKAP11", ["TCGA.DM.A1DA.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.938096852909675}], ["AKAP11", ["TCGA.F4.6856.01", "Signaling by GPCR"], {"weight": 0.940075234199229}], ["AKAP11", ["TCGA.F4.6856.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.903536216462069}], ["ALK", ["TCGA.AM.5820.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.90106479927928}], ["ALK", ["TCGA.G4.6304.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.930437711058758}], ["A1BG", ["TCGA.D5.6531.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.83417389218068}], ["A1BG", ["TCGA.D5.6531.01", "IRS-related events triggered by IGF1R"], {"weight": 0.863794295290603}], ["A1BG", ["TCGA.D5.6531.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.863638344288834}], ["A1BG", ["TCGA.D5.6531.01", "IGF1R signaling cascade"], {"weight": 0.863638344288834}], ["A1BG", ["TCGA.D5.6531.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.835659722236363}], ["A1BG", ["TCGA.D5.6531.01", "Degradation of the extracellular matrix"], {"weight": 0.787031026135027}], ["A1BG", ["TCGA.D5.6531.01", "Peptide hormone metabolism"], {"weight": 0.730314960963027}], ["SRY", ["TCGA.AA.3697.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.854628109324113}], ["SRY", ["TCGA.AD.6889.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.911791223686947}], ["E2F7", ["TCGA.D5.5541.01", "Transcription of E2F targets under negative control by DREAM complex"], {"weight": 0.840092629646588}], ["E2F7", ["TCGA.D5.5541.01", "G0 and Early G1"], {"weight": 0.85128777319875}], ["MTNR1B", ["TCGA.AD.6965.01", "Defensins"], {"weight": 0.529684568124998}], ["MTNR1B", ["TCGA.DM.A1D6.01", "Initial triggering of complement"], {"weight": 0.893477723123613}], ["MTNR1B", ["TCGA.DM.A1D6.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.819777466281955}], ["MTNR1B", ["TCGA.DM.A1D6.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.819777466281955}], ["LTBP3", ["TCGA.AZ.6599.01", "Extracellular matrix organization"], {"weight": 0.929805344632082}], ["LTBP3", ["TCGA.AZ.6599.01", "Elastic fibre formation"], {"weight": 0.908056295120012}], ["LTBP3", ["TCGA.AZ.6599.01", "Molecules associated with elastic fibres"], {"weight": 0.891073572880357}], ["LTBP3", ["TCGA.AZ.6599.01", "Initial triggering of complement"], {"weight": 0.768756151304627}], ["CNDP2", ["TCGA.AZ.6598.01", "Drug ADME"], {"weight": 0.947419333647141}], ["CNDP2", ["TCGA.AZ.6598.01", "APAP ADME"], {"weight": 0.895428256054728}], ["SIN3A", ["TCGA.AA.3697.01", "SUMOylation of DNA methylation proteins"], {"weight": 0.713702563741622}], ["SIN3A", ["TCGA.D5.6924.01", "Signaling by Retinoic Acid"], {"weight": 0.659873361472987}], ["RAMP3", ["TCGA.CM.5344.01", "G alpha (s) signalling events"], {"weight": 0.950252403008829}], ["RAMP3", ["TCGA.CM.5344.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.903547527436848}], ["RAMP3", ["TCGA.CM.5344.01", "Peptide ligand-binding receptors"], {"weight": 0.880853402124029}], ["CCR5", ["TCGA.G4.6303.01", "GPCR ligand binding"], {"weight": 0.936740991363423}], ["CCR5", ["TCGA.G4.6303.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.933889714141467}], ["CCR5", ["TCGA.G4.6303.01", "Peptide ligand-binding receptors"], {"weight": 0.933667311630734}], ["CCR5", ["TCGA.G4.6303.01", "Chemokine receptors bind chemokines"], {"weight": 0.900363344628877}], ["CCR5", ["TCGA.G4.6322.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.941758929195329}], ["CCR5", ["TCGA.G4.6322.01", "Chemokine receptors bind chemokines"], {"weight": 0.911006917955723}], ["CCR5", ["TCGA.G4.6322.01", "Peptide ligand-binding receptors"], {"weight": 0.925642132269132}], ["ITPR2", ["TCGA.AY.6197.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.850861066409545}], ["ITPR2", ["TCGA.AY.6197.01", "Leishmania parasite growth and survival"], {"weight": 0.850861066409545}], ["ITPR2", ["TCGA.AY.6197.01", "G alpha (q) signalling events"], {"weight": 0.874976778404892}], ["ITPR2", ["TCGA.AZ.4615.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.769425338392248}], ["ITPR2", ["TCGA.G4.6588.01", "CD22 mediated BCR regulation"], {"weight": 0.845674779448259}], ["CNTN1", ["TCGA.AY.6197.01", "Interaction between L1 and Ankyrins"], {"weight": 0.940537219669653}], ["CNTN1", ["TCGA.CM.5864.01", "Interaction between L1 and Ankyrins"], {"weight": 0.943169693085426}], ["ATP4A", ["TCGA.AA.3697.01", "Transport of small molecules"], {"weight": 0.774504776224063}], ["UXS1", ["TCGA.AZ.6605.01", "Drug ADME"], {"weight": 0.71716882950811}], ["UXS1", ["TCGA.G4.6304.01", "Drug ADME"], {"weight": 0.905290260310104}], ["UXS1", ["TCGA.G4.6304.01", "Glucuronidation"], {"weight": 0.924230037029918}], ["UXS1", ["TCGA.G4.6304.01", "Aspirin ADME"], {"weight": 0.956799918439727}], ["UXS1", ["TCGA.G4.6304.01", "Heme degradation"], {"weight": 0.857874331212839}], ["UXS1", ["TCGA.G4.6586.01", "Glucuronidation"], {"weight": 0.912710181669138}], ["RECQL5", ["TCGA.CM.6676.01", "FGFR2 ligand binding and activation"], {"weight": 0.828552815375487}], ["GTF2IRD1", ["TCGA.DM.A28H.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.780768181555255}], ["CWC27", ["TCGA.CM.6166.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.760327704319826}], ["OR2T6", ["TCGA.CM.6676.01", "Signaling by GPCR"], {"weight": 0.923423267081397}], ["OR2T6", ["TCGA.CM.6676.01", "GPCR downstream signalling"], {"weight": 0.927310112344142}], ["OR2T6", ["TCGA.CM.6676.01", "GPCR ligand binding"], {"weight": 0.930515375055293}], ["OR2T6", ["TCGA.CM.6676.01", "Ca2+ pathway"], {"weight": 0.829467114617049}], ["OR2T6", ["TCGA.CM.6676.01", "Transmission across Chemical Synapses"], {"weight": 0.919068285139607}], ["OR2T6", ["TCGA.CM.6676.01", "Glucagon-type ligand receptors"], {"weight": 0.903446979995957}], ["OR2T6", ["TCGA.CM.6676.01", "Inwardly rectifying K+ channels"], {"weight": 0.916515122490889}], ["OR2T6", ["TCGA.CM.6676.01", "G beta:gamma signalling through BTK"], {"weight": 0.89713202299519}], ["OR2T6", ["TCGA.CM.6676.01", "G alpha (i) signalling events"], {"weight": 0.923259446575554}], ["OR2T6", ["TCGA.CM.6676.01", "G alpha (s) signalling events"], {"weight": 0.930215286757261}], ["OR2T6", ["TCGA.CM.6676.01", "Peptide hormone metabolism"], {"weight": 0.731869568428783}], ["OR2T6", ["TCGA.CM.6676.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.914581375105324}], ["OR2T6", ["TCGA.CM.6676.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.887790551793512}], ["OR2T6", ["TCGA.CM.6676.01", "Activation of G protein gated Potassium channels"], {"weight": 0.90087086553749}], ["OR2T6", ["TCGA.CM.6676.01", "G protein gated Potassium channels"], {"weight": 0.90087086553749}], ["OR2T6", ["TCGA.CM.6676.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.90087086553749}], ["OR2T6", ["TCGA.CM.6676.01", "Chemokine receptors bind chemokines"], {"weight": 0.879573591566996}], ["OR2T6", ["TCGA.CM.6676.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.719939491769965}], ["OR2T6", ["TCGA.CM.6676.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.886443445721034}], ["OR2T6", ["TCGA.CM.6676.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.847957186841051}], ["OR2T6", ["TCGA.CM.6676.01", "Leishmania parasite growth and survival"], {"weight": 0.847957186841051}], ["OR2T6", ["TCGA.CM.6676.01", "G-protein beta:gamma signalling"], {"weight": 0.909430185696782}], ["OR2T6", ["TCGA.CM.6676.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.887679009075476}], ["OR2T6", ["TCGA.CM.6676.01", "Potassium Channels"], {"weight": 0.942925738933003}], ["OR2T6", ["TCGA.CM.6676.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.822854227939003}], ["OR2T6", ["TCGA.CM.6676.01", "Regulation of insulin secretion"], {"weight": 0.783161847190737}], ["OR2T6", ["TCGA.CM.6676.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.851618217221875}], ["OR2T6", ["TCGA.CM.6676.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.887905967029069}], ["OR2T6", ["TCGA.CM.6676.01", "Signal amplification"], {"weight": 0.897735075086957}], ["OR2T6", ["TCGA.CM.6676.01", "GABA receptor activation"], {"weight": 0.586285632081347}], ["OR2T6", ["TCGA.CM.6676.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.851618217221875}], ["OR2T6", ["TCGA.CM.6676.01", "G beta:gamma signalling through CDC42"], {"weight": 0.851618217221875}], ["OR2T6", ["TCGA.CM.6676.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.814428215133029}], ["USP8", ["TCGA.DM.A28M.01", "Costimulation by the CD28 family"], {"weight": 0.925163492359262}], ["FCN3", ["TCGA.CK.5912.01", "Regulation of Complement cascade"], {"weight": 0.835184422087874}], ["FCN3", ["TCGA.CK.5912.01", "Complement cascade"], {"weight": 0.874694311952037}], ["FCN3", ["TCGA.CK.5912.01", "Classical antibody-mediated complement activation"], {"weight": 0.659345792888901}], ["FCN3", ["TCGA.CK.5912.01", "Initial triggering of complement"], {"weight": 0.857885266449948}], ["SLC25A22", ["TCGA.CK.5916.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.86116830408612}], ["SUMF1", ["TCGA.AZ.4323.01", "Visual phototransduction"], {"weight": 0.781809311246393}], ["SUMF1", ["TCGA.AZ.4323.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.750066384341669}], ["SUMF1", ["TCGA.AZ.4323.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.791953343998869}], ["SUMF1", ["TCGA.AZ.4323.01", "Retinoid metabolism and transport"], {"weight": 0.791953343998869}], ["SUMF1", ["TCGA.D5.6537.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.834868582722234}], ["FLVCR1", ["TCGA.DM.A28K.01", "TNFs bind their physiological receptors"], {"weight": 0.437025900835146}], ["SYT1", ["TCGA.AA.3697.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.60706764553703}], ["CSNK1A1L", ["TCGA.AA.3697.01", "Phase 0 - rapid depolarisation"], {"weight": 0.867970600452268}], ["CSNK1A1L", ["TCGA.AA.3697.01", "RET signaling"], {"weight": 0.890566438565944}], ["TAAR1", ["TCGA.AA.3697.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.886353313298266}], ["IL18", ["TCGA.CA.6716.01", "Signaling by GPCR"], {"weight": 0.946982288472678}], ["IL18", ["TCGA.CA.6716.01", "Chemokine receptors bind chemokines"], {"weight": 0.930119557442263}], ["IL18", ["TCGA.CA.6716.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.941643177715347}], ["IL18", ["TCGA.CA.6716.01", "Peptide ligand-binding receptors"], {"weight": 0.940559962047487}], ["IL18", ["TCGA.CA.6716.01", "Binding and entry of HIV virion"], {"weight": 0.71370366964229}], ["DOCK10", ["TCGA.AD.6901.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.818162642811088}], ["CSF2RB", ["TCGA.CM.5862.01", "O-linked glycosylation"], {"weight": -0.0130259782764402}], ["CSF2RB", ["TCGA.G4.6315.01", "Classical antibody-mediated complement activation"], {"weight": 0.694816627183325}], ["CSF2RB", ["TCGA.G4.6315.01", "Creation of C4 and C2 activators"], {"weight": 0.654543192452281}], ["CSF2RB", ["TCGA.G4.6586.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.906657943514922}], ["CSF2RB", ["TCGA.G4.6586.01", "Leishmania parasite growth and survival"], {"weight": 0.906657943514922}], ["APBA3", ["TCGA.G4.6293.01", "Neuronal System"], {"weight": 0.889798020136936}], ["APBA3", ["TCGA.G4.6586.01", "Neurexins and neuroligins"], {"weight": 0.952525089071484}], ["GSTP1", ["TCGA.AA.3697.01", "APAP ADME"], {"weight": 0.827050288269374}], ["GSTP1", ["TCGA.AM.5821.01", "APAP ADME"], {"weight": 0.940859750394705}], ["GSTP1", ["TCGA.D5.6533.01", "Drug ADME"], {"weight": 0.849850293411395}], ["GSTP1", ["TCGA.D5.6533.01", "Glutathione conjugation"], {"weight": 0.886408499021716}], ["GSTP1", ["TCGA.D5.6533.01", "RA biosynthesis pathway"], {"weight": 0.87158384200977}], ["GSTP1", ["TCGA.D5.6533.01", "Ethanol oxidation"], {"weight": 0.917457450895655}], ["GSTP1", ["TCGA.D5.6533.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.870906989172426}], ["SDC4", ["TCGA.AA.3712.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.855899460364887}], ["SDC4", ["TCGA.AA.3712.01", "Retinoid metabolism and transport"], {"weight": 0.855899460364887}], ["SDC4", ["TCGA.G4.6321.01", "GPCR ligand binding"], {"weight": 0.882480932945291}], ["USP15", ["TCGA.CM.6171.01", "Elastic fibre formation"], {"weight": 0.863128440752523}], ["PPP2R3A", ["TCGA.AA.3697.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.900204384976328}], ["PPP2R3A", ["TCGA.AA.3697.01", "Muscle contraction"], {"weight": 0.874087690061988}], ["PPP2R3A", ["TCGA.AA.3697.01", "Extra-nuclear estrogen signaling"], {"weight": 0.822252613651334}], ["PPP2R3A", ["TCGA.AM.5821.01", "Cardiac conduction"], {"weight": 0.94311399832056}], ["PPP2R3A", ["TCGA.AY.6196.01", "Metabolism"], {"weight": 0.90661993300475}], ["PPP2R3A", ["TCGA.AZ.6598.01", "Cardiac conduction"], {"weight": 0.936623289359397}], ["PPP2R3A", ["TCGA.AZ.6598.01", "Muscle contraction"], {"weight": 0.949887709093812}], ["PPP2R3A", ["TCGA.AZ.6598.01", "Ion homeostasis"], {"weight": 0.928604230143236}], ["PPP2R3A", ["TCGA.G4.6309.01", "Cardiac conduction"], {"weight": 0.925004696624407}], ["PPP2R3A", ["TCGA.G4.6309.01", "Muscle contraction"], {"weight": 0.927117417552899}], ["GUCY2D", ["TCGA.AA.3697.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.822797873357625}], ["GUCY2D", ["TCGA.AA.3697.01", "Platelet homeostasis"], {"weight": 0.803034399644664}], ["GUCY2D", ["TCGA.AA.3697.01", "Visual phototransduction"], {"weight": 0.801162938477103}], ["GUCY2D", ["TCGA.AA.3697.01", "Activation of the phototransduction cascade"], {"weight": 0.819844058382504}], ["GUCY2D", ["TCGA.G4.6302.01", "Regulation of beta-cell development"], {"weight": 0.670889878140579}], ["HOMER3", ["TCGA.D5.6537.01", "Activation of NMDA receptors and postsynaptic events"], {"weight": 0.909315554494514}], ["HOMER3", ["TCGA.D5.6537.01", "Post NMDA receptor activation events"], {"weight": 0.936093464855713}], ["HOMER3", ["TCGA.D5.6537.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.933510824482411}], ["NSMAF", ["TCGA.D5.6535.01", "TNFs bind their physiological receptors"], {"weight": 0.390112957867316}], ["NSMAF", ["TCGA.D5.6932.01", "TNFs bind their physiological receptors"], {"weight": 0.374388302870248}], ["ABCC9", ["TCGA.AA.3697.01", "Potassium Channels"], {"weight": 0.94143773650975}], ["ABCC9", ["TCGA.AA.3697.01", "Inwardly rectifying K+ channels"], {"weight": 0.911596260609214}], ["ABCC9", ["TCGA.AZ.4615.01", "Potassium Channels"], {"weight": 0.960032627884665}], ["ABCC9", ["TCGA.AZ.4615.01", "Inwardly rectifying K+ channels"], {"weight": 0.930583571581494}], ["ABCC9", ["TCGA.D5.6535.01", "Neuronal System"], {"weight": 0.921594010055653}], ["ABCC9", ["TCGA.D5.6535.01", "Cardiac conduction"], {"weight": 0.860485931528439}], ["ABCC9", ["TCGA.D5.6535.01", "Muscle contraction"], {"weight": 0.862496644393056}], ["PIGQ", ["TCGA.G4.6586.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.962503510117437}], ["TLE1", ["TCGA.CM.5344.01", "Collagen chain trimerization"], {"weight": 0.889102832090545}], ["TLE1", ["TCGA.CM.5344.01", "Biological oxidations"], {"weight": 0.908397134658139}], ["TLE1", ["TCGA.CM.5344.01", "Glucuronidation"], {"weight": 0.863882898306332}], ["SH3BP5", ["TCGA.AA.3697.01", "Protein-protein interactions at synapses"], {"weight": 0.852184989988579}], ["CYP3A7", ["TCGA.AA.3697.01", "Ethanol oxidation"], {"weight": 0.865591593686242}], ["CYP3A7", ["TCGA.AA.3697.01", "Glucuronidation"], {"weight": 0.863012920172147}], ["CYP3A7", ["TCGA.DM.A28H.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.860505293382069}], ["CYP3A7", ["TCGA.DM.A28H.01", "Biological oxidations"], {"weight": 0.925748627355102}], ["MMP15", ["TCGA.D5.6540.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.942053789556472}], ["MMP15", ["TCGA.DM.A1D9.01", "Caspase-mediated cleavage of cytoskeletal proteins"], {"weight": 0.592510141354115}], ["MMP15", ["TCGA.DM.A1D9.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.731982881137396}], ["SOAT1", ["TCGA.AA.3697.01", "Phase II - Conjugation of compounds"], {"weight": 0.811110905779699}], ["SOAT1", ["TCGA.AA.3697.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.885911740238875}], ["SOAT1", ["TCGA.CA.6719.01", "Biological oxidations"], {"weight": 0.900210840314369}], ["SOAT1", ["TCGA.CM.5861.01", "Biological oxidations"], {"weight": 0.948570073020797}], ["SOAT1", ["TCGA.CM.5861.01", "Phase I - Functionalization of compounds"], {"weight": 0.941171869560969}], ["CAMKK2", ["TCGA.AA.3712.01", "Neuronal System"], {"weight": 0.908649654626019}], ["ITGA3", ["TCGA.AA.3712.01", "Extracellular matrix organization"], {"weight": 0.861720981549154}], ["ITGA3", ["TCGA.DM.A1DB.01", "Elastic fibre formation"], {"weight": 0.916540373475723}], ["ITGA3", ["TCGA.DM.A1DB.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.489086632735667}], ["ITGA3", ["TCGA.DM.A1DB.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.503704395864326}], ["ITGA3", ["TCGA.DM.A1DB.01", "NCAM1 interactions"], {"weight": 0.942832659071014}], ["CAMKK2", ["TCGA.AA.3712.01", "Transmission across Chemical Synapses"], {"weight": 0.904746941259461}], ["CAMKK2", ["TCGA.AA.3712.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.912664255411818}], ["CAMKK2", ["TCGA.CK.5913.01", "Neuronal System"], {"weight": 0.937369995190427}], ["CAMKK2", ["TCGA.CK.5913.01", "Transmission across Chemical Synapses"], {"weight": 0.93095961400146}], ["CAMKK2", ["TCGA.CK.5913.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.918781475660385}], ["ALPP", ["TCGA.F4.6703.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.823829040898237}], ["UGT1A4", ["TCGA.AA.3712.01", "Glucuronidation"], {"weight": 0.905000731336847}], ["UGT1A4", ["TCGA.AA.3712.01", "Drug ADME"], {"weight": 0.870811461476923}], ["UGT1A4", ["TCGA.AA.3712.01", "Heme degradation"], {"weight": 0.66947281872766}], ["OR5W2", ["TCGA.AA.3712.01", "Calmodulin induced events"], {"weight": 0.833296536209854}], ["OR5W2", ["TCGA.AA.3712.01", "CaM pathway"], {"weight": 0.833296536209854}], ["OR5W2", ["TCGA.AA.3712.01", "Ca-dependent events"], {"weight": 0.833296536209854}], ["OR5W2", ["TCGA.AA.3712.01", "G-protein mediated events"], {"weight": 0.855546579254736}], ["OR5W2", ["TCGA.AU.3779.01", "GPCR ligand binding"], {"weight": 0.922995111407682}], ["OR5W2", ["TCGA.AU.3779.01", "G alpha (s) signalling events"], {"weight": 0.9476569044554}], ["OR5W2", ["TCGA.AU.3779.01", "GPCR downstream signalling"], {"weight": 0.944792412705874}], ["OR5W2", ["TCGA.AU.3779.01", "Signaling by GPCR"], {"weight": 0.944937614237211}], ["OR5W2", ["TCGA.AU.3779.01", "G alpha (i) signalling events"], {"weight": 0.943263177819054}], ["OR5W2", ["TCGA.AU.3779.01", "Glucagon-type ligand receptors"], {"weight": 0.910421807557298}], ["OR5W2", ["TCGA.AU.3779.01", "Integration of energy metabolism"], {"weight": 0.856874263587356}], ["OR5W2", ["TCGA.AU.3779.01", "Regulation of insulin secretion"], {"weight": 0.8661452131282}], ["OR5W2", ["TCGA.AU.3779.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.912216829389828}], ["OR5W2", ["TCGA.AU.3779.01", "Transmission across Chemical Synapses"], {"weight": 0.903431648693707}], ["OR5W2", ["TCGA.AU.3779.01", "Signaling by BMP"], {"weight": 0.811960176182193}], ["OR5W2", ["TCGA.AU.3779.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.904529723366056}], ["OR5W2", ["TCGA.AU.3779.01", "Signal amplification"], {"weight": 0.909992547113957}], ["OR5W2", ["TCGA.AU.3779.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.899483077459864}], ["OR5W2", ["TCGA.AU.3779.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.897225040489133}], ["OR5W2", ["TCGA.AU.3779.01", "GABA B receptor activation"], {"weight": 0.916938097202}], ["OR5W2", ["TCGA.AU.3779.01", "Activation of GABAB receptors"], {"weight": 0.916938097202}], ["OR5W2", ["TCGA.AU.3779.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.898338738632192}], ["OR5W2", ["TCGA.AU.3779.01", "Presynaptic function of Kainate receptors"], {"weight": 0.884542624643584}], ["OR5W2", ["TCGA.AU.3779.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.887171437331586}], ["OR5W2", ["TCGA.AU.3779.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.921126661938847}], ["OR5W2", ["TCGA.AU.3779.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.899207807817322}], ["OR5W2", ["TCGA.AU.3779.01", "Peptide hormone metabolism"], {"weight": 0.74396299295872}], ["OR5W2", ["TCGA.AU.3779.01", "G-protein activation"], {"weight": 0.897679224962627}], ["OR5W2", ["TCGA.AU.3779.01", "Thromboxane signalling through TP receptor"], {"weight": 0.891755752338562}], ["OR5W2", ["TCGA.AU.3779.01", "GPER1 signaling"], {"weight": 0.89712541952136}], ["OR5W2", ["TCGA.AU.3779.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.89712541952136}], ["OR5W2", ["TCGA.AU.3779.01", "G beta:gamma signalling through BTK"], {"weight": 0.868729409074679}], ["OR5W2", ["TCGA.AU.3779.01", "Inwardly rectifying K+ channels"], {"weight": 0.858898265202123}], ["OR5W2", ["TCGA.AU.3779.01", "G alpha (q) signalling events"], {"weight": 0.917743415334279}], ["KREMEN2", ["TCGA.AA.3712.01", "Regulation of FZD by ubiquitination"], {"weight": 0.816682754134071}], ["CBR3", ["TCGA.AA.3712.01", "Phase II - Conjugation of compounds"], {"weight": 0.850037541520013}], ["CBR3", ["TCGA.AA.3712.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.822338108491039}], ["CBR3", ["TCGA.AM.5820.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.851335528278163}], ["CBR3", ["TCGA.D5.6537.01", "Drug ADME"], {"weight": 0.877075598454706}], ["CBR3", ["TCGA.D5.6537.01", "Biological oxidations"], {"weight": 0.930392830931988}], ["CBR3", ["TCGA.D5.6537.01", "Heme degradation"], {"weight": 0.816416076528723}], ["CBR3", ["TCGA.D5.6537.01", "Aspirin ADME"], {"weight": 0.828673774311728}], ["CBR3", ["TCGA.D5.6537.01", "Phase II - Conjugation of compounds"], {"weight": 0.831695390194046}], ["SCIN", ["TCGA.AA.3712.01", "Caspase-mediated cleavage of cytoskeletal proteins"], {"weight": 0.608943460742392}], ["GYS1", ["TCGA.AA.3712.01", "Integration of energy metabolism"], {"weight": 0.900889817884485}], ["GYS1", ["TCGA.AZ.4615.01", "Neuronal System"], {"weight": 0.943117391213063}], ["NMNAT2", ["TCGA.AZ.4682.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.622231067220021}], ["WNT8B", ["TCGA.AA.3712.01", "Signaling Pathways"], {"weight": 0.892752933201185}], ["FGFR1", ["TCGA.CM.6171.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.84392171301651}], ["FGFR1", ["TCGA.G4.6309.01", "Signaling by GPCR"], {"weight": 0.938516430494785}], ["TERT", ["TCGA.G4.6588.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.8566557875036}], ["SOX2", ["TCGA.AD.6964.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.810383095755536}], ["SOX2", ["TCGA.AD.6964.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.846163641896464}], ["SOX2", ["TCGA.AZ.6603.01", "APAP ADME"], {"weight": 0.579380897729539}], ["SOX2", ["TCGA.DM.A28C.01", "Classical antibody-mediated complement activation"], {"weight": 0.708513363535539}], ["SOX2", ["TCGA.DM.A28C.01", "Creation of C4 and C2 activators"], {"weight": 0.767596085580047}], ["ITGAD", ["TCGA.AZ.6607.01", "Collagen formation"], {"weight": 0.965206680199113}], ["ITGAD", ["TCGA.AZ.6607.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.954721434450219}], ["ITGAD", ["TCGA.AZ.6607.01", "Molecules associated with elastic fibres"], {"weight": 0.858376183817258}], ["ITGAD", ["TCGA.AZ.6607.01", "Laminin interactions"], {"weight": 0.900192204598535}], ["ITGAD", ["TCGA.AZ.6607.01", "Non-integrin membrane-ECM interactions"], {"weight": 0.848891623523064}], ["ITGAD", ["TCGA.AZ.6607.01", "TGF-beta receptor signaling activates SMADs"], {"weight": 0.857828644676197}], ["ITGAD", ["TCGA.AZ.6607.01", "MET activates PTK2 signaling"], {"weight": 0.888411223107083}], ["ITGAD", ["TCGA.AZ.6607.01", "Syndecan interactions"], {"weight": 0.848671554293421}], ["ITGAD", ["TCGA.AZ.6607.01", "Signaling by TGFB family members"], {"weight": 0.89356093058496}], ["ITGAD", ["TCGA.AZ.6607.01", "Other semaphorin interactions"], {"weight": 0.700274154662369}], ["ACSS1", ["TCGA.CK.5913.01", "Biological oxidations"], {"weight": 0.94022753948978}], ["LAMB1", ["TCGA.AD.6889.01", "G-protein beta:gamma signalling"], {"weight": 0.936412295249305}], ["LAMB1", ["TCGA.AD.6901.01", "Degradation of the extracellular matrix"], {"weight": 0.60339204795129}], ["LAMB1", ["TCGA.CM.5861.01", "Non-integrin membrane-ECM interactions"], {"weight": 0.849328506197356}], ["ARID4B", ["TCGA.F4.6461.01", "SUMOylation of intracellular receptors"], {"weight": 0.45469535276328}], ["ABLIM3", ["TCGA.AD.6888.01", "CD22 mediated BCR regulation"], {"weight": 0.790052018454753}], ["ABLIM3", ["TCGA.D5.6532.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.873381734631833}], ["ABLIM3", ["TCGA.D5.6532.01", "Costimulation by the CD28 family"], {"weight": 0.882781420048555}], ["ABLIM3", ["TCGA.D5.6532.01", "NCAM signaling for neurite out-growth"], {"weight": 0.943332174490955}], ["ABLIM3", ["TCGA.D5.6532.01", "CD28 dependent Vav1 pathway"], {"weight": 0.841749446115467}], ["ABLIM3", ["TCGA.D5.6532.01", "DAP12 signaling"], {"weight": 0.879539296596862}], ["ABLIM3", ["TCGA.DM.A28F.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.878356520519999}], ["ABLIM3", ["TCGA.DM.A28F.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.938469896596082}], ["ABLIM3", ["TCGA.DM.A28F.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.936841649844544}], ["ABLIM3", ["TCGA.DM.A28F.01", "Neurexins and neuroligins"], {"weight": 0.921655623972395}], ["ABLIM3", ["TCGA.DM.A28F.01", "Assembly and cell surface presentation of NMDA receptors"], {"weight": 0.794038611071866}], ["ABLIM3", ["TCGA.DM.A28F.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.90335830868157}], ["ABLIM3", ["TCGA.DM.A28F.01", "DAP12 signaling"], {"weight": 0.886974719369934}], ["ABLIM3", ["TCGA.G4.6303.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.888528785525809}], ["NOTCH4", ["TCGA.AY.6197.01", "Cardiac conduction"], {"weight": 0.934871201198291}], ["NOTCH4", ["TCGA.AZ.5407.01", "Molecules associated with elastic fibres"], {"weight": 0.852589418014696}], ["ALDH3A1", ["TCGA.AU.6004.01", "Biological oxidations"], {"weight": 0.892542358450113}], ["ALDH3A1", ["TCGA.AU.6004.01", "Ethanol oxidation"], {"weight": 0.906628641631446}], ["ALDH3A1", ["TCGA.CM.5344.01", "Phase II - Conjugation of compounds"], {"weight": 0.846713187857542}], ["ALDH3A1", ["TCGA.CM.5344.01", "Ethanol oxidation"], {"weight": 0.9132800910163}], ["ALDH3A1", ["TCGA.CM.5344.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.873102856603089}], ["ALDH3A1", ["TCGA.CM.5344.01", "Nucleotide catabolism"], {"weight": 0.58121784797622}], ["ALDH3A1", ["TCGA.CM.6674.01", "Biological oxidations"], {"weight": 0.870947438180279}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Biological oxidations"], {"weight": 0.960492107363309}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Arachidonic acid metabolism"], {"weight": 0.955355926211637}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Phase I - Functionalization of compounds"], {"weight": 0.969850017635579}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.939581772402661}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Phase II - Conjugation of compounds"], {"weight": 0.875974705929621}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.891755445004826}], ["CYP4A11", ["TCGA.DM.A1HA.01", "Fatty acid metabolism"], {"weight": 0.937502522674562}], ["ITGB4", ["TCGA.AA.3713.01", "Extracellular matrix organization"], {"weight": 0.68238272295743}], ["ITGB4", ["TCGA.D5.6536.01", "Transmission across Chemical Synapses"], {"weight": 0.902668899192257}], ["ITGB4", ["TCGA.D5.6536.01", "Neuronal System"], {"weight": 0.90204716222576}], ["ITGB4", ["TCGA.D5.6536.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.901388062338216}], ["ITGB4", ["TCGA.D5.6536.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.936990356320605}], ["ITGB4", ["TCGA.D5.6536.01", "Collagen chain trimerization"], {"weight": 0.917355317539}], ["ITGB4", ["TCGA.F4.6570.01", "O-linked glycosylation"], {"weight": 0.921444567083273}], ["ITGB4", ["TCGA.F4.6570.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.899588316268711}], ["RNF123", ["TCGA.CM.5868.01", "GPCR ligand binding"], {"weight": 0.919857425684699}], ["RNF123", ["TCGA.CM.5868.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.917450029321954}], ["RNF123", ["TCGA.CM.5868.01", "Peptide ligand-binding receptors"], {"weight": 0.916676421117602}], ["ADSSL1", ["TCGA.D5.6926.01", "Glutathione conjugation"], {"weight": 0.843745727217614}], ["RASA1", ["TCGA.G4.6586.01", "Scavenging of heme from plasma"], {"weight": 0.705401053904834}], ["OR4A15", ["TCGA.AY.6386.01", "Glucagon-type ligand receptors"], {"weight": 0.927598952625209}], ["OR4A15", ["TCGA.AY.6386.01", "GABA receptor activation"], {"weight": 0.874495287053309}], ["OR4A15", ["TCGA.AY.6386.01", "Inwardly rectifying K+ channels"], {"weight": 0.919938985328768}], ["OR4A15", ["TCGA.AY.6386.01", "Activation of G protein gated Potassium channels"], {"weight": 0.914157143851348}], ["OR4A15", ["TCGA.AY.6386.01", "G protein gated Potassium channels"], {"weight": 0.914157143851348}], ["OR4A15", ["TCGA.AY.6386.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.914157143851348}], ["OR4A15", ["TCGA.AY.6386.01", "GABA B receptor activation"], {"weight": 0.921046638230349}], ["OR4A15", ["TCGA.AY.6386.01", "Activation of GABAB receptors"], {"weight": 0.921046638230349}], ["OR4A15", ["TCGA.AY.6386.01", "G beta:gamma signalling through BTK"], {"weight": 0.880656982403447}], ["OR4A15", ["TCGA.AY.6386.01", "G beta:gamma signalling through CDC42"], {"weight": 0.878089600858554}], ["OR4A15", ["TCGA.CM.5341.01", "G alpha (z) signalling events"], {"weight": 0.898681190630185}], ["HTR1E", ["TCGA.CM.6172.01", "Peptide hormone biosynthesis"], {"weight": 0.695286628326212}], ["EPS15L1", ["TCGA.D5.6926.01", "Biological oxidations"], {"weight": 0.923310723249702}], ["EPS15L1", ["TCGA.D5.6926.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.834402015124474}], ["SLC6A11", ["TCGA.CM.6169.01", "SLC-mediated transmembrane transport"], {"weight": 0.883928756900266}], ["SLC6A11", ["TCGA.CM.6169.01", "Transmission across Chemical Synapses"], {"weight": 0.8809665041046}], ["CALHM1", ["TCGA.AM.5821.01", "Interaction between L1 and Ankyrins"], {"weight": 0.954554231490814}], ["CALHM1", ["TCGA.AM.5821.01", "Phase 0 - rapid depolarisation"], {"weight": 0.941045068153467}], ["PRKD1", ["TCGA.D5.6538.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.908041046228696}], ["PRKD1", ["TCGA.D5.6538.01", "Signaling by GPCR"], {"weight": 0.937056467658686}], ["PRKD1", ["TCGA.D5.6538.01", "GPCR downstream signalling"], {"weight": 0.939854466537455}], ["KCNS1", ["TCGA.AM.5821.01", "Potassium Channels"], {"weight": 0.966389989591389}], ["KCNS1", ["TCGA.D5.6926.01", "Potassium Channels"], {"weight": 0.834917661309152}], ["PHC2", ["TCGA.AA.3713.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.84168523792282}], ["PHC2", ["TCGA.AA.3713.01", "Resolution of D-Loop Structures"], {"weight": 0.84168523792282}], ["CYP2C19", ["TCGA.CA.6718.01", "Biological oxidations"], {"weight": 0.96438331582357}], ["KCNJ12", ["TCGA.D5.6537.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.928507798616804}], ["KCNJ12", ["TCGA.D5.6537.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.907722207994614}], ["KCNJ12", ["TCGA.D5.6537.01", "Signal amplification"], {"weight": 0.918458488262754}], ["KCNJ12", ["TCGA.D5.6537.01", "Glucagon-type ligand receptors"], {"weight": 0.935415000720483}], ["KCNJ12", ["TCGA.D5.6537.01", "G-protein beta:gamma signalling"], {"weight": 0.921679435734294}], ["KCNJ12", ["TCGA.D5.6537.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.910825388030652}], ["KCNJ12", ["TCGA.D5.6537.01", "G alpha (z) signalling events"], {"weight": 0.93264469644218}], ["KCNJ12", ["TCGA.D5.6537.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.928810424245626}], ["KCNJ12", ["TCGA.D5.6537.01", "G beta:gamma signalling through BTK"], {"weight": 0.904019864994146}], ["KCNJ12", ["TCGA.D5.6537.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.911374100462336}], ["KCNJ12", ["TCGA.D5.6537.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.905200192300623}], ["KCNJ12", ["TCGA.D5.6537.01", "G-protein activation"], {"weight": 0.923083204355831}], ["KCNJ12", ["TCGA.D5.6537.01", "Thromboxane signalling through TP receptor"], {"weight": 0.900785594745917}], ["KCNJ12", ["TCGA.D5.6537.01", "G beta:gamma signalling through CDC42"], {"weight": 0.902209066961401}], ["KCNJ12", ["TCGA.D5.6537.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.876293886354726}], ["KCNJ12", ["TCGA.D5.6537.01", "Voltage gated Potassium channels"], {"weight": 0.916460188225401}], ["KCNJ12", ["TCGA.D5.6537.01", "Presynaptic function of Kainate receptors"], {"weight": 0.905957961351239}], ["KCNJ12", ["TCGA.D5.6537.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.91734451811741}], ["KCNJ12", ["TCGA.G4.6294.01", "GPCR ligand binding"], {"weight": 0.951460650095033}], ["KCNJ12", ["TCGA.G4.6294.01", "G alpha (s) signalling events"], {"weight": 0.959358606624312}], ["KCNJ12", ["TCGA.G4.6294.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.93125496277647}], ["KCNJ12", ["TCGA.G4.6294.01", "G alpha (q) signalling events"], {"weight": 0.926917423766312}], ["KCNJ12", ["TCGA.G4.6294.01", "Voltage gated Potassium channels"], {"weight": 0.908745232369296}], ["KCNJ12", ["TCGA.G4.6298.01", "Phase 4 - resting membrane potential"], {"weight": 0.920291915946602}], ["KCNJ12", ["TCGA.G4.6311.01", "Neuronal System"], {"weight": 0.868242513486146}], ["TSC1", ["TCGA.G4.6628.01", "Transmission across Chemical Synapses"], {"weight": 0.90499958429849}], ["TSC1", ["TCGA.G4.6628.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.887128732303332}], ["DPEP2", ["TCGA.F4.6805.01", "Biological oxidations"], {"weight": 0.885925895941901}], ["KLC4", ["TCGA.CK.5915.01", "Generation of second messenger molecules"], {"weight": 0.949359755136222}], ["NECAP2", ["TCGA.F4.6703.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.914980578180031}], ["CPB2", ["TCGA.AD.6889.01", "Complement cascade"], {"weight": 0.897932695468371}], ["CPB2", ["TCGA.F4.6570.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.767847708858935}], ["JMJD7-PLA2G4B", ["TCGA.DM.A1D4.01", "Biological oxidations"], {"weight": 0.944939893177898}], ["JMJD7-PLA2G4B", ["TCGA.DM.A1D4.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.916058847811411}], ["JMJD7-PLA2G4B", ["TCGA.DM.A1D4.01", "G-protein mediated events"], {"weight": 0.900619350882714}], ["JMJD7-PLA2G4B", ["TCGA.G4.6588.01", "Phase II - Conjugation of compounds"], {"weight": 0.818433930753615}], ["SNX1", ["TCGA.AY.6196.01", "Peptide ligand-binding receptors"], {"weight": 0.889553872290027}], ["SNX1", ["TCGA.AY.6196.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.889553872290027}], ["MED16", ["TCGA.DM.A1D0.01", "Complement cascade"], {"weight": 0.927781159201172}], ["MED16", ["TCGA.DM.A1D0.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.90610064789298}], ["MED16", ["TCGA.DM.A1D0.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.90610064789298}], ["MED16", ["TCGA.DM.A1D0.01", "Diseases of Immune System"], {"weight": 0.88356930138206}], ["MED16", ["TCGA.DM.A1D0.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.88356930138206}], ["LRRTM1", ["TCGA.AU.3779.01", "Extracellular matrix organization"], {"weight": 0.821400854644411}], ["LRRTM1", ["TCGA.G4.6304.01", "Extracellular matrix organization"], {"weight": 0.913169961360882}], ["LRRTM1", ["TCGA.G4.6304.01", "Non-integrin membrane-ECM interactions"], {"weight": 0.833670545009792}], ["ENAH", ["TCGA.AM.5820.01", "Generation of second messenger molecules"], {"weight": 0.943995337317706}], ["ENAH", ["TCGA.AM.5820.01", "TCR signaling"], {"weight": 0.946907665022197}], ["ENPP3", ["TCGA.AD.6964.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.873530741284538}], ["ENPP3", ["TCGA.D5.6928.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.8855780108371}], ["SERPINH1", ["TCGA.G4.6317.01", "Integrin cell surface interactions"], {"weight": 0.932281657782441}], ["SERPINH1", ["TCGA.G4.6317.01", "NCAM1 interactions"], {"weight": 0.946174740765318}], ["MYBL1", ["TCGA.D5.6932.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.890383775665578}], ["MYBL1", ["TCGA.G4.6295.01", "G0 and Early G1"], {"weight": 0.883304982140659}], ["ATP6V1B2", ["TCGA.CM.4744.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.848551538831031}], ["CDX2", ["TCGA.AD.6889.01", "Glucagon-type ligand receptors"], {"weight": 0.936675397320599}], ["CDX2", ["TCGA.G4.6586.01", "GPCR ligand binding"], {"weight": 0.956937760351762}], ["CDX2", ["TCGA.G4.6586.01", "Glucagon-type ligand receptors"], {"weight": 0.941006045308547}], ["CDX2", ["TCGA.G4.6586.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.946921082728926}], ["GNAI3", ["TCGA.CM.5861.01", "Signaling by GPCR"], {"weight": 0.950318153373321}], ["GNAI3", ["TCGA.CM.5861.01", "GPCR downstream signalling"], {"weight": 0.953817075792513}], ["GNAI3", ["TCGA.CM.5861.01", "G alpha (i) signalling events"], {"weight": 0.953856140033384}], ["GNAI3", ["TCGA.CM.5861.01", "G alpha (s) signalling events"], {"weight": 0.961566909057973}], ["AWAT2", ["TCGA.AA.3713.01", "RA biosynthesis pathway"], {"weight": 0.759481255543937}], ["AWAT2", ["TCGA.AA.3713.01", "Ethanol oxidation"], {"weight": 0.792658583437595}], ["AWAT2", ["TCGA.CA.6718.01", "Ethanol oxidation"], {"weight": 0.916436576069745}], ["AWAT2", ["TCGA.CA.6718.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.835642319426057}], ["AWAT2", ["TCGA.F4.6807.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.641792272908625}], ["AWAT2", ["TCGA.F4.6807.01", "Ethanol oxidation"], {"weight": 0.66556706572259}], ["EPHB4", ["TCGA.CK.5916.01", "Signaling by GPCR"], {"weight": 0.924052882041445}], ["EPHB4", ["TCGA.CK.5916.01", "GPCR downstream signalling"], {"weight": 0.931889671869701}], ["EPHB4", ["TCGA.F4.6569.01", "GABA receptor activation"], {"weight": 0.805669582668098}], ["EPHB4", ["TCGA.F4.6569.01", "TNFs bind their physiological receptors"], {"weight": 0.298674871697066}], ["SERPINB8", ["TCGA.AZ.6599.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.907133523804123}], ["SERPINB8", ["TCGA.AZ.6599.01", "Retinoid metabolism and transport"], {"weight": 0.907133523804123}], ["SERPINB8", ["TCGA.AZ.6599.01", "Scavenging of heme from plasma"], {"weight": 0.865283493709374}], ["STAT4", ["TCGA.DM.A1DA.01", "Interleukin-10 signaling"], {"weight": 0.920140828631937}], ["LOXL3", ["TCGA.CM.6166.01", "Extracellular matrix organization"], {"weight": 0.875269632356382}], ["LOX", ["TCGA.CK.5913.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.919805077027885}], ["LOX", ["TCGA.CK.5913.01", "Collagen formation"], {"weight": 0.933553206908766}], ["LOX", ["TCGA.CK.5913.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.943263110846569}], ["LOX", ["TCGA.DM.A1D8.01", "Extracellular matrix organization"], {"weight": 0.886077524994616}], ["CPA1", ["TCGA.D5.6536.01", "Peptide hormone metabolism"], {"weight": 0.781730149688191}], ["CPA1", ["TCGA.D5.6536.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.736112530558884}], ["PLA2G3", ["TCGA.AM.5821.01", "Drug ADME"], {"weight": 0.940086857821724}], ["PLA2G3", ["TCGA.AM.5821.01", "Regulation of insulin secretion"], {"weight": 0.941399586644255}], ["PLA2G3", ["TCGA.AM.5821.01", "Aspirin ADME"], {"weight": 0.932188543238673}], ["PLA2G3", ["TCGA.CK.4952.01", "Biological oxidations"], {"weight": 0.941850100781957}], ["PLA2G3", ["TCGA.CK.4952.01", "Drug ADME"], {"weight": 0.902448693970035}], ["PLA2G3", ["TCGA.CK.4952.01", "Phase II - Conjugation of compounds"], {"weight": 0.850771192681611}], ["GPC1", ["TCGA.CM.6678.01", "Adaptive Immune System"], {"weight": 0.873821576050785}], ["GPC1", ["TCGA.CM.6678.01", "TNFs bind their physiological receptors"], {"weight": 0.406610917722856}], ["GPC1", ["TCGA.CM.6678.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.904371251831077}], ["PAH", ["TCGA.DM.A28F.01", "Phase I - Functionalization of compounds"], {"weight": 0.934008784008109}], ["LYN", ["TCGA.AZ.6601.01", "Drug ADME"], {"weight": 0.91143533706489}], ["LYN", ["TCGA.AZ.6601.01", "Signaling by GPCR"], {"weight": 0.926937091042335}], ["LYN", ["TCGA.AZ.6601.01", "GPCR downstream signalling"], {"weight": 0.940139814398955}], ["LYN", ["TCGA.D5.5540.01", "Regulation of Complement cascade"], {"weight": 0.948961893232084}], ["HLA-DOA", ["TCGA.AM.5821.01", "Kinesins"], {"weight": 0.894205390756805}], ["IL3RA", ["TCGA.CM.6162.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.754077113664215}], ["HTR1A", ["TCGA.CA.6716.01", "Regulation of Complement cascade"], {"weight": 0.843909796684567}], ["HTR1A", ["TCGA.CK.4952.01", "Chemokine receptors bind chemokines"], {"weight": 0.935462606014299}], ["HTR1A", ["TCGA.DM.A0XD.01", "Biological oxidations"], {"weight": 0.92652176859887}], ["HTR1A", ["TCGA.DM.A0XD.01", "Chemokine receptors bind chemokines"], {"weight": 0.940120122971824}], ["OSM", ["TCGA.AD.6895.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.89520245432163}], ["GATAD2A", ["TCGA.F4.6569.01", "Post-translational protein phosphorylation"], {"weight": 0.738982334847661}], ["SV2B", ["TCGA.D5.5538.01", "L1CAM interactions"], {"weight": 0.853177392157266}], ["SV2B", ["TCGA.D5.5538.01", "ECM proteoglycans"], {"weight": 0.790260999929743}], ["SV2B", ["TCGA.D5.6541.01", "Extracellular matrix organization"], {"weight": 0.85424583622599}], ["APOA4", ["TCGA.AD.5900.01", "Metabolism of vitamins and cofactors"], {"weight": 0.751077407150004}], ["APOA4", ["TCGA.D5.6537.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.927110336330854}], ["APOA4", ["TCGA.D5.6537.01", "Retinoid metabolism and transport"], {"weight": 0.927110336330854}], ["APOA4", ["TCGA.D5.6926.01", "RA biosynthesis pathway"], {"weight": 0.851927335793944}], ["APOA4", ["TCGA.D5.6926.01", "Platelet homeostasis"], {"weight": 0.769079597823706}], ["APOA4", ["TCGA.D5.6926.01", "Visual phototransduction"], {"weight": 0.725660312581806}], ["APOA4", ["TCGA.D5.6926.01", "TNFs bind their physiological receptors"], {"weight": 0.365153180814509}], ["BRD7", ["TCGA.CM.6166.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.837335482187158}], ["DNAJB11", ["TCGA.G4.6310.01", "Adaptive Immune System"], {"weight": 0.909887721498547}], ["CLPB", ["TCGA.G4.6295.01", "APAP ADME"], {"weight": 0.816161358183179}], ["SULT2B1", ["TCGA.AZ.6598.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.909558877538194}], ["SULT2B1", ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.80377709127572}], ["LSS", ["TCGA.AD.6901.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.827463109981456}], ["LSS", ["TCGA.AD.6901.01", "Phase II - Conjugation of compounds"], {"weight": 0.846469763891156}], ["XIAP", ["TCGA.D5.5538.01", "Signaling by BMP"], {"weight": 0.911586059595223}], ["AK7", ["TCGA.G4.6295.01", "G1/S-Specific Transcription"], {"weight": 0.887114936429862}], ["PTPN3", ["TCGA.CK.5914.01", "CD22 mediated BCR regulation"], {"weight": 0.807526933243598}], ["PTPN3", ["TCGA.CK.5914.01", "Complement cascade"], {"weight": 0.830068391029033}], ["PTPN3", ["TCGA.CK.5914.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.739663639000192}], ["PTPN3", ["TCGA.CM.6166.01", "Chemokine receptors bind chemokines"], {"weight": 0.904077654579374}], ["PTPN3", ["TCGA.CM.6166.01", "CD22 mediated BCR regulation"], {"weight": 0.80009777242848}], ["PTPN3", ["TCGA.CM.6166.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.808224091121402}], ["POLR1A", ["TCGA.G4.6317.01", "Cardiac conduction"], {"weight": 0.940049344172618}], ["POLR1A", ["TCGA.G4.6317.01", "GABA B receptor activation"], {"weight": 0.940819394075444}], ["POLR1A", ["TCGA.G4.6317.01", "Activation of GABAB receptors"], {"weight": 0.940819394075444}], ["POLR1A", ["TCGA.G4.6317.01", "GABA receptor activation"], {"weight": 0.93200495271633}], ["POLR1A", ["TCGA.G4.6317.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.928502780513359}], ["POLR1A", ["TCGA.G4.6317.01", "Physiological factors"], {"weight": 0.797366114790638}], ["POLR1A", ["TCGA.G4.6317.01", "G alpha (z) signalling events"], {"weight": 0.932502079840387}], ["RGS14", ["TCGA.AD.5900.01", "G alpha (i) signalling events"], {"weight": 0.933578518924471}], ["RGS14", ["TCGA.AD.5900.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.875367100118418}], ["STK36", ["TCGA.AM.5821.01", "PLC beta mediated events"], {"weight": 0.913851406980781}], ["STK36", ["TCGA.DM.A28M.01", "G alpha (i) signalling events"], {"weight": 0.943385464889448}], ["STK36", ["TCGA.DM.A28M.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.92072444113882}], ["STK36", ["TCGA.DM.A28M.01", "Leishmania parasite growth and survival"], {"weight": 0.92072444113882}], ["STK36", ["TCGA.DM.A28M.01", "Leishmania infection"], {"weight": 0.906307081933589}], ["STK36", ["TCGA.DM.A28M.01", "Parasitic Infection Pathways"], {"weight": 0.906307081933589}], ["STK36", ["TCGA.DM.A28M.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.933974476298361}], ["STK36", ["TCGA.DM.A28M.01", "Opioid Signalling"], {"weight": 0.935976668546038}], ["STK36", ["TCGA.DM.A28M.01", "PLC beta mediated events"], {"weight": 0.919110959676637}], ["STK36", ["TCGA.DM.A28M.01", "G-protein mediated events"], {"weight": 0.923702425088914}], ["STK36", ["TCGA.DM.A28M.01", "GPER1 signaling"], {"weight": 0.928499675786717}], ["STK36", ["TCGA.DM.A28M.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.928499675786717}], ["STK36", ["TCGA.DM.A28M.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.936716365276275}], ["STK36", ["TCGA.DM.A28M.01", "Regulation of insulin secretion"], {"weight": 0.931929217693542}], ["STK36", ["TCGA.DM.A28M.01", "PKA activation in glucagon signalling"], {"weight": 0.917708102293206}], ["STK36", ["TCGA.DM.A28M.01", "Inflammasomes"], {"weight": 0.764728890572921}], ["STK36", ["TCGA.DM.A28M.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.89384540656688}], ["STAT3", ["TCGA.AU.3779.01", "Glucuronidation"], {"weight": 0.864173880157701}], ["STAT3", ["TCGA.AU.3779.01", "Chemokine receptors bind chemokines"], {"weight": 0.911043724200708}], ["STAT3", ["TCGA.AU.3779.01", "Signaling Pathways"], {"weight": 0.857832755503889}], ["STAT3", ["TCGA.AU.3779.01", "Aspirin ADME"], {"weight": 0.769766257272044}], ["STAT3", ["TCGA.AU.3779.01", "Interleukin-6 family signaling"], {"weight": 0.890545996726776}], ["STAT3", ["TCGA.AU.3779.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.787362617911357}], ["STAT3", ["TCGA.DM.A1HA.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.929793518732301}], ["STAT3", ["TCGA.DM.A1HA.01", "Chemokine receptors bind chemokines"], {"weight": 0.945346326046242}], ["STAT3", ["TCGA.DM.A1HA.01", "Interleukin-10 signaling"], {"weight": 0.955956188813493}], ["STAT3", ["TCGA.DM.A1HA.01", "TNFs bind their physiological receptors"], {"weight": 0.558889205711162}], ["TPM1", ["TCGA.CM.6171.01", "Muscle contraction"], {"weight": 0.933752669412058}], ["CA9", ["TCGA.AZ.6600.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], {"weight": 0.600916395263823}], ["CA9", ["TCGA.AZ.6600.01", "Metal ion SLC transporters"], {"weight": 0.413435592734736}], ["MED14", ["TCGA.F4.6704.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.772708239066612}], ["MED14", ["TCGA.G4.6307.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.927033268621612}], ["MED14", ["TCGA.G4.6307.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.927033268621612}], ["MED14", ["TCGA.G4.6307.01", "Diseases of Immune System"], {"weight": 0.932577561925888}], ["MED14", ["TCGA.G4.6307.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.932577561925888}], ["MED14", ["TCGA.G4.6307.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.911524931705794}], ["MED14", ["TCGA.G4.6307.01", "Other interleukin signaling"], {"weight": 0.728039457279951}], ["HSD3B7", ["TCGA.AD.5900.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.851874787417779}], ["HSD3B7", ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.891188125845829}], ["HSD3B7", ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.936690455581804}], ["HSD3B7", ["TCGA.G4.6588.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.899329318305966}], ["IDH1", ["TCGA.CA.5796.01", "Aspartate and asparagine metabolism"], {"weight": 0.641348432887586}], ["IDH1", ["TCGA.G4.6322.01", "Phase I - Functionalization of compounds"], {"weight": 0.942256481333933}], ["NTRK3", ["TCGA.DM.A1D9.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.928710003142095}], ["NTRK3", ["TCGA.DM.A1D9.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.898447823877492}], ["NTRK3", ["TCGA.DM.A1D9.01", "Leishmania parasite growth and survival"], {"weight": 0.898447823877492}], ["NTRK3", ["TCGA.DM.A1D9.01", "CD22 mediated BCR regulation"], {"weight": 0.777561947101069}], ["DNAJC6", ["TCGA.G4.6320.01", "Scavenging by Class A Receptors"], {"weight": 0.461035862903663}], ["GGT5", ["TCGA.AD.6889.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.911112388992675}], ["GGT5", ["TCGA.AD.6964.01", "Recycling of bile acids and salts"], {"weight": 0.770682072865708}], ["GGT5", ["TCGA.AZ.6598.01", "Arachidonic acid metabolism"], {"weight": 0.928672323561216}], ["GGT5", ["TCGA.AZ.6601.01", "APAP ADME"], {"weight": 0.897083204542699}], ["GGT5", ["TCGA.CM.6169.01", "APAP ADME"], {"weight": 0.786225834630906}], ["GGT5", ["TCGA.D5.6535.01", "Phase II - Conjugation of compounds"], {"weight": 0.760674940070097}], ["GGT5", ["TCGA.D5.6535.01", "APAP ADME"], {"weight": 0.745173684094981}], ["GGT5", ["TCGA.D5.6535.01", "Aspartate and asparagine metabolism"], {"weight": 0.704721997631919}], ["GGT5", ["TCGA.D5.6535.01", "Fatty acid metabolism"], {"weight": 0.878939353919983}], ["OLA1", ["TCGA.CM.4743.01", "Chemokine receptors bind chemokines"], {"weight": 0.93627073125626}], ["CYP11A1", ["TCGA.AD.5900.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.908905681777616}], ["PIK3AP1", ["TCGA.AD.6889.01", "CD22 mediated BCR regulation"], {"weight": 0.872075108271238}], ["SLC2A1", ["TCGA.CM.4748.01", "Biological oxidations"], {"weight": 0.853217972009238}], ["SLC2A1", ["TCGA.CM.4748.01", "Phase I - Functionalization of compounds"], {"weight": 0.844659722401307}], ["SCN4A", ["TCGA.AD.5900.01", "Interaction between L1 and Ankyrins"], {"weight": 0.879285119709551}], ["SCN4A", ["TCGA.AD.6895.01", "Phase 0 - rapid depolarisation"], {"weight": 0.925555967919157}], ["SCN4A", ["TCGA.CK.5915.01", "Muscle contraction"], {"weight": 0.951551345568046}], ["SCN4A", ["TCGA.CK.5915.01", "Phase 0 - rapid depolarisation"], {"weight": 0.945805205678026}], ["SCN4A", ["TCGA.CK.5915.01", "Interaction between L1 and Ankyrins"], {"weight": 0.953866881792291}], ["SCN4A", ["TCGA.CK.5915.01", "NCAM signaling for neurite out-growth"], {"weight": 0.939965172100269}], ["SCN4A", ["TCGA.CK.5915.01", "L1CAM interactions"], {"weight": 0.897017014882491}], ["SCN4A", ["TCGA.CM.5344.01", "Interaction between L1 and Ankyrins"], {"weight": 0.917829755349179}], ["SCN4A", ["TCGA.CM.5344.01", "Phase 0 - rapid depolarisation"], {"weight": 0.850845440461535}], ["SCN4A", ["TCGA.CM.5344.01", "L1CAM interactions"], {"weight": 0.866773103791931}], ["SCN4A", ["TCGA.CM.5344.01", "Cardiac conduction"], {"weight": 0.845283379717116}], ["SCN4A", ["TCGA.G4.6311.01", "Interaction between L1 and Ankyrins"], {"weight": 0.889471844489145}], ["SCN4A", ["TCGA.G4.6311.01", "Phase 0 - rapid depolarisation"], {"weight": 0.831813482421373}], ["SCN4A", ["TCGA.G4.6311.01", "NCAM signaling for neurite out-growth"], {"weight": 0.914017858541739}], ["SCN4A", ["TCGA.G4.6320.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946936823501628}], ["SCN4A", ["TCGA.G4.6320.01", "Phase 0 - rapid depolarisation"], {"weight": 0.941347209450374}], ["ALDH9A1", ["TCGA.AD.5900.01", "Ethanol oxidation"], {"weight": 0.860704741650932}], ["ALDH9A1", ["TCGA.AD.5900.01", "Neurotransmitter release cycle"], {"weight": 0.913400341949279}], ["BMPR1B", ["TCGA.DM.A1HA.01", "Stimuli-sensing channels"], {"weight": 0.934469596125375}], ["PLIN4", ["TCGA.D5.6898.01", "Biological oxidations"], {"weight": 0.846357337696048}], ["PLIN4", ["TCGA.D5.6898.01", "Ethanol oxidation"], {"weight": 0.795892033079514}], ["PLIN4", ["TCGA.D5.6930.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.747073187906813}], ["PLIN4", ["TCGA.G4.6294.01", "RA biosynthesis pathway"], {"weight": 0.928726414628277}], ["PLIN4", ["TCGA.G4.6294.01", "Signaling by Retinoic Acid"], {"weight": 0.813821087637047}], ["PLIN4", ["TCGA.G4.6320.01", "RA biosynthesis pathway"], {"weight": 0.912435279836126}], ["TIE1", ["TCGA.F4.6704.01", "Biological oxidations"], {"weight": 0.937662165357404}], ["TIE1", ["TCGA.F4.6704.01", "Ethanol oxidation"], {"weight": 0.64512184011003}], ["TIE1", ["TCGA.F4.6704.01", "Phase I - Functionalization of compounds"], {"weight": 0.91816081265005}], ["ATXN3", ["TCGA.AZ.6598.01", "Peptide ligand-binding receptors"], {"weight": 0.935145208541354}], ["ATXN3", ["TCGA.AZ.6598.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.935658571776681}], ["C9", ["TCGA.F4.6856.01", "Antimicrobial peptides"], {"weight": 0.637629380441509}], ["SLC18A1", ["TCGA.CK.4952.01", "Neuronal System"], {"weight": 0.938251426800955}], ["SCNN1D", ["TCGA.DM.A28M.01", "Ion channel transport"], {"weight": 0.958342277574637}], ["SCNN1D", ["TCGA.DM.A28M.01", "Stimuli-sensing channels"], {"weight": 0.932239078420314}], ["GRIK5", ["TCGA.AD.6888.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.932985622979848}], ["GRIK5", ["TCGA.AD.6888.01", "Presynaptic function of Kainate receptors"], {"weight": 0.912812187562619}], ["GRIK5", ["TCGA.AD.6888.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.919781438566119}], ["GRIK5", ["TCGA.AD.6888.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.821045927608708}], ["PAPPA2", ["TCGA.CM.5341.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.668585021992486}], ["PAPPA2", ["TCGA.D5.6920.01", "Chemokine receptors bind chemokines"], {"weight": 0.856919474702279}], ["PAPPA2", ["TCGA.D5.6920.01", "Degradation of the extracellular matrix"], {"weight": 0.855818603401431}], ["PAPPA2", ["TCGA.D5.6920.01", "Basigin interactions"], {"weight": 0.705627371002191}], ["SYT12", ["TCGA.AZ.6598.01", "Neurexins and neuroligins"], {"weight": 0.928489283430482}], ["SYT12", ["TCGA.D5.6540.01", "Neurexins and neuroligins"], {"weight": 0.949138960812353}], ["ELN", ["TCGA.AZ.6599.01", "Integrin cell surface interactions"], {"weight": 0.926930766538305}], ["ELN", ["TCGA.AZ.6599.01", "Collagen formation"], {"weight": 0.958338519527441}], ["ELN", ["TCGA.AZ.6599.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.94138606609037}], ["KCNV1", ["TCGA.AY.5543.01", "Neuronal System"], {"weight": 0.934565342489689}], ["CNTNAP1", ["TCGA.CK.5916.01", "Interaction between L1 and Ankyrins"], {"weight": 0.922467396632827}], ["CNTNAP1", ["TCGA.CM.5861.01", "Interaction between L1 and Ankyrins"], {"weight": 0.947426049639928}], ["CNTNAP1", ["TCGA.G4.6588.01", "Interaction between L1 and Ankyrins"], {"weight": 0.947276461508488}], ["A4GNT", ["TCGA.AD.5900.01", "O-linked glycosylation of mucins"], {"weight": 0.929576907350186}], ["A4GNT", ["TCGA.AM.5821.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.921664017539622}], ["A4GNT", ["TCGA.F4.6570.01", "Defective GALNT3 causes HFTC"], {"weight": 0.919948009041489}], ["A4GNT", ["TCGA.F4.6570.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.919948009041489}], ["A4GNT", ["TCGA.F4.6570.01", "Termination of O-glycan biosynthesis"], {"weight": 0.934792576116287}], ["A4GNT", ["TCGA.F4.6570.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.919948009041489}], ["A4GNT", ["TCGA.F4.6570.01", "O-linked glycosylation of mucins"], {"weight": 0.947583380791173}], ["MFAP3", ["TCGA.AY.6197.01", "Molecules associated with elastic fibres"], {"weight": 0.91794692587523}], ["PTGES2", ["TCGA.AD.6548.01", "Biological oxidations"], {"weight": 0.93469018377561}], ["CYSLTR2", ["TCGA.AD.6548.01", "Signaling by GPCR"], {"weight": 0.88909266747032}], ["CYSLTR2", ["TCGA.AD.6548.01", "G alpha (s) signalling events"], {"weight": 0.912258954857791}], ["CYSLTR2", ["TCGA.AD.6548.01", "GPCR downstream signalling"], {"weight": 0.879824990339395}], ["PTGES2", ["TCGA.AD.6548.01", "Phase II - Conjugation of compounds"], {"weight": 0.874063059312155}], ["PTGES2", ["TCGA.AD.6548.01", "Signaling by Retinoic Acid"], {"weight": 0.638257146909194}], ["PTGES2", ["TCGA.AD.6548.01", "Ethanol oxidation"], {"weight": 0.78584212672591}], ["PTGES2", ["TCGA.AD.6548.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.839455774570048}], ["NOXRED1", ["TCGA.DM.A282.01", "FOXO-mediated transcription of cell death genes"], {"weight": 0.79234008475331}], ["CCT6B", ["TCGA.AD.6888.01", "Signaling by GPCR"], {"weight": 0.95164089340224}], ["RIPK1", ["TCGA.AD.6888.01", "Signaling Pathways"], {"weight": 0.931373930373063}], ["RIPK1", ["TCGA.AD.6888.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.91958195131612}], ["RIPK1", ["TCGA.AD.6888.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.91958195131612}], ["RIPK1", ["TCGA.AD.6888.01", "Diseases of Immune System"], {"weight": 0.887878860156382}], ["RIPK1", ["TCGA.AD.6888.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.887878860156382}], ["RIPK1", ["TCGA.AD.6888.01", "Innate Immune System"], {"weight": 0.931029496465256}], ["MAGEH1", ["TCGA.AD.6888.01", "Elastic fibre formation"], {"weight": 0.906331998499789}], ["MAGEH1", ["TCGA.AD.6888.01", "Collagen formation"], {"weight": 0.934477977259058}], ["KCNMA1", ["TCGA.AD.6888.01", "Immune System"], {"weight": 0.898311656487821}], ["KCNMA1", ["TCGA.AD.6888.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.92083356070574}], ["KCNMA1", ["TCGA.AD.6888.01", "Leishmania parasite growth and survival"], {"weight": 0.92083356070574}], ["KCNMA1", ["TCGA.AD.6888.01", "Integration of energy metabolism"], {"weight": 0.935096764964227}], ["KCNMA1", ["TCGA.AD.6888.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.929455479232787}], ["KCNMA1", ["TCGA.AD.6888.01", "Opioid Signalling"], {"weight": 0.929159529442995}], ["KCNMA1", ["TCGA.AD.6888.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.927908638401673}], ["KCNMA1", ["TCGA.AD.6888.01", "Aquaporin-mediated transport"], {"weight": 0.927908638401673}], ["KCNMA1", ["TCGA.AD.6888.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.932610285518837}], ["KCNMA1", ["TCGA.AD.6888.01", "Developmental Biology"], {"weight": 0.902559842416769}], ["KCNMA1", ["TCGA.AD.6888.01", "GPER1 signaling"], {"weight": 0.925181745798651}], ["KCNMA1", ["TCGA.AD.6888.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.925181745798651}], ["KCNMA1", ["TCGA.AD.6888.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.890839061967089}], ["KCNMA1", ["TCGA.AD.6888.01", "Ca-dependent events"], {"weight": 0.865905258357225}], ["SCAI", ["TCGA.AD.6888.01", "Defective B3GALTL causes PpS"], {"weight": 0.902971713854781}], ["SCAI", ["TCGA.AD.6888.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.902971713854781}], ["SCAI", ["TCGA.AD.6888.01", "Keratan sulfate biosynthesis"], {"weight": 0.909925632245951}], ["SCAI", ["TCGA.AD.6888.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.881320782746641}], ["SCAI", ["TCGA.AD.6888.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.755820975041464}], ["SCAI", ["TCGA.AD.6888.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.917698890860527}], ["SCAI", ["TCGA.AD.6888.01", "O-linked glycosylation"], {"weight": 0.910536301250238}], ["CCT6B", ["TCGA.AD.6888.01", "GPCR downstream signalling"], {"weight": 0.95573301562231}], ["CCT6B", ["TCGA.AD.6888.01", "G alpha (i) signalling events"], {"weight": 0.94047162591561}], ["CCT6B", ["TCGA.AD.6888.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.947795588314929}], ["CCT6B", ["TCGA.AD.6888.01", "G alpha (q) signalling events"], {"weight": 0.940161567839953}], ["CCT6B", ["TCGA.AD.6888.01", "Classical antibody-mediated complement activation"], {"weight": 0.7329590147793}], ["CCT6B", ["TCGA.AD.6888.01", "G-protein beta:gamma signalling"], {"weight": 0.935839790830945}], ["CCT6B", ["TCGA.AD.6888.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.924959192842433}], ["CCT6B", ["TCGA.AD.6888.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.90692433431391}], ["CCT6B", ["TCGA.AD.6888.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.927615977378315}], ["CCT6B", ["TCGA.AD.6888.01", "Signal amplification"], {"weight": 0.914068595459858}], ["CCT6B", ["TCGA.AD.6888.01", "G beta:gamma signalling through BTK"], {"weight": 0.914352376816078}], ["CCT6B", ["TCGA.AD.6888.01", "GABA receptor activation"], {"weight": 0.919135113659151}], ["CCT6B", ["TCGA.AD.6888.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.903162128228377}], ["CCT6B", ["TCGA.AD.6888.01", "G beta:gamma signalling through CDC42"], {"weight": 0.911473986898966}], ["CCT6B", ["TCGA.AD.6888.01", "Peptide hormone metabolism"], {"weight": 0.858244551483593}], ["CCT6B", ["TCGA.AD.6888.01", "Thromboxane signalling through TP receptor"], {"weight": 0.902009936175368}], ["CCT6B", ["TCGA.AD.6888.01", "Creation of C4 and C2 activators"], {"weight": 0.776564509134162}], ["CCT6B", ["TCGA.AD.6888.01", "Glucagon-type ligand receptors"], {"weight": 0.935806319443076}], ["CCT6B", ["TCGA.AD.6888.01", "GABA B receptor activation"], {"weight": 0.927773901992208}], ["CCT6B", ["TCGA.AD.6888.01", "Activation of GABAB receptors"], {"weight": 0.927773901992208}], ["CCT6B", ["TCGA.AD.6888.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.910470973449745}], ["CCT6B", ["TCGA.AD.6888.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.90030364306515}], ["CCT6B", ["TCGA.AD.6888.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.918027637674987}], ["CCT6B", ["TCGA.CA.6718.01", "GPCR ligand binding"], {"weight": 0.900136387080286}], ["MYBPC2", ["TCGA.AD.6888.01", "Initial triggering of complement"], {"weight": 0.817193904550891}], ["MYBPC2", ["TCGA.D5.5537.01", "Muscle contraction"], {"weight": 0.910209709123267}], ["MYBPC2", ["TCGA.D5.5537.01", "Heme degradation"], {"weight": 0.660973274446002}], ["MYBPC2", ["TCGA.D5.6529.01", "Heme degradation"], {"weight": 0.645439899624439}], ["MYBPC2", ["TCGA.F4.6459.01", "Physiological factors"], {"weight": 0.755376776760824}], ["HRH4", ["TCGA.AD.6888.01", "Chemokine receptors bind chemokines"], {"weight": 0.942210938102732}], ["HRH4", ["TCGA.AD.6888.01", "Binding and entry of HIV virion"], {"weight": 0.830114505619257}], ["HRH4", ["TCGA.AD.6888.01", "Interleukin-10 signaling"], {"weight": 0.947642490933533}], ["HRH4", ["TCGA.AD.6888.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.934717748436607}], ["HRH4", ["TCGA.AD.6888.01", "Specification of primordial germ cells"], {"weight": 0.867814032330703}], ["SDC3", ["TCGA.AD.6888.01", "GPCR ligand binding"], {"weight": 0.954866512983406}], ["SDC3", ["TCGA.AD.6888.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.951983906847028}], ["SDC3", ["TCGA.AD.6888.01", "Peptide ligand-binding receptors"], {"weight": 0.951349154023059}], ["SDC3", ["TCGA.AD.6888.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.923806581134809}], ["SDC3", ["TCGA.AD.6888.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.814784774197927}], ["SDC3", ["TCGA.AD.6888.01", "Diseases of glycosylation"], {"weight": 0.889861686722436}], ["SDC3", ["TCGA.AD.6888.01", "Signaling by Interleukins"], {"weight": 0.892298417905735}], ["SDC3", ["TCGA.AD.6888.01", "G-protein activation"], {"weight": 0.932221617599795}], ["SDC3", ["TCGA.AD.6888.01", "IRS-related events triggered by IGF1R"], {"weight": 0.894839914644842}], ["SDC3", ["TCGA.AD.6888.01", "Calcitonin-like ligand receptors"], {"weight": 0.826225599090136}], ["SDC3", ["TCGA.AD.6888.01", "HS-GAG biosynthesis"], {"weight": 0.928156826608234}], ["SDC3", ["TCGA.AD.6888.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.894839914644842}], ["SDC3", ["TCGA.AD.6888.01", "IGF1R signaling cascade"], {"weight": 0.894839914644842}], ["SDC3", ["TCGA.AD.6888.01", "FGFR4 ligand binding and activation"], {"weight": 0.894062508858868}], ["SDC3", ["TCGA.AD.6888.01", "Signaling by Receptor Tyrosine Kinases"], {"weight": 0.9162059285159}], ["SDC3", ["TCGA.AD.6888.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.88328373457359}], ["SDC3", ["TCGA.AD.6888.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.894062508858868}], ["SDC3", ["TCGA.AD.6888.01", "FGFR2 ligand binding and activation"], {"weight": 0.9186468248667}], ["SDC3", ["TCGA.AD.6888.01", "Scavenging by Class A Receptors"], {"weight": 0.508625943091848}], ["SDC3", ["TCGA.AD.6888.01", "IRS-mediated signalling"], {"weight": 0.883807045667622}], ["SDC3", ["TCGA.AD.6888.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.934683733952072}], ["SDC3", ["TCGA.AD.6888.01", "Retinoid metabolism and transport"], {"weight": 0.934683733952072}], ["SDC3", ["TCGA.AD.6888.01", "Phospholipase C-mediated cascade: FGFR1"], {"weight": 0.907189180087418}], ["TRPC7", ["TCGA.AD.6888.01", "Platelet homeostasis"], {"weight": 0.892206078593881}], ["TRPC7", ["TCGA.AD.6888.01", "Stimuli-sensing channels"], {"weight": 0.89092672555542}], ["TRPC7", ["TCGA.AD.6888.01", "Ion homeostasis"], {"weight": 0.915589152871594}], ["TRPC7", ["TCGA.AD.6888.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.901008973880078}], ["TRPC7", ["TCGA.AD.6888.01", "Netrin-1 signaling"], {"weight": 0.839331956692094}], ["TRPC7", ["TCGA.CM.6675.01", "Stimuli-sensing channels"], {"weight": 0.919329738701861}], ["TRPC7", ["TCGA.CM.6675.01", "Ion channel transport"], {"weight": 0.930334128653808}], ["TRPC7", ["TCGA.G4.6586.01", "Ion homeostasis"], {"weight": 0.943500331969661}], ["TRPC7", ["TCGA.G4.6586.01", "Platelet calcium homeostasis"], {"weight": 0.945798930594603}], ["TRPC7", ["TCGA.G4.6586.01", "Ion channel transport"], {"weight": 0.961632719851585}], ["RHOT1", ["TCGA.AD.6889.01", "Signaling by GPCR"], {"weight": 0.945296608654539}], ["ITGA4", ["TCGA.AZ.6598.01", "Extracellular matrix organization"], {"weight": 0.916871926683976}], ["ITGA4", ["TCGA.CA.5796.01", "Extracellular matrix organization"], {"weight": 0.771550424921465}], ["ITGA4", ["TCGA.CA.5796.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.623857462975863}], ["ITGA4", ["TCGA.CA.5796.01", "Defective B3GALTL causes PpS"], {"weight": 0.838201572033901}], ["ITGA4", ["TCGA.CA.5796.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.838241050484248}], ["ITGA4", ["TCGA.G4.6298.01", "Cytokine Signaling in Immune system"], {"weight": 0.877441572439324}], ["ITGA4", ["TCGA.G4.6298.01", "Ligand-dependent caspase activation"], {"weight": 0.793655938909842}], ["ITGA4", ["TCGA.G4.6298.01", "Signaling by Interleukins"], {"weight": 0.879346454108247}], ["ITGA6", ["TCGA.D5.6538.01", "Interleukin-2 family signaling"], {"weight": 0.867112334795531}], ["ITGA6", ["TCGA.F4.6703.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.854907518150587}], ["PTCH2", ["TCGA.AD.6889.01", "GPCR ligand binding"], {"weight": 0.938227140671983}], ["PTCH2", ["TCGA.AD.6889.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.917235897098307}], ["PPP3CA", ["TCGA.AZ.4682.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.908945760771992}], ["OR7A5", ["TCGA.AD.6889.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.932572663498906}], ["USP10", ["TCGA.D5.6538.01", "Interferon Signaling"], {"weight": 0.913298690586337}], ["ISLR", ["TCGA.AD.6889.01", "Initial triggering of complement"], {"weight": 0.842511630297751}], ["ISLR", ["TCGA.AD.6889.01", "Creation of C4 and C2 activators"], {"weight": 0.817919291050681}], ["HPSE2", ["TCGA.DM.A1D7.01", "TNFs bind their physiological receptors"], {"weight": 0.245259381426216}], ["HPSE2", ["TCGA.G4.6306.01", "Calcitonin-like ligand receptors"], {"weight": 0.86130022771266}], ["STAMBP", ["TCGA.CM.4750.01", "Dermatan sulfate biosynthesis"], {"weight": 0.750446890272846}], ["NPTN", ["TCGA.AD.6889.01", "GABA receptor activation"], {"weight": 0.906851505123677}], ["CYP2A6", ["TCGA.AU.6004.01", "Phase II - Conjugation of compounds"], {"weight": 0.820229253167705}], ["CYP2A6", ["TCGA.CM.6166.01", "Arachidonic acid metabolism"], {"weight": 0.92223339781805}], ["CYP2A6", ["TCGA.CM.6166.01", "Heme degradation"], {"weight": 0.812703254058183}], ["CYP2A6", ["TCGA.CM.6166.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.914077165908706}], ["CYP2A6", ["TCGA.CM.6166.01", "RA biosynthesis pathway"], {"weight": 0.909390637172265}], ["CYP2A6", ["TCGA.D5.6533.01", "Biological oxidations"], {"weight": 0.923772163563985}], ["CYP2A6", ["TCGA.D5.6533.01", "Phase II - Conjugation of compounds"], {"weight": 0.868827386716913}], ["CYP2A6", ["TCGA.D5.6533.01", "Aspirin ADME"], {"weight": 0.859970689962882}], ["CYP2A6", ["TCGA.D5.6533.01", "Glucuronidation"], {"weight": 0.924605709438584}], ["RHOT1", ["TCGA.AD.6889.01", "GPCR downstream signalling"], {"weight": 0.947234497078092}], ["RHOT1", ["TCGA.D5.6536.01", "Signaling by GPCR"], {"weight": 0.940402168499139}], ["RHOT1", ["TCGA.D5.6536.01", "GPCR downstream signalling"], {"weight": 0.941161878627335}], ["PF4", ["TCGA.CM.5861.01", "Complement cascade"], {"weight": 0.799512023024816}], ["SPTBN4", ["TCGA.AD.6889.01", "Interaction between L1 and Ankyrins"], {"weight": 0.950971732181479}], ["SPTBN4", ["TCGA.AY.6196.01", "Interaction between L1 and Ankyrins"], {"weight": 0.858479778015742}], ["SPTBN4", ["TCGA.AZ.6601.01", "L1CAM interactions"], {"weight": 0.86099395270829}], ["SPTBN4", ["TCGA.AZ.6601.01", "Interaction between L1 and Ankyrins"], {"weight": 0.912986700569045}], ["SPTBN4", ["TCGA.G4.6307.01", "Phase 0 - rapid depolarisation"], {"weight": 0.937025784075616}], ["OR9Q1", ["TCGA.CM.6674.01", "G alpha (q) signalling events"], {"weight": 0.902925636520025}], ["TAF3", ["TCGA.AD.6890.01", "Biological oxidations"], {"weight": 0.827385546358615}], ["OR13A1", ["TCGA.AD.6889.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.924531192545301}], ["PICK1", ["TCGA.AD.6889.01", "Synaptic adhesion-like molecules"], {"weight": 0.837032359251483}], ["ADAMTS5", ["TCGA.AZ.5403.01", "Collagen chain trimerization"], {"weight": 0.838110315846102}], ["ADAMTS5", ["TCGA.D5.5538.01", "O-linked glycosylation"], {"weight": 0.888250937675592}], ["ADAMTS5", ["TCGA.D5.5538.01", "Lewis blood group biosynthesis"], {"weight": 0.477395230288889}], ["ADAMTS5", ["TCGA.D5.5538.01", "Blood group systems biosynthesis"], {"weight": 0.476688638244306}], ["ASIP", ["TCGA.AD.6889.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.935831055169665}], ["OR5AC2", ["TCGA.D5.5538.01", "Neuronal System"], {"weight": 0.920175101461027}], ["OR5AC2", ["TCGA.D5.5538.01", "GPCR ligand binding"], {"weight": 0.921074639675469}], ["OR5AC2", ["TCGA.D5.5538.01", "Signaling by GPCR"], {"weight": 0.91861274252325}], ["OR5AC2", ["TCGA.D5.5538.01", "G alpha (s) signalling events"], {"weight": 0.952146607886833}], ["OR5AC2", ["TCGA.D5.5538.01", "G alpha (i) signalling events"], {"weight": 0.916618314531409}], ["OR5AC2", ["TCGA.D5.5538.01", "GPCR downstream signalling"], {"weight": 0.929415310448254}], ["OR5AC2", ["TCGA.D5.5538.01", "Activation of NMDA receptors and postsynaptic events"], {"weight": 0.884860139303011}], ["OR5AC2", ["TCGA.D5.5538.01", "Glucagon-type ligand receptors"], {"weight": 0.918511945955484}], ["OR5AC2", ["TCGA.D5.5538.01", "Potassium Channels"], {"weight": 0.946496837276918}], ["OR5AC2", ["TCGA.D5.5538.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.903069071570386}], ["OR5AC2", ["TCGA.D5.5538.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.880706507449624}], ["OR5AC2", ["TCGA.D5.5538.01", "Regulation of insulin secretion"], {"weight": 0.913308536340611}], ["OR5AC2", ["TCGA.D5.5538.01", "Post NMDA receptor activation events"], {"weight": 0.865772470728166}], ["OR5AC2", ["TCGA.D5.5538.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.753898989123275}], ["OR5AC2", ["TCGA.D5.5538.01", "Integration of energy metabolism"], {"weight": 0.885342594846958}], ["OR5AC2", ["TCGA.D5.5538.01", "Peptide hormone metabolism"], {"weight": 0.675865883249295}], ["OR5AC2", ["TCGA.D5.5538.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.790187802437691}], ["OR5AC2", ["TCGA.D5.5538.01", "Signal amplification"], {"weight": 0.813155080779802}], ["OR5AC2", ["TCGA.D5.5538.01", "Platelet homeostasis"], {"weight": 0.717546063508564}], ["LRIG1", ["TCGA.CM.6169.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.785477685890478}], ["LRIG1", ["TCGA.F4.6808.01", "CD22 mediated BCR regulation"], {"weight": 0.77651775908281}], ["GNB3", ["TCGA.D5.5537.01", "Phase 4 - resting membrane potential"], {"weight": 0.888354565383944}], ["KAT6A", ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.862778230195166}], ["KAT6A", ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts"], {"weight": 0.88534635424776}], ["KAT6A", ["TCGA.CM.4743.01", "Bile acid and bile salt metabolism"], {"weight": 0.877923353591104}], ["KAT6A", ["TCGA.CM.4743.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.831078705114829}], ["KAT6A", ["TCGA.CM.4743.01", "Recycling of bile acids and salts"], {"weight": 0.847612517524525}], ["OR6B2", ["TCGA.G4.6311.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.882141294833846}], ["OR6B2", ["TCGA.G4.6311.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.885844870252378}], ["OR6B2", ["TCGA.G4.6311.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.892470518574078}], ["OR6B2", ["TCGA.G4.6311.01", "Leishmania parasite growth and survival"], {"weight": 0.808735321027226}], ["OR6B2", ["TCGA.G4.6311.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.812759423963521}], ["OR6B2", ["TCGA.G4.6311.01", "Signal amplification"], {"weight": 0.812403428192569}], ["OR6B2", ["TCGA.G4.6311.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.873608426067803}], ["OR6B2", ["TCGA.G4.6311.01", "Aquaporin-mediated transport"], {"weight": 0.873608426067803}], ["OR6B2", ["TCGA.G4.6311.01", "GPER1 signaling"], {"weight": 0.873608426067803}], ["OR6B2", ["TCGA.G4.6311.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.873608426067803}], ["OR6B2", ["TCGA.G4.6311.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.834913525010316}], ["ADAMTS17", ["TCGA.D5.6927.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.942714620565909}], ["ADAMTS17", ["TCGA.DM.A1DB.01", "O-linked glycosylation"], {"weight": 0.931962031509063}], ["ADAMTS17", ["TCGA.G4.6302.01", "Defective B3GALTL causes PpS"], {"weight": 0.870735827812258}], ["ADAMTS17", ["TCGA.G4.6302.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.870661983915383}], ["ALDH1A1", ["TCGA.AD.6889.01", "RA biosynthesis pathway"], {"weight": 0.867235209731641}], ["ALDH1A1", ["TCGA.AD.6895.01", "RA biosynthesis pathway"], {"weight": 0.862571342301414}], ["ALDH1A1", ["TCGA.AD.6895.01", "Ethanol oxidation"], {"weight": 0.91141625551375}], ["CCR10", ["TCGA.DM.A28E.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.806400342720927}], ["CCR10", ["TCGA.DM.A28E.01", "Neuronal System"], {"weight": 0.946631998175501}], ["CCR10", ["TCGA.DM.A28E.01", "Immune System"], {"weight": 0.898914788846413}], ["CCR10", ["TCGA.DM.A28E.01", "Muscle contraction"], {"weight": 0.941082203081434}], ["CCR10", ["TCGA.DM.A28E.01", "Complement cascade"], {"weight": 0.937550193034492}], ["CCR10", ["TCGA.DM.A28E.01", "Transmission across Chemical Synapses"], {"weight": 0.932198867602233}], ["CCR10", ["TCGA.DM.A28E.01", "Potassium Channels"], {"weight": 0.964813870158929}], ["CCR10", ["TCGA.DM.A28E.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.938839129274555}], ["CCR10", ["TCGA.DM.A28E.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.91806539102654}], ["CCR10", ["TCGA.DM.A28E.01", "Leishmania parasite growth and survival"], {"weight": 0.91806539102654}], ["CCR10", ["TCGA.DM.A28E.01", "G alpha (s) signalling events"], {"weight": 0.961881591791486}], ["CCR10", ["TCGA.DM.A28E.01", "Regulation of Complement cascade"], {"weight": 0.904892095127753}], ["CCR10", ["TCGA.DM.A28E.01", "Biological oxidations"], {"weight": 0.926287020299332}], ["CCR10", ["TCGA.DM.A28E.01", "Initial triggering of complement"], {"weight": 0.886418661505244}], ["CCR10", ["TCGA.DM.A28E.01", "Leishmania infection"], {"weight": 0.899911476788066}], ["CCR10", ["TCGA.DM.A28E.01", "Parasitic Infection Pathways"], {"weight": 0.899911476788066}], ["CCR10", ["TCGA.DM.A28E.01", "G-protein beta:gamma signalling"], {"weight": 0.930716123658204}], ["CCR10", ["TCGA.DM.A28E.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.919544266171863}], ["CCR10", ["TCGA.DM.A28E.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.797939632869272}], ["CCR10", ["TCGA.DM.A28E.01", "Transport of small molecules"], {"weight": 0.903081605851458}], ["CCR10", ["TCGA.DM.A28E.01", "G alpha (q) signalling events"], {"weight": 0.905398740394873}], ["CCR10", ["TCGA.DM.A28E.01", "Regulation of insulin secretion"], {"weight": 0.933382418123853}], ["CCR10", ["TCGA.DM.A28E.01", "GABA receptor activation"], {"weight": 0.918317353499438}], ["CCR10", ["TCGA.DM.A28E.01", "Glucagon-type ligand receptors"], {"weight": 0.932105765660676}], ["CCR10", ["TCGA.DM.A28E.01", "GABA B receptor activation"], {"weight": 0.928724257132783}], ["CCR10", ["TCGA.DM.A28E.01", "Activation of GABAB receptors"], {"weight": 0.928724257132783}], ["CCR10", ["TCGA.DM.A28E.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.914859287034827}], ["CCR10", ["TCGA.DM.A28E.01", "Cytokine Signaling in Immune system"], {"weight": 0.879864439531043}], ["CCR10", ["TCGA.DM.A28E.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.92181198341672}], ["CCR10", ["TCGA.DM.A28E.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.888038577848754}], ["CCR10", ["TCGA.DM.A28E.01", "Aquaporin-mediated transport"], {"weight": 0.888038577848754}], ["CCR10", ["TCGA.DM.A28E.01", "Adaptive Immune System"], {"weight": 0.908180194634023}], ["CCR10", ["TCGA.DM.A28E.01", "Presynaptic function of Kainate receptors"], {"weight": 0.896758513146394}], ["CCR10", ["TCGA.DM.A28E.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.921775280277811}], ["CCR10", ["TCGA.DM.A28E.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.9296547337598}], ["CCR10", ["TCGA.DM.A28E.01", "Integration of energy metabolism"], {"weight": 0.933952692309585}], ["CCR10", ["TCGA.DM.A28E.01", "Phase I - Functionalization of compounds"], {"weight": 0.94299899885805}], ["CCR10", ["TCGA.DM.A28E.01", "G beta:gamma signalling through BTK"], {"weight": 0.90581429094872}], ["CCR10", ["TCGA.DM.A28E.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.907948673466901}], ["CCR10", ["TCGA.DM.A28E.01", "Signaling by Interleukins"], {"weight": 0.891974490325722}], ["CCR10", ["TCGA.DM.A28E.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.912976404544242}], ["CCR10", ["TCGA.DM.A28E.01", "G alpha (z) signalling events"], {"weight": 0.921605353134634}], ["CCR10", ["TCGA.DM.A28E.01", "Activation of G protein gated Potassium channels"], {"weight": 0.919540205763288}], ["CCR10", ["TCGA.DM.A28E.01", "G protein gated Potassium channels"], {"weight": 0.919540205763288}], ["CCR10", ["TCGA.DM.A28E.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.919540205763288}], ["CCR10", ["TCGA.DM.A28E.01", "Scavenging by Class A Receptors"], {"weight": 0.347042621505415}], ["CCR10", ["TCGA.DM.A28E.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.891307386664233}], ["CCR10", ["TCGA.DM.A28E.01", "G beta:gamma signalling through CDC42"], {"weight": 0.894289462848477}], ["CCR10", ["TCGA.DM.A28E.01", "GPER1 signaling"], {"weight": 0.921125000288789}], ["CCR10", ["TCGA.DM.A28E.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.921125000288789}], ["CCR10", ["TCGA.DM.A28E.01", "Ca2+ pathway"], {"weight": 0.876979827772703}], ["CCR10", ["TCGA.DM.A28E.01", "Inwardly rectifying K+ channels"], {"weight": 0.92750276029963}], ["ST8SIA4", ["TCGA.DM.A285.01", "Interferon gamma signaling"], {"weight": 0.920154410922164}], ["SH3GL1", ["TCGA.CM.6674.01", "GABA receptor activation"], {"weight": 0.854536995222774}], ["CYP4A22", ["TCGA.AM.5821.01", "Arachidonic acid metabolism"], {"weight": 0.949463303134523}], ["CYP4A22", ["TCGA.AZ.6607.01", "Biological oxidations"], {"weight": 0.955404166710203}], ["CYP4A22", ["TCGA.AZ.6607.01", "Phase I - Functionalization of compounds"], {"weight": 0.953715977718351}], ["CYP4A22", ["TCGA.AZ.6607.01", "Fatty acid metabolism"], {"weight": 0.89154202517779}], ["CYP4A22", ["TCGA.AZ.6607.01", "Arachidonic acid metabolism"], {"weight": 0.892360356384861}], ["CYP4A22", ["TCGA.CM.5864.01", "Biological oxidations"], {"weight": 0.894577061661563}], ["CYP4A22", ["TCGA.CM.5864.01", "Phase II - Conjugation of compounds"], {"weight": 0.819311471051337}], ["CYP4A22", ["TCGA.DM.A0XF.01", "RA biosynthesis pathway"], {"weight": 0.86634402721893}], ["CYP4A22", ["TCGA.DM.A282.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.725882106046991}], ["CYP4A22", ["TCGA.DM.A282.01", "Heme degradation"], {"weight": 0.753537717289539}], ["CYP4A22", ["TCGA.DM.A282.01", "Arachidonic acid metabolism"], {"weight": 0.89620323888011}], ["MAP2K2", ["TCGA.AD.6889.01", "Chemokine receptors bind chemokines"], {"weight": 0.926594724927784}], ["ETV5", ["TCGA.CM.5861.01", "Chemokine receptors bind chemokines"], {"weight": 0.934416992148447}], ["ETV5", ["TCGA.CM.5861.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.948889122036406}], ["ETV5", ["TCGA.CM.5861.01", "Peptide ligand-binding receptors"], {"weight": 0.947424637388743}], ["TRPC5", ["TCGA.G4.6628.01", "Phase 0 - rapid depolarisation"], {"weight": 0.922416784081357}], ["LGI1", ["TCGA.AD.6889.01", "Phase 0 - rapid depolarisation"], {"weight": 0.942602846784098}], ["LGI1", ["TCGA.F4.6570.01", "Phase 0 - rapid depolarisation"], {"weight": 0.910612298383093}], ["LGI1", ["TCGA.F4.6570.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.874603757176399}], ["ATF6", ["TCGA.DM.A1D9.01", "Initial triggering of complement"], {"weight": 0.752681230590692}], ["ATF6", ["TCGA.DM.A1D9.01", "Classical antibody-mediated complement activation"], {"weight": 0.694067634146318}], ["ATF6", ["TCGA.DM.A1D9.01", "Creation of C4 and C2 activators"], {"weight": 0.741833715589156}], ["COL8A1", ["TCGA.CM.4743.01", "Collagen chain trimerization"], {"weight": 0.920584403178407}], ["CPT1A", ["TCGA.F4.6805.01", "Drug ADME"], {"weight": 0.693148089478606}], ["PPFIA1", ["TCGA.AD.6889.01", "Neuronal System"], {"weight": 0.952961770638668}], ["PPFIA1", ["TCGA.CM.4744.01", "Protein-protein interactions at synapses"], {"weight": 0.940122727646126}], ["PPFIA1", ["TCGA.CM.4744.01", "Neurexins and neuroligins"], {"weight": 0.950958797841871}], ["PPFIA1", ["TCGA.CM.4744.01", "Neurotransmitter release cycle"], {"weight": 0.823857925706642}], ["OR4C3", ["TCGA.F4.6808.01", "G alpha (i) signalling events"], {"weight": 0.946327002518043}], ["OR4C3", ["TCGA.F4.6808.01", "GABA receptor activation"], {"weight": 0.907805288696452}], ["OR4C3", ["TCGA.F4.6808.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.924778920228939}], ["OR4C3", ["TCGA.F4.6808.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.919346649853929}], ["OR4C3", ["TCGA.F4.6808.01", "Glucagon-type ligand receptors"], {"weight": 0.930287908097055}], ["OR4C3", ["TCGA.F4.6808.01", "GPCR ligand binding"], {"weight": 0.942788054047496}], ["OR4C3", ["TCGA.F4.6808.01", "G-protein beta:gamma signalling"], {"weight": 0.928195444081275}], ["OR4C3", ["TCGA.F4.6808.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.880896458037297}], ["OR4C3", ["TCGA.F4.6808.01", "Aquaporin-mediated transport"], {"weight": 0.880896458037297}], ["OR4C3", ["TCGA.F4.6808.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.926525184165858}], ["OR4C3", ["TCGA.F4.6808.01", "GPER1 signaling"], {"weight": 0.918213344677092}], ["OR4C3", ["TCGA.F4.6808.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.918213344677092}], ["OR4C3", ["TCGA.F4.6808.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.912738491853302}], ["OR4C3", ["TCGA.F4.6808.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.909335996042442}], ["OR4C3", ["TCGA.F4.6808.01", "G alpha (q) signalling events"], {"weight": 0.939527335400365}], ["OR4C3", ["TCGA.F4.6808.01", "G alpha (z) signalling events"], {"weight": 0.918302885883059}], ["OR4C3", ["TCGA.F4.6808.01", "Potassium Channels"], {"weight": 0.905655268692102}], ["IDH2", ["TCGA.CK.4948.01", "Biological oxidations"], {"weight": 0.869783838235702}], ["MERTK", ["TCGA.AY.5543.01", "Peptide hormone metabolism"], {"weight": 0.777381148233058}], ["MERTK", ["TCGA.CM.5349.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.874414310377094}], ["RENBP", ["TCGA.AD.6889.01", "Sialic acid metabolism"], {"weight": 0.796336314638281}], ["NCL", ["TCGA.CK.4952.01", "Glucuronidation"], {"weight": 0.869670340763201}], ["NCL", ["TCGA.CM.5341.01", "Major pathway of rRNA processing in the nucleolus and cytosol"], {"weight": 0.941604391408021}], ["NCL", ["TCGA.CM.5341.01", "SARS-CoV-1-host interactions"], {"weight": 0.888001988611471}], ["NCL", ["TCGA.CM.5341.01", "SARS-CoV-1 Infection"], {"weight": 0.845464356876923}], ["NCL", ["TCGA.CM.5341.01", "Regulation of gene expression by Hypoxia-inducible Factor"], {"weight": 0.856976528646826}], ["NCL", ["TCGA.CM.5341.01", "Metabolism of RNA"], {"weight": 0.911326199479054}], ["NCL", ["TCGA.G4.6306.01", "Nicotinate metabolism"], {"weight": 0.766886546340455}], ["WNT1", ["TCGA.CM.4743.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.902377420397014}], ["GNAI2", ["TCGA.AD.6889.01", "G alpha (i) signalling events"], {"weight": 0.947114632323375}], ["NPNT", ["TCGA.AD.6964.01", "ECM proteoglycans"], {"weight": 0.887096535586277}], ["PRKCA", ["TCGA.AD.6889.01", "G alpha (q) signalling events"], {"weight": 0.945441100180911}], ["PRKCA", ["TCGA.G4.6588.01", "Visual phototransduction"], {"weight": 0.921501923881225}], ["SLC9A3", ["TCGA.AD.6889.01", "Peptide ligand-binding receptors"], {"weight": 0.934722439558407}], ["SLC9A3", ["TCGA.AD.6895.01", "Peptide ligand-binding receptors"], {"weight": 0.940293295708816}], ["SLC9A3", ["TCGA.AD.6895.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.940348832260565}], ["TBX5", ["TCGA.G4.6588.01", "Cardiac conduction"], {"weight": 0.932336232938105}], ["FAS", ["TCGA.CK.4947.01", "Visual phototransduction"], {"weight": 0.66828648126683}], ["PASD1", ["TCGA.AZ.4323.01", "Cardiac conduction"], {"weight": 0.908042668992487}], ["PASD1", ["TCGA.AZ.4323.01", "Ethanol oxidation"], {"weight": 0.459259297129833}], ["NR0B1", ["TCGA.D5.6533.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.776622154982954}], ["NR0B1", ["TCGA.D5.6533.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.708724859540773}], ["NR0B1", ["TCGA.D5.6533.01", "Signaling Pathways"], {"weight": 0.885416612749746}], ["TACR2", ["TCGA.D5.6537.01", "GPCR ligand binding"], {"weight": 0.947003653723771}], ["TACR2", ["TCGA.D5.6537.01", "Chemokine receptors bind chemokines"], {"weight": 0.935193122597611}], ["TACR2", ["TCGA.D5.6537.01", "Peptide ligand-binding receptors"], {"weight": 0.941621319540878}], ["TACR2", ["TCGA.D5.6537.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.950487440312476}], ["OR10H3", ["TCGA.DM.A1D4.01", "GPCR downstream signalling"], {"weight": 0.958615608502929}], ["OR10H3", ["TCGA.DM.A1D4.01", "Signaling by GPCR"], {"weight": 0.948512780870939}], ["OR10H3", ["TCGA.DM.A1D4.01", "G alpha (i) signalling events"], {"weight": 0.948360977829031}], ["OR10H3", ["TCGA.DM.A1D4.01", "G alpha (s) signalling events"], {"weight": 0.960825193151628}], ["OR10H3", ["TCGA.DM.A1D4.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.914170523414338}], ["OR10H3", ["TCGA.DM.A1D4.01", "G alpha (q) signalling events"], {"weight": 0.942031837931535}], ["OR10H3", ["TCGA.DM.A1D4.01", "Ca-dependent events"], {"weight": 0.894087630919557}], ["OR10H3", ["TCGA.DM.A1D4.01", "PKA activation in glucagon signalling"], {"weight": 0.889929033822303}], ["OR10H3", ["TCGA.DM.A1D4.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.901083695622334}], ["OR10H3", ["TCGA.DM.A1D4.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.904956799930409}], ["OR10H3", ["TCGA.DM.A1D4.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.92147924630092}], ["OR10H3", ["TCGA.DM.A1D4.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.904956799930409}], ["OR10H3", ["TCGA.DM.A1D4.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.894321867087876}], ["OR10H3", ["TCGA.DM.A1D4.01", "Glucagon-type ligand receptors"], {"weight": 0.932539597150989}], ["SLC6A13", ["TCGA.G4.6298.01", "SLC-mediated transmembrane transport"], {"weight": 0.859062145607623}], ["SLPI", ["TCGA.AD.6889.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.932332695698027}], ["SLPI", ["TCGA.AZ.6598.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.916835882074049}], ["ST6GAL2", ["TCGA.CK.5913.01", "O-linked glycosylation"], {"weight": 0.919056751097051}], ["ST6GAL2", ["TCGA.D5.6929.01", "O-linked glycosylation"], {"weight": 0.882532691741926}], ["ST6GAL2", ["TCGA.D5.6929.01", "Blood group systems biosynthesis"], {"weight": 0.682606809544811}], ["DPPA4", ["TCGA.G4.6588.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.895180831718507}], ["DPPA4", ["TCGA.G4.6588.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.863135945259575}], ["PCDH15", ["TCGA.AD.6889.01", "Sensory processing of sound"], {"weight": 0.950332887496328}], ["PCDH15", ["TCGA.AD.6889.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.949050303217037}], ["PCDH15", ["TCGA.AD.6889.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.94466621464321}], ["OSTM1", ["TCGA.CM.6171.01", "Stimuli-sensing channels"], {"weight": 0.904004834400012}], ["OR5K1", ["TCGA.AD.6890.01", "Inwardly rectifying K+ channels"], {"weight": 0.916965019812919}], ["OR5K1", ["TCGA.AD.6890.01", "Phase 4 - resting membrane potential"], {"weight": 0.81170845478527}], ["OR5K1", ["TCGA.AD.6890.01", "Glucagon-type ligand receptors"], {"weight": 0.907743416231634}], ["OR5K1", ["TCGA.AD.6890.01", "G beta:gamma signalling through BTK"], {"weight": 0.896025714345365}], ["OR5K1", ["TCGA.AD.6890.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.838001131328701}], ["OR5K1", ["TCGA.AD.6890.01", "G-protein beta:gamma signalling"], {"weight": 0.912967517390128}], ["OR5K1", ["TCGA.AD.6890.01", "G beta:gamma signalling through CDC42"], {"weight": 0.892872742751966}], ["OR5K1", ["TCGA.AD.6890.01", "Signal amplification"], {"weight": 0.853534996385533}], ["OR5K1", ["TCGA.AD.6890.01", "GABA receptor activation"], {"weight": 0.84261256137813}], ["OR5K1", ["TCGA.AD.6890.01", "Presynaptic function of Kainate receptors"], {"weight": 0.875701744252168}], ["OR5K1", ["TCGA.AD.6890.01", "Activation of G protein gated Potassium channels"], {"weight": 0.89400045529878}], ["OR5K1", ["TCGA.AD.6890.01", "G protein gated Potassium channels"], {"weight": 0.89400045529878}], ["OR5K1", ["TCGA.AD.6890.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.89400045529878}], ["OR5K1", ["TCGA.AD.6890.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.891729239794393}], ["OR5K1", ["TCGA.AD.6890.01", "GABA B receptor activation"], {"weight": 0.900999386429451}], ["OR5K1", ["TCGA.AD.6890.01", "Activation of GABAB receptors"], {"weight": 0.900999386429451}], ["OR5K1", ["TCGA.AD.6890.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.891033937168599}], ["OR5K1", ["TCGA.AD.6890.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.887087162904349}], ["OR5K1", ["TCGA.AD.6890.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.857911429064578}], ["OR5K1", ["TCGA.AD.6890.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.857911429064578}], ["OR5K1", ["TCGA.AD.6890.01", "GPCR ligand binding"], {"weight": 0.90673907337293}], ["OR5K1", ["TCGA.AD.6890.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.896263098498621}], ["SHC4", ["TCGA.AD.6890.01", "Degradation of the extracellular matrix"], {"weight": 0.798022285702296}], ["SHC4", ["TCGA.AD.6890.01", "Interleukin-6 family signaling"], {"weight": 0.910818143597864}], ["SHC4", ["TCGA.AD.6890.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.918896411203222}], ["SHC4", ["TCGA.AD.6890.01", "Protein-protein interactions at synapses"], {"weight": 0.864843568016044}], ["SHC4", ["TCGA.AD.6890.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.942331326720321}], ["SYT9", ["TCGA.AD.6890.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.108005980196511}], ["FBXL7", ["TCGA.DM.A1HA.01", "GPCR ligand binding"], {"weight": 0.94717659779264}], ["FBXL7", ["TCGA.DM.A1HA.01", "Peptide ligand-binding receptors"], {"weight": 0.935005209714888}], ["FBXL7", ["TCGA.DM.A1HA.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.941755346218592}], ["ADAMTS10", ["TCGA.CK.5913.01", "Defective B3GALTL causes PpS"], {"weight": 0.905333361080253}], ["ADAMTS10", ["TCGA.CK.5913.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.905282889355881}], ["AP2M1", ["TCGA.AD.6895.01", "Neuronal System"], {"weight": 0.930973894483139}], ["COL14A1", ["TCGA.AZ.6599.01", "Signaling by Receptor Tyrosine Kinases"], {"weight": 0.897790747007876}], ["COL14A1", ["TCGA.CM.6674.01", "Degradation of the extracellular matrix"], {"weight": 0.872367635507389}], ["TTC27", ["TCGA.D5.6929.01", "GPCR downstream signalling"], {"weight": 0.927405840974526}], ["CAMKK1", ["TCGA.AD.6895.01", "Trafficking of AMPA receptors"], {"weight": 0.916840389023327}], ["CAMKK1", ["TCGA.AD.6895.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.916840389023327}], ["USP33", ["TCGA.G4.6586.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.95639356852386}], ["USP33", ["TCGA.G4.6588.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.9477926825673}], ["IGF1", ["TCGA.D5.6535.01", "Regulation of gene expression by Hypoxia-inducible Factor"], {"weight": 0.750132937012922}], ["SCN11A", ["TCGA.CK.4947.01", "Stimuli-sensing channels"], {"weight": 0.838660295720882}], ["NMT1", ["TCGA.AD.6895.01", "TP53 Regulates Transcription of Death Receptors and Ligands"], {"weight": 0.636199285622615}], ["NMT1", ["TCGA.DM.A1D0.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.835889073489298}], ["NMT1", ["TCGA.DM.A1D0.01", "Ion homeostasis"], {"weight": 0.907423584757594}], ["APP", ["TCGA.AZ.6600.01", "Antimicrobial peptides"], {"weight": 0.520546271488254}], ["APP", ["TCGA.CM.6163.01", "Extracellular matrix organization"], {"weight": 0.794767831465899}], ["APP", ["TCGA.CM.6163.01", "Signaling by GPCR"], {"weight": 0.890924023842798}], ["APP", ["TCGA.CM.6163.01", "Common Pathway of Fibrin Clot Formation"], {"weight": 0.820999961958605}], ["APP", ["TCGA.CM.6163.01", "GPCR downstream signalling"], {"weight": 0.883894947890458}], ["APP", ["TCGA.CM.6163.01", "Cardiac conduction"], {"weight": 0.778783700681113}], ["APP", ["TCGA.G4.6310.01", "Innate Immune System"], {"weight": 0.888549224116423}], ["APP", ["TCGA.G4.6310.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.781754117880634}], ["APP", ["TCGA.G4.6310.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.781754117880634}], ["APP", ["TCGA.G4.6310.01", "Complement cascade"], {"weight": 0.787381255912302}], ["APP", ["TCGA.G4.6310.01", "Scavenging of heme from plasma"], {"weight": 0.748698578688385}], ["APP", ["TCGA.G4.6310.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.743771180982014}], ["APP", ["TCGA.G4.6310.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.743771180982014}], ["APP", ["TCGA.G4.6310.01", "Inflammasomes"], {"weight": 0.795057738807825}], ["APP", ["TCGA.G4.6310.01", "Scavenging by Class A Receptors"], {"weight": 0.393465987250296}], ["APP", ["TCGA.G4.6310.01", "The NLRP3 inflammasome"], {"weight": 0.755276342488407}], ["APP", ["TCGA.G4.6310.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.673450285446036}], ["PRKG1", ["TCGA.CM.6678.01", "Cardiac conduction"], {"weight": 0.821668541975724}], ["FZD3", ["TCGA.AD.6895.01", "Signaling by GPCR"], {"weight": 0.921229514727809}], ["FZD3", ["TCGA.AD.6895.01", "GPCR ligand binding"], {"weight": 0.933785735940836}], ["OR52I2", ["TCGA.CM.4748.01", "Peptide hormone biosynthesis"], {"weight": 0.799153761326508}], ["OR52I2", ["TCGA.DM.A28F.01", "Neuronal System"], {"weight": 0.939513365705814}], ["OR52I2", ["TCGA.DM.A28F.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.902478488520922}], ["OR52I2", ["TCGA.G4.6298.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.91072839769511}], ["TSSK1B", ["TCGA.DM.A1HA.01", "Integration of energy metabolism"], {"weight": 0.954089227958096}], ["TSSK1B", ["TCGA.G4.6298.01", "Integration of energy metabolism"], {"weight": 0.930545983526432}], ["RHOA", ["TCGA.AD.6895.01", "Extracellular matrix organization"], {"weight": 0.886220949401423}], ["RHOA", ["TCGA.AD.6965.01", "Signaling by GPCR"], {"weight": 0.947188965551188}], ["RHOA", ["TCGA.AD.6965.01", "GPCR downstream signalling"], {"weight": 0.947713753051067}], ["RHOA", ["TCGA.AD.6965.01", "Extracellular matrix organization"], {"weight": 0.819770642474507}], ["RHOA", ["TCGA.AD.6965.01", "Signaling Pathways"], {"weight": 0.88226963762122}], ["ESD", ["TCGA.D5.5538.01", "Ethanol oxidation"], {"weight": 0.8032760238006}], ["ESD", ["TCGA.D5.5538.01", "RA biosynthesis pathway"], {"weight": 0.723742515606347}], ["OR14I1", ["TCGA.CM.5868.01", "GPCR downstream signalling"], {"weight": 0.9459682802767}], ["OR14I1", ["TCGA.CM.5868.01", "G alpha (q) signalling events"], {"weight": 0.93419323494371}], ["OR14I1", ["TCGA.CM.5868.01", "Signal amplification"], {"weight": 0.909607310087204}], ["OR14I1", ["TCGA.CM.5868.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.900978779530136}], ["OR14I1", ["TCGA.CM.5868.01", "G alpha (s) signalling events"], {"weight": 0.950532661332282}], ["OR14I1", ["TCGA.CM.5868.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.909123060105524}], ["OR14I1", ["TCGA.CM.5868.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.909514970192998}], ["OR14I1", ["TCGA.CM.5868.01", "G beta:gamma signalling through BTK"], {"weight": 0.907854435830677}], ["OR14I1", ["TCGA.CM.5868.01", "GABA B receptor activation"], {"weight": 0.915215029063464}], ["OR14I1", ["TCGA.CM.5868.01", "Activation of GABAB receptors"], {"weight": 0.915215029063464}], ["OR14I1", ["TCGA.CM.5868.01", "G-protein beta:gamma signalling"], {"weight": 0.921664943254356}], ["OR14I1", ["TCGA.CM.5868.01", "Activation of the phototransduction cascade"], {"weight": 0.773862839754921}], ["OR14I1", ["TCGA.CM.5868.01", "Glucagon-type ligand receptors"], {"weight": 0.910699827291952}], ["OR14I1", ["TCGA.CM.5868.01", "Presynaptic function of Kainate receptors"], {"weight": 0.898566902410247}], ["OR14I1", ["TCGA.CM.5868.01", "Inwardly rectifying K+ channels"], {"weight": 0.916771491967141}], ["OR14I1", ["TCGA.CM.5868.01", "Opioid Signalling"], {"weight": 0.933983696601214}], ["OR14I1", ["TCGA.CM.5868.01", "Activation of G protein gated Potassium channels"], {"weight": 0.910839789640189}], ["OR14I1", ["TCGA.CM.5868.01", "G protein gated Potassium channels"], {"weight": 0.910839789640189}], ["OR14I1", ["TCGA.CM.5868.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.908427838412495}], ["OR14I1", ["TCGA.CM.5868.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.910839789640189}], ["OR14I1", ["TCGA.CM.5868.01", "G-protein activation"], {"weight": 0.908722378117778}], ["OR14I1", ["TCGA.CM.5868.01", "Thromboxane signalling through TP receptor"], {"weight": 0.883747356068555}], ["OR14I1", ["TCGA.CM.5868.01", "G alpha (z) signalling events"], {"weight": 0.911745502366942}], ["OR14I1", ["TCGA.CM.5868.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.903975555004712}], ["OR14I1", ["TCGA.CM.5868.01", "Regulation of insulin secretion"], {"weight": 0.889503320184367}], ["OR14I1", ["TCGA.CM.5868.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.878166836729276}], ["OR14I1", ["TCGA.CM.5868.01", "Sensory perception of taste"], {"weight": 0.868951561354057}], ["OR14I1", ["TCGA.CM.5868.01", "LGI-ADAM interactions"], {"weight": 0.621834033931284}], ["OR14I1", ["TCGA.CM.5868.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.897447238748045}], ["OR14I1", ["TCGA.CM.5868.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.878166836729276}], ["OR14I1", ["TCGA.CM.5868.01", "G beta:gamma signalling through CDC42"], {"weight": 0.878166836729276}], ["OR14I1", ["TCGA.CM.5868.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.898454705084527}], ["OR14I1", ["TCGA.CM.5868.01", "Sensory perception of sweet, bitter, and umami (glutamate) taste"], {"weight": 0.862157253370338}], ["OR14I1", ["TCGA.CM.5868.01", "Inactivation, recovery and regulation of the phototransduction cascade"], {"weight": 0.771305145192926}], ["FGF8", ["TCGA.G4.6320.01", "FGFR1 ligand binding and activation"], {"weight": 0.909972740775438}], ["ARHGEF25", ["TCGA.AZ.6605.01", "Extracellular matrix organization"], {"weight": 0.898123060060808}], ["AGFG1", ["TCGA.AZ.4682.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.93066340636221}], ["AGFG1", ["TCGA.AZ.4682.01", "Glutamate Neurotransmitter Release Cycle"], {"weight": 0.767338489623428}], ["AGFG1", ["TCGA.AZ.4682.01", "Other interleukin signaling"], {"weight": 0.740061971960459}], ["AGFG1", ["TCGA.AZ.4682.01", "Peptide ligand-binding receptors"], {"weight": 0.914708867726359}], ["AGFG1", ["TCGA.AZ.4682.01", "Norepinephrine Neurotransmitter Release Cycle"], {"weight": 0.736025005739421}], ["AGFG1", ["TCGA.AZ.4682.01", "Neurexins and neuroligins"], {"weight": 0.88626941788678}], ["AGFG1", ["TCGA.AZ.4682.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.857367847673376}], ["AGFG1", ["TCGA.AZ.4682.01", "GABA synthesis, release, reuptake and degradation"], {"weight": 0.886341374962777}], ["AGFG1", ["TCGA.AZ.4682.01", "Generation of second messenger molecules"], {"weight": 0.806504095485984}], ["AGFG1", ["TCGA.AZ.4682.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.857367847673376}], ["TRIM45", ["TCGA.DM.A28K.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.928278322029894}], ["TRIM45", ["TCGA.DM.A28K.01", "Generation of second messenger molecules"], {"weight": 0.905347998083268}], ["TRIM45", ["TCGA.DM.A28K.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.926405832454662}], ["TRIM45", ["TCGA.DM.A28K.01", "PD-1 signaling"], {"weight": 0.924401966959394}], ["MX1", ["TCGA.D5.6538.01", "Interferon gamma signaling"], {"weight": 0.928614960371112}], ["MOGAT2", ["TCGA.CM.4752.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.648144270193229}], ["CCT8", ["TCGA.AD.6895.01", "G alpha (i) signalling events"], {"weight": 0.923465697767511}], ["TRPC1", ["TCGA.DM.A1D7.01", "Cardiac conduction"], {"weight": 0.946097939061993}], ["CYP2A13", ["TCGA.AD.6895.01", "Phase II - Conjugation of compounds"], {"weight": 0.87910118440181}], ["CYP2A13", ["TCGA.CM.6674.01", "Phase II - Conjugation of compounds"], {"weight": 0.785436221394938}], ["CYP2A13", ["TCGA.CM.6674.01", "Aspirin ADME"], {"weight": 0.792537312055637}], ["CYP2A13", ["TCGA.D5.6930.01", "Biological oxidations"], {"weight": 0.91988300491194}], ["CYP2A13", ["TCGA.D5.6930.01", "Phase II - Conjugation of compounds"], {"weight": 0.88693077414734}], ["TUBA3E", ["TCGA.F4.6805.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.506449947853834}], ["TUBA3E", ["TCGA.G4.6293.01", "Biological oxidations"], {"weight": 0.853502894146805}], ["AP2M1", ["TCGA.AD.6895.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.913981037851075}], ["AIFM1", ["TCGA.G4.6315.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.72229541741368}], ["INSRR", ["TCGA.CK.4948.01", "Peptide hormone metabolism"], {"weight": 0.709580862036549}], ["INSRR", ["TCGA.D5.6929.01", "Defective B3GALTL causes PpS"], {"weight": 0.869251448495687}], ["INSRR", ["TCGA.D5.6929.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.869251448495687}], ["INSRR", ["TCGA.D5.6929.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.826985295172545}], ["INSRR", ["TCGA.G4.6304.01", "Insulin processing"], {"weight": 0.827505643671732}], ["SLC11A2", ["TCGA.CM.6171.01", "SLC-mediated transmembrane transport"], {"weight": 0.899914411413731}], ["KL", ["TCGA.AD.6895.01", "Glucuronidation"], {"weight": 0.906327303427264}], ["KL", ["TCGA.AD.6895.01", "Heme degradation"], {"weight": 0.691174478154584}], ["KL", ["TCGA.AZ.6598.01", "Glucuronidation"], {"weight": 0.878380316275513}], ["KL", ["TCGA.CK.5916.01", "Phase II - Conjugation of compounds"], {"weight": 0.825460139060196}], ["KL", ["TCGA.CK.5916.01", "Glucuronidation"], {"weight": 0.877917601483174}], ["KL", ["TCGA.D5.6930.01", "Glucuronidation"], {"weight": 0.913765419474465}], ["CYP11B1", ["TCGA.CM.5861.01", "RA biosynthesis pathway"], {"weight": 0.930751026026146}], ["CYP11B1", ["TCGA.CM.5861.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.90803413383389}], ["CYP11B1", ["TCGA.D5.5538.01", "Biological oxidations"], {"weight": 0.946024879605317}], ["CYP11B1", ["TCGA.D5.5538.01", "Drug ADME"], {"weight": 0.80090718832894}], ["CYP11B1", ["TCGA.D5.5538.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.554940503032944}], ["CYP11B1", ["TCGA.D5.6541.01", "Drug ADME"], {"weight": 0.898479265040835}], ["CYP11B1", ["TCGA.D5.6541.01", "Biological oxidations"], {"weight": 0.930725848569931}], ["CYP11B1", ["TCGA.D5.6541.01", "Arachidonic acid metabolism"], {"weight": 0.837096477436359}], ["CYP11B1", ["TCGA.D5.6541.01", "RA biosynthesis pathway"], {"weight": 0.598005927986386}], ["CYP11B1", ["TCGA.D5.6541.01", "Phase I - Functionalization of compounds"], {"weight": 0.907302892546695}], ["CYP11B1", ["TCGA.D5.6928.01", "Metabolism"], {"weight": 0.882579638952384}], ["CYP11B1", ["TCGA.D5.6928.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.610325536198241}], ["CYP11B1", ["TCGA.D5.6928.01", "Synthesis of bile acids and bile salts"], {"weight": 0.65696127990602}], ["SLC40A1", ["TCGA.AD.6895.01", "Transport of small molecules"], {"weight": 0.951379617262555}], ["SLC40A1", ["TCGA.CA.6718.01", "SLC-mediated transmembrane transport"], {"weight": 0.918930443097786}], ["SLC40A1", ["TCGA.CA.6718.01", "Transport of bile salts and organic acids, metal ions and amine compounds"], {"weight": 0.775757357881387}], ["SLC40A1", ["TCGA.CA.6718.01", "Metal ion SLC transporters"], {"weight": 0.780206420057325}], ["FUT2", ["TCGA.AM.5820.01", "Blood group systems biosynthesis"], {"weight": 0.762889075518925}], ["FUT2", ["TCGA.AZ.6601.01", "Blood group systems biosynthesis"], {"weight": 0.771315727592198}], ["NTNG2", ["TCGA.AD.6895.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.860395823764599}], ["NTNG2", ["TCGA.CK.5913.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.844549383315614}], ["NTNG2", ["TCGA.CM.4743.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.964534698881284}], ["SRC", ["TCGA.AD.6899.01", "Extracellular matrix organization"], {"weight": 0.856121261156739}], ["GPC6", ["TCGA.D5.6534.01", "Post-translational protein phosphorylation"], {"weight": 0.692999786679224}], ["GPC6", ["TCGA.D5.6534.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.769358267483387}], ["GPC6", ["TCGA.D5.6534.01", "Visual phototransduction"], {"weight": 0.661813373774349}], ["GPC6", ["TCGA.D5.6534.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.761508043605116}], ["GPC6", ["TCGA.D5.6534.01", "Retinoid metabolism and transport"], {"weight": 0.761508043605116}], ["GPC6", ["TCGA.D5.6534.01", "Scavenging by Class A Receptors"], {"weight": 0.747509246844131}], ["OR4D10", ["TCGA.D5.6541.01", "Transmission across Chemical Synapses"], {"weight": 0.908344568985101}], ["OR4D10", ["TCGA.D5.6541.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.905476038518677}], ["OR4D10", ["TCGA.D5.6541.01", "Potassium Channels"], {"weight": 0.907856642557681}], ["OR4D10", ["TCGA.D5.6541.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.914797859024067}], ["OR4D10", ["TCGA.D5.6541.01", "Signal amplification"], {"weight": 0.904380634619958}], ["OR4D10", ["TCGA.D5.6541.01", "Glucagon-type ligand receptors"], {"weight": 0.923236458473727}], ["OR4D10", ["TCGA.D5.6541.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.93259048726377}], ["OR4D10", ["TCGA.D5.6541.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.897225982603925}], ["OR4D10", ["TCGA.D5.6541.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.834932856732439}], ["OR4D10", ["TCGA.D5.6541.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.898492351632116}], ["OR4D10", ["TCGA.D5.6541.01", "GABA B receptor activation"], {"weight": 0.911861713044845}], ["OR4D10", ["TCGA.D5.6541.01", "Activation of GABAB receptors"], {"weight": 0.911861713044845}], ["SPI1", ["TCGA.AZ.6599.01", "Complement cascade"], {"weight": 0.855442055865034}], ["SPI1", ["TCGA.AZ.6599.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.90114538687945}], ["SPI1", ["TCGA.AZ.6599.01", "Regulation of Complement cascade"], {"weight": 0.778630206193324}], ["OR52N4", ["TCGA.AD.6901.01", "Glucagon-type ligand receptors"], {"weight": 0.900991182491264}], ["LIN28A", ["TCGA.AD.6901.01", "APAP ADME"], {"weight": 0.770102723713744}], ["AVPR2", ["TCGA.AD.6901.01", "Visual phototransduction"], {"weight": 0.835265024861877}], ["AVPR2", ["TCGA.AD.6901.01", "GABA receptor activation"], {"weight": 0.842238423543198}], ["MC4R", ["TCGA.AD.6901.01", "Peptide hormone biosynthesis"], {"weight": 0.633408439795759}], ["SRMS", ["TCGA.CM.4747.01", "Biological oxidations"], {"weight": 0.86344507701416}], ["SRMS", ["TCGA.CM.4747.01", "Ethanol oxidation"], {"weight": 0.80038711015603}], ["SRMS", ["TCGA.CM.4747.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.878259685979896}], ["NDUFA13", ["TCGA.AD.6963.01", "Peptide ligand-binding receptors"], {"weight": 0.893400141351898}], ["NDUFA13", ["TCGA.AD.6963.01", "GPCR ligand binding"], {"weight": 0.910082039766309}], ["NDUFA13", ["TCGA.AD.6963.01", "Phase I - Functionalization of compounds"], {"weight": 0.897536713489648}], ["NDUFA13", ["TCGA.AD.6963.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.892735230879956}], ["NDUFA13", ["TCGA.AD.6963.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.860245788370053}], ["NDUFA13", ["TCGA.AD.6963.01", "Degradation of the extracellular matrix"], {"weight": 0.854947655134073}], ["LPAR6", ["TCGA.CK.5915.01", "GPCR ligand binding"], {"weight": 0.953355899618711}], ["LPAR6", ["TCGA.CK.5915.01", "Complement cascade"], {"weight": 0.921929031140431}], ["LPAR6", ["TCGA.CK.5915.01", "Regulation of Complement cascade"], {"weight": 0.890157458385808}], ["LPAR6", ["TCGA.CK.5915.01", "Chemokine receptors bind chemokines"], {"weight": 0.947581113474463}], ["LPAR6", ["TCGA.CK.5915.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.874105843320961}], ["LPAR6", ["TCGA.CK.5915.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.914433915133341}], ["LPAR6", ["TCGA.CK.5915.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.939826971726444}], ["OR6B3", ["TCGA.AD.6963.01", "GABA receptor activation"], {"weight": 0.911973522752541}], ["OR6B3", ["TCGA.AD.6963.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.914915221337096}], ["OR6B3", ["TCGA.AD.6963.01", "Potassium Channels"], {"weight": 0.950476852457413}], ["OR6B3", ["TCGA.AD.6963.01", "GABA B receptor activation"], {"weight": 0.924898374547125}], ["OR6B3", ["TCGA.AD.6963.01", "Activation of GABAB receptors"], {"weight": 0.924898374547125}], ["OR6B3", ["TCGA.AD.6963.01", "Glucagon-type ligand receptors"], {"weight": 0.919336532492061}], ["OR6B3", ["TCGA.AD.6963.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.932133171644815}], ["OR6B3", ["TCGA.AD.6963.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.875378565296236}], ["OR6B3", ["TCGA.AD.6963.01", "Aquaporin-mediated transport"], {"weight": 0.875378565296236}], ["OR6B3", ["TCGA.AD.6963.01", "GPER1 signaling"], {"weight": 0.918650307561019}], ["OR6B3", ["TCGA.AD.6963.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.918650307561019}], ["OR6B3", ["TCGA.AD.6963.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.88595090298571}], ["OR6B3", ["TCGA.AD.6963.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.920075460497831}], ["OR6B3", ["TCGA.AD.6963.01", "Signal amplification"], {"weight": 0.884061903354126}], ["OR6B3", ["TCGA.AD.6963.01", "G alpha (z) signalling events"], {"weight": 0.928016930474318}], ["OR4C13", ["TCGA.AD.6963.01", "Phase 4 - resting membrane potential"], {"weight": 0.773012289167742}], ["OR4C13", ["TCGA.AD.6963.01", "Regulation of insulin secretion"], {"weight": 0.91711815299545}], ["PAK1", ["TCGA.F4.6703.01", "Extracellular matrix organization"], {"weight": 0.913324710011748}], ["PAK1", ["TCGA.F4.6703.01", "Drug ADME"], {"weight": 0.91751191571593}], ["PAK1", ["TCGA.F4.6703.01", "Signaling by GPCR"], {"weight": 0.938185600403599}], ["ITGB1", ["TCGA.AD.6964.01", "Extracellular matrix organization"], {"weight": 0.881060093789587}], ["PTPN11", ["TCGA.CM.6675.01", "NCAM1 interactions"], {"weight": 0.938166473044942}], ["PTPN11", ["TCGA.CM.6675.01", "G alpha (12/13) signalling events"], {"weight": 0.870546044762856}], ["PTPN11", ["TCGA.CM.6675.01", "Transport of small molecules"], {"weight": 0.925510874932966}], ["PTPN11", ["TCGA.CM.6675.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.875873675914764}], ["PTPN11", ["TCGA.D5.6538.01", "Adaptive Immune System"], {"weight": 0.918062293134916}], ["PTPN11", ["TCGA.D5.6538.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.890070031188155}], ["PTPN11", ["TCGA.D5.6538.01", "Costimulation by the CD28 family"], {"weight": 0.93134097105923}], ["PTPN11", ["TCGA.D5.6538.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.866711737021064}], ["PTPN11", ["TCGA.D5.6538.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.782686492253175}], ["PTPN11", ["TCGA.D5.6538.01", "TNFs bind their physiological receptors"], {"weight": 0.54748818874307}], ["PTPN11", ["TCGA.D5.6538.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.867312503632982}], ["PTPN11", ["TCGA.D5.6538.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.877119545411197}], ["PTPN11", ["TCGA.D5.6538.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.88980652887885}], ["PTPN11", ["TCGA.D5.6538.01", "Other interleukin signaling"], {"weight": 0.672624954445394}], ["DYNC1I1", ["TCGA.CM.5348.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.643668936483366}], ["DYNC1I1", ["TCGA.CM.5348.01", "APAP ADME"], {"weight": 0.66636749178531}], ["LAMB4", ["TCGA.DM.A0XF.01", "Extracellular matrix organization"], {"weight": 0.856039236557256}], ["LAMB4", ["TCGA.DM.A0XF.01", "Integrin cell surface interactions"], {"weight": 0.89593854134409}], ["ITGB1", ["TCGA.AD.6964.01", "O-linked glycosylation"], {"weight": 0.890466670971208}], ["ITGB1", ["TCGA.CK.5916.01", "Extracellular matrix organization"], {"weight": 0.868797200898641}], ["ITGB1", ["TCGA.D5.6927.01", "Extracellular matrix organization"], {"weight": 0.886894058766485}], ["ITGB1", ["TCGA.D5.6927.01", "Integrin cell surface interactions"], {"weight": 0.8606703567921}], ["POLR3B", ["TCGA.AZ.4615.01", "G alpha (i) signalling events"], {"weight": 0.947157062325165}], ["SPTBN1", ["TCGA.CM.6164.01", "Phase 0 - rapid depolarisation"], {"weight": 0.885257828951339}], ["SPTBN1", ["TCGA.G4.6304.01", "Interaction between L1 and Ankyrins"], {"weight": 0.944393959246309}], ["SPTBN1", ["TCGA.G4.6304.01", "Cardiac conduction"], {"weight": 0.928893867551104}], ["SPTBN1", ["TCGA.G4.6304.01", "Phase 0 - rapid depolarisation"], {"weight": 0.911322413768766}], ["SPTBN1", ["TCGA.G4.6307.01", "Interaction between L1 and Ankyrins"], {"weight": 0.947650054693748}], ["OR8H2", ["TCGA.DM.A28C.01", "Signaling by GPCR"], {"weight": 0.949181337928657}], ["OR8H2", ["TCGA.DM.A28C.01", "G alpha (i) signalling events"], {"weight": 0.942253895310141}], ["OR8H2", ["TCGA.DM.A28C.01", "Potassium Channels"], {"weight": 0.95959284133647}], ["OR8H2", ["TCGA.DM.A28C.01", "G alpha (q) signalling events"], {"weight": 0.94652248451749}], ["OR8H2", ["TCGA.DM.A28C.01", "Leishmania infection"], {"weight": 0.904205534565109}], ["OR8H2", ["TCGA.DM.A28C.01", "Parasitic Infection Pathways"], {"weight": 0.904205534565109}], ["OR8H2", ["TCGA.DM.A28C.01", "G-protein beta:gamma signalling"], {"weight": 0.931952251582354}], ["OR8H2", ["TCGA.DM.A28C.01", "Activation of G protein gated Potassium channels"], {"weight": 0.928460080455994}], ["OR8H2", ["TCGA.DM.A28C.01", "G protein gated Potassium channels"], {"weight": 0.928460080455994}], ["OR8H2", ["TCGA.DM.A28C.01", "Interaction between L1 and Ankyrins"], {"weight": 0.924219885493152}], ["OR8H2", ["TCGA.DM.A28C.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.928460080455994}], ["OR8H2", ["TCGA.DM.A28C.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.921679401589829}], ["OR8H2", ["TCGA.DM.A28C.01", "Leishmania parasite growth and survival"], {"weight": 0.921679401589829}], ["OR8H2", ["TCGA.DM.A28C.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.877961945437147}], ["OR8H2", ["TCGA.DM.A28C.01", "GABA B receptor activation"], {"weight": 0.932491304934337}], ["OR8H2", ["TCGA.DM.A28C.01", "Activation of GABAB receptors"], {"weight": 0.932491304934337}], ["OR8H2", ["TCGA.DM.A28C.01", "Inwardly rectifying K+ channels"], {"weight": 0.931524471928796}], ["OR8H2", ["TCGA.DM.A28C.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.919985511105195}], ["OR8H2", ["TCGA.DM.A28C.01", "Initial triggering of complement"], {"weight": 0.887098388774045}], ["OR8H2", ["TCGA.DM.A28C.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.923837678414653}], ["OR8H2", ["TCGA.DM.A28C.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.910536103055952}], ["OR8H2", ["TCGA.DM.A28C.01", "Platelet calcium homeostasis"], {"weight": 0.917747075890187}], ["OR8H2", ["TCGA.DM.A28C.01", "G alpha (s) signalling events"], {"weight": 0.959435210591895}], ["OR8H2", ["TCGA.DM.A28C.01", "Presynaptic function of Kainate receptors"], {"weight": 0.913779049765112}], ["OR8H2", ["TCGA.DM.A28C.01", "Transport of small molecules"], {"weight": 0.912719653819017}], ["OR8H2", ["TCGA.DM.A28C.01", "GABA receptor activation"], {"weight": 0.896073554151134}], ["OR8H2", ["TCGA.DM.A28C.01", "G beta:gamma signalling through BTK"], {"weight": 0.910008386006004}], ["OR8H2", ["TCGA.DM.A28C.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.900527688340057}], ["OR8H2", ["TCGA.DM.A28C.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.907503019814163}], ["OR8H2", ["TCGA.DM.A28C.01", "G beta:gamma signalling through CDC42"], {"weight": 0.903344230056245}], ["OR8H2", ["TCGA.DM.A28C.01", "Signal amplification"], {"weight": 0.914260476011874}], ["OR8H2", ["TCGA.DM.A28C.01", "G-protein activation"], {"weight": 0.931262086150466}], ["OR8H2", ["TCGA.DM.A28C.01", "Glucagon-type ligand receptors"], {"weight": 0.928359461120687}], ["OR8H2", ["TCGA.DM.A28C.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.930559927163619}], ["OR8H2", ["TCGA.DM.A28C.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.944041838405649}], ["OR8H2", ["TCGA.DM.A28C.01", "Opioid Signalling"], {"weight": 0.930069192146065}], ["OR8H2", ["TCGA.DM.A28C.01", "Phase 4 - resting membrane potential"], {"weight": 0.859747906764107}], ["OR8H2", ["TCGA.DM.A28C.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.90429631832029}], ["OR8H2", ["TCGA.DM.A28C.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.915491480093923}], ["OR8H2", ["TCGA.DM.A28C.01", "Thromboxane signalling through TP receptor"], {"weight": 0.898160523401831}], ["OR8H2", ["TCGA.DM.A28C.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.754527686032608}], ["OR8H2", ["TCGA.DM.A28C.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.754527686032608}], ["OR8H2", ["TCGA.DM.A28C.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.924189922298313}], ["OR8H2", ["TCGA.DM.A28C.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.880938847499927}], ["OR8H2", ["TCGA.DM.A28C.01", "Integration of energy metabolism"], {"weight": 0.903194139948352}], ["OR8H2", ["TCGA.DM.A28C.01", "Biological oxidations"], {"weight": 0.910987842185854}], ["OR8H2", ["TCGA.DM.A28C.01", "Activation of the phototransduction cascade"], {"weight": 0.856719132849522}], ["OR8H2", ["TCGA.DM.A28C.01", "Phase I - Functionalization of compounds"], {"weight": 0.928531553226447}], ["OR8H2", ["TCGA.DM.A28C.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.89984030440724}], ["OR8H2", ["TCGA.F4.6569.01", "Integration of energy metabolism"], {"weight": 0.878579359612957}], ["OR8H2", ["TCGA.F4.6569.01", "Activation of G protein gated Potassium channels"], {"weight": 0.888729337384916}], ["OR8H2", ["TCGA.F4.6569.01", "G protein gated Potassium channels"], {"weight": 0.888729337384916}], ["OR8H2", ["TCGA.F4.6569.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.888729337384916}], ["OR8H2", ["TCGA.F4.6569.01", "Presynaptic function of Kainate receptors"], {"weight": 0.87099060048907}], ["OR8H2", ["TCGA.F4.6569.01", "Regulation of insulin secretion"], {"weight": 0.864436492156354}], ["OR8H2", ["TCGA.F4.6569.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.883344568010086}], ["OR8H2", ["TCGA.F4.6569.01", "Signal amplification"], {"weight": 0.895612485216047}], ["OR8H2", ["TCGA.F4.6569.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.88022223990197}], ["OR8H2", ["TCGA.F4.6569.01", "G beta:gamma signalling through BTK"], {"weight": 0.842452580119097}], ["OR8H2", ["TCGA.F4.6569.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.842452580119097}], ["OR8H2", ["TCGA.F4.6569.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.860160965138315}], ["MMP3", ["TCGA.AD.6964.01", "Collagen chain trimerization"], {"weight": 0.911610501090401}], ["MMP3", ["TCGA.F4.6703.01", "Collagen chain trimerization"], {"weight": 0.935536656247186}], ["GPC2", ["TCGA.AD.6964.01", "Metabolism"], {"weight": 0.888840937184548}], ["GPC2", ["TCGA.F4.6703.01", "O-linked glycosylation"], {"weight": 0.904882648081616}], ["GPC2", ["TCGA.F4.6703.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.856308200427704}], ["GPC2", ["TCGA.F4.6703.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.871528371761684}], ["GPC2", ["TCGA.F4.6703.01", "Metabolism"], {"weight": 0.911714133107441}], ["FCGR3A", ["TCGA.DM.A1D4.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.782528465606903}], ["FCGR3A", ["TCGA.DM.A1D4.01", "Leishmania infection"], {"weight": 0.895086168009166}], ["FCGR3A", ["TCGA.DM.A1D4.01", "Parasitic Infection Pathways"], {"weight": 0.895086168009166}], ["FCGR3A", ["TCGA.DM.A1D4.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.900141408095026}], ["FCGR3A", ["TCGA.DM.A1D4.01", "Leishmania parasite growth and survival"], {"weight": 0.900141408095026}], ["GAD1", ["TCGA.D5.6930.01", "Signaling by Nuclear Receptors"], {"weight": 0.722443922824783}], ["ATP1A2", ["TCGA.D5.6924.01", "Heme degradation"], {"weight": 0.642284888781034}], ["ATP1A2", ["TCGA.G4.6625.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.573915618869158}], ["SPHK2", ["TCGA.DM.A28H.01", "Immune System"], {"weight": 0.908633851035869}], ["SPHK2", ["TCGA.DM.A28H.01", "Interleukin-35 Signalling"], {"weight": 0.871328126296829}], ["SPHK2", ["TCGA.DM.A28H.01", "Depolymerization of the Nuclear Lamina"], {"weight": 0.873714372058617}], ["SPHK2", ["TCGA.DM.A28H.01", "Interleukin-27 signaling"], {"weight": 0.845269779897938}], ["TBC1D1", ["TCGA.AZ.5407.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.811329746624055}], ["HIPK1", ["TCGA.G4.6302.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.87350487897314}], ["MAGED2", ["TCGA.CM.5349.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.650265418377337}], ["MAGED2", ["TCGA.DM.A1DA.01", "Complement cascade"], {"weight": 0.955861845329277}], ["SLC2A14", ["TCGA.D5.6541.01", "Integration of energy metabolism"], {"weight": 0.861512485996564}], ["OR10A7", ["TCGA.AD.6964.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.879901415048195}], ["TCF4", ["TCGA.CM.4744.01", "Glucuronidation"], {"weight": 0.82073905057486}], ["TCF4", ["TCGA.CM.4744.01", "Phase II - Conjugation of compounds"], {"weight": 0.82982107253054}], ["CAPNS2", ["TCGA.D5.7000.01", "Extracellular matrix organization"], {"weight": 0.839685151288613}], ["CAPNS2", ["TCGA.D5.7000.01", "Degradation of the extracellular matrix"], {"weight": 0.869911715921201}], ["ARPC1A", ["TCGA.CM.5868.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.691514982776799}], ["ARPC1A", ["TCGA.CM.5868.01", "Binding and entry of HIV virion"], {"weight": 0.682981871217073}], ["ARPC1A", ["TCGA.CM.5868.01", "Protein-protein interactions at synapses"], {"weight": 0.834758508727734}], ["LMAN1", ["TCGA.AZ.6598.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.929586613683808}], ["LMAN1", ["TCGA.CM.6170.01", "Extracellular matrix organization"], {"weight": 0.840227840854599}], ["LMAN1", ["TCGA.CM.6170.01", "Collagen formation"], {"weight": 0.911363547705156}], ["LMAN1", ["TCGA.F4.6856.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.897639677459064}], ["EGFR", ["TCGA.AZ.6599.01", "Signaling by GPCR"], {"weight": 0.955336566382056}], ["EGFR", ["TCGA.AZ.6599.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.87079813314741}], ["EGFR", ["TCGA.AZ.6599.01", "Classical antibody-mediated complement activation"], {"weight": 0.715057782601958}], ["EGFR", ["TCGA.AZ.6599.01", "Post-translational protein phosphorylation"], {"weight": 0.810190650986423}], ["EGFR", ["TCGA.AZ.6599.01", "Creation of C4 and C2 activators"], {"weight": 0.757081895810059}], ["EGFR", ["TCGA.AZ.6599.01", "Other interleukin signaling"], {"weight": 0.82365701077723}], ["CHRND", ["TCGA.CA.6716.01", "Neuronal System"], {"weight": 0.878172449635899}], ["CHRND", ["TCGA.CA.6716.01", "Transmission across Chemical Synapses"], {"weight": 0.859546545951317}], ["GRB2", ["TCGA.AD.6964.01", "Signaling by ERBB2 KD Mutants"], {"weight": 0.884494110764717}], ["GRB2", ["TCGA.AD.6964.01", "GRB2 events in ERBB2 signaling"], {"weight": 0.873324639596254}], ["GRB2", ["TCGA.AD.6964.01", "Signaling by ERBB2 in Cancer"], {"weight": 0.884494110764717}], ["GRB2", ["TCGA.AD.6964.01", "GRB2 events in EGFR signaling"], {"weight": 0.818476170570677}], ["GRB2", ["TCGA.AD.6964.01", "SHC1 events in EGFR signaling"], {"weight": 0.81844110080052}], ["FARP1", ["TCGA.AZ.5407.01", "Extracellular matrix organization"], {"weight": 0.834177404416298}], ["PPP1CA", ["TCGA.AD.6964.01", "Glycosaminoglycan metabolism"], {"weight": 0.753615439184495}], ["OR1C1", ["TCGA.G4.6323.01", "Phase 4 - resting membrane potential"], {"weight": 0.771638725525202}], ["ACSL6", ["TCGA.CA.6718.01", "Fatty acid metabolism"], {"weight": 0.898107974581407}], ["UGT2A3", ["TCGA.DM.A28K.01", "Phase I - Functionalization of compounds"], {"weight": 0.950913005034439}], ["GPR50", ["TCGA.CM.5868.01", "Signaling by GPCR"], {"weight": 0.941716281781165}], ["GPR50", ["TCGA.CM.5868.01", "G alpha (i) signalling events"], {"weight": 0.947277863832253}], ["GPR50", ["TCGA.CM.5868.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.761680329462915}], ["GPR50", ["TCGA.G4.6299.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.780094545410311}], ["ADAM23", ["TCGA.D5.6529.01", "Phase 0 - rapid depolarisation"], {"weight": 0.740818740322958}], ["CLIP4", ["TCGA.CM.6677.01", "Insulin processing"], {"weight": 0.701683380926187}], ["RTN3", ["TCGA.CA.6718.01", "Synaptic adhesion-like molecules"], {"weight": 0.842275919908302}], ["DPYSL4", ["TCGA.D5.6529.01", "Degradation of the extracellular matrix"], {"weight": 0.697436186289952}], ["DPYSL4", ["TCGA.D5.6529.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.916535565674196}], ["DPYSL4", ["TCGA.D5.6529.01", "NCAM1 interactions"], {"weight": 0.725670157870415}], ["NOTCH1", ["TCGA.AZ.4615.01", "Signaling Pathways"], {"weight": 0.900515157338677}], ["NOTCH1", ["TCGA.G4.6586.01", "Signaling Pathways"], {"weight": 0.929478712672672}], ["NOTCH1", ["TCGA.G4.6586.01", "Diseases of metabolism"], {"weight": 0.881757970440842}], ["NOTCH1", ["TCGA.G4.6588.01", "Signaling Pathways"], {"weight": 0.918386449149042}], ["EPHA5", ["TCGA.DM.A1D8.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.933732321316005}], ["CREB3", ["TCGA.AD.6965.01", "Phase 0 - rapid depolarisation"], {"weight": 0.913404705358086}], ["CREB3", ["TCGA.AD.6965.01", "Muscle contraction"], {"weight": 0.907867544005912}], ["ELK1", ["TCGA.AD.6965.01", "Transmission across Chemical Synapses"], {"weight": 0.90154035790496}], ["TFB1M", ["TCGA.D5.6531.01", "Signaling by Retinoic Acid"], {"weight": 0.68480700603152}], ["DNMT3A", ["TCGA.G4.6310.01", "Glucuronidation"], {"weight": 0.856965478178686}], ["DNMT3A", ["TCGA.G4.6310.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.84513450926604}], ["DNMT3A", ["TCGA.G4.6310.01", "Phase II - Conjugation of compounds"], {"weight": 0.890402654058413}], ["NHLRC2", ["TCGA.AD.6965.01", "Cardiac conduction"], {"weight": 0.90372254299345}], ["NHLRC2", ["TCGA.AD.6965.01", "Complement cascade"], {"weight": 0.793740552930186}], ["NHLRC2", ["TCGA.AD.6965.01", "Regulation of Complement cascade"], {"weight": 0.728406990649979}], ["NHLRC2", ["TCGA.AD.6965.01", "Classical antibody-mediated complement activation"], {"weight": 0.597916625865896}], ["CTSB", ["TCGA.AM.5820.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.940877390662804}], ["ADAM12", ["TCGA.D5.6531.01", "GPCR downstream signalling"], {"weight": 0.928163562780007}], ["ADAM12", ["TCGA.DM.A1DA.01", "Regulation of insulin secretion"], {"weight": 0.942238145457743}], ["ADAM12", ["TCGA.DM.A1DA.01", "G alpha (z) signalling events"], {"weight": 0.917573589994862}], ["ADAM12", ["TCGA.G4.6323.01", "Extracellular matrix organization"], {"weight": 0.835624060356227}], ["ADAM12", ["TCGA.G4.6323.01", "ECM proteoglycans"], {"weight": 0.863829267994399}], ["ADAM12", ["TCGA.G4.6323.01", "L1CAM interactions"], {"weight": 0.863902865480161}], ["ADAM12", ["TCGA.G4.6323.01", "Initial triggering of complement"], {"weight": 0.641710428924241}], ["ADAM17", ["TCGA.AZ.6598.01", "Nuclear signaling by ERBB4"], {"weight": 0.934692110130061}], ["ADAM17", ["TCGA.D5.6531.01", "Signaling by GPCR"], {"weight": 0.930321789974879}], ["ADAM17", ["TCGA.D5.6531.01", "Formation of axial mesoderm"], {"weight": 0.788271273685086}], ["ADAM17", ["TCGA.G4.6588.01", "Signaling by GPCR"], {"weight": 0.946111138378374}], ["IBSP", ["TCGA.AZ.6598.01", "NCAM1 interactions"], {"weight": 0.9467970043842}], ["IBSP", ["TCGA.AZ.6598.01", "NCAM signaling for neurite out-growth"], {"weight": 0.948494121037133}], ["CTSB", ["TCGA.AM.5820.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.936420772529849}], ["CTSB", ["TCGA.AM.5820.01", "PD-1 signaling"], {"weight": 0.93764987632198}], ["IL20RA", ["TCGA.D5.6927.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.885216242594461}], ["IL20RA", ["TCGA.D5.6927.01", "Interleukin-6 family signaling"], {"weight": 0.887364694698085}], ["JAK2", ["TCGA.AM.5820.01", "Immune System"], {"weight": 0.854544116748878}], ["JAK2", ["TCGA.AM.5820.01", "Cytokine Signaling in Immune system"], {"weight": 0.84055391825423}], ["JAK2", ["TCGA.DM.A0XD.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.922018590199276}], ["OR10J1", ["TCGA.CM.5861.01", "G alpha (z) signalling events"], {"weight": 0.936750697002842}], ["OR10J1", ["TCGA.D5.6533.01", "G alpha (i) signalling events"], {"weight": 0.917899278081388}], ["OR10J1", ["TCGA.D5.6533.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.89705061778813}], ["OR10J1", ["TCGA.D5.6533.01", "GPCR ligand binding"], {"weight": 0.940527744065349}], ["OR10J1", ["TCGA.D5.6533.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.913025055286638}], ["SH2B1", ["TCGA.CM.6674.01", "Protein-protein interactions at synapses"], {"weight": 0.84049159715803}], ["OR7E24", ["TCGA.DM.A0X9.01", "GPCR ligand binding"], {"weight": 0.94757464031769}], ["OR9Q2", ["TCGA.CM.5862.01", "GPCR downstream signalling"], {"weight": 0.939766122015594}], ["OR9Q2", ["TCGA.CM.5862.01", "Signaling by GPCR"], {"weight": 0.941406197938602}], ["OR9Q2", ["TCGA.CM.5862.01", "G alpha (i) signalling events"], {"weight": 0.935945474375152}], ["OR9Q2", ["TCGA.CM.5862.01", "Synaptic adhesion-like molecules"], {"weight": 0.79282761925444}], ["OR9Q2", ["TCGA.CM.5862.01", "Potassium Channels"], {"weight": 0.959548757269941}], ["OR9Q2", ["TCGA.CM.5862.01", "GPCR ligand binding"], {"weight": 0.949638339775883}], ["PLOD1", ["TCGA.AU.6004.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.946329145564418}], ["GHR", ["TCGA.D5.6931.01", "Interleukin-6 family signaling"], {"weight": 0.850127572738271}], ["GHR", ["TCGA.D5.6931.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.841101996855609}], ["KCNJ15", ["TCGA.G4.6315.01", "Neuronal System"], {"weight": 0.921010044332568}], ["KCNJ15", ["TCGA.G4.6315.01", "Potassium Channels"], {"weight": 0.877194206277548}], ["KCNJ15", ["TCGA.G4.6315.01", "GABA receptor activation"], {"weight": 0.870847644779631}], ["KCNJ15", ["TCGA.G4.6315.01", "GABA B receptor activation"], {"weight": 0.907244297400017}], ["KCNJ15", ["TCGA.G4.6315.01", "Activation of GABAB receptors"], {"weight": 0.907244297400017}], ["OR51Q1", ["TCGA.D5.6529.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.882070921012031}], ["OR51Q1", ["TCGA.D5.6529.01", "Glucagon-type ligand receptors"], {"weight": 0.900543623541093}], ["OR51Q1", ["TCGA.D5.6529.01", "Regulation of insulin secretion"], {"weight": 0.891596256645324}], ["OR51Q1", ["TCGA.D5.6529.01", "Transmission across Chemical Synapses"], {"weight": 0.861976248259154}], ["OR51Q1", ["TCGA.D5.6529.01", "GABA receptor activation"], {"weight": 0.600797898242907}], ["OR51Q1", ["TCGA.D5.6529.01", "Integration of energy metabolism"], {"weight": 0.87128634856497}], ["OR51Q1", ["TCGA.D5.6529.01", "Signal amplification"], {"weight": 0.882070921012031}], ["OR51Q1", ["TCGA.D5.6529.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.884187705991725}], ["OR51Q1", ["TCGA.D5.6529.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.894740325513714}], ["OR51Q1", ["TCGA.D5.6529.01", "Presynaptic function of Kainate receptors"], {"weight": 0.87808722452172}], ["OR51Q1", ["TCGA.D5.6529.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.885585779984686}], ["OR51Q1", ["TCGA.D5.6529.01", "G-protein activation"], {"weight": 0.886923268977039}], ["OR51Q1", ["TCGA.D5.6529.01", "Thromboxane signalling through TP receptor"], {"weight": 0.860738677611746}], ["OR51Q1", ["TCGA.D5.6529.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.884187705991725}], ["OR51Q1", ["TCGA.D5.6529.01", "Inwardly rectifying K+ channels"], {"weight": 0.898030168314446}], ["OR51Q1", ["TCGA.D5.6529.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.914469989874785}], ["OR51Q1", ["TCGA.D5.6529.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.850386655848324}], ["OR51Q1", ["TCGA.D5.6529.01", "G protein gated Potassium channels"], {"weight": 0.878946304780996}], ["OR51Q1", ["TCGA.D5.6529.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.878946304780996}], ["OR51Q1", ["TCGA.G4.6315.01", "GPCR downstream signalling"], {"weight": 0.917702765085816}], ["OR51Q1", ["TCGA.G4.6315.01", "G-protein beta:gamma signalling"], {"weight": 0.916017629442468}], ["OR51Q1", ["TCGA.G4.6315.01", "G alpha (s) signalling events"], {"weight": 0.946767598202414}], ["OR51Q1", ["TCGA.G4.6315.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.856408626729679}], ["OR51Q1", ["TCGA.G4.6315.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.896238240525304}], ["OR51Q1", ["TCGA.G4.6315.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.904345893731356}], ["OR51Q1", ["TCGA.G4.6315.01", "G beta:gamma signalling through BTK"], {"weight": 0.875897960337138}], ["OR51Q1", ["TCGA.G4.6315.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.896354233303523}], ["OR51Q1", ["TCGA.G4.6315.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.873193564658895}], ["OR51Q1", ["TCGA.G4.6315.01", "G beta:gamma signalling through CDC42"], {"weight": 0.872530417138889}], ["OR51Q1", ["TCGA.G4.6315.01", "G alpha (q) signalling events"], {"weight": 0.872830815574269}], ["OR51Q1", ["TCGA.G4.6315.01", "Voltage gated Potassium channels"], {"weight": 0.833806252335976}], ["OR51Q1", ["TCGA.G4.6315.01", "Presynaptic function of Kainate receptors"], {"weight": 0.873193564658895}], ["OR51Q1", ["TCGA.G4.6315.01", "Glucagon-type ligand receptors"], {"weight": 0.906292955217866}], ["OR51Q1", ["TCGA.G4.6315.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.87572787669027}], ["OR51Q1", ["TCGA.G4.6315.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.892802077503244}], ["OR51Q1", ["TCGA.G4.6315.01", "Peptide hormone metabolism"], {"weight": 0.729516619352741}], ["OR51Q1", ["TCGA.G4.6315.01", "G-protein activation"], {"weight": 0.872405530718862}], ["OR51Q1", ["TCGA.G4.6315.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.864428402333952}], ["OR51Q1", ["TCGA.G4.6315.01", "Opioid Signalling"], {"weight": 0.886297292235595}], ["PTPN7", ["TCGA.CM.6166.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.910612907977813}], ["PTPN7", ["TCGA.CM.6166.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.851516026611585}], ["GRK6", ["TCGA.AM.5820.01", "Chemokine receptors bind chemokines"], {"weight": 0.926957987794173}], ["GRK6", ["TCGA.DM.A282.01", "Signaling by GPCR"], {"weight": 0.948956434984714}], ["GRK6", ["TCGA.DM.A282.01", "GPCR downstream signalling"], {"weight": 0.952896367249585}], ["GRK6", ["TCGA.DM.A282.01", "Chemokine receptors bind chemokines"], {"weight": 0.938173855803096}], ["GRK6", ["TCGA.DM.A282.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.948376870636588}], ["GRK6", ["TCGA.DM.A282.01", "Peptide ligand-binding receptors"], {"weight": 0.947733616027046}], ["GRK6", ["TCGA.DM.A282.01", "Interleukin-10 signaling"], {"weight": 0.948155829275308}], ["GRK6", ["TCGA.DM.A282.01", "G alpha (s) signalling events"], {"weight": 0.958556221321517}], ["GRK6", ["TCGA.DM.A282.01", "Signaling by ERBB4"], {"weight": 0.844961632515781}], ["GRK6", ["TCGA.DM.A282.01", "Nuclear signaling by ERBB4"], {"weight": 0.779774767752629}], ["WNT5A", ["TCGA.AM.5820.01", "GABA receptor activation"], {"weight": 0.889472734396858}], ["WNT5A", ["TCGA.AZ.6600.01", "GPCR ligand binding"], {"weight": 0.916766378562569}], ["WNT5A", ["TCGA.AZ.6600.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.647279956172758}], ["WNT5A", ["TCGA.AZ.6601.01", "GABA receptor activation"], {"weight": 0.873443989104286}], ["WNT5A", ["TCGA.G4.6295.01", "Protein-protein interactions at synapses"], {"weight": 0.898845820890456}], ["WNT5A", ["TCGA.G4.6295.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.879207866014456}], ["WNT5A", ["TCGA.G4.6295.01", "Neurexins and neuroligins"], {"weight": 0.930052504772932}], ["WNT5A", ["TCGA.G4.6315.01", "Signaling by GPCR"], {"weight": 0.913881182623097}], ["WNT5A", ["TCGA.G4.6315.01", "GPCR ligand binding"], {"weight": 0.931155681667476}], ["WNT5A", ["TCGA.G4.6315.01", "Signaling by Interleukins"], {"weight": 0.8431264809682}], ["TAS2R43", ["TCGA.F4.6461.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.861870118016798}], ["TAS2R43", ["TCGA.F4.6461.01", "Chemokine receptors bind chemokines"], {"weight": 0.829622047347023}], ["TAS2R43", ["TCGA.F4.6461.01", "Degradation of the extracellular matrix"], {"weight": 0.812712181535693}], ["NR1H3", ["TCGA.D5.6541.01", "Ethanol oxidation"], {"weight": 0.839196865652516}], ["NR1H3", ["TCGA.G4.6309.01", "Signaling Pathways"], {"weight": 0.914321759052136}], ["OR1L4", ["TCGA.CK.5914.01", "GPCR ligand binding"], {"weight": 0.952977513060064}], ["OR1L4", ["TCGA.CK.5914.01", "Glucagon-type ligand receptors"], {"weight": 0.933916713357061}], ["OR1L4", ["TCGA.CK.5914.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.725033103146113}], ["OR1L4", ["TCGA.CK.5914.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.90818255150646}], ["OR1L4", ["TCGA.CK.5914.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.908470212751914}], ["OR1L4", ["TCGA.CK.5914.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.907428780409824}], ["HEXB", ["TCGA.AM.5820.01", "Lewis blood group biosynthesis"], {"weight": 0.720770005142697}], ["OR6Y1", ["TCGA.D5.5537.01", "Peptide hormone metabolism"], {"weight": 0.766140743326803}], ["OR6Y1", ["TCGA.D5.5537.01", "G alpha (s) signalling events"], {"weight": 0.951607219013468}], ["OR6Y1", ["TCGA.D5.5537.01", "Transport of small molecules"], {"weight": 0.904207290202726}], ["OR6Y1", ["TCGA.D5.5537.01", "Potassium Channels"], {"weight": 0.94436809064292}], ["OR6Y1", ["TCGA.D5.5537.01", "Regulation of insulin secretion"], {"weight": 0.887457970742426}], ["OR6Y1", ["TCGA.D5.5537.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.896341298466552}], ["OR6Y1", ["TCGA.D5.5537.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.850896053202572}], ["OR6Y1", ["TCGA.D5.5537.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.694375146785125}], ["OR6Y1", ["TCGA.D5.5537.01", "Signal amplification"], {"weight": 0.901637734855491}], ["OR6Y1", ["TCGA.D5.5537.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.902037007637253}], ["OR6Y1", ["TCGA.D5.5537.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.918985360230134}], ["OR6Y1", ["TCGA.D5.5537.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.889985638764122}], ["OR6Y1", ["TCGA.D5.5537.01", "Leishmania infection"], {"weight": 0.805386681633061}], ["OR6Y1", ["TCGA.D5.5537.01", "G beta:gamma signalling through BTK"], {"weight": 0.895358929660086}], ["OR6Y1", ["TCGA.D5.5537.01", "Platelet homeostasis"], {"weight": 0.776924700658036}], ["OR6Y1", ["TCGA.D5.5537.01", "Glucagon-type ligand receptors"], {"weight": 0.898487195305585}], ["OR6Y1", ["TCGA.D5.5537.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.905603027460654}], ["OR6Y1", ["TCGA.D5.5537.01", "Aquaporin-mediated transport"], {"weight": 0.905603027460654}], ["OR6Y1", ["TCGA.D5.5537.01", "Inwardly rectifying K+ channels"], {"weight": 0.907302618360333}], ["OR6Y1", ["TCGA.D5.5537.01", "Activation of GABAB receptors"], {"weight": 0.906537340698306}], ["IRAK2", ["TCGA.F4.6856.01", "Defensins"], {"weight": 0.554668940384087}], ["PPFIA4", ["TCGA.AZ.6601.01", "Neuronal System"], {"weight": 0.896697716625795}], ["PPFIA4", ["TCGA.AZ.6601.01", "Protein-protein interactions at synapses"], {"weight": 0.89473512114926}], ["PPFIA4", ["TCGA.CK.5913.01", "Protein-protein interactions at synapses"], {"weight": 0.924946575283437}], ["PPFIA4", ["TCGA.CK.5913.01", "Neurexins and neuroligins"], {"weight": 0.915539892185976}], ["PPFIA4", ["TCGA.CK.5916.01", "Neuronal System"], {"weight": 0.902063667747934}], ["PPFIA4", ["TCGA.D5.7000.01", "Protein-protein interactions at synapses"], {"weight": 0.869898798526792}], ["OR5K3", ["TCGA.DM.A28F.01", "Potassium Channels"], {"weight": 0.962981937408151}], ["OR5K3", ["TCGA.DM.A28F.01", "GABA B receptor activation"], {"weight": 0.936743014742257}], ["OR5K3", ["TCGA.DM.A28F.01", "Activation of GABAB receptors"], {"weight": 0.936743014742257}], ["OR5K3", ["TCGA.DM.A28F.01", "Platelet homeostasis"], {"weight": 0.881292317954239}], ["OR5K3", ["TCGA.DM.A28F.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.927969131464439}], ["OR5K3", ["TCGA.DM.A28F.01", "Activation of the phototransduction cascade"], {"weight": 0.78770259980242}], ["OR5K3", ["TCGA.DM.A28F.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.926267520220072}], ["OR5K3", ["TCGA.G4.6304.01", "Neuronal System"], {"weight": 0.946760175403835}], ["OR13F1", ["TCGA.DM.A28G.01", "Signaling by GPCR"], {"weight": 0.929221593293877}], ["OR13F1", ["TCGA.DM.A28G.01", "GPCR downstream signalling"], {"weight": 0.929341856336719}], ["OR13F1", ["TCGA.DM.A28G.01", "G alpha (i) signalling events"], {"weight": 0.93179155566265}], ["OR13F1", ["TCGA.DM.A28G.01", "GPCR ligand binding"], {"weight": 0.939187356446346}], ["OR13F1", ["TCGA.DM.A28G.01", "G-protein beta:gamma signalling"], {"weight": 0.891964303587071}], ["OR13F1", ["TCGA.DM.A28G.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.870705377810094}], ["OR13F1", ["TCGA.DM.A28G.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.820663830490189}], ["OR13F1", ["TCGA.DM.A28G.01", "Leishmania parasite growth and survival"], {"weight": 0.820663830490189}], ["OR13F1", ["TCGA.DM.A28G.01", "G beta:gamma signalling through BTK"], {"weight": 0.851690675873405}], ["OR13F1", ["TCGA.DM.A28G.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.848283651962602}], ["OR13F1", ["TCGA.DM.A28G.01", "Regulation of insulin secretion"], {"weight": 0.827364423337479}], ["OR13F1", ["TCGA.DM.A28G.01", "Signal amplification"], {"weight": 0.865595291723985}], ["OR13F1", ["TCGA.DM.A28G.01", "G alpha (q) signalling events"], {"weight": 0.918559434454759}], ["OR13F1", ["TCGA.DM.A28G.01", "G alpha (s) signalling events"], {"weight": 0.941032663994393}], ["OR13F1", ["TCGA.DM.A28G.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.881292443525765}], ["OR13F1", ["TCGA.DM.A28G.01", "Glucagon-type ligand receptors"], {"weight": 0.901746095278656}], ["OR13F1", ["TCGA.DM.A28G.01", "G beta:gamma signalling through CDC42"], {"weight": 0.841469899241244}], ["OR13F1", ["TCGA.DM.A28H.01", "Potassium Channels"], {"weight": 0.964528485301302}], ["OR13F1", ["TCGA.DM.A28H.01", "GPCR ligand binding"], {"weight": 0.936579558104397}], ["OR13F1", ["TCGA.DM.A28H.01", "G alpha (s) signalling events"], {"weight": 0.964104806502132}], ["OR13F1", ["TCGA.DM.A28H.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.918788354588049}], ["OR13F1", ["TCGA.DM.A28H.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.933627745287693}], ["OR13F1", ["TCGA.DM.A28H.01", "Signal amplification"], {"weight": 0.926271860845383}], ["OR13F1", ["TCGA.DM.A28H.01", "G beta:gamma signalling through BTK"], {"weight": 0.921667389435263}], ["OR13F1", ["TCGA.DM.A28H.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.922618569182206}], ["OR13F1", ["TCGA.DM.A28H.01", "Inwardly rectifying K+ channels"], {"weight": 0.934087709320425}], ["OR13F1", ["TCGA.DM.A28H.01", "G-protein beta:gamma signalling"], {"weight": 0.937499772701949}], ["OR11H4", ["TCGA.AZ.6599.01", "G alpha (i) signalling events"], {"weight": 0.933442856224885}], ["OR11H4", ["TCGA.AZ.6599.01", "G-protein beta:gamma signalling"], {"weight": 0.930150370450089}], ["OR11H4", ["TCGA.AZ.6599.01", "G alpha (s) signalling events"], {"weight": 0.957783938254322}], ["OR11H4", ["TCGA.AZ.6599.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.917481848881573}], ["OR11H4", ["TCGA.AZ.6599.01", "GABA receptor activation"], {"weight": 0.916836917883129}], ["OR11H4", ["TCGA.AZ.6599.01", "Activation of SMO"], {"weight": 0.918921701205079}], ["OR11H4", ["TCGA.AZ.6599.01", "G beta:gamma signalling through BTK"], {"weight": 0.909375695570784}], ["OR11H4", ["TCGA.AZ.6599.01", "G alpha (q) signalling events"], {"weight": 0.934932643789657}], ["OR11H4", ["TCGA.AZ.6599.01", "G alpha (z) signalling events"], {"weight": 0.906734888492548}], ["OR11H4", ["TCGA.AZ.6599.01", "GABA B receptor activation"], {"weight": 0.928293618595688}], ["OR11H4", ["TCGA.AZ.6599.01", "Activation of GABAB receptors"], {"weight": 0.928293618595688}], ["OR11H4", ["TCGA.AZ.6599.01", "G-protein activation"], {"weight": 0.908182965804964}], ["OR11H4", ["TCGA.AZ.6599.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.902683123790043}], ["OR11H4", ["TCGA.AZ.6599.01", "Glucagon-type ligand receptors"], {"weight": 0.925222952402047}], ["OR11H4", ["TCGA.AZ.6599.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.899055344521254}], ["OR11H4", ["TCGA.AZ.6599.01", "G beta:gamma signalling through CDC42"], {"weight": 0.904970481907166}], ["OR11H4", ["TCGA.AZ.6599.01", "Opioid Signalling"], {"weight": 0.933236352226096}], ["OR11H4", ["TCGA.AZ.6599.01", "Platelet activation, signaling and aggregation"], {"weight": 0.925007874052547}], ["OR11H4", ["TCGA.AZ.6599.01", "Presynaptic function of Kainate receptors"], {"weight": 0.899055344521254}], ["OR11H4", ["TCGA.AZ.6599.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.903900064772002}], ["OR11H4", ["TCGA.AZ.6599.01", "Ca2+ pathway"], {"weight": 0.927431806915389}], ["OR11H4", ["TCGA.AZ.6599.01", "Signal amplification"], {"weight": 0.909579226478221}], ["OR11H4", ["TCGA.AZ.6599.01", "Potassium Channels"], {"weight": 0.908577479909661}], ["OR11H4", ["TCGA.AZ.6599.01", "Activation of G protein gated Potassium channels"], {"weight": 0.912607251379539}], ["OR11H4", ["TCGA.AZ.6599.01", "G protein gated Potassium channels"], {"weight": 0.912607251379539}], ["OR11H4", ["TCGA.AZ.6599.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.92050093930267}], ["OR11H4", ["TCGA.AZ.6599.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.912607251379539}], ["OR11H4", ["TCGA.AZ.6599.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.894347109706012}], ["OR11H4", ["TCGA.D5.6924.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.889672546372321}], ["OR11H4", ["TCGA.D5.6924.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.901502942875955}], ["OR11H4", ["TCGA.D5.6924.01", "G alpha (i) signalling events"], {"weight": 0.90267007518356}], ["OR11H4", ["TCGA.D5.6924.01", "activated TAK1 mediates p38 MAPK activation"], {"weight": 0.695840826972663}], ["OR11H4", ["TCGA.D5.6924.01", "GPCR downstream signalling"], {"weight": 0.891857930781691}], ["OR11H4", ["TCGA.D5.6924.01", "Integration of energy metabolism"], {"weight": 0.879779815274702}], ["OR11H4", ["TCGA.D5.6924.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.812799412388092}], ["OR11H4", ["TCGA.D5.6924.01", "Peptide hormone metabolism"], {"weight": 0.738636327575465}], ["OR11H4", ["TCGA.D5.6924.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.871484717008373}], ["NTRK1", ["TCGA.CM.5862.01", "Classical antibody-mediated complement activation"], {"weight": 0.615250330814682}], ["OR4N2", ["TCGA.G4.6586.01", "GABA receptor activation"], {"weight": 0.937878556683204}], ["OR4N2", ["TCGA.G4.6586.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.938452548531712}], ["OR4N2", ["TCGA.G4.6586.01", "G beta:gamma signalling through BTK"], {"weight": 0.926454588619758}], ["OR6C1", ["TCGA.AZ.4615.01", "Glucagon-type ligand receptors"], {"weight": 0.933304912169071}], ["OR51B5", ["TCGA.D5.6535.01", "Transmission across Chemical Synapses"], {"weight": 0.90230599144602}], ["OR51B5", ["TCGA.D5.6535.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.898899750615424}], ["OR51B5", ["TCGA.D5.6535.01", "GABA receptor activation"], {"weight": 0.898948642835967}], ["OR51B5", ["TCGA.D5.6535.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.911827560875882}], ["OR51B5", ["TCGA.D5.6535.01", "Regulation of insulin secretion"], {"weight": 0.87515373151378}], ["OR51B5", ["TCGA.D5.6535.01", "G alpha (i) signalling events"], {"weight": 0.942243804609114}], ["OR51B5", ["TCGA.D5.6535.01", "Glucagon-type ligand receptors"], {"weight": 0.908543446506815}], ["OR51B5", ["TCGA.D5.6535.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.888913065928044}], ["OR51B5", ["TCGA.D5.6535.01", "GPCR ligand binding"], {"weight": 0.914232536748386}], ["OR51B5", ["TCGA.D5.6535.01", "GABA B receptor activation"], {"weight": 0.913108311362074}], ["OR51B5", ["TCGA.D5.6535.01", "Activation of GABAB receptors"], {"weight": 0.913108311362074}], ["OR51B5", ["TCGA.D5.6535.01", "Inwardly rectifying K+ channels"], {"weight": 0.859259802645908}], ["OR51B5", ["TCGA.D5.6535.01", "Activation of G protein gated Potassium channels"], {"weight": 0.898678969346881}], ["OR51B5", ["TCGA.D5.6535.01", "G protein gated Potassium channels"], {"weight": 0.898678969346881}], ["OR51B5", ["TCGA.D5.6535.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.898678969346881}], ["OR51B5", ["TCGA.D5.6535.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.86780287946988}], ["OR51B5", ["TCGA.D5.6535.01", "G alpha (z) signalling events"], {"weight": 0.89573228900404}], ["OR51B5", ["TCGA.D5.6535.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.788145949717176}], ["OR51B5", ["TCGA.D5.6535.01", "G beta:gamma signalling through BTK"], {"weight": 0.847073740065439}], ["OR51B5", ["TCGA.D5.6535.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.887980273373417}], ["OR51B5", ["TCGA.D5.6535.01", "G beta:gamma signalling through CDC42"], {"weight": 0.847073740065439}], ["OR51B5", ["TCGA.D5.6535.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.847073740065439}], ["OR51B5", ["TCGA.D5.6535.01", "Opioid Signalling"], {"weight": 0.908746204048745}], ["OR51B5", ["TCGA.D5.6535.01", "G-protein activation"], {"weight": 0.847073740065439}], ["OR1N2", ["TCGA.CM.6677.01", "GABA receptor activation"], {"weight": 0.631430358289039}], ["OR1N2", ["TCGA.CM.6677.01", "Glucagon-type ligand receptors"], {"weight": 0.907160038604685}], ["OR1N2", ["TCGA.CM.6677.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.906353114723936}], ["OR1N2", ["TCGA.CM.6677.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.833087834889556}], ["OR1N2", ["TCGA.CM.6677.01", "Potassium Channels"], {"weight": 0.941685633785343}], ["OR1N2", ["TCGA.CM.6677.01", "Signal amplification"], {"weight": 0.844668227568651}], ["OR1N2", ["TCGA.CM.6677.01", "Platelet homeostasis"], {"weight": 0.797954122162251}], ["OR1N2", ["TCGA.CM.6677.01", "Inwardly rectifying K+ channels"], {"weight": 0.914299320871855}], ["OR1N2", ["TCGA.CM.6677.01", "GABA B receptor activation"], {"weight": 0.91239990208076}], ["OR1N2", ["TCGA.CM.6677.01", "Activation of GABAB receptors"], {"weight": 0.91239990208076}], ["OR1N2", ["TCGA.CM.6677.01", "Activation of G protein gated Potassium channels"], {"weight": 0.906610334137702}], ["OR1N2", ["TCGA.CM.6677.01", "G protein gated Potassium channels"], {"weight": 0.906610334137702}], ["OR1N2", ["TCGA.CM.6677.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.906610334137702}], ["OR1N2", ["TCGA.CM.6677.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.890879631536004}], ["OR1N2", ["TCGA.CM.6677.01", "Regulation of insulin secretion"], {"weight": 0.892006711351651}], ["OR1N2", ["TCGA.CM.6677.01", "G beta:gamma signalling through BTK"], {"weight": 0.864078403684131}], ["OR1N2", ["TCGA.CM.6677.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.864078403684131}], ["OR1N2", ["TCGA.CM.6677.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.864078403684131}], ["OR1N2", ["TCGA.CM.6677.01", "G beta:gamma signalling through CDC42"], {"weight": 0.864078403684131}], ["OR1N2", ["TCGA.CM.6677.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.893087046184531}], ["OR1N2", ["TCGA.CM.6677.01", "Presynaptic function of Kainate receptors"], {"weight": 0.864078403684131}], ["OR1N2", ["TCGA.CM.6677.01", "Extra-nuclear estrogen signaling"], {"weight": 0.874547765343452}], ["OR1N1", ["TCGA.AZ.6600.01", "G alpha (i) signalling events"], {"weight": 0.867573981449197}], ["OR1N1", ["TCGA.AZ.6600.01", "Transmission across Chemical Synapses"], {"weight": 0.833268519270003}], ["OR1N1", ["TCGA.AZ.6600.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.797644239136556}], ["S1PR2", ["TCGA.CM.5349.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.732545724058011}], ["PRKCQ", ["TCGA.CM.5344.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.727544639650166}], ["PRKCQ", ["TCGA.CM.5344.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.91349285886418}], ["PRKCQ", ["TCGA.CM.5344.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.903007379085711}], ["PRKCQ", ["TCGA.CM.5344.01", "PD-1 signaling"], {"weight": 0.900899465402723}], ["PRKCQ", ["TCGA.CM.5344.01", "Leishmania infection"], {"weight": 0.821703643388462}], ["PRKCQ", ["TCGA.CM.5344.01", "Parasitic Infection Pathways"], {"weight": 0.821703643388462}], ["PRKCQ", ["TCGA.CM.5344.01", "TNFs bind their physiological receptors"], {"weight": 0.302915248479125}], ["PRKCQ", ["TCGA.CM.5344.01", "Costimulation by the CD28 family"], {"weight": 0.834501667278894}], ["PRKCQ", ["TCGA.CM.5344.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.876398734131183}], ["COG5", ["TCGA.DM.A0XD.01", "Interaction between L1 and Ankyrins"], {"weight": 0.934900745825388}], ["GLI1", ["TCGA.CM.5341.01", "Translation"], {"weight": 0.921383236704751}], ["IL7R", ["TCGA.G4.6317.01", "G alpha (q) signalling events"], {"weight": 0.938757290808807}], ["IL7R", ["TCGA.G4.6317.01", "Interleukin-10 signaling"], {"weight": 0.963367062082361}], ["IL7R", ["TCGA.G4.6317.01", "Costimulation by the CD28 family"], {"weight": 0.953649578944746}], ["GATA2", ["TCGA.AM.5820.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.919086664190052}], ["GATA2", ["TCGA.AM.5820.01", "Peptide ligand-binding receptors"], {"weight": 0.917244518612053}], ["GATA2", ["TCGA.CM.6170.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.915996439449098}], ["GATA2", ["TCGA.CM.6170.01", "GPCR downstream signalling"], {"weight": 0.918034917988002}], ["GATA2", ["TCGA.CM.6170.01", "Signaling by Retinoic Acid"], {"weight": 0.584871158480664}], ["GATA2", ["TCGA.CM.6170.01", "G alpha (q) signalling events"], {"weight": 0.891965196184973}], ["SERPINA1", ["TCGA.F4.6703.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.947186521817841}], ["SERPINA1", ["TCGA.F4.6703.01", "Chemokine receptors bind chemokines"], {"weight": 0.917070839522119}], ["SERPINA1", ["TCGA.F4.6703.01", "Dissolution of Fibrin Clot"], {"weight": 0.911672295604732}], ["THBS1", ["TCGA.D5.6928.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.868596264294745}], ["THBS1", ["TCGA.D5.6928.01", "O-linked glycosylation"], {"weight": 0.889411585938968}], ["THBS1", ["TCGA.G4.6302.01", "Post-translational protein phosphorylation"], {"weight": 0.796751701382984}], ["THBS1", ["TCGA.G4.6302.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.79381391821759}], ["OR6N1", ["TCGA.CM.5349.01", "Signaling by GPCR"], {"weight": 0.914386162920394}], ["OR6N1", ["TCGA.CM.5349.01", "GPCR ligand binding"], {"weight": 0.914960685274572}], ["OR6N1", ["TCGA.CM.5349.01", "GPCR downstream signalling"], {"weight": 0.920646618591573}], ["OR2T4", ["TCGA.F4.6570.01", "Glucagon-type ligand receptors"], {"weight": 0.924654321459609}], ["BCAN", ["TCGA.CM.4752.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.925355793537827}], ["BCAN", ["TCGA.CM.4752.01", "Collagen formation"], {"weight": 0.934946477920899}], ["BCAN", ["TCGA.CM.6162.01", "Chondroitin sulfate biosynthesis"], {"weight": 0.864737284690163}], ["GBP6", ["TCGA.D5.6538.01", "PD-1 signaling"], {"weight": 0.950841323041111}], ["GBP6", ["TCGA.D5.6538.01", "Generation of second messenger molecules"], {"weight": 0.95292224522311}], ["GBP6", ["TCGA.D5.6538.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.951342570271097}], ["GBP6", ["TCGA.D5.6538.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.951342570271097}], ["GBP6", ["TCGA.D5.6538.01", "Interferon alpha/beta signaling"], {"weight": 0.92132688058705}], ["GBP6", ["TCGA.D5.6538.01", "Peptide hormone metabolism"], {"weight": 0.740367818536497}], ["COX5A", ["TCGA.CM.5349.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.769697063670003}], ["COX5A", ["TCGA.CM.5349.01", "Biological oxidations"], {"weight": 0.852014619474071}], ["INPP5F", ["TCGA.AM.5820.01", "Downstream TCR signaling"], {"weight": 0.943697798287082}], ["MAL", ["TCGA.D5.6924.01", "ERBB2 Regulates Cell Motility"], {"weight": 0.762518669823499}], ["MAL", ["TCGA.D5.6924.01", "SHC1 events in ERBB4 signaling"], {"weight": 0.69362185281926}], ["SUOX", ["TCGA.DM.A0X9.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.92244089788701}], ["SUOX", ["TCGA.DM.A0X9.01", "Phase II - Conjugation of compounds"], {"weight": 0.786940994507928}], ["SUOX", ["TCGA.G4.6323.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.879101248760084}], ["SFTPD", ["TCGA.D5.6533.01", "Formation of axial mesoderm"], {"weight": 0.778931828123659}], ["AOC3", ["TCGA.CM.4752.01", "Biological oxidations"], {"weight": 0.888945523776484}], ["AOC3", ["TCGA.CM.4752.01", "Ethanol oxidation"], {"weight": 0.82435328897768}], ["AOC3", ["TCGA.CM.4752.01", "Phase I - Functionalization of compounds"], {"weight": 0.918219663903001}], ["AOC3", ["TCGA.CM.4752.01", "Neurotransmitter release cycle"], {"weight": 0.816244295972397}], ["AOC3", ["TCGA.CM.5341.01", "Biological oxidations"], {"weight": 0.95608348534572}], ["AOC3", ["TCGA.CM.5341.01", "Phase I - Functionalization of compounds"], {"weight": 0.950829750631514}], ["FCN2", ["TCGA.G4.6294.01", "Complement cascade"], {"weight": 0.874030212591168}], ["FCN2", ["TCGA.G4.6294.01", "Regulation of Complement cascade"], {"weight": 0.826741220554314}], ["FCN1", ["TCGA.CK.5914.01", "Regulation of Complement cascade"], {"weight": 0.79930297901363}], ["PMEPA1", ["TCGA.AM.5820.01", "Formation of axial mesoderm"], {"weight": 0.872972859473771}], ["PMEPA1", ["TCGA.AM.5820.01", "Signaling by Activin"], {"weight": 0.906766411934054}], ["AK5", ["TCGA.G4.6304.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.833544652671387}], ["NR1H2", ["TCGA.G4.6586.01", "Phase I - Functionalization of compounds"], {"weight": 0.944794964374411}], ["HSD17B3", ["TCGA.AY.6197.01", "Glucuronidation"], {"weight": 0.851614152097337}], ["HSD17B3", ["TCGA.CA.6718.01", "Glucuronidation"], {"weight": 0.942975318995844}], ["HSD17B3", ["TCGA.CA.6718.01", "Heme degradation"], {"weight": 0.755897719531569}], ["UGT2B15", ["TCGA.CA.6718.01", "Aspirin ADME"], {"weight": 0.943886761549776}], ["ABCG5", ["TCGA.CA.5797.01", "Transport of small molecules"], {"weight": 0.909637837365887}], ["DISP2", ["TCGA.G4.6588.01", "GPCR ligand binding"], {"weight": 0.938435298396471}], ["MMP17", ["TCGA.AZ.6607.01", "Extracellular matrix organization"], {"weight": 0.936444618184056}], ["MMP17", ["TCGA.AZ.6607.01", "Degradation of the extracellular matrix"], {"weight": 0.897975956781662}], ["MMP17", ["TCGA.AZ.6607.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.955189312301566}], ["MMP17", ["TCGA.CM.6166.01", "Degradation of the extracellular matrix"], {"weight": 0.800609339807433}], ["AKR1C4", ["TCGA.G4.6306.01", "Biological oxidations"], {"weight": 0.911195796118052}], ["UGT1A7", ["TCGA.DM.A1D8.01", "Biological oxidations"], {"weight": 0.925151654672368}], ["UGT1A7", ["TCGA.DM.A1D8.01", "Glucuronidation"], {"weight": 0.92883372203404}], ["UGT1A7", ["TCGA.DM.A1D8.01", "Aspirin ADME"], {"weight": 0.869592115112925}], ["UGT1A7", ["TCGA.DM.A1D8.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.827437015408283}], ["UGT1A7", ["TCGA.DM.A1D8.01", "Visual phototransduction"], {"weight": 0.875530007913951}], ["LRRTM3", ["TCGA.DM.A28G.01", "Extracellular matrix organization"], {"weight": 0.848706842294292}], ["IDO2", ["TCGA.AM.5821.01", "Tryptophan catabolism"], {"weight": 0.918940125174428}], ["IDO2", ["TCGA.D5.6929.01", "Biological oxidations"], {"weight": 0.909677291896458}], ["IDO2", ["TCGA.D5.6929.01", "Glucuronidation"], {"weight": 0.893194072394559}], ["IDO2", ["TCGA.D5.6929.01", "Aspirin ADME"], {"weight": 0.826026757796351}], ["IDO2", ["TCGA.D5.6929.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.773005837979466}], ["IDO2", ["TCGA.D5.6929.01", "Phase I - Functionalization of compounds"], {"weight": 0.946924501943621}], ["IDO2", ["TCGA.D5.6929.01", "Metabolism of amine-derived hormones"], {"weight": 0.685330975542956}], ["IDO2", ["TCGA.F4.6809.01", "Biological oxidations"], {"weight": 0.727588677509495}], ["IDO2", ["TCGA.F4.6809.01", "Glucuronidation"], {"weight": 0.780688674785526}], ["IDO2", ["TCGA.F4.6809.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.383848097954841}], ["IDO2", ["TCGA.F4.6809.01", "APAP ADME"], {"weight": 0.428155039463633}], ["FMO1", ["TCGA.CK.5913.01", "Ethanol oxidation"], {"weight": 0.895763185252213}], ["FMO1", ["TCGA.G4.6626.01", "Drug ADME"], {"weight": 0.905197222754836}], ["FMO1", ["TCGA.G4.6626.01", "Arachidonic acid metabolism"], {"weight": 0.949310621555761}], ["FMO1", ["TCGA.G4.6626.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.930699216173209}], ["FMO1", ["TCGA.G4.6626.01", "Aspirin ADME"], {"weight": 0.817138108324319}], ["FMO1", ["TCGA.G4.6626.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.8335251932758}], ["KCNQ4", ["TCGA.DM.A1D8.01", "Cardiac conduction"], {"weight": 0.923518266124184}], ["KCNQ4", ["TCGA.DM.A1D8.01", "Phase 4 - resting membrane potential"], {"weight": 0.9200065014947}], ["KCNQ4", ["TCGA.DM.A1D8.01", "Muscle contraction"], {"weight": 0.926615984755195}], ["KCNQ4", ["TCGA.DM.A1D8.01", "Sensory processing of sound"], {"weight": 0.91071414212058}], ["KCNQ4", ["TCGA.DM.A1D8.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.907336439536102}], ["KCNQ4", ["TCGA.DM.A1D8.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.927776332781062}], ["B3GNTL1", ["TCGA.CM.6161.01", "Sialic acid metabolism"], {"weight": 0.615780137239911}], ["B3GNTL1", ["TCGA.CM.6161.01", "Termination of O-glycan biosynthesis"], {"weight": 0.901810003763717}], ["B3GNTL1", ["TCGA.CM.6171.01", "O-linked glycosylation"], {"weight": 0.92595127290437}], ["CNDP1", ["TCGA.CK.4950.01", "RA biosynthesis pathway"], {"weight": 0.368865940339338}], ["GCDH", ["TCGA.AZ.6603.01", "Ethanol oxidation"], {"weight": 0.611910375487721}], ["PTPRD", ["TCGA.CK.5912.01", "Neuronal System"], {"weight": 0.927863808327373}], ["PTPRD", ["TCGA.CK.5912.01", "Protein-protein interactions at synapses"], {"weight": 0.890647173338802}], ["PTPRD", ["TCGA.D5.5540.01", "Neuronal System"], {"weight": 0.945006056871202}], ["SETMAR", ["TCGA.AM.5821.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.955406358568747}], ["HYAL4", ["TCGA.CM.5862.01", "Phase II - Conjugation of compounds"], {"weight": 0.7637777626513}], ["SOAT2", ["TCGA.AM.5821.01", "Biological oxidations"], {"weight": 0.962082404563316}], ["PSMB1", ["TCGA.DM.A28M.01", "Immune System"], {"weight": 0.911005240423717}], ["PSMB1", ["TCGA.DM.A28M.01", "GPCR ligand binding"], {"weight": 0.944040223999797}], ["PSMB1", ["TCGA.DM.A28M.01", "Cytokine Signaling in Immune system"], {"weight": 0.886098886597285}], ["PSMB1", ["TCGA.DM.A28M.01", "TNFs bind their physiological receptors"], {"weight": 0.467542997413514}], ["PSMB1", ["TCGA.DM.A28M.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.86477544662987}], ["OR2T35", ["TCGA.AM.5821.01", "G-protein mediated events"], {"weight": 0.915540197388005}], ["OR2T35", ["TCGA.AM.5821.01", "Opioid Signalling"], {"weight": 0.933856078480177}], ["OR2T35", ["TCGA.AM.5821.01", "GABA receptor activation"], {"weight": 0.934053579612231}], ["OR2T35", ["TCGA.AM.5821.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.919570486128559}], ["OR2T35", ["TCGA.G4.6311.01", "Transmission across Chemical Synapses"], {"weight": 0.847879796082305}], ["OR2T35", ["TCGA.G4.6311.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.861808851782964}], ["OR2T35", ["TCGA.G4.6311.01", "GABA receptor activation"], {"weight": 0.850403310449116}], ["ABLIM2", ["TCGA.F4.6854.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.878668534002505}], ["ALDH1B1", ["TCGA.AM.5821.01", "Transmission across Chemical Synapses"], {"weight": 0.944726630786265}], ["ALDH1B1", ["TCGA.AZ.4615.01", "Neurotransmitter release cycle"], {"weight": 0.936396828069284}], ["ALDH1B1", ["TCGA.G4.6588.01", "Transmission across Chemical Synapses"], {"weight": 0.944487909892806}], ["ALDH1B1", ["TCGA.G4.6588.01", "Biological oxidations"], {"weight": 0.935950439118236}], ["ALDH1B1", ["TCGA.G4.6588.01", "RA biosynthesis pathway"], {"weight": 0.90054031686701}], ["ALDH1B1", ["TCGA.G4.6588.01", "Phase I - Functionalization of compounds"], {"weight": 0.957646601560837}], ["ALDH1B1", ["TCGA.G4.6588.01", "Ethanol oxidation"], {"weight": 0.937539702634574}], ["RUNX3", ["TCGA.AM.5821.01", "Regulation of RUNX1 Expression and Activity"], {"weight": 0.876976373133621}], ["TAAR6", ["TCGA.AZ.4323.01", "Peptide hormone biosynthesis"], {"weight": 0.920745233949621}], ["TAAR6", ["TCGA.AZ.4323.01", "GPCR ligand binding"], {"weight": 0.892512422302664}], ["TAAR6", ["TCGA.AZ.4323.01", "Potassium Channels"], {"weight": 0.949201563403432}], ["TAAR6", ["TCGA.AZ.4323.01", "Biological oxidations"], {"weight": 0.93009482964856}], ["TAAR6", ["TCGA.AZ.4323.01", "Glucagon-type ligand receptors"], {"weight": 0.912971911729892}], ["TAAR6", ["TCGA.AZ.4323.01", "Peptide hormone metabolism"], {"weight": 0.821659107683539}], ["TAAR6", ["TCGA.AZ.4323.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.933369915675728}], ["TAAR6", ["TCGA.AZ.4323.01", "G alpha (s) signalling events"], {"weight": 0.914274284867063}], ["TAAR6", ["TCGA.AZ.4323.01", "Voltage gated Potassium channels"], {"weight": 0.910983033173533}], ["TAAR6", ["TCGA.AZ.4323.01", "Signaling by GPCR"], {"weight": 0.893657900828662}], ["TAAR6", ["TCGA.AZ.4323.01", "Phase 4 - resting membrane potential"], {"weight": 0.765511149569023}], ["TAAR6", ["TCGA.AZ.4323.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.846511026982553}], ["TAAR6", ["TCGA.AZ.4323.01", "Peptide ligand-binding receptors"], {"weight": 0.834575439866924}], ["NADSYN1", ["TCGA.G4.6588.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.893203719133271}], ["NOX1", ["TCGA.CM.4747.01", "Heme degradation"], {"weight": 0.656161284500669}], ["PRSS3", ["TCGA.F4.6703.01", "Antimicrobial peptides"], {"weight": 0.67467169469558}], ["YEATS2", ["TCGA.DM.A28G.01", "Physiological factors"], {"weight": 0.657448036201969}], ["PIP4K2C", ["TCGA.CM.4752.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.887980498344451}], ["PIP4K2C", ["TCGA.CM.4752.01", "G-protein beta:gamma signalling"], {"weight": 0.887980498344451}], ["AP1S3", ["TCGA.DM.A1HA.01", "Generation of second messenger molecules"], {"weight": 0.932967119142309}], ["AP1S3", ["TCGA.DM.A1HA.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.922117598101143}], ["AP1S3", ["TCGA.DM.A1HA.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.926372194572397}], ["AP1S3", ["TCGA.DM.A1HA.01", "PD-1 signaling"], {"weight": 0.916447422714272}], ["AP1S3", ["TCGA.G4.6315.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.931256883014051}], ["AP1S3", ["TCGA.G4.6315.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.931256883014051}], ["AP1S3", ["TCGA.G4.6315.01", "Generation of second messenger molecules"], {"weight": 0.932807625167104}], ["AP1S3", ["TCGA.G4.6315.01", "PD-1 signaling"], {"weight": 0.931822031894684}], ["CETP", ["TCGA.CM.6165.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.815614572133701}], ["OPN1LW", ["TCGA.AZ.5403.01", "GPCR downstream signalling"], {"weight": 0.92836620791376}], ["PPP6R1", ["TCGA.CM.5344.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.686088830647669}], ["IL2RB", ["TCGA.D5.6928.01", "TNFs bind their physiological receptors"], {"weight": 0.453623697919698}], ["OR6A2", ["TCGA.CK.4948.01", "Signaling by GPCR"], {"weight": 0.946658489128062}], ["ARSG", ["TCGA.AM.5821.01", "Metabolism"], {"weight": 0.944070608833402}], ["ARSG", ["TCGA.DM.A1D6.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.851743253203461}], ["CCT2", ["TCGA.AM.5821.01", "GPCR ligand binding"], {"weight": 0.942177485420539}], ["KDM6A", ["TCGA.CM.4747.01", "Phase II - Conjugation of compounds"], {"weight": 0.760095003654496}], ["KDM6A", ["TCGA.CM.4747.01", "Glucuronidation"], {"weight": 0.856188530272095}], ["KDM6A", ["TCGA.CM.4747.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.490532594712703}], ["KDM6A", ["TCGA.F4.6463.01", "Phase II - Conjugation of compounds"], {"weight": 0.581297955202351}], ["KDM6A", ["TCGA.F4.6463.01", "Aspirin ADME"], {"weight": 0.701251538875212}], ["GSTM3", ["TCGA.AM.5821.01", "Aflatoxin activation and detoxification"], {"weight": 0.907563114081745}], ["GSTM3", ["TCGA.CK.4952.01", "Arachidonic acid metabolism"], {"weight": 0.912444205790814}], ["GSTM3", ["TCGA.DM.A28G.01", "RA biosynthesis pathway"], {"weight": 0.905136190313101}], ["GSTM3", ["TCGA.DM.A28G.01", "Signaling by Retinoic Acid"], {"weight": 0.741078024955186}], ["OR6C68", ["TCGA.D5.6920.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.853348375576408}], ["OR6C68", ["TCGA.D5.6920.01", "GPCR ligand binding"], {"weight": 0.904448450404661}], ["FOXA1", ["TCGA.G4.6588.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.838498643346601}], ["CCRL2", ["TCGA.DM.A1HA.01", "G alpha (i) signalling events"], {"weight": 0.962555859269815}], ["PEMT", ["TCGA.CA.6716.01", "Arachidonic acid metabolism"], {"weight": 0.91038171226317}], ["PEMT", ["TCGA.CA.6716.01", "Acyl chain remodelling of PE"], {"weight": 0.850437617287762}], ["OR1I1", ["TCGA.AM.5821.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.943120220961692}], ["OR1I1", ["TCGA.CM.5861.01", "Transmission across Chemical Synapses"], {"weight": 0.943517713452946}], ["OR1I1", ["TCGA.CM.5861.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.942478255509396}], ["INHBC", ["TCGA.G4.6302.01", "Regulation of signaling by NODAL"], {"weight": 0.844000984747567}], ["ENPP1", ["TCGA.AZ.6601.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.877329917140426}], ["ENPP1", ["TCGA.CM.5861.01", "Nicotinate metabolism"], {"weight": 0.822799590553155}], ["ENPP1", ["TCGA.CM.5861.01", "Collagen chain trimerization"], {"weight": 0.924784889785107}], ["ENPP1", ["TCGA.CM.5861.01", "Phase II - Conjugation of compounds"], {"weight": 0.886704415099849}], ["ENPP1", ["TCGA.CM.5861.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.876589976032101}], ["ENPP1", ["TCGA.F4.6570.01", "Biological oxidations"], {"weight": 0.945345494312791}], ["ENPP1", ["TCGA.F4.6570.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.911211564186244}], ["OR2Y1", ["TCGA.CM.6166.01", "GPCR downstream signalling"], {"weight": 0.943557458944209}], ["OR2Y1", ["TCGA.CM.6166.01", "Signaling by GPCR"], {"weight": 0.941719245054691}], ["OR2Y1", ["TCGA.CM.6166.01", "G alpha (i) signalling events"], {"weight": 0.934186775969195}], ["OR2Y1", ["TCGA.CM.6166.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.905818605808417}], ["OR2Y1", ["TCGA.CM.6166.01", "Leishmania parasite growth and survival"], {"weight": 0.905818605808417}], ["OR2Y1", ["TCGA.CM.6166.01", "Neuronal System"], {"weight": 0.92415096431509}], ["OR2Y1", ["TCGA.CM.6166.01", "Regulation of insulin secretion"], {"weight": 0.921692172353456}], ["OR2Y1", ["TCGA.CM.6166.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.917982188634759}], ["OR2Y1", ["TCGA.CM.6166.01", "G-protein mediated events"], {"weight": 0.857741231125257}], ["OR2Y1", ["TCGA.CM.6166.01", "Peptide hormone metabolism"], {"weight": 0.839406787887777}], ["OR2Y1", ["TCGA.CM.6166.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.929927079545463}], ["OR2Y1", ["TCGA.CM.6166.01", "G-protein activation"], {"weight": 0.921595841715187}], ["OR2Y1", ["TCGA.CM.6166.01", "Integration of energy metabolism"], {"weight": 0.904776271469843}], ["OR2Y1", ["TCGA.CM.6166.01", "GABA B receptor activation"], {"weight": 0.923836039098546}], ["OR2Y1", ["TCGA.CM.6166.01", "Activation of GABAB receptors"], {"weight": 0.923836039098546}], ["OR2Y1", ["TCGA.CM.6166.01", "G beta:gamma signalling through BTK"], {"weight": 0.921330100397181}], ["OR2Y1", ["TCGA.CM.6166.01", "Glucagon-type ligand receptors"], {"weight": 0.919450485272347}], ["OR2Y1", ["TCGA.CM.6166.01", "Activation of G protein gated Potassium channels"], {"weight": 0.919873805056577}], ["GMPS", ["TCGA.D5.6540.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.880671626607538}], ["GMPS", ["TCGA.D5.6930.01", "Drug ADME"], {"weight": 0.894336681615717}], ["GMPS", ["TCGA.G4.6588.01", "Platelet homeostasis"], {"weight": 0.869485431118892}], ["ORC3", ["TCGA.G4.6588.01", "Unwinding of DNA"], {"weight": 0.8439345642934}], ["CLSPN", ["TCGA.CM.6166.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.791369361590937}], ["SOAT2", ["TCGA.AM.5821.01", "Phase I - Functionalization of compounds"], {"weight": 0.9646512250688}], ["SOAT2", ["TCGA.AM.5821.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.933349047718324}], ["SOAT2", ["TCGA.G4.6626.01", "Biological oxidations"], {"weight": 0.935391704623896}], ["SOAT2", ["TCGA.G4.6626.01", "Phase II - Conjugation of compounds"], {"weight": 0.779335241804693}], ["OR10C1", ["TCGA.CA.6716.01", "G alpha (i) signalling events"], {"weight": 0.947637672922934}], ["OR10C1", ["TCGA.CA.6716.01", "GPCR ligand binding"], {"weight": 0.939138973206311}], ["OR10C1", ["TCGA.CA.6716.01", "Leishmania infection"], {"weight": 0.854382507574608}], ["OR10C1", ["TCGA.CA.6716.01", "Parasitic Infection Pathways"], {"weight": 0.854382507574608}], ["OR10C1", ["TCGA.CA.6716.01", "G alpha (q) signalling events"], {"weight": 0.939244377541011}], ["OR10C1", ["TCGA.CA.6716.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.896699466250556}], ["OR10C1", ["TCGA.CA.6716.01", "Leishmania parasite growth and survival"], {"weight": 0.896699466250556}], ["OR10C1", ["TCGA.CA.6716.01", "Peptide hormone metabolism"], {"weight": 0.852310015847054}], ["OR10C1", ["TCGA.CA.6716.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.925146498669871}], ["OR10C1", ["TCGA.CA.6716.01", "Regulation of insulin secretion"], {"weight": 0.890726362252122}], ["OR10C1", ["TCGA.CA.6716.01", "Signal amplification"], {"weight": 0.902602841527568}], ["OR10C1", ["TCGA.CA.6716.01", "G alpha (z) signalling events"], {"weight": 0.91731055434667}], ["OR10C1", ["TCGA.CA.6716.01", "Potassium Channels"], {"weight": 0.949485457314205}], ["OR10C1", ["TCGA.CA.6716.01", "Activation of the phototransduction cascade"], {"weight": 0.810571280692767}], ["OR10C1", ["TCGA.CA.6716.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.891615018276334}], ["OR10C1", ["TCGA.CA.6716.01", "Phase 4 - resting membrane potential"], {"weight": 0.799182287563138}], ["OR10C1", ["TCGA.CA.6716.01", "Integration of energy metabolism"], {"weight": 0.875093783889224}], ["OR10C1", ["TCGA.CA.6716.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.894971165048205}], ["OR10C1", ["TCGA.CA.6716.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.915323552851477}], ["OR10C1", ["TCGA.CA.6716.01", "G beta:gamma signalling through BTK"], {"weight": 0.907725235336441}], ["OR10C1", ["TCGA.F4.6806.01", "Regulation of Complement cascade"], {"weight": 0.557485293508897}], ["OR10C1", ["TCGA.F4.6806.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.866387692905328}], ["OR10C1", ["TCGA.F4.6806.01", "G alpha (s) signalling events"], {"weight": 0.92999176563969}], ["OR4A5", ["TCGA.DM.A282.01", "GPCR ligand binding"], {"weight": 0.937967160987837}], ["OR4A5", ["TCGA.DM.A282.01", "Leishmania infection"], {"weight": 0.875759785481603}], ["OR4A5", ["TCGA.DM.A282.01", "Parasitic Infection Pathways"], {"weight": 0.875759785481603}], ["OR4A5", ["TCGA.DM.A282.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.689427191632306}], ["OR4A5", ["TCGA.DM.A282.01", "Platelet homeostasis"], {"weight": 0.90602490304027}], ["OR4A5", ["TCGA.DM.A282.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.897801079138663}], ["OR4A5", ["TCGA.DM.A282.01", "Leishmania parasite growth and survival"], {"weight": 0.897801079138663}], ["OR4A5", ["TCGA.DM.A282.01", "G-protein mediated events"], {"weight": 0.927216176983108}], ["OR4A5", ["TCGA.DM.A282.01", "Opioid Signalling"], {"weight": 0.936453503968762}], ["OR4A5", ["TCGA.DM.A282.01", "Glycosaminoglycan metabolism"], {"weight": 0.832205188078785}], ["OR4A5", ["TCGA.DM.A282.01", "Platelet calcium homeostasis"], {"weight": 0.875034837493517}], ["OR4A5", ["TCGA.DM.A282.01", "Regulation of insulin secretion"], {"weight": 0.912628001267486}], ["OR4A5", ["TCGA.DM.A282.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.905356564548542}], ["OR4A5", ["TCGA.DM.A282.01", "G alpha (z) signalling events"], {"weight": 0.887995399188778}], ["OR4A5", ["TCGA.DM.A282.01", "Integration of energy metabolism"], {"weight": 0.899482525143868}], ["ACYP2", ["TCGA.AM.5821.01", "Ethanol oxidation"], {"weight": 0.943079362533109}], ["FMO3", ["TCGA.D5.6532.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.827305731169919}], ["FMO3", ["TCGA.D5.6532.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.750738429513022}], ["GLP1R", ["TCGA.AY.6196.01", "Surfactant metabolism"], {"weight": 0.854577462810781}], ["GLP1R", ["TCGA.D5.6531.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.911713293605279}], ["GLP1R", ["TCGA.D5.6531.01", "GPCR ligand binding"], {"weight": 0.930770767247207}], ["OR10H5", ["TCGA.D5.6920.01", "Neuronal System"], {"weight": 0.85125704755201}], ["OR10H5", ["TCGA.D5.6920.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.854999270585549}], ["HLA-DQB1", ["TCGA.G4.6298.01", "Costimulation by the CD28 family"], {"weight": 0.906122843177416}], ["ADAM28", ["TCGA.AZ.6605.01", "Collagen formation"], {"weight": 0.917792335932087}], ["ADAM28", ["TCGA.AZ.6605.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.920205224612098}], ["ADAM28", ["TCGA.AZ.6605.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.891270426555574}], ["ADAM28", ["TCGA.AZ.6605.01", "Collagen degradation"], {"weight": 0.881869491453638}], ["ADAM28", ["TCGA.AZ.6605.01", "Collagen chain trimerization"], {"weight": 0.857207528752429}], ["ADAM28", ["TCGA.AZ.6605.01", "Defective B3GALTL causes PpS"], {"weight": 0.810367858716355}], ["ADAM28", ["TCGA.AZ.6605.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.810367858716355}], ["ADAM28", ["TCGA.AZ.6605.01", "Diseases of glycosylation"], {"weight": 0.773610801284337}], ["ADAM28", ["TCGA.AZ.6605.01", "Scavenging by Class A Receptors"], {"weight": 0.580622451925647}], ["ADAM28", ["TCGA.AZ.6605.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.558122600062056}], ["SEC16B", ["TCGA.F4.6856.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.894509405888963}], ["MIA2", ["TCGA.D5.6928.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.939800733270737}], ["MIA2", ["TCGA.D5.6928.01", "Collagen formation"], {"weight": 0.940004030942614}], ["TREML2", ["TCGA.G4.6317.01", "Complement cascade"], {"weight": 0.926353989053788}], ["TREML2", ["TCGA.G4.6317.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.737838459848202}], ["TREML2", ["TCGA.G4.6317.01", "Initial triggering of complement"], {"weight": 0.899293979586966}], ["TREML2", ["TCGA.G4.6317.01", "Creation of C4 and C2 activators"], {"weight": 0.905527637080871}], ["GCNT4", ["TCGA.F4.6856.01", "O-linked glycosylation of mucins"], {"weight": 0.932277020781219}], ["GCNT4", ["TCGA.F4.6856.01", "Termination of O-glycan biosynthesis"], {"weight": 0.903460207276119}], ["CHIA", ["TCGA.CA.6718.01", "Blood group systems biosynthesis"], {"weight": 0.765283878763775}], ["SLC26A7", ["TCGA.F4.6856.01", "Transport of small molecules"], {"weight": 0.906487027093059}], ["WNT5B", ["TCGA.AU.3779.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.795182018243939}], ["DTNA", ["TCGA.AU.3779.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.899273717926523}], ["DTNA", ["TCGA.AU.3779.01", "Collagen formation"], {"weight": 0.912470553885785}], ["ALOX5", ["TCGA.AU.3779.01", "Phase II - Conjugation of compounds"], {"weight": 0.805528910760929}], ["ALOX5", ["TCGA.AU.3779.01", "Ethanol oxidation"], {"weight": 0.854610692975445}], ["ALOX5", ["TCGA.AU.3779.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.714871391482517}], ["ALOX5", ["TCGA.AU.3779.01", "RA biosynthesis pathway"], {"weight": 0.789863878480294}], ["ALOX5", ["TCGA.CM.6171.01", "Arachidonic acid metabolism"], {"weight": 0.895680784209879}], ["ALOX5", ["TCGA.G4.6293.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.797548575511278}], ["MPP1", ["TCGA.AU.3779.01", "Sensory processing of sound by outer hair cells of the cochlea"], {"weight": 0.906629300432054}], ["MPP1", ["TCGA.G4.6588.01", "Neurexins and neuroligins"], {"weight": 0.951199533048707}], ["NEU3", ["TCGA.AU.3779.01", "Metabolism"], {"weight": 0.876919608014587}], ["KLK13", ["TCGA.D5.5538.01", "Peptide ligand-binding receptors"], {"weight": 0.918369396063376}], ["KLK13", ["TCGA.D5.5538.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.919197838736419}], ["KLK13", ["TCGA.D5.5538.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.613540781760027}], ["WDR5", ["TCGA.F4.6809.01", "Phase II - Conjugation of compounds"], {"weight": 0.680155659182063}], ["ATP6V0A4", ["TCGA.AY.6197.01", "Ion channel transport"], {"weight": 0.921258794323716}], ["B4GALT5", ["TCGA.D5.6928.01", "Defective GALNT3 causes HFTC"], {"weight": 0.882117479073985}], ["B4GALT5", ["TCGA.D5.6928.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.882117479073985}], ["B4GALT5", ["TCGA.D5.6928.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.882117479073985}], ["HLA-E", ["TCGA.D5.5541.01", "Extracellular matrix organization"], {"weight": 0.831354640537382}], ["HLA-E", ["TCGA.D5.5541.01", "ECM proteoglycans"], {"weight": 0.88707055985185}], ["HLA-E", ["TCGA.D5.5541.01", "L1CAM interactions"], {"weight": 0.839730428341001}], ["TFDP1", ["TCGA.AZ.5407.01", "Drug ADME"], {"weight": 0.789754072601143}], ["TFDP1", ["TCGA.DM.A1D0.01", "TNFs bind their physiological receptors"], {"weight": 0.513269457374349}], ["TFDP1", ["TCGA.DM.A1D0.01", "Cytokine Signaling in Immune system"], {"weight": 0.88473192890619}], ["XCR1", ["TCGA.DM.A282.01", "Complement cascade"], {"weight": 0.857715741035739}], ["XCR1", ["TCGA.DM.A282.01", "Regulation of Complement cascade"], {"weight": 0.851424163430591}], ["XCR1", ["TCGA.DM.A282.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.763455252850291}], ["XCR1", ["TCGA.DM.A282.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.84111782894842}], ["XCR1", ["TCGA.DM.A282.01", "Phase 4 - resting membrane potential"], {"weight": 0.695557600776831}], ["PGM2L1", ["TCGA.D5.6540.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.837386882663115}], ["CLCF1", ["TCGA.AU.6004.01", "Interleukin-6 family signaling"], {"weight": 0.889386289759177}], ["VCL", ["TCGA.CM.4744.01", "Muscle contraction"], {"weight": 0.94396758388087}], ["VCL", ["TCGA.CM.4744.01", "Nervous system development"], {"weight": 0.919566084963267}], ["VCL", ["TCGA.CM.4744.01", "Axon guidance"], {"weight": 0.924396123088488}], ["VCL", ["TCGA.CM.4744.01", "Intrinsic Pathway of Fibrin Clot Formation"], {"weight": 0.901898433070648}], ["TRPV2", ["TCGA.D5.6540.01", "Stimuli-sensing channels"], {"weight": 0.927804893069553}], ["TRPV2", ["TCGA.D5.6540.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.915802944497568}], ["NAPA", ["TCGA.CM.5344.01", "Extracellular matrix organization"], {"weight": 0.876254403415091}], ["NAPA", ["TCGA.CM.5344.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.941780884021414}], ["NAPA", ["TCGA.CM.5344.01", "Collagen formation"], {"weight": 0.925946444522909}], ["NAPA", ["TCGA.CM.5344.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.900196225756093}], ["NAPA", ["TCGA.CM.5344.01", "Synaptic adhesion-like molecules"], {"weight": 0.785656792170118}], ["NAPA", ["TCGA.CM.5344.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.873417963962887}], ["NAPA", ["TCGA.CM.5344.01", "Long-term potentiation"], {"weight": 0.877855692415919}], ["NAPA", ["TCGA.G4.6320.01", "Protein-protein interactions at synapses"], {"weight": 0.931924546164084}], ["PAX8", ["TCGA.AU.6004.01", "Phase 0 - rapid depolarisation"], {"weight": 0.834835295919472}], ["PAX8", ["TCGA.AZ.6601.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.904314581597769}], ["PAX8", ["TCGA.DM.A28H.01", "G alpha (q) signalling events"], {"weight": 0.936117478806169}], ["PAX8", ["TCGA.DM.A28H.01", "Regulation of insulin secretion"], {"weight": 0.933578646947538}], ["PAX8", ["TCGA.DM.A28H.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.926375885330961}], ["PAX8", ["TCGA.DM.A28H.01", "Leishmania infection"], {"weight": 0.900503495553751}], ["PAX8", ["TCGA.DM.A28H.01", "Parasitic Infection Pathways"], {"weight": 0.900503495553751}], ["PAX8", ["TCGA.DM.A28H.01", "Voltage gated Potassium channels"], {"weight": 0.852200628865664}], ["PAX8", ["TCGA.DM.A28H.01", "G alpha (z) signalling events"], {"weight": 0.900134078601898}], ["PAX8", ["TCGA.DM.A28H.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.905556108203795}], ["PAX8", ["TCGA.DM.A28H.01", "Leishmania parasite growth and survival"], {"weight": 0.905556108203795}], ["MITF", ["TCGA.DM.A0X9.01", "Heme degradation"], {"weight": 0.745869006593687}], ["MITF", ["TCGA.G4.6586.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.921258166326353}], ["ARNT", ["TCGA.AZ.6598.01", "Biological oxidations"], {"weight": 0.952353811346}], ["SLC2A4", ["TCGA.CK.4952.01", "Synthesis of bile acids and bile salts via 27-hydroxycholesterol"], {"weight": 0.871065826219787}], ["HSD17B1", ["TCGA.AY.6196.01", "Phase II - Conjugation of compounds"], {"weight": 0.816967192185123}], ["HSD17B1", ["TCGA.AY.6196.01", "Glucuronidation"], {"weight": 0.90237681539185}], ["HSD17B1", ["TCGA.AY.6196.01", "Aspirin ADME"], {"weight": 0.847741793737437}], ["HSD17B1", ["TCGA.AZ.5407.01", "Biological oxidations"], {"weight": 0.900384302015501}], ["HSD17B1", ["TCGA.AZ.5407.01", "Phase II - Conjugation of compounds"], {"weight": 0.768862624161583}], ["HSD17B1", ["TCGA.AZ.6601.01", "Glucuronidation"], {"weight": 0.91799098495775}], ["HSD17B1", ["TCGA.CM.5863.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.682121153973648}], ["HSD17B1", ["TCGA.CM.5863.01", "Drug ADME"], {"weight": 0.770402668694345}], ["HSD17B1", ["TCGA.CM.5863.01", "Aspirin ADME"], {"weight": 0.691009801444465}], ["HSD17B1", ["TCGA.CM.5863.01", "Phase II - Conjugation of compounds"], {"weight": 0.642771990350423}], ["HSD17B1", ["TCGA.CM.5863.01", "Biological oxidations"], {"weight": 0.8496104193288}], ["HSD17B1", ["TCGA.D5.6920.01", "Biological oxidations"], {"weight": 0.819270053655978}], ["HSD17B1", ["TCGA.D5.6927.01", "RA biosynthesis pathway"], {"weight": 0.823725825449863}], ["HSD17B1", ["TCGA.D5.6927.01", "Glucuronidation"], {"weight": 0.858845734605664}], ["HSD17B1", ["TCGA.D5.6927.01", "Phase II - Conjugation of compounds"], {"weight": 0.836026327969275}], ["HSD17B1", ["TCGA.D5.6927.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.865325786518313}], ["HSD17B1", ["TCGA.D5.6928.01", "Phase II - Conjugation of compounds"], {"weight": 0.9081372446895}], ["HSD17B1", ["TCGA.D5.6928.01", "Glucuronidation"], {"weight": 0.907344540709285}], ["HSD17B1", ["TCGA.F4.6855.01", "Biological oxidations"], {"weight": 0.936355383362641}], ["HSD17B1", ["TCGA.F4.6855.01", "Glucuronidation"], {"weight": 0.878115541747626}], ["HSD17B1", ["TCGA.F4.6855.01", "Drug ADME"], {"weight": 0.778661847136848}], ["HSD17B1", ["TCGA.F4.6855.01", "Phase II - Conjugation of compounds"], {"weight": 0.846845533475632}], ["HSD17B1", ["TCGA.F4.6855.01", "RA biosynthesis pathway"], {"weight": 0.801309409307297}], ["HSD17B1", ["TCGA.F4.6855.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.539098378632396}], ["HSD17B1", ["TCGA.G4.6302.01", "Phase II - Conjugation of compounds"], {"weight": 0.843892981470525}], ["HSD17B1", ["TCGA.G4.6302.01", "Glucuronidation"], {"weight": 0.912681497703331}], ["SULT1E1", ["TCGA.AU.6004.01", "Glucuronidation"], {"weight": 0.883842049290661}], ["SULT1E1", ["TCGA.AU.6004.01", "Aspirin ADME"], {"weight": 0.842773491118205}], ["SULT1E1", ["TCGA.AU.6004.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.644975565152424}], ["ABCC4", ["TCGA.AZ.4615.01", "APAP ADME"], {"weight": 0.889178136748486}], ["ABCC4", ["TCGA.DM.A285.01", "Drug ADME"], {"weight": 0.870728436592621}], ["ABCC4", ["TCGA.DM.A285.01", "APAP ADME"], {"weight": 0.894811505295748}], ["SYN1", ["TCGA.AY.5543.01", "Protein-protein interactions at synapses"], {"weight": 0.906378319709537}], ["PDYN", ["TCGA.AY.5543.01", "G alpha (i) signalling events"], {"weight": 0.931321549049127}], ["PDYN", ["TCGA.CM.4750.01", "GABA receptor activation"], {"weight": 0.899047312628532}], ["PDYN", ["TCGA.CM.4750.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.92120834172801}], ["PDYN", ["TCGA.CM.4750.01", "Integration of energy metabolism"], {"weight": 0.901151728404664}], ["PDYN", ["TCGA.F4.6854.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.902082665131722}], ["PDYN", ["TCGA.F4.6854.01", "GPCR downstream signalling"], {"weight": 0.917748507374056}], ["PDYN", ["TCGA.F4.6854.01", "Signaling by GPCR"], {"weight": 0.909896739205018}], ["ADAMTS1", ["TCGA.D5.6931.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.865209066507472}], ["ADAMTS1", ["TCGA.G4.6297.01", "Diseases of glycosylation"], {"weight": 0.839277312938294}], ["ADAMTS1", ["TCGA.G4.6297.01", "Diseases of metabolism"], {"weight": 0.747806900343811}], ["ADAMTS1", ["TCGA.G4.6297.01", "Defective B3GALTL causes PpS"], {"weight": 0.880904463824973}], ["ADAMTS1", ["TCGA.G4.6297.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.880827091580857}], ["PRKAG1", ["TCGA.AY.5543.01", "Transmission across Chemical Synapses"], {"weight": 0.917556509970975}], ["PRKAG1", ["TCGA.AY.5543.01", "IRS-related events triggered by IGF1R"], {"weight": 0.881535123710522}], ["PRKAG1", ["TCGA.AY.5543.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.881535123710522}], ["PRKAG1", ["TCGA.AY.5543.01", "IGF1R signaling cascade"], {"weight": 0.881535123710522}], ["PRKAG1", ["TCGA.CM.5348.01", "Phase II - Conjugation of compounds"], {"weight": 0.778302382819517}], ["PRKAG1", ["TCGA.CM.5348.01", "Biological oxidations"], {"weight": 0.847880657076989}], ["PAK4", ["TCGA.AY.5543.01", "ECM proteoglycans"], {"weight": 0.922386076560352}], ["PAK4", ["TCGA.D5.5540.01", "Phase 4 - resting membrane potential"], {"weight": 0.86960047534739}], ["PAK4", ["TCGA.DM.A1HA.01", "Extracellular matrix organization"], {"weight": 0.929740366103817}], ["PAK4", ["TCGA.DM.A1HA.01", "ECM proteoglycans"], {"weight": 0.938866967972026}], ["KCND3", ["TCGA.AZ.4682.01", "Neuronal System"], {"weight": 0.926510660094058}], ["KCND3", ["TCGA.AZ.4682.01", "Potassium Channels"], {"weight": 0.947830362365948}], ["KCND3", ["TCGA.AZ.4682.01", "Cardiac conduction"], {"weight": 0.907576809180886}], ["DTX3", ["TCGA.AY.6196.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.871293266008254}], ["DTX3", ["TCGA.AY.6196.01", "Diseases of glycosylation"], {"weight": 0.850758655313151}], ["DTX3", ["TCGA.AY.6196.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.712307342474742}], ["LONP1", ["TCGA.AY.6196.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.755797033174676}], ["LONP1", ["TCGA.AZ.5403.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.543504022333508}], ["ST6GAL1", ["TCGA.AY.6196.01", "O-linked glycosylation"], {"weight": 0.913588604592608}], ["SH2B3", ["TCGA.G4.6320.01", "Receptor-type tyrosine-protein phosphatases"], {"weight": 0.76363597507174}], ["LCMT2", ["TCGA.CM.6170.01", "Drug ADME"], {"weight": 0.891870773547396}], ["DVL2", ["TCGA.AY.6197.01", "Signaling by GPCR"], {"weight": 0.921785499646858}], ["DVL2", ["TCGA.AY.6197.01", "G alpha (s) signalling events"], {"weight": 0.949031470540232}], ["DVL2", ["TCGA.AY.6197.01", "Signaling Pathways"], {"weight": 0.890909491050226}], ["DVL2", ["TCGA.G4.6586.01", "G alpha (s) signalling events"], {"weight": 0.964375801315909}], ["DVL2", ["TCGA.G4.6586.01", "G alpha (q) signalling events"], {"weight": 0.932553273985825}], ["SLC17A6", ["TCGA.DM.A1DA.01", "Neurotransmitter release cycle"], {"weight": 0.897425017673743}], ["SLC17A6", ["TCGA.G4.6309.01", "Transmission across Chemical Synapses"], {"weight": 0.931674543632991}], ["SLC17A6", ["TCGA.G4.6320.01", "Sensory processing of sound"], {"weight": 0.900737950196012}], ["SLC17A6", ["TCGA.G4.6320.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.897957297217777}], ["NRIP1", ["TCGA.D5.6922.01", "Signaling by Retinoic Acid"], {"weight": 0.613916043700847}], ["NRIP1", ["TCGA.F4.6808.01", "SUMOylation of intracellular receptors"], {"weight": 0.756017966102296}], ["KCNC2", ["TCGA.AY.6197.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.914927022782072}], ["KCNC2", ["TCGA.AZ.6598.01", "Regulation of insulin secretion"], {"weight": 0.928305194053597}], ["KCNC2", ["TCGA.CM.5861.01", "Regulation of insulin secretion"], {"weight": 0.933773310651768}], ["KCNC2", ["TCGA.CM.5861.01", "Trafficking of AMPA receptors"], {"weight": 0.935508996489845}], ["KCNC2", ["TCGA.CM.5861.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.935508996489845}], ["NTSR1", ["TCGA.CM.5868.01", "Chemokine receptors bind chemokines"], {"weight": 0.915929437578031}], ["NTSR1", ["TCGA.F4.6463.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.774952446873939}], ["NTSR1", ["TCGA.F4.6805.01", "GPCR ligand binding"], {"weight": 0.900109113250487}], ["NTSR1", ["TCGA.F4.6805.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.857173645145405}], ["HLA-G", ["TCGA.CM.6676.01", "Classical antibody-mediated complement activation"], {"weight": 0.578291717569915}], ["HLA-G", ["TCGA.CM.6676.01", "Regulation of Complement cascade"], {"weight": 0.712502873225547}], ["HLA-G", ["TCGA.CM.6676.01", "DAP12 interactions"], {"weight": 0.896390794226909}], ["HLA-G", ["TCGA.CM.6676.01", "Creation of C4 and C2 activators"], {"weight": 0.562365040882012}], ["GH2", ["TCGA.AZ.6607.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.897610761740745}], ["PRKAR1A", ["TCGA.AY.6197.01", "Chemokine receptors bind chemokines"], {"weight": 0.932490308344012}], ["OR10G2", ["TCGA.F4.6808.01", "GPCR downstream signalling"], {"weight": 0.945177173931567}], ["OR10G2", ["TCGA.F4.6808.01", "Signaling by GPCR"], {"weight": 0.94228702075043}], ["OR10G2", ["TCGA.F4.6808.01", "G alpha (s) signalling events"], {"weight": 0.958713891109097}], ["OR10G2", ["TCGA.F4.6808.01", "G beta:gamma signalling through BTK"], {"weight": 0.903598819293944}], ["OR10G2", ["TCGA.F4.6808.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.906705253342076}], ["OR10G2", ["TCGA.F4.6808.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.91530477488641}], ["OR10G2", ["TCGA.F4.6808.01", "Signal amplification"], {"weight": 0.920782824810992}], ["OR10G2", ["TCGA.F4.6808.01", "GABA B receptor activation"], {"weight": 0.913734396546806}], ["OR10G2", ["TCGA.F4.6808.01", "Activation of GABAB receptors"], {"weight": 0.913734396546806}], ["OR10G2", ["TCGA.F4.6808.01", "G beta:gamma signalling through CDC42"], {"weight": 0.895988945519093}], ["OR10G2", ["TCGA.F4.6808.01", "Presynaptic function of Kainate receptors"], {"weight": 0.902705663414551}], ["OR10G2", ["TCGA.F4.6808.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.91387264052025}], ["OR10G2", ["TCGA.F4.6808.01", "Activation of the phototransduction cascade"], {"weight": 0.821368272518183}], ["RASGRF2", ["TCGA.AZ.6601.01", "Phase 0 - rapid depolarisation"], {"weight": 0.861909976702655}], ["RASGRF2", ["TCGA.AZ.6601.01", "Phase 2 - plateau phase"], {"weight": 0.830959317125555}], ["RSPO3", ["TCGA.DM.A28F.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.732347866257404}], ["RSPO3", ["TCGA.DM.A28F.01", "SHC1 events in ERBB4 signaling"], {"weight": 0.819004561676322}], ["CYP2U1", ["TCGA.AY.6197.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.867302684367445}], ["CYP2U1", ["TCGA.D5.6533.01", "Arachidonic acid metabolism"], {"weight": 0.852057397298041}], ["CYP2U1", ["TCGA.D5.6533.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.744954698540419}], ["CYP2U1", ["TCGA.D5.6533.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.744954698540419}], ["CYP2U1", ["TCGA.D5.6533.01", "Acyl chain remodelling of PE"], {"weight": 0.852004048410678}], ["CYP2U1", ["TCGA.D5.6533.01", "Phase I - Functionalization of compounds"], {"weight": 0.935412674104262}], ["CYP2U1", ["TCGA.D5.6533.01", "Acyl chain remodelling of PS"], {"weight": 0.878206084322088}], ["PRKAB1", ["TCGA.DM.A1HA.01", "Signaling Pathways"], {"weight": 0.942929010511115}], ["AP1M2", ["TCGA.G4.6320.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.723278834753176}], ["ADK", ["TCGA.AY.6197.01", "Platelet homeostasis"], {"weight": 0.906809217406731}], ["GHSR", ["TCGA.DM.A1D9.01", "Chemokine receptors bind chemokines"], {"weight": 0.935187709963047}], ["GHSR", ["TCGA.DM.A1D9.01", "Glucagon-type ligand receptors"], {"weight": 0.929232794780994}], ["GHSR", ["TCGA.DM.A1D9.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.935250189754048}], ["GHSR", ["TCGA.DM.A1D9.01", "G-protein activation"], {"weight": 0.926780673177509}], ["GHSR", ["TCGA.DM.A1D9.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.895278373272784}], ["GHSR", ["TCGA.DM.A1D9.01", "G beta:gamma signalling through CDC42"], {"weight": 0.919682270972936}], ["GHSR", ["TCGA.DM.A1D9.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.890614672336875}], ["GHSR", ["TCGA.DM.A1D9.01", "Thromboxane signalling through TP receptor"], {"weight": 0.893082092785267}], ["GHSR", ["TCGA.DM.A1D9.01", "Activation of the phototransduction cascade"], {"weight": 0.880522604136434}], ["GHSR", ["TCGA.DM.A1D9.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.92014237705476}], ["ACAA1", ["TCGA.D5.6532.01", "Biological oxidations"], {"weight": 0.910570429686621}], ["PPP1R3F", ["TCGA.D5.6536.01", "Phase II - Conjugation of compounds"], {"weight": 0.850086755178399}], ["PPP1R3F", ["TCGA.D5.6536.01", "Glucuronidation"], {"weight": 0.876642110401222}], ["PPP1R3F", ["TCGA.G4.6297.01", "GPCR downstream signalling"], {"weight": 0.911089820581457}], ["PPP1R3F", ["TCGA.G4.6586.01", "Signaling by GPCR"], {"weight": 0.959706250543593}], ["PPP1R3F", ["TCGA.G4.6586.01", "GPCR downstream signalling"], {"weight": 0.959690224448072}], ["PPP1R3F", ["TCGA.G4.6586.01", "G alpha (i) signalling events"], {"weight": 0.961173689664558}], ["PPP1R16B", ["TCGA.CM.5863.01", "Basigin interactions"], {"weight": 0.650844386125854}], ["PPP1R16B", ["TCGA.CM.5864.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.653117266425784}], ["B3GAT1", ["TCGA.AY.6386.01", "Glycosaminoglycan metabolism"], {"weight": 0.850439232423501}], ["AVP", ["TCGA.AY.6386.01", "Transport of small molecules"], {"weight": 0.892920184642289}], ["WNT11", ["TCGA.AY.6386.01", "GPCR ligand binding"], {"weight": 0.941028040179088}], ["WNT11", ["TCGA.AY.6386.01", "Signaling by GPCR"], {"weight": 0.932560926276787}], ["WNT11", ["TCGA.AY.6386.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.910253300669432}], ["WNT11", ["TCGA.D5.6924.01", "Regulation of FZD by ubiquitination"], {"weight": 0.694032249365397}], ["MCM3", ["TCGA.AZ.4323.01", "Ion channel transport"], {"weight": 0.905457406388151}], ["PTHLH", ["TCGA.AZ.4615.01", "GPCR ligand binding"], {"weight": 0.949200053728483}], ["PTHLH", ["TCGA.AZ.4615.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.938317385884918}], ["PTHLH", ["TCGA.CK.5915.01", "GPCR downstream signalling"], {"weight": 0.943869435631541}], ["PTHLH", ["TCGA.CK.5915.01", "G alpha (s) signalling events"], {"weight": 0.960678607007033}], ["PREB", ["TCGA.G4.6588.01", "Unblocking of NMDA receptors, glutamate binding and activation"], {"weight": 0.914864071734967}], ["ARR3", ["TCGA.AZ.4615.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.947708531381227}], ["OR2M3", ["TCGA.AZ.4615.01", "Activation of G protein gated Potassium channels"], {"weight": 0.921857048731189}], ["OR2M3", ["TCGA.DM.A1D7.01", "Signaling by GPCR"], {"weight": 0.928792519562999}], ["OR2M3", ["TCGA.DM.A1D7.01", "GPCR ligand binding"], {"weight": 0.929998211688451}], ["OR2M3", ["TCGA.DM.A1D7.01", "G alpha (i) signalling events"], {"weight": 0.922931524232212}], ["OR2M3", ["TCGA.DM.A1D7.01", "G alpha (q) signalling events"], {"weight": 0.934383998026306}], ["OR2M3", ["TCGA.DM.A1D7.01", "G alpha (s) signalling events"], {"weight": 0.945191916857723}], ["OR2M3", ["TCGA.F4.6855.01", "G alpha (i) signalling events"], {"weight": 0.912550106097011}], ["OR2M3", ["TCGA.F4.6855.01", "GPCR downstream signalling"], {"weight": 0.929049836202947}], ["OR2M3", ["TCGA.F4.6855.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.860141978747012}], ["OR2M3", ["TCGA.F4.6855.01", "Signal amplification"], {"weight": 0.869591981972158}], ["OR2M3", ["TCGA.F4.6855.01", "GPCR ligand binding"], {"weight": 0.901208912649647}], ["OR2M3", ["TCGA.F4.6855.01", "Peptide hormone metabolism"], {"weight": 0.717807406749984}], ["OR2M3", ["TCGA.F4.6855.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.883209349087652}], ["OR2M3", ["TCGA.F4.6855.01", "Glucagon-type ligand receptors"], {"weight": 0.901808130080851}], ["OR51V1", ["TCGA.AZ.4615.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.921857048731189}], ["B4GALT2", ["TCGA.CM.6171.01", "Blood group systems biosynthesis"], {"weight": 0.923484997901315}], ["B4GALT2", ["TCGA.CM.6171.01", "Lewis blood group biosynthesis"], {"weight": 0.916728919216277}], ["BAG4", ["TCGA.D5.6540.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.73185526393812}], ["PIK3R2", ["TCGA.AZ.4615.01", "Phase 0 - rapid depolarisation"], {"weight": 0.919468904400612}], ["PIK3R2", ["TCGA.AZ.4615.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.902257536474661}], ["PIK3R2", ["TCGA.AZ.4615.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.93848503451016}], ["PIK3R2", ["TCGA.AZ.4615.01", "Regulation of insulin secretion"], {"weight": 0.922718950657066}], ["PIK3R2", ["TCGA.G4.6315.01", "Signaling Pathways"], {"weight": 0.897747352138716}], ["PIK3R2", ["TCGA.G4.6315.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.93155197633615}], ["PIK3R2", ["TCGA.G4.6315.01", "Costimulation by the CD28 family"], {"weight": 0.889062601626853}], ["PIK3R2", ["TCGA.G4.6315.01", "Cell surface interactions at the vascular wall"], {"weight": 0.751619592915802}], ["PIK3R2", ["TCGA.G4.6315.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.93155197633615}], ["PIK3R2", ["TCGA.G4.6315.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.913595439956722}], ["PIK3R2", ["TCGA.G4.6315.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.931382542861099}], ["PIK3R2", ["TCGA.G4.6315.01", "TCR signaling"], {"weight": 0.93733571609799}], ["PIK3R2", ["TCGA.G4.6315.01", "IRS-related events triggered by IGF1R"], {"weight": 0.856786522850978}], ["TCF3", ["TCGA.AZ.6607.01", "Drug ADME"], {"weight": 0.912499064357179}], ["SGK1", ["TCGA.CK.4948.01", "Phase II - Conjugation of compounds"], {"weight": 0.78225909355575}], ["SGK1", ["TCGA.CK.4948.01", "Glucuronidation"], {"weight": 0.853406842187062}], ["SSTR5", ["TCGA.AZ.5407.01", "GPCR ligand binding"], {"weight": 0.936724633352919}], ["SSTR5", ["TCGA.AZ.5407.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.943516880090044}], ["SSTR5", ["TCGA.AZ.5407.01", "Peptide ligand-binding receptors"], {"weight": 0.943872631412424}], ["MED17", ["TCGA.F4.6460.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.716575975407245}], ["AKR1C3", ["TCGA.AZ.4615.01", "Phase II - Conjugation of compounds"], {"weight": 0.891939380227519}], ["AKR1C3", ["TCGA.AZ.4615.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.841870051967964}], ["AKR1C3", ["TCGA.AZ.4615.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.760418349520638}], ["CX3CL1", ["TCGA.AZ.4615.01", "Peptide ligand-binding receptors"], {"weight": 0.946337581726693}], ["CX3CL1", ["TCGA.AZ.4615.01", "Antimicrobial peptides"], {"weight": 0.695612590225207}], ["CX3CL1", ["TCGA.AZ.4615.01", "Chemokine receptors bind chemokines"], {"weight": 0.909256553841714}], ["CX3CL1", ["TCGA.DM.A1D6.01", "Signaling by GPCR"], {"weight": 0.953084228369424}], ["CX3CL1", ["TCGA.DM.A1D6.01", "GPCR downstream signalling"], {"weight": 0.954779432434318}], ["CX3CL1", ["TCGA.DM.A1D6.01", "Chemokine receptors bind chemokines"], {"weight": 0.951124562659225}], ["CX3CL1", ["TCGA.DM.A1D6.01", "G alpha (q) signalling events"], {"weight": 0.950007768220656}], ["CX3CL1", ["TCGA.DM.A1D6.01", "Interleukin-10 signaling"], {"weight": 0.958609402641037}], ["CX3CL1", ["TCGA.DM.A1D6.01", "Binding and entry of HIV virion"], {"weight": 0.864071979514245}], ["CX3CL1", ["TCGA.DM.A1D6.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.792962780289082}], ["CX3CL1", ["TCGA.G4.6315.01", "G alpha (i) signalling events"], {"weight": 0.910358206327378}], ["CX3CL1", ["TCGA.G4.6315.01", "Chemokine receptors bind chemokines"], {"weight": 0.922589327733506}], ["CX3CL1", ["TCGA.G4.6315.01", "Interleukin-10 signaling"], {"weight": 0.936846625203305}], ["CX3CL1", ["TCGA.G4.6315.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.93905757320175}], ["CX3CL1", ["TCGA.G4.6315.01", "Peptide ligand-binding receptors"], {"weight": 0.938052785521265}], ["RHOQ", ["TCGA.AZ.4615.01", "Signaling by GPCR"], {"weight": 0.944260682354122}], ["RHOQ", ["TCGA.AZ.4615.01", "GPCR downstream signalling"], {"weight": 0.947809640940034}], ["STMN2", ["TCGA.AZ.4615.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.914133878128233}], ["PEX5L", ["TCGA.G4.6626.01", "Unwinding of DNA"], {"weight": 0.792886803913037}], ["PEX5L", ["TCGA.G4.6626.01", "Transcription of E2F targets under negative control by DREAM complex"], {"weight": 0.880104244984611}], ["PEX5L", ["TCGA.G4.6626.01", "G0 and Early G1"], {"weight": 0.891073751075644}], ["x", ["TCGA.AZ.4681.01", "Binding and entry of HIV virion"], {"weight": 0.808950426412199}], ["x", ["TCGA.AZ.4681.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.885076605105382}], ["x", ["TCGA.AZ.4681.01", "Unwinding of DNA"], {"weight": 0.838559484970467}], ["x", ["TCGA.AZ.4681.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.910513537857931}], ["x", ["TCGA.AZ.4681.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.907423404876472}], ["x", ["TCGA.AZ.4681.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.888561234581935}], ["x", ["TCGA.AZ.4681.01", "Leishmania parasite growth and survival"], {"weight": 0.888561234581935}], ["x", ["TCGA.AZ.4681.01", "G-protein beta:gamma signalling"], {"weight": 0.918597349836982}], ["x", ["TCGA.AZ.4681.01", "DNA strand elongation"], {"weight": 0.886466706360728}], ["x", ["TCGA.AZ.4681.01", "Cellular response to starvation"], {"weight": 0.907999304362668}], ["x", ["TCGA.AZ.4681.01", "Azathioprine ADME"], {"weight": 0.76758726858327}], ["x", ["TCGA.AZ.4681.01", "Viral mRNA Translation"], {"weight": 0.912701067376955}], ["x", ["TCGA.AZ.4681.01", "Eukaryotic Translation Elongation"], {"weight": 0.898598829965745}], ["x", ["TCGA.AZ.4681.01", "Eukaryotic Translation Termination"], {"weight": 0.897777999045885}], ["x", ["TCGA.AZ.4681.01", "Peptide chain elongation"], {"weight": 0.912701067376955}], ["x", ["TCGA.AZ.4681.01", "Formation of a pool of free 40S subunits"], {"weight": 0.916749703611186}], ["x", ["TCGA.AZ.4681.01", "G beta:gamma signalling through CDC42"], {"weight": 0.854740626448252}], ["x", ["TCGA.AZ.4681.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.896519220468514}], ["x", ["TCGA.AZ.4681.01", "rRNA processing"], {"weight": 0.908368096100807}], ["x", ["TCGA.AZ.4681.01", "Selenocysteine synthesis"], {"weight": 0.912701067376955}], ["x", ["TCGA.AZ.4681.01", "Regulation of insulin secretion"], {"weight": 0.913072332536733}], ["x", ["TCGA.AZ.4681.01", "G alpha (z) signalling events"], {"weight": 0.887690571338944}], ["x", ["TCGA.AZ.4681.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.826786674705249}], ["x", ["TCGA.AZ.4681.01", "rRNA processing in the nucleus and cytosol"], {"weight": 0.924852757925055}], ["x", ["TCGA.AZ.4681.01", "Immune System"], {"weight": 0.905796605513371}], ["x", ["TCGA.AZ.4681.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.798943794859881}], ["x", ["TCGA.AZ.4681.01", "Post-chaperonin tubulin folding pathway"], {"weight": 0.838805946174866}], ["x", ["TCGA.AZ.4681.01", "Major pathway of rRNA processing in the nucleolus and cytosol"], {"weight": 0.934272649338135}], ["x", ["TCGA.AZ.4681.01", "Influenza Viral RNA Transcription and Replication"], {"weight": 0.919531785516477}], ["x", ["TCGA.AZ.4681.01", "Integration of energy metabolism"], {"weight": 0.931690674073726}], ["x", ["TCGA.AZ.4681.01", "Leishmania infection"], {"weight": 0.886688106121637}], ["x", ["TCGA.AZ.4681.01", "Parasitic Infection Pathways"], {"weight": 0.886688106121637}], ["x", ["TCGA.AZ.4681.01", "Signal amplification"], {"weight": 0.869612745075304}], ["x", ["TCGA.AZ.4681.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.870831832009804}], ["x", ["TCGA.AZ.4681.01", "Selenoamino acid metabolism"], {"weight": 0.9022233385137}], ["x", ["TCGA.AZ.4681.01", "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"], {"weight": 0.912701067376955}], ["x", ["TCGA.AZ.4681.01", "Response of EIF2AK4 (GCN2) to amino acid deficiency"], {"weight": 0.90238589294543}], ["x", ["TCGA.AZ.4681.01", "L13a-mediated translational silencing of Ceruloplasmin expression"], {"weight": 0.927948568009263}], ["x", ["TCGA.AZ.4681.01", "GTP hydrolysis and joining of the 60S ribosomal subunit"], {"weight": 0.916749703611186}], ["x", ["TCGA.AZ.4681.01", "GPER1 signaling"], {"weight": 0.902105602595483}], ["x", ["TCGA.AZ.4681.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.902105602595483}], ["x", ["TCGA.AZ.4681.01", "G alpha (i) signalling events"], {"weight": 0.934326257222425}], ["x", ["TCGA.AZ.4681.01", "Influenza Infection"], {"weight": 0.920503769159575}], ["x", ["TCGA.AZ.4681.01", "Ribavirin ADME"], {"weight": 0.686894063982581}], ["x", ["TCGA.AZ.4681.01", "Eukaryotic Translation Initiation"], {"weight": 0.90361810389096}], ["x", ["TCGA.AZ.4681.01", "Cap-dependent Translation Initiation"], {"weight": 0.90361810389096}], ["x", ["TCGA.AZ.4681.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.893276095781017}], ["x", ["TCGA.AZ.4681.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.893276095781017}], ["x", ["TCGA.AZ.4681.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.897589103991812}], ["x", ["TCGA.AZ.4681.01", "Aquaporin-mediated transport"], {"weight": 0.897589103991812}], ["x", ["TCGA.AZ.4681.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.86735428719483}], ["x", ["TCGA.AZ.4681.01", "Protein folding"], {"weight": 0.912556254571702}], ["x", ["TCGA.AZ.4681.01", "Cell surface interactions at the vascular wall"], {"weight": 0.799317399639485}], ["x", ["TCGA.AZ.4681.01", "Telomere Maintenance"], {"weight": 0.870700918318038}], ["x", ["TCGA.AZ.4681.01", "Nonsense-Mediated Decay (NMD)"], {"weight": 0.912457833476053}], ["x", ["TCGA.AZ.4681.01", "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"], {"weight": 0.912457833476053}], ["x", ["TCGA.AZ.4681.01", "Nervous system development"], {"weight": 0.911049595516924}], ["x", ["TCGA.AZ.4681.01", "Diseases of Immune System"], {"weight": 0.881259823423914}], ["x", ["TCGA.AZ.4681.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.881259823423914}], ["x", ["TCGA.AZ.4681.01", "Chromosome Maintenance"], {"weight": 0.882239603416473}], ["x", ["TCGA.AZ.4681.01", "Platelet homeostasis"], {"weight": 0.866167306696729}], ["x", ["TCGA.AZ.4681.01", "Extra-nuclear estrogen signaling"], {"weight": 0.914037922921}], ["x", ["TCGA.AZ.4681.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.862168434967704}], ["x", ["TCGA.AZ.4681.01", "Chemokine receptors bind chemokines"], {"weight": 0.911859994811885}], ["x", ["TCGA.AZ.4681.01", "SARS-CoV-2 modulates host translation machinery"], {"weight": 0.842492476124659}], ["x", ["TCGA.AZ.4681.01", "CD28 dependent PI3K/Akt signaling"], {"weight": 0.857796712672805}], ["x", ["TCGA.AZ.4681.01", "Signaling Pathways"], {"weight": 0.928863388051056}], ["x", ["TCGA.AZ.4681.01", "SRP-dependent cotranslational protein targeting to membrane"], {"weight": 0.912701067376955}], ["x", ["TCGA.AZ.4681.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.874294701915894}], ["x", ["TCGA.AZ.4681.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.819800462222553}], ["x", ["TCGA.AZ.4681.01", "Translesion synthesis by POLK"], {"weight": 0.807547478339125}], ["x", ["TCGA.AZ.4681.01", "Translesion synthesis by POLI"], {"weight": 0.807547478339125}], ["x", ["TCGA.AZ.4681.01", "EGR2 and SOX10-mediated initiation of Schwann cell myelination"], {"weight": 0.813614675411215}], ["x", ["TCGA.AZ.4681.01", "Opioid Signalling"], {"weight": 0.874378480303583}], ["x", ["TCGA.AZ.4681.01", "B Cell Activation"], {"weight": 0.924898117935135}], ["x", ["TCGA.AZ.4681.01", "APOBEC3G mediated resistance to HIV-1 infection"], {"weight": 0.701071873796892}], ["x", ["TCGA.AZ.4681.01", "CD22 mediated BCR regulation"], {"weight": 0.671212434054145}], ["x", ["TCGA.AZ.4681.01", "Early Phase of HIV Life Cycle"], {"weight": 0.739773019967334}], ["x", ["TCGA.AZ.4681.01", "Activation of the pre-replicative complex"], {"weight": 0.849572699608636}], ["x", ["TCGA.AZ.4681.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.748269148448164}], ["x", ["TCGA.AZ.4681.01", "Heme degradation"], {"weight": 0.807592645077542}], ["x", ["TCGA.AZ.4681.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.751853980841921}], ["x", ["TCGA.AZ.4681.01", "Regulation of Complement cascade"], {"weight": 0.812281092989582}], ["x", ["TCGA.AZ.4681.01", "Chaperonin-mediated protein folding"], {"weight": 0.914421546101147}], ["x", ["TCGA.CA.6717.01", "TCOF1"], {"weight": 0.798345147107298}], ["x", ["TCGA.CA.6717.01", "NSRP1"], {"weight": 0.798872822299746}], ["x", ["TCGA.CA.6717.01", "OPA1"], {"weight": 0.803631111823524}], ["x", ["TCGA.CA.6717.01", "ITGA8"], {"weight": 0.804549953813067}], ["x", ["TCGA.CA.6717.01", "ITGA1"], {"weight": 0.804377992855189}], ["x", ["TCGA.CA.6717.01", "ITGA2"], {"weight": 0.803431225352987}], ["x", ["TCGA.CA.6717.01", "ITGA6"], {"weight": 0.805063704764925}], ["x", ["TCGA.CA.6717.01", "ITGA7"], {"weight": 0.804603634166145}], ["x", ["TCGA.CA.6717.01", "BCL2A1"], {"weight": 0.803661774684076}], ["x", ["TCGA.CA.6717.01", "ITGAV"], {"weight": 0.809588439772892}], ["x", ["TCGA.CA.6717.01", "ITGAL"], {"weight": 0.804421957725029}], ["x", ["TCGA.CA.6717.01", "ITGAD"], {"weight": 0.804487629804939}], ["x", ["TCGA.CA.6717.01", "ITGAE"], {"weight": 0.80403348225634}], ["x", ["TCGA.CA.6717.01", "IGF2R"], {"weight": 0.80322344829617}], ["x", ["TCGA.CA.6717.01", "CPEB4"], {"weight": 0.798444058227765}], ["x", ["TCGA.CA.6717.01", "CPEB3"], {"weight": 0.798171086316971}], ["x", ["TCGA.CA.6717.01", "CPEB2"], {"weight": 0.798508277355604}], ["x", ["TCGA.CA.6717.01", "STAT5B"], {"weight": 0.804209315178295}], ["x", ["TCGA.CA.6717.01", "CFI"], {"weight": 0.803915917897541}], ["x", ["TCGA.CA.6717.01", "CFP"], {"weight": 0.804114173982192}], ["x", ["TCGA.CA.6717.01", "ZNF479"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "NLGN3"], {"weight": 0.798583036552331}], ["x", ["TCGA.CA.6717.01", "NUP107"], {"weight": 0.803274992854276}], ["x", ["TCGA.CA.6717.01", "ZNF471"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "NR1D2"], {"weight": 0.804384157249407}], ["x", ["TCGA.CA.6717.01", "DLGAP3"], {"weight": 0.798456432291028}], ["x", ["TCGA.CA.6717.01", "PTPN13"], {"weight": 0.803962518795335}], ["x", ["TCGA.CA.6717.01", "PTPN12"], {"weight": 0.798404031336073}], ["x", ["TCGA.CA.6717.01", "CDK7"], {"weight": 0.803078336713761}], ["x", ["TCGA.CA.6717.01", "OR52N2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "HOXA10"], {"weight": 0.793421302112718}], ["x", ["TCGA.CA.6717.01", "GALNTL5"], {"weight": 0.804406604612198}], ["x", ["TCGA.CA.6717.01", "GALNTL6"], {"weight": 0.804406604612198}], ["x", ["TCGA.CA.6717.01", "GCNT4"], {"weight": 0.803769920256625}], ["x", ["TCGA.CA.6717.01", "PDK2"], {"weight": 0.803901937814658}], ["x", ["TCGA.CA.6717.01", "PDK4"], {"weight": 0.803991389514508}], ["x", ["TCGA.CA.6717.01", "LNPEP"], {"weight": 0.803572812047356}], ["x", ["TCGA.CA.6717.01", "SEC61A1"], {"weight": 0.809150050695081}], ["x", ["TCGA.CA.6717.01", "PRKCB"], {"weight": 0.809087599984729}], ["x", ["TCGA.CA.6717.01", "RAB3GAP2"], {"weight": 0.803647417571351}], ["x", ["TCGA.CA.6717.01", "LTN1"], {"weight": 0.803415582427769}], ["x", ["TCGA.CA.6717.01", "COL14A1"], {"weight": 0.802887543064202}], ["x", ["TCGA.CA.6717.01", "SNAP91"], {"weight": 0.803324306242489}], ["x", ["TCGA.CA.6717.01", "TMEFF1"], {"weight": 0.79915704709226}], ["x", ["TCGA.CA.6717.01", "ZNF300"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "PPP3CC"], {"weight": 0.803873168154802}], ["x", ["TCGA.CA.6717.01", "ADRA2A"], {"weight": 0.808984177373752}], ["x", ["TCGA.CA.6717.01", "SYT1"], {"weight": 0.803250679187618}], ["x", ["TCGA.CA.6717.01", "NBN"], {"weight": 0.803813114000133}], ["x", ["TCGA.CA.6717.01", "FUBP1"], {"weight": 0.803732812571578}], ["x", ["TCGA.CA.6717.01", "BRIP1"], {"weight": 0.803518406124476}], ["x", ["TCGA.CA.6717.01", "PDE11A"], {"weight": 0.809333490791982}], ["x", ["TCGA.CA.6717.01", "TTC28"], {"weight": 0.803927508864625}], ["x", ["TCGA.CA.6717.01", "OBSCN"], {"weight": 0.798521448588107}], ["x", ["TCGA.CA.6717.01", "SORBS3"], {"weight": 0.804100553449377}], ["x", ["TCGA.CA.6717.01", "BCLAF1"], {"weight": 0.804126312831337}], ["x", ["TCGA.CA.6717.01", "CCP110"], {"weight": 0.803300743369676}], ["x", ["TCGA.CA.6717.01", "EPB41L1"], {"weight": 0.803361877507471}], ["x", ["TCGA.CA.6717.01", "EPB41L3"], {"weight": 0.798553145258298}], ["x", ["TCGA.CA.6717.01", "EPB41L2"], {"weight": 0.798553145258298}], ["x", ["TCGA.CA.6717.01", "EPB41L5"], {"weight": 0.798640041699399}], ["x", ["TCGA.CA.6717.01", "ACSS3"], {"weight": 0.804152369367218}], ["x", ["TCGA.CA.6717.01", "ACSS2"], {"weight": 0.809485929785481}], ["x", ["TCGA.CA.6717.01", "KIDINS220"], {"weight": 0.804335931847733}], ["x", ["TCGA.CA.6717.01", "UTY"], {"weight": 0.798674778776448}], ["x", ["TCGA.CA.6717.01", "PACRG"], {"weight": 0.79772834531717}], ["x", ["TCGA.CA.6717.01", "SAFB"], {"weight": 0.798270440024986}], ["x", ["TCGA.CA.6717.01", "NGLY1"], {"weight": 0.803357154067291}], ["x", ["TCGA.CA.6717.01", "LMX1B"], {"weight": 0.798484939946916}], ["x", ["TCGA.CA.6717.01", "ADAM15"], {"weight": 0.804245615138551}], ["x", ["TCGA.CA.6717.01", "ADAM17"], {"weight": 0.803522129427712}], ["x", ["TCGA.CA.6717.01", "G3BP1"], {"weight": 0.803967888613496}], ["x", ["TCGA.CA.6717.01", "SHANK1"], {"weight": 0.798535532612413}], ["x", ["TCGA.CA.6717.01", "PCSK1"], {"weight": 0.804141750849082}], ["x", ["TCGA.CA.6717.01", "PCSK5"], {"weight": 0.803987546796777}], ["x", ["TCGA.CA.6717.01", "DPYSL4"], {"weight": 0.804174506699033}], ["x", ["TCGA.CA.6717.01", "OR2T33"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "LAMB1"], {"weight": 0.804331106738522}], ["x", ["TCGA.CA.6717.01", "LAMB2"], {"weight": 0.804343491305364}], ["x", ["TCGA.CA.6717.01", "CYSLTR2"], {"weight": 0.803257619320271}], ["x", ["TCGA.CA.6717.01", "LAMB4"], {"weight": 0.804578316172346}], ["x", ["TCGA.CA.6717.01", "RSRC1"], {"weight": 0.803627663727357}], ["x", ["TCGA.CA.6717.01", "ARHGAP40"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "NLGN1"], {"weight": 0.798583036552331}], ["x", ["TCGA.CA.6717.01", "GPRC6A"], {"weight": 0.803246972487983}], ["x", ["TCGA.CA.6717.01", "ABI1"], {"weight": 0.803934557723702}], ["x", ["TCGA.CA.6717.01", "AOC3"], {"weight": 0.809850153690124}], ["x", ["TCGA.CA.6717.01", "CLINT1"], {"weight": 0.803344662871235}], ["x", ["TCGA.CA.6717.01", "ADCY4"], {"weight": 0.81452931820469}], ["x", ["TCGA.CA.6717.01", "ADCY1"], {"weight": 0.796865519507962}], ["x", ["TCGA.CA.6717.01", "ADCY8"], {"weight": 0.814524311088062}], ["x", ["TCGA.CA.6717.01", "DDI1"], {"weight": 0.803028539486758}], ["x", ["TCGA.CA.6717.01", "XRCC5"], {"weight": 0.803519641157592}], ["x", ["TCGA.CA.6717.01", "MEIS1"], {"weight": 0.803443806535979}], ["x", ["TCGA.CA.6717.01", "CTLA4"], {"weight": 0.809546327099939}], ["x", ["TCGA.CA.6717.01", "KCNA4"], {"weight": 0.793060006853577}], ["x", ["TCGA.CA.6717.01", "KCNA2"], {"weight": 0.793060006853577}], ["x", ["TCGA.CA.6717.01", "KCNA3"], {"weight": 0.793060006853577}], ["x", ["TCGA.CA.6717.01", "ACACB"], {"weight": 0.804556090462631}], ["x", ["TCGA.CA.6717.01", "ZDHHC9"], {"weight": 0.804448861969652}], ["x", ["TCGA.CA.6717.01", "OR8J3"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR8J1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "BPNT1"], {"weight": 0.80994037114716}], ["x", ["TCGA.CA.6717.01", "SERPINB3"], {"weight": 0.803942920387425}], ["x", ["TCGA.CA.6717.01", "SERPINB4"], {"weight": 0.798470226517866}], ["x", ["TCGA.CA.6717.01", "ELP2"], {"weight": 0.797957920780478}], ["x", ["TCGA.CA.6717.01", "ZNF682"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "HFE"], {"weight": 0.79831633863108}], ["x", ["TCGA.CA.6717.01", "CSNK1A1L"], {"weight": 0.803525968489095}], ["x", ["TCGA.CA.6717.01", "RIN3"], {"weight": 0.798974135836121}], ["x", ["TCGA.CA.6717.01", "RIN2"], {"weight": 0.804287668713444}], ["x", ["TCGA.CA.6717.01", "RIPK1"], {"weight": 0.809759872272933}], ["x", ["TCGA.CA.6717.01", "PDCL"], {"weight": 0.803564993974824}], ["x", ["TCGA.CA.6717.01", "ZNF416"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ACTN1"], {"weight": 0.804407177323276}], ["x", ["TCGA.CA.6717.01", "ABLIM3"], {"weight": 0.809723908940132}], ["x", ["TCGA.CA.6717.01", "TTC30A"], {"weight": 0.798410228210709}], ["x", ["TCGA.CA.6717.01", "TTC30B"], {"weight": 0.798410228210709}], ["x", ["TCGA.CA.6717.01", "TMPRSS6"], {"weight": 0.804335931847733}], ["x", ["TCGA.CA.6717.01", "SIPA1L1"], {"weight": 0.804230234526628}], ["x", ["TCGA.CA.6717.01", "QKI"], {"weight": 0.803832334925988}], ["x", ["TCGA.CA.6717.01", "SLC17A8"], {"weight": 0.798339940468374}], ["x", ["TCGA.CA.6717.01", "EAF2"], {"weight": 0.798314775791882}], ["x", ["TCGA.CA.6717.01", "SYNCRIP"], {"weight": 0.803421972658188}], ["x", ["TCGA.CA.6717.01", "TYR"], {"weight": 0.809678290417974}], ["x", ["TCGA.CA.6717.01", "ZNF202"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SLU7"], {"weight": 0.803136873595055}], ["x", ["TCGA.CA.6717.01", "SLK"], {"weight": 0.798607085916439}], ["x", ["TCGA.CA.6717.01", "NOTCH2"], {"weight": 0.809809558615876}], ["x", ["TCGA.CA.6717.01", "ZNF655"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "TCTEX1D2"], {"weight": 0.798410228210709}], ["x", ["TCGA.CA.6717.01", "RAPGEF5"], {"weight": 0.80400689177528}], ["x", ["TCGA.CA.6717.01", "RAPGEF6"], {"weight": 0.79875602722645}], ["x", ["TCGA.CA.6717.01", "RAPGEF2"], {"weight": 0.803880571111329}], ["x", ["TCGA.CA.6717.01", "GLDC"], {"weight": 0.809574513370041}], ["x", ["TCGA.CA.6717.01", "MARK4"], {"weight": 0.803319687944796}], ["x", ["TCGA.CA.6717.01", "MARK1"], {"weight": 0.793496578496182}], ["x", ["TCGA.CA.6717.01", "MARK3"], {"weight": 0.804547474088374}], ["x", ["TCGA.CA.6717.01", "WDR19"], {"weight": 0.80334342462426}], ["x", ["TCGA.CA.6717.01", "APEH"], {"weight": 0.804269919725035}], ["x", ["TCGA.CA.6717.01", "DEFB136"], {"weight": 0.804371281536558}], ["x", ["TCGA.CA.6717.01", "RIMKLB"], {"weight": 0.80971694858249}], ["x", ["TCGA.CA.6717.01", "POMT1"], {"weight": 0.799126096634313}], ["x", ["TCGA.CA.6717.01", "POMT2"], {"weight": 0.799126096634313}], ["x", ["TCGA.CA.6717.01", "EDC3"], {"weight": 0.798508841168302}], ["x", ["TCGA.CA.6717.01", "ANAPC1"], {"weight": 0.803113600191857}], ["x", ["TCGA.CA.6717.01", "ANAPC4"], {"weight": 0.803114379242516}], ["x", ["TCGA.CA.6717.01", "PSMD13"], {"weight": 0.803039622282431}], ["x", ["TCGA.CA.6717.01", "EXOSC10"], {"weight": 0.80925119024365}], ["x", ["TCGA.CA.6717.01", "MYLK4"], {"weight": 0.803557235283886}], ["x", ["TCGA.CA.6717.01", "FYCO1"], {"weight": 0.798281060542184}], ["x", ["TCGA.CA.6717.01", "MND1"], {"weight": 0.798321502983513}], ["x", ["TCGA.CA.6717.01", "RAB27A"], {"weight": 0.798161281797547}], ["x", ["TCGA.CA.6717.01", "ZNF770"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "TRIM6"], {"weight": 0.798681659248344}], ["x", ["TCGA.CA.6717.01", "DPH2"], {"weight": 0.804554287727624}], ["x", ["TCGA.CA.6717.01", "PAH"], {"weight": 0.804636535823157}], ["x", ["TCGA.CA.6717.01", "DCN"], {"weight": 0.805154476601886}], ["x", ["TCGA.CA.6717.01", "FLRT3"], {"weight": 0.798423397171212}], ["x", ["TCGA.CA.6717.01", "HSPA4L"], {"weight": 0.798745378913057}], ["x", ["TCGA.CA.6717.01", "SEL1L2"], {"weight": 0.798204094404193}], ["x", ["TCGA.CA.6717.01", "RGS5"], {"weight": 0.804107300753569}], ["x", ["TCGA.CA.6717.01", "CD28"], {"weight": 0.809399338890003}], ["x", ["TCGA.CA.6717.01", "FAT1"], {"weight": 0.803938405484003}], ["x", ["TCGA.CA.6717.01", "COL27A1"], {"weight": 0.79928058394637}], ["x", ["TCGA.CA.6717.01", "HIST1H1D"], {"weight": 0.803572322984226}], ["x", ["TCGA.CA.6717.01", "HIST1H1E"], {"weight": 0.804027583661889}], ["x", ["TCGA.CA.6717.01", "CAB39"], {"weight": 0.803876937768546}], ["x", ["TCGA.CA.6717.01", "BCL2L14"], {"weight": 0.804048248943346}], ["x", ["TCGA.CA.6717.01", "BLOC1S1"], {"weight": 0.803417684797425}], ["x", ["TCGA.CA.6717.01", "NPC1"], {"weight": 0.804448987226865}], ["x", ["TCGA.CA.6717.01", "NCOA2"], {"weight": 0.819930006588606}], ["x", ["TCGA.CA.6717.01", "NCOA3"], {"weight": 0.809035295010467}], ["x", ["TCGA.CA.6717.01", "NCOA1"], {"weight": 0.821178504567614}], ["x", ["TCGA.CA.6717.01", "NCOA6"], {"weight": 0.820029348973942}], ["x", ["TCGA.CA.6717.01", "SREK1"], {"weight": 0.803571488490386}], ["x", ["TCGA.CA.6717.01", "ZNF490"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "NLGN4Y"], {"weight": 0.798583036552331}], ["x", ["TCGA.CA.6717.01", "FBN2"], {"weight": 0.80465853512381}], ["x", ["TCGA.CA.6717.01", "FBN1"], {"weight": 0.804677586155766}], ["x", ["TCGA.CA.6717.01", "PDE1C"], {"weight": 0.809329233730896}], ["x", ["TCGA.CA.6717.01", "TRAIP"], {"weight": 0.803418919260188}], ["x", ["TCGA.CA.6717.01", "NID2"], {"weight": 0.804230234526628}], ["x", ["TCGA.CA.6717.01", "NID1"], {"weight": 0.804517062914537}], ["x", ["TCGA.CA.6717.01", "FCER1A"], {"weight": 0.803819587295256}], ["x", ["TCGA.CA.6717.01", "OR4D1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "FANCM"], {"weight": 0.802956160848394}], ["x", ["TCGA.CA.6717.01", "FANCL"], {"weight": 0.802975138317434}], ["x", ["TCGA.CA.6717.01", "FANCI"], {"weight": 0.803322266600432}], ["x", ["TCGA.CA.6717.01", "F13B"], {"weight": 0.798777553280377}], ["x", ["TCGA.CA.6717.01", "IGLL1"], {"weight": 0.80432685829647}], ["x", ["TCGA.CA.6717.01", "HSPD1"], {"weight": 0.803976938380668}], ["x", ["TCGA.CA.6717.01", "WWP1"], {"weight": 0.803392214463271}], ["x", ["TCGA.CA.6717.01", "CTSC"], {"weight": 0.803341551595028}], ["x", ["TCGA.CA.6717.01", "CTSG"], {"weight": 0.804791070857421}], ["x", ["TCGA.CA.6717.01", "CTSS"], {"weight": 0.80365558307957}], ["x", ["TCGA.CA.6717.01", "EMD"], {"weight": 0.803770134280908}], ["x", ["TCGA.CA.6717.01", "AFF4"], {"weight": 0.798293572063716}], ["x", ["TCGA.CA.6717.01", "AFF1"], {"weight": 0.798314775791882}], ["x", ["TCGA.CA.6717.01", "PDPR"], {"weight": 0.803917465002547}], ["x", ["TCGA.CA.6717.01", "PDP2"], {"weight": 0.803951715139707}], ["x", ["TCGA.CA.6717.01", "UBA5"], {"weight": 0.803415582427769}], ["x", ["TCGA.CA.6717.01", "NRCAM"], {"weight": 0.79836779697038}], ["x", ["TCGA.CA.6717.01", "LYZ"], {"weight": 0.80395736591984}], ["x", ["TCGA.CA.6717.01", "IP6K3"], {"weight": 0.809757379901697}], ["x", ["TCGA.CA.6717.01", "NFKBIE"], {"weight": 0.802934172868253}], ["x", ["TCGA.CA.6717.01", "NR5A2"], {"weight": 0.803783651487799}], ["x", ["TCGA.CA.6717.01", "VAV3"], {"weight": 0.803618259028097}], ["x", ["TCGA.CA.6717.01", "FOXN2"], {"weight": 0.799411158778511}], ["x", ["TCGA.CA.6717.01", "PYGO1"], {"weight": 0.798553607091665}], ["x", ["TCGA.CA.6717.01", "FERMT2"], {"weight": 0.803709273224857}], ["x", ["TCGA.CA.6717.01", "FERMT3"], {"weight": 0.804544897079758}], ["x", ["TCGA.CA.6717.01", "USP16"], {"weight": 0.80331747969249}], ["x", ["TCGA.CA.6717.01", "USP19"], {"weight": 0.804114360016285}], ["x", ["TCGA.CA.6717.01", "KLC3"], {"weight": 0.803398507039244}], ["x", ["TCGA.CA.6717.01", "ZNF519"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF510"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF20"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SI"], {"weight": 0.804105008137971}], ["x", ["TCGA.CA.6717.01", "NRP2"], {"weight": 0.798311969065922}], ["x", ["TCGA.CA.6717.01", "SPHKAP"], {"weight": 0.804612837465118}], ["x", ["TCGA.CA.6717.01", "PROS1"], {"weight": 0.80455379589114}], ["x", ["TCGA.CA.6717.01", "TNKS2"], {"weight": 0.802956160848394}], ["x", ["TCGA.CA.6717.01", "PON1"], {"weight": 0.810219001100283}], ["x", ["TCGA.CA.6717.01", "ROCK2"], {"weight": 0.803665023723436}], ["x", ["TCGA.CA.6717.01", "DOCK8"], {"weight": 0.804213434561373}], ["x", ["TCGA.CA.6717.01", "GRIA2"], {"weight": 0.803868637167255}], ["x", ["TCGA.CA.6717.01", "DOCK1"], {"weight": 0.803860954520296}], ["x", ["TCGA.CA.6717.01", "DOCK5"], {"weight": 0.804018689539341}], ["x", ["TCGA.CA.6717.01", "ZNF750"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF665"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ATF6B"], {"weight": 0.803711771669443}], ["x", ["TCGA.CA.6717.01", "PIR"], {"weight": 0.803097824536244}], ["x", ["TCGA.CA.6717.01", "PHAX"], {"weight": 0.803282006532758}], ["x", ["TCGA.CA.6717.01", "EPHA7"], {"weight": 0.80403654974003}], ["x", ["TCGA.CA.6717.01", "EPHA5"], {"weight": 0.80403654974003}], ["x", ["TCGA.CA.6717.01", "COL9A2"], {"weight": 0.799647069853913}], ["x", ["TCGA.CA.6717.01", "ARL6"], {"weight": 0.803837819067353}], ["x", ["TCGA.CA.6717.01", "TSR1"], {"weight": 0.803329963734555}], ["x", ["TCGA.CA.6717.01", "CYP4A11"], {"weight": 0.809163853638894}], ["x", ["TCGA.CA.6717.01", "SLC17A6"], {"weight": 0.798339940468374}], ["x", ["TCGA.CA.6717.01", "ARL13B"], {"weight": 0.804122520568005}], ["x", ["TCGA.CA.6717.01", "GFM1"], {"weight": 0.803475361276484}], ["x", ["TCGA.CA.6717.01", "DCTN1"], {"weight": 0.803217621047232}], ["x", ["TCGA.CA.6717.01", "KCMF1"], {"weight": 0.798497602253505}], ["x", ["TCGA.CA.6717.01", "KNTC1"], {"weight": 0.80331690110589}], ["x", ["TCGA.CA.6717.01", "PLCL1"], {"weight": 0.798731063627412}], ["x", ["TCGA.CA.6717.01", "IGSF3"], {"weight": 0.793220265616748}], ["x", ["TCGA.CA.6717.01", "ITGB2"], {"weight": 0.804493472166268}], ["x", ["TCGA.CA.6717.01", "ITGB7"], {"weight": 0.804510271308298}], ["x", ["TCGA.CA.6717.01", "ITGB6"], {"weight": 0.804515604148518}], ["x", ["TCGA.CA.6717.01", "SLC37A1"], {"weight": 0.804418399370376}], ["x", ["TCGA.CA.6717.01", "USP34"], {"weight": 0.803541706180136}], ["x", ["TCGA.CA.6717.01", "FGG"], {"weight": 0.804449463591837}], ["x", ["TCGA.CA.6717.01", "FGA"], {"weight": 0.804445346788939}], ["x", ["TCGA.CA.6717.01", "OSBP"], {"weight": 0.804369462291121}], ["x", ["TCGA.CA.6717.01", "TMED7"], {"weight": 0.803341009262331}], ["x", ["TCGA.CA.6717.01", "ZNF304"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "TAAR1"], {"weight": 0.809175058579812}], ["x", ["TCGA.CA.6717.01", "SCN9A"], {"weight": 0.803558873678053}], ["x", ["TCGA.CA.6717.01", "ABCB1"], {"weight": 0.804006233793002}], ["x", ["TCGA.CA.6717.01", "ABCB4"], {"weight": 0.809933619654472}], ["x", ["TCGA.CA.6717.01", "GOLGB1"], {"weight": 0.798203591526023}], ["x", ["TCGA.CA.6717.01", "SNRNP200"], {"weight": 0.803138372715575}], ["x", ["TCGA.CA.6717.01", "GADD45G"], {"weight": 0.798843367989038}], ["x", ["TCGA.CA.6717.01", "SCN1A"], {"weight": 0.803415878985946}], ["x", ["TCGA.CA.6717.01", "ZNF273"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "KCNV2"], {"weight": 0.793060006853577}], ["x", ["TCGA.CA.6717.01", "ITGA11"], {"weight": 0.804559252421705}], ["x", ["TCGA.CA.6717.01", "MAML3"], {"weight": 0.803570724504567}], ["x", ["TCGA.CA.6717.01", "HERC3"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "HERC4"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "HERC6"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "PEX5L"], {"weight": 0.798908570373267}], ["x", ["TCGA.CA.6717.01", "CD58"], {"weight": 0.798591655788311}], ["x", ["TCGA.CA.6717.01", "LRP2"], {"weight": 0.810501968242985}], ["x", ["TCGA.CA.6717.01", "LRP1"], {"weight": 0.809705607618857}], ["x", ["TCGA.CA.6717.01", "LRP6"], {"weight": 0.804138186712452}], ["x", ["TCGA.CA.6717.01", "MAP2"], {"weight": 0.79336874860604}], ["x", ["TCGA.CA.6717.01", "C8A"], {"weight": 0.803849676032537}], ["x", ["TCGA.CA.6717.01", "MAP7"], {"weight": 0.800682876485023}], ["x", ["TCGA.CA.6717.01", "PTPN22"], {"weight": 0.798102894825033}], ["x", ["TCGA.CA.6717.01", "SPATA5L1"], {"weight": 0.79844981108485}], ["x", ["TCGA.CA.6717.01", "MTPN"], {"weight": 0.798556456893544}], ["x", ["TCGA.CA.6717.01", "MAPT"], {"weight": 0.803880571111329}], ["x", ["TCGA.CA.6717.01", "MSR1"], {"weight": 0.804727827529382}], ["x", ["TCGA.CA.6717.01", "CHRNA6"], {"weight": 0.79843554770773}], ["x", ["TCGA.CA.6717.01", "CHRNA1"], {"weight": 0.803893135097476}], ["x", ["TCGA.CA.6717.01", "CHRNA2"], {"weight": 0.798453254312441}], ["x", ["TCGA.CA.6717.01", "FSHR"], {"weight": 0.8091726565582}], ["x", ["TCGA.CA.6717.01", "AP5Z1"], {"weight": 0.798349789666544}], ["x", ["TCGA.CA.6717.01", "SPATA5"], {"weight": 0.79836291464375}], ["x", ["TCGA.CA.6717.01", "KDM2A"], {"weight": 0.798437862219252}], ["x", ["TCGA.CA.6717.01", "SIRPA"], {"weight": 0.798583308568938}], ["x", ["TCGA.CA.6717.01", "TRAPPC8"], {"weight": 0.798269060879854}], ["x", ["TCGA.CA.6717.01", "SIM1"], {"weight": 0.804023279628162}], ["x", ["TCGA.CA.6717.01", "NADSYN1"], {"weight": 0.809425497125627}], ["x", ["TCGA.CA.6717.01", "RELT"], {"weight": 0.804112880803604}], ["x", ["TCGA.CA.6717.01", "RELN"], {"weight": 0.809831204359631}], ["x", ["TCGA.CA.6717.01", "PTH2R"], {"weight": 0.809175058579812}], ["x", ["TCGA.CA.6717.01", "KLK2"], {"weight": 0.804317989005035}], ["x", ["TCGA.CA.6717.01", "KLK3"], {"weight": 0.804225024499516}], ["x", ["TCGA.CA.6717.01", "COPS3"], {"weight": 0.803728182008834}], ["x", ["TCGA.CA.6717.01", "ZNF596"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF599"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SSB"], {"weight": 0.803819704464686}], ["x", ["TCGA.CA.6717.01", "ZNF334"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF333"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "TEX15"], {"weight": 0.798334626588931}], ["x", ["TCGA.CA.6717.01", "SNRNP40"], {"weight": 0.803144448952249}], ["x", ["TCGA.CA.6717.01", "CYP24A1"], {"weight": 0.815639084800538}], ["x", ["TCGA.CA.6717.01", "ZNF33B"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SNRNP48"], {"weight": 0.803482493252772}], ["x", ["TCGA.CA.6717.01", "CASQ2"], {"weight": 0.803204110489369}], ["x", ["TCGA.CA.6717.01", "NPY2R"], {"weight": 0.809015391094436}], ["x", ["TCGA.CA.6717.01", "ZFP90"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "PROK1"], {"weight": 0.803255816880772}], ["x", ["TCGA.CA.6717.01", "FBXO45"], {"weight": 0.798186314430611}], ["x", ["TCGA.CA.6717.01", "KIF16B"], {"weight": 0.803504920890282}], ["x", ["TCGA.CA.6717.01", "COL6A3"], {"weight": 0.802919660714901}], ["x", ["TCGA.CA.6717.01", "COL6A2"], {"weight": 0.799656693403389}], ["x", ["TCGA.CA.6717.01", "COL6A5"], {"weight": 0.799656693403389}], ["x", ["TCGA.CA.6717.01", "LRRK2"], {"weight": 0.803997363243749}], ["x", ["TCGA.CA.6717.01", "TGFB1I1"], {"weight": 0.79881660610493}], ["x", ["TCGA.CA.6717.01", "MRPL15"], {"weight": 0.808826138334234}], ["x", ["TCGA.CA.6717.01", "MRPL17"], {"weight": 0.814426162386062}], ["x", ["TCGA.CA.6717.01", "RNF123"], {"weight": 0.803418919260188}], ["x", ["TCGA.CA.6717.01", "PHLPP1"], {"weight": 0.804518613734848}], ["x", ["TCGA.CA.6717.01", "SCN11A"], {"weight": 0.80357797290783}], ["x", ["TCGA.CA.6717.01", "DIS3"], {"weight": 0.803740219277517}], ["x", ["TCGA.CA.6717.01", "CHKA"], {"weight": 0.809736413268102}], ["x", ["TCGA.CA.6717.01", "BMS1"], {"weight": 0.803181740158756}], ["x", ["TCGA.CA.6717.01", "DST"], {"weight": 0.804280219094025}], ["x", ["TCGA.CA.6717.01", "DSP"], {"weight": 0.798177948715976}], ["x", ["TCGA.CA.6717.01", "DSE"], {"weight": 0.804164823794084}], ["x", ["TCGA.CA.6717.01", "GRIN3A"], {"weight": 0.804063428818032}], ["x", ["TCGA.CA.6717.01", "HECW2"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "NFATC3"], {"weight": 0.804450075371661}], ["x", ["TCGA.CA.6717.01", "ALKBH8"], {"weight": 0.799313938029334}], ["x", ["TCGA.CA.6717.01", "CDK20"], {"weight": 0.797850888707697}], ["x", ["TCGA.CA.6717.01", "OCIAD1"], {"weight": 0.798638772764351}], ["x", ["TCGA.CA.6717.01", "HELQ"], {"weight": 0.798752908267828}], ["x", ["TCGA.CA.6717.01", "MAP1B"], {"weight": 0.809712540555134}], ["x", ["TCGA.CA.6717.01", "UPF1"], {"weight": 0.809158662204142}], ["x", ["TCGA.CA.6717.01", "IL1B"], {"weight": 0.804345174064876}], ["x", ["TCGA.CA.6717.01", "COMP"], {"weight": 0.80914714214517}], ["x", ["TCGA.CA.6717.01", "ZNF154"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "KIFAP3"], {"weight": 0.803339016369191}], ["x", ["TCGA.CA.6717.01", "ZNF143"], {"weight": 0.803481813062887}], ["x", ["TCGA.CA.6717.01", "KCNN3"], {"weight": 0.803831797908327}], ["x", ["TCGA.CA.6717.01", "PKIA"], {"weight": 0.803604522035969}], ["x", ["TCGA.CA.6717.01", "NIT2"], {"weight": 0.803822281367718}], ["x", ["TCGA.CA.6717.01", "MAPK6"], {"weight": 0.803457355892268}], ["x", ["TCGA.CA.6717.01", "CUZD1"], {"weight": 0.798628933100016}], ["x", ["TCGA.CA.6717.01", "MUC16"], {"weight": 0.809342211011919}], ["x", ["TCGA.CA.6717.01", "RASGRP2"], {"weight": 0.80360543157877}], ["x", ["TCGA.CA.6717.01", "RASGRP3"], {"weight": 0.803598725595515}], ["x", ["TCGA.CA.6717.01", "HCK"], {"weight": 0.803841084424404}], ["x", ["TCGA.CA.6717.01", "C7orf26"], {"weight": 0.797696767128837}], ["x", ["TCGA.CA.6717.01", "ZNF426"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF423"], {"weight": 0.798077919842891}], ["x", ["TCGA.CA.6717.01", "NEDD4"], {"weight": 0.803399448689399}], ["x", ["TCGA.CA.6717.01", "LMOD1"], {"weight": 0.804100553449377}], ["x", ["TCGA.CA.6717.01", "OR5W2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "AGXT2"], {"weight": 0.810288876626538}], ["x", ["TCGA.CA.6717.01", "SYNJ2"], {"weight": 0.809309745405513}], ["x", ["TCGA.CA.6717.01", "RAB5C"], {"weight": 0.80324130853733}], ["x", ["TCGA.CA.6717.01", "WNT7A"], {"weight": 0.809436822720539}], ["x", ["TCGA.CA.6717.01", "ADSSL1"], {"weight": 0.809430589586076}], ["x", ["TCGA.CA.6717.01", "HCLS1"], {"weight": 0.798575224720786}], ["x", ["TCGA.CA.6717.01", "FCHO2"], {"weight": 0.803350243299827}], ["x", ["TCGA.CA.6717.01", "PHF7"], {"weight": 0.798688771173014}], ["x", ["TCGA.CA.6717.01", "PHF1"], {"weight": 0.798371706420582}], ["x", ["TCGA.CA.6717.01", "RPS24"], {"weight": 0.809295788413268}], ["x", ["TCGA.CA.6717.01", "OR1E1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "ATRX"], {"weight": 0.799029900739844}], ["x", ["TCGA.CA.6717.01", "ZC3H6"], {"weight": 0.798525380847117}], ["x", ["TCGA.CA.6717.01", "DRD5"], {"weight": 0.80916791357165}], ["x", ["TCGA.CA.6717.01", "SNAPC1"], {"weight": 0.803481813062887}], ["x", ["TCGA.CA.6717.01", "KIF3A"], {"weight": 0.803321686114961}], ["x", ["TCGA.CA.6717.01", "DCAF5"], {"weight": 0.804414057921158}], ["x", ["TCGA.CA.6717.01", "DIAPH2"], {"weight": 0.79893937948095}], ["x", ["TCGA.CA.6717.01", "SNX32"], {"weight": 0.79869294551168}], ["x", ["TCGA.CA.6717.01", "GABRR2"], {"weight": 0.798378260636368}], ["x", ["TCGA.CA.6717.01", "TRIM55"], {"weight": 0.798581217996718}], ["x", ["TCGA.CA.6717.01", "ZNF212"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "PRMT3"], {"weight": 0.797746868981999}], ["x", ["TCGA.CA.6717.01", "HSD17B2"], {"weight": 0.809309745405513}], ["x", ["TCGA.CA.6717.01", "HSD17B4"], {"weight": 0.809449746071275}], ["x", ["TCGA.CA.6717.01", "PARD3"], {"weight": 0.809436822720539}], ["x", ["TCGA.CA.6717.01", "CEP192"], {"weight": 0.803300743369676}], ["x", ["TCGA.CA.6717.01", "CNOT1"], {"weight": 0.803438920937305}], ["x", ["TCGA.CA.6717.01", "RFC1"], {"weight": 0.803493660030515}], ["x", ["TCGA.CA.6717.01", "SHOC2"], {"weight": 0.803634099891387}], ["x", ["TCGA.CA.6717.01", "ERCC2"], {"weight": 0.803131754099971}], ["x", ["TCGA.CA.6717.01", "ERCC3"], {"weight": 0.803127389298214}], ["x", ["TCGA.CA.6717.01", "ERCC4"], {"weight": 0.803229481708233}], ["x", ["TCGA.CA.6717.01", "ERCC6"], {"weight": 0.803179739032305}], ["x", ["TCGA.CA.6717.01", "MRPS16"], {"weight": 0.803437974782203}], ["x", ["TCGA.CA.6717.01", "PFKP"], {"weight": 0.809412502154771}], ["x", ["TCGA.CA.6717.01", "SSR2"], {"weight": 0.809177481436419}], ["x", ["TCGA.CA.6717.01", "ZFPM2"], {"weight": 0.798395205199358}], ["x", ["TCGA.CA.6717.01", "UBE2O"], {"weight": 0.803417802724952}], ["x", ["TCGA.CA.6717.01", "RASA1"], {"weight": 0.80353563802866}], ["x", ["TCGA.CA.6717.01", "DOCK10"], {"weight": 0.798561485407692}], ["x", ["TCGA.CA.6717.01", "DOCK11"], {"weight": 0.798561485407692}], ["x", ["TCGA.CA.6717.01", "CDH11"], {"weight": 0.798415119724707}], ["x", ["TCGA.CA.6717.01", "CDH10"], {"weight": 0.798415119724707}], ["x", ["TCGA.CA.6717.01", "CDH12"], {"weight": 0.798415119724707}], ["x", ["TCGA.CA.6717.01", "CDH18"], {"weight": 0.798415119724707}], ["x", ["TCGA.CA.6717.01", "OR4A16"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR4A15"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "NIPBL"], {"weight": 0.797678853495465}], ["x", ["TCGA.CA.6717.01", "ITSN1"], {"weight": 0.80325259114197}], ["x", ["TCGA.CA.6717.01", "ITSN2"], {"weight": 0.803312190087212}], ["x", ["TCGA.CA.6717.01", "MEFV"], {"weight": 0.798155050655699}], ["x", ["TCGA.CA.6717.01", "ABL2"], {"weight": 0.804798617573987}], ["x", ["TCGA.CA.6717.01", "IL9R"], {"weight": 0.803417839427575}], ["x", ["TCGA.CA.6717.01", "AARS"], {"weight": 0.803697613302142}], ["x", ["TCGA.CA.6717.01", "SRA1"], {"weight": 0.809596786131497}], ["x", ["TCGA.CA.6717.01", "OR9I1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "GTF3C6"], {"weight": 0.803767254065921}], ["x", ["TCGA.CA.6717.01", "GARS"], {"weight": 0.803766441659147}], ["x", ["TCGA.CA.6717.01", "ATAD5"], {"weight": 0.79817493191798}], ["x", ["TCGA.CA.6717.01", "MTIF2"], {"weight": 0.80349923263115}], ["x", ["TCGA.CA.6717.01", "CALB1"], {"weight": 0.804047131128659}], ["x", ["TCGA.CA.6717.01", "AGGF1"], {"weight": 0.799106439658631}], ["x", ["TCGA.CA.6717.01", "WDHD1"], {"weight": 0.804214785269471}], ["x", ["TCGA.CA.6717.01", "AHCTF1"], {"weight": 0.80331690110589}], ["x", ["TCGA.CA.6717.01", "NPFFR2"], {"weight": 0.803257619320271}], ["x", ["TCGA.CA.6717.01", "SALL4"], {"weight": 0.803945132902488}], ["x", ["TCGA.CA.6717.01", "RPS6KB1"], {"weight": 0.803774791348328}], ["x", ["TCGA.CA.6717.01", "ISY1"], {"weight": 0.803438920937305}], ["x", ["TCGA.CA.6717.01", "F2RL2"], {"weight": 0.80910115795135}], ["x", ["TCGA.CA.6717.01", "XAB2"], {"weight": 0.803078336713761}], ["x", ["TCGA.CA.6717.01", "TRIM50"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "HPX"], {"weight": 0.804756866051334}], ["x", ["TCGA.CA.6717.01", "CALHM1"], {"weight": 0.798871867314584}], ["x", ["TCGA.CA.6717.01", "HPR"], {"weight": 0.804713826660152}], ["x", ["TCGA.CA.6717.01", "RPL3"], {"weight": 0.808904833262087}], ["x", ["TCGA.CA.6717.01", "INHA"], {"weight": 0.803983172360325}], ["x", ["TCGA.CA.6717.01", "UGT8"], {"weight": 0.815310593940635}], ["x", ["TCGA.CA.6717.01", "ZNF624"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "CAMK2G"], {"weight": 0.804051290928448}], ["x", ["TCGA.CA.6717.01", "JAK2"], {"weight": 0.804250367554235}], ["x", ["TCGA.CA.6717.01", "JAK1"], {"weight": 0.804198634454112}], ["x", ["TCGA.CA.6717.01", "PRKDC"], {"weight": 0.803582600834877}], ["x", ["TCGA.CA.6717.01", "TLL1"], {"weight": 0.799237883924891}], ["x", ["TCGA.CA.6717.01", "PBK"], {"weight": 0.803461076865547}], ["x", ["TCGA.CA.6717.01", "KIF21A"], {"weight": 0.803501336183804}], ["x", ["TCGA.CA.6717.01", "RIMS1"], {"weight": 0.803623132427007}], ["x", ["TCGA.CA.6717.01", "TMEM67"], {"weight": 0.80333112444827}], ["x", ["TCGA.CA.6717.01", "TAGLN3"], {"weight": 0.803640062833035}], ["x", ["TCGA.CA.6717.01", "PRKD1"], {"weight": 0.803850258201425}], ["x", ["TCGA.CA.6717.01", "MCTS1"], {"weight": 0.799029847210171}], ["x", ["TCGA.CA.6717.01", "REST"], {"weight": 0.798212387318404}], ["x", ["TCGA.CA.6717.01", "POU1F1"], {"weight": 0.799262815614662}], ["x", ["TCGA.CA.6717.01", "ZNF543"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF549"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "TAS2R50"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "RARB"], {"weight": 0.803773008542311}], ["x", ["TCGA.CA.6717.01", "SLC25A5"], {"weight": 0.803731796100282}], ["x", ["TCGA.CA.6717.01", "SYF2"], {"weight": 0.803187450574221}], ["x", ["TCGA.CA.6717.01", "MCM8"], {"weight": 0.803717416493452}], ["x", ["TCGA.CA.6717.01", "ZNF625"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "UGT2B15"], {"weight": 0.809301167766683}], ["x", ["TCGA.CA.6717.01", "VPS52"], {"weight": 0.803634278048855}], ["x", ["TCGA.CA.6717.01", "EPRS"], {"weight": 0.803926807240576}], ["x", ["TCGA.CA.6717.01", "SUPT16H"], {"weight": 0.803359306614938}], ["x", ["TCGA.CA.6717.01", "NRK"], {"weight": 0.804463532062621}], ["x", ["TCGA.CA.6717.01", "EME1"], {"weight": 0.802980099258882}], ["x", ["TCGA.CA.6717.01", "MOGS"], {"weight": 0.803736493731312}], ["x", ["TCGA.CA.6717.01", "SALL1"], {"weight": 0.793299610557965}], ["x", ["TCGA.CA.6717.01", "ZNF782"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "UBE3C"], {"weight": 0.803414478599481}], ["x", ["TCGA.CA.6717.01", "UBE3D"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "GLOD4"], {"weight": 0.798823233827376}], ["x", ["TCGA.CA.6717.01", "STX3"], {"weight": 0.798496160150045}], ["x", ["TCGA.CA.6717.01", "CNKSR2"], {"weight": 0.804072717603492}], ["x", ["TCGA.CA.6717.01", "AUTS2"], {"weight": 0.798506477112093}], ["x", ["TCGA.CA.6717.01", "ATP7A"], {"weight": 0.799086706993536}], ["x", ["TCGA.CA.6717.01", "PDE2A"], {"weight": 0.809355842337687}], ["x", ["TCGA.CA.6717.01", "SCFD2"], {"weight": 0.792946311387011}], ["x", ["TCGA.CA.6717.01", "TTI1"], {"weight": 0.804086709427518}], ["x", ["TCGA.CA.6717.01", "TADA2B"], {"weight": 0.803627219142939}], ["x", ["TCGA.CA.6717.01", "KIF9"], {"weight": 0.798359610930483}], ["x", ["TCGA.CA.6717.01", "KIF6"], {"weight": 0.803504920890282}], ["x", ["TCGA.CA.6717.01", "AP3M1"], {"weight": 0.798314632617978}], ["x", ["TCGA.CA.6717.01", "AP3M2"], {"weight": 0.798298443829057}], ["x", ["TCGA.CA.6717.01", "ESYT2"], {"weight": 0.798700764496097}], ["x", ["TCGA.CA.6717.01", "OR9A4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "RB1"], {"weight": 0.803959829005272}], ["x", ["TCGA.CA.6717.01", "FAM160A2"], {"weight": 0.792141118892191}], ["x", ["TCGA.CA.6717.01", "NAALADL2"], {"weight": 0.804663374394678}], ["x", ["TCGA.CA.6717.01", "AQP5"], {"weight": 0.798777760940414}], ["x", ["TCGA.CA.6717.01", "ACTC1"], {"weight": 0.79889096598201}], ["x", ["TCGA.CA.6717.01", "DNA2"], {"weight": 0.803639627665387}], ["x", ["TCGA.CA.6717.01", "OR2M4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR2M7"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "TP53BP1"], {"weight": 0.803247375551791}], ["x", ["TCGA.CA.6717.01", "OR2M3"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "GRK7"], {"weight": 0.803706394551}], ["x", ["TCGA.CA.6717.01", "KLHL5"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "KLHL8"], {"weight": 0.797683268889783}], ["x", ["TCGA.CA.6717.01", "TCTN2"], {"weight": 0.80333112444827}], ["x", ["TCGA.CA.6717.01", "TCTN1"], {"weight": 0.80333112444827}], ["x", ["TCGA.CA.6717.01", "SYNE1"], {"weight": 0.803565143997074}], ["x", ["TCGA.CA.6717.01", "SYNE2"], {"weight": 0.797997540734944}], ["x", ["TCGA.CA.6717.01", "OTC"], {"weight": 0.804133301997119}], ["x", ["TCGA.CA.6717.01", "UBQLN1"], {"weight": 0.802945083702304}], ["x", ["TCGA.CA.6717.01", "TNR"], {"weight": 0.803728469329582}], ["x", ["TCGA.CA.6717.01", "SV2C"], {"weight": 0.804190560151827}], ["x", ["TCGA.CA.6717.01", "GPR15"], {"weight": 0.809175058579812}], ["x", ["TCGA.CA.6717.01", "ARNTL"], {"weight": 0.809492803014106}], ["x", ["TCGA.CA.6717.01", "KCNMA1"], {"weight": 0.803457140132091}], ["x", ["TCGA.CA.6717.01", "ARNT2"], {"weight": 0.809086409624359}], ["x", ["TCGA.CA.6717.01", "LETM1"], {"weight": 0.798856099008853}], ["x", ["TCGA.CA.6717.01", "RAD51AP1"], {"weight": 0.803624535296818}], ["x", ["TCGA.CA.6717.01", "PLCG2"], {"weight": 0.809570047095186}], ["x", ["TCGA.CA.6717.01", "DKK4"], {"weight": 0.804423148144647}], ["x", ["TCGA.CA.6717.01", "CEP350"], {"weight": 0.798344983104934}], ["x", ["TCGA.CA.6717.01", "HDAC2"], {"weight": 0.803590151868544}], ["x", ["TCGA.CA.6717.01", "HDAC8"], {"weight": 0.803515568304231}], ["x", ["TCGA.CA.6717.01", "CST3"], {"weight": 0.804098513374301}], ["x", ["TCGA.CA.6717.01", "CST6"], {"weight": 0.799908022670241}], ["x", ["TCGA.CA.6717.01", "STARD8"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "ZNF547"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "CEBPZ"], {"weight": 0.803584852210255}], ["x", ["TCGA.CA.6717.01", "CTNNA2"], {"weight": 0.80448465449825}], ["x", ["TCGA.CA.6717.01", "CERS6"], {"weight": 0.809826585641009}], ["x", ["TCGA.CA.6717.01", "CERS5"], {"weight": 0.809838109224642}], ["x", ["TCGA.CA.6717.01", "RGSL1"], {"weight": 0.803948722264812}], ["x", ["TCGA.CA.6717.01", "MAN1A1"], {"weight": 0.798624291411715}], ["x", ["TCGA.CA.6717.01", "LCT"], {"weight": 0.809694833950423}], ["x", ["TCGA.CA.6717.01", "POLE2"], {"weight": 0.809068011613706}], ["x", ["TCGA.CA.6717.01", "NLRC4"], {"weight": 0.803641151341231}], ["x", ["TCGA.CA.6717.01", "COL18A1"], {"weight": 0.799666666094713}], ["x", ["TCGA.CA.6717.01", "OPRK1"], {"weight": 0.809015391094436}], ["x", ["TCGA.CA.6717.01", "DNAH17"], {"weight": 0.798280556484527}], ["x", ["TCGA.CA.6717.01", "DNAH10"], {"weight": 0.799105244218109}], ["x", ["TCGA.CA.6717.01", "GLI2"], {"weight": 0.803726416566655}], ["x", ["TCGA.CA.6717.01", "EDN3"], {"weight": 0.803252245993784}], ["x", ["TCGA.CA.6717.01", "PREX2"], {"weight": 0.798709444369451}], ["x", ["TCGA.CA.6717.01", "OXGR1"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "MADD"], {"weight": 0.809585409221339}], ["x", ["TCGA.CA.6717.01", "OR10J5"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "ZNF701"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF700"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF704"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "RNF111"], {"weight": 0.803385154986898}], ["x", ["TCGA.CA.6717.01", "DHX8"], {"weight": 0.803135439260248}], ["x", ["TCGA.CA.6717.01", "DHX9"], {"weight": 0.803152230396284}], ["x", ["TCGA.CA.6717.01", "NUP98"], {"weight": 0.803789735036361}], ["x", ["TCGA.CA.6717.01", "NSL1"], {"weight": 0.80331690110589}], ["x", ["TCGA.CA.6717.01", "SMAD1"], {"weight": 0.80340042153691}], ["x", ["TCGA.CA.6717.01", "TCEA1"], {"weight": 0.803297524727334}], ["x", ["TCGA.CA.6717.01", "LEO1"], {"weight": 0.803343264381705}], ["x", ["TCGA.CA.6717.01", "MR1"], {"weight": 0.798606782286282}], ["x", ["TCGA.CA.6717.01", "APC"], {"weight": 0.803551325115126}], ["x", ["TCGA.CA.6717.01", "CLIC4"], {"weight": 0.809981878435684}], ["x", ["TCGA.CA.6717.01", "CDC5L"], {"weight": 0.80313162056939}], ["x", ["TCGA.CA.6717.01", "AP2A1"], {"weight": 0.803556036523877}], ["x", ["TCGA.CA.6717.01", "BRD7"], {"weight": 0.803444568690577}], ["x", ["TCGA.CA.6717.01", "DMD"], {"weight": 0.803758166862709}], ["x", ["TCGA.CA.6717.01", "EREG"], {"weight": 0.809501195120136}], ["x", ["TCGA.CA.6717.01", "ASAP2"], {"weight": 0.803843813474662}], ["x", ["TCGA.CA.6717.01", "SRRM2"], {"weight": 0.803153812440258}], ["x", ["TCGA.CA.6717.01", "ARHGAP20"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "ARHGAP25"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "ARHGAP29"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "OR2H2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "RSAD2"], {"weight": 0.798687483246806}], ["x", ["TCGA.CA.6717.01", "DYNC1LI1"], {"weight": 0.804062433214354}], ["x", ["TCGA.CA.6717.01", "ABCG2"], {"weight": 0.809509886957217}], ["x", ["TCGA.CA.6717.01", "ABCG8"], {"weight": 0.80345827613191}], ["x", ["TCGA.CA.6717.01", "AKR1B15"], {"weight": 0.803930238544621}], ["x", ["TCGA.CA.6717.01", "ZNF136"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "DAZL"], {"weight": 0.804122132786936}], ["x", ["TCGA.CA.6717.01", "CCL28"], {"weight": 0.809014020769955}], ["x", ["TCGA.CA.6717.01", "CCL26"], {"weight": 0.803805682184774}], ["x", ["TCGA.CA.6717.01", "LDLR"], {"weight": 0.803894125007802}], ["x", ["TCGA.CA.6717.01", "OR52L1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "AASDH"], {"weight": 0.799176939042759}], ["x", ["TCGA.CA.6717.01", "LRRC40"], {"weight": 0.798745636243411}], ["x", ["TCGA.CA.6717.01", "LRRC49"], {"weight": 0.803658385338128}], ["x", ["TCGA.CA.6717.01", "ATP6V0A4"], {"weight": 0.803621045241554}], ["x", ["TCGA.CA.6717.01", "NACA2"], {"weight": 0.804160174950339}], ["x", ["TCGA.CA.6717.01", "KRT3"], {"weight": 0.798683683944452}], ["x", ["TCGA.CA.6717.01", "KRT1"], {"weight": 0.804443758419989}], ["x", ["TCGA.CA.6717.01", "DACT1"], {"weight": 0.798594705124626}], ["x", ["TCGA.CA.6717.01", "ZNF382"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "RIPK4"], {"weight": 0.80330790014227}], ["x", ["TCGA.CA.6717.01", "RECK"], {"weight": 0.798983087816349}], ["x", ["TCGA.CA.6717.01", "SPTBN5"], {"weight": 0.809197940260077}], ["x", ["TCGA.CA.6717.01", "SPTBN1"], {"weight": 0.809164973911243}], ["x", ["TCGA.CA.6717.01", "PYCARD"], {"weight": 0.803256238569068}], ["x", ["TCGA.CA.6717.01", "APOB"], {"weight": 0.815258126997394}], ["x", ["TCGA.CA.6717.01", "NUFIP1"], {"weight": 0.797979124508644}], ["x", ["TCGA.CA.6717.01", "FBXO32"], {"weight": 0.803418919260188}], ["x", ["TCGA.CA.6717.01", "ALAS2"], {"weight": 0.803759140715201}], ["x", ["TCGA.CA.6717.01", "TIGIT"], {"weight": 0.79871157994657}], ["x", ["TCGA.CA.6717.01", "REV3L"], {"weight": 0.803808327554529}], ["x", ["TCGA.CA.6717.01", "RNF19A"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "NEK7"], {"weight": 0.797733263005854}], ["x", ["TCGA.CA.6717.01", "CIB3"], {"weight": 0.80398291200082}], ["x", ["TCGA.CA.6717.01", "OR6X1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "STAB1"], {"weight": 0.804272130904176}], ["x", ["TCGA.CA.6717.01", "STAB2"], {"weight": 0.803908144231369}], ["x", ["TCGA.CA.6717.01", "IMPACT"], {"weight": 0.798326932635086}], ["x", ["TCGA.CA.6717.01", "EVC2"], {"weight": 0.798589373840951}], ["x", ["TCGA.CA.6717.01", "OR6C74"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "CHN1"], {"weight": 0.803683988460675}], ["x", ["TCGA.CA.6717.01", "APPL1"], {"weight": 0.803725755577764}], ["x", ["TCGA.CA.6717.01", "APPL2"], {"weight": 0.79884956481794}], ["x", ["TCGA.CA.6717.01", "OR2T10"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR6S1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "POR"], {"weight": 0.809799778451664}], ["x", ["TCGA.CA.6717.01", "ROBO3"], {"weight": 0.79933260984425}], ["x", ["TCGA.CA.6717.01", "ROBO2"], {"weight": 0.804326183356045}], ["x", ["TCGA.CA.6717.01", "HTR2A"], {"weight": 0.803250477256139}], ["x", ["TCGA.CA.6717.01", "HTR2C"], {"weight": 0.803235035246945}], ["x", ["TCGA.CA.6717.01", "HTR2B"], {"weight": 0.803250477256139}], ["x", ["TCGA.CA.6717.01", "TBPL1"], {"weight": 0.803506345885638}], ["x", ["TCGA.CA.6717.01", "ATP5S"], {"weight": 0.803679463918876}], ["x", ["TCGA.CA.6717.01", "ME1"], {"weight": 0.809288313542986}], ["x", ["TCGA.CA.6717.01", "CYP7B1"], {"weight": 0.809242165453444}], ["x", ["TCGA.CA.6717.01", "CPD"], {"weight": 0.803455029121301}], ["x", ["TCGA.CA.6717.01", "HHIP"], {"weight": 0.803947160509645}], ["x", ["TCGA.CA.6717.01", "KRT10"], {"weight": 0.80447926395661}], ["x", ["TCGA.CA.6717.01", "ARIH1"], {"weight": 0.803633951246208}], ["x", ["TCGA.CA.6717.01", "PLA2G4A"], {"weight": 0.809682300925096}], ["x", ["TCGA.CA.6717.01", "PLA2G4E"], {"weight": 0.809436332080395}], ["x", ["TCGA.CA.6717.01", "OR8H1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "COL11A1"], {"weight": 0.8028947467205}], ["x", ["TCGA.CA.6717.01", "SIPA1L2"], {"weight": 0.798999461135652}], ["x", ["TCGA.CA.6717.01", "SERPIND1"], {"weight": 0.798606782286283}], ["x", ["TCGA.CA.6717.01", "PRPF4B"], {"weight": 0.80381503778064}], ["x", ["TCGA.CA.6717.01", "RORB"], {"weight": 0.804391077424309}], ["x", ["TCGA.CA.6717.01", "ZNF470"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "KPNA4"], {"weight": 0.804308317761558}], ["x", ["TCGA.CA.6717.01", "B4GALT1"], {"weight": 0.809303732966849}], ["x", ["TCGA.CA.6717.01", "B4GALT7"], {"weight": 0.809850153690124}], ["x", ["TCGA.CA.6717.01", "OR5L2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "BOLL"], {"weight": 0.803968956063659}], ["x", ["TCGA.CA.6717.01", "ZKSCAN5"], {"weight": 0.798490455004968}], ["x", ["TCGA.CA.6717.01", "TMEM181"], {"weight": 0.798433393147616}], ["x", ["TCGA.CA.6717.01", "HCAR3"], {"weight": 0.809015391094436}], ["x", ["TCGA.CA.6717.01", "TAF7"], {"weight": 0.803662615971771}], ["x", ["TCGA.CA.6717.01", "TAF5"], {"weight": 0.803265041292702}], ["x", ["TCGA.CA.6717.01", "TAF3"], {"weight": 0.803462455777484}], ["x", ["TCGA.CA.6717.01", "TAF2"], {"weight": 0.803426361451948}], ["x", ["TCGA.CA.6717.01", "TAF1"], {"weight": 0.80359256534994}], ["x", ["TCGA.CA.6717.01", "FNIP1"], {"weight": 0.7989390025356}], ["x", ["TCGA.CA.6717.01", "FNIP2"], {"weight": 0.7989390025356}], ["x", ["TCGA.CA.6717.01", "ARFGEF1"], {"weight": 0.803973286787437}], ["x", ["TCGA.CA.6717.01", "ARFGEF2"], {"weight": 0.803774702950198}], ["x", ["TCGA.CA.6717.01", "SEC22A"], {"weight": 0.798493867355484}], ["x", ["TCGA.CA.6717.01", "PDCD11"], {"weight": 0.803161821492443}], ["x", ["TCGA.CA.6717.01", "ZNF677"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF676"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ACLY"], {"weight": 0.814383612335404}], ["x", ["TCGA.CA.6717.01", "IFIH1"], {"weight": 0.8037587820826}], ["x", ["TCGA.CA.6717.01", "KIF4B"], {"weight": 0.803398507039244}], ["x", ["TCGA.CA.6717.01", "MCF2"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "PCF11"], {"weight": 0.803144448952249}], ["x", ["TCGA.CA.6717.01", "PRKG1"], {"weight": 0.803770134280908}], ["x", ["TCGA.CA.6717.01", "PRKG2"], {"weight": 0.803786440975149}], ["x", ["TCGA.CA.6717.01", "CREM"], {"weight": 0.803849676032537}], ["x", ["TCGA.CA.6717.01", "ACSM1"], {"weight": 0.815153522409083}], ["x", ["TCGA.CA.6717.01", "ACSM4"], {"weight": 0.815153522409083}], ["x", ["TCGA.CA.6717.01", "EIF4ENIF1"], {"weight": 0.804131898049149}], ["x", ["TCGA.CA.6717.01", "TRIM26"], {"weight": 0.798681659248344}], ["x", ["TCGA.CA.6717.01", "GNPAT"], {"weight": 0.809789763284126}], ["x", ["TCGA.CA.6717.01", "NTSR2"], {"weight": 0.803255816880772}], ["x", ["TCGA.CA.6717.01", "OR4D10"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "BAG4"], {"weight": 0.80410852854184}], ["x", ["TCGA.CA.6717.01", "KMO"], {"weight": 0.809248634359968}], ["x", ["TCGA.CA.6717.01", "TMPO"], {"weight": 0.792667769401979}], ["x", ["TCGA.CA.6717.01", "NAP1L1"], {"weight": 0.803698996384841}], ["x", ["TCGA.CA.6717.01", "XIAP"], {"weight": 0.803783023880161}], ["x", ["TCGA.CA.6717.01", "KANK1"], {"weight": 0.799459168525445}], ["x", ["TCGA.CA.6717.01", "UBR2"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "MYLIP"], {"weight": 0.803659605876124}], ["x", ["TCGA.CA.6717.01", "GTF3A"], {"weight": 0.803755839989419}], ["x", ["TCGA.CA.6717.01", "MAPK10"], {"weight": 0.804082246069788}], ["x", ["TCGA.CA.6717.01", "FZD3"], {"weight": 0.80410724346347}], ["x", ["TCGA.CA.6717.01", "ASH1L"], {"weight": 0.803166755947298}], ["x", ["TCGA.CA.6717.01", "LPXN"], {"weight": 0.798686785953897}], ["x", ["TCGA.CA.6717.01", "ESCO2"], {"weight": 0.797678853495465}], ["x", ["TCGA.CA.6717.01", "ESCO1"], {"weight": 0.797678853495465}], ["x", ["TCGA.CA.6717.01", "TARBP2"], {"weight": 0.79788812941694}], ["x", ["TCGA.CA.6717.01", "PSPC1"], {"weight": 0.798191970384022}], ["x", ["TCGA.CA.6717.01", "RAPGEF4"], {"weight": 0.809430589586076}], ["x", ["TCGA.CA.6717.01", "ATR"], {"weight": 0.803686650045164}], ["x", ["TCGA.CA.6717.01", "CDC25A"], {"weight": 0.803563779713792}], ["x", ["TCGA.CA.6717.01", "WDFY4"], {"weight": 0.798911308894347}], ["x", ["TCGA.CA.6717.01", "WDFY3"], {"weight": 0.798844825083856}], ["x", ["TCGA.CA.6717.01", "AK7"], {"weight": 0.815457341484574}], ["x", ["TCGA.CA.6717.01", "MME"], {"weight": 0.803372177790041}], ["x", ["TCGA.CA.6717.01", "MDC1"], {"weight": 0.803297417787867}], ["x", ["TCGA.CA.6717.01", "EXOSC5"], {"weight": 0.809238927654252}], ["x", ["TCGA.CA.6717.01", "SKP1"], {"weight": 0.80338948682726}], ["x", ["TCGA.CA.6717.01", "IFI16"], {"weight": 0.798364564810857}], ["x", ["TCGA.CA.6717.01", "SPECC1"], {"weight": 0.798450268132827}], ["x", ["TCGA.CA.6717.01", "USP22"], {"weight": 0.803000913740136}], ["x", ["TCGA.CA.6717.01", "CARD9"], {"weight": 0.803984807277289}], ["x", ["TCGA.CA.6717.01", "ADAMTS5"], {"weight": 0.803283717160045}], ["x", ["TCGA.CA.6717.01", "ZNF311"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ARHGEF3"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "BMP2K"], {"weight": 0.798882653255362}], ["x", ["TCGA.CA.6717.01", "COCH"], {"weight": 0.793255471084876}], ["x", ["TCGA.CA.6717.01", "MAEL"], {"weight": 0.803609368857948}], ["x", ["TCGA.CA.6717.01", "GRM3"], {"weight": 0.80900726530888}], ["x", ["TCGA.CA.6717.01", "SP100"], {"weight": 0.803120619912768}], ["x", ["TCGA.CA.6717.01", "PARG"], {"weight": 0.798378560906731}], ["x", ["TCGA.CA.6717.01", "AOC2"], {"weight": 0.809862769791232}], ["x", ["TCGA.CA.6717.01", "DDX4"], {"weight": 0.803572611221281}], ["x", ["TCGA.CA.6717.01", "SCN3A"], {"weight": 0.803568646111534}], ["x", ["TCGA.CA.6717.01", "ZNF211"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SLC7A5"], {"weight": 0.810528956779794}], ["x", ["TCGA.CA.6717.01", "IPO8"], {"weight": 0.803439338732972}], ["x", ["TCGA.CA.6717.01", "IPO5"], {"weight": 0.798007832482785}], ["x", ["TCGA.CA.6717.01", "NRBP1"], {"weight": 0.804384157249407}], ["x", ["TCGA.CA.6717.01", "PLOD2"], {"weight": 0.799249194412006}], ["x", ["TCGA.CA.6717.01", "RAD21"], {"weight": 0.803196998191285}], ["x", ["TCGA.CA.6717.01", "PAPPA"], {"weight": 0.804710689577323}], ["x", ["TCGA.CA.6717.01", "PIK3C2A"], {"weight": 0.808965095639802}], ["x", ["TCGA.CA.6717.01", "PIK3C2G"], {"weight": 0.809208328219731}], ["x", ["TCGA.CA.6717.01", "CEP72"], {"weight": 0.803298139442447}], ["x", ["TCGA.CA.6717.01", "CEP78"], {"weight": 0.803300743369676}], ["x", ["TCGA.CA.6717.01", "MST1"], {"weight": 0.804745230307161}], ["x", ["TCGA.CA.6717.01", "SMG6"], {"weight": 0.809609964767285}], ["x", ["TCGA.CA.6717.01", "PPEF1"], {"weight": 0.798063674859816}], ["x", ["TCGA.CA.6717.01", "GPR45"], {"weight": 0.809175058579812}], ["x", ["TCGA.CA.6717.01", "FUT5"], {"weight": 0.809994077474089}], ["x", ["TCGA.CA.6717.01", "FUT8"], {"weight": 0.803948722264812}], ["x", ["TCGA.CA.6717.01", "OR1J4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "CSPP1"], {"weight": 0.798505181523269}], ["x", ["TCGA.CA.6717.01", "NOP58"], {"weight": 0.80313146967425}], ["x", ["TCGA.CA.6717.01", "ETS1"], {"weight": 0.803803844277724}], ["x", ["TCGA.CA.6717.01", "CHRM2"], {"weight": 0.808887513503009}], ["x", ["TCGA.CA.6717.01", "GLRX"], {"weight": 0.809954573040484}], ["x", ["TCGA.CA.6717.01", "MMP2"], {"weight": 0.803822068275787}], ["x", ["TCGA.CA.6717.01", "MMP1"], {"weight": 0.80396044110476}], ["x", ["TCGA.CA.6717.01", "USP38"], {"weight": 0.802972633462309}], ["x", ["TCGA.CA.6717.01", "REV1"], {"weight": 0.803315861867732}], ["x", ["TCGA.CA.6717.01", "ZNF532"], {"weight": 0.79906391897392}], ["x", ["TCGA.CA.6717.01", "NPAS4"], {"weight": 0.803847062704462}], ["x", ["TCGA.CA.6717.01", "NPAS2"], {"weight": 0.809317669528887}], ["x", ["TCGA.CA.6717.01", "AP4E1"], {"weight": 0.803400003491572}], ["x", ["TCGA.CA.6717.01", "FSTL1"], {"weight": 0.793330771122808}], ["x", ["TCGA.CA.6717.01", "NUF2"], {"weight": 0.803306025531891}], ["x", ["TCGA.CA.6717.01", "MED31"], {"weight": 0.809604442915754}], ["x", ["TCGA.CA.6717.01", "FGF14"], {"weight": 0.803626036895949}], ["x", ["TCGA.CA.6717.01", "OXNAD1"], {"weight": 0.804456127134807}], ["x", ["TCGA.CA.6717.01", "CYP2C19"], {"weight": 0.810417600233792}], ["x", ["TCGA.CA.6717.01", "KCNJ16"], {"weight": 0.803819517583548}], ["x", ["TCGA.CA.6717.01", "KCNJ15"], {"weight": 0.803849676032537}], ["x", ["TCGA.CA.6717.01", "PUM1"], {"weight": 0.803385189580897}], ["x", ["TCGA.CA.6717.01", "NOS1"], {"weight": 0.803806642016813}], ["x", ["TCGA.CA.6717.01", "NOS2"], {"weight": 0.803467197933678}], ["x", ["TCGA.CA.6717.01", "NOS3"], {"weight": 0.809313340509829}], ["x", ["TCGA.CA.6717.01", "LCP2"], {"weight": 0.803756676303167}], ["x", ["TCGA.CA.6717.01", "LCP1"], {"weight": 0.798726460328698}], ["x", ["TCGA.CA.6717.01", "TESK2"], {"weight": 0.803609035827305}], ["x", ["TCGA.CA.6717.01", "NUP85"], {"weight": 0.803065177725656}], ["x", ["TCGA.CA.6717.01", "MED23"], {"weight": 0.809184878811706}], ["x", ["TCGA.CA.6717.01", "COL5A1"], {"weight": 0.802559095437262}], ["x", ["TCGA.CA.6717.01", "LAMP2"], {"weight": 0.79831109770393}], ["x", ["TCGA.CA.6717.01", "NAT10"], {"weight": 0.80345127588923}], ["x", ["TCGA.CA.6717.01", "NCAPG"], {"weight": 0.798384625042423}], ["x", ["TCGA.CA.6717.01", "PARP4"], {"weight": 0.804331040586654}], ["x", ["TCGA.CA.6717.01", "BCAS3"], {"weight": 0.798628977133673}], ["x", ["TCGA.CA.6717.01", "CD80"], {"weight": 0.809382934923605}], ["x", ["TCGA.CA.6717.01", "CD86"], {"weight": 0.809393758382511}], ["x", ["TCGA.CA.6717.01", "AFG3L2"], {"weight": 0.803714257531706}], ["x", ["TCGA.CA.6717.01", "PTBP2"], {"weight": 0.803581318402125}], ["x", ["TCGA.CA.6717.01", "CACNA2D2"], {"weight": 0.804061174829922}], ["x", ["TCGA.CA.6717.01", "CACNA2D1"], {"weight": 0.80305273719395}], ["x", ["TCGA.CA.6717.01", "MTA1"], {"weight": 0.79818056053563}], ["x", ["TCGA.CA.6717.01", "NCAM2"], {"weight": 0.799095693287055}], ["x", ["TCGA.CA.6717.01", "CGN"], {"weight": 0.803986240922774}], ["x", ["TCGA.CA.6717.01", "ARL6IP5"], {"weight": 0.79884641416328}], ["x", ["TCGA.CA.6717.01", "SEC31A"], {"weight": 0.79838955853887}], ["x", ["TCGA.CA.6717.01", "PDGFD"], {"weight": 0.798786334889617}], ["x", ["TCGA.CA.6717.01", "B2M"], {"weight": 0.803460767117435}], ["x", ["TCGA.CA.6717.01", "ABCD2"], {"weight": 0.804629993036456}], ["x", ["TCGA.CA.6717.01", "DSEL"], {"weight": 0.804211525775523}], ["x", ["TCGA.CA.6717.01", "COL21A1"], {"weight": 0.799331261128602}], ["x", ["TCGA.CA.6717.01", "KCNH7"], {"weight": 0.793060006853577}], ["x", ["TCGA.CA.6717.01", "KCNH1"], {"weight": 0.793060006853577}], ["x", ["TCGA.CA.6717.01", "KCNH3"], {"weight": 0.793060006853577}], ["x", ["TCGA.CA.6717.01", "KCNH8"], {"weight": 0.793060006853577}], ["x", ["TCGA.CA.6717.01", "HLA-DMB"], {"weight": 0.798312223787502}], ["x", ["TCGA.CA.6717.01", "SYTL4"], {"weight": 0.809667372459251}], ["x", ["TCGA.CA.6717.01", "MTRR"], {"weight": 0.804057120755268}], ["x", ["TCGA.CA.6717.01", "IL10RB"], {"weight": 0.798807727554278}], ["x", ["TCGA.CA.6717.01", "BMP10"], {"weight": 0.804114206408452}], ["x", ["TCGA.CA.6717.01", "ZNF454"], {"weight": 0.798442628871467}], ["x", ["TCGA.CA.6717.01", "PTPN1"], {"weight": 0.803840867809141}], ["x", ["TCGA.CA.6717.01", "GRK6"], {"weight": 0.803715721347296}], ["x", ["TCGA.CA.6717.01", "GPNMB"], {"weight": 0.804114360016285}], ["x", ["TCGA.CA.6717.01", "PSMA4"], {"weight": 0.803034873036053}], ["x", ["TCGA.CA.6717.01", "MSH4"], {"weight": 0.798264388616599}], ["x", ["TCGA.CA.6717.01", "FOXO1"], {"weight": 0.809268867421023}], ["x", ["TCGA.CA.6717.01", "FOXO4"], {"weight": 0.804248549441241}], ["x", ["TCGA.CA.6717.01", "UBR5"], {"weight": 0.803290907450076}], ["x", ["TCGA.CA.6717.01", "UBR4"], {"weight": 0.803414478599481}], ["x", ["TCGA.CA.6717.01", "INVS"], {"weight": 0.798416246426673}], ["x", ["TCGA.CA.6717.01", "CDC25C"], {"weight": 0.803728938953241}], ["x", ["TCGA.CA.6717.01", "ACAN"], {"weight": 0.809010997122439}], ["x", ["TCGA.CA.6717.01", "SAE1"], {"weight": 0.804175454276199}], ["x", ["TCGA.CA.6717.01", "SDHD"], {"weight": 0.809554009746897}], ["x", ["TCGA.CA.6717.01", "TNXB"], {"weight": 0.803728469329582}], ["x", ["TCGA.CA.6717.01", "DLG1"], {"weight": 0.803645313469486}], ["x", ["TCGA.CA.6717.01", "DLG2"], {"weight": 0.803978736812067}], ["x", ["TCGA.CA.6717.01", "GABRG1"], {"weight": 0.804028185259789}], ["x", ["TCGA.CA.6717.01", "TOMM6"], {"weight": 0.803424190362988}], ["x", ["TCGA.CA.6717.01", "GEMIN5"], {"weight": 0.80938536553172}], ["x", ["TCGA.CA.6717.01", "KIF18A"], {"weight": 0.803128252506852}], ["x", ["TCGA.CA.6717.01", "EIF3A"], {"weight": 0.809120434832343}], ["x", ["TCGA.CA.6717.01", "EIF3E"], {"weight": 0.80914751162253}], ["x", ["TCGA.CA.6717.01", "MKKS"], {"weight": 0.79899879952883}], ["x", ["TCGA.CA.6717.01", "BARD1"], {"weight": 0.803793023296677}], ["x", ["TCGA.CA.6717.01", "SMG1"], {"weight": 0.809546147603207}], ["x", ["TCGA.CA.6717.01", "OR10G4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR10G3"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR10G9"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "DBF4B"], {"weight": 0.798202428898915}], ["x", ["TCGA.CA.6717.01", "GRIK1"], {"weight": 0.798680047971858}], ["x", ["TCGA.CA.6717.01", "GRIK2"], {"weight": 0.798680047971858}], ["x", ["TCGA.CA.6717.01", "GRIK4"], {"weight": 0.798680047971858}], ["x", ["TCGA.CA.6717.01", "GRIK5"], {"weight": 0.798680047971858}], ["x", ["TCGA.CA.6717.01", "ZNF732"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "PPP1R3A"], {"weight": 0.803618892935968}], ["x", ["TCGA.CA.6717.01", "INPP5F"], {"weight": 0.809556351116132}], ["x", ["TCGA.CA.6717.01", "CNST"], {"weight": 0.798243866781215}], ["x", ["TCGA.CA.6717.01", "CHIA"], {"weight": 0.799304102038167}], ["x", ["TCGA.CA.6717.01", "CASR"], {"weight": 0.808882498654508}], ["x", ["TCGA.CA.6717.01", "ADAM23"], {"weight": 0.797893569463489}], ["x", ["TCGA.CA.6717.01", "TTF1"], {"weight": 0.803453858486633}], ["x", ["TCGA.CA.6717.01", "ANXA1"], {"weight": 0.808884869657745}], ["x", ["TCGA.CA.6717.01", "ANXA3"], {"weight": 0.798554002880049}], ["x", ["TCGA.CA.6717.01", "ANXA6"], {"weight": 0.804020664337872}], ["x", ["TCGA.CA.6717.01", "POU5F1"], {"weight": 0.804012296120383}], ["x", ["TCGA.CA.6717.01", "SASS6"], {"weight": 0.798237245984116}], ["x", ["TCGA.CA.6717.01", "PUS7"], {"weight": 0.798404693930341}], ["x", ["TCGA.CA.6717.01", "COL12A1"], {"weight": 0.799316084962364}], ["x", ["TCGA.CA.6717.01", "PFAS"], {"weight": 0.809307077607057}], ["x", ["TCGA.CA.6717.01", "PMS1"], {"weight": 0.798330964990387}], ["x", ["TCGA.CA.6717.01", "GRIP1"], {"weight": 0.804146513758159}], ["x", ["TCGA.CA.6717.01", "MED12L"], {"weight": 0.803534263461652}], ["x", ["TCGA.CA.6717.01", "FAF1"], {"weight": 0.804126151565677}], ["x", ["TCGA.CA.6717.01", "FAF2"], {"weight": 0.802962367323482}], ["x", ["TCGA.CA.6717.01", "PGM1"], {"weight": 0.809370199180078}], ["x", ["TCGA.CA.6717.01", "CDC27"], {"weight": 0.803113600191857}], ["x", ["TCGA.CA.6717.01", "CDC23"], {"weight": 0.803108203400191}], ["x", ["TCGA.CA.6717.01", "STRADB"], {"weight": 0.80393405213546}], ["x", ["TCGA.CA.6717.01", "VPS35"], {"weight": 0.803380950724477}], ["x", ["TCGA.CA.6717.01", "TAS2R41"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "BRAP"], {"weight": 0.803811742754324}], ["x", ["TCGA.CA.6717.01", "NEDD4L"], {"weight": 0.803365875032551}], ["x", ["TCGA.CA.6717.01", "BRAF"], {"weight": 0.804430372307551}], ["x", ["TCGA.CA.6717.01", "TRAF3IP1"], {"weight": 0.798403347785601}], ["x", ["TCGA.CA.6717.01", "MMP16"], {"weight": 0.804599155266839}], ["x", ["TCGA.CA.6717.01", "MMP11"], {"weight": 0.804599155266839}], ["x", ["TCGA.CA.6717.01", "MMP13"], {"weight": 0.803409144591119}], ["x", ["TCGA.CA.6717.01", "SCLT1"], {"weight": 0.803248858469721}], ["x", ["TCGA.CA.6717.01", "ALG10"], {"weight": 0.803736493731312}], ["x", ["TCGA.CA.6717.01", "DDX58"], {"weight": 0.803663388224689}], ["x", ["TCGA.CA.6717.01", "DNAH2"], {"weight": 0.798280556484527}], ["x", ["TCGA.CA.6717.01", "DNAH1"], {"weight": 0.803638090775055}], ["x", ["TCGA.CA.6717.01", "DNAH6"], {"weight": 0.803877784355016}], ["x", ["TCGA.CA.6717.01", "DNAH7"], {"weight": 0.798280556484527}], ["x", ["TCGA.CA.6717.01", "DNAH5"], {"weight": 0.803638090775055}], ["x", ["TCGA.CA.6717.01", "DNAH8"], {"weight": 0.803638090775055}], ["x", ["TCGA.CA.6717.01", "OR8K1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "CALD1"], {"weight": 0.80408083058423}], ["x", ["TCGA.CA.6717.01", "CSTF3"], {"weight": 0.803125154797686}], ["x", ["TCGA.CA.6717.01", "CSTF2"], {"weight": 0.803125154797686}], ["x", ["TCGA.CA.6717.01", "BPTF"], {"weight": 0.803804370352139}], ["x", ["TCGA.CA.6717.01", "JMJD1C"], {"weight": 0.798674778776448}], ["x", ["TCGA.CA.6717.01", "PPP6R3"], {"weight": 0.803519257029612}], ["x", ["TCGA.CA.6717.01", "EFCAB7"], {"weight": 0.803824333512063}], ["x", ["TCGA.CA.6717.01", "SIAE"], {"weight": 0.798463660415433}], ["x", ["TCGA.CA.6717.01", "NPEPPS"], {"weight": 0.797967174358849}], ["x", ["TCGA.CA.6717.01", "GNPNAT1"], {"weight": 0.804165825671988}], ["x", ["TCGA.CA.6717.01", "OR4M1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "SCTR"], {"weight": 0.8091726565582}], ["x", ["TCGA.CA.6717.01", "WNT5A"], {"weight": 0.809030912193202}], ["x", ["TCGA.CA.6717.01", "HNRNPH1"], {"weight": 0.803142917755658}], ["x", ["TCGA.CA.6717.01", "HNRNPUL2"], {"weight": 0.803991831119871}], ["x", ["TCGA.CA.6717.01", "PAIP1"], {"weight": 0.803422337208352}], ["x", ["TCGA.CA.6717.01", "DCAF12"], {"weight": 0.804414057921158}], ["x", ["TCGA.CA.6717.01", "PAPSS1"], {"weight": 0.810057856650586}], ["x", ["TCGA.CA.6717.01", "TXK"], {"weight": 0.803691013909081}], ["x", ["TCGA.CA.6717.01", "SIGLEC11"], {"weight": 0.80349676944315}], ["x", ["TCGA.CA.6717.01", "PLXND1"], {"weight": 0.804048172868711}], ["x", ["TCGA.CA.6717.01", "UROS"], {"weight": 0.809377815655775}], ["x", ["TCGA.CA.6717.01", "NXF3"], {"weight": 0.80364711560858}], ["x", ["TCGA.CA.6717.01", "ANPEP"], {"weight": 0.809608689830825}], ["x", ["TCGA.CA.6717.01", "DCC"], {"weight": 0.804087002005504}], ["x", ["TCGA.CA.6717.01", "POLE"], {"weight": 0.809066365681433}], ["x", ["TCGA.CA.6717.01", "POLN"], {"weight": 0.803139948073792}], ["x", ["TCGA.CA.6717.01", "IL17F"], {"weight": 0.798566687673967}], ["x", ["TCGA.CA.6717.01", "IL17A"], {"weight": 0.798670848758717}], ["x", ["TCGA.CA.6717.01", "PSMD1"], {"weight": 0.803038427657491}], ["x", ["TCGA.CA.6717.01", "CHRDL1"], {"weight": 0.792902035222886}], ["x", ["TCGA.CA.6717.01", "SGMS2"], {"weight": 0.809889961027831}], ["x", ["TCGA.CA.6717.01", "EPS15"], {"weight": 0.803250679187618}], ["x", ["TCGA.CA.6717.01", "ZNF649"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF644"], {"weight": 0.798255726608912}], ["x", ["TCGA.CA.6717.01", "STON2"], {"weight": 0.803293833888647}], ["x", ["TCGA.CA.6717.01", "PRCC"], {"weight": 0.803168460000392}], ["x", ["TCGA.CA.6717.01", "PRCP"], {"weight": 0.804249035406633}], ["x", ["TCGA.CA.6717.01", "ZNF397"], {"weight": 0.791962975958135}], ["x", ["TCGA.CA.6717.01", "IFT52"], {"weight": 0.798377485317147}], ["x", ["TCGA.CA.6717.01", "LPA"], {"weight": 0.804183173308738}], ["x", ["TCGA.CA.6717.01", "JAM3"], {"weight": 0.804204807950306}], ["x", ["TCGA.CA.6717.01", "GALNT5"], {"weight": 0.804406604612198}], ["x", ["TCGA.CA.6717.01", "GALNT7"], {"weight": 0.804406604612198}], ["x", ["TCGA.CA.6717.01", "GALNT2"], {"weight": 0.803539904559158}], ["x", ["TCGA.CA.6717.01", "GALNT3"], {"weight": 0.804391077424309}], ["x", ["TCGA.CA.6717.01", "KIF14"], {"weight": 0.798643907069493}], ["x", ["TCGA.CA.6717.01", "KIF15"], {"weight": 0.80349362890188}], ["x", ["TCGA.CA.6717.01", "KIF11"], {"weight": 0.803411059353688}], ["x", ["TCGA.CA.6717.01", "NLRP4"], {"weight": 0.803404376133591}], ["x", ["TCGA.CA.6717.01", "NLRP1"], {"weight": 0.79817543765473}], ["x", ["TCGA.CA.6717.01", "NLRP2"], {"weight": 0.79585230343671}], ["x", ["TCGA.CA.6717.01", "NLRP8"], {"weight": 0.793447520102857}], ["x", ["TCGA.CA.6717.01", "CD101"], {"weight": 0.803769557531997}], ["x", ["TCGA.CA.6717.01", "KIF1B"], {"weight": 0.803504920890282}], ["x", ["TCGA.CA.6717.01", "CD109"], {"weight": 0.809667372459251}], ["x", ["TCGA.CA.6717.01", "ZFP30"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "LOXL3"], {"weight": 0.798796716646226}], ["x", ["TCGA.CA.6717.01", "DEFB126"], {"weight": 0.804371281536558}], ["x", ["TCGA.CA.6717.01", "COPB1"], {"weight": 0.803329257598722}], ["x", ["TCGA.CA.6717.01", "POFUT2"], {"weight": 0.804127427546024}], ["x", ["TCGA.CA.6717.01", "ZNF616"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "BOD1L1"], {"weight": 0.797995338176407}], ["x", ["TCGA.CA.6717.01", "MAP4K3"], {"weight": 0.804335931847733}], ["x", ["TCGA.CA.6717.01", "TRIM71"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "NRG1"], {"weight": 0.809416816591204}], ["x", ["TCGA.CA.6717.01", "NRG3"], {"weight": 0.809469973135739}], ["x", ["TCGA.CA.6717.01", "KHK"], {"weight": 0.809451929807418}], ["x", ["TCGA.CA.6717.01", "OR1L1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "TRAK1"], {"weight": 0.799283715342217}], ["x", ["TCGA.CA.6717.01", "ZFC3H1"], {"weight": 0.793303565266127}], ["x", ["TCGA.CA.6717.01", "STAG1"], {"weight": 0.803202475295853}], ["x", ["TCGA.CA.6717.01", "RNF220"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "PLS1"], {"weight": 0.798824264037409}], ["x", ["TCGA.CA.6717.01", "CLASP1"], {"weight": 0.803630410777258}], ["x", ["TCGA.CA.6717.01", "RAD54L2"], {"weight": 0.799029900739844}], ["x", ["TCGA.CA.6717.01", "HACL1"], {"weight": 0.804325606903021}], ["x", ["TCGA.CA.6717.01", "IQSEC1"], {"weight": 0.804065381465703}], ["x", ["TCGA.CA.6717.01", "SESN1"], {"weight": 0.804087581687065}], ["x", ["TCGA.CA.6717.01", "ZFYVE16"], {"weight": 0.798312890715075}], ["x", ["TCGA.CA.6717.01", "SLIT1"], {"weight": 0.804413079797146}], ["x", ["TCGA.CA.6717.01", "ZNF680"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "PDE8A"], {"weight": 0.809470396923783}], ["x", ["TCGA.CA.6717.01", "DBT"], {"weight": 0.80943924160682}], ["x", ["TCGA.CA.6717.01", "MED1"], {"weight": 0.82116774387749}], ["x", ["TCGA.CA.6717.01", "TCF7"], {"weight": 0.803259258020059}], ["x", ["TCGA.CA.6717.01", "PPP5C"], {"weight": 0.804024995682818}], ["x", ["TCGA.CA.6717.01", "MDN1"], {"weight": 0.803820230608611}], ["x", ["TCGA.CA.6717.01", "AMPD1"], {"weight": 0.809421536813687}], ["x", ["TCGA.CA.6717.01", "MYO18B"], {"weight": 0.798504511058344}], ["x", ["TCGA.CA.6717.01", "AXIN1"], {"weight": 0.80389858920134}], ["x", ["TCGA.CA.6717.01", "MMRN1"], {"weight": 0.80458572189113}], ["x", ["TCGA.CA.6717.01", "PLA2R1"], {"weight": 0.80996389983678}], ["x", ["TCGA.CA.6717.01", "TSSK1B"], {"weight": 0.803609035827305}], ["x", ["TCGA.CA.6717.01", "CD34"], {"weight": 0.803817581753296}], ["x", ["TCGA.CA.6717.01", "CD36"], {"weight": 0.799771779767961}], ["x", ["TCGA.CA.6717.01", "TOPORS"], {"weight": 0.79800708284468}], ["x", ["TCGA.CA.6717.01", "OR9K2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "ADAMTS12"], {"weight": 0.804127427546024}], ["x", ["TCGA.CA.6717.01", "ADAMTS16"], {"weight": 0.8032904231433}], ["x", ["TCGA.CA.6717.01", "ADAMTS18"], {"weight": 0.8032904231433}], ["x", ["TCGA.CA.6717.01", "KERA"], {"weight": 0.808998724015546}], ["x", ["TCGA.CA.6717.01", "OR51A7"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR52A1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "RASGRF2"], {"weight": 0.803721056989214}], ["x", ["TCGA.CA.6717.01", "ZNF480"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF483"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF485"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ESD"], {"weight": 0.81616054560764}], ["x", ["TCGA.CA.6717.01", "DSPP"], {"weight": 0.80461647223628}], ["x", ["TCGA.CA.6717.01", "NR1H4"], {"weight": 0.809506188818967}], ["x", ["TCGA.CA.6717.01", "GRM7"], {"weight": 0.80900726530888}], ["x", ["TCGA.CA.6717.01", "NR2F1"], {"weight": 0.804072592304206}], ["x", ["TCGA.CA.6717.01", "NOXRED1"], {"weight": 0.798320747850057}], ["x", ["TCGA.CA.6717.01", "EIF2S2"], {"weight": 0.809134690314881}], ["x", ["TCGA.CA.6717.01", "TRAT1"], {"weight": 0.803873506667186}], ["x", ["TCGA.CA.6717.01", "TPR"], {"weight": 0.803466487205048}], ["x", ["TCGA.CA.6717.01", "SNAI2"], {"weight": 0.803684262270538}], ["x", ["TCGA.CA.6717.01", "HRG"], {"weight": 0.804575749199806}], ["x", ["TCGA.CA.6717.01", "ECHS1"], {"weight": 0.80997446685026}], ["x", ["TCGA.CA.6717.01", "PVALB"], {"weight": 0.804047131128659}], ["x", ["TCGA.CA.6717.01", "SCIN"], {"weight": 0.804110207591079}], ["x", ["TCGA.CA.6717.01", "PPP4R4"], {"weight": 0.803413881603709}], ["x", ["TCGA.CA.6717.01", "PPP4R1"], {"weight": 0.803036024398138}], ["x", ["TCGA.CA.6717.01", "MAP3K2"], {"weight": 0.804313723415563}], ["x", ["TCGA.CA.6717.01", "MAP3K1"], {"weight": 0.80483872255622}], ["x", ["TCGA.CA.6717.01", "ZWILCH"], {"weight": 0.80331141005835}], ["x", ["TCGA.CA.6717.01", "SETD2"], {"weight": 0.803804699980801}], ["x", ["TCGA.CA.6717.01", "DZIP3"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "TACC2"], {"weight": 0.797936535308237}], ["x", ["TCGA.CA.6717.01", "ST8SIA4"], {"weight": 0.799082236253343}], ["x", ["TCGA.CA.6717.01", "OR2A25"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "CTDNEP1"], {"weight": 0.80366212714683}], ["x", ["TCGA.CA.6717.01", "MASTL"], {"weight": 0.803274756612443}], ["x", ["TCGA.CA.6717.01", "MAST4"], {"weight": 0.797870825460444}], ["x", ["TCGA.CA.6717.01", "CD180"], {"weight": 0.80441630999632}], ["x", ["TCGA.CA.6717.01", "IL23R"], {"weight": 0.803889383450556}], ["x", ["TCGA.CA.6717.01", "TLN1"], {"weight": 0.804161769196997}], ["x", ["TCGA.CA.6717.01", "STRN"], {"weight": 0.803982211916554}], ["x", ["TCGA.CA.6717.01", "SYN3"], {"weight": 0.798449294533989}], ["x", ["TCGA.CA.6717.01", "ZNF556"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "RNASEL"], {"weight": 0.798693437364373}], ["x", ["TCGA.CA.6717.01", "USP26"], {"weight": 0.798161853048758}], ["x", ["TCGA.CA.6717.01", "ZNF558"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF568"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF564"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "OR5AS1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "SDAD1"], {"weight": 0.803615382854325}], ["x", ["TCGA.CA.6717.01", "FGF8"], {"weight": 0.798345283653129}], ["x", ["TCGA.CA.6717.01", "SDC2"], {"weight": 0.809814741112353}], ["x", ["TCGA.CA.6717.01", "NMRK1"], {"weight": 0.809447591180682}], ["x", ["TCGA.CA.6717.01", "XYLB"], {"weight": 0.809838109224642}], ["x", ["TCGA.CA.6717.01", "PCDH7"], {"weight": 0.809614071290135}], ["x", ["TCGA.CA.6717.01", "DGKG"], {"weight": 0.809412721122133}], ["x", ["TCGA.CA.6717.01", "DDX55"], {"weight": 0.803426089559267}], ["x", ["TCGA.CA.6717.01", "BTAF1"], {"weight": 0.79864025079175}], ["x", ["TCGA.CA.6717.01", "KIAA0319"], {"weight": 0.803324306242489}], ["x", ["TCGA.CA.6717.01", "LHX6"], {"weight": 0.793535509272572}], ["x", ["TCGA.CA.6717.01", "COL2A1"], {"weight": 0.802892053988756}], ["x", ["TCGA.CA.6717.01", "DNAH3"], {"weight": 0.803638090775055}], ["x", ["TCGA.CA.6717.01", "FOLH1"], {"weight": 0.81004073706884}], ["x", ["TCGA.CA.6717.01", "EXOC3"], {"weight": 0.803439094401789}], ["x", ["TCGA.CA.6717.01", "EXOC1"], {"weight": 0.803465375309731}], ["x", ["TCGA.CA.6717.01", "HAP1"], {"weight": 0.798713357022701}], ["x", ["TCGA.CA.6717.01", "ANK1"], {"weight": 0.803432400804118}], ["x", ["TCGA.CA.6717.01", "ANK2"], {"weight": 0.803435187643025}], ["x", ["TCGA.CA.6717.01", "ANK3"], {"weight": 0.803449558690532}], ["x", ["TCGA.CA.6717.01", "CENPO"], {"weight": 0.803248415544379}], ["x", ["TCGA.CA.6717.01", "CENPJ"], {"weight": 0.803248415544379}], ["x", ["TCGA.CA.6717.01", "CENPH"], {"weight": 0.803250593461149}], ["x", ["TCGA.CA.6717.01", "CENPF"], {"weight": 0.80331141005835}], ["x", ["TCGA.CA.6717.01", "CENPE"], {"weight": 0.803128252506852}], ["x", ["TCGA.CA.6717.01", "SSH2"], {"weight": 0.798438910798859}], ["x", ["TCGA.CA.6717.01", "CENPW"], {"weight": 0.798438552476348}], ["x", ["TCGA.CA.6717.01", "DHX30"], {"weight": 0.798182551865534}], ["x", ["TCGA.CA.6717.01", "DHX34"], {"weight": 0.798225384183454}], ["x", ["TCGA.CA.6717.01", "GREB1"], {"weight": 0.798622027975495}], ["x", ["TCGA.CA.6717.01", "MYO9A"], {"weight": 0.798531497439089}], ["x", ["TCGA.CA.6717.01", "ARSJ"], {"weight": 0.803917752283612}], ["x", ["TCGA.CA.6717.01", "EZH2"], {"weight": 0.803641857689018}], ["x", ["TCGA.CA.6717.01", "STIP1"], {"weight": 0.803652479787255}], ["x", ["TCGA.CA.6717.01", "ABCC1"], {"weight": 0.815069382184768}], ["x", ["TCGA.CA.6717.01", "STAP1"], {"weight": 0.798544025336378}], ["x", ["TCGA.CA.6717.01", "MRRF"], {"weight": 0.803472517224036}], ["x", ["TCGA.CA.6717.01", "PGGT1B"], {"weight": 0.798382132545438}], ["x", ["TCGA.CA.6717.01", "RXFP2"], {"weight": 0.809170275007116}], ["x", ["TCGA.CA.6717.01", "RBM34"], {"weight": 0.803306851976226}], ["x", ["TCGA.CA.6717.01", "TIE1"], {"weight": 0.803609035827305}], ["x", ["TCGA.CA.6717.01", "SH3GL3"], {"weight": 0.803289426702626}], ["x", ["TCGA.CA.6717.01", "SH3GL2"], {"weight": 0.803190775748331}], ["x", ["TCGA.CA.6717.01", "UGGT2"], {"weight": 0.798466474522931}], ["x", ["TCGA.CA.6717.01", "DCLRE1C"], {"weight": 0.803546746468752}], ["x", ["TCGA.CA.6717.01", "CYP4A22"], {"weight": 0.809223560648124}], ["x", ["TCGA.CA.6717.01", "ZNF804B"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "LYPLA1"], {"weight": 0.809470396923783}], ["x", ["TCGA.CA.6717.01", "MC2R"], {"weight": 0.8091726565582}], ["x", ["TCGA.CA.6717.01", "RBPMS2"], {"weight": 0.798843054315255}], ["x", ["TCGA.CA.6717.01", "MTHFD2L"], {"weight": 0.809489123154348}], ["x", ["TCGA.CA.6717.01", "GOPC"], {"weight": 0.798726632912948}], ["x", ["TCGA.CA.6717.01", "ARHGEF26"], {"weight": 0.798945042754528}], ["x", ["TCGA.CA.6717.01", "DSCAM"], {"weight": 0.803910882765328}], ["x", ["TCGA.CA.6717.01", "OSMR"], {"weight": 0.803409257360821}], ["x", ["TCGA.CA.6717.01", "BIVM"], {"weight": 0.798554016849424}], ["x", ["TCGA.CA.6717.01", "SPTSSB"], {"weight": 0.809889961027831}], ["x", ["TCGA.CA.6717.01", "ANKRA2"], {"weight": 0.798798928889806}], ["x", ["TCGA.CA.6717.01", "HFM1"], {"weight": 0.803505819201353}], ["x", ["TCGA.CA.6717.01", "RXRG"], {"weight": 0.803848840292658}], ["x", ["TCGA.CA.6717.01", "ABCA7"], {"weight": 0.803904198481003}], ["x", ["TCGA.CA.6717.01", "NBEAL1"], {"weight": 0.798364651748122}], ["x", ["TCGA.CA.6717.01", "NBEAL2"], {"weight": 0.798364651748122}], ["x", ["TCGA.CA.6717.01", "ACSM2A"], {"weight": 0.809584319939477}], ["x", ["TCGA.CA.6717.01", "KCNU1"], {"weight": 0.803457140132091}], ["x", ["TCGA.CA.6717.01", "TRA2A"], {"weight": 0.798933164010845}], ["x", ["TCGA.CA.6717.01", "VLDLR"], {"weight": 0.809581638900087}], ["x", ["TCGA.CA.6717.01", "ETFA"], {"weight": 0.812006270248386}], ["x", ["TCGA.CA.6717.01", "TRAF3IP3"], {"weight": 0.804293594343946}], ["x", ["TCGA.CA.6717.01", "NDC80"], {"weight": 0.803300743369676}], ["x", ["TCGA.CA.6717.01", "INTS6"], {"weight": 0.803362630512228}], ["x", ["TCGA.CA.6717.01", "INTS8"], {"weight": 0.80340213200452}], ["x", ["TCGA.CA.6717.01", "MPP1"], {"weight": 0.793653909342677}], ["x", ["TCGA.CA.6717.01", "SFTPC"], {"weight": 0.803757669355064}], ["x", ["TCGA.CA.6717.01", "MPP4"], {"weight": 0.799106439658631}], ["x", ["TCGA.CA.6717.01", "MYLK"], {"weight": 0.803956967384499}], ["x", ["TCGA.CA.6717.01", "YME1L1"], {"weight": 0.798436200508504}], ["x", ["TCGA.CA.6717.01", "GORASP1"], {"weight": 0.803872230502318}], ["x", ["TCGA.CA.6717.01", "FNDC3A"], {"weight": 0.797847024099484}], ["x", ["TCGA.CA.6717.01", "CCDC138"], {"weight": 0.798459056665688}], ["x", ["TCGA.CA.6717.01", "STK36"], {"weight": 0.803744823071229}], ["x", ["TCGA.CA.6717.01", "CHRNB3"], {"weight": 0.798453254312441}], ["x", ["TCGA.CA.6717.01", "PLXNA4"], {"weight": 0.809477437720191}], ["x", ["TCGA.CA.6717.01", "SCAI"], {"weight": 0.804245615138551}], ["x", ["TCGA.CA.6717.01", "BDNF"], {"weight": 0.804141750849082}], ["x", ["TCGA.CA.6717.01", "KDM5A"], {"weight": 0.80440355864778}], ["x", ["TCGA.CA.6717.01", "KDM5B"], {"weight": 0.798769909983259}], ["x", ["TCGA.CA.6717.01", "GYS2"], {"weight": 0.809390617570562}], ["x", ["TCGA.CA.6717.01", "ETV1"], {"weight": 0.804495653326046}], ["x", ["TCGA.CA.6717.01", "CACYBP"], {"weight": 0.798358727381905}], ["x", ["TCGA.CA.6717.01", "BRPF3"], {"weight": 0.803649662735296}], ["x", ["TCGA.CA.6717.01", "BRPF1"], {"weight": 0.803649662735296}], ["x", ["TCGA.CA.6717.01", "OVCH1"], {"weight": 0.804513206354704}], ["x", ["TCGA.CA.6717.01", "FBXL13"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "FBXL17"], {"weight": 0.798186314430611}], ["x", ["TCGA.CA.6717.01", "FBXL18"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "GRP"], {"weight": 0.803252245993784}], ["x", ["TCGA.CA.6717.01", "THSD4"], {"weight": 0.804127427546024}], ["x", ["TCGA.CA.6717.01", "AFTPH"], {"weight": 0.798161917054121}], ["x", ["TCGA.CA.6717.01", "ZC3H15"], {"weight": 0.80412430602887}], ["x", ["TCGA.CA.6717.01", "ATP1A4"], {"weight": 0.804027798486895}], ["x", ["TCGA.CA.6717.01", "ATP1A2"], {"weight": 0.803930940899551}], ["x", ["TCGA.CA.6717.01", "ATP1A1"], {"weight": 0.803896490804038}], ["x", ["TCGA.CA.6717.01", "IFT88"], {"weight": 0.798377485317147}], ["x", ["TCGA.CA.6717.01", "HMG20A"], {"weight": 0.79864265677383}], ["x", ["TCGA.CA.6717.01", "NRXN2"], {"weight": 0.798455049152855}], ["x", ["TCGA.CA.6717.01", "NRXN1"], {"weight": 0.798449468645363}], ["x", ["TCGA.CA.6717.01", "PPP6R2"], {"weight": 0.803257379316971}], ["x", ["TCGA.CA.6717.01", "LARP4B"], {"weight": 0.8041903696308}], ["x", ["TCGA.CA.6717.01", "VCL"], {"weight": 0.804078924437063}], ["x", ["TCGA.CA.6717.01", "DNAJA4"], {"weight": 0.799275050919652}], ["x", ["TCGA.CA.6717.01", "UTRN"], {"weight": 0.803921062647509}], ["x", ["TCGA.CA.6717.01", "UBR1"], {"weight": 0.803412283420566}], ["x", ["TCGA.CA.6717.01", "MYO1H"], {"weight": 0.797675179078979}], ["x", ["TCGA.CA.6717.01", "MYO1E"], {"weight": 0.797586221483541}], ["x", ["TCGA.CA.6717.01", "MYO1D"], {"weight": 0.797675179078979}], ["x", ["TCGA.CA.6717.01", "MYO1B"], {"weight": 0.797586221483541}], ["x", ["TCGA.CA.6717.01", "NEMF"], {"weight": 0.803846331489116}], ["x", ["TCGA.CA.6717.01", "NMS"], {"weight": 0.808891075967916}], ["x", ["TCGA.CA.6717.01", "MYO16"], {"weight": 0.798854782579459}], ["x", ["TCGA.CA.6717.01", "TRNT1"], {"weight": 0.804277455791625}], ["x", ["TCGA.CA.6717.01", "PTGS2"], {"weight": 0.809202289766463}], ["x", ["TCGA.CA.6717.01", "ZFAND5"], {"weight": 0.799015561408739}], ["x", ["TCGA.CA.6717.01", "EVI5"], {"weight": 0.797645065677919}], ["x", ["TCGA.CA.6717.01", "TERF1"], {"weight": 0.798302026134172}], ["x", ["TCGA.CA.6717.01", "CHD1"], {"weight": 0.793366860115485}], ["x", ["TCGA.CA.6717.01", "CHD4"], {"weight": 0.803650218783931}], ["x", ["TCGA.CA.6717.01", "CHD7"], {"weight": 0.804335267154958}], ["x", ["TCGA.CA.6717.01", "CHD9"], {"weight": 0.8197436919928}], ["x", ["TCGA.CA.6717.01", "CHD8"], {"weight": 0.803919051954641}], ["x", ["TCGA.CA.6717.01", "CAP1"], {"weight": 0.810180722002061}], ["x", ["TCGA.CA.6717.01", "CAP2"], {"weight": 0.804413079797146}], ["x", ["TCGA.CA.6717.01", "TTC5"], {"weight": 0.803802977541803}], ["x", ["TCGA.CA.6717.01", "TTC4"], {"weight": 0.80348472777241}], ["x", ["TCGA.CA.6717.01", "PIKFYVE"], {"weight": 0.809418926497987}], ["x", ["TCGA.CA.6717.01", "TTC8"], {"weight": 0.803682390268915}], ["x", ["TCGA.CA.6717.01", "PRDM16"], {"weight": 0.798674778776448}], ["x", ["TCGA.CA.6717.01", "MPO"], {"weight": 0.803778327575881}], ["x", ["TCGA.CA.6717.01", "TRPC5"], {"weight": 0.803169495506072}], ["x", ["TCGA.CA.6717.01", "ADH5"], {"weight": 0.809416339582502}], ["x", ["TCGA.CA.6717.01", "RMI1"], {"weight": 0.803510128482449}], ["x", ["TCGA.CA.6717.01", "GRIN2A"], {"weight": 0.809372531700658}], ["x", ["TCGA.CA.6717.01", "IL6ST"], {"weight": 0.803573479124608}], ["x", ["TCGA.CA.6717.01", "TAS2R16"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "TAS2R10"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "TAS2R13"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "CYP26A1"], {"weight": 0.796049009330839}], ["x", ["TCGA.CA.6717.01", "RRP12"], {"weight": 0.803598952033283}], ["x", ["TCGA.CA.6717.01", "ACAT1"], {"weight": 0.814247804698156}], ["x", ["TCGA.CA.6717.01", "OR8S1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "IL2RG"], {"weight": 0.804226220365303}], ["x", ["TCGA.CA.6717.01", "ZFYVE28"], {"weight": 0.798375866735827}], ["x", ["TCGA.CA.6717.01", "ERC1"], {"weight": 0.803202338509794}], ["x", ["TCGA.CA.6717.01", "ERC2"], {"weight": 0.804057244361245}], ["x", ["TCGA.CA.6717.01", "SLC37A2"], {"weight": 0.804418399370376}], ["x", ["TCGA.CA.6717.01", "B3GNT4"], {"weight": 0.809434501925555}], ["x", ["TCGA.CA.6717.01", "B3GNT2"], {"weight": 0.809428118958911}], ["x", ["TCGA.CA.6717.01", "FN1"], {"weight": 0.804391546591919}], ["x", ["TCGA.CA.6717.01", "TBC1D4"], {"weight": 0.803712066249246}], ["x", ["TCGA.CA.6717.01", "PTK2"], {"weight": 0.804282086184473}], ["x", ["TCGA.CA.6717.01", "PRKAA2"], {"weight": 0.809589839111164}], ["x", ["TCGA.CA.6717.01", "PRKAA1"], {"weight": 0.809275723070883}], ["x", ["TCGA.CA.6717.01", "ATG16L1"], {"weight": 0.80349223338209}], ["x", ["TCGA.CA.6717.01", "DDX23"], {"weight": 0.803147536158318}], ["x", ["TCGA.CA.6717.01", "DDX20"], {"weight": 0.80933781579765}], ["x", ["TCGA.CA.6717.01", "ZNF157"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "DDX24"], {"weight": 0.803588303653463}], ["x", ["TCGA.CA.6717.01", "NT5M"], {"weight": 0.809335109120611}], ["x", ["TCGA.CA.6717.01", "NT5E"], {"weight": 0.80922513887938}], ["x", ["TCGA.CA.6717.01", "ZNF430"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "PTCD3"], {"weight": 0.803481138580148}], ["x", ["TCGA.CA.6717.01", "NAA15"], {"weight": 0.795563633331948}], ["x", ["TCGA.CA.6717.01", "OR52J3"], {"weight": 0.803991169588641}], ["x", ["TCGA.CA.6717.01", "RNF6"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "TMCO3"], {"weight": 0.798617672078691}], ["x", ["TCGA.CA.6717.01", "ACTR3"], {"weight": 0.80356656262287}], ["x", ["TCGA.CA.6717.01", "GNRHR"], {"weight": 0.803255816880772}], ["x", ["TCGA.CA.6717.01", "KHDRBS2"], {"weight": 0.798721964603053}], ["x", ["TCGA.CA.6717.01", "WNT8B"], {"weight": 0.809365328056431}], ["x", ["TCGA.CA.6717.01", "HIPK1"], {"weight": 0.803895072220069}], ["x", ["TCGA.CA.6717.01", "LEMD3"], {"weight": 0.803690265714934}], ["x", ["TCGA.CA.6717.01", "NAPA"], {"weight": 0.803022611608526}], ["x", ["TCGA.CA.6717.01", "LARP7"], {"weight": 0.793476889590141}], ["x", ["TCGA.CA.6717.01", "LGR5"], {"weight": 0.803336530724446}], ["x", ["TCGA.CA.6717.01", "BIRC6"], {"weight": 0.797946201362953}], ["x", ["TCGA.CA.6717.01", "S100A7"], {"weight": 0.798832582209576}], ["x", ["TCGA.CA.6717.01", "AIP"], {"weight": 0.804871316129602}], ["x", ["TCGA.CA.6717.01", "ZNF528"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "KDM3B"], {"weight": 0.798674778776448}], ["x", ["TCGA.CA.6717.01", "URB1"], {"weight": 0.803801172447885}], ["x", ["TCGA.CA.6717.01", "SEC24D"], {"weight": 0.80370064275479}], ["x", ["TCGA.CA.6717.01", "SEC24A"], {"weight": 0.803824237334936}], ["x", ["TCGA.CA.6717.01", "SHF"], {"weight": 0.798954183295659}], ["x", ["TCGA.CA.6717.01", "DYNC2H1"], {"weight": 0.803685593208603}], ["x", ["TCGA.CA.6717.01", "OR1D2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "STX7"], {"weight": 0.798456007414377}], ["x", ["TCGA.CA.6717.01", "KIF2B"], {"weight": 0.803129677159219}], ["x", ["TCGA.CA.6717.01", "BRCA1"], {"weight": 0.803781658626773}], ["x", ["TCGA.CA.6717.01", "BRCA2"], {"weight": 0.803507029214318}], ["x", ["TCGA.CA.6717.01", "SMURF1"], {"weight": 0.803961583076795}], ["x", ["TCGA.CA.6717.01", "SYCE1"], {"weight": 0.797819653451895}], ["x", ["TCGA.CA.6717.01", "UVRAG"], {"weight": 0.803670497413533}], ["x", ["TCGA.CA.6717.01", "COPG1"], {"weight": 0.803335072308296}], ["x", ["TCGA.CA.6717.01", "POLQ"], {"weight": 0.79862080824108}], ["x", ["TCGA.CA.6717.01", "PCGF5"], {"weight": 0.798044664003655}], ["x", ["TCGA.CA.6717.01", "CX3CR1"], {"weight": 0.803562003185126}], ["x", ["TCGA.CA.6717.01", "SMC1A"], {"weight": 0.803193404691788}], ["x", ["TCGA.CA.6717.01", "SMC1B"], {"weight": 0.797970733545599}], ["x", ["TCGA.CA.6717.01", "TRIM45"], {"weight": 0.798681659248344}], ["x", ["TCGA.CA.6717.01", "NEB"], {"weight": 0.79871339277941}], ["x", ["TCGA.CA.6717.01", "PFDN4"], {"weight": 0.804136528471498}], ["x", ["TCGA.CA.6717.01", "MTHFR"], {"weight": 0.815008891930778}], ["x", ["TCGA.CA.6717.01", "PDE4DIP"], {"weight": 0.803916513342339}], ["x", ["TCGA.CA.6717.01", "LATS2"], {"weight": 0.798510411571113}], ["x", ["TCGA.CA.6717.01", "TAF1B"], {"weight": 0.803720769204201}], ["x", ["TCGA.CA.6717.01", "F9"], {"weight": 0.804358929016808}], ["x", ["TCGA.CA.6717.01", "CHL1"], {"weight": 0.803970586061182}], ["x", ["TCGA.CA.6717.01", "ERLIN1"], {"weight": 0.803226112102149}], ["x", ["TCGA.CA.6717.01", "CPSF3"], {"weight": 0.803092618383083}], ["x", ["TCGA.CA.6717.01", "TTLL5"], {"weight": 0.798459056665688}], ["x", ["TCGA.CA.6717.01", "DBF4"], {"weight": 0.803841993385579}], ["x", ["TCGA.CA.6717.01", "GCC1"], {"weight": 0.798461868428983}], ["x", ["TCGA.CA.6717.01", "TBC1D8B"], {"weight": 0.803455029121301}], ["x", ["TCGA.CA.6717.01", "OR6A2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "ZNF398"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "RLN2"], {"weight": 0.809175058579812}], ["x", ["TCGA.CA.6717.01", "CRNKL1"], {"weight": 0.803135382279285}], ["x", ["TCGA.CA.6717.01", "CPB2"], {"weight": 0.803499778004928}], ["x", ["TCGA.CA.6717.01", "ZNF583"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "GPD1L"], {"weight": 0.809425497125627}], ["x", ["TCGA.CA.6717.01", "AOX1"], {"weight": 0.809471528735435}], ["x", ["TCGA.CA.6717.01", "TIMM9"], {"weight": 0.803377530768237}], ["x", ["TCGA.CA.6717.01", "PKN2"], {"weight": 0.80383674903052}], ["x", ["TCGA.CA.6717.01", "KCNE2"], {"weight": 0.798367439944345}], ["x", ["TCGA.CA.6717.01", "PRAM1"], {"weight": 0.798180086128253}], ["x", ["TCGA.CA.6717.01", "CSNK1D"], {"weight": 0.803333413578125}], ["x", ["TCGA.CA.6717.01", "ADAMTS20"], {"weight": 0.804127427546024}], ["x", ["TCGA.CA.6717.01", "USP15"], {"weight": 0.803139948073792}], ["x", ["TCGA.CA.6717.01", "CIT"], {"weight": 0.798480828768875}], ["x", ["TCGA.CA.6717.01", "CUBN"], {"weight": 0.810067696073032}], ["x", ["TCGA.CA.6717.01", "OR52B6"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "DIMT1"], {"weight": 0.80363120894516}], ["x", ["TCGA.CA.6717.01", "PARP14"], {"weight": 0.803907120084677}], ["x", ["TCGA.CA.6717.01", "TUBA1B"], {"weight": 0.804037772647765}], ["x", ["TCGA.CA.6717.01", "EVC"], {"weight": 0.798589373840951}], ["x", ["TCGA.CA.6717.01", "WSB1"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "FTCD"], {"weight": 0.815300999009057}], ["x", ["TCGA.CA.6717.01", "MINPP1"], {"weight": 0.81602593000278}], ["x", ["TCGA.CA.6717.01", "GANAB"], {"weight": 0.798856102214638}], ["x", ["TCGA.CA.6717.01", "RAB2A"], {"weight": 0.803781740726153}], ["x", ["TCGA.CA.6717.01", "ETNK2"], {"weight": 0.809844063342209}], ["x", ["TCGA.CA.6717.01", "RAB23"], {"weight": 0.798081421446685}], ["x", ["TCGA.CA.6717.01", "PPP2R3A"], {"weight": 0.803486256366025}], ["x", ["TCGA.CA.6717.01", "ARRDC1"], {"weight": 0.798266385685382}], ["x", ["TCGA.CA.6717.01", "OR4C13"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "TNS1"], {"weight": 0.80407480572819}], ["x", ["TCGA.CA.6717.01", "HIF1A"], {"weight": 0.809659854313787}], ["x", ["TCGA.CA.6717.01", "FBXW7"], {"weight": 0.803403664471096}], ["x", ["TCGA.CA.6717.01", "TGFBR1"], {"weight": 0.803849338165781}], ["x", ["TCGA.CA.6717.01", "TJP2"], {"weight": 0.798504479670425}], ["x", ["TCGA.CA.6717.01", "CCT6A"], {"weight": 0.80383864878071}], ["x", ["TCGA.CA.6717.01", "PER2"], {"weight": 0.803945183123984}], ["x", ["TCGA.CA.6717.01", "ZNF610"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF615"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SLC3A1"], {"weight": 0.799621986816784}], ["x", ["TCGA.CA.6717.01", "MS4A13"], {"weight": 0.803847389033648}], ["x", ["TCGA.CA.6717.01", "OR1L8"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "MSRB3"], {"weight": 0.804770160387189}], ["x", ["TCGA.CA.6717.01", "CAMK1G"], {"weight": 0.803965562849256}], ["x", ["TCGA.CA.6717.01", "HHAT"], {"weight": 0.80410347431575}], ["x", ["TCGA.CA.6717.01", "WDR5B"], {"weight": 0.798325944685018}], ["x", ["TCGA.CA.6717.01", "NALCN"], {"weight": 0.804054595524923}], ["x", ["TCGA.CA.6717.01", "TDRD9"], {"weight": 0.803609368857948}], ["x", ["TCGA.CA.6717.01", "TDRD3"], {"weight": 0.798129145578995}], ["x", ["TCGA.CA.6717.01", "TDRD7"], {"weight": 0.797933986618305}], ["x", ["TCGA.CA.6717.01", "TLK2"], {"weight": 0.798101053958551}], ["x", ["TCGA.CA.6717.01", "CACNB4"], {"weight": 0.803039023694468}], ["x", ["TCGA.CA.6717.01", "B3GALNT1"], {"weight": 0.804695808401527}], ["x", ["TCGA.CA.6717.01", "KIF20B"], {"weight": 0.803504920890282}], ["x", ["TCGA.CA.6717.01", "GNAT3"], {"weight": 0.808969749645826}], ["x", ["TCGA.CA.6717.01", "ZNF551"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF559"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "CACNG3"], {"weight": 0.803358974419629}], ["x", ["TCGA.CA.6717.01", "CACNG4"], {"weight": 0.803443536080136}], ["x", ["TCGA.CA.6717.01", "ATF4"], {"weight": 0.803600115745564}], ["x", ["TCGA.CA.6717.01", "PTGER3"], {"weight": 0.809009948507908}], ["x", ["TCGA.CA.6717.01", "OR13C4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "SENP5"], {"weight": 0.798117413901938}], ["x", ["TCGA.CA.6717.01", "EPS8"], {"weight": 0.804345234388001}], ["x", ["TCGA.CA.6717.01", "ADAMTSL3"], {"weight": 0.804127427546024}], ["x", ["TCGA.CA.6717.01", "SEPSECS"], {"weight": 0.809571482912598}], ["x", ["TCGA.CA.6717.01", "CEPT1"], {"weight": 0.809630624262674}], ["x", ["TCGA.CA.6717.01", "ZNF790"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF791"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF792"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "PPP1R7"], {"weight": 0.798399175400472}], ["x", ["TCGA.CA.6717.01", "FGFR2"], {"weight": 0.803648294603809}], ["x", ["TCGA.CA.6717.01", "FGFR1"], {"weight": 0.803706062206344}], ["x", ["TCGA.CA.6717.01", "DCTD"], {"weight": 0.809378945201899}], ["x", ["TCGA.CA.6717.01", "UBE2T"], {"weight": 0.803006380166825}], ["x", ["TCGA.CA.6717.01", "PDE3B"], {"weight": 0.809297384478442}], ["x", ["TCGA.CA.6717.01", "ASMT"], {"weight": 0.809481892152905}], ["x", ["TCGA.CA.6717.01", "BIRC7"], {"weight": 0.798896432886597}], ["x", ["TCGA.CA.6717.01", "EIF1"], {"weight": 0.803558536523363}], ["x", ["TCGA.CA.6717.01", "BIRC2"], {"weight": 0.80361904747676}], ["x", ["TCGA.CA.6717.01", "ANKRD17"], {"weight": 0.809985512465928}], ["x", ["TCGA.CA.6717.01", "STRA6"], {"weight": 0.804049656170816}], ["x", ["TCGA.CA.6717.01", "NT5C2"], {"weight": 0.80942417096826}], ["x", ["TCGA.CA.6717.01", "SIGLEC10"], {"weight": 0.798606782286282}], ["x", ["TCGA.CA.6717.01", "HIBADH"], {"weight": 0.80370564600479}], ["x", ["TCGA.CA.6717.01", "TNFAIP3"], {"weight": 0.80395567537939}], ["x", ["TCGA.CA.6717.01", "OR13D1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "ARHGEF10"], {"weight": 0.798581352109374}], ["x", ["TCGA.CA.6717.01", "ARHGEF17"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "REN"], {"weight": 0.803652954728205}], ["x", ["TCGA.CA.6717.01", "SCAF8"], {"weight": 0.804334572733989}], ["x", ["TCGA.CA.6717.01", "GPD2"], {"weight": 0.80945645205453}], ["x", ["TCGA.CA.6717.01", "CAD"], {"weight": 0.808897677733434}], ["x", ["TCGA.CA.6717.01", "FBLN5"], {"weight": 0.798575222503744}], ["x", ["TCGA.CA.6717.01", "CYLD"], {"weight": 0.80399532054102}], ["x", ["TCGA.CA.6717.01", "ZNF184"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF180"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF189"], {"weight": 0.798490455004968}], ["x", ["TCGA.CA.6717.01", "SEMA5A"], {"weight": 0.804120547120916}], ["x", ["TCGA.CA.6717.01", "SCN5A"], {"weight": 0.803483383246373}], ["x", ["TCGA.CA.6717.01", "TGFB2"], {"weight": 0.804038797189645}], ["x", ["TCGA.CA.6717.01", "TNIP3"], {"weight": 0.798505230089228}], ["x", ["TCGA.CA.6717.01", "HSPH1"], {"weight": 0.804133301997119}], ["x", ["TCGA.CA.6717.01", "MYOM1"], {"weight": 0.798113316611526}], ["x", ["TCGA.CA.6717.01", "FBXO5"], {"weight": 0.802909943420824}], ["x", ["TCGA.CA.6717.01", "FBXO7"], {"weight": 0.803416690458602}], ["x", ["TCGA.CA.6717.01", "SNTB2"], {"weight": 0.79843554770773}], ["x", ["TCGA.CA.6717.01", "CORO1C"], {"weight": 0.798089474843955}], ["x", ["TCGA.CA.6717.01", "HECTD2"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "ADAD1"], {"weight": 0.797810869104671}], ["x", ["TCGA.CA.6717.01", "GPR22"], {"weight": 0.799587432176848}], ["x", ["TCGA.CA.6717.01", "EPSTI1"], {"weight": 0.799198596486823}], ["x", ["TCGA.CA.6717.01", "PLXNB2"], {"weight": 0.798573312501581}], ["x", ["TCGA.CA.6717.01", "PLXNB1"], {"weight": 0.798424136298519}], ["x", ["TCGA.CA.6717.01", "PAPPA2"], {"weight": 0.804752331990115}], ["x", ["TCGA.CA.6717.01", "ROCK1"], {"weight": 0.803645892536712}], ["x", ["TCGA.CA.6717.01", "NAGK"], {"weight": 0.799226954088754}], ["x", ["TCGA.CA.6717.01", "THBS4"], {"weight": 0.809996266933244}], ["x", ["TCGA.CA.6717.01", "TNFSF11"], {"weight": 0.803681915477458}], ["x", ["TCGA.CA.6717.01", "CCT2"], {"weight": 0.803809149242327}], ["x", ["TCGA.CA.6717.01", "ASPH"], {"weight": 0.803564665347552}], ["x", ["TCGA.CA.6717.01", "SSTR4"], {"weight": 0.809015391094436}], ["x", ["TCGA.CA.6717.01", "CTNNB1"], {"weight": 0.804127452612339}], ["x", ["TCGA.CA.6717.01", "WNK2"], {"weight": 0.803431873114527}], ["x", ["TCGA.CA.6717.01", "WNK3"], {"weight": 0.803431873114527}], ["x", ["TCGA.CA.6717.01", "TNIP1"], {"weight": 0.798505230089228}], ["x", ["TCGA.CA.6717.01", "LBR"], {"weight": 0.803794286106982}], ["x", ["TCGA.CA.6717.01", "ATP1B3"], {"weight": 0.80394608813096}], ["x", ["TCGA.CA.6717.01", "SNX2"], {"weight": 0.803426792571109}], ["x", ["TCGA.CA.6717.01", "SNX5"], {"weight": 0.803422080011694}], ["x", ["TCGA.CA.6717.01", "FABP4"], {"weight": 0.809473093449325}], ["x", ["TCGA.CA.6717.01", "GABRA4"], {"weight": 0.803896085233042}], ["x", ["TCGA.CA.6717.01", "GABRA1"], {"weight": 0.803822424247411}], ["x", ["TCGA.CA.6717.01", "FABP9"], {"weight": 0.804339940471823}], ["x", ["TCGA.CA.6717.01", "DOCK2"], {"weight": 0.80425272211309}], ["x", ["TCGA.CA.6717.01", "GRIA1"], {"weight": 0.803670497413533}], ["x", ["TCGA.CA.6717.01", "NPY5R"], {"weight": 0.809015391094436}], ["x", ["TCGA.CA.6717.01", "NEU1"], {"weight": 0.804949408197582}], ["x", ["TCGA.CA.6717.01", "OPRL1"], {"weight": 0.809015391094436}], ["x", ["TCGA.CA.6717.01", "MED13"], {"weight": 0.80916791357165}], ["x", ["TCGA.CA.6717.01", "MUSK"], {"weight": 0.803893389821094}], ["x", ["TCGA.CA.6717.01", "RSPO3"], {"weight": 0.803336530724446}], ["x", ["TCGA.CA.6717.01", "EIF5B"], {"weight": 0.80916557190612}], ["x", ["TCGA.CA.6717.01", "STK39"], {"weight": 0.798714429536544}], ["x", ["TCGA.CA.6717.01", "RAF1"], {"weight": 0.804180723466254}], ["x", ["TCGA.CA.6717.01", "ZNF716"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF713"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ASB11"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "ASB16"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "RPP38"], {"weight": 0.803229210823441}], ["x", ["TCGA.CA.6717.01", "TROVE2"], {"weight": 0.798463587676435}], ["x", ["TCGA.CA.6717.01", "FDPS"], {"weight": 0.804432353760788}], ["x", ["TCGA.CA.6717.01", "TNC"], {"weight": 0.803684850812224}], ["x", ["TCGA.CA.6717.01", "DICER1"], {"weight": 0.803085096175482}], ["x", ["TCGA.CA.6717.01", "AQR"], {"weight": 0.803515018809486}], ["x", ["TCGA.CA.6717.01", "DNM1L"], {"weight": 0.799489356749051}], ["x", ["TCGA.CA.6717.01", "DPYS"], {"weight": 0.80920577660901}], ["x", ["TCGA.CA.6717.01", "YLPM1"], {"weight": 0.798803366530968}], ["x", ["TCGA.CA.6717.01", "ATM"], {"weight": 0.803840645650818}], ["x", ["TCGA.CA.6717.01", "PLCH1"], {"weight": 0.809526429096037}], ["x", ["TCGA.CA.6717.01", "MEF2A"], {"weight": 0.80983287475691}], ["x", ["TCGA.CA.6717.01", "TRIO"], {"weight": 0.80904428198443}], ["x", ["TCGA.CA.6717.01", "RABL2A"], {"weight": 0.798570994868835}], ["x", ["TCGA.CA.6717.01", "SLC16A1"], {"weight": 0.809323459898925}], ["x", ["TCGA.CA.6717.01", "ARHGAP35"], {"weight": 0.809469973135739}], ["x", ["TCGA.CA.6717.01", "PIBF1"], {"weight": 0.79803550608501}], ["x", ["TCGA.CA.6717.01", "CACNA1H"], {"weight": 0.803129363240979}], ["x", ["TCGA.CA.6717.01", "CACNA1I"], {"weight": 0.80366666001297}], ["x", ["TCGA.CA.6717.01", "CACNA1A"], {"weight": 0.804240136168088}], ["x", ["TCGA.CA.6717.01", "CACNA1B"], {"weight": 0.803315233089193}], ["x", ["TCGA.CA.6717.01", "CACNA1C"], {"weight": 0.803969257435508}], ["x", ["TCGA.CA.6717.01", "CACNA1D"], {"weight": 0.803974312189353}], ["x", ["TCGA.CA.6717.01", "CACNA1E"], {"weight": 0.804210768470451}], ["x", ["TCGA.CA.6717.01", "CACNA1F"], {"weight": 0.803207652577776}], ["x", ["TCGA.CA.6717.01", "XPOT"], {"weight": 0.797732636399325}], ["x", ["TCGA.CA.6717.01", "NSMCE1"], {"weight": 0.798137420142039}], ["x", ["TCGA.CA.6717.01", "PRKAB2"], {"weight": 0.809580510650428}], ["x", ["TCGA.CA.6717.01", "PAX6"], {"weight": 0.803768613328042}], ["x", ["TCGA.CA.6717.01", "MBD3L1"], {"weight": 0.798240946228296}], ["x", ["TCGA.CA.6717.01", "DSG2"], {"weight": 0.798721784869789}], ["x", ["TCGA.CA.6717.01", "DSG3"], {"weight": 0.799022920554824}], ["x", ["TCGA.CA.6717.01", "DSG1"], {"weight": 0.799022920554824}], ["x", ["TCGA.CA.6717.01", "DET1"], {"weight": 0.803416690458602}], ["x", ["TCGA.CA.6717.01", "KCNJ8"], {"weight": 0.810108137541017}], ["x", ["TCGA.CA.6717.01", "MTTP"], {"weight": 0.804130943745238}], ["x", ["TCGA.CA.6717.01", "FOXR1"], {"weight": 0.798374626194629}], ["x", ["TCGA.CA.6717.01", "NCOR1"], {"weight": 0.8090265953206}], ["x", ["TCGA.CA.6717.01", "TEC"], {"weight": 0.803603811097193}], ["x", ["TCGA.CA.6717.01", "HADHB"], {"weight": 0.814058631753785}], ["x", ["TCGA.CA.6717.01", "ALS2"], {"weight": 0.798561485407692}], ["x", ["TCGA.CA.6717.01", "AP1M1"], {"weight": 0.803476066325028}], ["x", ["TCGA.CA.6717.01", "TKTL2"], {"weight": 0.80938536553172}], ["x", ["TCGA.CA.6717.01", "OR4K2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "LMO7"], {"weight": 0.803415582427769}], ["x", ["TCGA.CA.6717.01", "PSMC1"], {"weight": 0.803019953671302}], ["x", ["TCGA.CA.6717.01", "PSMC2"], {"weight": 0.803040821851918}], ["x", ["TCGA.CA.6717.01", "MARCH6"], {"weight": 0.803404376133591}], ["x", ["TCGA.CA.6717.01", "SLIT2"], {"weight": 0.804686322376287}], ["x", ["TCGA.CA.6717.01", "OR4S2"], {"weight": 0.804025419725802}], ["x", ["TCGA.CA.6717.01", "LUC7L2"], {"weight": 0.803570003413373}], ["x", ["TCGA.CA.6717.01", "CYP4F3"], {"weight": 0.809204162268457}], ["x", ["TCGA.CA.6717.01", "TIAM1"], {"weight": 0.803869972798745}], ["x", ["TCGA.CA.6717.01", "KATNAL2"], {"weight": 0.798174219798139}], ["x", ["TCGA.CA.6717.01", "GSTM4"], {"weight": 0.809695287174931}], ["x", ["TCGA.CA.6717.01", "MED13L"], {"weight": 0.809606952960735}], ["x", ["TCGA.CA.6717.01", "MCM6"], {"weight": 0.803712715356118}], ["x", ["TCGA.CA.6717.01", "MCM4"], {"weight": 0.803703551833358}], ["x", ["TCGA.CA.6717.01", "DUSP11"], {"weight": 0.798770303094615}], ["x", ["TCGA.CA.6717.01", "EPC1"], {"weight": 0.798608935335632}], ["x", ["TCGA.CA.6717.01", "TMF1"], {"weight": 0.798453954227715}], ["x", ["TCGA.CA.6717.01", "NRAP"], {"weight": 0.798565985725786}], ["x", ["TCGA.CA.6717.01", "CABLES1"], {"weight": 0.804365857730846}], ["x", ["TCGA.CA.6717.01", "ZNF607"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "MRPL53"], {"weight": 0.803443017685654}], ["x", ["TCGA.CA.6717.01", "IQCE"], {"weight": 0.79886440291832}], ["x", ["TCGA.CA.6717.01", "TCF4"], {"weight": 0.804157409609457}], ["x", ["TCGA.CA.6717.01", "DSTYK"], {"weight": 0.803609035827305}], ["x", ["TCGA.CA.6717.01", "NF2"], {"weight": 0.803663293185267}], ["x", ["TCGA.CA.6717.01", "NF1"], {"weight": 0.803521215621541}], ["x", ["TCGA.CA.6717.01", "IL5RA"], {"weight": 0.803379956677924}], ["x", ["TCGA.CA.6717.01", "ATXN2"], {"weight": 0.803880842663683}], ["x", ["TCGA.CA.6717.01", "RUNX1T1"], {"weight": 0.804113679725945}], ["x", ["TCGA.CA.6717.01", "TAOK3"], {"weight": 0.798990572824796}], ["x", ["TCGA.CA.6717.01", "OR6C65"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "SULT1E1"], {"weight": 0.809862769791232}], ["x", ["TCGA.CA.6717.01", "MYBPC1"], {"weight": 0.79871339277941}], ["x", ["TCGA.CA.6717.01", "SPRY3"], {"weight": 0.80400689177528}], ["x", ["TCGA.CA.6717.01", "TRPC1"], {"weight": 0.8036563108482}], ["x", ["TCGA.CA.6717.01", "TRPC6"], {"weight": 0.803811742754324}], ["x", ["TCGA.CA.6717.01", "RBMX"], {"weight": 0.80316022977556}], ["x", ["TCGA.CA.6717.01", "NDUFS1"], {"weight": 0.803696351576743}], ["x", ["TCGA.CA.6717.01", "NOD1"], {"weight": 0.804298398694108}], ["x", ["TCGA.CA.6717.01", "CCNB3"], {"weight": 0.803876820748723}], ["x", ["TCGA.CA.6717.01", "CCNB1"], {"weight": 0.80371223793165}], ["x", ["TCGA.CA.6717.01", "LAMC3"], {"weight": 0.804343491305364}], ["x", ["TCGA.CA.6717.01", "CWF19L2"], {"weight": 0.803673834922913}], ["x", ["TCGA.CA.6717.01", "ERN2"], {"weight": 0.803609035827305}], ["x", ["TCGA.CA.6717.01", "MDH1"], {"weight": 0.809449030113471}], ["x", ["TCGA.CA.6717.01", "CASP6"], {"weight": 0.803567674715166}], ["x", ["TCGA.CA.6717.01", "CASP4"], {"weight": 0.803717992168276}], ["x", ["TCGA.CA.6717.01", "CASP8"], {"weight": 0.804582627252327}], ["x", ["TCGA.CA.6717.01", "AKT3"], {"weight": 0.803560659802902}], ["x", ["TCGA.CA.6717.01", "HYAL4"], {"weight": 0.804134491990167}], ["x", ["TCGA.CA.6717.01", "NCF2"], {"weight": 0.803725395361459}], ["x", ["TCGA.CA.6717.01", "UNC13C"], {"weight": 0.793653909342677}], ["x", ["TCGA.CA.6717.01", "UNC13A"], {"weight": 0.793653909342677}], ["x", ["TCGA.CA.6717.01", "KCNB2"], {"weight": 0.793060006853577}], ["x", ["TCGA.CA.6717.01", "GABRA2"], {"weight": 0.803809941113443}], ["x", ["TCGA.CA.6717.01", "OR8I2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "BLZF1"], {"weight": 0.804041157508507}], ["x", ["TCGA.CA.6717.01", "G3BP2"], {"weight": 0.798280123178057}], ["x", ["TCGA.CA.6717.01", "RPTN"], {"weight": 0.79799603055388}], ["x", ["TCGA.CA.6717.01", "IRAK2"], {"weight": 0.805269945821477}], ["x", ["TCGA.CA.6717.01", "IRAK3"], {"weight": 0.804459905781314}], ["x", ["TCGA.CA.6717.01", "CEP290"], {"weight": 0.803298139442447}], ["x", ["TCGA.CA.6717.01", "ACVR1B"], {"weight": 0.802848660686516}], ["x", ["TCGA.CA.6717.01", "GABBR1"], {"weight": 0.809000664599635}], ["x", ["TCGA.CA.6717.01", "SERPINE1"], {"weight": 0.804491913049919}], ["x", ["TCGA.CA.6717.01", "CAPNS2"], {"weight": 0.798356682303226}], ["x", ["TCGA.CA.6717.01", "CDC123"], {"weight": 0.804057244361245}], ["x", ["TCGA.CA.6717.01", "OCRL"], {"weight": 0.809263534297683}], ["x", ["TCGA.CA.6717.01", "WDR60"], {"weight": 0.798410228210709}], ["x", ["TCGA.CA.6717.01", "GPR156"], {"weight": 0.804310074803768}], ["x", ["TCGA.CA.6717.01", "TG"], {"weight": 0.804220885542524}], ["x", ["TCGA.CA.6717.01", "PPFIA2"], {"weight": 0.802878883350213}], ["x", ["TCGA.CA.6717.01", "RTN4"], {"weight": 0.798459445799598}], ["x", ["TCGA.CA.6717.01", "HGF"], {"weight": 0.804427530531981}], ["x", ["TCGA.CA.6717.01", "ELMO1"], {"weight": 0.803715006525263}], ["x", ["TCGA.CA.6717.01", "OR5K4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR5K3"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "ATXN7L1"], {"weight": 0.79854800353138}], ["x", ["TCGA.CA.6717.01", "BTLA"], {"weight": 0.798696146879999}], ["x", ["TCGA.CA.6717.01", "RAB18"], {"weight": 0.80367759520866}], ["x", ["TCGA.CA.6717.01", "LYST"], {"weight": 0.798364651748122}], ["x", ["TCGA.CA.6717.01", "LSM3"], {"weight": 0.803147536158318}], ["x", ["TCGA.CA.6717.01", "USP48"], {"weight": 0.804061804986205}], ["x", ["TCGA.CA.6717.01", "USP46"], {"weight": 0.802747709836115}], ["x", ["TCGA.CA.6717.01", "RPAP3"], {"weight": 0.798957969819579}], ["x", ["TCGA.CA.6717.01", "SEC23A"], {"weight": 0.803758410357325}], ["x", ["TCGA.CA.6717.01", "OR4K15"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR4K17"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "SCAF11"], {"weight": 0.803818679000913}], ["x", ["TCGA.CA.6717.01", "SON"], {"weight": 0.799079711331199}], ["x", ["TCGA.CA.6717.01", "PON3"], {"weight": 0.810219001100283}], ["x", ["TCGA.CA.6717.01", "PON2"], {"weight": 0.810219001100283}], ["x", ["TCGA.CA.6717.01", "UGP2"], {"weight": 0.80368871346075}], ["x", ["TCGA.CA.6717.01", "NDST3"], {"weight": 0.809983622701927}], ["x", ["TCGA.CA.6717.01", "NDST4"], {"weight": 0.809983622701927}], ["x", ["TCGA.CA.6717.01", "OR1A2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "NBEA"], {"weight": 0.798364651748122}], ["x", ["TCGA.CA.6717.01", "DCAF4L1"], {"weight": 0.79850178538865}], ["x", ["TCGA.CA.6717.01", "DIS3L"], {"weight": 0.803830180114995}], ["x", ["TCGA.CA.6717.01", "SYDE2"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "SYDE1"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "GLUD2"], {"weight": 0.820833031961185}], ["x", ["TCGA.CA.6717.01", "PDIA2"], {"weight": 0.799057422114984}], ["x", ["TCGA.CA.6717.01", "TTC21B"], {"weight": 0.803327664369096}], ["x", ["TCGA.CA.6717.01", "MUC6"], {"weight": 0.809360543475021}], ["x", ["TCGA.CA.6717.01", "ADRB2"], {"weight": 0.808947190944623}], ["x", ["TCGA.CA.6717.01", "HOMER2"], {"weight": 0.798407544942156}], ["x", ["TCGA.CA.6717.01", "TRIM10"], {"weight": 0.798681659248344}], ["x", ["TCGA.CA.6717.01", "CCRL2"], {"weight": 0.804458033765526}], ["x", ["TCGA.CA.6717.01", "BTK"], {"weight": 0.809348159690729}], ["x", ["TCGA.CA.6717.01", "PRELP"], {"weight": 0.809828525427346}], ["x", ["TCGA.CA.6717.01", "NUP155"], {"weight": 0.80350461968}], ["x", ["TCGA.CA.6717.01", "ATXN2L"], {"weight": 0.804380981932733}], ["x", ["TCGA.CA.6717.01", "WTAP"], {"weight": 0.803718300685845}], ["x", ["TCGA.CA.6717.01", "PPARGC1A"], {"weight": 0.796364756644274}], ["x", ["TCGA.CA.6717.01", "XDH"], {"weight": 0.797976531611668}], ["x", ["TCGA.CA.6717.01", "RBPJ"], {"weight": 0.804023982796796}], ["x", ["TCGA.CA.6717.01", "PPBP"], {"weight": 0.810072735154365}], ["x", ["TCGA.CA.6717.01", "DDIT4L"], {"weight": 0.803945126543641}], ["x", ["TCGA.CA.6717.01", "PRICKLE2"], {"weight": 0.798259932620568}], ["x", ["TCGA.CA.6717.01", "PCYOX1"], {"weight": 0.798278318632466}], ["x", ["TCGA.CA.6717.01", "KALRN"], {"weight": 0.803223578317143}], ["x", ["TCGA.CA.6717.01", "CD1B"], {"weight": 0.798556330020808}], ["x", ["TCGA.CA.6717.01", "CELF6"], {"weight": 0.804223846765271}], ["x", ["TCGA.CA.6717.01", "SPAM1"], {"weight": 0.804413079797147}], ["x", ["TCGA.CA.6717.01", "ENPEP"], {"weight": 0.803800913689963}], ["x", ["TCGA.CA.6717.01", "HEATR1"], {"weight": 0.803177189947589}], ["x", ["TCGA.CA.6717.01", "IKBKB"], {"weight": 0.80379888804682}], ["x", ["TCGA.CA.6717.01", "GNL3"], {"weight": 0.803470539683651}], ["x", ["TCGA.CA.6717.01", "GNL2"], {"weight": 0.803518970755902}], ["x", ["TCGA.CA.6717.01", "COL28A1"], {"weight": 0.799316084962364}], ["x", ["TCGA.CA.6717.01", "SMARCAL1"], {"weight": 0.798893327446618}], ["x", ["TCGA.CA.6717.01", "RSPO4"], {"weight": 0.803336530724446}], ["x", ["TCGA.CA.6717.01", "VCP"], {"weight": 0.803803031178534}], ["x", ["TCGA.CA.6717.01", "MTDH"], {"weight": 0.798896801337415}], ["x", ["TCGA.CA.6717.01", "EXO1"], {"weight": 0.803546746468752}], ["x", ["TCGA.CA.6717.01", "LRRTM4"], {"weight": 0.792866468016705}], ["x", ["TCGA.CA.6717.01", "LRRTM3"], {"weight": 0.792866468016705}], ["x", ["TCGA.CA.6717.01", "EPAS1"], {"weight": 0.809278371118984}], ["x", ["TCGA.CA.6717.01", "TTBK2"], {"weight": 0.80333112444827}], ["x", ["TCGA.CA.6717.01", "KNG1"], {"weight": 0.809967360036072}], ["x", ["TCGA.CA.6717.01", "ITGA10"], {"weight": 0.804599952915292}], ["x", ["TCGA.CA.6717.01", "SEMA6D"], {"weight": 0.79892264942653}], ["x", ["TCGA.CA.6717.01", "SCN2B"], {"weight": 0.798417685539668}], ["x", ["TCGA.CA.6717.01", "SCN2A"], {"weight": 0.803526440189204}], ["x", ["TCGA.CA.6717.01", "ZNF208"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "DECR1"], {"weight": 0.803876018086134}], ["x", ["TCGA.CA.6717.01", "OR5C1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "HERC2"], {"weight": 0.803375356534807}], ["x", ["TCGA.CA.6717.01", "TDRD12"], {"weight": 0.803572611221281}], ["x", ["TCGA.CA.6717.01", "QARS"], {"weight": 0.804072164591762}], ["x", ["TCGA.CA.6717.01", "OGDHL"], {"weight": 0.809585409221339}], ["x", ["TCGA.CA.6717.01", "CEP68"], {"weight": 0.803916513342339}], ["x", ["TCGA.CA.6717.01", "ZFYVE9"], {"weight": 0.798268127827177}], ["x", ["TCGA.CA.6717.01", "ZFYVE1"], {"weight": 0.803222928059841}], ["x", ["TCGA.CA.6717.01", "RXFP1"], {"weight": 0.809170275007116}], ["x", ["TCGA.CA.6717.01", "CCDC88A"], {"weight": 0.799174242221315}], ["x", ["TCGA.CA.6717.01", "ROBO1"], {"weight": 0.804633896663724}], ["x", ["TCGA.CA.6717.01", "FBXL5"], {"weight": 0.803405795432716}], ["x", ["TCGA.CA.6717.01", "FBXL4"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "CTR9"], {"weight": 0.803383467074486}], ["x", ["TCGA.CA.6717.01", "SLC26A2"], {"weight": 0.796660846494864}], ["x", ["TCGA.CA.6717.01", "MIA2"], {"weight": 0.798064906703501}], ["x", ["TCGA.CA.6717.01", "PEMT"], {"weight": 0.809305004283468}], ["x", ["TCGA.CA.6717.01", "LRP4"], {"weight": 0.804397782440089}], ["x", ["TCGA.CA.6717.01", "OR1I1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "AKAP14"], {"weight": 0.803671241940796}], ["x", ["TCGA.CA.6717.01", "AKAP13"], {"weight": 0.803748923039143}], ["x", ["TCGA.CA.6717.01", "AKAP11"], {"weight": 0.803951600347824}], ["x", ["TCGA.CA.6717.01", "WDR88"], {"weight": 0.797956849503056}], ["x", ["TCGA.CA.6717.01", "JAG1"], {"weight": 0.803201725268853}], ["x", ["TCGA.CA.6717.01", "PTPN21"], {"weight": 0.810042048946809}], ["x", ["TCGA.CA.6717.01", "TNRC6C"], {"weight": 0.803696127439059}], ["x", ["TCGA.CA.6717.01", "TNRC6A"], {"weight": 0.803716165614618}], ["x", ["TCGA.CA.6717.01", "ARHGEF6"], {"weight": 0.803823432449705}], ["x", ["TCGA.CA.6717.01", "ARHGEF4"], {"weight": 0.798575165838775}], ["x", ["TCGA.CA.6717.01", "ADAMTS9"], {"weight": 0.8032904231433}], ["x", ["TCGA.CA.6717.01", "CDH9"], {"weight": 0.798415119724707}], ["x", ["TCGA.CA.6717.01", "CDH8"], {"weight": 0.798415119724707}], ["x", ["TCGA.CA.6717.01", "CDH1"], {"weight": 0.803968251346845}], ["x", ["TCGA.CA.6717.01", "CDH2"], {"weight": 0.804323153163604}], ["x", ["TCGA.CA.6717.01", "CDH7"], {"weight": 0.798415119724707}], ["x", ["TCGA.CA.6717.01", "DOPEY2"], {"weight": 0.798463587676435}], ["x", ["TCGA.CA.6717.01", "DOPEY1"], {"weight": 0.798463587676435}], ["x", ["TCGA.CA.6717.01", "MYO3A"], {"weight": 0.798703270536096}], ["x", ["TCGA.CA.6717.01", "ZNF436"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF431"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "MERTK"], {"weight": 0.803372119270109}], ["x", ["TCGA.CA.6717.01", "CUL4A"], {"weight": 0.803949880911391}], ["x", ["TCGA.CA.6717.01", "IMMT"], {"weight": 0.803535030710752}], ["x", ["TCGA.CA.6717.01", "LRPPRC"], {"weight": 0.806428281325226}], ["x", ["TCGA.CA.6717.01", "FMNL1"], {"weight": 0.79893937948095}], ["x", ["TCGA.CA.6717.01", "GRM8"], {"weight": 0.80900726530888}], ["x", ["TCGA.CA.6717.01", "MAPRE1"], {"weight": 0.803124020457526}], ["x", ["TCGA.CA.6717.01", "MAPRE3"], {"weight": 0.804372034845784}], ["x", ["TCGA.CA.6717.01", "MAPRE2"], {"weight": 0.798095007737141}], ["x", ["TCGA.CA.6717.01", "GRM1"], {"weight": 0.803196068670976}], ["x", ["TCGA.CA.6717.01", "SEPT6"], {"weight": 0.798197315286367}], ["x", ["TCGA.CA.6717.01", "NVL"], {"weight": 0.8033353186361}], ["x", ["TCGA.CA.6717.01", "ST13"], {"weight": 0.798445541095706}], ["x", ["TCGA.CA.6717.01", "ZNF546"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SPOCK3"], {"weight": 0.798911227664152}], ["x", ["TCGA.CA.6717.01", "YTHDC2"], {"weight": 0.798546004189962}], ["x", ["TCGA.CA.6717.01", "NR3C2"], {"weight": 0.804090519027341}], ["x", ["TCGA.CA.6717.01", "SEC23IP"], {"weight": 0.803478947164646}], ["x", ["TCGA.CA.6717.01", "ATP6V1A"], {"weight": 0.803421063063597}], ["x", ["TCGA.CA.6717.01", "DTL"], {"weight": 0.80421871281913}], ["x", ["TCGA.CA.6717.01", "RAP1GDS1"], {"weight": 0.798709444369451}], ["x", ["TCGA.CA.6717.01", "PDE6B"], {"weight": 0.809427832909538}], ["x", ["TCGA.CA.6717.01", "MVK"], {"weight": 0.809799778451664}], ["x", ["TCGA.CA.6717.01", "ALK"], {"weight": 0.80401738427871}], ["x", ["TCGA.CA.6717.01", "ALB"], {"weight": 0.809685161361153}], ["x", ["TCGA.CA.6717.01", "ZNF19"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF14"], {"weight": 0.798908362129968}], ["x", ["TCGA.CA.6717.01", "ZNF17"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF10"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "RRN3"], {"weight": 0.803978736812067}], ["x", ["TCGA.CA.6717.01", "TGFBR3"], {"weight": 0.804093560760477}], ["x", ["TCGA.CA.6717.01", "BCAR3"], {"weight": 0.798661146722842}], ["x", ["TCGA.CA.6717.01", "SOX6"], {"weight": 0.798966043931972}], ["x", ["TCGA.CA.6717.01", "SOX7"], {"weight": 0.798966043931972}], ["x", ["TCGA.CA.6717.01", "KLRC2"], {"weight": 0.809536653085774}], ["x", ["TCGA.CA.6717.01", "INHBA"], {"weight": 0.803764928213979}], ["x", ["TCGA.CA.6717.01", "STAU2"], {"weight": 0.798347843590732}], ["x", ["TCGA.CA.6717.01", "SDHAF2"], {"weight": 0.804104347894319}], ["x", ["TCGA.CA.6717.01", "AGTR2"], {"weight": 0.808967413315051}], ["x", ["TCGA.CA.6717.01", "BAZ1B"], {"weight": 0.803595204876973}], ["x", ["TCGA.CA.6717.01", "ABCC8"], {"weight": 0.797210128095738}], ["x", ["TCGA.CA.6717.01", "RYR3"], {"weight": 0.804263082756573}], ["x", ["TCGA.CA.6717.01", "RYR2"], {"weight": 0.803214802601746}], ["x", ["TCGA.CA.6717.01", "GOLGA4"], {"weight": 0.798461868428983}], ["x", ["TCGA.CA.6717.01", "ENPP6"], {"weight": 0.796025535779433}], ["x", ["TCGA.CA.6717.01", "ENPP2"], {"weight": 0.809928441871141}], ["x", ["TCGA.CA.6717.01", "ENPP3"], {"weight": 0.793743968295519}], ["x", ["TCGA.CA.6717.01", "ENPP1"], {"weight": 0.796632814051366}], ["x", ["TCGA.CA.6717.01", "ZNF287"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "RFXAP"], {"weight": 0.793709895027832}], ["x", ["TCGA.CA.6717.01", "IFNA8"], {"weight": 0.798598171857108}], ["x", ["TCGA.CA.6717.01", "TIMM22"], {"weight": 0.803688491059958}], ["x", ["TCGA.CA.6717.01", "CRYAB"], {"weight": 0.799191875865801}], ["x", ["TCGA.CA.6717.01", "ELF1"], {"weight": 0.804218057132762}], ["x", ["TCGA.CA.6717.01", "CFL2"], {"weight": 0.803738371556847}], ["x", ["TCGA.CA.6717.01", "RNF17"], {"weight": 0.799419089101931}], ["x", ["TCGA.CA.6717.01", "COL7A1"], {"weight": 0.802389424668756}], ["x", ["TCGA.CA.6717.01", "RIT2"], {"weight": 0.79847801073173}], ["x", ["TCGA.CA.6717.01", "HRH2"], {"weight": 0.80916791357165}], ["x", ["TCGA.CA.6717.01", "COL4A6"], {"weight": 0.808632156522086}], ["x", ["TCGA.CA.6717.01", "COL4A4"], {"weight": 0.808625992433016}], ["x", ["TCGA.CA.6717.01", "COL4A1"], {"weight": 0.805024128444361}], ["x", ["TCGA.CA.6717.01", "PLCZ1"], {"weight": 0.80945339072057}], ["x", ["TCGA.CA.6717.01", "GGCX"], {"weight": 0.799230247354327}], ["x", ["TCGA.CA.6717.01", "LHCGR"], {"weight": 0.809158662204142}], ["x", ["TCGA.CA.6717.01", "KDM3A"], {"weight": 0.804049913104482}], ["x", ["TCGA.CA.6717.01", "CFHR3"], {"weight": 0.804149215433534}], ["x", ["TCGA.CA.6717.01", "SUGP2"], {"weight": 0.798830317909547}], ["x", ["TCGA.CA.6717.01", "MYBL1"], {"weight": 0.798594547634472}], ["x", ["TCGA.CA.6717.01", "TUFM"], {"weight": 0.803445573787337}], ["x", ["TCGA.CA.6717.01", "A1BG"], {"weight": 0.80458572189113}], ["x", ["TCGA.CA.6717.01", "OR4L1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "ZNF587"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF326"], {"weight": 0.793542194812316}], ["x", ["TCGA.CA.6717.01", "SRY"], {"weight": 0.798507667178995}], ["x", ["TCGA.CA.6717.01", "EIF2AK3"], {"weight": 0.804231328801921}], ["x", ["TCGA.CA.6717.01", "EIF2AK4"], {"weight": 0.804311197367896}], ["x", ["TCGA.CA.6717.01", "PIGF"], {"weight": 0.794267189072696}], ["x", ["TCGA.CA.6717.01", "PIGK"], {"weight": 0.799054572329845}], ["x", ["TCGA.CA.6717.01", "PIGP"], {"weight": 0.803830559036654}], ["x", ["TCGA.CA.6717.01", "PIGV"], {"weight": 0.798647830826315}], ["x", ["TCGA.CA.6717.01", "NTRK2"], {"weight": 0.804114360016285}], ["x", ["TCGA.CA.6717.01", "ATG2B"], {"weight": 0.798372193896616}], ["x", ["TCGA.CA.6717.01", "GPR4"], {"weight": 0.803257619320271}], ["x", ["TCGA.CA.6717.01", "C1orf35"], {"weight": 0.798289603311293}], ["x", ["TCGA.CA.6717.01", "TPRKB"], {"weight": 0.797642258861831}], ["x", ["TCGA.CA.6717.01", "MLH3"], {"weight": 0.798274843388762}], ["x", ["TCGA.CA.6717.01", "ZNF418"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "AKAP4"], {"weight": 0.803270995410268}], ["x", ["TCGA.CA.6717.01", "AKAP6"], {"weight": 0.803204110489369}], ["x", ["TCGA.CA.6717.01", "EIF2D"], {"weight": 0.797997541694302}], ["x", ["TCGA.CA.6717.01", "AKAP9"], {"weight": 0.803708393094912}], ["x", ["TCGA.CA.6717.01", "EIF2A"], {"weight": 0.803569751961962}], ["x", ["TCGA.CA.6717.01", "CETN3"], {"weight": 0.803855311785933}], ["x", ["TCGA.CA.6717.01", "PCLO"], {"weight": 0.804247861375737}], ["x", ["TCGA.CA.6717.01", "DNAJC8"], {"weight": 0.803168460000392}], ["x", ["TCGA.CA.6717.01", "DNAJC7"], {"weight": 0.798325925290553}], ["x", ["TCGA.CA.6717.01", "GOSR1"], {"weight": 0.798279654067375}], ["x", ["TCGA.CA.6717.01", "TAS2R5"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "TAS2R3"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "CDK5RAP2"], {"weight": 0.803295559655459}], ["x", ["TCGA.CA.6717.01", "NEO1"], {"weight": 0.798846337989459}], ["x", ["TCGA.CA.6717.01", "ZC3H13"], {"weight": 0.803778634803193}], ["x", ["TCGA.CA.6717.01", "DPYD"], {"weight": 0.809485929785481}], ["x", ["TCGA.CA.6717.01", "MEP1A"], {"weight": 0.798690932152903}], ["x", ["TCGA.CA.6717.01", "ME2"], {"weight": 0.809168704547679}], ["x", ["TCGA.CA.6717.01", "ANGPT2"], {"weight": 0.803841993385579}], ["x", ["TCGA.CA.6717.01", "ANGPT4"], {"weight": 0.798326412357819}], ["x", ["TCGA.CA.6717.01", "GUCA1C"], {"weight": 0.804156310014666}], ["x", ["TCGA.CA.6717.01", "DOT1L"], {"weight": 0.798281548413147}], ["x", ["TCGA.CA.6717.01", "SYCP2"], {"weight": 0.797997540734944}], ["x", ["TCGA.CA.6717.01", "SYCP1"], {"weight": 0.797819653451895}], ["x", ["TCGA.CA.6717.01", "ARHGDIB"], {"weight": 0.803672580734699}], ["x", ["TCGA.CA.6717.01", "TANC2"], {"weight": 0.798365540371389}], ["x", ["TCGA.CA.6717.01", "KBTBD13"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "ZNF99"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "RAET1E"], {"weight": 0.798622547885611}], ["x", ["TCGA.CA.6717.01", "ERBB4"], {"weight": 0.803360759820942}], ["x", ["TCGA.CA.6717.01", "SPRED1"], {"weight": 0.803457875113376}], ["x", ["TCGA.CA.6717.01", "AHNAK"], {"weight": 0.795388006763701}], ["x", ["TCGA.CA.6717.01", "BCAP29"], {"weight": 0.80428056953166}], ["x", ["TCGA.CA.6717.01", "TAS2R30"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "TAS2R31"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "NDUFS6"], {"weight": 0.803699111962732}], ["x", ["TCGA.CA.6717.01", "ZRANB1"], {"weight": 0.803158708932002}], ["x", ["TCGA.CA.6717.01", "ZRANB2"], {"weight": 0.803571176714603}], ["x", ["TCGA.CA.6717.01", "MICAL2"], {"weight": 0.798930937663691}], ["x", ["TCGA.CA.6717.01", "CLTC"], {"weight": 0.803593179570704}], ["x", ["TCGA.CA.6717.01", "ZNF597"], {"weight": 0.798298635662241}], ["x", ["TCGA.CA.6717.01", "AAK1"], {"weight": 0.803314571638297}], ["x", ["TCGA.CA.6717.01", "SNRPN"], {"weight": 0.803145988389287}], ["x", ["TCGA.CA.6717.01", "ZDHHC17"], {"weight": 0.79863598786395}], ["x", ["TCGA.CA.6717.01", "NCAN"], {"weight": 0.809293652924662}], ["x", ["TCGA.CA.6717.01", "DDX42"], {"weight": 0.803152230396284}], ["x", ["TCGA.CA.6717.01", "DDX46"], {"weight": 0.803165139334758}], ["x", ["TCGA.CA.6717.01", "LSM14A"], {"weight": 0.793351302114071}], ["x", ["TCGA.CA.6717.01", "STX19"], {"weight": 0.798310655699701}], ["x", ["TCGA.CA.6717.01", "OR2A5"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR9G4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "E2F5"], {"weight": 0.803821712741667}], ["x", ["TCGA.CA.6717.01", "OR10AD1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "GPR161"], {"weight": 0.803625740439454}], ["x", ["TCGA.CA.6717.01", "MTHFD1"], {"weight": 0.820150225463361}], ["x", ["TCGA.CA.6717.01", "SLX4"], {"weight": 0.802965482612377}], ["x", ["TCGA.CA.6717.01", "AZI2"], {"weight": 0.798268313532032}], ["x", ["TCGA.CA.6717.01", "ZNF433"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF439"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SECISBP2"], {"weight": 0.809473093449325}], ["x", ["TCGA.CA.6717.01", "OR5H2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "TXLNG"], {"weight": 0.799482593535723}], ["x", ["TCGA.CA.6717.01", "GTF3C3"], {"weight": 0.803731796100282}], ["x", ["TCGA.CA.6717.01", "IL12RB2"], {"weight": 0.803980755978448}], ["x", ["TCGA.CA.6717.01", "ATP6AP2"], {"weight": 0.804209611183783}], ["x", ["TCGA.CA.6717.01", "ACOT4"], {"weight": 0.809678290417974}], ["x", ["TCGA.CA.6717.01", "ACOT2"], {"weight": 0.809498770945388}], ["x", ["TCGA.CA.6717.01", "RBBP8"], {"weight": 0.803559036727241}], ["x", ["TCGA.CA.6717.01", "RBBP7"], {"weight": 0.803423735581115}], ["x", ["TCGA.CA.6717.01", "RBBP5"], {"weight": 0.803584946165926}], ["x", ["TCGA.CA.6717.01", "ZFP28"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "TCP1"], {"weight": 0.803814285130998}], ["x", ["TCGA.CA.6717.01", "NARF"], {"weight": 0.798024219637628}], ["x", ["TCGA.CA.6717.01", "LRBA"], {"weight": 0.798364651748122}], ["x", ["TCGA.CA.6717.01", "PPP2R5D"], {"weight": 0.799933565340252}], ["x", ["TCGA.CA.6717.01", "PPP2R5E"], {"weight": 0.808991679746981}], ["x", ["TCGA.CA.6717.01", "NAMPT"], {"weight": 0.80451701820994}], ["x", ["TCGA.CA.6717.01", "SYNJ1"], {"weight": 0.809283277460112}], ["x", ["TCGA.CA.6717.01", "LRFN2"], {"weight": 0.804335931847733}], ["x", ["TCGA.CA.6717.01", "PAG1"], {"weight": 0.80950961829737}], ["x", ["TCGA.CA.6717.01", "ZNF667"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "MTNR1B"], {"weight": 0.809014020769955}], ["x", ["TCGA.CA.6717.01", "ZEB1"], {"weight": 0.799032215237589}], ["x", ["TCGA.CA.6717.01", "OR1F1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "RRAGB"], {"weight": 0.803927765667968}], ["x", ["TCGA.CA.6717.01", "PTPRB"], {"weight": 0.79864383562338}], ["x", ["TCGA.CA.6717.01", "PTPRO"], {"weight": 0.798824802274542}], ["x", ["TCGA.CA.6717.01", "PTPRM"], {"weight": 0.804194335232306}], ["x", ["TCGA.CA.6717.01", "PTPRJ"], {"weight": 0.798456255171671}], ["x", ["TCGA.CA.6717.01", "DMP1"], {"weight": 0.804503016710621}], ["x", ["TCGA.CA.6717.01", "IFIT2"], {"weight": 0.798699527712288}], ["x", ["TCGA.CA.6717.01", "WDR35"], {"weight": 0.80334342462426}], ["x", ["TCGA.CA.6717.01", "WDR36"], {"weight": 0.803170500177347}], ["x", ["TCGA.CA.6717.01", "WDR31"], {"weight": 0.803384366427147}], ["x", ["TCGA.CA.6717.01", "TLE4"], {"weight": 0.803368972915261}], ["x", ["TCGA.CA.6717.01", "CDC7"], {"weight": 0.803787462604508}], ["x", ["TCGA.CA.6717.01", "MBD5"], {"weight": 0.80403134715234}], ["x", ["TCGA.CA.6717.01", "SLC25A12"], {"weight": 0.809563692537329}], ["x", ["TCGA.CA.6717.01", "CCDC14"], {"weight": 0.798551122377684}], ["x", ["TCGA.CA.6717.01", "IRF5"], {"weight": 0.803455186002931}], ["x", ["TCGA.CA.6717.01", "ITK"], {"weight": 0.803743531160645}], ["x", ["TCGA.CA.6717.01", "RICTOR"], {"weight": 0.804063428818032}], ["x", ["TCGA.CA.6717.01", "ARAP1"], {"weight": 0.803657857291333}], ["x", ["TCGA.CA.6717.01", "RDX"], {"weight": 0.80389351905632}], ["x", ["TCGA.CA.6717.01", "PPP1R42"], {"weight": 0.80326332108734}], ["x", ["TCGA.CA.6717.01", "KIT"], {"weight": 0.803600880148856}], ["x", ["TCGA.CA.6717.01", "WASL"], {"weight": 0.803552837808825}], ["x", ["TCGA.CA.6717.01", "DGKH"], {"weight": 0.809412721122133}], ["x", ["TCGA.CA.6717.01", "TNFSF13B"], {"weight": 0.803379711870864}], ["x", ["TCGA.CA.6717.01", "PDE9A"], {"weight": 0.809430589586076}], ["x", ["TCGA.CA.6717.01", "LRP12"], {"weight": 0.809780107579069}], ["x", ["TCGA.CA.6717.01", "BBS9"], {"weight": 0.803682390268915}], ["x", ["TCGA.CA.6717.01", "BBS5"], {"weight": 0.803682390268915}], ["x", ["TCGA.CA.6717.01", "AGL"], {"weight": 0.804099534016913}], ["x", ["TCGA.CA.6717.01", "RAB11A"], {"weight": 0.803256820990563}], ["x", ["TCGA.CA.6717.01", "PIK3CA"], {"weight": 0.809718542267041}], ["x", ["TCGA.CA.6717.01", "PIK3CB"], {"weight": 0.809670996134093}], ["x", ["TCGA.CA.6717.01", "PIK3CG"], {"weight": 0.809728174592426}], ["x", ["TCGA.CA.6717.01", "MAK"], {"weight": 0.798655626140753}], ["x", ["TCGA.CA.6717.01", "UTP20"], {"weight": 0.803177189947589}], ["x", ["TCGA.CA.6717.01", "CTH"], {"weight": 0.815169545903091}], ["x", ["TCGA.CA.6717.01", "RAB11FIP1"], {"weight": 0.798709678266128}], ["x", ["TCGA.CA.6717.01", "CLIP3"], {"weight": 0.804172853547116}], ["x", ["TCGA.CA.6717.01", "CD47"], {"weight": 0.804238608436426}], ["x", ["TCGA.CA.6717.01", "FPGT"], {"weight": 0.799008123070826}], ["x", ["TCGA.CA.6717.01", "ZNF43"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "IL31RA"], {"weight": 0.798508157973806}], ["x", ["TCGA.CA.6717.01", "OR8D4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "WEE2"], {"weight": 0.803872965531099}], ["x", ["TCGA.CA.6717.01", "SCN10A"], {"weight": 0.803550938119425}], ["x", ["TCGA.CA.6717.01", "PDS5B"], {"weight": 0.803308704745654}], ["x", ["TCGA.CA.6717.01", "ACVR2A"], {"weight": 0.79851635861707}], ["x", ["TCGA.CA.6717.01", "CLGN"], {"weight": 0.804088149518602}], ["x", ["TCGA.CA.6717.01", "SMARCA1"], {"weight": 0.803965636525631}], ["x", ["TCGA.CA.6717.01", "SMARCA5"], {"weight": 0.80345603966377}], ["x", ["TCGA.CA.6717.01", "OR51B4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "CUL1"], {"weight": 0.803393169532265}], ["x", ["TCGA.CA.6717.01", "CUL2"], {"weight": 0.803583760327248}], ["x", ["TCGA.CA.6717.01", "ARHGAP5"], {"weight": 0.80360543157877}], ["x", ["TCGA.CA.6717.01", "ARHGAP6"], {"weight": 0.803683988460675}], ["x", ["TCGA.CA.6717.01", "MRPL2"], {"weight": 0.808835023046918}], ["x", ["TCGA.CA.6717.01", "IDO2"], {"weight": 0.81509243667421}], ["x", ["TCGA.CA.6717.01", "ARAP2"], {"weight": 0.803666280468567}], ["x", ["TCGA.CA.6717.01", "DOLK"], {"weight": 0.803991353966012}], ["x", ["TCGA.CA.6717.01", "ANKHD1"], {"weight": 0.809596786131497}], ["x", ["TCGA.CA.6717.01", "SIN3A"], {"weight": 0.803399772078026}], ["x", ["TCGA.CA.6717.01", "LRIT1"], {"weight": 0.798887540657785}], ["x", ["TCGA.CA.6717.01", "CCT8L2"], {"weight": 0.798364883652347}], ["x", ["TCGA.CA.6717.01", "MEX3C"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "LACTB2"], {"weight": 0.798396143422176}], ["x", ["TCGA.CA.6717.01", "BTRC"], {"weight": 0.803328217051396}], ["x", ["TCGA.CA.6717.01", "MTMR2"], {"weight": 0.809449030113471}], ["x", ["TCGA.CA.6717.01", "MTMR1"], {"weight": 0.809501097320121}], ["x", ["TCGA.CA.6717.01", "FARP2"], {"weight": 0.809670607771016}], ["x", ["TCGA.CA.6717.01", "FARP1"], {"weight": 0.798581352109374}], ["x", ["TCGA.CA.6717.01", "STXBP1"], {"weight": 0.803355308847187}], ["x", ["TCGA.CA.6717.01", "EXOC2"], {"weight": 0.803459908883042}], ["x", ["TCGA.CA.6717.01", "FRS3"], {"weight": 0.804245615138552}], ["x", ["TCGA.CA.6717.01", "EXOC6"], {"weight": 0.803476655402395}], ["x", ["TCGA.CA.6717.01", "MGAT4B"], {"weight": 0.798643795605064}], ["x", ["TCGA.CA.6717.01", "PRKCG"], {"weight": 0.809161284942305}], ["x", ["TCGA.CA.6717.01", "MUL1"], {"weight": 0.804085387627389}], ["x", ["TCGA.CA.6717.01", "ZNF571"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF577"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SETDB2"], {"weight": 0.798246042876525}], ["x", ["TCGA.CA.6717.01", "PHKA1"], {"weight": 0.803987238819214}], ["x", ["TCGA.CA.6717.01", "PHKA2"], {"weight": 0.803408086122087}], ["x", ["TCGA.CA.6717.01", "ILK"], {"weight": 0.80410659791391}], ["x", ["TCGA.CA.6717.01", "MORF4L1"], {"weight": 0.803001364786092}], ["x", ["TCGA.CA.6717.01", "IL6"], {"weight": 0.803515535222573}], ["x", ["TCGA.CA.6717.01", "IL4"], {"weight": 0.803622375809607}], ["x", ["TCGA.CA.6717.01", "IL2"], {"weight": 0.804020589451988}], ["x", ["TCGA.CA.6717.01", "DTX1"], {"weight": 0.803201725268853}], ["x", ["TCGA.CA.6717.01", "RB1CC1"], {"weight": 0.803764358950127}], ["x", ["TCGA.CA.6717.01", "PI4K2B"], {"weight": 0.809587477675697}], ["x", ["TCGA.CA.6717.01", "CENPP"], {"weight": 0.803250593461149}], ["x", ["TCGA.CA.6717.01", "TLR3"], {"weight": 0.7992224422881}], ["x", ["TCGA.CA.6717.01", "TLR1"], {"weight": 0.804342385484359}], ["x", ["TCGA.CA.6717.01", "TLR6"], {"weight": 0.80973159158709}], ["x", ["TCGA.CA.6717.01", "TLR7"], {"weight": 0.794597569775921}], ["x", ["TCGA.CA.6717.01", "NUP205"], {"weight": 0.80350461968}], ["x", ["TCGA.CA.6717.01", "TFEC"], {"weight": 0.798946135584981}], ["x", ["TCGA.CA.6717.01", "SMCHD1"], {"weight": 0.798293587657459}], ["x", ["TCGA.CA.6717.01", "DGUOK"], {"weight": 0.804165320779473}], ["x", ["TCGA.CA.6717.01", "SSBP2"], {"weight": 0.798507427533378}], ["x", ["TCGA.CA.6717.01", "ZCCHC12"], {"weight": 0.798894271279886}], ["x", ["TCGA.CA.6717.01", "FBXW12"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "FBXW11"], {"weight": 0.803725671873739}], ["x", ["TCGA.CA.6717.01", "CYP11A1"], {"weight": 0.810530425707102}], ["x", ["TCGA.CA.6717.01", "MYH10"], {"weight": 0.797987995978485}], ["x", ["TCGA.CA.6717.01", "MYH13"], {"weight": 0.798245330290975}], ["x", ["TCGA.CA.6717.01", "OR6K3"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "LEF1"], {"weight": 0.803178209012301}], ["x", ["TCGA.CA.6717.01", "NAA35"], {"weight": 0.79572545953252}], ["x", ["TCGA.CA.6717.01", "ATAD2B"], {"weight": 0.79844981108485}], ["x", ["TCGA.CA.6717.01", "PGD"], {"weight": 0.809331044856834}], ["x", ["TCGA.CA.6717.01", "PGR"], {"weight": 0.803807105717395}], ["x", ["TCGA.CA.6717.01", "DMXL2"], {"weight": 0.798381699497505}], ["x", ["TCGA.CA.6717.01", "DMXL1"], {"weight": 0.798775541869136}], ["x", ["TCGA.CA.6717.01", "ADAR"], {"weight": 0.798699527712288}], ["x", ["TCGA.CA.6717.01", "RNF113B"], {"weight": 0.798225384183454}], ["x", ["TCGA.CA.6717.01", "RNF113A"], {"weight": 0.798225384183454}], ["x", ["TCGA.CA.6717.01", "RANBP6"], {"weight": 0.798193907952478}], ["x", ["TCGA.CA.6717.01", "UBQLNL"], {"weight": 0.80373523704448}], ["x", ["TCGA.CA.6717.01", "UIMC1"], {"weight": 0.803404967936901}], ["x", ["TCGA.CA.6717.01", "SLC9A4"], {"weight": 0.798576839594792}], ["x", ["TCGA.CA.6717.01", "MSMO1"], {"weight": 0.809240040005221}], ["x", ["TCGA.CA.6717.01", "A2M"], {"weight": 0.804471003105641}], ["x", ["TCGA.CA.6717.01", "FAS"], {"weight": 0.804425565746916}], ["x", ["TCGA.CA.6717.01", "CSPG4"], {"weight": 0.809305004283468}], ["x", ["TCGA.CA.6717.01", "GUCY1A2"], {"weight": 0.809316849164054}], ["x", ["TCGA.CA.6717.01", "SCN7A"], {"weight": 0.803368890272047}], ["x", ["TCGA.CA.6717.01", "TRMT1"], {"weight": 0.803674045331068}], ["x", ["TCGA.CA.6717.01", "SEMA3A"], {"weight": 0.809527326289479}], ["x", ["TCGA.CA.6717.01", "SEMA3C"], {"weight": 0.798942592607786}], ["x", ["TCGA.CA.6717.01", "SEMA3D"], {"weight": 0.798858430298691}], ["x", ["TCGA.CA.6717.01", "SEMA3G"], {"weight": 0.798858430298691}], ["x", ["TCGA.CA.6717.01", "GLP2R"], {"weight": 0.809175058579812}], ["x", ["TCGA.CA.6717.01", "ZNF253"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF257"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "AR"], {"weight": 0.803703071351806}], ["x", ["TCGA.CA.6717.01", "NDUFAB1"], {"weight": 0.806291069187895}], ["x", ["TCGA.CA.6717.01", "NDUFB8"], {"weight": 0.803696351576743}], ["x", ["TCGA.CA.6717.01", "TRPC4AP"], {"weight": 0.809554009746897}], ["x", ["TCGA.CA.6717.01", "MARS"], {"weight": 0.804058306156532}], ["x", ["TCGA.CA.6717.01", "TAF8"], {"weight": 0.803359306614938}], ["x", ["TCGA.CA.6717.01", "MYOF"], {"weight": 0.798530177210595}], ["x", ["TCGA.CA.6717.01", "CNOT7"], {"weight": 0.803447624698932}], ["x", ["TCGA.CA.6717.01", "GNPDA1"], {"weight": 0.809556351116132}], ["x", ["TCGA.CA.6717.01", "SLC12A2"], {"weight": 0.803652289153046}], ["x", ["TCGA.CA.6717.01", "CCDC129"], {"weight": 0.798643751314088}], ["x", ["TCGA.CA.6717.01", "PIWIL2"], {"weight": 0.803572611221281}], ["x", ["TCGA.CA.6717.01", "PIWIL1"], {"weight": 0.798744780654284}], ["x", ["TCGA.CA.6717.01", "GABARAPL2"], {"weight": 0.803301650003374}], ["x", ["TCGA.CA.6717.01", "KDM4D"], {"weight": 0.798674778776448}], ["x", ["TCGA.CA.6717.01", "PSME4"], {"weight": 0.803062014170286}], ["x", ["TCGA.CA.6717.01", "TOPBP1"], {"weight": 0.803703966469874}], ["x", ["TCGA.CA.6717.01", "NARS2"], {"weight": 0.799101937100016}], ["x", ["TCGA.CA.6717.01", "GMPS"], {"weight": 0.809280028753391}], ["x", ["TCGA.CA.6717.01", "EPHB3"], {"weight": 0.803868139047839}], ["x", ["TCGA.CA.6717.01", "NOP10"], {"weight": 0.79806477109102}], ["x", ["TCGA.CA.6717.01", "CCR5"], {"weight": 0.808956005539124}], ["x", ["TCGA.CA.6717.01", "ZNF860"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZFP2"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "XRN1"], {"weight": 0.803555802548812}], ["x", ["TCGA.CA.6717.01", "PABPC3"], {"weight": 0.80378031009864}], ["x", ["TCGA.CA.6717.01", "CTNNBL1"], {"weight": 0.803163493402485}], ["x", ["TCGA.CA.6717.01", "DLC1"], {"weight": 0.809585409221339}], ["x", ["TCGA.CA.6717.01", "GLI3"], {"weight": 0.803731552455326}], ["x", ["TCGA.CA.6717.01", "ORC2"], {"weight": 0.803690363810413}], ["x", ["TCGA.CA.6717.01", "RARS2"], {"weight": 0.804347406829854}], ["x", ["TCGA.CA.6717.01", "BAK1"], {"weight": 0.803639317721853}], ["x", ["TCGA.CA.6717.01", "CNTFR"], {"weight": 0.803400938552716}], ["x", ["TCGA.CA.6717.01", "TACR3"], {"weight": 0.803257619320271}], ["x", ["TCGA.CA.6717.01", "TACR1"], {"weight": 0.803111981252441}], ["x", ["TCGA.CA.6717.01", "RGS22"], {"weight": 0.804107300753569}], ["x", ["TCGA.CA.6717.01", "VPS53"], {"weight": 0.803639858556348}], ["x", ["TCGA.CA.6717.01", "OR10K2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "PIK3C3"], {"weight": 0.809177481436419}], ["x", ["TCGA.CA.6717.01", "ZMPSTE24"], {"weight": 0.804023540633422}], ["x", ["TCGA.CA.6717.01", "MRPL37"], {"weight": 0.803481138580148}], ["x", ["TCGA.CA.6717.01", "MRPL38"], {"weight": 0.803481138580148}], ["x", ["TCGA.CA.6717.01", "THOC2"], {"weight": 0.803087584370529}], ["x", ["TCGA.CA.6717.01", "ZNF671"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "RNF103"], {"weight": 0.803462851388397}], ["x", ["TCGA.CA.6717.01", "ZNF679"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF678"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "PHLDB2"], {"weight": 0.799048935676252}], ["x", ["TCGA.CA.6717.01", "MTMR14"], {"weight": 0.809501097320121}], ["x", ["TCGA.CA.6717.01", "MTMR12"], {"weight": 0.809546020361798}], ["x", ["TCGA.CA.6717.01", "ST3GAL3"], {"weight": 0.815227682245853}], ["x", ["TCGA.CA.6717.01", "CEP135"], {"weight": 0.803278140418431}], ["x", ["TCGA.CA.6717.01", "WIPF1"], {"weight": 0.798309428065974}], ["x", ["TCGA.CA.6717.01", "MON1B"], {"weight": 0.79891952956056}], ["x", ["TCGA.CA.6717.01", "PPM1A"], {"weight": 0.804517939719312}], ["x", ["TCGA.CA.6717.01", "PPM1L"], {"weight": 0.804593077971951}], ["x", ["TCGA.CA.6717.01", "CHEK2"], {"weight": 0.803302481009964}], ["x", ["TCGA.CA.6717.01", "GINS3"], {"weight": 0.798384877004742}], ["x", ["TCGA.CA.6717.01", "C9"], {"weight": 0.803970822610798}], ["x", ["TCGA.CA.6717.01", "C3"], {"weight": 0.808978078275967}], ["x", ["TCGA.CA.6717.01", "C2"], {"weight": 0.803745898984604}], ["x", ["TCGA.CA.6717.01", "C7"], {"weight": 0.803834148844648}], ["x", ["TCGA.CA.6717.01", "C6"], {"weight": 0.803819517583548}], ["x", ["TCGA.CA.6717.01", "CP"], {"weight": 0.804037212066872}], ["x", ["TCGA.CA.6717.01", "RMND5A"], {"weight": 0.798792143127279}], ["x", ["TCGA.CA.6717.01", "AP3B1"], {"weight": 0.803228029184411}], ["x", ["TCGA.CA.6717.01", "PPP1CB"], {"weight": 0.803907700576683}], ["x", ["TCGA.CA.6717.01", "MPPED1"], {"weight": 0.80424294689127}], ["x", ["TCGA.CA.6717.01", "ZYX"], {"weight": 0.803908609182769}], ["x", ["TCGA.CA.6717.01", "IL1R2"], {"weight": 0.804621731981886}], ["x", ["TCGA.CA.6717.01", "ARPC3"], {"weight": 0.803557827050086}], ["x", ["TCGA.CA.6717.01", "ITPR2"], {"weight": 0.809236941421033}], ["x", ["TCGA.CA.6717.01", "ITPR1"], {"weight": 0.809228042609651}], ["x", ["TCGA.CA.6717.01", "IL1RN"], {"weight": 0.804555248171395}], ["x", ["TCGA.CA.6717.01", "LAP3"], {"weight": 0.809608689830825}], ["x", ["TCGA.CA.6717.01", "HIVEP1"], {"weight": 0.809476020449944}], ["x", ["TCGA.CA.6717.01", "HIVEP2"], {"weight": 0.798823798009938}], ["x", ["TCGA.CA.6717.01", "CHSY1"], {"weight": 0.804150988395311}], ["x", ["TCGA.CA.6717.01", "ARHGAP15"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "ARHGAP12"], {"weight": 0.798588611806003}], ["x", ["TCGA.CA.6717.01", "SETX"], {"weight": 0.798858411556466}], ["x", ["TCGA.CA.6717.01", "ZNF540"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "DDX17"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "DDX18"], {"weight": 0.798290275430832}], ["x", ["TCGA.CA.6717.01", "ARFIP1"], {"weight": 0.804078409390353}], ["x", ["TCGA.CA.6717.01", "TRIP11"], {"weight": 0.804129600593542}], ["x", ["TCGA.CA.6717.01", "OR2D2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "EHHADH"], {"weight": 0.814818473649828}], ["x", ["TCGA.CA.6717.01", "NTPCR"], {"weight": 0.809305004283468}], ["x", ["TCGA.CA.6717.01", "TAS1R1"], {"weight": 0.804107300753569}], ["x", ["TCGA.CA.6717.01", "GTF2E1"], {"weight": 0.803578309152922}], ["x", ["TCGA.CA.6717.01", "TCTE3"], {"weight": 0.798410228210709}], ["x", ["TCGA.CA.6717.01", "CLSPN"], {"weight": 0.798522997903403}], ["x", ["TCGA.CA.6717.01", "MSH2"], {"weight": 0.803712715356118}], ["x", ["TCGA.CA.6717.01", "MSH3"], {"weight": 0.803384792593087}], ["x", ["TCGA.CA.6717.01", "MSH6"], {"weight": 0.80370719750898}], ["x", ["TCGA.CA.6717.01", "OR10AG1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "HAL"], {"weight": 0.804889199456447}], ["x", ["TCGA.CA.6717.01", "MCMDC2"], {"weight": 0.798705400268303}], ["x", ["TCGA.CA.6717.01", "THSD7A"], {"weight": 0.804127427546024}], ["x", ["TCGA.CA.6717.01", "RBMS3"], {"weight": 0.804522007317426}], ["x", ["TCGA.CA.6717.01", "CNTRL"], {"weight": 0.803300743369676}], ["x", ["TCGA.CA.6717.01", "BRMS1"], {"weight": 0.798349693357057}], ["x", ["TCGA.CA.6717.01", "FOXK2"], {"weight": 0.804027583661889}], ["x", ["TCGA.CA.6717.01", "TNPO3"], {"weight": 0.79806630773759}], ["x", ["TCGA.CA.6717.01", "SLC18B1"], {"weight": 0.804288887254467}], ["x", ["TCGA.CA.6717.01", "HCFC2"], {"weight": 0.804395686653476}], ["x", ["TCGA.CA.6717.01", "FKBP6"], {"weight": 0.803238320745879}], ["x", ["TCGA.CA.6717.01", "ACE2"], {"weight": 0.803915917897541}], ["x", ["TCGA.CA.6717.01", "NCAPD3"], {"weight": 0.798215940684813}], ["x", ["TCGA.CA.6717.01", "SOAT1"], {"weight": 0.803997620849586}], ["x", ["TCGA.CA.6717.01", "SRGAP1"], {"weight": 0.803782699650525}], ["x", ["TCGA.CA.6717.01", "SRGAP3"], {"weight": 0.803782699650525}], ["x", ["TCGA.CA.6717.01", "SMC3"], {"weight": 0.803188098337955}], ["x", ["TCGA.CA.6717.01", "SMC2"], {"weight": 0.803262279397199}], ["x", ["TCGA.CA.6717.01", "SMC5"], {"weight": 0.797919246807933}], ["x", ["TCGA.CA.6717.01", "PYROXD1"], {"weight": 0.798717894507927}], ["x", ["TCGA.CA.6717.01", "SMC6"], {"weight": 0.79776164446666}], ["x", ["TCGA.CA.6717.01", "LTF"], {"weight": 0.804034294246463}], ["x", ["TCGA.CA.6717.01", "LTV1"], {"weight": 0.803279291123009}], ["x", ["TCGA.CA.6717.01", "PDGFRA"], {"weight": 0.804164362332049}], ["x", ["TCGA.CA.6717.01", "CNTN1"], {"weight": 0.798830650333171}], ["x", ["TCGA.CA.6717.01", "CNTN6"], {"weight": 0.799010272166237}], ["x", ["TCGA.CA.6717.01", "CNGA4"], {"weight": 0.803557235283886}], ["x", ["TCGA.CA.6717.01", "COASY"], {"weight": 0.809296641631319}], ["x", ["TCGA.CA.6717.01", "UNC80"], {"weight": 0.798871867314584}], ["x", ["TCGA.CA.6717.01", "IQGAP2"], {"weight": 0.798405786988203}], ["x", ["TCGA.CA.6717.01", "PCMTD1"], {"weight": 0.803873757028727}], ["x", ["TCGA.CA.6717.01", "BMPR2"], {"weight": 0.80365747161136}], ["x", ["TCGA.CA.6717.01", "CLVS1"], {"weight": 0.798439057293004}], ["x", ["TCGA.CA.6717.01", "KDR"], {"weight": 0.803836306132168}], ["x", ["TCGA.CA.6717.01", "ZNF354B"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "GPSM2"], {"weight": 0.803824698411618}], ["x", ["TCGA.CA.6717.01", "GPSM1"], {"weight": 0.803750578517282}], ["x", ["TCGA.CA.6717.01", "VPS33B"], {"weight": 0.798461516113551}], ["x", ["TCGA.CA.6717.01", "PRDM9"], {"weight": 0.798036262594469}], ["x", ["TCGA.CA.6717.01", "OLAH"], {"weight": 0.803412999301718}], ["x", ["TCGA.CA.6717.01", "KL"], {"weight": 0.809554009746897}], ["x", ["TCGA.CA.6717.01", "OR7D2"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR7D4"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "SART3"], {"weight": 0.798370422788443}], ["x", ["TCGA.CA.6717.01", "NDUFV3"], {"weight": 0.803700502154685}], ["x", ["TCGA.CA.6717.01", "LAMA1"], {"weight": 0.804432802695062}], ["x", ["TCGA.CA.6717.01", "LAMA2"], {"weight": 0.804343491305364}], ["x", ["TCGA.CA.6717.01", "LAMA3"], {"weight": 0.809694698970571}], ["x", ["TCGA.CA.6717.01", "LAMA4"], {"weight": 0.804444847160544}], ["x", ["TCGA.CA.6717.01", "F5"], {"weight": 0.80441995904822}], ["x", ["TCGA.CA.6717.01", "F7"], {"weight": 0.804655098569305}], ["x", ["TCGA.CA.6717.01", "F8"], {"weight": 0.804412584791178}], ["x", ["TCGA.CA.6717.01", "ATP4A"], {"weight": 0.804005585262122}], ["x", ["TCGA.CA.6717.01", "CNOT10"], {"weight": 0.803496133363019}], ["x", ["TCGA.CA.6717.01", "KCND2"], {"weight": 0.798672583575594}], ["x", ["TCGA.CA.6717.01", "MAGI2"], {"weight": 0.803797552579062}], ["x", ["TCGA.CA.6717.01", "MAGI1"], {"weight": 0.802883809847961}], ["x", ["TCGA.CA.6717.01", "UGT2B7"], {"weight": 0.809301167766683}], ["x", ["TCGA.CA.6717.01", "UGT2B4"], {"weight": 0.809301167766683}], ["x", ["TCGA.CA.6717.01", "SELL"], {"weight": 0.798796190545052}], ["x", ["TCGA.CA.6717.01", "BST1"], {"weight": 0.809876016158578}], ["x", ["TCGA.CA.6717.01", "TNIK"], {"weight": 0.80425272211309}], ["x", ["TCGA.CA.6717.01", "OR52E6"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "EXOC6B"], {"weight": 0.798777760940414}], ["x", ["TCGA.CA.6717.01", "CYP39A1"], {"weight": 0.80925009119064}], ["x", ["TCGA.CA.6717.01", "ZNF442"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF443"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "AP1G1"], {"weight": 0.803440733924646}], ["x", ["TCGA.CA.6717.01", "OR5M3"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "OR5M1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "DOK6"], {"weight": 0.798297251009484}], ["x", ["TCGA.CA.6717.01", "ARMC1"], {"weight": 0.798592656073414}], ["x", ["TCGA.CA.6717.01", "HSPA5"], {"weight": 0.803146644691881}], ["x", ["TCGA.CA.6717.01", "HSPA4"], {"weight": 0.803872935234807}], ["x", ["TCGA.CA.6717.01", "HSPA8"], {"weight": 0.803318451906085}], ["x", ["TCGA.CA.6717.01", "LIFR"], {"weight": 0.803373676554588}], ["x", ["TCGA.CA.6717.01", "PPP2R2C"], {"weight": 0.80340390207601}], ["x", ["TCGA.CA.6717.01", "TTR"], {"weight": 0.803868778938289}], ["x", ["TCGA.CA.6717.01", "TTN"], {"weight": 0.798690331346733}], ["x", ["TCGA.CA.6717.01", "MIOS"], {"weight": 0.798674562506212}], ["x", ["TCGA.CA.6717.01", "PELI3"], {"weight": 0.804440854749358}], ["x", ["TCGA.CA.6717.01", "SRPK2"], {"weight": 0.798255846098548}], ["x", ["TCGA.CA.6717.01", "BDKRB1"], {"weight": 0.808891075967916}], ["x", ["TCGA.CA.6717.01", "PES1"], {"weight": 0.809120434832343}], ["x", ["TCGA.CA.6717.01", "ZNF600"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF606"], {"weight": 0.798490455004968}], ["x", ["TCGA.CA.6717.01", "GCK"], {"weight": 0.815639307293017}], ["x", ["TCGA.CA.6717.01", "PRPF40B"], {"weight": 0.799002059875803}], ["x", ["TCGA.CA.6717.01", "PAPOLG"], {"weight": 0.79854117520355}], ["x", ["TCGA.CA.6717.01", "PAPOLA"], {"weight": 0.803133898685314}], ["x", ["TCGA.CA.6717.01", "SLC25A3"], {"weight": 0.803916112969437}], ["x", ["TCGA.CA.6717.01", "KIF5C"], {"weight": 0.798776094390893}], ["x", ["TCGA.CA.6717.01", "CDK1"], {"weight": 0.80365032127832}], ["x", ["TCGA.CA.6717.01", "USP45"], {"weight": 0.80353999933781}], ["x", ["TCGA.CA.6717.01", "USP47"], {"weight": 0.798215865239216}], ["x", ["TCGA.CA.6717.01", "VDAC1"], {"weight": 0.809743293401258}], ["x", ["TCGA.CA.6717.01", "ADRB3"], {"weight": 0.80914533370576}], ["x", ["TCGA.CA.6717.01", "MCM3AP"], {"weight": 0.798546262911643}], ["x", ["TCGA.CA.6717.01", "RPL22"], {"weight": 0.809349887403056}], ["x", ["TCGA.CA.6717.01", "TRIM37"], {"weight": 0.803420040098077}], ["x", ["TCGA.CA.6717.01", "TPP2"], {"weight": 0.798772040959556}], ["x", ["TCGA.CA.6717.01", "ULBP3"], {"weight": 0.798622547885611}], ["x", ["TCGA.CA.6717.01", "ULBP1"], {"weight": 0.798622547885611}], ["x", ["TCGA.CA.6717.01", "IFIT1B"], {"weight": 0.804060309182182}], ["x", ["TCGA.CA.6717.01", "P2RY13"], {"weight": 0.809016767976347}], ["x", ["TCGA.CA.6717.01", "LEPR"], {"weight": 0.803617883454136}], ["x", ["TCGA.CA.6717.01", "CYP2C8"], {"weight": 0.809563238673323}], ["x", ["TCGA.CA.6717.01", "OR10P1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "DHFR"], {"weight": 0.81521824653488}], ["x", ["TCGA.CA.6717.01", "SNTG2"], {"weight": 0.79843554770773}], ["x", ["TCGA.CA.6717.01", "SLC1A3"], {"weight": 0.798848732087177}], ["x", ["TCGA.CA.6717.01", "SF3B1"], {"weight": 0.803180261456664}], ["x", ["TCGA.CA.6717.01", "ADD1"], {"weight": 0.798667508841565}], ["x", ["TCGA.CA.6717.01", "SLC11A1"], {"weight": 0.79904410350587}], ["x", ["TCGA.CA.6717.01", "CWC22"], {"weight": 0.80314909235244}], ["x", ["TCGA.CA.6717.01", "FMO2"], {"weight": 0.809882896583687}], ["x", ["TCGA.CA.6717.01", "FMO3"], {"weight": 0.809876016158578}], ["x", ["TCGA.CA.6717.01", "SH2D2A"], {"weight": 0.803754984205864}], ["x", ["TCGA.CA.6717.01", "DPP4"], {"weight": 0.80390845331309}], ["x", ["TCGA.CA.6717.01", "OR6N1"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "NOC3L"], {"weight": 0.803484126092015}], ["x", ["TCGA.CA.6717.01", "OR2T6"], {"weight": 0.804065094100603}], ["x", ["TCGA.CA.6717.01", "CEP164"], {"weight": 0.803259478173832}], ["x", ["TCGA.CA.6717.01", "STAT4"], {"weight": 0.803702528549962}], ["x", ["TCGA.CA.6717.01", "ELOVL2"], {"weight": 0.815714802251582}], ["x", ["TCGA.CA.6717.01", "ELOVL1"], {"weight": 0.815698655381692}], ["x", ["TCGA.CA.6717.01", "DUSP4"], {"weight": 0.803945132902488}], ["x", ["TCGA.CA.6717.01", "RBL1"], {"weight": 0.803746965493278}], ["x", ["TCGA.CA.6717.01", "HEY1"], {"weight": 0.803534457058902}], ["x", ["TCGA.CA.6717.01", "TRPA1"], {"weight": 0.804509566484152}], ["x", ["TCGA.CA.6717.01", "SCN4A"], {"weight": 0.80357797290783}], ["x", ["TCGA.CA.6717.01", "SCN4B"], {"weight": 0.803272032684702}], ["x", ["TCGA.CA.6717.01", "ACTA2"], {"weight": 0.804021615218647}], ["x", ["TCGA.CA.6717.01", "ACTA1"], {"weight": 0.804050156369996}], ["x", ["TCGA.CA.6717.01", "ZNF221"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF224"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ZNF226"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "OTUD5"], {"weight": 0.803658385338128}], ["x", ["TCGA.CA.6717.01", "SPCS3"], {"weight": 0.809195057603827}], ["x", ["TCGA.CA.6717.01", "MGAT4A"], {"weight": 0.798643795605064}], ["x", ["TCGA.CA.6717.01", "BZW1"], {"weight": 0.792675359481456}], ["x", ["TCGA.CA.6717.01", "CYP3A7"], {"weight": 0.809268867421023}], ["x", ["TCGA.CA.6717.01", "CYP3A4"], {"weight": 0.809164892922978}], ["x", ["TCGA.CA.6717.01", "LDB1"], {"weight": 0.798380856985965}], ["x", ["TCGA.CA.6717.01", "TRPC3"], {"weight": 0.798390137436889}], ["x", ["TCGA.CA.6717.01", "TRPC7"], {"weight": 0.798482232115155}], ["x", ["TCGA.CA.6717.01", "SEC62"], {"weight": 0.803748553970149}], ["x", ["TCGA.CA.6717.01", "MGAM"], {"weight": 0.804016206751732}], ["x", ["TCGA.CA.6717.01", "MYH2"], {"weight": 0.803500887828253}], ["x", ["TCGA.CA.6717.01", "MYH1"], {"weight": 0.79871339277941}], ["x", ["TCGA.CA.6717.01", "MYH7"], {"weight": 0.79819842627043}], ["x", ["TCGA.CA.6717.01", "MYH4"], {"weight": 0.79871339277941}], ["x", ["TCGA.CA.6717.01", "MYH8"], {"weight": 0.798546166356018}], ["x", ["TCGA.CA.6717.01", "CADM3"], {"weight": 0.79871157994657}], ["x", ["TCGA.CA.6717.01", "PNLIPRP3"], {"weight": 0.809449746071275}], ["x", ["TCGA.CA.6717.01", "TMOD1"], {"weight": 0.798697795931185}], ["x", ["TCGA.CA.6717.01", "GPR37"], {"weight": 0.804692349001258}], ["x", ["TCGA.CA.6717.01", "GK2"], {"weight": 0.815562131878221}], ["x", ["TCGA.CA.6717.01", "GK5"], {"weight": 0.804413421252574}], ["x", ["TCGA.CA.6717.01", "AHCYL2"], {"weight": 0.803915917897541}], ["x", ["TCGA.CA.6717.01", "SEPT10"], {"weight": 0.798108429158948}], ["x", ["TCGA.CA.6717.01", "CLDN18"], {"weight": 0.798025074863175}], ["x", ["TCGA.CA.6717.01", "PHIP"], {"weight": 0.798489198465528}], ["x", ["TCGA.CA.6717.01", "ZNF521"], {"weight": 0.798077919842891}], ["x", ["TCGA.CA.6717.01", "ZNF529"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "IFNA14"], {"weight": 0.798585787290266}], ["x", ["TCGA.CA.6717.01", "MAN2C1"], {"weight": 0.809619854170863}], ["x", ["TCGA.CA.6717.01", "LAT"], {"weight": 0.809338996167969}], ["x", ["TCGA.CA.6717.01", "PANK1"], {"weight": 0.809459309978051}], ["x", ["TCGA.CA.6717.01", "NFASC"], {"weight": 0.798397649301144}], ["x", ["TCGA.CA.6717.01", "OPRM1"], {"weight": 0.809135937528494}], ["x", ["TCGA.CA.6717.01", "NTS"], {"weight": 0.803445416044609}], ["x", ["TCGA.CA.6717.01", "ST6GALNAC3"], {"weight": 0.803834328842775}], ["x", ["TCGA.CA.6717.01", "KIF13A"], {"weight": 0.798376260562505}], ["x", ["TCGA.CA.6717.01", "KIF13B"], {"weight": 0.803497797827506}], ["x", ["TCGA.CA.6717.01", "AVPR1A"], {"weight": 0.803248719466942}], ["x", ["TCGA.CA.6717.01", "HPS4"], {"weight": 0.798047809691745}], ["x", ["TCGA.CA.6717.01", "NCKIPSD"], {"weight": 0.798340629016655}], ["x", ["TCGA.CA.6717.01", "MCHR2"], {"weight": 0.808891075967916}], ["x", ["TCGA.CA.6717.01", "HPSE"], {"weight": 0.80996389983678}], ["x", ["TCGA.CA.6717.01", "ARID1A"], {"weight": 0.803647815906303}], ["x", ["TCGA.CA.6717.01", "SPTAN1"], {"weight": 0.803337907462798}], ["x", ["TCGA.CA.6717.01", "SND1"], {"weight": 0.803832265409278}], ["x", ["TCGA.CA.6717.01", "USP8"], {"weight": 0.804042078194571}], ["x", ["TCGA.CA.6717.01", "USP1"], {"weight": 0.803619834159483}], ["x", ["TCGA.CA.6717.01", "USP6"], {"weight": 0.798886594072932}], ["x", ["TCGA.CA.6717.01", "USP7"], {"weight": 0.803360696246289}], ["x", ["TCGA.CA.6717.01", "ZNF721"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "ETFDH"], {"weight": 0.798448012874411}], ["x", ["TCGA.CA.6717.01", "MYO5B"], {"weight": 0.798601552042845}], ["x", ["TCGA.CA.6717.01", "MYO5A"], {"weight": 0.803384849203053}], ["x", ["TCGA.CA.6717.01", "GBP3"], {"weight": 0.798598171857108}], ["x", ["TCGA.CA.6717.01", "GBP6"], {"weight": 0.798602428918194}], ["x", ["TCGA.CA.6717.01", "GBP4"], {"weight": 0.798602428918194}], ["x", ["TCGA.CA.6717.01", "UBLCP1"], {"weight": 0.79760671931093}], ["x", ["TCGA.CA.6717.01", "DARS2"], {"weight": 0.799322123300017}], ["x", ["TCGA.CA.6717.01", "APH1B"], {"weight": 0.803843965892631}], ["x", ["TCGA.CA.6717.01", "STAT1"], {"weight": 0.803611900493239}], ["x", ["TCGA.CA.6717.01", "HTATSF1"], {"weight": 0.798868238589203}], ["x", ["TCGA.CA.6717.01", "PDE4D"], {"weight": 0.809249271180222}], ["x", ["TCGA.CA.6717.01", "CAND2"], {"weight": 0.79764311607746}], ["x", ["TCGA.CA.6717.01", "TMOD2"], {"weight": 0.803532464205487}], ["x", ["TCGA.CA.6717.01", "ZNF71"], {"weight": 0.798727371562164}], ["x", ["TCGA.CA.6717.01", "SFTPA2"], {"weight": 0.803861520079373}], ["x", ["TCGA.CA.6717.01", "CD2AP"], {"weight": 0.809527326289479}], ["x", ["TCGA.CA.6717.01", "CPS1"], {"weight": 0.809850153690124}], ["x", ["TCGA.CA.6717.01", "ACAP2"], {"weight": 0.798886594072932}], ["x", ["TCGA.CA.6717.01", "NOM1"], {"weight": 0.798156265155835}], ["x", ["TCGA.CA.6717.01", "SELE"], {"weight": 0.804040512328955}], ["x", ["TCGA.CA.6717.01", "VCAN"], {"weight": 0.809008405219757}], ["x", ["TCGA.D5.6539.01", "DLGAP4"], {"weight": 0.611847817615385}], ["x", ["TCGA.D5.6539.01", "GRIA2"], {"weight": 0.553436567112263}], ["x", ["TCGA.D5.6539.01", "RELN"], {"weight": 0.580352212780335}], ["x", ["TCGA.D5.6539.01", "KCNN3"], {"weight": 0.52191976603542}], ["x", ["TCGA.D5.6539.01", "NPFFR2"], {"weight": 0.584174499793549}], ["x", ["TCGA.D5.6539.01", "OR2AK2"], {"weight": 0.549302880919341}], ["x", ["TCGA.D5.6539.01", "KRAS"], {"weight": 0.579719111391679}], ["x", ["TCGA.D5.6539.01", "SYNE1"], {"weight": 0.548082695975543}], ["x", ["TCGA.D5.6539.01", "BRD4"], {"weight": 0.522938199462433}], ["x", ["TCGA.D5.6539.01", "OR3A1"], {"weight": 0.549302880919341}], ["x", ["TCGA.D5.6539.01", "PIK3C2G"], {"weight": 0.579216697463713}], ["x", ["TCGA.D5.6539.01", "DSEL"], {"weight": 0.613055803941105}], ["x", ["TCGA.D5.6539.01", "ARRB2"], {"weight": 0.586073213071647}], ["x", ["TCGA.D5.6539.01", "CLASP1"], {"weight": 0.549727702652727}], ["x", ["TCGA.D5.6539.01", "MYO18B"], {"weight": 0.585475130183487}], ["x", ["TCGA.D5.6539.01", "KERA"], {"weight": 0.580766649331845}], ["x", ["TCGA.D5.6539.01", "NR1H4"], {"weight": 0.551020305791197}], ["x", ["TCGA.D5.6539.01", "TP53"], {"weight": 0.548332886149485}], ["x", ["TCGA.D5.6539.01", "MYBPC1"], {"weight": 0.548441775439581}], ["x", ["TCGA.D5.6539.01", "TBP"], {"weight": 0.550283537622109}], ["x", ["TCGA.D5.6539.01", "EIF2AK1"], {"weight": 0.550715205118796}], ["x", ["TCGA.D5.6539.01", "PTEN"], {"weight": 0.579537610861374}], ["x", ["TCGA.D5.6539.01", "OR6C4"], {"weight": 0.549302880919341}], ["x", ["TCGA.D5.6539.01", "SEMA3D"], {"weight": 0.521611684843026}], ["x", ["TCGA.D5.6539.01", "KDR"], {"weight": 0.580051949558501}], ["OR52M1", ["TCGA.AZ.4682.01", "Transmission across Chemical Synapses"], {"weight": 0.907343443515479}], ["OR52M1", ["TCGA.AZ.4682.01", "G alpha (i) signalling events"], {"weight": 0.932619533362162}], ["OR52M1", ["TCGA.AZ.4682.01", "GPCR downstream signalling"], {"weight": 0.942487943828604}], ["OR52M1", ["TCGA.AZ.4682.01", "Signaling by GPCR"], {"weight": 0.932706663605967}], ["OR52M1", ["TCGA.AZ.4682.01", "GABA B receptor activation"], {"weight": 0.919802114395461}], ["OR52M1", ["TCGA.AZ.4682.01", "Activation of GABAB receptors"], {"weight": 0.919802114395461}], ["OR52M1", ["TCGA.AZ.4682.01", "G-protein beta:gamma signalling"], {"weight": 0.92996804057274}], ["OR52M1", ["TCGA.AZ.4682.01", "G alpha (s) signalling events"], {"weight": 0.94867481515773}], ["OR52M1", ["TCGA.AZ.4682.01", "Integration of energy metabolism"], {"weight": 0.890062363244384}], ["OR52M1", ["TCGA.AZ.4682.01", "Presynaptic function of Kainate receptors"], {"weight": 0.898902088223388}], ["OR52M1", ["TCGA.AZ.4682.01", "Signal amplification"], {"weight": 0.86342492837022}], ["OR52M1", ["TCGA.AZ.4682.01", "Regulation of insulin secretion"], {"weight": 0.878078637108033}], ["OR52M1", ["TCGA.AZ.4682.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.662136820032791}], ["OR52M1", ["TCGA.AZ.4682.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.905944405352572}], ["OR52M1", ["TCGA.AZ.4682.01", "Platelet homeostasis"], {"weight": 0.738910611429332}], ["OR52M1", ["TCGA.AZ.4682.01", "Activation of G protein gated Potassium channels"], {"weight": 0.907735872794821}], ["OR52M1", ["TCGA.AZ.4682.01", "G protein gated Potassium channels"], {"weight": 0.907735872794821}], ["OR52M1", ["TCGA.AZ.4682.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.915237695053491}], ["OR52M1", ["TCGA.AZ.4682.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.907735872794821}], ["OR52M1", ["TCGA.AZ.4682.01", "Inwardly rectifying K+ channels"], {"weight": 0.91598132881035}], ["OR52M1", ["TCGA.AZ.4682.01", "G beta:gamma signalling through BTK"], {"weight": 0.911391244412205}], ["OR52M1", ["TCGA.AZ.4682.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.909044228235443}], ["OR52M1", ["TCGA.AZ.4682.01", "Vasopressin regulates renal water homeostasis via Aquaporins"], {"weight": 0.910056968107205}], ["OR52M1", ["TCGA.AZ.4682.01", "Aquaporin-mediated transport"], {"weight": 0.910056968107205}], ["OR52M1", ["TCGA.AZ.4682.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.843065199235246}], ["OR52M1", ["TCGA.AZ.4682.01", "Activation of the phototransduction cascade"], {"weight": 0.868208839857882}], ["OR52M1", ["TCGA.AZ.4682.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.610888324888764}], ["OR52M1", ["TCGA.AZ.4682.01", "GPER1 signaling"], {"weight": 0.90500231706221}], ["OR52M1", ["TCGA.AZ.4682.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.90500231706221}], ["OR52M1", ["TCGA.AZ.4682.01", "GPCR ligand binding"], {"weight": 0.91325222499394}], ["OR52M1", ["TCGA.AZ.4682.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.90430337960592}], ["OR52M1", ["TCGA.AZ.4682.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.868851628442891}], ["OR52M1", ["TCGA.AZ.4682.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.888113370474258}], ["OR52M1", ["TCGA.AZ.4682.01", "G beta:gamma signalling through CDC42"], {"weight": 0.907061481858569}], ["OR52M1", ["TCGA.AZ.4682.01", "Opioid Signalling"], {"weight": 0.858229359878388}], ["OR52M1", ["TCGA.AZ.4682.01", "Phase 4 - resting membrane potential"], {"weight": 0.790159176052411}], ["OR52M1", ["TCGA.AZ.4682.01", "G alpha (z) signalling events"], {"weight": 0.909107632041387}], ["OR52M1", ["TCGA.AZ.4682.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.890510281367291}], ["OR52M1", ["TCGA.AZ.4682.01", "G-protein mediated events"], {"weight": 0.814579089549183}], ["OR52M1", ["TCGA.AZ.4682.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.874572118262483}], ["SDC2", ["TCGA.AZ.5403.01", "Extracellular matrix organization"], {"weight": 0.905076800842707}], ["DBNL", ["TCGA.AZ.5403.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.596932560838266}], ["DBNL", ["TCGA.AZ.5403.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.83192765482896}], ["WASF1", ["TCGA.CM.6171.01", "Drug ADME"], {"weight": 0.897548725633311}], ["ADCYAP1", ["TCGA.DM.A1D4.01", "Peptide ligand-binding receptors"], {"weight": 0.955573834981906}], ["ADCYAP1", ["TCGA.DM.A1D4.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.956083934934274}], ["SCO2", ["TCGA.AZ.5407.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.676817656121257}], ["PRKCG", ["TCGA.D5.7000.01", "Trafficking of AMPA receptors"], {"weight": 0.885464081147922}], ["PRKCG", ["TCGA.D5.7000.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.885464081147922}], ["PRKCG", ["TCGA.DM.A1DA.01", "Nicotinate metabolism"], {"weight": 0.860143308492921}], ["ADCY3", ["TCGA.AZ.6600.01", "G alpha (s) signalling events"], {"weight": 0.922573667063176}], ["ADCY3", ["TCGA.AZ.6600.01", "Signaling by GPCR"], {"weight": 0.894778081910789}], ["ADCY3", ["TCGA.AZ.6600.01", "GPCR downstream signalling"], {"weight": 0.904250462892527}], ["ADCY3", ["TCGA.D5.6924.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.927081402472504}], ["RAB5A", ["TCGA.D5.6932.01", "Voltage gated Potassium channels"], {"weight": 0.827164479187263}], ["RAB5A", ["TCGA.G4.6304.01", "Defensins"], {"weight": 0.786203730694526}], ["RAB5A", ["TCGA.G4.6304.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.880096117626608}], ["MAP3K12", ["TCGA.CK.5916.01", "Free fatty acids regulate insulin secretion"], {"weight": 0.668663184358815}], ["KRT19", ["TCGA.CM.4743.01", "Developmental Biology"], {"weight": 0.903765918726526}], ["IHH", ["TCGA.D5.5540.01", "G1/S Transition"], {"weight": 0.934799886013492}], ["AZU1", ["TCGA.G4.6302.01", "FGFR4 ligand binding and activation"], {"weight": 0.752175539418777}], ["SSH1", ["TCGA.CM.6171.01", "Chemokine receptors bind chemokines"], {"weight": 0.928858618287743}], ["SMURF1", ["TCGA.AZ.6598.01", "GPCR ligand binding"], {"weight": 0.94799351637058}], ["SMURF1", ["TCGA.CK.5914.01", "Signaling Pathways"], {"weight": 0.905415833099529}], ["GBA", ["TCGA.AZ.6601.01", "GPCR ligand binding"], {"weight": 0.88405471523823}], ["SLC3A2", ["TCGA.AZ.6598.01", "Transport of small molecules"], {"weight": 0.928337225949922}], ["SLC3A2", ["TCGA.CM.6171.01", "Transport of small molecules"], {"weight": 0.932456156563099}], ["SLC3A2", ["TCGA.CM.6171.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.937954581589851}], ["TRPV4", ["TCGA.AZ.6598.01", "Calmodulin induced events"], {"weight": 0.89710453867469}], ["TRPV4", ["TCGA.AZ.6598.01", "CaM pathway"], {"weight": 0.89710453867469}], ["TRPV4", ["TCGA.AZ.6598.01", "Ca-dependent events"], {"weight": 0.89710453867469}], ["TRPV4", ["TCGA.AZ.6598.01", "Trafficking of AMPA receptors"], {"weight": 0.938301120681975}], ["TRPV4", ["TCGA.AZ.6598.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.938301120681975}], ["TRPV4", ["TCGA.AZ.6598.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.918759730006724}], ["TRPV4", ["TCGA.CM.5860.01", "Synaptic adhesion-like molecules"], {"weight": 0.859454564021139}], ["TRPV4", ["TCGA.CM.5860.01", "Protein-protein interactions at synapses"], {"weight": 0.888589823060129}], ["TRPV4", ["TCGA.CM.5860.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.893308592534846}], ["TRPV4", ["TCGA.CM.5860.01", "G alpha (i) signalling events"], {"weight": 0.927674950750635}], ["TRPV4", ["TCGA.CM.5860.01", "Response to elevated platelet cytosolic Ca2+"], {"weight": 0.78147656375653}], ["TRPV4", ["TCGA.CM.5860.01", "Trafficking of AMPA receptors"], {"weight": 0.904460580335368}], ["TRPV4", ["TCGA.CM.5860.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.904460580335368}], ["TRPV4", ["TCGA.CM.5860.01", "Long-term potentiation"], {"weight": 0.826621167059711}], ["TRPV4", ["TCGA.G4.6320.01", "G alpha (i) signalling events"], {"weight": 0.943158065486227}], ["STRA6", ["TCGA.CM.4743.01", "Metabolism of fat-soluble vitamins"], {"weight": 0.924364438577262}], ["STRA6", ["TCGA.CM.4743.01", "Retinoid metabolism and transport"], {"weight": 0.924364438577262}], ["STRA6", ["TCGA.CM.4743.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.906724569473592}], ["OR13D1", ["TCGA.D5.6932.01", "GPCR ligand binding"], {"weight": 0.943574218216955}], ["OR13D1", ["TCGA.D5.6932.01", "Potassium Channels"], {"weight": 0.891002315322223}], ["OR13D1", ["TCGA.D5.6932.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.893314323833633}], ["OR13D1", ["TCGA.D5.6932.01", "Integration of energy metabolism"], {"weight": 0.906423043158138}], ["OR13D1", ["TCGA.D5.6932.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.897117371622518}], ["OR13D1", ["TCGA.D5.6932.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.903395438457703}], ["OR13D1", ["TCGA.F4.6461.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.636228884743793}], ["REN", ["TCGA.AZ.6598.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.94178751435799}], ["REN", ["TCGA.AZ.6598.01", "G alpha (q) signalling events"], {"weight": 0.940670380485547}], ["ROCK1", ["TCGA.F4.6570.01", "Signaling by GPCR"], {"weight": 0.943002313698036}], ["ROCK1", ["TCGA.F4.6570.01", "GPCR downstream signalling"], {"weight": 0.948316921654212}], ["MYLK3", ["TCGA.CA.5797.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.847568773235112}], ["MYLK3", ["TCGA.CA.5797.01", "Activation of the phototransduction cascade"], {"weight": 0.710704728847719}], ["RPAP3", ["TCGA.AZ.6598.01", "G alpha (i) signalling events"], {"weight": 0.950104211906232}], ["UGT1A5", ["TCGA.AZ.6598.01", "Aspirin ADME"], {"weight": 0.944285254095121}], ["DGKI", ["TCGA.CM.5862.01", "RA biosynthesis pathway"], {"weight": 0.880942239679449}], ["DGKI", ["TCGA.CM.5862.01", "CD22 mediated BCR regulation"], {"weight": 0.784870040955711}], ["DGKI", ["TCGA.D5.6932.01", "Phase II - Conjugation of compounds"], {"weight": 0.832303863891224}], ["DGKI", ["TCGA.D5.6932.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.797522417089057}], ["C2", ["TCGA.DM.A1DA.01", "Regulation of Complement cascade"], {"weight": 0.953861394468396}], ["LTB", ["TCGA.CK.5915.01", "TNFs bind their physiological receptors"], {"weight": 0.533765259399658}], ["CYP46A1", ["TCGA.AZ.6598.01", "Bile acid and bile salt metabolism"], {"weight": 0.837293545671215}], ["CYP46A1", ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts"], {"weight": 0.813269649676485}], ["CYP46A1", ["TCGA.AZ.6598.01", "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"], {"weight": 0.792685994786978}], ["CYP46A1", ["TCGA.D5.5540.01", "Biological oxidations"], {"weight": 0.956944784756675}], ["ST3GAL5", ["TCGA.G4.6586.01", "Keratan sulfate biosynthesis"], {"weight": 0.936404628976187}], ["ST3GAL5", ["TCGA.G4.6586.01", "Keratan sulfate/keratin metabolism"], {"weight": 0.936404628976187}], ["DOLK", ["TCGA.D5.6534.01", "Glucuronidation"], {"weight": 0.821459491719582}], ["LGALS9C", ["TCGA.AZ.6599.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.950360990385827}], ["LGALS9C", ["TCGA.AZ.6599.01", "SLC-mediated transmembrane transport"], {"weight": 0.935594438789985}], ["PDCD1LG2", ["TCGA.AZ.6599.01", "Generation of second messenger molecules"], {"weight": 0.939414116968765}], ["PDCD1LG2", ["TCGA.AZ.6599.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.93408697184857}], ["PDCD1LG2", ["TCGA.AZ.6599.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.934093620915452}], ["PDCD1LG2", ["TCGA.AZ.6599.01", "Defensins"], {"weight": 0.679895084439221}], ["INPP5D", ["TCGA.AZ.6599.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.793917712135816}], ["INPP5D", ["TCGA.AZ.6599.01", "Immune System"], {"weight": 0.894724458910634}], ["MAP3K7", ["TCGA.AZ.6599.01", "Interleukin-10 signaling"], {"weight": 0.934469343725228}], ["TRIM62", ["TCGA.AZ.6599.01", "PD-1 signaling"], {"weight": 0.934527414253424}], ["TRIM62", ["TCGA.AZ.6599.01", "NCAM1 interactions"], {"weight": 0.937194236584919}], ["TRIM62", ["TCGA.AZ.6599.01", "FCGR activation"], {"weight": 0.880522523643993}], ["FBP1", ["TCGA.G4.6295.01", "Carbohydrate metabolism"], {"weight": 0.910731730882012}], ["FBP1", ["TCGA.G4.6295.01", "Fatty acid metabolism"], {"weight": 0.940758342385645}], ["SDSL", ["TCGA.CM.6680.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.562683575536775}], ["SDSL", ["TCGA.CM.6680.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.904121680927141}], ["OR4D11", ["TCGA.AZ.6600.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.836768536656941}], ["OR4D11", ["TCGA.AZ.6605.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.799943411201845}], ["KCNMB2", ["TCGA.CM.5868.01", "Potassium Channels"], {"weight": 0.947034702802945}], ["KCNMB2", ["TCGA.CM.5868.01", "Platelet homeostasis"], {"weight": 0.767553726406048}], ["KCNMB2", ["TCGA.CM.5868.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.621194681624015}], ["ATP6V1D", ["TCGA.DM.A1D0.01", "Ion channel transport"], {"weight": 0.941333716899292}], ["DGKH", ["TCGA.CM.5864.01", "Signaling by GPCR"], {"weight": 0.929424206789995}], ["DGKH", ["TCGA.CM.5864.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.840102548853439}], ["DGKH", ["TCGA.CM.5864.01", "G alpha (q) signalling events"], {"weight": 0.910813923220322}], ["SMARCC1", ["TCGA.D5.6532.01", "Ion channel transport"], {"weight": 0.927423706308664}], ["SMARCC1", ["TCGA.D5.6532.01", "Stimuli-sensing channels"], {"weight": 0.908834440857732}], ["GSTA4", ["TCGA.F4.6461.01", "Biological oxidations"], {"weight": 0.935431539984108}], ["GSTA4", ["TCGA.F4.6461.01", "Phase II - Conjugation of compounds"], {"weight": 0.831413457043977}], ["GSTA4", ["TCGA.F4.6461.01", "APAP ADME"], {"weight": 0.848395872204282}], ["GSTA4", ["TCGA.F4.6461.01", "Ethanol oxidation"], {"weight": 0.775230830911829}], ["GSTA4", ["TCGA.F4.6461.01", "Aflatoxin activation and detoxification"], {"weight": 0.872345853703406}], ["GSTA4", ["TCGA.F4.6461.01", "Glutathione conjugation"], {"weight": 0.850131761458577}], ["MADD", ["TCGA.G4.6626.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.84168018463003}], ["SLA2", ["TCGA.D5.6536.01", "Generation of second messenger molecules"], {"weight": 0.854178962452731}], ["SLA2", ["TCGA.D5.6536.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.925370182512346}], ["SLA2", ["TCGA.D5.6536.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.927052830186508}], ["SLA2", ["TCGA.D5.6536.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.868676576785228}], ["SLA2", ["TCGA.D5.6536.01", "Leishmania parasite growth and survival"], {"weight": 0.868676576785228}], ["SLA2", ["TCGA.D5.6536.01", "Leishmania infection"], {"weight": 0.876386098559889}], ["SLA2", ["TCGA.D5.6536.01", "Parasitic Infection Pathways"], {"weight": 0.876386098559889}], ["KRT8", ["TCGA.CM.4744.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.77378210198641}], ["PIK3R5", ["TCGA.CK.5913.01", "TNFs bind their physiological receptors"], {"weight": 0.55664755785707}], ["ZAP70", ["TCGA.CM.5862.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.947876108712872}], ["ZAP70", ["TCGA.CM.5862.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.949918583548197}], ["ZAP70", ["TCGA.CM.5862.01", "Generation of second messenger molecules"], {"weight": 0.929418757117272}], ["ZAP70", ["TCGA.CM.5862.01", "PD-1 signaling"], {"weight": 0.948457137524767}], ["ZAP70", ["TCGA.CM.5862.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.931623882451243}], ["ZAP70", ["TCGA.CM.5862.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.906079607755246}], ["ACVR1B", ["TCGA.F4.6806.01", "Peptide hormone metabolism"], {"weight": 0.681372552521175}], ["JAG1", ["TCGA.DM.A1D8.01", "Blood group systems biosynthesis"], {"weight": 0.806720071140086}], ["JAG1", ["TCGA.DM.A1D8.01", "Lewis blood group biosynthesis"], {"weight": 0.790506054632075}], ["JAG1", ["TCGA.DM.A1D8.01", "Sialic acid metabolism"], {"weight": 0.615695981430105}], ["LRPPRC", ["TCGA.D5.6929.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.609681498382668}], ["CES2", ["TCGA.CM.6162.01", "Glucuronidation"], {"weight": 0.864682055707948}], ["GGT6", ["TCGA.DM.A1DB.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.914847295730385}], ["GGT6", ["TCGA.DM.A1DB.01", "Neurotransmitter release cycle"], {"weight": 0.866804749264611}], ["GGT6", ["TCGA.DM.A1DB.01", "Arachidonic acid metabolism"], {"weight": 0.932999863998614}], ["ZIC3", ["TCGA.AZ.6601.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.831885964286603}], ["ZIC3", ["TCGA.AZ.6601.01", "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"], {"weight": 0.762523856237716}], ["ZIC3", ["TCGA.G4.6306.01", "Formation of the anterior neural plate"], {"weight": 0.764219219986645}], ["ZIC3", ["TCGA.G4.6586.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.835522451284768}], ["IL1R2", ["TCGA.DM.A1D8.01", "Leishmania infection"], {"weight": 0.907959469362726}], ["IL1R2", ["TCGA.DM.A1D8.01", "Parasitic Infection Pathways"], {"weight": 0.907959469362726}], ["TBC1D7", ["TCGA.AZ.6601.01", "Transmission across Chemical Synapses"], {"weight": 0.890709758155994}], ["TBC1D7", ["TCGA.AZ.6601.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.90137480070735}], ["GCG", ["TCGA.G4.6310.01", "Inwardly rectifying K+ channels"], {"weight": 0.908966622189098}], ["GPX5", ["TCGA.DM.A1D6.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.93991967820833}], ["GPX5", ["TCGA.DM.A1D6.01", "Leishmania parasite growth and survival"], {"weight": 0.93991967820833}], ["GPX5", ["TCGA.DM.A1D6.01", "Phase I - Functionalization of compounds"], {"weight": 0.953086879583659}], ["GPX5", ["TCGA.DM.A1D6.01", "Arachidonic acid metabolism"], {"weight": 0.959230000186702}], ["GPX5", ["TCGA.DM.A1D6.01", "Drug ADME"], {"weight": 0.850047941606676}], ["GPX5", ["TCGA.DM.A1D6.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.922748937786336}], ["GPX5", ["TCGA.DM.A1D6.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.924114472760356}], ["GPX5", ["TCGA.DM.A1D6.01", "Heme degradation"], {"weight": 0.804062952175961}], ["GPX5", ["TCGA.DM.A1D6.01", "Phase II - Conjugation of compounds"], {"weight": 0.873207354608717}], ["CRMP1", ["TCGA.AZ.6605.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.916780546938057}], ["OR6C70", ["TCGA.AZ.6607.01", "Inwardly rectifying K+ channels"], {"weight": 0.877256621038884}], ["OR6C70", ["TCGA.AZ.6607.01", "GPCR ligand binding"], {"weight": 0.92094291965641}], ["OR6C70", ["TCGA.AZ.6607.01", "Activation of G protein gated Potassium channels"], {"weight": 0.910630613841963}], ["OR6C70", ["TCGA.AZ.6607.01", "G protein gated Potassium channels"], {"weight": 0.910630613841963}], ["OR6C70", ["TCGA.AZ.6607.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.910630613841963}], ["OR6C70", ["TCGA.AZ.6607.01", "Signaling by GPCR"], {"weight": 0.931531193957906}], ["GNG4", ["TCGA.AZ.6607.01", "Phase 0 - rapid depolarisation"], {"weight": 0.902891443226738}], ["GNG4", ["TCGA.AZ.6607.01", "Transmission across Chemical Synapses"], {"weight": 0.898367311963087}], ["VAMP3", ["TCGA.AZ.6607.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.930024381639711}], ["PCOLCE", ["TCGA.AZ.6607.01", "Collagen chain trimerization"], {"weight": 0.942787227062097}], ["PCOLCE", ["TCGA.AZ.6607.01", "Elastic fibre formation"], {"weight": 0.883688108248249}], ["PCOLCE", ["TCGA.AZ.6607.01", "Defective B3GALTL causes PpS"], {"weight": 0.878938597356938}], ["PCOLCE", ["TCGA.AZ.6607.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.878938597356938}], ["OR2L5", ["TCGA.AZ.6607.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.908372958612622}], ["OR2L5", ["TCGA.AZ.6607.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.939517870241928}], ["OR2L5", ["TCGA.CM.6169.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.87444854925185}], ["OR2L5", ["TCGA.CM.6169.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.886869767818732}], ["OR2L5", ["TCGA.CM.6169.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.914279551859124}], ["RCAN1", ["TCGA.AZ.6607.01", "Signaling by Retinoic Acid"], {"weight": 0.39297054476807}], ["AKR7A3", ["TCGA.CA.5796.01", "Biological oxidations"], {"weight": 0.852684073375834}], ["IKBKB", ["TCGA.CA.6716.01", "TNFs bind their physiological receptors"], {"weight": 0.380583695693105}], ["IKBKB", ["TCGA.CA.6716.01", "Signaling by Interleukins"], {"weight": 0.846242252762607}], ["IKBKB", ["TCGA.CA.6716.01", "Defensins"], {"weight": 0.531995118508815}], ["OR5AN1", ["TCGA.DM.A28F.01", "Voltage gated Potassium channels"], {"weight": 0.880308161464637}], ["OR5AN1", ["TCGA.DM.A28F.01", "Phase 4 - resting membrane potential"], {"weight": 0.870178249695926}], ["OR5AN1", ["TCGA.DM.A28F.01", "G alpha (s) signalling events"], {"weight": 0.962855292059832}], ["OR5AN1", ["TCGA.DM.A28F.01", "Leishmania infection"], {"weight": 0.870486249687264}], ["OR5AN1", ["TCGA.DM.A28F.01", "Inwardly rectifying K+ channels"], {"weight": 0.931612344887263}], ["OR5AN1", ["TCGA.DM.A28F.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.915161972393662}], ["OR5AN1", ["TCGA.DM.A28F.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.914639232147539}], ["OR5AN1", ["TCGA.DM.A28F.01", "Signal amplification"], {"weight": 0.881988965389366}], ["OR5AN1", ["TCGA.G4.6311.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.808735321027226}], ["OR5AN1", ["TCGA.G4.6311.01", "Presynaptic function of Kainate receptors"], {"weight": 0.862111988953929}], ["OR5AN1", ["TCGA.G4.6311.01", "Glucagon-type ligand receptors"], {"weight": 0.880120699501229}], ["OR5AN1", ["TCGA.G4.6311.01", "G beta:gamma signalling through BTK"], {"weight": 0.834913525010316}], ["IMPAD1", ["TCGA.CM.4743.01", "Glycosaminoglycan metabolism"], {"weight": 0.866292344423224}], ["OR4A16", ["TCGA.DM.A0X9.01", "Neuronal System"], {"weight": 0.930226900255136}], ["OR4A16", ["TCGA.DM.A0X9.01", "Potassium Channels"], {"weight": 0.953018583390854}], ["OR4A16", ["TCGA.DM.A0X9.01", "G alpha (i) signalling events"], {"weight": 0.934025599827568}], ["PLA2G4A", ["TCGA.CM.6165.01", "Signaling by Retinoic Acid"], {"weight": 0.599102019706909}], ["PLA2G4A", ["TCGA.CM.6165.01", "Ethanol oxidation"], {"weight": 0.695446880785926}], ["PLA2G4A", ["TCGA.G4.6588.01", "Drug ADME"], {"weight": 0.868482521143371}], ["OR8H1", ["TCGA.G4.6303.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.902598202864941}], ["OR8H1", ["TCGA.G4.6303.01", "G alpha (s) signalling events"], {"weight": 0.93653376331314}], ["OR8H1", ["TCGA.G4.6303.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.894275263144618}], ["OR8H1", ["TCGA.G4.6303.01", "G beta:gamma signalling through BTK"], {"weight": 0.893217828582791}], ["OR8H1", ["TCGA.G4.6303.01", "Signal amplification"], {"weight": 0.897017803267599}], ["OR8H1", ["TCGA.G4.6303.01", "G alpha (q) signalling events"], {"weight": 0.913446886400579}], ["FZD4", ["TCGA.CA.6718.01", "GABA receptor activation"], {"weight": 0.8837345634924}], ["EGLN1", ["TCGA.CA.6718.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.899359151989357}], ["ANPEP", ["TCGA.D5.5539.01", "Extracellular matrix organization"], {"weight": 0.791116882799785}], ["ANPEP", ["TCGA.D5.5539.01", "Drug ADME"], {"weight": 0.711427815705006}], ["ANPEP", ["TCGA.D5.5539.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.783787969595419}], ["ANPEP", ["TCGA.DM.A28K.01", "Drug ADME"], {"weight": 0.86778269316656}], ["CD22", ["TCGA.DM.A0XF.01", "Diseases of Immune System"], {"weight": 0.847167370333446}], ["CD22", ["TCGA.DM.A0XF.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.847167370333446}], ["MAP2K6", ["TCGA.CM.5868.01", "TNFs bind their physiological receptors"], {"weight": 0.455104606204463}], ["MAP2K6", ["TCGA.CM.5868.01", "Diseases of Immune System"], {"weight": 0.781040989081108}], ["MAP2K6", ["TCGA.CM.5868.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.781040989081108}], ["MAP2K6", ["TCGA.CM.5868.01", "Long-term potentiation"], {"weight": 0.898223512100026}], ["NMU", ["TCGA.F4.6808.01", "Complement cascade"], {"weight": 0.902858960125413}], ["NMU", ["TCGA.F4.6808.01", "Regulation of Complement cascade"], {"weight": 0.860913685658021}], ["NMU", ["TCGA.F4.6808.01", "Initial triggering of complement"], {"weight": 0.837423792273248}], ["NMU", ["TCGA.F4.6808.01", "Peptide ligand-binding receptors"], {"weight": 0.936151242618388}], ["NMU", ["TCGA.F4.6808.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.946949630622398}], ["NMU", ["TCGA.F4.6808.01", "Chemokine receptors bind chemokines"], {"weight": 0.933287892277274}], ["ADH5", ["TCGA.CA.6718.01", "Phase II - Conjugation of compounds"], {"weight": 0.939905033126062}], ["HIF1A", ["TCGA.CK.5916.01", "Digestion and absorption"], {"weight": 0.680423209161935}], ["HIF1A", ["TCGA.D5.6928.01", "APAP ADME"], {"weight": 0.770626823137116}], ["HIF1A", ["TCGA.G4.6628.01", "Cytochrome P450 - arranged by substrate type"], {"weight": 0.882328571145229}], ["GNAT3", ["TCGA.CA.6718.01", "Signaling by GPCR"], {"weight": 0.928292733023978}], ["GNAT3", ["TCGA.CA.6718.01", "G alpha (i) signalling events"], {"weight": 0.94593038397849}], ["GNAT3", ["TCGA.CA.6718.01", "GPCR downstream signalling"], {"weight": 0.936630134019766}], ["GNAT3", ["TCGA.DM.A1D9.01", "GPCR downstream signalling"], {"weight": 0.947767295689799}], ["GNAT3", ["TCGA.DM.A1D9.01", "Signaling by GPCR"], {"weight": 0.945486966513909}], ["GNAT3", ["TCGA.DM.A1D9.01", "G alpha (i) signalling events"], {"weight": 0.947185616817126}], ["GNAT3", ["TCGA.DM.A1D9.01", "G alpha (z) signalling events"], {"weight": 0.933210503466441}], ["GNAT3", ["TCGA.DM.A1D9.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.912906749935734}], ["GNAT3", ["TCGA.DM.A1D9.01", "Signal amplification"], {"weight": 0.904865007526993}], ["CEPT1", ["TCGA.DM.A1D9.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.82181710169613}], ["CEPT1", ["TCGA.DM.A1D9.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.82181710169613}], ["CEPT1", ["TCGA.DM.A1D9.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.853668188697731}], ["FABP6", ["TCGA.CA.6718.01", "Bile acid and bile salt metabolism"], {"weight": 0.888573039384217}], ["FABP6", ["TCGA.CA.6718.01", "Synthesis of bile acids and bile salts"], {"weight": 0.891190899247151}], ["HADHB", ["TCGA.CM.5341.01", "Metabolism"], {"weight": 0.912165254413355}], ["HADHB", ["TCGA.CM.5861.01", "Ethanol oxidation"], {"weight": 0.925888412317101}], ["GGCT", ["TCGA.CA.6718.01", "APAP ADME"], {"weight": 0.845966691854794}], ["ZRANB2", ["TCGA.CA.6719.01", "Phase II - Conjugation of compounds"], {"weight": 0.862773065903074}], ["ZRANB2", ["TCGA.CA.6719.01", "Drug ADME"], {"weight": 0.94612195212606}], ["ZRANB2", ["TCGA.CA.6719.01", "APAP ADME"], {"weight": 0.774522013192651}], ["ZRANB2", ["TCGA.CA.6719.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.876277041382141}], ["ZRANB2", ["TCGA.CA.6719.01", "Ethanol oxidation"], {"weight": 0.638484614942398}], ["PAK3", ["TCGA.F4.6569.01", "Diseases associated with O-glycosylation of proteins"], {"weight": 0.840249353126685}], ["PAK3", ["TCGA.F4.6569.01", "ECM proteoglycans"], {"weight": 0.86337707327157}], ["OPN3", ["TCGA.DM.A1D0.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.94986325828648}], ["OPN3", ["TCGA.DM.A1D0.01", "Platelet homeostasis"], {"weight": 0.90649807355857}], ["RASGRP1", ["TCGA.DM.A1HA.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.855629637325408}], ["RASGRP1", ["TCGA.DM.A1HA.01", "NCAM1 interactions"], {"weight": 0.955102572511497}], ["RASGRP1", ["TCGA.DM.A1HA.01", "Presynaptic depolarization and calcium channel opening"], {"weight": 0.91626674632187}], ["GPCPD1", ["TCGA.CA.6718.01", "Metabolism of lipids"], {"weight": 0.915603422950342}], ["GPCPD1", ["TCGA.DM.A282.01", "Neuronal System"], {"weight": 0.935520094568031}], ["GPCPD1", ["TCGA.DM.A282.01", "Transmission across Chemical Synapses"], {"weight": 0.913961984428423}], ["CFHR3", ["TCGA.G4.6315.01", "Complement cascade"], {"weight": 0.864062517616169}], ["CFHR3", ["TCGA.G4.6315.01", "Initial triggering of complement"], {"weight": 0.852122997587562}], ["CFHR3", ["TCGA.G4.6315.01", "Leishmania infection"], {"weight": 0.881159918786694}], ["CFHR3", ["TCGA.G4.6315.01", "Parasitic Infection Pathways"], {"weight": 0.881159918786694}], ["CFHR3", ["TCGA.G4.6315.01", "Regulation of Complement cascade"], {"weight": 0.85968671230785}], ["CFHR3", ["TCGA.G4.6315.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.742883537158173}], ["CFHR3", ["TCGA.G4.6315.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.742883537158173}], ["CFHR3", ["TCGA.G4.6315.01", "Biological oxidations"], {"weight": 0.861056030513812}], ["KCNK2", ["TCGA.CK.5916.01", "Cardiac conduction"], {"weight": 0.921250604939424}], ["RAB3C", ["TCGA.DM.A1D6.01", "Scavenging by Class A Receptors"], {"weight": 0.443839401874353}], ["C5", ["TCGA.CA.6719.01", "Extracellular matrix organization"], {"weight": 0.854894437553488}], ["C5", ["TCGA.CA.6719.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.79613536483103}], ["C5", ["TCGA.CA.6719.01", "Degradation of the extracellular matrix"], {"weight": 0.809565660017469}], ["C5", ["TCGA.CK.5913.01", "Antimicrobial peptides"], {"weight": 0.797865380449453}], ["STK40", ["TCGA.CK.4947.01", "Biological oxidations"], {"weight": 0.864777111285791}], ["GJD2", ["TCGA.G4.6297.01", "Signaling by Retinoic Acid"], {"weight": 0.683242282079367}], ["OR10AG1", ["TCGA.CK.4947.01", "Complement cascade"], {"weight": 0.696324559123343}], ["OR10AG1", ["TCGA.CK.4947.01", "GABA receptor activation"], {"weight": 0.778964786305139}], ["OR10AG1", ["TCGA.CK.4947.01", "Phase 4 - resting membrane potential"], {"weight": 0.761271400587191}], ["OR10AG1", ["TCGA.DM.A1DA.01", "GABA receptor activation"], {"weight": 0.93696281209869}], ["OR10AG1", ["TCGA.G4.6298.01", "Regulation of insulin secretion"], {"weight": 0.926725784222875}], ["OR10AG1", ["TCGA.G4.6298.01", "G beta:gamma signalling through BTK"], {"weight": 0.923003601063832}], ["GPR132", ["TCGA.CK.4947.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.714288674187172}], ["SOS1", ["TCGA.CK.4948.01", "Interaction between L1 and Ankyrins"], {"weight": 0.927603617867466}], ["SOS1", ["TCGA.D5.6536.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.742082123468387}], ["SOS1", ["TCGA.D5.6536.01", "G alpha (q) signalling events"], {"weight": 0.89532778852656}], ["SOS1", ["TCGA.D5.6536.01", "Drug ADME"], {"weight": 0.863397733791594}], ["SOS1", ["TCGA.D5.6536.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.750297553539202}], ["SOS1", ["TCGA.D5.6536.01", "TNFs bind their physiological receptors"], {"weight": 0.404657866803325}], ["SOS1", ["TCGA.D5.6536.01", "Interleukin-10 signaling"], {"weight": 0.78191778165379}], ["SOS1", ["TCGA.D5.6536.01", "Interaction between L1 and Ankyrins"], {"weight": 0.924839085367423}], ["SOS1", ["TCGA.F4.6463.01", "Drug ADME"], {"weight": 0.85246016444815}], ["SOS1", ["TCGA.F4.6463.01", "Extracellular matrix organization"], {"weight": 0.831122865047848}], ["SOS1", ["TCGA.F4.6463.01", "FGFR4 ligand binding and activation"], {"weight": 0.873289488716738}], ["SOS1", ["TCGA.F4.6463.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.873289488716738}], ["SOS1", ["TCGA.F4.6463.01", "IRS-related events triggered by IGF1R"], {"weight": 0.904467364648706}], ["SOS1", ["TCGA.F4.6463.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.904362326704523}], ["SOS1", ["TCGA.F4.6463.01", "IGF1R signaling cascade"], {"weight": 0.904362326704523}], ["SOS1", ["TCGA.F4.6463.01", "Insulin receptor signalling cascade"], {"weight": 0.893579739009332}], ["SOS1", ["TCGA.F4.6463.01", "PI-3K cascade:FGFR4"], {"weight": 0.879313833487316}], ["SOS1", ["TCGA.F4.6463.01", "IRS-mediated signalling"], {"weight": 0.890172762186277}], ["SOS1", ["TCGA.F4.6463.01", "FGFRL1 modulation of FGFR1 signaling"], {"weight": 0.882431635057892}], ["SOS1", ["TCGA.F4.6463.01", "SHC-mediated cascade:FGFR4"], {"weight": 0.922808717362715}], ["SOS1", ["TCGA.F4.6463.01", "FRS-mediated FGFR4 signaling"], {"weight": 0.922800521628444}], ["SOS1", ["TCGA.F4.6463.01", "Downstream signaling of activated FGFR4"], {"weight": 0.922792353555473}], ["SOS1", ["TCGA.F4.6463.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.536342549965119}], ["SOS1", ["TCGA.F4.6463.01", "Signaling by Insulin receptor"], {"weight": 0.861042241141839}], ["SOS1", ["TCGA.F4.6463.01", "Signaling by activated point mutants of FGFR3"], {"weight": 0.828298906400826}], ["SOS1", ["TCGA.F4.6463.01", "FGFR3 mutant receptor activation"], {"weight": 0.828298906400826}], ["NPY2R", ["TCGA.CK.4948.01", "Chemokine receptors bind chemokines"], {"weight": 0.90873934017594}], ["NPY2R", ["TCGA.CK.4948.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.737017225318605}], ["NPY2R", ["TCGA.CK.5914.01", "Chemokine receptors bind chemokines"], {"weight": 0.927760865139244}], ["SMAD3", ["TCGA.CK.4948.01", "Formation of axial mesoderm"], {"weight": 0.697381331460701}], ["SMAD3", ["TCGA.CK.4952.01", "Signaling Pathways"], {"weight": 0.926475127746273}], ["SMAD3", ["TCGA.DM.A1DA.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.91924849583074}], ["SMAD3", ["TCGA.DM.A28M.01", "Signaling by Interleukins"], {"weight": 0.907293788090556}], ["SMAD3", ["TCGA.G4.6310.01", "Cytokine Signaling in Immune system"], {"weight": 0.897743545628464}], ["SMAD3", ["TCGA.G4.6310.01", "Signaling by Interleukins"], {"weight": 0.912551539594124}], ["SMAD3", ["TCGA.G4.6310.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.844443981169672}], ["SMAD3", ["TCGA.G4.6310.01", "Signaling Pathways"], {"weight": 0.874328207840758}], ["SMAD3", ["TCGA.G4.6310.01", "PI3K/AKT Signaling in Cancer"], {"weight": 0.843286502589396}], ["ANXA1", ["TCGA.CK.4948.01", "Peptide ligand-binding receptors"], {"weight": 0.941437212965868}], ["ANXA1", ["TCGA.CK.4948.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.940948667607005}], ["UBL7", ["TCGA.CK.4950.01", "GABA receptor activation"], {"weight": 0.357309350704654}], ["RHEB", ["TCGA.CK.4952.01", "Carnitine metabolism"], {"weight": 0.79012792270677}], ["TRIM39", ["TCGA.CK.4952.01", "GPCR ligand binding"], {"weight": 0.936106820116473}], ["MAP3K15", ["TCGA.CK.4952.01", "Phase I - Functionalization of compounds"], {"weight": 0.942894030570166}], ["NXF3", ["TCGA.CK.5912.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.819248916918757}], ["TUBGCP2", ["TCGA.CK.5912.01", "G-protein mediated events"], {"weight": 0.865089163940155}], ["TUBGCP2", ["TCGA.CK.5912.01", "PLC beta mediated events"], {"weight": 0.861862342558133}], ["SLA", ["TCGA.CM.5861.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.931944521125519}], ["SLA", ["TCGA.G4.6315.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.892844745969237}], ["SLA", ["TCGA.G4.6315.01", "Leishmania parasite growth and survival"], {"weight": 0.892844745969237}], ["SLA", ["TCGA.G4.6315.01", "Platelet homeostasis"], {"weight": 0.852412101115942}], ["SLA", ["TCGA.G4.6315.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.842679093162395}], ["IL6ST", ["TCGA.D5.7000.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.886361358143971}], ["IL6ST", ["TCGA.D5.7000.01", "Interleukin-6 family signaling"], {"weight": 0.896815674628343}], ["IL6ST", ["TCGA.G4.6317.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.924575552412339}], ["IL6ST", ["TCGA.G4.6317.01", "Leishmania parasite growth and survival"], {"weight": 0.924575552412339}], ["IL6ST", ["TCGA.G4.6317.01", "Leishmania infection"], {"weight": 0.912788673303012}], ["IL6ST", ["TCGA.G4.6317.01", "Parasitic Infection Pathways"], {"weight": 0.912788673303012}], ["IL6ST", ["TCGA.G4.6317.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.932333775539021}], ["IL6ST", ["TCGA.G4.6317.01", "Platelet activation, signaling and aggregation"], {"weight": 0.925703491159135}], ["IL6ST", ["TCGA.G4.6317.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.943350558037898}], ["IL6ST", ["TCGA.G4.6317.01", "FCGR3A-mediated IL10 synthesis"], {"weight": 0.938747728470627}], ["IL6ST", ["TCGA.G4.6317.01", "Azathioprine ADME"], {"weight": 0.830955241055006}], ["IL6ST", ["TCGA.G4.6317.01", "FCGR activation"], {"weight": 0.910141212945204}], ["RPS6KA4", ["TCGA.CK.5913.01", "L1CAM interactions"], {"weight": 0.947960058658658}], ["RPS6KA4", ["TCGA.CM.6677.01", "L1CAM interactions"], {"weight": 0.845814702548271}], ["ADH1B", ["TCGA.CK.5913.01", "Phase II - Conjugation of compounds"], {"weight": 0.862918400127366}], ["ADH1B", ["TCGA.CK.5913.01", "Glucuronidation"], {"weight": 0.935897533455017}], ["ADH1B", ["TCGA.F4.6570.01", "Phase II - Conjugation of compounds"], {"weight": 0.933133938692008}], ["ADH1B", ["TCGA.F4.6570.01", "Glutathione conjugation"], {"weight": 0.913096977374394}], ["OR2J3", ["TCGA.CK.5913.01", "Glucagon-type ligand receptors"], {"weight": 0.918712815244082}], ["OR2J3", ["TCGA.CK.5913.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.928435606738522}], ["OR8I2", ["TCGA.CK.5913.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.936620574208986}], ["RGS4", ["TCGA.CK.5913.01", "G alpha (i) signalling events"], {"weight": 0.928667903698199}], ["RGS4", ["TCGA.CK.5913.01", "Signaling by GPCR"], {"weight": 0.941411465606671}], ["RGS4", ["TCGA.G4.6306.01", "Signaling by GPCR"], {"weight": 0.945525488775792}], ["RGS4", ["TCGA.G4.6306.01", "GPCR downstream signalling"], {"weight": 0.945747894229249}], ["RGS4", ["TCGA.G4.6306.01", "G alpha (s) signalling events"], {"weight": 0.961909314964675}], ["RGS4", ["TCGA.G4.6306.01", "Transmission across Chemical Synapses"], {"weight": 0.939254822273326}], ["RGS4", ["TCGA.G4.6306.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.917181062658873}], ["RGS4", ["TCGA.G4.6306.01", "G alpha (i) signalling events"], {"weight": 0.946896344627278}], ["RGS4", ["TCGA.G4.6306.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.796979182785693}], ["RGS4", ["TCGA.G4.6306.01", "GABA receptor activation"], {"weight": 0.718476315062579}], ["RGS4", ["TCGA.G4.6306.01", "Signal amplification"], {"weight": 0.920090481937149}], ["RGS4", ["TCGA.G4.6306.01", "GABA B receptor activation"], {"weight": 0.922355036586783}], ["RGS4", ["TCGA.G4.6306.01", "Activation of GABAB receptors"], {"weight": 0.922355036586783}], ["RGS4", ["TCGA.G4.6306.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.912407187007001}], ["RGS4", ["TCGA.G4.6306.01", "Opioid Signalling"], {"weight": 0.915378959414376}], ["RGS4", ["TCGA.G4.6306.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.920238456852837}], ["RGS4", ["TCGA.G4.6306.01", "G alpha (q) signalling events"], {"weight": 0.924878960236787}], ["ARF5", ["TCGA.CK.5913.01", "Interaction between L1 and Ankyrins"], {"weight": 0.928712775489111}], ["ARF5", ["TCGA.G4.6626.01", "Signaling by GPCR"], {"weight": 0.952120799025366}], ["ARF5", ["TCGA.G4.6626.01", "Interaction between L1 and Ankyrins"], {"weight": 0.946614250837277}], ["GPX7", ["TCGA.CK.5913.01", "Glutathione conjugation"], {"weight": 0.908683762117049}], ["IDS", ["TCGA.D5.6924.01", "Metabolism"], {"weight": 0.857501621799149}], ["PON2", ["TCGA.D5.6929.01", "Drug ADME"], {"weight": 0.825223816503854}], ["MC3R", ["TCGA.CK.5914.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.949648087158189}], ["MC3R", ["TCGA.CK.5914.01", "Peptide ligand-binding receptors"], {"weight": 0.948121806814794}], ["MC3R", ["TCGA.CM.4743.01", "Signaling by GPCR"], {"weight": 0.949286012746695}], ["MC3R", ["TCGA.CM.4743.01", "GPCR downstream signalling"], {"weight": 0.952599922154779}], ["MC3R", ["TCGA.DM.A1DB.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.951978915417806}], ["FGF12", ["TCGA.D5.6538.01", "Cardiac conduction"], {"weight": 0.912988237267203}], ["FGF12", ["TCGA.G4.6586.01", "L1CAM interactions"], {"weight": 0.942256311590259}], ["FGF12", ["TCGA.G4.6586.01", "FGFR2 ligand binding and activation"], {"weight": 0.918594947251972}], ["FGF12", ["TCGA.G4.6586.01", "Activated point mutants of FGFR2"], {"weight": 0.897602609318648}], ["SPRED1", ["TCGA.CK.5914.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.753359028545237}], ["SPRED1", ["TCGA.CK.5914.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.753359028545237}], ["CDC37", ["TCGA.CM.5861.01", "Long-term potentiation"], {"weight": 0.928626838260439}], ["RGS6", ["TCGA.F4.6570.01", "G alpha (i) signalling events"], {"weight": 0.957005683891212}], ["RGS6", ["TCGA.G4.6303.01", "Signaling by GPCR"], {"weight": 0.932309026904675}], ["RGS6", ["TCGA.G4.6303.01", "GPCR downstream signalling"], {"weight": 0.930290078576807}], ["RGS6", ["TCGA.G4.6303.01", "G alpha (i) signalling events"], {"weight": 0.937391937181115}], ["NFKB2", ["TCGA.CM.5861.01", "Innate Immune System"], {"weight": 0.886647684120002}], ["PSMD2", ["TCGA.G4.6298.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.89331670882726}], ["PSMD2", ["TCGA.G4.6298.01", "TNFs bind their physiological receptors"], {"weight": 0.526305720518541}], ["STK11", ["TCGA.G4.6294.01", "Integration of energy metabolism"], {"weight": 0.921215976186376}], ["THBS4", ["TCGA.CM.4750.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.907440319447227}], ["THBS4", ["TCGA.CM.6166.01", "TNFs bind their physiological receptors"], {"weight": 0.577213926031823}], ["KLRD1", ["TCGA.G4.6302.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.83697199083679}], ["GGT7", ["TCGA.D5.6924.01", "Biological oxidations"], {"weight": 0.93072536259489}], ["GGT7", ["TCGA.D5.6924.01", "Phase II - Conjugation of compounds"], {"weight": 0.887424308727919}], ["GGT7", ["TCGA.D5.6924.01", "Drug ADME"], {"weight": 0.951089663734076}], ["GGT7", ["TCGA.D5.6924.01", "RA biosynthesis pathway"], {"weight": 0.79291054573515}], ["GGT7", ["TCGA.D5.6924.01", "APAP ADME"], {"weight": 0.835047771968545}], ["GGT7", ["TCGA.D5.6924.01", "Ethanol oxidation"], {"weight": 0.733842535374846}], ["GGT7", ["TCGA.D5.6924.01", "Glutathione conjugation"], {"weight": 0.762673812832513}], ["GGT7", ["TCGA.D5.6924.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.823061500029695}], ["GGT7", ["TCGA.D5.6924.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.687912027804861}], ["RNF25", ["TCGA.DM.A1D0.01", "GPCR ligand binding"], {"weight": 0.947512723346359}], ["RNF25", ["TCGA.DM.A1D0.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.942627676678029}], ["RNF25", ["TCGA.DM.A1D0.01", "Peptide ligand-binding receptors"], {"weight": 0.941166771806211}], ["GPR84", ["TCGA.CM.5863.01", "Peptide hormone biosynthesis"], {"weight": 0.510949282145791}], ["GPR84", ["TCGA.CM.5863.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.786915530242187}], ["KLHDC3", ["TCGA.G4.6626.01", "Transcriptional regulation of pluripotent stem cells"], {"weight": 0.884105561017561}], ["FGF17", ["TCGA.D5.6924.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.649284743759884}], ["FGF17", ["TCGA.D5.6924.01", "FGFR4 ligand binding and activation"], {"weight": 0.731632616897015}], ["FGF17", ["TCGA.D5.6924.01", "Phospholipase C-mediated cascade; FGFR4"], {"weight": 0.731389989560769}], ["FGF17", ["TCGA.D5.6924.01", "PI-3K cascade:FGFR4"], {"weight": 0.744490704734923}], ["FGF17", ["TCGA.D5.6924.01", "Defective GALNT3 causes HFTC"], {"weight": 0.593096255231146}], ["FGF17", ["TCGA.D5.6924.01", "SHC-mediated cascade:FGFR4"], {"weight": 0.729612768340693}], ["FGF17", ["TCGA.D5.6924.01", "IRS-related events triggered by IGF1R"], {"weight": 0.794283199783611}], ["FGF17", ["TCGA.D5.6924.01", "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"], {"weight": 0.794283199783611}], ["FGF17", ["TCGA.D5.6924.01", "IGF1R signaling cascade"], {"weight": 0.794283199783611}], ["FGF17", ["TCGA.D5.6924.01", "FGFR2c ligand binding and activation"], {"weight": 0.825852473640072}], ["FGF17", ["TCGA.D5.6924.01", "Defective C1GALT1C1 causes TNPS"], {"weight": 0.5930012903692}], ["FGF17", ["TCGA.D5.6924.01", "FRS-mediated FGFR4 signaling"], {"weight": 0.743878769816096}], ["FGF17", ["TCGA.D5.6924.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.898994377738389}], ["CAP1", ["TCGA.CM.5341.01", "Regulation of expression of SLITs and ROBOs"], {"weight": 0.909349226625303}], ["PARD6G", ["TCGA.D5.6531.01", "Metabolism of water-soluble vitamins and cofactors"], {"weight": 0.710721345006563}], ["OR1L8", ["TCGA.F4.6703.01", "GPCR ligand binding"], {"weight": 0.950011609811637}], ["OR1L8", ["TCGA.F4.6703.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.947037194537701}], ["OR1L8", ["TCGA.F4.6703.01", "Glucagon-type ligand receptors"], {"weight": 0.911826078714686}], ["EIF4G1", ["TCGA.G4.6304.01", "Signaling Pathways"], {"weight": 0.920003156974823}], ["CD79A", ["TCGA.CM.4743.01", "Regulation of Complement cascade"], {"weight": 0.881098967929634}], ["CD79A", ["TCGA.CM.4743.01", "Complement cascade"], {"weight": 0.919743468231037}], ["MAPK4", ["TCGA.DM.A1HA.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.748120778798231}], ["SLC1A2", ["TCGA.CM.4743.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.930751562432978}], ["MGP", ["TCGA.CM.4744.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.909658303548006}], ["MGP", ["TCGA.CM.5860.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.922893160352446}], ["MGP", ["TCGA.CM.5860.01", "Collagen chain trimerization"], {"weight": 0.886918194465547}], ["MGP", ["TCGA.CM.5860.01", "Heme degradation"], {"weight": 0.676181989350583}], ["OR2AK2", ["TCGA.CM.4744.01", "GABA receptor activation"], {"weight": 0.913145482890511}], ["OR2AK2", ["TCGA.CM.4744.01", "GABA B receptor activation"], {"weight": 0.939588632476947}], ["OR2AK2", ["TCGA.CM.4744.01", "Activation of GABAB receptors"], {"weight": 0.939588632476947}], ["OR2AK2", ["TCGA.CM.4744.01", "Adenylate cyclase inhibitory pathway"], {"weight": 0.916587617517767}], ["OR2AK2", ["TCGA.CM.4744.01", "G alpha (s) signalling events"], {"weight": 0.964673086699574}], ["OR2AK2", ["TCGA.CM.4744.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.94818132316502}], ["OR2AK2", ["TCGA.CM.4744.01", "G alpha (z) signalling events"], {"weight": 0.930475709885912}], ["OR2AK2", ["TCGA.CM.4744.01", "Platelet homeostasis"], {"weight": 0.907566537554073}], ["UFL1", ["TCGA.CM.4744.01", "GPCR ligand binding"], {"weight": 0.94404279168548}], ["PRKACB", ["TCGA.CM.4748.01", "Cardiac conduction"], {"weight": 0.927058191605958}], ["PRKACB", ["TCGA.CM.4748.01", "Muscle contraction"], {"weight": 0.939924961762355}], ["CTPS2", ["TCGA.CM.4750.01", "Nucleotide catabolism"], {"weight": 0.809009760331029}], ["CTPS2", ["TCGA.CM.4750.01", "Ribavirin ADME"], {"weight": 0.700376241465027}], ["RAF1", ["TCGA.DM.A28H.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.935549842078094}], ["RAF1", ["TCGA.DM.A28H.01", "Extracellular matrix organization"], {"weight": 0.885630877501597}], ["RAF1", ["TCGA.DM.A28H.01", "Adaptive Immune System"], {"weight": 0.904310044882973}], ["RAF1", ["TCGA.DM.A28H.01", "Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"], {"weight": 0.831021240493827}], ["RAF1", ["TCGA.DM.A28H.01", "Chemokine receptors bind chemokines"], {"weight": 0.928967320422369}], ["ITPKA", ["TCGA.D5.7000.01", "CD22 mediated BCR regulation"], {"weight": 0.525508186408178}], ["RXRG", ["TCGA.D5.6529.01", "SLC-mediated transmembrane transport"], {"weight": 0.683580298240186}], ["RXRG", ["TCGA.D5.6529.01", "Defective B3GALTL causes PpS"], {"weight": 0.814054227309581}], ["RXRG", ["TCGA.D5.6529.01", "O-glycosylation of TSR domain-containing proteins"], {"weight": 0.814054227309581}], ["ATP6V0C", ["TCGA.CM.5341.01", "Cellular response to starvation"], {"weight": 0.918257360430141}], ["NR1H4", ["TCGA.CM.5341.01", "Cellular responses to stress"], {"weight": 0.920687593068469}], ["NR1H4", ["TCGA.CM.5341.01", "Cellular responses to stimuli"], {"weight": 0.920687593068469}], ["NR1H4", ["TCGA.G4.6302.01", "Biological oxidations"], {"weight": 0.916339152574031}], ["ABI2", ["TCGA.CM.5344.01", "Generation of second messenger molecules"], {"weight": 0.909251696794888}], ["PRSS1", ["TCGA.CM.5348.01", "Extracellular matrix organization"], {"weight": 0.855150784161603}], ["PRSS1", ["TCGA.CM.5348.01", "Collagen formation"], {"weight": 0.948991800224892}], ["PRSS1", ["TCGA.CM.5348.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.927570225601236}], ["PRSS1", ["TCGA.CM.5348.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.936258737288204}], ["PRSS1", ["TCGA.CM.5348.01", "Peptide ligand-binding receptors"], {"weight": 0.831737068898165}], ["PRSS1", ["TCGA.CM.5348.01", "Degradation of the extracellular matrix"], {"weight": 0.854457041242466}], ["PRSS1", ["TCGA.CM.5348.01", "Signaling by GPCR"], {"weight": 0.894966427874553}], ["PRSS1", ["TCGA.CM.5348.01", "Interleukin-4 and Interleukin-13 signaling"], {"weight": 0.678094269700465}], ["EDNRA", ["TCGA.G4.6294.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.949994889832306}], ["EDNRA", ["TCGA.G4.6294.01", "Peptide ligand-binding receptors"], {"weight": 0.94239265756621}], ["EDNRA", ["TCGA.G4.6294.01", "Chemokine receptors bind chemokines"], {"weight": 0.939541895549396}], ["AKT3", ["TCGA.G4.6317.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.945486844727776}], ["AKT3", ["TCGA.G4.6317.01", "Generation of second messenger molecules"], {"weight": 0.949585885823249}], ["AKT3", ["TCGA.G4.6317.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.944387867068718}], ["AKT3", ["TCGA.G4.6317.01", "PD-1 signaling"], {"weight": 0.946327108458722}], ["GPC4", ["TCGA.CM.6680.01", "TNFs bind their physiological receptors"], {"weight": 0.361676487171761}], ["ITGA5", ["TCGA.CM.5861.01", "Integrin cell surface interactions"], {"weight": 0.934491217735985}], ["ITGA5", ["TCGA.D5.6928.01", "Extracellular matrix organization"], {"weight": 0.865707591941721}], ["ITGA5", ["TCGA.G4.6586.01", "Elastic fibre formation"], {"weight": 0.944251854045717}], ["RPS6KB1", ["TCGA.CM.5861.01", "CD22 mediated BCR regulation"], {"weight": 0.872949373149333}], ["ADAM2", ["TCGA.D5.5541.01", "Blood group systems biosynthesis"], {"weight": 0.788628598240906}], ["ADAM2", ["TCGA.D5.5541.01", "O-linked glycosylation"], {"weight": 0.636675584770771}], ["ADAM2", ["TCGA.D5.5541.01", "Lewis blood group biosynthesis"], {"weight": 0.774023889247349}], ["ADAM2", ["TCGA.D5.5541.01", "O-linked glycosylation of mucins"], {"weight": 0.89835915330939}], ["AKR1B10", ["TCGA.CM.5861.01", "Digestion"], {"weight": 0.715990659265484}], ["AKR1B10", ["TCGA.CM.5861.01", "Digestion and absorption"], {"weight": 0.714500714120623}], ["AKR1B10", ["TCGA.DM.A1DB.01", "Blood group systems biosynthesis"], {"weight": 0.805354169248909}], ["AKR1B10", ["TCGA.DM.A1DB.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.831196590415588}], ["AKR1B10", ["TCGA.DM.A1DB.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.805977603710712}], ["AKR1B10", ["TCGA.DM.A1DB.01", "Lewis blood group biosynthesis"], {"weight": 0.786034642977618}], ["MMP10", ["TCGA.CM.5861.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.822460624476608}], ["MMP10", ["TCGA.CM.6674.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.913194834841828}], ["OR8K1", ["TCGA.F4.6463.01", "Peptide hormone biosynthesis"], {"weight": 0.511308929221656}], ["OR8K1", ["TCGA.F4.6463.01", "Phase 4 - resting membrane potential"], {"weight": 0.669332339348473}], ["OR8K1", ["TCGA.F4.6463.01", "Neuronal System"], {"weight": 0.841114237944033}], ["CCNB1", ["TCGA.F4.6570.01", "Diseases of metabolism"], {"weight": 0.79044421665151}], ["HP", ["TCGA.CM.5861.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.863766316218169}], ["HP", ["TCGA.CM.5861.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.863766316218169}], ["GUCA1A", ["TCGA.CM.5861.01", "Activation of the phototransduction cascade"], {"weight": 0.904399787403382}], ["MTMR14", ["TCGA.CM.5861.01", "FCERI mediated Ca+2 mobilization"], {"weight": 0.858902771068902}], ["CCKAR", ["TCGA.G4.6317.01", "Potassium Channels"], {"weight": 0.962040347032394}], ["CCKAR", ["TCGA.G4.6317.01", "Inwardly rectifying K+ channels"], {"weight": 0.940555468114807}], ["CCKAR", ["TCGA.G4.6317.01", "Activation of G protein gated Potassium channels"], {"weight": 0.933753143443214}], ["CCKAR", ["TCGA.G4.6317.01", "G protein gated Potassium channels"], {"weight": 0.933753143443214}], ["CCKAR", ["TCGA.G4.6317.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.933753143443214}], ["CCKAR", ["TCGA.G4.6317.01", "Glucagon-type ligand receptors"], {"weight": 0.935136543623871}], ["CCKAR", ["TCGA.G4.6317.01", "G-protein activation"], {"weight": 0.935824454040513}], ["CCKAR", ["TCGA.G4.6317.01", "Thromboxane signalling through TP receptor"], {"weight": 0.915161893872115}], ["CCKAR", ["TCGA.G4.6317.01", "G beta:gamma signalling through BTK"], {"weight": 0.919165695857408}], ["CCKAR", ["TCGA.G4.6317.01", "Presynaptic function of Kainate receptors"], {"weight": 0.921395016024058}], ["CCKAR", ["TCGA.G4.6317.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.92866002236538}], ["CCKAR", ["TCGA.G4.6317.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.920608085414938}], ["CCKAR", ["TCGA.G4.6317.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.908429601994062}], ["CCKAR", ["TCGA.G4.6317.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.909706117746342}], ["CCKAR", ["TCGA.G4.6317.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.940244991545729}], ["CCKAR", ["TCGA.G4.6317.01", "Regulation of FZD by ubiquitination"], {"weight": 0.871983584211032}], ["CCKAR", ["TCGA.G4.6317.01", "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"], {"weight": 0.924194402244915}], ["CCKAR", ["TCGA.G4.6317.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.888608329843557}], ["CCKAR", ["TCGA.G4.6317.01", "Thrombin signalling through proteinase activated receptors (PARs)"], {"weight": 0.915161893872115}], ["SEPHS1", ["TCGA.D5.6534.01", "Metabolism"], {"weight": 0.866461343330352}], ["SEPHS1", ["TCGA.D5.6534.01", "mitochondrial fatty acid beta-oxidation of saturated fatty acids"], {"weight": 0.579350741848854}], ["ACSL3", ["TCGA.G4.6304.01", "Regulation of insulin secretion"], {"weight": 0.920487748030151}], ["ACSL3", ["TCGA.G4.6304.01", "Integration of energy metabolism"], {"weight": 0.944137501491582}], ["GNRH1", ["TCGA.CM.5862.01", "Chemokine receptors bind chemokines"], {"weight": 0.934378150486652}], ["GNRH1", ["TCGA.CM.5862.01", "Peptide ligand-binding receptors"], {"weight": 0.937175080167379}], ["SERPINA3", ["TCGA.CM.5863.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.944098078021149}], ["PDE8A", ["TCGA.CM.5863.01", "GPCR downstream signalling"], {"weight": 0.910319895793819}], ["CLEC7A", ["TCGA.CM.5868.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.876067839344627}], ["CLEC7A", ["TCGA.CM.5868.01", "Leishmania parasite growth and survival"], {"weight": 0.876067839344627}], ["CLEC7A", ["TCGA.CM.5868.01", "Platelet activation, signaling and aggregation"], {"weight": 0.883800746915154}], ["CLEC7A", ["TCGA.CM.5868.01", "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"], {"weight": 0.881126019401118}], ["TESK2", ["TCGA.CM.5864.01", "Integration of energy metabolism"], {"weight": 0.90250605176953}], ["CREB3L3", ["TCGA.CM.5868.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.90721461809819}], ["CREB3L3", ["TCGA.CM.5868.01", "Phase 0 - rapid depolarisation"], {"weight": 0.920895781034395}], ["CREB3L3", ["TCGA.CM.5868.01", "Trafficking of AMPA receptors"], {"weight": 0.923999570550096}], ["CREB3L3", ["TCGA.CM.5868.01", "Glutamate binding, activation of AMPA receptors and synaptic plasticity"], {"weight": 0.923999570550096}], ["CREB3L3", ["TCGA.CM.5868.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.905017592282305}], ["OR4K1", ["TCGA.CM.6161.01", "Neuronal System"], {"weight": 0.875825931050015}], ["OR4K1", ["TCGA.CM.6161.01", "Transmission across Chemical Synapses"], {"weight": 0.870056618336238}], ["OR4K1", ["TCGA.CM.6161.01", "G alpha (s) signalling events"], {"weight": 0.94153613022878}], ["OR4K1", ["TCGA.CM.6161.01", "GPCR ligand binding"], {"weight": 0.902114902682434}], ["OR4K1", ["TCGA.CM.6161.01", "Phase 4 - resting membrane potential"], {"weight": 0.781622948291866}], ["OR4K1", ["TCGA.CM.6161.01", "Potassium Channels"], {"weight": 0.941026209834153}], ["OR4K1", ["TCGA.CM.6161.01", "Signaling by GPCR"], {"weight": 0.912344654823092}], ["OR4K1", ["TCGA.CM.6161.01", "Glucagon-type ligand receptors"], {"weight": 0.900344897996231}], ["UBA52", ["TCGA.CM.6162.01", "GPCR ligand binding"], {"weight": 0.906509921370933}], ["UBA52", ["TCGA.CM.6162.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.853075086094198}], ["RAC3", ["TCGA.CM.6162.01", "Drug ADME"], {"weight": 0.778221412925123}], ["RAC3", ["TCGA.CM.6162.01", "Signaling by GPCR"], {"weight": 0.889748307410644}], ["RAC3", ["TCGA.CM.6162.01", "GPCR downstream signalling"], {"weight": 0.893912020410158}], ["PEG10", ["TCGA.CM.6162.01", "Scavenging by Class A Receptors"], {"weight": 0.747341914700306}], ["PEG10", ["TCGA.CM.6162.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.67970553004718}], ["PEG10", ["TCGA.CM.6162.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.707642292026478}], ["S1PR1", ["TCGA.DM.A28H.01", "Platelet homeostasis"], {"weight": 0.877441686793396}], ["DEFB113", ["TCGA.CM.6162.01", "Defensins"], {"weight": 0.227687464711754}], ["TECR", ["TCGA.G4.6628.01", "Fatty acid metabolism"], {"weight": 0.885327649826814}], ["G6PD", ["TCGA.CM.6678.01", "Glucuronidation"], {"weight": 0.813607831338131}], ["G6PD", ["TCGA.F4.6854.01", "Biological oxidations"], {"weight": 0.827458798938223}], ["G6PD", ["TCGA.F4.6854.01", "Digestion"], {"weight": 0.412923863769163}], ["G6PD", ["TCGA.F4.6854.01", "Digestion and absorption"], {"weight": 0.411124789553851}], ["CYP2C8", ["TCGA.CM.6163.01", "Ethanol oxidation"], {"weight": 0.840162477236636}], ["CYP2C8", ["TCGA.CM.6163.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.718679326454678}], ["CYP2C8", ["TCGA.D5.6532.01", "RA biosynthesis pathway"], {"weight": 0.92539450413144}], ["CYP2C8", ["TCGA.D5.6532.01", "Signal amplification"], {"weight": 0.882819051023973}], ["CYP2C8", ["TCGA.D5.6532.01", "Scavenging of heme from plasma"], {"weight": 0.67374614679141}], ["CYP2C8", ["TCGA.D5.6532.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.898271718667685}], ["CYP2C8", ["TCGA.D5.6532.01", "Erythrocytes take up carbon dioxide and release oxygen"], {"weight": 0.765255073892661}], ["CYP2C8", ["TCGA.D5.6532.01", "O2/CO2 exchange in erythrocytes"], {"weight": 0.765255073892661}], ["CYP2C8", ["TCGA.D5.6532.01", "Phase II - Conjugation of compounds"], {"weight": 0.819664124439101}], ["PCOLCE2", ["TCGA.CM.6164.01", "Collagen chain trimerization"], {"weight": 0.887928170552842}], ["MKLN1", ["TCGA.CM.6164.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.726265387762845}], ["TRAPPC6B", ["TCGA.CM.6168.01", "Collagen formation"], {"weight": 0.893683560003294}], ["TRAPPC6B", ["TCGA.CM.6168.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.93126183991662}], ["TRAPPC6B", ["TCGA.CM.6168.01", "Assembly of collagen fibrils and other multimeric structures"], {"weight": 0.850263597812445}], ["OR4F15", ["TCGA.G4.6295.01", "Regulation of insulin secretion"], {"weight": 0.914622115886092}], ["OR4F15", ["TCGA.G4.6295.01", "Integration of energy metabolism"], {"weight": 0.920414473755225}], ["OR2Z1", ["TCGA.G4.6309.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.907161062554377}], ["OR10G9", ["TCGA.CM.6169.01", "GPCR ligand binding"], {"weight": 0.939615417526402}], ["OR10G9", ["TCGA.CM.6169.01", "Glucagon-type ligand receptors"], {"weight": 0.860446956172774}], ["OR10G9", ["TCGA.CM.6169.01", "Inwardly rectifying K+ channels"], {"weight": 0.899970260764334}], ["OR10G9", ["TCGA.CM.6169.01", "Activation of G protein gated Potassium channels"], {"weight": 0.886869767818732}], ["OR10G9", ["TCGA.CM.6169.01", "G protein gated Potassium channels"], {"weight": 0.886869767818732}], ["HNRNPH1", ["TCGA.CM.6170.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.572488160336647}], ["GPT2", ["TCGA.CM.6170.01", "Metabolism"], {"weight": 0.872220447172994}], ["APOOL", ["TCGA.CM.6170.01", "ERBB2 Activates PTK6 Signaling"], {"weight": 0.876948473630217}], ["APOOL", ["TCGA.CM.6170.01", "PI3K events in ERBB2 signaling"], {"weight": 0.876948473630217}], ["APOOL", ["TCGA.CM.6170.01", "ERBB2 Regulates Cell Motility"], {"weight": 0.876948473630217}], ["APOOL", ["TCGA.CM.6170.01", "GRB2 events in ERBB2 signaling"], {"weight": 0.876948473630217}], ["APOOL", ["TCGA.CM.6170.01", "Downregulation of ERBB2 signaling"], {"weight": 0.901472171943907}], ["APOOL", ["TCGA.CM.6170.01", "Signaling by ERBB4"], {"weight": 0.831356538809534}], ["APOOL", ["TCGA.CM.6170.01", "Signaling by ERBB2 TMD/JMD mutants"], {"weight": 0.876948473630217}], ["APOOL", ["TCGA.CM.6170.01", "SHC1 events in ERBB2 signaling"], {"weight": 0.876948473630217}], ["APOOL", ["TCGA.CM.6170.01", "Signaling by ERBB2 KD Mutants"], {"weight": 0.876948473630217}], ["APOOL", ["TCGA.CM.6170.01", "Signaling by ERBB2 in Cancer"], {"weight": 0.876948473630217}], ["APOOL", ["TCGA.CM.6170.01", "GRB2 events in EGFR signaling"], {"weight": 0.845338295248021}], ["APOOL", ["TCGA.CM.6170.01", "SHC1 events in EGFR signaling"], {"weight": 0.845338295248021}], ["TCP1", ["TCGA.CM.6171.01", "GPCR ligand binding"], {"weight": 0.909156083841709}], ["ITGB5", ["TCGA.CM.6171.01", "Molecules associated with elastic fibres"], {"weight": 0.838387925379009}], ["KLF4", ["TCGA.G4.6320.01", "Formation of the anterior neural plate"], {"weight": 0.718790035939413}], ["OR51T1", ["TCGA.G4.6626.01", "GPCR ligand binding"], {"weight": 0.944216351984314}], ["OR51T1", ["TCGA.G4.6626.01", "Activation of GABAB receptors"], {"weight": 0.934150671069613}], ["OR51T1", ["TCGA.G4.6626.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.905689383844236}], ["OR51T1", ["TCGA.G4.6626.01", "Regulation of insulin secretion"], {"weight": 0.928813272577425}], ["OR51T1", ["TCGA.G4.6626.01", "Leishmania infection"], {"weight": 0.903534734769612}], ["OR51T1", ["TCGA.G4.6626.01", "Parasitic Infection Pathways"], {"weight": 0.903534734769612}], ["OR51T1", ["TCGA.G4.6626.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.881814180730555}], ["OR51T1", ["TCGA.G4.6626.01", "Initial triggering of complement"], {"weight": 0.784179160247981}], ["OR51T1", ["TCGA.G4.6626.01", "Chemokine receptors bind chemokines"], {"weight": 0.909164290712869}], ["OR51T1", ["TCGA.G4.6626.01", "Phase 4 - resting membrane potential"], {"weight": 0.858740984007867}], ["OR51T1", ["TCGA.G4.6626.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.787142231151765}], ["OR51T1", ["TCGA.G4.6626.01", "Regulation of Complement cascade"], {"weight": 0.837058509433496}], ["OR51T1", ["TCGA.G4.6626.01", "Voltage gated Potassium channels"], {"weight": 0.900021621525564}], ["OR51T1", ["TCGA.G4.6626.01", "Interleukin-10 signaling"], {"weight": 0.915722114517753}], ["OR52B2", ["TCGA.F4.6856.01", "GPCR ligand binding"], {"weight": 0.938933535634018}], ["OR52B2", ["TCGA.F4.6856.01", "G beta:gamma signalling through BTK"], {"weight": 0.890294062922567}], ["TRIM33", ["TCGA.G4.6302.01", "Signaling by Activin"], {"weight": 0.783477435398169}], ["TRIM33", ["TCGA.G4.6302.01", "Signaling by NODAL"], {"weight": 0.754547027597564}], ["TCP1", ["TCGA.CM.6171.01", "G alpha (i) signalling events"], {"weight": 0.952258509395636}], ["TCP1", ["TCGA.CM.6171.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.884395222006998}], ["TCP1", ["TCGA.CM.6171.01", "Peptide ligand-binding receptors"], {"weight": 0.880882351742154}], ["TCP1", ["TCGA.CM.6674.01", "Signaling by GPCR"], {"weight": 0.926497213394277}], ["TCP1", ["TCGA.CM.6674.01", "GPCR downstream signalling"], {"weight": 0.925049118251513}], ["TCP1", ["TCGA.CM.6674.01", "G alpha (i) signalling events"], {"weight": 0.921950090287702}], ["OR51B4", ["TCGA.G4.6309.01", "GPCR ligand binding"], {"weight": 0.937136459021639}], ["GOT2", ["TCGA.CM.6171.01", "Neurotransmitter release cycle"], {"weight": 0.906547436312018}], ["GOT2", ["TCGA.F4.6463.01", "Metabolism"], {"weight": 0.865365043028656}], ["GOT2", ["TCGA.F4.6463.01", "Biological oxidations"], {"weight": 0.842641869943912}], ["GOT2", ["TCGA.F4.6463.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.586697268369233}], ["GOT2", ["TCGA.F4.6463.01", "Metabolism of amine-derived hormones"], {"weight": 0.809966329777084}], ["GOT2", ["TCGA.F4.6463.01", "Bile acid and bile salt metabolism"], {"weight": 0.655471030956619}], ["GOT2", ["TCGA.F4.6463.01", "Ethanol oxidation"], {"weight": 0.629622877468467}], ["GOT2", ["TCGA.G4.6297.01", "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"], {"weight": 0.597422617621931}], ["TOM1L2", ["TCGA.CM.6171.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.921419224513582}], ["CYP3A5", ["TCGA.CM.6171.01", "Phase II - Conjugation of compounds"], {"weight": 0.895313449755262}], ["CYP3A5", ["TCGA.CM.6171.01", "Glucuronidation"], {"weight": 0.854066963048119}], ["CLCN7", ["TCGA.F4.6856.01", "Ion channel transport"], {"weight": 0.894587579118412}], ["CLCN7", ["TCGA.F4.6856.01", "Stimuli-sensing channels"], {"weight": 0.861655884294107}], ["EZR", ["TCGA.CM.6674.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.702187410758108}], ["RALB", ["TCGA.CM.6674.01", "Peptide ligand-binding receptors"], {"weight": 0.93905278838355}], ["RALB", ["TCGA.CM.6674.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.937414695631935}], ["OR1D5", ["TCGA.CM.6674.01", "GPCR ligand binding"], {"weight": 0.940023332907119}], ["CD151", ["TCGA.CM.6674.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.944250525873641}], ["ELOVL2", ["TCGA.G4.6323.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.658268401972079}], ["ELOVL2", ["TCGA.G4.6626.01", "Glucuronidation"], {"weight": 0.884789070083217}], ["DNTT", ["TCGA.DM.A282.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.83273136953754}], ["DNTT", ["TCGA.F4.6460.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.718061375104099}], ["CDK8", ["TCGA.CM.6675.01", "Regulation of insulin secretion"], {"weight": 0.913365536589652}], ["CDK8", ["TCGA.CM.6675.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.863743865350662}], ["CDK8", ["TCGA.CM.6675.01", "Activation of ATR in response to replication stress"], {"weight": 0.875550835481191}], ["CDK8", ["TCGA.CM.6675.01", "Integration of energy metabolism"], {"weight": 0.917023377092084}], ["CDK8", ["TCGA.CM.6675.01", "Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects"], {"weight": 0.863800966735705}], ["CDK8", ["TCGA.CM.6675.01", "Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"], {"weight": 0.863800966735705}], ["HMGB2", ["TCGA.CM.6676.01", "Diseases of Immune System"], {"weight": 0.810031380634005}], ["HMGB2", ["TCGA.CM.6676.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.810031380634005}], ["HMGB2", ["TCGA.CM.6676.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.827908621129522}], ["HMGB2", ["TCGA.CM.6676.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.827908621129522}], ["HMGB2", ["TCGA.CM.6676.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.777624823475917}], ["HMGB2", ["TCGA.CM.6676.01", "Integrin cell surface interactions"], {"weight": 0.873950013227472}], ["PDXK", ["TCGA.CM.6676.01", "Glucuronidation"], {"weight": 0.896418841908129}], ["PDXK", ["TCGA.CM.6676.01", "RA biosynthesis pathway"], {"weight": 0.796393203764046}], ["PDXK", ["TCGA.CM.6676.01", "Aspirin ADME"], {"weight": 0.82230897646088}], ["GDA", ["TCGA.CM.6676.01", "Activation of the phototransduction cascade"], {"weight": 0.789226611384296}], ["GDA", ["TCGA.CM.6676.01", "Adaptive Immune System"], {"weight": 0.86940629206936}], ["CDC73", ["TCGA.CM.6677.01", "Synthesis, secretion, and deacylation of Ghrelin"], {"weight": 0.628695102063876}], ["CALN1", ["TCGA.CM.6677.01", "Sensory processing of sound"], {"weight": 0.837449384683267}], ["XRCC3", ["TCGA.CM.6677.01", "Transcription of E2F targets under negative control by DREAM complex"], {"weight": 0.836780400826731}], ["XRCC3", ["TCGA.CM.6677.01", "G0 and Early G1"], {"weight": 0.836780400826731}], ["HSPA1L", ["TCGA.D5.6538.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.853200699750126}], ["HSPA1L", ["TCGA.D5.6538.01", "Defensins"], {"weight": 0.669355086152779}], ["HSPA1L", ["TCGA.D5.6538.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.593973638746361}], ["HSPA1L", ["TCGA.D5.6538.01", "Toll-like Receptor Cascades"], {"weight": 0.889460023421154}], ["ATP4B", ["TCGA.CM.6678.01", "Transport of small molecules"], {"weight": 0.864160290864332}], ["ETS1", ["TCGA.CM.6679.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.932955147010174}], ["ETS1", ["TCGA.CM.6679.01", "Heme degradation"], {"weight": 0.355564109785869}], ["ETS1", ["TCGA.CM.6679.01", "APAP ADME"], {"weight": 0.0273321839660052}], ["GABRR2", ["TCGA.G4.6298.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.950001029640127}], ["GABRR2", ["TCGA.G4.6298.01", "Generation of second messenger molecules"], {"weight": 0.953099177302539}], ["GABRR2", ["TCGA.G4.6298.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.948564597161412}], ["GABRR2", ["TCGA.G4.6298.01", "PD-1 signaling"], {"weight": 0.947245425253888}], ["SLC16A3", ["TCGA.CM.6680.01", "Drug ADME"], {"weight": 0.757599058910366}], ["SLC16A3", ["TCGA.CM.6680.01", "SLC-mediated transmembrane transport"], {"weight": 0.921454719012093}], ["KLB", ["TCGA.CM.6680.01", "Regulation of FZD by ubiquitination"], {"weight": 0.732629942502315}], ["DPYS", ["TCGA.D5.5537.01", "Ethanol oxidation"], {"weight": 0.835844792954769}], ["TAS2R3", ["TCGA.D5.5537.01", "Signaling by GPCR"], {"weight": 0.938657686235959}], ["MASP2", ["TCGA.DM.A285.01", "Complement cascade"], {"weight": 0.887369509678725}], ["MASP2", ["TCGA.DM.A285.01", "Regulation of Complement cascade"], {"weight": 0.831492089820106}], ["MASP2", ["TCGA.DM.A285.01", "Initial triggering of complement"], {"weight": 0.787033538489861}], ["MASP2", ["TCGA.DM.A285.01", "Classical antibody-mediated complement activation"], {"weight": 0.64748315475995}], ["MASP2", ["TCGA.G4.6320.01", "Classical antibody-mediated complement activation"], {"weight": 0.745375280620733}], ["MASP2", ["TCGA.G4.6320.01", "Creation of C4 and C2 activators"], {"weight": 0.84245417521366}], ["MASP2", ["TCGA.G4.6320.01", "Regulation of Complement cascade"], {"weight": 0.823641333302061}], ["MASP2", ["TCGA.G4.6320.01", "Initial triggering of complement"], {"weight": 0.804984183787523}], ["MASP2", ["TCGA.G4.6320.01", "Complement cascade"], {"weight": 0.854574899091028}], ["MASP2", ["TCGA.G4.6322.01", "Complement cascade"], {"weight": 0.800905808948705}], ["UTP3", ["TCGA.D5.5540.01", "Cell Cycle"], {"weight": 0.942382150504414}], ["UTP3", ["TCGA.D5.5540.01", "Metabolism"], {"weight": 0.945138428772941}], ["UTP3", ["TCGA.D5.5540.01", "mRNA decay by 3' to 5' exoribonuclease"], {"weight": 0.850512598635172}], ["UQCR10", ["TCGA.D5.5541.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.822387854330576}], ["APLNR", ["TCGA.DM.A28M.01", "Initial triggering of complement"], {"weight": 0.94319303867709}], ["APLNR", ["TCGA.DM.A28M.01", "Purinergic signaling in leishmaniasis infection"], {"weight": 0.75798142857884}], ["APLNR", ["TCGA.DM.A28M.01", "Cell recruitment (pro-inflammatory response)"], {"weight": 0.75798142857884}], ["POLR3GL", ["TCGA.G4.6310.01", "Activation of the phototransduction cascade"], {"weight": 0.742366693001212}], ["DOK6", ["TCGA.D5.5541.01", "Collagen degradation"], {"weight": 0.868835570264997}], ["CLEC5A", ["TCGA.DM.A1D6.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.84757407926605}], ["OR51F2", ["TCGA.D5.6529.01", "GABA B receptor activation"], {"weight": 0.893694257050616}], ["OR51F2", ["TCGA.D5.6529.01", "Activation of GABAB receptors"], {"weight": 0.893694257050616}], ["OR51F2", ["TCGA.D5.6529.01", "G beta:gamma signalling through BTK"], {"weight": 0.850386655848324}], ["OR51F2", ["TCGA.D5.6529.01", "Activation of G protein gated Potassium channels"], {"weight": 0.878946304780996}], ["OR51F2", ["TCGA.D5.6529.01", "G beta:gamma signalling through PLC beta"], {"weight": 0.850386655848324}], ["OR51F2", ["TCGA.D5.6529.01", "G beta:gamma signalling through CDC42"], {"weight": 0.850386655848324}], ["PNLIP", ["TCGA.D5.6531.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.804158176841268}], ["IL22", ["TCGA.D5.6531.01", "Transcriptional regulation of granulopoiesis"], {"weight": 0.58945928883323}], ["OR8B3", ["TCGA.D5.6531.01", "Glucagon-type ligand receptors"], {"weight": 0.906693914630212}], ["OR8B3", ["TCGA.D5.6531.01", "Inwardly rectifying K+ channels"], {"weight": 0.917973616729721}], ["OR1M1", ["TCGA.D5.6531.01", "G alpha (s) signalling events"], {"weight": 0.945368749201192}], ["OR1M1", ["TCGA.G4.6626.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.931366763406789}], ["OR1M1", ["TCGA.G4.6626.01", "Leishmania parasite growth and survival"], {"weight": 0.931366763406789}], ["OR1M1", ["TCGA.G4.6626.01", "G beta:gamma signalling through BTK"], {"weight": 0.91294231208065}], ["OR1M1", ["TCGA.G4.6626.01", "Aquaporin-mediated transport"], {"weight": 0.897123061039396}], ["PTPRA", ["TCGA.D5.6531.01", "Defective GALNT12 causes CRCS1"], {"weight": 0.805409967181616}], ["KCNIP4", ["TCGA.D5.6533.01", "Neurexins and neuroligins"], {"weight": 0.898313530747815}], ["KCNIP4", ["TCGA.D5.6533.01", "Protein-protein interactions at synapses"], {"weight": 0.902647605441481}], ["KCNIP4", ["TCGA.D5.6898.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.894869113440824}], ["KCNIP4", ["TCGA.D5.6898.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.891563010920077}], ["OR10A3", ["TCGA.D5.6533.01", "Signaling by GPCR"], {"weight": 0.928739509096214}], ["OR10A3", ["TCGA.D5.6533.01", "GPCR downstream signalling"], {"weight": 0.930367567782137}], ["HEY1", ["TCGA.D5.6533.01", "Lewis blood group biosynthesis"], {"weight": 0.870004478868911}], ["HEY1", ["TCGA.D5.6533.01", "Blood group systems biosynthesis"], {"weight": 0.870004478868911}], ["HEY1", ["TCGA.D5.6533.01", "Keratan sulfate biosynthesis"], {"weight": 0.880130725884321}], ["TFDP2", ["TCGA.D5.6534.01", "Biological oxidations"], {"weight": 0.88915220540757}], ["TFDP2", ["TCGA.D5.6534.01", "Drug ADME"], {"weight": 0.828461091366738}], ["TFDP2", ["TCGA.D5.6534.01", "Aspirin ADME"], {"weight": 0.875967674903421}], ["CBS", ["TCGA.D5.6534.01", "Phase II - Conjugation of compounds"], {"weight": 0.807034941257592}], ["CBS", ["TCGA.D5.6534.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.827414286588013}], ["CBS", ["TCGA.D5.6534.01", "Degradation of cysteine and homocysteine"], {"weight": 0.827707664261462}], ["AK3", ["TCGA.D5.6535.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.731940743635528}], ["VPS37D", ["TCGA.D5.6535.01", "Stimuli-sensing channels"], {"weight": 0.873094096313664}], ["VPS37D", ["TCGA.D5.6535.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.655603289631935}], ["OR1A2", ["TCGA.D5.6535.01", "Signal amplification"], {"weight": 0.839128802607742}], ["OR1A2", ["TCGA.D5.6535.01", "Signaling by GPCR"], {"weight": 0.925338067196961}], ["OR1A2", ["TCGA.D5.6535.01", "GPCR downstream signalling"], {"weight": 0.938390254767192}], ["OR1A2", ["TCGA.D5.6535.01", "Prostacyclin signalling through prostacyclin receptor"], {"weight": 0.847073740065439}], ["OR1A2", ["TCGA.D5.6535.01", "Transport of small molecules"], {"weight": 0.856773685634249}], ["OR1A2", ["TCGA.D5.6535.01", "Thromboxane signalling through TP receptor"], {"weight": 0.847073740065439}], ["PDE1C", ["TCGA.F4.6463.01", "Nucleotide catabolism"], {"weight": 0.568972033264261}], ["OPHN1", ["TCGA.D5.6538.01", "Ligand-dependent caspase activation"], {"weight": 0.81311029118532}], ["GCSH", ["TCGA.D5.6538.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.787110462459793}], ["STIM2", ["TCGA.D5.6538.01", "Platelet calcium homeostasis"], {"weight": 0.893902938989854}], ["SLC7A7", ["TCGA.D5.6540.01", "Transport of small molecules"], {"weight": 0.945681771799078}], ["SLC7A7", ["TCGA.D5.6540.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.92358456318906}], ["SLC7A7", ["TCGA.D5.6540.01", "SLC-mediated transmembrane transport"], {"weight": 0.895189669784864}], ["MAPT", ["TCGA.DM.A1D4.01", "Phase 0 - rapid depolarisation"], {"weight": 0.948680799718367}], ["MAPT", ["TCGA.DM.A1D4.01", "Ion homeostasis"], {"weight": 0.952531034063758}], ["HBP1", ["TCGA.D5.6540.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.929287935493863}], ["CAPZB", ["TCGA.D5.6540.01", "Sensory processing of sound by inner hair cells of the cochlea"], {"weight": 0.93931555375802}], ["MED1", ["TCGA.D5.6540.01", "Signaling Pathways"], {"weight": 0.921294129280108}], ["CAPNS1", ["TCGA.D5.6540.01", "Extracellular matrix organization"], {"weight": 0.929890538246433}], ["CAPNS1", ["TCGA.F4.6570.01", "Extracellular matrix organization"], {"weight": 0.869916239415432}], ["CAPNS1", ["TCGA.F4.6570.01", "Degradation of the extracellular matrix"], {"weight": 0.854525903949769}], ["SUCLG1", ["TCGA.D5.6540.01", "Ethanol oxidation"], {"weight": 0.942991104287935}], ["NPBWR2", ["TCGA.D5.6922.01", "GPCR downstream signalling"], {"weight": 0.930316014838726}], ["NPBWR2", ["TCGA.D5.6922.01", "Signaling by GPCR"], {"weight": 0.920780876307215}], ["VIP", ["TCGA.D5.6922.01", "G alpha (s) signalling events"], {"weight": 0.920420561554005}], ["TAAR8", ["TCGA.D5.6924.01", "Peptide hormone biosynthesis"], {"weight": 0.61384198042796}], ["ARNTL", ["TCGA.D5.6924.01", "Glucuronidation"], {"weight": 0.853392303729046}], ["ARNTL", ["TCGA.D5.6924.01", "Tryptophan catabolism"], {"weight": 0.54030793063441}], ["SORT1", ["TCGA.D5.6924.01", "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"], {"weight": 0.154758725679816}], ["F11", ["TCGA.DM.A1D6.01", "G alpha (i) signalling events"], {"weight": 0.950113202120248}], ["F11", ["TCGA.DM.A1D6.01", "Cell surface interactions at the vascular wall"], {"weight": 0.818063684989423}], ["F11", ["TCGA.DM.A1D6.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.934770760283724}], ["F11", ["TCGA.DM.A1D6.01", "Creation of C4 and C2 activators"], {"weight": 0.861669786461015}], ["MAX", ["TCGA.D5.6927.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.898990009245147}], ["MAX", ["TCGA.F4.6570.01", "Scavenging by Class A Receptors"], {"weight": 0.681961411911763}], ["SDF4", ["TCGA.DM.A1HA.01", "Leishmania infection"], {"weight": 0.925125205393077}], ["SDF4", ["TCGA.DM.A1HA.01", "Parasitic Infection Pathways"], {"weight": 0.925125205393077}], ["ARSI", ["TCGA.DM.A28C.01", "RA biosynthesis pathway"], {"weight": 0.85093891833704}], ["CYP26C1", ["TCGA.D5.6928.01", "RA biosynthesis pathway"], {"weight": 0.901146043790913}], ["CAPN10", ["TCGA.G4.6297.01", "Extracellular matrix organization"], {"weight": 0.892112315928552}], ["CAPN10", ["TCGA.G4.6297.01", "Degradation of the extracellular matrix"], {"weight": 0.840908708417211}], ["ASB7", ["TCGA.DM.A0XD.01", "Peptide ligand-binding receptors"], {"weight": 0.934754359267309}], ["ASB7", ["TCGA.DM.A0XD.01", "GPCR ligand binding"], {"weight": 0.934029560223649}], ["ASB7", ["TCGA.DM.A0XD.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.935594992715618}], ["CACNB3", ["TCGA.D5.6929.01", "G alpha (i) signalling events"], {"weight": 0.929490186507975}], ["DECR1", ["TCGA.D5.6929.01", "Signaling by GPCR"], {"weight": 0.929274165658288}], ["DECR1", ["TCGA.D5.6929.01", "Response to elevated platelet cytosolic Ca2+"], {"weight": 0.769767675580026}], ["DECR1", ["TCGA.D5.6929.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.925661126695864}], ["DECR1", ["TCGA.D5.6929.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.876275028015234}], ["RELT", ["TCGA.DM.A1D7.01", "Chemokine receptors bind chemokines"], {"weight": 0.903083725744419}], ["CGN", ["TCGA.G4.6323.01", "Trafficking and processing of endosomal TLR"], {"weight": 0.653706386762686}], ["IFNA2", ["TCGA.F4.6806.01", "IL-6-type cytokine receptor ligand interactions"], {"weight": 0.869056131445945}], ["IFNA2", ["TCGA.F4.6806.01", "Interleukin-6 family signaling"], {"weight": 0.884853877823025}], ["NSF", ["TCGA.D5.6930.01", "Neuronal System"], {"weight": 0.869249044597116}], ["NSF", ["TCGA.D5.6930.01", "Transmission across Chemical Synapses"], {"weight": 0.867182379747604}], ["NSF", ["TCGA.D5.6930.01", "GABA receptor activation"], {"weight": 0.847490083441804}], ["NSF", ["TCGA.D5.6930.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.853214183233959}], ["COASY", ["TCGA.D5.6930.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.674279617540627}], ["BBOX1", ["TCGA.D5.6932.01", "Biological oxidations"], {"weight": 0.900000649329397}], ["BBOX1", ["TCGA.D5.6932.01", "Ethanol oxidation"], {"weight": 0.858479484952095}], ["RPS6KA3", ["TCGA.D5.7000.01", "L1CAM interactions"], {"weight": 0.839057808554217}], ["PIK3CB", ["TCGA.D5.7000.01", "Signaling by GPCR"], {"weight": 0.941131462309917}], ["PIK3CB", ["TCGA.D5.7000.01", "GPCR downstream signalling"], {"weight": 0.947285986102049}], ["PIK3CB", ["TCGA.D5.7000.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.803905726048859}], ["PIK3CB", ["TCGA.D5.7000.01", "TNFs bind their physiological receptors"], {"weight": 0.334968839804698}], ["NFATC2", ["TCGA.DM.A0X9.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.899977564210346}], ["RASGRP3", ["TCGA.DM.A0X9.01", "NCAM1 interactions"], {"weight": 0.855011638769339}], ["RASGRP3", ["TCGA.DM.A0X9.01", "NCAM signaling for neurite out-growth"], {"weight": 0.813785476023954}], ["FBXL5", ["TCGA.DM.A0XF.01", "GPCR ligand binding"], {"weight": 0.928499320651593}], ["FBXL5", ["TCGA.DM.A0XF.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.928937653421102}], ["FBXL5", ["TCGA.DM.A0XF.01", "Peptide ligand-binding receptors"], {"weight": 0.926429369220616}], ["LIPE", ["TCGA.DM.A0XF.01", "GPCR downstream signalling"], {"weight": 0.945027657234918}], ["LIPE", ["TCGA.DM.A0XF.01", "Signaling by GPCR"], {"weight": 0.942339314067899}], ["LIPE", ["TCGA.DM.A0XF.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.787222859372807}], ["LIPE", ["TCGA.F4.6570.01", "Neuronal System"], {"weight": 0.904158786055044}], ["LIPE", ["TCGA.F4.6570.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.862959269044992}], ["LIPE", ["TCGA.F4.6570.01", "Integration of energy metabolism"], {"weight": 0.930283380287583}], ["LIPE", ["TCGA.G4.6299.01", "Neuronal System"], {"weight": 0.93062479958061}], ["LIPE", ["TCGA.G4.6299.01", "Transmission across Chemical Synapses"], {"weight": 0.922760859364998}], ["LIPE", ["TCGA.G4.6299.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.919007141415086}], ["LIPE", ["TCGA.G4.6299.01", "RA biosynthesis pathway"], {"weight": 0.88171794545819}], ["LIPE", ["TCGA.G4.6299.01", "Signaling by Retinoic Acid"], {"weight": 0.822313656723841}], ["LIPE", ["TCGA.G4.6299.01", "G alpha (s) signalling events"], {"weight": 0.954148098246851}], ["LIPE", ["TCGA.G4.6299.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.90915279729094}], ["TXNRD1", ["TCGA.DM.A0XF.01", "Recycling of bile acids and salts"], {"weight": 0.798350194061351}], ["PLS3", ["TCGA.DM.A1D0.01", "Chemokine receptors bind chemokines"], {"weight": 0.940321848824392}], ["PLS3", ["TCGA.DM.A1D0.01", "Stimuli-sensing channels"], {"weight": 0.896527076440226}], ["PLS3", ["TCGA.DM.A1D0.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.83259725243822}], ["PLS3", ["TCGA.DM.A1D0.01", "SUMOylation of intracellular receptors"], {"weight": 0.765247091785531}], ["PSMD3", ["TCGA.DM.A1D0.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.915429167591316}], ["AGER", ["TCGA.DM.A1D4.01", "Integrin cell surface interactions"], {"weight": 0.912527011119227}], ["FBXO4", ["TCGA.DM.A28C.01", "GPCR ligand binding"], {"weight": 0.942318094790878}], ["FBXO4", ["TCGA.DM.A28C.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.936770356864472}], ["FBXO4", ["TCGA.DM.A28C.01", "Peptide ligand-binding receptors"], {"weight": 0.934117220243379}], ["OR5C1", ["TCGA.DM.A1D4.01", "GPCR ligand binding"], {"weight": 0.943215302785698}], ["OR5C1", ["TCGA.DM.A1D4.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.920850134536759}], ["OR5C1", ["TCGA.DM.A1D4.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.752244619406048}], ["OR5C1", ["TCGA.DM.A1D4.01", "Calmodulin induced events"], {"weight": 0.919829821286142}], ["OR5C1", ["TCGA.DM.A1D4.01", "CaM pathway"], {"weight": 0.919829821286142}], ["OR5C1", ["TCGA.DM.A1D4.01", "Aquaporin-mediated transport"], {"weight": 0.904956799930409}], ["OR5C1", ["TCGA.DM.A1D4.01", "GPER1 signaling"], {"weight": 0.904956799930409}], ["OR5C1", ["TCGA.DM.A1D4.01", "GABA B receptor activation"], {"weight": 0.92607098265229}], ["OR5C1", ["TCGA.DM.A1D4.01", "Activation of GABAB receptors"], {"weight": 0.92607098265229}], ["OR5C1", ["TCGA.DM.A1D4.01", "GABA receptor activation"], {"weight": 0.88838275534935}], ["OR5C1", ["TCGA.DM.A1D4.01", "PLC beta mediated events"], {"weight": 0.896091138473942}], ["OR5C1", ["TCGA.DM.A1D4.01", "G-protein beta:gamma signalling"], {"weight": 0.911342832765627}], ["OR5C1", ["TCGA.DM.A1D4.01", "Activation of the phototransduction cascade"], {"weight": 0.809007417640616}], ["OR5C1", ["TCGA.DM.A1D4.01", "Opioid Signalling"], {"weight": 0.937980750108822}], ["GZMH", ["TCGA.DM.A1D6.01", "Extracellular matrix organization"], {"weight": 0.894302834342354}], ["MAPKBP1", ["TCGA.DM.A1D6.01", "Ion channel transport"], {"weight": 0.942018785733718}], ["PTGES3", ["TCGA.DM.A1D7.01", "Arachidonic acid metabolism"], {"weight": 0.863496097465381}], ["WNT3A", ["TCGA.G4.6299.01", "GPCR ligand binding"], {"weight": 0.932037799195799}], ["WNT3A", ["TCGA.G4.6299.01", "WNT ligand biogenesis and trafficking"], {"weight": 0.902534333734431}], ["WNT3A", ["TCGA.G4.6299.01", "The canonical retinoid cycle in rods (twilight vision)"], {"weight": 0.748000890652379}], ["WNT3A", ["TCGA.G4.6299.01", "Signaling by BMP"], {"weight": 0.849420919660049}], ["PTGIS", ["TCGA.DM.A1D8.01", "Arachidonic acid metabolism"], {"weight": 0.951246699688479}], ["PTGIS", ["TCGA.DM.A1D8.01", "Synthesis of Leukotrienes (LT) and Eoxins (EX)"], {"weight": 0.824375725977827}], ["PTGIS", ["TCGA.DM.A1D8.01", "Phase I - Functionalization of compounds"], {"weight": 0.925135611276608}], ["CACNG7", ["TCGA.DM.A1D9.01", "GPCR ligand binding"], {"weight": 0.947502461887489}], ["CACNG7", ["TCGA.DM.A1D9.01", "Phase 0 - rapid depolarisation"], {"weight": 0.93258086001272}], ["PFKFB4", ["TCGA.DM.A1D9.01", "Integration of energy metabolism"], {"weight": 0.934037473577631}], ["FANCG", ["TCGA.DM.A1DB.01", "Resolution of D-loop Structures through Holliday Junction Intermediates"], {"weight": 0.895151221187768}], ["GNB2", ["TCGA.DM.A1DB.01", "Peptide ligand-binding receptors"], {"weight": 0.951423836071634}], ["GNB2", ["TCGA.DM.A1DB.01", "Regulation of Complement cascade"], {"weight": 0.859164470100841}], ["GNB2", ["TCGA.DM.A1DB.01", "Complement cascade"], {"weight": 0.893390505897681}], ["OR6T1", ["TCGA.DM.A1HA.01", "Signaling by GPCR"], {"weight": 0.961639925959982}], ["COLEC10", ["TCGA.DM.A1HA.01", "Complement cascade"], {"weight": 0.909459984481193}], ["COLEC10", ["TCGA.DM.A1HA.01", "Regulation of Complement cascade"], {"weight": 0.915039281824727}], ["COLEC10", ["TCGA.DM.A1HA.01", "Classical antibody-mediated complement activation"], {"weight": 0.75209051041017}], ["COLEC10", ["TCGA.DM.A1HA.01", "Initial triggering of complement"], {"weight": 0.860304328987414}], ["OR6T1", ["TCGA.DM.A1HA.01", "Regulation of insulin secretion"], {"weight": 0.946043558737345}], ["OR6T1", ["TCGA.DM.A1HA.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.948768412596561}], ["OR6T1", ["TCGA.DM.A1HA.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.927624305869633}], ["OR6T1", ["TCGA.DM.A1HA.01", "Leishmania parasite growth and survival"], {"weight": 0.927624305869633}], ["OR6T1", ["TCGA.DM.A1HA.01", "G alpha (s) signalling events"], {"weight": 0.964548531960179}], ["OR6T1", ["TCGA.DM.A1HA.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.948477501486844}], ["OR6T1", ["TCGA.DM.A1HA.01", "Platelet homeostasis"], {"weight": 0.90161391746343}], ["OR6T1", ["TCGA.DM.A1HA.01", "G-protein beta:gamma signalling"], {"weight": 0.936042727796619}], ["OR6T1", ["TCGA.DM.A1HA.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.934089126919003}], ["OR6T1", ["TCGA.DM.A1HA.01", "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"], {"weight": 0.942493837499753}], ["OR6T1", ["TCGA.DM.A1HA.01", "Signal amplification"], {"weight": 0.942470405602003}], ["OR6T1", ["TCGA.DM.A1HA.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.926002527120237}], ["OR6T1", ["TCGA.DM.A1HA.01", "Glucagon-type ligand receptors"], {"weight": 0.938092432107113}], ["OR6T1", ["TCGA.DM.A1HA.01", "G-protein activation"], {"weight": 0.944446349164335}], ["OR6T1", ["TCGA.DM.A1HA.01", "Thromboxane signalling through TP receptor"], {"weight": 0.926987457130475}], ["OR6T1", ["TCGA.DM.A1HA.01", "Presynaptic function of Kainate receptors"], {"weight": 0.917700036892941}], ["OR6T1", ["TCGA.DM.A1HA.01", "G beta:gamma signalling through BTK"], {"weight": 0.913873297960678}], ["OR6T1", ["TCGA.DM.A1HA.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.926902929404991}], ["OR6T1", ["TCGA.DM.A1HA.01", "ADORA2B mediated anti-inflammatory cytokines production"], {"weight": 0.923657676390414}], ["OR6T1", ["TCGA.DM.A1HA.01", "ADP signalling through P2Y purinoceptor 12"], {"weight": 0.926196909648985}], ["OR6T1", ["TCGA.DM.A1HA.01", "Opioid Signalling"], {"weight": 0.956896335553269}], ["OR6T1", ["TCGA.DM.A1HA.01", "Glucagon signaling in metabolic regulation"], {"weight": 0.941086584863406}], ["OR6T1", ["TCGA.DM.A285.01", "GPCR ligand binding"], {"weight": 0.937406213894635}], ["OR6T1", ["TCGA.DM.A285.01", "Signaling by GPCR"], {"weight": 0.939150977793592}], ["OR6T1", ["TCGA.DM.A285.01", "GPCR downstream signalling"], {"weight": 0.938885274781188}], ["OR6T1", ["TCGA.DM.A285.01", "G alpha (i) signalling events"], {"weight": 0.939786067230229}], ["OR6T1", ["TCGA.DM.A285.01", "Potassium Channels"], {"weight": 0.946294776866004}], ["OR6T1", ["TCGA.DM.A285.01", "Glucagon-type ligand receptors"], {"weight": 0.914092124462741}], ["OR6T1", ["TCGA.DM.A285.01", "G alpha (s) signalling events"], {"weight": 0.956584586826068}], ["OR6T1", ["TCGA.DM.A285.01", "G-protein beta:gamma signalling"], {"weight": 0.918895859853236}], ["OR6T1", ["TCGA.DM.A285.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.932378848803261}], ["OR6T1", ["TCGA.DM.A285.01", "Anti-inflammatory response favouring Leishmania parasite infection"], {"weight": 0.871019671729645}], ["OR6T1", ["TCGA.DM.A285.01", "Leishmania parasite growth and survival"], {"weight": 0.871019671729645}], ["OR6T1", ["TCGA.DM.A285.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.901166480458819}], ["TAS2R30", ["TCGA.DM.A282.01", "Initial triggering of complement"], {"weight": 0.805367290466067}], ["OR4D6", ["TCGA.DM.A28F.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.715412343860921}], ["OR4D6", ["TCGA.DM.A28F.01", "Parasitic Infection Pathways"], {"weight": 0.870486249687264}], ["OR4D6", ["TCGA.DM.A28F.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.924090817532319}], ["SAR1A", ["TCGA.DM.A28F.01", "Keratan sulfate biosynthesis"], {"weight": 0.896935503036279}], ["OR10V1", ["TCGA.DM.A28F.01", "Transmission across Chemical Synapses"], {"weight": 0.926065492271596}], ["OR10V1", ["TCGA.DM.A28F.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.923342097054556}], ["OR10V1", ["TCGA.DM.A28F.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.847146097690949}], ["GCLC", ["TCGA.DM.A28F.01", "Biological oxidations"], {"weight": 0.935309021711816}], ["GCLC", ["TCGA.DM.A28F.01", "Phase II - Conjugation of compounds"], {"weight": 0.808017164290106}], ["GCLC", ["TCGA.DM.A28F.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.860398011827643}], ["GCLC", ["TCGA.DM.A28F.01", "RA biosynthesis pathway"], {"weight": 0.83167042263332}], ["GCLC", ["TCGA.DM.A28F.01", "Drug ADME"], {"weight": 0.876466355370835}], ["GCLC", ["TCGA.DM.A28F.01", "Biosynthesis of specialized proresolving mediators (SPMs)"], {"weight": 0.835059125661185}], ["NCAN", ["TCGA.DM.A28F.01", "Extracellular matrix organization"], {"weight": 0.871645329098726}], ["NCAN", ["TCGA.F4.6808.01", "Keratan sulfate biosynthesis"], {"weight": 0.853853340534671}], ["CST7", ["TCGA.DM.A28H.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.936628046606153}], ["CST7", ["TCGA.DM.A28H.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.933858520259394}], ["CST7", ["TCGA.DM.A28H.01", "PD-1 signaling"], {"weight": 0.933784667802527}], ["CST7", ["TCGA.DM.A28H.01", "Generation of second messenger molecules"], {"weight": 0.933150527155703}], ["CST7", ["TCGA.DM.A28H.01", "MHC class II antigen presentation"], {"weight": 0.92794972760862}], ["SPATA2", ["TCGA.DM.A28H.01", "GPCR downstream signalling"], {"weight": 0.951452595635691}], ["SPATA2", ["TCGA.DM.A28H.01", "Neuronal System"], {"weight": 0.946095376382664}], ["SPATA2", ["TCGA.DM.A28H.01", "G alpha (i) signalling events"], {"weight": 0.947835523069463}], ["SPATA2", ["TCGA.DM.A28H.01", "Transmission across Chemical Synapses"], {"weight": 0.934316382653857}], ["SPATA2", ["TCGA.DM.A28H.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.94360594523809}], ["OR1S2", ["TCGA.DM.A28M.01", "GPCR downstream signalling"], {"weight": 0.946859471565736}], ["OR1S2", ["TCGA.DM.A28M.01", "GABA receptor activation"], {"weight": 0.929216043531811}], ["MED27", ["TCGA.DM.A28M.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.920596075558922}], ["MED27", ["TCGA.DM.A28M.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.920596075558922}], ["MED27", ["TCGA.DM.A28M.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.807853552780779}], ["MED27", ["TCGA.DM.A28M.01", "Regulation of TLR by endogenous ligand"], {"weight": 0.91776708493701}], ["MED27", ["TCGA.DM.A28M.01", "Diseases of Immune System"], {"weight": 0.897955416396061}], ["MED27", ["TCGA.DM.A28M.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.897955416396061}], ["MAPKAP1", ["TCGA.DM.A28M.01", "Signaling by GPCR"], {"weight": 0.945294441999328}], ["CXCL14", ["TCGA.DM.A28M.01", "Interleukin-10 signaling"], {"weight": 0.939457795853488}], ["CXCL14", ["TCGA.DM.A28M.01", "Chemokine receptors bind chemokines"], {"weight": 0.94830473010434}], ["CXCL14", ["TCGA.DM.A28M.01", "Peptide ligand-binding receptors"], {"weight": 0.944687158919867}], ["CXCL14", ["TCGA.DM.A28M.01", "Class A/1 (Rhodopsin-like receptors)"], {"weight": 0.944922904377823}], ["CXCL14", ["TCGA.DM.A28M.01", "Defensins"], {"weight": 0.691299767585837}], ["PAPSS1", ["TCGA.F4.6459.01", "Collagen chain trimerization"], {"weight": 0.850482455497213}], ["SUMF2", ["TCGA.F4.6461.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.807953997673796}], ["SOX4", ["TCGA.F4.6463.01", "Primitive streak formation"], {"weight": 0.691934942417667}], ["ASNS", ["TCGA.F4.6569.01", "Biological oxidations"], {"weight": 0.874072948393923}], ["ASNS", ["TCGA.F4.6569.01", "RA biosynthesis pathway"], {"weight": 0.825403886729519}], ["HADH", ["TCGA.F4.6569.01", "Ethanol oxidation"], {"weight": 0.667479959016446}], ["CSNK1G1", ["TCGA.G4.6306.01", "GPCR ligand binding"], {"weight": 0.949949169731998}], ["CSNK1G1", ["TCGA.G4.6306.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.941024168805737}], ["CSNK1G1", ["TCGA.G4.6306.01", "Activation of SMO"], {"weight": 0.904669669832069}], ["RNF207", ["TCGA.F4.6570.01", "Post-translational modification: synthesis of GPI-anchored proteins"], {"weight": 0.806502641630617}], ["CCT7", ["TCGA.F4.6570.01", "G alpha (s) signalling events"], {"weight": 0.952069895602132}], ["HSD17B8", ["TCGA.F4.6570.01", "Glucuronidation"], {"weight": 0.891344157051276}], ["HCN2", ["TCGA.G4.6586.01", "Potassium Channels"], {"weight": 0.966079217817018}], ["CLIC2", ["TCGA.F4.6570.01", "Cardiac conduction"], {"weight": 0.894166147826121}], ["LIN28B", ["TCGA.F4.6703.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.804105359271786}], ["LIN28B", ["TCGA.F4.6703.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.776060991715386}], ["LIN28B", ["TCGA.F4.6703.01", "Scavenging by Class A Receptors"], {"weight": 0.786476990494687}], ["MSN", ["TCGA.G4.6295.01", "Transport of inorganic cations/anions and amino acids/oligopeptides"], {"weight": 0.8855856046972}], ["LAP3", ["TCGA.F4.6807.01", "Phase II - Conjugation of compounds"], {"weight": 0.771559430725129}], ["LAP3", ["TCGA.F4.6807.01", "Drug ADME"], {"weight": 0.800216267017239}], ["LAP3", ["TCGA.F4.6807.01", "Collagen formation"], {"weight": 0.932414822726295}], ["LAP3", ["TCGA.F4.6807.01", "Metabolism"], {"weight": 0.866800585317451}], ["LAP3", ["TCGA.F4.6807.01", "Degradation of cysteine and homocysteine"], {"weight": 0.476386402356919}], ["LAP3", ["TCGA.F4.6807.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.919351370265061}], ["IKZF3", ["TCGA.F4.6808.01", "Translocation of ZAP-70 to Immunological synapse"], {"weight": 0.950433334704837}], ["IKZF3", ["TCGA.F4.6808.01", "Phosphorylation of CD3 and TCR zeta chains"], {"weight": 0.949168567666574}], ["IKZF3", ["TCGA.F4.6808.01", "Generation of second messenger molecules"], {"weight": 0.932436242723594}], ["IKZF3", ["TCGA.F4.6808.01", "PD-1 signaling"], {"weight": 0.948638404410134}], ["IKZF3", ["TCGA.F4.6808.01", "TCR signaling"], {"weight": 0.923620037181657}], ["IKZF3", ["TCGA.F4.6808.01", "Cell surface interactions at the vascular wall"], {"weight": 0.756328409103629}], ["ADH1A", ["TCGA.F4.6808.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.898396664747221}], ["PIK3R3", ["TCGA.F4.6854.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.802528090722232}], ["PIK3R3", ["TCGA.F4.6854.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.852126881786942}], ["PIK3R3", ["TCGA.F4.6854.01", "Extracellular matrix organization"], {"weight": 0.848850693844562}], ["PIK3R3", ["TCGA.F4.6854.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.822944492895524}], ["DTWD2", ["TCGA.F4.6855.01", "Ethanol oxidation"], {"weight": 0.786472721556277}], ["CTSZ", ["TCGA.F4.6856.01", "Metabolism of Angiotensinogen to Angiotensins"], {"weight": 0.777035391576606}], ["OR1E2", ["TCGA.F4.6856.01", "GABA receptor activation"], {"weight": 0.889601714961397}], ["OR1E2", ["TCGA.F4.6856.01", "G-protein beta:gamma signalling"], {"weight": 0.909166791345983}], ["OR1E2", ["TCGA.F4.6856.01", "Glucagon-type ligand receptors"], {"weight": 0.90469318617088}], ["OR1E2", ["TCGA.F4.6856.01", "G beta:gamma signalling through CDC42"], {"weight": 0.889546498967355}], ["MMRN1", ["TCGA.G4.6306.01", "Elastic fibre formation"], {"weight": 0.921602340800322}], ["MMRN1", ["TCGA.G4.6306.01", "Complement cascade"], {"weight": 0.914185526593903}], ["MMRN1", ["TCGA.G4.6306.01", "Initial triggering of complement"], {"weight": 0.90896601859025}], ["MMRN1", ["TCGA.G4.6306.01", "Regulation of Complement cascade"], {"weight": 0.902746369149972}], ["MMRN1", ["TCGA.G4.6306.01", "Classical antibody-mediated complement activation"], {"weight": 0.771726664195995}], ["MMRN1", ["TCGA.G4.6306.01", "Creation of C4 and C2 activators"], {"weight": 0.863333822712367}], ["MMRN1", ["TCGA.G4.6306.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.844906344620848}], ["MMRN1", ["TCGA.G4.6306.01", "Scavenging by Class A Receptors"], {"weight": 0.492895223307416}], ["CYP2C18", ["TCGA.F4.6856.01", "RA biosynthesis pathway"], {"weight": 0.85795393112355}], ["CYP2C18", ["TCGA.F4.6856.01", "Glucuronidation"], {"weight": 0.811692795709001}], ["DPEP1", ["TCGA.F4.6856.01", "Biological oxidations"], {"weight": 0.889848390799614}], ["AMBP", ["TCGA.G4.6293.01", "Activation of Matrix Metalloproteinases"], {"weight": 0.883583245220356}], ["LIF", ["TCGA.G4.6293.01", "Regulation of IGF Activity by IGFBP"], {"weight": 0.879425835143456}], ["LIF", ["TCGA.G4.6293.01", "Peptide hormone metabolism"], {"weight": 0.801326021141703}], ["LIF", ["TCGA.G4.6293.01", "Glycosaminoglycan metabolism"], {"weight": 0.795219656866441}], ["FGF3", ["TCGA.G4.6309.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.728858897197747}], ["GATA6", ["TCGA.G4.6293.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.790413333271845}], ["RAC2", ["TCGA.G4.6294.01", "Signaling by GPCR"], {"weight": 0.95250715197749}], ["KLRG1", ["TCGA.G4.6294.01", "Arachidonic acid metabolism"], {"weight": 0.829006044845932}], ["NR4A1", ["TCGA.G4.6294.01", "Phase II - Conjugation of compounds"], {"weight": 0.831098336903401}], ["NR4A1", ["TCGA.G4.6294.01", "Glucuronidation"], {"weight": 0.861497923449278}], ["RAC2", ["TCGA.G4.6294.01", "GPCR downstream signalling"], {"weight": 0.952847867891314}], ["APCS", ["TCGA.G4.6294.01", "Extracellular matrix organization"], {"weight": 0.835656533174535}], ["APCS", ["TCGA.G4.6294.01", "Sensory processing of sound"], {"weight": 0.901897791968615}], ["POLR2G", ["TCGA.G4.6294.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.609811919537946}], ["TNNC2", ["TCGA.G4.6294.01", "Muscle contraction"], {"weight": 0.90904822041385}], ["STX4", ["TCGA.G4.6295.01", "Neurotransmitter release cycle"], {"weight": 0.92052474896222}], ["STX4", ["TCGA.G4.6295.01", "Dopamine Neurotransmitter Release Cycle"], {"weight": 0.901592036886294}], ["STX4", ["TCGA.G4.6295.01", "GABA synthesis, release, reuptake and degradation"], {"weight": 0.911033962759488}], ["PTP4A1", ["TCGA.G4.6295.01", "Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects"], {"weight": 0.871772342589768}], ["PTP4A1", ["TCGA.G4.6295.01", "Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"], {"weight": 0.871772342589768}], ["PTP4A1", ["TCGA.G4.6295.01", "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"], {"weight": 0.875155395318645}], ["PTP4A1", ["TCGA.G4.6295.01", "Cyclin D associated events in G1"], {"weight": 0.922193653728833}], ["PTP4A1", ["TCGA.G4.6295.01", "G1 Phase"], {"weight": 0.922193653728833}], ["ELOVL3", ["TCGA.G4.6297.01", "Phase II - Conjugation of compounds"], {"weight": 0.724159214467228}], ["ELOVL3", ["TCGA.G4.6297.01", "Drug ADME"], {"weight": 0.859062520246227}], ["ELOVL3", ["TCGA.G4.6297.01", "Glucuronidation"], {"weight": 0.636131670771584}], ["OR52L1", ["TCGA.G4.6299.01", "G-protein activation"], {"weight": 0.898876900070545}], ["OR52L1", ["TCGA.G4.6299.01", "GABA B receptor activation"], {"weight": 0.914521189618431}], ["OR52L1", ["TCGA.G4.6299.01", "Class B/2 (Secretin family receptors)"], {"weight": 0.919472237321915}], ["RDH5", ["TCGA.G4.6299.01", "Biological oxidations"], {"weight": 0.963712846410321}], ["RDH5", ["TCGA.G4.6299.01", "Ethanol oxidation"], {"weight": 0.931799910760906}], ["RDH5", ["TCGA.G4.6299.01", "Phase I - Functionalization of compounds"], {"weight": 0.958152751501641}], ["RDH5", ["TCGA.G4.6299.01", "Glucuronidation"], {"weight": 0.893472537271934}], ["RDH5", ["TCGA.G4.6299.01", "Phase II - Conjugation of compounds"], {"weight": 0.908479511592067}], ["P4HA2", ["TCGA.G4.6302.01", "Collagen biosynthesis and modifying enzymes"], {"weight": 0.944356557568311}], ["VBP1", ["TCGA.G4.6302.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.758170606796363}], ["ABAT", ["TCGA.G4.6302.01", "Degradation of cysteine and homocysteine"], {"weight": 0.246069917541617}], ["DBH", ["TCGA.G4.6303.01", "Ethanol oxidation"], {"weight": 0.836194843885804}], ["PCYOX1L", ["TCGA.G4.6304.01", "Elastic fibre formation"], {"weight": 0.930177216480925}], ["PCYOX1L", ["TCGA.G4.6304.01", "Complement cascade"], {"weight": 0.892569951401338}], ["PCYOX1L", ["TCGA.G4.6304.01", "Regulation of Complement cascade"], {"weight": 0.844030621630945}], ["ADRB2", ["TCGA.G4.6304.01", "Chemokine receptors bind chemokines"], {"weight": 0.935586549508845}], ["CPSF4", ["TCGA.G4.6306.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.745622193249306}], ["GSN", ["TCGA.G4.6306.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.775530090708021}], ["OR2W1", ["TCGA.G4.6307.01", "Neuronal System"], {"weight": 0.934781211854171}], ["OR2W1", ["TCGA.G4.6307.01", "Transmission across Chemical Synapses"], {"weight": 0.921135508393406}], ["OR2W1", ["TCGA.G4.6307.01", "GPCR ligand binding"], {"weight": 0.933635649637793}], ["OR2W1", ["TCGA.G4.6307.01", "G alpha (i) signalling events"], {"weight": 0.947780872945424}], ["OR2W1", ["TCGA.G4.6307.01", "Potassium Channels"], {"weight": 0.961046584042092}], ["OR2W1", ["TCGA.G4.6307.01", "Initial triggering of complement"], {"weight": 0.804348991020076}], ["OR2W1", ["TCGA.G4.6307.01", "G alpha (q) signalling events"], {"weight": 0.937459255856841}], ["OR2W1", ["TCGA.G4.6307.01", "Platelet homeostasis"], {"weight": 0.889051882747929}], ["OR2W1", ["TCGA.G4.6307.01", "Neurotransmitter receptors and postsynaptic signal transmission"], {"weight": 0.920840404358216}], ["OR2W1", ["TCGA.G4.6307.01", "Nitric oxide stimulates guanylate cyclase"], {"weight": 0.792068735360256}], ["OR2W1", ["TCGA.G4.6307.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.708294868816589}], ["OR2W1", ["TCGA.G4.6307.01", "G alpha (s) signalling events"], {"weight": 0.950964092621725}], ["OR2W1", ["TCGA.G4.6307.01", "Neurexins and neuroligins"], {"weight": 0.879230051902832}], ["OR2W1", ["TCGA.G4.6307.01", "Protein-protein interactions at synapses"], {"weight": 0.892365724353588}], ["OR2W1", ["TCGA.G4.6307.01", "Glucagon-type ligand receptors"], {"weight": 0.928750469837139}], ["OR2W1", ["TCGA.G4.6307.01", "G-protein beta:gamma signalling"], {"weight": 0.927250071870071}], ["OR2W1", ["TCGA.G4.6307.01", "Activation of kainate receptors upon glutamate binding"], {"weight": 0.929762773530306}], ["OR2W1", ["TCGA.G4.6307.01", "G beta:gamma signalling through PI3Kgamma"], {"weight": 0.918510458075853}], ["OR2W1", ["TCGA.G4.6307.01", "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"], {"weight": 0.831976128134302}], ["OR2W1", ["TCGA.G4.6307.01", "Signal amplification"], {"weight": 0.928812822935372}], ["OR2W1", ["TCGA.G4.6307.01", "Activation of G protein gated Potassium channels"], {"weight": 0.925899591069116}], ["OR2W1", ["TCGA.G4.6307.01", "G protein gated Potassium channels"], {"weight": 0.925899591069116}], ["OR2W1", ["TCGA.G4.6307.01", "Platelet calcium homeostasis"], {"weight": 0.887765753860113}], ["OR2W1", ["TCGA.G4.6307.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], {"weight": 0.925899591069116}], ["OR2W1", ["TCGA.G4.6307.01", "ADP signalling through P2Y purinoceptor 1"], {"weight": 0.924040513708516}], ["OR2W1", ["TCGA.G4.6307.01", "Regulation of insulin secretion"], {"weight": 0.902779111928288}], ["OR2W1", ["TCGA.G4.6307.01", "Scavenging by Class A Receptors"], {"weight": 0.421026392472989}], ["OR2W1", ["TCGA.G4.6307.01", "Serotonin Neurotransmitter Release Cycle"], {"weight": 0.865450027332235}], ["PPARG", ["TCGA.G4.6307.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], {"weight": 0.852891499245848}], ["OR11L1", ["TCGA.G4.6309.01", "G alpha (s) signalling events"], {"weight": 0.951539377915943}], ["CBL", ["TCGA.G4.6310.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.880524212663248}], ["CBL", ["TCGA.G4.6310.01", "TNFs bind their physiological receptors"], {"weight": 0.610831692551056}], ["CBL", ["TCGA.G4.6310.01", "Constitutive Signaling by Aberrant PI3K in Cancer"], {"weight": 0.856282971087668}], ["CBL", ["TCGA.G4.6310.01", "FCGR activation"], {"weight": 0.895295589951892}], ["CBL", ["TCGA.G4.6310.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.912451041713211}], ["CBL", ["TCGA.G4.6310.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.912451041713211}], ["CBL", ["TCGA.G4.6310.01", "CD22 mediated BCR regulation"], {"weight": 0.860035735695862}], ["CBL", ["TCGA.G4.6310.01", "Drug ADME"], {"weight": 0.887837883189644}], ["CBL", ["TCGA.G4.6310.01", "Cell surface interactions at the vascular wall"], {"weight": 0.758606105860279}], ["CBL", ["TCGA.G4.6310.01", "Diseases of Immune System"], {"weight": 0.876116295083403}], ["CBL", ["TCGA.G4.6310.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.876116295083403}], ["CBL", ["TCGA.G4.6310.01", "Role of phospholipids in phagocytosis"], {"weight": 0.836262930515877}], ["CBL", ["TCGA.G4.6310.01", "Interleukin-2 family signaling"], {"weight": 0.809609104274842}], ["CBL", ["TCGA.G4.6310.01", "Fcgamma receptor (FCGR) dependent phagocytosis"], {"weight": 0.903299773718841}], ["CBL", ["TCGA.G4.6310.01", "Negative regulation of the PI3K/AKT network"], {"weight": 0.835855121035089}], ["CBL", ["TCGA.G4.6310.01", "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"], {"weight": 0.857499519859014}], ["CBL", ["TCGA.G4.6314.01", "Negative regulation of TCF-dependent signaling by WNT ligand antagonists"], {"weight": 0.800287672742671}], ["HSPA4", ["TCGA.G4.6311.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.666578709173082}], ["FAAH", ["TCGA.G4.6314.01", "Arachidonic acid metabolism"], {"weight": 0.864562058312669}], ["FTL", ["TCGA.G4.6315.01", "Scavenging by Class A Receptors"], {"weight": 0.553809702942985}], ["FTL", ["TCGA.G4.6315.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.600087063426492}], ["IRF4", ["TCGA.G4.6315.01", "Adaptive Immune System"], {"weight": 0.877314901640666}], ["PSMA1", ["TCGA.G4.6317.01", "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"], {"weight": 0.887701465629516}], ["CDC37L1", ["TCGA.G4.6317.01", "Chemokine receptors bind chemokines"], {"weight": 0.948937911722811}], ["CDC37L1", ["TCGA.G4.6317.01", "Classical antibody-mediated complement activation"], {"weight": 0.850760064402659}], ["CDC37L1", ["TCGA.G4.6317.01", "Formation of Fibrin Clot (Clotting Cascade)"], {"weight": 0.935454332699192}], ["PSMA1", ["TCGA.G4.6317.01", "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"], {"weight": 0.908647835618289}], ["PSMA1", ["TCGA.G4.6317.01", "Transcriptional regulation of testis differentiation"], {"weight": 0.883772189542668}], ["KLK6", ["TCGA.G4.6317.01", "Cytokine Signaling in Immune system"], {"weight": 0.891469157254986}], ["KLK6", ["TCGA.G4.6317.01", "Role of phospholipids in phagocytosis"], {"weight": 0.830997210204491}], ["NPPA", ["TCGA.G4.6320.01", "Cardiac conduction"], {"weight": 0.942174968085517}], ["NPPA", ["TCGA.G4.6320.01", "Muscle contraction"], {"weight": 0.941216504308391}], ["FGF14", ["TCGA.G4.6320.01", "Phospholipase C-mediated cascade: FGFR1"], {"weight": 0.885848941390464}], ["FGF14", ["TCGA.G4.6320.01", "PI-3K cascade:FGFR1"], {"weight": 0.885848941390464}], ["STAT2", ["TCGA.G4.6320.01", "Chemokine receptors bind chemokines"], {"weight": 0.93080916319392}], ["CYB5R1", ["TCGA.G4.6323.01", "Binding and Uptake of Ligands by Scavenger Receptors"], {"weight": 0.566623246877266}], ["MMP1", ["TCGA.G4.6586.01", "Extracellular matrix organization"], {"weight": 0.932682397149405}], ["BLNK", ["TCGA.G4.6586.01", "MyD88 deficiency (TLR2/4)"], {"weight": 0.903664482253588}], ["BLNK", ["TCGA.G4.6586.01", "IRAK4 deficiency (TLR2/4)"], {"weight": 0.903664482253588}], ["BLNK", ["TCGA.G4.6586.01", "Diseases of Immune System"], {"weight": 0.880421093641711}], ["BLNK", ["TCGA.G4.6586.01", "Defects in Toll-like Receptor Cascades"], {"weight": 0.880421093641711}], ["NME4", ["TCGA.G4.6588.01", "G alpha (i) signalling events"], {"weight": 0.951777494283809}], ["LRFN1", ["TCGA.G4.6588.01", "Trafficking of GluR2-containing AMPA receptors"], {"weight": 0.933939299074012}], ["COX11", ["TCGA.G4.6625.01", "Cytosolic sulfonation of small molecules"], {"weight": 0.643532175756777}], ["RGS8", ["TCGA.G4.6628.01", "G alpha (s) signalling events"], {"weight": 0.95340733084678}], ["RGS8", ["TCGA.G4.6628.01", "Adrenaline,noradrenaline inhibits insulin secretion"], {"weight": 0.924773221463817}], ["PTGES", ["TCGA.G4.6628.01", "Arachidonic acid metabolism"], {"weight": 0.934671916312307}], ["RDH14", ["TCGA.G4.6628.01", "RA biosynthesis pathway"], {"weight": 0.85885557022105}], ["KIF22", ["TCGA.G4.6628.01", "Interaction between L1 and Ankyrins"], {"weight": 0.914391566251743}]], "not_cover_set": ["PC", "SCN9A", "LRR1", "PPP1R12A", "DNAH8", "TWIST1", "ABCA2", "F9", "RBBP7", "IL15RA", "RNF43", "MAP2", "LRBA", "TDG", "NPFFR1", "ACLY", "OR4C46", "NMUR2", "NPSR1", "RSPO4", "MEP1A", "CLIP3", "MSH5", "MEIS1", "NEDD4", "APBB1IP", "NBAS", "PIK3C2B", "ZC3H3", "MRPS2", "GRM2", "NKD1", "IFT80", "BMP7", "NT5C", "WDR59", "OGT", "ESRRB", "DYNC1H1", "BTC", "TRIM36", "CDH6", "HTR7", "DOT1L", "PPP1R15A", "PDS5B", "CLGN", "EXOC6", "POLD1", "MPDZ", "ASH2L", "NFIC", "MTCH2", "ROBO3", "KCNC1", "GFPT2", "ZNF135", "ZNF793", "ZNF560", "ZIK1", "OR2M7", "CENPF", "LATS2", "KDELR2", "CHAT", "KRT85", "ZNF227", "LTN1", "GABRB3", "RPA4", "PCF11", "CDC25C", "PRDM4", "DAAM2", "GNRHR", "IRS4", "EPB41", "COG7", "RPL5", "GALK2", "GFM2", "ZNF644", "KCNMB1", "RBMXL2", "KCTD1", "NUSAP1", "FAM170A", ["TCGA.A6.5657.01", "RA biosynthesis pathway"], "UNC5A", "IPMK", "FANCA", "NAALADL2", "KCNS2", "DKK2", "DHX8", "OGDH", "ACOX3", "CAV3", "SMARCE1", "INPP5B", "OR51I1", "RXRB", "VARS", "TDRD7", "RSPO2", "HEXIM2", "CWF19L2", "PTPRU", "PTPRB", "CCDC14", "CCT8L2", "KDM4A", "TTK", "CHUK", "GOT1", "TUBGCP6", "TNFRSF11A", "NIPBL", "MYO1E", "AASDH", "ZNF676", "ZNF530", "ZNF408", "ZNF607", "ASIC5", "TMPRSS2", "LYPD6", "KCNN2", "CBX2", "MYF6", "LRRC41", "REV3L", "AURKC", "IL13RA2", "WDR24", "POU2F2", "GPR27", "HLCS", "DEPDC7", "PADI4", "RUNX1T1", "ZNF423", "ABTB1", "BCAS3", "ZNF680", "CHMP1B", "PDK4", "DAG1", "PSMB8", "SMPD4", "TTC28", "FBXO10", "FBXO11", "SAFB", "CCNA1", "MGA", "OPTN", "NPEPL1", "ARID4A", "FBF1", "TRIM9", "PRDM14", "FANCM", "HOXA1", "WWP1", "CTSA", "VAV1", "USP19", "KLC1", "AGAP2", "CKAP5", "RBM27", "KCMF1", "SRP54", "CHRNA5", "FGFR1OP2", "TEX10", "PHLPP1", "SH3GLB2", "UPF2", "MAPK6", "BCOR", "SYNJ2", "ZC3H6", "SEL1L", "CBX3", "CDH11", "ABL1", "KIF21B", "NUP210", "HOGA1", "CEP250", "DNA2", "KLHL3", "SYNE2", "MYBBP1A", "RPGRIP1L", "HDAC9", "GP9", "DNAH17", "MECOM", "RSAD2", "RND2", "LRRC4B", "NANS", "CABP2", "CIB3", "MRPS22", "ARIH2", "FUZ", "KPNA6", "WWC1", "ACTR1A", "PRPF3", "GPAM", "SSU72", "GTF3A", "USP21", "HPGDS", "HLA-F", "IPO9", "KIF26B", "NCAPH2", "NUF2", "MXD1", "MIS18A", "PTBP2", "FOXP3", "SAE1", "ERCC6L", "TTF2", "TTF1", "SASS6", "DNAH2", "CSTF3", "SGIP1", "KIF17", "KIF1B", "ICAM1", "CTDSP2", "CTDSPL", "SGK2", "MAP4K3", "STAG1", "HMGA2", "CLASP1", "TCF7", "PRDX1", "AXIN1", "ADAMTS12", "HRG", "MAP3K8", "MAP3K1", "MAP3K5", "OR2A25", "NLRX1", "STRN", "TOP2B", "NUMA1", "EXOC3", "CENPL", "DHX34", "RBM39", "MELK", "CYBRD1", "CAB39L", "SPON2", "ITIH3", "SFTPB", "SURF4", "PLXNA3", "MAP2K1", "KDM5B", "CACYBP", "SPN", "SDK2", "TERF1", "CHD8", "SKIV2L", "SPEN", "DAXX", "PLEKHM2", "LGR4", "SEC24A", "CSNK1D", "GLRA3", "SH3RF1", "TPMT", "IGF2BP1", "PER1", "WDR44", "CTTNBP2", "GFPT1", "PPT2", "ARHGEF16", "SEC61B", "FBXO2", "SNTB1", "TAS2R8", "CCT5", "DLAT", "ASB10", "PNISR", "NOL6", "GK", "ARHGAP32", "MTTP", "SHC2", "QRFPR", "SGPP1", "NF2", "NF1", "BLK", "RRAS", "AMBRA1", "ACVR1C", "SERPINE1", "SSTR1", "HES5", "GPR150", "LYST", "USP48", "LRTOMT", "SUV39H1", "NDST2", "DIS3L", "CRBN", "TSG101", "ADM", "CELF6", "DDB1", "HERC2", "BNIP1", "CDH2", "NUAK1", "FGD3", "YTHDC2", "SOX6", "MRPS25", "ENPP2", "COL8A2", "DNM2", "OR4L1", "PIGU", "ZC3H13", "DPF2", "DPF1", "BCAP29", "SPDYE1", "LIPG", "GTF3C3", "PPP2R5E", "KTN1", "PEX2", "TINF2", "DMPK", "APC2", "SLC25A12", "GCAT", "RAB11A", "MTMR4", "DEPDC5", "SCYL1", "STXBP2", "STXBP5", "PHKA1", "RAMP2", "BRSK2", "COG6", "PSME4", "MTSS1", "PABPC1", "CTNNBL1", "DLC1", "TRIP10", "TRIP11", "OR2D3", "CSTF2T", "HCFC1", "FBXO25", "STRN3", "PRPF38A", "DYSF", "ABR", "CLOCK", "OR5M3", "SHROOM3", "LEPR", "CSGALNACT2", "ADD1", "FMOD", "STX1B", "PAN3", "LDB3", "MYH1", "CAPN5", "ZCRB1", "KIF13B", "HPS6", "NCKIPSD", "RAG1", "SND1", "RALGAPB", "LINGO1", "STAT1", "HTATSF1", "TMOD2", "DEFB119", "IFI16", "CCDC166", "SETD1A", "KDM3B", "KIRREL2", "KIRREL3", "ENPP4", "PDIK1L", "B4GALNT1", "EIF4ENIF1", "QRSL1", "ANKRD17", "HTRA1", "SLC4A1AP", "ACSM4", "GALNT9", "MLF1", "EPC2", "AGK", "HCFC2", "ELOVL1", "SMS", "ABCD1", "BTAF1", "ATAD3A", "RPAP1", "AFAP1", "CTU2", "ITLN1", "ATL3", "ALG13", "POGZ", "MYO1H", "REPIN1", "TDRD3", "TLK1", "G3BP2", "GPR149", "COMMD10", "BRD3", "LRRC47", "PIWIL1", "SPATS2", "BEND7", "RAN", "UBE4A", "CALD1", "STAG2", "CAPN14", "HMGXB3", "FRMD6", "ACBD5", "UHRF1BP1", "ANKLE2", "SAP130", "RPS6KA1", "MIS18BP1", "INTS4", "PTGER3", "DNAJC2", "CAPN1", ["TCGA.A6.5664.01", "Cytosolic sulfonation of small molecules"], "NSRP1", "CPEB4", "CFH", "SPPL2A", "NLGN3", "RAD9B", "CHMP6", "GGA2", "FAHD2A", "STS", "BRIP1", "ENO1", "USE1", "PPP1R13B", "FAM53C", "KCNA4", "KCNA2", "ASXL1", "ADAP1", "KLHL11", "SLK", "RAPGEF2", "EEF1A2", "CHPF", "PPA1", "RAB1B", "MYH7B", "HIST1H1E", "HIST1H1B", "SOS2", "SLC38A9", "RIF1", "FANCI", "ACTB", "MARS2", "FERMT3", "TAP1", "HNMT", "SPHKAP", "HS6ST2", "RBM22", "RRM2", "DCTN1", "UVSSA", "CD58", "UGT1A8", "CHRNA6", "FOXM1", "UBTF", "SMPD2", "UGDH", "MRPL19", "RNF126", "GNAQ", "RRH", "VAC14", "CEP192", "CBX8", "ERCC3", "PFKP", "CLEC4M", "B9D2", "CDH12", "AARS", "GTF3C1", "EEA1", "KIFC2", "PRKDC", "KIF21A", "DHX16", "PMEL", "UBE3B", "UBE3A", "CYSLTR1", "SCFD1", "AP3M2", "CXCR2", "PAWR", "GATAD2B", "TP53BP1", "KLHL5", "SNTA1", "ZNRF3", "EFCAB1", "DKK1", "AP4B1", "NLRC5", "DNAH10", "PLAT", "ZC3H18", "MUS81", "TCEA2", "MRPS18A", "BRD8", "AMOTL1", "RHPN1", "CUX1", "PHC3", "YTHDF2", "ZMIZ2", "CHN1", "AXL", "SVIL", "DES", "ONECUT1", "FAM83H", "HSPB1", "TAF1", "ARFGEF2", "PDCD11", "WDR70", "MCF2", "VPS72", "FZD1", "ASH1L", "AK1", "MDC1", "PARG", "CEP76", "CEP72", "SMG6", "SFN", "NOP56", "USP38", "CARD10", "PDE5A", "PARP1", "PARP2", "LIG3", "SEC31A", "UBOX5", "NUP133", "SMG9", "FRMPD4", "DNAJB6", "SFPQ", "ANXA2", "CDC23", "TAS2R40", "SCLT1", "RIOK1", "DDX54", "DNAH7", "PPP6R3", "OXER1", "HMMR", "KLHL25", "POLH", "SGMS1", "PRCC", "IFT57", "JAM3", "KIF1C", "TMEM87A", "MAP4K2", "MAP4K5", "NUMB", "APOA1", "GHRH", "SESN2", "ZFYVE16", "AXIN2", "KAT2B", "HOXB2", "DCTPP1", "MASTL", "TOP2A", "EXOC7", "CENPI", "CENPE", "DHX37", "ATAD3C", "KANSL1", "ETF1", "ABCA7", "TRA2B", "VLDLR", "DERL1", "INTS1", "CCDC130", "MAP2K7", "MAP2K5", "ETV4", "LUZP4", "DPYSL5", "CPLX2", "GALR1", "BMP6", "CHD5", "CHD4", "MPL", "GRIN2D", "LIMD1", "CDK12", "OXT", "COQ2", "LGR5", "BRWD1", "GNG12", "SEC24B", "MPLKIP", "BRCA2", "KIF23", "ARNTL2", "SERPINF2", "CIT", "MOGAT3", "GLRA2", "OR4C11", "OLR1", "PER3", "TLK2", "KIF20A", "PTGER2", "STK4", "NTN4", "SENP3", "HAUS3", "HIST1H2BL", "TNFAIP3", "ARHGEF18", "RBM5", "CAD", "ADAD1", "OFD1", "WNK3", "SNX6", "TUBB6", "ASB11", "FDPS", "HEXIM1", "MLST8", "PLCH1", "SLC16A1", "ARHGAP33", "DCUN1D1", "AP1M1", "TUBB4A", "LMO7", "ATG14", "PKNOX1", "CPT1C", "MCM7", "CABLES1", "DSTYK", "PAPOLB", "TACC3", "IRAK4", "DMAP1", "TAF1D", "HUWE1", "LMAN2L", "GLB1", "WTAP", "PPBP", "DDIT4L", "COBL", "CEP68", "ZFYVE1", "CTR9", "AJUBA", "PTPN23", "ARHGEF1", "CDH9", "GRM8", "EPN1", "KDELR1", "MVK", "ZNF14", "LILRA1", "CNKSR1", "BCAR1", "GOLGA4", "TUFM", "SRSF1", "SRSF9", "SF3B3", "CYP17A1", "GPR4", "CDK5RAP2", "NEO1", "TAOK2", "ARHGDIB", "TANC2", "RAET1E", "TBX21", "ZDHHC17", "ESPL1", "U2AF2", "SLX4", "MLLT1", "LRFN3", "MBD5", "IRF3", "CHRD", "CSDE1", "UTP20", "UNG", "ARHGAP6", "OR4F6", "LRIT1", "ING5", "MTMR8", "S1PR4", "PRKCH", "PRKCD", "PRKCZ", "CCDC93", "CENPM", "ECI1", "SMCHD1", "IL27RA", "MYH11", "LIG1", "TRMT1", "SEMA3F", "DERA", "C17orf75", "RAB8B", "KDM4B", "TOPBP1", "XRN1", "VPS53", "THOC1", "PPM1B", "CAPN2", "PPP1R16A", "PNPLA6", "MAN1C1", "NCAPD3", "SMC5", "HNF1A", "CNGA2", "IQGAP3", "TUBA4A", "PICALM", "HSPA12A", "PAFAH2", "TAF1L", "TEP1", "CFC1", "SERPINA4", "L3MBTL1", "ACTL6B", "HSPA2", "MKL1", "PELI2", "CTCF", "PAPOLG", "IFNGR2", "VDAC3", "SIRPB1", "TRIM37", "POLR2F", "NAT8L", "CEP164", "SEMA4C", "SEMA4G", "KIR2DL3", "HTRA2", "TBCB", "TUBGCP4", "AVPR1A", "MKL2", "USP4", "FAM13A", "MAP1S", "RBM14", "KCTD19", "IGSF3", "KDM2B", "MRI1", "MUC15", "KRI1", "PHF1", "ATRX", "HPN", "UGT8", "RETNLB", "GBA2", "GALNT10", "PADI2", "MMACHC", "USP37", "SMTN", "SEL1L3", "MDN1", "GALC", "EYA3", "SDAD1", "DDX55", "HEXDC", "FBLN2", "HBS1L", "BMP8A", "MICALL1", "NDUFS1", "CCDC88A", "TRIP4", "SUPT6H", "SLC22A16", "NDUFB11", "NDUFA10", "SMARCA1", "SORL1", "PHLDB2", "MON1B", "GDF5", "MTF2", "ST6GALNAC4", "GLB1L3", "BOD1L1", "TXNDC17", "ALDH16A1", "ARSE", "FPGT", "ZMYM3", "BCLAF1", "PPAN-P2RY11", "SALL1", "RSPH9", "ADNP", "WSB2", "MGAT4A", "ABCD2", "DMXL2", "AUTS2", "SETX", "PRRC2A", "ZNF300", "MARK1", "FAT4", "RPAIN", "ZNF514", "ZNF273", "NASP", "PRMT3", "GET4", "RAD51D", "SOGA1", "MSL3", "DDX59", "ZNF562", "ZNF34", "NPAT", "MYO1G", "NEMF", "ZNF398", "HIST1H2BC", "ZNF180", "ZNF233", "ZNF716", "ZDHHC5", "ZNF287", "ZNF45", "LRGUK", "CISD2", "ATG2A", "ZNF331", "ZNF433", "RAB4B", "MIER2", "MIER3", "SCYL2", "NAA35", "ZNF25", "ZFP3", "ASIC3", "BEND3", "ZNF777", "NOM1", "B4GALNT2", "TRPM6", "VNN1", "COQ6", "TRIM56", "EEF1A1", "FBXO40", "NLRP9", "BRPF3", "RNF44", "SMARCD2", "CLVS1", "DEPDC1B", "RAB27B", "LARP4B", "WIPI2", "ZFR2", "TECPR1", "DCPS", "NRIP2", "EIF3F", "FBXL18", "RPS6KA6", "TMEM70", "DNASE2", "PLXNB2", "KDM6B", "DET1", "PLEKHG6", "RGS9BP", "BBS5", "RPL14", "MYH13", "NEUROG3", "RIN3", "MEFV", "DEFB118", "LAMP2", "GADD45GIP1", "PMP2", "USP6", "CAND2", "MEIS2", "ACSF3", "ZNF311", "IL17RA", "GULP1", "SCN3B", "AHNAK", "ARID2", "HAND1", "PABPN1L", "ETV3", "FABP2", "RHOBTB3", "CCNL2", "RAB11FIP1", "GK2", "ZNF417", "GLB1L2", "MLH1", "TAF2", "DDX39B", "POT1", "MST1R", "METTL14", "TGFBR1", "HTR5A", "ENY2", "MGAM", "MKNK2", "HTR3A", "ACAP2", "PSAPL1", "ALPI", "CDH17", "COL23A1", "KIAA0753", "WWC2", "RFC1", "PFKM", "MCM8", "NOV", "LLGL2", "PCDHGB6", "KPNA5", "BDP1", "GMIP", "PPP1R3A", "MMP19", "PLXND1", "DEFB127", "EXOC4", "NMUR1", "FTSJ3", "RNF6", "RPGRIP1", "KIF20B", "SENP2", "HAUS5", "ASB18", "LILRB3", "ELSPBP1", "OR10A2", "ATXN2L", "DNASE2B", "UIMC1", "PIWIL4", "WDR62", "NCAPD2", "IQGAP2", "RGMB", "OR10P1", "CEACAM8", "NACAD", "MICAL1", "PAM", "ZNF543", "ZNF548", "ZNF708", "FUT7", "ESF1", "TCEAL2", "ZNF347", "ZNF551", "NAA11", "NEU2", "SLC30A5", "ZNF585A", "DOPEY1", "ATG2B", "ZNF772", "ZC3HAV1", "PNPLA1", "ZNF705A", "ITGA9", "TIMM44", "ZNF830", "COBLL1", "CNGB1", "PCNT", "NGLY1", "NLGN1", "GPRC6A", "KCNA3", "ASXL2", "QKI", "TPD52L1", "ALDH3A2", "ANAPC4", "PFN2", "TRIM5", "CYTH3", "FCER1A", "GPR65", "VAV3", "GSTA1", "GSTA3", "PPID", "SERPINI1", "COPS2", "GPN3", "GPR119", "DAB2", "CCDC22", "ZNF219", "UTP14C", "KDM4C", "RPL8", "REST", "MAP3K13", "STAMBPL1", "TNKS1BP1", "GPR18", "EFCAB3", "DHX9", "LRRC49", "NMD3", "CLUAP1", "CHN2", "MRPS23", "HS3ST2", "MET", "GABRP", "OR3A1", "ZNF473", "IREB2", "TMEM181", "TAF5", "CSAD", "MAPK14", "BMP2K", "IPO8", "PIK3C2A", "NAE1", "MED30", "FGF10", "NONO", "GALNT13", "LIMK2", "ANXA7", "M6PR", "DNAH6", "TP53BP2", "POLE", "KIF14", "KIF15", "SPARC", "DSPP", "TPR", "PPP4R1", "DZIP1", "SGCZ", "ADCYAP1R1", "CENPJ", "EZH2", "SARS", "IFNA6", "MAP2K4", "BORA", "UTRN", "BCR", "EVI5", "MYSM1", "S100A9", "DRG1", "PFDN4", "CRNKL1", "ZNF451", "WSB1", "KAT8", "VIPR2", "DNTTIP1", "MYOM1", "SIRT1", "TAS2R1", "ASPA", "ESRRG", "NNT", "AQR", "SCP2", "RALGAPA2", "TES", "CDKN2C", "NME3", "MED7", "UST", "IQCG", "OR6C65", "CASP3", "GABRA2", "CEP290", "SEC23B", "RBPJ", "NUP54", "IL22RA2", "ANKRD28", "EXO1", "RAB9A", "SCCPDH", "OR11H6", "KLRC1", "SDHAF2", "CAMK4", "FRG1", "EIF2AK3", "PIGY", "AKAP6", "GOSR1", "SYCP2", "AAK1", "PTPRR", "GAPVD1", "WDR33", "IRF6", "DGKA", "BBS7", "HOXC4", "ILK", "NUP205", "NAA38", "LIG4", "COG3", "STK24", "POLD3", "OR10K2", "AP3B2", "RING1", "TRIP12", "FOXK2", "ASZ1", "FKBP6", "RPS27L", "TAF13", "RGS21", "DOK5", "ACSL1", "PKD2L1", "SH2D2A", "LIN9", "MYH8", "CAPN7", "NTS", "OR10H1", "USP2", "ALDOB", "NSD1", "MMAA", "NR2E1", "CHAF1A", "GTPBP10", "QPRT", "GINS1", "TRAPPC8", "PHGDH", "CKMT1B", "ZNF33B", "SMARCD3", "RUSC2", "HDAC7", "MFGE8", "ATR", "ADAMTS6", "DUSP4", "DUSP6", "C1orf50", "ZNF554", "SATB1", "GABRB2", "CCM2", "FUT5", "CACNB4", "ARHGEF17", "ECSIT", "P2RY6", "KLF8", "DOPEY2", "NUMBL", "HECW1", "ESYT2", "DAPK1", "LAS1L", "BIRC6", "FGD1", "NDUFS8", "ARHGEF9", "GFM1", "CERS4", "TCEAL1", "SEPT9", "RBM10", "RANBP6", "RRBP1", "SEMA4B", "SEMA4F", "NKAP", "FARS2", "PBX2", "RIN1", "RFC4", "FANCB", "GARS", "KIR3DL2", "ITPKC", "SMO", "RTN4", "MEX3C", "OR2A12", "RLIM", "TCF20", "RALY", "PRKRA", "NEU4", "ZNF711", "FBXL6", "MPPED2", "ZNF442", "TSEN2", "AFF1", "WDR48", "OR56B4", "RAE1", "STRADB", "SGMS2", "STEAP3", "MYO16", "DAB2IP", "ARSB", "FPR2", "FUT9", ["TCGA.A6.6652.01", "Classical antibody-mediated complement activation"], "CPEB3", "STAT5B", "SGSM3", "GGA1", "FOXN3", "CCDC77", "ADAM10", "PCSK5", "NUP188", "OR5J2", "EHMT2", "SSRP1", "FYCO1", "TRIM4", "FLRT2", "RASSF1", "SMARCC2", "FANCE", "NFKBIA", "KLC2", "COL9A2", "RPL39L", "TEAD2", "AP5Z1", "EGR4", "KIF16B", "FBXO41", "DENND1C", "RANGAP1", "NEDD1", "PROCR", "UNKL", "KLHDC10", "CDH13", "HKDC1", "FRAT1", "TUBB2B", "INHA", "DGCR8", "NOX3", "GPT", "SF1", "BRD1", "CSF2RA", "ARHGAP20", "STAT6", "FOXP4", "B4GALT3", "CREM", "TRIM28", "SOCS3", "PSPC1", "WDFY2", "TBCD", "NOC2L", "SUN1", "SRP68", "ARHGEF3", "SLC7A5", "IPO7", "CSPP1", "CHRM5", "MGAT1", "FMNL3", "ITPKB", "MUT", "FAN1", "CCNK", "GABRG1", "CHP2", "DNAJB5", "ANXA3", "PGM2", "EGLN2", "GTF2A1", "DCAF16", "STON2", "NAGLU", "OR9K2", "GALE", "FCGR3B", "DYRK2", "OSBPL1A", "SKAP1", "CD180", "USP26", "SSH2", "NBEAL1", "IKZF5", "HMG20B", "RNF130", "MYO10", "CHD3", "RHO", "RAB3IP", "ACTR8", "CDKN1B", "SMC1B", "PKN2", "PRAM1", "SREBF2", "MTA3", "PER2", "TNFRSF9", "RGL2", "OR10Q1", "UNC45A", "ACTBL2", "FBXO5", "WNK4", "OPRL1", "LYVE1", "LRCH1", "PKMYT1", "SBNO1", "ELMO3", "USP46", "SCAF11", "PHKG1", "SNW1", "MOCS1", "PPARD", "CD14", "KITLG", "PALB2", "RTF1", "PAICS", "TP73", "USP24", "CDH8", "PROKR2", "CUL4A", "SLC2A2", "KHDRBS1", "FAM32A", "SRSF4", "DNAJC3", "SEC61G", "SYCP1", "USH1C", "DDX47", "MLLT3", "WDR38", "PTPRJ", "TLE2", "ARAP1", "INO80C", "OR6C2", "AGL", "CTH", "TBL1Y", "CHPF2", "WBP1", "ANXA11", "RTKN", "MIB2", "ACP1", "DMC1", "PI4K2A", "FBXW12", "FBXW11", "PPP2R1A", "ADAR", "SLC9A4", "MNAT1", "DNMBP", "CCR1", "GSR", "PABPC3", "TACR1", "SOCS6", "ARPC2", "RAB11FIP2", "ARHGAP10", "DDX18", "PNPLA2", "SRGAP1", "SRGAP3", "LTA", "FKBPL", "STRN4", "PPP2R2A", "SRPK2", "RPS7", "LPIN3", "SNTG2", "HEYL", "RAD18", "SYNGAP1", "ADPRHL1", "YIPF2", "NLE1", "MAP7", "ACSM3", "SPTLC2", "PADI3", "KDM5A", "RASSF4", "PRDM16", "MUC21", "NIP7", "RAB11FIP5", "NR1I3", "MGLL", "GDF6", "PSPH", "ATXN7L1", "WDR88", "SLC27A4", "ZNF302", "FXR1", "ARL13A", "ZNF304", "HKR1", "TNRC18", "APOL2", "KCTD3", "ZNF484", "ZNF263", "MKI67", "ZNF557", "ASPM", "NEU1", "HECA", "ZFP2", "PRRC2B", "ZNF529", "BCL11A", "IL16", "PCSK2", "OR8U1", "PDCL3", "CAV1", "IFIH1", "PSMA8", "SMG8", "EYA4", "EYA1", "MYO9B", "TBC1D5", "ARHGEF11", "CABLES2", "HIST1H2AA", "FNBP1", "ZDHHC8", "RRP12", "ZNF337", "ZNF354A", "SLC1A3", "CHST8", "RTEL1", "RAB3GAP2", "CHMP4B", "PDSS2", "ALOX12B", "CNR1", "ZNF207", "CPN1", "RIN2", "RNGTT", "ADIPOR2", "MPHOSPH10", "CD28", "HIST1H1D", "FANCL", "KRIT1", "NACA", "PYGO1", "RABGEF1", "USP11", "PLD1", "DOCK5", "TH", "ITCH", "IGSF5", "SNRNP200", "ITGA11", "COMP", "BUB1", "PREP", "APBB2", "DIAPH3", "CD207", "DPM2", "ABL2", "RINT1", "DCAF4", "ITM2B", "CAMK2B", "NUP214", "DHX15", "NAA25", "CD8B", "KIF7", "ESYT1", "ESYT3", "IPPK", "ULK1", "SV2C", "PSMD4", "COPS7A", "HDAC1", "XRCC2", "RNF111", "MGRN1", "TAS2R60", "BRD4", "GAB4", "GAB1", "GNA11", "LDLR", "EBF1", "DACT1", "RECK", "NUFIP1", "ME1", "UBR2", "SKP1", "SUPT7L", "OR56B1", "MED23", "ADM2", "MTA1", "LONP2", "KCNH2", "MFN1", "PIH1D1", "NNMT", "UBR4", "LHB", "SMG5", "EIF3B", "CASR", "VPS36", "GNB4", "KLHL24", "PSMD1", "KIF19", "POFUT1", "KHK", "XPO6", "MADCAM1", "ADAMTS19", "RNF20", "HOXB3", "NR2F1", "TMED10", "MAP3K9", "MAP3K6", "KIAA0319", "ARHGEF26", "HFM1", "NBEAL2", "RNF34", "GORASP2", "CHRNB3", "ETV6", "THSD4", "CPLX1", "DNAJA4", "PRKAA2", "NMNAT3", "TMCO3", "SCAF4", "SEC24D", "GTPBP1", "POLQ", "SMC1A", "TSSK2", "FTCD", "RGPD1", "ELK4", "THPO", "CACNG5", "STK3", "NCKAP1L", "LY6G6F", "ZC3H8", "ARHGEF19", "ARHGAP11A", "DRAP1", "CDC45", "ARHGAP39", "DSG3", "SHROOM2", "OR2AG2", "MCM6", "NRAP", "MRPL54", "BLM", "RBMX", "NDUFS2", "TCF7L1", "TNKS", "PDLIM7", "ISG20L2", "UGP2", "EHD3", "GLUD1", "TRIM10", "EFNA5", "RBM17", "PAPLN", "PFKFB3", "DNAJC8", "DNAJC1", "GOSR2", "CDC16", "STX19", "NKX2-5", "BCL9L", "INO80E", "WWTR1", "AGA", "GAS6", "PDS5A", "CATSPER4", "SIN3B", "BTRC", "YIPF5", "REPS1", "TLR2", "BAZ2A", "LSP1", "PIWIL2", "NOP14", "CDS1", "ORC4", "ORC1", "CNTFR", "RNF103", "TYROBP", "LTF", "MCMBP", "NDN", "MAGI3", "RPL27", "RPL22", "SNRNP35", "DUSP7", "RBL1", "RAD17", "CNNM2", "CNNM4", "EIF4B", "GBP1", "PHF20L1", "NFIA", "C4orf19", "FAHD2B", "KDM2A", "SLC25A25", "PLXNC1", "REEP4", "PADI1", "TAF5L", "TOB1", "IL17RC", "TUT1", "CORIN", "KDM8", "KAT6B", "MAGT1", "ZNF215", "NPC1", "ZFR", "ZNF596", "DDX27", "OCIAD1", "CYHR1", "LYL1", "GANC", "FSTL1", "UBR7", "ZNF616", "MMADHC", "GPAT2", "ZNF611", "SENP8", "ZNF710", "IQCE", "VPS16", "SRFBP1", "HGFAC", "FBRSL1", "MAPRE2", "ENPP7", "ZRANB3", "PVRIG", "ZNF432", "CLIP2", "ZNF43", "ZNF860", "ZNF678", "RBM4B", "GINS4", "ZNF460", "ERCC6L2", "ZNF540", "POP4", "TOR1AIP1", "DLGAP4", "KRR1", "LAMB3", "IL24", "BCL3", "HFE", "RIPK2", "WFS1", "POMT2", "SIPA1", "CDH24", "MLYCD", "BCL2L11", "NID2", "CTSD", "UBA1", "PHF20", "IP6K2", "TP53RK", "PDGFC", "CHST12", "ROCK2", "ITGB6", "ABCB4", "ABCB8", "SPRED2", "CXADR", "MAD2L2", "TGFB1I1", "MRPL11", "DHH", "FOS", "C20orf27", "FOXRED2", "FOXRED1", "RAB5C", "PHF8", "TMBIM4", "KIF3A", "PARD3", "RFC5", "CBX4", "CD247", "MRPS12", "RASAL1", "WNT8A", "SHANK2", "CTBP1", "ITPK1", "MPND", "RARA", "MOGS", "CYP1A1", "SHMT1", "SNRNP70", "POLE2", "RGS16", "NUP98", "ARHGAP28", "UBFD1", "MRPL33", "SAMHD1", "CABP4", "BMF", "CCDC8", "HS3ST1", "ACE", "HHIP", "KPNA7", "TRRAP", "HDLBP", "PRPF6", "CDON", "GNPAT", "BAG3", "MAPK13", "INCENP", "SPECC1", "SUN2", "CARD8", "ARHGEF2", "SLC7A8", "TST", "AP1S1", "XYLT2", "TRPM8", "NDUFAF1", "C4BPA", "CCNF", "KIF18A", "EIF3J", "SMG1", "OPN1SW", "TRAF3IP1", "AHSG", "DNAH1", "SYMPK", "SIGLEC11", "TCF12", "LTB4R", "POLM", "CD101", "NFRKB", "GALT", "OR51A4", "SMC4", "PRPF19", "TRAF5", "ITPA", "SGCA", "TXNDC16", "DENR", "RPP25", "NDUFB3", "P4HB", "TRAP1", "DERL2", "MYL2", "WIZ", "BRPF1", "RAC1", "MRPL28", "RNF139", "CHDH", "MCF2L", "CAMSAP3", "TRIM8", "OR8S1", "TBC1D4", "DDX23", "DDX21", "ENGASE", "GNS", "PLK4", "DTNB", "PKN3", "RNF38", "ADAMTSL2", "ARHGEF10L", "LDLRAP1", "IMP3", "ACIN1", "SNX2", "PML", "ACTL6A", "YLPM1", "DSG2", "RPN1", "LUC7L2", "MCM4", "SQSTM1", "EPC1", "SGPP2", "PPP1R18", "SCARB2", "ERN2", "OR2B2", "SOX13", "EHD2", "EHD1", "UGT1A6", "WNT2B", "PRICKLE2", "VCP", "TTBK2", "CCDC88C", "FMNL2", "ECT2", "NR3C1", "ATP6V1A", "ATP6V1H", "JOSD1", "H1FOO", "HRH1", "VPS37C", "PIGR", "DDX46", "ELAVL4", "ELAVL3", "DNAI2", "CDX4", "RRAGB", "PTPRO", "FIG4", "WASL", "WBP4", "ARHGAP4", "RNF40", "MTMR2", "PHKA2", "TOP3A", "DTX4", "COG2", "NDUFB8", "IWS1", "CNOT3", "STK25", "CCR2", "ATP2B1", "PCK1", "METAP1D", "SIK1", "HIVEP2", "CHSY1", "ARHGAP19", "MYOCD", "PNPLA7", "FOXK1", "PAK6", "CDC42BPB", "RPL7L1", "VDR", "AMOT", "TEX264", "OR52E4", "WNT16", "GCK", "HSCB", "KIF5B", "USP43", "FZD9", "SF3B2", "CWC22", "STX11", "SEMA4D", "ZNF225", "PHF12", "CLDN10", "C1GALT1", "OR13H1", "ST6GALNAC1", "BTBD2", "GLDC", "TYMP", "SLC4A7", "CDYL", "MUTYH", "HPD", "FAM213B", "LETM1", "DAZAP1", "MSLN", "ACADL", "G6PC3", "ATIC", "NR4A2", "UPP1", "TAOK3", "ATG9A", "OGDHL", "NR3C2", "LDHB", "GUK1", "MCMDC2", "ULBP1", "CGB8", "RAD54L2", "NR4A3", "HSPH1", "FAM83B", "PGRMC1", "MAN2C1", "CDCA4", "DSP", "SLC24A4", "UBAP2L", "CELSR2", "TUBD1", "TRAK1", "PPIP5K2", "OVCH1", "PCGF3", "RBM4", "VRK2", "GJB1", "SEPT5", "EIF2B3", "WRAP73", "REXO1", "COL4A3BP", "ING4", "PGA5", "TNPO3", "HPS1", "TPP2", "CCNL1", "CELF4", "PMM2", "CHAF1B", "IVD", "MVD", "FAM186B", "FUK", "C2orf49", "ZNF750", "ZNF155", "ZNF619", "SAFB2", "EWSR1", "NAF1", "RAB40B", "ZKSCAN3", "PMS1", "ZNF764", "ERP44", "HENMT1", "PRMT8", "ZNF419", "ZNF256", "ZNF267", "OR52N5", "HNRNPAB", "DIAPH2", "RBCK1", "MR1", "PARP4", "BRS3", "KCNJ5", "OR6C3", "CCR3", "GIPR", "ZNHIT1", "CDC20B", "CDC5L", "CASP8", "UROD", "ZNF569", "ZNF441", "POLG2", ["TCGA.AA.3489.01", "Cytosolic sulfonation of small molecules"], "DDIT3", "RALBP1", "PATL1", "EOMES", "FBXO15", "CCP110", "ILF3", "PPP1R13L", "ADPGK", "CSNK1G3", "BRSK1", "PHF21A", "RBPJL", "KLHL18", "WDR11", "NMI", "PFN4", "SSX2IP", "TAF4B", "RGS9", "PLCD1", "BCL2L14", "GTF2H1", "ERF", "IGLL5", "CTSO", "SH3KBP1", "DLX1", "CRKL", "HS6ST1", "AMT", "EPHA7", "SIM1", "SPRED3", "TSEN54", "GTF3C2", "COL1A1", "MRPL15", "DENND1B", "CDRT1", "BMS1", "COL17A1", "CHERP", "PKIA", "ZNF420", "LMOD1", "TNFRSF25", "UBE2M", "UBE2O", "ITSN1", "KCNF1", "OR5D14", "XAB2", "ACO2", "ACVR1", "TMEM67", "VPS52", "MEN1", "TADA2B", "DYNC2LI1", "MAT2B", "ACTC1", "KLHL9", "ULK2", "HDAC6", "TRAPPC10", "TSKS", "CERS6", "TFB2M", "GPI", "GABRB1", "OR56A4", "RBMXL3", "PNP", "IL4R", "GADL1", "AKR1B15", "DAZL", "NEUROG1", "MYF5", "TIMM50", "RPA1", "TAOK1", "UNC79", "NEK7", "TBPL1", "SIPA1L2", "CLK3", "KPNA4", "CSPG5", "SEC22C", "EIF4E3", "KMO", "RAP1GAP2", "FAM120A", "PTH", "MECR", "CARD9", "PROKR1", "MAEL", "DHDDS", "PAQR3", "RAD21", "KCTD13", "MLC1", "XYLT1", "DHODH", "NCAPG", "BCAS4", "CCDC74B", "FES", "MAPK8IP1", "RBM12B", "CDC25B", "MCRS1", "CALU", "KCTD5", "UPF3A", "HSD17B10", "CSTF1", "UCHL5", "FOXG1", "PAPSS2", "KLHL20", "GALNT1", "COPB2", "OR10T2", "RDH16", "PFKFB2", "TACC2", "FARSA", "SGCB", "CENPN", "STIP1", "SPAG9", "IL18R1", "FTSJ1", "SCAP", "IKZF1", "UGCG", "ATP2A3", "IFT81", "ATG4D", "API5", "PARD6B", "RFX5", "RNF4", "RNF2", "EPM2A", "KIF2A", "ENSA", "PLK2", "LATS1", "TTLL5", "GCC1", "ARAF", "SHCBP1", "CSNK1E", "DCP1B", "USP13", "VSIG4", "VPS26B", "MTA2", "RGPD3", "TDRD9", "ASCC3", "RPL3L", "CACNG3", "SENP5", "CXCL1", "UBE2A", "SPR", "NT5C2", "ARHGEF12", "VAMP5", "UCK2", "MIDN", "GPR20", "VANGL1", "ASB17", "COL16A1", "ARHGAP30", "NUP210L", "KBTBD6", "PSMC5", "SLIT2", "THRAP3", "RNF168", "ATXN2", "MYBPC3", "NOD1", "GBF1", "IRAK3", "KPNB1", "BACE1", "TNNI2", "SON", "LNX1", "SYDE2", "FGL2", "MLXIP", "MOCS2", "DYRK1A", "SEMA6D", "GLYR1", "ZFYVE9", "CD2", "E4F1", "TNRC6C", "CDH7", "MED20", "SEPT3", "BAHD1", "YTHDC1", "PLEKHG5", "RIT2", "XPNPEP2", "SRSF6", "ZNF326", "PIGA", "MLH3", "CRY1", "DPF3", "NDUFS3", "MICAL2", "DDX41", "OR2A2", "MTHFD2", "ATP6AP2", "TOLLIP", "SYNJ1", "IFIT2", "CCDC12", "BID", "PARK7", "ARF4", "ARGLU1", "NUBP2", "ACVR2B", "ARAP2", "PA2G4", "MIB1", "RIOK2", "MTMR7", "S1PR3", "TNFRSF17", "CDK2", "GPATCH1", "NINL", "IL4", "TLR1", "TLR6", "TLR8", "SYVN1", "MYH14", "BBS12", "SLAMF1", "PCBP2", "TRPC4AP", "GNPDA2", "CDS2", "IDE", "PIK3C3", "ESRP1", "MRPL38", "THOC5", "WIPF1", "ST20-MTHFS", "MSH2", "MSH3", "GPR83", "SMC2", "GPSM2", "DDX3X", "LSM10", "NDUFV3", "CUL7", "C1QA", "PAF1", "BST1", "DSTN", "HSPA6", "MIOS", "SRPK3", "ASB4", "ASB5", "ATG3", "HIP1R", "RGP1", "PHIP", "BANP", "BTBD6", "ACAP1", "CNTN3", "OPA1", "CTRB2", "CYP24A1", "MCAM", "RAD21L1", "NAIF1", "DMBT1", "POTEE", "ANXA5", "LGALS9", "MMP25", "NSUN6", "DIMT1", "TSC22D4", "HJURP", "TMEM126B", "PRLHR", "FOXN4", "CHD2", "COX15", "MBTD1", "XPNPEP1", "RPH3A", "MYCBPAP", "ARSD", "SPAM1", "HUS1B", "SLC12A4", "TBC1D23", "ZNF197", "ZNF324", "ZNF202", "ZNF775", "ZNF496", "ZNF519", "ZNF510", "ZNF33A", "CHMP1A", "RAB40C", "RAB40A", "ZNF133", "ACBD4", "ZNF677", "MAST4", "LHX6", "UGGT2", "LARP7", "GNPTG", "CA10", "WDR55", "ZNF791", "ZNF235", "AIFM3", "ZNF37A", "KATNB1", "ADCK1", "ZNF208", "ZNF431", "ZNF546", "ZNF746", "RBM19", "ZNF584", "ISCA1", "PCDHA2", "AARS2", "ZNF679", "ZNF335", "ZNF70", "ZNF77", "IFT43", "PCM1", "CHKB", "CBX6", "DCLK1", "CXCR5", "LPXN", "MGAT3", "ADAM20", "TRAF2", "DPYSL3", "BMP5", "BCAT1", "CPSF2", "ENPP6", "PPM1K", "CHST1", "RRP1B", "ATOH1", "ING1", "ZNF778", "CARD6", "MYLK4", "TCERG1", "HCLS1", "KRT4", "DFFA", "LPAR1", "FPR1", "FRMD1", "COPA", "SRBD1", "ZNF20", "ZNF614", "PHF14", "CISH", "COPS6", "TRIM55", "ALS2", "SLIT3", "RICTOR", "CHTOP", "DEGS2", "ZNF610", "ZNF75D", "RAPGEF6", "ARHGAP29", "ACTR10", "PIAS1", "MYO1C", "GNAT1", "MON1A", "SF3B1", "INSC", "TOMM22", "RUVBL2", "CRLS1", "SNRPB", "AMY2B", "DLST", "SSBP2", ["TCGA.AA.3660.01", "RA biosynthesis pathway"], "WDR18", "MTX1", "OPRK1", "RGS11", "OR2T12", "CDC25A", "HLA-C", "ICAM3", "EYA2", "KCNIP3", "GCFC2", "EMD", "TNR", "PHLDA1", "RGPD5", "TOPORS", "TSEN15", "GOLGA5", "ZMYND8", "NUDT11", "GLRX3", "CCDC9", "SLTM", "ASPDH", "ZNF492", "NLGN2", "TIAL1", "FUBP3", "ADAM15", "G3BP1", "OR4A47", "SSSCA1", "WDR19", "SLC25A31", "ORM1", "EDC4", "ANAPC1", "CSF1R", "CREB1", "TNK2", "HSPA4L", "EIF4EBP3", "MRPS7", "GAMT", "TRAIP", "FANCC", "AFF4", "NT5C1A", "SCD5", "KIFC3", "RUSC1", "ATF6B", "EPHA4", "EPHA1", "ILVBL", "BAIAP2L1", "KCNV2", "HERC4", "TEAD3", "HK2", "MAPKAPK3", "PDIA5", "TRAPPC9", "KLK1", "IGF2", "FBXL20", "ZNF143", "P2RY11", "L2HGDH", "CRHR2", "CRHR1", "YOD1", "SKI", "ATRN", "SNAPC2", "CGB5", "MRPS15", "UBE2B", "HTR1F", "CPA3", "IL9R", "HNRNPL", "HOXD3", "CDK11A", "EEF1D", "RPL7", "PTF1A", "TAGLN3", "DCLK2", "TTI1", "CXCR4", "ADORA1", "FHL2", "TCTN2", "UBQLN4", "GRB10", "ARNT2", "HDAC2", "CEBPA", "EDN3", "TUBA8", "NUP93", "SRRM2", "KCNK5", "GTF2F1", "CCDC151", "EDIL3", "CCDC58", "ZMIZ1", "MRPL40", "LAGE3", "ACD", "TRH", "PRPF4B", "ZNF385A", "EXOSC9", "IPO4", "PAQR5", "CEP70", "DDX39A", "OR1J2", "UBD", "TNFRSF10C", "MLKL", "PABPC1L", "PTBP1", "RCC1", "RCC2", "ARRB1", "JMY", "ADRA1A", "ADRA1D", "SPP2", "TTC37", "OR10G7", "VPS37A", "GPRC5A", "OR51I2", "TOR1B", "USP35", "C8orf34", "POLI", "PSMD6", "NSFL1C", "COPB1", "TRIM71", "PPP5C", "TPH2", "MAP3K4", "WAS", "VEGFA", "TRIB3", "DHX36", "EZH1", "PRDM1", "CBLL1", "RNF32", "RNF31", "CCDC138", "MAP2K3", "PSMF1", "ASS1", "IFT88", "PPP6R2", "CHD9", "RMI1", "RPGR", "KIF27", "RPRD2", "TAF1B", "MX2", "DBF4", "TBC1D8B", "SREBF1", "EVC", "ETNK2", "MBTPS1", "ATF4", "ATF2", "RRP9", "BAAT", "PDE3B", "BIRC5", "SIGLEC15", "HAUS4", "TNFAIP2", "ARHGEF15", "TNIP3", "NR2C1", "FBXO6", "SIRT6", "NAGS", "FANCD2", "EML4", "HLA-DPB1", "RPP38", "IFT172", "LUC7L3", "GLCE", "PPP1R10", "SLIRP", "RWDD3", "CASP1", "CIITA", "RPTN", "IRAK1", "TNNT2", "XRN2", "XRCC1", "GAL", "GFRA2", "SNX9", "SYDE1", "UGT1A9", "PDIA2", "TNFRSF6B", "RSU1", "CD1E", "GNL3", "SEMA6A", "PRPF31", "FBXL3", "BNIP2", "AKAP10", "GLS2", "IMPDH2", "ARHGEF7", "CDH3", "MED24", "ALDH7A1", "YES1", "ZC3H11A", "BAZ1B", "GOLGA1", "GGCX", "EIF2B4", "SRSF7", "ZER1", "EIF2AK1", "PIGG", "PIGK", "AKAP4", "EIF2A", "PMPCA", "VPS45", "E2F4", "OR5H2", "ACHE", "WDR35", "IRF1", "LCAT", "ARAP3", "PDE9A", "BICD1", "ZSWIM2", "AASS", "TMCO1", "ING2", "MTMR3", "STXBP1", "SETDB1", "MORF4L2", "NHLRC1", "TLR3", "TLR7", "GZMB", "OR6K2", "MAP1LC3C", "SF3A1", "BBS10", "SSNA1", "CNOT6", "EPHB3", "CLDN23", "CSN3", "PCK2", "ST3GAL6", "BCKDHB", "SH3D19", "AP3B1", "IL1RN", "ARHGAP17", "OR2D2", "PACSIN1", "HAL", "OR2L13", "MYO18A", "GYG1", "WDR90", "VPS33B", "MRPS30", "TAF10", "TNIK", "SPATA21", "THBS3", "TOP1", "NOSTRIN", "SLMAP", "USP45", "RPS5", "P2RY13", "SLC1A1", "DUSP8", "HEY2", "SPCS1", "MINK1", "YAP1", "ABCE1", "SCUBE2", "AMN", "RSF1", "HDGF", "ZP4", "ATP5S", "ESCO2", "TCN1", "FNDC3A", "RASSF2", "CRYL1", "EPHX2", "RBM12", "OVGP1", "FLT3LG", "CENPB", "MAK16", "ELOVL6", "GK5", "MCPH1", "PSTK", "ACOT7", "EBP", "AZIN1", "TM7SF2", "ZNF521", "DSCC1", "ZNF526", "NUCKS1", "NT5C1B", "TRUB1", "WDR6", "CAMTA2", "ZNF785", "ZNF701", "PDIA4", "GAL3ST1", "VHLL", "BAG6", "ACAD10", "NIPSNAP1", "ZNF454", "ZNF544", "ZNF425", "DDX50", "ZNF649", "ZNF396", "ZFP30", "HOXB9", "ZNF564", "SPTSSA", "KRT77", "ZNF157", "RAB20", "NTAN1", "TDRD6", "ABCF1", "ZNF100", "ZNF18", "KIN", "COMMD5", "SEC63", "CLDN12", "SLC3A1", "SLC22A7", "RAB6A", "AMH", "ERCC2", "CST3", "ABCG8", "GP1BA", "FNIP2", "ACTR1B", "ZNF541", "PRDX5", "INTS7", "SARS2", "KYNU", "CCDC85A", "ARHGAP36", "MZT1", "AP5S1", "KLRC2", "RAET1L", "MICAL3", "NPHP1", "STIL", "GDF15", "PRSS54", "SPAG6", "WDR61", "SNRPA1", "BHLHE41", "TUBGCP3", "BASP1", "GATA5", "LMF2", "ESCO1", "ZNF212", "DDHD1", "GATC", "TCN2", "ZNF668", "ERI1", "CDK7", "PCSK9", "PRIM1", "THOC6", "AGPAT2", "DCAF13", "IL17F", "CLASP2", "SYN3", "DDOST", "WNT10A", "RPL13A", "FGF21", "RBM15", "CD96", "MAST3", "CLDN5", "PLD4", "MRPS31", "HPS4", "SPTLC1", "PITRM1", "PCMTD1", "LMF1", "FEM1B", "FLII", "ZNF670", "ZNF589", "DNTTIP2", "ZBTB43", "STAU1", "ZNF250", "UBE2Q2", "PDK1", "KDM1B", "SGSM1", "GJC1", "NBN", "FBXO17", "MMS19", "FAIM2", "TYR", "ATXN3L", "ZSCAN10", "PPAT", "HOXA7", "ZNF22", "PPIE", "DCTN5", "ITGB8", "EPHA10", "P2RX6", "UPF1", "KIFAP3", "CSRNP2", "CDH10", "CD55", "NPFFR2", "POLR3D", "HMGCS2", "FEN1", "APAF1", "NMT2", "SCFD2", "CPSF4L", "DARS", "STARD8", "CERS2", "OR13J1", "PREX1", "CNPY3", "AMOTL2", "ASAP1", "CSNK1A1", "RND3", "OR6X1", "HSF1", "HMOX2", "KARS", "PRPF4", "HUS1", "LPAR5", "IPO5", "JUP", "TSEN34", "KCNJ10", "LCP1", "RPRD1A", "EIF3G", "LAT2", "HLA-DMB", "IL10RB", "RARG", "PTPN1", "SDHB", "GRWD1", "OR52I1", "SCTR", "KLHL22", "LPL", "MKS1", "RGS7", "NPR1", "C9orf78", "MYL4", "TSNARE1", "PPRC1", "BMP2", "CAPG", "DBN1", "TACC1", "FBLIM1", "ACTR6", "KHDRBS2", "SYCE1", "GCC2", "CR2", "KCNE4", "TELO2", "PPP2R3B", "FBXW5", "KAT7", "GUCY2C", "KATNA1", "PPP1R8", "FMN1", "HAUS8", "HECTD3", "KHSRP", "ASB16", "DNALI1", "LARS", "MEF2D", "PSMC3", "RCHY1", "PROC", "NOD2", "OR5K2", "LSM1", "DCAF4L1", "CD40LG", "EPS8L2", "TXNDC5", "ALOX15", "SCN2B", "HPCAL4", "CDH5", "FGF23", "LILRA4", "EIF2B5", "CPPED1", "CRY2", "RNF152", "P2RY2", "KBTBD13", "FFAR2", "ERBB3", "SPSB1", "PLEKHO2", "RBBP6", "IRF7", "MAK", "WEE2", "CATSPER3", "CATSPERG", "MTFMT", "OAT", "SEMA3C", "CNOT8", "NUPL2", "TCIRG1", "HIVEP1", "COPE", "WBP11", "SLC18B1", "FKBP8", "HTR3B", "GPR37L1", "EXOC6B", "SHROOM1", "PRPF40A", "USP44", "ADRB3", "PYY", "COMMD4", "IK", "KIR2DL4", "ACER2", "ACER3", "MYH4", "CADM3", "ARID1B", "SPATA5L1", "COCH", "SEC62", "MPHOSPH8", "RAB40AL", "FAM160A2", "ZNF480", "CHD1", "DLL3", "ZNF234", "ZNF500", "ZNF506", "ZNF688", "BAZ1A", "CERK", "NAGK", "HYAL1", "SS18L1", "ANKRD46", "OLAH", "LRRC4C", "ALG12", "SFXN2", "LPCAT4", "IL18RAP", "AGXT", "RAPGEF1", "NPLOC4", "SSBP4", "PSMD11", "ARL1", "FGG", "RUNX2", "LRP6", "PRPH", "CDCA7", "PROK1", "FBXO43", "HECW2", "NIT2", "NUP153", "INPP4B", "ENTPD8", "SNAPC4", "CDH18", "UBE3C", "KIF9", "TTLL12", "ASAP3", "ARHGAP24", "OR2H1", "MBOAT1", "NGF", "OR7G2", "NAT2", "KRT17", "ALDH1L1", "GNG7", "HSF2", "RORC", "TAF6", "TRIM24", "ECM1", "CSF3R", "ARPC4", "EXOSC5", "USP22", "PHF21B", "NEURL1B", "CHRM1", "CIAO1", "GABRG3", "TTC31", "FAF1", "LIN54", "UAP1L1", "NLRP3", "HMGA1", "ACADM", "MAP3K3", "RNASEL", "FLOT2", "INTS8", "LGALS3", "MPI", "CDK15", "OR2G6", "NAPG", "AIP", "TFR2", "PDE10A", "EVL", "OR13C3", "RAPSN", "UBE2F", "TYRP1", "CASP7", "NCF4", "LBP", "TTC21B", "PPARGC1B", "HTR6", "GRHL1", "RBM18", "TGFBR3", "SH2D3C", "RAD23B", "ELF1", "FAM3C", "RALGDS", "ATP6AP1", "RBBP8", "RRAGA", "CD40", "GLYCTK", "SH3PXD2B", "CUL5", "ARHGAP1", "LEF1", "RANBP9", "GLP2R", "SLC12A6", "ORC5", "PPM1J", "ARHGAP15", "SRXN1", "COL13A1", "HSPA12B", "SLC25A6", "MCM3AP", "RBL2", "STUB1", "GIPC1", "NFIX", "RPL18A", "COX6C", "PINK1", "MFN2", "XPO7", "BMP4", "RPL23A", "YARS", "VPS4A", "TRIM7", "C8G", "MAB21L2", "CALB2", "OXSM", "ULK3", "PMM1", "NOP2", "JMJD6", "DCAF12", "DHX32", "WRAP53", "ANKHD1-EIF4EBP3", "NKX2-1", "TNFRSF18", "BBS2", "HSPB8", "EIF5", "TCOF1", "SERPINB6", "SREK1", "TRAPPC3", "RCE1", "UTP14A", "PGS1", "MEPCE", "SYS1", "NOP58", "SEC31B", "AP3S2", "BLOC1S2", "ERC2", "LGR6", "GABRA4", "ATXN7L2", "TPBG", "MTRF1L", "MRPL3", "TNPO2", "MTCH1", "DEFB136", "FSTL3", "NVL", "LENG8", "DDX10", "OMD", "PIGM", "KCNA6", "DCAF4L2", "GCNT3", "MOB2", "ZNF592", "IDUA", "ARRDC1", "FUT8", "CLCA1", "CLCNKB", "LRWD1", "RNF128", "ACSM2A", "CFHR1", "IFNA14", "UVRAG", "HPS3", "TNFAIP1", "BATF", "A4GALT", "SWI5", "PSG1", "CDK9", "LPCAT1", "SRD5A1", "PSMB5", "SORBS1", "UNC5B", "BOC", "WDR1", "CCNA2", "DYNC1I2", "WNT10B", "XRCC5", "OR8J1", "ZNF653", "NFYA", "CTRB1", "OR5B3", "WWP2", "PDP2", "NUDC", "NDUFA4", "AHI1", "SNCAIP", "HERC3", "C8A", "TEAD4", "UTS2R", "DROSHA", "PSMG4", "KLK4", "COPS3", "EGR2", "PPP1R14A", "MAPK8", "TCL1A", "ERCC1", "MRPS11", "SSR2", "HNRNPK", "DCAF6", "PRR5", "PCP2", "GSC", "TCTN1", "GRB14", "HDAC4", "CERS5", "MAN2A1", "VANGL2", "TAP2", "RRP7A", "PFDN2", "RIPK4", "FBXO30", "MRPL48", "ZP1", "CPD", "KRT10", "GABRD", "ATP6V0D2", "SFI1", "CALML4", "BAG2", "FZD8", "EXOSC3", "DDX1", "PPEF1", "NPAS2", "NPAS1", "SNTG1", "OR14A16", "BMP10", "PIAS3", "EIF3I", "EIF3D", "NOL11", "ARFGAP1", "RNF149", "ANXA6", "DDX56", "DTNBP1", "NLRP1", "GIT2", "ELL3", "OR4X1", "SETD3", "DZIP3", "RBFOX2", "DGKE", "FLOT1", "RAVER1", "DCLRE1A", "INTS9", "RASSF6", "PMVK", "ACAT2", "CDK16", "B3GNT4", "OR2G2", "SHH", "DLL4", "PLK3", "TRIM46", "ACVRL1", "GABPA", "RAB24", "LEFTY2", "PPP1R7", "PSIP1", "UFC1", "CYLD", "PLXNB1", "SIRT3", "SNX4", "CNN2", "EIF5B", "XCL2", "XCL1", "TAS2R14", "SULT1A2", "MEF2C", "ARHGAP31", "PIBF1", "TKTL2", "VPS41", "PACS1", "FDXR", "MRPL55", "CRISP2", "SUZ12", "IFT74", "PRMT7", "SPSB4", "CELF1", "SMARCAL1", "ACTG1", "NPPC", "TDRD12", "USP25", "HTR4", "AKT1S1", "DTL", "COX4I1", "RETSAT", "ZMAT2", "SF3B4", "HNF4G", "E2F3", "IL12RB2", "WDR31", "ZBTB16", "TAF6L", "DAO", "BBS1", "CUL2", "ARHGAP9", "ICOSLG", "IDO1", "OR2AT4", "TAB1", "GLA", "MUL1", "CCDC92", "TFE3", "UBXN7", "POGLUT1", "IAPP", "MYH10", "RUNX1", "CSPG4", "CREB3L4", "GINS2", "DDX17", "PIM1", "METTL3", "SMC6", "CLVS2", "GPHN", "SART3", "CYC1", "ASB2", "SAG", "USP47", "RPS3", "POLR2D", "LPIN1", "SEMA4A", "PNLIPRP3", "TMOD1", "CLDN19", "IFNA10", "HPSE", "OR10H4", "USP7", "PTH1R", "SLC7A10", "GLRB", "HELQ", "GSTZ1", "IL33", "TDO2", "TNIP1", "SUGP2", "HTR3C", "AANAT", "BRD9", "FAM91A1", "ZNF655", "FXR2", "TMPO", "ZNF532", "PIN4", "PUS7", "ZNF692", "ASCC2", "ZNF30", "NFIL3", "PDE12", "NPHP3", "ZNF689", "TOR1AIP2", "LDB2", "ZNF71", "GMPPA", "PIGB", "PGM3", "FAM98A", "BSND", "SLC19A3", "LIMS1", "SNTB2", "PGAM2", "MSH6", "CHCHD3", "PWP1", "SAMD8", "ASIC1", "ITGA2B", "KIAA1522", "UBE2L3", "ADRA2A", "SMPD3", "DPYSL2", "CDC34", "VPS28", "CDC42EP2", "MTM1", "IFT46", "CRCP", "GPBAR1", "FMR1", "HIST1H1C", "PRTN3", "CTSW", "GPR68", "DYNLT3", "IST1", "TRAPPC2", "ERRFI1", "NANOG", "CCL17", "RPS28", "SNX32", "MYOG", "HNRNPR", "CAMK2A", "MKRN1", "EME1", "TUBB4B", "OTC", "MAN1A1", "NLRC4", "XPC", "OR2H2", "KRT5", "IMPACT", "ROR2", "LIMS2", "MAEA", "GRM3", "PIK3C2G", "GPR45", "PUF60", "GEMIN4", "ASAH2", "NCAPH", "CD8A", "LIMK1", "PDGFD", "CIB2", "PTPN2", "GEMIN7", "EIF3L", "BARD1", "HNRNPH2", "DCAF11", "CREB5", "GALNT2", "PSEN2", "POLR1D", "ELL2", "MTHFD2L", "NCK2", "INTS2", "PLAA", "ATG4B", "DNAJA1", "IL6R", "NMNAT1", "WT1", "TPX2", "CDKN1A", "KIF2C", "CPB1", "TPM3", "SNRNP27", "ROBO4", "VAMP2", "MID1", "SFXN3", "PLD3", "CEP152", "MED13L", "TMF1", "CASP5", "LSM4", "NDST4", "NUP155", "PRMT1", "CD209", "IL22RA1", "AGMAT", "ACTG2", "NPM1", "FMNL1", "PKDCC", "GJA4", "SUGP1", "CLTB", "FGF2", "IRF8", "PANX1", "IDH3B", "TNFSF13B", "GAPDHS", "BBS9", "CATSPERB", "ING3", "DGUOK", "ZCCHC12", "OR6K6", "CCNT1", "DQX1", "ZMPSTE24", "SOCS5", "UBA7", "GTF2E1", "PACSIN3", "HIST2H2AC", "ERLEC1", "CNTRL", "SMC3", "PELI3", "PRPF40B", "ULBP2", "ULBP3", "ANO6", "RCVRN", "BZW2", "SEPT10", "CAPN9", "HPS5", "RMI2", "CLEC4D", "PSAT1", "ALKBH8", "COX10", "PEX5", "COX6B1", "DDR1", "BACE2", "RAI1", "BOK", "PDIA6", "RCOR3", "FOXD3", "SLC9A7", "RUFY3", "TRPV3", "TPRN", "RTCA", "SLC5A6", "PEX10", "TOP1MT", "DUOX2", "ZNF486", "ZNF583", "NAA16", "ZNF585B", "ZNF586", "ZNF445", "ZNF600", "FLAD1", "DSE", "F12", "ZC3H4", "FLT3", "GSDMD", "EPOR", "OR11A1", "TADA1", "CABP7", "CHRM3", "MFAP5", "RAB13", "HMGCR", "PRICKLE1", "TPK1", "SDR9C7", "ZNF571", "POLB", "NOL9", "RAB17", "CFB", "ZNF114", "OIP5", "SEC61A1", "H2AFY2", "HIRA", "GDI2", "RPTOR", "SLC17A8", "EAF2", "ADIPOR1", "SUPT5H", "KNTC1", "MKNK1", "TUBG2", "CHRNA3", "CDCA8", "FDFT1", "SIAH1", "ZDHHC21", "EGF", "RPL3", "SLC25A5", "OR5H14", "PDE2A", "RAD51C", "RABGGTA", "MZT2A", "CNTF", "RCL1", "TFAP2D", "MRPL49", "CLPX", "B4GALT1", "AGPAT3", "NUP43", "RAPGEF4", "EXOSC1", "NAT10", "PSMA6", "PIF1", "EIF3M", "RNF146", "PFAS", "JMJD1C", "OR4M1", "HNRNPUL1", "RANBP10", "XPO1", "TBL3", "RASGRF1", "MAP3K2", "SETD7", "SGCG", "SGCE", "DHX38", "TRIB1", "PGGT1B", "EPHB2", "GRPR", "RNF138", "HIST2H2BF", "OR1D2", "IFI6", "NSUN2", "EFTUD2", "KIAA0930", "UBAC1", "GEN1", "MED10", "MLEC", "NCBP1", "CDC40", "PRKAB2", "MED8", "TPD52", "HEATR1", "SIK2", "DIABLO", "OR52H1", "AACS", "ZRANB1", "IRF9", "RDX", "CUL3", "MRPL9", "TSTA3", "RNPEP", "FAU", "PCBP1", "TAF8", "DVL1", "EXOC3L4", "DHCR7", "CHEK1", "ATF7IP", "FKBP4", "VSIG2", "CD74", "OR5M1", "PES1", "VASN", "RPS2", "PAN2", "FBL", "STYK1", "NFIB", "CNGB3", "NIT1", "PHF7", "CMTM3", "CLK2", "OXNAD1", "DBI", "NR2F6", "FOLH1", "TREM1", "SSBP3", "PGD", "SIGMAR1", "COX7A2", "ACOT1", "IP6K3", "TRAK2", "SLC37A1", "GALNS", "COQ5", "ZFPM2", "HARS", "ZNF786", "BDH1", "RHBDF2", "XPO5", "UEVLD", "DDX25", "ZNF528", "SNX8", "TLX3", "VPS18", "GOLGA3", "TYW3", "NOC3L", "EXTL3", "HERC5", "ABCG2", "PGM1", "CDC27", "ASB14", "RHOU", "EFEMP1", "CRAT", ["TCGA.AD.6965.01", "RA biosynthesis pathway"], "ZNF599", "ZNF517", "ZNF667", "SLC18A2", "OR6V1", "OR2T34", "SKA1", "ZW10", "TCTEX1D1", "ACTR3B", "OR13G1", "CLEC1B", "TRIM6", "NCOA5", "NCR2", "CFLAR", "IGLL1", "ZFP36L1", "UBA2", "USP16", "INPP1", "NRP1", "KIFC1", "HACE1", "GFRA3", "RNASEH2A", "TAAR2", "HERC6", "CHRNA7", "CDCA5", "SFRP2", "SFRP4", "TAS2R20", "IL11", "MS4A2", "OR2F2", "RNF8", "GABRR1", "HSD17B4", "SSR1", "APOC3", "CDH15", "NPHS2", "OR5D16", "AHCTF1", "RPS6KB2", "OTUB1", "TAS2R50", "OR2L2", "OR2V2", "OR14C36", "ZBP1", "UTP6", "OR10J3", "NSL1", "IGFBP1", "RHPN2", "NUP160", "GTF2F2", "PITPNA", "HTR2A", "OR8H3", "ELL", "B4GALT7", "OR4B1", "KIF4A", "DEFB108B", "EPX", "GABPB1", "F13A1", "MMP7", "REV1", "CD80", "CD86", "MAVS", "GRK4", "OR2AE1", "PIAS2", "AP4M1", "IFNE", "OR10G3", "INPP5A", "INPP5E", "RAB7A", "POLK", "UPF3B", "GHRL", "OR6B1", "OR52A1", "MICB", "ARSH", "SH3GL2", "DCLRE1B", "ITIH4", "MYL9", "SFTPC", "GORASP1", "OR5M10", "UBE2Q1", "HLA-DPA1", "CHD1L", "NMB", "TAX1BP1", "PIKFYVE", "C1D", "ACTR5", "COPZ1", "KIF25", "YY1", "TLR10", "ERLIN1", "CCNE2", "OR7A10", "OR7A17", "GANAB", "STX10", "FBXW9", "CACNB2", "OR51D1", "FBXO7", "TNIP2", "EFNA1", "OR52W1", "OR6Q1", "LILRB4", "PQBP1", "RFXANK", "DEPTOR", "IL17RD", "REPS2", "DAPP1", "IL5RA", "TNFSF14", "LAMC1", "NCF2", "OR2S2", "ELMO2", "OR5K4", "NOXO1", "NDST3", "OR8A1", "TMEM173", "GPR55", "LRP8", "SEPT6", "TGOLN2", "CD4", "BTN3A1", "HRH3", "PFKFB1", "TAS2R31", "PRKAG3", "OR9G4", "IFITM3", "IFITM2", "OR3A2", "IRF2", "CUL1", "FCER2", "RNF41", "CDK4", "DTX2", "OR6K3", "TMEM38B", "TNFRSF14", "COG1", "CACNG1", "UTS2", "CD3EAP", "EHHADH", "TMEM115", "POP1", "PILRA", "F5", "OR51M1", "OR52E2", "OR52E8", "CEP89", "CYP4F2", "TRIM34", "STX16", "OR2T8", "OR2T1", "OR51E2", "IFNA17", "GBP3", "TMOD4", "DLGAP5", "FLRT3", "ARL13B", "PSMG2", "KLHL8", "MBOAT2", "NEK9", "TAF4", "TAF9", "IDH3G", "ARL6IP4", "ECD", "GEMIN8", "GEMIN6", "GEMIN5", "ETFB", "SSPN", "APPBP2", "TTC4", "ATG16L1", "DDX20", "NUDT12", "FBXO8", "DHX58", "ABCC6", "MYBL2", "PIGP", "PEX19", "FGFBP2", "PNPLA3", "MCM9", "RCAN3", "COMMD2", "CEACAM1", "TNFRSF21", "SRA1", "CPT2", "ANGPTL4", "POU1F1", "METTL17", "MRPS35", "SFTPA2", "SLC7A9", "TAF7L", "TAT", "MRPS17", "HPX", "TK2", "PMS2", "SPINT2", "CLEC2D", "ENG", "HMG20A", "CD200R1", "GMNC", "GTPBP4", "TIPIN", "TTLL1", "EPSTI1", "STAG3", "TIMELESS", "NSMCE1", "AIFM2", "MRPL53", "AP4S1", "BBS4", "SIM2", "C7", "CLDN16", "MTR", "N6AMT1", "PDPR", "MRPL13", "SNCG", "GPN1", "NIF3L1", "GLG1", "GART", "ARL2BP", "MAN1A2", "MAN2A2", "PHOSPHO1", "PYGM", "TMEM214", "NUP62CL", "GALNT7", "ZNF687", "KANSL2", "MPP4", "MRPL23", "PCGF1", "HHAT", "C1GALT1C1", "EEF1B2", "OLFM2", "PROZ", "MDH2", "PDLIM1", "PRMT6", "DHDH", "KREMEN1", "IMMT", "GCLM", "NAPSA", "ME2", "SCARA5", "DIS3L2", "UTP23", "CCDC91", "MIP", "PABPC4", "GSTK1", "MRPL30", "POU2F3", "SDR16C5", "WDSUB1", "RAB36", "PDCD6IP", "GM2A", "ST6GALNAC3", "DDO", "TIA1", "VARS2", "SEL1L2", "SI", "GLRX5", "LIAS", "CNTD2", "GTF2A1L", "CUEDC2", "ACADVL", "DLG5", "PMPCB", "PRPS1L1", "S100P", "HTR3D", "ATP7B", "RNASET2", "ZNF214", "ZNF415", "POC1B", "CDK2AP1", "PSG3", "ZIM3", "ZNF664", "ZNF154", "IL1RL1", "ZNF624", "ZNF549", "ZNF382", "ZNF470", "ALAD", "NLRP8", "ZNF773", "ZNF556", "ZNF169", "ZNF804B", "BIVM", "ZNF264", "APIP", "KRT71", "ZNF3", "ZNF615", "ZNF552", "NDUFC2-KCTD14", "CHTF18", "NUDT7", "LARS2", "ZNF669", "CHAMP1", "NEXN", "ZNF19", "HLX", "LYRM4", "IL36G", "ZFP28", "UBAP2", "TRMT6", "YARS2", "NOP10", "MTMR12", "LSG1", "ZNF354B", "DPCD", "POC1B-GALNT4", "ZNF443", "TMEM43", "ZNF774", "BDH2", "AMACR", "SLC10A2", "SURF6", "ARSK", "SNX7", "OGG1", "FUCA1", "CYB5R3", "C21orf2", "MBD4", "PSG9", "ITLN2", "FBXL19", "PSMB7", "CHMP4C", "PDE11A", "PPT1", "IL27", "CTLA4", "SERPINB5", "PSMD13", "NUP62", "OR8B4", "LYZ", "FGF6", "FGF5", "SIRPA", "FAHD1", "KLK3", "IL1A", "AGXT2", "ENTPD6", "BUD13", "PLIN2", "NODAL", "BSCL2", "MCAT", "HSD17B12", "GPR15", "OR5AU1", "TRIM48", "NACA2", "APOH", "CABP5", "ALDH1L2", "VAPA", "CDO1", "TRIM22", "MAPK15", "AK8", "MC5R", "STARD13", "USP39", "OR5AK2", "RAD1", "IL10RA", "MSH4", "MMP14", "DDX58", "OR1L1", "ACADS", "ZWILCH", "IL23R", "SOD2", "NPS", "NDC80", "MZF1", "OR5B2", "FANCF", "CEP57", "NMS", "HLA-DRB5", "OR52J3", "MTHFR", "ERLIN2", "OXCT1", "MTAP", "OR52B6", "CAMK1G", "PRODH", "ATF5", "SAMM50", "RRP8", "IARS", "HECTD2", "TAS2R7", "CBLC", "LILRB1", "GFAP", "PJA2", "SESN3", "UMPS", "APLF", "P4HA3", "SPRY2", "HYAL3", "IFNAR2", "OR4K15", "XAF1", "ARHGEF4", "NFE2L2", "CDA", "KDM3A", "MEP1B", "TAS2R38", "SRPRB", "DNMT3L", "OR4N4", "DMP1", "ISG15", "CCNG1", "OR6C6", "CLIP1", "OR4Q3", "CCR8", "TDGF1", "CHEK2", "TRIM31", "OR7D4", "SRP72", "TAPBP", "ADRB1", "OR2T2", "CWF19L1", "GBP2", "GBP7", "GBP4", "APLP2", "RAB6C", "LGMN", "LCLAT1", "HLA-DQA1", "MRPL10", "PCMT1", "KXD1", "DFFB", "MRPL47", "TULP3", "USP17L2", "SULT1C3", "ZFAND2B", "NKD2", "MRC2", "ILKAP", "DDX24", "TMEM123", "LEFTY1", "BIRC7", "IMP4", "VPREB1", "DSG1", "MRPL52", "UNC13A", "NBR1", "KLRC4", "MRPS27", "CCDC114", "MBL2", "RAET1G", "CCNG2", "GAS8", "SNAP47", "ZNF24", "GLIPR1L2", "MRPL35", "FYTTD1", "SYT10", "KIR2DL1", "PARVB", "TNFRSF11B", "MYO5B", "TPSAB1", "VPREB3", "DEGS1", "CRTAM", "DSC2", "CPA4", "NAIP", "APPL2", "B4GALT4", "LCA5L", "PRELP", "KBTBD12", "ZNF574", "CEBPZ", "SGTA", "RRP1", "ATP7A", "LHX4", "NIN", "MGMT", "ZNF471", "ZNF839", "ZNF665", "PPIG", "ALKBH3", "ZNF141", "PRAME", "MAN2B2", "CPOX", "NLRP2", "PLA2R1", "ZNF485", "ZNF563", "ZNF641", "B3GALNT1", "ZNF559", "ZNF790", "DUSP11", "ZNF468", "DCBLD2", "ZNF195", "ZNF99", "ZNF440", "ZNF224", "RAI14", "TMPRSS4", "EMILIN3", "FERMT1", "THUMPD3", "UBXN6", "TNKS2", "GC", "LTA4H", "MBD3L1", "LRRTM2", "CLEC4C", "TSPYL2", "ZFP14", "SYT7", "SLC9A3R2", "EPB41L2", "WNT3", "WWOX", "GRK5", "TUBA1A", "MYLK2", "TRIM2", "TXN2", "PPIB", "OS9", "FGR", "NPY1R", "TTC12", "MRPL16", "SIAH2", "TRADD", "NAPB", "PLIN3", "UBQLN1", "IGFBP2", "ARHGAP25", "MYOD1", "UBE2D2", "APPL1", "HTR2B", "TJAP1", "RGS19", "BCL2L2-PABPN1", "ZBED1", "ATP6V1C2", "INPP5J", "SPINT1", "ACAD9", "POLE4", "DGKQ", "PLA2G15", "SP3", "FBXL13", "NOC4L", "PPWD1", "UBE2K", "MYD88", "SNX18", "ESPN", "MFAP4", "SPRY4", "CASP2", "HES1", "HIST1H2AC", "FBXL2", "TNFRSF13C", "PRKAG2", "ELAVL1", "MRPL2", "CD79B", "BRMS1", "ACE2", "MCM2", "MRPS34", "NDUFV1", "C1QC", "MARCKSL1", "VDAC1", "RPL10L", "IP6K1", "RNF125", "ENTPD5", "NARFL", "GCKR", "AKR1C1", "NRBF2", "PATZ1", "CDC7", "TMEM17", "CCS", "ATAD2B", "UAP1", "MSRA", "BHMT2", "APEH", "SLC25A10", "TRMT61A", "OXSR1", "NGDN", "CLCA2", "TONSL", "TADA3", "SRPK1", "EFNB1", "NCKAP5L", "TUBA1C", "JAM2", "RSL1D1", "DNAJA2", "CD1A", "MC1R", "DBR1", "CDK20", "ILF2", "OSBP", "TARSL2", "PPM1L", "ZNF606", "PCID2", "ANAPC2", "EXOSC10", "THRA", "MRPS5", "HOXA2", "INTS10", "RBM28", "ARL6", "FXN", "VTI1A", "ERCC4", "CTTNBP2NL", "F2RL2", "STX8", "HDAC11", "GTSE1", "PNOC", "CITED2", "RNF19A", "DEK", "TBPL2", "TFIP11", "LPAR2", "TIMP3", "FGF18", "SMU1", "BIN1", "ARID3A", "HS3ST3B1", "POU5F1", "PPP1R12C", "POLN", "KIF12", "WDR20", "POLR1B", "SH3GL3", "KDM5D", "TSFM", "PRKAA1", "ASPSCR1", "KCNIP2", "CXCL3", "CXCL5", "CXCL9", "SEMA5A", "MED18", "PSMC1", "MARCH6", "MCM5", "HYAL2", "IPCEF1", "CTHRC1", "OR6C76", "INHBB", "EIF2AK2", "GUCA1C", "OAS3", "BICD2", "SMARCA5", "CXCL12", "CDK5", "PPIL4", "SYK", "HNRNPA2B1", "PPP4C", "FBXO27", "NDUFB10", "SCN4B", "TRIM72", "GCNT1", "XRCC4", "IGSF8", "MAOB", "ZP3", "RNF216", "GPD1", "LGI3", "GPD1L", "CASP4", "UGT1A3", "ACOT4", "FAH", "AMDHD1", "HACL1", "HADHA", "ACOT8", "HIBCH", "RBMX2", "ZKSCAN5", "ALCAM", "ANGEL1", "GHITM", "P2RX3", "TOP3B", "ZNF416", "TREH", "ZNF620", "ERAL1", "ZNF567", "STT3B", "ACTL8", "PEX13", "ZNF573", "SSBP1", "SLC37A2", "CLCNKA", "ALG1", "CELSR3", "CPEB2", "SORBS3", "KCNA7", "KISS1", "NFATC2IP", "CTDP1", "XPO4", "RNF135", "SEPT8", "DUSP5", "HAT1", "HIST2H3D", "ZNF747", "THAP9", "NPTX1", "ADAM11", "SKA3", "DDI2", "DDI1", "ELP4", "EHMT1", "CYTH4", "AKR7A2", "SLC38A1", "OR4D1", "RBM25", "MRPL17", "WNT4", "APBB1", "RNMT", "RASAL2", "CALB1", "CCAR1", "DAPK2", "RAD51AP1", "PLAU", "GGPS1", "CCDC59", "MRPL46", "RAB3IL1", "TARBP2", "TNFRSF10B", "OR10G8", "NCS1", "RRM2B", "SLC27A1", "SLC27A2", "SGCD", "IDH3A", "MYO9A", "DERL3", "ETV7", "UBR1", "BCAT2", "KCNIP1", "CTNNAL1", "CD2BP2", "PSMD9", "SIGLEC10", "VAMP8", "SNAP25", "DIRAS2", "FOXR1", "ATG13", "CRTC3", "SNRPN", "STX18", "E2F5", "ARFGAP2", "ZEB1", "CLDN6", "CLEC3B", "ARF1", "TSPO", "RPF1", "EBNA1BP2", "SUCLG2", "TMOD3", "CD2AP", "GNGT1", "PSMG3", "NDUFB6", "HMGXB4", "ACOT2", "C11orf54", "MBOAT7", "B3GNT8", "MAD2L1BP", "NMRK1", "NFKBIL1", "RECQL", "ACTL7A", "MYO1B", "ZNF490", "NEIL1", "DDX31", "PLS1", "ZNF749", "ZNF671", "ZNF446", "BOLL", ["TCGA.AZ.4681.01", "G beta:gamma signalling through BTK"], ["TCGA.AZ.4681.01", "Adrenaline,noradrenaline inhibits insulin secretion"], ["TCGA.AZ.4681.01", "tRNA modification in the nucleus and cytosol"], ["TCGA.AZ.4681.01", "ADP signalling through P2Y purinoceptor 12"], ["TCGA.AZ.4681.01", "Prostacyclin signalling through prostacyclin receptor"], ["TCGA.AZ.4681.01", "Glucagon-type ligand receptors"], ["TCGA.AZ.4681.01", "G beta:gamma signalling through PLC beta"], ["TCGA.AZ.4681.01", "Thromboxane signalling through TP receptor"], ["TCGA.AZ.4681.01", "Presynaptic function of Kainate receptors"], ["TCGA.AZ.4681.01", "G-protein activation"], ["TCGA.AZ.4681.01", "Activation of G protein gated Potassium channels"], ["TCGA.AZ.4681.01", "G protein gated Potassium channels"], ["TCGA.AZ.4681.01", "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"], ["TCGA.AZ.4681.01", "GABA receptor activation"], ["TCGA.AZ.4681.01", "GABA B receptor activation"], ["TCGA.AZ.4681.01", "Activation of GABAB receptors"], "DCT", "NCAPG2", "PDCD7", "ESRP2", "HAO1", "KRT6A", "MGAT4B", ["TCGA.AZ.4682.01", "Heme degradation"], "ANP32B", "RPRD1B", "LAMTOR2", ["TCGA.AZ.5403.01", "Classical antibody-mediated complement activation"], "SLC7A6", "CABP1", "VPS54", "UTP18", "ZNF550", "CCNB2", "PEX11G", "ARTN", "SYT2", "ARHGAP40", "ELP3", "MARK4", "TIRAP", "NFYB", "THRB", "MOS", "IDI1", "SLC25A13", "PENK", "PYGO2", "ARL2", "STIM1", "RELA", "NTF3", "EFHD2", "ISL1", "MAPK7", "MAPK9", "WNT7A", "FCHO2", "DRD2", "APBB3", "MRPS10", "MBP", "NPBWR1", "ADAM8", "HSPA14", "OR9A4", "AQP2", "PSMD5", "ATP6V0A1", "PYCARD", "OR7G3", "FNIP1", "CALML6", "MYL12B", "ARPC5", "C3AR1", "BCKDK", "EXOSC4", "PAOX", "TXNL4A", "NUP85", "MXD4", "CCNY", "MMP13", "BANF1", "HNRNPH3", "HNRNPUL2", "PAIP1", "DCAF17", "MAP4K1", "CD226", "NOLC1", "CD36", "POLR1E", "CENPK", "OR5M11", "MPG", "BRF2", "RNF5", "LEMD3", "RPL19", "IGFBP6", "S100A8", "COPG1", "GTPBP2", "CEP97", "FSCN1", "VIPR1", "HCST", "CACNG4", "SEPSECS", "UBE2H", "CAT", "VAMP4", "KCNMB3", "APTX", "STK39", "FOPNL", "NCBP2", "DLD", "LIMA1", "NCF1", "C4A", "WDR60", "HGS", "SEC23A", "H1FX", "PNPT1", "LMAN2", "LIPC", "VTA1", "MED21", "TRAPPC1", "ZMAT5", "NDRG3", "PIGS", "AKAP8", "CETN1", "RNF150", "TXLNG", "HYI", "DDX19A", "FOSL2", "TRIM68", "STXBP4", "S1PR5", "EID3", "FOSB", "SPDYC", "EXOC3L1", "CCR9", "NUP88", "RMND5A", "NOXA1", "PMP22", "ARL8B", "POU2F1", "L3MBTL2", "IFNGR1", "TRIM35", "NOMO1", "NSMCE4A", "DUSP3", "TNNC1", "PHF10", "CAPN3", "PRDM15", "FAM13B", "COX5B", "NDUFB5", "FBLN5", "ATXN7L3", "NDUFS4", "KDM4D", "GDF7", "CHST4", "LRP2BP", "B3GNT2", "SERPINF1", "C1orf122", "SIAH3", "ST6GALNAC6", "POC1A", "SCLY", "WDR73", "RPE", "WRB", "ZNF394", "RCN2", "TCEAL4", "ZBTB2", "ZNF418", "ZNF597", "PEX7", "FPGS", "ZNF776", "RPH3AL", "ZNF226", "ADPRHL2", "ZNF354C", "BTD", "UROC1", "CD6", "TP53I3", "STRAP", "BAP1", "VHL", "HIST1H4B", "DYNC1LI1", "FOXH1", "HIST1H3D", "SDHD", "STK38", "HIST1H2BJ", "ARPC1B", "UQCRC1", "SNX22", "CKMT2", "CFDP1", "RRP15", "CLCA4", "GTF3C5", "CIR1", "HAGHL", "ZNF136", "IL18BP", "MIF4GD", "ITGAE", "TESC", "OR2C3", "RAB6B", "MARK2", "TRIM3", "GTF2H4", "PLA2G12B", "ABCB6", "PFKL", "TMEM209", "HOXD1", "NUDT19", "OR2M5", "GNA15", "FBXO31", "LGALS3BP", "PISD", "WDR74", "ETS2", "TNFRSF10D", "PSMA5", "NCKAP1", "INVS", "CNST", "GNB5", "MICU1", "RDH13", "MAFK", "DGKG", "SP1", "MMP24", "PTK6", "BIRC3", "GNG11", "SMURF2", "MAGED1", "COX18", "FBXW8", "GAPDH", "TGFBRAP1", "SNRNP25", "REL", "TNFSF11", "FOLR2", "BGLAP", "RRP36", "RNPS1", "ERN1", "RAB1A", "QARS", "FGF22", "CRTC2", "AGTR2", "IFNA8", "RNF14", "IPO13", "KSR2", "P2RY1", "RPS10", "WDR34", "TLE3", "TLE4", "TP63", "RAB11FIP3", "SEMA3G", "GTF2E2", "AIM2", "PARVG", "CNOT10", "MYL10", "NUTF2", "SRGN", "AHCYL1", "GNMT", "ACO1", "NMRAL1", "NFS1", "CCNI", "DMWD", "ACAD8", "CD63", "SIGLEC14", "CORO1B", "INTU", "DDA1", "ANKZF1", "HSD11B2", "ARSA", "HGD", "ZNF317", "STARD5", "NTN3", "CNBP", "CLPS", "GREM2", "PLP2", "C19orf47", "LRRFIP2", "ZNF681", "NOBOX", "ZNF248", "ZNF704", "LMCD1", "TUBB3", "ZNF257", "CDK5RAP1", ["TCGA.AZ.6603.01", "RA biosynthesis pathway"], "CXCR1", "KCNE1", "AICDA", "CSE1L", "THOC2", "HNRNPA3", "PIN1", "SPOPL", "FFAR3", "TSN", "ZNF189", "ZNF439", "MARS", ["TCGA.CA.6717.01", "SRBD1"], ["TCGA.CA.6717.01", "FAM91A1"], ["TCGA.CA.6717.01", "ATP7B"], ["TCGA.CA.6717.01", "GPR149"], ["TCGA.CA.6717.01", "ALG8"], ["TCGA.CA.6717.01", "ALG2"], ["TCGA.CA.6717.01", "ALG6"], ["TCGA.CA.6717.01", "RTN3"], ["TCGA.CA.6717.01", "FAT4"], ["TCGA.CA.6717.01", "CEP55"], ["TCGA.CA.6717.01", "EMB"], ["TCGA.CA.6717.01", "ZFR"], ["TCGA.CA.6717.01", "GLRB"], ["TCGA.CA.6717.01", "SLC4A7"], ["TCGA.CA.6717.01", "ANTXR1"], ["TCGA.CA.6717.01", "ANTXR2"], ["TCGA.CA.6717.01", "SIRPG"], ["TCGA.CA.6717.01", "ZFR2"], ["TCGA.CA.6717.01", "DENND1B"], ["TCGA.CA.6717.01", "PCDH15"], ["TCGA.CA.6717.01", "KRT6A"], ["TCGA.CA.6717.01", "DSC2"], ["TCGA.CA.6717.01", "TARDBP"], ["TCGA.CA.6717.01", "CCNDBP1"], ["TCGA.CA.6717.01", "IL1RL1"], ["TCGA.CA.6717.01", "IL1RL2"], ["TCGA.CA.6717.01", "TRPM6"], ["TCGA.CA.6717.01", "ABT1"], ["TCGA.CA.6717.01", "PLXNC1"], ["TCGA.CA.6717.01", "EXTL1"], ["TCGA.CA.6717.01", "EXTL2"], ["TCGA.CA.6717.01", "EDA2R"], ["TCGA.CA.6717.01", "KCNK2"], ["TCGA.CA.6717.01", "EIF5A2"], ["TCGA.CA.6717.01", "PTPRZ1"], ["TCGA.CA.6717.01", "DMBT1"], ["TCGA.CA.6717.01", "MGAT5B"], ["TCGA.CA.6717.01", "GREB1L"], ["TCGA.CA.6717.01", "GXYLT2"], ["TCGA.CA.6717.01", "MGAT5"], ["TCGA.CA.6717.01", "CLCA1"], ["TCGA.CA.6717.01", "CLCA4"], ["TCGA.CA.6717.01", "TRPM7"], ["TCGA.CA.6717.01", "HARS2"], ["TCGA.CA.6717.01", "CLCNKB"], ["TCGA.CA.6717.01", "ANGEL1"], ["TCGA.CA.6717.01", "A1CF"], ["TCGA.CA.6717.01", "ALG13"], ["TCGA.CA.6717.01", "KLHL29"], ["TCGA.CA.6717.01", "NLRP5"], ["TCGA.CA.6717.01", "CLEC2D"], ["TCGA.CA.6717.01", "UGGT1"], ["TCGA.CA.6717.01", "NPAT"], ["TCGA.CA.6717.01", "TNFSF4"], ["TCGA.CA.6717.01", "SLC12A4"], ["TCGA.CA.6717.01", "CD200R1"], ["TCGA.CA.6717.01", "CDK16"], ["TCGA.CA.6717.01", "LGI4"], ["TCGA.CA.6717.01", "FAM208A"], ["TCGA.CA.6717.01", "GLRA2"], ["TCGA.CA.6717.01", "ALCAM"], ["TCGA.CA.6717.01", "ZSCAN29"], ["TCGA.CA.6717.01", "ZSCAN22"], ["TCGA.CA.6717.01", "DZANK1"], ["TCGA.CA.6717.01", "SPECC1L"], ["TCGA.CA.6717.01", "ASPM"], ["TCGA.CA.6717.01", "MAN1B1"], ["TCGA.CA.6717.01", "SLC16A7"], ["TCGA.CA.6717.01", "CNTNAP2"], ["TCGA.CA.6717.01", "ZEB2"], ["TCGA.CA.6717.01", "SERPINA10"], ["TCGA.CA.6717.01", "PGBD1"], ["TCGA.CA.6717.01", "NEXN"], ["TCGA.CA.6717.01", "CD96"], ["TCGA.CA.6717.01", "RNF13"], ["TCGA.CA.6717.01", "THUMPD3"], ["TCGA.CA.6717.01", "MBL2"], ["TCGA.CA.6717.01", "MIER1"], ["TCGA.CA.6717.01", "CAPN14"], ["TCGA.CA.6717.01", "CAPN11"], ["TCGA.CA.6717.01", "PCDHA2"], ["TCGA.CA.6717.01", "KLHL32"], ["TCGA.CA.6717.01", "PEX1"], ["TCGA.CA.6717.01", "PTPRD"], ["TCGA.CA.6717.01", "SNX27"], ["TCGA.CA.6717.01", "PANX1"], ["TCGA.CA.6717.01", "PEX12"], ["TCGA.CA.6717.01", "SUB1"], ["TCGA.CA.6717.01", "PDE12"], ["TCGA.CA.6717.01", "APOBEC1"], ["TCGA.CA.6717.01", "ZC3HAV1"], ["TCGA.CA.6717.01", "ZFP3"], ["TCGA.CA.6717.01", "PTPRN2"], ["TCGA.CA.6717.01", "SORL1"], ["TCGA.CA.6717.01", "CDKN2AIP"], ["TCGA.CA.6717.01", "RAI14"], ["TCGA.CA.6717.01", "BEST1"], ["TCGA.CA.6717.01", "TTC7B"], ["TCGA.CA.6717.01", "CNTN3"], ["TCGA.CA.6717.01", "CNTN4"], ["TCGA.CA.6717.01", "CNTN5"], ["TCGA.CA.6717.01", "CDKL5"], ["TCGA.CA.6717.01", "HTR3D"], ["TCGA.CA.6717.01", "HTR3C"], ["TCGA.CA.6717.01", "ZNF335"], ["TCGA.CA.6717.01", "AZGP1"], ["TCGA.CA.6717.01", "TNFSF8"], ["TCGA.CA.6717.01", "ADD3"], ["TCGA.CA.6717.01", "IKBIP"], ["TCGA.CA.6717.01", "PUS10"], ["TCGA.CA.6717.01", "CAPN7"], ["TCGA.CA.6717.01", "CAPN6"], ["TCGA.CA.6717.01", "SLC26A7"], ["TCGA.CA.6717.01", "NIN"], "NR1D2", "RAB3GAP1", "PLA2G7", "ACSS3", "ARHGAP44", "SUPV3L1", "CYTH1", "CLEC4E", "FERMT2", "FGF7", "SRSF11", "DCTN3", "USP30", "MAPKAPK2", "SNRNP40", "OR2G3", "INO80", "SUCNR1", "ACADSB", "SHOC2", "PTRH2", "POLR3F", "POLR3C", "NOX4", "CNKSR2", "OR6S1", "OR7G1", "OR3A3", "PPP3R1", "QSOX1", "ACSM1", "EXOSC7", "DDX4", "AP1S2", "AP4E1", "AFG3L2", "PTBP3", "GPNMB", "GSTO2", "RALA", "KLRC4-KLRK1", "UCHL1", "TESPA1", "AP3S1", "NR2F2", "CEP41", "FNBP1L", "MPP5", "MRPL22", "TTC5", "CDK17", "ICOS", "TAF1A", "CCNE1", "MOGAT1", "OR1L6", "CACNG2", "MTHFD1L", "YWHAZ", "YWHAG", "FABP3", "FABP9", "CCL1", "OR2B3", "RAB14", "OR4K14", "OR52A5", "KNG1", "RXFP1", "SEPT7", "FGF20", "TIMM21", "ANGPT2", "SHC3", "NDUFS5", "COPS4", "DDX42", "GPR161", "OR1F1", "PPP1R42", "CRLF1", "LDHAL6A", "CXCL16", "RABGGTB", "TLR4", "CNOT2", "TAGLN2", "FAM217B", "ARFIP1", "FKBP7", "SYT11", "MYB", "HNRNPCL1", "HSPA9", "ADD2", "TAB3", "USP1", "DDC", "TEX12", "NUS1", "ATP6V0A2", "KPNA1", "ABHD5", "TWF1", "TFCP2", "EIF2S3", "PBX3", "WDR5B", "MBTPS2", "SAP30L", "SCGN", "TERF2IP", "SEC23IP", "MAP1LC3A", "GNPDA1", "PPOX", "RSL24D1", "METAP1", "RSRC1", "SYNCRIP", "BROX", "NRIP3", "MTIF3", "ERMAP", "NXF1", "MPP2", "THSD1", "PTCD3", "VRK1", "PGAP1", "MOCS3", "WDR36", "LTV1", "SERPINA5", "YPEL5", "MASP1", "IFIT1B", "CLDN18", "EXD1", "ZNF682", "ZNF28", "ZNF660", "RAD54B", "RAD54L", "ABCB7", "ZNF625", "ZNF627", "VNN2", "ZNF675", "DEFB114", "DEFB115", "ZNF737", "ZNF732", "ZNF397", "GALNT5", "ZFC3H1", "ZNF483", "ZNF568", "ZNF566", "ACOT13", "TUFT1", "FST", "NAA15", "ZNF184", "ZNF461", "ZNF350", "ACMSD", "FAR1", "ZNF577", "ZNF221", "ZNF721", "ETFDH", "NAT8", "SKAP2", "ZEB2", "SLC4A2", "TRMT61B", "ACSS2", "MTIF2", "ZBTB32", "RPP40", "WDR3", "IL34", "FUS", "UBQLNL", "USP6NL", "CTTN", "OR13C9", "PIP5K1A", "EFCAB11", "ABCD4", "MPPED1", "SERTAD4", "PANK3", "MAB21L1", "NFKBIZ", "KBTBD7", "OSCAR", "CEP63", "SVIP", "CFL1", "OXCT2", "IQCF1", "LGALS9B", "FUT4", "RPLP1", "LACTB2", "TRHR", "CALCOCO1", "YBX1", "TFPI", "KBTBD8", "DNMT1", "HSPA13", "CLIC4", "RPL31", "SNRPB2", "C4BPB", "EIF3E", "SMG7", "ATP6V1C1", "KCTD2", "CSTF2", "TRAF7", "ADRM1", "RPL30", "CORO1C", "EPAS1", "TREM2", "OR1Q1", "C1orf35", "CLTA", "LSM14A", "EEF2", "KCNAB3", "ZYX", "UBN1", "ACSL5", "CH25H", "IDI2", "SPIN1", "HIST1H4J", "CCDC124", "ODC1", "S100A2", "TBC1D20", ["TCGA.CK.5915.01", "Classical antibody-mediated complement activation"], ["TCGA.CK.5915.01", "Creation of C4 and C2 activators"], "IL20", "LHPP", "SERPINB2", "ELP2", "TCTEX1D2", "ANAPC5", "OR10S1", "DHX40", "NFYC", "CCNI2", "PPP6C", "USP14", "MOB1B", "PTH2R", "DENND1A", "THBD", "IL1B", "BUB3", "RPS24", "KIAA2013", "ERCC8", "DNAJC10", "KCTD17", "SMAD6", "IGFBP3", "ALAS2", "GABRE", "CYBB", "PDCD1", "PRNP", "UFM1", "OR1J4", "FER", "HLA-DMA", "CDC14A", "SPDEF", "GYG2", "NDUFB7", "HIC1", "ZFAND4", "TAS2R10", "ACTR3", "STX5", "MCU", "STRADA", "MED4", "EIF4G2", "HAUS6", "HECTD1", "RAB3A", "TAS2R19", "KCNJ9", "MED9", "IFNAR1", "TRIM17", "PRMT5", "PDE6B", "CD46", "EXOC5", "RNF113A", "CNOT7", "TACR3", "HIF1AN", "RNF181", "OR7D2", "SPATA2L", "ARMC8", "PAPOLA", "CNIH2", "RORB", "NDUFA5", "ELOVL7", "NAP1L4", "INSIG1", "DBF4B", "MYO1D", "DNER", "POP7", "NUDT13", "CIDEC", "ALG3", "ZFP90", "SLC25A27", "SCMH1", "STAU2", "ZNF253", "CD320", "RPL12", "CBX7", "RAD51B", "EDN1", "ICMT", "ALDH18A1", "WDFY1", "OR9A2", "DNAJB4", "COTL1", "CENPO", "KCTD15", "TIMM8A", "MDFIC", "ATP1B1", "SNX5", "SOX17", "RRAGC", "SNCA", "NT5C1B-RDH14", "PRPF8", "RBMS3", "CSF3", "SNAPIN", "DUSP9", "BTBD1", "POMT1", "OSBP2", "SSB", "CCDC6", "DCAF10", "B3GNT5", "GSTM5", "NHEJ1", "FKBP3", "PIM2", "MIOX", "ATG5", "NARS", "TSSC4", "AIMP2", "BRD2", "CYB5R4", "ESAM", "ZMYND19", "ALG10", "ORMDL3", "ZNF613", "ASCC1", "MAN1B1", "ZNF79", "USP18", "EXOC2", "KATNAL2", "PABPC5", "APH1B", "ACSM2B", "TNF", "BABAM1", "POLD2", "ZNF621", "EDAR", "SLU7", "DRD3", "RFC2", "H2AFY", "OCM2", "RNF7", "ADAMTSL5", "UBE2V2", "OR5P2", "MZT2B", ["TCGA.CM.5348.01", "Ethanol oxidation"], "NSA2", "TK1", "PACSIN2", "RAB35", "TBCA", "FAM8A1", "TRAF3IP3", "SPCS3", "C3orf58", "ADSS", "HPCA", "HNRNPA1", "MRPL14", "RPS25", "DKC1", "ARHGAP26", "HS3ST3A1", "RNF19B", "SMYD2", "WIF1", "RGR", "FGF16", "ATP6V0B", "CGA", "PRKAR1B", "MTRR", "THEM4", "FAF2", "IFI35", "OSBPL10", "UBE2E2", "INTS5", "PRPS2", "AFTPH", "ATG4A", "B3GNT9", "URB1", "EIF1", "BIRC2", "HIST1H2BD", "OGN", "HCRTR2", "PTTG1", "SLBP", "ATG10", "EEFSEC", "PGAM1", "TRIAP1", "SACM1L", "IFNA1", "FPR3", "U2AF1", "PPP2R5B", "MAG", "POLR2C", "GPN2", "CASP10", "RPN2", "RASGRP4", "CCNO", "GLRA4", "CCNDBP1", "LRRC40", "ENDOG", "TWF2", "PDRG1", "ISCU", "APEX2", "ZNF436", "SNX27", "LMO2", "C12orf10", "SET", "HS3ST4", "KDM5C", "CHRNA2", "SST", "TMEFF2", "SCPEP1", "SELPLG", "GPAA1", "SPRY3", "PDCD4", "GINS3", "ABCD3", "ISY1", "TRAF1", "PCGF6", "HPDL", "ZNF211", "PCYOX1", "HRAS", "GLB1L", "AAAS", "LPCAT2", "SPATA13", "RGS1", "STAM2", "TUBB2A", "POLR3K", "TP53AIP1", "LMNB1", "MRPS28", "PAFAH1B1", "UBC", "NDFIP1", "ANGEL2", "GABRG2", "FAM199X", "ZC3H15", "MINPP1", "OR4C12", "RPL32", "OR13C8", "SIRT2", "NRTN", "CXXC1", "ELAVL2", "INHBE", "TIMM22", "TSSK4", "CETN3", "OR2T3", "RPS11", "LAMTOR1", "TAF11", "SYAP1", "SSH3", "PON1", "UPRT", "ASRGL1", "CDC42EP4", "ELAC2", "SRR", "TIMM17B", "UCP2", "ZNF140", "GMDS", "ATG16L2", "EIF6", "CD300LB", "PACRG", ["TCGA.CM.6164.01", "RA biosynthesis pathway"], "CANX", "TAF12", "TDP1", "BCAS2", "RAB3D", "KDM1A", "FOXC2", "ZNF334", "GLIPR1", "CELA2B", "SEC24C", "AMHR2", "FBXO22", "ZMAT3", "MRPL39", "SUPT4H1", "P2RY10", "RRS1", ["TCGA.CM.6170.01", "Erythrocytes take up carbon dioxide and release oxygen"], ["TCGA.CM.6170.01", "O2/CO2 exchange in erythrocytes"], "SNRNP48", "ADA", "XRCC6", "PLRG1", "CCL24", "CCL26", "RASGEF1A", "AHCY", "RARRES2", "DEFB125", "NRG2", "STAP1", "RPL7A", "CSRP2", "NCSTN", "SAC3D1", "IFITM1", "CNOT4", "AP1G1", "HSP90AA1", "ATG7", "GPR37", "SFTPA1", "FZR1", "ENO3", "DCXR", "SLAIN2", "PCBD1", "POLR2M", "DHX35", "GOLPH3", "NOL10", "TUBE1", "IL32", "ST6GALNAC5", "TPI1", "MRPS16", "DAPK3", "SAP30BP", "CALCRL", "SMARCB1", "TPH1", "NT5M", "NUDT16L1", "HSPB11", "KEAP1", "TARS", "DNAJC5", "FCGR2B", "CKM", "SUPT3H", "UBE2E1", "ADORA2A", "STX1A", "CLDN11", "CLDN14", "FOXN2", "NDUFA7", "HAPLN1", "FBRS", "HOOK1", "PHAX", "ZCCHC17", "EXOSC8", "LCOR", "MPP6", "UMOD", "ZNF23", ["TCGA.CM.6677.01", "Purine ribonucleoside monophosphate biosynthesis"], "CHM", "MSRB3", "NXT2", "DCUN1D2", "ZNF12", "ZNF699", ["TCGA.CM.6679.01", "RA biosynthesis pathway"], "LCK", "BCAP31", "NUDCD2", "RRAGD", "PAG1", "CSF2", "CHRDL1", "ADIPOQ", "RPL35", "NMBR", "PRR5L", "CDC42EP3", "ETNK1", "ZNF333", "DPH2", "NAP1L1", "SCML2", "TFAM", "PHPT1", "LDHC", "MARCO", "DDX5", "FGD4", "FBLN1", "ERP29", "HNRNPD", "INO80D", "CLDN17", "UBXN2A", "ZNF493", ["TCGA.D5.6534.01", "TNFs bind their physiological receptors"], "PIP", "CDC14B", "HNRNPA0", "UBE2R2", "PHLDA3", "EIF4EBP2", "TNFSF9", "FBXL12", "F7", "MCFD2", "KRT3", "PLOD3", "RFFL", "CCR4", "THOC7", "RABIF", "LFNG", ["TCGA.D5.6539.01", "FAT4"], ["TCGA.D5.6539.01", "ZNF423"], ["TCGA.D5.6539.01", "NEMF"], ["TCGA.D5.6539.01", "MCMDC2"], ["TCGA.D5.6539.01", "TRPC3"], ["TCGA.D5.6539.01", "PANK2"], "SYT8", "NDEL1", "KLHL12", "ARCN1", "PDP1", "DYNLT1", "HLA-DQA2", "UBE2J2", "CUZD1", "DCLK3", "PTGIR", "AHR", "TUBB", "WARS", "UBB", "PTCRA", "THTPA", "AGPAT5", "BAMBI", "PXN", "LTBR", "CENPQ", "KANSL3", "SLC10A1", "FBXL15", "CAP2", "PFDN1", "SNAP23", "CRB3", "POLA1", "LDHD", "LDHA", "GSPT2", "NRF1", "PTP4A3", "AMY2A", "DNAL4", "ASB1", "LDB1", "POMGNT1", "DMGDH", "IZUMO1", "G6PC2", "ZKSCAN4", "RPUSD2", "LMO3", "RABEP2", "DDX28", "SYTL1", "DEFB121", "PCBP4", "SHISA9", "SEPT2", "GZMA", "SFTA3", "KLHL2", "FAM98B", "FBXL16", "ASF1A", "SCD", "CALR", "HDAC3", "H2AFZ", "HS3ST5", "RORA", "BATF2", "GH1", "CSNK2A2", "PWP2", "CACNG6", "EFNA4", "HIST1H2AH", "RFXAP", "FBXO44", "RARS2", "NDUFV2", "ATRIP", "ACER1", "TGIF2", "ANKRD13A", "ANKRA2", "RBM3", "GJB2", "RCAN2", "DEFB116", "CHMP5", "PPIL1", "WNT2", "CLINT1", "H6PD", "UBA5", "KLC3", "EGR3", "FADD", "TRIM14", "FCHO1", "ZNRF1", "TRIM41", "RND1", "AURKB", "TRIM63", "TRIM21", "MYLIP", "JUN", "CHAD", "PHB", "CDK18", "TDRKH", "FBXO9", "CNN3", "BCL7C", "ASB13", "CBLB", "LMO4", "SNRPA", "RAB11B", "PPIL3", "OPN5", "CYR61", "ELOVL4", "ATP6V1E2", "DCAF8", "ASL", "SPTLC3", "ATAD3B", "PCGF5", "USP51", "GPD2", "BCS1L", "CYP39A1", "SLC11A1", "PHF19", "DPH5", "MRPS6", "SOSTDC1", "TMED4", "SEC22A", "RIOK3", "B3GNT3", "NXT1", "PAAF1", "ADAM30", "RBMS2", "ZNF383", "TNFAIP8L1", "ZNF565", "IGF2BP2", "ZNF713", "SEPT14", "PIGV", "PARS2", "GRAMD4", "CYBA", "CHRNB1", "GRASP", "IGF2BP3", "U2AF1L4", "RAPGEF5", "RPS6", "SDS", "YWHAE", "PGK2", "OTUB2", "DKK4", "ALAS1", "PTGDR", "TANK", "MST1", "PUM1", "ADRA1B", "ANGPTL3", "GPR17", "TAS2R42", "GIT1", "RCN1", "HOXB4", "NPY", "MYL3", "TNNT3", "ANGPT4", "CRLF2", "NSDHL", "OR8D4", "FCGR2A", "FRS3", "VDAC2", "MRPL32", "MRPS24", "DAP3", "TFDP3", "SLC25A24", "BIRC8", "CLEC12A", "RAB43", "CCDC97", "GNE", "ZNF782", "SPTSSB", "TRNT1", "ZNF75A", "RBPMS", "RFNG", "TXN", "TBL2", "GNAT2", "BTK", "KCNA10", "TRIM50", "KRT18", "TMPRSS11B", "SERPINC1", "PRDX2", "ITGB3BP", "CLDN2", "OTUD5", "MEAF6", "OR9I1", "FBP2", "HSPA8", "HAAO", "ZNF479", "TMPRSS6", "MCEE", "CD48", "ALG11", "TIMP2", "SNF8", "DTX3L", "RNF217", "NDRG1", "CS", "UBLCP1", "HIST1H2BF", "RPUSD4", "NXF5", ["TCGA.DM.A1D6.01", "Classical antibody-mediated complement activation"], "NAA20", "PJA1", "COPS5", "RRM1", "ZNF547", "HARS2", ["TCGA.DM.A1D9.01", "RA biosynthesis pathway"], "RAP1GAP", "HMOX1", "PORCN", "CDC26", "TNFRSF4", "TLX2", "SAMD12", "PRDM7", "ZNF707", ["TCGA.DM.A1DB.01", "Classical antibody-mediated complement activation"], "VPS26A", "HBG1", "IL17RB", "HOOK2", ["TCGA.DM.A282.01", "Classical antibody-mediated complement activation"], "GATAD1", "TPRKB", ["TCGA.DM.A28E.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A28E.01", "Creation of C4 and C2 activators"], ["TCGA.DM.A28E.01", "RA biosynthesis pathway"], ["TCGA.DM.A28E.01", "Glucuronidation"], ["TCGA.DM.A28E.01", "Heme degradation"], ["TCGA.DM.A28E.01", "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"], "SEC61A2", "MED6", "SERPINA10", "ATP6V1G2", "HTR3E", "CPLX4", ["TCGA.DM.A28G.01", "Classical antibody-mediated complement activation"], "FARSB", ["TCGA.DM.A28H.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A28H.01", "Creation of C4 and C2 activators"], "OR5P3", ["TCGA.DM.A28K.01", "Classical antibody-mediated complement activation"], ["TCGA.DM.A28K.01", "Creation of C4 and C2 activators"], "UBA3", "SUFU", "ZFPL1", "CERS3", "GSK3A", "PIP5K1B", "HNRNPF", "ATF1", "UBE2U", "MED28", "DEFB124", "ZNF799", "CSNK1G2", "CER1", "NR1D1", "BHMT", "PDHA1", "CTSE", "CTSS", "AEBP2", "SNAPC1", "NEGR1", "PRSS8", "CAMKMT", "POLDIP3", "WDR75", "PSMA2", "SESN1", "GOPC", "MMP20", "RTN4R", "BUB1B", "RPL27A", "BLZF1", "BYSL", "PTPN21", "SAP18", "OR4N5", "PPP2R5C", "RPS13", "IFT27", "BRCC3", "TNFRSF1A", "TBL1X", "GRB7", "POLR2B", "CEP135", "PPM1F", "SEPT11", "UBE2E3", "CSK", "CEACAM6", "PPCS", "PBLD", "PCBD2", "HEXA", "PRPF38B", "STK35", "HP1BP3", "ZDHHC9", "DRG2", "SLC25A14", "VGLL1", "NFKB1", "UBE3D", "PTN", "NENF", "ARHGDIA", "TOM1", "GLS", "HM13", "DHX33", "ALG9", "PIGN", "MED26", "LILRA2", "OCLN", ["TCGA.F4.6805.01", "Ethanol oxidation"], "TFAP4", "TTC26", "YWHAH", "ARX", "ZNF700", "PIPOX", "SDCCAG8", "GLE1", "STX2", "HSPBP1", "ADRA2C", "CTSH", "LY96", "RPS27", "GNA13", "PPP1R3C", "PSMC4", "CAPN13", "OASL", "CRTAP", "CHMP7", "SIRPG", "WNT7B", "ENTPD3", "RNF122", "MFNG", "INPP5K", "WNT9B", "GRPEL1", "ASB8", "SRP14", "ST13", "RANBP1", "BHLHE40", "RPL23", "POLR2E", "LPIN2", "MTX2", "AKR1B1", "STBD1", "VPS39", "GLUL", "NR2C2AP", "GPR22", "CDK5RAP3", "LHX9", "ZNF792", "ZNF740", "NDUFA4L2", "PGRMC2", "NCR3", "C17orf80", "MESP2", "GPS2", "GTF3C4", "GRPEL2", "SRI", "ALYREF", "CD1D", "CDC42EP5", "EIF1AX", "PTDSS2", "AUH", "ASMT", "SCRT2", "ZNF254", "LPCAT3", "BEX1", "LMAN1L", "PLCD4", "HSD11B1", "PSMB4", "HNRNPM", "PLIN1", "SYF2", "LUM", "FUT6", "MGAT2", "PTPN6", "RAB2A", "B3GALT5", "BSG", "PTGFR", "TGFBI", "MFAP2", "CCL2", "MDH1", "CCNT2", "ORC6", "RPS4X", "VASP", "HBA1", "MGAT5", "AAMP", "KHDRBS3", "BOLA1", "PERP", "STOML2", "CENPH", "CAMK1", "HAO2", ["TCGA.G4.6307.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6307.01", "Creation of C4 and C2 activators"], "CNR2", "MPHOSPH6", "PLA2G16", "PARN", "RPA3", "TIGIT", "TM9SF4", "ARIH1", "CALML3", "CHRM4", "ICAM4", "UBE2W", "SULT1A1", "GNL2", "PRL", "H2BFWT", "RBBP4", "CLDN1", "CCK", "SPA17", "CCND1", "PPP1R17", "PHYH", "ZNF696", "NARF", "ZNF570", "P2RX4", "ERC1", "ZNF92", "RPA2", "EIF4A3", "ECI2", "ZNF662", "SLC33A1", "TROVE2", "EIF4E1B", "TRIM32", "FAAH2", "INTS3", "EIF2B1", "CFP", "RNF114", "TAF7", "DEFB112", "PIAS4", "NT5E", "PHKG2", "HIST3H3", "NDUFS7", "HSP90AB1", "TFF3", "SPCS2", "RAB3B", "ZNF205", "EXOG", "ASCL1", "TFAP2E", "DDX49", "EFCAB7", "NUDT5", "SERPINE2", "PNPO", ["TCGA.G4.6323.01", "Classical antibody-mediated complement activation"], ["TCGA.G4.6323.01", "Creation of C4 and C2 activators"], "CRYM", "CKS1B", "SHMT2", "P2RY14", "ARG2", "DNAJB12", "CHMP2B", "NDUFA12", "CPSF7", "RGL1", "TALDO1", "RSPO1", "XPOT", "PPP1R1A", "PIP5KL1", "ZBTB12", "FOSL1", "RAMP1", "RNF113B", "LAT", "NDUFA3", "DEFB132", "DPH1", "P2RX5", "SPG7", "FBXL14", "RPL13", "PDX1", "GRK1", "SNAPC3", "PSMD12", "NFKBIB", "TSR1", "LRRC14", "MRPL12", "SCT", "LHFPL2", "MAT2A", "GRK7", "FCGR1B", "TIPRL", "SARNP", "CLP1", "ZWINT", "PCYT1A", "HIST3H2A", "TESK1", "TKT", "VPS35", "GATM", "CTDSP1", "RPL39", "TTC8", "PDPN", "TSSK3", "OR13C4", "KCNMB4", "DUSP10", "CHRNE", "CUL4B", "NDRG2", "RPL10", "RABEPK", "GZMM", "PPP2R1B", "TSHB", "PLCB2", "ARHGAP12", "GDF1", "RPS9", "EIF4H", "PRDX6", "SS18", "DAD1", "HIST1H3H", "B3GNT7", "CHORDC1", "GNL3L", "FAM122B", "ALG2", "P2RX2", "BTG1", "COX6A2", "ZFP37", "MIER1", "DCTN4", "TOR1A", "TRMT11", ["TCGA.G4.6626.01", "Classical antibody-mediated complement activation"], "HOXB13", "FKBP1A", "INSL5", "SHARPIN", "CAPZA3", "OR10Z1", "UBE2N", "POLR3G", "CYP2R1", "DNAJB14", "ACAA2", "IL12A", "IRF2BP1", "TOMM6", "PRC1", "TDRD1", "VEGFB", "CHPT1", "YME1L1", "IFNA4", "XPA", "PSMC6", "RXFP4", "IFNA7", "AKAP5", "DNAJC7", "DDX19B", "UBXN1", "INSIG2", "ADORA2B", "P4HA1", "DUSP1", "IL19", "MRPL44", "MYBPC1", "CD1C", "RAB4A", "SPDYE3", "MRPL18", "AGGF1", "MRPL43", "CPLX3", "NOB1", "KCNE2", "DEFB129", "ST8SIA5", "LPGAT1", "LMO1", "ABCB10"], "total_weight": 12374.154627125443, "total_sum_of_weights": 986515.0263356693}